PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Caucheteux, SM; Kanellopoulos-Langevin, C; Ojcius, DM				Caucheteux, SM; Kanellopoulos-Langevin, C; Ojcius, DM			At the innate frontiers between mother and fetus: Linking abortion with complement activation	IMMUNITY			English	Article							TRYPTOPHAN CATABOLISM; CUTTING EDGE; NKT CELLS; PREGNANCY; PLACENTA	The intricate mechanisms regulating fetomaternal interactions are still largely uncharacterized. Recent papers have revealed a major role for the innate immune system during abortion. Different experimental conditions-deletion of a complement regulator, injection of anti-phospholipid antibodies into mothers, or allorecognition of fetuses in the presence of an IDO inhibitor-all lead to complement activation, inflammation, and fetal loss. These observations also raise new questions on the relationship between the adaptive and innate systems during pregnancy.	Inst Jacques Monod, Lab Immune Regulat & Dev, CNRS, UMR 7592, F-75251 Paris 5, France; Univ Paris 06, F-75251 Paris, France; Univ Paris 07, F-75251 Paris 5, France; Univ Paris 07, Inst Pasteur, INSERM, U277,Unite Biol Mol Gene, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Kanellopoulos-Langevin, C (corresponding author), Inst Jacques Monod, Lab Immune Regulat & Dev, CNRS, UMR 7592, 2 Pl Jussieu, F-75251 Paris 5, France.		Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495				Ait-Azzouzene D, 1998, J IMMUNOL, V161, P2677; Bonney EA, 1998, NAT MED, V4, P1128, DOI 10.1038/2624; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P13741, DOI 10.1073/pnas.162491699; Dang Y, 2001, J IMMUNOL, V166, P3641, DOI 10.4049/jimmunol.166.6.3641; Hobbs NK, 2002, CELL, V110, P43, DOI 10.1016/S0092-8674(02)00806-1; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Ito K, 2000, P NATL ACAD SCI USA, V97, P740, DOI 10.1073/pnas.97.2.740; Jiang SP, 1998, J IMMUNOL, V160, P3086; Medawar Peter, 1953, S SOC EXP BIOL, V44, P320; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Morgan BP, 2000, CURR BIOL, V10, pR381, DOI 10.1016/S0960-9822(00)00476-0; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Ojcius DM, 2002, FASEB J, V16, P202, DOI 10.1096/fj.01-0758com; RISK JM, 1991, HUM IMMUNOL, V30, P162, DOI 10.1016/0198-8859(91)90030-D; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yamasaki M, 2001, J IMMUNOL, V166, P7244, DOI 10.4049/jimmunol.166.12.7244	19	57	62	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2003	18	2					169	172		10.1016/S1074-7613(03)00028-1	http://dx.doi.org/10.1016/S1074-7613(03)00028-1			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594944	Bronze			2022-12-18	WOS:000181138100001
J	Trcka, J; Moroi, Y; Clynes, RA; Goldberg, SM; Bergtold, A; Perales, MA; Ma, MH; Ferrone, CR; Carroll, MC; Ravetch, JV; Houghton, AN				Trcka, J; Moroi, Y; Clynes, RA; Goldberg, SM; Bergtold, A; Perales, MA; Ma, MH; Ferrone, CR; Carroll, MC; Ravetch, JV; Houghton, AN			Redundant and alternative roles for activating Fc receptors and complement in an anti body-dependent model of autoimmune vitiligo	IMMUNITY			English	Article							REVERSE ARTHUS REACTION; TUMOR-NECROSIS-FACTOR; BROWN LOCUS PROTEIN; DEFICIENT MICE; INFLAMMATORY RESPONSES; TARGETED DISRUPTION; ULTRAVIOLET-LIGHT; IMMUNE-RESPONSE; C5A RECEPTOR; IN-VIVO	Complement and Fc receptor (FcR)-positive cells mediate effector functions of antibodies. Antibody-dependent immunity against the melanosome membrane glycoprotein gp75/tyrosinase-related protein-1 (TYRP-1) of melanocytes leads to autoimmune hypopigmentation (vitiligo) in mice. Hypopigmentation occurred in mice deficient in activating FcR containing the common gamma subunit (FcgammaR gamma(-/-)) and in mice deficient in the C3 complement component. Mice doubly deficient in both FcgammaRgamma and C3 did not develop hypopigmentation, suggesting that complement and FcgammaR formed redundant mechanisms. Following passive immunization with antibody, no further adaptive immune responses were required. Chimeric FcgammaR gamma(-/-),C3(-/-) mice reconstituted with bone marrow from either FcgammaR gamma(-/-) or C3-/- mice or adoptively transferred with FcgammaR gamma(+/-) macrophages did develop antibody-mediated hypopigmentation. Thus, either complement or macrophages expressing activating FcgammaR can independently and alternatively mediate disease in a model of autoimmune vitiligo.	Mem Sloan Kettering Canc Ctr, Swim Amer Lab, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Med & Microbiol, New York, NY 10032 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Columbia University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Rockefeller University	Houghton, AN (corresponding author), Mem Sloan Kettering Canc Ctr, Swim Amer Lab, 1275 York Ave, New York, NY 10021 USA.		Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; PERALES, MIGUEL-ANGEL/0000-0002-5910-4571	NCI NIH HHS [CA09501, CA09512, CA56821] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009501, T32CA009512, R01CA056821] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baumann U, 2000, J IMMUNOL, V164, P1065, DOI 10.4049/jimmunol.164.2.1065; Bowne WB, 1999, J EXP MED, V190, P1717, DOI 10.1084/jem.190.11.1717; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Fischer MB, 1996, J IMMUNOL, V157, P549; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Heller T, 1999, J IMMUNOL, V163, P985; HERNANDEZCASELLES T, 1993, J IMMUNOL, V151, P3999; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOCK A, 1990, J EXP MED, V172, P1609, DOI 10.1084/jem.172.6.1609; Kohl J, 1999, MOL IMMUNOL, V36, P893, DOI 10.1016/S0161-5890(99)00111-X; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; LEDER LD, 1964, KLIN WOCHENSCHR, V42, P553, DOI 10.1007/BF01486688; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Naftzger C, 1996, P NATL ACAD SCI USA, V93, P14809, DOI 10.1073/pnas.93.25.14809; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nordlund JJ, 1998, PIGMENTARY SYSTEM PH, P513; ODLING KA, 1987, IMMUNOL CELL BIOL, V65, P337, DOI 10.1038/icb.1987.38; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; SONG YH, 1994, LANCET, V344, P1049, DOI 10.1016/S0140-6736(94)91709-4; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Takechi Y, 1996, CLIN CANCER RES, V2, P1837; THOMSON TM, 1988, J INVEST DERMATOL, V90, P459, DOI 10.1111/1523-1747.ep12460906; TIGELAAR RE, 1995, J INVEST DERMATOL S, V105, P43; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; Weber LW, 1998, J CLIN INVEST, V102, P1258, DOI 10.1172/JCI4004; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	40	57	58	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					861	868		10.1016/S1074-7613(02)00327-8	http://dx.doi.org/10.1016/S1074-7613(02)00327-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121667	Bronze			2022-12-18	WOS:000176534000011
J	Ellmeier, W; Sunshine, MJ; Maschek, R; Littman, DR				Ellmeier, W; Sunshine, MJ; Maschek, R; Littman, DR			Combined deletion of CD8 locus cis-regulatory elements affects initiation but not maintenance of CD8 expression	IMMUNITY			English	Review							RECEPTOR-ALPHA-BETA; T-CELLS; POSITIVE SELECTION; GENE-EXPRESSION; DEVELOPING THYMOCYTES; STOCHASTIC MECHANISM; LINEAGE COMMITMENT; SURFACE EXPRESSION; TRANSGENIC MICE; GLOBIN LOCUS	Developmental stage-, subset-, and lineage-specific CD8 enhancers have been identified recently by transgenic reporter analyses. Enhancer E8(II) (CIV-4,5) is active in both immature double-positive thymocytes (DP) and mature CD8 single-positive (SP) thymocytes and T cells, whereas E8(I) (CIII-1,2) directs expression only in mature cells. In mice lacking either E8(I) (CIII-1,2) or E8(II) (CIV-4,5), there was no effect on CD8 expression in DP thymocytes. However, deletion of both enhancers resulted in variegated expression of CD8, with appearance of CD4(+)CD8 SP thymocytes expressing surface markers characteristic of DIP thymocytes. Consequently, fewer mature CD8(+) T cells developed from the reduced pool of DIP cells. These results suggest that the initiation of CD8 expression is mediated by cis-regulatory elements that are distinct from any that may be involved in maintenance of expression.	Univ Vienna, Inst Immunol, A-1235 Vienna, Austria; Univ Vienna, Inst Immunol, A-1235 Vienna, Austria; Univ Vienna, Competence Ctr Biomol Therapeut, A-1235 Vienna, Austria; NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med,Mol Pathogenesis Program, New York, NY 10016 USA	University of Vienna; University of Vienna; University of Vienna; Howard Hughes Medical Institute; New York University	Ellmeier, W (corresponding author), Univ Vienna, Inst Immunol, Brunner Str 59, A-1235 Vienna, Austria.	wilfried.ellmeier@univie.ac.at		Sunshine, Mary Jean/0000-0002-2188-7881; Ellmeier, Wilfried/0000-0001-8192-8481				Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Donda A, 1996, EUR J IMMUNOL, V26, P493, DOI 10.1002/eji.1830260232; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Higgs DR, 1998, CELL, V95, P299, DOI 10.1016/S0092-8674(00)81761-4; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; von Boehmer H, 2000, CURR BIOL, V10, pR642, DOI 10.1016/S0960-9822(00)00665-5; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Zhang XL, 1998, J IMMUNOL, V161, P2254; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	40	57	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2002	16	5					623	634		10.1016/S1074-7613(02)00309-6	http://dx.doi.org/10.1016/S1074-7613(02)00309-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049715	Bronze			2022-12-18	WOS:000175820400002
J	Grewal, IS; Foellmer, HG; Grewal, KD; Wang, H; Lee, WP; Tumas, D; Janeway, CA; Flavell, RA				Grewal, IS; Foellmer, HG; Grewal, KD; Wang, H; Lee, WP; Tumas, D; Janeway, CA; Flavell, RA			CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SELECTIN-DEFICIENT MICE; CENTRAL-NERVOUS-SYSTEM; MONOCLONAL-ANTIBODY MEL-14; T-CELLS; LEUKOCYTE RECRUITMENT; LYMPHOCYTE MIGRATION; P-SELECTIN; IN-VIVO; INFLAMMATION	Adhesion molecules are believed to facilitate infiltration of leukocytes into the CNS of mice with experimental allergic encephalomyelitis (EAE). The role of the adhesion molecule cD62L (L-selectin) in the immunopathology of EAE is not known. To study this, we crossed CD62L-deficient mice with myelin basic protein-specific TCR (MBP-TCR) transgenic mice. CD62L-deficient MBP-TCR transgenic mice failed to develop antigen-induced EAE, and, despite the presence of leukocyte infiltration, damage to myelin in the CNS was not seen. EAE could, however, be induced in CD62L-deficient mice upon adoptive transfer of wildtype macrophages. Our results suggest that CD62L is not required for activation of autoimmune CD4 T cells but is important for the final destructive function of effector cells in the CNS and support a novel mechanism whereby CD62L expressed on effector cells is important in mediating myelin damage.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Genentech Inc, Dept Immunol, S San Francisco, CA 94080 USA	Yale University; Howard Hughes Medical Institute; Yale University; Roche Holding; Genentech	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.			Grewal, Iqbal S/0000-0002-4775-055X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036529] Funding Source: NIH RePORTER; NIAID NIH HHS [1 P01 AI36529] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Archelos JJ, 1998, J NEUROL SCI, V159, P127, DOI 10.1016/S0022-510X(98)00154-3; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; DAWSON J, 1992, EUR J IMMUNOL, V22, P1647, DOI 10.1002/eji.1830220646; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; HUANG K, 1991, J CLIN INVEST, V88, P1778, DOI 10.1172/JCI115498; HUANG K, 1994, J NEUROIMMUNOL, V53, P133, DOI 10.1016/0165-5728(94)90023-X; JOHNSON RC, 1995, BLOOD, V86, P1106; KUTTNER BJ, 1979, J IMMUNOL, V122, P1666; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LEPAULT F, 1994, EUR J IMMUNOL, V24, P3106, DOI 10.1002/eji.1830241229; LEPAULT F, 1995, EUR J IMMUNOL, V25, P1502, DOI 10.1002/eji.1830250605; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; MARTIN R, 1995, CRIT REV CL LAB SCI, V32, P121, DOI 10.3109/10408369509084683; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; PIZCUETA P, 1994, AM J PATHOL, V145, P461; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; ROSEN SD, 1993, RES IMMUNOL, V144, P699, DOI 10.1016/S0923-2494(93)80054-3; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Xu JC, 1996, J EXP MED, V183, P589, DOI 10.1084/jem.183.2.589; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494	34	57	60	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2001	14	3					291	302		10.1016/S1074-7613(01)00110-8	http://dx.doi.org/10.1016/S1074-7613(01)00110-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290338	Bronze			2022-12-18	WOS:000167959500008
J	Clausen, BE; Waldburger, JM; Schwenk, F; Barras, E; Mach, B; Rajewsky, K; Forster, I; Reith, W				Clausen, BE; Waldburger, JM; Schwenk, F; Barras, E; Mach, B; Rajewsky, K; Forster, I; Reith, W			Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice	IMMUNITY			English	Article							BARE-LYMPHOCYTE-SYNDROME; SEVERE COMBINED IMMUNODEFICIENCY; COLONY-STIMULATING FACTOR; MOUSE BONE-MARROW; GENE-EXPRESSION; POSITIVE SELECTION; COOPERATIVE BINDING; INVARIANT CHAIN; DEFICIENT MICE; T-CELLS	Patients with major histocompatibility complex class II (MHC-II) deficiency are known to carry mutations in either the RFX complex or the trans-activator CIITA. While the pivotal role of CIITA for MHC-II gene transcription is supported by the essential absence of MHC-II molecules in CIITA-deficient mice, we demonstrate here that RFX5(-/-) mice retain expression of MHC-II in thymic medulla, mature dendritic cells, and activated B cells. Nevertheless, RFX5(-/-) mice develop a severe immunodeficiency due to the lack of MHC-II in thymic cortex, failure of positive selection of CD4(+) T cells, and absence of MHC-II on resting B cells and resident or IFN gamma-activated macrophages. This differential requirement for CIITA and RFX5 in subsets of antigen-presenting cells may be specific for the mouse; it may, however, also exist in humans without having been noticed so far.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Geneva, Sch Med, Louis Jeantet Lab Mol Genet, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland	University of Cologne; University of Geneva	Forster, I (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.		CLAUSEN, Björn Erik/A-8229-2010; Förster, Irmgard/P-8545-2016	CLAUSEN, Björn Erik/0000-0002-2484-7842; Förster, Irmgard/0000-0002-7644-5642; Rajewsky, Klaus/0000-0002-6633-6370				BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; CARDELL S, 1994, ADV IMMUNOL, V55, P423; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Coffman R L, 1982, Immunol Rev, V69, P5; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; DEPREVAL C, 1988, NEW ENGL J MED, V318, P1295, DOI 10.1056/NEJM198805193182003; Douhan J, 1997, J EXP MED, V185, P1885, DOI 10.1084/jem.185.11.1885; Douhan J, 1996, J EXP MED, V183, P1063, DOI 10.1084/jem.183.3.1063; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; HADAM MR, 1986, PROGR IMMUNODEFICIEN, V2, P89; HAUBER I, 1995, J EXP MED, V181, P1411, DOI 10.1084/jem.181.4.1411; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JANEWAY CA, 1984, IMMUNOL TODAY, V5, P99, DOI 10.1016/0167-5699(84)90043-4; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KERN I, 1995, INT IMMUNOL, V7, P1295, DOI 10.1093/intimm/7.8.1295; KLEIN C, 1993, J PEDIATR-US, V123, P921, DOI 10.1016/S0022-3476(05)80388-9; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; LEVINE F, 1984, J IMMUNOL, V132, P959; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; MANNHALTER JW, 1986, PROGR IMMUNODEFICIEN, V2, P107; MORENO CS, 1995, J IMMUNOL, V155, P4313; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; NOCERA A, 1993, HUM IMMUNOL, V38, P231, DOI 10.1016/0198-8859(93)90547-E; NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149; ONO SJ, 1991, J EXP MED, V173, P629, DOI 10.1084/jem.173.3.629; REITH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; REITH W, 1998, IN PRESS PRIMARY IMM; REUDL C, 1996, EUR J IMMUNOL, V26, P1801; RIEUXLAUCAT F, 1993, EUR J IMMUNOL, V23, P928, DOI 10.1002/eji.1830230425; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; SCHEICHER C, 1992, J IMMUNOL METHODS, V154, P253, DOI 10.1016/0022-1759(92)90199-4; SCHUURMAN HJ, 1985, HUM IMMUNOL, V13, P69, DOI 10.1016/0198-8859(85)90014-X; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SEIDL C, 1992, J IMMUNOL, V148, P1576; SHCOLL T, 1997, P NATL ACAD SCI USA, V94, P6330; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Torres RM, 1997, LAB PROTOCOLS CONDIT; VANEWIJK W, 1988, CELL, V53, P357, DOI 10.1016/0092-8674(88)90156-0; Villard J, 1997, HUM MUTAT, V10, P430; ZEGERS BJM, 1986, PROGR IMMUNODEFICIEN, V2, P97	62	57	59	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					143	155		10.1016/S1074-7613(00)80467-7	http://dx.doi.org/10.1016/S1074-7613(00)80467-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9491996	Bronze			2022-12-18	WOS:000072201800002
J	MAGGI, E; ANNUNZIATO, F; MANETTI, R; BIAGIOTTI, R; GIUDIZI, MG; RAVINA, A; ALMERIGOGNA, F; BOIANI, N; ALDERSON, M; ROMAGNANI, S				MAGGI, E; ANNUNZIATO, F; MANETTI, R; BIAGIOTTI, R; GIUDIZI, MG; RAVINA, A; ALMERIGOGNA, F; BOIANI, N; ALDERSON, M; ROMAGNANI, S			ACTIVATION OF HIV EXPRESSION BY CD30 TRIGGERING IN CD4(+) T-CELLS FROM HIV-INFECTED INDIVIDUALS	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; HODGKINS-DISEASE; RECEPTOR; FAMILY; REPLICATION; ANTIGEN; DEFINES	CD30 is a member of the tumor necrosis factor receptor superfamily, preferentially expressed by T cells producing type 2 helper (Th2) cytokines, whose ligand (CD30L) has been identified on B cells, activated macrophages, and a subset of activated T cells. We show here that cross-linking CD30 with an agonistic CD30-specific monoclonal antibody, as well as with CD30L(+) CD8(+) T cell clones or CD30L(+) B cells, enhanced HIV replication in CD4(+) T cells from HIV-infected individuals, and such a potentiating effect was inhibited by anti-CD30L antibody, The anti-CD30L antibody also exerted a suppressive effect on spontaneous HIV replication occurring in lymph node cells from an HIV-seropositive patient, showing CD30L expression by both B and CD8(+) T lymphocytes, Thus, CD30 triggering by CD30L-expressing cells may play an important role in the activation of HIV expression from latently infected CD4(+) T cells.	UNIV PISA,IST CLIN MED 1,PISA,ITALY; IMMUNEX RES & DEV CORP,SEATTLE,WA 98101	University of Pisa	MAGGI, E (corresponding author), UNIV FLORENCE,IST CLIN MED 3,VIALE MORGAGNI 85,I-50134 FLORENCE,ITALY.		Annunziato, Francesco/C-1155-2013; Maggi, Enrico/AAA-8045-2019; Almerigogna, Fabio/AAL-4583-2020; Almerigogna, Fabio/A-4636-2012	Maggi, Enrico/0000-0002-1824-3583; Annunziato, Francesco/0000-0001-8798-7589				BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961; BUTERA ST, 1993, AIDS, V7, P911, DOI 10.1097/00002030-199307000-00002; CLERICI M, 1993, J CLIN INVEST, V91, P759, DOI 10.1172/JCI116294; DELPRETE G, 1995, FASEB J, V9, P81, DOI 10.1096/fasebj.9.1.7821763; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; JOSIMOVICALASEV.O, 1989, EUR J IMMUNOL, V19, P157; MACCHIA D, 1993, NATURE, V363, P464, DOI 10.1038/363464a0; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; MAGGI E, 1994, J EXP MED, V180, P489, DOI 10.1084/jem.180.2.489; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; MANETTI R, 1994, J EXP MED, V180, P2407, DOI 10.1084/jem.180.6.2407; PIZZOLO G, 1994, AIDS, V8, P741, DOI 10.1097/00002030-199406000-00003; POLL G, 1990, P NATL ACAD SCI USA, V87, P782; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STEIN H, 1985, BLOOD, V66, P848; 1987, MMWR-MORBID MORTAL W, V36, P1	19	57	57	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					251	255		10.1016/1074-7613(95)90094-2	http://dx.doi.org/10.1016/1074-7613(95)90094-2			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648397	Bronze			2022-12-18	WOS:A1995RR33900010
J	Kramer, B; Knoll, R; Bonaguro, L; ToVinh, M; Raabe, J; Astaburuaga-Garcia, R; Schulte-Schrepping, J; Kaiser, KM; Rieke, GJ; Bischoff, J; Monin, MB; Hoffmeister, C; Schlabe, S; De Domenico, E; Reusch, N; Handler, K; Reynolds, G; Bluthgen, N; Hack, G; Finnemann, C; Nischalke, HD; Strassburg, CP; Stephenson, E; Su, YP; Gardner, L; Yuan, D; Chen, D; Goldman, J; Rosenstiel, P; Schmidt, SV; Latz, E; Hrusovsky, K; Ball, AJ; Johnson, JM; Koenig, PA; Schmidt, FI; Haniffa, M; Heath, JR; Kummerer, BM; Keitel, V; Jensen, B; Stubbemann, P; Kurth, F; Sander, LE; Sawitzki, B; Aschenbrenner, AC; Schultze, JL; Nattermann, J				Kraemer, Benjamin; Knoll, Rainer; Bonaguro, Lorenzo; ToVinh, Michael; Raabe, Jan; Astaburuaga-Garcia, Rosario; Schulte-Schrepping, Jonas; Kaiser, Kim Melanie; Rieke, Gereon J.; Bischoff, Jenny; Monin, Malte B.; Hoffmeister, Christoph; Schlabe, Stefan; De Domenico, Elena; Reusch, Nico; Haendler, Kristian; Reynolds, Gary; Bluethgen, Nils; Hack, Gudrun; Finnemann, Claudia; Nischalke, Hans D.; Strassburg, Christian P.; Stephenson, Emily; Su, Yapeng; Gardner, Louis; Yuan, Dan; Chen, Daniel; Goldman, Jason; Rosenstiel, Philipp; Schmidt, Susanne, V; Latz, Eicke; Hrusovsky, Kevin; Ball, Andrew J.; Johnson, Joe M.; Koenig, Paul-Albert; Schmidt, Florian, I; Haniffa, Muzlifah; Heath, James R.; Kuemmerer, Beate M.; Keitel, Verena; Jensen, Bjoern; Stubbemann, Paula; Kurth, Florian; Sander, Leif E.; Sawitzki, Birgit; Aschenbrenner, Anna C.; Schultze, Joachim L.; Nattermann, Jacob		Deutsch COVID-19 OMICS Initiative	Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; INTERFERON-GAMMA; LIVER FIBROSIS; CYTOMETRY DATA; RESPONSES; THERAPY; CONTRIBUTE; INDUCTION; INFECTION; INFERENCE	Longitudinal analyses of the innate immune system, including the earliest time points, are essential to understand the immunopathogenesis and clinical course of coronavirus disease (COVID-19). Here, we performed a detailed characterization of natural killer (NK) cells in 205 patients (403 samples; days 2 to 41 after symptom onset) from four independent cohorts using single-cell transcriptomics and proteomics together with functional studies. We found elevated interferon (IFN)-a plasma levels in early severe COVD-19 alongside increased NK cell expression of IFN-stimulated genes (ISGs) and genes involved in IFN-a signaling, while up regulation of tumor necrosis factor (TNF)-induced genes was observed in moderate diseases. NK cells exert anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) activity but are functionally impaired in severe COVID-19. Further, NK cell dysfunction may be relevant for the development of fibrotic lung disease in severe COVID-19, as NK cells exhibited impaired anti-fibrotic activity. Our study indicates preferential IFN-a and TNF responses in severe and moderate COVID-19, respectively, and associates a prolonged IFNa-induced NK cell response with poorer disease outcome.	[Kraemer, Benjamin; ToVinh, Michael; Raabe, Jan; Kaiser, Kim Melanie; Rieke, Gereon J.; Bischoff, Jenny; Monin, Malte B.; Hoffmeister, Christoph; Schlabe, Stefan; Hack, Gudrun; Finnemann, Claudia; Nischalke, Hans D.; Strassburg, Christian P.; Nattermann, Jacob] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany; [Knoll, Rainer; Bonaguro, Lorenzo; Schulte-Schrepping, Jonas; De Domenico, Elena; Reusch, Nico; Haendler, Kristian; Aschenbrenner, Anna C.; Schultze, Joachim L.] Deutsch Zentrum Neurodegenerat Erkrankungen, Syst Med, Bonn, Germany; [Knoll, Rainer; Bonaguro, Lorenzo; Schulte-Schrepping, Jonas; Reusch, Nico; Aschenbrenner, Anna C.; Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Bonn, Germany; [Astaburuaga-Garcia, Rosario; Bluethgen, Nils] Charite Univ Med Berlin, Berlin, Germany; [Astaburuaga-Garcia, Rosario; Bluethgen, Nils] Free Univ Berlin, Berlin, Germany; [Astaburuaga-Garcia, Rosario; Bluethgen, Nils] Humboldt Univ, Inst Pathol, Berlin, Germany; [Astaburuaga-Garcia, Rosario; Bluethgen, Nils] Humboldt Univ, IRI Life Sci, Berlin, Germany; [Astaburuaga-Garcia, Rosario; Bluethgen, Nils] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Schlabe, Stefan; Kuemmerer, Beate M.; Nattermann, Jacob] German Ctr Infect Res DZIF, Heidelberg, Germany; [De Domenico, Elena; Haendler, Kristian; Aschenbrenner, Anna C.; Schultze, Joachim L.] Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, PRECISE Platform Genom & Epigen DZNE, Bonn, Germany; [De Domenico, Elena; Haendler, Kristian; Aschenbrenner, Anna C.; Schultze, Joachim L.] Univ Bonn, Bonn, Germany; [Reynolds, Gary; Stephenson, Emily; Gardner, Louis; Haniffa, Muzlifah] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Su, Yapeng; Yuan, Dan; Chen, Daniel; Goldman, Jason; Heath, James R.] Inst Syst Biol, Seattle, WA 98109 USA; [Heath, James R.] Board Directors Isoplexis, Branford, CT 06405 USA; [Goldman, Jason] Swedish Med Ctr, Swedish Ctr Res & Innovat, Seattle, WA 98109 USA; [Goldman, Jason] Providence St Joseph Hlth, Renton, WA 98057 USA; [Goldman, Jason] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98109 USA; [Rosenstiel, Philipp] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Rosenstiel, Philipp] Univ Med Ctr Schleswig Holstein, Kiel, Germany; [Schmidt, Susanne, V; Latz, Eicke; Koenig, Paul-Albert; Schmidt, Florian, I] Univ Bonn, Inst Innate Immun, Med Fac, Bonn, Germany; [Hrusovsky, Kevin; Ball, Andrew J.; Johnson, Joe M.] Quanterix Corp, Billerica, MA USA; [Koenig, Paul-Albert; Schmidt, Florian, I] Univ Bonn, Med Fac, Core Facil Nanobodies, Bonn, Germany; [Haniffa, Muzlifah] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England; [Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, Dept Dermatol, Newcastle Upon Tyne, Tyne & Wear, England; [Heath, James R.] Univ Washington, Dept Bioengn, Seattle, WA 98105 USA; [Heath, James R.] Board Directors PACT Pharma, San Francisco, CA 94080 USA; [Kuemmerer, Beate M.] Univ Bonn, Inst Virol, Med Fac, Bonn, Germany; [Keitel, Verena; Jensen, Bjoern] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Stubbemann, Paula; Kurth, Florian; Sander, Leif E.] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany; [Kurth, Florian; Sander, Leif E.] German Ctr Lung Res DZL, Marburg, Germany; [Sawitzki, Birgit] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Aschenbrenner, Anna C.] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Aschenbrenner, Anna C.] Radboud Univ Nijmegen Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; German Center for Infection Research; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Newcastle University - UK; Institute for Systems Biology (ISB); Swedish Medical Center; University of Washington; University of Washington Seattle; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Bonn; University of Bonn; Wellcome Trust Sanger Institute; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Washington; University of Washington Seattle; University of Bonn; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; Radboud University Nijmegen	Nattermann, J (corresponding author), Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany.; Nattermann, J (corresponding author), German Ctr Infect Res DZIF, Heidelberg, Germany.	jacob.nattermann@ukbonn.de	Ludwig, Kerstin U/H-7828-2019; Johnson, Joseph/AGF-0866-2022; Goldman, Jason D./AAD-9419-2020; Vogel, Jörg/D-5574-2011; Goldman, Jason/AEL-9703-2022; Nunes da Rocha, Ulisses/AAE-5158-2021; Kümmerer, Beate/HGV-0882-2022; Bischoff, Jenny/AAO-9674-2021; Schmidt, Florian Ingo/J-1672-2019; Vehreschild, Jorg Janne/G-6764-2013; Latz, Eicke/H-3951-2014; Bartholomaus, Alexander/AAR-1277-2021	Ludwig, Kerstin U/0000-0002-8541-2519; Johnson, Joseph/0000-0001-9728-9792; Goldman, Jason D./0000-0002-3825-6832; Vogel, Jörg/0000-0003-2220-1404; Nunes da Rocha, Ulisses/0000-0001-6972-6692; Bischoff, Jenny/0000-0002-7700-2915; Schmidt, Florian Ingo/0000-0002-9979-9769; Marz, Manja/0000-0003-4783-8823; Sawitzki, Birgit/0000-0001-8166-8579; Tovinh, Michael/0000-0002-1625-9741; Kramer, Benjamin/0000-0002-1385-9709; Knoll, Rainer/0000-0001-8320-5885; Vehreschild, Jorg Janne/0000-0002-5446-7170; Su, Yapeng/0000-0002-6305-8467; Astaburuaga-Garcia, Rosario/0000-0003-1179-4080; Latz, Eicke/0000-0003-1488-5666; Stegle, Oliver/0000-0002-8818-7193; Velavan, Thirumalaisamy P/0000-0002-9809-9883; Keitel, Verena/0000-0003-1383-7662; Gardner, Louis/0000-0002-7200-978X; Bartholomaus, Alexander/0000-0003-0970-7304; Rajewsky, Nikolaus/0000-0002-4785-4332; Kim-Hellmuth, Sarah/0000-0001-8791-5729; Ganzenmueller, Tina/0000-0002-3791-4709; Ralser, Markus/0000-0001-9535-7413; Chen, Daniel/0000-0001-6660-6257; Hanses, Frank/0000-0002-0007-8014; Kurth, Florian/0000-0002-3807-473X; Handler, Kristian/0000-0001-5273-5277; Yuan, Dan/0000-0001-9651-8020; De Domenico, Elena/0000-0003-0336-8284; Angelov, Angel/0000-0002-9228-0817; Raabe, Jan/0000-0002-6894-1451	German Research Foundation (DFG) [SFB TR57, SPP1937, KR 4521/1-1, INST 37/1049-1, INST 216/981-1, INST 257/605-1, INST 269/768-1, INST 217/988-1, INST 217/577-1, EXC2151 - 390873048, SFB1454 - 432325352]; DZIF, Germany [TTU 04.816, 04.817]; Hector Foun-dation [M89]; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; EU [733100, 00160389, 847422]; Federal Ministry of Education and Research (BMBF) [COVIMMUNE 01KI20343]; Medical Faculty of the University of Bonn; Emmy Noether Programme [322568668]; Biomedical Advanced Research and Development Authority [HHSO10201600031C]; Mary Gates Research Fellowship; Mahan Fellowship in the Herbold Computational Biology Program of the Fred Hutch Cancer Research Center; Department of Genomics & Immunoreg-ulation at the LIMES Institute; Parker Institute for Cancer Immunotherapy; Washington State Andy Hill CARE Fund	German Research Foundation (DFG)(German Research Foundation (DFG)); DZIF, Germany; Hector Foun-dation; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany(Helmholtz Association); EU(European Commission); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Medical Faculty of the University of Bonn; Emmy Noether Programme(German Research Foundation (DFG)); Biomedical Advanced Research and Development Authority; Mary Gates Research Fellowship; Mahan Fellowship in the Herbold Computational Biology Program of the Fred Hutch Cancer Research Center; Department of Genomics & Immunoreg-ulation at the LIMES Institute; Parker Institute for Cancer Immunotherapy; Washington State Andy Hill CARE Fund	This work was supported by the German Research Foundation (DFG) (SFB TR57 and SPP1937 to J.N.; KR 4521/1-1 to B.K.; INST 37/1049-1, INST 216/981-1, INST 257/605-1, INST 269/768-1, INST 217/988-1, INST 217/577-1, EXC2151 - 390873048 to J.L.S.; and SFB1454 - 432325352 to A.C.A. and J.L.S.) ; the DZIF, Germany (TTU 04.816 and 04.817 to J.N.) ; the Hector Foun-dation (M89 to J.N.) ; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany (sparse2big to J.L.S) ; EU projects SYSCID (733100 to J.L.S.) ; ERA CVD (00160389 to J.L.S.) ; ImmunoSep (847422 to J.L.S.) ; the Federal Ministry of Education and Research (BMBF) (COVIMMUNE 01KI20343 to J.N., E.L., B.M.K.) ; funds from the Medical Faculty of the University of Bonn (to P.K. and F.S.) ; Emmy Noether Programme 322568668 (to F.I.S.) ; the ACA was sup-ported by an intramural grant from the Department of Genomics & Immunoreg-ulation at the LIMES Institute; Parker Institute for Cancer Immunotherapy; The Washington State Andy Hill CARE Fund (to J.R.H.) ; The Biomedical Advanced Research and Development Authority HHSO10201600031C (to J.R.H.) ; Mary Gates Research Fellowship (to D.C.) ; and the Mahan Fellowship in the Herbold Computational Biology Program of the Fred Hutch Cancer Research Center (to Y.S.) .	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Alvarez M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127729; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; [Anonymous], 2020, NEW ENGL J MED, DOI DOI 10.1056/NEJMC2005203; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Baranek T, 2012, CELL HOST MICROBE, V12, P571, DOI 10.1016/j.chom.2012.09.002; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bennett T.D., 2021, NATL COVID COHORT CO; Bernardes JP, 2020, IMMUNITY, V53, P1296, DOI 10.1016/j.immuni.2020.11.017; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Blom K, 2016, J IMMUNOL, V197, P2762, DOI 10.4049/jimmunol.1600950; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen TJ, 2014, CURR TOP MICROBIOL, V377, P127, DOI 10.1007/82_2014_364; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Ding L, 2016, J IMMUNOL, V197, P303, DOI 10.4049/jimmunol.1502479; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Glassner A, 2013, J HEPATOL, V59, P427, DOI 10.1016/j.jhep.2013.04.029; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Jeffrey K.L., NAT IMMUNOL, V7, P774; Jiang YJ, 2020, CLIN IMMUNOL, V218, DOI 10.1016/j.clim.2020.108516; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Koenig PA, 2021, SCIENCE, V371, P691, DOI 10.1126/science.abe6230; Kokordelis P, 2014, HEPATOLOGY, V59, P814, DOI 10.1002/hep.26782; Kong YX, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00308-2; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Kurth F., 2020, NAT MED, V26, P842; Kverneland AH, 2016, CYTOM PART A, V89A, P543, DOI 10.1002/cyto.a.22855; Lee AJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01261; Lee AJ, 2017, J EXP MED, V214, P1153, DOI 10.1084/jem.20160880; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Maier M.J., 2021, DIRICHLETREG DIRICHL; Marshall JD, 2006, IMMUNOLOGY, V117, P38, DOI 10.1111/j.1365-2567.2005.02261.x; Maucourant C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6832; McInnes L., 2018, J OPEN SOURCE SOFTW, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Melville J., 2020, UWOT UNIFORM MANIFOL; Merino A, 2019, J CLIN INVEST, V129, P3770, DOI 10.1172/JCI125916; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Ong S, 2015, AM J PATHOL, V185, P847, DOI 10.1016/j.ajpath.2014.11.023; Osman M, 2020, BLOOD ADV, V4, P5035, DOI 10.1182/bloodadvances.2020002650; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Rajaram S, 2020, IMMUNITY, V52, P887, DOI 10.1016/j.immuni.2020.04.018; Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4; Salerno F, 2018, NAT IMMUNOL, V19, P828, DOI 10.1038/s41590-018-0155-6; Sawitzki B, 2020, LANCET, V395, P1627, DOI 10.1016/S0140-6736(20)30167-7; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Schultheiss C, 2020, IMMUNITY, V53, P442, DOI 10.1016/j.immuni.2020.06.024; Schultze JL, 2021, CELL, V184, P1671, DOI 10.1016/j.cell.2021.02.029; Smith SL, 2020, BLOOD ADV, V4, P1388, DOI 10.1182/bloodadvances.2019000699; Stephenson E, 2021, NAT MED, V27, P904, DOI 10.1038/s41591-021-01329-2; Stuart T., 2019, CELL, V177, P1888, DOI [DOI 10.1016/j.cell.2019.05.031, DOI 10.1016/J.CELL.2019.05.031]; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Toptan T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124396; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Varchetta S, 2021, CELL MOL IMMUNOL, V18, P604, DOI 10.1038/s41423-020-00557-9; Wang DW, 2020, J COASTAL RES, P1, DOI [10.1001/jama.2020.1585, 10.2112/JCR-SI109-001.1]; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Xu G, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00225-2; Yang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11947-7; Yang H, 2019, NAT MED, V25, P1428, DOI 10.1038/s41591-019-0566-4; Yao CF, 2021, CELL REP, V34, DOI [10.1016/j.celrep.2020.108590, 10.1016/j.celrep.2021.108943]; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhang PN, 2019, J CELL BIOCHEM, V120, P17345, DOI 10.1002/jcb.28998; Zhang Q., COV CONTACT COHORT A, V370; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	104	56	56	8	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2650	+		10.1016/j.immuni.2021.09.002	http://dx.doi.org/10.1016/j.immuni.2021.09.002		NOV 2021	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LN	34592166	Green Published, Bronze			2022-12-18	WOS:000718365500006
J	Burn, GL; Foti, A; Marsman, G; Patel, DF; Zychlinsky, A				Burn, Garth Lawrence; Foti, Alessandro; Marsman, Gerben; Patel, Dhiren Ferise; Zychlinsky, Arturo			The Neutrophil	IMMUNITY			English	Review							INTERSTITIAL LUNG-DISEASE; T-CELLS; EXTRACELLULAR TRAPS; CANCER; RESOLUTION; RECEPTOR; TISSUE; INFLAMMATION; RESPONSES; SUBSET	Neutrophils are immune cells with unusual biological features that furnish potent antimicrobial properties. These cells phagocytose and subsequently kill prokaryotic and eukaryotic organisms very efficiently. Importantly, it is not only their ability to attack microbes within a constrained intracellular compartment that endows neutrophils with antimicrobial function. They can unleash their effectors into the extracellular space, where, even post-mortem, their killing machinery can endure and remain functional. The antimicrobial activity of neutrophils must not be misconstrued as being microbe specific and should be viewed more generally as biotoxic. Outside of fighting infections, neutrophils can harness their noxious machinery in other contexts, like cancer. Inappropriate or dysregulated neutrophil activation damages the host and contributes to autoimmune and inflammatory disease. Here we review a number of topics related to neutrophil biology based on contemporary findings.	[Burn, Garth Lawrence; Foti, Alessandro; Marsman, Gerben; Patel, Dhiren Ferise; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Zychlinsky, A (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Charitepl 1, D-10117 Berlin, Germany.	zychlinsky@mpiib-berlin.mpg.de		Marsman, Gerben/0000-0002-5376-8000				Aarts CEM, 2019, BLOOD ADV, V3, P3562, DOI 10.1182/bloodadvances.2019031609; Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2; Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Alder MN, 2017, CRIT CARE MED, V45, pE426, DOI 10.1097/CCM.0000000000002102; Amulic B, 2017, DEV CELL, V43, P449, DOI 10.1016/j.devcel.2017.10.013; Aoun L, 2020, BIOPHYS J, V119, P1157, DOI 10.1016/j.bpj.2020.07.033; Apel F, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.aax7942; Armstrong L, 2009, CLIN EXP IMMUNOL, V156, P336, DOI 10.1111/j.1365-2249.2009.03906.x; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Ballesteros I, 2020, CELL, V183, P1282, DOI 10.1016/j.cell.2020.10.003; Bardoel BW, 2014, CELL HOST MICROBE, V15, P526, DOI 10.1016/j.chom.2014.04.011; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Bouti P, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.619925; Burgener SS, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a037028; Camp JV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00550; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Castanheira FVS, 2019, BLOOD, V133, P2178, DOI 10.1182/blood-2018-11-844530; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Choudhury SR, 2019, CELL, V178, P1205, DOI 10.1016/j.cell.2019.07.017; Clancy DM, 2018, CELL REP, V22, P2937, DOI 10.1016/j.celrep.2018.02.062; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Dalal PJ, 2021, J EXP MED, V218, DOI 10.1084/jem.20192378; de Buhr N, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1895-4; Demers M, 2014, SEMIN THROMB HEMOST, V40, P277, DOI 10.1055/s-0034-1370765; Deniset JF, 2017, J EXP MED, V214, P1333, DOI 10.1084/jem.20161621; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Dinauer MC, 2016, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2016.1.43; Drexler HCA, 2019, MOL CELL PROTEOMICS, V18, P2058, DOI 10.1074/mcp.RA119.001716; El Rayes T, 2015, P NATL ACAD SCI USA, V112, P16000, DOI 10.1073/pnas.1507294112; Ellett F, 2018, NAT BIOMED ENG, V2, P207, DOI 10.1038/s41551-018-0208-z; Ericson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108553; Eruslanov EB, 2017, TRENDS CANCER, V3, P149, DOI 10.1016/j.trecan.2016.12.006; Faget J, 2017, CELL REP, V21, P3190, DOI 10.1016/j.celrep.2017.11.052; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Governa V, 2017, CLIN CANCER RES, V23, P3847, DOI 10.1158/1078-0432.CCR-16-2047; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Guo YH, 2020, CELL HOST MICROBE, V28, P104, DOI 10.1016/j.chom.2020.05.002; Gupta S, 2020, P NATL ACAD SCI USA, V117, P16481, DOI 10.1073/pnas.2003603117; Hagerling C, 2019, P NATL ACAD SCI USA, V116, P21704, DOI 10.1073/pnas.1907660116; Hawes MC, 2015, CANCER RES, V75, P4260, DOI 10.1158/0008-5472.CAN-15-1546; Hee Ryu OK, 2005, J BIOL CHEM, V280, P17415, DOI 10.1074/jbc.M500340200; Hensley-McBain T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007672; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Hoang AN, 2013, TECHNOLOGY, V1, P49, DOI 10.1142/S2339547813500040; Hou Q., 2018, SCI TRANSL MED, V10, P1; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Hulsdunker J, 2018, BLOOD, V131, P1858, DOI 10.1182/blood-2017-10-812891; Jawale CV, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay5691; Joshi N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187162; Kamenyeva O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004827; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kienle K, 2016, IMMUNOL REV, V273, P76, DOI 10.1111/imr.12458; Kim JH, 2018, NAT IMMUNOL, V19, P192, DOI 10.1038/s41590-017-0030-x; Kish DD, 2019, J IMMUNOL, V202, P1045, DOI 10.4049/jimmunol.1800841; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Kobayashi SD, 2018, J INNATE IMMUN, V10, P432, DOI 10.1159/000487756; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Krishnamoorthy N., SCI IMMUNOL, V3, P1; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Langereis JD, 2017, J LEUKOCYTE BIOL, V102, P1399, DOI 10.1189/jlb.3A0217-051RR; Lawrence SM, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00057-17; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Li PS, 2020, NAT IMMUNOL, V21, P1444, DOI 10.1038/s41590-020-0783-5; Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094; Lim K, 2020, NAT IMMUNOL, V21, P1046, DOI 10.1038/s41590-020-0746-x; Linhares-Lacerda L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59486-2; Lok LSC, 2019, P NATL ACAD SCI USA, V116, P19083, DOI 10.1073/pnas.1905054116; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Margraf A, 2020, BLOOD, V136, P2200, DOI 10.1182/blood.2020004948; Marini O, 2017, BLOOD, V129, P1343, DOI 10.1182/blood-2016-04-713206; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Matlung HL, 2018, CELL REP, V23, P3946, DOI 10.1016/j.celrep.2018.05.082; MAUER AM, 1960, J CLIN INVEST, V39, P1481, DOI 10.1172/JCI104167; Mauracher LM, 2018, J THROMB HAEMOST, V16, P508, DOI 10.1111/jth.13951; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Michael M, 2020, CURR OPIN CELL BIOL, V63, P31, DOI 10.1016/j.ceb.2019.12.008; Michael M, 2019, ESSAYS BIOCHEM, V63, P607, DOI 10.1042/EBC20190011; Michaeli J, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1356965; Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008; Mistry P, 2019, P NATL ACAD SCI USA, V116, P25222, DOI 10.1073/pnas.1908576116; Mocsai A, 2015, CARDIOVASC RES, V107, P373, DOI 10.1093/cvr/cvv159; Monceaux V, 2016, BLOOD, V128, P993, DOI 10.1182/blood-2015-11-680918; Naumenko V, 2018, CELL TISSUE RES, V371, P505, DOI 10.1007/s00441-017-2763-0; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Nemeth T, 2020, NAT REV DRUG DISCOV, V19, P253, DOI 10.1038/s41573-019-0054-z; Newburger PE, 2016, HEMATOL-AM SOC HEMAT, P38, DOI 10.1182/asheducation-2016.1.38; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Owen-Woods C, 2020, J CLIN INVEST, V130, P2301, DOI 10.1172/JCI133661; Palsson-McDermott EM, 2020, CELL RES, V30, P300, DOI 10.1038/s41422-020-0291-z; Panova V, 2021, MUCOSAL IMMUNOL, V14, P26, DOI 10.1038/s41385-020-0298-2; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Parsa R, 2016, J EXP MED, V213, P1537, DOI 10.1084/jem.20150577; Patel DF, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0017-2018; Patel S, 2018, NAT IMMUNOL, V19, P1236, DOI 10.1038/s41590-018-0229-5; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Peiro T, 2018, THORAX, V73, P546, DOI 10.1136/thoraxjnl-2017-210010; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Poplimont H, 2020, CURR BIOL, V30, P2761, DOI 10.1016/j.cub.2020.05.030; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Pulsifer AR, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00909-19; Puttur F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7638; Radermecker C, 2019, NAT IMMUNOL, V20, P1444, DOI 10.1038/s41590-019-0496-9; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Rayes RF, 2020, J IMMUNOL, V204, P2285, DOI 10.4049/jimmunol.1900240; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; Riyapa D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221016; Rosowski EE, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.041889; Roy J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02993-6; Rudziak P, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/4123605; Sadiku P, 2021, CELL METAB, V33, DOI [10.1016/j.cmet.2021.03.018, 10.1016/j.cmet.2020.11.016]; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Saha P, 2017, J IMMUNOL, V198, P4293, DOI 10.4049/jimmunol.1700261; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shaul ME, 2019, NAT REV CLIN ONCOL, V16, P601, DOI 10.1038/s41571-019-0222-4; Shaul ME, 2018, FEBS J, V285, P4316, DOI 10.1111/febs.14524; Siler U, 2017, J ALLERGY CLIN IMMUN, V139, P212, DOI 10.1016/j.jaci.2016.04.041; Silvestre-Roig C, 2020, NAT REV CARDIOL, V17, P327, DOI 10.1038/s41569-019-0326-7; Singhal S, 2016, CANCER CELL, V30, P120, DOI 10.1016/j.ccell.2016.06.001; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Skokowa J, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.32; SMITH JB, 1970, J ANAT, V107, P87; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Song DK, 2019, NAT MICROBIOL, V4, P97, DOI 10.1038/s41564-018-0290-8; Souwer Y, 2018, J ALLERGY CLIN IMMUN, V141, P2286, DOI 10.1016/j.jaci.2018.01.003; Subramanian BC, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201910215; Svitkina T, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a018267; Swidergall M, 2019, CELL REP, V28, P423, DOI 10.1016/j.celrep.2019.06.020; Szczerba BM, 2019, NATURE, V566, P553, DOI 10.1038/s41586-019-0915-y; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; Talla U, 2019, J LEUKOCYTE BIOL, V106, P1367, DOI 10.1002/JLB.4A0319-079RR; Tamassia N, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12952; Teijeira A, 2020, IMMUNITY, V52, P856, DOI 10.1016/j.immuni.2020.03.001; Thalin C, 2016, THROMB RES, V139, P56, DOI 10.1016/j.thromres.2016.01.009; Tsourouktsoglou TD, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107602; Tweedy L, 2020, SCIENCE, V369, P1075, DOI 10.1126/science.aay9792; Ulfig A, 2021, CELL MOL LIFE SCI, V78, P385, DOI 10.1007/s00018-020-03591-y; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; Valenta H, 2020, ADV EXP MED BIOL, V1246, P153, DOI 10.1007/978-3-030-40406-2_9; van Rees DJ, 2016, SEMIN IMMUNOL, V28, P94, DOI 10.1016/j.smim.2016.02.004; Vareechon C, 2017, CELL HOST MICROBE, V21, P611, DOI 10.1016/j.chom.2017.04.001; Veiga-da-Cunha M, 2019, P NATL ACAD SCI USA, V116, P1241, DOI 10.1073/pnas.1816143116; Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7; Vono M, 2017, BLOOD, V129, P1991, DOI 10.1182/blood-2016-10-744441; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Wang LZY, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03076; Warnatsch A, 2017, IMMUNITY, V46, P421, DOI 10.1016/j.immuni.2017.02.013; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Wculek SK, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101277; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Wigerblad G, 2020, NAT REV RHEUMATOL, V16, P73, DOI 10.1038/s41584-019-0352-1; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Wortmann SB, 2020, BLOOD, V136, P1033, DOI 10.1182/blood.2019004465; Yang LB, 2020, NATURE, V583, P133, DOI 10.1038/s41586-020-2394-6; Yang S. -C., 2020, BIOMED J; Yang WT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09046-8; Yvan-Charvet L, 2019, TRENDS IMMUNOL, V40, P598, DOI 10.1016/j.it.2019.05.004; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502; Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999	182	56	56	10	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1377	1391		10.1016/j.immuni.2021.06.006	http://dx.doi.org/10.1016/j.immuni.2021.06.006		JUL 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260886	Bronze			2022-12-18	WOS:000672812100006
J	Tsui, C; Martinez-Martin, N; Gaya, M; Maldonado, P; Llorian, M; Legrave, NM; Rossi, M; MacRae, JI; Cameron, AJ; Parker, PJ; Leitges, M; Bruckbauer, A; Batista, FD				Tsui, Carlson; Martinez-Martin, Nuria; Gaya, Mauro; Maldonado, Paula; Llorian, Miriam; Legrave, Nathalie M.; Rossi, Merja; MacRae, James I.; Cameron, Angus J.; Parker, Peter J.; Leitges, Michael; Bruckbauer, Andreas; Batista, Facundo D.			Protein Kinase C-beta Dictates B Cell Fate by Regulating Mitochondrial Remodeling, Metabolic Reprogramming, and Heme Biosynthesis	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; SECRETING PLASMA-CELLS; MHC CLASS-II; IMMUNOGLOBULIN SECRETION; GERMINAL-CENTERS; DIFFERENTIATION; ACTIVATION; EXPRESSION; SELECTION; BLIMP-1	PKC beta-null (Prkcb(-/-)) mice are severely immunodeficient. Here we show that mice whose B cells lack PKC beta failed to form germinal centers and plasma cells, which undermined affinity maturation and antibody production in response to immunization. Moreover, these mice failed to develop plasma cells in response to viral infection. At the cellular level, we have shown that Prkcb(-/-) B cells exhibited defective antigen polarization and mTORC1 signaling. While altered antigen polarization impaired antigen presentation and likely restricted the potential of GC development, defective mTORC1 signaling impaired metabolic reprogramming, mitochondrial remodeling, and heme biosynthesis in these cells, which altogether overwhelmingly opposed plasma cell differentiation. Taken together, our study reveals mechanistic insights into the function of PKC beta as a key regulator of B cell polarity and metabolic reprogramming that instructs B cell fate.	[Tsui, Carlson; Martinez-Martin, Nuria; Maldonado, Paula; Bruckbauer, Andreas; Batista, Facundo D.] Francis Crick Inst, Lymphocyte Interact Lab, London NW1 1AT, England; [Gaya, Mauro; Batista, Facundo D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Llorian, Miriam] Francis Crick Inst, Bioinformat, London NW1 1AT, England; [Legrave, Nathalie M.; Rossi, Merja; MacRae, James I.] Francis Crick Inst, Metabol, London NW1 1AT, England; [Cameron, Angus J.] Queen Mary Univ London, Barts Canc Inst, London EC1M 6BQ, England; [Parker, Peter J.] Francis Crick Inst, Prot Phosphorylat Lab, London NW1 1AT, England; [Parker, Peter J.] Kings Coll London, Sch Canc & Pharmaceut Sci, London SE1 1UL, England; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0349 Oslo, Norway; [Bruckbauer, Andreas] Imperial Coll London, FILM, London SW7 2BB, England; [Martinez-Martin, Nuria] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Francis Crick Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Francis Crick Institute; Francis Crick Institute; University of London; Queen Mary University London; Francis Crick Institute; University of London; King's College London; University of Oslo; Imperial College London; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Tsui, C; Batista, FD (corresponding author), Francis Crick Inst, Lymphocyte Interact Lab, London NW1 1AT, England.; Batista, FD (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	carlson.tsui@crick.ac.uk; fbatista1@mgh.harvard.edu	Martinez-Martin, Nuria/A-9160-2017; Leitges, Michael/AAN-1953-2021	Martinez-Martin, Nuria/0000-0003-2309-8920; parker, peter/0000-0002-6218-2933; Leitges, Michael/0000-0003-4203-6995	Francis Crick Institute core - CRUK [FC001035, FC001136]; UK Medical Research Council [FC001035, FC001136]; Wellcome Trust [FC001035, FC001136]; UCL ORS Award; Marie Sklodowska-Curie individual postdoctoral fellowship; center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institutes of Health (NIH) [UM1AI100663]; Philip T. and Susan M. Ragon Institute Foundation; Bill and Melinada Gates Foundation Innovation Award [228966]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R01AI135052] Funding Source: NIH RePORTER	Francis Crick Institute core - CRUK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UCL ORS Award; Marie Sklodowska-Curie individual postdoctoral fellowship; center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip T. and Susan M. Ragon Institute Foundation; Bill and Melinada Gates Foundation Innovation Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Daisuke Kitamura (Tokyo University of Sciences) for 40LB cells. We thank Dinis Calado (The Francis Crick Institute) for advice and suggestions. We thank the BRF and flow cytometry unit (The Francis Crick Institute) for animal maintenance and technical support. We thank the Advanced Sequencing and Bioinformatics (The Francis Crick Institute) for assistance. We thank all members of the Lymphocyte Interaction Laboratory (The Francis Crick Institute and Ragon Institute) for critical comments. All work presented here was supported by the Francis Crick Institute core funded by CRUK (FC001035 and FC001136), the UK Medical Research Council (FC001035 and FC001136), Wellcome Trust (FC001035 and FC001136), UCL ORS Award to C.T., a Marie Sklodowska-Curie individual postdoctoral fellowship to N.M.-M., the center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institutes of Health (NIH; UM1AI100663), the Philip T. and Susan M. Ragon Institute Foundation, and the Bill and Melinada Gates Foundation Innovation Award (228966) to F.D.B.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Benhamron S, 2015, MOL CELL BIOL, V35, P153, DOI 10.1128/MCB.01187-14; Blair D, 2012, BIOCHEM J, V448, P165, DOI 10.1042/BJ20121225; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Burbage M, 2015, J EXP MED, V212, P53, DOI 10.1084/jem.20141143; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Keppler SJ, 2015, IMMUNITY, V43, P660, DOI 10.1016/j.immuni.2015.09.004; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Martinez-Martin N, 2017, SCIENCE, V355, P641, DOI 10.1126/science.aal3908; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Siemasko K, 1998, J IMMUNOL, V160, P5203; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483	48	56	57	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1144	+		10.1016/j.immuni.2018.04.031	http://dx.doi.org/10.1016/j.immuni.2018.04.031			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29884460	Green Published, hybrid			2022-12-18	WOS:000436456900014
J	Wu, J; Zhang, HD; Shi, XM; Xiao, X; Fan, YH; Minze, LJ; Wang, J; Ghobrial, RM; Xia, JH; Sciammas, R; Li, XC; Chen, WH				Wu, Jie; Zhang, Hedong; Shi, Xiaomin; Xiao, Xiang; Fan, Yihui; Minze, Laurie J.; Wang, Jin; Ghobrial, Rafik M.; Xia, Jiahong; Sciammas, Roger; Li, Xian C.; Chen, Wenhao			Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4(+) T Cell Dysfunction	IMMUNITY			English	Article							ALLOGRAFT-REJECTION; ANTIGEN PRESENTATION; UNTREATED MELANOMA; DIFFERENTIATION; EXHAUSTION; EXPRESSION; BATF; ACTIVATION; MECHANISMS; IPILIMUMAB	CD4(+) T cells orchestrate immune responses and destruction of allogeneic organ transplants, but how this process is regulated on a transcriptional level remains unclear. Here, we demonstrated that interferon regulatory factor 4 (IRF4) was a key transcriptional determinant controlling T cell responses during transplantation. IRF4 deletion in mice resulted in progressive establishment of CD4(+) T cell dysfunction and long-term allograft survival. Mechanistically, IRF4 repressed PD-1, Helios, and other molecules associated with T cell dysfunction. In the absence of IRF4, chromatin accessibility and binding of Helios at PD-1 cis-regulatory elements were increased, resulting in enhanced PD-1 expression and CD4(+) T cell dysfunction. The dysfunctional state of Irf4-deficient T cells was initially reversible by PD-1 ligand blockade, but it progressively developed into an irreversible state. Hence, IRF4 controls a core regulatory circuit of CD4(+) T cell dysfunction, and targeting IRF4 represents a potential therapeutic strategy for achieving transplant acceptance.	[Wu, Jie; Zhang, Hedong; Shi, Xiaomin; Xiao, Xiang; Fan, Yihui; Minze, Laurie J.; Wang, Jin; Ghobrial, Rafik M.; Sciammas, Roger; Li, Xian C.; Chen, Wenhao] Texas Med Ctr, Houston Methodist Res Inst, Immunobiol & Transplant Sci Ctr, Houston, TX 77030 USA; [Wu, Jie; Xia, Jiahong] Huazhong Univ Sci & Technol, Union Hosp, Dept Cardiovasc Surg, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Wang, Jin; Ghobrial, Rafik M.; Li, Xian C.; Chen, Wenhao] Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10065 USA; [Sciammas, Roger] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology; Cornell University; University of California System; University of California Davis	Chen, WH (corresponding author), Texas Med Ctr, Houston Methodist Res Inst, Immunobiol & Transplant Sci Ctr, Houston, TX 77030 USA.; Chen, WH (corresponding author), Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10065 USA.	wchen@houstonmethodist.org	Chen, Wenhao/J-6553-2019; Muller, Elmi/I-3258-2014	Chen, Wenhao/0000-0002-0626-3739; Muller, Elmi/0000-0003-4891-5296; Wang, Jin/0000-0002-3116-0838; Wu, Jie/0000-0002-8880-2520; xiao, xiang/0000-0001-6644-6118	American Heart Association [11SDG7690000]; Houston Methodist Research Institute; US National Institutes of Health [R01AI106200]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106200] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Houston Methodist Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the flow cytometry and the pathology core facilities at Houston Methodist for excellent services and Dr. Zhiqiang Zhang for discussions. We thank the Genomic and RNA Profiling Core at Baylor College of Medicine for excellent services. This study was supported by a grant from the American Heart Association (11SDG7690000 to W.C.), the startup fund from Houston Methodist Research Institute (to W.C.), and the US National Institutes of Health grant (R01AI106200 to X.C.L.).	Alhamad T, 2016, AM J TRANSPLANT, V16, P1332, DOI 10.1111/ajt.13711; Bally APR, 2016, J IMMUNOL, V196, P2431, DOI 10.4049/jimmunol.1502643; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; BOLTON EM, 1989, J EXP MED, V169, P1931, DOI 10.1084/jem.169.6.1931; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen WH, 2007, J IMMUNOL, V179, P1542, DOI 10.4049/jimmunol.179.3.1542; Conlon TM, 2012, J IMMUNOL, V188, P2643, DOI 10.4049/jimmunol.1102830; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Gupta S, 2011, TRANSPLANTATION, V91, pE65, DOI 10.1097/TP.0b013e3182157d44; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lipson EJ, 2016, NEW ENGL J MED, V374, P896, DOI 10.1056/NEJMc1509268; Liu ZM, 2013, IMMUNOL REV, V252, P183, DOI 10.1111/imr.12038; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Mahnke J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35521; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Martinez RJ, 2012, J IMMUNOL, V188, P170, DOI 10.4049/jimmunol.1101311; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Miyahara Y, 2012, AM J TRANSPLANT, V12, P1409, DOI 10.1111/j.1600-6143.2012.04006.x; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Nayar R, 2012, P NATL ACAD SCI USA, V109, pE2794, DOI 10.1073/pnas.1205742109; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Rogers NJ, 2001, AM J TRANSPLANT, V1, P97, DOI 10.1034/j.1600-6143.2001.001002097.x; Ross EM, 2014, EUR J IMMUNOL, V44, P2048, DOI 10.1002/eji.201343999; Safinia N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00438; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Xiao X, 2016, IMMUNITY, V44, P1271, DOI 10.1016/j.immuni.2016.05.013; Yang H, 2002, TRANSPLANTATION, V74, P291, DOI 10.1097/00007890-200208150-00002; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	50	56	59	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1114	+		10.1016/j.immuni.2017.11.003	http://dx.doi.org/10.1016/j.immuni.2017.11.003			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29221730	Green Accepted, Bronze			2022-12-18	WOS:000418486500015
J	Iatsenko, I; Kondo, S; Mengin-Lecreulx, D; Lemaitre, B				Iatsenko, Igor; Kondo, Shu; Mengin-Lecreulx, Dominique; Lemaitre, Bruno			PGRP-SD, an Extracellular Pattern-Recognition Receptor, Enhances Peptidoglycan-Mediated Activation of the Drosophila Imd Pathway	IMMUNITY			English	Article							GRAM-NEGATIVE BACTERIA; IMMUNE-RESPONSE; FUNGAL-INFECTIONS; BINDING-PROTEIN; DAP-TYPE; LC; AMIDASE; TOLL; LE; MELANOGASTER	Activation of the innate immune response in Metazoans is initiated through the recognition of microbes by host pattern-recognition receptors. In Drosophila, diaminopimelic acid ( DAP)-containing peptidoglycan from Gram-negative bacteria is detected by the transmembrane receptor PGRP-LC and by the intracellular receptor PGRP-LE. Here, we show that PGRP-SD acted upstream of PGRP-LC as an extracellular receptor to enhance peptidoglycan-mediated activation of Imd signaling. Consistent with this, PGRP-SD mutants exhibited impaired activation of the Imd pathway and increased susceptibility to DAP-type bacteria. PGRP-SD enhanced the localization of peptidoglycans to the cell surface and hence promoted signaling. Moreover, PGRP-SD antagonized the action of PGRP-LB, an extracellular negative regulator, to fine-tune the intensity of the immune response. These data reveal that Drosophila PGRP-SD functions as an extracellular receptor similar to mammalian CD14 and demonstrate that, comparable to lipopolysaccharide sensing in mammals, Drosophila relies on both intra-and extracellular receptors for the detection of bacteria.	[Iatsenko, Igor; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland; [Kondo, Shu] Natl Inst Genet, Invertebrate Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka 4118540, Japan; [Mengin-Lecreulx, Dominique] Univ Paris Sud, CNRS, CEA, Inst Integrat Biol Cell, F-91198 Gif Sur Yvette, France; [Mengin-Lecreulx, Dominique] Univ Paris Saclay, F-91198 Gif Sur Yvette, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Iatsenko, I; Lemaitre, B (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland.	igor.iatsenko@epfl.ch; bruno.lemaitre@epfl.ch	Kondo, Shu/AAH-8921-2020; Lemaitre, Bruno/T-8146-2019; Iatsenko, Igor/AAI-6699-2021	Kondo, Shu/0000-0002-4625-8379; Lemaitre, Bruno/0000-0001-7970-1667; Iatsenko, Igor/0000-0002-9249-8998; MENGIN-LECREULX, Dominique/0000-0003-3205-0275				Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Neyen C, 2016, NAT IMMUNOL, V17, P1150, DOI 10.1038/ni.3536; Neyen C, 2016, CURR OPIN IMMUNOL, V38, P8, DOI 10.1016/j.coi.2015.10.007; Neyen C, 2014, METHODS, V68, P116, DOI 10.1016/j.ymeth.2014.02.023; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmidt RL, 2008, FASEB J, V22, P918, DOI 10.1096/fj.06-7907com; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang L, 2008, P NATL ACAD SCI USA, V105, P11881, DOI 10.1073/pnas.0710092105; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231	41	56	58	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1013	1023		10.1016/j.immuni.2016.10.029	http://dx.doi.org/10.1016/j.immuni.2016.10.029			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851910	Bronze, Green Submitted			2022-12-18	WOS:000389473500013
J	Cupovic, J; Onder, L; Gil-Cruz, C; Weiler, E; Caviezel-Firner, S; Perez-Shibayama, C; Rulicke, T; Bechmann, I; Ludewig, B				Cupovic, Jovana; Onder, Lucas; Gil-Cruz, Cristina; Weiler, Elke; Caviezel-Firner, Sonja; Perez-Shibayama, Christian; Ruelicke, Thomas; Bechmann, Ingo; Ludewig, Burkhard			Central Nervous System Stromal Cells Control Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation	IMMUNITY			English	Article							FIBROBLASTIC RETICULAR CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LYMPHOID CHEMOKINES CCL19; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; ORGAN CHEMOKINE; EXPRESSION; IMMUNITY; INFECTION; NODES	Stromal cells generate a complex cellular scaffold that provides specialized microenvironments for lymphocyte activation in secondary lymphoid organs. Here, we assessed whether local activation of stromal cells in the central nervous system (CNS) is mandatory to transfer immune recognition from secondary lymphoid organs into the infected tissue. We report that neurotropic virus infection in mice triggered the establishment of such stromal cell niches in the CNS. CNS stromal cell activation was dominated by a rapid and vigorous production of CC-motif chemokine receptor (CCR) 7 ligands CCL19 and CCL21 by vascular endothelial cells and adjacent fibroblastic reticular cell (FRC)-like cells in the perivascular space. Moreover, CCR7 ligands produced by CNS stromal cells were crucial to support recruitment and local re-activation of antiviral CD8(+) T cells and to protect the host from lethal neuroinflammatory disease, indicating that CNS stromal cells generate confined microenvironments that control protective T cell immunity.	[Cupovic, Jovana; Onder, Lucas; Gil-Cruz, Cristina; Caviezel-Firner, Sonja; Perez-Shibayama, Christian; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Weiler, Elke; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Weiler, Elke] Univ Ulm, Inst Neurobiol, D-89081 Ulm, Germany; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, A-1210 Vienna, Austria	Kantonsspital St. Gallen; Leipzig University; Ulm University; University of Veterinary Medicine Vienna	Ludewig, B (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland.	burkhard.ludewig@kssg.ch		Gil Cruz, Cristina/0000-0001-5285-6503	Swiss MS Society; Helmut Horten Foundation; Swiss National Science Foundation [146133]; Austrian GEN-AU III project Austromouse	Swiss MS Society; Helmut Horten Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian GEN-AU III project Austromouse	We would like to thank Rita De Giuli and Manuela Schegg for technical support. This study was funded by grants from the Swiss MS Society (to B.L.), the Helmut Horten Foundation (to B.L.) and the Swiss National Science Foundation (146133, to B.L.) and by the Austrian GEN-AU III project Austromouse (to T.R.).	Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bagai R, 2005, J IMMUNOL, V174, P7711, DOI 10.4049/jimmunol.174.12.7711; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Bose F, 2013, AM J PATHOL, V183, P413, DOI 10.1016/j.ajpath.2013.04.021; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000686; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Christopherson KW, 2003, BLOOD, V101, P801, DOI 10.1182/blood-2002-05-1586; Columba-Cabezas S, 2003, BRAIN PATHOL, V13, P38; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gil-Cruz C, 2012, P NATL ACAD SCI USA, V109, P1233, DOI 10.1073/pnas.1115154109; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937; Junt T, 2002, J IMMUNOL, V168, P6032, DOI 10.4049/jimmunol.168.12.6032; Junt T, 2004, J IMMUNOL, V173, P6684, DOI 10.4049/jimmunol.173.11.6684; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Krumbholz M, 2007, J NEUROIMMUNOL, V190, P72, DOI 10.1016/j.jneuroim.2007.07.024; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mionnet C, 2011, BLOOD, V118, P6115, DOI 10.1182/blood-2011-07-367409; Moseman EA, 2013, IMMUNOL REV, V255, P110, DOI 10.1111/imr.12093; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Nindl V, 2012, EUR J IMMUNOL, V42, P2311, DOI 10.1002/eji.201142209; Noor S, 2010, INFECT IMMUN, V78, P2257, DOI 10.1128/IAI.01314-09; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Pashenkov M, 2003, J NEUROIMMUNOL, V135, P154, DOI 10.1016/S0165-5728(02)00441-1; PERLMAN S, 1990, J EXP MED, V172, P1127, DOI 10.1084/jem.172.4.1127; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013	47	56	58	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					622	633		10.1016/j.immuni.2015.12.022	http://dx.doi.org/10.1016/j.immuni.2015.12.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26921107	Bronze, Green Published			2022-12-18	WOS:000372784200019
J	Perdiguero, EG; Klapproth, K; Schulz, C; Busch, K; de Bruijn, M; Rodewald, HR; Geissmann, F				Perdiguero, Elisa Gomez; Klapproth, Kay; Schulz, Christian; Busch, Katrin; de Bruijn, Marella; Rodewald, Hans-Reimer; Geissmann, Frederic			The Origin of Tissue-Resident Macrophages: When an Erythro-myeloid Progenitor Is an Erythro-myeloid Progenitor	IMMUNITY			English	Letter							HEMATOPOIETIC STEM-CELLS		[Perdiguero, Elisa Gomez] Inst Pasteur, CNRS URA 2578, F-75015 Paris, France; [Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, London SE1 1UL, England; [Klapproth, Kay; Busch, Katrin; Rodewald, Hans-Reimer] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; [Schulz, Christian] Univ Munich, D-81377 Munich, Germany; [de Bruijn, Marella] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [de Bruijn, Marella] John Radcliffe Hosp, Oxford OX3 9DS, England; [Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; King's College London; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Oxford; University of Oxford; Memorial Sloan Kettering Cancer Center	Rodewald, HR (corresponding author), Deutsch Krebsforschungszentrum, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	hr.rodewald@Dkfz-Heidelberg.de; geissmaf@mskcc.org	Schulz, Christian/J-8545-2012; Perdiguero, Elisa Gomez/U-2120-2018	Schulz, Christian/0000-0003-3878-7833; Perdiguero, Elisa Gomez/0000-0002-7717-7897	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; Wellcome Trust [101853] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016	5	56	57	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1023	1024		10.1016/j.immuni.2015.11.022	http://dx.doi.org/10.1016/j.immuni.2015.11.022			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682973	Bronze			2022-12-18	WOS:000366846600001
J	Capucha, T; Mizraji, G; Segev, H; Blecher-Gonen, R; Winter, D; Khalaileh, A; Tabib, Y; Attal, T; Nassar, M; Zelentsova, K; Kisos, H; Zenke, M; Sere, K; Hieronymus, T; Burstyn-Cohen, T; Amit, I; Wilensky, A; Hovav, AH				Capucha, Tal; Mizraji, Gabriel; Segev, Hadas; Blecher-Gonen, Ronnie; Winter, Deborah; Khalaileh, Abed; Tabib, Yaara; Attal, Tsipora; Nassar, Maria; Zelentsova, Katya; Kisos, Hen; Zenke, Martin; Sere, Kristin; Hieronymus, Thomas; Burstyn-Cohen, Tal; Amit, Ido; Wilensky, Asaf; Hovav, Avi-Hai			Distinct Murine Mucosal Langerhans Cell Subsets Develop from Pre-dendritic Cells and Monocytes	IMMUNITY			English	Article							IN-VIVO; CONTACT HYPERSENSITIVITY; SKIN; IMMUNIZATION; MACROPHAGES; ORIGINS; RENEW; MICE; DNA	Langerhans cells (LCs) populate the mucosal epithelium, a major entry portal for pathogens, yet their ontogeny remains unclear. We found that, in contrast to skin LCs originating from self-renewing radioresistant embryonic precursors, oral mucosal LCs derive from circulating radiosensitive precursors. Mucosal LCs can be segregated into CD103(+) CD11b(lo) (CD103(+)) and CD11b(+)CD103(-) (CD11b(+)) subsets. We further demonstrated that similar to non-lymphoid dendritic cells (DCs), CD103(+) LCs originate from pre-DCs, whereas CD11b(+) LCs differentiate from both pre-DCs and monocytic precursors. Despite this ontogenetic discrepancy between skin and mucosal LCs, the transcriptomic signature and immunological function of oral LCs highly resemble those of skin LCs but not DCs. These findings, along with the epithelial position, morphology, and expression of the LC-associated phenotype strongly suggest that oral mucosal LCs are genuine LCs. Collectively, in a tissue-dependent manner, murine LCs differentiate from at least three distinct precursors (embryonic, pre-DC, and monocytic) in steady state.	[Capucha, Tal; Mizraji, Gabriel; Segev, Hadas; Tabib, Yaara; Attal, Tsipora; Nassar, Maria; Zelentsova, Katya; Kisos, Hen; Burstyn-Cohen, Tal; Hovav, Avi-Hai] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, IL-91120 Jerusalem, Israel; [Blecher-Gonen, Ronnie; Winter, Deborah; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Khalaileh, Abed] Hadassah Hebrew Univ Med Ctr, Dept Gen Surg, IL-91120 Jerusalem, Israel; [Zenke, Martin; Sere, Kristin; Hieronymus, Thomas] Rhein Westfal TH Aachen, Fac Med, Dept Cell Biol, Inst Biomed Engn, D-52074 Aachen, Germany; [Zenke, Martin; Sere, Kristin; Hieronymus, Thomas] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany; [Wilensky, Asaf] Hadassah Med Ctr, Fac Med Dent, Dept Periodontol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science; Hebrew University of Jerusalem; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; Hebrew University of Jerusalem; Hadassah University Medical Center	Hovav, AH (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, IL-91120 Jerusalem, Israel.	avihaih@ekmd.huji.ac.il	Hieronymus, Thomas/AAU-1995-2020; Winter, Deborah R./AAQ-9253-2020; Burstyn-Cohen, Tal/K-8846-2012	Hieronymus, Thomas/0000-0002-7879-6518; Winter, Deborah R./0000-0003-1806-673X; Burstyn-Cohen, Tal/0000-0002-2324-2921; Blecher, Ronnie/0000-0003-2847-1149	Israel Science Foundation [1418/11]; German-Israeli Foundation; START Program of the Medical Faculty RWTH Aachen University; European Research Council [1782/11]	Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); START Program of the Medical Faculty RWTH Aachen University; European Research Council(European Research Council (ERC)European Commission)	We thank Professor Steffen Jung for helpful discussion. This work was supported by grants from the Israel Science Foundation (1418/11 to A.H) and the German-Israeli Foundation for young investigators (to A.H.). Part of the work was supported by the START Program of the Medical Faculty RWTH Aachen University (to K.S. and T.H) and European Research Council grants (1782/11 to I.A.).	Arizon M, 2012, P NATL ACAD SCI USA, V109, P7043, DOI 10.1073/pnas.1116770109; BARRETT AW, 1993, CLIN EXP IMMUNOL, V92, P158; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cohen-Sela E, 2006, J CONTROL RELEASE, V113, P23, DOI 10.1016/j.jconrel.2006.03.010; Elnekave M, 2010, J IMMUNOL, V185, P3463, DOI 10.4049/jimmunol.1001825; Etchart N, 2001, J IMMUNOL, V167, P384, DOI 10.4049/jimmunol.167.1.384; Gaiser MR, 2012, P NATL ACAD SCI USA, V109, pE889, DOI 10.1073/pnas.1117674109; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hervouet C, 2010, J IMMUNOL, V184, P4842, DOI 10.4049/jimmunol.0901695; Hovav AH, 2014, MUCOSAL IMMUNOL, V7, P27, DOI 10.1038/mi.2013.42; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; KOTANI H, 1991, ARCH HISTOL CYTOL, V54, P51, DOI 10.1679/aohc.54.51; KRIPKE ML, 1990, J NATL CANCER I, V82, P1392, DOI 10.1093/jnci/82.17.1392; Kurita T, 2010, DIFFERENTIATION, V80, P99, DOI 10.1016/j.diff.2010.06.007; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lungova V, 2011, J ANAT, V218, P699, DOI 10.1111/j.1469-7580.2011.01367.x; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Martinez-Cingolani C, 2014, BLOOD, V124, P2411, DOI 10.1182/blood-2014-04-568311; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Milne P, 2015, BLOOD, V125, P470, DOI 10.1182/blood-2014-08-593582; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; NEWCOMB GM, 1986, ARCH ORAL BIOL, V31, P727, DOI 10.1016/0003-9969(86)90004-X; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Schlitzer A, 2012, BLOOD, V119, P6063, DOI 10.1182/blood-2012-03-418400; Sere K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23083; Strobl H, 1996, J IMMUNOL, V157, P1499; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004	41	56	56	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					369	381		10.1016/j.immuni.2015.06.017	http://dx.doi.org/10.1016/j.immuni.2015.06.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26231115	Bronze			2022-12-18	WOS:000360101200018
J	Kalia, V; Penny, LA; Yuzefpolskiy, Y; Baumann, FM; Sarkar, S				Kalia, Vandana; Penny, Laura Anne; Yuzefpolskiy, Yevgeniy; Baumann, Florian Martin; Sarkar, Surojit			Quiescence of Memory CD8(+) T Cells Is Mediated by Regulatory T Cells through Inhibitory Receptor CTLA-4	IMMUNITY			English	Article							IN-VIVO; DIFFERENTIATION; EFFECTOR; PROLIFERATION; NAIVE; INFECTIONS; FATES; AUTOIMMUNITY; STIMULATION; INDUCTION	Immune memory cells are poised to rapidly expand and elaborate effector functions upon reinfection yet exist in a functionally quiescent state. The paradigm is that memory T cells remain inactive due to lack of T cell receptor (TCR) stimuli. Here, we report that regulatory T (Treg) cells orchestrate memory T cell quiescence by suppressing effector and proliferation programs through inhibitory receptor, cytotoxic-T-lymphocyte-associated protein-4 (CTLA-4). Loss of Treg cells resulted in activation of genome-wide transcriptional programs characteristic of effector T cells and drove transitioning as well as established memory CD8(+) T cells toward terminally differentiated KLRG-1(hi)IL-7R alpha(lo)GzmB(hi) phenotype, with compromised metabolic fitness, longevity, polyfunctionality, and protective efficacy. CTLA-4 functionally replaced Treg cells in trans to rescue memory T cell defects and restore homeostasis. These studies present the CTLA-4-CD28-CD80/CD86 axis as a potential target to accelerate vaccine-induced immunity and improve T cell memory quality in current cancer immunotherapies proposing transient Treg cell ablation.	[Kalia, Vandana; Penny, Laura Anne; Yuzefpolskiy, Yevgeniy; Baumann, Florian Martin; Sarkar, Surojit] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sarkar, S (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	sarkarkalia@gmail.com			Huck Institutes of Life Sciences at PSU; NIH [AI103748]; USDA AES (Mechanisms of Immune Responses to Pathogens and Vaccines) [4531]; Careers in Immunology Fellowship from American Association of Immunologists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI103748] Funding Source: NIH RePORTER	Huck Institutes of Life Sciences at PSU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA AES (Mechanisms of Immune Responses to Pathogens and Vaccines); Careers in Immunology Fellowship from American Association of Immunologists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research funding from the Huck Institutes of Life Sciences at PSU (S.S. and V.K.), NIH (AI103748, S.S.), USDA AES project #4531 (Mechanisms of Immune Responses to Pathogens and Vaccines, V.K. and S.S.), and a Careers in Immunology Fellowship from the American Association of Immunologists (S.S.) to support Y.Y. The authors would like to thank Dr. Andrea Cooper (Trudeau Institute) for critically reading the manuscript, Dr. Hozefa Bandukwala (Pfizer) for helpful discussions, and the Huck Institutes of Life Sciences Genomics and Flow Cytometry core facilities.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Khan AA, 2013, BLOOD, V121, P4473, DOI 10.1182/blood-2012-06-435412; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yuzefpolskiy Y., 2014, CELL MOL IMMUNOL	38	56	60	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1116	1129		10.1016/j.immuni.2015.05.023	http://dx.doi.org/10.1016/j.immuni.2015.05.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084026	Bronze			2022-12-18	WOS:000356362800016
J	Kumar, V; Dasoveanu, DC; Chyou, S; Tzeng, TC; Rozo, C; Liang, Y; Stohl, W; Fu, YX; Ruddle, NH; Lu, TT				Kumar, Varsha; Dasoveanu, Dragos C.; Chyou, Susan; Tzeng, Te-Chen; Rozo, Cristina; Liang, Yong; Stohl, William; Fu, Yang-Xin; Ruddle, Nancy H.; Lu, Theresa T.			A Dendritic-Cell-Stromal Axis Maintains Immune Responses in Lymph Nodes	IMMUNITY			English	Article							FIBROBLASTIC RETICULAR CELLS; CD11C(+) CELLS; T-CELLS; B-CELLS; HOMEOSTASIS; EXPRESSION; SYSTEM; GROWTH; ENTRY; MICROENVIRONMENTS	Within secondary lymphoid tissues, stromal reticular cells support lymphocyte function, and targeting reticular cells is a potential strategy for controlling pathogenic lymphocytes in disease. However, the mechanisms that regulate reticular cell function are not well understood. Here we found that during an immune response in lymph nodes, dendritic cells (DCs) maintain reticular cell survival in multiple compartments. DC-derived lymphotoxin beta receptor (LT beta R) ligands were critical mediators, and LT beta R signaling on reticular cells mediated cell survival by modulating podoplanin (PDPN). PDPN modulated integrin-mediated cell adhesion, which maintained cell survival. This DC-stromal axis maintained lymphocyte survival and the ongoing immune response. Our findings provide insight into the functions of DCs, LTbR, and PDPN and delineate a DC-stromal axis that can potentially be targeted in autoimmune or lymphoproliferative diseases.	[Kumar, Varsha; Dasoveanu, Dragos C.; Chyou, Susan; Tzeng, Te-Chen; Rozo, Cristina; Lu, Theresa T.] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA; [Lu, Theresa T.] Hosp Special Surg, Pediat Rheumatol, New York, NY 10021 USA; [Lu, Theresa T.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Liang, Yong; Fu, Yang-Xin] Univ Chicago, Pritzker Sch Med, Dept Pathol, Chicago, IL 60637 USA; [Stohl, William] Univ So Calif, Keck Sch Med, Dept Rheumatol, Los Angeles, CA 90033 USA; [Ruddle, Nancy H.] Yale Univ, Sch Med, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA	Cornell University; University of Chicago; University of Southern California; Yale University	Lu, TT (corresponding author), Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA.	lut@hss.edu		fu, yang-xin/0000-0001-8441-6617; Lu, Theresa/0000-0002-5707-8744	Alliance for Lupus Research; St. Giles Foundation;  [R01 AI079178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079178] Funding Source: NIH RePORTER	Alliance for Lupus Research; St. Giles Foundation; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge everyone in the Lu lab for helping hands, Alessandra Pernis and Jane Salmon and labs for helpful discussions, Michel Nussenzweig for zDC-DTR mice, and Jeff Browning and Adrian Erlebacher for helpful comments on the manuscript. This work was supported by R01 AI079178 (T.L.), the Alliance for Lupus Research (T.L.), and the St. Giles Foundation (T.L.).	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Benahmed F, 2014, J IMMUNOL, V192, P4153, DOI 10.4049/jimmunol.1301765; Boulianne B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00243; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Chyou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032828; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junt T, 2006, EUR J IMMUNOL, V36, P2061, DOI 10.1002/eji.200626255; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mionnet C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001672; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tzeng TC, 2010, J IMMUNOL, V184, P4247, DOI 10.4049/jimmunol.0902914; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111; Zhu MZ, 2011, J IMMUNOL, V186, P7156, DOI 10.4049/jimmunol.1002097	41	56	56	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					719	730		10.1016/j.immuni.2015.03.015	http://dx.doi.org/10.1016/j.immuni.2015.03.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902483	Green Accepted, Bronze			2022-12-18	WOS:000353347500017
J	Tsai, SH; Kinoshita, M; Kusu, T; Kayama, H; Okumura, R; Ikeda, K; Shimada, Y; Takeda, A; Yoshikawa, S; Obata-Ninomiya, K; Kurashima, Y; Sato, S; Umemoto, E; Kiyono, H; Karasuyama, H; Takeda, K				Tsai, Shih Han; Kinoshita, Makoto; Kusu, Takashi; Kayama, Hisako; Okumura, Ryu; Ikeda, Kayo; Shimada, Yosuke; Takeda, Akira; Yoshikawa, Soichiro; Obata-Ninomiya, Kazushige; Kurashima, Yosuke; Sato, Shintaro; Umemoto, Eiji; Kiyono, Hiroshi; Karasuyama, Hajime; Takeda, Kiyoshi			The Ectoenzyme E-NPP3 Negatively Regulates ATP-Dependent Chronic Allergic Responses by Basophils and Mast Cells	IMMUNITY			English	Article							AIRWAY INFLAMMATION; T-CELLS; ACTIVATION; ROLES; ASTHMA; CD39; PROTECTION; MECHANISM; AUTOTAXIN; NTPDASE	Crosslinking of the immunoglobulin receptor Fc epsilon RI activates basophils and mast cells to induce immediate and chronic allergic inflammation. However, it remains unclear how the chronic allergic inflammation is regulated. Here, we showed that ecto-nucleotide pyrophosphatase-phosphodiesterase 3 ( E-NPP3), also known as CD203c, rapidly induced by Fc epsilon RI crosslinking, negatively regulated chronic allergic inflammation. Basophil and mast cell numbers increased in Enpp3(-/-) mice with augmented serum ATP concentrations. Enpp3(-/-) mice were highly sensitive to chronic allergic pathologies, which was reduced by ATP blockade. Fc epsilon RI crosslinking induced ATP secretion from basophils and mast cells, and ATP activated both cells. ATP clearance was impaired in Enpp3(-/-) cells. Enpp3(-/-) P2rx7(-/-) mice showed decreased responses to FceRI crosslinking. Thus, ATP released by Fc epsilon RI crosslinking stimulates basophils and mast cells for further activation causing allergic inflammation. E-NPP3 decreases ATP concentration and suppresses basophil and mast cell activity.	[Tsai, Shih Han; Kinoshita, Makoto; Kusu, Takashi; Kayama, Hisako; Okumura, Ryu; Ikeda, Kayo; Shimada, Yosuke; Takeda, Akira; Umemoto, Eiji; Takeda, Kiyoshi] Osaka Univ, WPI Immunol Frontier Res Ctr, Grad Sch Med, Lab Immune Regulat,Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan; [Tsai, Shih Han; Kinoshita, Makoto; Kusu, Takashi; Kayama, Hisako; Okumura, Ryu; Ikeda, Kayo; Shimada, Yosuke; Kurashima, Yosuke; Sato, Shintaro; Umemoto, Eiji; Kiyono, Hiroshi; Karasuyama, Hajime; Takeda, Kiyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Yoshikawa, Soichiro; Obata-Ninomiya, Kazushige; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Tokyo 1138519, Japan; [Kurashima, Yosuke; Sato, Shintaro; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Dept Microbiol & Immunol, Tokyo 1088639, Japan	Osaka University; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); University of Tokyo	Takeda, K (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Grad Sch Med, Lab Immune Regulat,Dept Microbiol & Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ktakeda@ongene.med.osaka-u.ac.jp	Karasuyama, Hajime/A-7966-2011; Umemoto, Eiji/AAX-6562-2021; Takeda, Akira/AAH-7892-2019; Kiyono, Hiroshi/AAC-6735-2022; Takeda, Kiyoshi/C-9331-2009	Karasuyama, Hajime/0000-0003-0689-0836; Takeda, Akira/0000-0003-4748-4543; Obata-Ninomiya, Kazushige/0000-0002-0984-6518; Takeda, Akira/0000-0002-8173-9135; Takeda, Kiyoshi/0000-0002-1778-6332; Sato, Shintaro/0000-0001-5156-3354	Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency; Ministry of Health, Labour and Welfare	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank Y. Uno and M. Tajima for generation of Enpp3<SUP>-/-</SUP> mice, T. Kondo and Y. Magota for technical assistance, S. Pareek for critical reading of the manuscript, and C. Hidaka for secretarial assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Japan Science and Technology Agency, and by the Ministry of Health, Labour and Welfare.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Bischoff SC, 1999, P NATL ACAD SCI USA, V96, P8080, DOI 10.1073/pnas.96.14.8080; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Buhring HJ, 2004, INT ARCH ALLERGY IMM, V133, P317, DOI 10.1159/000077351; Buhring HJ, 2001, BLOOD, V97, P3303, DOI 10.1182/blood.V97.10.3303; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Denlinger LC, 2013, AM J RESP CRIT CARE, V187, P28, DOI 10.1164/rccm.201204-0750OC; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Ghannadan M, 2002, INT ARCH ALLERGY IMM, V127, P299, DOI 10.1159/000057747; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Manthei DM, 2012, J ALLERGY CLIN IMMUN, V130, P496, DOI 10.1016/j.jaci.2012.05.040; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Schetinger MRC, 2007, BIOFACTORS, V31, P77, DOI 10.1002/biof.5520310205; Shiratori M, 2010, J NEUROCHEM, V114, P810, DOI 10.1111/j.1471-4159.2010.06809.x; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Sudo N, 1996, J IMMUNOL, V156, P3970; Swanson KD, 1998, J BIOL CHEM, V273, P19965, DOI 10.1074/jbc.273.32.19965; Umemoto E, 2011, CRIT REV IMMUNOL, V31, P147, DOI 10.1615/CritRevImmunol.v31.i2.40; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wakahara K, 2013, ALLERGY, V68, P180, DOI 10.1111/all.12072; Wang LN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/350949; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	41	56	57	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					279	293		10.1016/j.immuni.2015.01.015	http://dx.doi.org/10.1016/j.immuni.2015.01.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692702	Bronze			2022-12-18	WOS:000349916400012
J	Gulen, MF; Bulek, K; Xiao, H; Yu, MJ; Gao, J; Sun, L; Beurel, E; Kaidanovich-Beilin, O; Fox, PL; DiCorleto, PE; Wang, JA; Qin, J; Wald, DN; Woodgett, JR; Jope, RS; Carman, J; Dongre, A; Li, XX				Gulen, Muhammet F.; Bulek, Katarzyna; Xiao, Hui; Yu, Minjia; Gao, Ji; Sun, Lillian; Beurel, Eleonore; Kaidanovich-Beilin, Oksana; Fox, Paul L.; DiCorleto, Paul E.; Wang, Jian-an; Qin, Jun; Wald, David N.; Woodgett, James R.; Jope, Richard S.; Carman, Julie; Dongre, Ashok; Li, Xiaoxia			Inactivation of the Enzyme GSK3 alpha by the Kinase IKKi Promotes AKT-mTOR Signaling Pathway that Mediates Interleukin-1-Induced Th17 Cell Maintenance	IMMUNITY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; T-CELLS; SKELETAL-MUSCLE; DIFFERENTIATION; INHIBITION; RAPAMYCIN; EFFECTOR; INSULIN; LINEAGE; T(H)17	Interleukin-1 (IL-1)-induced activation of the mTOR kinase pathway has major influences on Th17 cell survival, proliferation, and effector function. Via biochemical and genetic approaches, the kinases IKKi and GSK3 alpha were identified as the critical intermediate signaling components for IL-1-induced AKT activation, which in turn activated mTOR. Although insulin-induced AKT activation is known to phosphorylate and inactivate GSK3 alpha and GSK3 beta, we found that GSK3 alpha but not GSK3 beta formed a constitutive complex to phosphorylate and suppress AKT activation, showing that a reverse action from GSK to AKT can take place. Upon IL-1 stimulation, IKKi was activated to mediate GSK3 alpha phosphorylation at S21, thereby inactivating GSK3 alpha to promote IL-1-induced AKT-mTOR activation. Thus, IKKi has a critical role in Th17 cell maintenance and/or proliferation through the GSK-AKT-mTOR pathway, implicating the potential of IKKi as a therapeutic target.	[Gulen, Muhammet F.; Bulek, Katarzyna; Yu, Minjia; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Fox, Paul L.; DiCorleto, Paul E.] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Fox, Paul L.; DiCorleto, Paul E.] Cleveland Clin Fdn, Cleveland Clin Lerner Coll Med, Cleveland, OH 44195 USA; [Qin, Jun] Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Xiao, Hui] Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Gao, Ji; Carman, Julie; Dongre, Ashok] Bristol Myers Squibb Co, Discovery Biol, Princeton, NJ 08543 USA; [Sun, Lillian; Wald, David N.] Case Western Reserve Univ Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Beurel, Eleonore; Jope, Richard S.] Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Kaidanovich-Beilin, Oksana; Woodgett, James R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wang, Jian-an] Zhejiang Univ, Affiliated Hosp 2, Dept Mol Cardiol, Scholl Med, Hangzhou 310009, Peoples R China; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Bristol-Myers Squibb; Case Western Reserve University; University of Miami; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Zhejiang University; University of Toronto	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Woodgett, Jim/F-1087-2010; Bulek, Katarzyna/L-7517-2015	Woodgett, Jim/0000-0003-3731-5797; Dongre, Ashok/0000-0001-9624-4584; Sun, Lillian/0000-0001-7890-4489; Kaidanovich-Beilin, Oksana/0000-0002-5427-1151; Qin, Jun/0000-0002-2647-9270; Gulen, Muhammet/0000-0002-7139-6781	NIH [2PO1 HL 029582-26A1, 2PO1CA062220-16A1]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095380, R00MH090236] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from NIH (2PO1 HL 029582-26A1; 2PO1CA062220-16A1). The Pdpk1<SUP>-/-</SUP> DLD1 and HCT116 cells were provided by B. Vogelstein of Johns Hopkins Kimmel Cancer Center, Baltimore, MD.	Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gao J, 2004, TOXICOL IN VITRO, V18, P533, DOI 10.1016/j.tiv.2004.01.012; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nelsen CJ, 2003, J BIOL CHEM, V278, P3656, DOI 10.1074/jbc.M209374200; Pang JX, 2002, J PROTEOME RES, V1, P161, DOI 10.1021/pr015518w; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108	38	56	60	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					800	812		10.1016/j.immuni.2012.08.019	http://dx.doi.org/10.1016/j.immuni.2012.08.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23142783	Green Accepted, Bronze			2022-12-18	WOS:000311460000008
J	Jun, HK; Lee, SH; Lee, HR; Choi, BK				Jun, Hye-Kyoung; Lee, Sung-Hoon; Lee, Hae-Ri; Choi, Bong-Kyu			Integrin alpha 5 beta 1 Activates the NLRP3 Inflammasome by Direct Interaction with a Bacterial Surface Protein	IMMUNITY			English	Article							NALP3 INFLAMMASOME; CLINICAL-PARAMETERS; EXPRESSION; GLYCOSYLATION; MACROPHAGES; IL-1-BETA; RECEPTORS; RELEASE; DISEASE; COMPLEX	Integrins are cell-surface heterodimeric glycoproteins composed of alpha and beta subunits that mediate cell-cell, cell-extracellular matrix, and cell-pathogen interactions. In this study, we report a specific role of integrin alpha 5 beta 1 in NLRP3 inflammasome activation in macrophages stimulated by Td92, a surface protein of the periodontopathogen, Treponema denticola. The direct interaction of Td92 with the cell membrane integrin alpha 5 beta 1 resulted in ATP release and K+ efflux, which are the main events in NLRP3 activation. This interaction was arginine-glycine-aspartate (RGD)-independent, and Td92 internalization was not required for the activity. An integrin alpha 5 beta 1 antibody and oxATP, an ATP receptor antagonist, inhibited NLRP3 expression, caspase-1 activation., interleukin-1 beta (IL-1 beta) secretion, and proIL-1 beta synthesis, all of which were regulated by NF-kappa B activation. Therefore, our data has identified the integrin alpha 5 beta 1 as a principal cell membrane receptor for both NLRP3 inflammasome activation and IL-1 beta transcription by a bacterial protein, which could exaggerate inflammation, a characteristic of periodontitis.	[Jun, Hye-Kyoung; Lee, Hae-Ri; Choi, Bong-Kyu] Seoul Natl Univ, Sch Dent, Dept Oral Microbiol & Immunol, Seoul, South Korea; [Choi, Bong-Kyu] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea; [Lee, Sung-Hoon] Dankook Univ, Coll Dent, Dept Oral Microbiol & Immunol, Cheonan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Dankook University	Choi, BK (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Microbiol & Immunol, Seoul, South Korea.	bongchoi@snu.ac.kr	Lee, Hae-Ri/AAH-1010-2020	Lee, Hae-Ri/0000-0003-4197-1252	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0017319]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (2010-0017319).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; Chen XM, 1997, BIOCHEM BIOPH RES CO, V234, P594, DOI 10.1006/bbrc.1997.6593; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Ferreira SB, 2008, INFECT IMMUN, V76, P3725, DOI 10.1128/IAI.00546-08; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Jun HK, 2008, INFECT IMMUN, V76, P2428, DOI 10.1128/IAI.01128-07; Jun HK, 2007, MICROBIOL-SGM, V153, P2386, DOI 10.1099/mic.0.2007/006650-0; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Liu CM, 1996, CYTOKINE, V8, P161, DOI 10.1006/cyto.1996.0023; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Roman J, 2000, CYTOKINE, V12, P1581, DOI 10.1006/cyto.2000.0759; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Teles R, 2010, J PERIODONTOL, V81, P89, DOI 10.1902/jop.2009.090397; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725	29	56	58	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					755	768		10.1016/j.immuni.2012.05.002	http://dx.doi.org/10.1016/j.immuni.2012.05.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22608495	Bronze			2022-12-18	WOS:000304976000010
J	Holgate, ST; Davies, DE				Holgate, Stephen T.; Davies, Donna E.			Rethinking the Pathogenesis of Asthma	IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; PERSISTENT ASTHMA; EPITHELIAL-CELLS; RHINOVIRUS; INFECTION; DISEASE; LIFE; MECHANISMS; RISK	Asthma research has focused primarily on allergic pathways on the basis that the majority of asthma is associated with atopy, the recruitment of the Th2-type T cell, the cytokines, and the chemokines that are released on exposure to allergens, and the IgE pathway. However, despite considerable investment by industry, targeting these pathways has not resulted in new treatments being developed beyond blockade of cysteinyl leukotrienes and IgE and improvements in inhaled corticosteroids and beta(2)-adrenoceptor bronchodilators. Increasingly, it is recognized that asthma is a heterogeneous disorder, and while important, allergen sensitization is only one component of the disease, with many other environmental and genetic factors playing a role. In addition, these factors act locally on a susceptible airway epithelium that is both structurally and functionally deficient. It may be worthwhile to focus on increasing the resilience of the airways to environmental insults in addition to improving strategies that modify adaptive immunity or suppress inflammation.	[Holgate, Stephen T.; Davies, Donna E.] Univ Southampton, Sch Med, Div 3, Southampton S016 61D, Hants, England	University of Southampton	Holgate, ST (corresponding author), Univ Southampton, Sch Med, Div 3, Southampton S016 61D, Hants, England.	s.holgate@soton.ac.uk	Davies, Donna E/H-2993-2012	Davies, Donna/0000-0002-5117-2991	MRC [G0800766] Funding Source: UKRI; Medical Research Council [G0800766] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; [Anonymous], 2008, LANCET, V372, P1009, DOI 10.1016/S0140-6736(08)61414-2; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Bradding P, 2009, THORAX, V64, P278, DOI 10.1136/thx.2008.106427; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dharmage SC, 2009, EUR RESPIR J, V33, P237, DOI 10.1183/09031936.00062907; Erin EM, 2006, AM J RESP CRIT CARE, V174, P753, DOI 10.1164/rccm.200601-072OC; Haahtela T, 2006, THORAX, V61, P663, DOI 10.1136/thx.2005.055699; Holgate S, 2008, EUR RESPIR J, V32, P1433, DOI 10.1183/09031936.00053108; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; HOLGATE ST, 1989, RESP MED, V83, P25, DOI 10.1016/S0954-6111(89)80247-1; Holgate S, 2009, RESP MED, V103, P1098, DOI 10.1016/j.rmed.2009.03.008; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Sears MR, 2008, J ALLERGY CLIN IMMUN, V122, P662, DOI 10.1016/j.jaci.2008.08.003; Stevens MT, 2007, PHARM STAT, V6, P123, DOI 10.1002/pst.279; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Tschernig T, 2001, THORAX, V56, P427, DOI 10.1136/thorax.56.6.427; van der Wouden JC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002173.pub2; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yano H, 2007, CLIN CANCER RES, V13, P6494, DOI 10.1158/1078-0432.CCR-07-1324	36	56	59	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 18	2009	31	3					362	367		10.1016/j.immuni.2009.08.013	http://dx.doi.org/10.1016/j.immuni.2009.08.013			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766079	Bronze			2022-12-18	WOS:000270525900002
J	Walsh, PT; Strom, TB; Turka, LA				Walsh, PT; Strom, TB; Turka, LA			Routes to transplant tolerance versus rejection: The role of cytokines	IMMUNITY			English	Review							REGULATORY T-CELLS; CARDIAC ALLOGRAFT SURVIVAL; DENDRITIC CELLS; IL-2 RECEPTOR; IN-VIVO; INFECTIOUS TOLERANCE; AUTOIMMUNE-DISEASE; BLOCKADE-RESISTANT; CD4(+); INDUCTION	The alloimmune response can be divided into specific junctures where critical decisions between tolerance and immunity are made which define the outcome of the transplant. At these "decision nodes" various cytokines direct alloresponsive T cells to develop either a proinflammatory response aimed at graft destruction or an immunoregulatory response facilitating graft acceptance. This review will focus on the role of these cytokines in influencing the progression of an alloimmune response leading ultimately to either allograft survival or rejection.	Univ Penn, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Immunol, Boston, MA 02215 USA	University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Turka, LA (corresponding author), Univ Penn, 700 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	turka@mail.med.upenn.edu	Walsh, Patrick/I-7909-2014	Walsh, Patrick/0000-0002-0130-8766	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, R01AI037691] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-41521, AI-37691, R01 AI037691, P01 AI041521] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barbara JAJ, 2000, TRANSPLANTATION, V70, P1641, DOI 10.1097/00007890-200012150-00017; BATCHELOR JR, 1982, TRANSPL P, V14, P535; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BROMBERG JS, 1995, CURR OPIN IMMUNOL, V7, P639, DOI 10.1016/0952-7915(95)80070-0; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; Colovai AI, 2000, TRANSPLANTATION, V69, P1304, DOI 10.1097/00007890-200004150-00016; Dai ZH, 1998, J IMMUNOL, V161, P1659; Dai ZH, 2000, J IMMUNOL, V165, P3031, DOI 10.4049/jimmunol.165.6.3031; Debruyne LA, 1998, GENE THER, V5, P1079, DOI 10.1038/sj.gt.3300694; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; DUNNE A, 2003, SCI STKE; Ferrari-Lacraz S, 2001, J IMMUNOL, V167, P3478, DOI 10.4049/jimmunol.167.6.3478; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Harris NL, 1999, IMMUNOL CELL BIOL, V77, P304, DOI 10.1046/j.1440-1711.1999.00835.x; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hornick PI, 2000, CIRCULATION, V101, P2405, DOI 10.1161/01.CIR.101.20.2405; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Josien R, 1998, J CLIN INVEST, V102, P1920, DOI 10.1172/JCI4221; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kishimoto K, 2002, J CLIN INVEST, V109, P1471, DOI 10.1172/JCI14947; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Konieczny BT, 1998, J IMMUNOL, V160, P2059; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; KUPIECWEGLINSKI JW, 1987, TRANSPLANT P, V19, P591; Lee WT, 1996, J IMMUNOL, V157, P5300; Li XC, 1998, J IMMUNOL, V161, P2241; Li XC, 1998, J IMMUNOL, V161, P890; Li XC, 2001, IMMUNITY, V14, P407, DOI 10.1016/S1074-7613(01)00121-2; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Li XC, 2000, J IMMUNOL, V164, P1193, DOI 10.4049/jimmunol.164.3.1193; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; MADSEN JC, 1988, NATURE, V332, P161, DOI 10.1038/332161a0; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; MITRA RS, 1995, J IMMUNOL, V154, P2668; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mueller DL, 1996, J IMMUNOL, V156, P1764; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; Newell KA, 1999, J IMMUNOL, V163, P2358; Nikolic B, 1997, IMMUNOL RES, V16, P217, DOI 10.1007/BF02786391; O'Connell PJ, 2002, J IMMUNOL, V168, P143, DOI 10.4049/jimmunol.168.1.143; Onodera K, 1997, J IMMUNOL, V158, P1572; Pettigrew GJ, 1998, J IMMUNOL, V161, P1292; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Piccotti JR, 1996, J IMMUNOL, V157, P1951; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; REED MH, 1989, TRANSPLANTATION, V47, P55, DOI 10.1097/00007890-198901000-00013; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Smith JA, 2000, J HYDROMETEOROL, V1, P5, DOI 10.1175/1525-7541(2000)001<0005:CRAFIT>2.0.CO;2; STEIGER J, 1995, J IMMUNOL, V155, P489; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Streilein JW, 2002, HUM IMMUNOL, V63, P435, DOI 10.1016/S0198-8859(02)00393-2; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Sykes M, 2001, IMMUNITY, V14, P417, DOI 10.1016/S1074-7613(01)00122-4; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; TINUBU SA, 1994, J IMMUNOL, V153, P4330; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wang CK, 1999, TRANSPLANT P, V31, P951, DOI 10.1016/S0041-1345(98)01851-X; Wang H, 2003, J IMMUNOL, V171, P3823, DOI 10.4049/jimmunol.171.7.3823; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Womer KL, 2001, PHILOS T ROY SOC B, V356, P639, DOI 10.1098/rstb.2001.0843; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Zhai Y, 2002, J IMMUNOL, V169, P4667, DOI 10.4049/jimmunol.169.8.4667; Zhang ZX, 2001, TRANSPLANT P, V33, P84, DOI 10.1016/S0041-1345(00)01915-1; ZHENG XX, 1995, J IMMUNOL, V154, P5590; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; [No title captured]	91	56	59	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					121	131		10.1016/S1074-7613(04)00024-X	http://dx.doi.org/10.1016/S1074-7613(04)00024-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975235	Bronze, Green Accepted			2022-12-18	WOS:000221442400002
J	Donnadieu, E; Jouvin, MH; Rana, S; Moffatt, MF; Mockford, EH; Cookson, WO; Kinet, JP				Donnadieu, E; Jouvin, MH; Rana, S; Moffatt, MF; Mockford, EH; Cookson, WO; Kinet, JP			Competing functions encoded in the allergy-associated Fc epsilon RI beta gene	IMMUNITY			English	Article							HIGH-AFFINITY RECEPTOR; IMMUNOGLOBULIN-E RECEPTOR; PRE-MESSENGER-RNA; UBIQUITIN-PROTEASOME PATHWAY; EPIDERMAL LANGERHANS CELLS; HUMAN-BLOOD BASOPHILS; IGE RECEPTOR; ENDOPLASMIC-RETICULUM; TRANSFECTED CELLS; CHROMOSOME 11Q13	Allergic reactions are triggered via crosslinking of the high-affinity receptor for immunoglobulin E, FcepsilonRI. In humans, FcepsilonRI is expressed as a tetramer (alphabetagamma(2)) and a trimer (alphagamma(2)). The beta subunit is an amplifier of FcepsilonRI surface expression and signaling. Here, we show that as a consequence of alternative splicing, the FcepsilonRIbeta gene encodes two proteins with opposing and competing functions. One isoform is the full-length classical beta, the other a novel truncated form, beta(T). In contrast to beta, beta(T) prevents FcepsilonRI surface expression by inhibiting alpha chain maturation. Moreover, beta(T) competes with beta to control FcepsilonRI surface expression in vitro. We propose that the relative abundance of the products of the beta gene may control the level of FcepsilonRI surface expression and thereby influence susceptibility to allergic diseases.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Oxford, Asthma Genet Grp, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Oxford; Wellcome Centre for Human Genetics	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.	jkinet@caregroup.harvard.edu	Cookson, William/HHC-1790-2022; Donnadieu, Emmanuel/P-4566-2017					Adra CN, 1999, CLIN GENET, V55, P431, DOI 10.1034/j.1399-0004.1999.550606.x; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; COLLEE JM, 1993, LANCET, V342, P936, DOI 10.1016/0140-6736(93)91988-X; COOKSON W, 1999, NATURE, V402, P85; Cookson WOC, 2002, CHEST, V121, p7S, DOI 10.1378/chest.121.3_suppl.7S-a; COOKSON WOCM, 1989, LANCET, V1, P1292; Cresswell P, 1997, CURR BIOL, V7, pR552, DOI 10.1016/S0960-9822(06)00279-X; Cullen BR, 2002, NAT IMMUNOL, V3, P597, DOI 10.1038/ni0702-597; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Donnadieu E, 2000, J IMMUNOL, V165, P3917, DOI 10.4049/jimmunol.165.7.3917; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; Folster-Holst R, 1998, HUM GENET, V102, P236, DOI 10.1007/s004390050685; Green SL, 1998, AM J RESP CRIT CARE, V158, P1487, DOI 10.1164/ajrccm.158.5.9707099; Hijazi Z, 1998, CLIN GENET, V53, P149; Hill MR, 1996, HUM MOL GENET, V5, P959, DOI 10.1093/hmg/5.7.959; HILL MR, 1995, BRIT MED J, V311, P776, DOI 10.1136/bmj.311.7008.776; Hizawa N, 1998, J ALLERGY CLIN IMMUN, V102, P449, DOI 10.1016/S0091-6749(98)70134-4; HOLOWKA D, 1982, MOL IMMUNOL, V19, P219, DOI 10.1016/0161-5890(82)90334-0; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kimura T, 1996, J BIOL CHEM, V271, P27962, DOI 10.1074/jbc.271.44.27962; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; KINET JP, 1987, BIOCHEMISTRY-US, V26, P4605, DOI 10.1021/bi00389a002; KUSTER H, 1992, J BIOL CHEM, V267, P12782; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laprise C, 2000, IMMUNOGENETICS, V51, P695, DOI 10.1007/s002510000185; LEONARD EJ, 1984, J LEUKOCYTE BIOL, V35, P169; LETOURNEUR O, 1995, J BIOL CHEM, V270, P8249, DOI 10.1074/jbc.270.14.8249; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; Lin R, 1996, J VIRAL HEPATITIS, V3, P85, DOI 10.1111/j.1365-2893.1996.tb00086.x; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Moffatt MF, 1999, CURR OPIN IMMUNOL, V11, P606, DOI 10.1016/S0952-7915(99)00024-2; Nagata H, 2001, HUM GENET, V109, P262, DOI 10.1007/s004390100561; Nissim-Rafinia M, 2002, TRENDS GENET, V18, P123, DOI 10.1016/S0168-9525(01)02619-1; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Palmer LJ, 1998, AM J RESP CRIT CARE, V158, P1825, DOI 10.1164/ajrccm.158.6.9804037; RA C, 1989, J BIOL CHEM, V264, P15323; Rigoli L, 2000, ACTA PAEDIATR, V89, P1056, DOI 10.1080/713794577; Saini SS, 2001, J ALLERGY CLIN IMMUN, V107, P832, DOI 10.1067/mai.2001.114653; SAITO H, 1995, INT ARCH ALLERGY IMM, V107, P63, DOI 10.1159/000236932; SCHWARZBAUM S, 1989, EUR J IMMUNOL, V19, P1015, DOI 10.1002/eji.1830190610; SHIRAKAWA T, 1994, CLIN GENET, V46, P228; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; Sorek R, 2001, NAT BIOTECHNOL, V19, P196, DOI 10.1038/85613; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; VANHERWERDEN L, 1995, LANCET, V346, P1262, DOI 10.1016/S0140-6736(95)91863-9; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vonakis BM, 1997, J BIOL CHEM, V272, P24072, DOI 10.1074/jbc.272.38.24072; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILSON BS, 1995, J BIOL CHEM, V270, P4013, DOI 10.1074/jbc.270.8.4013; Wurzburg BA, 2002, MOL IMMUNOL, V38, P1063, DOI 10.1016/S0161-5890(02)00035-4; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835	64	56	63	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					665	674		10.1016/S1074-7613(03)00115-8	http://dx.doi.org/10.1016/S1074-7613(03)00115-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753743	Bronze			2022-12-18	WOS:000182962200011
J	Weil, R; Schwamborn, K; Alcover, A; Bessia, C; Di Bartolo, V; Israel, A				Weil, R; Schwamborn, K; Alcover, A; Bessia, C; Di Bartolo, V; Israel, A			Induction of the NF-kappa B cascade by recruitment of the scaffold molecule NEMO to the T cell receptor	IMMUNITY			English	Article							KINASE C-THETA; IMMUNOLOGICAL SYNAPSE; PKC-THETA; ACTIVATION; PROTEIN; COMPLEX; ZAP-70; ASSOCIATION; INHIBITOR; ANTIGEN	The mechanism by which TCR signaling activates NF-kappaB is poorly understood. We demonstrate here that the IKK kinase complex is recruited to the immunological synapse and can be coprecipitated with the TCR after T cell activation. Using ZAP-70-deficient T cells expressing a hybrid molecule between the SH2 domain of ZAP-70 and NEMO/IKKgamma, we showed that targeting NEMO to the immunological synapse, and more specifically its 120 N-terminal amino acids, was sufficient to selectively restore NF-kappaB activation in response to TCR ligation. Finally, we demonstrated that targeting of NEMO to the membrane of T cells was sufficient to induce constitutive NF-kappaB activation. This study shows that the localization of NEMO to the immunological synapse is important for TCR-induced NF-kappaB activation and offers a powerful system to dissect the NF-kappaB cascade in T cells.	Inst Pasteur, FRE 2364, CNRS, Unite Biol Mol Express Gen, F-75724 Paris 15, France; Inst Pasteur, CNRS URA 1960, Unite Biol Interact Cellulaires, F-75724 Paris 15, France; Inst Pasteur, CNRS URA 1960, Unite Biol Interact Cellulaires, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Weil, R (corresponding author), Inst Pasteur, FRE 2364, CNRS, Unite Biol Mol Express Gen, 25 Rue Dr Roux, F-75724 Paris 15, France.	rweil@pasteur.fr	Di Bartolo, Vincenzo/AAL-6834-2020	Di Bartolo, Vincenzo/0000-0002-5453-947X; Schwamborn, Klaus/0000-0001-9702-6036; Weil, Robert/0000-0001-5235-0932; Alcover, Andres/0000-0002-9507-3450				Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Di Bartolo V, 2002, EUR J IMMUNOL, V32, P568; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grazioli L, 1998, J BIOL CHEM, V273, P8916, DOI 10.1074/jbc.273.15.8916; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Herndon TM, 2001, J IMMUNOL, V166, P5654, DOI 10.4049/jimmunol.166.9.5654; Jose ES, 2000, IMMUNITY, V12, P161, DOI 10.1016/S1074-7613(00)80169-7; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; LI Q, 2002, NATURE REV IMMUNOL, V2, P275; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Niedergang F, 1997, J IMMUNOL, V159, P1703; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Weil R, 1999, MOL CELL BIOL, V19, P6345; Weil R, 1997, J BIOL CHEM, V272, P9942; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	26	56	61	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2003	18	1					13	26		10.1016/S1074-7613(02)00506-X	http://dx.doi.org/10.1016/S1074-7613(02)00506-X			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530972	Bronze			2022-12-18	WOS:000180860600003
J	Xu, XN; Screaton, GR; McMichael, AJ				Xu, XN; Screaton, GR; McMichael, AJ			Virus infections: Escape, resistance, and counterattack	IMMUNITY			English	Article							CD8(+) T-CELLS; APOPTOSIS; FAS; LYMPHOCYTES; RECEPTOR; MACROPHAGES; GP120; DEATH	Many viruses establish life-long infections in their natural host with few if any clinical manifestations. The relationship between virus and host is a dynamic process in which the virus has evolved the means to coexist by reducing its visibility, while the host immune system attempts to suppress and eliminate infection without damage to itself. This short review describes a variety of strategies that are employed by viruses to evade host immune responses. These include virus-associated escape from T cell recognition, and resistance to apoptosis and counterattack, with special reference to two papers published in this issue of Immunity.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Xu, XN (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England.			Screaton, Gavin/0000-0002-3549-4309				Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Favre-Felix N, 2000, J IMMUNOL, V164, P5023, DOI 10.4049/jimmunol.164.10.5023; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Liu SX, 2001, J IMMUNOL, V166, P5407, DOI 10.4049/jimmunol.166.9.5407; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; O'Connell J, 2001, NAT MED, V7, P271, DOI 10.1038/85395; Raftery MJ, 2001, IMMUNITY, V15, P997, DOI 10.1016/S1074-7613(01)00239-4; Sarid R, 1997, NAT MED, V3, P293, DOI 10.1038/nm0397-293; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; Tollefson AE, 1998, NATURE, V392, P726, DOI 10.1038/33712; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; XU X, 1997, J EXP MED, V186, P1; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1	27	56	60	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					867	870		10.1016/S1074-7613(01)00255-2	http://dx.doi.org/10.1016/S1074-7613(01)00255-2			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754809	Bronze			2022-12-18	WOS:000172961400002
J	Lu, FWM; Yasutomo, K; Goodman, GB; McHeyzer-Williams, LJ; McHeyzer-Williams, MG; Germain, RN; Ashwell, JD				Lu, FWM; Yasutomo, K; Goodman, GB; McHeyzer-Williams, LJ; McHeyzer-Williams, MG; Germain, RN; Ashwell, JD			Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to "holes" in the T cell repertoire	IMMUNITY			English	Article							POSITIVE SELECTION; CYTOCHROME-C; RECEPTOR; MACROPHAGE; APOPTOSIS; COMPLEX; THYMUS; MODEL	We have proposed that glucocorticoids antagonize TCR-mediated activation and influence which TCR avidities result in positive or negative selection. We now analyze the immune response of mice whose thymocytes express antisense transcripts to the glucocorticoid receptor (TKO mice). TKO mice responded normal ly to the complex antigen PPD but were proliferative nonresponders to pigeon cytochrome c 81-104 (PCC), having a large decrease in the frequency of PCC-responsive CD4(+) T cells. Unlike wild-type T cells, few TKO T cells in PCC-specific cell lines expressed V alpha 11(+)V beta 3(+). Furthermore, for naive CD4(+) T cells from unimmunized TKO mice, the frequencies of many of the molecular features common to the CDR3 regions of PCC-responsive V alpha 11(+)V beta 3(+) cells were substantially decreased. Thus, thymocyte glucocorticoid hyporesponsiveness resulted in loss of cells capable of responding to PCC, corresponding to an antigen-specific "hole" in the T cell repertoire.	NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	jda@box-j.nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Yasutomo, Koji/0000-0003-0411-2037	DIVISION OF BASIC SCIENCES - NCI [Z01BC009290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000757] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHWELL JD, 2000, IN PRESS ANN REV IMM; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; DAVIS MM, 1995, ANN NY ACAD SCI, V756, P1, DOI 10.1111/j.1749-6632.1995.tb44477.x; DING L, 1993, J IMMUNOL, V151, P1224; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; FOX BS, 1987, J IMMUNOL, V139, P1578; IWATA M, 1991, EUR J IMMUNOL, V21, P643, DOI 10.1002/eji.1830210316; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KING LB, 1995, IMMUNITY, V3, P647, DOI 10.1016/1074-7613(95)90135-3; MATIS LA, 1987, CELL, V51, P59, DOI 10.1016/0092-8674(87)90010-9; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; McHeyzerWilliams MG, 1996, IMMUNOL REV, V150, P5, DOI 10.1111/j.1600-065X.1996.tb00693.x; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; SPRENT J, 1988, IMMUNOL REV, V101, P172; Tolosa E, 1998, IMMUNITY, V8, P67, DOI 10.1016/S1074-7613(00)80459-8; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vacchio MS, 1997, J EXP MED, V185, P2033, DOI 10.1084/jem.185.11.2033; Vacchio MS, 1999, J IMMUNOL, V163, P1327; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0; ZACHARCHUK CM, 1991, ANN NY ACAD SCI, V636, P52, DOI 10.1111/j.1749-6632.1991.tb33438.x; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037	23	56	56	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					183	192		10.1016/S1074-7613(00)80171-5	http://dx.doi.org/10.1016/S1074-7613(00)80171-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714684	Bronze			2022-12-18	WOS:000085621400008
J	Tetsu, O; Ishihara, H; Kanno, R; Kamiyasu, M; Inoue, H; Tokuhisa, T; Taniguchi, M; Kanno, M				Tetsu, O; Ishihara, H; Kanno, R; Kamiyasu, M; Inoue, H; Tokuhisa, T; Taniguchi, M; Kanno, M			mel-18 negatively regulates cell cycle progression upon B cell antigen receptor stimulation through a cascade leading to c-myc/cdc25	IMMUNITY			English	Article							POLYCOMB GROUP GENE; DNA-BINDING PROTEIN; ZINC-FINGER; C-MYC; DROSOPHILA-MELANOGASTER; POLYHOMEOTIC PROTEIN; BMI-1 PROTOONCOGENE; TUMOR-SUPPRESSOR; DEFICIENT MICE; GROWTH-CONTROL	mel-18 is a mammalian Polycomb group gene encoding a transcriptional repressor with tumor suppressive activity. Overexpression of mel-18 in mice results in cell cycle arrest of B cells upon B cell receptor stimulation with downregulation of c-myc. This phenotype is rescued in mel-18/c-myc double-transgenic mice, suggesting that c-myc locates downstream of mel-18. In mel-IS transgenic mice, the downregulation of cyclins D2 and E; CDK4, -6, and -7; and CDC25A causes the impairment in the activities of cyclin-dependent kinases, resulting in hypophosphorylation of the retinoblastoma protein. In contrast, the upregulation of c-Myc, CDC25, and CDC2/CDK2 kinase activities results in the augmentation of B cell proliferation in mel-18-deficient mice. We therefore propose that mel-IS negatively regulates the cell cycle through a c-myc/cdc25 cascade.	Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chiba 2608670, Japan; Japan Sci & Technol Corp, CREST, Chiba 2608670, Japan; Chiba Univ, Grad Sch Med, Dept Dev Genet, Chiba 2608670, Japan; Hiroshima Univ, Sch Med, Dept Immunol & Parasitol, Hiroshima 7348551, Japan	Chiba University; Japan Science & Technology Agency (JST); Chiba University; Hiroshima University	Kanno, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chiba 2608670, Japan.		Taniguchi, Masaru/N-7932-2015	Taniguchi, Masaru/0000-0001-7821-7179; Tetsu, Osamu/0000-0003-1820-7539; Kanno, masamoto/0000-0001-9169-3444				Akasaka T, 1996, DEVELOPMENT, V122, P1513; Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Bornemann D, 1996, DEVELOPMENT, V122, P1621; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Coligan JE., 1994, CURRENT PROTOCOLS IM; Core N, 1997, DEVELOPMENT, V124, P721; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; HANSON KD, 1994, MOL CELL BIOL, V14, P5748, DOI 10.1128/MCB.14.9.5748; HASEGAWA M, 1998, IN PRESS MAMMALIAN P; HAUPT Y, 1993, ONCOGENE, V8, P3161; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; HOANG AT, 1994, P NATL ACAD SCI USA, V91, P6875, DOI 10.1073/pnas.91.15.6875; Hobert O, 1996, MOL CELL BIOL, V16, P3066; ISHIDA A, 1993, GENE, V129, P249, DOI 10.1016/0378-1119(93)90275-8; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; JIANG W, 1993, ONCOGENE, V8, P3447; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; KEHRL JH, 1994, CRIT REV ONCOL HEMAT, V16, P145, DOI 10.1016/1040-8428(94)90046-9; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; PEARCE JJH, 1992, DEVELOPMENT, V114, P921; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; SANTAMARIA P, 1995, MOL GEN GENET, V246, P282, DOI 10.1007/BF00288600; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; SOTO MC, 1995, GENETICS, V140, P231; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; STRUHL G, 1985, EMBO J, V4, P4259; TAGAWA M, 1990, J BIOL CHEM, V265, P20021; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; WEDEEN C, 1986, CELL, V44, P739, DOI 10.1016/0092-8674(86)90840-8; WHITE RAH, 1985, NATURE, V318, P563, DOI 10.1038/318563a0; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	52	56	57	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					439	448		10.1016/S1074-7613(00)80627-5	http://dx.doi.org/10.1016/S1074-7613(00)80627-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806630	Bronze			2022-12-18	WOS:000076680700002
J	WARE, R; JIANG, H; BRAUNSTEIN, N; KENT, J; WIENER, E; LEONARD, C				WARE, R; JIANG, H; BRAUNSTEIN, N; KENT, J; WIENER, E; LEONARD, C			HUMAN CD8(+) T-LYMPHOCYTE CLONES SPECIFIC FOR T-CELL RECEPTOR V-BETA FAMILIES EXPRESSED ON AUTOLOGOUS CD4(+) T-CELLS	IMMUNITY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE ENCEPHALOMYELITIS; MONOCLONAL-ANTIBODIES; FUNCTIONAL-ANALYSIS; ENTEROTOXIN-B; SUPPRESSOR; INTERFERON; SUBSETS; IMMUNOREGULATION; DIFFERENTIATION	CD8(+) T cells control immune responses, and recent studies suggest that this regulation is, in part, specifically directed towards TCR structures expressed by CD4(+) cells. To develop a system to study the role of the TCR in regulatory interactions, we isolated clones of CD4+ cells expressing identified TCR V beta chains. These CD4(+) clones were used to stimulate and expand autologous CD8(+) cells, which kill the inducing CD4+ clone as well as independently isolated autologous CD4+ clones sharing the same TCR V beta as the inducing cell but not CD4+ T cells expressing different V beta TCRs. This V beta-specific cytotoxicity is dependent on the state of activation of the target cells and is not inhibited by an anti-class I monoclonal antibody, W6/32. We envision that V beta-specific CD8(+) T cells of this type may regulate immune responses by direct interaction with antigen-activated CD4(+) cells.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032	Columbia University; Columbia University				Wiener, Ethan/0000-0003-3216-0618	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014969, R37AI024748] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 24748, AI 14969] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLOOM BR, 1992, ANNU REV IMMUNOL, V10, P453, DOI 10.1146/annurev.iy.10.040192.002321; BLOOM BR, 1992, IMMUNOL TODAY, V13, P131, DOI 10.1016/0167-5699(92)90110-S; DANGL JL, 1982, CYTOMETRY, V2, P395; DORF ME, 1984, ANNU REV IMMUNOL, V2, P127, DOI 10.1146/annurev.iy.02.040184.001015; EARDLEY DD, 1978, J EXP MED, V147, P1106, DOI 10.1084/jem.147.4.1106; FELLOUS M, 1979, EUR J IMMUNOL, V9, P446, DOI 10.1002/eji.1830090606; FRIEDMAN SM, 1981, J IMMUNOL, V126, P1702; GAUR A, 1992, SCIENCE, V258, P1491, DOI 10.1126/science.1279812; GAUR A, 1993, SCIENCE, V259, P91, DOI 10.1126/science.8418501; GOODMAN JW, 1983, ANNU REV IMMUNOL, V1, P465, DOI 10.1146/annurev.iy.01.040183.002341; GREEN DR, 1983, ANNU REV IMMUNOL, V1, P439, DOI 10.1146/annurev.iy.01.040183.002255; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; JANDINSKI J, 1976, J EXP MED, V143, P1382, DOI 10.1084/jem.143.6.1382; Jerne N. K, 1975, HARVEY LECT, V70, P93; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; JIANG H, 1995, IMMUNITY, V2; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KIMURA H, 1984, NATURE, V308, P463, DOI 10.1038/308463a0; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; KOIDE J, 1990, J IMMUNOL, V144, P32; KUMAR V, 1993, J EXP MED, V178, P909, DOI 10.1084/jem.178.3.909; LAMB JR, 1982, NATURE, V300, P456, DOI 10.1038/300456a0; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; LINDAHL P, 1974, EUR J IMMUNOL, V4, P779, DOI 10.1002/eji.1830041202; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; NOAR D, 1991, ANN NY ACAD SCI, V636, P135; PAUL P, 1987, P NATL ACAD SCI USA, V84, P2872, DOI 10.1073/pnas.84.9.2872; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; SHINOHARA N, 1988, NATURE, V336, P481, DOI 10.1038/336481a0; STANTON TH, 1983, TRANSPLANTATION, V36, P352; SUN D, 1988, NATURE, V332, P843, DOI 10.1038/332843a0; THOMAS Y, 1980, J IMMUNOL, V125, P2402; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J	37	56	58	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1995	2	2					177	184		10.1016/S1074-7613(95)80066-2	http://dx.doi.org/10.1016/S1074-7613(95)80066-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7895174	Bronze			2022-12-18	WOS:A1995QH13200006
J	Alameh, MG; Tombacz, I; Bettini, E; Lederer, K; Sittplangkoon, C; Wilmore, JR; Gaudette, BT; Soliman, OY; Pine, M; Hicks, P; Manzoni, TB; Knox, JJ; Johnson, JL; Laczko, D; Muramatsu, H; Davis, B; Meng, WZ; Rosenfeld, AM; Strohmeier, S; Lin, PJC; Mui, BL; Tam, YK; Kariko, K; Jacquet, A; Krammer, F; Bates, P; Cancro, MP; Weissman, D; Prak, ETL; Allman, D; Locci, M; Pardi, N				Alameh, Mohamad-Gabriel; Tombacz, Istvan; Bettini, Emily; Lederer, Katlyn; Sittplangkoon, Chutamath; Wilmore, Joel R.; Gaudette, Brian T.; Soliman, Ousamah Y.; Pine, Matthew; Hicks, Philip; Manzoni, Tomaz B.; Knox, James J.; Johnson, John L.; Laczko, Dorottya; Muramatsu, Hiromi; Davis, Benjamin; Meng, Wenzhao; Rosenfeld, Aaron M.; Strohmeier, Shirin; Lin, Paulo J. C.; Mui, Barbara L.; Tam, Ying K.; Kariko, Katalin; Jacquet, Alain; Krammer, Florian; Bates, Paul; Cancro, Michael P.; Weissman, Drew; Prak, Eline T. Luning; Allman, David; Locci, Michela; Pardi, Norbert			Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses	IMMUNITY			English	Article							GERMINAL CENTER RESPONSES; TOLL-LIKE RECEPTORS; B-CELL; IMMUNE-RESPONSE; DIFFERENTIATION; INNATE; MICE; BCL6; POLARIZATION; GENERATION	Adjuvants are critical for improving the quality and magnitude of adaptive immune responses to vaccination. Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA vaccines have shown great efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mechanism of action of this vaccine platform is not well-characterized. Using influenza virus and SARS-CoV-2 mRNA and protein subunit vaccines, we demonstrated that our LNP formulation has intrinsic adjuvant activity that promotes induction of strong T follicular helper cell, germinal center B cell, long-lived plasma cell, and memory B cell responses that are associated with durable and protective antibodies in mice. Comparative experiments demonstrated that this LNP formulation outperformed a widely used MF59-like adjuvant, AddaVax. The adjuvant activity of the LNP relies on the ionizable lipid component and on IL-6 cytokine induction but not on MyD88- or MAVS-dependent sensing of LNPs. Our study identified LNPs as a versatile adjuvant that enhances the efficacy of traditional and next-generation vaccine platforms.	[Alameh, Mohamad-Gabriel; Tombacz, Istvan; Soliman, Ousamah Y.; Pine, Matthew; Laczko, Dorottya; Muramatsu, Hiromi; Davis, Benjamin; Kariko, Katalin; Weissman, Drew; Pardi, Norbert] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Bettini, Emily; Lederer, Katlyn; Hicks, Philip; Manzoni, Tomaz B.; Bates, Paul; Locci, Michela] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Sittplangkoon, Chutamath; Jacquet, Alain] Chulalongkorn Univ, Fac Med, Ctr Excellence Vaccine Res & Dev, Bangkok, Thailand; [Wilmore, Joel R.; Gaudette, Brian T.; Knox, James J.; Johnson, John L.; Meng, Wenzhao; Rosenfeld, Aaron M.; Cancro, Michael P.; Prak, Eline T. Luning; Allman, David] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hicks, Philip] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Strohmeier, Shirin; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Lin, Paulo J. C.; Mui, Barbara L.; Tam, Ying K.] Acuitas Therapeut, Vancouver, BC, Canada; [Kariko, Katalin] BioNTech RNA Pharmaceut, Mainz, Germany	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Chulalongkorn University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; BioNTech SE	Pardi, N (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.; Locci, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	michela.locci@pennmedicine.upenn.edu; pnorbert@pennmedicine.upenn.edu	Krammer, Florian/H-3237-2019; Jacquet, Alain/GQI-0546-2022	Krammer, Florian/0000-0003-4121-776X; Jacquet, Alain/0000-0002-0980-9741; Gaudette, Brian/0000-0001-6627-3085; Cancro, Michael/0000-0002-8659-3227; Wilmore, Joel/0000-0002-2797-5604; Bettini, Emily/0000-0003-0424-2472; Alameh, Mohamad-Gabriel/0000-0002-5672-6930; Pine, Matthew/0000-0002-3493-021X	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI146101, R01AI153064]; NIAID [R01AI153064, R01AI139123, R01AI154932, P30-AI 0450080, R01AI123738]; NIH/NIAID [UM1-AI-144371, 1U19AI135902, U19-AI142596, R01-AI124429, HHS-NIH-NIAID-BAA2018]; SRA from BioNTech [P01 AI106697]; NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); SRA from BioNTech; NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC)	N.P. was supported by the National Institute of Allergy and Infectious Diseases (NIAID; R01AI146101 and R01AI153064) . M.L. was supported by NIAID (R01AI123738 and R01AI153064) . D.W. is supported by NIH/NIAID (UM1-AI-144371, 1U19AI135902, U19-AI142596, R01-AI124429, and HHS-NIH-NIAID-BAA2018) and an SRA from BioNTech. E.L.P., W.M., J.K.K., and A.M.R. were supported by P01 AI106697. F.K. was supported by NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051. D.A. was supported by NIAID (R01AI139123 and R01AI154932) . We thank the NIH Tetramer Core Facility for producing the I-A (d) Influenza A HA PE-conjugated tetramer (HNTNGVTAACSHE) used in this study and the Human Immunology Core facility for assistance with immu-noglobulin gene rearrangement sequencing (with infrastructure support from P30 CA016520 and P30-AI 0450080) . We thank Dr. Florin Tuluc and Jennifer Murray of the Children's Hospital of Philadelphia (CHOP) Flow Cytometry core facility for technical assistance. PR8 HA probes for initial LLPC and MBC studies were provided by Scott E. Hensley (University of Pennsylvania) . Mouse-adapted A/Puerto Rico/8/1934 influenza virus for challenge studies was provided by Michael J. Hogan and Laurence C. Eisenlohr (CHOP) . We thank Michael J. Hogan for critical reading of the manuscript. The graphical ab-stract was created with BioRender.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alameh Mohamad-Gabriel, 2020, Curr Top Microbiol Immunol, DOI 10.1007/82_2020_202; Alberer M, 2017, LANCET, V390, P1511, DOI 10.1016/S0140-6736(17)31665-3; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Arunachalam PS, 2021, NATURE, V596, P410, DOI 10.1038/s41586-021-03791-x; Awasthi S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw7083; Awasthi S, 2019, VACCINE, V37, P3770, DOI 10.1016/j.vaccine.2019.05.068; Baiersdorfer M, 2019, MOL THER-NUCL ACIDS, V15, P26, DOI 10.1016/j.omtn.2019.02.018; Bettini E, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020147; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Clement RL, 2019, NAT IMMUNOL, V20, P1360, DOI 10.1038/s41590-019-0472-4; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Corrie BD, 2018, IMMUNOL REV, V284, P24, DOI 10.1111/imr.12666; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; De Giovanni M, 2020, NAT IMMUNOL, V21, P321, DOI 10.1038/s41590-020-0596-6; Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001; Doria-Rose NA, 2015, CURR OPIN VIROL, V11, P137, DOI 10.1016/j.coviro.2015.04.002; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fonseca VR, 2019, IMMUNOL REV, V288, P112, DOI 10.1111/imr.12739; Freyn AW, 2021, MOL THER-METH CLIN D, V22, DOI 10.1016/j.omtm.2021.06.003; Freyn AW, 2020, MOL THER, V28, P1569, DOI 10.1016/j.ymthe.2020.04.018; Gavillet BM, 2015, J IMMUNOL, V194, P4836, DOI 10.4049/jimmunol.1402071; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Hur S, 2019, ANNU REV IMMUNOL, V37, P349, DOI 10.1146/annurev-immunol-042718-041356; Iwasaki A, 2016, ANNU REV IMMUNOL, V34, P575, DOI 10.1146/annurev-immunol-032414-112315; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Johnson JL, 2020, IMMUNITY, V52, P842, DOI 10.1016/j.immuni.2020.03.020; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Kulkarni JA, 2019, ACCOUNTS CHEM RES, V52, P2435, DOI 10.1021/acs.accounts.9b00368; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Lederer K., GERMINAL CTR RESPONS, V2021; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094; Lindgren G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01539; Linterman Michelle A, 2016, F1000Res, V5, DOI 10.12688/f1000research.7388.1; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Ma CS, 2015, J ALLERGY CLIN IMMUN, V136, P993, DOI 10.1016/j.jaci.2015.05.036; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Mudd PA., 2021, SARS COV 2 MRNA VACC, DOI 10.1101/2021.09.08.459485; Mui B, 2003, METHOD ENZYMOL, V367, P3; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Olafsdottir TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep39097; Pardi N, 2019, MOL THER-NUCL ACIDS, V15, P36, DOI 10.1016/j.omtn.2019.03.003; Pardi N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05482-0; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Riteau N, 2016, J IMMUNOL, V197, P3884, DOI 10.4049/jimmunol.1600883; Rosenfeld AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02107; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shirai S, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030433; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Swaminathan G, 2016, SCI REP-UK, V6, DOI 10.1038/srep34215; Swaminathan G, 2016, VACCINE, V34, P110, DOI 10.1016/j.vaccine.2015.10.132; Tapia K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003703; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012	85	55	55	14	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2877	+		10.1016/j.immuni.2021.11.001	http://dx.doi.org/10.1016/j.immuni.2021.11.001		DEC 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6LX	34852217	Bronze, Green Published			2022-12-18	WOS:000731658800006
J	Graham, C; Seow, J; Huettner, I; Khan, H; Kouphou, N; Acors, S; Winstone, H; Pickering, S; Galao, RP; Dupont, L; Lista, MJ; Jimenez-Guardeno, JM; Laing, AG; Wu, Y; Joseph, M; Muir, L; van Gils, MJ; Ng, WM; Duyvesteyn, HME; Zhao, YG; Bowden, TA; Shankar-Hari, M; Rosa, A; Cherepanov, P; McCoy, LE; Hayday, AC; Neil, SJD; Malim, MH; Doores, KJ				Graham, Carl; Seow, Jeffrey; Huettner, Isabella; Khan, Hataf; Kouphou, Neophytos; Acors, Sam; Winstone, Helena; Pickering, Suzanne; Galao, Rui Pedro; Dupont, Liane; Lista, Maria Jose; Jimenez-Guardeno, Jose M.; Laing, Adam G.; Wu, Yin; Joseph, Magdalene; Muir, Luke; van Gils, Marit J.; Ng, Weng M.; Duyvesteyn, Helen M. E.; Zhao, Yuguang; Bowden, Thomas A.; Shankar-Hari, Manu; Rosa, Annachiara; Cherepanov, Peter; McCoy, Laura E.; Hayday, Adrian C.; Neil, Stuart J. D.; Malim, Michael H.; Doores, Katie J.			Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant	IMMUNITY			English	Article							B-CELLS; BINDING; EFFICIENT; MUTATIONS; REVEAL; SYSTEM; BROAD	Interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the receptor ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing antibodies, and several neutralizing epitopes on RBD have been molecularly characterized. Analysis of circulating SARS-CoV-2 variants has revealed mutations arising in the RBD, N-terminal domain (NTD) and S2 subunits of Spike. To understand how these mutations affect Spike antigenicity, we isolated and characterized >100 monoclonal antibodies targeting epitopes on RBD, NTD, and S2 from SARS-CoV-2-infected individuals. Approximately 45% showed neutralizing activity, of which similar to 20% were NTD specific. NTD-specific antibodies formed two distinct groups: the first was highly potent against infectious virus, whereas the second was less potent and displayed glycandependant neutralization activity. Mutations present in B.1.1.7 Spike frequently conferred neutralization resistance to NTD-specific antibodies. This work demonstrates that neutralizing antibodies targeting subdominant epitopes should be considered when investigating antigenic drift in emerging variants.	[Graham, Carl; Seow, Jeffrey; Huettner, Isabella; Khan, Hataf; Kouphou, Neophytos; Acors, Sam; Winstone, Helena; Pickering, Suzanne; Galao, Rui Pedro; Dupont, Liane; Lista, Maria Jose; Jimenez-Guardeno, Jose M.; Shankar-Hari, Manu; Neil, Stuart J. D.; Malim, Michael H.; Doores, Katie J.] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England; [Laing, Adam G.; Wu, Yin; Joseph, Magdalene; Hayday, Adrian C.] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [Wu, Yin; Joseph, Magdalene; Rosa, Annachiara; Cherepanov, Peter; Hayday, Adrian C.] Francis Crick Inst, London, England; [Muir, Luke; McCoy, Laura E.] UCL, Div Infect & Immun, London, England; [van Gils, Marit J.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Infect & Immun, Dept Med Microbiol, Amsterdam, Netherlands; [Ng, Weng M.; Duyvesteyn, Helen M. E.; Zhao, Yuguang; Bowden, Thomas A.] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford, England; [Neil, Stuart J. D.; Malim, Michael H.; Doores, Katie J.] Genotype To Phenotype UK Natl Virol Consortium, London, England	University of London; King's College London; University of London; King's College London; Francis Crick Institute; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; Wellcome Centre for Human Genetics	Doores, KJ (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England.; Doores, KJ (corresponding author), Genotype To Phenotype UK Natl Virol Consortium, London, England.	katie.doores@kcl.ac.uk	Cherepanov, Peter P/F-6859-2010; Galao, Rui/AAX-1398-2021; Shankar-Hari, Manu/I-6948-2012; van Gils, Marit J./H-4791-2019; Jimenez-Guardeno, Jose Manuel/AAG-8915-2019	Cherepanov, Peter P/0000-0002-0634-538X; Shankar-Hari, Manu/0000-0002-5338-2538; van Gils, Marit J./0000-0003-3422-8161; Jimenez-Guardeno, Jose Manuel/0000-0002-1726-8033; Acors, Sam/0000-0001-6428-7707; Seow, Jeffrey/0000-0003-0722-8561; Malim, Michael/0000-0002-7699-2064; Muir, Luke/0000-0002-7834-6066; Galao, Rui/0000-0003-3368-5053; Ng, Weng Ming/0000-0001-8218-5544; Wu, Yin/0000-0003-4080-3935; Dupont, Liane/0000-0002-2124-4069; khan, Hataf/0000-0003-1128-0266; Kouphou, Neophytos/0000-0002-4945-8640	King's Together Rapid; UK Medical Research Council (MRC) [MC/PC/15068]; Fondation Dormeur, Vaduz; Huo Family Foundation; MRC Programme Grant [MR/S023747/1]; Wellcome Trust [208354/Z/17/Z, 106223/Z/14/Z]; NIAID [U54 AI150472, AI076119]; UK CIC (Covid-Immunology-Consortium); Rosetrees Trust; UCL Coronavirus Response Fund; National Institute for Health Research Clinician Scientist Award [CS-2016-16-011]; European Union [RIA2020EF-3008]; MRC-KCL Doctoral Training Partnership in Biomedical Sciences [MR/N013700/1]; MRC-KCL Doctoral Training Partnership in Biomedical Sciences industrial Collaborative Award in Science & Engineering (iCASE); Orchard Therapeutics [MR/R015643/1]; Francis Crick Institute [FC001061]; Cancer Research UK; UK Medical Research Council; Medical Research Council [MR/S007555/1]; Wellcome Centre [203141/Z/16/Z]; Medical Research Council Career Development Award [MR/R008698/1]; Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London; King's College Hospital NHS Foundation Trust	King's Together Rapid; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Dormeur, Vaduz; Huo Family Foundation; MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UK CIC (Covid-Immunology-Consortium); Rosetrees Trust(Rosetrees Trust); UCL Coronavirus Response Fund; National Institute for Health Research Clinician Scientist Award; European Union(European Commission); MRC-KCL Doctoral Training Partnership in Biomedical Sciences(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-KCL Doctoral Training Partnership in Biomedical Sciences industrial Collaborative Award in Science & Engineering (iCASE)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Orchard Therapeutics; Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Centre; Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London; King's College Hospital NHS Foundation Trust	This work was funded by; King's Together Rapid COVID-19 Call award to M.H.M., K.J.D., and S.J.D.N., UK Medical Research Council (MRC) Discovery award MC/PC/15068 to S.J.D.N., K.J.D., and M.H.M., Fondation Dormeur, Vaduz for funding equipment to K.J.D., a Huo Family Foundation award to M.H.M., K.J.D., M.S.H., and S.J.D.N., MRC Programme Grant (MR/S023747/1 to M.H.M.), Wellcome Trust Multi-User Equipment Grant 208354/Z/17/Z to M.H.M., S.J.D.N., K.D., and A.C.H., Wellcome Trust Investigator Award 106223/Z/14/Z to M.H.M., NIAID Awards U54 AI150472 and AI076119 to M.H.M., The UK CIC (Covid-Immunology-Consortium) to A.C.H., the Rosetrees Trust to A.C.H., and UCL Coronavirus Response Fund to L.E.M. (made possible through generous donations from UCL's supporters, alumni, and friends). M.S.H. is funded by the National Institute for Health Research Clinician Scientist Award (CS-2016-16-011). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. This study is part of the EDCTP2 program supported by the European Union (grant number RIA2020EF-3008 COVAB). The views and opinions of authors expressed herein do not necessarily state or reflect those of EDCTP. C.G. and H.W. were supported by the MRC-KCL Doctoral Training Partnership in Biomedical Sciences (MR/N013700/1). S.A. was supported by an MRC-KCL Doctoral Training Partnership in Biomedical Sciences industrial Collaborative Award in Science & Engineering (iCASE) in partnership with Orchard Therapeutics (MR/R015643/1). Work in P.C. laboratory is funded by the Francis Crick Institute (FC001061), which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. T.A.B. is supported by the Medical Research Council (MR/S007555/1). The Wellcome Centre for Human Genetics is supported by Wellcome Centre grant 203141/Z/16/Z. L.E.M. was supported by a Medical Research Council Career Development Award MR/R008698/1. This work was supported by the Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Andreano E., 2021, CELL; Andreano Emanuele, 2020, bioRxiv, DOI 10.1101/2020.12.28.424451; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Beaudoin-Bussieres G, 2020, MBIO, V11, DOI 10.1128/mBio.02590-20; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Crawford KHD, 2021, J INFECT DIS, V223, P197, DOI 10.1093/infdis/jiaa618; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; Dixon E.V., 2014, THESIS; Doores KJ, 2015, J VIROL, V89, P1105, DOI 10.1128/JVI.02905-14; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Floyd K., 2021, INFECT MRNA 1273 VAC; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Grehan K, 2015, METHODSX, V2, P379, DOI 10.1016/j.mex.2015.09.003; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guthmiller JJ, 2021, MBIO, V12, DOI 10.1128/mBio.02940-20; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Kim SI, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd6990; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Legros V, 2021, CELL MOL IMMUNOL, V18, P318, DOI 10.1038/s41423-020-00588-2; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Li W, 2020, P NATL ACAD SCI USA, V117, P29832, DOI 10.1073/pnas.2010197117; Liu Hejun, 2020, Immunity, V53, P1272, DOI [10.1101/2020.08.02.233536, 10.1016/j.immuni.2020.10.023]; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; Muecksch F, 2021, J INFECT DIS, V223, P389, DOI 10.1093/infdis/jiaa659; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pickering S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008817; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Prevost J, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100126; Rees-Spear C, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108890; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Rosa Annachiara, 2021, medRxiv, DOI 10.1101/2021.01.21.21249203; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Seydoux E, 2020, IMMUNITY, V53, P98, DOI 10.1016/j.immuni.2020.06.001; Shen X., 2021, CELL HOST MICROBE; Starr Tyler N, 2020, bioRxiv, DOI [10.1126/science.abf9302, 10.1101/2020.11.30.405472]; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Thompson CP, 2020, EUROSURVEILLANCE, V25, P33, DOI 10.2807/1560-7917.ES.2020.25.42.2000685; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; van den Brink EN, 2005, J VIROL, V79, P1635, DOI 10.1128/JVI.79.3.1635-1644.2005; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Wang Pengfei, 2021, bioRxiv, DOI 10.1101/2021.01.25.428137; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Weissman D., 2021, CELL HOST MICROBE, V29, pE4, DOI DOI 10.1016/j.chom.2020.11.012; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wickham Hadley, 2016, J STAT SOFTW, DOI DOI 10.18637/JSS.V077.B02; Winstone H, 2021, J VIROL, V95, DOI 10.1128/JVI.02422-20; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n359; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu Nicholas C, 2020, bioRxiv, DOI 10.1101/2020.07.26.222232; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yang Q, 2020, ELIFE, V9, DOI 10.7554/eLife.61552; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou TQ, 2020, CELL HOST MICROBE, V28, P867, DOI 10.1016/j.chom.2020.11.004; Zohar T, 2020, CELL, V183, P1508, DOI 10.1016/j.cell.2020.10.052; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	86	55	56	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1276	+	e6	10.1016/j.immuni.2021.03.023	http://dx.doi.org/10.1016/j.immuni.2021.03.023		JUN 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33836142	Green Published, hybrid			2022-12-18	WOS:000659882900017
J	Zeng, Y; Liu, C; Gong, YD; Bai, ZJ; Hou, SY; He, J; Bian, ZL; Li, ZC; Ni, YL; Yan, J; Huang, T; Shi, H; Ma, CY; Chen, XY; Wang, JY; Bian, LH; Lan, Y; Liu, B; Hu, HB				Zeng, Yang; Liu, Chen; Gong, Yandong; Bai, Zhijie; Hou, Siyuan; He, Jian; Bian, Zhilei; Li, Zongcheng; Ni, Yanli; Yan, Jing; Huang, Tao; Shi, Hui; Ma, Chunyu; Chen, Xueying; Wang, Jinyong; Bian, Lihong; Lan, Yu; Liu, Bing; Hu, Hongbo			Single-Cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; TCR GENE REARRANGEMENTS; T-CELL; GAMMA-DELTA; EPITHELIAL-CELLS; LINEAGE COMMITMENT; PRECURSOR CELLS; CD7 EXPRESSION; YOLK-SAC; RECEPTOR	Generation of the first T lymphocytes in the human embryo involves the emergence, migration, and thymus seeding of lymphoid progenitors together with concomitant thymus organogenesis, which is the initial step to establish the entire adaptive immune system. However, the cellular and molecular programs regulating this process remain unclear. We constructed a single-cell transcriptional landscape of human early T lymphopoiesis by using cells from multiple hemogenic and hematopoietic sites spanning embryonic and fetal stages. Among heterogenous early thymic progenitors, one subtype shared common features with a subset of lymphoid progenitors in fetal liver that are known as thymus-seeding progenitors. Unbiased bioinformatics analysis identified a distinct type of pre-thymic lymphoid progenitors in the aorta-gonad-mesonephros (AGM) region. In parallel, weinvestigated thymic epithelial cell development and potential cell-cell interactions during thymus organogenesis. Together, our data provide insights intohuman earlyTlymphopoiesis that prospectively direct T lymphocyte regeneration, which might lead to development of clinical applications.	[Zeng, Yang; Li, Zongcheng; Ni, Yanli; Liu, Bing] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, State Key Lab Expt Hematol, Beijing 100071, Peoples R China; [Liu, Chen; Gong, Yandong; Bai, Zhijie; Hou, Siyuan; He, Jian; Yan, Jing; Huang, Tao; Shi, Hui; Liu, Bing] Acad Mil Med Sci, Acad Mil Med Sci, State Key Lab Prote, Beijing 100071, Peoples R China; [Ma, Chunyu; Bian, Lihong] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Gynecol, Beijing 100071, Peoples R China; [Bian, Zhilei; Lan, Yu; Liu, Bing] Jinan Univ, Sch Med, Inst Hematol, Key Lab Regenerat Med,Minist Educ, Guangzhou 510632, Guangdong, Peoples R China; [Chen, Xueying; Hu, Hongbo] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Rheumatol & Immunol,Rare Dis Ctr,Collaborat, Chengdu 610041, Peoples R China; [Wang, Jinyong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Liu, Bing] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Liu, Bing] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Bian, Zhilei; Lan, Yu] Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou 510530, Guangdong, Peoples R China	Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Jinan University; Sichuan University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Liu, B (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, State Key Lab Expt Hematol, Beijing 100071, Peoples R China.; Liu, B (corresponding author), Acad Mil Med Sci, Acad Mil Med Sci, State Key Lab Prote, Beijing 100071, Peoples R China.; Lan, Y; Liu, B (corresponding author), Jinan Univ, Sch Med, Inst Hematol, Key Lab Regenerat Med,Minist Educ, Guangzhou 510632, Guangdong, Peoples R China.; Hu, HB (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Rheumatol & Immunol,Rare Dis Ctr,Collaborat, Chengdu 610041, Peoples R China.; Liu, B (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China.; Liu, B (corresponding author), Chinese Acad Med Sci, Blood Dis Hosp, Tianjin 300020, Peoples R China.; Lan, Y (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou 510530, Guangdong, Peoples R China.	rainyblue_1999@126.com; bingliu17@yahoo.com; hongbohu@scu.edu.cn	Li, Zongcheng/AAN-1952-2021; Liu, Bing/ABH-2370-2021; Lan, Yu/AAV-2236-2021; Li, Zongcheng/AFP-2645-2022; Hu, Hongbo/J-8059-2016	Liu, Bing/0000-0002-7313-6924; Lan, Yu/0000-0002-4731-5945; Li, Zongcheng/0000-0002-5189-5268; Hu, Hongbo/0000-0002-8177-7641; Gong, Yandong/0000-0003-3971-1478; he, jian/0000-0002-8632-4924	National Key R&D Program of China [2019YFA0110201, 2017YFA0103401, 2016YFA0100601, 2016YFA0502203]; National Natural Science Foundation of China [31425012, 31930054, 31871173, 81890991, 91740111, 81871232, 81800102, 81900115]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2017ZT07S347]; Beijing Municipal Science and Technology Commission [Z171100000417009]; Beijing Municipal Science and Technology Commission (Beijing Leading Talents Program) [Z171100001117159]; State Key Laboratory of Proteomics [SKLP-K201502]; Key Research and Development Program of Guangdong Province [2019B020234002]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Municipal Science and Technology Commission (Beijing Leading Talents Program); State Key Laboratory of Proteomics; Key Research and Development Program of Guangdong Province	This study was supported by grants from the National Key R&D Program of China (2019YFA0110201, 2017YFA0103401, 2016YFA0100601 and 2016YFA0502203), the National Natural Science Foundation of China (31425012, 31930054, 31871173, 81890991, 91740111, 81871232, 81800102 and 81900115), the Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2017ZT07S347), the Beijing Municipal Science and Technology Commission (Z171100000417009 and Beijing Leading Talents Program Z171100001117159), the State Key Laboratory of Proteomics (SKLP-K201502), and the Key Research and Development Program of Guangdong Province (2019B020234002).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; BARCENA A, 1993, BLOOD, V82, P3401; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Blom B, 1999, BLOOD, V93, P3033; BULMER JN, 1988, J REPROD IMMUNOL, V14, P291, DOI 10.1016/0165-0378(88)90028-9; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen LP, 2014, CANCER J, V20, P254, DOI 10.1097/PPO.0000000000000062; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Dai Y, 2005, MOL CELL BIOL, V25, P4413, DOI 10.1128/MCB.25.11.4413-4425.2005; De Obaldia ME, 2013, BLOOD, V121, P64, DOI 10.1182/blood-2012-08-451773; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Famili F, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2016-0095; Farley AM, 2013, DEVELOPMENT, V140, P2015, DOI 10.1242/dev.087320; Flies DB, 2015, J IMMUNOL, V194, P5294, DOI 10.4049/jimmunol.1402648; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; GALY A, 1993, J EXP MED, V178, P391, DOI 10.1084/jem.178.2.391; Garcia-Leon MJ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165597; Gasser, 1975, J ANAT, V120, P607; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Griffith AV, 2009, DEV BIOL, V327, P216, DOI 10.1016/j.ydbio.2008.12.019; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guo R., 2019, BIORXIV, DOI [10.1101/, DOI 10.1101/]; Gupta R., 2016, CLIN ANAT, V29, P15; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; HAYNES BF, 1989, IMMUNOL TODAY, V10, P87, DOI 10.1016/0167-5699(89)90232-6; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; He XH, 2005, STEM CELLS DEV, V14, P188, DOI 10.1089/scd.2005.14.188; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Jenkinson WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053416; Joachims ML, 2006, J IMMUNOL, V176, P1543, DOI 10.4049/jimmunol.176.3.1543; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kecha O, 2000, ENDOCRINOLOGY, V141, P1209, DOI 10.1210/en.141.3.1209; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kosti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01104; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Kuo YH, 2008, BLOOD, V111, P1543, DOI 10.1182/blood-2007-07-104422; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Lattin JE, 2009, MOL IMMUNOL, V47, P340, DOI 10.1016/j.molimm.2009.09.012; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lee SY, 2010, SEMIN IMMUNOL, V22, P237, DOI 10.1016/j.smim.2010.04.008; Lehnert K, 1998, EUR J IMMUNOL, V28, P3605, DOI 10.1002/(SICI)1521-4141(199811)28:11<3605::AID-IMMU3605>3.3.CO;2-A; Li L, 2017, CELL STEM CELL, V20, P891, DOI 10.1016/j.stem.2017.05.009; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lis R, 2017, NATURE, V545, P439, DOI 10.1038/nature22326; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; LOBACH DF, 1987, J CLIN IMMUNOL, V7, P81, DOI 10.1007/BF00916002; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Manley NR, 2010, PROG MOL BIOL TRANSL, V92, P103, DOI 10.1016/S1877-1173(10)92005-X; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Miles A, 2008, AM J PHYSIOL-GASTR L, V294, pG1257, DOI 10.1152/ajpgi.00266.2007; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mori K, 2010, CELL IMMUNOL, V260, P66, DOI 10.1016/j.cellimm.2009.09.007; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Patel SR, 2006, GENE EXPR PATTERNS, V6, P794, DOI 10.1016/j.modgep.2006.01.011; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Reber LL, 2016, EUR RESPIR J, V47, P1040, DOI 10.1183/13993003.00065-2016; Regnard C, 2003, J CELL SCI, V116, P4181, DOI 10.1242/jcs.00743; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; SCHMITT C, 1993, BLOOD, V82, P3675; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Seach Natalie, 2013, Methods Mol Biol, V945, P251, DOI 10.1007/978-1-62703-125-7_15; Sekai M, 2014, IMMUNITY, V41, P753, DOI 10.1016/j.immuni.2014.10.011; Shibata K, 2014, J IMMUNOL, V192, P2210, DOI 10.4049/jimmunol.1302145; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taghon T, 2009, BLOOD, V113, P3254, DOI 10.1182/blood-2008-07-168906; Takeuchi A, 2001, J IMMUNOL, V167, P2157, DOI 10.4049/jimmunol.167.4.2157; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Thiele BJ, 2004, CIRC RES, V95, P1058, DOI 10.1161/01.RES.0000149166.33833.08; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tokunaga T, 2009, AUTOIMMUNITY, V42, P653, DOI 10.3109/08916930903120941; Tsai PT, 2003, BLOOD, V102, P3947, DOI 10.1182/blood-2003-05-1657; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Varas A, 2009, CELL CYCLE, V8, P4119, DOI 10.4161/cc.8.24.10149; Varga I, 2011, BRATISL MED J, V112, P368; Venanzi ES, 2007, J IMMUNOL, V179, P5693, DOI 10.4049/jimmunol.179.9.5693; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997; Zhou J, 2019, CELL STEM CELL, V24, P285, DOI 10.1016/j.stem.2018.11.023; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	118	55	57	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					930	+		10.1016/j.immuni.2019.09.008	http://dx.doi.org/10.1016/j.immuni.2019.09.008			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31604687	Bronze			2022-12-18	WOS:000497811300015
J	Ruckwardt, TJ; Morabito, KM; Graham, BS				Ruckwardt, Tracy J.; Morabito, Kaitlyn M.; Graham, Barney S.			Immunological Lessons from Respiratory Syncytial Virus Vaccine Development	IMMUNITY			English	Review							BRONCHOALVEOLAR LAVAGE FLUID; CHIMPANZEE CORYZA AGENT; NF-KAPPA-B; G-GLYCOPROTEIN; MONOCLONAL-ANTIBODY; FUSION GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; SUBUNIT VACCINE; F-GLYCOPROTEIN	Respiratory syncytial virus (RSV) has eluded active vaccination efforts for more than five decades and continues to cause substantial morbidity and mortality in infants, the immunocompromised, and older adults Although newer approaches of passive antibody-mediated protection show promise, vaccines aimed at eliciting fusion protein (F)-targeting antibodies have repeatedly failed to meet pre-established, modest-efficacy goals. Newer candidates, including protein-based vaccines, live-attenuated viruses, and gene-based delivery platforms, incorporate structurally defined and stabilized versions of the prefusion form of the F glycoprotein and are advancing rapidly into critical efficacy studies in susceptible target populations. This review discusses the storied history of RSV vaccine development, immunological lessons learned along the way, and critical findings about protein structure that remodeled our understanding of protective immunity to this important pathogen.	[Ruckwardt, Tracy J.; Morabito, Kaitlyn M.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853; Morabito, Kaitlyn/0000-0002-4849-4690	National Institute of Allergy and Infectious Diseases	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funding from the National Institute of Allergy and Infectious Diseases.	Adams JM, 1941, J AMER MED ASSOC, V116, P925, DOI 10.1001/jama.1941.02820100019005; ADAMS JM, 1948, PEDIATRICS, V1, P398; Aliprantis A, 2018, OPEN FORUM INFECT DI, V5, pS424; Atwell JE, 2016, J INFECT DIS, V213, P423, DOI 10.1093/infdis/jiv401; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; BEEM M, 1960, NEW ENGL J MED, V263, P523, DOI 10.1056/NEJM196009152631101; BELSHE RB, 1982, J INFECT DIS, V145, P311, DOI 10.1093/infdis/145.3.311; BELSHE RB, 1993, J INFECT DIS, V168, P1024, DOI 10.1093/infdis/168.4.1024; Berry CE, 2016, AM J RESP CRIT CARE, V194, P607, DOI 10.1164/rccm.201604-0753OC; Bitko V, 2007, J VIROL, V81, P1786, DOI 10.1128/JVI.01420-06; Boyoglu-Barnum S, 2014, J VIROL, V88, P10569, DOI 10.1128/JVI.01503-14; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Chirkova T, 2015, J GEN VIROL, V96, P2543, DOI 10.1099/vir.0.000218; Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13; Choi EH, 2002, J INFECT DIS, V186, P1207, DOI 10.1086/344310; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Christiaansen AF, 2014, IMMUNOL RES, V59, P109, DOI 10.1007/s12026-014-8540-1; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; Connor E, 1997, PEDIATRICS, V99, P93; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033; Cullen LM, 2015, J VIROL, V89, P6835, DOI 10.1128/JVI.00384-15; de Swart RL, 2002, J VIROL, V76, P11561, DOI 10.1128/JVI.76.22.11561-11569.2002; Delgado M Florencia, 2004, Expert Rev Vaccines, V3, P693, DOI 10.1586/14760584.3.6.693; Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/inf.0000000000001916, 10.1097/INF.0000000000001916]; El Saleeby CM, 2004, CLIN INFECT DIS, V39, pE17, DOI 10.1086/421779; Falloon J, 2017, J INFECT DIS, V216, P1362, DOI 10.1093/infdis/jix503; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 1996, VACCINE, V14, P1214, DOI 10.1016/S0264-410X(96)00030-8; Falsey AR, 1997, VACCINE, V15, P1130, DOI 10.1016/S0264-410X(97)00002-9; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Gan SW, 2012, J BIOL CHEM, V287, P24671, DOI 10.1074/jbc.M111.332791; Gentile DA, 2003, HUM IMMUNOL, V64, P338, DOI 10.1016/S0198-8859(02)00827-3; Ghosh S, 2000, BONE MARROW TRANSPL, V25, P751, DOI 10.1038/sj.bmt.1702228; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Goodpasture EW, 1939, AM J DIS CHILD, V57, P997; Goodwin E, 2018, IMMUNITY, V48, P339, DOI 10.1016/j.immuni.2018.01.005; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; GRAHAM BS, 1993, PEDIATR RES, V34, P167, DOI 10.1203/00006450-199308000-00013; GRAHAM BS, 1995, J INFECT DIS, V171, P1468, DOI 10.1093/infdis/171.6.1468; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; GROOTHUIS JR, 1995, PEDIATRICS, V95, P463; Gurnett-Bander A, 2016, US patent, Patent No. [10,125,188, 10125188]; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; Heidema J, 2007, J IMMUNOL, V179, P8410, DOI 10.4049/jimmunol.179.12.8410; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Jallow S, 2019, CLIN INFECT DIS, V69, P151, DOI 10.1093/cid/ciy1071; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Johnson S, 1999, J INFECT DIS, V180, P35, DOI 10.1086/314846; Johnson TR, 2012, J VIROL, V86, P1339, DOI 10.1128/JVI.06096-11; Johnson TR, 2004, J VIROL, V78, P8753, DOI 10.1128/JVI.78.16.8753-8760.2004; Johnson TR, 2004, J VIROL, V78, P6024, DOI 10.1128/JVI.78.11.6024-6032.2004; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Johnson TR, 1999, J VIROL, V73, P8485, DOI 10.1128/JVI.73.10.8485-8495.1999; Jones BG, 2012, VACCINE, V30, P959, DOI 10.1016/j.vaccine.2011.11.046; Jones HG, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006935; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; Kalina WV, 2005, VACCINE, V23, P4625, DOI 10.1016/j.vaccine.2005.04.032; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Karron RA, 2013, CURR TOP MICROBIOL, V372, P259, DOI 10.1007/978-3-642-38919-1_13; Ke Z., 2018, VIRUSES, V10, pE446; Killikelly AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34108; KIM HW, 1976, PEDIATR RES, V10, P75, DOI 10.1203/00006450-197601000-00015; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim YJ, 2014, J INFECT DIS, V209, P1195, DOI 10.1093/infdis/jit832; Kiss G, 2014, J VIROL, V88, P7602, DOI 10.1128/JVI.00256-14; Krishnaswamy S, 2019, HUM VACC IMMUNOTHER, V15, P942, DOI 10.1080/21645515.2018.1564433; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466; Langley JM, 2018, J INFECT DIS, V218, P378, DOI 10.1093/infdis/jiy177; Liang B, 2017, J VIROL, V91, DOI 10.1128/JVI.00189-17; Liang B, 2015, J VIROL, V89, P9499, DOI 10.1128/JVI.01373-15; Liu X, 2017, J VIROL, V91, DOI 10.1128/JVI.01101-17; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40387-y; Luchsinger V, 2012, CLIN INFECT DIS, V54, P905, DOI 10.1093/cid/cir955; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; Luongo C, 2013, J VIROL, V87, P1985, DOI 10.1128/JVI.02769-12; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046; Mazur NI, 2018, LANCET INFECT DIS, V18, pE295, DOI 10.1016/S1473-3099(18)30292-5; McFarland EJ, 2018, J INFECT DIS, V217, P1347, DOI 10.1093/infdis/jiy040; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Mehta J, 2013, COPD, V10, P293, DOI 10.3109/15412555.2012.744741; Meng J, 2014, MBIO, V5, DOI 10.1128/mBio.01704-14; MORRIS JA, 1956, P SOC EXP BIOL MED, V92, P544, DOI 10.3181/00379727-92-22538; Mousa JJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.271; Munoz FM, 2019, OBSTET GYNECOL, V133, P739, DOI 10.1097/AOG.0000000000003161; Munoz FM, 2015, CURR OPIN INFECT DIS, V28, P221, DOI 10.1097/QCO.0000000000000161; Munywoki PK, 2014, J INFECT DIS, V209, P1685, DOI 10.1093/infdis/jit828; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894, DOI 10.1128/JCM.24.5.894-898.1986; Neemann K, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0490-9; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; O'Brien KL, 2015, LANCET INFECT DIS, V15, P1398, DOI 10.1016/S1473-3099(15)00247-9; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; PARADISO PR, 1994, PEDIATR INFECT DIS J, V13, P792, DOI 10.1097/00006454-199409000-00008; Parrish J, 1826, N AM MED SURG J, V1, P24; Phung E, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7010023; Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4; PIEDRA PA, 1993, VACCINE, V11, P1415, DOI 10.1016/0264-410X(93)90170-3; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Poletti P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0283-x; Power UF, 2001, J INFECT DIS, V184, P1456, DOI 10.1086/324426; PRINCE GA, 1985, J VIROL, V55, P517, DOI 10.1128/JVI.55.3.517-520.1985; Puthothu B, 2006, J INFECT DIS, V193, P438, DOI 10.1086/499316; Rima B, 2017, J GEN VIROL, V98, P2912, DOI 10.1099/jgv.0.000959; ROBERTS SR, 1994, J VIROL, V68, P4538, DOI 10.1128/JVI.68.7.4538-4546.1994; Rostad CA, 2018, J VIROL, V92, DOI 10.1128/JVI.01568-17; Ruckwardt TJ, 2016, CURR OPIN VIROL, V16, P151, DOI 10.1016/j.coviro.2016.01.003; Russell CJ, 2016, EXPERT REV VACCINES, V15, P189, DOI 10.1586/14760584.2016.1114418; Schepens B, 2014, EMBO MOL MED, V6, P1436, DOI 10.15252/emmm.201404005; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Schmidt ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00678; Shaw CA, 2013, VACCINE, V31, P306, DOI 10.1016/j.vaccine.2012.11.006; Shi T, 2020, J INFECT DIS, V222, pS577, DOI 10.1093/infdis/jiz059; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053; Stobart CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13916; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Trefny P, 2000, PEDIATR PULM, V30, P302, DOI 10.1002/1099-0496(200010)30:4<302::AID-PPUL5>3.0.CO;2-R; TRISTRAM DA, 1993, J INFECT DIS, V167, P191, DOI 10.1093/infdis/167.1.191; Villafana T, 2017, EXPERT REV VACCINES, V16, P737, DOI 10.1080/14760584.2017.1333425; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; WITTIG HJ, 1959, J ALLERGY, V30, P19, DOI 10.1016/0021-8707(59)90054-1; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09; Zhu Q, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1928	147	55	61	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					429	442		10.1016/j.immuni.2019.08.007	http://dx.doi.org/10.1016/j.immuni.2019.08.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31533056	Bronze			2022-12-18	WOS:000486184600007
J	Stone, SL; Peel, JN; Scharer, CD; Risley, CA; Chisolm, DA; Schultz, MD; Yu, BF; Ballesteros-Tato, A; Wojciechowski, W; Mousseau, B; Misra, RS; Hanidu, A; Jiang, HP; Qi, ZH; Boss, JM; Randall, TD; Brodeur, SR; Goldrath, AW; Weinmann, AS; Rosenberg, AF; Lund, FE				Stone, Sara L.; Peel, Jessica N.; Scharer, Christopher D.; Risley, Christopher A.; Chisolm, Danielle A.; Schultz, Michael D.; Yu, Bingfei; Ballesteros-Tato, Andre; Wojciechowski, Wojciech; Mousseau, Betty; Misra, Ravi S.; Hanidu, Adedayo; Jiang, Huiping; Qi, Zhenhao; Boss, Jeremy M.; Randall, Troy D.; Brodeur, Scott R.; Goldrath, Ananda W.; Weinmann, Amy S.; Rosenberg, Alexander F.; Lund, Frances E.			T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-gamma on B Cells	IMMUNITY			English	Article							FACTOR-KAPPA-B; TERMINAL DIFFERENTIATION; INTERFERON-GAMMA; MOLECULAR-MECHANISMS; CUTTING EDGE; EXPRESSION; RECEPTOR; MEMORY; INNATE; CIRCUITRY	Although viral infections elicit robust interferon-gamma (IFN-gamma) and long-lived antibody-secreting cell (ASC) responses, the roles for IFN-gamma and IFN-gamma-induced transcription factors (TFs) in ASC development are unclear. We showed that B cell intrinsic expression of IFN-gamma R and the IFN-gamma-induced TF T-bet were required for T-helper 1 cell-induced differentiation of B cells into ASCs. IFN-gamma R signaling induced Blimp1 expression in B cells but also initiated an inflammatory gene program that, if not restrained, prevented ASC formation. T-bet did not affect Blimp1 upregulation in IFN-gamma-activated B cells but instead regulated chromatin accessibility within the Ifng and Ifngr2 loci and repressed the IFN-gamma-induced inflammatory gene program. Consistent with this, B cell intrinsic T-bet was required for formation of long-lived ASCs and secondary ASCs following viral, but not nematode, infection. Therefore, T-bet facilitates differentiation of IFN-gamma-activated inflammatory effector B cells into ASCs in the setting of IFN-gamma-, but not IL-4-, induced inflammatory responses.	[Stone, Sara L.; Peel, Jessica N.; Risley, Christopher A.; Chisolm, Danielle A.; Schultz, Michael D.; Mousseau, Betty; Weinmann, Amy S.; Rosenberg, Alexander F.; Lund, Frances E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Scharer, Christopher D.; Boss, Jeremy M.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Yu, Bingfei; Goldrath, Ananda W.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Ballesteros-Tato, Andre; Randall, Troy D.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Wojciechowski, Wojciech; Misra, Ravi S.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hanidu, Adedayo; Jiang, Huiping; Qi, Zhenhao; Brodeur, Scott R.] Boerhinger Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Rosenberg, Alexander F.] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA; [Wojciechowski, Wojciech] Univ Rochester, Sch Med & Dent, Flow Cytometry Shared Resource Lab, Ctr Pediat Biomed Res, Rochester, NY 14642 USA; [Jiang, Huiping] Epizyme Inc, Cambridge, MA 02139 USA; [Qi, Zhenhao] Bristol Myers Squibb Co, Pennington, NJ 08534 USA; [Brodeur, Scott R.] Janssen R&D, Spring House, PA 19477 USA	University of Alabama System; University of Alabama Birmingham; Emory University; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; University of Rochester; University of Alabama System; University of Alabama Birmingham; University of Rochester; Bristol-Myers Squibb; Johnson & Johnson; Janssen Pharmaceuticals	Lund, FE (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	flund@uab.edu		Wojciechowski, Wojciech/0000-0002-3272-9635; Scharer, Christopher/0000-0001-7716-8504	Boehringer Ingelheim Pharmaceutical; NIH [P30 AR048311, P30 AI027767, G20RR022807-01, P01 AI078907, R01 AI110508, P01 AI125180, U19 AI109962, R01 HL069409, R01 AI097357, R01 AI061061, R01 AI23733-01]; UAB Medical Scientist Training Program [NIGMS T32GM008361]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI125180, R37AI049660, R01AI061061, U19AI110483, T32AI007051, R01AI110508, U19AI109962, P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	Boehringer Ingelheim Pharmaceutical(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Medical Scientist Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Thomas Scott Simpler, Uma Mudunuru, Rebecca Burnham, and Holly Bachus for technical support and Drs. Eric Meffre (Yale University), Shane Crotty (LIAI), and Mark Shlomchik (University of Pittsburgh) for providing mouse strains that were used in the experiments. Boehringer Ingelheim Pharmaceutical (to F.E.L., S.R.B., and H.J.) provided support for Affymetrix transcriptome analysis. Funding for all other experiments was provided by the NIH: P01 AI078907, R01 AI110508 (to F.E.L.), P01 AI125180 (to F.E.L. and A.S.W.), U19 AI109962 (to F.E.L. and T.D.R.), R01 HL069409 and R01 AI097357 (to T.D.R.), R01 AI061061 (to A.S.W.), and R01 AI23733-01 (to J.M.B. and C.D.S.). S.L.S. received grant support from the UAB Medical Scientist Training Program NIGMS T32GM008361. NIH P30 AR048311 and P30 AI027767 provided support for the UAB consolidated flow cytometry core, and G20RR022807-01 provided support for the UAB Animal Resources Program X-irradiator.	Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368; Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chisolm DA, 2017, IMMUNITY, V47, P251, DOI 10.1016/j.immuni.2017.07.015; Deenick EK, 2005, EUR J IMMUNOL, V35, P2949, DOI 10.1002/eji.200425719; Domeier PP, 2016, J EXP MED, V213, P715, DOI 10.1084/jem.20151722; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Iwata S, 2017, IMMUNITY, V46, P983, DOI 10.1016/j.immuni.2017.05.005; Jackson SW, 2016, J EXP MED, V213, P733, DOI 10.1084/jem.20151724; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; KEES U, 1984, J EXP MED, V159, P365, DOI 10.1084/jem.159.2.365; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klein U, 2015, CURR OPIN HEMATOL, V22, P379, DOI 10.1097/MOH.0000000000000160; Knox JJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92943; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; MCINTYRE TM, 1993, J EXP MED, V177, P1031, DOI 10.1084/jem.177.4.1031; Miller SA, 2010, IMMUNOL REV, V238, P233, DOI 10.1111/j.1600-065X.2010.00952.x; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oestreich KJ, 2012, TRENDS IMMUNOL, V33, P78, DOI 10.1016/j.it.2011.10.005; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Pollard KM, 2013, DISCOV MED, V16, P123; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy K, 2019, IMMUNITY, V50, P616, DOI 10.1016/j.immuni.2019.02.004; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Scharer CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27030; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sellars M, 2009, J EXP MED, V206, P1073, DOI 10.1084/jem.20082311; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; 2005, ONCOGENE, V24, P6945, DOI DOI 10.1038/SJ.ONC.1208842; 2017, CELL IMMUNOL, V321, P40, DOI DOI 10.1016/J.CELLIMM.2017.05.008; 2012, NAT IMMUNOL, V13, P681, DOI DOI 10.1038/NI.2309; 2014, BIOINFORMATICS, V30, P523, DOI DOI 10.1093/BIOINFORMATICS/BTT703; 2008, J CLIN INVEST, V118, P1417, DOI DOI 10.1172/JCI30065	68	55	57	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1172	+		10.1016/j.immuni.2019.04.004	http://dx.doi.org/10.1016/j.immuni.2019.04.004			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31076359	Green Accepted, Bronze			2022-12-18	WOS:000468429500010
J	Varol, D; Mildner, A; Blank, T; Shemer, A; Barashi, N; Yona, S; David, E; Boura-Halfon, S; Segal-Hayoun, Y; Chappell-Maor, L; Keren-Shaul, H; Leshkowitz, D; Hornstein, E; Fuhrmann, M; Amit, I; Maggio, N; Prinz, M; Jung, S				Varol, Diana; Mildner, Alexander; Blank, Thomas; Shemer, Anat; Barashi, Neta; Yona, Simon; David, Eyal; Boura-Halfon, Sigalit; Segal-Hayoun, Yifat; Chappell-Maor, Louise; Keren-Shaul, Hadas; Leshkowitz, Dena; Hornstein, Eran; Fuhrmann, Martin; Amit, Ido; Maggio, Nicola; Prinz, Marco; Jung, Steffen			Dicer Deficiency Differentially Impacts Microglia of the Developing and Adult Brain	IMMUNITY			English	Article							LONG-TERM POTENTIATION; DNA-DAMAGE; SYSTEMIC INFLAMMATION; TISSUE MACROPHAGES; SMALL RNAS; EXPRESSION; MONOCYTES; REVEALS; CELLS; TREM2	Microglia seed the embryonic neuro-epithelium, expand and actively sculpt neuronal circuits in the developing central nervous system, but eventually adopt relative quiescence and ramified morphology in the adult. Here, we probed the impact of post-transcriptional control by microRNAs (miRNAs) on microglial performance during development and adulthood by generating mice lacking microglial Dicer expression at these distinct stages. Conditional Dicer ablation in adult microglia revealed that miRNAs were required to limit microglial responses to challenge. After peripheral endotoxin exposure, Dicer-deficient microglia expressed more pro-inflammatory cytokines than wild-type microglia and thereby compromised hippocampal neuronal functions. In contrast, prenatal Dicer ablation resulted in spontaneous microglia activation and revealed a role for Dicer in DNA repair and preservation of genome integrity. Accordingly, Dicer deficiency rendered otherwise radio-resistant microglia sensitive to gamma irradiation. Collectively, the differential impact of the Dicer ablation on microglia of the developing and adult brain highlights the changes these cells undergo with time.	[Varol, Diana; Mildner, Alexander; Shemer, Anat; Barashi, Neta; Yona, Simon; David, Eyal; Boura-Halfon, Sigalit; Segal-Hayoun, Yifat; Chappell-Maor, Louise; Keren-Shaul, Hadas; Amit, Ido; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Blank, Thomas; Prinz, Marco] Univ Freiburg, Inst Neuropathol, Fac Med, D-79106 Freiburg, Germany; [Leshkowitz, Dena] Weizmann Inst Sci, Life Sci Core Facil, IL-76100 Rehovot, Israel; [Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Fuhrmann, Martin] German Ctr Neurodegenerat Dis DZNE, Neuroimmunol & Imaging, D-53105 Bonn, Germany; [Maggio, Nicola] Tel Aviv Univ, Sackler Fac Med, Chaim Sheba Med Ctr, Dept Neurol, IL-5262 Tel Aviv, Israel; [Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, IL-5262 Tel Aviv, Israel; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	Weizmann Institute of Science; University of Freiburg; Weizmann Institute of Science; Weizmann Institute of Science; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; University of Freiburg	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	mildner, alexander/AFK-2161-2022; Jung, Steffen/K-1409-2012; Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; Yona, Simon/ABE-6572-2020; Fuhrmann, Martin/J-2707-2018; mildner, alexander/AAF-9451-2022	mildner, alexander/0000-0002-2019-8427; Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; Fuhrmann, Martin/0000-0001-7672-2913; mildner, alexander/0000-0002-2019-8427; Yona, Simon/0000-0002-3984-2008; Blank, Thomas/0000-0002-3969-405X	Israeli Science Foundation [887/11]; Minerva Foundation; European Research Council [340345]; Deutsche Forschungsgemeinschaft [CRC/TRR167]; ERC consolidator program (FP7)	Israeli Science Foundation(Israel Science Foundation); Minerva Foundation; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC consolidator program (FP7)	We would like to thank all members of the Jung laboratory for helpful discussion, the staff of the Weizmann Animal facility for the excellent care, E. Feldmesser for critical assistance with miRNA microarray data analysis, I. Orr for conducting the bioinformatic evaluation of miR target enrichment, and R. Rotkopf for advice concerning statistics. We thank T. Paz-Elizur, U. Swain, and V. Krizhanovsky (WIS), B. Stevens, and D. Schafer for critical advice. This work was supported by the Israeli Science Foundation (887/11), the Minerva Foundation, the European Research Council (340345), and the Deutsche Forschungsgemeinschaft (CRC/TRR167 "NeuroMac" for S.J., I.A., M.P., and T.B.). Work of E.H. is supported by ERC consolidator program (FP7) and Minerva Foundation.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gelfand BD, 2015, CELL REP, V11, P1686, DOI 10.1016/j.celrep.2015.05.023; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guerreiro R, 2013, NEW ENGL J MED, V369, P1569, DOI 10.1056/NEJMc1306509; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ihaka Ross., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.1080/10618600.1996.10474713, 10.2307/1390807]; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuipers H, 2010, J IMMUNOL, V185, P400, DOI 10.4049/jimmunol.0903912; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00046; Mancino A, 2013, EMBO J, V32, P816, DOI 10.1038/emboj.2013.28; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Orlowski D, 2003, INT J DEV NEUROSCI, V21, P445, DOI 10.1016/j.ijdevneu.2003.09.001; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Riazi K, 2015, J NEUROSCI, V35, P4942, DOI 10.1523/JNEUROSCI.4485-14.2015; Saba R., 2012, PLOS ONE, V7; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strehl A, 2014, EXP NEUROL, V261, P230, DOI 10.1016/j.expneurol.2014.04.033; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swahari V, 2016, CELL REP, V14, P216, DOI 10.1016/j.celrep.2015.12.037; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Vereker E, 2000, J BIOL CHEM, V275, P26252, DOI 10.1074/jbc.M002226200; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-211; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	80	55	58	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					1030	+		10.1016/j.immuni.2017.05.003	http://dx.doi.org/10.1016/j.immuni.2017.05.003			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636953	Green Submitted, Bronze			2022-12-18	WOS:000403665900016
J	He, B; Xing, SJ; Chen, CY; Gao, P; Teng, L; Shan, Q; Gullicksrud, JA; Martin, MD; Yu, SY; Harty, JT; Badovinac, VP; Tan, K; Xue, HH				He, Bing; Xing, Shaojun; Chen, Changya; Gao, Peng; Teng, Li; Shan, Qiang; Gullicksrud, Jodi A.; Martin, Matthew D.; Yu, Shuyang; Harty, John T.; Badovinac, Vladimir P.; Tan, Kai; Xue, Hai-Hui			CD8(+) T Cells Utilize Highly Dynamic Enhancer Repertoires and Regulatory Circuitry in Response to Infections	IMMUNITY			English	Article							GENE-EXPRESSION; SUPER-ENHANCERS; TRANSCRIPTION FACTORS; MEMORY; DIFFERENTIATION; EFFECTOR; IDENTITY; SIGNATURES; INSIGHTS; DISEASE	Differentiation of effector and memory CD8(+) T cells is accompanied by extensive changes in the transcriptome and histone modifications at gene promoters; however, the enhancer repertoire and associated gene regulatory networks are poorly defined. Using histone mark chromatin immunoprecipitation coupled with deep sequencing, we mapped the enhancer and super-enhancer landscapes in antigen-specific naive, differentiated effector, and central memory CD8(+) T cells during LCMV infection. Epigenomics-based annotation revealed a highly dynamic repertoire of enhancers, which were inherited, de novo activated, decommissioned and re-activated during CD8(+) T cell responses. We employed a computational algorithm to pair enhancers with target gene promoters. On average, each enhancer targeted three promoters and each promoter was regulated by two enhancers. By identifying enriched transcription factor motifs in enhancers, we defined transcriptional regulatory circuitry at each CD8(+) T cell response stage. These multi-dimensional datasets provide a blueprint for delineating molecular mechanisms underlying functional differentiation of CD8(+) T cells.	[He, Bing; Gao, Peng; Tan, Kai; Xue, Hai-Hui] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [He, Bing; Gao, Peng; Tan, Kai; Xue, Hai-Hui] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [He, Bing; Gao, Peng; Tan, Kai] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Xing, Shaojun; Shan, Qiang; Gullicksrud, Jodi A.; Harty, John T.; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Martin, Matthew D.; Badovinac, Vladimir P.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Chen, Changya] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA; [Gullicksrud, Jodi A.; Martin, Matthew D.; Harty, John T.; Badovinac, Vladimir P.; Xue, Hai-Hui] Univ Iowa, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA; [Tan, Kai; Xue, Hai-Hui] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Teng, Li] Illumina Inc, San Diego, CA 92122 USA; [Yu, Shuyang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; Illumina; China Agricultural University	Tan, K; Xue, HH (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA.; Tan, K; Xue, HH (corresponding author), Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA.; Tan, K (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.; Xue, HH (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.; Xue, HH (corresponding author), Univ Iowa, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA.; Tan, K; Xue, HH (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	tank1@email.chop.edu; hai-hui-xue@uiowa.edu	Gao, Peng/ABB-3865-2020	Gao, Peng/0000-0002-7785-2389; Harty, John/0000-0001-7266-2802; Tan, Kai/0000-0002-9104-5567; Xue, Hai-Hui/0000-0002-9163-7669; Xing, Shaojun/0000-0003-0777-2196; Shan, Qiang/0000-0002-7089-0278; Badovinac, Vladimir/0000-0003-3180-2439	NIH [AI115149, HG006130, GM104369, GM108716, AI112579, AI105351, AI121080, AI119160, AI042767, AI114543, GM113961]; Department of Veteran Affairs [BX002903]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042767, R21AI042767, R01AI112579, R01AI121080, R21AI119160, R21AI105351, R01AI114543, R21AI115149, R01AI042767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108716, R01GM113961, R01GM104369] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank I. Antoshechkin (Millard and Muriel Jacobs Genetics and Genomics Laboratory at the Caltech) for RNA-seq, the Genomics Division of the Iowa Institute of Human Genetics for ChIP-seq, the University of Iowa Flow Cytometry Core facility for cell sorting and the Research Information Services at the Children's Hospital of Philadelphia for providing computing support. This study was primarily supported by a grant from the NIH (AI115149 to H.-H.X. and K.T.), and also supported by grants from the NIH (HG006130, GM104369, and GM108716 to K.T.; AI112579, AI105351, and AI121080 to H.-H.X.; AI119160 to H.H.X. and V.B.P.; AI042767 to J.T.H.; and AI114543 and GM113961 to V.B.P.) and from the Department of Veteran Affairs (BX002903 to H.H.X.).	Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Firpi HA, 2010, BIOINFORMATICS, V26, P1579, DOI 10.1093/bioinformatics/btq248; Guo YX, 2014, J IMMUNOL, V192, P3336, DOI 10.4049/jimmunol.1301949; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; He B, 2014, P NATL ACAD SCI USA, V111, pE2191, DOI 10.1073/pnas.1320308111; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hosoya-Ohmura S, 2011, MOL CELL BIOL, V31, P1894, DOI 10.1128/MCB.05065-11; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Martin MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005219; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Seumois G, 2014, NAT IMMUNOL, V15, P777, DOI 10.1038/ni.2937; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	35	55	55	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1341	1354		10.1016/j.immuni.2016.11.009	http://dx.doi.org/10.1016/j.immuni.2016.11.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27986453	Green Accepted, Bronze			2022-12-18	WOS:000392918100018
J	Ohyagi, H; Onai, N; Sato, T; Yotsumoto, S; Liu, J; Akiba, H; Yagita, H; Atarashi, K; Honda, K; Roers, A; Muller, W; Kurabayashi, K; Hosoi-Amaike, M; Takahashi, N; Hirokawa, M; Matsushima, K; Sawada, K; Ohteki, T				Ohyagi, Hideaki; Onai, Nobuyuki; Sato, Taku; Yotsumoto, Satoshi; Liu, Jiajia; Akiba, Hisaya; Yagita, Hideo; Atarashi, Koji; Honda, Kenya; Roers, Axel; Mueller, Werner; Kurabayashi, Kazutaka; Hosoi-Amaike, Mayuka; Takahashi, Naoto; Hirokawa, Makoto; Matsushima, Kouji; Sawada, Kenichi; Ohteki, Toshiaki			Monocyte-Derived Dendritic Cells Perform Hemophagocytosis to Fine-Tune Excessive Immune Responses	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; APOPTOTIC CELLS; T-CELLS; VIRAL PERSISTENCE; INNATE IMMUNITY; INFECTION; INTERLEUKIN-10; EXPRESSION; PHOSPHATIDYLSERINE; STIMULATION	Because immune responses simultaneously defend and injure the host, the immune system must be finely regulated to ensure the host's survival. Here, we have shown that when injected with high Toll-like receptor ligand doses or infected with lymphocytic choriomeningitis virus (LCMV) clone 13, which has a high viral turnover, inflammatory monocyte-derived dendritic cells (Mo-DCs) engulfed apoptotic erythroid cells. In this process, called hemophagocytosis, phosphatidylserine (PS) served as an "eat-me" signal. Type I interferons were necessary for both PS exposure on erythroid cells and the expression of PS receptors in the Mo-DCs. Importantly, hemophagocytosis was required for interleukin-10 (IL-10) production from Mo-DCs. Blocking hemophagocytosis or Mo-DC-derived IL-10 significantly increased cytotoxic T cell lymphocyte activity, tissue damage, and mortality in virus-infected hosts, suggesting that hemophagocytosis moderates immune responses to ensure the host's survival in vivo. This sheds light on the physiological relevance of hemophagocytosis in severe inflammatory and infectious diseases.	[Ohyagi, Hideaki; Liu, Jiajia; Takahashi, Naoto; Sawada, Kenichi] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 0108543, Japan; [Onai, Nobuyuki; Sato, Taku; Yotsumoto, Satoshi; Kurabayashi, Kazutaka; Hosoi-Amaike, Mayuka; Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan; [Onai, Nobuyuki; Sato, Taku; Matsushima, Kouji; Ohteki, Toshiaki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Akiba, Hisaya; Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Atarashi, Koji; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; [Roers, Axel] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, D-01307 Dresden, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Hirokawa, Makoto] Akita Univ Hosp, Clin Oncol Ctr, Akita 0108543, Japan; [Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan	Akita University; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Juntendo University; University of Tokyo; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Manchester; Akita University; University of Tokyo	Ohteki, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan.	ohteki.bre@mri.tmd.ac.jp	Atarashi, Koji/I-5363-2014; Honda, Kenya/N-5297-2015; Muller, Werner/B-9044-2008	Atarashi, Koji/0000-0001-5422-0736; Muller, Werner/0000-0002-1297-9725; Onai, Nobuyuki/0000-0003-2246-4917	Takeda Science Foundation; Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University; Ministry of Education, Science, Sports and Culture of Japan; Challenging Exploratory Research; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST); Grants-in-Aid for Scientific Research [25461503] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Kamioka for secretarial support, Shoko Kuroda for technical assistance, Nobuhiko Kamada (Keio University) for the B6.Ccl2<SUP>-/-</SUP> mice, Shigekazu Nagata (Kyoto University) for the B6.Mfge8<SUP>-/-</SUP> mice, Dean Sheppard (University of California, San Francisco) for the Ab against integrin alpha<INF>v</INF>beta<INF>5</INF>, Pamela S. Ohashi (Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University of Toronto, Toronto) for the LCMV Armstrong, and Toshitaka Akatsuka (Saitama Medical University) for the LCMV Clone 13. This work was supported by the Takeda Science Foundation (T.O.), the Joint Usage/Research Program of the Medical Research Institute, Tokyo Medical and Dental University (K. S.), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan (T.O.), Challenging Exploratory Research (T.O.), and Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST) (T.O.).	Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Budiani Dyah R., 2002, Journal of Microbiology Immunology and Infection, V35, P265; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Clerici M, 1996, BLOOD, V88, P574, DOI 10.1182/blood.V88.2.574.bloodjournal882574; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Djavani M, 2001, J VIROL, V75, P6204, DOI 10.1128/JVI.75.13.6204-6208.2001; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Larroche C, 2004, AUTOIMMUN REV, V3, P159, DOI 10.1016/S1568-9972(03)00091-0; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Maakaroun NR, 2010, REV MED VIROL, V20, P93, DOI 10.1002/rmv.638; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Nordoy I, 2000, J INFECT DIS, V181, P51, DOI 10.1086/315184; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2006, EUR J HAEMATOL, V77, P432, DOI 10.1111/j.1600-0609.2006.00730.x; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; TAKAHASHI K, 1990, J IMMUNOL, V145, P4371; TARUMI T, 1995, EXP HEMATOL, V23, P1310; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Waibler Z, 2008, EUR J IMMUNOL, V38, P3127, DOI 10.1002/eji.200838184; Xiao S, 2007, J EXP MED, V204, P1691, DOI 10.1084/jem.20062498; Xiao S, 2011, EUR J IMMUNOL, V41, P1539, DOI 10.1002/eji.201040993; YASUDA M, 1995, INT IMMUNOL, V7, P251, DOI 10.1093/intimm/7.2.251; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	61	55	58	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					584	598		10.1016/j.immuni.2013.06.019	http://dx.doi.org/10.1016/j.immuni.2013.06.019			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24035363	Bronze			2022-12-18	WOS:000330949600020
J	Maruyama, K; Fukasaka, M; Vandenbon, A; Saitoh, T; Kawasaki, T; Kondo, T; Yokoyama, KK; Kidoya, H; Takakura, N; Standley, D; Takeuchi, O; Akira, S				Maruyama, Kenta; Fukasaka, Masahiro; Vandenbon, Alexis; Saitoh, Tatsuya; Kawasaki, Takumi; Kondo, Takeshi; Yokoyama, Kazunari K.; Kidoya, Hiroyasu; Takakura, Nobuyuki; Standley, Daron; Takeuchi, Osamu; Akira, Shizuo			The Transcription Factor Jdp2 Controls Bone Homeostasis and Antibacterial Immunity by Regulating Osteoclast and Neutrophil Differentiation	IMMUNITY			English	Article							DIMERIZATION PROTEIN-2 JDP2; COLONY-STIMULATING FACTOR; GRANULOCYTE; GRANULES; RECEPTOR; MICE	Jdp2 is an AP-1 family transcription factor that regulates the epigenetic status of histones. Previous in vitro studies revealed that Jdp2 is involved in osteoclastogenesis. However, the roles of Jdp2 in vivo and its pleiotropic functions are largely unknown. Here we generated Jdp2(-/-) mice and discovered its crucial roles not only in bone metabolism but also in differentiation of neutrophils. Jdp2(-/-) mice exhibited osteopetrosis resulting from impaired osteoclastogenesis. Jdp2(-/-) neutrophils were morphologically normal but had impaired surface expression of Ly6G, bactericidal function, and apoptosis. We also found that ATF3 was an inhibitor of neutrophil differentiation and that Jdp2 directly suppresses its expression via inhibition of histone acetylation. Strikingly, Jdp2(-/-) mice were highly susceptible to Staphylococcus aureus and Candida albicans infection. Thus, Jdp2 plays pivotal roles in in vivo bone homeostasis and host defense by regulating osteoclast and neutrophil differentiation.	[Maruyama, Kenta; Fukasaka, Masahiro; Saitoh, Tatsuya; Kawasaki, Takumi; Kondo, Takeshi; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Host Def Lab, Suita, Osaka 5650871, Japan; [Vandenbon, Alexis; Standley, Daron] Osaka Univ, Lab Syst Immunol, WPI Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan; [Kidoya, Hiroyasu; Takakura, Nobuyuki; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Yokoyama, Kazunari K.] Kaohsiung Med Univ Hosp, Canc Ctr, Kaohsiung 807, Taiwan; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 6068507, Japan	Osaka University; Osaka University; Osaka University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kyoto University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	KONDO, Takeshi/AGV-4963-2022; Standley, Daron/D-2343-2009; Vandenbon, Alexis/N-4428-2019; Takeuchi, Osamu/AAG-9359-2019; Vandenbon, Alexis/A-8430-2017; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science (JSPS); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank S. Tartey and D. On for technical advice; E. Kamada and M. Kageyama for secretarial assistance; K. Nojima, Y. Fujiwara, and M. Kumagai for technical assistance; and T. Kawai and Y. Kumagai for fruitful discussions. This work was supported by Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science, and Technology, grants from the Ministry of Health, Labour, and Welfare of Japan, the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), and a research fellowship from the JSPS for the Promotion of Science for Young Scientists. K.M. designed and performed most of the experiments. M.F., T.S., T. Kawasaki, T. Kondo, H.K., N.T., and O.T. contributed the immunological experiments. A.V. and D.S. analyzed the ChIP-seq data. K.K.Y. provided the Jdp2 antibody. The manuscript was written by K.M. S.A. supervised the overall research.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bertram A, 2012, J IMMUNOL, V188, P4043, DOI 10.4049/jimmunol.1101651; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; FORMAN HJ, 1986, ANNU REV PHYSIOL, V48, P669; HESTDAL K, 1991, J IMMUNOL, V147, P22; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Huang YC, 2010, KAOHSIUNG J MED SCI, V26, P515, DOI 10.1016/S1607-551X(10)70081-4; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Maruyama K, 2007, INFECT IMMUN, V75, P1520, DOI 10.1128/IAI.01316-06; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nishinaka Y, 2011, BIOCHEM BIOPH RES CO, V413, P75, DOI 10.1016/j.bbrc.2011.08.052; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Weidenfeld-Baranboim K, 2009, NUCLEIC ACIDS RES, V37, P2194, DOI 10.1093/nar/gkp083; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	33	55	56	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1024	1036		10.1016/j.immuni.2012.08.022	http://dx.doi.org/10.1016/j.immuni.2012.08.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23200825	Bronze			2022-12-18	WOS:000312575000011
J	Kraus, M; Saijo, K; Torres, RM; Rajewsky, K				Kraus, M; Saijo, K; Torres, RM; Rajewsky, K			Ig-alpha cytoplasmic truncation renders immature B cells more sensitive to antigen contact	IMMUNITY			English	Article							REACTIVE LYMPHOCYTES-B; RECEPTOR SIGNAL-TRANSDUCTION; ACTIVATION MOTIF; NEGATIVE SELECTION; ALLELIC EXCLUSION; TRANSGENIC MICE; BETA; IMMUNOGLOBULIN; ANTIBODY; TOLERANCE	To study the function of Ig-alpha in the selection of autoreactive B cells, we have analyzed mb-1 cytoplasmic truncation mutant mice (mb-1(Delta c/Delta c)), which coexpress transgenes encoding hen egg lysozyme (HEL) and HEL-specific immunoglobulin. We demonstrate that in the presence of soluble MEL (sHEL) and dependent on the mb-1(Delta c) mutation, most immature B cells bearing the MEL-specific Ig transgene undergo rearrangements of endogenous kappa light chains, resulting in loss of MEL specificity. Moreover, immature B cells from Ig-alpha mutant mice respond to BCR cross-linking with an exaggerated and prolonged calcium response and induction of protein tyrosine phosphorylation. Our data imply a negative signaling role for Ig-alpha in immature B cells.	Univ Cologne, Inst Genet, Dept Immunol, D-50931 Cologne, Germany; Univ Cologne, Inst Genet, Lab Lymphocyte Signaling, D-50931 Cologne, Germany; Basel Inst Immunol, CH-4005 Basel, Switzerland	University of Cologne; University of Cologne	Kraus, M (corresponding author), Univ Cologne, Inst Genet, Dept Immunol, Weyertal 121, D-50931 Cologne, Germany.			Rajewsky, Klaus/0000-0002-6633-6370				Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Fang W, 1998, IMMUNITY, V9, P35, DOI 10.1016/S1074-7613(00)80586-5; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; JUSTEMENT LB, 1990, J IMMUNOL, V144, P3272; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; Pao LI, 1998, J IMMUNOL, V160, P3305; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; TADDIE JA, 1994, J BIOL CHEM, V269, P13529; Teh YM, 1997, J EXP MED, V185, P1753, DOI 10.1084/jem.185.10.1753; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tseng J, 1997, BLOOD, V89, P1513, DOI 10.1182/blood.V89.5.1513.1513_1513_1520; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; YAO XR, 1995, J IMMUNOL, V155, P652	44	55	57	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					537	545		10.1016/S1074-7613(00)80129-6	http://dx.doi.org/10.1016/S1074-7613(00)80129-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591179	Bronze			2022-12-18	WOS:000083952200006
J	Monroe, RJ; Sleckman, BP; Monroe, BC; Khor, B; Claypool, S; Ferrini, R; Davidson, L; Alt, FW				Monroe, RJ; Sleckman, BP; Monroe, BC; Khor, B; Claypool, S; Ferrini, R; Davidson, L; Alt, FW			Developmental regulation of TCR delta locus accessibility and expression by the TCR delta enhancer	IMMUNITY			English	Article							T-CELL DEVELOPMENT; RECEPTOR ALPHA/DELTA-LOCUS; ALPHA-BETA-LINEAGE; GAMMA-DELTA; GENE REARRANGEMENT; TRANSCRIPTIONAL ENHANCER; V(D)J RECOMBINATION; TARGETED DELETION; IG-KAPPA; C-ALPHA	We have used gene-targeted mutation to assess the role of the T cell receptor delta (TCR delta) enhancer (E delta) in alpha beta and gamma delta T cell development. Mice lacking E delta exhibited no defects in alpha beta T cell development but had a severe reduction in thymic and peripheral gamma delta T cells and decreased VDJ delta rearrangements. Simultaneous deletion of both E delta and the TCR alpha enhancer (E alpha) demonstrated that residual TCR delta rearrangements were not driven by E alpha, implicating additional elements in TCR delta locus accessibility. Surprisingly, while deletion of E delta severely impaired germline TCR delta expression in double-negative thymocytes, absence of E delta did not affect expression of mature delta transcripts in gamma delta T cells. We conclude that E delta has an important role in TCR delta locus regulation at early, but not late, stages of gamma delta T cell development.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@rascal.med.harvard.edu		Claypool, Steven/0000-0001-5316-1623; Khor, Bernard/0000-0003-4689-5092	PHS HHS [A.I.20047, A.I.01297-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arden Bernhard, 1995, Immunogenetics, V42, P501; BONNEVILLE M, 1989, NATURE, V342, P931, DOI 10.1038/342931a0; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Burtrum DB, 1996, J IMMUNOL, V157, P4293; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; Coligan JE., 1994, CURRENT PROTOCOLS IM; DECHASSEVAL R, 1993, EUR J IMMUNOL, V23, P1294, DOI 10.1002/eji.1830230616; DEVILLARTAY JP, 1990, RES IMMUNOL, V141, P618, DOI 10.1016/0923-2494(90)90069-B; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; ELLIOTT JF, 1988, NATURE, V331, P627; EZQUERRA A, 1990, J IMMUNOL, V145, P1311; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; GILL LL, 1991, EUR J IMMUNOL, V21, P807, DOI 10.1002/eji.1830210339; GODFREY DI, 1994, J IMMUNOL, V152, P4783; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; Krangel MS, 1998, IMMUNOL REV, V165, P131, DOI 10.1111/j.1600-065X.1998.tb01236.x; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LANSFORD R, 1996, MOL IMMUNOL, P248; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; Mertsching E, 1997, EUR J IMMUNOL, V27, P389, DOI 10.1002/eji.1830270208; MIGONE N, 1995, IMMUNOGENETICS, V42, P323, DOI 10.1007/BF00179393; NAKAJIMA PB, 1995, IMMUNITY, V3, P609, DOI 10.1016/1074-7613(95)90132-9; Okada A, 1994, Semin Immunol, V6, P185, DOI 10.1006/smim.1994.1024; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; REDONDO JM, 1990, SCIENCE, V247, P1225, DOI 10.1126/science.2156339; Roberts JL, 1997, J EXP MED, V185, P131, DOI 10.1084/jem.185.1.131; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; SATYANARAYANA K, 1988, P NATL ACAD SCI USA, V85, P8166, DOI 10.1073/pnas.85.21.8166; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sleckman BP, 1998, IMMUNOL REV, V165, P121, DOI 10.1111/j.1600-065X.1998.tb01235.x; Sleckman BP, 1998, J EXP MED, V188, P1465, DOI 10.1084/jem.188.8.1465; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; TOMOYUKI T, 1992, GROWTH DIFFER, V34, P561; VANELP J, 1993, P NATL ACAD SCI USA, V90, P9664, DOI 10.1073/pnas.90.20.9664; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; WANG K, 1994, GENOMICS, V20, P419, DOI 10.1006/geno.1994.1196; WHITE J, 1989, J IMMUNOL, V143, P1822; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219	57	55	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1999	10	5					503	513		10.1016/S1074-7613(00)80050-3	http://dx.doi.org/10.1016/S1074-7613(00)80050-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367896	Bronze			2022-12-18	WOS:000080709400002
J	Moriyama, S; Adachi, Y; Sato, T; Tonouchi, K; Sun, L; Fukushi, S; Yamada, S; Kinoshita, H; Nojima, K; Kanno, T; Tobiume, M; Ishijima, K; Kuroda, Y; Park, ES; Onodera, T; Matsumura, T; Takano, T; Terahara, K; Isogawa, M; Nishiyama, A; Kawana-Tachikawa, A; Shinkai, M; Tachikawa, N; Nakamura, S; Okai, T; Okuma, K; Matano, T; Fujimoto, T; Maeda, K; Ohnishi, M; Wakita, T; Suzuki, T; Takahashi, Y				Moriyama, Saya; Adachi, Yu; Sato, Takashi; Tonouchi, Keisuke; Sun, Lin; Fukushi, Shuetsu; Yamada, Souichi; Kinoshita, Hitomi; Nojima, Kiyoko; Kanno, Takayuki; Tobiume, Minoru; Ishijima, Keita; Kuroda, Yudai; Park, Eun-Sil; Onodera, Taishi; Matsumura, Takayuki; Takano, Tomohiro; Terahara, Kazutaka; Isogawa, Masanori; Nishiyama, Ayae; Kawana-Tachikawa, Ai; Shinkai, Masaharu; Tachikawa, Natsuo; Nakamura, Shigeki; Okai, Takahiro; Okuma, Kazu; Matano, Tetsuro; Fujimoto, Tsuguto; Maeda, Ken; Ohnishi, Makoto; Wakita, Takaji; Suzuki, Tadaki; Takahashi, Yoshimasa			Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants	IMMUNITY			English	Article							RECEPTOR-BINDING DOMAIN; B-CELLS; MEMORY; RESPONSES; KINETICS; MILD; P.1	Antibody titers against SARS-CoV-2 slowly wane over time. Here, we examined how time affects antibody potency. To assess the impact of antibody maturation on durable neutralizing activity against original SARS-CoV-2 and emerging variants of concern (VOCs), we analyzed receptor binding domain (RBD)-specific IgG antibodies in convalescent plasma taken 1-10 months after SARS-CoV-2 infection. Longitudinal evaluation of total RBD IgG and neutralizing antibody revealed declining total antibody titers but improved neutralization potency per antibody to original SARS-CoV-2, indicative of antibody response maturation. Neutralization assays with authentic viruses revealed that early antibodies capable of neutralizing original SARS-CoV-2 had limited reactivity toward B.1.351 (501Y.V2) and P.1 (501Y.V3) variants. Antibodies from late convalescents exhibited increased neutralization potency to VOCs, suggesting persistence of cross-neutralizing antibodies in plasma. Thus, maturation of the antibody response to SARS-CoV-2 potentiates cross-neutralizing ability to circulating variants, suggesting that declining antibody titers may not be indicative of declining protection.	[Moriyama, Saya; Adachi, Yu; Tonouchi, Keisuke; Sun, Lin; Onodera, Taishi; Matsumura, Takayuki; Takano, Tomohiro; Terahara, Kazutaka; Isogawa, Masanori; Nishiyama, Ayae; Takahashi, Yoshimasa] Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo 1628640, Japan; [Sato, Takashi; Shinkai, Masaharu] Tokyo Shinagawa Hosp, Tokyo 1408522, Japan; [Tonouchi, Keisuke] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo 1628480, Japan; [Fukushi, Shuetsu; Yamada, Souichi; Kinoshita, Hitomi] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan; [Nojima, Kiyoko; Okuma, Kazu] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo 2080011, Japan; [Kanno, Takayuki; Tobiume, Minoru; Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan; [Ishijima, Keita; Kuroda, Yudai; Park, Eun-Sil; Maeda, Ken] Natl Inst Infect Dis, Dept Vet Sci, Tokyo 1628640, Japan; [Kawana-Tachikawa, Ai; Matano, Tetsuro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo 1628640, Japan; [Tachikawa, Natsuo] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa 2210855, Japan; [Nakamura, Shigeki] Tokyo Med Univ, Tokyo 1608402, Japan; [Okai, Takahiro] Kawakita Gen Hosp, Tokyo 1660001, Japan; [Fujimoto, Tsuguto] Natl Inst Infect Dis, Ctr Emergency Preparedness & Response, Tokyo 1628640, Japan; [Ohnishi, Makoto; Wakita, Takaji] Natl Inst Infect Dis, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID); Waseda University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Tokyo Medical University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Takahashi, Y (corresponding author), Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo 1628640, Japan.	ytakahas@niid.go.jp	Isogawa, Masanori/AAN-8969-2021; Suzuki, Tadaki/ABH-2661-2020	Isogawa, Masanori/0000-0001-8730-4303; Maeda, Ken/0000-0002-3488-5439; Matsumura, Takayuki/0000-0003-1760-3484; Terahara, Kazutaka/0000-0001-9876-4356; Takano, Tomohiro/0000-0003-4267-1147; Takahashi, Yoshimasa/0000-0001-6342-4087; Fujimoto, Tsuguto/0000-0002-4861-4349	Japan Agency for Medical Research and Development [JP19fk0108104, JP20fk0108104]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	We thank Dr. Katsumi Maenaka at Hokkaido University for providing the S trimer graphic; Akira Dosaka, Eriko Izumiyama, Masataka Tokita, and Ryoko Itami at the National Institute of Infectious Diseases for their technical support; and the Japanese Red Cross Society for providing donated blood based on the "Guidelines on the use of donated blood in R&D, etc". This work was supported by Japan Agency for Medical Research and Development under grant numbers JP19fk0108104 (T. Suzuki and Y.T.) and JP20fk0108104 (T. Suzuki and Y.T.).	Abayasingam A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100228; Adachi Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11821-6; Ali A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67685-0; Andreano E, 2021, CELL, V184, P1821, DOI 10.1016/j.cell.2021.02.035; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Chen XY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00301-9; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Clark SA, 2021, CELL, V184, P2605, DOI 10.1016/j.cell.2021.03.027; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garcia-Beltran WF, 2021, CELL, V184, P476, DOI 10.1016/j.cell.2020.12.015; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Liu Hejun, 2020, Immunity, V53, P1272, DOI [10.1101/2020.08.02.233536, 10.1016/j.immuni.2020.10.023]; Lynch KL, 2021, CLIN INFECT DIS, V72, P301, DOI 10.1093/cid/ciaa979; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; McNamara HA, 2020, CELL HOST MICROBE, V28, P572, DOI 10.1016/j.chom.2020.07.001; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Onodera T, 2016, J IMMUNOL, V196, P4172, DOI 10.4049/jimmunol.1600046; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pradenas E, 2021, MED-CAMBRIDGE, V2, P313, DOI 10.1016/j.medj.2021.01.005; Rijkers G, 2020, J INFECT DIS, V222, P1265, DOI 10.1093/infdis/jiaa463; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.21203/rs.3.rs-57112/v1, 10.1101/2020.08.11.20171843]; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Tani H, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01490-7; Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Wang PF, 2021, CELL HOST MICROBE, V29, P747, DOI 10.1016/j.chom.2021.04.007; Wang Pengfei, 2021, bioRxiv, DOI 10.1101/2021.01.25.428137; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	55	54	54	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1841	+		10.1016/j.immuni.2021.06.015	http://dx.doi.org/10.1016/j.immuni.2021.06.015		AUG 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34246326	Green Published, hybrid			2022-12-18	WOS:000684589700019
J	Lindesmith, LC; McDaniel, JR; Changela, A; Verardi, R; Kerr, SA; Costantini, V; Brewer-Jensen, PD; Mallory, ML; Voss, WN; Boutz, DR; Blazeck, JJ; Ippolito, GC; Vinje, J; Kwong, PD; Georgiou, G; Baric, RS				Lindesmith, Lisa C.; McDaniel, Jonathan R.; Changela, Anita; Verardi, Raffaello; Kerr, Scott A.; Costantini, Veronica; Brewer-Jensen, Paul D.; Mallory, Michael L.; Voss, William N.; Boutz, Daniel R.; Blazeck, John J.; Ippolito, Gregory C.; Vinje, Jan; Kwong, Peter D.; Georgiou, George; Baric, Ralph S.			Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination	IMMUNITY			English	Article							VIRUS-LIKE PARTICLES; BLOOD GROUP ANTIGENS; CRYSTALLOGRAPHIC STRUCTURE; BLOCKING ANTIBODIES; MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; H7N9 INFLUENZA; INFECTION; IMMUNOGENICITY; PROTECTION	Rapidly evolving RNA viruses, such as the GII.4 strain of human norovirus (HuNoV), and their vaccines elicit complex serological responses associated with previous exposure. Specific correlates of protection, moreover, remain poorly understood. Here, we report the GII.4-serological antibody repertoire- pre- and post-vaccination-and select several antibody clonotypes for epitope and structural analysis. The humoral response was dominated by GII.4-specific antibodies that blocked ancestral strains or by antibodies that bound to divergent genotypes and did not block viral-entry-ligand interactions. However, one antibody, A1431, showed broad blockade toward tested GII.4 strains and neutralized the pandemic GII.P16-GII.4 Sydney strain. Structural mapping revealed conserved epitopes, which were occluded on the virion or partially exposed, allowing for broad blockade with neutralizing activity. Overall, our results provide high-resolution molecular information on humoral immune responses after HuNoV vaccination and demonstrate that infection-derived and vaccine-elicited antibodies can exhibit broad blockade and neutralization against this prevalent human pathogen.	[Lindesmith, Lisa C.; Brewer-Jensen, Paul D.; Mallory, Michael L.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [McDaniel, Jonathan R.; Voss, William N.; Blazeck, John J.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Changela, Anita; Verardi, Raffaello; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kerr, Scott A.; Boutz, Daniel R.; Georgiou, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Costantini, Veronica; Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [Kerr, Scott A.] BioFire Inc, Salt Lake City, UT 84108 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Centers for Disease Control & Prevention - USA	Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	gg@che.utexas.edu; rbaric@email.unc.edu	Vinje, Jan/ABE-6336-2020; Ariel, Pablo/AGJ-4118-2022; Ippolito, Gregory C./AAR-2930-2021	Ippolito, Gregory C./0000-0002-7565-7002; Costantini, Veronica/0000-0002-1532-4345; Vinje, Jan/0000-0002-1530-3675	Intramural Research Program of'' the Vaccine Research Center, NIAID, NIH; intramural food safety program at CDC; NIH [R56AI106006, U19 AI109761 CETR]; Defense Threat Reduction Agency (DTRA) [HDTRA1-12-C-0105]; Wellcome Trust [203268/Z/16/Z]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109761, ZIAAI005022] Funding Source: NIH RePORTER	Intramural Research Program of'' the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); intramural food safety program at CDC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank Takeda Vaccines for provision of human samples; the Genome Sequencing and Analysis Facility at the University of Texas at Austin for performing Illumina next-generation sequencing; the Center for Biomedical Research Support Proteomics Facility at the University of Texas at Austin for providing mass spectrometry analysis; and Victoria Madden of Microscopy Services Laboratory, Department of Pathology and Laboratory Medicine, University of North Carolina-Chapel Hill for expert technical support. Support for this work was provided by the Intramural Research Program of'' the Vaccine Research Center, NIAID, NIH, and the intramural food safety program at CDC and by grants from the NIH (R56AI106006, G.G. and R.S.B. and U19 AI109761 CETR, R.S.B.), Defense Threat Reduction Agency (DTRA) (contract HDTRA1-12-C-0105, G.G.), and the Wellcome Trust [203268/Z/16/Z] (R.S.B.). Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Agnihothram S, 2018, J VIROL, V92, DOI [10.1128/JVI.00027-18, 10.1128/jvi.00027-18]; Ahmed SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035791; Alvarado G, 2018, GASTROENTEROLOGY, V155, P1898, DOI 10.1053/j.gastro.2018.08.039; Atmar RL, 2018, CURR OPIN INFECT DIS, V31, P422, DOI [10.1097/QCO.0000000000000476, 10.1097/qco.0000000000000476]; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Baric RS, 2002, J VIROL, V76, P3023, DOI 10.1128/JVI.76.6.3023-3030.2002; Belongia Edward A, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334554; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bootz A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006601; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Burke RM, 2019, J INFECT DIS, V219, P1364, DOI 10.1093/infdis/jiy569; Cannon JL, 2017, J CLIN MICROBIOL, V55, P2208, DOI 10.1128/JCM.00455-17; Cardemil CV, 2017, INFECT DIS CLIN N AM, V31, P839, DOI 10.1016/j.idc.2017.07.012; Carmona-Vicente N, 2015, J MED VIROL, V87, P675, DOI 10.1002/jmv.24112; Chen J, 2017, CELL REP, V18, P237, DOI 10.1016/j.celrep.2016.12.013; Chen R, 2004, J VIROL, V78, P6469, DOI 10.1128/JVI.78.12.6469-6479.2004; Costantini V, 2018, EMERG INFECT DIS, V24, P1453, DOI 10.3201/eid2408.180126; Debbink Kari, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15k01s31; Debbink K, 2014, J VIROL, V88, P7256, DOI 10.1128/JVI.00785-14; Debbink K, 2014, CLIN INFECT DIS, V58, P1746, DOI 10.1093/cid/ciu120; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185, DOI 10.1128/JCM.31.8.2185-2191.1993; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; JIANG X, 1995, J CLIN MICROBIOL, V33, P1452, DOI 10.1128/JCM.33.6.1452-1455.1995; Kilic T, 2018, J VIROL, V92, DOI [10.1128/JVI.00413-18, 10.1128/jvi.00413-18]; Kocher JF, 2018, PLOTKINS VACCINES, P698; Kolawole AO, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00334-17; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon YD, 2018, CELL REP, V22, P1798, DOI 10.1016/j.celrep.2018.01.023; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Leroux-Roels G, 2018, J INFECT DIS, V217, P597, DOI 10.1093/infdis/jix572; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2018, J INFECT DIS, V217, P1145, DOI 10.1093/infdis/jix651; Lindesmith LC, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00518-17; Lindesmith LC, 2017, J INFECT DIS, V215, P984, DOI 10.1093/infdis/jix045; Lindesmith LC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001807; Lindesmith LC, 2014, J VIROL, V88, P8826, DOI 10.1128/JVI.01192-14; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lindesmith LC, 2012, J VIROL, V86, P873, DOI 10.1128/JVI.06200-11; LoBue AD, 2006, VACCINE, V24, P5220, DOI 10.1016/j.vaccine.2006.03.080; Mallory ML, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020177; Malm M, 2014, J INFECT DIS, V210, P1755, DOI 10.1093/infdis/jiu361; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDaniel JR, 2016, NAT PROTOC, V11, P429, DOI 10.1038/nprot.2016.024; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mroczek ES, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00096; Nurminen K, 2011, J MED VIROL, V83, P525, DOI 10.1002/jmv.21990; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JS, 2015, HELICOBACTER, V20, P260, DOI 10.1111/hel.12198; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Petrignani M, 2018, J CLIN VIROL, V105, P1, DOI 10.1016/j.jcv.2018.05.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pogan R, 2018, CURR OPIN VIROL, V31, P59, DOI 10.1016/j.coviro.2018.05.003; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Shanker S, 2016, P NATL ACAD SCI USA, V113, pE5830, DOI 10.1073/pnas.1609990113; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Singh BK, 2015, J VIROL, V89, P2024, DOI 10.1128/JVI.02968-14; Snijder J, 2018, IMMUNITY, V48, P799, DOI 10.1016/j.immuni.2018.03.026; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Treanor JJ, 2014, J INFECT DIS, V210, P1763, DOI 10.1093/infdis/jiu337; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	88	54	55	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1530	+		10.1016/j.immuni.2019.05.007	http://dx.doi.org/10.1016/j.immuni.2019.05.007			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216462	Green Published, hybrid			2022-12-18	WOS:000471876100021
J	Ciucci, T; Vecchio, MS; Gao, YY; Ardori, FT; Candia, J; Mehta, M; Zhao, YM; Tran, B; Pepper, M; Tessarollo, L; McGavern, DB; Bosselut, R				Ciucci, Thomas; Vecchio, Melanie S.; Gao, Yayi; Ardori, Francesco Tomassoni; Candia, Julian; Mehta, Monika; Zhao, Yongmei; Tran, Bao; Pepper, Marion; Tessarollo, Lino; McGavern, Dorian B.; Bosselut, Remy			The Emergence and Functional Fitness of Memory CD4(+) T Cells Require the Transcription Factor Thpok	IMMUNITY			English	Article							FOLLICULAR HELPER; GENE-EXPRESSION; EFFECTOR; CD8(+); LINEAGE; COMMITMENT; DIFFERENTIATION; RESPONSES; ANTIGEN; PROTECTION	Memory CD4(+) T cells mediate long-term immunity, and their generation is a key objective of vaccination strategies. However, the transcriptional circuitry controlling the emergence of memory cells from early CD4(+) antigen-responders remains poorly understood. Here, using single-cell RNA-seq to study the transcriptome of virus-specific CD4(+) T cells, we identified a gene signature that distinguishes potential memory precursors from effector cells. We found that both that signature and the emergence of memory CD4(+) T cells required the transcription factor Thpok. We further demonstrated that Thpok cell-intrinsically protected memory cells from a dysfunctional, effector-like transcriptional program, similar to but distinct from the exhaustion pattern of cells responding to chronic infection. Mechanistically, Thpok-bound genes encoding the transcription factors Blimp1 and Runx3 and acted by antagonizing their expression. Thus, a Thpok-dependent circuitry promotes both memory CD4(+) T cells' differentiation and functional fitness, two previously unconnected critical attributes of adaptive immunity.	[Ciucci, Thomas; Vecchio, Melanie S.; Gao, Yayi; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ardori, Francesco Tomassoni; Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Candia, Julian] NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bldg 10, Bethesda, MD 20892 USA; [Mehta, Monika; Zhao, Yongmei; Tran, Bao] Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA; [Pepper, Marion] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy.bosselut@nih.gov	McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X; Mehta, Monika/0000-0003-3928-3733; Tomassoni Ardori, Francesco/0000-0002-8824-3693; Ciucci, Thomas/0000-0002-5828-0207	NCI Office of Science and Technology Resources; National Cancer Institute, Center for Cancer Research, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001226, R01AI108626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003112] Funding Source: NIH RePORTER	NCI Office of Science and Technology Resources; National Cancer Institute, Center for Cancer Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Castro and H. Kwak for animal care and genotyping and Q. Xiao for technical assistance; D. Swing and R. Koogle for help in generating the Zbtb7b<SUP>Bio</SUP> allele; M. Jenkins for helpful discussions; Y. Belkaid, J. Zhu, J. O'Shea, Ming Li, F. Gounari, and the NIH tetramer facility for mice and reagents; Anne Gegonne, the CCR Flow Cytometry Core, and the NIH High performance computing cluster for assistance; G. Abou Ezzi, J. Ashwell, D. Barber, A. Bhandoola, L. Chopp, J. Cowan, C. Harly, and A. Magen for critical reading of the manuscript; and D. Goldstein, M. Malik, and the NCI Office of Science and Technology Resources for their support. This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Cho YL, 2017, CELL REP, V20, P806, DOI 10.1016/j.celrep.2017.07.005; Ciucci T, 2017, P NATL ACAD SCI USA, V114, P13236, DOI 10.1073/pnas.1711160114; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Djuretic IM, 2009, ADV IMMUNOL, V104, P1, DOI 10.1016/S0065-2776(08)04001-7; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kojo S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00768-1; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; McKinstry KK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6377; Miyazaki M, 2014, NAT IMMUNOL, V15, P767, DOI 10.1038/ni.2928; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Nish SA, 2017, J EXP MED, V214, P39, DOI 10.1084/jem.20161046; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schiemann M, 2003, EUR J IMMUNOL, V33, P2875, DOI 10.1002/eji.200324224; Setoguchi R, 2009, J IMMUNOL, V183, P4467, DOI 10.4049/jimmunol.0901428; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tubo NJ, 2016, SCIENCE, V351, P511, DOI 10.1126/science.aad0483; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; Valkenburg SA, 2018, VACCINE, V36, P4198, DOI 10.1016/j.vaccine.2018.06.007; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang Q, 2001, J EXP MED, V194, P1721, DOI 10.1084/jem.194.12.1721; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	69	54	54	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					91	+		10.1016/j.immuni.2018.12.019	http://dx.doi.org/10.1016/j.immuni.2018.12.019			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30638736	Green Accepted, Bronze			2022-12-18	WOS:000455661600013
J	Pronovost, GN; Hsiao, EY				Pronovost, Geoffrey N.; Hsiao, Elaine Y.			Perinatal Interactions between the Microbiome, Immunity, and Neurodevelopment	IMMUNITY			English	Review							TOLL-LIKE RECEPTORS; ADULT HIPPOCAMPAL NEUROGENESIS; FETAL-BRAIN DEVELOPMENT; NONOBESE DIABETIC MICE; CHAIN FATTY-ACIDS; GUT MICROBIOTA; ANTIBIOTIC-TREATMENT; EARLY-LIFE; NEURONAL DIFFERENTIATION; DOPAMINERGIC-NEURONS	The microbiome modulates host immune function across the gastrointestinal tract, peripheral lymphoid organs, and central nervous system. In this review, we highlight emerging evidence that microbial effects on select immune phenotypes arise developmentally, where the maternal and neonatal microbiome influence immune cell ontogeny in the offspring during gestation and early postnatal life. We further discuss roles for the perinatal microbiome and early-life immunity in regulating normal neurodevelopmental processes. In addition, we examine evidence that abnormalities in microbiota-neuroimmune interactions during early life are associated with altered risk of neurological disorders in humans. Finally, we conclude by evaluating the potential implications of microbiota-immune interventions for neurological conditions. Continued progress toward dissecting mechanistic interactions between the perinatal microbiota, immune system, and nervous system might uncover fundamental insights into how developmental interactions across physiological systems inform later-life health and disease.	[Pronovost, Geoffrey N.; Hsiao, Elaine Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Pronovost, GN; Hsiao, EY (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	geoffpro@ucla.edu; ehsiao@ucla.edu			Ruth L. Kirschstein National Research Service Award from the NIH [AI007323]; Alfred P. Sloan Foundation; Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Preparation of this review was supported by Ruth L. Kirschstein National Research Service Award AI007323 from the NIH to G.N.P. and fellowships from the Alfred P. Sloan Foundation and Packard Foundation to E.Y.H.	Ahn J, 2015, BIOCHEM BIOPH RES CO, V466, P52, DOI 10.1016/j.bbrc.2015.08.104; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Astafurov K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104416; Barak B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00272; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Borenstein AR, 2006, ALZ DIS ASSOC DIS, V20, P63, DOI 10.1097/01.wad.0000201854.62116.d7; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Bryceson YT, 2005, J NEUROIMMUNOL, V161, P177, DOI 10.1016/j.jneuroim.2004.11.018; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Candon S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125448; Careaga M, 2017, BIOL PSYCHIAT, V81, P391, DOI 10.1016/j.biopsych.2016.10.020; Castillo-Ruiz A, 2018, BRAIN BEHAV IMMUN, V67, P218, DOI 10.1016/j.bbi.2017.08.027; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen E, 2013, CURR MOL MED, V13, P1474; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Chu DM, 2016, GUT MICROBES, V7, P459, DOI 10.1080/19490976.2016.1241357; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; El Aidy S, 2013, GUT MICROBES, V4, P118, DOI 10.4161/gmic.23362; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Gonzalez-Perez G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00265; Gonzalez-Perez G, 2016, J IMMUNOL, V196, P3768, DOI 10.4049/jimmunol.1502322; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hu YJ, 2016, J AUTOIMMUN, V72, P47, DOI 10.1016/j.jaut.2016.05.001; Hu YJ, 2015, J IMMUNOL, V195, P4176, DOI 10.4049/jimmunol.1500884; Humann J, 2016, CELL HOST MICROBE, V19, P388, DOI [10.1016/j.chom.2016.02.009, 10.1016/j.chom.2016.05.017]; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jasarevic E, 2018, NAT NEUROSCI, V21, P1061, DOI 10.1038/s41593-018-0182-5; Jensen ML, 2014, AM J PHYSIOL-GASTR L, V306, pG59, DOI 10.1152/ajpgi.00213.2013; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Josefsdottir KS, 2017, BLOOD, V129, P729, DOI 10.1182/blood-2016-03-708594; Jost T, 2014, CURR MICROBIOL, V68, P419, DOI 10.1007/s00284-013-0491-6; Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Kimura E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26386; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lammert CR, 2018, J IMMUNOL, V201, P845, DOI 10.4049/jimmunol.1701755; Latchney SE, 2013, J NEUROCHEM, V125, P430, DOI 10.1111/jnc.12130; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Leclercq S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15062; Lindsay KL, 2013, J MATERN-FETAL NEO M, V26, P772, DOI 10.3109/14767058.2012.755166; Ling ZD, 1998, EXP NEUROL, V149, P411, DOI 10.1006/exnr.1998.6715; LU J, 2018, SCI REP UK, V8; Mackos AR, 2017, HORM BEHAV, V88, P70, DOI 10.1016/j.yhbeh.2016.10.006; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Marin IA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43859; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; MEISEL JS, 2018, MICROBIOME, V6; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Minter MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11047-w; Modgil S, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-9; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Moraga A, 2014, FASEB J, V28, P4710, DOI 10.1096/fj.14-252452; Morgan XC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0637-x; Mouihate A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00173; Nakamura Y, 2012, IMMUNITY, V37, P85, DOI 10.1016/j.immuni.2012.04.013; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Nolan AM, 2014, DIFFERENTIATION, V88, P124, DOI 10.1016/j.diff.2014.12.006; O'Keeffe GW, 2008, NAT NEUROSCI, V11, P135, DOI 10.1038/nn2034; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ogbonnaya ES, 2015, BIOL PSYCHIAT, V78, pE7, DOI 10.1016/j.biopsych.2014.12.023; Okun E, 2010, J NEUROCHEM, V114, P462, DOI 10.1111/j.1471-4159.2010.06778.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Seguin JA, 2009, NEUROPSYCH DIS TREAT, V5, P5; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Singh N, 2010, J BIOL CHEM, V285, P27601, DOI 10.1074/jbc.M110.102947; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stencel-Gabriel K, 2009, AM J REPROD IMMUNOL, V61, P246, DOI 10.1111/j.1600-0897.2009.00687.x; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Stokholm J, 2014, CLIN MICROBIOL INFEC, V20, P629, DOI 10.1111/1469-0691.12411; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Tormo-Badia N, 2014, SCAND J IMMUNOL, V80, P250, DOI 10.1111/sji.12205; Tremlett H, 2017, ANN NEUROL, V81, P369, DOI 10.1002/ana.24901; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vuong HE, 2017, ANNU REV NEUROSCI, V40, P21, DOI 10.1146/annurev-neuro-072116-031347; Vuong HE, 2017, BIOL PSYCHIAT, V81, P411, DOI 10.1016/j.biopsych.2016.08.024; WANG J, 1994, J NEUROSURG, V80, P484, DOI 10.3171/jns.1994.80.3.0484; Wu WL, 2017, BRAIN BEHAV IMMUN, V62, P11, DOI 10.1016/j.bbi.2016.11.007; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651; Yoshimura A, 1999, J IMMUNOL, V163, P1; Yoshiya K, 2011, AM J PHYSIOL-GASTR L, V301, pG1020, DOI 10.1152/ajpgi.00239.2011; Zhang K, 2013, BRAIN RES, V1490, P193, DOI 10.1016/j.brainres.2012.10.025; Zohar O, 2008, J IMMUNOL, V180, P6447, DOI 10.4049/jimmunol.180.10.6447	125	54	56	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					18	36		10.1016/j.immuni.2018.11.016	http://dx.doi.org/10.1016/j.immuni.2018.11.016			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650376	Bronze, Green Accepted			2022-12-18	WOS:000455661600008
J	Lian, H; Zang, R; Wei, J; Ye, W; Hu, MM; Chen, YD; Zhang, XN; Guo, Y; Lei, CQ; Yang, Q; Luo, WW; Li, S; Shu, HB				Lian, Huan; Zang, Ru; Wei, Jin; Ye, Wen; Hu, Ming-Ming; Chen, Yun-Da; Zhang, Xia-Nan; Guo, Yi; Lei, Cao-Qi; Yang, Qing; Luo, Wei-Wei; Li, Shu; Shu, Hong-Bing			The Zinc-Finger Protein ZCCHC3 Binds RNA and Facilitates Viral RNA Sensing and Activation of the RIG-I-like Receptors	IMMUNITY			English	Article							CELLULAR ANTIVIRAL RESPONSE; INNATE IMMUNE-RESPONSE; NF-KAPPA-B; IFN-BETA; RECOGNITION; VIRUS; MDA5; UBIQUITINATION; IRF3; PHOSPHORYLATION	Recognition of viral RNA by the retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) initiates innate antiviral immune response. How the binding of viral RNA to and activation of the RLRs are regulated remains enigmatic. In this study, we identified ZCCHC3 as a positive regulator of the RLRs including RIG-I and MDA5. ZCCHC3 deficiency markedly inhibited RNA virus-triggered induction of downstream antiviral genes, and ZCCHC3-deficient mice were more susceptible to RNA virus infection. ZCCHC3 was associated with RIG-I and MDA5 and functions in two distinct processes for regulation of RIG-I and MDA5 activities. ZCCHC3 bound to dsRNA and enhanced the binding of RIG-I and MDA5 to dsRNA. ZCCHC3 also recruited the E3 ubiquitin ligase TRIM25 to the RIG-I and MDA5 complexes to facilitate its K63-linked polyubiquitination and activation. Thus, ZCCHC3 is a co-receptor for RIG-I and MDA5, which is critical for RLR-mediated innate immune response to RNA virus.	[Lian, Huan; Zang, Ru; Wei, Jin; Ye, Wen; Hu, Ming-Ming; Chen, Yun-Da; Zhang, Xia-Nan; Guo, Yi; Lei, Cao-Qi; Yang, Qing; Li, Shu; Shu, Hong-Bing] Wuhan Univ, Med Res Inst, Sch Med, Wuhan 430071, Peoples R China; [Chen, Yun-Da; Zhang, Xia-Nan; Guo, Yi; Lei, Cao-Qi; Shu, Hong-Bing] Wuhan Univ, Life Sci, Wuhan 430072, Peoples R China; [Luo, Wei-Wei] Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Li, S; Shu, HB (corresponding author), Wuhan Univ, Med Res Inst, Sch Med, Wuhan 430071, Peoples R China.; Shu, HB (corresponding author), Wuhan Univ, Life Sci, Wuhan 430072, Peoples R China.	shuli@whu.edu.cn; shuh@whu.edu.cn	WEI, JIN/ABE-6512-2021	Wei, Jin/0000-0002-2832-1610	State Key R&D Program of China [2017YFA0505800, 2016YFA0502102]; National Natural Science Foundation of China [31630045, 31521091, 31830024, 31671465]; Chinese 111 project [BP2018015]	State Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the State Key R&D Program of China (2017YFA0505800, 2016YFA0502102), the National Natural Science Foundation of China (31630045, 31521091, 31830024, and 31671465), and the Chinese 111 project (BP2018015).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hu MM, 2017, J EXP MED, V214, P973, DOI 10.1084/jem.20161015; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Lang XT, 2017, J EXP MED, V214, P459, DOI 10.1084/jem.20160592; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li XJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P23, DOI 10.1016/j.abb.2009.06.008; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Wallach D, 2013, IMMUNITY, V38, P402, DOI 10.1016/j.immuni.2013.02.014; Wei J, 2017, P NATL ACAD SCI USA, V114, P13000, DOI 10.1073/pnas.1713462114; Wei J, 2015, J IMMUNOL, V195, P2870, DOI 10.4049/jimmunol.1501111; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yan J, 2014, J MOL CELL BIOL, V6, P154, DOI 10.1093/jmcb/mju005; Yang Q, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006600; Yang Y, 2016, CELL RES, V26, P288, DOI 10.1038/cr.2016.16; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou Q, 2014, CELL HOST MICROBE, V16, P450, DOI 10.1016/j.chom.2014.09.006	36	54	57	5	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					438	+		10.1016/j.immuni.2018.08.014	http://dx.doi.org/10.1016/j.immuni.2018.08.014			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30193849	Bronze			2022-12-18	WOS:000444909600012
J	Kimura, D; Miyakoda, M; Kimura, K; Honma, K; Hara, H; Yoshida, H; Yui, K				Kimura, Daisuke; Miyakoda, Mana; Kimura, Kazumi; Honma, Kiri; Hara, Hiromitsu; Yoshida, Hiroki; Yui, Katsuyuki			Interleukin-27-Producing CD4(+) T Cells Regulate Protective Immunity during Malaria Parasite Infection	IMMUNITY			English	Article							IL-2 PRODUCTION; RESPONSES; PLASMODIUM; EXPRESSION; WSX-1; IMMUNOPATHOLOGY; PROLIFERATION; INFLAMMATION; RESISTANCE; REQUIRES	Interleukin-27 (IL-27) is a heterodimeric regulatory cytokine of the IL-12 family, which is produced by macrophages, dendritic cells, and B cells upon stimulation through innate immune receptors. Here, we described regulatory CD4(+) T cells that produce IL-27 in response to T cell receptor stimulation during malaria infection, inhibiting IL-2 production and clonal expansion of other T cells in an IL-27-dependent manner. IL-27-producing CD4(+) T cells were Foxp3(-)CD11a(+)CD49d(+) malaria antigen-specific CD4+ T cells and were distinct from interferon-gamma (IFN-gamma) producing Th1 or IL-10 producing Tr1 cells. In mice lacking IL-27 in T cells, IL-2 production was restored and clonal expansion and IFN-gamma production by specific CD4(+) T cells were improved, culminating in reduced parasite burden. This study highlights a unique population of IL-27 producing regulatory CD4(+) T cells and their critical role in the regulation of the protective immune response against malaria parasites.	[Kimura, Daisuke; Miyakoda, Mana; Kimura, Kazumi; Honma, Kiri; Yui, Katsuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Immunol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan; [Hara, Hiromitsu; Yoshida, Hiroki] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, 5-1-1 Nabeshima, Saga 8498501, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan	Nagasaki University; Saga University; Kagoshima University	Yui, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Immunol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	katsu@nagasaki-u.ac.jp			Nagasaki University; Ministry of Education, Science, Sports, and Culture, Japan [21390125, 25293101, 25113717]; Global COE Program, Nagasaki University	Nagasaki University; Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program, Nagasaki University	We thank Dr. S. Hori for providing Foxp3<SUP>hCD2</SUP> knockin mice; Drs. H. Kosaka and W.R. Heath for OT-II mice; Dr. M. Murakami for the IL-2 expression plasmid; and Ms. N. Kawamoto for technical help. D.K. was supported by the President's Discretionary Fund of Nagasaki University, and K.Y. by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture, Japan (21390125, 25293101, and 25113717) and by the Global COE Program, Nagasaki University.	Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Butler NS, 2013, TRENDS PARASITOL, V29, P593, DOI 10.1016/j.pt.2013.10.002; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; HO M, 1988, J IMMUNOL, V141, P2755; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kimura D, 2010, INT IMMUNOL, V22, P941, DOI 10.1093/intimm/dxq448; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Luyendyk J, 2002, INFECT IMMUN, V70, P2941, DOI 10.1128/IAI.70.6.2941-2949.2002; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Wirtz S, 2005, J IMMUNOL, V174, P2814, DOI 10.4049/jimmunol.174.5.2814; Xia H, 2014, TUBERCULOSIS, V94, P579, DOI 10.1016/j.tube.2014.07.003; Yang WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040450; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134	43	54	56	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					672	682		10.1016/j.immuni.2016.02.011	http://dx.doi.org/10.1016/j.immuni.2016.02.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26968425	Bronze			2022-12-18	WOS:000372784200023
J	Di Paolo, NC; Shafiani, S; Day, T; Papayannoupoulou, T; Russell, DW; Iwakura, Y; Sherman, D; Urdahl, K; Shayakhmetov, DM				Di Paolo, Nelson C.; Shafiani, Shahin; Day, Tracey; Papayannoupoulou, Thalia; Russell, David W.; Iwakura, Yoichiro; Sherman, David; Urdahl, Kevin; Shayakhmetov, Dmitry M.			Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection	IMMUNITY			English	Article							CD4 T-CELLS; IMMUNE-RESPONSE; MICE DEFICIENT; IDENTIFICATION; RECEPTOR; IL-1-ALPHA; INNATE	The interleukin-1 receptor I (IL-1RI) is critical for host resistance to Mycobacterium tuberculosis (Mtb), yet the mechanisms of IL-1RI-mediated pathogen control remain unclear. Here, we show that without IL-1RI, Mtb-infected newly recruited Ly6G(hi) myeloid cells failed to upregulate tumor necrosis factor receptor I (TNF-RI) and to produce reactive oxygen species, resulting in compromised pathogen control. Furthermore, simultaneous ablation of IL-1RI and TNF-RI signaling on either stroma or hematopoietic cells led to early lethality, indicating non-redundant and synergistic roles of IL-1 and TNF in mediating macrophage-stroma cross-talk that was critical for optimal control of Mtb infection. Finally, we show that even in the presence of functional Mtb-specific adaptive immunity, the lack of IL-1 alpha and not IL-1 beta led to an exuberant intracellular pathogen replication and progressive non-resolving inflammation. Our study reveals functional interdependence between IL-1 and TNF in enabling Mtb control mechanisms that are critical for host survival.	[Di Paolo, Nelson C.; Shayakhmetov, Dmitry M.] Emory Univ, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Shafiani, Shahin; Day, Tracey; Sherman, David; Urdahl, Kevin] Ctr Infect Dis Res, Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Papayannoupoulou, Thalia; Russell, David W.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Iwakura, Yoichiro] Univ Tokyo, Ctr Expt Med & Syst Biol, Inst Med Sci, Lab Mol Pathogenesis, Tokyo 1088639, Japan; [Urdahl, Kevin] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Shayakhmetov, Dmitry M.] Emory Univ, Ctr Transplantat & Immunomediated Disorders, Atlanta, GA 30322 USA; [Shayakhmetov, Dmitry M.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Shayakhmetov, Dmitry M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Shayakhmetov, Dmitry M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA	Emory University; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); University of Washington; University of Washington Seattle; University of Tokyo; University of Washington; University of Washington Seattle; Emory University; Emory University; Emory University; Emory University	Di Paolo, NC (corresponding author), Emory Univ, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA.	ncdipaolo@emory.edu; dmitryshay@emory.edu	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Urdahl, Kevin/0000-0003-0088-1066	Grand Challenges Explorations grant from the Bill and Melinda Gates Foundation [51778]; NIH [AI065429, AI107960, U19 AI106761, AI076327]; Children's Healthcare of Atlanta (CHOA) Research Trust; Paul G. Allen Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076327, R01AI107960, R01AI065429, U19AI106761] Funding Source: NIH RePORTER	Grand Challenges Explorations grant from the Bill and Melinda Gates Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Healthcare of Atlanta (CHOA) Research Trust; Paul G. Allen Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are thankful to Alan Aderem (Center for Infectious Disease Research) for providing Casp1<SUP>-/-</SUP>Casp11<SUP>-/-</SUP> and Il1b<SUP>-/-</SUP> mice from colonies at the Institute for Systems Biology (Seattle, WA). We are grateful to John MacMicking (Yale University School of Medicine), James Sisson (Center for Infectious Disease Research), and Ron N. Apte (Ben-Gurion University of the Negev) for helpful discussion. We thank Raymond Kong, Robert Thacker, and Amnis-EMD Millipore for generously sharing their expertise and facilities to run Image-Stream analyses. We thank Stephanie Larra (University of Washington) for technical assistance with electron microscopy analyses. This study was supported by the Grand Challenges Explorations grant from the Bill and Melinda Gates Foundation #51778; NIH grants AI065429 and AI107960, and Children's Healthcare of Atlanta (CHOA) Research Trust support to D.M.S.; and by NIH U19 AI106761 and AI076327 and the Paul G. Allen Family Foundation grants to K.U.	Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Cantini F, 2015, AUTOIMMUN REV, V14, P503, DOI 10.1016/j.autrev.2015.01.011; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Diedrich CR, 2013, J IMMUNOL, V190, P6320, DOI 10.4049/jimmunol.1202043; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Guler R, 2011, VACCINE, V29, P1339, DOI 10.1016/j.vaccine.2010.10.045; HULEIHEL M, 1990, EUR J IMMUNOL, V20, P731, DOI 10.1002/eji.1830200404; Josephson NC, 2002, P NATL ACAD SCI USA, V99, P8295, DOI 10.1073/pnas.122131099; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; KURTJONES EA, 1985, P NATL ACAD SCI USA, V82, P1204, DOI 10.1073/pnas.82.4.1204; Lyadova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010469; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Ni J, 2009, VACCINE, V27, P5480, DOI 10.1016/j.vaccine.2009.07.001; Niki Y, 2004, J IMMUNOL, V172, P577, DOI 10.4049/jimmunol.172.1.577; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	35	54	55	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1125	1136		10.1016/j.immuni.2015.11.016	http://dx.doi.org/10.1016/j.immuni.2015.11.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682985	Bronze, Green Accepted			2022-12-18	WOS:000366846600016
J	McDonald, BD; Bunker, JJ; Erickson, SA; Oh-Hora, M; Bendelac, A				McDonald, Benjamin D.; Bunker, Jeffrey J.; Erickson, Steven A.; Oh-Hora, Masatsugu; Bendelac, Albert			Crossreactive alpha beta T Cell Receptors Are the Predominant Targets of Thymocyte Negative Selection	IMMUNITY			English	Article							POSITIVE SELECTION; THYMIC SELECTION; CLONAL DELETION; REPERTOIRE; MHC; ANTIGEN; MICE; RECOGNITION; REQUIREMENT; PEPTIDES	The precise impact of thymic positive and negative selection on the T cell receptor (TCR) repertoire remains controversial. Here, we used unbiased, high-throughput cloning and retroviral expression of individual pre-selection TCRs to provide a direct assessment of these processes at the clonal level in vivo. We found that 15% of random TCRs induced signaling and directed positive (7.5%) or negative (7.5%) selection, depending on strength of signal, whereas the remaining 85% failed to induce signaling or selection. Most negatively selected TCRs exhibited promiscuous crossreactivity toward multiple other major histocompatibility complex (MHC) haplotypes. In contrast, TCRs that were positively selected or non-selected were minimally crossreactive. Negative selection of crossreactive TCRs led to clonal deletion but also recycling into intestinal CD4(-)CD8 beta(-) intraepithelial lymphocytes (iIELs). Thus, broadly crossreactive TCRs arise at low frequency in the pre-selection repertoire but constitute the primary drivers of thymic negative selection and iIEL lineage differentiation.	[McDonald, Benjamin D.; Bunker, Jeffrey J.; Erickson, Steven A.; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [McDonald, Benjamin D.; Bunker, Jeffrey J.; Erickson, Steven A.; Bendelac, Albert] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Oh-Hora, Masatsugu] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan	University of Chicago; University of Chicago; Kyushu University	Bendelac, A (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu		Bunker, Jeffrey/0000-0002-9351-7003	NIH Medical Scientist Training Program [T32GM007281]; NIH [RO1 AI038339]; Digestive Diseases Research Center of Excellence [P30DK42086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Savage for providing V beta 3 and V beta 8.3 transgenic mice; A. Chervonsky for SV-40 transformed fibroblast cell lines; and D. Leclerc and M. Olson for cell sorting. B.D.M. and J.J.B. were supported by an NIH Medical Scientist Training Program grant T32GM007281. Research was supported by NIH RO1 AI038339 and by Digestive Diseases Research Center of Excellence P30DK42086.	Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Inaba Kayo, 2009, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0307s86; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; KNOWLES BB, 1979, J IMMUNOL, V122, P1798; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Logunova NN, 2005, J EXP MED, V202, P73, DOI 10.1084/jem.20050198; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; Savage AK, 2011, J IMMUNOL, V186, P5801, DOI 10.4049/jimmunol.1100119; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; Turner VM, 2010, J IMMUNOL METHODS, V360, P162, DOI 10.1016/j.jim.2010.06.007; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Vrisekoop N, 2014, IMMUNITY, V41, P181, DOI 10.1016/j.immuni.2014.07.007; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	31	54	54	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					859	869		10.1016/j.immuni.2015.09.009	http://dx.doi.org/10.1016/j.immuni.2015.09.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26522985	Green Accepted, Bronze			2022-12-18	WOS:000366846000008
J	Kvistborg, P; Gouttefangeas, C; Aghaeepour, N; Cazaly, A; Chattopadhyay, PK; Chan, C; Eckl, J; Finak, G; Hadrup, SR; Maecker, HT; Maurer, D; Mosmann, T; Qiu, P; Scheuermann, RH; Welters, MJP; Ferrari, G; Brinkman, RR; Britten, CM				Kvistborg, Pia; Gouttefangeas, Cecile; Aghaeepour, Nima; Cazaly, Angelica; Chattopadhyay, Pratip K.; Chan, Cliburn; Eckl, Judith; Finak, Greg; Hadrup, Sine Reker; Maecker, Holden T.; Maurer, Dominik; Mosmann, Tim; Qiu, Peng; Scheuermann, Richard H.; Welters, Marij J. P.; Ferrari, Guido; Brinkman, Ryan R.; Britten, Cedrik M.			Thinking Outside the Gate: Single-Cell Assessments in Multiple Dimensions	IMMUNITY			English	Letter							FLOW-CYTOMETRY DATA		[Kvistborg, Pia] Netherlands Canc Inst, NL-1006 BE Amsterdam, Netherlands; [Gouttefangeas, Cecile] Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany; [Aghaeepour, Nima] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Cazaly, Angelica] NIH, ImmunoTechnol Sect, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Chattopadhyay, Pratip K.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Chan, Cliburn] Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Eckl, Judith] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Dept Biostat Bioinformat & Epidemiol, Seattle, WA 98155 USA; [Finak, Greg] Herlev Hosp, Ctr Canc Immune Therapy, DK-2730 Herlev, Denmark; [Hadrup, Sine Reker] Stanford Univ, Stanford Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Maecker, Holden T.] Immat Biotechnol GmbH, D-72076 Tubingen, Germany; [Maurer, Dominik] Univ Rochester, David D Smith Ctr Vaccine Biol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Mosmann, Tim] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Qiu, Peng] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA 92037 USA; [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Welters, Marij J. P.] Leiden Univ, Dept Clin Oncol, Med Ctr, NL-2300 RA Leiden, Netherlands; [Ferrari, Guido] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Britten, Cedrik M.] BioNTech RNA Pharmaceut GmbH, D-55131 Mainz, Germany	Netherlands Cancer Institute; Eberhard Karls University of Tubingen; University of Southampton; National Institutes of Health (NIH) - USA; Duke University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Fred Hutchinson Cancer Center; University of Copenhagen; Herlev & Gentofte Hospital; Stanford University; Immatics Biotechnologies GmbH; University of Rochester; University System of Georgia; Georgia Institute of Technology; Emory University; J. Craig Venter Institute; University of California System; University of California San Diego; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Duke University; BioNTech SE	Brinkman, RR (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	rbrinkman@bccrc.ca; cebritten@web.de	Ferrari, Guido/Z-2137-2019; Hadrup, Sine Reker/P-3388-2014; Brinkman, Ryan/B-1108-2008; Ferrari, Guido/A-6088-2015	Hadrup, Sine Reker/0000-0002-5937-4344; Brinkman, Ryan/0000-0002-9765-2990; Ferrari, Guido/0000-0001-7747-3349; Finak, Greg/0000-0003-4341-9090; Chattopadhyay, Pratip/0000-0002-5457-9666	The Danish Cancer Society [R72-A4531] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA163481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI054953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008400] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA163481] Funding Source: Medline; NIAID NIH HHS [R24 AI054953] Funding Source: Medline; NIBIB NIH HHS [R01 EB008400] Funding Source: Medline	The Danish Cancer Society(Danish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Aghaeepour N, 2012, CYTOM PART A, V81A, P1022, DOI 10.1002/cyto.a.22209; Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Spidlen J, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-14	8	54	54	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					591	592		10.1016/j.immuni.2015.04.006	http://dx.doi.org/10.1016/j.immuni.2015.04.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902473	Bronze, Green Accepted			2022-12-18	WOS:000353347500001
J	Han, D; Walsh, MC; Cejas, PJ; Dang, NN; Kim, YF; Kim, J; Charrier-Hisamuddin, L; Chau, L; Zhang, Q; Bittinger, K; Bushman, FD; Turka, LA; Shen, H; Reizis, B; DeFranco, AL; Wu, GD; Choi, Y				Han, Daehee; Walsh, Matthew C.; Cejas, Pedro J.; Dang, Nicholas N.; Kim, Youngmi F.; Kim, Jihyun; Charrier-Hisamuddin, Laetitia; Chau, Lillian; Zhang, Qin; Bittinger, Kyle; Bushman, Frederic D.; Turka, Laurence A.; Shen, Hao; Reizis, Boris; DeFranco, Anthony L.; Wu, Gary D.; Choi, Yongwon			Dendritic Cell Expression of the Signaling Molecule TRAF6 Is Critical for Gut Microbiota-Dependent Immune Tolerance	IMMUNITY			English	Article							REGULATORY T-CELLS; TGF-BETA; TOLEROGENIC RESPONSES; HOMEOSTASIS; ACTIVATION; DISEASE; A20; INTERLEUKIN-2; AUTOIMMUNITY; INFLAMMATION	The intracellular signaling molecule TRAF6 is critical for Toll-like receptor (TLR)-mediated activation of dendritic cells (DCs). We now report that DC-specific deletion of TRAF6 (TRAF6 Delta DC) resulted, unexpectedly, in loss of mucosal tolerance, characterized by spontaneous development of T helper 2 (Th2) cells in the lamina propria and eosinophilic enteritis and fibrosis in the small intestine. Loss of tolerance required the presence of gut commensal microbiota but was independent of DC-expressed MyD88. Further, TRAF6 Delta DC mice exhibited decreased regulatory T (Treg) cell numbers in the small intestine and diminished induction of iTreg cells in response to model antigen. Evidence suggested that this defect was associated with diminished DC expression of interleukin-2 (IL-2). Finally, we demonstrate that aberrant Th2 cell-associated responses in TRAF6 Delta DC mice could be mitigated via restoration of Treg cell activity. Collectively, our findings reveal a role for TRAF6 in directing DC maintenance of intestinal immune tolerance through balanced induction of Treg versus Th2 cell immunity.	[Han, Daehee; Walsh, Matthew C.; Cejas, Pedro J.; Dang, Nicholas N.; Kim, Youngmi F.; Kim, Jihyun; Choi, Yongwon] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chau, Lillian; Wu, Gary D.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Zhang, Qin; Bittinger, Kyle; Bushman, Frederic D.; Shen, Hao] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Turka, Laurence A.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Turka, Laurence A.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Han, Daehee; Choi, Yongwon] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; Columbia University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pohang University of Science & Technology (POSTECH)	Choi, Y (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu	shen, hao/HGF-0551-2022; Bittinger, Kyle/ABG-2342-2020	Bushman, Frederic/0000-0003-4740-4056; Reizis, Boris/0000-0003-1140-7853	World Class University (WCU) program, NRF, MEST, Korea [R31-10105]; Korea Institute of Oriental Medicine (KIOM), MEST, Korea [K13050]; National Institutes of Health [AI064909, AI43620, AI039368, AI079724, AI083022, AI095740, AI037691]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043620, R01AI064909, R21AI079724, R01AI037691, R01AI039368, R01AI095740, R56AI095740, U19AI083022] Funding Source: NIH RePORTER	World Class University (WCU) program, NRF, MEST, Korea; Korea Institute of Oriental Medicine (KIOM), MEST, Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank Eddy Chen and Jang Eun Lee for helpful discussion. This work was supported in part by the World Class University (WCU) program, NRF, MEST, Korea (R31-10105 to D.H. and Y.C.), by the Korea Institute of Oriental Medicine (KIOM), MEST, Korea (No. K13050 to Y.C.), and by the National Institutes of Health (AI064909 to Y.C., AI43620 to Y.C. and L.A.T., AI039368 to G.D.W., AI079724, AI083022, and AI095740 to H.S., and AI037691 to L.A.T.).	Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Chiffoleau E, 2003, J IMMUNOL, V171, P5751, DOI 10.4049/jimmunol.171.11.5751; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Kel JM, 2010, J IMMUNOL, V185, P3248, DOI 10.4049/jimmunol.1000981; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Kulhankova K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043609; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lucendo AJ, 2010, SCAND J GASTROENTERO, V45, P1013, DOI 10.3109/00365521003690251; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Masterson JC, 2011, CURR OPIN GASTROEN, V27, P515, DOI 10.1097/MOG.0b013e32834b314c; McKarns SC, 2008, J IMMUNOL, V181, P1272, DOI 10.4049/jimmunol.181.2.1272; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Rescigno M, 2011, CELL MICROBIOL, V13, P1312, DOI 10.1111/j.1462-5822.2011.01626.x; Santaolalla R, 2011, CURR OPIN GASTROEN, V27, P125, DOI 10.1097/MOG.0b013e3283438dea; Sgouroudis E, 2011, AUTOIMMUNITY, V44, P406, DOI 10.3109/08916934.2010.536795; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Swiatczak B, 2012, SEMIN IMMUNOL, V24, P43, DOI 10.1016/j.smim.2011.11.004; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang FL, 2007, CANCER IMMUNOL IMMUN, V56, P1785, DOI 10.1007/s00262-007-0322-3; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824	42	54	58	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1211	1222		10.1016/j.immuni.2013.05.012	http://dx.doi.org/10.1016/j.immuni.2013.05.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23791643	Green Accepted, Bronze			2022-12-18	WOS:000330947500016
J	Gray, DHD; Kupresanin, F; Berzins, SP; Herold, MJ; O'Reilly, LA; Bouillet, P; Strasser, A				Gray, Daniel H. D.; Kupresanin, Fiona; Berzins, Stuart P.; Herold, Marco J.; O'Reilly, Lorraine A.; Bouillet, Philippe; Strasser, Andreas			The BH3-Only Proteins Bim and Puma Cooperate to Impose Deletional Tolerance of Organ-Specific Antigens	IMMUNITY			English	Article							PROGRAMMED CELL-DEATH; FAMILY-MEMBER BIM; LYMPHOCYTE DEVELOPMENT; APOPTOTIC RESPONSES; AUTOIMMUNE-DISEASE; DEFICIENT MICE; T-CELLS; BAX; EXPRESSION; HOMEOSTASIS	Although the proapoptotic BH3-only protein, Bim, is required for deletion of autoreactive thymocytes, Bim-deficient mice do not succumb to extensive organ-specific autoimmune disease. To determine whether other BH3-only proteins safeguard tolerance in the absence of Bim, we screened mice lacking Bim as well as other BH3-only proteins. Most strains showed no additional defects; however, mice deficient for both Puma and Bim spontaneously developed autoimmunity in multiple organs, and their T cells could transfer organ-specific autoimmunity. Puma- and Bim-double-deficient mice had a striking accumulation of mature, single-positive thymocytes, suggesting an additional defect in thymic deletion was the basis for disease. Transgenic mouse models of thymocyte deletion by peripheral neoantigens confirmed that the loss of Bim and Puma allowed increased numbers of autoreactive thymocytes to escape deletion. Our data show that Puma cooperates with Bim to impose a thymic-deletion checkpoint to peripheral self-antigens and cement the notion that defects in apoptosis alone are sufficient to cause autoimmune disease.	[Gray, Daniel H. D.; Kupresanin, Fiona; Herold, Marco J.; O'Reilly, Lorraine A.; Bouillet, Philippe; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3052, Australia; [Gray, Daniel H. D.; Herold, Marco J.; O'Reilly, Lorraine A.; Bouillet, Philippe; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Berzins, Stuart P.] Univ Ballarat, Ballarat, Vic 3353, Australia; [Berzins, Stuart P.] Ballarat Canc Res Ctr, Ballarat, Vic 3353, Australia	Walter & Eliza Hall Institute; University of Melbourne; Federation University Australia	Gray, DHD (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3052, Australia.	dgray@wehi.edu.au; strasser@wehi.edu.au	Bouillet, Philippe/E-1241-2013; Gray, Daniel HD/A-3293-2013; Herold, Marco J/C-8039-2013; Strasser, Andreas/C-7581-2013	Bouillet, Philippe/0000-0002-9012-6058; Gray, Daniel HD/0000-0002-8457-8242; Herold, Marco J/0000-0001-7539-7581; Strasser, Andreas/0000-0002-5020-4891	Australian National Health and Medical Research Council (NHMRC) [637332, 1009145, 637353]; Juvenile Diabetes Foundation; Leukemia and Lymphoma Society (New York; Specialized Center of Research) [7413]; National Cancer Institute (National Institutes of Health) [CA 43540]; NATIONAL CANCER INSTITUTE [R01CA043540] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Leukemia and Lymphoma Society (New York; Specialized Center of Research)(Leukemia and Lymphoma Society); National Cancer Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge C. Thompson (Memorial Sloan-Kettering Cancer Center, New York) for the kind gift of Bak<SUP>-/-</SUP> mice, N. Danial (Dana-Farber Cancer Institute, Boston) for Bad<SUP>-/-</SUP> mice, and T. Jacks (Massachusetts Institute of Technology, Cambridge, MA, USA) for Trp53<SUP>-/-</SUP> mice; K. Mason and D. Huang for the provision of Bax<SUP>-/-</SUP>Bak<SUP>-/-</SUP> mouse fetal livers; G. Dewson for the provision of antibodies; G. Siciliano, K. Vella, K. Trueman, and G.-F. Dabrowski for animal care; and B. Holbert, C. Young, A. Policheni, and the WEHI Cytometry and Histology Facilities for technical assistance. This work was supported by the Australian National Health and Medical Research Council (NHMRC project grants 637332 and 1009145, Australia Fellowship to A.S., and Career Development Fellowship (637353) to D.H.D.G), the Juvenile Diabetes Foundation, the Leukemia and Lymphoma Society (New York; Specialized Center of Research grant 7413), and the National Cancer Institute (National Institutes of Health; CA 43540). This work was made possible through Victorian State Government Operational Infrastructure Support and the Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Coultas L, 2005, EMBO J, V24, P3963, DOI 10.1038/sj.emboj.7600857; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gleeson PA, 1996, IMMUNOL REV, V149, P97, DOI 10.1111/j.1600-065X.1996.tb00901.x; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2007, P NATL ACAD SCI USA, V104, P18193, DOI 10.1073/pnas.0709160104; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu Q, 2009, J IMMUNOL, V183, P7761, DOI 10.4049/jimmunol.0902181; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Jorgensen TN, 2007, J IMMUNOL, V179, P3417, DOI 10.4049/jimmunol.179.6.3417; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Suen AYW, 2012, P NATL ACAD SCI USA, V109, P893, DOI 10.1073/pnas.1114834109; Szymczak-Workman AL, 2011, J IMMUNOL, V187, P4416, DOI 10.4049/jimmunol.1100548; Taniguchi RT, 2011, IMMUNOL CELL BIOL, V89, P40, DOI 10.1038/icb.2010.132; Teh CE, 2010, P NATL ACAD SCI USA, V107, P14709, DOI 10.1073/pnas.1009209107; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	47	54	58	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					451	462		10.1016/j.immuni.2012.05.030	http://dx.doi.org/10.1016/j.immuni.2012.05.030			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22960223	Green Accepted, Bronze			2022-12-18	WOS:000309199000010
J	Kang, ZZ; Swaidani, S; Yin, WG; Wang, CH; Barlow, JL; Gulen, MF; Bulek, K; Do, JS; Aronica, M; McKenzie, ANJ; Min, BK; Li, XX				Kang, Zizhen; Swaidani, Shadi; Yin, Weiguo; Wang, Chenhui; Barlow, Jillian L.; Gulen, Muhammet Fatih; Bulek, Katarzyna; Do, Jeong-su; Aronica, Mark; McKenzie, Andrew N. J.; Min, Booki; Li, Xiaoxia			Epithelial Cell-Specific Act1 Adaptor Mediates Interleukin-25-Dependent Helminth Expulsion through Expansion of Lin(-)c-Kit(+) Innate Cell Population	IMMUNITY			English	Article							IMMUNE-RESPONSES; EXPRESSION; IL-25; INFLAMMATION; ACTIVATION; CYTOKINES; MACROPHAGES; INTERFACE; PROMOTES; GROWTH	Interleukin-25 (IL-25 or IL-17E), a member of the structurally related 11,17 family, functions as an important mediator of T helper 2 cell-type (type 2) responses. We examined the cell type-specific role of IL-25-induced Act1-mediated signaling in protective immunity against helminth infection. Targeted Act1 deficiency in epithelial cells resulted in a marked delay in worm expulsion and abolished the expansion of the Lin(-)c-Kit(+) innate cell population in the mesenteric lymph node, lung, and liver. Th2 cell-inducing cytokine (IL-25 and IL-33) expression were reduced in the intestinal epithelial cells from the infected and IL-25-injected epithelial-specific Act1-deficient mice. Adoptive transfer of Lin(-)c-Kit(+) cells or combined injection of IL-25 and IL-33 restored the type 2 responses in these mice. Taken together, these results suggest that epithelial-specific Act1 mediates the expansion of the Lin(-)c-Kit(+) innate cell population through the positive-feedback loop of IL-25, initiating the type 2 immunity against helminth infection.	[Kang, Zizhen; Swaidani, Shadi; Yin, Weiguo; Wang, Chenhui; Gulen, Muhammet Fatih; Bulek, Katarzyna; Do, Jeong-su; Min, Booki; Li, Xiaoxia] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Aronica, Mark] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Barlow, Jillian L.; McKenzie, Andrew N. J.] MRC Lab Mol Biol, Cambridge CB2 OQH, England	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA.	lix@ccf.org	Bulek, Katarzyna/L-7517-2015; Do, Jeong su/G-9483-2014	Do, Jeong-su/0000-0002-2375-2585; Barlow, Jillian Lynne/0000-0002-8680-3589; Swaidani, Shadi/0000-0003-1506-4472; Gulen, Muhammet/0000-0002-7139-6781; Wang, Chenhui/0000-0002-3186-3066	National Institutes of Health [RO1HL098935-01A1, AI080908]; Sandler award for asthma [09-0035]; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, R01HL098935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler award for asthma; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge G. Kollias for provision of CD11bCre transgenic mice. This investigation was supported by National Institutes of Health grants RO1HL098935-01A1 (X.L.) and AI080908 (B.M.) and Sandler award for asthma 09-0035 (X.L.).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Day K P, 1979, Parasite Immunol, V1, P217, DOI 10.1111/j.1365-3024.1979.tb00708.x; EVANS GS, 1994, ANNU REV PHYSIOL, V56, P399; EVANS GS, 1992, J CELL SCI, V101, P219; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gregory LG, 2010, AM J RESP CRIT CARE, V182, P143, DOI 10.1164/rccm.200905-0725OC; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; KATONA IM, 1988, J IMMUNOL, V140, P3206; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Li XX, 2008, CYTOKINE, V41, P105, DOI 10.1016/j.cyto.2007.09.015; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Neill DR, 2011, TRENDS PARASITOL, V27, P214, DOI 10.1016/j.pt.2011.01.001; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Pan GH, 2001, J IMMUNOL, V167, P6559, DOI 10.4049/jimmunol.167.11.6559; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199; Strickland DH, 2010, CURR OPIN IMMUNOL, V22, P789, DOI 10.1016/j.coi.2010.10.019; Swaidani S, 2011, J IMMUNOL, V187, P3155, DOI 10.4049/jimmunol.1002790; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Trajkovic V, 2001, J NEUROIMMUNOL, V119, P183, DOI 10.1016/S0165-5728(01)00391-5; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wen F, 2003, GENESIS, V35, P100, DOI 10.1002/gene.10169; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450	55	54	56	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					821	833		10.1016/j.immuni.2012.03.021	http://dx.doi.org/10.1016/j.immuni.2012.03.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22608496	Green Accepted, Bronze			2022-12-18	WOS:000304976000015
J	Mantegazza, AR; Guttentag, SH; El-Benna, J; Sasai, M; Iwasaki, A; Shen, H; Laufer, TM; Marks, MS				Mantegazza, Adriana R.; Guttentag, Susan H.; El-Benna, Jamel; Sasai, Miwa; Iwasaki, Akiko; Shen, Hao; Laufer, Terri M.; Marks, Michael S.			Adaptor Protein-3 in Dendritic Cells Facilitates Phagosomal Toll-like Receptor Signaling and Antigen Presentation to CD4(+) T Cells	IMMUNITY			English	Article							HERMANSKY-PUDLAK-SYNDROME; MHC CLASS-II; CROSS-PRESENTATION; BETA-3A SUBUNIT; IMMUNE-RESPONSE; TRAFFICKING; AP-3; MATURATION; MUTATIONS; COMPLEX	Effective major histocompatibility complex-II (MHC-II) antigen presentation from phagocytosed particles requires phagosome-intrinsic Toll-like receptor (TLR) signaling, but the molecular mechanisms underlying TLR delivery to phagosomes and how signaling regulates antigen presentation are incompletely understood. We show a requirement in dendritic cells (DCs) for adaptor protein-3 (AP-3) in efficient TLR recruitment to phagosomes and MHC-II presentation of antigens internalized by phagocytosis but not receptor-mediated endocytosis. DCs from AP-3-deficient pearl mice elicited impaired CD4(+) T cell activation and Th1 effector cell function to particulate antigen in vitro and to recombinant Listeria monocytogenes infection in vivo. Whereas phagolysosome maturation and peptide:MHC-II complex assembly proceeded normally in pearl DCs, peptide:MHC-II export to the cell surface was impeded. This correlated with reduced TLR4 recruitment and proinflammatory signaling from phagosomes by particulate TLR ligands. We propose that AP-3-dependent TLR delivery from endosomes to phagosomes and subsequent signaling mobilize peptide:MHC-II export from intracellular stores.	[Mantegazza, Adriana R.; Marks, Michael S.] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Mantegazza, Adriana R.; Marks, Michael S.] Univ Penn, Perelman Sch Med, Dept Lab Med, Philadelphia, PA 19104 USA; [Mantegazza, Adriana R.; Marks, Michael S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Shen, Hao] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Laufer, Terri M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Guttentag, Susan H.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [El-Benna, Jamel] Univ Paris 07, INSERM, U773, Fac Med, F-75018 Paris, France; [Sasai, Miwa; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Laufer, Terri M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Yale University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Marks, MS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	Iwasaki, Akiko/Z-1591-2019; Marks, Michael S/Q-7223-2019; shen, hao/HGF-0551-2022; Guttentag, Susan/ABE-7405-2020; Guttentag, Susan H/D-8705-2013	Iwasaki, Akiko/0000-0002-7824-9856; Marks, Michael S/0000-0001-7435-7262; Guttentag, Susan/0000-0003-4420-5879; Guttentag, Susan H/0000-0003-4420-5879; Mantegazza, Adriana/0000-0002-7583-0231; Sasai, Miwa/0000-0001-6440-3958	National Institutes of Health [R01 EY015625, R21 AI092398, R21 AI079724, R01 AI081884, R01 AI064705]; University Research Foundation from the University of Pennsylvania; HPS Network; United States Veterans Administration; NATIONAL EYE INSTITUTE [R01EY015625] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064705, R01AI081884, R21AI092398, R21AI079724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Foundation from the University of Pennsylvania; HPS Network; United States Veterans Administration; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Steinman, M. Pepper Pew, M. Jenkins, A. Rudensky, J. Liboon, S. Chatterjee, A. Fisher, S. Ross, S. Akira, P. Oliver, L. Eisenlohr, M. Chou, and C. Lopez for generous gifts of reagents; A. Stout, P. Zhang, S. Leach, A. Sitaram, and C. Lopez Haber for technical assistance; and the Amigorena laboratory for experimental protocols. This work was supported by National Institutes of Health grants R01 EY015625 (to M.S.M.), R21 AI092398 (to A.R.M. and M.S.M.), R21 AI079724 (to H.S.), and R01 AI081884 and R01 AI064705 (to A.I); a University Research Foundation grant from the University of Pennsylvania (to M.S.M.); Donna and Richard Appel and the HPS Network (to S.H.G.); and a research grant from the United States Veterans Administration (to T.M.L.).	Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bougneres L, 2009, IMMUNITY, V31, P232, DOI 10.1016/j.immuni.2009.06.022; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Calvo PA, 1999, J BIOL CHEM, V274, P12780, DOI 10.1074/jbc.274.18.12780; Caplan S, 2000, IMMUNOL LETT, V72, P113, DOI 10.1016/S0165-2478(00)00176-0; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Enders A, 2006, BLOOD, V108, P81, DOI 10.1182/blood-2005-11-4413; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Fitch Frank W, 2006, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0313s72; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Fontana S, 2006, BLOOD, V107, P4857, DOI 10.1182/blood-2005-11-4398; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jung J, 2006, BLOOD, V108, P362, DOI 10.1182/blood-2005-11-4377; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Muraille E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001154; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sevilla LM, 2001, CELL IMMUNOL, V210, P143, DOI 10.1006/cimm.2001.1817; Shotelersuk V, 2000, AM J MED, V108, P423, DOI 10.1016/S0002-9343(99)00436-2; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wenham M, 2010, HAEMATOL-HEMATOL J, V95, P333, DOI 10.3324/haematol.2009.012286; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	57	54	55	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					782	794		10.1016/j.immuni.2012.02.018	http://dx.doi.org/10.1016/j.immuni.2012.02.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22560444	Bronze, Green Accepted			2022-12-18	WOS:000304976000012
J	Yin, YY; Mariuzza, RA				Yin, Yiyuan; Mariuzza, Roy A.			The Multiple Mechanisms of T Cell Receptor Cross-reactivity	IMMUNITY			English	Editorial Material							PEPTIDES; SELF; MHC	The ability of a single T cell to recognize the diverse peptides it encounters is based on T cell receptor crossreactivity. In this issue of Immunity, Macdonald et al. (2009) and Borbulevych et al. (2009) provide new insights into the structural principles underlying this fundamental property of T cells.	[Yin, Yiyuan; Mariuzza, Roy A.] Univ Maryland, Inst Biotechnol, WM Keck Lab Struct Biol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA	University System of Maryland; University of Maryland Baltimore	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biotechnol, WM Keck Lab Struct Biol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA.		Yin, Yiyuan/A-1384-2016; Yin, Yiyuan/AAP-3069-2020	Yin, Yiyuan/0000-0003-1077-810X; Yin, Yiyuan/0000-0003-1077-810X				Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107	10	54	55	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					849	851		10.1016/j.immuni.2009.12.002	http://dx.doi.org/10.1016/j.immuni.2009.12.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064442	Bronze			2022-12-18	WOS:000273616400003
J	Letvin, NL				Letvin, Norman L.			Correlates of immune protection and the development of a human immunodeficiency virus vaccine	IMMUNITY			English	Article							HIV-1; INFECTION; VIREMIA; NEUTRALIZATION; ANTIBODY; MONKEYS; TRIAL	Because established vaccine technologies are not likely to provide protection against human immunodeficiency virus (HIV) infection, efforts are being focused on defining immunologic and virologic correlates of HIV containment with the hope that this information will provide direction to new approaches for HIV vaccination.	Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Letvin, NL (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	nletvin@bidmc.harvard.edu						BODIAN D, 1955, SCIENCE, V122, P105, DOI 10.1126/science.122.3159.105; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; GUINEE VF, 1966, PEDIATRICS, V37, P649; Jenner E., 1801, INQUIRY CAUSES EFFEC; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Morrow Gavin, 2007, Curr HIV/AIDS Rep, V4, P29, DOI 10.1007/s11904-007-0005-x; NATHANSON N, 1962, B JOHNS HOPKINS HOSP, V111, P198; Permar SR, 2004, J INFECT DIS, V190, P998, DOI 10.1086/422846; PLOTKIN SA, 1999, VACCINES; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WHATMORE AM, 1995, J VIROL, V69, P5117, DOI 10.1128/JVI.69.8.5117-5123.1995; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999	19	54	55	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	2007	27	3					366	369		10.1016/j.immuni.2007.09.001	http://dx.doi.org/10.1016/j.immuni.2007.09.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892845	Bronze			2022-12-18	WOS:000249843400002
J	McGargill, MA; Wen, BG; Walsh, CM; Hedrick, SM				McGargill, MA; Wen, BG; Walsh, CM; Hedrick, SM			A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity	IMMUNITY			English	Article							NEGATIVE REGULATION; MOTH-EATEN; REGULATORY ROLE; ACTIVATION; PROTEIN; MICE; KINASE; DISRUPTION; LEADS; CBL	DRAK2 is a member of the death-associated protein (DAP)-like family of serine/threonine kinases. Members of this family induce apoptosis in various cell types. DRAK2, in particular, is specifically expressed in T cells and B cells, and it is differentially regulated during T cell development. To determine whether DRAK2 regulates lymphocyte apoptosis, we produced Drak2(-1-) mice. Contrary to our expectations, Drak2(-/-) T cells did not demonstrate any defects in apoptosis or negative selection; however, T cells from Drak2-1mice exhibited enhanced sensitivity to T cell receptor-mediated stimulation with a reduced requirement for costimulation. These results provide evidence that DRAK2 raises the threshold for T cell activation by negatively regulating signals through the TCR. In contrast to other models of T cell hypersensitivity, Drak2-1mice were remarkably resistant to experimental autoimmune encephalomyelitis (EAE). These results expose a new pathway regulating T cell activation and highlight the intricacies of induced autoimmune disease.	Univ Calif San Diego, Div Biol Sci, Dept Cellular & Mol Med, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hedrick, SM (corresponding author), Univ Calif San Diego, Div Biol Sci, Dept Cellular & Mol Med, Moores Canc Ctr, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	McGargill, Maureen/N-8131-2018; Hedrick, Stephen M/E-9171-2010	McGargill, Maureen/0000-0002-0916-0372; Hedrick, Stephen/0000-0002-6345-8751; Walsh, Craig/0000-0001-7808-2817	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053091-01, R01 AI053091, AI53091-01] Funding Source: Medline; NIDDK NIH HHS [T32 DK007233-28, T32 DK007233, 5T32DK07233] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Clark LB, 1999, J IMMUNOL, V162, P2546; COHEN SS, 2000, MILKEN I REV, V2, P16; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Cross AH, 2001, J NEUROIMMUNOL, V112, P1, DOI 10.1016/S0165-5728(00)00409-4; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dittel BN, 2000, J AUTOIMMUN, V14, P311, DOI 10.1006/jaut.2000.0371; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Frasca D, 2002, EXP GERONTOL, V37, P321, DOI 10.1016/S0531-5565(01)00199-1; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Kawai T, 1999, ONCOGENE, V18, P3471, DOI 10.1038/sj.onc.1202701; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kogel D, 2001, BIOESSAYS, V23, P352, DOI 10.1002/bies.1050; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Page DM, 1998, J IMMUNOL, V160, P120; Pedotti R, 2003, TRENDS IMMUNOL, V24, P479, DOI 10.1016/S1471-4906(03)00233-3; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	41	54	57	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					781	791		10.1016/j.immuni.2004.10.008	http://dx.doi.org/10.1016/j.immuni.2004.10.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589167	Green Accepted, Bronze			2022-12-18	WOS:000225901600006
J	Jung, D; Bassing, CH; Fugmann, SD; Cheng, HL; Schatz, DG; Alt, FW				Jung, D; Bassing, CH; Fugmann, SD; Cheng, HL; Schatz, DG; Alt, FW			Extrachromosomal recombination substrates recapitulate beyond 12/23 restricted V(D)J recombination in nonlymphoid cells	IMMUNITY			English	Article							SIGNAL SEQUENCES; REGION; GENE; REARRANGEMENT; CLEAVAGE; COMPLEX; RAG-2; DNA; EXPRESSION; ELEMENTS	V(D)J recombination occurs efficiently only between gene segments flanked by recombination signals (RSs) containing 12 and 23 base pair spacers (the 12/23 rule). A further limitation "beyond the 12/23 rule" (B12/23) exists at the TCRbeta locus and ensures Dbeta usage. Herein, we show that extrachromosomal V(D)J recombination substrates recapitulate B12/23 restriction in nonlymphoid cells. We further demonstrate that the Vbeta coding flank, the 12-RS heptamer/nonamer, and the 23-RS spacer each can significantly influence B12/23 restriction. Finally, purified core RAG1 and RAG2 proteins (together with HMG2) also reproduce B12/23 restriction in a cell-free system. Our findings indicate that B12/23 restriction of V(D)J recombination is cemented at the level of interactions between the RAG proteins and TCRbeta RS sequences.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Yale University; Yale University	Alt, FW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@rascal.med.harvard.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI020047, R37AI032524, R01AI032524] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 32524, AI 20047] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; CONCANNON P, 1986, P NATL ACAD SCI USA, V83, P6598, DOI 10.1073/pnas.83.17.6598; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Doty RT, 1999, BLOOD, V93, P3017; EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; EZEKIEL UR, 1995, IMMUNITY, V2, P381, DOI 10.1016/1074-7613(95)90146-9; Fanning L, 1996, IMMUNOGENETICS, V44, P146, DOI 10.1007/BF02660064; Feeney AJ, 2000, IMMUNOL REV, V175, P59, DOI 10.1111/j.1600-065X.2000.imr017508.x; FERRADINI L, 1991, EUR J IMMUNOL, V21, P935, DOI 10.1002/eji.1830210412; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; GAUSS GH, 1992, GENE DEV, V6, P1553, DOI 10.1101/gad.6.8.1553; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Kim DR, 1998, MOL CELL BIOL, V18, P4679, DOI 10.1128/MCB.18.8.4679; KIMURA N, 1986, J EXP MED, V164, P739, DOI 10.1084/jem.164.3.739; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Livak F, 2000, J EXP MED, V192, P1191, DOI 10.1084/jem.192.8.1191; MAX EE, 1979, P NATL ACAD SCI USA, V76, P3450, DOI 10.1073/pnas.76.7.3450; McMahan CJ, 1997, MOL CELL BIOL, V17, P4544, DOI 10.1128/MCB.17.8.4544; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; Pan PY, 1997, INT IMMUNOL, V9, P515, DOI 10.1093/intimm/9.4.515; POSNETT DN, 1994, J EXP MED, V179, P1707, DOI 10.1084/jem.179.5.1707; Roman CAJ, 1997, IMMUNITY, V7, P13, DOI 10.1016/S1074-7613(00)80506-3; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sawchuk DJ, 1997, J EXP MED, V185, P2025, DOI 10.1084/jem.185.11.2025; Sekiguchi J, 2001, MOL CELL, V8, P1383, DOI 10.1016/S1097-2765(01)00423-3; SHEEHAN KM, 1993, MOL CELL BIOL, V13, P1363, DOI 10.1128/MCB.13.3.1363; Sikes ML, 1998, J IMMUNOL, V161, P1399; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; Sleckman BP, 2000, P NATL ACAD SCI USA, V97, P7975, DOI 10.1073/pnas.130190597; Steen SB, 1999, MOL CELL BIOL, V19, P3010; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Tillman RE, 2002, J EXP MED, V195, P309, DOI 10.1084/jem.20011803; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VanDyk LF, 1996, J IMMUNOL, V157, P4005; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; West RB, 1998, MOL CELL BIOL, V18, P6408, DOI 10.1128/MCB.18.11.6408; Wu C, 2003, IMMUNITY, V18, P75, DOI 10.1016/S1074-7613(02)00515-0; Yu KF, 2002, J BIOL CHEM, V277, P5040, DOI 10.1074/jbc.M109772200	53	54	54	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2003	18	1					65	74		10.1016/S1074-7613(02)00507-1	http://dx.doi.org/10.1016/S1074-7613(02)00507-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530976				2022-12-18	WOS:000180860600007
J	Pradhan, D; Morrow, JS				Pradhan, D; Morrow, JS			The spectrin-ankyrin skeleton controls CD45 surface display and interleukin-2 production	IMMUNITY			English	Article							PROTEIN-KINASE-C; TYROSINE-PHOSPHATASE; LIPID RAFTS; IMMUNOLOGICAL SYNAPSE; T-LYMPHOCYTES; CELL; GOLGI; ACTIVATION; BINDS; IDENTIFICATION	With T cell receptor stimulation, intracellular pools of CD45 and spectrin move to the surface. These processes are coupled. In both peripheral lymphocytes and Jurkat T cells, PI spectrin and ankyrin associate with CD45. In Jurkat T cells, PI spectrin peptides suppress surface recruitment of CD45 and CD3 and abrogate T cell activation. Other glycoproteins such as CD43 are not altered by the spectrin peptides. Spectrin's effects are mediated by ankyrin, which binds directly to the cytoplasmic domain of CD45 (K-d = 4.3 +/- 3.0 nM). These data reveal a novel and unexpected contribution of the spectrin-ankyrin skeleton to the control of T lymphocyte function.	Yale Univ, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06510 USA	Yale University; Yale University	Morrow, JS (corresponding author), Yale Univ, Dept Pathol, 310 Cedar St, New Haven, CT 06510 USA.	jon.morrow@yale.edu	Pradhan, Debabrata/W-5476-2019	Pradhan, Debabrata/0000-0003-4995-6882				Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Beck KA, 1998, BBA-MOL CELL RES, V1404, P153, DOI 10.1016/S0167-4889(98)00054-8; BLACK JD, 1988, J CELL BIOL, V106, P97, DOI 10.1083/jcb.106.1.97; Buckley RH, 2000, IMMUNOL RES, V22, P237, DOI 10.1385/IR:22:2-3:237; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Czyzyk JK, 1998, BIOCHEM BIOPH RES CO, V243, P444, DOI 10.1006/bbrc.1998.8114; De Matteis MA, 2000, J CELL SCI, V113, P2331; De Matteis MA, 2001, METHOD ENZYMOL, V329, P405; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; GREGORIO CC, 1994, J CELL BIOL, V125, P345, DOI 10.1083/jcb.125.2.345; GREGORIO CC, 1993, BLOOD CELLS, V19, P361; GREGORIO CC, 1992, P NATL ACAD SCI USA, V89, P4947, DOI 10.1073/pnas.89.11.4947; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; LEDBETTER JA, 1993, CURR OPIN IMMUNOL, V5, P334, DOI 10.1016/0952-7915(93)90050-3; LEE JK, 1988, CELL, V55, P807, DOI 10.1016/0092-8674(88)90136-5; Leitenberg D, 2001, SEMIN IMMUNOL, V13, P129, DOI 10.1006/smim.2000.0304; LOKESHWAR VB, 1992, J BIOL CHEM, V267, P21551; Masso-Welch PA, 1999, J LEUKOCYTE BIOL, V66, P617, DOI 10.1002/jlb.66.4.617; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; MINAMI Y, 1991, J BIOL CHEM, V266, P9222; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; PAULY JL, 1986, J IMMUNOL, V136, P246; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; Sakaguchi G, 1998, BIOCHEM BIOPH RES CO, V248, P846, DOI 10.1006/bbrc.1998.9067; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; TURKA LA, 1992, EUR J IMMUNOL, V22, P551, DOI 10.1002/eji.1830220238; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Wallace VA, 1997, J IMMUNOL, V158, P3205; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	43	54	55	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2002	17	3					303	315		10.1016/S1074-7613(02)00396-5	http://dx.doi.org/10.1016/S1074-7613(02)00396-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354383	Bronze			2022-12-18	WOS:000178163100007
J	Kim, DS; Xu, M; Nie, L; Peng, XC; Jimi, E; Voll, RE; Nguyen, T; Ghosh, S; Sun, XH				Kim, DS; Xu, M; Nie, L; Peng, XC; Jimi, E; Voll, RE; Nguyen, T; Ghosh, S; Sun, XH			Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappa B activities	IMMUNITY			English	Article							T-CELL DEVELOPMENT; ALPHA-BETA; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; RAG-1-DEFICIENT MICE; NEGATIVE SELECTION; ALLELIC EXCLUSION; TYROSINE KINASES; TRANSGENIC MICE; DNA-BINDING	E2A and HEB are basic helix-loop-helix transcription factors essential for T cell development. Complete inhibition of their activities through transgenic overexpression of their inhibitors Id1 and Tal1 leads to a dramatic loss of thymocytes. Here, we suggest that bHLH proteins play important roles in establishing thresholds for pre-TCR and TCR signaling. Inhibition of their function allows double-negative cells to differentiate without a functional pre-TCR, while anti-CD3 stimulation downregulates bHLH activities. We also find that the transcription factor NF-kappaB becomes activated in transgenic thymocytes. Further activation of NF-kappaB exacerbates the loss of thymocytes, whereas inhibition of NF-kappaB leads to the rescue of double-positive thymocytes. Therefore, we propose that E2A and HEB negatively regulate pre-TCR and TCR signaling and their removal causes hyperactivation and apoptosis of thymocytes.	Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem,Sect Immunobiol, New Haven, CT 06520 USA	Oklahoma Medical Research Foundation; Howard Hughes Medical Institute; Yale University	Sun, XH (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.				NATIONAL CANCER INSTITUTE [R01CA077553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI033597, R21AI033597, R01AI033443] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA077553, CA77553] Funding Source: Medline; NCRR NIH HHS [P20 RR015577, RR15577] Funding Source: Medline; NIAID NIH HHS [AI33443, R01 AI033597, R01 AI033443, AI33597] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barndt R, 1999, J IMMUNOL, V163, P3331; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; BASH RO, 1995, BLOOD, V86, P666, DOI 10.1182/blood.V86.2.666.bloodjournal862666; BEGLEY CG, 1991, P NATL ACAD SCI USA, V88, P869, DOI 10.1073/pnas.88.3.869; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Haks MC, 1999, SEMIN IMMUNOL, V11, P23, DOI 10.1006/smim.1998.0153; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; Jacobs H, 2000, SEMIN IMMUNOL, V12, P487, DOI 10.1006/smim.2000.0262; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Miyazaki T, 1997, J EXP MED, V186, P877, DOI 10.1084/jem.186.6.877; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; SEN J, 1995, J IMMUNOL, V154, P3213; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Sugawara T, 1998, J IMMUNOL, V161, P2888; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZUNIGAPFLUCKER JC, 1993, J EXP MED, V178, P1139, DOI 10.1084/jem.178.4.1139	59	54	54	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					9	21		10.1016/S1074-7613(02)00264-9	http://dx.doi.org/10.1016/S1074-7613(02)00264-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825562	Bronze			2022-12-18	WOS:000173575700003
J	Poudrier, J; Weng, XD; Kay, DG; Pare, G; Calvo, EL; Hanna, Z; Kosco-Vilbois, MH; Jolicoeur, P				Poudrier, J; Weng, XD; Kay, DG; Pare, G; Calvo, EL; Hanna, Z; Kosco-Vilbois, MH; Jolicoeur, P			The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; T-CELLS; TYPE-1 INFECTION; LYMPHOID ORGANS; CD40 LIGAND; ALTERED SIALYLATION; ANTIBODY-PRODUCTION; MALIGNANT-LYMPHOMA; DENDRITIC CELLS	The mechanisms responsible for degeneration of germinal centers (GC) and follicular dendritic cell (FDC) networks during progression to AIDS remain elusive. Here, we show that CD4(+) T cells from CD4C/HIV-1 Tg mice, which develop a severe AIDS-like disease, express low levels of CD40 ligand. Accordingly, GC formation, FDC networks, and immunoglobulin isotype switching are impaired in these animals. However, Tg B cells respond to in vitro CD40 stimulation. Total serum IgG levels are reduced in Tg mice, whereas total IgM levels are increased with a significant amount showing DNA specificity. IFN-gamma- and IL-6-deficient CD4C/HIV-1 Tg mice also develop the AIDS-like disease and produce auto-Ab. Thus, CD4C/HIV-1 Tg mice have immune dysfunction accompanied by autoimmune responses.	Clin Res Inst Montreal, Mol Biol Lab, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; McGill Univ, Div Expt Med, Montreal, PQ H3G 1A4, Canada; Serono Pharmaceut Res Inst, Dept Immunol, Geneva, Switzerland	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Poudrier, J (corresponding author), Clin Res Inst Montreal, Mol Biol Lab, Montreal, PQ H2W 1R7, Canada.		Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059846] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59846] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; CLERICI M, 1994, IMMUNOL TODAY, V15, P575, DOI 10.1016/0167-5699(94)90220-8; Cyster JG, 2000, NAT IMMUNOL, V1, P9, DOI 10.1038/76859; DITZEL HJ, 1994, P NATL ACAD SCI USA, V91, P3710, DOI 10.1073/pnas.91.9.3710; EDELMAN AS, 1989, FASEB J, V3, P22, DOI 10.1096/fasebj.3.1.2562947; ELSADR W, 1984, DIAGN CLIN IMMUNOL, V2, P73; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Emilie D, 1997, METHODS, V11, P133, DOI 10.1006/meth.1996.0397; EMILIE D, 1994, RES IMMUNOL, V145, P595, DOI 10.1016/S0923-2494(05)80039-2; FOX CH, 1991, J INFECT DIS, V164, P1051, DOI 10.1093/infdis/164.6.1051; Galvan M, 1998, J IMMUNOL, V161, P641; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; Hanna Z, 1998, J VIROL, V72, P121, DOI 10.1128/JVI.72.1.121-132.1998; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; HERNDIER BG, 1994, AIDS, V8, P1025, DOI 10.1097/00002030-199408000-00003; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; KOOPMAN G, 1992, IMMUNOL REV, V126, P21, DOI 10.1111/j.1600-065X.1992.tb00629.x; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; KoscoVilbois MH, 1997, IMMUNOL TODAY, V18, P225; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; LAFEUILLADE A, 1991, AIDS, V5, P1139, DOI 10.1097/00002030-199109000-00014; LEFEBVRE JC, 1994, VIROLOGY, V199, P265, DOI 10.1006/viro.1994.1124; MACCHIA D, 1993, NATURE, V363, P464, DOI 10.1038/363464a0; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Moodley D, 1997, ANN TROP PAEDIATR, V17, P83, DOI 10.1080/02724936.1997.11747868; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PANTALEO G, 1995, ANNU REV IMMUNOL, V13, P487, DOI 10.1146/annurev.immunol.13.1.487; Perrin C, 1997, CLIN EXP IMMUNOL, V110, P22; PILERI S, 1986, HISTOPATHOLOGY, V10, P1107, DOI 10.1111/j.1365-2559.1986.tb02552.x; Poudrier J, 1999, J IMMUNOL, V163, P1153; Poudrier J, 1998, EUR J IMMUNOL, V28, P3371, DOI 10.1002/(SICI)1521-4141(199810)28:10<3371::AID-IMMU3371>3.0.CO;2-C; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; ROOTBERNSTEIN RS, 1990, RES IMMUNOL, V141, P321, DOI 10.1016/0923-2494(90)90024-S; Rosenberg YJ, 1997, EUR J IMMUNOL, V27, P3214, DOI 10.1002/eji.1830271219; Saoudi A, 1996, IMMUNOL REV, V149, P195, DOI 10.1111/j.1600-065X.1996.tb00905.x; Shearer GM, 1998, IMMUNITY, V9, P587, DOI 10.1016/S1074-7613(00)80656-1; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; TENNERRACZ K, 1986, AM J PATHOL, V123, P9; TennerRacz K, 1995, CURR TOP MICROBIOL, V201, P141; TERUYAFELDSTEIN J, 1995, AM J SURG PATHOL, V19, P357, DOI 10.1097/00000478-199503000-00014; Than S, 1997, J INFECT DIS, V175, P47, DOI 10.1093/infdis/175.1.47; Tinkle BT, 1997, J VIROL, V71, P4809, DOI 10.1128/JVI.71.6.4809-4814.1997; Tinkle BT, 1997, J CLIN INVEST, V100, P32, DOI 10.1172/JCI119518; Vanham G, 1999, CLIN EXP IMMUNOL, V117, P335; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Wolthers KC, 1997, AIDS RES HUM RETROV, V13, P1023, DOI 10.1089/aid.1997.13.1023; Wu WY, 1997, GLYCOBIOLOGY, V7, P349, DOI 10.1093/glycob/7.3.349; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	55	54	54	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					173	185		10.1016/S1074-7613(01)00177-7	http://dx.doi.org/10.1016/S1074-7613(01)00177-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520454	Bronze			2022-12-18	WOS:000170717200001
J	Rolink, AG; Brocker, T; Bluethmann, H; Kosco-Vilbois, MH; Andersson, J; Melchers, F				Rolink, AG; Brocker, T; Bluethmann, H; Kosco-Vilbois, MH; Andersson, J; Melchers, F			Mutations affecting either generation or survival of cells influence the pool size of mature B cells	IMMUNITY			English	Article							CLASS-II MOLECULES; HEAT-STABLE ANTIGEN(HI); C57BL/6 TRANSGENIC MICE; ALPHA-D GENE; T-CELLS; A-BETA; INVARIANT CHAIN; LYMPHOID ORGANS; DEFICIENT MICE; SINGLE CELLS	The mature B cell compartment of MHC class II-deficient B6 I-A alpha(-/-) and the btk-defective CBA/N mouse strain is 4- to 5-fold smaller than in wild-type B6 mice. The defect in B6 I-A alpha(-/-) mice is intrinsic to B cells and due to a 4- to 5-fold reduced lifespan, which however can be normalized by an I-E alpha(d) transgene, but only when expressed early during B cell development. The reduced number of mature B cells in the btk-defective CBA/N mouse is due to a 4- to 5-fold lower number of immature splenic B cells entering the mature compartment. The combined defects of reduced lifespan and impaired generation in double mutant mice result in a severe deficiency in the mature B cell pool.	Basel Inst Immunol, CH-4005 Basel, Switzerland; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; F Hoffmann La Roche & Co Ltd, Dept Roche Genet, CH-4070 Basel, Switzerland; Serono Pharmaceut Res Inst, CH-1228 Plan Les Ouates, Switzerland	Max Planck Society; Roche Holding	Rolink, AG (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.			Brocker, Thomas/0000-0001-7060-5433				ALLMAN DM, 1992, J IMMUNOL, V149, P2533; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; ANDERSON GD, 1989, J IMMUNOL, V143, P3757; ANDERSON GD, 1989, J EXP MED, V170, P1003, DOI 10.1084/jem.170.3.1003; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GU H, 1992, ANN NY ACAD SCI, V651, P304; HARDY RR, 1983, NATURE, V306, P270, DOI 10.1038/306270a0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; Kenty G, 1998, J IMMUNOL, V160, P606; Khan WN, 1997, INT IMMUNOL, V9, P395, DOI 10.1093/intimm/9.3.395; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Klaus GGB, 1997, EUR J IMMUNOL, V27, P2749, DOI 10.1002/eji.1830271102; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LORTAN JE, 1987, EUR J IMMUNOL, V17, P1311, DOI 10.1002/eji.1830170914; Lu LW, 1999, J IMMUNOL, V162, P1931; MACLENNAN I, 1993, IMMUNOL TODAY, V14, P29, DOI 10.1016/0167-5699(93)90321-B; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MARKOWITZ JS, 1993, J IMMUNOL, V150, P1223; MATSUNAGA M, 1990, J EXP MED, V171, P577, DOI 10.1084/jem.171.2.577; MINETA T, 1990, IMMUNOLOGY, V69, P385; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Newton K, 1998, CURR OPIN GENET DEV, V8, P68, DOI 10.1016/S0959-437X(98)80064-6; Oka Y, 1996, INT IMMUNOL, V8, P1675, DOI 10.1093/intimm/8.11.1675; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; RAHEMTULLA A, 1991, NATURE, V353, P80; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; ROLINK AG, 1996, IMMUNITY, V5, P433; RUBERTI G, 1993, J IMMUNOL, V151, P6185; SCHER I, 1982, IMMUNOL REV, V64, P117, DOI 10.1111/j.1600-065X.1982.tb00421.x; SCHER I, 1982, ADV IMMUNOL, V33, P1, DOI 10.1016/S0065-2776(08)60834-2; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TARLINTON D, 1993, INT IMMUNOL, V5, P1629, DOI 10.1093/intimm/5.12.1629; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WIDERA G, 1987, CELL, V51, P175, DOI 10.1016/0092-8674(87)90145-0; Woodland RT, 1996, J IMMUNOL, V156, P2143; YAMAMURA K, 1985, NATURE, V316, P67, DOI 10.1038/316067a0	48	54	54	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					619	628		10.1016/S1074-7613(00)80061-8	http://dx.doi.org/10.1016/S1074-7613(00)80061-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367907	Bronze			2022-12-18	WOS:000080709400013
J	Yang, Y; Charlton, B; Shimada, A; DalCanto, R; Fathman, CG				Yang, Y; Charlton, B; Shimada, A; DalCanto, R; Fathman, CG			Monoclonal T cells identified in early NOD islet infiltrates	IMMUNITY			English	Article							NONOBESE DIABETIC MOUSE; V-BETA-GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR REPERTOIRE; ELEMENT USAGE; CHAIN; MICE; LYMPHOCYTES; MYOGLOBIN	To examine the hypothesis that a single initiating antigen was recognized by a monoclonal T cell population leading to subsequent inflammatory insulitis in nonobese (NOD) mouse islets, we examined the T cell receptor (TCR) V beta repertoire of islet-infiltrating T cells in very young (2-week-old) NOD mice. In independent experiments, we repeatedly identified one monoclonal TCR V beta 8.2 gene product expressed by T lymphocytes infiltrating the islets of NOD mice at 2 weeks of age. The resultant inflammatory response quickly obscures the monoclonal nature of the initiating event. These data suggest that autoimmune diabetes in NOD mice may be initiated by recognition of a single autoantigen.	AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,CANBERRA,ACT 2601,AUSTRALIA	Australian National University; John Curtin School of Medical Research	Yang, Y (corresponding author), STANFORD UNIV,SCH MED,DIV RHEUMATOL & IMMUNOL,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039959, P01DK044837] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 44837, DK 39959] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; BELL RB, 1993, J IMMUNOL, V150, P4085; BURNS FR, 1989, J EXP MED, V169, P27, DOI 10.1084/jem.169.1.27; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; CONRAD B, 1994, NATURE, V371, P351, DOI 10.1038/371351a0; DANSKA JS, 1990, J EXP MED, V172, P27, DOI 10.1084/jem.172.1.27; GALLEY KA, 1995, J IMMUNOL, V154, P2969; GOLD DP, 1994, CURR OPIN IMMUNOL, V6, P907, DOI 10.1016/0952-7915(94)90012-4; HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P800; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; INFANTE AJ, 1992, J IMMUNOL, V148, P3385; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; LIVINGSTONE A, 1991, J IMMUNOL, V146, P529; MAEDA T, 1991, DIABETES, V40, P1580, DOI 10.2337/diabetes.40.12.1580; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; MILLER ML, 1988, J IMMUNOL, V140, P4108; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; ROHANE PW, 1995, DIABETES, V44, P550, DOI 10.2337/diabetes.44.5.550; RUBERTI G, 1993, J IMMUNOL, V151, P6185; RUBERTI G, 1991, J EXP MED, V174, P83, DOI 10.1084/jem.174.1.83; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; SHIZURU JA, 1991, J EXP MED, V174, P633, DOI 10.1084/jem.174.3.633; STAMENKOVIC I, 1988, P NATL ACAD SCI USA, V85, P1179, DOI 10.1073/pnas.85.4.1179; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TOYODA H, 1992, IMMUNOL LETT, V32, P241, DOI 10.1016/0165-2478(92)90056-T; WATERS SH, 1992, DIABETES, V41, P308, DOI 10.2337/diabetes.41.3.308; ZAMVIL SS, 1988, J EXP MED, V167, P1586, DOI 10.1084/jem.167.5.1586	35	54	57	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1996	4	2					189	194		10.1016/S1074-7613(00)80683-4	http://dx.doi.org/10.1016/S1074-7613(00)80683-4			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624809	Bronze			2022-12-18	WOS:A1996TX22500009
J	SCHUMACHER, TNM; PLOEGH, HL				SCHUMACHER, TNM; PLOEGH, HL			ARE MHC-BOUND PEPTIDES A NUISANCE FOR POSITIVE SELECTION	IMMUNITY			English	Article							CLASS-I MOLECULES; CD8+ T-CELLS; ANTIGEN PRESENTATION; MUTATIONS; BINDING; HLA-A2		MIT,DEPT BIOL,CAMBRIDGE,MA 02142; MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	SCHUMACHER, TNM (corresponding author), MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE CTR 9,CAMBRIDGE,MA 02142, USA.		Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804				ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BERG L, 1990, CELL, V60, P1041; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JACOBS H, 1990, EUR J IMMUNOL, V20, P2333, DOI 10.1002/eji.1830201024; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JANEWAY C, 1992, Current Biology, V2, P26, DOI 10.1016/0960-9822(92)90419-B; KISLELOW P, 1988, NATURE, V335, P730; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; OHASHI PS, 1993, INT IMMUNOL, V5, P131, DOI 10.1093/intimm/5.2.131; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VANSANTON HM, 1994, IN PRESS J EXP MED; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5	22	54	55	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1994	1	9					721	723		10.1016/S1074-7613(94)80013-8	http://dx.doi.org/10.1016/S1074-7613(94)80013-8			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895161				2022-12-18	WOS:A1994PX64800001
J	HUANG, JH; GETTY, RR; CHISARI, FV; FOWLER, P; GREENSPAN, NS; TYKOCINSKI, ML				HUANG, JH; GETTY, RR; CHISARI, FV; FOWLER, P; GREENSPAN, NS; TYKOCINSKI, ML			PROTEIN TRANSFER OF PREFORMED MHC-PEPTIDE COMPLEXES SENSITIZES TARGET-CELLS TO T-CELL CYTOLYSIS	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DECAY-ACCELERATING FACTOR; LIPID-LINKED FORM; CLASS-I MOLECULES; MEMBRANE ANCHOR; LYMPHOCYTES-T; LATERAL DIFFUSION; MASS-SPECTROMETRY; ANTIGEN; ACTIVATION	Recombinant GPI-anchored HLA-A2.1 (HLA-A2.1-GPI/beta(2)m) was used as a protein transfer vehicle to deliver a hepatitis B virus antigenic peptide to the surfaces of cytotoxic T cell targets. Empty HLA-A2.1-GPI/beta(2)m was first produced in D. melanogaster cotransfectants and immunoaffinity purified. Cell coating with HLA-2.1-GPI/beta(2)m was shown to occur rapidly, and to be protein concentration dependent. Protein-transferred HLA-A2.1-GPI/beta(2)m effectively presented a hepatitis B virus peptide to peptide-specific HLA-A2.1-restricted T cell crones in cytotoxicity assays. Protein transfer of functional GPI-modified class I MHC-antigenic peptide complexes represents a never strategy for delivering functional antigenic complexes to cell surfaces that bypasses limitations of gene transfer and permits control of antigenic peptide densities at cell surfaces.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA	Scripps Research Institute	HUANG, JH (corresponding author), CASE WESTERN RESERVE UNIV, INST PATHOL, BIOMED RES BLDG, ROOM 925, CLEVELAND, OH 44106 USA.		Chisari, Francis V/A-3086-2008; Greenspan, Neil/AAJ-4795-2020	Chisari, Francis/0000-0002-4832-1044	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020001, R01AI031044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038181] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI31044, R01 AI20001] Funding Source: Medline; NIDDK NIH HHS [P01 DK38181] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHBURNER M, 1989, DROSOPHILA LABORATOR, P308; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BULOW R, 1988, BIOCHEMISTRY-US, V27, P2384; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; ELLIOTT TJ, 1990, P NATL ACAD SCI USA, V87, P5213, DOI 10.1073/pnas.87.13.5213; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; HENDERSON RA, 1993, P NATL ACAD SCI USA, V90, P10275, DOI 10.1073/pnas.90.21.10275; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HISTUMOTO Y, 1993, INT IMMUNOL, V5, P805, DOI 10.1093/intimm/5.7.805; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; HUANG JH, 1994, MOL IMMUNOL, V31, P1017; HUCZKO EL, 1993, J IMMUNOL, V151, P2572; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JANEWAY CA, 1993, CURR OPIN IMMUNOL, V5, P313, DOI 10.1016/0952-7915(93)90048-W; KEMBLE GW, 1993, J CELL BIOL, V122, P1253, DOI 10.1083/jcb.122.6.1253; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; MANN DW, 1989, J IMMUNOL, V142, P318; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; MORAN P, 1992, J IMMUNOL, V149, P1736; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; PARHAM P, 1983, METHOD ENZYMOL, V92, P110; PARKER KC, 1992, MOL IMMUNOL, V29, P371, DOI 10.1016/0161-5890(92)90024-R; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; SCHEIRLE A, 1992, J IMMUNOL, V149, P1994; SLECKMAN BP, 1991, J IMMUNOL, V147, P428; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; STRAUS DS, 1985, P NATL ACAD SCI USA, V82, P6245, DOI 10.1073/pnas.82.18.6245; TYKOCINSKI ML, 1988, P NATL ACAD SCI USA, V85, P3555, DOI 10.1073/pnas.85.10.3555; TYKOCINSKI ML, 1992, NK CELL MEDIATED CYT, P393; WANECK GL, 1988, P NATL ACAD SCI USA, V85, P577, DOI 10.1073/pnas.85.2.577; WEBER MC, 1994, EXP CELL RES, V210, P107, DOI 10.1006/excr.1994.1016; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; ZHANG F, 1992, P NATL ACAD SCI USA, V89, P5231, DOI 10.1073/pnas.89.12.5231; ZHANG F, 1991, J CELL BIOL, V115, P75, DOI 10.1083/jcb.115.1.75	43	54	59	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1994	1	7					607	613		10.1016/1074-7613(94)90050-7	http://dx.doi.org/10.1016/1074-7613(94)90050-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600289				2022-12-18	WOS:A1994PN12700009
J	Meyer, SN; Scuoppo, C; Vlasevska, S; Bal, E; Holmes, AB; Holloman, M; Garcia-Ibanez, L; Nataraj, S; Duval, R; Vantrimpont, T; Basso, K; Brooks, N; Dalla-Favera, R; Pasqualucci, L				Meyer, Stefanie N.; Scuoppo, Claudio; Vlasevska, Sofija; Bal, Elodie; Holmes, Antony B.; Holloman, Mara; Garcia-Ibanez, Laura; Nataraj, Sarah; Duval, Romain; Vantrimpont, Thomas; Basso, Katia; Brooks, Nigel; Dalla-Favera, Riccardo; Pasqualucci, Laura			Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma	IMMUNITY			English	Article							FOLLICULAR LYMPHOMA; BINDING PROTEIN; READ ALIGNMENT; P300; CBP; GENOME; COACTIVATOR; ACETYLATION; EXPRESSION; PROMOTES	Inactivating mutations of the CREBBP and EP300 acetyltransferases are among the most common genetic alterations in diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL). Here, we examined the relationship between these two enzymes in germinal center (GC) B cells, the normal counterpart of FL and DLBCL, and in lymphomagenesis by using conditional GC-directed deletion mouse models targeting Crebbp or Ep300. We found that CREBBP and EP300 modulate common as well as distinct transcriptional programs implicated in separate anatomic and functional GC compartments. Consistently, deletion of Ep300 but not Crebbp impaired the fitness of GC B cells in vivo. Combined loss of Crebbp and Ep300 completely abrogated GC formation, suggesting that these proteins partially compensate for each other through common transcriptional targets. This synthetic lethal interaction was retained in CREBBP-mutant DLBCL cells and could be pharmacologically targeted with selective small molecule inhibitors of CREBBP and EP300 function. These data provide proof-of-principle for the clinical development of EP300-specific inhibitors in FL and DLBCL.	[Meyer, Stefanie N.; Scuoppo, Claudio; Vlasevska, Sofija; Bal, Elodie; Holmes, Antony B.; Holloman, Mara; Garcia-Ibanez, Laura; Nataraj, Sarah; Duval, Romain; Vantrimpont, Thomas; Basso, Katia; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Scuoppo, Claudio; Basso, Katia; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Brooks, Nigel] Chesterford Res Pk, Cell Centr, Cambridge CB10 1XL, England; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.; Pasqualucci, L (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.; Pasqualucci, L (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA.	lp171@cumc.columbia.edu		Nataraj, Sarah/0000-0002-1683-2763; Duval, Romain/0000-0002-5785-0685	National Institutes of Health (NIH) [RO1-CA172492, P50-CA192937]; Sanofi Innovator Award; Leukemia & Lymphoma Society Translational Research Project award; NIH/NCI Cancer Center Support Grant [P30CA013696]; NATIONAL CANCER INSTITUTE [P30CA013696, R01CA172492, P50CA192937] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi Innovator Award; Leukemia & Lymphoma Society Translational Research Project award; NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank T. Mo for assistance with the mouse colony maintenance; H. Tang for technical support; R. Kumar for bioinformatics support with the genomic validation of DLBCL cell lines; F. Bosch for critically reading the manuscript; N. Compagno for the generation of the neutral sgRNA control; Izabela Krupska at the JP Sulzberger Genome Center of Columbia University and Genewiz, Inc. for help with high-throughput sequencing; and Charles Karan at the High-Throughput Screening Facility of the Herbert Irving Comprehensive Cancer Center (HICCC) for help with the drug treatment assays. We also thank K. Rajewsky (Max Delbruck Center for Molecular Medicine, Berlin, Germany) for the C gamma 1<SUP>Cre/+</SUP>mice and Paul Brindle (Department of Biochemistry, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA) for the Crebbp and Ep300 floxed mice. This study was supported by grants from the National Institutes of Health (NIH) RO1-CA172492 to L.P. and P50-CA192937 to R.D.F., a Sanofi Innovator Award to L.P., and a Leukemia & Lymphoma Society Translational Research Project award to L.P. This research was also funded in part through the NIH/NCI Cancer Center Support Grant P30CA013696 and used the Flow Cytometry and the Genomics and High-Throughput Screening Shared Resources of the HICCC. S. Meyer is a fellow of the Swiss National Science Foundation.	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Arthur SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06354-3; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Brescia P, 2018, CANCER CELL, V34, P453, DOI 10.1016/j.ccell.2018.08.006; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chan HM, 2001, J CELL SCI, V114, P2363; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; Garcia-Ramirez I, 2017, BLOOD, V129, P2645, DOI 10.1182/blood-2016-08-733469; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Goodman RH, 2000, GENE DEV, V14, P1553; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hashwah H, 2017, P NATL ACAD SCI USA, V114, P9701, DOI 10.1073/pnas.1619555114; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Khiem D, 2008, P NATL ACAD SCI USA, V105, P17067, DOI 10.1073/pnas.0804868105; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lasko LM, 2017, NATURE, V550, P128, DOI 10.1038/nature24028; Lefranc M. P, 2018, NUCLEIC ACIDS RES, V27, P209; Leiserson MDM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0700-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Milpied P, 2018, NAT IMMUNOL, V19, P1013, DOI 10.1038/s41590-018-0181-4; Montoto S, 2007, J CLIN ONCOL, V25, P2426, DOI 10.1200/JCO.2006.09.3260; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Ogiwara H, 2016, CANCER DISCOV, V6, P430, DOI 10.1158/2159-8290.CD-15-0754; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pegg N, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.11590; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schmidt J, 2018, BLOOD, V132, P2687, DOI 10.1182/blood-2018-03-837039; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow SH, 2016, WHO CLASSIFICATION T, V2; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weinert BT, 2018, CELL, V174, P231, DOI 10.1016/j.cell.2018.04.033; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilker PR, 2008, NAT IMMUNOL, V9, P603, DOI 10.1038/ni.1609; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yan JW, 2018, I S BIOMED IMAGING, P6, DOI 10.1109/ISBI.2018.8363511; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	74	53	55	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					535	+		10.1016/j.immuni.2019.08.006	http://dx.doi.org/10.1016/j.immuni.2019.08.006			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31519498	Green Accepted, Bronze			2022-12-18	WOS:000486184600015
J	Andrews, SF; Chambers, MJ; Schramm, CA; Plyler, J; Raab, JE; Kanekiyo, M; Gillespie, RA; Ransier, A; Darko, S; Hu, JF; Chen, XJ; Yassine, HM; Boyington, JC; Crank, MC; Chen, GL; Coates, E; Mascola, JR; Douek, DC; Graham, BS; Ledgerwood, JE; McDermott, AB				Andrews, Sarah F.; Chambers, Michael J.; Schramm, Chaim A.; Plyler, Jason; Raab, Julie E.; Kanekiyo, Masaru; Gillespie, Rebecca A.; Ransier, Amy; Darko, Sam; Hu, Jianfei; Chen, Xuejun; Yassine, Hadi M.; Boyington, Jeffrey C.; Crank, Michelle C.; Chen, Grace L.; Coates, Emily; Mascola, John R.; Douek, Daniel C.; Graham, Barney S.; Ledgerwood, Julie E.; McDermott, Adrian B.			Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin	IMMUNITY			English	Article							RNA-SEQ; MONOCLONAL-ANTIBODIES; IMMUNE HISTORY; EXPRESSION; INFECTION; POPULATION; BLOOD; PATHOGENESIS; REVEALS; SUBSETS	Vaccine-induced memory B cell responses to evolving viruses like influenza A involve activation of pre-existing immunity and generation of new responses. To define the contribution of these two types of responses, we analyzed the response to H7N9 vaccination in H7N9-naive adults. We performed comprehensive comparisons at the single-cell level of the kinetics, Ig repertoire, and activation phenotype of established pre-existing memory B cells recognizing conserved epitopes and the newly generated memory B cells directed toward H7 strain-specific epitopes. The recall response to conserved epitopes on H7 HA involved a transient expansion of memory B cells with little observed adaptation. However, the B cell response to newly encountered epitopes was phenotypically distinct and generated a sustained memory population that evolved and affinity matured months after vaccination. These findings establish clear differences between newly generated and pre-existing memory B cells, highlighting the challenges in achieving long-lasting, broad protection against an ever-evolving virus.	[Andrews, Sarah F.; Chambers, Michael J.; Schramm, Chaim A.; Plyler, Jason; Raab, Julie E.; Kanekiyo, Masaru; Gillespie, Rebecca A.; Ransier, Amy; Darko, Sam; Hu, Jianfei; Chen, Xuejun; Boyington, Jeffrey C.; Crank, Michelle C.; Chen, Grace L.; Coates, Emily; Mascola, John R.; Douek, Daniel C.; Graham, Barney S.; Ledgerwood, Julie E.; McDermott, Adrian B.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20902 USA; [Yassine, Hadi M.] Qatar Univ Biomed Res Ctr, Doha, Qatar	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Andrews, SF; McDermott, AB (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20902 USA.	sarah.andrews2@nih.gov; adrian.mcdermott@nih.gov	YASSINE, HADI M./AAW-6475-2020; McDermott, Adrian B/E-7306-2011; Kanekiyo, Masaru/Y-9820-2018; Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021	YASSINE, HADI M./0000-0001-7592-2788; Kanekiyo, Masaru/0000-0001-5767-1532; Graham, Barney S./0000-0001-8112-0853; McDermott, Adrian/0000-0003-0616-9117	Intramural Research Program of the Vaccine Research Center; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005133, ZIAAI005143, ZIAAI005047, ZIAAI005033, ZIAAI005003] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank David Ambrozak and Julianne Hill for help with flow cytometry, Martha Nason for statistical advice, and Susan Moir for helpful discussions. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Andrews SF, 2017, SCI IMMUNOL, V2; Angeletti D, 2018, TRENDS IMMUNOL, V39, P549, DOI 10.1016/j.it.2018.04.008; Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Burton AR, 2018, J CLIN INVEST, V128, P4588, DOI [10.1172/jci121960, 10.1172/JCI121960]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chang LY, 2017, J VIRAL HEPATITIS, V24, P389, DOI 10.1111/jvh.12659; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Corbett KS, 2019, MBIO, V10, DOI 10.1128/mBio.02810-18; DeZure AD, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0016-6; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Doi H, 2014, CLIN IMMUNOL, V150, P184, DOI 10.1016/j.clim.2013.12.001; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han BK, 2016, SEMIN ARTHRITIS RHEU, V45, P496, DOI 10.1016/j.semarthrit.2015.08.001; Henry C, 2018, TRENDS IMMUNOL, V39, P70, DOI 10.1016/j.it.2017.08.003; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Kardava L, 2014, J CLIN INVEST, V124, P3252, DOI 10.1172/JCI74351; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Knox JJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92943; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laserson U, 2014, P NATL ACAD SCI USA, V111, P4928, DOI 10.1073/pnas.1323862111; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li HF, 2016, J IMMUNOL, V196, P4064, DOI 10.4049/jimmunol.1501027; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Lindeman I, 2018, NAT METHODS, V15, P563, DOI 10.1038/s41592-018-0082-3; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Matsuda K, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau2710; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Nachbagauer R, 2018, CURR OPIN IMMUNOL, V53, P51, DOI 10.1016/j.coi.2018.04.001; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Oliviero B, 2015, J VIRAL HEPATITIS, V22, P391, DOI 10.1111/jvh.12336; Phalke S, 2018, CURR OPIN IMMUNOL, V55, P75, DOI 10.1016/j.coi.2018.09.007; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Poonia B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33719-x; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Raymond DD, 2018, P NATL ACAD SCI USA, V115, P168, DOI 10.1073/pnas.1715471115; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Salimzadeh L, 2018, J CLIN INVEST, V128, P4573, DOI [10.1172/JCI121957, 10.1172/jci121957]; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Stamper K, 2018, TLS-TIMES LIT SUPPL, P10; Su S, 2017, TRENDS MICROBIOL, V25, P713, DOI 10.1016/j.tim.2017.06.008; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Teros-Jaakkola T, 2017, J MICROBIOL IMMUNOL; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu NC, 2017, J MOL BIOL, V429, P2694, DOI 10.1016/j.jmb.2017.06.015; Wu YCB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00081; Yassine HM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26538-7	75	53	55	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					398	+		10.1016/j.immuni.2019.06.024	http://dx.doi.org/10.1016/j.immuni.2019.06.024			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31350180	Bronze			2022-12-18	WOS:000482088500020
J	Zhang, LJ; Chen, SX; Guerrero-Juarez, CF; Li, FW; Tong, Y; Liang, YQ; Liggins, M; Chen, X; Chen, H; Li, M; Hata, T; Zheng, Y; Plikus, MV; Gallo, RL				Zhang, Ling-juan; Chen, Stella Xiang; Guerrero-Juarez, Christian F.; Li, Fengwu; Tong, Yun; Liang, Yuqiong; Liggins, Marc; Chen, Xu; Chen, Hao; Li, Min; Hata, Tissa; Zheng, Ye; Plikus, Maksim, V; Gallo, Richard L.			Age-Related Loss of Innate Immune Antimicrobial Function of Dermal Fat Is Mediated by Transforming Growth Factor Beta	IMMUNITY			English	Article							STAPHYLOCOCCUS-AUREUS; CELLS; DIFFERENTIATION; RECRUITMENT; INHIBITOR; FIBROSIS; PROTECT; MYD88	Dermal fibroblasts (dFBs) resist infection by locally differentiating into adipocytes and producing cathelicidin antimicrobial peptide in response to Staphylococcus aureus (S. aureus). Here, we show that neonatal skin was enriched with adipogenic dFBs and immature dermal fat that highly expressed cathelicidin. The pool of adipogenic and antimicrobial dFBs declined after birth, leading to an age-dependent loss of dermal fat and a decrease in adipogenesis and cathelidicin production in response to infection. Transforming growth factor beta (TGF-beta), which acted on uncommitted embryonic and adult dFBs and inhibited their adipogenic and antimicrobial function, was identified as a key upstream regulator of this process. Furthermore, inhibition of the TGF-beta receptor restored the adipogenic and antimicrobial function of dFBs in culture and increased resistance of adult mice to S. aureus infection. These results provide insight into changes that occur in the skin innate immune system between the perinatal and adult periods of life.	[Zhang, Ling-juan] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Zhang, Ling-juan; Chen, Stella Xiang; Li, Fengwu; Tong, Yun; Liggins, Marc; Hata, Tissa; Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92093 USA; [Guerrero-Juarez, Christian F.; Plikus, Maksim, V] Univ Calif Irvine, Dept Dev & Cell Biol, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Guerrero-Juarez, Christian F.; Plikus, Maksim, V] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Chen, Xu; Chen, Hao; Li, Min] Chinese Acad Med Sci, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Inst Dermatol, Nanjing 210042, Jiangsu, Peoples R China; [Chen, Xu; Chen, Hao; Li, Min] Peking Union Med Coll, Nanjing 210042, Jiangsu, Peoples R China; [Liang, Yuqiong; Zheng, Ye] Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, La Jolla, CA 92037 USA	Xiamen University; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Salk Institute	Zhang, LJ (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China.; Zhang, LJ; Gallo, RL (corresponding author), Univ Calif San Diego, Dept Dermatol, San Diego, CA 92093 USA.	lingjuan.zhang@xmu.edu.cn; rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009; Zhang, Lingjuan/K-3080-2017; Zhang, Ling-juan/V-6141-2019	Gallo, Richard L/0000-0002-1401-7861; Zhang, Lingjuan/0000-0001-6937-4578; Zhang, Ling-juan/0000-0001-6937-4578; Plikus, Maksim/0000-0002-8845-2559; Tong, Yun/0000-0003-2003-1843	NIH [R01-AI107027, R01-AR069653, R01-AI083358, R01-AR052728, U19-AI117673, U01-AR073159, R01-AR067273]; Pew Charitable Trust; National Science Foundation (NSF) [DMS1763272]; Simons Foundation [594598]; NSF-GRFP [DGE-1321846]; MBRS-IMSD training grant [GM055246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117673, R01AI107027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trust; National Science Foundation (NSF)(National Science Foundation (NSF)); Simons Foundation; NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); MBRS-IMSD training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant R01-AR069653 to L.Z. and R.L.G. and NIH grants R01-AI083358, R01-AR052728, and U19-AI117673 to R.L.G. M.V.P. is supported by a Pew Charitable Trust grant, NIH grants U01-AR073159 and R01-AR067273, National Science Foundation (NSF) grant DMS1763272, and Simons Foundation grant 594598 (to Qing Nie). C.F.G.J. is supported by NSF-GRFP grant DGE-1321846 and MBRS-IMSD training grant GM055246. Y.Z. is supported by NIH grant R01-AI107027. We thank the flow-cytometry core at the University of California, San Diego, for flow-cytometry studies and Prof. Pier Lorenzo Puri for comments on the manuscript.	Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Chia JJ, 2016, J CLIN INVEST, V126, P4331, DOI 10.1172/JCI85740; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Dillen CA, 2018, J CLIN INVEST, V128, P1026, DOI 10.1172/JCI96481; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; El Agha E, 2017, CELL STEM CELL, V20, P571, DOI 10.1016/j.stem.2017.03.011; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Feuerstein R, 2015, J IMMUNOL, V194, P2735, DOI 10.4049/jimmunol.1402566; Futata EA, 2012, EXPERT REV ANTI-INFE, V10, P289, DOI [10.1586/eri.12.9, 10.1586/ERI.12.9]; Georgountzou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00957; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hibino T, 2004, J DERMATOL SCI, V35, P9, DOI 10.1016/j.jdermsci.2003.12.003; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; KIRKLAND JL, 1993, BIOCHEM CELL BIOL, V71, P556, DOI 10.1139/o93-079; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Markell LM, 2010, CARCINOGENESIS, V31, P2127, DOI 10.1093/carcin/bgq191; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Philippeos C, 2018, J INVEST DERMATOL, V138, P811, DOI 10.1016/j.jid.2018.01.016; Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792; Rivera-Gonzalez GC, 2016, CELL STEM CELL, V19, P738, DOI 10.1016/j.stem.2016.09.002; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Soma T, 2002, J INVEST DERMATOL, V118, P993, DOI 10.1046/j.1523-1747.2002.01746.x; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tabib T, 2018, J INVEST DERMATOL, V138, P802, DOI 10.1016/j.jid.2017.09.045; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972; Zwick RK, 2018, CELL METAB, V27, P68, DOI 10.1016/j.cmet.2017.12.002	32	53	58	17	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					121	+		10.1016/j.immuni.2018.11.003	http://dx.doi.org/10.1016/j.immuni.2018.11.003			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30594464	Bronze, Green Accepted			2022-12-18	WOS:000455661600015
J	Sanin, DE; Matsushita, M; Geltink, RIK; Grzes, KM; Bakker, NV; Corrado, M; Kabat, AM; Buck, MD; Qiu, J; Lawless, SJ; Cameron, AM; Villa, M; Baixauli, F; Patterson, AE; Hassler, F; Curtis, JD; O'Neill, CM; O'Sullivan, D; Wu, DJ; Mittler, G; Huang, SCC; Pearce, EL; Pearce, EJ				Sanin, David E.; Matsushita, Mai; Geltink, Ramon I. Klein; Grzes, Katarzyna M.; Bakker, Nikki van Teijlingen; Corrado, Mauro; Kabat, Agnieszka M.; Buck, Michael D.; Qiu, Jing; Lawless, Simon J.; Cameron, Alanna M.; Villa, Matteo; Baixauli, Francesc; Patterson, Annette E.; Haessler, Fabian; Curtis, Jonathan D.; O'Neill, Christina M.; O'Sullivan, David; Wu, Duojiao; Mittler, Gerhard; Huang, Stanley Ching-Cheng; Pearce, Erika L.; Pearce, Edward J.			Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2	IMMUNITY			English	Article							ALTERNATIVE ACTIVATION; READ ALIGNMENT; CELL; REVEALS; IDENTIFICATION; ENRICHMENT	Metabolic engagement is intrinsic to immune cell function. Prostaglandin E2 (PGE2) has been shown to modulate macrophage activation, yet how PGE2 might affect metabolism is unclear. Here, we show that PGE2 caused mitochondrial membrane potential (Delta psi(m)) to dissipate in interleukin-4-activated (M(IL-4)) macrophages. Effects on Delta psi(m) were a consequence of PGE2-initiated transcriptional regulation of genes, particularly Got1, in the malateaspartate shuttle (MAS). Reduced Delta psi(m) caused alterations in the expression of 126 voltage-regulated genes (VRGs), including those encoding resistin-like molecule a (RELM alpha), a key marker of M(IL-4) cells, and genes that regulate the cell cycle. The transcription factor ETS variant 1 (ETV1) played a role in the regulation of 38% of the VRGs. These results reveal ETV1 as a Delta psi(m)-sensitive transcription factor and Delta psi(m) as amediator of mitochondrial-directed nuclear gene expression.	[Sanin, David E.; Matsushita, Mai; Geltink, Ramon I. Klein; Grzes, Katarzyna M.; Bakker, Nikki van Teijlingen; Corrado, Mauro; Kabat, Agnieszka M.; Buck, Michael D.; Qiu, Jing; Lawless, Simon J.; Cameron, Alanna M.; Villa, Matteo; Baixauli, Francesc; Patterson, Annette E.; Haessler, Fabian; Curtis, Jonathan D.; O'Sullivan, David; Pearce, Erika L.; Pearce, Edward J.] Max Planck Inst Epigenet & Immunobiol, Dept Immunometab, Freiburg, Germany; [O'Neill, Christina M.; Huang, Stanley Ching-Cheng] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Wu, Duojiao] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Mittler, Gerhard] Max Planck Inst Immunobiol & Epigenet, Prote, Freiburg, Germany; [Bakker, Nikki van Teijlingen; Pearce, Edward J.] Univ Freiburg, Fac Biol, Freiburg, Germany; [Buck, Michael D.] Francis Crick Inst, London, England; [Qiu, Jing] Pfizer Inc, San Diego, CA USA; [Huang, Stanley Ching-Cheng] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Washington University (WUSTL); Fudan University; Max Planck Society; University of Freiburg; Francis Crick Institute; Pfizer; Case Western Reserve University	Pearce, EJ (corresponding author), Max Planck Inst Epigenet & Immunobiol, Dept Immunometab, Freiburg, Germany.; Pearce, EJ (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.	pearceed@ie-freiburg.mpg.de	Huang, Stanley Ching-Cheng/AAE-7866-2019; Sanin, David E/CAA-0391-2022; Sanin, David E/CAA-0373-2022; Baixauli, Francesc/L-4957-2016	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267; Matsushita, Mai/0000-0001-5693-461X; Klein Geltink, Ramon/0000-0003-4610-3059; Villa, Matteo/0000-0003-2684-0596; Buck, Michael/0000-0002-9611-1199; Baixauli, Francesc/0000-0002-9676-2901	NIH [AI110481, CA18125]; Max Planck Society; Swiss National Science Foundation; Alexander von Humboldt Fellowship Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alexander von Humboldt Fellowship Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Pearce laboratories and Drs. Angelika Rambold, Anne Rensing-Ehl, Devon Ryan, Senthilkumar Ramamoorthy, and Barbara Hummel for invaluable advice and assistance and the UCLA Metabolomics Centre, the Electron Microscopy Laboratory at the University of Padova, and the Metabolomics, Imaging, and Deep Sequencing facilities at the Max Planck Institute of Immunobiology and Epigenetics for technical support. We acknowledge the transcriptional analysis that Dr. Max Artyomov performed on the early stages of the study. This work was funded by the NIH (AI110481 to E.J.P. and CA18125 to E.L.P.) and the Max Planck Society. M.M. is supported by the Swiss National Science Foundation, and A.M.K., M.C., and F.B. are supported by the Alexander von Humboldt Fellowship Foundation.7	Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Basingab FS, 2016, CANCER IMMUNOL RES, V4, P400, DOI 10.1158/2326-6066.CIR-15-0146; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gottlieb RA, 2016, CELL CALCIUM, V60, P88, DOI 10.1016/j.ceca.2016.04.006; Harada M, 2017, INT HEART J, V58, P3, DOI 10.1536/ihj.16-614; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Iwahashi H, 2000, J IMMUNOL, V164, P5403, DOI 10.4049/jimmunol.164.10.5403; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jiang HL, 2016, CANCER RES, V76, P952, DOI 10.1158/0008-5472.CAN-15-1630; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Miyoshi H, 2017, EMBO J, V36, P5, DOI 10.15252/embj.201694660; Musa YR, 2018, J PROTEOME RES, V17, P76, DOI 10.1021/acs.jproteome.7b00369; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tan K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7580; Tang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04100-1; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Woyda-Ploszczyca AM, 2017, BBA-BIOENERGETICS, V1858, P21, DOI 10.1016/j.bbabio.2016.10.003; Xu T, 2017, NATURE, V548, P228, DOI 10.1038/nature23475; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	58	53	53	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1021	+		10.1016/j.immuni.2018.10.011	http://dx.doi.org/10.1016/j.immuni.2018.10.011			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566880	Green Accepted, Bronze			2022-12-18	WOS:000453556500009
J	Guo, XZJ; Dash, P; Crawford, JC; Allen, EK; Zamora, AE; Boyd, DF; Duan, SS; Bajracharya, R; Awad, WA; Apiwattanakul, N; Vogel, P; Kanneganti, TD; Thomas, PG				Guo, Xi-zhi J.; Dash, Pradyot; Crawford, Jeremy Chase; Allen, E. Kaitlynn; Zamora, Anthony E.; Boyd, David F.; Duan, Susu; Bajracharya, Resha; Awad, Walid A.; Apiwattanakul, Nopporn; Vogel, Peter; Kanneganti, Thirumala-Devi; Thomas, Paul G.			Lung gamma delta T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity	IMMUNITY			English	Article							VIRUS-INFECTION; INTERFERON-GAMMA; IL-17; INFLAMMATION; HOMEOSTASIS; ACTIVATION; PLASTICITY; PROMOTES; SYSTEM; RATHER	Compared to adults, infants suffer higher rates of hospitalization, severe clinical complications, and mortality due to influenza infection. We found that gamma delta T cells protected neonatal mice against mortality during influenza infection. gamma delta T cell deficiency did not alter viral clearance or interferon-gamma production. Instead, neonatal influenza infection induced the accumulation of interleukin-17A (IL-17A)-producing gamma delta T cells, which was associated with IL-33 production by lung epithelial cells. Neonates lacking IL-17A-expressing gamma delta T cells or Il33 had higher mortality upon influenza infection. gamma delta T cells and IL-33 promoted lung infiltration of group 2 innate lymphoid cells and regulatory T cells, resulting in increased amphiregulin secretion and tissue repair. In influenza-infected children, IL-17A, IL-33, and amphiregulin expression were correlated, and increased IL-17A levels in nasal aspirates were associated with better clinical outcomes. Our results indicate that gamma delta T cells are required in influenza-infected neonates to initiate protective immunity and mediate lung homeostasis.	[Guo, Xi-zhi J.; Dash, Pradyot; Crawford, Jeremy Chase; Allen, E. Kaitlynn; Zamora, Anthony E.; Boyd, David F.; Duan, Susu; Bajracharya, Resha; Awad, Walid A.; Kanneganti, Thirumala-Devi; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Guo, Xi-zhi J.; Thomas, Paul G.] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA; [Apiwattanakul, Nopporn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Infect Dis,Dept Pediat, Bangkok 10400, Thailand; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Mahidol University; St Jude Children's Research Hospital	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Thomas, PG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA.	paul.thomas@stjude.org	Crawford, Jeremy Chase/G-5711-2013; Guo, Xizhi/T-9360-2019; Kanneganti, Thirumala-Devi/Y-2503-2019; Apiwattanakul, Nopporn/AAF-3288-2022; Vogel, Peter/N-2490-2018; Zamora, Anthony E./O-2836-2017; Apiwattanakul, Nopporn/AFH-8488-2022; Thomas, Paul G./H-1063-2018	Crawford, Jeremy Chase/0000-0003-4096-6048; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Zamora, Anthony E./0000-0001-5712-5339; Thomas, Paul G./0000-0001-7955-0256	NIH [R01 AI121832]; Hartwell Foundation Individual Biomedical Research Award; St. Jude Center of Excellence for Influenza Research and Surveillance [HHSN272201400006C]; ALSAC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121832] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation Individual Biomedical Research Award; St. Jude Center of Excellence for Influenza Research and Surveillance; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the St. Jude Children's Research Hospital Animal Resource Center's staff for their support and excellent animal care. We thank Drs. Greig Lennon and Richard Cross in the Department of Immunology Flow Cytometry Core Facility at St. Jude for cell sorting. We thank Dr. Stephania Cormier for helpful discussions and instruction in neonatal infections. This work was supported by NIH grant R01 AI121832, The Hartwell Foundation Individual Biomedical Research Award, St. Jude Center of Excellence for Influenza Research and Surveillance HHSN272201400006C, and ALSAC (to P.G.T.).	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Cicin-Sain L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002849; CLARKSON DB, 1993, ACM T MATH SOFTWARE, V19, P484, DOI 10.1145/168173.168412; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Dash P., 2014, INFLUENZA PATHOG CON, VII, P121; Dash P, 2015, METHODS MOL BIOL, V1343, P181, DOI 10.1007/978-1-4939-2963-4_15; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Duan S, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00025; Duan SS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004642; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Garcia AM, 2000, IMMUNOL RES, V22, P177, DOI 10.1385/IR:22:2-3:177; Gorski SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003615; Guo XZJ, 2017, SEMIN IMMUNOPATHOL, V39, P541, DOI 10.1007/s00281-017-0636-y; Guo XZJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.54; Hall OJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005840; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; HOLM S, 1979, SCAND J STAT, V6, P65; Huang HQ, 2015, IMMUNOL CELL BIOL, V93, P126, DOI 10.1038/icb.2014.79; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kashani E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7477; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; La Gruta NL, 2014, TRENDS IMMUNOL, V35, P396, DOI 10.1016/j.it.2014.06.004; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mamedov MR, 2018, IMMUNITY, V48, P350, DOI 10.1016/j.immuni.2018.01.009; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Munoz Flor M, 2003, Paediatr Respir Rev, V4, P99, DOI 10.1016/S1526-0542(03)00027-7; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Pan B, 2015, SCI REP-UK, V5, DOI 10.1038/srep16053; Papotto PH, 2017, NAT IMMUNOL, V18, P604, DOI 10.1038/ni.3726; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Romagnoli PA, 2016, P NATL ACAD SCI USA, V113, P8502, DOI 10.1073/pnas.1600713113; Rosenberger CM, 2014, J GEN VIROL, V95, P350, DOI 10.1099/vir.0.058438-0; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Sriperumbudur A, 2017, J CELL COMMUN SIGNAL, V11, P95, DOI 10.1007/s12079-016-0365-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Venables W.N., 2002, MODERN APPL STAT S, V4th; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wang XH, 2011, CELL MOL IMMUNOL, V8, P462, DOI 10.1038/cmi.2011.38; Weitkamp JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099042, 10.1371/journal.pone.0105487]; You DH, 2008, J IMMUNOL, V181, P3486, DOI 10.4049/jimmunol.181.5.3486; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020	72	53	57	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					531	+		10.1016/j.immuni.2018.07.011	http://dx.doi.org/10.1016/j.immuni.2018.07.011			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30170813	Bronze, Green Accepted			2022-12-18	WOS:000444909600019
J	Chisolm, DA; Savic, D; Moore, AJ; Ballesteros-Tato, A; Leon, B; Crossman, DK; Murre, C; Myers, RM; Weinmann, AS				Chisolm, Danielle A.; Savic, Daniel; Moore, Amanda J.; Ballesteros-Tato, Andre; Leon, Beatriz; Crossman, David K.; Murre, Cornelis; Myers, Richard M.; Weinmann, Amy S.			CCCTC-Binding Factor Translates Interleukin 2-and alpha-Ketoglutarate-Sensitive Metabolic Changes in T Cells into Context-Dependent Gene Programs	IMMUNITY			English	Article							EMBRYONIC STEM-CELLS; EFFECTOR RESPONSES; SELF-RENEWAL; HUMAN GENOME; DIFFERENTIATION; ACTIVATION; EXPRESSION; MEMORY; DNA; MICROENVIRONMENT	Despite considerable research connecting cellular metabolism with differentiation decisions, the underlying mechanisms that translate metabolite-sensitive activities into unique gene programs are still unclear. We found that aspects of the interleukin-2 (IL-2)-sensitive effector gene program in CD4(+) and CD8(+) T cells in type 1 conditions (Th1) were regulated by glutamine and alpha-ketoglutarate (alpha KG)-induced events, in part through changes in DNA and histone methylation states. We further identified a mechanism by which IL-2- and alpha KG-sensitive metabolic changes regulated the association of CCCTC-binding factor (CTCF) with select genomic sites. alpha KG-sensitive CTCF sites were often associated with loci containing IL-2- and alpha KG-sensitive genome organization patterns and gene expression in T cells. IL-2-and alpha KG-sensitive CTCF sites in T cells were also associated with genes from developmental pathways that had alpha KG-sensitive expression in embryonic stem cells. The data collectively support a mechanism wherein CTCF serves to translate alpha KG-sensitive metabolic changes into context-dependent differentiation gene programs.	[Crossman, David K.; Myers, Richard M.; Weinmann, Amy S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Crossman, David K.; Murre, Cornelis; Myers, Richard M.; Weinmann, Amy S.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Moore, Amanda J.; Ballesteros-Tato, Andre; Crossman, David K.; Weinmann, Amy S.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Crossman, David K.; Murre, Cornelis] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Moore, Amanda J.; Crossman, David K.; Murre, Cornelis] Univ Alabama Birmingham, Heflin Ctr Genom Sci, Birmingham, AL 35294 USA; [Moore, Amanda J.; Myers, Richard M.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	University of Alabama System; University of Alabama Birmingham; HudsonAlpha Institute for Biotechnology; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Weinmann, AS (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	weinmann@uab.edu	Savic, Daniel/N-5525-2018	Savic, Daniel/0000-0002-6693-0265; Ballesteros-Tato, Andre/0000-0002-4833-593X	National Institutes of Health [AI061061, AI113026, AI110480, AI116584, AI00880, AI09599, DK242301, AI102853]; Comprehensive Minority Faculty and Student Development Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102853, R56AI061061, R01AI100880, Z01AI000880, R01AI110480, R21AI113026, R01AI061061, R01AI116584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Minority Faculty and Student Development Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Wayne Cheng and members of the Weinmann lab, as well as Kimberly Newberry and Sarah Meadows from the Myers lab, for key technical assistance and helpful discussions. We thank the National Institutes of Health (AI061061 and AI113026 to A.S.W.; AI110480 to A.B.-T.; AI116584 to B.L.; AI00880, AI09599, DK242301, and AI102853 to C.M.) and the Comprehensive Minority Faculty and Student Development Program (D.A.C.) for funding. IL-2 was provided by the NCI preclinical repository.	Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bonora G, 2014, CURR OPIN GENET DEV, V27, P92, DOI 10.1016/j.gde.2014.05.002; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chisolm DA, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00292; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Fang R., 2015, NAT REV IMMUNOL, V11, P109; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Johnson MO, 2016, SEMIN IMMUNOL, V28, P505, DOI 10.1016/j.smim.2016.09.003; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Ryall JG, 2015, CELL STEM CELL, V17, P651, DOI 10.1016/j.stem.2015.11.012; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teif VB, 2014, GENOME RES, V24, P1285, DOI 10.1101/gr.164418.113; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	53	53	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					251	+		10.1016/j.immuni.2017.07.015	http://dx.doi.org/10.1016/j.immuni.2017.07.015			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813658	Bronze, Green Accepted			2022-12-18	WOS:000407788300012
J	Kawamura, S; Onai, N; Miya, F; Sato, T; Tsunoda, T; Kurabayashi, K; Yotsumoto, S; Kuroda, S; Takenaka, K; Akashi, K; Ohteki, T				Kawamura, Shunsuke; Onai, Nobuyuki; Miya, Fuyuki; Sato, Taku; Tsunoda, Tatsuhiko; Kurabayashi, Kazutaka; Yotsumoto, Satoshi; Kuroda, Shoko; Takenaka, Katsuto; Akashi, Koichi; Ohteki, Toshiaki			Identification of a Human Clonogenic Progenitor with Strict Monocyte Differentiation Potential: A Counterpart of Mouse cMoPs	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; MYELOID PROGENITOR; MACROPHAGES; TISSUE; LINEAGE; BLOOD; RISE; NOMENCLATURE; POPULATION; RECEPTORS	Monocytes give rise to macrophages and dendritic cells (DCs) under steady-state and inflammatory conditions, thereby contributing to host defense and tissue pathology. A common monocyte progenitor (cMoP) that is strictly committed to the monocyte lineage has been recently identified in mice. Here, we identified human cMoPs as a CLEC12A(hi)CD64(hi) subpopulation of conventional granulocyte-monocyte progenitors (cGMPs) in umbilical cord blood and in bone marrow. Human cMoPs gave rise to monocyte subsets without showing any potential for differentiating into myeloid or lymphoid cells. Within the cGMP population, we also identified revised GMPs that completely lacked DC and lymphoid potential. Collectively, our findings expand and revise the current understanding of human myeloid cell differentiation pathways.	[Kawamura, Shunsuke; Onai, Nobuyuki; Sato, Taku; Kurabayashi, Kazutaka; Yotsumoto, Satoshi; Kuroda, Shoko; Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan; [Kawamura, Shunsuke] Japan Soc Promot Sci, Tokyo 1020083, Japan; [Sato, Taku] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo 1138510, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Lab Med Sci Math, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Takenaka, Katsuto; Akashi, Koichi] Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Takenaka, Katsuto] Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8128582, Japan	Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); RIKEN; Kyushu University; Kyushu University	Ohteki, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan.	ohteki.bre@mri.tmd.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Onai, Nobuyuki/0000-0003-2246-4917; Kawamura, Shunsuke/0000-0001-6267-9926; Miya, Fuyuki/0000-0001-6758-2015	Uehara Memorial Foundation; SECOM Science and Technology Foundation; Ministry of Education, Science, Sports and Culture of Japan [24590576, 26253029, 15K15150];  [6043]; Grants-in-Aid for Scientific Research [16K07211, 15H04717] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); SECOM Science and Technology Foundation; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Kamioka for secretarial support, H. Kawamoto (Kyoto University) for the D114<SUP>+</SUP> Tst4 stromal cells, K. Sugimoto (Niigata University) and N. Kiyokawa (National Center for Child Health and Development) for the MS5 stromal cells, the Japanese Red Cross Kanto-Koshinetsu Cord Blood Bank (Tokyo) for umbilical-cord blood, and Kyowa Hakko Kirin for human recombinant thrombopoietin. This work was supported by the Uehara Memorial Foundation (T.O.), the SECOM Science and Technology Foundation (T.O.), a Grant-in Aid for JSPS Fellows (6043, S. Kawamura), and a Grant-in-Aid for Scientific Research and a Grant-in-Aid for Exploratory Research from the Ministry of Education, Science, Sports and Culture of Japan (24590576 to N.O. and 26253029 and 15K15150 to T.O.).	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Chicha L, 2004, J EXP MED, V200, P1519, DOI 10.1084/jem.20040809; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; ITOH K, 1989, EXP HEMATOL, V17, P145; Kato M, 2008, EUR J HAEMATOL, V80, P151, DOI 10.1111/j.1600-0609.2007.00991.x; Lahoud MH, 2009, J IMMUNOL, V182, P7587, DOI 10.4049/jimmunol.0900464; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; OLWEUS J, 1995, BLOOD, V85, P2402, DOI 10.1182/blood.V85.9.2402.bloodjournal8592402; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Stec M, 2012, ANTICANCER RES, V32, P4749; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	50	53	53	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					835	+		10.1016/j.immuni.2017.04.019	http://dx.doi.org/10.1016/j.immuni.2017.04.019			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514689	Bronze			2022-12-18	WOS:000401316300018
J	Dias, S; D'Amico, A; Cretney, E; Liao, Y; Tellier, J; Bruggeman, C; Almeida, FF; Leahy, J; Belz, GT; Smyth, GK; Shi, W; Nutt, SL				Dias, Sheila; D'Amico, Angela; Cretney, Erika; Liao, Yang; Tellier, Julie; Bruggeman, Christine; Almeida, Francisca F.; Leahy, Jamie; Belz, Gabrielle T.; Smyth, Gordon K.; Shi, Wei; Nutt, Stephen L.			Effector Regulatory T Cell Differentiation and Immune Homeostasis Depend on the Transcription Factor Myb	IMMUNITY			English	Article							FACTOR C-MYB; INFLAMMATION; FOXP3; DISTINCT; GATA-3; REQUIREMENT; EXPRESSION; THYMOCYTES; TOLERANCE; RESPONSES	FoxP3-expressing regulatory T (Treg) cells are essential for maintaining immune homeostasis. Activated Treg cells undergo further differentiation into an effector state that highly expresses genes critical for Treg cell function, although how this process is coordinated on a transcriptional level is poorly understood. Here, we demonstrate that mice lacking the transcription factor Myb in Treg cells succumbed to a multi-organ inflammatory disease. Myb was specifically expressed in, and required for the differentiation of, thymus-derived effector Treg cells. The combination of transcriptome and genomic footprint analyses revealed that Myb directly regulated a large proportion of the gene expression specific to effector Treg cells, identifying Myb as a critical component of the gene regulatory network controlling effector Treg cell differentiation and function.	[Dias, Sheila; D'Amico, Angela; Cretney, Erika; Liao, Yang; Tellier, Julie; Bruggeman, Christine; Almeida, Francisca F.; Leahy, Jamie; Belz, Gabrielle T.; Smyth, Gordon K.; Shi, Wei; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Dias, Sheila; Cretney, Erika; Liao, Yang; Tellier, Julie; Almeida, Francisca F.; Belz, Gabrielle T.; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3010, Australia; [Bruggeman, Christine] Sanquin Res, Dept Blood Cell Res, NL-1006 AN Amsterdam, Netherlands	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne	Nutt, SL (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.; Nutt, SL (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	nutt@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Belz, Gabrielle T/C-9350-2013	Nutt, Stephen L/0000-0002-0020-6637; Belz, Gabrielle T/0000-0002-9660-9587; Tellier, Julie/0000-0003-2787-8174; F. de Almeida, Francisca/0000-0001-6632-7610; , Yang/0000-0002-9746-2839	Australian National Health and Medical Research Council (NHMRC) [1054618, 1047313, 637325]; Commonwealth Serum Laboratories Centenary Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Serum Laboratories Centenary Fellowship	We thank Jon Frampton (University of Birmingham) and Alexander Rudensky (Memorial Sloan Kettering Cancer Center) for mouse strains, John Stamatoyannopoulos and Richard Sandstrom (University of Washington) for assistance with the Treg cell DHS dataset, Jason Corby and Stephen Wilcox for technical assistance, Kylie Grieg for assistance in developing the Myb GFP strain, and Axel Kallies, Michael Chopin, Ajithkumar Vasanthakumar, and Daniel Gray for helpful comments on the manuscript. This project was supported by the Australian National Health and Medical Research Council (NHMRC) through program (1054618 to G.T.B. and S.L.N.) and project (1047313 to E.C. and 637325 to S.L.N.) grants and fellowships (to G.K.S. and S.L.N.). W.S. was supported by a Commonwealth Serum Laboratories Centenary Fellowship. This work was made possible through Victorian State Government Operational Infrastructure Support and the NHMRC Independent Research Institute Infrastructure Support Scheme (9000364).	Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bengtsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133280; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; BICHTHUY LT, 1987, J IMMUNOL, V139, P1550; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Greig KT, 2008, SEMIN IMMUNOL, V20, P247, DOI 10.1016/j.smim.2008.05.003; Gustafsson M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2722; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Nakata Y, 2010, BLOOD, V116, P1280, DOI 10.1182/blood-2009-05-223255; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Yuan J, 2010, J IMMUNOL, V184, P2793, DOI 10.4049/jimmunol.0902846; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	42	53	53	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					78	91		10.1016/j.immuni.2016.12.017	http://dx.doi.org/10.1016/j.immuni.2016.12.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099866	Bronze			2022-12-18	WOS:000392918300012
J	Kristiansen, TA; Gyllenback, EJ; Zriwil, A; Bjorklund, T; Daniel, JA; Sitnicka, E; Soneji, S; Bryder, D; Yuan, J				Kristiansen, Trine A.; Gyllenback, Elin Jaensson; Zriwil, Alya; Bjorklund, Tomas; Daniel, Jeremy A.; Sitnicka, Ewa; Soneji, Shamit; Bryder, David; Yuan, Joan			Cellular Barcoding Links B-1a B Cell Potential to a Fetal Hematopoietic Stem Cell State at the Single-Cell Level	IMMUNITY			English	Article							BONE-MARROW; LINEAGE COMMITMENT; SELF-RENEWAL; DEVELOPMENTAL SWITCH; CLONAL ANALYSIS; HETEROGENEITY; PROGENITORS; DISTINCT; DIFFERENTIATION; IDENTIFICATION	Hematopoietic stem cells (HSCs) undergo a functional switch in neonatal mice hallmarked by a decrease in self-renewing divisions and entry into quiescence. Here, we investigated whether the developmental attenuation of B-1a cell output is a consequence of a shift in stem cell state during ontogeny. Using cellular barcoding for in vivo single-cell fate analyses, we found that fetal liver definitive HSCs gave rise to both B-1a and B-2 cells. Whereas B-1a potential diminished in all HSCs with time, B-2 output was maintained. B-1a and B-2 plasticity could be reinitiated in a subset of adult HSCs by ectopic expression of the RNA binding protein LIN28B, a key regulator of fetal hematopoiesis, and this coincided with the clonal reversal to fetal-like elevated self-renewal and repopulation potential. These results anchor the attenuation of B-1a cell output to fetal HSC behavior and demonstrate that the developmental decline in regenerative potential represents a reversible HSC state.	[Kristiansen, Trine A.; Gyllenback, Elin Jaensson; Zriwil, Alya; Sitnicka, Ewa; Soneji, Shamit; Bryder, David; Yuan, Joan] Lund Univ, Div Mol Hematol, Dept Lab Med, Fac Med,Lund Stem Cell Ctr, S-22242 Lund, Sweden; [Bjorklund, Tomas] Lund Univ, Dept Expt Med Sci, Mol Neuromodulat, Fac Med, S-22242 Lund, Sweden; [Daniel, Jeremy A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Chromatin Struct & Funct Grp,Ctr Prot Res, DK-2200 Copenhagen, Denmark	Lund University; Lund University; Novo Nordisk Foundation; University of Copenhagen	Yuan, J (corresponding author), Lund Univ, Div Mol Hematol, Dept Lab Med, Fac Med,Lund Stem Cell Ctr, S-22242 Lund, Sweden.	joan.yuan@med.lu.se	Daniel, Jeremy/S-4729-2016; Bryder, David/Q-6292-2019; Bjorklund, Tomas/S-7034-2019; yuan, joan/A-8185-2013	Daniel, Jeremy/0000-0002-1981-5571; Bjorklund, Tomas/0000-0001-7968-0034; yuan, joan/0000-0001-9129-8356; Bryder, David/0000-0002-8761-4237	Swedish Cancer Foundation; Swedish Research Council; StemTherapy; Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation [NNF14CC0001]	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); StemTherapy; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	J.Y. is supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, StemTherapy, and The Knut and Alice Wallenberg Foundation. We thank the Ion Torrent group at National Genomics Infrastructure (SciLifeLab) in Uppsala, Sweden, for sequencing; Lund Stem Cell Center FACS Core Facility for expert assistance; Rong Lu for providing us with the barcoding library; George Q. Daley for the tet-Lin28b mouse model, John F. Kearney for reagents used in the S. pneumoniae challenge, and Jenny Hansson, Stefan Muljo, Charlotta Boiers, Stijn Vanhee, and Shalin Naik for discussions and critical reading of the manuscript. E.J.G. is supported by a grant from the Swedish Cancer Foundation. J.A.D. is supported by the Novo Nordisk Foundation (NNF14CC0001).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Barber CL, 2011, P NATL ACAD SCI USA, V108, P13700, DOI 10.1073/pnas.1107172108; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; BRILES DE, 1982, J EXP MED, V156, P1177, DOI 10.1084/jem.156.4.1177; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Ghosn EEB, 2016, STEM CELL REP, V6, P137, DOI 10.1016/j.stemcr.2015.11.011; Ghosn EEB, 2015, ANN NY ACAD SCI, V1362, P23, DOI 10.1111/nyas.12881; Ghosn EEB, 2012, P NATL ACAD SCI USA, V109, P5394, DOI 10.1073/pnas.1121632109; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; He SH, 2011, GENE DEV, V25, P1613, DOI 10.1101/gad.2052911; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; IKUTA K, 1991, J EXP MED, V174, P1279, DOI 10.1084/jem.174.5.1279; KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kobayashi M, 2014, P NATL ACAD SCI USA, V111, P12151, DOI 10.1073/pnas.1407370111; Lo Celso Cristina, 2007, J Vis Exp, P157, DOI 10.3791/157; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Naik SH, 2014, EXP HEMATOL, V42, P598, DOI 10.1016/j.exphem.2014.05.003; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Rajewsky K, 2015, ANN NY ACAD SCI, V1362, P6, DOI 10.1111/nyas.12767; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Yoshimoto M, 2015, ANN NY ACAD SCI, V1362, P16, DOI 10.1111/nyas.12612; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhou Y, 2015, J EXP MED, V212, P569, DOI 10.1084/jem.20141510; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zorita E, 2015, BIOINFORMATICS, V31, P1913, DOI 10.1093/bioinformatics/btv053	56	53	53	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					346	357		10.1016/j.immuni.2016.07.014	http://dx.doi.org/10.1016/j.immuni.2016.07.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533015	Bronze			2022-12-18	WOS:000382267300016
J	van den Boorn, JG; Jakobs, C; Hagen, C; Renn, M; Luiten, RM; Melief, CJM; Tuting, T; Garbi, N; Hartmann, G; Hornung, V				van den Boorn, Jasper G.; Jakobs, Christopher; Hagen, Christian; Renn, Marcel; Luiten, Rosalie M.; Melief, Cornelis J. M.; Tueting, Thomas; Garbi, Natalio; Hartmann, Gunther; Hornung, Veit			Inflammasome-Dependent Induction of Adaptive NK Cell Memory	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CONTACT HYPERSENSITIVITY; RESIDENT MACROPHAGES; DENDRITIC CELLS; T-CELLS; MONOBENZONE; ACTIVATION; SKIN; VITILIGO; IMMUNITY	Monobenzone is a pro-hapten that is exclusively metabolized by melanocytes, thereby haptenizing melanocyte-specific antigens, which results in cytotoxic autoimmunity specifically against pigmented cells. Studying monobenzone in a setting of contact hypersensitivity (CHS), we observed that monobenzone induced a long-lasting, melanocyte-specific immune response that was dependent on NK cells, yet fully intact in the absence of T-and B cells. Consistent with the concept of "memory NK cells," mono-benzone- induced NK cells resided in the liver and transfer of these cells conferred melanocyte-specific immunity to naive animals. Monobenzone-exposed skin displayed macrophage infiltration and cutaneous lymph nodes showed an inflammasome-dependent influx of macrophages with a tissue-resident phenotype, coinciding with local NK cell activation. Indeed, macrophage depletion or the absence of the NLRP3 inflammasome, the adaptor protein ASC or interleukin-18 (IL-18) abolished monobenzone CHS, thereby establishing a non-redundant role for the NLRP3 inflammasome as a critical proinflammatory checkpoint in the induction of hapten-dependent memory NK cells.	[van den Boorn, Jasper G.; Hagen, Christian; Renn, Marcel; Hartmann, Gunther] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Jakobs, Christopher; Hornung, Veit] Univ Hosp Bonn, Inst Mol Med, Bonn, Germany; [Luiten, Rosalie M.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [Luiten, Rosalie M.] Univ Amsterdam, Acad Med Ctr, Netherlands Inst Pigment Disorders, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Melief, Cornelis J. M.] ISA Pharmaceut, Leiden, Netherlands; [Tueting, Thomas] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Garbi, Natalio] Univ Hosp Bonn, Inst Expt Immunol, Bonn, Germany; [Hornung, Veit] Univ Munich, Gene Ctr, Munich, Germany; [Hornung, Veit] Univ Munich, Dept Biochem, Munich, Germany	University of Bonn; University of Bonn; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bonn; University of Bonn; University of Munich; University of Munich	van den Boorn, JG (corresponding author), Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany.; Hornung, V (corresponding author), Univ Hosp Bonn, Inst Mol Med, Bonn, Germany.; Hornung, V (corresponding author), Univ Munich, Gene Ctr, Munich, Germany.; Hornung, V (corresponding author), Univ Munich, Dept Biochem, Munich, Germany.	jvdboorn@uni-bonn.de; hornung@genzentrum.lmu.de	Luiten, Rosalie M/I-7633-2019; Hartmann, Gunther/P-7492-2017; Tüting, Thomas/AAJ-3610-2021; Hornung, Veit/C-3565-2012	Luiten, Rosalie M/0000-0002-0800-0721; Hartmann, Gunther/0000-0003-1021-2018; Tüting, Thomas/0000-0001-7146-0934; Hornung, Veit/0000-0002-4150-194X; Renn, Marcel/0000-0002-0120-4035	BONFOR Junior Research Group; German Research Foundation [SFB704]	BONFOR Junior Research Group; German Research Foundation(German Research Foundation (DFG))	We kindly thank Maximilian Rothe, Salvador Vento, and the flow cytometry core facility for great technical support. This work was supported by BONFOR Junior Research Group funding 2011-1-3 and 2012-1-2 to J.G.v.d.B. and grants from the German Research Foundation (SFB704) to V.H.T.T., G.H., and V.H. are members of the Excellence cluster ImmunoSensation. C.J.M.M. is employed as Chief Scientific Officer by ISA Pharmaceuticals and as such receives a salary. C.J.M.M. also has Stock Appreciation Rights in ISA Pharmaceuticals and is inventor of several patents and patent applications in the area of synthetic long peptide vaccines. These patents are owned by ISA Pharma or have been licensed to ISA by Leiden University Mecial Center. C.J.M.M. is also a member of the scientific advisory board of Immatics GmbH.	AlGhamdi KM, 2011, J EUR ACAD DERMATOL, V25, P749, DOI 10.1111/j.1468-3083.2010.03876.x; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; CATONA A, 1987, MED J AUSTRALIA, V146, P320, DOI 10.5694/j.1326-5377.1987.tb120272.x; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Ezzedine K, 2015, LANCET, V386, P74, DOI 10.1016/S0140-6736(14)60763-7; FORMAN L, 1953, BRIT J DERMATOL, V65, P406, DOI 10.1111/j.1365-2133.1953.tb13174.x; GAD SC, 1986, TOXICOL APPL PHARM, V84, P93, DOI 10.1016/0041-008X(86)90419-9; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Majewska-Szczepanik M, 2013, IMMUNOLOGY, V140, P98, DOI 10.1111/imm.12120; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; NORDLUND JJ, 1985, ARCH DERMATOL, V121, P1141, DOI 10.1001/archderm.121.9.1141; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; van den Boorn JG, 2011, PIGM CELL MELANOMA R, V24, P673, DOI 10.1111/j.1755-148X.2011.00878.x; van den Boorn JG, 2011, J INVEST DERMATOL, V131, P1240, DOI 10.1038/jid.2011.16; van den Boorn JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010626; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; Van Kaer L, 2015, EUR J IMMUNOL, V45, P1916, DOI 10.1002/eji.201545761; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Yu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051040; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225	43	53	53	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1406	1421		10.1016/j.immuni.2016.05.008	http://dx.doi.org/10.1016/j.immuni.2016.05.008			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27287410	Bronze			2022-12-18	WOS:000378341200018
J	Butt, D; Chan, TD; Bourne, K; Hermes, JR; Nguyen, A; Statham, A; O'Reilly, LA; Strasser, A; Price, S; Schofield, P; Christ, D; Basten, A; Ma, CS; Tangye, SG; Phan, TG; Rao, VK; Brink, R				Butt, Danyal; Chan, Tyani D.; Bourne, Katherine; Hermes, Jana R.; Nguyen, Akira; Statham, Aaron; O'Reilly, Lorraine A.; Strasser, Andreas; Price, Susan; Schofield, Peter; Christ, Daniel; Basten, Antony; Ma, Cindy S.; Tangye, Stuart G.; Tri Giang Phan; Rao, V. Koneti; Brink, Robert			FAS Inactivation Releases Unconventional Germinal Center B Cells that Escape Antigen Control and Drive IgE and Autoantibody Production	IMMUNITY			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELLS; GENE-MUTATIONS; IN-VIVO; LIGAND; APOPTOSIS; MICE; DISEASE; ELIMINATION	The mechanistic links between genetic variation and autoantibody production in autoimmune disease remain obscure. Autoimmune lymphoproliferative syndrome (ALPS) is caused by inactivating mutations in FAS or FASL, with autoantibodies thought to arise through failure of FAS-mediated removal of self-reactive germinal center (GC) B cells. Here we show that FAS is in fact not required for this process. Instead, FAS inactivation led to accumulation of a population of unconventional GC B cells that underwent somatic hypermutation, survived despite losing antigen reactivity, and differentiated into a large population of plasma cells that included autoantibody-secreting clones. IgE(+) plasma cell numbers, in particular, increased after FAS inactivation and a major cohort of ALPS-affected patients were found to have hyper-IgE. We propose that these previously unidentified cells, designated "rogue GC B cells,'' are a major driver of autoantibody production and provide a mechanistic explanation for the linked production of IgE and autoantibodies in autoimmune disease.	[Butt, Danyal; Chan, Tyani D.; Bourne, Katherine; Hermes, Jana R.; Nguyen, Akira; Statham, Aaron; Schofield, Peter; Christ, Daniel; Basten, Antony; Ma, Cindy S.; Tangye, Stuart G.; Tri Giang Phan; Brink, Robert] Garvan Inst Med Res, Div Immunol, Darlinghurst, NSW 2010, Australia; [Butt, Danyal; Chan, Tyani D.; Christ, Daniel; Basten, Antony; Ma, Cindy S.; Tangye, Stuart G.; Tri Giang Phan; Brink, Robert] UNSW Australia, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [O'Reilly, Lorraine A.; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3052, Australia; [O'Reilly, Lorraine A.; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Price, Susan; Rao, V. Koneti] NIAID, Mol Dev Sect, Immunol Lab, Div Intramural Res,NIH, Bethesda, MD 20892 USA	Garvan Institute of Medical Research; University of New South Wales Sydney; Walter & Eliza Hall Institute; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Brink, R (corresponding author), Garvan Inst Med Res, Div Immunol, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	r.brink@garvan.org.au	Christ, Daniel/C-1861-2018; Tangye, Stuart G/H-4023-2014; Brink, Robert/B-7910-2010; Strasser, Andreas/C-7581-2013; Rao, V. Koneti/AAR-2171-2020; S, Cindy/B-2340-2012; Phan, Tri/G-3937-2012	Christ, Daniel/0000-0002-7313-3977; Tangye, Stuart G/0000-0002-5360-5180; Brink, Robert/0000-0002-9586-3655; Strasser, Andreas/0000-0002-5020-4891; Rao, V. Koneti/0000-0002-7881-6902; S, Cindy/0000-0001-5387-8413; Phan, Tri/0000-0002-4909-2984; Chan, Tyani/0000-0001-9276-8479	Australian Postgraduate Award; National Health and Medical Research Council (NHMRC) [1054669, 1020363, 1050146, 1008820, 1042925, 1005097, 1002280]; Asthma Foundation NSW; R.G. Arnott Foundation; NHMRC [1044477, 1016953, 1009145, 1016701]; Leukemia and Lymphoma Society (SCOR) [7413, 7001-13]; National Institute of Allergy and Infectious Diseases; NIH Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000732] Funding Source: NIH RePORTER	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation NSW; R.G. Arnott Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society (SCOR)(Leukemia and Lymphoma Society); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Salomon, C. Brownlee, and Garvan Institute Flow Facility staff for single-cell sorting and J. Kingham and the staff of Australian BioResources for animal husbandry. We also thank C. Goodnow, A. Collins, and J. Davies for their comments on the manuscript. D.B. is supported by an Australian Postgraduate Award and T.D.C., A. Strasser, D. C., C.S.M., S.G.T., T.G.P., and R.B. by National Health and Medical Research Council (NHMRC) fellowships 1054669, 1020363, 1050146, 1008820, 1042925, 1005097, and 1002280. This work was funded by Asthma Foundation NSW, R.G. Arnott Foundation, NHMRC Project Grant 1044477, and NHMRC Program Grant 1016953. Additional support came from NHMRC Project Grant 1009145, NHMRC Program Grant 1016701, Leukemia and Lymphoma Society (SCOR grants #7413 and #7001-13), and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases and the NIH Clinical Center.	Afshar-Sterle S, 2014, NAT MED, V20, P283, DOI 10.1038/nm.3442; Ait-Azzouzene D, 2010, J IMMUNOL, V185, P1015, DOI 10.4049/jimmunol.1000698; Alabyev B, 2008, INT IMMUNOL, V20, P1279, DOI 10.1093/intimm/dxn087; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Brink R, 2014, CURR OPIN IMMUNOL, V28, P97, DOI 10.1016/j.coi.2014.03.001; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Dahlke I, 2006, J ALLERGY CLIN IMMUN, V117, P1477, DOI 10.1016/j.jaci.2005.12.1359; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HAN SH, 1995, J IMMUNOL, V155, P556; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Hoch S, 2000, CELL IMMUNOL, V203, P103, DOI 10.1006/cimm.2000.1681; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; Messingham KAN, 2014, IMMUNOL RES, V59, P273, DOI 10.1007/s12026-014-8547-7; NOSSAL GJV, 1988, IMMUNOL CELL BIOL, V66, P105, DOI 10.1038/icb.1988.14; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; PERMIN H, 1978, ACTA PATH MICRO IM C, V86, P245; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Price S, 2014, BLOOD, V123, P1989, DOI 10.1182/blood-2013-10-535393; PROVOST TT, 1974, CLIN EXP IMMUNOL, V18, P193; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Takahashi S, 2013, INT IMMUNOL, V25, P287, DOI 10.1093/intimm/dxs109; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Thaunat O, 2012, SCIENCE, V335, P475, DOI 10.1126/science.1214100; Verbeke CS, 1999, J PATHOL, V189, P155, DOI 10.1002/(SICI)1096-9896(199910)189:2<155::AID-PATH442>3.0.CO;2-9; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089730; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009	44	53	53	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					890	902		10.1016/j.immuni.2015.04.010	http://dx.doi.org/10.1016/j.immuni.2015.04.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25979420	Bronze			2022-12-18	WOS:000354827400015
J	Pelletier, S; Gingras, S; Green, DR				Pelletier, Stephane; Gingras, Sebastien; Green, Douglas R.			Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function	IMMUNITY			English	Review							ONE-STEP GENERATION; OFF-TARGET ACTIVITY; STREPTOCOCCUS-THERMOPHILUS; EPIGENETIC MODIFICATIONS; NEISSERIA-MENINGITIDIS; NUCLEASE SPECIFICITY; CRISPR/CAS9 SYSTEMS; CAS SYSTEMS; GUIDED RNA; DUAL-RNA	Clustered regularly interspaced palindromic repeats (CRISPR)-associated (Cas9) technology has proven a formidable addition to our armory of approaches for genomic editing. Derived from pathways in archaea and bacteria that mediate the resistance to exogenous genomic material, the CRISPR-Cas9 system utilizes a short single guide RNA (sgRNA) to direct the endonuclease Cas9 to virtually anywhere in the genome. Upon targeting, Cas9 generates DNA double-strand breaks (DSBs) and facilitates the repair or insertion of mutations, insertion of recombinase recognition sites, or large DNA elements. Here, we discuss the practical advantages of the CRISPR-Cas9 system over conventional and other nuclease-based targeting technologies and provide suggestions for the use of this technology to address immunological questions.	[Pelletier, Stephane; Gingras, Sebastien; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38103 USA	St Jude Children's Research Hospital	Pelletier, S (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38103 USA.	stephane.pelletier@stjude.org; douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417; Pelletier, Stephane/0000-0002-1127-0212	U.S. NIH; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828, R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Transgenic/Gene Knockout Shared Resource (St. Jude Children's Research Hospital) for CRISPR/Cas9 injections and Dr. Helen Beere for helpful discussions. The authors received support from the U.S. NIH and the American Lebanese Syrian Associated Charities.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Javierre BM, 2008, TRENDS IMMUNOL, V29, P616, DOI 10.1016/j.it.2008.08.008; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nagy A., 2003, MANIPULATING MOUSE E; Oh B, 2000, DEVELOPMENT, V127, P3795; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Vanden Berghe W, 2006, BIOCHEM PHARMACOL, V72, P1114, DOI 10.1016/j.bcp.2006.07.012; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	63	53	61	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					18	27		10.1016/j.immuni.2015.01.004	http://dx.doi.org/10.1016/j.immuni.2015.01.004			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607456	Bronze, Green Accepted			2022-12-18	WOS:000348197500008
J	Siracusa, MC; Saenz, SA; Wojno, EDT; Kim, BS; Osborne, LC; Ziegler, CG; Benitez, AJ; Ruymann, KR; Farber, DL; Sleiman, PM; Hakonarson, H; Cianferoni, A; Wang, ML; Spergel, JM; Comeau, MR; Artis, D				Siracusa, Mark C.; Saenz, Steven A.; Wojno, Elia D. Tait; Kim, Brian S.; Osborne, Lisa C.; Ziegler, Carly G.; Benitez, Alain J.; Ruymann, Kathryn R.; Farber, Donna L.; Sleiman, Patrick M.; Hakonarson, Hakon; Cianferoni, Antonella; Wang, Mei-Lun; Spergel, Jonathan M.; Comeau, Michael R.; Artis, David			Thymic Stromal Lymphopoietin-Mediated Extramedullary Hematopoiesis Promotes Allergic Inflammation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; HUMAN EPITHELIAL-CELLS; EOSINOPHILIC ESOPHAGITIS; PROGENITOR CELLS; STEM-CELLS; NEOADJUVANT CHEMOTHERAPY; HELMINTH INFECTION; CYTOKINE RESPONSES; MAST-CELLS; TSLP	Extramedullary hematopoiesis (EMH) refers to the differentiation of hematopoietic stem cells (HSCs) into effector cells that occurs in compartments outside of the bone marrow. Previous studies linked pattern-recognition receptor (PRR)-expressing HSCs, EMH, and immune responses to microbial stimuli. However, whether EMH operates in broader immune contexts remains unknown. Here, we demonstrate a previously unrecognized role for thymic stromal lymphopoietin (TSLP) in promoting the population expansion of progenitor cells in the periphery and identify that TSLP-elicited progenitors differentiated into effector cells including macrophages, dendritic cells, and granulocytes and that these cells contributed to type 2 cytokine responses. The frequency of circulating progenitor cells was also increased in allergic patients with a gain-of-function polymorphism in TSLP, suggesting the TSLP-EMH pathway might operate in human disease. These data identify that TSLP-induced EMH contributes to the development of allergic inflammation and indicate that EMH is a conserved mechanism of innate immunity.	[Siracusa, Mark C.; Saenz, Steven A.; Wojno, Elia D. Tait; Kim, Brian S.; Osborne, Lisa C.; Ziegler, Carly G.; Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Dept Microbiol, Philadelphia, PA 19104 USA; [Kim, Brian S.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Benitez, Alain J.; Wang, Mei-Lun] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Ruymann, Kathryn R.; Cianferoni, Antonella; Spergel, Jonathan M.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Dept Pediat, Philadelphia, PA 19104 USA; [Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Sleiman, Patrick M.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Sleiman, Patrick M.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Sleiman, Patrick M.; Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Comeau, Michael R.] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Amgen	Artis, D (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Dept Microbiol, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Osborne, Lisa/K-3027-2015; Kim, Brian/GZK-6649-2022	Osborne, Lisa/0000-0002-7170-3235; Kim, Brian/0000-0002-8100-7161; Ziegler, Carly/0000-0002-8279-7150; Artis, David/0000-0002-1753-4100; Farber, Donna/0000-0001-8236-9183; Tait Wojno, Elia/0000-0003-2822-296X; Spergel, Jonathan/0000-0002-4658-5353	National Institutes of Health [AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, AI06697, AI097333]; National Center for Research Resources; National Center for Advancing Translational Sciences [KL2TR000139]; BWF Investigator in Pathogenesis of Infectious Disease Award; CCFA; NCI; Abbot Nutrition [ANUS1013];  [KL2-RR024132];  [AI085828]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000139] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095466, F32AI085828, R21AI083480, R21AI087990, R01AI102942, R01AI097333, R01AI061570, P01AI106697, U01AI095608, R01AI074878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); BWF Investigator in Pathogenesis of Infectious Disease Award; CCFA; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abbot Nutrition; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Artis laboratory for discussions and critical reading, and Kyle Bittinger for assistance with PCA analysis. This work is supported by the National Institutes of Health (AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, AI06697, and AI097333 to D. A.), the National Center for Research Resources and the National Center for Advancing Translational Sciences (KL2TR000139), the BWF Investigator in Pathogenesis of Infectious Disease Award (D. A.), and the CCFA (D. A.). Human spleen tissue samples were provided by the CHTN, which is funded by the NCI. Human PBMCs were provided by M.-L. W. and A.J.B, funded by Abbot Nutrition (ANUS1013). B. S. K. is funded by KL2-RR024132, and M. C. S. is funded by AI085828. M. R. C. is an employee and shareholder of Amgen.	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Allakhverdi Z, 2012, ALLERGY, V67, P4, DOI 10.1111/j.1398-9995.2011.02703.x; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bunyavanich Supinda, 2011, Clin Mol Allergy, V9, P1, DOI 10.1186/1476-7961-9-1; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Giacomin PR, 2012, J IMMUNOL, V189, P4371, DOI 10.4049/jimmunol.1200691; Gribaldo L, 1999, EXP HEMATOL, V27, P1593, DOI 10.1016/S0301-472X(99)00107-1; Griseri T, 2012, IMMUNOLOGY, V137, P1; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Holmes R, 2009, COLD SPRING HARB PRO, V2009; Hunninghake GM, 2010, ALLERGY, V65, P1566, DOI 10.1111/j.1398-9995.2010.02415.x; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Millar EKA, 2009, HISTOPATHOLOGY, V54, P622, DOI 10.1111/j.1365-2559.2009.03246.x; Mukai K, 2012, BLOOD, V120, P76, DOI 10.1182/blood-2011-12-399113; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Osborn MJ, 2004, BLOOD, V103, P843, DOI 10.1182/blood-2003-05-1557; Papayannopoulou T, 1999, ANN NY ACAD SCI, V872, P187, DOI 10.1111/j.1749-6632.1999.tb08464.x; PAPAYANNOPOULOU T, 1999, ANN NY ACAD SCI, V872, P197; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Ratajczak MZ, 2010, LEUKEMIA, V24, P1667, DOI 10.1038/leu.2010.162; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Sharkis SJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003920; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang J, 2006, ANN CLIN LAB SCI, V36, P475; Wills-Karp M, 2011, NAT IMMUNOL, V12, P1025, DOI 10.1038/ni.2142; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	53	53	55	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1158	1170		10.1016/j.immuni.2013.09.016	http://dx.doi.org/10.1016/j.immuni.2013.09.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332033	Green Accepted, Bronze			2022-12-18	WOS:000330951000020
J	Harker, JA; Dolgoter, A; Zuniga, EI				Harker, James A.; Dolgoter, Aleksandr; Zuniga, Elina I.			Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4(+) T Cell Responses and Viral Control during Chronic Infection	IMMUNITY			English	Article							HELPER-CELLS; TGF-BETA; INTERLEUKIN-10 RECEPTOR; PD-1 EXPRESSION; B-CELLS; EXHAUSTION; STAT5; INFLAMMATION; AUTOIMMUNITY; COMBINATION	The outcome of chronic viral infections, which affect millions of people worldwide, is greatly dependent on CD4(+) T cells. Here we showed that T cell-specific ablation of the common interleukin-6 (IL-6) family receptor, gp130, profoundly compromised virus-specific CD4(+) T cell survival, T follicular helper responses, and IL-21 production at late stages of chronic lymphocytic choriomeningitis virus (LCMV) infection. These effects were cell intrinsic for CD4(+) T cells and were accompanied by a reduction of CD8(+) T cells, antibodies, and a severe failure in viral control. We identified IL-27 as a gp130 cytokine that promoted antiviral CD4(+) T cell accumulation in vivo and that rapidly induced IL-21 ex vivo. Furthermore, IL-27R was critical for control of persistent LCMV in vivo. These results reveal that gp130 cytokines (particularly IL-27) are key regulators of CD4(+) T cell responses during an established chronic viral infection, empowering both humoral and cytotoxic immunity.	[Harker, James A.; Dolgoter, Aleksandr; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA	University of California System; University of California San Diego	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA.	eizuniga@ucsd.edu		Harker, James/0000-0002-0301-6898	NIH [A1081923, AI101561, AI976621]; Leukemia and Lymphoma Society Scholar Award; Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101561, R01AI081923, R56AI097662] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Cd4-cre Il6st<SUP>fl/fl</SUP> mice were kindly provided by Werner Mueller (University of Manchester, UK). We would also like to thank Steve Hedrick, University of California, San Diego, for critically reading this manuscript. This research was funded by NIH grant A1081923, AI101561, AI976621, and Leukemia and Lymphoma Society Scholar Award to E.I.Z. J.A.H. was supported by an Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Benmira S, 2010, CURR HIV RES, V8, P441, DOI 10.2174/157016210793499286; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boettler T, 2012, VIRAL IMMUNOL, V25, P232, DOI 10.1089/vim.2011.0079; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fasnacht N, 2009, EUR J IMMUNOL, V39, P2173, DOI 10.1002/eji.200838710; Feng JY, 2012, J GASTROENTEROL, V47, P1048, DOI 10.1007/s00535-012-0568-1; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Garidou L, 2012, J VIROL, V86, P7060, DOI 10.1128/JVI.00164-12; Gil MP, 2006, BLOOD, V107, P987, DOI 10.1182/blood-2005-07-2834; Hammond SA, 1997, J VIROL, V71, P3840, DOI 10.1128/JVI.71.5.3840-3852.1997; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Iannello A, 2010, J IMMUNOL, V184, P114, DOI 10.4049/jimmunol.0901967; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Kaplan MH, 2011, BLOOD, V117, P6198, DOI 10.1182/blood-2011-02-334367; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Pallikkuth S, 2011, J IMMUNOL, V186, P6173, DOI 10.4049/jimmunol.1100264; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yoshimoto T, 2004, J IMMUNOL, V173, P2479, DOI 10.4049/jimmunol.173.4.2479; Yue FY, 2010, J IMMUNOL, V185, P498, DOI 10.4049/jimmunol.0903915	66	53	53	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					548	559		10.1016/j.immuni.2013.08.010	http://dx.doi.org/10.1016/j.immuni.2013.08.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	23993651	Green Accepted, Bronze			2022-12-18	WOS:000330949600017
J	Cao, E; Ramagopal, UA; Fedorov, A; Fedorov, E; Yan, QR; Lary, JW; Cole, JL; Nathenson, SG; Almo, SC				Cao, Erhu; Ramagopal, Udupi A.; Fedorov, Alexander; Fedorov, Elena; Yan, Qingrong; Lary, Jeffrey W.; Cole, James L.; Nathenson, Stanley G.; Almo, Steven C.			NTB-A receptor crystal structure: Insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family	IMMUNITY			English	Article							CONTROLS T-CELL; SEDIMENTATION-VELOCITY; CD58 LFA-3; SAP; ADHESION; PROTEIN; RESPONSES; CD2; DIFFERENTIATION; REDISTRIBUTION	The signaling lymphocytic activation molecule (SLAM) family includes homophilic and heterophilic receptors that regulate both innate and adaptive immunity. The ectodomains of most SLAM family members are composed of an N-terminal IgV domain and a C-terminal IgC2 domain. NK-T-B-antigen (NTB-A) is a homophilic receptor that stimulates cytotoxicity in natural killer (NK) cells, regulates bactericidal activities in neutrophils, and potentiates T helper 2 (Th2) responses. The 3.0 A crystal structure of the complete NTB-angstrom ectodomain revealed a rod-like monomer that self-associates to form a highly kinked dimer spanning an end-to-end distance of similar to 100 angstrom. The NTB-A homophilic and CD2-CD58 heterophilic dimers; show overall structural similarities but differ in detailed organization and physicochemical properties of their respective interfaces. The NTB-A structure suggests a mechanism responsible for binding specificity within the SLAM family and imposes physical constraints relevant to the colocalization of SLAM-family proteins with other signaling molecules in the immunological synapse.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Connecticut, Natl Analyt Ultracentrifugat Facil, Biotechnol Bioserv Ctr Unit 3149, Storrs, CT 06269 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut	Nathenson, SG (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	nathenso@aecom.yu.edu; almo@aecom.yu.edu	cao, erhu/A-7204-2011	Yan, Qingrong/0000-0001-9434-1540	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI007289, R01AI007289, R37AI007289] Funding Source: NIH RePORTER; NIAID NIH HHS [AI07289] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ames JB, 2005, BIOCHEMISTRY-US, V44, P6416, DOI 10.1021/bi050139s; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Ikemizu S, 1999, P NATL ACAD SCI USA, V96, P4289, DOI 10.1073/pnas.96.8.4289; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Latour S, 2004, SEMIN IMMUNOL, V16, P409, DOI 10.1016/j.smim.2004.08.020; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; MITCHELL EM, 1990, J MOL BIOL, V212, P151, DOI 10.1016/0022-2836(90)90312-A; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Roda-Navarro P, 2004, J IMMUNOL, V173, P3640, DOI 10.4049/jimmunol.173.6.3640; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; Veillette A, 2006, TRENDS IMMUNOL, V27, P228, DOI 10.1016/j.it.2006.03.003; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Zhang KQ, 2002, CYTOKINES CELL MOL T, V7, P25, DOI 10.1080/13684730216399	50	53	58	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2006	25	4					559	570		10.1016/j.immuni.2006.06.020	http://dx.doi.org/10.1016/j.immuni.2006.06.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17045824	Bronze			2022-12-18	WOS:000241481500008
J	Banerjee, D; Liou, HC; Sen, R				Banerjee, D; Liou, HC; Sen, R			c-ReI-dependent priming of naive T cells by inflammatory cytokines	IMMUNITY			English	Article							NF-KAPPA-B; NUCLEAR EXPORT SIGNAL; IN-VIVO; LYMPHOCYTE-PROLIFERATION; COSTIMULATORY MOLECULES; TRANSCRIPTION FACTORS; INDEPENDENT PATHWAYS; ADAPTIVE IMMUNITY; GENE-EXPRESSION; 3RD SIGNAL	The intrinsic refractoriness of naive T cells for cytokine production is counteracted by cells of the innate immune system. Upon sensing danger via Toll-like receptors, these cells upregulate T cell costimulatory molecules and secrete cytokines that enhance T cell activation. We show that cytokine-mediated priming of naive T cells requires the NF-kappa B family member c-Rel. In resting naive cells c-Rel is associated primarily with I kappa B beta, an inhibitory molecule that is not effectively degraded by TCR signals. Exposure of T cells to proinflammatory cytokines, TNF-alpha and IL-1 beta, shifts c-Rel to I kappa B alpha-associated complexes that are readily targeted by the TCR. As a consequence, IL-2 and IFN-gamma mRNA are produced more quickly, and at higher levels, in cytokine-primed T cells. This mechanism does not operate in effector T cells where cytokine gene expression is c-Rel-independent. We propose that c-Rel plays a crucial role as a target of innate signals in T cells.	NIA, Cellular & Mol Biol Lab, Baltimore, MD 21224 USA; Brandeis Univ, Rosenstiel Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Cornell Univ, Weill Sch Med, Dept Immunol, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Brandeis University; Brandeis University; Cornell University	Sen, R (corresponding author), NIA, Cellular & Mol Biol Lab, Baltimore, MD 21224 USA.	rs465z@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI041035, R01AI041035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000383] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI41035] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boffa DJ, 2003, CELL IMMUNOL, V222, P105, DOI 10.1016/S0008-8749(03)00114-X; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Church LD, 2005, J LEUKOCYTE BIOL, V78, P266, DOI 10.1189/jlb.1003456; Clark JM, 2004, P NATL ACAD SCI USA, V101, P1696, DOI 10.1073/pnas.0308231100; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Grigoriadis G, 1996, EMBO J, V15, P7099, DOI 10.1002/j.1460-2075.1996.tb01101.x; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Harhaj EW, 1996, MOL CELL BIOL, V16, P6736; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Haynes L, 2004, J IMMUNOL, V172, P5194, DOI 10.4049/jimmunol.172.9.5194; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Khoruts A, 2004, EUR J IMMUNOL, V34, P1085, DOI 10.1002/eji.200324170; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KURTJONES EA, 1987, J EXP MED, V166, P1774, DOI 10.1084/jem.166.6.1774; Lee SH, 2002, J BIOL CHEM, V277, P23358, DOI 10.1074/jbc.M111559200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; London CA, 1999, J IMMUNOL, V162, P766; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Mason N, 2002, J IMMUNOL, V168, P2590, DOI 10.4049/jimmunol.168.6.2590; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Pape KA, 1997, J IMMUNOL, V159, P591; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Ramos-Payan R, 2003, SCAND J IMMUNOL, V57, P439, DOI 10.1046/j.1365-3083.2003.01250.x; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; ROJO JM, 1989, EUR J IMMUNOL, V19, P2061, DOI 10.1002/eji.1830191114; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Schmidt CS, 2002, J IMMUNOL, V168, P5521, DOI 10.4049/jimmunol.168.11.5521; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Venkataraman L, 1996, J IMMUNOL, V157, P1149; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; Wan YSY, 2003, IMMUNITY, V18, P331, DOI 10.1016/S1074-7613(03)00053-0; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yamazaki T, 2003, NAT IMMUNOL, V4, P780, DOI 10.1038/ni949; Zhou XY, 2002, J IMMUNOL, V168, P3847, DOI 10.4049/jimmunol.168.8.3847	62	53	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					445	458		10.1016/j.immuni.2005.09.012	http://dx.doi.org/10.1016/j.immuni.2005.09.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226509	Bronze			2022-12-18	WOS:000232995800012
J	West, KL; Singha, NC; De Ioannes, P; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Cortes, P				West, KL; Singha, NC; De Ioannes, P; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Cortes, P			A direct interaction between the RAG2 C terminus and the core histones is required for efficient V(D)J recombination	IMMUNITY			English	Article							HELIX PROTEINS E2A; B-CELL; NONLYMPHOID CELLS; DNA-REPAIR; LYMPHOCYTE DEVELOPMENT; NUCLEOSOMAL DNA; GENE SEGMENTS; IN-VITRO; REARRANGEMENT; ACCESSIBILITY	V(D)J recombination is a tightly controlled process of somatic recombination whose regulation is mediated in part by chromatin structure. Here, we report that RAG2 binds directly to the core histone proteins. The interaction with histones is observed in developing lymphocytes and within the RAG1/RAG2 recombinase complex in a manner that is dependent on the RAG2 C terminus. Amino acids within the plant homeo domain (PHD)-like domain as well as a conserved acidic stretch of the RAG2 C terminus that is considered to be a linker region are important for this interaction. Point mutations that disrupt the RAG2-histone association inhibit the efficiency of the V(D)J recombination reaction at the endogenous immunoglobulin locus, with the most dramatic effect in the V to DJ(H) rearrangement.	CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center	Cortes, P (corresponding author), CUNY Mt Sinai Sch Med, Immunobiol Ctr, 1425 Madison Ave, New York, NY 10029 USA.	patricia.cortes@mssm.edu		Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI061093, R01AI045996] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIAID NIH HHS [P01 AI61093, AI 07605, AI45996] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; de Villartay JP, 2002, CURR OPIN ALLERGY CL, V2, P473, DOI 10.1097/00130832-200212000-00001; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Elkin SK, 2003, EMBO J, V22, P1931, DOI 10.1093/emboj/cdg184; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Ghosh JK, 2001, J EXP MED, V193, P769, DOI 10.1084/jem.193.6.769; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Jiang H, 2004, J BIOL CHEM, V279, P8478, DOI 10.1074/jbc.M311219200; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Jones JM, 2003, P NATL ACAD SCI USA, V100, P15446, DOI 10.1073/pnas.2637012100; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Langerak AW, 2001, BLOOD, V98, P2456, DOI 10.1182/blood.V98.8.2456; Lee AI, 2003, PLOS BIOL, V1, P56, DOI 10.1371/journal.pbio.0000001; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Montalbano A, 2003, J IMMUNOL, V171, P5296, DOI 10.4049/jimmunol.171.10.5296; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Muegge K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-211; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Patenge N, 2004, J BIOL CHEM, V279, P35360, DOI 10.1074/jbc.M405790200; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Ross AE, 2003, MOL CELL BIOL, V23, P5308, DOI 10.1128/MCB.23.15.5308-5319.2003; Roth DB, 2000, CELL, V103, P699, DOI 10.1016/S0092-8674(00)00173-2; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schwarz K, 2003, BIOESSAYS, V25, P1061, DOI 10.1002/bies.10344; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shockett PE, 2004, MOL IMMUNOL, V40, P813, DOI 10.1016/j.molimm.2003.09.009; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; Spanopoulou E, 1995, IMMUNITY, V3, P715, DOI 10.1016/1074-7613(95)90061-6; Swanson PC, 2004, J BIOL CHEM, V279, P4034, DOI 10.1074/jbc.M311100200; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Tsai CL, 2003, EMBO J, V22, P1922, DOI 10.1093/emboj/cdg185; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yurchenko V, 2003, GENE DEV, V17, P581, DOI 10.1101/gad.1058103	62	53	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					203	212		10.1016/j.immuni.2005.07.004	http://dx.doi.org/10.1016/j.immuni.2005.07.004			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111638	Bronze			2022-12-18	WOS:000231721700010
J	Xiong, N; Kang, CH; Raulet, DH				Xiong, N; Kang, CH; Raulet, DH			Redundant and unique roles of two enhancer elements in the TCR gamma locus in gene regulation and gamma delta T cell development	IMMUNITY			English	Article							BETA-GLOBIN LOCUS; RECEPTOR ALPHA/DELTA LOCUS; MATRIX ATTACHMENT REGIONS; HEAVY-CHAIN LOCUS; TARGETED DELETION; SWITCH RECOMBINATION; ALPHA-BETA; IG-KAPPA; REARRANGEMENT; TRANSCRIPTION	Many mammalian genes, including those encoding antigen receptors, contain more than one enhancer element. Deleting one element often does not prevent expression, but functional redundancy has never been directly demonstrated by gene targeting of multiple elements. We demonstrate that simultaneous deletion of two enhancer/LCR-like elements in the TCR Cgamma1 cluster, HsA and 3'E-Cgamma1, severely diminishes TCRgamma transcription, selectively impairs development of gammadelta thymocyte subsets, but only modestly reduces TCRgamma gene rearrangement, while deletion of each element separately has little effect. In contrast to these results in thymocytes, deletion of HsA alone reduces transcription of one Vgamma gene specifically in peripheral gammadelta T cells. Thus, the two elements exhibit functional redundancy in thymocytes but also have unique functions in other settings.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 489 Life Sci Addit, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu		Raulet, David/0000-0002-1257-8649	NIAID NIH HHS [R01 AI 31650] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031650] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Baker JE, 1998, IMMUNITY, V9, P159, DOI 10.1016/S1074-7613(00)80598-1; Baker JE, 1999, J EXP MED, V190, P669, DOI 10.1084/jem.190.5.669; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bender MA, 1998, BLOOD, V92, P4394, DOI 10.1182/blood.V92.11.4394.423k48_4394_4403; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; Hug BA, 1996, MOL CELL BIOL, V16, P2906; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Monroe RJ, 1999, IMMUNITY, V10, P503, DOI 10.1016/S1074-7613(00)80050-3; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SPENCER DM, 1991, P NATL ACAD SCI USA, V88, P800, DOI 10.1073/pnas.88.3.800; SULLIVAN S, 1985, J INVEST DERMATOL, V84, P491, DOI 10.1111/1523-1747.ep12273454; TAKAGAKI Y, 1989, J IMMUNOL, V142, P2112; Torres RM, 1997, LAB PROTOCOLS CONDIT; VERNOOIJ BTM, 1993, GENOMICS, V17, P566, DOI 10.1006/geno.1993.1373; Wiersma EJ, 1999, J BIOL CHEM, V274, P4858, DOI 10.1074/jbc.274.8.4858; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219	34	53	53	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					453	463		10.1016/S1074-7613(02)00285-6	http://dx.doi.org/10.1016/S1074-7613(02)00285-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911829	Bronze			2022-12-18	WOS:000174572800013
J	Brouwenstijn, N; Serwold, T; Shastri, N				Brouwenstijn, N; Serwold, T; Shastri, N			MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum	IMMUNITY			English	Article							PEPTIDE-BINDING; PROTEIN TRANSLOCATION; PROCESSING PATHWAY; T-CELLS; GENERATION; COMPLEX; TRANSPORTER; ER; SPECIFICITY; DEGRADATION	The large set of peptides presented by MHC (major histocompatibility complex) class I molecules are generated by proteolysis of diverse precursors in the cytoplasm and possibly in the endoplasmic reticulum (ER). To define the potential peptide trimming events in the ER, we analyzed proteolytic products generated in isolated microsomes. The residues flanking the N terminus of the final antigenic peptide were rapidly removed within the microsomes but only in the presence of appropriate MHC molecules. Remarkably, the precursor peptide was bound to the MHC molecules in a distinct conformation and required an aminopeptidase activity to generate the optimal peptide. The MHC molecules are therefore not only the final repositories of antigenic peptides, but they can also direct their excision from longer precursors.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, 229 Stanley Hall, Berkeley, CA 94720 USA.							AJITKUMAR P, 1988, CELL, V54, P47, DOI 10.1016/0092-8674(88)90178-X; Androlewicz MJ, 1996, IMMUNITY, V5, P1, DOI 10.1016/S1074-7613(00)80304-0; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Marusina K, 1997, BIOCHEMISTRY-US, V36, P856, DOI 10.1021/bi9619738; NEEFJES J, 1995, EUR J IMMUNOL, V25, P1133, DOI 10.1002/eji.1830250444; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Serwold T, 1999, J IMMUNOL, V162, P4712; SHASTRI N, 1993, J IMMUNOL, V150, P2724; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SHERMAN LA, 1981, IMMUNOGENETICS, V12, P183, DOI 10.1007/BF01561661; SONG ES, 1994, J BIOL CHEM, V269, P7024; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; UMEZAWA H, 1982, ANNU REV MICROBIOL, V36, P75, DOI 10.1146/annurev.mi.36.100182.000451; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; WALTER P, 1983, METHOD ENZYMOL, V96, P84; YellenShaw AJ, 1997, J EXP MED, V186, P1655, DOI 10.1084/jem.186.10.1655	36	53	53	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					95	104		10.1016/S1074-7613(01)00174-1	http://dx.doi.org/10.1016/S1074-7613(01)00174-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485741	Bronze			2022-12-18	WOS:000170153300010
J	Huleatt, JW; Lefrancois, L				Huleatt, JW; Lefrancois, L			beta 2 integrins and ICAM-1 are involved in establishment of the intestinal mucosal T cell compartment	IMMUNITY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INFLAMMATORY BOWEL-DISEASE; INTRAEPITHELIAL LYMPHOCYTES; GAMMA-DELTA; EPITHELIAL-CELLS; IN-VIVO; MONOCLONAL-ANTIBODIES; RECEPTOR-ALPHA/BETA; CYTOLYTIC ACTIVITY; HOMING RECEPTOR	Development of the mucosal immune system was examined in mice with partial loss of expression of ICAM-1 or CD18. Profound effects on Peyer's patch (PP), lamina propria (LP), and intraepithelial lymphocyte (IEL) T cell populations were observed in mutant mice. Normal expression of CD18 integrins and ICAM-1 was essential for development of the CD8 alpha beta TCR alpha beta LP and IEL compartment and for the generation of normal PP lymphocyte populations. The partial loss of CD8 alpha beta IEL correlated with the loss of TCR alpha beta IEL-mediated lytic activity. The presence of a subset of Thy1(+) TCR gamma delta IEL was also dependent on CD18 integrins and ICAM-1. Both the lytic activity and the expression of CD11c by TCR gamma delta IEL were up-regulated in the presence of TCR alpha beta T cells. Analysis of bone marrow chimeras demonstrated that a bone marrow-derived ICAM-1(+) accessory cell was involved in the generation of some TCR alpha beta IEL. These results demonstrated that ICAM-1 and beta 2 integrins were required for establishment of a normal intestinal immune system.			Huleatt, JW (corresponding author), UNIV CONNECTICUT,CTR HLTH,DIV RHEUMAT DIS,FARMINGTON,CT 06030, USA.							BALK SP, 1994, SCIENCE, V265, P259, DOI 10.1126/science.7517575; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Blackford J, 1996, EUR J IMMUNOL, V26, P525, DOI 10.1002/eji.1830260304; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; BLOOM S, 1995, CLIN EXP IMMUNOL, V101, P157; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CAMERINI V, 1993, J IMMUNOL, V151, P1765; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CHAO CC, 1994, EUR J IMMUNOL, V24, P3180, DOI 10.1002/eji.1830241240; CHIRATHAWORN C, 1995, J IMMUNOL, V155, P5479; DAILEY MO, 1985, J MOL CELL IMMUNOL, V2, P27; FINE JS, 1991, J IMMUNOL, V147, P2852; GOLSTEIN P, 1982, IMMUNOL REV, V68, P5, DOI 10.1111/j.1600-065X.1982.tb01058.x; GONZALO JA, 1995, INT IMMUNOL, V7, P1691, DOI 10.1093/intimm/7.10.1691; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; GRAMZINSKI RA, 1993, INT IMMUNOL, V5, P145, DOI 10.1093/intimm/5.2.145; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; HAMANN A, 1994, J IMMUNOL, V152, P3282; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; HOFFMAN RW, 1985, J IMMUNOL, V135, P5; HUA C, 1985, EUR J IMMUNOL, V15, P1029, DOI 10.1002/eji.1830151013; HULEATT JW, 1995, J IMMUNOL, V154, P5684; IBRAGHIMOV AR, 1994, J EXP MED, V180, P433, DOI 10.1084/jem.180.2.433; ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204; JAMES SP, 1991, GASTROENTEROL CLIN N, V20, P597; KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333; KAUFMANN SHE, 1993, P NATL ACAD SCI USA, V90, P9620, DOI 10.1073/pnas.90.20.9620; KAWAGUCHI M, 1993, P NATL ACAD SCI USA, V90, P8591, DOI 10.1073/pnas.90.18.8591; KILSHAW PJ, 1990, EUR J IMMUNOL, V20, P2201, DOI 10.1002/eji.1830201008; KING PD, 1995, J IMMUNOL, V154, P6080; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; KRAMER DR, 1995, J IMMUNOL, V154, P2051; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEFRANCOIS L, 1987, J IMMUNOL, V138, P3375; LEFRANCOIS L, 1994, EUR J IMMUNOL, V24, P635, DOI 10.1002/eji.1830240322; LEFRANCOIS L, 1989, SCIENCE, V243, P1716, DOI 10.1126/science.2564701; LEFRANCOIS L, 1994, MUCOSAL IMMUNOLOGY I, P61; LEFRANCOIS L, 1996, CURRENT PROTOCOLS IM; LI Y, 1995, J EXP MED, V182, P1079, DOI 10.1084/jem.182.4.1079; Maric I, 1996, J IMMUNOL, V156, P1408; MAYER L, 1991, GASTROENTEROLOGY, V100, P3, DOI 10.1016/0016-5085(91)90575-6; MAYER L, 1987, J EXP MED, V166, P1471, DOI 10.1084/jem.166.5.1471; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; NANNO M, 1994, J IMMUNOL, V153, P2014; PANJA A, 1993, J EXP MED, V178, P1115, DOI 10.1084/jem.178.3.1115; POUSSIER P, 1992, J EXP MED, V176, P187, DOI 10.1084/jem.176.1.187; SANCHEZMADRID F, 1982, CELL IMMUNOL, V73, P1, DOI 10.1016/0008-8749(82)90431-2; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SYDORA BC, 1993, J IMMUNOL, V150, P2179; TARGAN SR, 1995, J IMMUNOL, V154, P664; Tsuzuki Y, 1996, INT IMMUNOL, V8, P287, DOI 10.1093/intimm/8.3.287; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; WILSON RW, 1993, J IMMUNOL, V151, P1571; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95	64	53	53	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1996	5	3					263	273		10.1016/S1074-7613(00)80321-0	http://dx.doi.org/10.1016/S1074-7613(00)80321-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808681	Bronze			2022-12-18	WOS:A1996VJ79700008
J	Bok, K; Sitar, S; Graham, BS; Mascola, JR				Bok, Karin; Sitar, Sandra; Graham, Barney S.; Mascola, John R.			Accelerated COVID-19 vaccine development: milestones, lessons, and prospects	IMMUNITY			English	Review							BNT162B2; DESIGN; VIRUS; IMMUNOGENICITY; CORONAVIRUS; PERSPECTIVE; INFECTION; WORKERS; SAFETY; ADULTS	The development of effective vaccines to combat infectious diseases is a complex multi-year and multi-stakeholder process. To accelerate the development of vaccines for coronavirus disease 2019 (COVID-19), a novel pathogen emerging in late 2019 and spreading globally by early 2020, the United States government (USG) mounted an operation bridging public and private sector expertise and infrastructure. The success of the endeavor can be seen in the rapid advanced development of multiple vaccine candidates, with several demonstrating efficacy and now being administered around the globe. Here, we review the milestones enabling the USG-led effort, the methods utilized, and ensuing outcomes. We discuss the current status of COVID-19 vaccine development and provide a perspective for how partnership and preparedness can be better utilized in response to future public-health pandemic emergencies.	[Bok, Karin; Sitar, Sandra; Graham, Barney S.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@mail.nih.gov						Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Alberer M, 2017, LANCET, V390, P1511, DOI 10.1016/S0140-6736(17)31665-3; Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Angel Y, 2021, JAMA-J AM MED ASSOC, V325, P2457, DOI 10.1001/jama.2021.7152; Aran D., 2021, ESTIMATING REAL WORL, DOI [10.1101/2021.02.05, DOI 10.1101/2021.02.05]; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bahl A., 2021, VACCINATION REDUCES, DOI [10.1101/2021.06.09.21258617, DOI 10.1101/2021.06.09.21258617]; Barouch Dan H, 2021, medRxiv, DOI 10.1101/2021.07.05.21259918; Batty CJ, 2021, ADV DRUG DELIVER REV, V169, P168, DOI 10.1016/j.addr.2020.12.006; Beddingfield BJ, 2021, JACC-BASIC TRANSL SC, V6, P1, DOI 10.1016/j.jacbts.2020.10.003; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Bjo rk J., 2021, EFFECTIVENESS BNT162, DOI [10.1101/2021.04.20.21254636, DOI 10.1101/2021.04.20.21254636]; Bos R, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-00243-x; Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P2204, DOI 10.1001/jama.2021.7489; Butt AA, 2021, ANN INTERN MED, V174, P1404, DOI 10.7326/M21-1577; Callaway E, 2020, NATURE, V585, P174, DOI 10.1038/d41586-020-02544-6; Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P639, DOI 10.15585/mmwr.mm7017e2; CDC, INT CLIN CONS US COV; CDC, 2021, US COVID 19 CAS DEAT; CDC, 2021, SCI BRIEF COVID 19 V; Chodick G, 2022, CLIN INFECT DIS, V74, P472, DOI 10.1093/cid/ciab438; Choi A, 2021, J VIROL, V95, DOI 10.1128/JVI.01313-21; Chung H, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1943; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Collier ARY, 2021, JAMA-J AM MED ASSOC, V325, P2370, DOI 10.1001/jama.2021.7563; Corbett Kizzmekia S, 2021, bioRxiv, DOI 10.1101/2021.05.21.445189; Corchado-Garcia J., 2021, REAL WORLD EFFECTIVE; Corey L, 2020, SCIENCE, V368, P948, DOI 10.1126/science.abc5312; Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033; CureVac, 2021, CUREVAC UPD PHAS 2B; Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Davis BH, 2013, CYTOM PART B-CLIN CY, V84, P286, DOI 10.1002/cyto.b.21105; Destefano F., 2018, VACCINE SAFETY PLOTK, P1584; Dolgin E, 2021, NATURE, V594, P483, DOI 10.1038/d41586-021-01661-0; Ella R, 2021, LANCET, V398, P2173, DOI 10.1016/S0140-6736(21)02000-6; Ella R, 2021, LANCET INFECT DIS, V21, P950, DOI 10.1016/S1473-3099(21)00070-0; Fabiani M, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.17.2100420; FDA, 2020, FDA TAK ADD ACT FIGH; FDA, 2020, GUID IND; FDA, 2020, FDA TAK KEY ACT FIGH; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Food and Drug Administration (FDA), 2021, FDA ISS EM US AUTH 3; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; Gerberding JL, 2021, NEW ENGL J MED, V384, P393, DOI 10.1056/NEJMp2029466; Goldberg Y., 2021, PROTECTION PREVIOUS; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Graham BS, 2020, J CLIN INVEST, V130, P3348, DOI 10.1172/JCI139601; Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9; Gray KJ, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.03.023; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Haidar G., 2021, IMMUNOGENICITY COVID; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; Health and Human Services Department, 2020, DET PUBL HLTH EM; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; HHS, 2020, TRUMP ADM ANN FRAM L; Hilleman MR, 2000, J HUMAN VIROL, V3, P63; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Janssen, 2021, JOHNS JOHNS ANN SING; JHU, 2021, HUB INTERVIEW; Johnson & Johnson, 2020, JOHNS JOHNS IN PIV G; Johnson & Johnson (2020b), JOHNS JOHNS PREP RES; Jongeneelen M., BIORXIV, DOI [10.1101/2021.07.01.450707, DOI 10.1101/2021.07.01.450707]; Karim F., 2021, MEDRXIV, DOI 10.1101/2021.06.03.21258228; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280; Kremsner PG, 2021, WIEN KLIN WOCHENSCHR, V133, P931, DOI 10.1007/s00508-021-01922-y; Lee P, 2021, IMMUNE NETW, V21, DOI 10.4110/in.2021.21.e4; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Martinez-Baz I, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.21.2100438; Mascola JR, 2021, JAMA-J AM MED ASSOC, V325, P1261, DOI 10.1001/jama.2021.2088; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McLean A.A., 1984, HEPATITIS B VIRUS DI, P149; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Menni C, 2021, LANCET INFECT DIS, V21, P939, DOI 10.1016/S1473-3099(21)00224-3; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Moderna, 2020, MOD FULL ENR PHAS 3; Monin L, 2021, LANCET ONCOL, V22, P765, DOI 10.1016/S1470-2045(21)00213-8; Moriyama S, 2021, IMMUNITY, V54, P1841, DOI 10.1016/j.immuni.2021.06.015; Moustsen-Helms I.R., 2021, VACCINE EFFECTIVENES; Nasreen S, 2021, MEDRXIV, DOI [10.1101/2021.06.28.21259420v2, DOI 10.1101/2021.06.28.21259420V2, 10.1101/2021.06.28.21259420]; Novavax, 2021, NOV COVID 19 VACC DE; Novavax, 2020, NOV ANN IN PREVENT 1; Novavax (2021a), NOV COMPL ENR PREVEN; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Pawlowski C, 2021, MED-CAMBRIDGE, V2, P979, DOI 10.1016/j.medj.2021.06.007; Pegu A., MRNA 1273 STUDY GROU, V2021; PHE, COVID 19 VACC SURV R; Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI [10.15585/mmwr.mm7020e2, 10.15585/mmwr.mm7020e2externalicon]; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pritchard E, 2021, NAT MED, V27, P1370, DOI 10.1038/s41591-021-01410-w; Rauch S, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00311-w; Regev-Yochay G, 2021, LANCET REG HEALTH-EU, V7, DOI 10.1016/j.lanepe.2021.100150; Sanders RW, 2021, CELL HOST MICROBE, V29, P327, DOI 10.1016/j.chom.2021.02.002; Saunders KO, 2021, NATURE, V594, P553, DOI 10.1038/s41586-021-03594-0; Shatizadeh Malekshahi S, 2016, INFECT DIS-NOR, V5, DOI [10.5812/pedinfect.36953., DOI 10.1093/CID/CIAA344, DOI 10.1093/cid/ciaa344]; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17, 10.1056/NEJMx210016]; Slaoui M, 2020, NEW ENGL J MED, V383, P1701, DOI 10.1056/NEJMp2027405; Stephenson KE, 2021, JAMA-J AM MED ASSOC, V325, P1535, DOI 10.1001/jama.2021.3645; Swift M.D., 2021, CLIN INFECT DIS; Tande AJ, 2022, CLIN INFECT DIS, V74, P59, DOI 10.1093/cid/ciab229; Tang L, 2021, JAMA-J AM MED ASSOC, V325, P2500, DOI 10.1001/jama.2021.6564; Taubenberger JK, 2000, VIROLOGY, V274, P241, DOI 10.1006/viro.2000.0495; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tenforde M.W., 2021, EFFECTIVENESS SARS C; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P674, DOI 10.15585/mmwr.mm7018e1; Thompson MG, 2021, NEW ENGL J MED, V385, P320, DOI 10.1056/NEJMoa2107058; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Tian JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20653-8; US Food and Drug Administration, 2021, NEWS RELEASE; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; Villar J, 2021, JAMA PEDIATR, V175, P817, DOI 10.1001/jamapediatrics.2021.1050; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Walensky RP, 2021, JAMA-J AM MED ASSOC, V325, P1037, DOI 10.1001/jama.2021.2294; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008; Wei CJ, 2020, NAT REV DRUG DISCOV, V19, P239, DOI 10.1038/s41573-019-0056-x; Werbel WA, 2021, ANN INTERN MED, V174, P1330, DOI 10.7326/L21-0282; WHO, 2021, COVID 19 VACC TRACK; WHO, 2021, STAT COVID 19 VACC W; WHO, 2021, BACKGR DOC IN COVID; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yassi A., 2021, MEDRXIV; Young-Xu Y., 2021, COVERAGE EFFECTIVENE, DOI [10.1101/2021.06.14, DOI 10.1101/2021.06.14]; Zacay G, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab262; Zambrano LD, 2020, MMWR-MORBID MORTAL W, V69, P1641, DOI 10.15585/mmwr.mm6944e3; Zhang YJ, 2021, LANCET INFECT DIS, V21, P181, DOI 10.1016/S1473-3099(20)30843-4	139	52	52	5	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1636	1651		10.1016/j.immuni.2021.07.017	http://dx.doi.org/10.1016/j.immuni.2021.07.017		AUG 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34348117	hybrid, Green Published			2022-12-18	WOS:000684589700006
J	Mulder, K; Patel, AA; Kong, WT; Piot, C; Halitzki, E; Dunsmore, G; Khalilnezhad, S; Irac, SE; Dubuisson, A; Chevrier, M; Zhang, XM; Tam, JKC; Lim, TKH; Wong, RMM; Pai, R; Khalil, AIS; Chow, PKH; Wu, SZ; Al-Eryani, G; Roden, D; Swarbrick, A; Chan, JKY; Albani, S; Derosa, L; Zitvogel, L; Sharma, A; Chen, JM; Silvin, A; Bertoletti, A; Bleriot, C; Dutertre, CA; Ginhoux, F				Mulder, Kevin; Patel, Amit Ashok; Kong, Wan Ting; Piot, Cecile; Halitzki, Evelyn; Dunsmore, Garett; Khalilnezhad, Shabnam; Irac, Sergio Erdal; Dubuisson, Agathe; Chevrier, Marion; Zhang, Xiao Meng; Tam, John Kit Chung; Lim, Tony Kiat Hon; Wong, Regina Men Men; Pai, Rhea; Khalil, Ahmed Ibrahim Samir; Chow, Pierce Kah Hoe; Wu, Suny Z.; Al-Eryani, Ghamdan; Roden, Daniel; Swarbrick, Alexander; Chan, Jerry Kok Yen; Albani, Salvatore; Derosa, Lisa; Zitvogel, Laurence; Sharma, Ankur; Chen, Jinmiao; Silvin, Aymeric; Bertoletti, Antonio; Bleriot, Camille; Dutertre, Charles-Antoine; Ginhoux, Florent			Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease	IMMUNITY			English	Article							DENDRITIC CELLS; T-CELLS; DISTINCT; EXPRESSION; SUBSETS; REVEALS; DRIVES; TRANSCRIPTOMICS; IDENTIFICATION; NOMENCLATURE	Mononuclear phagocytes (MNPs) encompass dendritic cells, monocytes, and macrophages (MoMac), which exhibit antimicrobial, homeostatic, and immunoregulatory functions. We integrated 178,651 MNPs from 13 tissues across 41 datasets to generate a MNP single-cell RNA compendium (MNP-VERSE), a publicly available tool to map MNPs and define conserved gene signatures of MNP populations. Next, we generated a MoMac-focused compendium that revealed an array of specialized cell subsets widely distributed across multiple tissues. Specific pathological forms were expanded in cancer and inflammation. All neoplastic tissues contained conserved tumor-associated macrophage populations. In particular, we focused on IL4I1(+) CD274(PD-L1)(+)IDO1(+) macrophages, which accumulated in the tumor periphery in a T cell-dependent manner via interferon-g (IFN-gamma) and CD40/CD40L-induced maturation from IFN-primed monocytes. IL4I1_Macs exhibited immunosuppressive characteristics through tryptophan degradation and promoted the entry of regulatory T cell into tumors. This integrated analysis provides a robust online-available platform for uniform annotation and dissection of specific macrophage functions in healthy and pathological states.	[Mulder, Kevin; Patel, Amit Ashok; Dunsmore, Garett; Dubuisson, Agathe; Derosa, Lisa; Zitvogel, Laurence; Silvin, Aymeric; Bleriot, Camille; Dutertre, Charles-Antoine] Gustave Roussy Canc Campus, Villejuif, France; [Mulder, Kevin; Patel, Amit Ashok; Dunsmore, Garett; Dubuisson, Agathe; Zitvogel, Laurence; Silvin, Aymeric; Bleriot, Camille; Dutertre, Charles-Antoine] Inst Natl Sante & Rech Med INSERM U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France; [Mulder, Kevin; Kong, Wan Ting; Piot, Cecile; Halitzki, Evelyn; Khalilnezhad, Shabnam; Irac, Sergio Erdal; Chevrier, Marion; Zhang, Xiao Meng; Chen, Jinmiao; Dutertre, Charles-Antoine; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg, Singapore 138648, Singapore; [Halitzki, Evelyn] Univ Bonn, Life & Med Sci Inst, Bonn, Germany; [Tam, John Kit Chung] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, 1E Kent Ridge Rd, Singapore 119228, Singapore; [Lim, Tony Kiat Hon] Singapore Gen Hosp, Dept Pathol, 20 Coll Rd, Singapore 169856, Singapore; [Wong, Regina Men Men; Pai, Rhea; Sharma, Ankur] ASTAR, Genome Inst Singapore, 60 Biopolis St,Genome 02-01, Singapore 138672, Singapore; [Khalil, Ahmed Ibrahim Samir] Nanyang Technol Univ, 50 Nanyang Ave, Singapore 639798, Singapore; [Chow, Pierce Kah Hoe] Natl Canc Ctr, Div Surg Oncol, Singapore 169610, Singapore; [Wu, Suny Z.; Al-Eryani, Ghamdan; Roden, Daniel; Swarbrick, Alexander] Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia; [Wu, Suny Z.; Al-Eryani, Ghamdan; Roden, Daniel; Swarbrick, Alexander] Garvan Inst Med Res, Canc Res Div, Darlinghurst, NSW 2010, Australia; [Wu, Suny Z.; Al-Eryani, Ghamdan; Roden, Daniel; Swarbrick, Alexander] Univ New South Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Chan, Jerry Kok Yen] Duke NUS Med Sch, Acad Clin Program Obstet & Gynaecol, Singapore 169857, Singapore; [Chan, Jerry Kok Yen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, 1E Kent Ridge Rd, Singapore 119228, Singapore; [Chan, Jerry Kok Yen; Bertoletti, Antonio] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore; [Albani, Salvatore; Dutertre, Charles-Antoine; Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, 20 Coll Rd,Discovery Tower Level 8, Singapore 169856, Singapore; [Derosa, Lisa; Zitvogel, Laurence] Gustave Roussy, Canc Med Dept, Villejuif, France; [Zitvogel, Laurence] Univ Paris Saclay, Ile De France, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc BIOTHERIS, F-1428 Villejuif, France; [Sharma, Ankur] Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, POB 7214,6 Verdun St, Perth, WA 6009, Australia; [Sharma, Ankur] Univ Western Australia, Ctr Med Res, POB 7214,6 Verdun St, Perth, WA 6009, Australia; [Sharma, Ankur] Curtin Univ, Sch Pharm & Biomed Sci, Curtin Hlth Innovat Inst, Perth, WA 6102, Australia; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China; [Piot, Cecile] Francis Crick Inst, Immunobiol Lab, 1 Midland Rd, London NW1 1AT, England	UNICANCER; Gustave Roussy; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Bonn; National University of Singapore; Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Cancer Centre Singapore (NCCS); Garvan Institute of Medical Research; University of New South Wales Sydney; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; National University of Singapore; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Curtin University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Francis Crick Institute	Dutertre, CA (corresponding author), Gustave Roussy Canc Campus, Villejuif, France.; Dutertre, CA (corresponding author), Inst Natl Sante & Rech Med INSERM U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France.; Dutertre, CA; Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg, Singapore 138648, Singapore.; Dutertre, CA; Ginhoux, F (corresponding author), SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, 20 Coll Rd,Discovery Tower Level 8, Singapore 169856, Singapore.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China.	charles-antoine.dutertre@inserm.fr; florent_ginhoux@immunol.a-star.edu.sg	Bertoletti, Antonio/AAD-4830-2022; Sharma, Ankur/GQZ-7151-2022; Wu, Sunny Z./AAV-1870-2021; DEROSA, LISA/E-6814-2015; Chen, Jinmiao/ABE-5601-2021; Irac, Sergio Erdal/G-6690-2014	Bertoletti, Antonio/0000-0002-2942-0485; Wu, Sunny Z./0000-0002-6153-0449; Kong, Wan Ting/0000-0002-9271-841X; Swarbrick, Alexander/0000-0002-3051-5676; Mulder, Kevin/0000-0002-1568-6581; Dutertre, Charles-Antoine/0000-0001-7950-3652; Al-Eryani, Ghamdan/0000-0002-1137-1726; Chow, Pierce/0000-0003-0584-2584; Sharma, Ankur/0000-0002-6862-136X; BLERIOT, Camille/0000-0002-4298-2888; Khalil, Ahmed/0000-0003-0391-0942; Halitzki, Evelyn/0000-0002-5804-4837; Derosa, Lisa/0000-0003-0527-2964; ZITVOGEL, laurence/0000-0003-1596-0998; Irac, Sergio Erdal/0000-0001-5622-1409	Singapore Immunology Network (SIgN); Singapore National Research Foundation Senior Investigatorship (NRFI) [NRF2016NRF-NRFI001-02]; ARC foundation France [ANT202001330]; BMRC [IAF 311006]; BMRC transition funds [H16/99/b0/011]	Singapore Immunology Network (SIgN)(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation Senior Investigatorship (NRFI)(National Research Foundation, Singapore); ARC foundation France; BMRC(Agency for Science Technology & Research (A*STAR)); BMRC transition funds(Agency for Science Technology & Research (A*STAR))	We thank L. Robinson of Insight Editing London for critical review and editing of the manuscript; F.G. is an EMBO YIP awardee and is supported by Singapore Immunology Network (SIgN) core funding as well as a Singapore National Research Foundation Senior Investigatorship (NRFI) NRF2016NRF-NRFI001-02. This work was supported by the ARC foundation France (ANT202001330). The bioinformatics and immunogenomics platforms are part of the SIgN Immunomonitoring platform (supported by a BMRC IAF 311006 grant and BMRC transition funds #H16/99/b0/011).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bian ZL, 2020, NATURE, V582, P571, DOI 10.1038/s41586-020-2316-7; Bigley V, 2019, SEMIN CELL DEV BIOL, V86, P50, DOI 10.1016/j.semcdb.2018.02.020; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Bourdely P., 2020, TRANSCRIPTIONAL FUNC; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cheng JB, 2018, CELL REP, V25, P871, DOI 10.1016/j.celrep.2018.09.006; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Covarrubias AJ, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00305-3; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; James KR, 2020, NAT IMMUNOL, V21, P343, DOI 10.1038/s41590-020-0602-z; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Kim N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16164-1; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kuo D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau8587; Lee HO, 2020, NAT GENET, V52, P594, DOI 10.1038/s41588-020-0636-z; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McInnes L., 2018, ARXIV180203426; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Peters J.M., 2020, CONSENSUS TRANSCRIPT, DOI 10.1101/2020.08.06.240424; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Remmerie A, 2020, IMMUNITY, V53, P641, DOI 10.1016/j.immuni.2020.08.004; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Rozenblatt-Rosen O, 2017, NATURE, V550, P451, DOI 10.1038/550451a; Sadik A, 2020, CELL, V182, P1252, DOI 10.1016/j.cell.2020.07.038; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; Sharma A, 2020, CELL, V183, P377, DOI 10.1016/j.cell.2020.08.040; Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Stewart BJ, 2019, SCIENCE, V365, P1461, DOI 10.1126/science.aat5031; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Svensson V, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa073; van de Sande B, 2020, NAT PROTOC, V15, P2247, DOI 10.1038/s41596-020-0336-2; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wculek SK, 2020, NAT REV IMMUNOL, V20, P7, DOI 10.1038/s41577-019-0210-z; Xue D, 2019, J IMMUNOL, V202; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang F, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00881-3; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhao QY, 2012, J IMMUNOL, V188, P1117, DOI 10.4049/jimmunol.1100164; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9; Zhu Y, 2017, IMMUNITY, V47, P597, DOI 10.1016/j.immuni.2017.08.018; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	81	52	52	9	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1883	+		10.1016/j.immuni.2021.07.007	http://dx.doi.org/10.1016/j.immuni.2021.07.007		AUG 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34331874	Bronze			2022-12-18	WOS:000684589700022
J	Shi, LG; Sun, ZY; Su, W; Xu, F; Xie, D; Zhang, QX; Dai, XJ; Iyer, K; Hitchens, TK; Foley, LM; Li, SC; Stolz, DB; Chen, K; Ding, Y; Thomson, AW; Leak, RK; Chen, J; Hu, XM				Shi, Ligen; Sun, Zeyu; Su, Wei; Xu, Fei; Xie, Di; Zhang, Qingxiu; Dai, Xuejiao; Iyer, Kartik; Hitchens, T. Kevin; Foley, Lesley M.; Li, Sicheng; Stolz, Donna B.; Chen, Kong; Ding, Ying; Thomson, Angus W.; Leak, Rehana K.; Chen, Jun; Hu, Xiaoming			Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke	IMMUNITY			English	Article							REGULATORY T-CELLS; FUNCTIONAL RECOVERY; MICE; LYMPHOCYTES; EXPRESSION; THERAPY; DIFFERENTIATION; CORRELATE; PROTECTS; MYELIN	The precise mechanisms underlying the beneficial effects of regulatory T (Treg) cells on long-term tissue repair remain elusive. Here, using single-cell RNA sequencing and flow cytometry, we found that Treg cells infiltrated the brain 1 to 5 weeks after experimental stroke in mice. Selective depletion of Treg cells diminished oligodendrogenesis, white matter repair, and functional recovery after stroke. Transcriptomic analyses revealed potent immunomodulatory effects of brain-infiltrating Treg cells on other immune cells, including monocyte-lineage cells. Microglia depletion, but not T cell lymphopenia, mitigated the beneficial effects of transferred Treg cells on white matter regeneration. Mechanistically, Treg cell-derived osteopontin acted through integrin receptors on microglia to enhance microglial reparative activity, consequently promoting oligodendrogenesis and white matter repair. Increasing Treg cell numbers by delivering IL-2:IL-2 antibody complexes after stroke improved white matter integrity and rescued neurological functions over the long term. These findings reveal Treg cells as a neurorestorative target for stroke recovery.	[Shi, Ligen; Sun, Zeyu; Su, Wei; Xu, Fei; Xie, Di; Zhang, Qingxiu; Dai, Xuejiao; Iyer, Kartik; Li, Sicheng; Leak, Rehana K.; Chen, Jun; Hu, Xiaoming] Univ Pittsburgh, Sch Med, Pittsburgh Inst Brain Disorders & Recovery, Pittsburgh, PA 15213 USA; [Shi, Ligen; Sun, Zeyu; Su, Wei; Xu, Fei; Xie, Di; Zhang, Qingxiu; Dai, Xuejiao; Iyer, Kartik; Li, Sicheng; Leak, Rehana K.; Chen, Jun; Hu, Xiaoming] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; [Xu, Fei; Chen, Jun; Hu, Xiaoming] Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15261 USA; [Hitchens, T. Kevin; Foley, Lesley M.] Univ Pittsburgh, Anim Imaging Ctr, Pittsburgh, PA 15203 USA; [Hitchens, T. Kevin; Foley, Lesley M.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15203 USA; [Stolz, Donna B.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Chen, Kong] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Ding, Ying] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15213 USA; [Thomson, Angus W.] Univ Pittsburgh, Starzl Transplantat Inst, Dept Surg, Sch Med, Pittsburgh, PA 15213 USA; [Thomson, Angus W.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15213 USA; [Leak, Rehana K.] Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15282 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University	Hu, XM (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh Inst Brain Disorders & Recovery, Pittsburgh, PA 15213 USA.; Hu, XM (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA.; Hu, XM (corresponding author), Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15261 USA.	hux2@upmc.edu	Leak, Rehana K./I-2607-2019	Leak, Rehana K./0000-0003-2817-7417; Hitchens, T. Kevin/0000-0001-6576-6742; , Fei/0000-0002-8028-3201; Su, Wei/0000-0002-3284-7535; , Kartik/0000-0003-3888-0376; Chen, Jun/0000-0002-8077-3403	National Institute of Neurological Disorders and Stroke (NINDS) [NS094573]; University of Pittsburgh; U.S. Department of Veterans Affairs (VA) grant [I01 BX003651]; VA Senior Research Career Scientist Award; Duquesne University; NIH	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Pittsburgh(University of Pittsburgh); U.S. Department of Veterans Affairs (VA) grant(US Department of Veterans Affairs); VA Senior Research Career Scientist Award; Duquesne University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Rania Elbakri of the Health Sciences Sequencing Core at the University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh for her help with RNA-seq. We thank Mara Lisa Grove Sullivan of the Center for Biologic Imaging at the University of Pittsburgh for technical support with TEM. This work was supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) (NS094573 to X.H.) and by the fund from the University of Pittsburgh. X.H. is supported by a U.S. Department of Veterans Affairs (VA) grant (I01 BX003651). J.C. is a recipient of the VA Senior Research Career Scientist Award. R.L. is supported by Duquesne University and NIH grants.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; An CR, 2014, PROG NEUROBIOL, V115, P6, DOI 10.1016/j.pneurobio.2013.12.002; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Cengiz P, 2011, DEV NEUROSCI-BASEL, V33, P270, DOI 10.1159/000328430; Chu Min, 2012, Front Biosci (Elite Ed), V4, P1926; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Dai XJ, 2020, J CEREBR BLOOD F MET, V40, P639, DOI 10.1177/0271678X19830791; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Deverman BE, 2012, J NEUROSCI, V32, P2100, DOI 10.1523/JNEUROSCI.3803-11.2012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Ferreira LMR, 2019, NAT REV DRUG DISCOV, V18, P749, DOI 10.1038/s41573-019-0041-4; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Furusho M, 2015, GLIA, V63, P1714, DOI 10.1002/glia.22838; Galdino NAL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35037-8; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Giera S, 2018, ELIFE, V7, DOI 10.7554/eLife.33385; Glezer I, 2010, BRAIN BEHAV IMMUN, V24, P695, DOI 10.1016/j.bbi.2010.01.005; Gong L, 2018, NEUROPHARMACOLOGY, V138, P160, DOI 10.1016/j.neuropharm.2018.06.009; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hayakawa K, 2011, J NEUROSCI, V31, P10666, DOI 10.1523/JNEUROSCI.1944-11.2011; Hosking MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011340; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hu XM, 2018, NAT REV NEUROL, V14, P559, DOI 10.1038/s41582-018-0028-5; Huang Z, 2002, MOL CELL NEUROSCI, V19, P250, DOI 10.1006/mcne.2001.1077; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kamel H, 2012, ARCH NEUROL-CHICAGO, V69, P576, DOI 10.1001/archneurol.2011.3590; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Koizumi K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06301-2; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuboyama K, 2015, J NEUROSCI, V35, P12162, DOI 10.1523/JNEUROSCI.2127-15.2015; Ladwig A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7189421; Leavenworth JW, 2015, NAT IMMUNOL, V16, P96, DOI 10.1038/ni.3050; Li PY, 2013, STROKE, V44, P3509, DOI 10.1161/STROKEAHA.113.002637; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Li SC, 2021, J CEREBR BLOOD F MET, V41, P2280, DOI 10.1177/0271678X21995694; Liesz A, 2015, STROKE, V46, P1422, DOI 10.1161/STROKEAHA.114.008608; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moorman HR, 2020, CANCERS, V12, DOI 10.3390/cancers12113379; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nicaise AM, 2019, MOL NEUROBIOL, V56, P3380, DOI 10.1007/s12035-018-1310-7; Rabenstein M, 2016, J NEUROIMMUNOL, V299, P130, DOI 10.1016/j.jneuroim.2016.09.009; Rentsendorj A, 2018, BRAIN BEHAV IMMUN, V67, P163, DOI 10.1016/j.bbi.2017.08.019; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; Shen E, 2018, P NATL ACAD SCI USA, V115, P6780, DOI 10.1073/pnas.1805239115; Shevach EM, 2012, TRENDS IMMUNOL, V33, P626, DOI 10.1016/j.it.2012.07.007; Shi LG, 2020, J CEREBR BLOOD F MET, V40, pS49, DOI 10.1177/0271678X20925655; Shin YJ, 2011, GLIA, V59, P413, DOI 10.1002/glia.21110; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Thornton AM, 2019, EUR J IMMUNOL, V49, P398, DOI 10.1002/eji.201847935; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wahl AS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00381; Wang JX, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00361; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Yang JL, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00203; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang HY, 2018, J NEUROSCI, V38, P10168, DOI 10.1523/JNEUROSCI.3411-17.2018; Zhang QX, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000330; Zhang WQ, 2018, MED SCI MONITOR, V24, P1588, DOI 10.12659/MSM.905700; Zhao WH, 2012, NEUROBIOL DIS, V48, P418, DOI 10.1016/j.nbd.2012.07.008	76	52	52	8	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1527	+		10.1016/j.immuni.2021.04.022	http://dx.doi.org/10.1016/j.immuni.2021.04.022		JUL 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34015256	Green Accepted, Bronze			2022-12-18	WOS:000672812100016
J	Fanucchi, S; Dominguez-Andres, J; Joosten, LAB; Netea, MG; Mhlanga, MM				Fanucchi, Stephanie; Dominguez-Andres, Jorge; Joosten, Leo A. B.; Netea, Mihai G.; Mhlanga, Musa M.			The Intersection of Epigenetics and Metabolism in Trained Immunity	IMMUNITY			English	Review							GENE-EXPRESSION; NONSPECIFIC PROTECTION; INNATE IMMUNITY; STEM-CELLS; TRANSCRIPTION; HISTONE; INFLAMMATION; CHROMATIN; METHYLATION; RNA	The last few years have witnessed an increasing body of evidence that challenges the traditional view that immunological memory is an exclusive trait of the adaptive immune system. Myeloid cells can show increased responsiveness upon subsequent stimulation with the same or a different stimulus, well after the initial challenge. This de facto innate immune memory has been termed "trained immunity" and is involved in infections, vaccination and inflammatory diseases. Trained immunity is based on two main pillars: the epigenetic and metabolic reprogramming of cells. In this review we discuss the latest insights into the epigenetic mechanisms behind the induction of trained immunity, as well as the role of different cellular metabolites and metabolic networks in the induction, regulation and maintenance of trained immunity.	[Fanucchi, Stephanie] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Dept Integrat Biomed Sci,Div Chem Syst & Synthet, Anzio Rd Observ, ZA-7925 Cape Town, South Africa; [Fanucchi, Stephanie; Dominguez-Andres, Jorge; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Geert Grootepl 8, NL-6500 HB Nijmegen, Netherlands; [Fanucchi, Stephanie; Dominguez-Andres, Jorge; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Geert Grootepl 8, NL-6500 HB Nijmegen, Netherlands; [Dominguez-Andres, Jorge; Joosten, Leo A. B.; Netea, Mihai G.; Mhlanga, Musa M.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci RIMLS, NL-6525 GA Nijmegen, Netherlands; [Mhlanga, Musa M.] Radboud Univ Nijmegen, Dept Cell Biol, Epigen & Single Cell Biophys Grp, NL-6525 GA Nijmegen, Netherlands; [Mhlanga, Musa M.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Joosten, Leo A. B.] Iuliu Hatieganu Univ Med & Pharm, Dept Med Genet, Cluj Napoca 400349, Romania; [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Immunol & Metab, D-53115 Bonn, Germany	University of Cape Town; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Iuliu Hatieganu University of Medicine & Pharmacy; University of Bonn	Mhlanga, MM (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci RIMLS, NL-6525 GA Nijmegen, Netherlands.; Mhlanga, MM (corresponding author), Radboud Univ Nijmegen, Dept Cell Biol, Epigen & Single Cell Biophys Grp, NL-6525 GA Nijmegen, Netherlands.; Mhlanga, MM (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands.	intrim@mhlangalab.org	Mhlanga, Musa/D-1283-2011; Dominguez-Andres, Jorge/S-6211-2017	Mhlanga, Musa/0000-0003-1381-3409; Dominguez-Andres, Jorge/0000-0002-9091-1961	Netherlands Organization for Scientific Research; ERC [833247]; Competitiveness Operational Program grant of the Romanian Ministry of European Funds (HINT) [P_37_762, MySMIS 103587]; SIR South African Medical Research Council grant; Bill & Melinda Gates Foundation; South African Department of Science and Technology Centre of Competence Grant; South African Medical Research Council SHIP grant	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); Competitiveness Operational Program grant of the Romanian Ministry of European Funds (HINT); SIR South African Medical Research Council grant; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); South African Department of Science and Technology Centre of Competence Grant; South African Medical Research Council SHIP grant	M.G.N. was supported by a Spinoza Grant of the Netherlands Organization for Scientific Research and an ERC Advanced Grant (#833247). L.A.B.J. was supported by a Competitiveness Operational Program grant of the Romanian Ministry of European Funds (HINT, ID P_37_762; MySMIS 103587). S.F.'s research was supported by an SIR South African Medical Research Council grant. M.M.M.'s research was supported by a grant from the Bill & Melinda Gates Foundation, The South African Department of Science and Technology Centre of Competence Grant, and a South African Medical Research Council SHIP grant.	Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonilla FA, 2010, J ALLERGY CLIN IMMUN, V125, pS33, DOI 10.1016/j.jaci.2009.09.017; Burgess S.L., 2019, BIORXIV, DOI [10.1101/487652, DOI 10.1101/487652]; Burgess SL, 2014, MBIO, V5, DOI 10.1128/mBio.01817-14; Cassone A, 2018, MBIO, V9, DOI 10.1128/mBio.00570-18; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Christ A, 2019, NAT REV IMMUNOL, V19, P267, DOI 10.1038/s41577-019-0156-1; Cirovic B, 2020, CELL HOST MICROBE, V28, P322, DOI 10.1016/j.chom.2020.05.014; Cleophas MCP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37246-7; Cleophas MCP, 2016, ANN RHEUM DIS, V75, P593, DOI 10.1136/annrheumdis-2014-206258; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Crisan TO, 2017, P NATL ACAD SCI USA, V114, P5485, DOI 10.1073/pnas.1620910114; Ding W, 2015, CELL METAB, V22, P633, DOI 10.1016/j.cmet.2015.07.013; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dominguez-Andres J, 2019, EUR J IMMUNOL, V49, P2044, DOI 10.1002/eji.201848081; Dominguez-Andres J, 2019, J LEUKOCYTE BIOL, V105, P329, DOI 10.1002/JLB.MR0318-104R; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fanucchi S, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00002; Fanucchi S, 2019, NAT GENET, V51, P138, DOI 10.1038/s41588-018-0298-2; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Geisler SJ, 2015, DEVELOPMENT, V142, P2876, DOI 10.1242/dev.120030; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Ji J, 2019, ACS OMEGA, V4, P2331, DOI 10.1021/acsomega.8b03571; Jia YH, 2018, BBA-MOL BASIS DIS, V1864, P784, DOI 10.1016/j.bbadis.2017.12.029; Kachroo A, 2013, CURR OPIN PLANT BIOL, V16, P527, DOI 10.1016/j.pbi.2013.06.019; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Keating ST, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107548; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Klemm SL, 2019, NAT REV GENET, V20, P207, DOI 10.1038/s41576-018-0089-8; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Larsson AJM, 2019, NATURE, V565, P251, DOI 10.1038/s41586-018-0836-1; Li X, 2019, NAT REV GENET, V20, P503, DOI 10.1038/s41576-019-0135-1; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103573; Magagula L, 2017, BIOCHEM SOC T, V45, P953, DOI 10.1042/BST20160377; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Netea MG, 2020, CELL, V181, P969, DOI 10.1016/j.cell.2020.04.042; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Neill LAJ, 2020, NAT REV IMMUNOL, V20, P335, DOI 10.1038/s41577-020-0337-y; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Quinodoz S, 2014, TRENDS CELL BIOL, V24, P651, DOI 10.1016/j.tcb.2014.08.009; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ratter JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02564; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Shao WQ, 2017, NAT GENET, V49, P1045, DOI 10.1038/ng.3867; Shen HY, 2017, CELL, V171, P771, DOI 10.1016/j.cell.2017.09.051; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Sowter HM, 2003, CANCER RES, V63, P6130; Spurlock CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7932; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tantale K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12248; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weizman OE, 2019, NAT IMMUNOL, V20, P1004, DOI 10.1038/s41590-019-0430-1; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	78	52	54	10	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					32	43		10.1016/j.immuni.2020.10.011	http://dx.doi.org/10.1016/j.immuni.2020.10.011		JAN 2021	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33220235	Bronze, Green Accepted			2022-12-18	WOS:000607814000008
J	Schoofs, T; Barnes, CO; Suh-Toma, N; Golijanin, J; Schommers, P; Gruell, H; West, AP; Bach, F; Lee, YE; Nogueira, L; Georgiev, IS; Bailer, RT; Czartoski, J; Mascola, JR; Seaman, MS; McElrath, MJ; Doria-Rose, NA; Klein, F; Nussenzweig, MC; Bjorkman, PJ				Schoofs, Till; Barnes, Christopher O.; Suh-Toma, Nina; Golijanin, Jovana; Schommers, Philipp; Gruell, Henning; West, Anthony P., Jr.; Bach, Franziska; Lee, Yu Erica; Nogueira, Lilian; Georgiev, Ivelin S.; Bailer, Robert T.; Czartoski, Julie; Mascola, John R.; Seaman, Michael S.; McElrath, M. Juliana; Doria-Rose, Nicole A.; Klein, Florian; Nussenzweig, Michel C.; Bjorkman, Pamela J.			Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; STANDARDIZED ASSESSMENTS; VIRUS; VACCINE; PROTECTION; IDENTIFICATION; INFECTION; RESPONSES; SEQUENCE; BREADTH	Broadly neutralizing antibodies (bNAbs) against HIV-1 envelope (Env) inform vaccine design and are potential therapeutic agents. We identified SF12 and related bNAbs with up to 62% neutralization breadth from an HIV-infected donor. SF12 recognized a glycan-dominated epitope on Env's silent face and was potent against Glade AE viruses, which o are poorly covered by V3-glycan bNAbs. A 3.3 angstrom cryo-EM structure of a SF12-Env trimer complex showed additional contacts to Env protein residues by SF12 compared with VRC-PG05, the only other known donor-derived silent-face antibody, explaining SF12's increased neutralization breadth, potency, and resistance to Env mutation routes. Asymmetric binding of SF12 was associated with distinct N-glycan conformations across Env protomers, demonstrating intra-Env glycan heterogeneity. Administrating SF12 to HIV-1-infected humanized mice suppressed viremia and selected for viruses lacking the N448(gp)(120) glycan. Effective bNAbs can therefore be raised against HIV-1 Env's silent face, suggesting their potential for HIV-1 prevention, therapy, and vaccine development.	[Schoofs, Till; Golijanin, Jovana; Nogueira, Lilian; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Schoofs, Till; Schommers, Philipp; Gruell, Henning; Bach, Franziska; Klein, Florian] Univ Cologne, Lab Expt Immunol, Inst Virol, Fac Med, D-50931 Cologne, Germany; [Schoofs, Till; Schommers, Philipp; Gruell, Henning; Bach, Franziska; Klein, Florian] Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany; [Schoofs, Till; Schommers, Philipp; Gruell, Henning; Klein, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, D-50931 Cologne, Germany; [Barnes, Christopher O.; Suh-Toma, Nina; West, Anthony P., Jr.; Lee, Yu Erica; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Suh-Toma, Nina] Westridge High Sch, 324 Madeline Dr, Pasadena, CA 91105 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA; [Bailer, Robert T.; Mascola, John R.; Doria-Rose, Nicole A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Czartoski, Julie; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Seaman, Michael S.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Klein, Florian] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Schoofs, Till] GSK Vaccines, B-1300 Wavre, Belgium	Rockefeller University; University of Cologne; University of Cologne; German Center for Infection Research; University of Cologne; California Institute of Technology; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Cologne; Howard Hughes Medical Institute; Rockefeller University; GlaxoSmithKline	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	nussen@rockefeller.edu; bjorkman@caltech.edu	Schommers, Philipp/AAB-2978-2019; Mascola, John/AAI-7193-2021; Nussenzweig, Michel/AAE-7292-2019	Schommers, Philipp/0000-0003-3375-6800; Grull, Henning/0000-0002-0725-7138	NIH [UM1 AI068618, P01 AI057005, P50 GM082545-06]; Bill and Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases of the NIH [HIVRAD P01 AI100148, R01 AI131722]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [OPP1124068, 1146996]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; European Research Council [ERC-StG639961]; German Center for Infection Research (DZIF); Vaccine Research Center, NIAID/NIH; Ernst Jung Career Advancement Award for Medical Research; National Center for Advancing Translational Sciences (NCATS, NIH Clinical and Translational Science Award [CTSA] program) [UL1 TR001866]; DZIF [TI 07.002]; Hanna Gray Fellowship Program from the Howard Hughes Medical Institute; Postdoctoral Enrichment Program from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI131722, UM1AI069481, P01AI100148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); European Research Council(European Research Council (ERC)European Commission); German Center for Infection Research (DZIF); Vaccine Research Center, NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ernst Jung Career Advancement Award for Medical Research; National Center for Advancing Translational Sciences (NCATS, NIH Clinical and Translational Science Award [CTSA] program); DZIF; Hanna Gray Fellowship Program from the Howard Hughes Medical Institute; Postdoctoral Enrichment Program from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Bjorkman, Nussenzweig, and Klein labs for helpful discussions. We also thank Gaelle Breton and Kristie Gordon for help with flow cytometry sorting, and Anna Gazumyan, Hanna Janicki, Carola Ruping, Kanika Vanshylla, and Daniela Weiland for technical assistance. BG505 SOSIP.664-Avi, BG505 SOSIP.664-His, the CHO cell line expressing the B41 SOSIP Trimer, and the BG505.T332N gp160 expression plasmid were kind gifts of Albert Cupo, John P. Moore, and Rogier W. Sanders. The two protocols that subject 27845 was enrolled in were funded by the NIH (UM1 AI068618 and P01 AI057005) and the Bill and Melinda Gates Foundation. Structural studies were assisted by the Caltech Molecular Observatory (Dr. Jens Kaiser, director) and the Biological and Cryogenic Transmission Electron Microscopy Center at Caltech (Drs. Andrey Malyutin and Songye Chen, directors). Part of the cryo-EM work was performed at the Cold Spring Harbor Laboratories Course of Cryo-EM Methods with help from Drs. Gabriel Lander, Melanie Ohi, Matthjin Vos, David Veesler, and Justin Kollman. We thank the Gordon and Betty Moore and Beckman Foundations for gifts to Caltech to support the Molecular Observatory and electron microscopy. This work was supported by the National Institute of Allergy and Infectious Diseases of the NIH (HIVRAD P01 AI100148 to P.J.B. and M.C.N. and R01 AI131722 to I.S.G.); the NIH (P50 GM082545-06 to P.J.B.); the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (OPP1124068 to M.C.N. and P.J.B. and 1146996 to M.S.S.); the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) (1UM1 AI100663-01 to M.C.N.); the European Research Council (ERC-StG639961 to F.K.); the German Center for Infection Research (DZIF) (to F.K.); and in part by the intramural research program of the Vaccine Research Center, NIAID/NIH (to J.R.M.). T.S. was supported by the Ernst Jung Career Advancement Award for Medical Research, the National Center for Advancing Translational Sciences (NCATS, NIH Clinical and Translational Science Award [CTSA] program, UL1 TR001866), and the DZIF (TI 07.002). C.O.B was supported by the Hanna Gray Fellowship Program from the Howard Hughes Medical Institute and the Postdoctoral Enrichment Program from the Burroughs Wellcome Fund. P.S. and H.G. were supported by the DZIF. M.C.N. is a HHMI investigator.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bar-On Y, 2018, NAT MED, V24, P1701, DOI 10.1038/s41591-018-0186-4; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018; Borst AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37688; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung NPY, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-33; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Dingens AS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007159; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006148; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Freund NT, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2144; Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Gruell H, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0455-9; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Haynes BF, 2017, SCIENCE, V355, P1129, DOI 10.1126/science.aan0662; Haynes BF, 2015, CURR OPIN IMMUNOL, V35, P39, DOI 10.1016/j.coi.2015.05.007; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hotzel I, 2012, MABS-AUSTIN, V4, P753, DOI 10.4161/mabs.22189; Horwitz JA, 2017, CELL, V170, P637, DOI 10.1016/j.cell.2017.06.048; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4235; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Raju N, 2019, BIOINFORMATICS, V35, P3502, DOI 10.1093/bioinformatics/btz097; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Rusert P, 2016, NAT MED, V22, P1260, DOI 10.1038/nm.4187; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Siciliano B., 2008, SPRINGER HDB ROBOTIC, DOI [10.1007/978-3-540-30301-5, DOI 10.1007/978-3-540-30301-5]; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stewart JJ, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-1; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Wagh K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005520; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002; Zhou TQ, 2018, IMMUNITY, V48, P500, DOI 10.1016/j.immuni.2018.02.013; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	123	52	53	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1513	+		10.1016/j.immuni.2019.04.014	http://dx.doi.org/10.1016/j.immuni.2019.04.014			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31126879	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000471876100020
J	Baptista, AP; Gola, A; Huang, YF; Milanez-Almeida, P; Torabi-Parizi, P; Urban, JF; Shapiro, VS; Gerner, MY; Germain, RN				Baptista, Antonio P.; Gola, Anita; Huang, Yuefeng; Milanez-Almeida, Pedro; Torabi-Parizi, Parizad; Urban, Joseph F., Jr.; Shapiro, Virginia S.; Gerner, Michael Y.; Germain, Ronald N.			The Chemoattractant Receptor Ebi2 Drives Intranodal Naive CD4(+) T Cell Peripheralization to Promote Effective Adaptive Immunity	IMMUNITY			English	Article							DENDRITIC CELLS; LYMPH-NODE; B-CELLS; CD8(+); HELP; MIGRATION; MICE; REVEALS; MEMORY; LYMPHOCYTES	Lymph nodes (LNs) play critical roles in adaptive immunity by concentrating in one location the antigens, antigen-presenting cells, and antigen-responsive lymphocytes involved in such responses. Recent studies have revealed nonrandom localization of innate and adaptive immune cells within these organs, suggesting that microanatomical positioning optimizes responses involving sparse cooperating cells. Here, we report that the peripheral localization of LN cDC2 dendritic cells specialized for MHC-II antigen presentation is matched by a similarly biased paracortical distribution of CD4(+) T cells directed by the chemoattractant receptor Ebi2. In the absence of Ebi2, CD4(+) T cells lose their location bias and are delayed in antigen recognition, proliferative expansion, differentiation, direct effector activity, and provision of help for CD8(+) T cell-mediated memory responses, limiting host defense and vaccine responses. These findings demonstrate evolutionary selection for distinct niches within the LN that promote cellular responses, emphasizing the critical link between fine-grained tissue organization and host defense.	[Baptista, Antonio P.; Gola, Anita; Huang, Yuefeng; Milanez-Almeida, Pedro; Torabi-Parizi, Parizad; Gerner, Michael Y.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Crit Care Med Dept, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD 20705 USA; [Shapiro, Virginia S.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Huang, Yuefeng] Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Gerner, Michael Y.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); United States Department of Agriculture (USDA); Mayo Clinic; Columbia University; University of Washington; University of Washington Seattle	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@niaid.nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Milanez-Almeida, Pedro/AAN-1124-2020	Gerner, Michael/0000-0001-5406-8308; Milanez-Almeida, Pedro/0000-0001-8285-957X; Baptista, Antonio P./0000-0001-8182-8982; Urban, Joseph/0000-0002-1590-8869	Intramural Research Programs of NIAID; Clinical Center, NIH; NIAID K99 award [1K99AI123350-01A1]; NIH [RO1 AI083279]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083279, ZIAAI000758, ZIAAI000545, ZIAAI001034] Funding Source: NIH RePORTER	Intramural Research Programs of NIAID; Clinical Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID K99 award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Durai, T.L. Murphy, and K.M. Murphy for providing Flt3L<SUP>-/-</SUP> and Irf4<SUP>-/-</SUP> animals; N. Sakaguchi for providing Rag1-GFP mice; J. Furze, A. Worth, A. Turner, and the Jenner Institute Viral Vector Core facility for providing the Ad5.OVA vaccine construct; and A.M. Salman, S.M. Khan, and C.J. Janse for providing the transgenic chimeric P. Berghei-OVA sporozoite line. We acknowledge T.L. Murphy, K.M. Murphy, H. Wong, and A. Radtke for critical manuscript review. We thank allmembers of the Lymphocyte Biology Section for helpful comments during the course of these studies. This work was supported by the Intramural Research Programs of NIAID and the Clinical Center, NIH. Additionally, Y.H. was supported by NIAID K99 award 1K99AI123350-01A1, and V.S.S. was supported by NIH grant RO1 AI083279.	ALLAN W, 1990, J IMMUNOL, V144, P3980; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Calabro S, 2016, CELL REP, V16, P2472, DOI 10.1016/j.celrep.2016.07.076; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gaya M, 2018, CELL, V172, P517, DOI 10.1016/j.cell.2017.11.036; Gerner MY, 2017, J EXP MED, V214, P3105, DOI 10.1084/jem.20170335; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Gola A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9128; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; KATONA IM, 1988, J IMMUNOL, V140, P3206; KATONA IM, 1983, J IMMUNOL, V130, P350; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Kuwata N, 1999, J IMMUNOL, V163, P6355; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Lin JW, 2014, INFECT IMMUN, V82, P4654, DOI 10.1128/IAI.01940-14; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; Lu E, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5237; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Overstreet MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015948; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Wong HS, 2018, SEMIN IMMUNOL, V36, P17, DOI 10.1016/j.smim.2017.12.009; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; 2012, CELL, V150, P1235, DOI DOI 10.1016/J.CELL.2012.07.021; 2006, IMMUNITY, V25, P989, DOI DOI 10.1016/J.IMMUNI.2006.10.011; 2002, NAT MED, V8, P166; 2011, J IMMUNOL, V187, P4621, DOI DOI 10.4049/JIMMUNOL.1101542; 2002, NATURE, V420, P429, DOI DOI 10.1038/NATURE01146; 2017, NAT IMMUNOL, V18, P15, DOI DOI 10.1038/NI.3619	70	52	53	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1188	+		10.1016/j.immuni.2019.04.001	http://dx.doi.org/10.1016/j.immuni.2019.04.001			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31053504	Bronze			2022-12-18	WOS:000468429500011
J	Johnson, B; VanBlargan, LA; Xu, W; White, JP; Shan, C; Shi, PY; Zhang, R; Adhikari, J; Gross, ML; Leung, DW; Diamond, MS; Amarasinghe, GK				Johnson, Britney; VanBlargan, Laura A.; Xu, Wei; White, James P.; Shan, Chao; Shi, Pei-Yong; Zhang, Rong; Adhikari, Jagat; Gross, Michael L.; Leung, Daisy W.; Diamond, Michael S.; Amarasinghe, Gaya K.			Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability	IMMUNITY			English	Article							WEST-NILE-VIRUS; STRUCTURAL BASIS; FAMILY-MEMBERS; RECOGNITION; ANTIBODY; REPLICATION; TRANSLATION; METHYLATION; INDUCTION; INFECTION	Although interferon-induced proteins with tetratricopeptide repeats (IFIT proteins) inhibit infection of many viruses by recognizing their RNA, the regulatory mechanisms involved remain unclear. Here we report a crystal structure of cap 0 (m(7) GpppN) RNA bound to human IFIT1 in complex with the C-terminal domain of human IFIT3. Structural, biochemical, and genetic studies suggest that IFIT3 binding to IFIT1 has dual regulatory functions: (1) extending the half-life of IFIT1 and thereby increasing its steady-state amounts in cells; and (2) allosterically regulating the IFIT1 RNA-binding channel, thereby enhancing the specificity of recognition for cap 0 but not cap 1 (m(7) GpppNm) or 50-ppp RNA. Mouse Ifit3 lacks this key C-terminal domain and does not bind mouse Ifit1. The IFIT3 interaction with IFIT1 is important for restricting infection of viruses lacking 2'-O methylation in their RNA cap structures. Our experiments establish differences in the regulation of IFIT1 orthologs and define targets for modulation of human IFIT protein activity.	[Johnson, Britney; Leung, Daisy W.; Diamond, Michael S.; Amarasinghe, Gaya K.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [VanBlargan, Laura A.; White, James P.; Zhang, Rong; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Adhikari, Jagat; Gross, Michael L.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Diamond, Michael S.; Amarasinghe, Gaya K.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA; [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Xu, Wei] Guangzhou Med Univ, Guangzhou Eighth Peoples Hosp, Guangzhou 510060, Guangdong, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Guangzhou Medical University	Diamond, MS; Amarasinghe, GK (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS; Amarasinghe, GK (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	diamond@wusm.wustl.edu; gamarasinghe@wustl.edu	Shan, Chao/AAN-8190-2021; Xu, Wei/GQZ-2075-2022; Diamond, Michael/AAH-1733-2019; Zhang, Rong/J-5434-2018	Shan, Chao/0000-0002-3953-3782; Diamond, Michael/0000-0002-8791-3165; Zhang, Rong/0000-0003-2941-4808; Amarasinghe, Gaya/0000-0002-0418-9707	NIH [R01 AI10497, U19 AI109680, U19 AI083019, GM103422, AI107056, AI120943, AI109945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107056, F32AI010497, P01AI120943, U19AI083019, R01AI104972, U19AI109945, U19AI109680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016298] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following grants from the NIH: R01 AI10497 and U19 AI109680 (to M.S.D.), U19 AI083019 (to M.S.D. and G.K.A.), GM103422 (to M.L.G), AI107056 (to D.W.L), AI120943 (to G.K.A., D.W.L, and M.L.G,), and AI109945 (to G.K.A).	Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114; Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Brien J.D., 2013, CURR PROTOC MICROBIO, V31; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Daugherty MD, 2016, ELIFE, V5, DOI 10.7554/eLife.14228; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li YT, 2015, DEV COMP IMMUNOL, V50, P49, DOI 10.1016/j.dci.2014.10.008; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Pinto AK, 2015, J VIROL, V89, P9465, DOI 10.1128/JVI.00996-15; RHODES DP, 1976, J VIROL, V17, P33, DOI 10.1128/JVI.17.1.33-42.1976; Schmeisser H, 2010, J VIROL, V84, P10671, DOI 10.1128/JVI.00818-10; Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004; Werner M, 2011, NUCLEIC ACIDS RES, V39, P4756, DOI 10.1093/nar/gkr038; Zhang LL, 2013, ANTIVIR RES, V99, P197, DOI 10.1016/j.antiviral.2013.06.004; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	38	52	52	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					487	+		10.1016/j.immuni.2018.01.014	http://dx.doi.org/10.1016/j.immuni.2018.01.014			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29525521	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000427916900010
J	Michonneau, D; Sagoo, P; Breart, B; Garcia, Z; Celli, S; Bousso, P				Michonneau, David; Sagoo, Pervinder; Breart, Beatrice; Garcia, Zacarias; Celli, Susanna; Bousso, Philippe			The PD-1 Axis Enforces an Anatomical Segregation of CTL Activity that Creates Tumor Niches after Allogeneic Hematopoietic Stem Cell Transplantation	IMMUNITY			English	Article							VERSUS-HOST-DISEASE; CD8(+) T-CELLS; BONE-MARROW-TRANSPLANTATION; MINOR HISTOCOMPATIBILITY ANTIGENS; ACUTE MYELOID-LEUKEMIA; DENDRITIC CELLS; MOUSE MODELS; EFFECTOR; TOLERANCE; GVHD	Allogeneic hematopoietic stem cell transplantation (allo-HSCT), a curative treatment for hematologic malignancies, relies on donor cytotoxic T lymphocyte (CTL)-mediated graft-versus-leukemia (GVL) effect. Major complications of HSCT are graft-versus-host disease (GVHD) that targets specific tissues and tumor relapses. However, the mechanisms dictating the anatomical features of GVHD and GVL remain unclear. Here, we show that after HSCT, CTLs exhibited different killing activity in distinct tissues, being highest in the liver and lowest in lymph nodes. Differences were imposed by the microenvironment, partly through differential PD-1 ligand expression, which was strongly elevated in lymph nodes. Two-photon imaging revealed that PD-1 blockade restored CTL sensitivity to antigen and killing in lymph nodes. Weak CTL activity in lymph nodes promoted local tumor escape but could be reversed by anti-PD-1 treatment. Our results uncover a mechanism generating an anatomical segregation of CTL activity that might dictate sites of GVHD and create niches for tumor escape.	[Michonneau, David; Sagoo, Pervinder; Breart, Beatrice; Garcia, Zacarias; Celli, Susanna; Bousso, Philippe] Inst Pasteur, Equipe Labellisee Ligue Canc, Dynam Immune Responses Unit, F-75015 Paris, France; [Michonneau, David; Sagoo, Pervinder; Breart, Beatrice; Garcia, Zacarias; Celli, Susanna; Bousso, Philippe] INSERM, U668, F-75015 Paris, France; [Michonneau, David] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Bousso, P (corresponding author), Inst Pasteur, Equipe Labellisee Ligue Canc, Dynam Immune Responses Unit, F-75015 Paris, France.	philippe.bousso@pasteur.fr	Breart, Beatrice/M-7123-2014; Michonneau, David/L-1805-2017; BOUSSO, Philippe/M-6547-2014; Michonneau, David/AGY-7745-2022	Michonneau, David/0000-0003-4553-3065; BOUSSO, Philippe/0000-0002-6362-561X; Michonneau, David/0000-0003-4553-3065; Sagoo, Pervinder/0000-0003-2568-9126	Institut Pasteur, Inserm, Ligue Contre le Cancer (Equipe Labellisee); Fondation pour la Recherche Medicale; ERC starting grant (LymphocyteContacts); ITMO Cancer, Institut National du Cancer (Plan Cancer)	Institut Pasteur, Inserm, Ligue Contre le Cancer (Equipe Labellisee); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ERC starting grant (LymphocyteContacts); ITMO Cancer, Institut National du Cancer (Plan Cancer)	The authors wish to thank Gerard Socie for insightful discussions and members of the P.B. lab for comments on the manuscript. This work was supported by Institut Pasteur, Inserm, Ligue Contre le Cancer (Equipe Labellisee), the Fondation pour la Recherche Medicale, and an ERC starting grant (LymphocyteContacts). D.M. was supported by ITMO Cancer, Institut National du Cancer (Plan Cancer 2009-2013).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Al-Chaqmaqchi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060367; Armand P, 2013, J CLIN ONCOL, V31, P4199, DOI 10.1200/JCO.2012.48.3685; Asakura S, 2010, J CLIN INVEST, V120, P2370, DOI 10.1172/JCI39165; Bennett CL, 2011, BLOOD, V117, P7063, DOI 10.1182/blood-2011-01-329185; Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chakraverty R, 2006, J EXP MED, V203, P2021, DOI 10.1084/jem.20060376; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Dermime S, 1997, BONE MARROW TRANSPL, V19, P989, DOI 10.1038/sj.bmt.1700778; Dubrot J, 2014, J EXP MED, V211, P1153, DOI 10.1084/jem.20132000; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Flies DB, 2011, J IMMUNOL, V187, P1537, DOI 10.4049/jimmunol.1100660; Flutter B, 2010, J CLIN INVEST, V120, P3855, DOI 10.1172/JCI41446; GOULMY E, 1977, NATURE, V266, P544, DOI 10.1038/266544a0; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; Gratwohl A, 2013, HAEMATOLOGICA, V98, P1282, DOI 10.3324/haematol.2012.076349; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Harris AC, 2013, HAEMATOLOGICA, V98, P179, DOI 10.3324/haematol.2012.073189; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Koestner W, 2011, BLOOD, V117, P1030, DOI 10.1182/blood-2010-04-283119; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Macleod BL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004303; Matte-Martone C, 2011, J IMMUNOL, V187, P1653, DOI 10.4049/jimmunol.1100311; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; Nakasone H, 2015, BLOOD, V125, P3193, DOI 10.1182/blood-2014-11-613323; Norde WJ, 2011, CANCER RES, V71, P5111, DOI 10.1158/0008-5472.CAN-11-0108; Pasquini Marcelo, 2013, Clin Transpl, P187; Sackstein R, 2006, BIOL BLOOD MARROW TR, V12, P2, DOI 10.1016/j.bbmt.2005.09.015; Saha A, 2013, BLOOD, V122, P3062, DOI 10.1182/blood-2013-05-500801; Schilbach K, 2007, TRANSPLANTATION, V84, P214, DOI 10.1097/01.tp.0000268074.77929.54; Schneidawind D, 2013, BLOOD, V122, P3116, DOI 10.1182/blood-2013-08-453126; Sega EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086551; Shand JC, 2014, BIOL BLOOD MARROW TR, V20, P26, DOI 10.1016/j.bbmt.2013.10.009; Shimizu H, 2013, LEUKEMIA RES, V37, P1477, DOI 10.1016/j.leukres.2013.08.017; Tewalt EF, 2012, BLOOD, V120, P4772, DOI 10.1182/blood-2012-04-427013; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Toubai T, 2012, BLOOD, V119, P3844, DOI 10.1182/blood-2011-10-384057; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; Veenstra RG, 2012, BLOOD, V120, P682, DOI 10.1182/blood-2011-10-387977; Vincent K, 2011, BLOOD, V118, P2951, DOI 10.1182/blood-2011-04-350868; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	50	52	54	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					143	154		10.1016/j.immuni.2015.12.008	http://dx.doi.org/10.1016/j.immuni.2015.12.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26795248	Green Submitted, Bronze			2022-12-18	WOS:000368347000019
J	Kim, C; Wilson, T; Fischer, KF; Williams, MA				Kim, Chulwoo; Wilson, Theodore; Fischer, Kael F.; Williams, Matthew A.			Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4(+) Memory T Cells	IMMUNITY			English	Article							IN-VIVO; TCR; EFFECTOR; REPERTOIRE; EXPRESSION; RESPONSES; SELECTION; VIRUS; PROLIFERATION; TRANSCRIPTION	During CD4(+) T cell activation, T cell receptor (TCR) signals impact T cell fate, including recruitment, expansion, differentiation, trafficking, and survival. To determine the impact of TCR signals on the fate decision of activated CD4(+) T cells to become end-stage effector or long-lived memory T helper 1 (Th1) cells, we devised a deep-sequencing-based approach that allowed us to track the evolution of TCR repertoires after acute infection. The transition of effector Th1 cells into the memory pool was associated with a significant decrease in repertoire diversity, and the major histocompatibility complex (MHC) class II tetramer off rate, but not tetramer avidity, was a key predictive factor in the representation of individual clonal T cell populations at the memory stage. We conclude that stable and sustained interactions with antigens during the development of Th1 responses to acute infection are a determinative factor in promoting the differentiation of Th1 memory cells.	[Kim, Chulwoo; Wilson, Theodore; Fischer, Kael F.; Williams, Matthew A.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84121 USA; [Fischer, Kael F.] ARUP Labs, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	Williams, MA (corresponding author), Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84121 USA.	matthew.williams@path.utah.edu	Kim, Chulwoo/AAL-8854-2021; Fischer, Kael/F-7756-2015	Kim, Chulwoo/0000-0001-5736-8170; Fischer, Kael/0000-0002-7547-330X; Williams, Matthew/0000-0002-4721-4482	National Institutes of Health [AI080830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Cassiano for technical assistance, M. Pepper (University of Washington) for providing GP<INF>66-77</INF> tetramer constructs, D. Vignali (St. Jude Children's Research Hospital) for providing the retroviral plasmid expressing CD3 subunits, and B. Dalley (University of Utah Microarray Core Facility) for technical advice. This work was supported by National Institutes of Health grant AI080830 (to M.A.W.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Singh Y, 2010, J IMMUNOL, V185, P3408, DOI 10.4049/jimmunol.1001088; Stewart JJ, 1997, MOL IMMUNOL, V34, P1067, DOI 10.1016/S0161-5890(97)00130-2; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	47	52	53	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					508	520		10.1016/j.immuni.2013.08.033	http://dx.doi.org/10.1016/j.immuni.2013.08.033			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054329	Green Accepted, Bronze			2022-12-18	WOS:000330949600014
J	Park, H; Staehling, K; Tsang, M; Appleby, MW; Brunkow, ME; Margineantu, D; Hockenbery, DM; Habib, T; Liggitt, HD; Carlson, G; Iritani, BM				Park, Heon; Staehling, Karen; Tsang, Mark; Appleby, Mark W.; Brunkow, Mary E.; Margineantu, Daciana; Hockenbery, David M.; Habib, Tania; Liggitt, H. Denny; Carlson, George; Iritani, Brian M.			Disruption of Fnip1 Reveals a Metabolic Checkpoint Controlling B Lymphocyte Development	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; ENERGY-METABOLISM; CELL DEVELOPMENT; LKB1; PROLIFERATION; RECEPTOR; GROWTH; AMPK; DIFFERENTIATION; HOMEOSTASIS	The coordination of nutrient and energy availability with cell growth and division is essential for proper immune cell development and function. By using a chemical mutagenesis strategy in mice, we identified a pedigree that has a complete block in B cell development at the pre-B cell stage resulting from a deletion in the Fnip1 gene. Enforced expression of an immunoglobulin transgene failed to rescue B cell development. Whereas essential pre-B cell signaling molecules were activated normally in Fnip1-null preB cells, the metabolic: regulators AMPK and mTOR were dysregulated, resulting in excessive cell growth and enhanced sensitivity to apoptosis in response to metabolic stress (pre-B cell receptor crosslinking, oncogene activation). These results indicate that Folliculin-interacting protein 1 (Fnip1) is vital for B cell development and metabolic homeostasis and reveal a metabolic checkpoint that may ensure that pre-B cells have sufficient metabolic capacity to support division, while limiting lymphomagenesis caused by deregulated growth.	[Park, Heon; Tsang, Mark; Habib, Tania; Liggitt, H. Denny; Iritani, Brian M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Staehling, Karen; Appleby, Mark W.; Brunkow, Mary E.] Celltech R&D Inc, Bothell, WA 98021 USA; [Margineantu, Daciana; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Clin Div, Seattle, WA 98109 USA; [Carlson, George] McLaughlin Res Inst, Great Falls, MT 59405 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; McLaughlin Research Institute for Biomedical Sciences, Inc.	Iritani, BM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	biritani@uw.edu		Iritani, Brian/0000-0003-1903-7850	University of Washington [4162]; NIH [K26RR024462]; MMPC [09MCG96]; ITHS [UL1RR05014, P30 CA15704]; Celltech RD, Inc.; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024462, KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816] Funding Source: NIH RePORTER	University of Washington(University of Washington); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMPC; ITHS; Celltech RD, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the University of Washington Royalty Research Fund #4162, NIH K26RR024462, MMPC 09MCG96, ITHS UL1RR05014, and P30 CA15704 grants to B.M.I. We thank J. Cyster for kindly providing IGM<SUP>HEL</SUP> mice and J. Delrow and R. Basom for assistance with the microarray analyses. M.W.A. is an employee and shareholder of Novo Nordisk and is a former employee of ZymoGenetics Inc. M.W.A., K.S., and M.E.B. are former employees of Celltech R&D, Inc. This work was supported in part by funding from Celltech R&D, Inc.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Appleby MW, 2003, NAT REV IMMUNOL, V3, P463, DOI 10.1038/nri1109; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Bendixen AC, 2001, P NATL ACAD SCI USA, V98, P2443, DOI 10.1073/pnas.041493198; Cook MC, 2006, CURR OPIN IMMUNOL, V18, P627, DOI 10.1016/j.coi.2006.07.011; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Fleming HE, 2002, SEMIN IMMUNOL, V14, P423, DOI 10.1016/S1044532302000775; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; Kouro T, 2001, INT IMMUNOL, V13, P485, DOI 10.1093/intimm/13.4.485; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Park H, 2008, J EXP MED, V205, P2899, DOI 10.1084/jem.20080340; Rathmell JC, 2004, IMMUNOL REV, V197, P116, DOI 10.1111/j.0105-2896.2004.0096.x; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05	38	52	54	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					769	781		10.1016/j.immuni.2012.02.019	http://dx.doi.org/10.1016/j.immuni.2012.02.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22608497	Green Accepted, Bronze			2022-12-18	WOS:000304976000011
J	Heikenwalder, M; Kurrer, MO; Margalith, I; Kranich, J; Zeller, N; Haybaeck, J; Polymenidou, M; Matter, M; Bremer, J; Jackson, WS; Lindquist, S; Sigurdson, CJ; Aguzzi, A				Heikenwalder, Mathias; Kurrer, Michael O.; Margalith, Ilan; Kranich, Jan; Zeller, Nicolas; Haybaeck, Johannes; Polymenidou, Magdalini; Matter, Matthias; Bremer, Juliane; Jackson, Walker S.; Lindquist, Susan; Sigurdson, Christina J.; Aguzzi, Adriano			Lymphotoxin-Dependent Prion Replication in Inflammatory Stromal Cells of Granulomas	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; LYMPHOID-TISSUE; KNOCKOUT MICE; SCRAPIE; PROTEIN; NEUROINVASION; SUSCEPTIBILITY; ASSAY	Prior to invading the nervous system, prions frequently colonize lymphoid organs and sites of inflammatory lymphoneogenesis, where they colocalize with Mfge8(+) follicular dendritic cells (FDCs). Here, we report that soft-tissue granulomas, a frequent feature of chronic inflammation, expressed the cellular prion protein (PrPC, encoded by Prnp) and the lymphotoxin receptor (LT beta R), even though they lacked FDCs and did not display lymphoneogenesis. After intraperitoneal prion inoculation, granulomas of Prnp(+/+) mice, but not Prnp(-/-) granulomas or unaffected Prnp(+/+) skin, accumulated prion infectivity and disease-associated prion protein. Bone-marrow transfers between Prnp(+/+) and Prnp(-/-) mice and administration of lymphotoxin signaling antagonists indicated that prion replication required radioresistant PrPC-expressing cells and LT beta R signaling. Granulomatous PrPC was mainly expressed by stromal LT beta R+ mesenchymal cells that were absent from unaffected subcutis. Hence, granulomas can act as clinically silent reservoirs of prion infectivity. Furthermore, lymphotoxin-dependent prion replication can occur in inflammatory stromal cells that are distinct from FDCs.	[Heikenwalder, Mathias; Margalith, Ilan; Kranich, Jan; Zeller, Nicolas; Haybaeck, Johannes; Polymenidou, Magdalini; Matter, Matthias; Bremer, Juliane; Sigurdson, Christina J.; Aguzzi, Adriano] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Kurrer, Michael O.] Kantonsspital, Dept Pathol, CH-5001 Aarau, Switzerland; [Jackson, Walker S.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Aguzzi, A (corresponding author), Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Bremer, Juliane/E-2298-2012; Aguzzi, Adriano/A-3351-2008; Polymenidou, Magdalini/D-2254-2014; Heikenwalder, Mathias/AAA-2269-2020; Bremer, Juliane/AAH-9487-2020	Matter, Matthias/0000-0002-2005-5266; Jackson, Walker/0000-0002-3003-5509; Kranich, Jan/0000-0002-9928-4132; Aguzzi, Adriano/0000-0002-0344-6708	Bundesamt for Bildung und Wissenschaft; Neuroprion (Priogen); Ernst-Jung-Foundation; Stammbach foundation; ImmunoPrion, 2006-2009 [FP6-Food-023144]; Swiss National Science Foundation; Bonizzi-Theler foundation; Swiss MS Society; Prof, Dr. Max Cloetta foundation; Oncosuisee-foundation [02113-082007]; Kurt and Santa Hermann foundation; United States Department of Defense; NIH postdoctoral fellowship	Bundesamt for Bildung und Wissenschaft; Neuroprion (Priogen); Ernst-Jung-Foundation; Stammbach foundation; ImmunoPrion, 2006-2009; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler foundation; Swiss MS Society; Prof, Dr. Max Cloetta foundation; Oncosuisee-foundation; Kurt and Santa Hermann foundation; United States Department of Defense(United States Department of Defense); NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Browning for discussions and for kindly providing Hu-IgG and LT beta R-Fc, B. Seifert for help with statistical analyses, C. Julius, P. Schwarz, M. Wagner, R. Moos, A. Marcel, B. Odermatt, A. Fitsche, S. Behnke, and M. Konig for technical support, B. Ludewig for kindly providing plt/plt mice, and S. Luther for critical reading and supplying anti-CD31, CD34, and PDGFR alpha/beta antibodies. This work was supported by grants of the Bundesamt for Bildung und Wissenschaft, Neuroprion (Priogen) (A.A.), the Ernst-Jung-Foundation, the Stammbach foundation (A.A.), ImmunoPrion, FP6-Food-023144, 2006-2009 (A.A.), the Swiss National Science Foundation (A.A.), and the NCCR on neural plasticity and repair (A.A.). M.H. was supported by the Bonizzi-Theler foundation, the Swiss MS Society, the Prof, Dr. Max Cloetta foundation, the Oncosuisee-foundation (02113-082007), and the Kurt and Santa Hermann foundation. M.H., M.M., and J.B. were supported by the Hartmann Muller foundation and a Career Award of the University of Zurich, respectively. This work was supported by funding from the United States Department of Defense (S.L.) and an NIH postdoctoral fellowship (W.S.J.).	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 1997, NATURE, V389, P795, DOI 10.1038/39758; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; BRANDNER S, 1996, NATURE, V379, P330; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; DE TP, 1994, SCIENCE, V264, P703; Dlakic WM, 2007, J VIROL, V81, P4615, DOI 10.1128/JVI.02628-06; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kovacs GG, 2004, ANN NEUROL, V55, P121, DOI 10.1002/ana.10813; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Kumar V., 2004, ROBBINS COTRAN PATHO; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Montrasio F, 2001, P NATL ACAD SCI USA, V98, P4034, DOI 10.1073/pnas.051609398; MOORE RC, 1995, BIO-TECHNOL, V13, P999, DOI 10.1038/nbt0995-999; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oldstone MBA, 2002, J VIROL, V76, P4357, DOI 10.1128/JVI.76.9.4357-4363.2002; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Thomzig A, 2007, PLOS PATHOG, V3, P659, DOI 10.1371/journal.ppat.0030066; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Vorberg I, 1999, VIROLOGY, V255, P26, DOI 10.1006/viro.1998.9561	58	52	52	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					998	1008		10.1016/j.immuni.2008.10.014	http://dx.doi.org/10.1016/j.immuni.2008.10.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100703	Bronze			2022-12-18	WOS:000262012400018
J	Payne, KJ; Crooks, GM				Payne, Kimberly J.; Crooks, Gay M.			Immune-cell lineage commitment: Translation from mice to humans	IMMUNITY			English	Article							COMMON LYMPHOID PROGENITORS; HEMATOPOIETIC STEM-CELLS; T-CELLS; PRO-B; MOUSE; IDENTIFICATION; EXPRESSION; MURINE; IKAROS; ARISE	Much of the current understanding in hematopoietic stem cell differentiation into immune-cell lineages comes from mouse studies, but how well does it translate to the human system?.	Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Pediat, Los Angeles, CA 90027 USA; Childrens Hosp Los Angeles, Div Res Immunol Bone Marrow Transplantat, Los Angeles, CA 90027 USA; Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; Loma Linda University	Crooks, GM (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Pediat, 4650 Sunset Blvd MS 62, Los Angeles, CA 90027 USA.	gcrooks@chla.usc.edu	Payne, Kimberly/AAS-6814-2020	Payne, Kimberly/0000-0002-7025-5821				Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; de Bono B, 2004, J MOL BIOL, V342, P131, DOI 10.1016/j.jmb.2004.06.055; de Haan G, 2000, BLOOD, V96, P1374, DOI 10.1182/blood.V96.4.1374.h8001374_1374_1379; Fischer A, 2005, IMMUNOL REV, V203, P98, DOI 10.1111/j.0105-2896.2005.00223.x; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Hao QL, 1996, BLOOD, V88, P3306, DOI 10.1182/blood.V88.9.3306.bloodjournal8893306; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Johnson SE, 2005, J IMMUNOL, V175, P7325, DOI 10.4049/jimmunol.175.11.7325; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; SPANGRUDE GJ, 1992, BLOOD, V80, P1957; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Wilson SM, 2007, VET IMMUNOL IMMUNOP, V115, P10, DOI 10.1016/j.vetimm.2006.10.009; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005	26	52	53	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					674	677		10.1016/j.immuni.2007.05.011	http://dx.doi.org/10.1016/j.immuni.2007.05.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582340	Bronze			2022-12-18	WOS:000247646900002
J	Liu, Z; Widlak, P; Zou, Y; Xiao, F; Oh, M; Li, SY; Chang, MY; Shay, JW; Garrard, WT				Liu, Z; Widlak, P; Zou, Y; Xiao, F; Oh, M; Li, SY; Chang, MY; Shay, JW; Garrard, WT			A recombination silencer that specifies heterochromatin positioning and Ikaros association in the immunoglobulin kappa locus	IMMUNITY			English	Article							VARIABLE-REGION GENES; LIGHT-CHAIN GENE; ALLELIC EXCLUSION; TRANSCRIPTION; ENHANCER; EXPRESSION; CHROMATIN; SEQUENCE; REARRANGEMENT; ACTIVATION	Allelic exclusion ensures that individual B lymphocytes produce only one kind of antibody molecule. Previous studies have shown that allelic exclusion of the mouse Ig kappa locus occurs by the combination of monoallelic silencing and a low level of monoallelic activation for rearrangement combined with a negative feedback loop blocking additional functional rearrangements. Using yeast artificial chromosome-based single-copy isotransgenic mice, we have identified a cis-acting element that negatively regulates rearrangement in this locus, specifically in B cells. The element, termed Sis, resides in the V-J intervening sequence. Sis specifies the targeting of Ig kappa transgenes in pre-B and B cells to centromeric heterochromatin and associates with Ikaros, a repressor protein that also colocalizes with centromeric heterochromatin. Significantly, these are hallmarks of silenced endogenous germline Ig kappa genes in B cells. These results lead us to propose that Sis participates in the monoallelic silencing aspect of allelic exclusion regulation.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Maria Sklodowska Curie Canc Ctr, Dept Expt & Clin Radiobiol, PL-44100 Gliwice, Poland; Inst Oncol, PL-44100 Gliwice, Poland; Eli Lilly & Co, Lilly Corp Ctr, Integrat Biol Lilly Res Labs, Indianapolis, IN 46285 USA; Lankenau Inst Med Res, Wynnewood, PA 19096 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Eli Lilly; Lankenau Medical Center; Lankenau Institute for Medical Research	Garrard, WT (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	william.garrard@utsouthwestern.edu	Widlak, Piotr/AAL-8075-2021; Shay, Jerry W/F-7878-2011	Widlak, Piotr/0000-0001-5099-4726; Zou, Ying/0000-0003-2787-1917	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059809, R01GM029935] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59809, GM29935] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergman Y, 2004, NAT REV IMMUNOL, V4, P753, DOI 10.1038/nri1458; BLASQUEZ VC, 1989, J BIOL CHEM, V264, P21183; Brekke KM, 2004, IMMUNOGENETICS, V56, P490, DOI 10.1007/s00251-004-0659-0; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; BULFONEPAUS S, 1995, NUCLEIC ACIDS RES, V23, P1997, DOI 10.1093/nar/23.11.1997; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cocea L, 1999, J EXP MED, V189, P1443, DOI 10.1084/jem.189.9.1443; Coligan JE., 1994, CURRENT PROTOCOLS IM; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; George JB, 1995, P NATL ACAD SCI USA, V92, P12421, DOI 10.1073/pnas.92.26.12421; Goldmit M, 2002, EMBO J, V21, P5255, DOI 10.1093/emboj/cdf518; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; HOLE NJK, 1991, J IMMUNOL, V146, P4377; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LAUSTER R, 1993, EMBO J, V12, P4615, DOI 10.1002/j.1460-2075.1993.tb06150.x; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Li SY, 2000, J IMMUNOL, V164, P812, DOI 10.4049/jimmunol.164.2.812; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Liu ZM, 2002, J BIOL CHEM, V277, P32640, DOI 10.1074/jbc.M204065200; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; MARTIN DJ, 1990, MOL CELL BIOL, V10, P1950, DOI 10.1128/MCB.10.5.1950; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Nagaoka H, 2000, CURR OPIN IMMUNOL, V12, P187, DOI 10.1016/S0952-7915(99)00070-9; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Peterson KR, 1999, METHOD ENZYMOL, V306, P186; PIERCE JW, 1991, MOL CELL BIOL, V11, P1431, DOI 10.1128/MCB.11.3.1431; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; SAKSELA K, 1993, MOL CELL BIOL, V13, P3698, DOI 10.1128/MCB.13.6.3698; Schaarschmidt D, 2002, NUCLEIC ACIDS RES, V30, P4176, DOI 10.1093/nar/gkf532; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Sen R, 2005, NAT IMMUNOL, V6, P128, DOI 10.1038/ni0205-128; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Su RC, 2005, SEMIN IMMUNOL, V17, P129, DOI 10.1016/j.smim.2005.01.003; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; WHITEHURST C, 1992, NUCLEIC ACIDS RES, V20, P4929, DOI 10.1093/nar/20.18.4929	48	52	53	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					405	415		10.1016/j.immuni.2006.02.001	http://dx.doi.org/10.1016/j.immuni.2006.02.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618599	Bronze			2022-12-18	WOS:000237153000010
J	Sekiyama, A; Ueda, H; Kashiwamura, S; Sekiyama, R; Takeda, M; Rokutan, K; Okamura, H				Sekiyama, A; Ueda, H; Kashiwamura, S; Sekiyama, R; Takeda, M; Rokutan, K; Okamura, H			A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation	IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; PROTEIN-KINASE; GENE-EXPRESSION; GAMMA; INTERLEUKIN-1-BETA; INDUCTION; CYTOKINE; P38; INHIBITOR	Psychological/physical stresses are known to cause relapses of autoimmune and inflammatory diseases. To reveal a mechanism by which noninflammatory stresses affect host defenses, responses to immobilization stress in mice were investigated, focusing on the role of a multifunctional cytokine, interleukin-18 (IL-18). In the adrenal cortex, the stress induced IL-18 precursor proteins (pro-IL-18) via adrenocorticotropic hormone (ACTH) and a superoxide-mediated caspase-1 activation pathway, resulting in conversion of pro-IL-18 to the mature form, which was released into plasma. Inhibitors of caspase-1, reactive oxygen species, and P38 mitogen-activated protein kinase (MAPK) suppressed stress-induced accumulation of plasma IL-18. These inhibitors also blocked stress-induced IL-6 expression. This, together with the observation that IL-6 was not induced in IL-18-deficient mice, showed that IL-6 induction by stress is dependent on IL-18. In stressed organisms, IL-18 may influence pathological and physiological processes. Controlling the caspase-1 activating pathway to suppress IL-18 levels may provide preventative means against stress-related disruption of host defenses.	Hyogo Med Univ, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan; Osaka Univ, Grad Sch Med, Dept Clin Neurosci, Suita, Osaka 5650871, Japan; Esaka Hosp, Suita, Osaka 5640063, Japan; Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, Tokushima 7708503, Japan	Hyogo College of Medicine; University of Hyogo; Osaka University; Tokushima University	Sekiyama, A (corresponding author), Hyogo Med Univ, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan.	yamen@basic.med.tokushima-u.ac.jp						Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Blease K, 2001, INFLAMM RES, V50, P552, DOI 10.1007/PL00000233; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Bossu P, 2003, P NATL ACAD SCI USA, V100, P14181, DOI 10.1073/pnas.2336094100; Conti B, 1997, J BIOL CHEM, V272, P2035; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; DUGUE B, 1993, SCAND J CLIN LAB INV, V53, P555, DOI 10.3109/00365519309092553; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Guo ZH, 2003, BLOOD, V102, P4441, DOI 10.1182/blood-2002-11-3420; Han MJ, 2003, MOL CELLS, V15, P94; Hoshino T, 1999, J IMMUNOL, V162, P5070; Hur J, 2001, FEBS LETT, V507, P157, DOI 10.1016/S0014-5793(01)02975-1; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kokai M, 2002, J IMMUNOTHER, V25, pS68, DOI 10.1097/00002371-200203001-00011; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; McColl KS, 1998, MOL CELL ENDOCRINOL, V139, P229, DOI 10.1016/S0303-7207(98)00051-3; Mekaouche Mourad, 1994, Neuroimmunomodulation, V1, P292, DOI 10.1159/000097179; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; OKAMURA H, 2003, CYTOKINE HDB, P709; Parnet P, 1996, J BIOL CHEM, V271, P3967; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Schotte P, 2001, J BIOL CHEM, V276, P21153, DOI 10.1074/jbc.M102239200; Schubert C, 1999, PSYCHOSOM MED, V61, P876, DOI 10.1097/00006842-199911000-00024; Sillence DJ, 1997, BIOCHEM J, V324, P29, DOI 10.1042/bj3240029; Sugama S, 2000, J IMMUNOL, V165, P6287, DOI 10.4049/jimmunol.165.11.6287; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tingsborg S, 1997, MOL PSYCHIATR, V2, P122, DOI 10.1038/sj.mp.4000224; Ushio S, 1996, J IMMUNOL, V156, P4274; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Walker JG, 1999, RHEUMATOLOGY, V38, P1050, DOI 10.1093/rheumatology/38.11.1050; Wang H K, 1998, IDrugs, V1, P92; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523; Zorzon M, 2001, J NEUROL, V248, P416, DOI 10.1007/s004150170184	47	52	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					669	677		10.1016/j.immuni.2005.04.006	http://dx.doi.org/10.1016/j.immuni.2005.04.006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963782	Bronze			2022-12-18	WOS:000230180300005
J	Johmura, S; Oh-hora, M; Inabe, K; Nishikawa, Y; Hayashi, K; Vigorito, E; Kitamura, D; Turner, M; Shingu, K; Hikida, M; Kurosaki, T				Johmura, S; Oh-hora, M; Inabe, K; Nishikawa, Y; Hayashi, K; Vigorito, E; Kitamura, D; Turner, M; Shingu, K; Hikida, M; Kurosaki, T			Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK	IMMUNITY			English	Article							CELL ANTIGEN-RECEPTOR; NUCLEOTIDE EXCHANGE FACTORS; SIGNAL-TRANSDUCTION; B-LYMPHOCYTES; LIPID RAFTS; LINKER PROTEIN; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-2; NEGATIVE REGULATOR; KINASE ACTIVATION	Despite the importance of the Vav family proteins for B cell receptor (BCR) signaling, their activation mechanisms remain poorly understood. We demonstrate here that adaptor molecules Grb2 and BLNK, in addition to Vav, are required for efficient Rac1 activation in response to BCR stimulation. Loss of either Grb2 or BLNK results in decreased translocation of Vav3 to membrane rafts. By expression of Vav3 as a raft-targeted construct, the defective Rac1 activation in Grb2- or BLNK-deficient B cells is restored. Hence, our findings suggest that Grb2 and BLNK cooperate to localize Vav into membrane rafts, thereby contributing to optimal activation of Vav in B cells.	Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 3708506, Japan; Kansai Med Univ, Dept Anesthesiol, Moriguchi, Osaka 3708506, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Moriguchi, Osaka 5708506, Japan; Sci Univ Tokyo, Res Inst Biol Sci, Noda, Chiba 2780022, Japan; Babraham Inst, Mol Immunol Programme, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England	Kansai Medical University; Kansai Medical University; RIKEN; Tokyo University of Science; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Kurosaki, T (corresponding author), Kansai Med Univ, Inst Liver Res, Dept Mol Genet, 10-15 Fumizono Cho, Moriguchi, Osaka 3708506, Japan.		Turner, Martin/N-9976-2014; Kurosaki, Tomohiro/D-1306-2009	Turner, Martin/0000-0002-3801-9896; Kurosaki, Tomohiro/0000-0002-6352-304X				Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Boerth NJ, 2000, J EXP MED, V192, P1047, DOI 10.1084/jem.192.7.1047; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; CHEN CLH, 1982, J IMMUNOL, V129, P2580; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cherukuri A, 2001, IMMUNITY, V14, P169; DeFranco AL, 2001, NAT IMMUNOL, V2, P482, DOI 10.1038/88669; Doody GM, 2000, EMBO J, V19, P6173, DOI 10.1093/emboj/19.22.6173; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; Fujimoto M, 1999, IMMUNITY, V11, P191, DOI 10.1016/S1074-7613(00)80094-1; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Harmer SL, 1999, J BIOL CHEM, V274, P12183, DOI 10.1074/jbc.274.17.12183; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Ishiai M, 2000, J EXP MED, V192, P847, DOI 10.1084/jem.192.6.847; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Nishida M, 2001, EMBO J, V20, P2995, DOI 10.1093/emboj/20.12.2995; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; RAMOSMORALES F, 1995, ONCOGENE, V11, P1665; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; Sato S, 1997, P NATL ACAD SCI USA, V94, P13158, DOI 10.1073/pnas.94.24.13158; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; YE ZS, 1994, P NATL ACAD SCI USA, V91, P12629, DOI 10.1073/pnas.91.26.12629; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	64	52	54	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					777	787		10.1016/S1074-7613(03)00139-0	http://dx.doi.org/10.1016/S1074-7613(03)00139-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818159	Bronze			2022-12-18	WOS:000183767700008
J	Neild, AL; Roy, CR				Neild, AL; Roy, CR			Legionella reveal dendritic cell functions that facilitate selection of antigens for MHC class II presentation	IMMUNITY			English	Article							LEGIONNAIRES-DISEASE BACTERIUM; INTERFERON-GAMMA PRODUCTION; MOUSE BONE-MARROW; CD4+ T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; ENDOPLASMIC-RETICULUM; INTRACELLULAR GROWTH; HUMAN-MONOCYTES; PHAGOSOME TRAFFICKING; HUMAN MACROPHAGES	To understand how adaptive immune responses are generated against bacteria that avoid being delivered to lysosomes, interactions between professional antigen-presenting cells (APCs) and the intracellular pathogen Legionella pneumophila were examined. In contrast to murine bone marrow-derived macrophages (BMMs), we show that dendritic cells (DCs) restrict the growth of intracellular Legionella. Similar to what has been reported in BMMs, phagosomes containing Legionella matured into endoplasmic reticulum (ER)-derived organelles after DC internalization. Biogenesis of an ER-derived vacuole did not effectively sequester Legionella antigens from presentation on MHC class II molecules (MHC II). It was determined that proteins synthesized after Legionella had established residence in an ER-derived vacuole were presented by infected APCs. These data indicate that the ability of DCs to restrict intracellular growth of Legionella could be an important property that facilitates priming of protective T cell-mediated immune responses to vacuolar pathogens.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu		Roy, Craig/0000-0003-4490-440X	NIAID NIH HHS [AI48770] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048770] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; BECKERS MC, 1995, MAMM GENOME, V6, P540, DOI 10.1007/BF00356173; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Friedman H, 1988, Adv Exp Med Biol, V239, P327; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; Halme S, 1997, SCAND J INFECT DIS, P18; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; INABA K, 1985, SCIENCE, V229, P475, DOI 10.1126/science.3160115; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MARRA A, 1990, J IMMUNOL, V144, P2738; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; ORME IM, 1993, J INFECT DIS, V167, P1481, DOI 10.1093/infdis/167.6.1481; PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; SOUSA CRE, 1993, J EXP MED, V178, P509, DOI 10.1084/jem.178.2.509; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	42	52	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2003	18	6					813	823		10.1016/S1074-7613(03)00140-7	http://dx.doi.org/10.1016/S1074-7613(03)00140-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818162	Bronze			2022-12-18	WOS:000183767700011
J	Altmeyer, A; Simmons, RC; Krajewski, S; Reed, JC; Bornkamm, GW; ChenKiang, S				Altmeyer, A; Simmons, RC; Krajewski, S; Reed, JC; Bornkamm, GW; ChenKiang, S			Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; LYMPHOCYTE GROWTH TRANSFORMATION; NUCLEAR ANTIGEN-2; GENE-EXPRESSION; KAPPA-B; IN-VIVO; IMMUNOHISTOCHEMICAL ANALYSIS; BURKITTS-LYMPHOMA; TRANSGENIC MICE	Cell death in B cell terminal differentiation rapidly follows cell cycle arrest in IL-6 differentiation of EBV-immortalized, lgG-bearing human lymphoblastoid cells in vitro. G1 arrest is now found to coincide with repression of EBNA2 and LMP1, two EBV genes essential for B cell transformation, without activation of the viral lytic cycle. IL-6-differentiated B cells die by apoptosis, as evidenced by increases in Annexin V binding activity, PARP cleavage, and chromatin disorganization. Expression of Mcl-1, a Bcl-2 family member, was specifically induced during IL-6 differentiation and downregulated during apoptosis. Thus, IL-6 reverses EBV immortalization and activates the terminal differentiation program in IgG-bearing human B lymphoblastoid cells, including regulation of an anti-apoptotic gene to coordinate differentiation, cell cycle arrest, and cell death.	CORNELL UNIV,COLL MED,DEPT PATHOL,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DEPT MICROBIOL,NEW YORK,NY 10021; BURNHAM INST,LA JOLLA,CA 92037; INST KLIN MOL BIOL & TUMOR GENET,HAMATOLOGIKUM,D-81377 MUNICH,GERMANY	Cornell University; Cornell University; Sanford Burnham Prebys Medical Discovery Institute					NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044580] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NIAMS NIH HHS [AR44580] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABBOT SD, 1990, J VIROL, V64, P2126, DOI 10.1128/JVI.64.5.2126-2134.1990; Akashi K, 1996, IMMUNITY, V5, P147, DOI 10.1016/S1074-7613(00)80491-4; ALLDAY MJ, 1989, J GEN VIROL, V70, P1755, DOI 10.1099/0022-1317-70-7-1755; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Cayrol C, 1996, EMBO J, V15, P2748, DOI 10.1002/j.1460-2075.1996.tb00635.x; Chen-Kiang S, 1995, Curr Top Microbiol Immunol, V194, P189; COHEN JI, 1989, P NATL ACAD SCI USA, V86, P9558, DOI 10.1073/pnas.86.23.9558; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; Devergne O, 1996, MOL CELL BIOL, V16, P7098; FAHRAEUS R, 1990, P NATL ACAD SCI USA, V87, P7390, DOI 10.1073/pnas.87.19.7390; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Fries KL, 1996, J VIROL, V70, P8653, DOI 10.1128/JVI.70.12.8653-8659.1996; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GREGORY CD, 1991, NATURE, V349, P612, DOI 10.1038/349612a0; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; JIN XW, 1992, J VIROL, V66, P2746; Jochner N, 1996, EMBO J, V15, P375, DOI 10.1002/j.1460-2075.1996.tb00367.x; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KELLEHER CA, 1995, VIROLOGY, V208, P685, DOI 10.1006/viro.1995.1200; KEMPKES B, 1995, EMBO J, V14, P88, DOI 10.1002/j.1460-2075.1995.tb06978.x; Kieff E, 1996, VIROLOGY, P2343; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lomo J, 1996, CANCER RES, V56, P40; MARTIN JM, 1993, J VIROL, V67, P5269, DOI 10.1128/JVI.67.9.5269-5278.1993; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MAY LT, 1991, CYTOKINE, V3, P204, DOI 10.1016/1043-4666(91)90018-9; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Merville P, 1996, J EXP MED, V183, P227, DOI 10.1084/jem.183.1.227; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NATKUNAM Y, 1994, J IMMUNOL, V153, P3476; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; RAYNAL MC, 1989, P NATL ACAD SCI USA, V86, P8024, DOI 10.1073/pnas.86.20.8024; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; ROCHFORD R, 1993, P NATL ACAD SCI USA, V90, P352, DOI 10.1073/pnas.90.1.352; ROCHFORD R, 1995, J VIROL, V69, P150, DOI 10.1128/JVI.69.1.150-155.1995; ROECKEL D, 1987, ARCH VIROL, V97, P366; ROONEY C, 1989, J VIROL, V63, P1531, DOI 10.1128/JVI.63.4.1531-1539.1989; ROONEY CM, 1992, J VIROL, V66, P496, DOI 10.1128/JVI.66.1.496-504.1992; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; SCHATTNER EJ, 1995, J EXP MED, V182, P1557, DOI 10.1084/jem.182.5.1557; SINCLAIR AJ, 1994, EMBO J, V13, P3321, DOI 10.1002/j.1460-2075.1994.tb06634.x; SUNG NS, 1991, J VIROL, V65, P2164, DOI 10.1128/JVI.65.5.2164-2169.1991; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; TOMKINSON B, 1993, J VIROL, V67, P2014, DOI 10.1128/JVI.67.4.2014-2025.1993; WANG F, 1990, J VIROL, V64, P3407, DOI 10.1128/JVI.64.7.3407-3416.1990; WOISETSCHLAEGER M, 1991, P NATL ACAD SCI USA, V88, P3942, DOI 10.1073/pnas.88.9.3942; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630; ZimberStrobl U, 1996, EMBO J, V15, P7070, DOI 10.1002/j.1460-2075.1996.tb01098.x; ZIMBERSTROBL U, 1991, J VIROL, V65, P415, DOI 10.1128/JVI.65.1.415-423.1991; ZIMBERSTROBL U, 1993, EMBO J, V12, P167, DOI 10.1002/j.1460-2075.1993.tb05642.x	73	52	54	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					667	677		10.1016/S1074-7613(00)80387-8	http://dx.doi.org/10.1016/S1074-7613(00)80387-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390690	Bronze			2022-12-18	WOS:A1997YH55400009
J	Leu, TMJ; Eastman, QM; Schatz, DG				Leu, TMJ; Eastman, QM; Schatz, DG			Coding joint formation in a cell-free V(D)J recombination system	IMMUNITY			English	Article							STRAND-BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; RAG2 PROTEINS; SIGNAL; THYMOCYTES; MECHANISM; END; REARRANGEMENT; REQUIREMENT; 12/23-RULE	V(D)J recombination assembles the variable portion of antigen receptor genes in developing lymphocytes and is the only site-specific recombination reaction known in vertebrates. A cell-free system has been established that performs DNA cleavage, end processing, and joining to yield V(D)J coding joints that exhibit structural features similar to those formed in vivo. The reaction has the expected substrate, metal ion, and RAG protein requirements. The efficiency of coding joint formation is reduced dramatically by uncoupling the cleavage and joining portions of the reaction, indicating that a postcleavage coding end complex facilitates joining. By varying the reaction conditions, nucleotide loss from coding ends and heterogeneity of coding joints can be regulated. This cell-free system provides a novel tool for detailed mechanistic analyses of the end processing and joining steps of V(D)J recombination.	YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,DEPT BIOCHEM & MOL BIOPHYS,NEW HAVEN,CT 06520	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Leu, TMJ (corresponding author), UNIV ZURICH IRCHEL,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032524] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; BOUBNOV NV, 1993, MOL CELL BIOL, V13, P6957, DOI 10.1128/MCB.13.11.6957; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; CARROLL AM, 1993, J IMMUNOL, V150, P2222; CRAIG NL, 1988, ANNU REV GENET, V22, P77; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; GERSTEIN RM, 1993, NATURE, V363, P625, DOI 10.1038/363625a0; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GU Y, 1997, IN PRESS P NATL ACAD; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kornberg A., 1992, DNA REPLICATION; LEWIS SM, 1988, CELL, V55, P1099, DOI 10.1016/0092-8674(88)90254-1; LEWIS SM, 1991, EMBO J, V10, P3631, DOI 10.1002/j.1460-2075.1991.tb04929.x; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LIEBER MR, 1992, CELL, V70, P873, DOI 10.1016/0092-8674(92)90237-7; Livak F, 1996, MOL CELL BIOL, V16, P609; Livak F, 1997, J MOL BIOL, V267, P1, DOI 10.1006/jmbi.1996.0834; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Milne GT, 1996, MOL CELL BIOL, V16, P4189; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; Ramsden DA, 1997, CURR OPIN IMMUNOL, V9, P114, DOI 10.1016/S0952-7915(97)80167-7; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; ROTH DB, 1991, NUCLEIC ACIDS RES, V19, P7201, DOI 10.1093/nar/19.25.7201; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; Sawchuk DJ, 1997, J EXP MED, V185, P2025, DOI 10.1084/jem.185.11.2025; Schatz D G, 1997, Semin Immunol, V9, P149, DOI 10.1006/smim.1997.0068; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SHEEHAN KM, 1993, MOL CELL BIOL, V13, P1363, DOI 10.1128/MCB.13.3.1363; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; Steen SB, 1997, EMBO J, V16, P2656, DOI 10.1093/emboj/16.10.2656; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TACCIOLI GE, 1995, BIOESSAYS, V17, P949; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; WEAVER DT, 1995, TRENDS GENET, V11, P388, DOI 10.1016/S0168-9525(00)89121-0; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	46	52	52	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					303	314		10.1016/S1074-7613(00)80532-4	http://dx.doi.org/10.1016/S1074-7613(00)80532-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285414	Bronze			2022-12-18	WOS:A1997XT49200013
J	Young, F; Mizoguchi, E; Bhan, AK; Alt, FW				Young, F; Mizoguchi, E; Bhan, AK; Alt, FW			Constitutive Bcl-2 expression during immunoglobulin heavy chain promoted B cell differentiation expands novel precursor B cells	IMMUNITY			English	Article							SURROGATE LIGHT-CHAIN; MOUSE BONE-MARROW; PRE-B; LYMPHOCYTES-B; RAG-1-DEFICIENT MICE; TARGETED DISRUPTION; DEFICIENT MICE; MEMBRANE EXON; MUTANT MICE; SURFACE	To test for effects on B cell differentiation, we introduced immunoglobulin mu heavy chain (HC) and Bcl-2 transgenes, separately or together, into recombination-activating gene 2 (RAG-2)-deficient mice. Transgenic Bcl-2 expression led to increased numbers of RAG-deficient pro-B cells, but did not promote their further differentiation. Expression of the mu HC transgene promoted the differentiation of RAG-deficient pro-B cells into pre-B cells that also expressed certain differentiation markers characteristic of even more mature B cell stages. However, the extent of the mu HC-dependent differentiation effects was greatly enhanced by coexpression of the transgenic Bcl-2 gene, and a subset of pre-B cells from both HC and HC, Bcl-2-transgenic RAG-2-deficient animals expressed surface mu HCs that were functional as judged by crosslinking experiments. These experiments demonstrate that the pro-B to pre-B transition in vivo cannot be effected by the expression of Bcl-2 alone, and that nontransformed immature B-lineage cells are competent to receive signals through a surface mu complex.	HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; CHILDRENS HOSP, DWPT GENET & PEDIAT, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, CTR BLOOD RES, BOSTON, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School					NCI NIH HHS [CA42335] Funding Source: Medline; NIAID NIH HHS [AI20047, UO1 AI31541] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, R01AI020047, U01AI031541] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x; Borst J, 1996, CURR OPIN IMMUNOL, V8, P181, DOI 10.1016/S0952-7915(96)80056-2; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; BRUNSWICK M, 1989, P NATL ACAD SCI USA, V86, P6724, DOI 10.1073/pnas.86.17.6724; BURROWS PD, 1995, IMMUNOGLOBULIN GENES, P1; CAMPANA D, 1993, BLOOD, V81, P1025; Castigli E, 1996, INT IMMUNOL, V8, P405, DOI 10.1093/intimm/8.3.405; CHEN JZ, 1993, CURR OPIN IMMUNOL, V5, P194, DOI 10.1016/0952-7915(93)90004-C; CHERAYIL BJ, 1991, J EXP MED, V173, P111, DOI 10.1084/jem.173.1.111; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; GRAWUNDER U, 1993, INT IMMUNOL, V5, P1609, DOI 10.1093/intimm/5.12.1609; GREAVES M, 1993, BLOOD, V82, P1043; GREAVES MF, 1986, SCIENCE, V234, P697, DOI 10.1126/science.3535067; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hunger SP, 1996, BLOOD, V87, P1211, DOI 10.1182/blood.V87.4.1211.bloodjournal8741211; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Krop I, 1996, J IMMUNOL, V157, P48; LANSFORD R, 1996, MOL IMMUNOL, P1; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; MA A, 1992, EMBO J, V11, P2727, DOI 10.1002/j.1460-2075.1992.tb05338.x; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MEICHERS F, 1995, IMMUNOGLUBULIN GENES, P33; MISENER V, 1991, INT IMMUNOL, V3, P1129, DOI 10.1093/intimm/3.11.1129; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKANISHI K, 1992, P NATL ACAD SCI USA, V89, P3551, DOI 10.1073/pnas.89.8.3551; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; PARKS DR, 1986, HDB EXPT IMMUNOLOGY; PARROTT DMV, 1966, J EXP MED, V123, P191, DOI 10.1084/jem.123.1.191; PECANHA LMT, 1991, J IMMUNOL, V146, P833; Picker Louis J., 1993, P145; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; RETH MG, 1985, NATURE, V317, P353, DOI 10.1038/317353a0; ROLINK A, 1993, CURR OPIN IMMUNOL, V5, P207, DOI 10.1016/0952-7915(93)90006-E; ROLINK A, 1993, EUR J IMMUNOL, V23, P1284, DOI 10.1002/eji.1830230614; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0; TAKEMORI T, 1990, EMBO J, V9, P2493, DOI 10.1002/j.1460-2075.1990.tb07428.x; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	64	52	52	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1997	6	1					23	33		10.1016/S1074-7613(00)80239-3	http://dx.doi.org/10.1016/S1074-7613(00)80239-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052834	Bronze			2022-12-18	WOS:A1997XB16100003
J	Akashi, K; Weissman, IL				Akashi, K; Weissman, IL			The c-kit(+) maturation pathway in mouse thymic T cell development: Lineages and selection	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DOUBLE-POSITIVE THYMOCYTES; NEGATIVE SELECTION; C-KIT; CD4+8+ THYMOCYTES; TRANSGENIC MICE; DEFICIENT MICE; CD8 LINEAGE; INTERLEUKIN-7 RECEPTOR; INTERMEDIATE STEPS	Positive selection of T cells begins with TCR alpha beta(lo) thymic progenitors. Here, we show that the most efficient TCR(lo) progenitors are c-kit(+) with intermediate levels of CD4 and CD8 (DPint). Positive selection of DPint TCR(lo) c-kit(+) cells results in TCR(med) CD69(+) c-kit(+) transitional intermediates that show increased TCRV beta frequencies to selecting superantigen (SAg) that are committed to the CD4 or CD8 pathway. The cells on the c-kit(+) maturation pathway maintain Bcl-2 expression. Most DPint c-kit(+) progenitors fail positive selection, and become DPhi c-kit(+) cells that lose Bcl-2 expression. Some DPhi c-kit blast cells can be salvaged to produce mature single-positive (SP) cells. DPint c-kit(+) maturation to SP cells can occur in <12 hr in vitro on thymic stromal monolayers.	STANFORD UNIV,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305; KYUSHU UNIV,FAC MED,DEPT INTERNAL MED 1,FUKUOKA 812,JAPAN	Stanford University; Kyushu University	Akashi, K (corresponding author), STANFORD UNIV,SCH MED,DEPT PATHOL,STANFORD,CA 94305, USA.				NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER; NCI NIH HHS [CA-42551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADKINS B, 1987, ANNU REV IMMUNOL, V5, P325, DOI 10.1146/annurev.iy.05.040187.001545; ALAM SM, 1995, IMMUNITY, V3, P449; BLACKMAN MA, 1989, SCIENCE, V244, P214, DOI 10.1126/science.2784868; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CRISPE IN, 1987, NATURE, V329, P336, DOI 10.1038/329336a0; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DOMEN J, 1993, J EXP MED, V178, P1665, DOI 10.1084/jem.178.5.1665; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; GODFREY DI, 1992, J IMMUNOL, V149, P2281; GRATIOTDEANS J, 1994, P NATL ACAD SCI USA, V91, P10685, DOI 10.1073/pnas.91.22.10685; GRATIOTDEANS J, 1993, J IMMUNOL, V151, P83; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; GUIDOS CJ, 1989, J IMMUNOL, V142, P3773; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1989, J EXP MED, V169, P1533, DOI 10.1084/jem.169.5.1533; KERSH GJ, 1995, J IMMUNOL, V154, P1057; KISHIMOTO H, 1995, J EXP MED, V181, P649, DOI 10.1084/jem.181.2.649; KRAFT DL, 1993, J EXP MED, V178, P265, DOI 10.1084/jem.178.1.265; KYDD R, 1995, J IMMUNOL, V155, P3806; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; LUCAS B, 1995, J EXP MED, V181, P1623, DOI 10.1084/jem.181.5.1623; Lucas B, 1996, J IMMUNOL, V156, P1743; LUCAS B, 1994, J IMMUNOL, V153, P53; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; LUNDBERG K, 1994, J EXP MED, V179, P1475, DOI 10.1084/jem.179.5.1475; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MARRACK P, 1988, CELL, V53, P627, DOI 10.1016/0092-8674(88)90578-8; MATSUZAKI Y, 1993, J EXP MED, V178, P1238; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; METCALF D, 1966, CANCER RES, V26, P483; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOORE NC, 1994, IMMUNOLOGY, V81, P115; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; PARKS DR, 1984, METHOD ENZYMOL, V108, P197; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; SENMAJUMDAR A, 1992, J EXP MED, V176, P543, DOI 10.1084/jem.176.2.543; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SMALL M, 1984, EUR J IMMUNOL, V14, P936, DOI 10.1002/eji.1830141014; SMALL M, 1989, IMMUNOLOGY, V68, P371; SUDA T, 1991, J IMMUNOL, V146, P3068; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1994, EUR J IMMUNOL, V24, P1010, DOI 10.1002/eji.1830240436; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; VANEWIJK W, 1990, EUR J IMMUNOL, V20, P129, DOI 10.1002/eji.1830200119; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VANMEERWIJK JPM, 1995, J IMMUNOL, V154, P6314; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VASQUEZ NJ, 1994, IMMUNITY, V1, P45, DOI 10.1016/1074-7613(94)90008-6; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; VONBOEHMER H, 1993, J EXP MED, V183, P713; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WEISSMAN IL, 1967, J EXP MED, V126, P291, DOI 10.1084/jem.126.2.291; WEISSMAN IL, 1994, CELL, V76, P207, DOI 10.1016/0092-8674(94)90329-8; WEISSMAN IL, 1973, J EXP MED, V137, P504, DOI 10.1084/jem.137.2.504; WEISSMAN IL, 1975, J MED SCI, V11, P884; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; ZUNIGAPFLUCKER JC, 1989, NATURE, V338, P76, DOI 10.1038/338076a0	79	52	53	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					147	161		10.1016/S1074-7613(00)80491-4	http://dx.doi.org/10.1016/S1074-7613(00)80491-4			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769478	Bronze			2022-12-18	WOS:A1996VE58900005
J	NAUJOKAS, MF; ARNESON, LS; FINESCHI, B; PETERSON, ME; SITTERDING, S; HAMMOND, AT; REILLY, C; LO, D; MILLER, J				NAUJOKAS, MF; ARNESON, LS; FINESCHI, B; PETERSON, ME; SITTERDING, S; HAMMOND, AT; REILLY, C; LO, D; MILLER, J			POTENT EFFECTS OF LOW-LEVELS OF MHC CLASS II-ASSOCIATED INVARIANT CHAIN ON CD4(+) T-CELL DEVELOPMENT	IMMUNITY			English	Article							COMPLEX CLASS-II; CHONDROITIN SULFATE PROTEOGLYCAN; RECEPTOR-BEARING THYMOCYTES; ALPHA-BETA-HETERODIMERS; HLA-DR MOLECULES; POSITIVE SELECTION; ANTIGEN PRESENTATION; SURFACE EXPRESSION; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM	Invariant chain (li)-negative mice exhibit defects in MHC class II assembly and transport that results in reduced levels of surface class II, altered antigen presentation, and inefficient positive selection of CD4(+) T cells. Many CD4(+) T cells that do mature in ii-negative mice express a cell surface phenotype consistent with aberrant positive selection or peripheral activation. Reconstitution of these mice with low levels of either the p31 or p41 form of ii does not restore transport of the bulk of class II or class II surface expression, but surprisingly does restore positive selection as measured by numbers and surface phenotype of CD4(+) T cells. Thus, an ii-dependent process, independent of effects on class II surface density, appears to be required for normal positive selection of CD4(+) T cells.	UNIV CHICAGO, DEPT PHARMACOL & PHYSIOL SCI, CHICAGO, IL 60637 USA; Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	University of Chicago; Scripps Research Institute	NAUJOKAS, MF (corresponding author), UNIV CHICAGO, DEPT MOLEC GENET & CELL BIOL, 920 E 58TH ST, CHICAGO, IL 60637 USA.				NCI NIH HHS [CA-14599] Funding Source: Medline; NIGMS NIH HHS [GM-07183, GM-42071] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042071, T32GM007183] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; ANDERSON MS, 1993, J EXP MED, V178, P1959, DOI 10.1084/jem.178.6.1959; ARNESON LS, 1995, J CELL BIOL, V129, P1217, DOI 10.1083/jcb.129.5.1217; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; ASHTONRICKARDT PG, 1993, IMMUNOL REV, V135, P157, DOI 10.1111/j.1600-065X.1993.tb00648.x; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; BERTOLINO P, 1991, INT IMMUNOL, V3, P435, DOI 10.1093/intimm/3.5.435; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BIKOFF EK, 1995, IMMUNITY, V2, P301, DOI 10.1016/1074-7613(95)90054-3; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; BOGEN B, 1992, EUR J IMMUNOL, V22, P703, DOI 10.1002/eji.1830220313; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; BRADLEY LM, 1993, J IMMUNOL, V150, P3119; BRADLEY LM, 1992, J IMMUNOL, V148, P324; CARDELL S, 1995, IN PRESS J EXP MED; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CHERVONSKY AV, 1994, INT IMMUNOL, V6, P973, DOI 10.1093/intimm/6.7.973; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; FERBER I, 1994, SCIENCE, V263, P674, DOI 10.1126/science.8303275; FINK PJ, 1994, J IMMUNOL, V152, P4270; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GILFILLAN S, 1991, J IMMUNOL, V147, P4074; GODFREY DI, 1994, J IMMUNOL, V152, P4783; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUMBERT M, 1993, EUR J IMMUNOL, V23, P3158, DOI 10.1002/eji.1830231218; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KAMPGEN E, 1991, P NATL ACAD SCI USA, V88, P3014, DOI 10.1073/pnas.88.8.3014; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; KOCH N, 1982, NATURE, V299, P644, DOI 10.1038/299644a0; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LOSS GE, 1993, J IMMUNOL, V150, P3187; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MALCHEREK G, 1995, J EXP MED, V181, P527, DOI 10.1084/jem.181.2.527; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MILLER J, 1988, P NATL ACAD SCI USA, V85, P1359, DOI 10.1073/pnas.85.5.1359; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOMBURG F, 1993, J EXP MED, V178, P1453, DOI 10.1084/jem.178.4.1453; MORTON PA, 1995, J IMMUNOL, V154, P137; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; NADIMI F, 1991, EUR J IMMUNOL, V21, P1255, DOI 10.1002/eji.1830210524; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; NGUYEN QV, 1989, J BIOL CHEM, V264, P1631; NIJENHUIS M, 1994, EUR J IMMUNOL, V24, P247, DOI 10.1002/eji.1830240139; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; PIETERS J, 1993, J CELL SCI, V106, P831; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; RATH S, 1992, EUR J IMMUNOL, V22, P2121, DOI 10.1002/eji.1830220824; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SALAMERO J, 1990, EMBO J, V9, P3489, DOI 10.1002/j.1460-2075.1990.tb07557.x; SANT AJ, 1985, J IMMUNOL, V135, P416; SANT AJ, 1994, CURR OPIN IMMUNOL, V6, P57, DOI 10.1016/0952-7915(94)90034-5; SANT AJ, 1985, J EXP MED, V162, P1916, DOI 10.1084/jem.162.6.1916; SCHAIFF WT, 1991, J IMMUNOL, V147, P603; SCHAIFF WT, 1992, J EXP MED, V176, P657, DOI 10.1084/jem.176.3.657; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; SIMONSEN A, 1993, INT IMMUNOL, V5, P903, DOI 10.1093/intimm/5.8.903; SPAIN LM, 1994, J IMMUNOL, V152, P1709; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; TOURNE S, 1995, IN PRESS EUR J IMMUN; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; YAMAMOTO K, 1985, J IMMUNOL, V134, P3461; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	99	52	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1995	3	3					359	372		10.1016/1074-7613(95)90120-5	http://dx.doi.org/10.1016/1074-7613(95)90120-5			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7553000	Bronze			2022-12-18	WOS:A1995RX64500010
J	DECKER, DJ; LINTON, PJ; ZAHAREVITZ, S; BIERY, M; GINGERAS, TR; KLINMAN, NR				DECKER, DJ; LINTON, PJ; ZAHAREVITZ, S; BIERY, M; GINGERAS, TR; KLINMAN, NR			DEFINING SUBSETS OF NAIVE AND MEMORY B-CELLS BASED ON THE ABILITY OF THEIR PROGENY TO SOMATICALLY MUTATE IN-VITRO	IMMUNITY			English	Article							GERMINAL-CENTERS; IMMUNE-RESPONSE; INVITRO AMPLIFICATION; NUCLEIC-ACIDS; MATURATION; (4-HYDROXY-3-NITROPHENYL)ACETYL; SUBPOPULATIONS; REPLICATION; EXPRESSION; DIVERSITY	The increased affinity of memory antibody responses is due largely to the generation and selection of memory a cells that accumulate somatic mutations after initial antigenic stimulation. Further affinity maturation and mutation also accompany subsequent immunizations. Previous studies have suggested that, like primary antibody-forming eel (AFC) clones, secondary AFC do not accumulate further mutations and, therefore, the origins of progressive affinity maturation remain controversial, Here, we report the generation of somatically mutated memory B cell clones in vitro. Our findings confirm the existence of a naive B cell subset whose progeny, rather than generating AFC, somatically mutate and respond to subsequent antigenic stimulation. Interestingly, upon stimulation, a subset of memory B cells also generates antigen-responsive cells that accumulate further somatic mutations.	BAXTER DIAGNOST INC, LIFE SCI RES LAB, SAN DIEGO, CA 92121 USA		DECKER, DJ (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.			Gingeras, Thomas/0000-0001-9106-3573; Biery, Matthew/0000-0003-3315-982X	NIAID NIH HHS [AI-15797] Funding Source: Medline; NIA NIH HHS [AG-01743] Funding Source: Medline; PHS HHS [I32-A900080] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015797, R37AI015797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001743] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BOTHWELL ALM, 1984, BIOL IDIOTYPES, P19; BRUCE J, 1981, J IMMUNOL, V127, P2496; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; Decker Debra J., 1993, V2, P197; ELSEN HN, 1964, BIOCHEMISTRY-US, V3, P996; GINGERAS TR, 1990, ANN BIOL CLIN-PARIS, V48, P498; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Kabat EA, 1991, SEQUENCES PROTEINS I; KLINMAN NR, 1994, CURR OPIN IMMUNOL, V6, P420, DOI 10.1016/0952-7915(94)90121-X; KLINMAN NR, 1966, J IMMUNOL, V96, P587; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LINTON PJ, 1992, EUR J IMMUNOL, V22, P1293, DOI 10.1002/eji.1830220526; LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; MAKELA O, 1977, IMMUNOL REV, V34, P119, DOI 10.1111/j.1600-065X.1977.tb00370.x; MALLPIERO UV, 1987, IMMUNOL REV, V96, P59; MANSER T, 1987, IMMUNOL REV, V96, P141, DOI 10.1111/j.1600-065X.1987.tb00513.x; RILEY RL, 1985, J IMMUNOL, V135, P3050; SAKAI RK, 1988, SCIENCE, V239, P487; SHIOMCHIK MJ, 1989, PROGR IMMUNOLOGY, V7, P415; SIEKEVITZ M, 1987, CELL, V48, P757, DOI 10.1016/0092-8674(87)90073-0; STILLMAN CA, 1994, PCR METH APPL, V3, P320; VANEWIJK W, 1988, CELL, V53, P357, DOI 10.1016/0092-8674(88)90156-0; WU PQ, 1993, J IMMUNOL, V150, P3862; YIN XM, 1992, INT IMMUNOL, V4, P691, DOI 10.1093/intimm/4.6.691	37	52	52	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1995	2	2					195	203		10.1016/S1074-7613(95)80092-1	http://dx.doi.org/10.1016/S1074-7613(95)80092-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7534621	Bronze			2022-12-18	WOS:A1995QH13200008
J	COLBERT, RA; ROWLANDJONES, SL; MCMICHAEL, AJ; FRELINGER, JA				COLBERT, RA; ROWLANDJONES, SL; MCMICHAEL, AJ; FRELINGER, JA			DIFFERENCES IN PEPTIDE PRESENTATION BETWEEN B27 SUBTYPES - THE IMPORTANCE OF THE P1 SIDE-CHAIN IN MAINTAINING HIGH-AFFINITY PEPTIDE BINDING TO B-ASTERISK-2703	IMMUNITY			English	Article							MHC CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL RECOGNITION; HLA-B27 SUBTYPES; LYMPHOCYTES-T; ANKYLOSING-SPONDYLITIS; INFLAMMATORY DISEASE; MONOCLONAL-ANTIBODY; ENDOGENOUS PEPTIDES; ANTIGEN EXPRESSION	Susceptibility to spondyloarthropathies is strongly associated with the MHC class I molecule HLA-B27, and is hypothesized to result from the presentation of arthritogenic peptides. Subtypes of B27 that differ structurally but are disease-associated ought to be capable of presenting such peptides, while nondisease-associated subtypes would not. We demonstrate that B*2703, the predominant West African B27 subtype that may not predispose to disease, is not recognized by most B*2705-alloreactive CTL, and does not efficiently present a known B*2705-restricted influenza A nucleoprotein (NP) peptide. We show inefficient presentation is due to a reduced binding affinity of B*2703 for the NP peptide. Furthermore, substituting Arg for the naturally occurring Ser at P1 of the NP peptide, restores high affinity binding and efficient presentation by B*2703. Our results suggest that B*2703 will bind and present efficiently only a subset of the peptides that bind to B*2705, in particular those with Arg or Lys at P1. The apparent lack of disease in individuals with B*2703 may be due to an inability to bind and present putative arthritogenic peptides.	UNIV OXFORD, INST MOLEC MED, OXFORD OX3 9DU, ENGLAND	University of Oxford	COLBERT, RA (corresponding author), UNIV N CAROLINA, DEPT MICROBIOL & IMMUNOL, CHAPEL HILL, NC 27599 USA.		Frelinger, Jeffrey A/F-2448-2014	Frelinger, Jeffrey A/0000-0002-2503-6267	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020288, R01AI020288, R01AI029324] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-29324, AI-20288] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLUESTONE JA, 1993, J IMMUNOL, V151, P3943; BOWNESS P, 1993, EUR J IMMUNOL, V23, P1417, DOI 10.1002/eji.1830230702; BREBAN M, 1993, J EXP MED, V178, P1607, DOI 10.1084/jem.178.5.1607; BREUNING MH, 1982, HUM IMMUNOL, V5, P259, DOI 10.1016/0198-8859(82)90018-0; BREURVRIESENDORP BS, 1987, ANN RHEUM DIS, V46, P353, DOI 10.1136/ard.46.5.353; BREURVRIESENDORP BS, 1990, SCAND J RHEUMATOL, P36; BREWERTON DA, 1973, LANCET, V1, P904; BROOKS JM, 1993, J EXP MED, V178, P879, DOI 10.1084/jem.178.3.879; CALVO V, 1990, J IMMUNOL, V144, P4038; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; CHEN BP, 1990, J EXP MED, V172, P931, DOI 10.1084/jem.172.3.931; CHEN W, 1993, J EXP MED, V177, P869, DOI 10.1084/jem.177.3.869; CHOO SY, 1988, HUM IMMUNOL, V21, P209; CHOO SY, 1991, J IMMUNOL, V147, P174; CHOPPIN J, 1990, J EXP MED, V172, P889, DOI 10.1084/jem.172.3.889; COLBERT RA, 1993, P NATL ACAD SCI USA, V90, P6879, DOI 10.1073/pnas.90.14.6879; DECASTRO JAL, 1989, IMMUNOL TODAY, V10, P239, DOI 10.1016/0167-5699(89)90261-2; DeMars R, 1992, Trends Cell Biol, V2, P81, DOI 10.1016/0962-8924(92)90077-Z; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; ELVIN J, 1993, J IMMUNOL METHODS, V158, P161, DOI 10.1016/0022-1759(93)90210-X; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; FRELINGER JA, 1990, J EXP MED, V172, P827, DOI 10.1084/jem.172.3.827; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; HILL A, 1993, IMMUNOGENETICS, V37, P95; HILL AVS, 1991, LANCET, V337, P640, DOI 10.1016/0140-6736(91)92452-8; HUCZKO EL, 1993, J IMMUNOL, V151, P2572; HUET S, 1990, INT IMMUNOL, V2, P311, DOI 10.1093/intimm/2.4.311; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KHAN MA, 1992, RHEUM DIS CLIN N AM, V18, P1; LATRON F, 1992, SCIENCE, V257, P964, DOI 10.1126/science.1380181; LOPEZ D, 1992, J IMMUNOL, V148, P996; MACLEAN L, 1992, ANN RHEUM DIS, V51, P929, DOI 10.1136/ard.51.8.929; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MATSUI M, 1993, P NATL ACAD SCI USA, V90, P674, DOI 10.1073/pnas.90.2.674; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MURRAY R, 1990, CELL IMMUNOL, V128, P220, DOI 10.1016/0008-8749(90)90020-R; NEEFJES JJ, 1986, HUM IMMUNOL, V16, P169, DOI 10.1016/0198-8859(86)90046-7; PARHAM P, 1979, J IMMUNOL, V123, P342; PARKER KC, 1992, J IMMUNOL, V149, P3580; PAZMANY L, 1992, J EXP MED, V175, P361, DOI 10.1084/jem.175.2.361; ROJO S, 1993, J EXP MED, V177, P613, DOI 10.1084/jem.177.3.613; ROTZSCHKE O, 1994, IMMUNOGENETICS, V39, P74; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; TAUROG JD, 1993, J IMMUNOL, V150, P4168; TOUBERT A, 1984, IMMUNOGENETICS, V20, P513, DOI 10.1007/BF00364354; VEGA MA, 1985, J IMMUNOL, V135, P3323; VILLADANGOS JA, 1992, J IMMUNOL, V149, P505; VYAS JM, 1992, J IMMUNOL, V149, P3605; WARBURTON RJ, 1994, IN PRESS HUM IMMUNOL, V39; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403; ZWEERINK HJ, 1993, J IMMUNOL, V150, P1763	70	52	52	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1994	1	2					121	130		10.1016/1074-7613(94)90105-8	http://dx.doi.org/10.1016/1074-7613(94)90105-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7889404				2022-12-18	WOS:A1994PK16200004
J	Quast, I; Tarlinton, D				Quast, Isaak; Tarlinton, David			B cell memory: understanding COVID-19	IMMUNITY			English	Editorial Material								Immunological memory is a mechanism to protect us against reinfection. Antibodies produced by B cells are integral to this defense strategy and underlie virtually all vaccine success. Here, we explain how B cell memory is generated by infection and vaccination, what influences its efficacy and its persistence, and how characterizing these parameters in the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will help achieve protective immunity through vaccination.	[Quast, Isaak; Tarlinton, David] Monash Univ, Dept Pathol & Immunol, 89 Commercial Rd, Melbourne, Vic 3004, Australia	Monash University	Tarlinton, D (corresponding author), Monash Univ, Dept Pathol & Immunol, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	david.tarlinton@monash.edu	Quast, Isaak/ABG-5301-2021	Quast, Isaak/0000-0001-6517-8537; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) Australia Investigator Award [APP1175411]; Swiss National Science Foundation [P2ZHP3_164964, P300PA_177893]; NHMRC Australia [APP1145136]	National Health and Medical Research Council (NHMRC) Australia Investigator Award(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	D.T. was funded by National Health and Medical Research Council (NHMRC) Australia Investigator Award (APP1175411) and I.Q. by an Early Postdoc Mobility fellowship (P2ZHP3_164964) and an Advanced Postdoc Mobility fellowship (P300PA_177893) provided by the Swiss National Science Foundation and a Peter Doherty Early Career fellowship (APP1145136) provided by NHMRC Australia.	Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Robinson MJ, 2020, IMMUNOL REV, V296, P87, DOI 10.1111/imr.12895; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.21203/rs.3.rs-57112/v1, 10.1101/2020.08.11.20171843]; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531	13	51	51	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					205	210		10.1016/j.immuni.2021.01.014	http://dx.doi.org/10.1016/j.immuni.2021.01.014		FEB 2021	6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33513337	Bronze, Green Published			2022-12-18	WOS:000627407700006
J	Liu, HJ; Wu, NC; Yuan, M; Bangaru, S; Torres, JL; Caniels, TG; van Schooten, J; Zhu, XY; Lee, CCD; Brouwer, PJM; van Gils, MJ; Sanders, RW; Ward, AB; Wilson, IA				Liu, Hejun; Wu, Nicholas C.; Yuan, Meng; Bangaru, Sandhya; Torres, Jonathan L.; Caniels, Tom G.; van Schooten, Jelle; Zhu, Xueyong; Lee, Chang-Chun D.; Brouwer, Philip J. M.; van Gils, Marit J.; Sanders, Rogier W.; Ward, Andrew B.; Wilson, Ian A.			Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity	IMMUNITY			English	Article							SARS CORONAVIRUS; INFLUENZA; BINDING; DESIGN; DOMAIN; PROTEIN; EPITOPE	Most antibodies isolated from individuals with coronavirus disease 2019 (COVID-19) are specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, COVA1-16 is a relatively rare antibody that also cross-neutralizes SARS-CoV. Here, we determined a crystal structure of the COVA1-16 antibody fragment (Fab) with the SARS-CoV-2 receptor-binding domain (RBD) and negative-stain electron microscopy reconstructions with the spike glycoprotein trimer to elucidate the structural basis of its cross-reactivity. COVA1-16 binds a highly conserved epitope on the SARS-CoV-2 RBD, mainly through a long complementarity-determining region (CDR) H3, and competes with the angiotensin-converting enzyme 2 (ACE2) receptor because of steric hindrance rather than epitope overlap. COVA1-16 binds to a flexible up conformation of the RBD on the spike and relies on antibody avidity for neutralization. These findings, along with the structural and functional rationale for epitope conservation, provide insights for development of more universal SARS-like coronavirus vaccines and therapies.	[Liu, Hejun; Wu, Nicholas C.; Yuan, Meng; Bangaru, Sandhya; Torres, Jonathan L.; Zhu, Xueyong; Lee, Chang-Chun D.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Caniels, Tom G.; van Schooten, Jelle; Brouwer, Philip J. M.; van Gils, Marit J.; Sanders, Rogier W.] Univ Amsterdam, Dept Med Microbiol, Amsterdam UMC, Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Consortium HIV AIDS Vaccine Dev CHAVD, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; University of Amsterdam; Cornell University; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Consortium HIV AIDS Vaccine Dev CHAVD, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu	Yuan, Meng/I-1690-2012; van Gils, Marit J./H-4791-2019; Zhu, Xueyong/ABE-3068-2021; Liu, Hejun/L-9969-2014; Ward, Andrew/ABD-7728-2021; Wu, Nicholas/H-3822-2015	Yuan, Meng/0000-0001-9754-4503; van Gils, Marit J./0000-0003-3422-8161; Liu, Hejun/0000-0002-2412-7853; Ward, Andrew/0000-0001-7153-3769; Wu, Nicholas/0000-0002-9078-6697	NIH [K99 AI139445]; Bill and Melinda Gates Foundation [OPP1170236, OPP1132237, INV-002022]; NIH HIVRAD [P01 AI110657]; NIH CHAVD [UM1 AI44462]; Netherlands Organisation for Scientific Research (NWO) Vici grant; Fondation Dormeur, Vaduz; Health-Holland PPS allowance [LSHM20040]; AMC; COVID-19 grant from the Amsterdam Institute of Infection and Immunity; 2017 AMC PhD scholarship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH HIVRAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CHAVD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research (NWO) Vici grant(Netherlands Organization for Scientific Research (NWO)); Fondation Dormeur, Vaduz; Health-Holland PPS allowance; AMC; COVID-19 grant from the Amsterdam Institute of Infection and Immunity; 2017 AMC PhD scholarship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Henry Tien for technical support with the crystallization robot, Jeanne Matteson and Yuanzi Hua for contributions to mammalian cell culture, Wenli Yu for insect cell culture, Robyn Stanfield for assistance with data collection, and Paul Bieniasz for cells and plasmids for the pseudovirus neutralization assays. We are grateful to the staff of Stanford Synchrotron Radiation Laboratory (SSRL) Beamline 12-1 for assistance. This work was supported by NIH K99 AI139445 (to N.C.W.), the Bill and Melinda Gates Foundation (OPP1170236 to A.B.W. and I.A.W. and OPP1132237 and INV-002022 to R.W.S.), NIH HIVRAD (P01 AI110657 to R.W.S., A.B.W., and I.A.W.), NIH CHAVD (UM1 AI44462 to A.B.W. and I.A.W.), a Netherlands Organisation for Scientific Research (NWO) Vici grant (to R.W.S.), the Fondation Dormeur, Vaduz (to M.J.v.G.), and a Health-Holland PPS allowance (LSHM20040 to M.J.v.G.). M.J. v.G. is a recipient of an AMC fellowship and a COVID-19 grant from the Amsterdam Institute of Infection and Immunity. J.v.S. is a recipient of a 2017 AMC PhD scholarship. Use of the SSRL, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreano E., 2020, IDENTIFICATION NEUTR, DOI 10.1101/2020.05.05.078154; Ashkenazy H., 2016, NUCLEIC ACIDS RES, V44, pW344; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Bajic G, 2019, CELL HOST MICROBE, V25, P827, DOI 10.1016/j.chom.2019.04.003; Bangaru S, 2019, CELL, V177, P1136, DOI 10.1016/j.cell.2019.04.011; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061953; Huo JD, 2020, CELL HOST MICROBE, V28, P445, DOI [10.1016/j.chom.2020.06.010, 10.1016/j.chom.2020.07.002]; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kadam RU, 2017, SCIENCE, V358, P496, DOI 10.1126/science.aan0516; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li Wei, 2020, bioRxiv, DOI 10.1101/2020.05.13.093088; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; Lv Huibin, 2020, bioRxiv, DOI 10.1101/2020.03.15.993097; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan JH, 2020, J MOL BIOL, V432, P1158, DOI 10.1016/j.jmb.2019.11.028; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Schmidt Fabian, 2020, J Exp Med, V217, DOI [10.1101/2020.06.08.140871, 10.1084/jem.20201181]; Seydoux Emilie, 2020, bioRxiv, DOI 10.1101/2020.05.12.091298; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Strauch EM, 2017, NAT BIOTECHNOL, V35, P667, DOI 10.1038/nbt.3907; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Ward AB, 2020, CURR OPIN IMMUNOL, V65, P50, DOI 10.1016/j.coi.2020.03.013; Watanabe A, 2019, CELL, V177, P1124, DOI 10.1016/j.cell.2019.03.048; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu NC, 2020, PLOS PATHOG, V16, DOI [10.1371/journal.ppat.1009089, 10.1101/2020.09.21.305441]; Wu Nicholas C, 2020, bioRxiv, DOI 10.1101/2020.07.26.222232; Wu NC, 2018, NAT STRUCT MOL BIOL, V25, P115, DOI 10.1038/s41594-018-0025-9; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhou DM, 2020, NAT STRUCT MOL BIOL, V27, P950, DOI 10.1038/s41594-020-0480-y; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	71	51	50	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1272	+		10.1016/j.immuni.2020.10.023	http://dx.doi.org/10.1016/j.immuni.2020.10.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT		hybrid, Green Submitted, Green Published			2022-12-18	WOS:000599363300015
J	Gao, YM; Vasic, R; Song, YB; Teng, R; Liu, CY; Gbyli, R; Biancon, G; Nelakanti, R; Lobben, K; Kudo, E; Liu, W; Ardasheva, A; Fu, XY; Wang, XM; Joshi, P; Lee, V; Dura, B; Viero, G; Iwasaki, A; Fan, R; Xiao, A; Flavell, RA; Li, HB; Tebaldi, T; Halene, S				Gao, Yimeng; Vasic, Radovan; Song, Yuanbin; Teng, Rhea; Liu, Chengyang; Gbyli, Rana; Biancon, Giulia; Nelakanti, Raman; Lobben, Kirsten; Kudo, Eriko; Liu, Wei; Ardasheva, Anastasia; Fu, Xiaoying; Wang, Xiaman; Joshi, Poorval; Lee, Veronica; Dura, Burak; Viero, Gabriella; Iwasaki, Akiko; Fan, Rong; Xiao, Andrew; Flavell, Richard A.; Li, Hua-Bing; Tebaldi, Toma; Halene, Stephanie			m(6)A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development	IMMUNITY			English	Article							MESSENGER-RNA; DSRNA RESPONSE; STEM; N-6-METHYLADENOSINE; METHYLATION; DIFFERENTIATION; ACTIVATION; EXPRESSION; GENES; CELLS	N-6-methyladenosine (m(6)A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show that conditional deletion of the m(6)A writer METTL3 in murine fetal liver resulted in hematopoietic failure and perinatal lethality. Loss of METTL3 and m(6)A activated an aberrant innate immune response, mediated by the formation of endogenous double-stranded RNAs (dsRNAs). The aberrantly formed dsRNAs were long, highly m(6)A modified in their native state, characterized by low folding energies, and predominantly protein coding. We identified coinciding activation of pattern recognition receptor pathways normally tasked with the detection of foreign dsRNAs. Disruption of the aberrant immune response via abrogation of downstream Mays or Rnasel signaling partially rescued the observed hematopoietic defects in METTL3-deficient cells in vitro and in vivo. Our results suggest that m(6)A modification protects against endogenous dsRNA formation and a deleterious innate immune response during mammalian hematopoietic development.	[Gao, Yimeng; Vasic, Radovan; Song, Yuanbin; Teng, Rhea; Liu, Chengyang; Gbyli, Rana; Biancon, Giulia; Lobben, Kirsten; Liu, Wei; Ardasheva, Anastasia; Fu, Xiaoying; Wang, Xiaman; Joshi, Poorval; Lee, Veronica; Tebaldi, Toma; Halene, Stephanie] Yale Univ, Yale Canc Ctr, Sect Hematol, Sch Med, New Haven, CT 06520 USA; [Gao, Yimeng; Vasic, Radovan; Song, Yuanbin; Teng, Rhea; Liu, Chengyang; Gbyli, Rana; Biancon, Giulia; Lobben, Kirsten; Liu, Wei; Ardasheva, Anastasia; Fu, Xiaoying; Wang, Xiaman; Joshi, Poorval; Lee, Veronica; Tebaldi, Toma; Halene, Stephanie] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT 06520 USA; [Gao, Yimeng; Vasic, Radovan; Song, Yuanbin; Teng, Rhea; Liu, Chengyang; Gbyli, Rana; Biancon, Giulia; Nelakanti, Raman; Lobben, Kirsten; Liu, Wei; Ardasheva, Anastasia; Fu, Xiaoying; Wang, Xiaman; Joshi, Poorval; Lee, Veronica; Dura, Burak; Fan, Rong; Xiao, Andrew; Tebaldi, Toma; Halene, Stephanie] Yale Univ, Yale Stem Cell Ctr, Sch Med, New Haven, CT 06520 USA; [Gao, Yimeng; Vasic, Radovan; Song, Yuanbin; Teng, Rhea; Liu, Chengyang; Gbyli, Rana; Biancon, Giulia; Lobben, Kirsten; Liu, Wei; Ardasheva, Anastasia; Fu, Xiaoying; Wang, Xiaman; Joshi, Poorval; Lee, Veronica; Dura, Burak; Fan, Rong; Tebaldi, Toma; Halene, Stephanie] Yale Univ, Yale RNA Ctr, Sch Med, New Haven, CT 06520 USA; [Nelakanti, Raman; Xiao, Andrew] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Kudo, Eriko; Iwasaki, Akiko] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Kudo, Eriko; Iwasaki, Akiko; Flavell, Richard A.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Dura, Burak; Fan, Rong] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Dura, Burak; Fan, Rong] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA; [Viero, Gabriella] CNR Unit Trento, Inst Biophys, I-38123 Povo, Italy; [Iwasaki, Akiko; Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Li, Hua-Bing] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, State Key Lab Oncogenes & Related Genes, Sch Med, Shanghai 200025, Peoples R China; [Li, Hua-Bing] Shanghai Jiao Tong Univ, Sch Med, Yale Inst Immune Metab, Shanghai 200025, Peoples R China	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Howard Hughes Medical Institute; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tebaldi, T; Halene, S (corresponding author), Yale Univ, Yale Canc Ctr, Sect Hematol, Sch Med, New Haven, CT 06520 USA.; Tebaldi, T; Halene, S (corresponding author), Yale Univ, Dept Internal Med, Sch Med, New Haven, CT 06520 USA.; Tebaldi, T; Halene, S (corresponding author), Yale Univ, Yale Stem Cell Ctr, Sch Med, New Haven, CT 06520 USA.; Tebaldi, T; Halene, S (corresponding author), Yale Univ, Yale RNA Ctr, Sch Med, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, State Key Lab Oncogenes & Related Genes, Sch Med, Shanghai 200025, Peoples R China.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Yale Inst Immune Metab, Shanghai 200025, Peoples R China.	yimeng.gao@yale.edu; richard.flavell@yale.edu; huabing.li@shsmu.edu.cn; toma.tebaldi@yale.edu; stephanie.halene@yale.edu	Viero, Gabriella/G-2096-2012; Tebaldi, Toma/AAZ-5955-2020; Tebaldi, Toma/AAX-6869-2020; Li, Huabing/M-5390-2013	Viero, Gabriella/0000-0002-6755-285X; Tebaldi, Toma/0000-0002-0625-1631; Tebaldi, Toma/0000-0002-0625-1631; Ardasheva, Anastasia/0000-0001-5525-3564; Song, Yuanbin/0000-0001-5580-5998; Teng, Rhea/0000-0001-7924-0506; Lee, Veronica/0000-0002-4886-8621; Nelakanti, Raman/0000-0002-2085-4236; Joshi, Poorval/0000-0001-7886-9994; Li, Huabing/0000-0003-3573-6803; Liu, Chengyang/0000-0003-1005-8196	State of Connecticut under the Regenerative Medicine Research Fund; NIH/NIDDK [R01DK102792]; Frederick A. Deluca Foundation; National Natural Science Foundation of China [81801588, 91753141]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Howard Hughes Medical Institute; James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowships; American Society of Hematology Physician Scientist Career Development Award; William U. Gardner Memorial Student Research Fellowship; Yale Cooperative Center of Excellence in Hematology (YCCEH) (NIDDK) [U54DK106857]; CNR Short Term Mobility 2018; Young Scientists Fund of the National Natural Science Foundation of China [81800122]; Animal Modeling Core of the Yale Cooperative Center of Excellence in Hematology (NIDDK) [U54DK106857]	State of Connecticut under the Regenerative Medicine Research Fund; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Frederick A. Deluca Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Howard Hughes Medical Institute(Howard Hughes Medical Institute); James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowships; American Society of Hematology Physician Scientist Career Development Award; William U. Gardner Memorial Student Research Fellowship; Yale Cooperative Center of Excellence in Hematology (YCCEH) (NIDDK); CNR Short Term Mobility 2018; Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Animal Modeling Core of the Yale Cooperative Center of Excellence in Hematology (NIDDK)	We thank A. Brooks for research histology services. We thank Christopher Castaldi at the Yale Center for Genome Analysis (YCGA) for valuable advice and high-throughput sequencing and the Yale University High Performance Computing Center for use of clusters to run bioinformatics analysis. We thank Jun Zhao, Department of Pathology, Yale University School of Medicine, for her help with the single-cell RNA-seq analysis. We thank Grace Chen, Department of Immunobiology, Yale University School of Medicine, for the fruitful discussion regarding circular RNAs. We thank Shirui Chen, University of Tokyo, for her help with the J2 RIP-seq experiment. This study was supported in part by the State of Connecticut under the Regenerative Medicine Research Fund (to S.H.; its contents are solely the responsibility of the authors and do not necessarily represent the official views of the State of Connecticut or Connecticut Innovations), the NIH/NIDDK R01DK102792 (to S.H.), the Frederick A. Deluca Foundation (to S.H.), the National Natural Science Foundation of China (91753141 to H.-B.L.), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (to H.-B.L.), and the Howard Hughes Medical Institute (to R.A.F). Y.G. was supported by the James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowships. R.V. was supported by the American Society of Hematology Physician Scientist Career Development Award and the William U. Gardner Memorial Student Research Fellowship. T.T. was supported by a pilot grant from the Yale Cooperative Center of Excellence in Hematology (YCCEH) (NIDDK U54DK106857). G.V. was supported by CNR Short Term Mobility 2018. Y.S. was supported by the Young Scientists Fund of the National Natural Science Foundation of China (grant no. 81800122). X.F. was supported by the National Natural Science Foundation of China (no. 81801588). This study was supported by the Animal Modeling Core of the Yale Cooperative Center of Excellence in Hematology (NIDDK U54DK106857).	Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586; Barbieri P, 2017, MEAS OPER PERFORM, P3, DOI 10.1007/978-3-319-58883-4_1; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bertero A, 2018, NATURE, V555, P256, DOI 10.1038/nature25784; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Blango MG, 2016, GENOME RES, V26, P852, DOI 10.1101/gr.203992.116; Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792; Chen YG, 2019, MOL CELL, V76, P96, DOI 10.1016/j.molcel.2019.07.016; Cheng Y., 2019, CELL REP, V28; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; Dahlin JS, 2018, BLOOD, V131, pE1, DOI 10.1182/blood-2017-12-821413; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Donovan J, 2017, RNA, V23, P1660, DOI 10.1261/rna.062000.117; Dura B, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky1173; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Guo YL, 2015, STEM CELLS, V33, P3165, DOI 10.1002/stem.2079; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li Y, 2017, ELIFE, V6, DOI [10.7554/eLife.29914, 10.7554/eLife.25687]; Li ZR, 2018, CELL RES, V28, P904, DOI 10.1038/s41422-018-0072-0; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu JE, 2020, MOL CELL, V77, P426, DOI 10.1016/j.molcel.2019.09.032; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Lv JH, 2018, CELL RES, V28, P249, DOI 10.1038/cr.2017.143; Lybecker M, 2014, P NATL ACAD SCI USA, V111, P3134, DOI 10.1073/pnas.1315974111; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Nicolet BP, 2018, NUCLEIC ACIDS RES, V46, P8168, DOI 10.1093/nar/gky721; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Pulit-Penaloza JA, 2012, VIROLOGY, V425, P82, DOI 10.1016/j.virol.2012.01.006; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Raveh T, 1996, J BIOL CHEM, V271, P25479, DOI 10.1074/jbc.271.41.25479; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tong JY, 2018, CELL RES, V28, P253, DOI 10.1038/cr.2018.7; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2018, NAT NEUROSCI, V21, P195, DOI 10.1038/s41593-017-0057-1; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z; Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018; Xiang JF, 2018, MOL CELL, V69, P126, DOI 10.1016/j.molcel.2017.12.006; Yockey LJ, 2018, IMMUNITY, V49, P397, DOI 10.1016/j.immuni.2018.07.017; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou KI, 2016, J MOL BIOL, V428, P822, DOI 10.1016/j.jmb.2015.08.021	66	51	52	5	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1007	+		10.1016/j.immuni.2020.05.003	http://dx.doi.org/10.1016/j.immuni.2020.05.003			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32497523	Bronze, Green Accepted			2022-12-18	WOS:000541890000015
J	Mohamed, E; Sierra, RA; Trillo-Tinoco, J; Cao, Y; Innamarato, P; Payne, KK; Pulido, AD; Mandula, J; Zhang, SZ; Thevenot, P; Biswas, S; Abdalla, SK; Costich, TL; Hanggi, K; Anadon, CM; Flores, ER; Haura, EB; Mehrotra, S; Pilon-Thomas, S; Ruffell, B; Munn, DH; Cubillos-Ruiz, JR; Conejo-Garcia, JR; Rodriguez, PC				Mohamed, Eslam; Sierra, Rosa A.; Trillo-Tinoco, Jimena; Cao, Yu; Innamarato, Patrick; Payne, Kyle K.; Pulido, Alvaro de Mingo; Mandula, Jessica; Zhang, Shuzhong; Thevenot, Paul; Biswas, Subir; Abdalla, Sarah K.; Costich, Tara Lee; Hanggi, Kay; Anadon, Carmen M.; Flores, Elsa R.; Haura, Eric B.; Mehrotra, Shikhar; Pilon-Thomas, Shari; Ruffell, Brian; Munn, David H.; Cubillos-Ruiz, Juan R.; Conejo-Garcia, Jose R.; Rodriguez, Paulo C.			The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling	IMMUNITY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR XBP1; SUPPRESSOR-CELLS; ER STRESS; ANTITUMOR IMMUNITY; MITOCHONDRIAL-DNA; ACTIVATION; RECEPTOR; DIFFERENTIATION; PROGRESSION	The primary mechanisms supporting immunoregulatory polarization of myeloid cells upon infiltration into tumors remain largely unexplored. Elucidation of these signals could enable better strategies to restore protective anti-tumor immunity. Here, we investigated the role of the intrinsic activation of the PKR-like endoplasmic reticulum (ER) kinase (PERK) in the immunoinhibitory actions of tumor-associated myeloid-derived suppressor cells (tumor-MDSCs). PERK signaling increased in tumorMDSCs, and its deletion transformed MDSCs into myeloid cells that activated CD8(+) T cell-mediated immunity against cancer. Tumor-MDSCs lacking PERK exhibited disrupted NRF2-driven antioxidant capacity and impaired mitochondrial respiratory homeostasis. Moreover, reduced NRF2 signaling in PERK-deficient MDSCs elicited cytosolic mitochondrial DNA elevation and, consequently, STING-dependent expression of anti-tumor type I interferon. Reactivation of NRF2 signaling, conditional deletion of STING, or blockade of type I interferon receptor I restored the immunoinhibitory potential of PERK-ablated MDSCs. Our findings demonstrate the pivotal role of PERK in tumor-MDSC functionality and unveil strategies to reprogram immunosuppressive myelopoiesis in tumors to boost cancer immunotherapy.	[Mohamed, Eslam; Sierra, Rosa A.; Cao, Yu; Innamarato, Patrick; Payne, Kyle K.; Pulido, Alvaro de Mingo; Mandula, Jessica; Biswas, Subir; Abdalla, Sarah K.; Costich, Tara Lee; Hanggi, Kay; Anadon, Carmen M.; Pilon-Thomas, Shari; Ruffell, Brian; Conejo-Garcia, Jose R.; Rodriguez, Paulo C.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Trillo-Tinoco, Jimena] Bristol Myers Squibb, Devens, MA 01434 USA; [Zhang, Shuzhong] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Thevenot, Paul] Ochsner Hlth Syst, Inst Translat Res, New Orleans, LA 70121 USA; [Flores, Elsa R.; Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Mehrotra, Shikhar] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Munn, David H.] Augusta Univ, Dept Pediat, Georgia Canc Ctr, Augusta, GA 30912 USA; [Cubillos-Ruiz, Juan R.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY 10065 USA; [Cubillos-Ruiz, Juan R.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA	H Lee Moffitt Cancer Center & Research Institute; Bristol-Myers Squibb; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Ochsner Health System; H Lee Moffitt Cancer Center & Research Institute; Medical University of South Carolina; University System of Georgia; Augusta University; Cornell University; Cornell University	Rodriguez, PC (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	Paulo.Rodriguez@Moffitt.org	Conejo-Garcia, Jose R/V-1897-2019; BISWAS, SUBIR/AAZ-6856-2021; De Mingo Pulido, Alvaro/AAK-4809-2021; Rodríguez, Paulo/HDM-9539-2022; de Mingo Pulido, Alvaro/AAU-7552-2021	Conejo-Garcia, Jose R/0000-0001-6431-4074; BISWAS, SUBIR/0000-0003-2428-6288; De Mingo Pulido, Alvaro/0000-0001-9814-1837; Trillo-Tinoco, Jimena/0000-0002-1240-9650; Mandula, Jessica/0000-0003-2542-8073; Rodriguez, Paulo/0000-0001-7480-6566; Payne, Kyle/0000-0002-6531-9835; Munn, David/0000-0002-7711-2858; Hanggi, Kay/0000-0003-1435-3707; Anadon Galindo, Carmen Maria/0000-0002-8851-4545; Ruffell, Brian/0000-0002-3846-6872; Innamarato, Patrick/0000-0001-7601-1134	Moffitt Cancer Center [CCSG-CA076292]; NIH [R01CA184185, R01CA233512, R01CA103320, R01CA211229, R01CA157664, R01CA124515, R01CA178687]; Department of Defense (DOD) Ovarian Cancer Academy [W81XWH-16-1-0438]; Mark Foundation ASPIRE Award; Pershing Square Sohn Cancer Research Alliance; Stand Up to Cancer Phillip A. Sharp Award	Moffitt Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD) Ovarian Cancer Academy; Mark Foundation ASPIRE Award; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); Stand Up to Cancer Phillip A. Sharp Award	We thank the Flow Cytometry Core, the Tissue Imaging Core, and the Analytic Microscopy Core, all from Moffitt Cancer Center and partially funded through CCSG-CA076292. We also thank J. Francis from the Lung Data Service at Moffitt. This study was supported in part by NIH grants R01CA184185 and R01CA233512 (to P.C.R.); R01CA103320 and R01CA211229 (to D.H.M.); and R01CA157664, R01CA124515, and R01CA178687 (to J.R.C.-G.). J.R.C.-R. was supported by Department of Defense (DOD) Ovarian Cancer Academy grant W81XWH-16-1-0438, the Mark Foundation ASPIRE Award, the Pershing Square Sohn Cancer Research Alliance, and the Stand Up to Cancer Phillip A. Sharp Award.	Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Bettigole SE, 2015, NAT IMMUNOL, V16, P829, DOI 10.1038/ni.3225; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Bhattacharya S, 2013, ONCOGENE, V32, P4214, DOI 10.1038/onc.2012.439; Cao Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09263-1; Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004; Chang TK, 2018, MOL CELL, V71, P629, DOI 10.1016/j.molcel.2018.06.038; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Dong H, 2019, NAT IMMUNOL, V20, P865, DOI 10.1038/s41590-019-0388-z; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hurst KE, 2019, CANCER IMMUNOL RES, V7, P476, DOI 10.1158/2326-6066.CIR-18-0182; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; Lemos H, 2016, CANCER RES, V76, P2076, DOI 10.1158/0008-5472.CAN-15-1456; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lu X, 2017, NATURE, V543, P728, DOI 10.1038/nature21676; Maas NL, 2015, CLIN CANCER RES, V21, P675, DOI 10.1158/1078-0432.CCR-13-3239; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mohamed E, 2018, CELL MOL IMMUNOL, V15, P421, DOI 10.1038/s41423-018-0001-7; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olagnier D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05861-7; Perales-Puchalt A, 2017, CLIN CANCER RES, V23, P441, DOI 10.1158/1078-0432.CCR-16-0492; Pytel D, 2016, ONCOGENE, V35, P1207, DOI 10.1038/onc.2015.178; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Rojas-Rivera D, 2017, CELL DEATH DIFFER, V24, P1100, DOI 10.1038/cdd.2017.58; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Sharma MD, 2018, IMMUNITY, V48, P91, DOI 10.1016/j.immuni.2017.12.014; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Sierra RA, 2017, CANCER RES, V77, P5628, DOI 10.1158/0008-5472.CAN-17-0357; Singhal S, 2016, CANCER CELL, V30, P120, DOI 10.1016/j.ccell.2016.06.001; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Smith AL, 2015, J MED CHEM, V58, P1426, DOI 10.1021/jm5017494; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Sultan H, 2017, ONCOTARGET, V8, P70317, DOI 10.18632/oncotarget.19688; Svoronos N, 2017, CANCER DISCOV, V7, P72, DOI 10.1158/2159-8290.CD-16-0502; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; Trento C, 2017, HAEMATOLOGICA, V102, P818, DOI 10.3324/haematol.2016.155390; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Weber J, 2016, CANCER IMMUNOL RES, V4, P345, DOI 10.1158/2326-6066.CIR-15-0193; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu HT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7239; Xu MM, 2017, IMMUNITY, V47, P363, DOI 10.1016/j.immuni.2017.07.016; Yan DY, 2016, CELL REP, V16, P2914, DOI 10.1016/j.celrep.2016.08.035; Yu QJ, 2015, P NATL ACAD SCI USA, V112, P15420, DOI 10.1073/pnas.1516362112	63	51	52	7	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					668	+		10.1016/j.immuni.2020.03.004	http://dx.doi.org/10.1016/j.immuni.2020.03.004			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294407	Bronze, Green Accepted			2022-12-18	WOS:000526782600011
J	Kusnadi, A; Park, SH; Yuan, RX; Pannellini, T; Giannopoulou, E; Oliver, D; Lu, T; Park-Min, KH; Ivashkiv, LB				Kusnadi, Anthony; Park, Sung Ho; Yuan, Ruoxi; Pannellini, Tania; Giannopoulou, Eugenia; Oliver, David; Lu, Theresa; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.			The Cytokine TNF Promotes Transcription Factor SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair	IMMUNITY			English	Article							INNATE IMMUNE-RESPONSE; CHOLESTEROL-SYNTHESIS; LIPID-METABOLISM; T-CELLS; POLARIZATION; MECHANISMS; EXPRESSION; ACID; LOOP; LOCALIZATION	Cytokine tumor necrosis factor (TNF)-mediated macrophage polarization is important for inflammatory disease pathogenesis, but the mechanisms regulating polarization are not clear. We performed transcriptomic and epigenomic analysis of the TNF response in primary human macrophages and revealed late-phase activation of SREBP2, the master regulator of cholesterol biosynthesis genes. TNF stimulation extended the genomic profile of SREBP2 occupancy to include binding to and activation of inflammatory and interferon response genes independently of its functions in sterol metabolism. Genetic ablation of SREBP function shifted the balance of macrophage polarization from an inflammatory to a reparative phenotype in peritonitis and skin wound healing models. Genetic ablation of SREBP activity in myeloid cells or topical pharmacological inhibition of SREBP improved skin wound healing under homeostatic and chronic inflammatory conditions. Our results identify a function and mechanism of action for SREBPs in augmenting TNF-induced macrophage activation and inflammation and open therapeutic avenues for promoting wound repair.	[Kusnadi, Anthony; Lu, Theresa; Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Park-Min, Kyung-Hyun] Weill Cornell Grad Sch Med Sci, BCMB Allied Program, New York, NY 10065 USA; [Kusnadi, Anthony; Park, Sung Ho; Yuan, Ruoxi; Pannellini, Tania; Giannopoulou, Eugenia; Oliver, David; Lu, Theresa; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.] Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA; [Kusnadi, Anthony; Park, Sung Ho; Yuan, Ruoxi; Pannellini, Tania; Giannopoulou, Eugenia; Oliver, David; Lu, Theresa; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Giannopoulou, Eugenia] CUNY, New York City Coll Technol, Biol Sci Dept, Brooklyn, NY 11201 USA; [Park, Sung Ho] UNIST, Sch Life Sci, Ulsan 44919, South Korea	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; City University of New York (CUNY) System; Ulsan National Institute of Science & Technology (UNIST)	Ivashkiv, LB (corresponding author), Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.; Park-Min, KH (corresponding author), Weill Cornell Grad Sch Med Sci, BCMB Allied Program, New York, NY 10065 USA.; Park-Min, KH; Ivashkiv, LB (corresponding author), Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA.; Park-Min, KH; Ivashkiv, LB (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA.	parkmink@hss.edu; ivashkivl@hss.edu	Kusnadi, Anthony/AAG-5457-2021	Yuan, Ruoxi/0000-0002-8719-341X; Kusnadi, Anthony/0000-0002-6172-389X	NIH; Scleroderma Foundation; St. Giles Foundation; The Tow Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079178, R01AI044938, R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069562, R00AR061430, R01AR046713, R01AR050401, R01AR073156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; St. Giles Foundation; The Tow Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Orla O'Shea for tissue sectioning and histology, Weill Cornell Medicine Epigenomics and Genomics Core Facilities for next-generation sequencing, and Weill Cornell Medicine-HSS Flow Cytometry Core Facility for cell sorting. This work was supported by grants from the NIH to L.B.I., K.-H.P.-M., and T.L.; the Scleroderma Foundation to T.L.; the St. Giles Foundation to T.L.; and by support for the Rosensweig Genomics Center from The Tow Foundation.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Ander Bradley P, 2003, Exp Clin Cardiol, V8, P164; Assmann N, 2017, NAT IMMUNOL, V18, P1197, DOI 10.1038/ni.3838; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chia JJ, 2016, J CLIN INVEST, V126, P4331, DOI 10.1172/JCI85740; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; DeBose-Boyd RA, 2018, TRENDS BIOCHEM SCI, V43, P358, DOI 10.1016/j.tibs.2018.01.005; Dehelean CA, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-137; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fessler MB, 2016, TRENDS IMMUNOL, V37, P819, DOI 10.1016/j.it.2016.09.001; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Guo CS, 2018, IMMUNITY, V49, P842, DOI 10.1016/j.immuni.2018.08.021; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu MS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96260; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Huynh L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31959; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li LC, 2013, AM J PHYSIOL-HEART C, V304, pH874, DOI 10.1152/ajpheart.00096.2012; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Marshall CD, 2018, ADV WOUND CARE, V7, P29, DOI 10.1089/wound.2016.0696; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Ouyang N, 2018, EXP CELL RES, V367, P162, DOI 10.1016/j.yexcr.2018.03.032; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Perretti M, 2017, NAT REV RHEUMATOL, V13, P87, DOI 10.1038/nrrheum.2016.193; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rong SX, 2017, ELIFE, V6, DOI [10.7554/eLife.25015.001, 10.7554/eLife.25015]; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Soyal SM, 2015, TRENDS PHARMACOL SCI, V36, P406, DOI 10.1016/j.tips.2015.04.010; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Streit Markus, 2006, Int Wound J, V3, P171, DOI 10.1111/j.1742-481X.2006.00233.x; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Teich N, 2014, J CROHNS COLITIS, V8, P85, DOI 10.1016/j.crohns.2013.06.003; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wei W, 2016, CELL METAB, V23, P479, DOI 10.1016/j.cmet.2015.12.010; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085	86	51	55	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					241	+		10.1016/j.immuni.2019.06.005	http://dx.doi.org/10.1016/j.immuni.2019.06.005			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31303399	Bronze, Green Accepted			2022-12-18	WOS:000482088500009
J	Bando, JK; Gilfillan, S; Song, C; McDonald, KG; Huang, SCC; Newberry, RD; Kobayashi, Y; Allan, DSJ; Carlyle, JR; Cella, M; Colonna, M				Bando, Jennifer K.; Gilfillan, Susan; Song, Christina; McDonald, Keely G.; Huang, Stanley C. -C.; Newberry, Rodney D.; Kobayashi, Yasuhiro; Allan, David S. J.; Carlyle, James R.; Cella, Marina; Colonna, Marco			The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells	IMMUNITY			English	Article							RECEPTOR ACTIVATOR; EPITHELIAL-CELLS; INDUCER CELLS; TUFT CELLS; T-CELLS; LIGAND; DIFFERENTIATION; OSTEOCLAST; EXPRESSION; IMMUNITY	While signals that activate group 3 innate lymphoid cells (ILC3s) have been described, the factors that negatively regulate these cells are less well understood. Here we found that the tumor necrosis factor (TNF) superfamily member receptor activator of nuclear factor kappa B ligand (RANKL) suppressed ILC3 activity in the intestine. Deletion of RANKL in ILC3s and T cells increased C-C motif chemokine receptor 6 (CCR6)(+) ILC3 abundance and enhanced production of interleukin-17A (IL-17A) and IL-22 in response to IL-23 and during infection with the enteric murine pathogen Citrobacter rodentium. Additionally, CCR6(+) ILC3s produced higher amounts of the master transcriptional regulator ROR gamma t at steady state in the absence of RANKL. RANKL-mediated suppression was independent of T cells, and instead occurred via interactions between CCR6(+) ILC3s that expressed both RANKL and its receptor, RANK. Thus, RANK-RANKL interactions between ILC3s regulate ILC3 abundance and activation, suggesting that cell clustering may control ILC3 activity.	[Bando, Jennifer K.; Gilfillan, Susan; Song, Christina; McDonald, Keely G.; Huang, Stanley C. -C.; Newberry, Rodney D.; Cella, Marina; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kobayashi, Yasuhiro] Matsumoto Dent Univ, Inst Oral Sci, 1780 Hirooka Gohara, Shiojiri Nagano 3990781, Japan; [Allan, David S. J.; Carlyle, James R.] Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada; [Song, Christina] AbbVie, Redwood City, CA 94063 USA; [Huang, Stanley C. -C.] Case Western Reserve Univ Med, Cleveland, OH 44106 USA; [Allan, David S. J.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA	Washington University (WUSTL); Matsumoto Dental University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; AbbVie; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu	KOBAYASHI, YASUHIRO/AAU-4931-2021; Huang, Stanley Ching-Cheng/AAE-7866-2019; Cella, Marina/ABA-8564-2020; Carlyle, James R/A-1224-2008	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Carlyle, James/0000-0002-3579-0300; Cella, Marina/0000-0003-1230-1313; Bando, Jennifer/0000-0002-1331-7424	NIH [DE025884, DK103039, AI120606, CA176695, DK097317]; Digestive Diseases Research Core Center [P30 DK52574]; Crohn's and Colitis Foundation of America; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA176695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542, R21AI120606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103039, P30DK052574, R01DK097317] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center; Crohn's and Colitis Foundation of America; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Deborah Novack, Anna Ballard, and Jesse Gibbs for providing sRANKL and RANK-eGFP mice. Daved Fremont and Chris Nelson developed the sRANKL reagent. Gerard Eberl generously provided Rorc<SUP>Cre/+</SUP> mice. Daved Fremont, Michael Patnode, Blanda Di Luccia, Luisa Cervantes-Barragan, Alexander Barrow, and Victor Cortez provided helpful discussion. Tyler Ulland provided help with bone marrow chimera experiments. The Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine assisted with microarray experiments. All flow cytometry work was conducted in the Flow Cytometry and Fluorescence Activated Cell Sorting Core in the Department of Pathology and Immunology at Washington University School of Medicine. This work was supported by the NIH grants DE025884, DK103039, and AI120606 (to M. Colonna), CA176695 (to M. Cella), and DK097317 (to R.D.N.). This work was also supported by the Digestive Diseases Research Core Center (P30 DK52574); and the Crohn's and Colitis Foundation of America. J.K.B. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Allan DSJ, 2015, MUCOSAL IMMUNOL, V8, P340, DOI 10.1038/mi.2014.71; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Ashcroft AJ, 2003, IMMUNITY, V19, P849, DOI 10.1016/S1074-7613(03)00326-1; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cox JH, 2012, MUCOSAL IMMUNOL, V5, P99, DOI 10.1038/mi.2011.54; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Duffin R, 2016, SCIENCE, V351, P1333, DOI 10.1126/science.aad9903; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Guerrini MM, 2015, IMMUNITY, V43, P1174, DOI 10.1016/j.immuni.2015.10.017; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kim SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02729-6; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Mueller CG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00261; Nagashima K, 2017, NAT IMMUNOL, V18, P675, DOI 10.1038/ni.3732; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rahman MS, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.5; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Sugiyama M, 2012, INT IMMUNOL, V24, P369, DOI 10.1093/intimm/dxs002; van de Pavert SA, 2016, INT IMMUNOL, V28, P35, DOI 10.1093/intimm/dxv052; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Williamson E, 2002, J IMMUNOL, V169, P3606, DOI 10.4049/jimmunol.169.7.3606; Wittrant Y, 2006, INT J ONCOL, V28, P261; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	59	51	51	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1208	+		10.1016/j.immuni.2018.04.012	http://dx.doi.org/10.1016/j.immuni.2018.04.012			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29858011	Green Accepted, Bronze			2022-12-18	WOS:000436456900019
J	Cale, EM; Gorman, J; Radakovich, NA; Crooks, ET; Osawa, K; Tong, T; Li, JQ; Nagarajan, R; Ozorowski, G; Ambrozak, DR; Asokan, M; Bailer, RT; Bennici, AK; Chen, XJ; Doria-Rose, NA; Druz, A; Feng, Y; Joyce, MG; Louder, MK; O'Dell, S; Oliver, C; Pancera, M; Connors, M; Hope, TJ; Kepler, TB; Wyatt, RT; Ward, AB; Georgiev, IS; Kwong, PD; Mascola, JR; Binley, JM				Cale, Evan M.; Gorman, Jason; Radakovich, Nathan A.; Crooks, Ema T.; Osawa, Keiko; Tong, Tommy; Li, Jiaqi; Nagarajan, Raju; Ozorowski, Gabriel; Ambrozak, David R.; Asokan, Mangai; Bailer, Robert T.; Bennici, Anthony K.; Chen, Xuejun; Doria-Rose, Nicole A.; Druz, Aliaksandr; Feng, Yu; Joyce, M. Gordon; Louder, Mark K.; O'Dell, Sijy; Oliver, Courtney; Pancera, Marie; Connors, Mark; Hope, Thomas J.; Kepler, Thomas B.; Wyatt, Richard T.; Ward, Andrew B.; Georgiev, Ivelin S.; Kwong, Peter D.; Mascola, John R.; Binley, James M.			Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop	IMMUNITY			English	Article							CONFORMATIONAL EPITOPE; MONOCLONAL-ANTIBODIES; ELECTRON-MICROSCOPE; ENVELOPE TRIMERS; FUSION PEPTIDE; RECOGNITION; BROAD; IDENTIFICATION; QUATERNARY; REVEAL	Most HIV-1-specific neutralizing antibodies isolated to date exhibit unusual characteristics that complicate their elicitation. Neutralizing antibodies that target the V1V2 apex of the HIV-1 envelope (Env) trimer feature unusually long protruding loops, which enable them to penetrate the HIV-1 glycan shield. As antibodies with loops of requisite length are created through uncommon recombination events, an alternative mode of apex binding has been sought. Here, we isolated a lineage of Env apex-directed neutralizing antibodies, N90-VRC38.01-11, by using virus-like particles and conformationally stabilized Env trimers as B cell probes. A crystal structure of N90-VRC38.01 with a scaffolded V1V2 revealed a binding mode involving side-chain-to-side-chain interactions that reduced the distance the antibody loop must traverse the glycan shield, thereby facilitating V1V2 binding via a non-protruding loop. The N90-VRC38 lineage thus identifies a solution for V1V2-apex binding that provides a more conventional B cell pathway for vaccine design.	[Cale, Evan M.; Gorman, Jason; Radakovich, Nathan A.; Li, Jiaqi; Ambrozak, David R.; Asokan, Mangai; Bailer, Robert T.; Bennici, Anthony K.; Chen, Xuejun; Doria-Rose, Nicole A.; Druz, Aliaksandr; Joyce, M. Gordon; Louder, Mark K.; O'Dell, Sijy; Oliver, Courtney; Pancera, Marie; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Crooks, Ema T.; Osawa, Keiko; Tong, Tommy; Binley, James M.] San Diego Biomed Res Inst, San Diego, CA 92121 USA; [Nagarajan, Raju; Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Feng, Yu; Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hope, Thomas J.] Northwestern Univ, Feinberg Med Sch, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02118 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Northwestern University; Feinberg School of Medicine; Boston University; Vanderbilt University	Kwong, PD; Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Binley, JM (corresponding author), San Diego Biomed Res Inst, San Diego, CA 92121 USA.	pdkwong@nih.gov; jmascola@nih.gov; jbinley@sdbri.org	Gorman, Jason/AGG-9417-2022; Mascola, John/AAI-7193-2021; Raju, Nagarajan/H-9157-2013; Ozorowski, Gabriel/HCH-0634-2022; Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Raju, Nagarajan/0000-0003-3851-5520; Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Asokan, Mangaiarkarasi/0000-0001-9294-1833	NIH [RO1AI00790, RO1AI93278, R33AI84714, U19AI117892-02]; Vaccine Research Center, NIAID, NIH; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093278, ZIAAI005022, ZIAAI001090, P01AI104722, ZIAAI005095, R33AI084714, U19AI117892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants RO1AI00790, RO1AI93278, and R33AI84714 (J.M.B.) U19AI117892-02 (T.B.K.), and by the intramural research program of the Vaccine Research Center, NIAID, NIH. We thank Bob Whalen (Altravax) for Rev and SIV Gag plasmids, Yang Dai (Scripps Research Institute) for the pAV MLV Gag plasmid, David Montefiori (Duke University) for large cohort serum-virus neutralization data, and Jonathan Stuckey for assistance with figures. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract #W-31-109-Eng-38. We thank donor N90 for participating. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 Envelope plasmids used in our neutralization panel.	Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Briney BS, 2012, IMMUNOLOGY, V137, P56, DOI 10.1111/j.1365-2567.2012.03605.x; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006148; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gomez CY, 2006, J VIROL, V80, P8796, DOI 10.1128/JVI.02159-05; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McCoy LE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005110; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mengistu M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004772; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ross SA, 2001, PROTEIN SCI, V10, P450, DOI 10.1110/ps.32501; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	66	51	53	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					777	+		10.1016/j.immuni.2017.04.011	http://dx.doi.org/10.1016/j.immuni.2017.04.011			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514685	Bronze, Green Accepted			2022-12-18	WOS:000401316300014
J	Li, YY; Shen, Y; Hohensinner, P; Ju, JH; Wen, ZK; Goodman, SB; Zhang, H; Goronzy, JJ; Weyand, CM				Li, Yinyin; Shen, Yi; Hohensinner, Philipp; Ju, Jihang; Wen, Zhenke; Goodman, Stuart B.; Zhang, Hui; Goronzy, Joerg J.; Weyand, Cornelia M.			Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis	IMMUNITY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; TELOMERE REPLICATION; INDUCED SENESCENCE; STEM-CELLS; COMPLEX; HETEROCHROMATIN; TUMORIGENESIS; P16(INK4A); EXHAUSTION	Immune aging manifests with a combination of failing adaptive immunity and insufficiently restrained inflammation. In patients with rheumatoid arthritis (RA), T cell aging occurs prematurely, but the mechanisms involved and their contribution to tissuedestructive inflammation remain unclear. We found that RA CD4(+) T cells showed signs of aging during their primary immune responses and differentiated into tissue-invasive, proinflammatory effector cells. RA T cells had low expression of the doublestrand- break repair nuclease MRE11A, leading to telomeric damage, juxtacentromeric heterochromatin unraveling, and senescence marker upregulation. Inhibition of MRE11A activity in healthy T cells induced the aging phenotype, whereas MRE11A overexpression in RA T cells reversed it. In human-synovium chimeric mice, MRE11A (low) T cells were tissue-invasive and pro-arthritogenic, and MRE11A reconstitution mitigated synovitis. Our findings link premature T cell aging and tissue-invasiveness to telomere deprotection and heterochromatin unpacking, identifying MRE11A as a therapeutic target to combat immune aging and suppress dysregulated tissue inflammation.	[Li, Yinyin; Shen, Yi; Hohensinner, Philipp; Ju, Jihang; Wen, Zhenke; Zhang, Hui; Goronzy, Joerg J.; Weyand, Cornelia M.] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Hohensinner, Philipp] Med Univ Vienna, Dept Internal Med Cardiol 2, A-1090 Vienna, Austria; [Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthoped Surg & Bioengn, Stanford, CA 94305 USA	Stanford University; Medical University of Vienna; Stanford University	Weyand, CM (corresponding author), Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.	cweyand@stanford.edu	Weyand, Cornelia/AAH-3343-2021; Goodman, Stuart/AAZ-7499-2020	Goronzy, Jorg/0000-0001-7670-1856; Wen, Zhenke/0000-0003-0542-0349; Goodman, Stuart/0000-0002-1919-3717; Hohensinner, Philipp/0000-0003-4819-3190	National Institutes of Health [R01 AR042547, R01 HL117913, R01 AI108906, P01 HL129941, R01 AI108891, R01AR055650, R01AR063717, R01 AG045779, I01 BX001669]; Govenar Discovery Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058000, P01HL129941, R01HL117913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108891, R01AI108906, R01AI044142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055650, R01AR063717, R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045779, R01AG015043] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Govenar Discovery Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institutes of Health (R01 AR042547, R01 HL117913, R01 AI108906, P01 HL129941, R01 AI108891, R01AR055650, R01AR063717, R01 AG045779, and I01 BX001669) and from the Govenar Discovery Fund.	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Attwooll CL, 2009, MOL CELL BIOL, V29, P5540, DOI 10.1128/MCB.00479-09; Balestrini A., 2015, MOL CANC RES; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chou JP, 2013, CURR PHARM DESIGN, V19, P1680; Chow HM, 2015, NAT REV NEUROSCI, V16, P672, DOI 10.1038/nrn4020; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Dejardin J, 2015, TRENDS GENET, V31, P661, DOI 10.1016/j.tig.2015.09.003; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Diotti R, 2011, NUCLEUS-PHILA, V2, P119, DOI 10.4161/nucl.2.2.15135; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Fujii H, 2009, P NATL ACAD SCI USA, V106, P4360, DOI 10.1073/pnas.0811332106; Fumagalli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110969; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Gupta GP, 2013, MOL CELL, V52, P353, DOI 10.1016/j.molcel.2013.09.001; Hwang SH, 2015, P NATL ACAD SCI USA, V112, pE6535, DOI 10.1073/pnas.1514152112; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeong JH, 2010, MOL CANCER THER, V9, P2102, DOI 10.1158/1535-7163.MCT-09-1159; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; LAWRENCE JB, 1988, CELL, V52, P51; Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maas K, 2005, ARTHRITIS RHEUM-US, V52, P1047, DOI 10.1002/art.20931; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Pulko V, 2016, NAT IMMUNOL, V17, P966, DOI 10.1038/ni.3483; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Seyler TM, 2005, J CLIN INVEST, V115, P3083, DOI 10.1172/JCI25265; Shao L, 2010, EMBO MOL MED, V2, P415, DOI 10.1002/emmm.201000096; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Swanson EC, 2013, J CELL BIOL, V203, P929, DOI 10.1083/jcb.201306073; Takata H, 2005, MOL CELL, V17, P573, DOI 10.1016/j.molcel.2005.01.014; Taylor AMR, 2015, CLIN GENET, V87, P199, DOI 10.1111/cge.12453; Warrington KJ, 2001, ARTHRITIS RHEUM, V44, P13, DOI 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.0000000000000011; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252	56	51	52	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					903	916		10.1016/j.immuni.2016.09.013	http://dx.doi.org/10.1016/j.immuni.2016.09.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27742546	Green Accepted, Bronze			2022-12-18	WOS:000389473200020
J	Haghikia, A; Jorg, S; Duscha, A; Berg, J; Manzel, A; Waschbisch, A; Hammer, A; Lee, DH; May, C; Wilck, N; Balogh, A; Ostermann, AI; Schebb, NH; Akkad, DA; Grohme, DA; Kleinewietfeld, M; Kempa, S; Thone, J; Demir, S; Muller, DN; Gold, R; Linker, RA				Haghikia, Aiden; Joerg, Stefanie; Duscha, Alexander; Berg, Johannes; Manzel, Arndt; Waschbisch, Anne; Hammer, Anna; Lee, De-Hyung; May, Caroline; Wilck, Nicola; Balogh, Andras; Ostermann, Annika I.; Schebb, Nils Helge; Akkad, Denis A.; Grohme, Diana A.; Kleinewietfeld, Markus; Kempa, Stefan; Thoene, Jan; Demir, Seray; Mueller, Dominik N.; Gold, Ralf; Linker, Ralf A.			Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine (vol 43, pg 817, 2015)	IMMUNITY			English	Correction												aiden.haghikia@rub.de; ralf.linker@uk-erlangen.de	Linker, Ralf/AAD-8884-2020; Kleinewietfeld, Markus/AAI-4497-2021	Schebb, Nils Helge/0000-0003-1299-6629; Kaisler, Johannes/0000-0003-1753-700X; Wilck, Nicola/0000-0003-3189-5364; /0000-0001-8756-747X; Muller, Dominik N/0000-0003-3650-5644; Hammer, Anna/0000-0002-0422-8569; Haase, Stefanie/0000-0002-9371-4314				Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007	1	51	53	3	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					951	953		10.1016/j.immuni.2016.04.006	http://dx.doi.org/10.1016/j.immuni.2016.04.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096322	Bronze			2022-12-18	WOS:000374444300024
J	Koues, OI; Kowalewski, RA; Chang, LW; Pyfrom, SC; Schmidt, JA; Luo, H; Sandoval, LE; Hughes, TB; Bednarski, JJ; Cashen, AF; Payton, JE; Oltz, EM				Koues, Olivia I.; Kowalewski, Rodney A.; Chang, Li-Wei; Pyfrom, Sarah C.; Schmidt, Jennifer A.; Luo, Hong; Sandoval, Luis E.; Hughes, Tyler B.; Bednarski, Jeffrey J.; Cashen, Amanda F.; Payton, Jacqueline E.; Oltz, Eugene M.			Enhancer Sequence Variants and Transcription-Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B-Cell Lymphoma	IMMUNITY			English	Article							FOLLICULAR LYMPHOMA; SOMATIC HYPERMUTATION; SUPER-ENHANCERS; HOX GENES; LANDSCAPE; GENETICS; IDENTITY; ROLES	Most B-cell lymphomas arise in the germinal center (GC), where humoral immune responses evolve from potentially oncogenic cycles of mutation, proliferation, and clonal selection. Although lymphoma gene expression diverges significantly from GC B cells, underlying mechanisms that alter the activities of corresponding regulatory elements (REs) remain elusive. Here we define the complete pathogenic circuitry of human follicular lymphoma (FL), which activates or decommissions REs from normal GC B cells and commandeers enhancers from other lineages. Moreover, independent sets of transcription factors, whose expression was deregulated in FL, targeted commandeered versus decommissioned REs. Our approach revealed two distinct subtypes of low-grade FL, whose pathogenic circuitries resembled GC B or activated B cells. FL-altered enhancers also were enriched for sequence variants, including somatic mutations, which disrupt transcription-factor binding and expression of circuit-linked genes. Thus, the pathogenic regulatory circuitry of FL reveals distinct genetic and epigenetic etiologies for GC B-cell transformation.	[Koues, Olivia I.; Kowalewski, Rodney A.; Chang, Li-Wei; Pyfrom, Sarah C.; Schmidt, Jennifer A.; Luo, Hong; Sandoval, Luis E.; Hughes, Tyler B.; Payton, Jacqueline E.; Oltz, Eugene M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bednarski, Jeffrey J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Cashen, Amanda F.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Payton, JE (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	jpayton@wustl.edu; eoltz@wustl.edu	Bednarski, Jeff/GLN-6651-2022		NIH [CA156690, CA090547, TR000448, CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA156690, R01CA090547] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI102946] Funding Source: NIH RePORTER; Cancer Research UK [16491] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK)	This work was supported by NIH grants CA156690 (to J.E.P. and E.M.O.), CA090547 (to O.I.K.), TR000448 (to the Washington University Institute of Clinical and Translational Sciences), and CA91842 (to the Siteman Cancer Center). We thank B. Sleckman, T. Fehniger, N. Mosammaparast, M. Artyomov, and T. Wang for comments; the Washington University School of Medicine Lymphoma Banking Program of the Division of Medical Oncology in the Department of Medicine, N. Bartlett, N. Wagner-Johnston, K. Carson, and T. Fehniger for lymphoma biopsies and patient histories; M. Colonna for tonsil samples; and the Genome Technology Access Center for assistance with -omics analyses.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Archer Michael C, 2011, Genes Cancer, V2, P712, DOI 10.1177/1947601911423029; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Basu S, 2009, P NATL ACAD SCI USA, V106, P1433, DOI 10.1073/pnas.0804863106; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Cheung KJJ, 2009, BLOOD, V113, P137, DOI 10.1182/blood-2008-02-140616; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Dolken G, 1996, J CLIN ONCOL, V14, P1333; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang CX, 2014, BLOOD, V123, P1012, DOI 10.1182/blood-2013-07-518605; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Izutsu K, 2014, J CLIN EXP HEMATOP, V54, P31, DOI 10.3960/jslrt.54.31; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khodabakhshi AH, 2012, ONCOTARGET, V3, P1308; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Leich E, 2011, BEST PRACT RES CL HA, V24, P95, DOI 10.1016/j.beha.2011.02.003; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longo NS, 2009, BLOOD, V113, P3706, DOI 10.1182/blood-2008-10-183632; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Rehm A, 2011, BLOOD, V118, P1020, DOI 10.1182/blood-2010-11-321265; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Tarte K, 2002, BLOOD, V100, P1113, DOI 10.1182/blood.V100.4.1113.h81602001113_1113_1122; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Urayama KY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00300; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	52	51	52	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					186	198		10.1016/j.immuni.2014.12.021	http://dx.doi.org/10.1016/j.immuni.2014.12.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607463	Green Accepted, Bronze			2022-12-18	WOS:000348197500021
J	Kudryashova, E; Quintyn, R; Seveau, S; Lu, WY; Wysocki, VH; Kudryashov, DS				Kudryashova, Elena; Quintyn, Royston; Seveau, Stephanie; Lu, Wuyuan; Wysocki, Vicki H.; Kudryashov, Dmitri S.			Human Defensins Facilitate Local Unfolding of Thermodynamically Unstable Regions of Bacterial Protein Toxins	IMMUNITY			English	Article							MASS-SPECTROMETRY; LIGAND COMPLEXES; MARTX TOXINS; ACTIN; TRANSLOCATION; MECHANISM; INHIBIT; STABILITY; BINDING; DOMAIN	Defensins are short cationic, amphiphilic, cysteine-rich peptides that constitute the front-line immune defense against various pathogens. In addition to exerting direct antibacterial activities, defensins inactivate several classes of unrelated bacterial exotoxins. To date, no coherent mechanism has been proposed to explain defensins' enigmatic efficiency toward various toxins. In this study, we showed that binding of neutrophil alpha-defensin HNP1 to affected bacterial toxins caused their local unfolding, potentiated their thermal melting and precipitation, exposed new regions for proteolysis, and increased susceptibility to collisional quenchers without causing similar effects on tested mammalian structural and enzymatic proteins. Enteric alpha-defensin HD5 and beta-defensin hBD2 shared similar toxin-unfolding effects with HNP1, albeit to different degrees. We propose that protein susceptibility to inactivation by defensins is contingent to their thermolability and conformational plasticity and that defensin-induced unfolding is a key element in the general mechanism of toxin inactivation by human defensins.	[Kudryashova, Elena; Quintyn, Royston; Wysocki, Vicki H.; Kudryashov, Dmitri S.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Seveau, Stephanie] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Seveau, Stephanie] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kudryashov, DS (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	kudryashov.1@osu.edu	Kudryashov, Dmitri/P-9004-2014; Lu, Wuyuan/B-2268-2010; Kudryashova, Elena/K-8223-2019; Lu, Wuyuan/J-8452-2017; Kudryashova, Elena/ADL-6316-2022	Kudryashova, Elena/0000-0002-1646-1229; Lu, Wuyuan/0000-0003-1318-9968; Kudryashova, Elena/0000-0002-1646-1229; Wysocki, Vicki/0000-0003-0495-2538; Kudryashov, Dmitri/0000-0003-1782-3305	Ohio State University; NIH [R01NIAID107250, AI072732]; National Science Foundation grant [DBI 0923551]; Direct For Biological Sciences [1342108] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107250, R01AI072732] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation grant(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Borden Lacy (Vanderbilt University) for donating B. megaterium cells expressing TcdA- and TcdB-GTD constructs, Karla Satchell (Northwestern University) for the generous gift of anti-ACD antibody, and Irina Artsimovitch (The Ohio State University) for providing access to a real-time PCR instrument. This work was supported by The Ohio State University (a start-up fund to D.K.), NIH award numbers R01NIAID107250 (to S.S.) and AI072732 (to W.L.), and National Science Foundation grant DBI 0923551 to V.H.W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Arnett E, 2014, J IMMUNOL, V192, P234, DOI 10.4049/jimmunol.1301302; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Bokarewa M, 2004, THROMB HAEMOSTASIS, V91, P991, DOI 10.1169/TH03-11-0696; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Flatt JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061571; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gounder AP, 2012, J BIOL CHEM, V287, P24554, DOI 10.1074/jbc.M112.354068; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; Hooven TA, 2012, J ANTIMICROB CHEMOTH, V67, P2870, DOI 10.1093/jac/dks305; Hsu WL, 2012, BIOCOMPUT-PAC SYM, P116; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; Kohlgraf KG, 2010, FUTURE MICROBIOL, V5, P99, DOI [10.2217/fmb.09.104, 10.2217/FMB.09.104]; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kudryashova E, 2014, MOL MICROBIOL, V92, P1056, DOI 10.1111/mmi.12615; Kudryashova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045721; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Lyon AN, 2014, HUM MOL GENET, V23, P1990, DOI 10.1093/hmg/ddt595; Madison AN, 2007, INFECT IMMUN, V75, P4780, DOI 10.1128/IAI.00557-07; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Niu S, 2013, CURR OPIN CHEM BIOL, V17, P809, DOI 10.1016/j.cbpa.2013.06.019; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Senisterra GA, 2009, MOL BIOSYST, V5, P217, DOI 10.1039/b814377c; Seveau Stephanie, 2014, Subcell Biochem, V80, P161, DOI 10.1007/978-94-017-8881-6_9; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Thoren KL, 2011, MOL MICROBIOL, V80, P588, DOI 10.1111/j.1365-2958.2011.07614.x; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Vega LA, 2012, MOL MICROBIOL, V85, P1119, DOI 10.1111/j.1365-2958.2012.08163.x; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Yin S, 2008, J AM SOC MASS SPECTR, V19, P1199, DOI 10.1016/j.jasms.2008.05.012; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078937; Zhao L, 2014, CURR OPIN HEMATOL, V21, P37, DOI 10.1097/MOH.0000000000000005; Zhao L, 2012, J BIOL CHEM, V287, P18900, DOI 10.1074/jbc.M112.355255; Zhou MW, 2012, ANGEW CHEM INT EDIT, V51, P4336, DOI 10.1002/anie.201108700	55	51	54	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					709	721		10.1016/j.immuni.2014.10.018	http://dx.doi.org/10.1016/j.immuni.2014.10.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517613	Green Accepted, Bronze			2022-12-18	WOS:000345504900009
J	Wuthrich, M; Ersland, K; Sullivan, T; Galles, K; Klein, BS				Wuethrich, Marcel; Ersland, Karen; Sullivan, Thomas; Galles, Kevin; Klein, Bruce S.			Fungi Subvert Vaccine T Cell Priming at the Respiratory Mucosa by Preventing Chemokine-Induced Influx of Inflammatory Monocytes	IMMUNITY			English	Article							DENDRITIC CELLS; BLASTOMYCES-DERMATITIDIS; CHEMOATTRACTANT PROTEIN-3; IMMUNE-RESPONSES; BONE-MARROW; IN-VIVO; INFECTION; CCR2; RECRUITMENT; RESISTANCE	Vaccinologists strive to harness immunity at mucosal sites of pathogen entry. We studied respiratory delivery of an attenuated vaccine against Blastomyces dermatitidis. We created a T cell receptor transgenic mouse responsive to vaccine yeast and found that mucosal vaccination led to poor T cell activation in the draining nodes and differentiation in the lung. Mucosal vaccination subverted lung T cell priming by inducing matrix metalloproteinase 2 (MMP2), which impaired the action of the chemokine CCL7 on egress of CCR2(+) Ly6C(hi) inflammatory monocytes from the bone marrow and their recruitment to the lung. Studies in Mmp2(-/-) mice, or treatment with MMP inhibitor or rCCL7, restored recruitment of Ly6C(hi) monocytes to the lung and CD4(+) T cell priming. Mucosal vaccination against fungi and perhaps other respiratory pathogens may require manipulation of host MMPs in order to alter chemokine signals needed to recruit Ly6C(hi) monocytes and prime T cells at the respiratory mucosa.	[Wuethrich, Marcel; Sullivan, Thomas; Galles, Kevin; Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA; [Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Internal Med, Madison, WI 53792 USA; [Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol, Madison, WI 53792 USA; [Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Immunol, Madison, WI 53792 USA; [Ersland, Karen] Univ Wisconsin, Sch Med & Publ Hlth, Cell & Mol Pathol Grad Training Program, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wuthrich, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA.	mwuethri@wisc.edu; bsklein@wisc.edu			USPHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093553, R37AI035681, R01AI040996] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the USPHS to B.K. and M.W. We thank A. Starr and C. Overall from the University of British Columbia, Canada, for providing advice on the MMP2 assays and R. Gordon from the department of Pediatrics at the University of Wisconsin for assistance with illustrations.	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Blease K, 2000, J IMMUNOL, V165, P2603, DOI 10.4049/jimmunol.165.5.2603; Brandhorst TT, 1999, J EXP MED, V189, P1207, DOI 10.1084/jem.189.8.1207; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Deepe GS, 1998, RES IMMUNOL, V149, P397, DOI 10.1016/S0923-2494(98)80763-3; Ersland K, 2010, CELL HOST MICROBE, V7, P474, DOI 10.1016/j.chom.2010.05.010; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Osterholzer JJ, 2009, J IMMUNOL, V183, P8044, DOI 10.4049/jimmunol.0902823; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Rivera A, 2006, IMMUNITY, V25, P665, DOI 10.1016/j.immuni.2006.08.016; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Szymczak WA, 2009, J IMMUNOL, V183, P1964, DOI 10.4049/jimmunol.0901316; Traynor TR, 2000, J IMMUNOL, V164, P2021, DOI 10.4049/jimmunol.164.4.2021; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Wuthrich M, 2011, J IMMUNOL, V187, P1421, DOI 10.4049/jimmunol.1100921; Wuthrich M, 2000, J CLIN INVEST, V106, P1381, DOI 10.1172/JCI11037; Wuthrich M., 2012, ANN REV IMMUNOL; Wuthrich M, 2007, INFECT IMMUN, V75, P193, DOI 10.1128/IAI.01148-06	32	51	54	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					680	692		10.1016/j.immuni.2012.02.015	http://dx.doi.org/10.1016/j.immuni.2012.02.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22483803	Bronze, Green Accepted			2022-12-18	WOS:000303223900019
J	Xu, WW; Wang, P; Petri, B; Zhang, Y; Tang, WW; Sun, L; Kress, H; Mann, T; Shi, Y; Kubes, P; Wu, DQ				Xu, Wenwen; Wang, Ping; Petri, Bjoern; Zhang, Yong; Tang, Wenwen; Sun, Le; Kress, Holger; Mann, Tom; Shi, Yan; Kubes, Paul; Wu, Dianqing			Integrin-Induced PIP5K1C Kinase Polarization Regulates Neutrophil Polarization, Directionality, and In Vivo Infiltration	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; CELL REGULATION; ACTIVATION; GAMMA; RHOA; ADHESION; AFFINITY; POLARITY; PTEN; INFLAMMATION	Neutrophils are important in innate immunity and acute inflammatory responses. However, the regulation of their recruitment to sites of inflammation has not been well characterized. Here, we investigated the kinase PIP5K1C and showed that PIP5K1C deficiency impaired neutrophil recruitment because of an adhesion defect. PIP5K1C regulated the adhesion through facilitating RhoA GTPase and integrin activation by chemoattractants. Integrins could induce polarization of an isoform of PIP5K1C, PIP5K1C-90, in neutrophils through intracellular vesicle transport independently of exogenous chemoattractant. PIP5K1C-90 polarization was required for polarized RhoA activation at uropods and provided an initial directional cue for neutrophil polarization on the endothelium. Importantly, the polarization was also required for circumventing the inhibition of lamellipodium formation by RhoA so that neutrophils could form leading edges required for transendothelial migration. Because integrins are not known to regulate neutrophil polarization, our study revealed a previously underappreciated role of integrin signaling in neutrophil regulation.	[Xu, Wenwen; Wang, Ping] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Xu, Wenwen; Wang, Ping] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Xu, Wenwen; Wang, Ping; Zhang, Yong; Tang, Wenwen; Mann, Tom; Wu, Dianqing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Xu, Wenwen; Wang, Ping; Zhang, Yong; Tang, Wenwen; Mann, Tom; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Petri, Bjoern; Kubes, Paul] Univ Calgary, Snyder Inst Infect Immun & Inflammat, Calgary, AB T2N 4N1, Canada; [Shi, Yan] Univ Calgary, Fac Med, Calgary, AB T2N 4N1, Canada; [Sun, Le] AbMax, Beijing 100085, Peoples R China; [Kress, Holger] Yale Univ, Dept Mech Engn, New Haven, CT 06511 USA; [Kress, Holger] Eindhoven Univ Technol, Dept Appl Phys, NL-5612 AZ Eindhoven, Netherlands	East China Normal University; East China Normal University; Yale University; Yale University; University of Calgary; University of Calgary; Yale University; Eindhoven University of Technology	Wang, P (corresponding author), E China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	pwang@bio.ecnu.edu.cn; dan.wu@yale.edu	Tang, Wenwen/J-2011-2012		NIH [HL080706, HL070694, 1U54 RR022232-01, NS36251, DA018343]; German Academy of Sciences Leopoldina [BMBF-LPD 9901/8-162]; AHA;  [NSFC30800587];  [30971521];  [2010CB529704];  [09QA1401900];  [06DZ22923]; NATIONAL CANCER INSTITUTE [R01CA139395] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academy of Sciences Leopoldina; AHA(American Heart Association); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Orsulak and other members of the D.W. lab for various assistances, P. De Camilli for the pip5k1c mutant mice, plasmids, and reagents, and D. Calderwood for plasmids. This work was supported in part by NIH grants (HL080706, HL070694, 1U54 RR022232-01, NS36251, DA018343), by German Academy of Sciences Leopoldina (BMBF-LPD 9901/8-162) (H.K.), and by AHA and NSFC30800587, 30971521, 2010CB529704, 09QA1401900, 06DZ22923 (P.W.).	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Honing H, 2004, J LEUKOCYTE BIOL, V75, P523, DOI 10.1189/jlb.0203054; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Kim SV, 2006, SCIENCE, V314, P136, DOI 10.1126/science.1131920; Konstandin MH, 2006, J IMMUNOL METHODS, V310, P67, DOI 10.1016/j.jim.2005.12.005; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Kress H, 2009, NAT METHODS, V6, P905, DOI 10.1038/nmeth.1400; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rericha EC, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122pe26; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; SMILENOV L, 1994, MOL BIOL CELL, V5, P1215, DOI 10.1091/mbc.5.11.1215; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; WILSON RW, 1993, J IMMUNOL, V151, P1571; Wong K, 2007, J CELL BIOL, V179, P1141, DOI 10.1083/jcb.200706167; Wu DQ, 2005, CELL RES, V15, P52, DOI 10.1038/sj.cr.7290265; Wu Y, 2004, BIOCHEM BIOPH RES CO, V316, P666, DOI 10.1016/j.bbrc.2004.02.107; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhang Y, 2010, J BIOL CHEM, V285, P24805, DOI 10.1074/jbc.M110.142885	49	51	51	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					340	350		10.1016/j.immuni.2010.08.015	http://dx.doi.org/10.1016/j.immuni.2010.08.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20850356	Green Accepted, Bronze			2022-12-18	WOS:000282798500009
J	Lev, A; Takeda, K; Zanker, D; Maynard, JC; Dimberu, P; Waffarn, E; Gibbs, J; Netzer, N; Princiotta, MF; Neckers, L; Picard, D; Nicchitta, CV; Chen, W; Reiter, Y; Bennink, JR; Yewdelll, JW				Lev, Avital; Takeda, Kazuyo; Zanker, Damien; Maynard, Jason C.; Dimberu, Peniel; Waffarn, Elizabeth; Gibbs, James; Netzer, Nir; Princiotta, Michael F.; Neckers, Len; Picard, Didier; Nicchitta, Christopher V.; Chen, Weisan; Reiter, Yoram; Bennink, Jack R.; Yewdelll, Jonathan W.			The exception that reinforces the rule: Crosspriming by cytosolic peptides that escape degradation	IMMUNITY			English	Article							MHC CLASS-I; HEAT-SHOCK PROTEINS; COMPLEX-RESTRICTED SPECIFICITY; CYTOTOXIC T-LYMPHOCYTES; CROSS-PRESENTATION; ENDOPLASMIC-RETICULUM; IMMUNODOMINANCE HIERARCHY; RECOMBINANT ANTIBODIES; ANTIGEN PRESENTATION; PRESENTING CELLS	The nature of crosspriming immunogens for CD8(+) T cell responses is highly controversial. By using a panel of T cell receptor-like antibodies specific for viral peptides bound to mouse D-b major histocompatibility complex class I molecules, we show that an exceptional peptide (PA(224-233)) expressed as a viral minigene product formed a sizeable cytosolic pool continuously presented for hours after protein synthesis was inhibited. PA224-233 pool formation required active cytosolic heat-shock protein 90 but not ER g96 and uniquely enabled crosspriming by this peptide. These findings demonstrate that exceptional class I binding oligopeptides that escape proteolytic degradation are potent crosspriming agents. Thus, the feeble immunogenicity of natural proteasome products in crosspriming can be attributed to their evanescence in donor cells and not an absolute inability of cytosolic oligopeptides to be transferred to and presented by professional antigen-presenting cells.	[Lev, Avital; Takeda, Kazuyo; Dimberu, Peniel; Waffarn, Elizabeth; Gibbs, James; Netzer, Nir; Bennink, Jack R.; Yewdelll, Jonathan W.] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; [Neckers, Len] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zanker, Damien; Chen, Weisan] Ludwig Inst Canc Res, Melbourne Ctr Clin Sci, T Cell Lab, Heidelberg, Vic 3084, Australia; [Maynard, Jason C.; Nicchitta, Christopher V.] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Princiotta, Michael F.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Picard, Didier] Univ Geneva, Dept Biol Cellulaire, CH-1211 Geneva, Switzerland; [Reiter, Yoram] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ludwig Institute for Cancer Research; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Geneva; Technion Israel Institute of Technology	Yewdelll, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	jyewdell@nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Chen, Weisan/E-7828-2012	Chen, Weisan/0000-0002-5221-9771; Waffarn, Elizabeth/0000-0001-5484-7344; Zanker, Damien/0000-0003-1163-9902	Intramural NIH HHS [Z01 AI000814-11, Z01 AI000658-16, Z01 AI000653-16, Z01 AI000542-20] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011032, ZIASC010074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000814, Z01AI000653, Z01AI000542, Z01AI000658] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen PS, 1996, P NATL ACAD SCI USA, V93, P1820, DOI 10.1073/pnas.93.5.1820; Anton LC, 1997, J IMMUNOL, V158, P2535; Baker-LePain JC, 2002, J EXP MED, V196, P1447, DOI 10.1084/jem.20020436; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; Chen W, 2004, J IMMUNOL, V173, P5021, DOI 10.4049/jimmunol.173.8.5021; Cho Y, 2003, J VIROL, V77, P4679, DOI 10.1128/JVI.77.8.4679-4684.2003; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Demine R, 2005, J BIOL CHEM, V280, P17573, DOI 10.1074/jbc.M501233200; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; Donohue KB, 2006, IMMUNOLOGY, V119, P63, DOI 10.1111/j.1365-2567.2006.02406.x; Eisenlohr LC, 2007, NAT REV IMMUNOL, V7, P403, DOI 10.1038/nri2077; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Freigang S, 2007, P NATL ACAD SCI USA, V104, P13426, DOI 10.1073/pnas.0704423104; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Javid B, 2007, J IMMUNOL, V179, P2035, DOI 10.4049/jimmunol.179.4.2035; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Lev A, 2002, CANCER RES, V62, P3184; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Nicchitta CV, 2004, CELL STRESS CHAPERON, V9, P325, DOI 10.1379/CSC-62.1; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Oizumi S, 2007, J IMMUNOL, V179, P2310, DOI 10.4049/jimmunol.179.4.2310; Picard D, 2006, EXP CELL RES, V312, P3949, DOI 10.1016/j.yexcr.2006.08.026; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Speidel K, 1997, EUR J IMMUNOL, V27, P2391, DOI 10.1002/eji.1830270938; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; Ying M, 2006, FEBS J, V273, P513, DOI 10.1111/j.1742-4658.2005.05084.x	44	51	51	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					787	798		10.1016/j.immuni.2008.04.015	http://dx.doi.org/10.1016/j.immuni.2008.04.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549799	Green Accepted, Bronze			2022-12-18	WOS:000256760200010
J	Valk, E; Leung, R; Kang, H; Kaneko, K; Rudd, CE; Schneider, H				Valk, Elke; Leung, Rufina; Kang, Hyun; Kaneko, Kazuyo; Rudd, Christopher E.; Schneider, Helga			T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor	IMMUNITY			English	Article							LYMPHOCYTE-ASSOCIATED MOLECULE-4; CLATHRIN-ASSOCIATED PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNOLOGICAL SYNAPSE; NEGATIVE REGULATION; DISTINCT ROLES; CD28; ANTIGEN-4; LOCALIZATION; ACTIVATION	The costimulatory molecule CTLA-4 is a potent downregulator of T cell responses. Although localized mostly in intracellular compartments, little is understood regarding the mechanism that regulates its transport to the cell surface. In this study, we demonstrated that the adaptor TRIM (T cell receptor-interacting molecule) bound to CTLA-4 in the trans Golgi network (TGN) and promoted transport of CTLA-4 to the surface of T cells. Increased TRIM expression augmented surface CTLA-4 expression, and pulse-chase analysis showed a more rapid transport of CTLA-4 to the cell surface. A reduction of TRIM expression by small hairpin RNAs reduced the expression of surface CTLA-4. This resulted in a more localized pattern of CTLA-4 in the TGN. Altered CTLA-4 expression by TRIM was accompanied by corresponding changes in coreceptor-mediated effects on cytokine production and proliferation. Our findings identify a role for TRIM as a chaperone in regulating CTLA-4 expression and function by enhancing CTLA-4 transport to the surface of T cells.	Univ Cambridge, Dept Pathol, Div Immunol, Cell Signalling Sect, Cambridge CB2 1QP, England; Univ London Imperial Coll Sci Technol & Med, Div Invest Sci, Dept Immunol, Mol Immunol Sect,Fac Med, London W12 0NN, England; Harvard Univ, Dept Med, Boston, MA 02115 USA	University of Cambridge; Imperial College London; Harvard University	Schneider, H (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	hs383@cam.ac.uk	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alegre ML, 1996, J IMMUNOL, V157, P4762; Barrat FJ, 1999, P NATL ACAD SCI USA, V96, P8645, DOI 10.1073/pnas.96.15.8645; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Bruyns E, 1998, J EXP MED, V188, P561, DOI 10.1084/jem.188.3.561; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Cefai D, 1998, J IMMUNOL, V160, P2223; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Chuang E, 1997, J IMMUNOL, V159, P144; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Kirchgessner H, 2001, J EXP MED, V193, P1269, DOI 10.1084/jem.193.11.1269; Kliche S, 2004, SEMIN IMMUNOL, V16, P367, DOI 10.1016/j.smim.2004.08.017; Kolsch U, 2006, MOL CELL BIOL, V26, P3639, DOI 10.1128/MCB.26.9.3639-3648.2006; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINSLEY PS, 1995, J EXP MED, V182, P289, DOI 10.1084/jem.182.2.289; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Martin M, 2001, J EXP MED, V194, P1675, DOI 10.1084/jem.194.11.1675; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Miyatake S, 1998, BIOCHEM BIOPH RES CO, V249, P444, DOI 10.1006/bbrc.1998.9191; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Reuter A, 2004, CELL MOL LIFE SCI, V61, P2092, DOI 10.1007/s00018-004-4193-x; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 2002, SCI STKE, pPE18; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 1998, BIOCHEM BIOPH RES CO, V252, P14, DOI 10.1006/bbrc.1998.9559; Schneider H, 1999, J IMMUNOL, V163, P1868; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Simeoni L, 2005, MOL CELL BIOL, V25, P7557, DOI 10.1128/MCB.25.17.7557-7568.2005; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yi LA, 2004, INT IMMUNOL, V16, P539, DOI 10.1093/intimm/dxh055; Zhang LM, 1997, PARASITE, V4, P94; Zhu MH, 2005, J IMMUNOL, V174, P5612, DOI 10.4049/jimmunol.174.9.5612	51	51	56	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					807	821		10.1016/j.immuni.2006.08.024	http://dx.doi.org/10.1016/j.immuni.2006.08.024			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17070077	Bronze			2022-12-18	WOS:000242063100013
J	Ishida, D; Su, L; Tamura, A; Katayama, Y; Kawai, Y; Wang, SF; Taniwaki, M; Hamazaki, Y; Hattori, M; Minato, N				Ishida, D; Su, L; Tamura, A; Katayama, Y; Kawai, Y; Wang, SF; Taniwaki, M; Hamazaki, Y; Hattori, M; Minato, N			Rap1 signal controls B cell receptor repertoire and generation of self-reactive B1a cells	IMMUNITY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; T-CELL; OCA-B; AUTOANTIBODY PRODUCTION; SPA-1-DEFICIENT MICE; INDUCED ACTIVATION; ANTIGEN RECEPTOR; MARGINAL ZONE; PROTEIN SPA-1; COACTIVATOR	We previously reported that the mice deficient for SPA-1, a Rap1 GTPase-activating protein, developed hematopoietic stem cell disorders. Here, we demonstrate that SPA-1(-/-) mice show an age-dependent increase in B220(high) B1a cells producing anti-dsDNA antibody and lupus-like nephritis. SPA-1(-/-) peritoneal B1 cells revealed the altered V kappa gene repertoire, including skewed V kappa 4 usage and the significant Ig kappa/Ig lambda isotype inclusion indicative of extensive receptor editing. Rap1GTP induced OcaB gene activation via p38MAPK-dependent Creb phosphorylation, and consistently, SPA-1(-/-) immature BM B cells showing high Rap1GTP exhibited the augmented expression of OcaB and V kappa 4 genes. SPA-1(-/-) BM cells could transfer the autoimmunity in association with the generation of peritoneal B220(high) B1a cells in Rag-2(-/-) recipients. Finally, a portion of SPA-1(-/-) mice developed B1 cell leukemia with hemolytic autoantibody. Present results suggest that the regulated Rap1 signal in the immature B cells plays a role in modifying the B cell receptor repertoire and in maintaining the self-tolerance.	Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; Kyoto Prefectural Univ, Dept Hematol, Kyoto 6068566, Japan	Kyoto University; Kyoto University; Kyoto Prefectural University	Minato, N (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto 6068501, Japan.	minato@imm.med.kyoto-u.ac.jp	Hamazaki, Y*/Q-3076-2019	Hamazaki, Y*/0000-0001-5866-7340; RENAULT, Shufang/0000-0001-9234-1002				Atencio S, 2004, J IMMUNOL, V172, P4159, DOI 10.4049/jimmunol.172.7.4159; Balabanian K, 2003, J IMMUNOL, V170, P3392, DOI 10.4049/jimmunol.170.6.3392; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dillon TJ, 2005, MOL CELL BIOL, V25, P4117, DOI 10.1128/MCB.25.10.4117-4128.2005; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; HAYAKAWA K, 1988, ANNU REV IMMUNOL, V6, P197, DOI 10.1146/annurev.iy.06.040188.001213; Hess J, 2001, MOL CELL BIOL, V21, P1531, DOI 10.1128/MCB.21.5.1531-1539.2001; Ishida D, 2003, P NATL ACAD SCI USA, V100, P10919, DOI 10.1073/pnas.1834525100; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Jankovic M, 2003, INT IMMUNOL, V15, P1099, DOI 10.1093/intimm/dxg109; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kenny JJ, 2000, J IMMUNOL, V164, P4111, DOI 10.4049/jimmunol.164.8.4111; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Kometani K, 2004, TRENDS MOL MED, V10, P401, DOI 10.1016/j.molmed.2004.06.004; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Li LQ, 2005, J IMMUNOL, V175, P3133, DOI 10.4049/jimmunol.175.5.3133; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; Liang ZY, 2003, J IMMUNOL, V171, P3886, DOI 10.4049/jimmunol.171.7.3886; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pangalis GA, 2002, HEMATOL ONCOL, V20, P103, DOI 10.1002/hon.696; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; PHILLIPS JA, 1992, CANCER RES, V52, P437; Planelles L, 2004, CANCER CELL, V6, P399, DOI 10.1016/j.ccr.2004.08.033; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Rice JS, 2005, P NATL ACAD SCI USA, V102, P1608, DOI 10.1073/pnas.0409217102; Sawada Y, 2001, J CELL SCI, V114, P1221; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Stevens S, 2000, J IMMUNOL, V164, P6372, DOI 10.4049/jimmunol.164.12.6372; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Stork PJS, 2005, NAT CELL BIOL, V7, P338, DOI 10.1038/ncb0405-338; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7	60	51	51	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					417	427		10.1016/j.immuni.2006.02.007	http://dx.doi.org/10.1016/j.immuni.2006.02.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618600	Bronze			2022-12-18	WOS:000237153000011
J	Sarafova, SD; Erman, B; Yu, Q; Van Laethem, F; Guinter, T; Sharrow, SO; Feigenbaum, L; Wildt, KF; Ellmeier, W; Singer, A				Sarafova, SD; Erman, B; Yu, Q; Van Laethem, F; Guinter, T; Sharrow, SO; Feigenbaum, L; Wildt, KF; Ellmeier, W; Singer, A			Modulation of coreceptor transcription during positive selection dictates lineage fate independently of TCR/coreceptor specificity	IMMUNITY			English	Article							RESTRICTED T-CELLS; GENE-EXPRESSION; CD8 LINEAGE; TRANSGENIC MICE; DEVELOPING THYMOCYTES; STOCHASTIC MECHANISM; CD4-DEFICIENT MICE; INSTRUCTIVE MODEL; ANTIGEN RECEPTOR; REGULATES CD4	For developing T cells, coreceptor choice is matched to T cell antigen receptor (TCR) MHC specificity during positive selection in the thymus, but the mechanism remains uncertain. Here, we document that TCR-mediated positive selection signals inactivate the immature CD8(III) enhancer in double positive (DP) thymocytes, explaining in part the cessation of CD8 coreceptor transcription that occurs during positive selection. More importantly, by placing CD4 protein expression under the control of CD8 transcriptional regulatory elements, we demonstrate that cessation of CD4 coreceptor transcription during positive selection results in precisely the same lineage fate as cessation of CD8 coreceptor transcription. That is, MHC-II-signaled DP thymocytes differentiated into CD8-lineage cytotoxic T cells, despite the MHC-II specificity and CD4 dependence of their TCRs. This study demonstrates that termination of coreceptor transcription during positive selection promotes CD8-lineage fate, regardless of TCR specificity or coreceptor protein identity.	NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; NCI, Lab Immune Cell Biol, Bethesda, MD 20892 USA; Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; NCI, Frederick Canc Res & Dev Ctr, Ft Detrick, MD 21702 USA; Univ Vienna, Inst Immunol, VIRCC, A-1235 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sabanci University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Vienna	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bethesda, MD 20892 USA.	singera@nih.gov	erman, batu/AAE-1963-2020	Ellmeier, Wilfried/0000-0001-8192-8481	Austrian Science Fund FWF [Y 163] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC009273, ZIABC009273, Z01BC009255, ZICBC009255] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Basson MA, 1998, J EXP MED, V187, P1249; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Bosselut R, 2001, IMMUNITY, V14, P483, DOI 10.1016/S1074-7613(01)00128-5; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Cibotti R, 2000, MOL CELL BIOL, V20, P3852, DOI 10.1128/MCB.20.11.3852-3859.2000; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FELK N, 2005, J IMMUNOL, V174, P1513; Gascoigne N R, 1993, Semin Immunol, V5, P13, DOI 10.1006/smim.1993.1003; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, J IMMUNOL, V158, P4270; Itano A, 2000, IMMUNITY, V12, P383, DOI 10.1016/S1074-7613(00)80190-9; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Kao H, 2005, J EXP MED, V201, P149, DOI 10.1084/jem.20041574; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; MARUO S, 1997, J IMMUNOL, V158, P20; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MURPHY RF, 1985, CYTOMETRY, V6, P302, DOI 10.1002/cyto.990060405; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SEONG RH, 1992, NATURE, V356, P718, DOI 10.1038/356718a0; Singer A, 2004, ADV IMMUNOL, V83, P91; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	47	51	51	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					75	87		10.1016/j.immuni.2005.05.011	http://dx.doi.org/10.1016/j.immuni.2005.05.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039581	Bronze			2022-12-18	WOS:000231024800010
J	Morio, T; Hanissian, SH; Bacharier, LB; Teraoka, H; Nonoyama, S; Seki, M; Kondo, J; Nakano, H; Lee, SK; Geha, RS; Yata, J				Morio, T; Hanissian, SH; Bacharier, LB; Teraoka, H; Nonoyama, S; Seki, M; Kondo, J; Nakano, H; Lee, SK; Geha, RS; Yata, J			Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; DNA-BINDING; SWITCH RECOMBINATION; V(D)J RECOMBINATION; AUTOANTIGEN BINDS; GENE-PRODUCT; T-CELLS; RECEPTOR; ANTIGEN	CD40 plays a critical role in survival, growth, differentiation, and class switching of B lymphocytes. Although Ku is required for immunoglobulin class switching, how CD40 signal transduction is coupled to Ku is still unknown. Here, we show that CD40 directly interacts with Ku through the membrane-proximal region of cytoplasmic CD40. Ku was confined to the cytoplasm in human primary B cells, and the engagement of CD40 on the B cells cultured in the presence of IL-4 resulted in the dissociation of Ku from CD40, translocation of Ku into the nucleus, and increase in the activity of DNA-dependent protein kinase. These findings indicate that Ku is involved in the CD40 signal transduction pathway and may play an important role in the CD40-mediated events.	Tokyo Med & Dent Univ, Sch Med, Dept Pediat, Tokyo 1138519, Japan; Childrens Hosp, Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo 1010062, Japan; Mitsubishi Chem Corp, Yokohama Res Ctr, Kanagawa 2278502, Japan; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Japan Sci & Technol Corp, Tokyo 1010062, Japan; Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea; Yonsei Univ, Bioprod Res Ctr, Seoul 120749, South Korea	Tokyo Medical & Dental University (TMDU); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tokyo Medical & Dental University (TMDU); Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; Juntendo University; Japan Science & Technology Agency (JST); Yonsei University; Yonsei University	Morio, T (corresponding author), Tokyo Med & Dent Univ, Sch Med, Dept Pediat, Tokyo 1138519, Japan.			Bacharier, Leonard/0000-0003-0432-2704; Morio, Tomohiro/0000-0002-9259-1025; Nakano, Hiroyasu/0000-0003-4843-1427				Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; CAO QP, 1994, BIOCHEMISTRY-US, V33, P8548, DOI 10.1021/bi00194a021; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Chaudhuri A, 1997, J IMMUNOL, V159, P4244; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jabara HH, 1998, BLOOD, V92, P2435, DOI 10.1182/blood.V92.7.2435.2435_2435_2440; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Kehry MR, 1996, J IMMUNOL, V156, P2345; KONDO N, 1992, J BIOL CHEM, V267, P473; LAMAN JD, 1994, CURR OPIN IMMUNOL, V6, P636, DOI 10.1016/0952-7915(94)90153-8; LOH RKS, 1994, J ALLERGY CLIN IMMUN, V94, P784, DOI 10.1016/0091-6749(94)90187-2; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; MESSIER H, 1993, P NATL ACAD SCI USA, V90, P2685, DOI 10.1073/pnas.90.7.2685; MIMORI T, 1986, J BIOL CHEM, V261, P2274; MORIO T, 1995, P NATL ACAD SCI USA, V92, P11633, DOI 10.1073/pnas.92.25.11633; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; Muller C, 1998, ONCOGENE, V16, P1553, DOI 10.1038/sj.onc.1201676; Nagasawa M, 1997, CELL STRUCT FUNCT, V22, P585, DOI 10.1247/csf.22.585; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; SCHWARTZ JL, 1980, ENVIRON MUTAGEN, V2, P473, DOI 10.1002/em.2860020406; SHAPIRA SK, 1992, J EXP MED, V175, P289, DOI 10.1084/jem.175.1.289; Shieh B, 1997, INT IMMUNOL, V9, P1885, DOI 10.1093/intimm/9.12.1885; Shore D, 1998, SCIENCE, V281, P1818, DOI 10.1126/science.281.5384.1818; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; Teoh G, 1998, J CLIN INVEST, V101, P1379; Tovari J, 1998, CELL SIGNAL, V10, P277, DOI 10.1016/S0898-6568(97)00128-9; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Yumoto Y, 1998, J BIOCHEM-TOKYO, V124, P519, DOI 10.1093/oxfordjournals.jbchem.a022143; Zelazowski P, 1997, J IMMUNOL, V159, P2559	44	51	53	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					339	348		10.1016/S1074-7613(00)80109-0	http://dx.doi.org/10.1016/S1074-7613(00)80109-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514012	Bronze			2022-12-18	WOS:000082918500009
J	Sokal, A; Barba-Spaeth, G; Fernandez, I; Broketa, M; Azzaoui, I; de La Selle, A; Vandenberghe, A; Fourati, S; Roeser, A; Meola, A; Bouvier-Alias, M; Crickx, E; Languille, L; Michel, M; Godeau, B; Gallien, S; Melica, G; Nguyen, Y; Zarrouk, V; Canoui-Poitrine, F; Pirenne, F; Megret, J; Pawlotsky, JM; Fillatreau, S; Bruhns, P; Rey, FA; Weill, JC; Reynaud, CA; Chappert, P; Mahevas, M				Sokal, Aurelien; Barba-Spaeth, Giovanna; Fernandez, Ignacio; Broketa, Matteo; Azzaoui, Imane; de La Selle, Andrea; Vandenberghe, Alexis; Fourati, Slim; Roeser, Anais; Meola, Annalisa; Bouvier-Alias, Magali; Crickx, Etienne; Languille, Laetitia; Michel, Marc; Godeau, Bertrand; Gallien, Sebastien; Melica, Giovanna; Nguyen, Yann; Zarrouk, Virginie; Canoui-Poitrine, Florence; Pirenne, France; Megret, Jerome; Pawlotsky, Jean-Michel; Fillatreau, Simon; Bruhns, Pierre; Rey, Felix A.; Weill, Jean-Claude; Reynaud, Claude-Agnes; Chappert, Pascal; Mahevas, Matthieu			mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants	IMMUNITY			English	Article							ANTIBODY; MATURATION; INFECTION; BINDING	In addition to serum immunoglobulins, memory B cell (MBC) generation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is another layer of immune protection, but the quality of MBC responses in naive and coronavirus disease 2019 (COVID-19)-recovered individuals after vaccination remains ill defined. We studied longitudinal cohorts of naive and disease-recovered individuals for up to 2 months after SARSCoV-2 mRNA vaccination. We assessed the quality of the memory response by analysis of antibody repertoires, affinity, and neutralization against variants of concern (VOCs) using unbiased cultures of 2,452 MBCs. Upon boosting, the MBC pool of recovered individuals expanded selectively, matured further, and harbored potent neutralizers against VOCs. Although naive individuals had weaker neutralizing serum responses, half of their RBD-specific MBCs displayed high affinity toward multiple VOCs, including delta (B.1.617.2), and one-third retained neutralizing potency against beta (B.1.351). Our data suggest that an additional challenge in naive vaccinees could recall such affinity-matured MBCs and allow them to respond efficiently to VOCs.	[Sokal, Aurelien; de La Selle, Andrea; Roeser, Anais; Crickx, Etienne; Fillatreau, Simon; Weill, Jean-Claude; Reynaud, Claude-Agnes; Chappert, Pascal; Mahevas, Matthieu] Univ Paris, Inst Necker Enfants Malad INEM, INSERM U1151, CNRS,UMS 8253, Paris, France; [Sokal, Aurelien; Azzaoui, Imane; de La Selle, Andrea; Vandenberghe, Alexis; Roeser, Anais; Crickx, Etienne; Languille, Laetitia; Michel, Marc; Godeau, Bertrand; Mahevas, Matthieu] Univ Paris Est Creteil UPEC, Ctr Hosp Univ Henri Mondor, AP HP, Serv Med Interne, Creteil, France; [Barba-Spaeth, Giovanna; Fernandez, Ignacio; Meola, Annalisa; Rey, Felix A.] Univ Paris, Inst Pasteur, Unite Virol Struct, CNRS,UMR 3569, F-75015 Paris, France; [Broketa, Matteo; Bruhns, Pierre] Univ Paris, Inst Pasteur, Unit Antibodies Therapy & Pathol, INSERM,UMR 1222, F-75015 Paris, France; [Azzaoui, Imane; Vandenberghe, Alexis; Pirenne, France; Mahevas, Matthieu] Univ Paris Est Creteil UPEC, Inst Mondor Rech Biomed IMRB, INSERM U955, Equipe 2, Creteil, France; [Fourati, Slim; Bouvier-Alias, Magali; Pawlotsky, Jean-Michel] Ctr Hosp Univ Henri Mondor, AP HP, Dept Virol Bacteriol Hyg & Mycol Parasitol, Creteil, France; [Fourati, Slim; Bouvier-Alias, Magali; Pawlotsky, Jean-Michel] Univ Paris Est Creteil UPEC, Inst Mondor Rech Biomed IMRB, Equipe 18, INSERM U955, Creteil, France; [Gallien, Sebastien; Melica, Giovanna] Univ Paris Est Creteil UPEC, Ctr Hosp Univ Henri Mondor, AP HP, Serv Malad Infect, Creteil, France; [Nguyen, Yann; Zarrouk, Virginie] Univ Paris, Hop Beaujon, AP HP, Serv Med Interne, Clichy, France; [Canoui-Poitrine, Florence] Univ Paris Est Creteil UPEC, Ctr Hosp Univ Henri Mondor, AP HP,EA 7376,Inst Mondor Rech Biomed IMRB, Dept Sante Publ,Unite Rech Clin URC,CEpiA Clin Ep, Creteil, France; [Pirenne, France] Etab Frangais Sang EFS Ile France, Creteil, France; [Megret, Jerome] INSERM US24 CNRS UMS3633, Struct Federat Rech Necker, Plateforme Cytometrie Flux, Paris, France; [Chappert, Pascal] Inovarion, Paris, France; [Broketa, Matteo] Sorbonne Univ, Coll Doctoral, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Weill, JC; Reynaud, CA; Chappert, P; Mahevas, M (corresponding author), Univ Paris, Inst Necker Enfants Malad INEM, INSERM U1151, CNRS,UMS 8253, Paris, France.; Mahevas, M (corresponding author), Univ Paris Est Creteil UPEC, Ctr Hosp Univ Henri Mondor, AP HP, Serv Med Interne, Creteil, France.; Mahevas, M (corresponding author), Univ Paris Est Creteil UPEC, Inst Mondor Rech Biomed IMRB, INSERM U955, Equipe 2, Creteil, France.; Chappert, P (corresponding author), Inovarion, Paris, France.	jean-claude.weill@inserm.fr; claude-agnes.reynaud@inserm.fr; pascal.chappert@inserm.fr; matthieu.mahevas@aphp.fr	Gallien, Sébastien/F-9930-2015; Bruhns, Pierre/F-5567-2013	Gallien, Sébastien/0000-0002-8033-0936; Bruhns, Pierre/0000-0002-4709-8936; Fernandez, Ignacio/0000-0003-2632-8111; Nguyen, Yann/0000-0002-0866-3824; ROESER, Anais/0000-0001-6717-3115; chappert, pascal/0000-0002-9799-4608; Barba Spaeth, Giovanna/0000-0003-2069-9501; Azzaoui, Imane/0000-0001-5603-6780	Agence Nationale de la Recherche; Fondation pour la Recherche Medicale (ANR) [MEMO-COV-2-FRM]; Fondation Princesse Grace; ERC Advanced Investigator Grant (B-response); Institut Pasteur Urgence COVID-19 Fundraising Campaign; Poste d'Accueil from the In-stitut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de Recherches sur le Sida et les Hepa-tites Virales (ANRS); Association Natio-nale de la Recherche et de la Technologie (ANRT); SNFMI fellowship; ANR [ANR-14-CE16-0011- DROPmAbs]; Institut Carnot Pasteur Microbes et Sante [ANR 11 CARN 0017-01]; Institut Pasteur; INSERM	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (ANR)(French National Research Agency (ANR)); Fondation Princesse Grace; ERC Advanced Investigator Grant (B-response); Institut Pasteur Urgence COVID-19 Fundraising Campaign; Poste d'Accueil from the In-stitut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de Recherches sur le Sida et les Hepa-tites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Association Natio-nale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); SNFMI fellowship; ANR(French National Research Agency (ANR)); Institut Carnot Pasteur Microbes et Sante; Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank Garnett Kelsoe for providing the human cell culture system and invaluable advice. We thank A. Boucharlat and the Chemogenomic and Bio-logical screening core facility headed by F. Agou as well as P. England and the Molecular Biophysics core facility at the Institut Pasteur, Paris, France for support during the course of this work. We also thank Sebastien Storck, Lu-cie Da Silva, and Sandra Weller for advices and support and the physicians, Constance Guillaud, Raphael Lepeule, Frederic Schlemmer, Elena Fois, Henri Guillet, Nicolas De Prost, and Pascal Lim, whose patients were included in this study. The graphical abstract and Figures 1A and S4A were created using BioRender. This work was initiated by a grant from the Agence Nationale de la Recherche and the Fondation pour la Recherche Medicale (ANR; MEMO-COV-2-FRM) and funded by the Fondation Princesse Grace and by an ERC Advanced Investigator Grant (B-response) . Assistance Publique - Ho pitaux de Paris (AP-HP; Departement de la Recherche Clinique et du Developpe-ment) was the promotor and the sponsor of MEMO-COV-2. Work in the Unit of Structural Virology was funded by the Institut Pasteur Urgence COVID-19 Fundraising Campaign. A.S. was supported by a Poste d'Accueil from the In-stitut National de la Sante et de la Recherche Medicale (INSERM) , I.F. by a fellowship from the Agence Nationale de Recherches sur le Sida et les Hepa-tites Virales (ANRS) , M.B. by a CIFRE fellowship from the Association Natio-nale de la Recherche et de la Technologie (ANRT) , and A.d.L.S by a SNFMI fellowship. P.B. acknowledges funding from ANR (ANR-14-CE16-0011- DROPmAbs) , the Institut Carnot Pasteur Microbes et Sante (ANR 11 CARN 0017-01) , the Institut Pasteur, and INSERM.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Bednarski E., 2021, ANTIBODY EVOLUTION S, DOI [10.1101/2021.07.29.454333, DOI 10.1101/2021.07.29.454333]; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; Cherian S., 2021, BIORXIV, DOI [10.1101/2021.02.20.21251598, DOI 10.1101/2021.04.22.440932, 10.1101/2021.04.22.440932]; Crickx E, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc3961; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Dugan HL, 2021, IMMUNITY, V54, P1290, DOI 10.1016/j.immuni.2021.05.001; Ebinger JE, 2021, NAT MED, V27, P981, DOI 10.1038/s41591-021-01325-6; Edara VV, 2021, CELL HOST MICROBE, V29, P516, DOI 10.1016/j.chom.2021.03.009; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Greaney Allison J, 2021, bioRxiv, DOI 10.1101/2021.03.17.435863; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMoa2105000, 10.1056/NEJMc2107808]; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Hsieh Ching-Lin, 2020, Science, V369, P1501, DOI [10.1101/2020.05.30.125484, 10.1126/science.abd0826]; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Konstantinidis TG, 2021, J CLIN MED, V10, DOI 10.3390/jcm10132842; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Lad L, 2015, J BIOMOL SCREEN, V20, P498, DOI 10.1177/1087057114560123; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Manisty C, 2021, LANCET, V397, P1057, DOI 10.1016/S0140-6736(21)00501-8; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Muecksch F, 2021, IMMUNITY, V54, P1853, DOI 10.1016/j.immuni.2021.07.008; Pattekar, BIOXRIV; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Reynolds CJ, 2021, SCIENCE, V372, P1418, DOI 10.1126/science.abh1282; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.21203/rs.3.rs-57112/v1, 10.1101/2020.08.11.20171843]; Saadat S, 2021, JAMA-J AM MED ASSOC, V325, P1467, DOI 10.1001/jama.2021.3341; Sakharkar M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6916; Samanovic Marie I, 2021, medRxiv, DOI 10.1101/2021.02.07.21251311; Scheid JF, 2021, CELL, V184, P3205, DOI 10.1016/j.cell.2021.04.032; Sokal Aurelien, 2021, Cell, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Starr Tyler N, 2021, Cell Rep Med, V2, P100255, DOI [10.1101/2021.02.17.431683, 10.1016/j.xcrm.2021.100255]; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tong P, 2021, CELL, V184, P4969, DOI [10.1016/j.cell.2021.07.025, 10.1101/2021.03.10.434840]; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Shi Pei-Yong, 2021, Res Sq, DOI [10.1101/2021.01.07.425740, 10.21203/rs.3.rs-143532/v1]; Yuan Meng, 2021, bioRxiv, DOI [10.1126/science.abh1139, 10.1101/2021.02.16.430500]; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]	63	50	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2893	+		10.1016/j.immuni.2021.09.011	http://dx.doi.org/10.1016/j.immuni.2021.09.011		DEC 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6EH	34614412	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000731638600001
J	Evren, E; Ringqvist, E; Tripathi, KP; Sleiers, N; Rives, IC; Alisjahbana, A; Gao, Y; Sarhan, D; Halle, T; Sorini, C; Lepzien, R; Marquardt, N; Michaelsson, J; Smed-Sorensen, A; Botling, J; Karlsson, MCI; Villablanca, EJ; Willinger, T				Evren, Elza; Ringqvist, Emma; Tripathi, Kumar Parijat; Sleiers, Natalie; Rives, Ines Co; Alisjahbana, Arlisa; Gao, Yu; Sarhan, Dhifaf; Halle, Tor; Sorini, Chiara; Lepzien, Rico; Marquardt, Nicole; Michaelsson, Jakob; Smed-Sorensen, Anna; Botling, Johan; Karlsson, Mikael C., I; Villablanca, Eduardo J.; Willinger, Tim			Distinct developmental pathways from blood monocytes generate human lung macrophage diversity	IMMUNITY			English	Article							PULMONARY INTRAVASCULAR MACROPHAGES; FLOW-CYTOMETRIC ANALYSIS; ALVEOLAR MACROPHAGES; HEMATOPOIETIC STEM; SELF-RENEWAL; FETAL MONOCYTES; SYSTEM MICE; CELLS; DIFFERENTIATION; ORIGIN	The study of human macrophages and their ontogeny is an important unresolved issue. Here, we use a humanized mouse model expressing human cytokines to dissect the development of lung macrophages from human hematopoiesis in vivo. Human CD34(+) hematopoietic stem and progenitor cells (HSPCs) generated three macrophage populations, occupying separate anatomical niches in the lung. Intravascular cell labeling, cell transplantation, and fate-mapping studies established that classical CD14(+) blood monocytes derived from HSPCs migrated into lung tissue and gave rise to human interstitial and alveolar macrophages. In contrast, non-classical CD16(+) blood monocytes preferentially generated macrophages resident in the lung vasculature (pulmonary intravascular macrophages). Finally, single-cell RNA sequencing defined intermediate differentiation stages in human lung macrophage development from blood monocytes. This study identifies distinct developmental pathways from circulating monocytes to lung macrophages and reveals how cellular origin contributes to human macrophage identity, diversity, and localization in vivo.	[Evren, Elza; Ringqvist, Emma; Sleiers, Natalie; Rives, Ines Co; Alisjahbana, Arlisa; Gao, Yu; Marquardt, Nicole; Michaelsson, Jakob; Willinger, Tim] Karolinska Univ Hosp, Ctr Infect Med, Karolinska Inst, Dept Med Huddinge, S-14152 Stockholm, Sweden; [Tripathi, Kumar Parijat; Sorini, Chiara; Lepzien, Rico; Smed-Sorensen, Anna; Villablanca, Eduardo J.] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Div Immunol & Allergy, S-17164 Stockholm, Sweden; [Tripathi, Kumar Parijat; Sorini, Chiara; Villablanca, Eduardo J.] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Sarhan, Dhifaf; Karlsson, Mikael C., I] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17164 Stockholm, Sweden; [Halle, Tor; Botling, Johan] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Uppsala University	Willinger, T (corresponding author), Karolinska Univ Hosp, Ctr Infect Med, Karolinska Inst, Dept Med Huddinge, S-14152 Stockholm, Sweden.	tim.willinger@ki.se	Sorini, Chiara/M-5837-2015; /K-2942-2013; Ringqvist, Emma/AID-6735-2022; Botling, Johan/ABA-2586-2020; Botling, Johan/AGY-4218-2022; Ringqvist, Emma/AAP-1070-2021; Villablanca, Eduardo/E-1380-2016	Sorini, Chiara/0000-0002-6803-8377; /0000-0003-3186-4752; Ringqvist, Emma/0000-0001-6303-6076; Botling, Johan/0000-0003-2226-3517; GAO, Yu/0000-0002-4615-3614; Tripathi, Kumar Parijat/0000-0002-3998-599X; Evren, Elza/0000-0002-5656-4417; Alisjahbana, Arlisa/0000-0002-8400-8039; Villablanca, Eduardo/0000-0001-9522-9729; Sarhan, Dhifaf/0000-0003-0196-4496; Willinger, TIM/0000-0002-8720-7199	Bill and Melinda Gates Foundation; Swedish Research Council [2018-05973, 2015-02413, 2019-01099]; Karolinska Institutet [2-1060/2018]; Center for Innovative Medicine - Region Stockholm [2-538/2014, 20190152]; Swedish Heart-Lung Foundation [20190198]; Swedish Research Council; Swedish Heart-Lung Foundation; Cancerfonden	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Center for Innovative Medicine - Region Stockholm; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Cancerfonden(Swedish Cancer Society)	We acknowledge Regeneron Pharmaceuticals and Yale University where MISTRG mice were generated with financial support from the Bill and Melinda Gates Foundation. We thank Asa Bjorklund from the Swedish Bioinformatics Advisory Program (NBIS/SciLifeLab) for advice on scRNA-seq bioinformatics analysis and the Bioinformatics and Expression Analysis (BEA) Core Facility at Karolinska Institutet Huddinge. We acknowledge resources provided by the Swedish National Infrastructure for Computing (SNIC) at Uppsala University (UPPMAX infrastructure) partially funded by the Swedish Research Council (2018-05973). We thank Kjell Hultenby and Lars Haag from the Electron Microscopy Unit at Karolinska Institutet Huddinge for technical support. This work was supported by a faculty-funded career position at Karolinska Institutet (2-1060/2018), a Junior Investigator and Junior Project Research Grant from the Center for Innovative Medicine financed by Region Stockholm (2-538/2014; 20190152), as well as Project Grants from the Swedish Research Council (2015-02413; 2019-01099) and the Swedish Heart-Lung Foundation (20190198) to T.W. The work was also supported by grants from the Swedish Research Council (A.S.-S. and M.C.I.K.), the Swedish Heart-Lung Foundation (A.S.-S. and J.M.), and Cancerfonden (M.C.I.K.).	ALENGHAT E, 1984, PEDIATRICS, V74, P221; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Athanasiadis EI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02305-6; Baharom F, 2016, J IMMUNOL, V196, P4498, DOI 10.4049/jimmunol.1600071; Bharat A, 2016, AM J RESP CELL MOL, V54, P147, DOI 10.1165/rcmb.2015-0147LE; Bittmann I, 2001, AM J CLIN PATHOL, V115, P525; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Brain JD, 1999, AM J PHYSIOL-LUNG C, V276, pL146, DOI 10.1152/ajplung.1999.276.1.L146; Byrneee AJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20191236; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; DEHRING DJ, 1989, AM REV RESPIR DIS, V139, P1027, DOI 10.1164/ajrccm/139.4.1027; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC; Eguiluz-Gracia I, 2016, THORAX, V71, P1006, DOI 10.1136/thoraxjnl-2016-208292; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Evren E, 2020, IMMUNOLOGY, V160, P126, DOI 10.1111/imm.13154; Garbi N, 2017, PFLUG ARCH EUR J PHY, V469, P561, DOI 10.1007/s00424-017-1965-3; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hofer TP, 2015, BLOOD, V126, P2601, DOI 10.1182/blood-2015-06-651331; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Joshi N, 2018, CELL IMMUNOL, V330, P86, DOI 10.1016/j.cellimm.2018.01.005; Jung J, 2019, CELL REP, V26, P1906, DOI 10.1016/j.celrep.2019.01.050; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kjellstrom C, 2000, TRANSPLANTATION, V69, P1984, DOI 10.1097/00007890-200005150-00046; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Leung GA, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176180; Li FQ, 2020, EMBO J, V39, DOI 10.15252/embj.2019103205; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liegeois M, 2018, CELL IMMUNOL, V330, P91, DOI 10.1016/j.cellimm.2018.02.001; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Longworth Kim E., 1997, Frontiers in Bioscience (online), V2, pD232; Marquardt N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11632-9; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Nayak DK, 2016, AM J TRANSPLANT, V16, P2300, DOI 10.1111/ajt.13819; O'Connell PA, 2010, BLOOD, V116, P1136, DOI 10.1182/blood-2010-01-264754; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Patel VI, 2017, J IMMUNOL, V198, P1183, DOI 10.4049/jimmunol.1600777; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Phipps KD, 2011, CANCER RES, V71, P6676, DOI 10.1158/0008-5472.CAN-11-1748; Puttur F, 2019, IMMUNOL CELL BIOL, V97, P246, DOI 10.1111/imcb.12235; Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Saito Y, 2016, BLOOD, V128, P1829, DOI 10.1182/blood-2015-10-676452; Sajti E, 2020, NAT IMMUNOL, V21, P221, DOI 10.1038/s41590-019-0582-z; Sanchez CG, 2016, CELL STEM CELL, V18, P276, DOI 10.1016/j.stem.2015.11.004; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Schneberger D, 2012, AM J PHYSIOL-LUNG C, V302, pL498, DOI 10.1152/ajplung.00322.2011; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schuler A, 2008, BLOOD, V111, P4532, DOI 10.1182/blood-2007-10-116343; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Schwieger M, 2009, BLOOD, V114, P2476, DOI 10.1182/blood-2008-05-158196; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Sennello JA, 2017, AM J RESP CELL MOL, V56, P191, DOI 10.1165/rcmb.2016-0147OC; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sippel TR, 2019, BLOOD ADV, V3, P268, DOI 10.1182/bloodadvances.2018023887; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tak T, 2017, BLOOD, V130, P1474, DOI 10.1182/blood-2017-03-771261; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122; Trapnell BC, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0066-3; Ural BB, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax8756; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007; Yu YRA, 2016, AM J RESP CELL MOL, V54, P13, DOI 10.1165/rcmb.2015-0146OC; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00423; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	92	50	52	10	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					259	+		10.1016/j.immuni.2020.12.003	http://dx.doi.org/10.1016/j.immuni.2020.12.003		FEB 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33382972	Green Published			2022-12-18	WOS:000627407700011
J	Acharya, N; Madi, A; Zhang, HY; Klapholz, M; Escobar, G; Dulberg, S; Christian, E; Ferreira, M; Dixon, KO; Fell, G; Tooley, K; Mangani, D; Xia, JR; Singer, M; Bosenberg, M; Neuberg, D; Rozenblatt-Rosen, O; Regev, A; Kuchroo, VK; Anderson, AC				Acharya, Nandini; Madi, Asaf; Zhang, Huiyuan; Klapholz, Max; Escobar, Giulia; Dulberg, Shai; Christian, Elena; Ferreira, Michelle; Dixon, Karen O.; Fell, Geoffrey; Tooley, Katherine; Mangani, Davide; Xia, Junrong; Singer, Meromit; Bosenberg, Marcus; Neuberg, Donna; Rozenblatt-Rosen, Orit; Regev, Aviv; Kuchroo, Vijay K.; Anderson, Ana C.			Endogenous Glucocorticoid Signaling Regulates CD8(+)T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment	IMMUNITY			English	Article							T-CELLS; COMPLEMENTARY-DNA; RECEPTOR; MECHANISMS; INHIBITION; PD-1; ACTIVATION; IMMUNOSUPPRESSION; MODULATION; EXHAUSTION	Identifying signals in the tumor microenvironment (TME) that shape CD8(+) T cell phenotype can inform novel therapeutic approaches for cancer. Here, we identified a gradient of increasing glucocorticoid receptor (GR) expression and signaling from naive to dysfunctional CD8(+) tumor-infiltrating lymphocytes (TILs). Conditional deletion of the GR in CD8(+) TILs improved effector differentiation, reduced expression of the transcription factor TCF-1, and inhibited the dysfunctional phenotype, culminating in tumor growth inhibition. GR signaling transactivated the expression of multiple checkpoint receptors and promoted the induction of dysfunction-associated genes upon T cell activation. In the TME, monocyte-macrophage lineage cells produced glucocorticoids and genetic ablation of steroidogenesis in these cells as well as localized pharmacologic inhibition of glucocorticoid biosynthesis improved tumor growth control. Active glucocorticoid signaling associated with failure to respond to checkpoint blockade in both preclinical models and melanoma patients. Thus, endogenous steroid hormone signaling in CD8(+) TILs promotes dysfunction, with important implications for cancer immunotherapy.	[Acharya, Nandini; Madi, Asaf; Zhang, Huiyuan; Klapholz, Max; Escobar, Giulia; Christian, Elena; Dixon, Karen O.; Tooley, Katherine; Mangani, Davide; Xia, Junrong; Kuchroo, Vijay K.; Anderson, Ana C.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Acharya, Nandini; Madi, Asaf; Zhang, Huiyuan; Klapholz, Max; Escobar, Giulia; Christian, Elena; Dixon, Karen O.; Tooley, Katherine; Mangani, Davide; Xia, Junrong; Kuchroo, Vijay K.; Anderson, Ana C.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Acharya, Nandini; Madi, Asaf; Zhang, Huiyuan; Klapholz, Max; Escobar, Giulia; Christian, Elena; Dixon, Karen O.; Tooley, Katherine; Mangani, Davide; Xia, Junrong; Kuchroo, Vijay K.; Anderson, Ana C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Madi, Asaf; Dulberg, Shai] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Tel Aviv, Israel; [Christian, Elena; Singer, Meromit; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Ferreira, Michelle; Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Ferreira, Michelle; Bosenberg, Marcus] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Ferreira, Michelle; Bosenberg, Marcus] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Fell, Geoffrey; Neuberg, Donna] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 01225 USA; [Singer, Meromit] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Singer, Meromit] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Koch Inst, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Ludwig Ctr, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Yale University; Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kuchroo, VK; Anderson, AC (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Kuchroo, VK; Anderson, AC (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Kuchroo, VK; Anderson, AC (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.; Regev, A (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Koch Inst, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Ludwig Ctr, Cambridge, MA 02142 USA.	aregev@broadinstitute.org; vkuchroo@evergrande.hms.harvard.edu; acanderson@bwh.harvard.edu	Dixon, karen/AHB-4474-2022; Rozenblatt-Rosen, Orit/HDN-4182-2022; Anderson, Ana C/ABD-6829-2021; Escobar, Giulia/AFD-7497-2022; Mangani, Davide/A-3383-2017	Anderson, Ana C/0000-0002-0877-2932; Escobar, Giulia/0000-0001-9177-0251; Zhang, Huiyuan/0000-0003-0763-6856; Dulberg, Shai/0000-0001-8304-5324; Madi, Asaf/0000-0003-3441-3228; Mangani, Davide/0000-0001-5297-0234; Klapholz, Max/0000-0001-6527-8722; Dixon, Karen/0000-0001-7811-5439; Ferreira, Michelle/0000-0001-5335-349X; Tooley, Katherine/0000-0003-0587-0358; Christian, Elena/0000-0002-5593-0155	National Institutes of Health [R01NS045937, P01AI073748, R01CA229400]; Klarman Cell Observatory at the Broad Institute; HHMI; Brigham and Women's President's Scholar Award; SNSF postdoc mobility [P400PB_183910]; EMBO Long Term Fellowship [ALTF 182-2018]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory at the Broad Institute; HHMI(Howard Hughes Medical Institute); Brigham and Women's President's Scholar Award; SNSF postdoc mobility; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO))	We thank Deneen Kozoriz for cell sorting, Dr. Sally Kent for advice on human T cell culture, and Leslie Gaffney and Dr. Amit Bansal for figure preparation. This work was supported by grants from the National Institutes of Health (R01NS045937 to V.K.K., P01AI073748 to V.K.K. and A.C.A., R01CA229400 to A.C.A.) and by the Klarman Cell Observatory at the Broad Institute and HHMI. A.C.A. is a recipient of the Brigham and Women's President's Scholar Award. A.R. is an Investigator of the Howard Hughes Medical Institute. D.M is supported by SNSF postdoc mobility (P400PB_183910). G.E. is supported by EMBO Long Term Fellowship (ALTF 182-2018).	ABBASZADE IG, 1995, MOL ENDOCRINOL, V9, P1214, DOI 10.1210/me.9.9.1214; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arbour KC, 2018, J CLIN ONCOL, V36, P2872, DOI 10.1200/JCO.2018.79.0006; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BAIN PA, 1991, P NATL ACAD SCI USA, V88, P8870, DOI 10.1073/pnas.88.20.8870; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Bianchi M, 2000, P NATL ACAD SCI USA, V97, P9573, DOI 10.1073/pnas.160099797; Brattsand R, 1996, ALIMENT PHARM THERAP, V10, P81, DOI 10.1046/j.1365-2036.1996.22164025.x; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Carey KT, 2013, ENDOCRINOLOGY, V154, P1540, DOI 10.1210/en.2012-1820; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; CLARKE TR, 1993, MOL ENDOCRINOL, V7, P1569, DOI 10.1210/me.7.12.1569; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; DeLong Jonathan H, 2019, Immunohorizons, V3, P13, DOI 10.4049/immunohorizons.1800083; Downey SG, 2007, CLIN CANCER RES, V13, P6681, DOI 10.1158/1078-0432.CCR-07-0187; Faje AT, 2018, CANCER-AM CANCER SOC, V124, P3706, DOI 10.1002/cncr.31629; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Johnson DB, 2015, CANCER IMMUNOL RES, V3, P464, DOI 10.1158/2326-6066.CIR-14-0217; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jubb AW, 2017, CELL REP, V21, P3022, DOI 10.1016/j.celrep.2017.11.053; KARIN M, 1979, SCIENCE, V204, P176, DOI 10.1126/science.432639; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Kelly WJ, 2021, J NEURO-ONCOL, V151, P13, DOI 10.1007/s11060-020-03439-2; Kolde Raivo, 2015, F1000Res, V4, P574, DOI 10.12688/f1000research.6925.1; Kumar V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00049; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Maaten L.v.d., 2009, J MACHINE LEARNING R, V5, P348; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oh KS, 2017, IMMUNITY, V47, P298, DOI 10.1016/j.immuni.2017.07.012; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Sidler D, 2011, ONCOGENE, V30, P2411, DOI 10.1038/onc.2010.629; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Tiemessen MM, 2014, J IMMUNOL, V193, P5480, DOI 10.4049/jimmunol.1303417; Tokunaga A, 2019, J EXP MED, V216, P2701, DOI 10.1084/jem.20190738; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weber JS, 2008, J CLIN ONCOL, V26, P5950, DOI 10.1200/JCO.2008.16.1927; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Xing KL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0103-2; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	62	50	51	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					658	+		10.1016/j.immuni.2020.08.005	http://dx.doi.org/10.1016/j.immuni.2020.08.005			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937153	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000569806100019
J	Vasamsetti, SB; Florentin, J; Coppin, E; Stiekema, LCA; Zheng, KH; Nisar, MU; Sembrat, J; Levinthal, DJ; Rojas, M; Stroes, ESG; Kim, K; Dutta, P				Vasamsetti, Sathish Babu; Florentin, Jonathan; Coppin, Emilie; Stiekema, Lotte C. A.; Zheng, Kang H.; Nisar, Muhammad Umer; Sembrat, John; Levinthal, David J.; Rojas, Mauricio; Stroes, Erik S. G.; Kim, Kang; Dutta, Partha			Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; ATHEROSCLEROTIC LESIONS; MYOCARDIAL-INFARCTION; DIABETES PROMOTES; BONE-MARROW; MACROPHAGES; NERVE; INFLAMMATION; MONOCYTOSIS; SPLEEN	There is a growing body of research on the neural control of immunity and inflammation. However, it is not known whether the nervous system can regulate the production of inflammatory myeloid cells from hematopoietic progenitor cells in disease conditions. Myeloid cell numbers in diabetic patients were strongly correlated with plasma concentrations of norepinephrine, suggesting the role of sympathetic neuronal activation in myeloid cell production. The spleens of diabetic patients and mice contained higher numbers of tyrosine hydroxylase (TH)-expressing leukocytes that produced catecholamines. Granulocyte macrophage progenitors (GMPs) expressed the beta(2) adrenergic receptor, a target of catecholamines. Ablation of splenic sympathetic neuronal signaling using surgical, chemical, and genetic approaches diminished GMP proliferation and myeloid cell development. Finally, mice lacking TH-producing leukocytes had reduced GMP proliferation, resulting in diminished myelopoiesis. Taken together, our study demonstrates that catecholamines produced by leukocytes and sympathetic nerve termini promote GMP proliferation and myeloid cell development.	[Vasamsetti, Sathish Babu; Florentin, Jonathan; Coppin, Emilie; Sembrat, John; Rojas, Mauricio; Kim, Kang; Dutta, Partha] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15260 USA; [Stiekema, Lotte C. A.; Zheng, Kang H.; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Sembrat, John; Rojas, Mauricio] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA USA; [Sembrat, John; Rojas, Mauricio] Univ Pittsburgh, Med Ctr, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA USA; [Levinthal, David J.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Rojas, Mauricio; Kim, Kang] Univ Pittsburgh, Sch Med, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Nisar, Muhammad Umer; Kim, Kang] Univ Pittsburgh, Dept Bioengn, Sch Engn, Pittsburgh, PA USA; [Vasamsetti, Sathish Babu; Florentin, Jonathan; Coppin, Emilie; Dutta, Partha] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Kim, Kang; Dutta, Partha] Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Amsterdam; Academic Medical Center Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dutta, P (corresponding author), Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15260 USA.; Dutta, P (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.; Dutta, P (corresponding author), Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA 15260 USA.	duttapa@pitt.edu	Levinthal, David/AAJ-6606-2021; Vasamsetti, sathish Babu/ABE-1163-2020	Vasamsetti, sathish Babu/0000-0002-9682-7437; Zheng, Kang He/0000-0001-8954-1337; Levinthal, David/0000-0001-8453-8382	National Institutes of Health [4R00HL121076-03, 1R01HL143967]; NIH [1S10RR027383-01, 1S10OD019973-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL143967, R00HL121076] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants 4R00HL121076-03 and 1R01HL143967 (to P.D.). The small animal imaging system was supported by NIH 1S10RR027383-01 (to K.K.). We would like to acknowledge the NIH-supported microscopy resources in the Center for Biologic Imaging, specifically the confocal microscope supported by grant number 1S10OD019973-01. The graphical abstract was adapted from the Servier Medical Art (https://www.servier.com). We would like to thank Drs. Prabir Ray and Anuradha Ray for their critical review of the manuscript.	Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Barnes MA, 2015, CYTOKINE, V72, P210, DOI 10.1016/j.cyto.2015.01.008; Bokhari S, 2014, DIABETES CARE, V37, P3040, DOI 10.2337/dc14-0782; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; Carnevale D, 2014, IMMUNITY, V41, P737, DOI 10.1016/j.immuni.2014.11.002; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Dalli J, 2017, IMMUNITY, V46, P92, DOI 10.1016/j.immuni.2016.12.009; DELATORRE JC, 1976, NEUROSCIENCE, V1, P451, DOI 10.1016/0306-4522(76)90095-6; DiNicolantonio JJ, 2015, OPEN HEART, V2, DOI [10.1136/openhrt-2014-000230, 10.1136/openhrt-2015-000326]; Dutta P, 2015, J EXP MED, V212, P497, DOI 10.1084/jem.20141642; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693; Howard BV, 2002, CIRCULATION, V106, P523, DOI 10.1161/01.CIR.0000019552.77778.04; Johansson F, 2008, P NATL ACAD SCI USA, V105, P2082, DOI 10.1073/pnas.0709958105; Jung WC, 2017, SEMIN CELL DEV BIOL, V61, P60, DOI 10.1016/j.semcdb.2016.08.010; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Laukova M, 2013, IMMUNOBIOLOGY, V218, P780, DOI 10.1016/j.imbio.2012.08.279; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Libby P, 2013, J CLIN INVEST, V123, P3201, DOI 10.1172/JCI67526; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Muthu K, 2007, J NEUROIMMUNOL, V186, P27, DOI 10.1016/j.jneuroim.2007.02.007; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Orlandi A, 2010, BASIC RES CARDIOL, V105, P703, DOI 10.1007/s00395-010-0109-0; OSTMAN J, 1983, ACTA MED SCAND, P69; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schemann M, 2013, GASTROENTEROLOGY, V144, P698, DOI 10.1053/j.gastro.2013.01.040; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Spinetti G, 2013, CIRC RES, V112, P510, DOI 10.1161/CIRCRESAHA.112.300598; Straub RH, 2000, J LEUKOCYTE BIOL, V67, P553, DOI 10.1002/jlb.67.4.553; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Thorp AA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/341583; Tracey KJ, 2014, IMMUNITY, V41, P673, DOI 10.1016/j.immuni.2014.11.007; Trottier MD, 2012, P NATL ACAD SCI USA, V109, P7622, DOI 10.1073/pnas.1205129109; Veiga-Fernandes H, 2017, NAT IMMUNOL, V18, P116, DOI 10.1038/ni.3634; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wendt Thoralf, 2002, Curr Atheroscler Rep, V4, P228, DOI 10.1007/s11883-002-0024-4; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Zhang XS, 2015, J ULTRAS MED, V34, P111, DOI 10.7863/ultra.34.1.111	53	50	52	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					93	+		10.1016/j.immuni.2018.05.004	http://dx.doi.org/10.1016/j.immuni.2018.05.004			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29958804	Green Accepted, Bronze			2022-12-18	WOS:000438949100014
J	Zhou, TQ; Zheng, AQ; Baxa, U; Chuang, GY; Georgiev, IS; Kong, R; O'Dell, S; Shahzad-Ul-Hussan, S; Shen, CH; Tsybovsky, Y; Bailer, RT; Gift, SK; Louder, MK; McKee, K; Rawi, R; Stevenson, CH; Stewart-Jones, GBE; Taft, JD; Waltari, E; Yang, YP; Zhang, BS; Shivatare, SS; Shivatare, VS; Lee, CCD; Wu, CY; Mullikin, JC; Bewley, CA; Burton, DR; Polonis, VR; Shapiro, L; Wong, CH; Mascola, JR; Kwong, PD; Wu, XL				Zhou, Tongqing; Zheng, Anqi; Baxa, Ulrich; Chuang, Gwo-Yu; Georgiev, Ivelin S.; Kong, Rui; O'Dell, Sijy; Shahzad-ul-Hussan, Syed; Shen, Chen-Hsiang; Tsybovsky, Yaroslav; Bailer, Robert T.; Gift, Syna K.; Louder, Mark K.; McKee, Krisha; Rawi, Reda; Stevenson, Catherine H.; Stewart-Jones, Guillaume B. E.; Taft, Justin D.; Waltari, Eric; Yang, Yongping; Zhang, Baoshan; Shivatare, Sachin S.; Shivatare, Vidya S.; Lee, Chang-Chun D.; Wu, Chung-Yi; Mullikin, James C.; Bewley, Carole A.; Burton, Dennis R.; Polonis, Victoria R.; Shapiro, Lawrence; Wong, Chi-Huey; Mascola, John R.; Kwong, Peter D.; Wu, Xueling		NISC Comparative Sequencing	A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope	IMMUNITY			English	Article							CRYO-EM STRUCTURE; ELECTRON-MICROSCOPY; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE; CD4-BINDING SITE; GP120; ENV; RECOGNITION; REVEALS; TRIMER	Virtually the entire surface of the HIV-1-envelope trimer is recognized by neutralizing antibodies, except for a highly glycosylated region at the center of the "silent face" on the gp120 subunit. From an HIV-1-infected donor, #74, we identified antibody VRC-PG05, which neutralized 27% of HIV-1 strains. The crystal structure of the antigen-binding fragment of VRC-PG05 in complex with gp120 revealed an epitope comprised primarily of N-linked glycans from N262, N295, and N448 at the silent face center. Somatic hypermutation occurred preferentially at antibody residues that interacted with these glycans, suggesting somatic development of glycan recognition. Resistance to VRC-PG05 in donor #74 involved shifting of glycan-N448 to N446 or mutation of glycan-proximal residue E293. HIV-1 neutralization can thus be achieved at the silent face center by glycan-recognizing antibody; along with other known epitopes, the VRC-PG05 epitope completes coverage by neutralizing antibody of all major exposed regions of the prefusion closed trimer.	[Zhou, Tongqing; Zheng, Anqi; Chuang, Gwo-Yu; Georgiev, Ivelin S.; Kong, Rui; O'Dell, Sijy; Shahzad-ul-Hussan, Syed; Shen, Chen-Hsiang; Bailer, Robert T.; Louder, Mark K.; McKee, Krisha; Rawi, Reda; Stevenson, Catherine H.; Stewart-Jones, Guillaume B. E.; Taft, Justin D.; Yang, Yongping; Zhang, Baoshan; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.; Wu, Xueling] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Baxa, Ulrich; Tsybovsky, Yaroslav] Leidos Biomed Res Inc, Electron Microscopy Lab, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA; [Shahzad-ul-Hussan, Syed; Bewley, Carole A.] NIDDK, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA; [Gift, Syna K.; Polonis, Victoria R.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Gift, Syna K.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Waltari, Eric; Wu, Xueling] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Shivatare, Sachin S.; Shivatare, Vidya S.; Lee, Chang-Chun D.; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan; [Mullikin, James C.] NHGRI, NISC, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Shapiro, Lawrence; Kwong, Peter D.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Rockefeller University; Academia Sinica - Taiwan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Columbia University; Scripps Research Institute	Mascola, JR; Kwong, PD; Wu, XL (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.; Wu, XL (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.; Kwong, PD (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	jmascola@nih.gov; pdkwong@nih.gov; xwu@adarc.org	Shivatare, Sachin S/G-7264-2017; Zhou, Tongqing/A-6880-2010; Shapiro, Lawrence/AAE-7172-2019; Mascola, John/AAI-7193-2021; Wu, Chung-Yi/K-8334-2018	Shivatare, Sachin S/0000-0002-7512-752X; Zhou, Tongqing/0000-0002-3935-4637; Bewley, Carole/0000-0003-2203-0852; Waltari, Eric/0000-0001-6930-9645; Baxa, Ulrich/0000-0002-7263-5078; Thomas, James/0000-0002-2098-6458	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute, National Institutes of Health (NIH), from the NIH [R21 AI108399]; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; federal funds from the Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NIH [R01 AI131722, R01 AI072155]; Academia Sinica; Ministry of Science and Technology [106-0210-01-15-02, 104-0210-01-09-02, 103-2321-B-001-004]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005111, R01AI131722, R21AI108399, ZIAAI005095, ZICAI005112, R01AI072155, ZIAAI005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK032103] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute, National Institutes of Health (NIH), from the NIH; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; federal funds from the Frederick National Laboratory for Cancer Research, NIH; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G.J. Nabel and Z.-Y. Yang for assistance with probes, M. Roederer and S. Perfetto for assistance with B cell sorting, J. Stuckey for assistance with figures, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 envelope plasmids used in our neutralization panel. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), and the National Human Genome Research Institute, National Institutes of Health (NIH), from the NIH grant R21 AI108399 (X.W.), and from the International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium. This project has also been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science under contract number W-31-109-Eng-38. I.S.G. was supported by NIH grant R01 AI131722. V.S.S., C.-C. D. L., C.-Y.W., and C.-H.W. were supported by Academia Sinica and Ministry of Science and Technology grants 106-0210-01-15-02, 104-0210-01-09-02, and 103-2321-B-001-004. C.-H.W. was supported by NIH grant R01 AI072155. The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Bewley CA, 2013, BIOPOLYMERS, V99, P796, DOI 10.1002/bip.22329; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Chen MY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15487; Chuang GY, 2013, J VIROL, V87, P10047, DOI 10.1128/JVI.00984-13; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006148; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francois KO, 2011, J BIOL CHEM, V286, P42900, DOI 10.1074/jbc.M111.274456; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI citeulike-article-id:691774; He LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06778; Jia MX, 2016, J VIROL, V90, P4017, DOI 10.1128/JVI.02898-15; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Kabat EA, 1991, SEQUENCES PROTEINS I; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kong L, 2015, PROTEINS, V83, P590, DOI 10.1002/prot.24747; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lemmin T, 2017, STRUCTURE, V25, P1631, DOI 10.1016/j.str.2017.07.018; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Piehler B, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-33; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Stewart J. J., 1999, PROFILE QUASISPECIES; Stewart JJ, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-1; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tartaglia LJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005431; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Wang HQ, 2016, P NATL ACAD SCI USA, V113, pE7151, DOI 10.1073/pnas.1615939113; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhou TQ, 2017, CELL REP, V19, P719, DOI 10.1016/j.celrep.2017.04.013; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	68	50	51	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					500	+		10.1016/j.immuni.2018.02.013	http://dx.doi.org/10.1016/j.immuni.2018.02.013			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29548671	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000427916900011
J	Li, Q; Li, DL; Zhang, X; Wan, QQ; Zhang, W; Zheng, MK; Zou, L; Elly, C; Lee, JH; Liu, YC				Li, Qian; Li, Dulei; Zhang, Xian; Wan, Qingqing; Zhang, Wen; Zheng, Mingke; Zou, Le; Elly, Chris; Lee, Jee H.; Liu, Yun-Cai			E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA3; HYPOXIA-INDUCIBLE FACTORS; METABOLIC CHECKPOINT; DIFFERENTIATION; INFLAMMATION; PROGENITOR; DEFINES; LINEAGE	Group 2 innate lymphoid cells (ILC2s) are a specialized subset of lymphoid effector cells that are critically involved in allergic responses; however, the mechanisms of their regulation remain unclear. We report that conditional deletion of the E3 ubiquitin ligase VHLin innate lymphoid progenitors minimally affected early-stage bone marrow ILC2s but caused a selective and intrinsic decrease in mature ILC2 numbers in peripheral non-lymphoid tissues, resulting in reduced type 2 immune responses. VHL deficiency caused the accumulation of hypoxia-inducible factor 1 alpha (HIF1 alpha) and attenuated interleukin-33 (IL-33) receptor ST2 expression, which was rectified by HIF1 alpha ablation or inhibition. HIF1 alpha-driven expression of the glycolytic enzyme pyruvate kinase M2 down-modulated ST2 expression via epigenetic modification and inhibited IL-33-induced ILC2 development. Our study indicates that the VHL-HIF-glycolysis axis is essential for the late-stage maturation and function of ILC2s via targeting IL-33-ST2 pathway.	[Li, Qian; Li, Dulei; Zhang, Xian; Wan, Qingqing; Zhang, Wen; Zheng, Mingke; Zou, Le; Liu, Yun-Cai] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Inst Immunol, Sch Med, Beijing 100080, Peoples R China; [Elly, Chris; Lee, Jee H.; Liu, Yun-Cai] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	Tsinghua University; La Jolla Institute for Immunology	Liu, YC (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Inst Immunol, Sch Med, Beijing 100080, Peoples R China.; Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	yuncai_liu@mail.tsinghua.edu.cn		Zhang, Wen/0000-0002-9069-3773; LIU, YUN-CAI/0000-0002-0996-7109	Tsinghua-Peking Center for Life Sciences [NSFC81630041, YFC0903900, YFA0505802]; NIH [RO1AI123398]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123398] Funding Source: NIH RePORTER	Tsinghua-Peking Center for Life Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Sant'Angelo for providing the original Zbtb 16-cre mice and W.C. Zeng and other members of Liu lab for help and advice. This work is supported by funds from NSFC81630041, YFC0903900, YFA0505802, the Tsinghua-Peking Center for Life Sciences, and NIH RO1AI123398.	Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lee JH, 2015, IMMUNITY, V42, P1062, DOI 10.1016/j.immuni.2015.05.016; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	42	50	51	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					258	+		10.1016/j.immuni.2017.12.013	http://dx.doi.org/10.1016/j.immuni.2017.12.013			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29452935	Green Accepted, Bronze			2022-12-18	WOS:000425507800012
J	Minutti, CM; Drube, S; Blair, N; Schwartz, C; McCrae, JC; McKenzie, AN; Kamradt, T; Mokry, M; Coffer, PJ; Sibilia, M; Sijts, AJ; Fallon, PG; Maizels, RM; Zaiss, DM				Minutti, Carlos M.; Drube, Sebastian; Blair, Natalie; Schwartz, Christian; McCrae, Jame C.; McKenzie, Andrew N.; Kamradt, Thomas; Mokry, Michal; Coffer, Paul J.; Sibilia, Maria; Sijts, Alice J.; Fallon, Padraic G.; Maizels, Rick M.; Zaiss, Dietmar M.			Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent Fashion	IMMUNITY			English	Article							CUTTING EDGE; IMMUNITY; AMPHIREGULIN; MECHANISMS; PROMOTES; INTERLEUKIN-4; INFLAMMATION; PROTECTION; RESISTANCE; HELMINTHS	Gastro-intestinal helminth infections trigger the release of interleukin-33 (IL-33), which induces type-2 helper T cells (Th2 cells) at the site of infection to produce IL-13, thereby contributing to host resistance in a T cell receptor (TCR)-independent manner. Here, we show that, as a prerequisite for IL-33induced IL-13 secretion, Th2 cells required the expression of the epidermal growth factor receptor (EGFR) and of its ligand, amphiregulin, for the formation of a signaling complex between T1/ST2 (the IL33R) and EGFR. This shared signaling complex allowed IL-33 to induce the EGFR-mediated activation of the MAP-kinase signaling pathway and consequently the expression of IL-13. Lack of EGFR expression on T cells abrogated IL-13 expression in infected tissues and impaired host resistance. EGFR expression on Th2 cells was TCR-signaling dependent, and therefore, our data reveal a mechanism by which antigen presentation controls the innate effector function of Th2 cells at the site of inflammation.	[Minutti, Carlos M.; Blair, Natalie; McCrae, Jame C.; Maizels, Rick M.; Zaiss, Dietmar M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland; [Drube, Sebastian; Kamradt, Thomas] Univ Klinikum Jena, Inst Immunol, D-07743 Jena, Germany; [Schwartz, Christian; Fallon, Padraic G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Schwartz, Christian; Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin 12, Ireland; [Schwartz, Christian; Fallon, Padraic G.] Trinity Coll Dublin, Inst Translat Med, Dublin 8, Ireland; [McKenzie, Andrew N.] Med Res Council MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [Mokry, Michal; Coffer, Paul J.] Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CT Utrecht, Netherlands; [Mokry, Michal; Coffer, Paul J.] Univ Med Ctr Utrecht, Regenerat Med Ctr, NL-3584 CT Utrecht, Netherlands; [Sibilia, Maria] Med Univ Vienna, Comprehens Canc Ctr, Dept Med 1, Inst Canc Res, A-1090 Vienna, Austria; [Sijts, Alice J.] Fac Vet Med Utrecht, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands	University of Edinburgh; Friedrich Schiller University of Jena; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Medical University of Vienna; Utrecht University	Zaiss, DM (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland.	dietmar.zaiss@ed.ac.uk	Mokry, Michal/AAN-3809-2021; Coffer, Paul/AAF-7970-2020; Kamradt, Thomas/E-9971-2018; Fallon, Padraic/Y-2711-2019; Schwartz, Christian/K-3716-2015	Mokry, Michal/0000-0002-5298-4852; Fallon, Padraic/0000-0002-8401-7293; Sijts, Alice/0000-0003-3815-4788; Schwartz, Christian/0000-0002-7084-268X; Minutti, Carlos/0000-0002-9663-1928; Zaiss, Dietmar M.W./0000-0003-3596-7062; Sibilia, Maria/0000-0001-6129-5613	Medical Research Council [MR/M011755/1]; European Union [CIG-631413]; Austrian Science Fund (FWF) grants [SFB F3518-B20, W1212, P25925]; MRC grant [U105178805]; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MR/M011755/1, MC_U105178805] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Austrian Science Fund (FWF) grants(Austrian Science Fund (FWF)); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Martin Waterfall, Alison Fulton, and Nicola Logan for excellent technical assistance. Work in the D.M.Z. laboratory is supported by the Medical Research Council, grant MR/M011755/1, and the European Union, grant CIG-631413 ("EGF-R for Immunity''). The M.S. laboratory is supported by the Austrian Science Fund (FWF) grants SFB F3518-B20, W1212, and P25925. A.N.M. is funded by the MRC grant U105178805. C.S. is a long-term EMBO Fellow.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Burtness B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003734; Camberis M., 2003, CURRENT PROTOCOLS IM; Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hewitson JP, 2011, J IMMUNOL, V187, P4764, DOI 10.4049/jimmunol.1004140; Johnston CJC, 2015, JOVE-J VIS EXP, DOI 10.3791/52412; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Meulenbroeks C, 2015, J INVEST DERMATOL, V135, P222, DOI 10.1038/jid.2014.329; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pahl A, 2002, BRIT J PHARMACOL, V135, P1915, DOI 10.1038/sj.bjp.0704656; Reynolds LA, 2012, SEMIN IMMUNOPATHOL, V34, P829, DOI 10.1007/s00281-012-0347-3; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; Smith KA, 2016, MUCOSAL IMMUNOL, V9, P428, DOI 10.1038/mi.2015.73; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	39	50	51	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					710	+		10.1016/j.immuni.2017.09.013	http://dx.doi.org/10.1016/j.immuni.2017.09.013			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045902	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000413091600015
J	Mak, TW; Grusdat, M; Duncan, GS; Dostert, C; Nonnenmacher, Y; Cox, M; Binsfeld, C; Hao, ZY; Brustle, A; Itsumi, M; Jager, C; Chen, Y; Pinkenburg, O; Camara, B; Ollert, M; Bindslev-Jensen, C; Vasiliou, V; Gorrini, C; Lang, PA; Lohoff, M; Harris, IS; Hiller, K; Brenner, D				Mak, Tak W.; Grusdat, Melanie; Duncan, Gordon S.; Dostert, Catherine; Nonnenmacher, Yannic; Cox, Maureen; Binsfeld, Carole; Hao, Zhenyue; Brustle, Anne; Itsumi, Momoe; Jaeger, Christian; Chen, Ying; Pinkenburg, Olaf; Camara, Barbel; Ollert, Markus; Bindslev-Jensen, Carsten; Vasiliou, Vasilis; Gorrini, Chiara; Lang, Philipp A.; Lohoff, Michael; Harris, Isaac S.; Hiller, Karsten; Brenner, Dirk			Glutathione Primes T Cell Metabolism for Inflammation (vol 46, pg 675, 2017)	IMMUNITY			English	Correction												tmak@uhnresearch.ca; dirk.brenner@lih.lu	Cox, Maureen/AAY-7685-2020; Duncan, Gordon/AIE-7011-2022; Bindslev-Jensen, Carsten/H-1877-2011; Dostert, Catherine/AAJ-5473-2020	Bindslev-Jensen, Carsten/0000-0002-8940-038X; vasiliou, vasilis/0000-0003-2552-3118; Ollert, Markus W./0000-0002-8055-0103; Gorrini, Chiara/0000-0002-5239-6671	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022057] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019	1	50	51	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					1089	1090		10.1016/j.immuni.2017.06.009	http://dx.doi.org/10.1016/j.immuni.2017.06.009			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636957	Green Published, Bronze			2022-12-18	WOS:000403665900020
J	Toyonaga, K; Torigoe, S; Motomura, Y; Kamichi, T; Hayashi, JM; Morita, YS; Noguchi, N; Chuma, Y; Kiyohara, H; Matsuo, K; Tanaka, H; Nakagawa, Y; Sakuma, T; Ohmuraya, M; Yamamoto, T; Umemura, M; Matsuzaki, G; Yoshikai, Y; Yano, I; Miyamoto, T; Yamasaki, S				Toyonaga, Kenji; Torigoe, Shota; Motomura, Yoshitomo; Kamichi, Takane; Hayashi, Jennifer M.; Morita, Yasu S.; Noguchi, Naoto; Chuma, Yasushi; Kiyohara, Hideyasu; Matsuo, Kazuhiro; Tanaka, Hiroshi; Nakagawa, Yoshiko; Sakuma, Tetsushi; Ohmuraya, Masaki; Yamamoto, Takashi; Umemura, Masayuki; Matsuzaki, Goro; Yoshikai, Yasunobu; Yano, Ikuya; Miyamoto, Tomofumi; Yamasaki, Sho			C-Type Lectin Receptor DCAR Recognizes Mycobacterial Phosphatidyl-Inositol Mannosides to Promote a Th1 Response during Infection	IMMUNITY			English	Article							BACILLUS-CALMETTE-GUERIN; ANTIGEN-PRESENTING CELLS; HUMAN MACROPHAGES; DENDRITIC CELLS; T-CELLS; ACTIVATING RECEPTOR; PATTERN-RECOGNITION; ACYLATION STATE; INNATE IMMUNITY; CORD FACTOR	Phosphatidyl-inositol mannosides (PIM) are glycolipids unique to mycobacteria and other related bacteria that stimulate host immune responses and are implicated in mycobacteria pathogenicity. Here, we found that the FcRg-coupled C-type lectin receptor DCAR (dendritic cell immunoactivating receptor; gene symbol Clec4b1) is a direct receptor for PIM. Mycobacteria activated reporter cells expressing DCAR, and delipidation of mycobacteria abolished this activity. Acylated PIMs purified from mycobacteria were identified as ligands for DCAR. DCAR was predominantly expressed in small peritoneal macrophages and monocyte-derived inflammatory cells in lungs and spleen. These cells produced monocyte chemoattractant protein-1 (MCP-1) upon PIM treatment, and absence of DCAR or FcRg abrogated MCP-1 production. Upon mycobacterial infection, Clec4b1-deficient mice showed reduced numbers of monocyte-derived inflammatory cells at the infection site, impaired IFN gamma production by T cells, and an increased bacterial load. Thus, DCAR is a critical receptor for PIM that functions to promote T cell responses against mycobacteria.	[Toyonaga, Kenji; Torigoe, Shota; Kamichi, Takane; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Res Ctr Infect Dis, Div Mol Immunol, Fukuoka 8128582, Japan; [Motomura, Yoshitomo] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Kamichi, Takane] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Hayashi, Jennifer M.; Morita, Yasu S.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Noguchi, Naoto; Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Res Ctr Infect Dis, Div Host Def, Fukuoka 8128582, Japan; [Chuma, Yasushi; Kiyohara, Hideyasu; Matsuo, Kazuhiro; Yano, Ikuya] Japan BCG Lab, Kiyose 2040022, Japan; [Tanaka, Hiroshi] Tokyo Inst Technol, Grad Sch Sci & Technol, Dept Appl Chem, Tokyo 1528552, Japan; [Nakagawa, Yoshiko; Ohmuraya, Masaki] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima 7398526, Japan; [Umemura, Masayuki; Matsuzaki, Goro] Univ Ryukyus, Grad Sch Med, Mol Microbiol Grp, Dept Infect Dis,Trop Biosphere Res Ctr, Okinawa 9030213, Japan; [Ohmuraya, Masaki; Yamamoto, Takashi] Univ Ryukyus, Grad Sch Med, Dept Host Def, Okinawa 9030213, Japan; [Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Nat Prod Chem, Fukuoka 8128582, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan	Kyushu University; Kyushu University; Kyushu University; University of Massachusetts System; University of Massachusetts Amherst; Kyushu University; Tokyo Institute of Technology; Kumamoto University; Hiroshima University; University of the Ryukyus; University of the Ryukyus; Kyushu University; Chiba University	Yamasaki, S (corresponding author), Kyushu Univ, Med Inst Bioregulat, Res Ctr Infect Dis, Div Mol Immunol, Fukuoka 8128582, Japan.; Yamasaki, S (corresponding author), Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan.	yamasaki@bioreg.kyushu-u.ac.jp	Tanaka, Hiroshi/I-2402-2012; Matsuzaki, Goro/AAX-3110-2020; Yamamoto, Takashi/U-4790-2017; Sakuma, Tetsushi/A-7615-2013	Yamamoto, Takashi/0000-0002-6516-2903; Sakuma, Tetsushi/0000-0003-0396-1563; Matsuo, Keitaro/0000-0003-1761-6314; Hayashi, Jennifer/0000-0001-7153-9212; Morita, Yasu/0000-0002-4514-9242; Torigoe, Shota/0000-0002-4884-3686; Yamasaki, Sho/0000-0002-5184-6917; Noguchi, Naoto/0000-0002-2597-6101	MEXT [26110009, 26293099]; Takeda Science Foundation; Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus; Ministry of Health, Labour and Welfare (MHLW); Research on Development of New Drugs, the Japan Agency for Medical Research and Development (AMED; AMED-CREST, AMED;  [14J04460];  [16J06299]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus; Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Research on Development of New Drugs, the Japan Agency for Medical Research and Development (AMED(Japan Agency for Medical Research and Development (AMED)); AMED-CREST, AMED; ; 	We thank M. Kurata, R. Kiyotake, K. Shibata,W. Ohkawa, X. Lu, Z. Omahdi, M. Nagata, Y. Fukuda, and E. Ishikawa for technical support; Y. Izumi and T. Bamba for lipid analysis; M. Oh-hora, Y. Matsumura, and M. Tanaka for discussion; M. Ato for preparation of bacteria. This work was supported by Grant-in-Aid for Scientific Research (26293099), Grant-in-Aid for Scientific Research on Innovative Areas (26110009) from MEXT, Grant-in-Aid for JSPS Research Fellow (14J04460, 16J06299), Takeda Science Foundation, Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus, and Grants from the Ministry of Health, Labour and Welfare (MHLW) and the Research on Development of New Drugs, the Japan Agency for Medical Research and Development (AMED). This work was also supported by AMED-CREST, AMED.	Ainge GD, 2006, BIOORGAN MED CHEM, V14, P7615, DOI 10.1016/j.bmc.2006.07.003; Apostolou I, 1999, P NATL ACAD SCI USA, V96, P5141, DOI 10.1073/pnas.96.9.5141; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; Boonyarattanakalin S, 2008, J AM CHEM SOC, V130, P16791, DOI 10.1021/ja806283e; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Chow KV, 2016, J IMMUNOL, V196, P624, DOI 10.4049/jimmunol.1501202; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Court N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024631; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Driessen NN, 2009, INFECT IMMUN, V77, P4538, DOI 10.1128/IAI.01256-08; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Guerin ME, 2010, J BIOL CHEM, V285, P33577, DOI 10.1074/jbc.R110.168328; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo JP, 2009, GENES IMMUN, V10, P227, DOI 10.1038/gene.2009.4; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Hanashima S, 2015, CHEMBIOCHEM, V16, P1502, DOI 10.1002/cbic.201500103; Hattori Y, 2014, J BIOL CHEM, V289, P15405, DOI 10.1074/jbc.M114.566489; Heitmann L, 2013, IMMUNOBIOLOGY, V218, P506, DOI 10.1016/j.imbio.2012.06.005; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ito T, 2008, INT IMMUNOL, V20, P849, DOI 10.1093/intimm/dxn043; Jones BW, 2001, ANN RHEUM DIS, V60, pIII6; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; Miyake Y, 2015, J IMMUNOL, V194, P5366, DOI 10.4049/jimmunol.1402429; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Movahedzadeh F, 2004, MOL MICROBIOL, V51, P1003, DOI 10.1046/j.1365-2958.2003.03900.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakagawa Y, 2014, EXP ANIM TOKYO, V63, P349, DOI 10.1538/expanim.63.349; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; Ohira S, 2014, HETEROCYCLES, V89, P763, DOI 10.3987/COM-14-12944; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Parlane NA, 2012, VACCINE, V30, P580, DOI 10.1016/j.vaccine.2011.11.055; Patil PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8239; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Rocha-Ramirez LM, 2008, TUBERCULOSIS, V88, P212, DOI 10.1016/j.tube.2007.10.003; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Saito K, 2006, J IMMUNOL, V176, P2496, DOI 10.4049/jimmunol.176.4.2496; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Sena CBC, 2010, J BIOL CHEM, V285, P13326, DOI 10.1074/jbc.M109.077297; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sprott GD, 2004, INFECT IMMUN, V72, P5235, DOI 10.1128/IAI.72.9.5235-5246.2004; Takimoto H, 2006, CLIN EXP IMMUNOL, V144, P134, DOI 10.1111/j.1365-2249.2006.03043.x; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Villeneuve C, 2005, J LIPID RES, V46, P475, DOI 10.1194/jlr.M400308-JLR200; Vir P, 2014, APMIS, V122, P268, DOI 10.1111/apm.12141; Wilson GJ, 2015, CELL HOST MICROBE, V17, P252, DOI 10.1016/j.chom.2015.01.004; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702; Zheng T., 2015, J VACCINES VACCIN, V6, P277	75	50	50	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1245	1257		10.1016/j.immuni.2016.10.012	http://dx.doi.org/10.1016/j.immuni.2016.10.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27887882	Bronze			2022-12-18	WOS:000392918100011
J	Milasta, S; Dillon, CP; Sturm, OE; Verbist, KC; Brewer, TL; Quarato, G; Brown, SA; Frase, S; Janke, LJ; Perry, SS; Thomas, PG; Green, DR				Milasta, Sandra; Dillon, Christopher P.; Sturm, Oliver E.; Verbist, Katherine C.; Brewer, Taylor L.; Quarato, Giovanni; Brown, Scott A.; Frase, Sharon; Janke, Laura J.; Perry, S. Scott; Thomas, Paul G.; Green, Douglas R.			Apoptosis-Inducing-Factor-Dependent Mitochondrial Function Is Required for T Cell but Not B Cell Function	IMMUNITY			English	Article							COMPLEX-I-DEFICIENCY; OXIDOREDUCTASE NDI1 GENE; OXIDATIVE-PHOSPHORYLATION; REGULATES APOPTOSIS; FACTOR AIF; DEATH; HOMEOSTASIS; DYSFUNCTION; ACTIVATION; GENERATION	The role of apoptosis inducing factor (AIF) in promoting cell death versus survival remains controversial. We report that the loss of AIF in fibroblasts led to mitochondrial electron transport chain defects and loss of proliferation that could be restored by ectopic expression of the yeast NADH dehydrogenase Ndi1. Aif-deficiency in T cells led to decreased peripheral T cell numbers and defective homeostatic proliferation, but thymic T cell development was unaffected. In contrast, Aif-deficient B cells developed and functioned normally. The difference in the dependency of T cells versus B cells on AIF for function and survival correlated with their metabolic requirements. Ectopic Ndi1 expression rescued homeostatic proliferation of Aif-deficient T cells. Despite its reported roles in cell death, fibroblasts, thymocytes and B cells lacking AIF underwent normal death. These studies suggest that the primary role of AIF relates to complex I function, with differential effects on T and B cells.	[Milasta, Sandra; Dillon, Christopher P.; Brewer, Taylor L.; Quarato, Giovanni; Brown, Scott A.; Thomas, Paul G.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Sturm, Oliver E.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Verbist, Katherine C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Frase, Sharon] St Jude Childrens Res Hosp, Cell & Tissue Imaging Ctr, Memphis, TN 38105 USA; [Janke, Laura J.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Perry, S. Scott] St Jude Childrens Res Hosp, Dept Flow Cytometry, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	douglas.green@stjude.org	Thomas, Paul G./H-1063-2018; Green, Douglas R/N-8083-2018; Quarato, Giovanni/F-8272-2016; Janke, Laura/N-8121-2018	Thomas, Paul G./0000-0001-7955-0256; Green, Douglas R/0000-0002-7332-1417; Quarato, Giovanni/0000-0003-1167-3422; Janke, Laura/0000-0002-9871-6239; Verbist, Katherine/0000-0002-3511-5639	ALSAC; US National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208] Funding Source: NIH RePORTER	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Cross, Greig Lennon, and Parker Ingle for all cell sorting and Mao Yang for technical support. This work was supported by ALSAC and by grants from the US National Institutes of Health.	Badea TC, 2003, J NEUROSCI, V23, P2314; Banerjee H, 2012, J EXP MED, V209, P1641, DOI 10.1084/jem.20110306; Benit P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003208; Bettini ML, 2013, NAT PROTOC, V8, P1837, DOI 10.1038/nprot.2013.111; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chinta SJ, 2009, FREE RADICAL BIO MED, V46, P939, DOI 10.1016/j.freeradbiomed.2009.01.010; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Seo B.B., 2004, FUNCTIONAL EXPRESSIO; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yi JS, 2006, J IMMUNOL, V177, P852, DOI 10.4049/jimmunol.177.2.852	44	50	53	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					88	102		10.1016/j.immuni.2015.12.002	http://dx.doi.org/10.1016/j.immuni.2015.12.002			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26795252	Green Accepted, Bronze			2022-12-18	WOS:000368347000015
J	Rapaport, AS; Schriewer, J; Gilfillan, S; Hembrador, E; Crump, R; Plougastel, BF; Wang, YM; Le Friec, G; Gao, J; Cella, M; Pircher, H; Yokoyama, WM; Buller, RML; Colonna, M				Rapaport, Aaron S.; Schriewer, Jill; Gilfillan, Susan; Hembrador, Ed; Crump, Ryan; Plougastel, Beatrice F.; Wang, Yaming; Le Friec, Gaelle; Gao, Jian; Cella, Marina; Pircher, Hanspeter; Yokoyama, Wayne M.; Buller, R. Mark L.; Colonna, Marco			The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8(+) T Cells in Response to a Lethal Poxvirus Infection	IMMUNITY			English	Article							CLASS IB MOLECULE; NK CELLS; HLA-E; ECTROMELIA-VIRUS; STRUCTURAL BASIS; EXPRESSION; CD94/NKG2A; CD94; RESISTANCE; SURVIVAL	CD8(+) T cells and NK cells protect from viral infections by killing virally infected cells and secreting interferon-gamma. Several inhibitory receptors limit the magnitude and duration of these anti-viral responses. NKG2A, which is encoded by Klrc1, is a lectin-like inhibitory receptor that is expressed as a heterodimer with CD94 on NK cells and activated CD8(+) T cells. Previous studies on the impact of CD94/NKG2A heterodimers on anti-viral responses have yielded contrasting results and the in vivo function of NKG2A remains unclear. Here, we generated Klrc1(-/-) mice and found that NKG2A is selectively required for resistance to ectromelia virus (ECTV). NKG2A functions intrinsically within ECTV-specific CD8(+) T cells to limit excessive activation, prevent apoptosis, and preserve the specific CD8(+) T cell response. Thus, although inhibitory receptors often cause T cell exhaustion and viral spreading during chronic viral infections, NKG2A optimizes CD8(+) T cell responses during an acute poxvirus infection.	[Rapaport, Aaron S.; Gilfillan, Susan; Wang, Yaming; Le Friec, Gaelle; Cella, Marina; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Schriewer, Jill; Hembrador, Ed; Crump, Ryan; Buller, R. Mark L.] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Plougastel, Beatrice F.; Gao, Jian; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Pircher, Hanspeter] Univ Med Ctr Freiburg, Ctr Microbiol & Hyg, Inst Immunol, D-79104 Freiburg, Germany; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); University of Freiburg; Howard Hughes Medical Institute; Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Plougastel-Douglas, Beatrice/Q-3186-2019; Cella, Marina/ABA-8564-2020	Plougastel-Douglas, Beatrice/0000-0002-6389-561X; Colonna, Marco/0000-0001-5222-4987; Cella, Marina/0000-0003-1230-1313; Le Friec, Gaelle/0000-0002-2051-3829	NIH [1R56AI119083-01, T32-AI007172, HHSN272201300006C]; Rheumatic Diseases Core Center grant from National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30-AR048335]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, R56AI119083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatic Diseases Core Center grant from National Institute of Arthritis and Musculoskeletal and Skin Diseases; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	M. Colonna was supported by the NIH grant 1R56AI119083-01, A.S.R. by the NIH training grant T32-AI007172, B.F.P. by the Rheumatic Diseases Core Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30-AR048335), and W.M.Y. by the Howard Hughes Medical Institute. The authors thank the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of MHC tetramers, Scott Parker for technical assistance, John Yewdell for vaccinia virus, and Christina Song for help with preparing this manuscript.	ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Biron CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000816; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; BROWNSTEIN DG, 1995, J VIROL, V69, P6958, DOI 10.1128/JVI.69.11.6958-6964.1995; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Crouse J, 2014, IMMUNITY, V40, P961, DOI 10.1016/j.immuni.2014.05.003; Ely KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108385; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Gunturi A, 2003, J IMMUNOL, V170, P1737, DOI 10.4049/jimmunol.170.4.1737; Kabat J, 2002, J IMMUNOL, V169, P1948, DOI 10.4049/jimmunol.169.4.1948; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; McMahon CW, 2002, J IMMUNOL, V169, P1444, DOI 10.4049/jimmunol.169.3.1444; Miller JD, 2002, J IMMUNOL, V169, P693, DOI 10.4049/jimmunol.169.2.693; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Saether PC, 2011, J IMMUNOL, V187, P6365, DOI 10.4049/jimmunol.1102345; Schuster IS, 2014, IMMUNITY, V41, P646, DOI 10.1016/j.immuni.2014.09.013; Sei JJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004941; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Taylor L S, 2000, Rev Immunogenet, V2, P204; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ugolini S, 2001, NAT IMMUNOL, V2, P430, DOI 10.1038/87740; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Xu HC, 2014, IMMUNITY, V40, P949, DOI 10.1016/j.immuni.2014.05.004; Zeng L, 2012, J IMMUNOL, V188, P302, DOI 10.4049/jimmunol.1102379	38	50	52	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1112	1124		10.1016/j.immuni.2015.11.005	http://dx.doi.org/10.1016/j.immuni.2015.11.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26680205	Bronze, Green Accepted			2022-12-18	WOS:000366846600015
J	Cantaert, T; Schickel, JN; Bannock, JM; Ng, YS; Massad, C; Oe, T; Wu, R; Lavoie, A; Walter, JE; Notarangelo, LD; Al-Herz, W; Kilic, SS; Ochs, HD; Nonoyama, S; Durandy, A; Meffre, E				Cantaert, Tineke; Schickel, Jean-Nicolas; Bannock, Jason M.; Ng, Yen-Shing; Massad, Christopher; Oe, Tyler; Wu, Renee; Lavoie, Aubert; Walter, Jolan E.; Notarangelo, Luigi D.; Al-Herz, Waleed; Kilic, Sara Sebnem; Ochs, Hans D.; Nonoyama, Shigeaki; Durandy, Anne; Meffre, Eric			Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; V(D)J RECOMBINATION; AID EXPRESSION; DEFICIENCY; MECHANISMS; BCL6; P53; TRANSLOCATIONS; RECEPTORS	Activation-induced cytidine deaminase (AID), the enzyme- mediating class-switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin genes, is essential for the removal of developing autoreactive B cells. How AID mediates central B cell tolerance remains unknown. We report that AID enzymes were produced in a discrete population of immature B cells that expressed recombination-activating gene 2 (RAG2), suggesting that they undergo secondary recombination to edit autoreactive antibodies. However, most AID(+) immature B cells lacked anti-apoptotic MCL-1 and were deleted by apoptosis. AID inhibition using lentiviral-encoded short hairpin (sh)RNA in B cells developing in humanized mice resulted in a failure to remove autoreactive clones. Hence, B cell intrinsic AID expression mediates central B cell tolerance potentially through its RAG-coupled genotoxic activity in self-reactive immature B cells.	[Cantaert, Tineke; Schickel, Jean-Nicolas; Bannock, Jason M.; Ng, Yen-Shing; Massad, Christopher; Oe, Tyler; Wu, Renee; Meffre, Eric] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Lavoie, Aubert] CHU Quebec, Div Allergy Immunol, Quebec City, PQ G1V 4G2, Canada; [Walter, Jolan E.] Harvard Univ, Massachusetts Gen Hosp, Pediat Allergy & Immunol, Sch Med, Boston, MA 02114 USA; [Walter, Jolan E.] Harvard Univ, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Sch Med, Boston, MA 02114 USA; [Walter, Jolan E.; Notarangelo, Luigi D.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Safat 13110, Kuwait; [Kilic, Sara Sebnem] Uludag Univ, Fac Med, Dept Pediat, TR-16285 Gorukle, Turkey; [Ochs, Hans D.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Ochs, Hans D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 3598513, Japan; [Durandy, Anne] INSERM, UMR 1163, F-75015 Paris, France	Yale University; Laval University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Kuwait University; Uludag University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Defense Medical College - Japan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Meffre, E (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA.	eric.meffre@yale.edu	Notarangelo, Luigi D/F-9718-2016; Durandy, Anne/H-7475-2017; cantaert, tineke/HGB-2648-2022; Kilic, Sara Sebnem/AAH-1658-2021	Notarangelo, Luigi D/0000-0002-8335-0262; Durandy, Anne/0000-0001-7706-8466; cantaert, tineke/0000-0002-8911-1502; kilic, sara sebnem/0000-0001-8571-2581; Oe, Tyler/0000-0001-7178-7822	NIH-NIAID [AI061093, AI071087, AI082713]; INSERM, CEE EUROPAD-contract 7th Framework Program [201549]; Assiociation Contre le Cancer; Rubicon program, Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071087, P01AI061093, U19AI082713] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); INSERM, CEE EUROPAD-contract 7th Framework Program; Assiociation Contre le Cancer; Rubicon program, Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are very much indebted to the patients and their families. We thank Dr. L. Devine and C. Wang for cell sorting, Dr. P. Soulas-Sprauel for kindly providing the pTRIP-Ubi-GFP lentiviral vector for shRNA delivery, Dr. J.C. Delpech for help with immunostainings and Dr. D. Schatz for providing the anti-RAG2 antibodies and discussions. We also thank all the members of the Immunodeficiency Clinic of the Centre Hospitalier de l'Universite Laval. This work was supported by Grant Numbers AI061093, AI071087, and AI082713 from NIH-NIAID (to E.M.) and INSERM, CEE EUROPAD-contract 7th Framework Program (#201549), and Assiociation Contre le Cancer (to A.D.). T.C. received support from the Rubicon program, Netherlands Organization for Scientific Research.	Perez MA, 2010, PEDIATR INFECT DIS J, V29, P1052, DOI 10.1097/INF.0b013e3181e6c69b; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Isnardi I, 2008, IMMUNITY, V29, P746, DOI 10.1016/j.immuni.2008.09.015; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Juszczynski P, 2009, BLOOD, V114, P5315, DOI 10.1182/blood-2009-02-204362; Kinnunen T, 2013, J CLIN INVEST, V123, P2737, DOI 10.1172/JCI68775; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuraoka M, 2011, P NATL ACAD SCI USA, V108, P11560, DOI 10.1073/pnas.1102571108; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Martensson IL, 2002, SEMIN IMMUNOL, V14, P335, DOI 10.1016/S1044-5323(02)00066-0; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Menard L, 2014, J ALLERGY CLIN IMMUN, V133, P1149, DOI 10.1016/j.jaci.2013.10.051; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Meyers G, 2011, P NATL ACAD SCI USA, V108, P11554, DOI 10.1073/pnas.1102600108; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029141; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Radic MZ, 1995, ANN NY ACAD SCI, V764, P384; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Romberg N, 2013, J CLIN INVEST, V123, P4283, DOI 10.1172/JCI69854; Saito M, 2009, P NATL ACAD SCI USA, V106, P11294, DOI 10.1073/pnas.0903854106; Sauer AV, 2012, J CLIN INVEST, V122, P2141, DOI 10.1172/JCI61788; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schickel JN, 2012, EMBO MOL MED, V4, P1261, DOI 10.1002/emmm.201201595; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Swaminathan S, 2015, NAT IMMUNOL, V16, P766, DOI 10.1038/ni.3160; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Umiker BR, 2014, EUR J IMMUNOL, V44, P3093, DOI 10.1002/eji.201344282; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Zaheen A, 2009, BLOOD, V114, P547, DOI 10.1182/blood-2009-03-211763; Zahn A, 2014, P NATL ACAD SCI USA, V111, pE988, DOI 10.1073/pnas.1320486111	55	50	50	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					884	895		10.1016/j.immuni.2015.10.002	http://dx.doi.org/10.1016/j.immuni.2015.10.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26546282	Green Accepted, Bronze			2022-12-18	WOS:000366846000010
J	de Gassart, A; Martinon, F				de Gassart, Aude; Martinon, Fabio			Pyroptosis: Caspase-11 Unlocks the Gates of Death	IMMUNITY			English	Editorial Material							CELL-DEATH; CHANNEL		[de Gassart, Aude; Martinon, Fabio] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Martinon, F (corresponding author), Univ Lausanne, Dept Biochem, 155 Ch Boveresses, CH-1066 Epalinges, Switzerland.	fabio.martinon@unil.ch	Martinon, Fabio/A-5575-2009	Martinon, Fabio/0000-0002-6969-822X; De Gassart, Aude/0000-0002-0574-344X				Adamson SE, 2014, FEBS LETT, V588, P1416, DOI 10.1016/j.febslet.2014.03.009; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009	10	50	50	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					835	837		10.1016/j.immuni.2015.10.024	http://dx.doi.org/10.1016/j.immuni.2015.10.024			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588774	Bronze			2022-12-18	WOS:000366846000003
J	Cook, KD; Shpargel, KB; Starmer, J; Whitfield-Larry, F; Conley, B; Allard, DE; Rager, JE; Fry, RC; Davenport, ML; Magnuson, T; Whitmire, JK; Su, MA				Cook, Kevin D.; Shpargel, Karl B.; Starmer, Joshua; Whitfield-Larry, Fatima; Conley, Bridget; Allard, Denise E.; Rager, Julia E.; Fry, Rebecca C.; Davenport, Marsha L.; Magnuson, Terry; Whitmire, Jason K.; Su, Maureen A.			T Follicular Helper Cell-Dependent Clearance of a Persistent Virus Infection Requires T Cell Expression of the Histone Demethylase UTX	IMMUNITY			English	Article							B-CELLS; X-INACTIVATION; DEFICIENT MICE; DIFFERENTIATION; RESPONSES; GENE; PLASTICITY; INTERFERONS; EXHAUSTION; CHROMATIN	Epigenetic changes, including histone methylation, control T cell differentiation and memory formation, though the enzymes that mediate these processes are not clear. We show that UTX, a histone H3 lysine 27 (H3K27) demethylase, supports T follicular helper (Tfh) cell responses that are essential for B cell antibody generation and the resolution of chronic viral infections. Mice with a T cell-specific UTX deletion had fewer Tfh cells, reduced germinal center responses, lacked virus-specific immunoglobulin G (IgG), and wereunable toresolve chronic lymphocyticchoriomeningitis virus infections. UTX-deficient T cells showed decreased expression of interleukin-6 receptor-alpha and other Tfh cell-related genes that were associated with increased H3K27 methylation. Additionally, Turner Syndrome subjects, who are predisposed to chronic ear infections, had reduced UTX expression in immune cells and decreased circulating CD4(+) CXCR5(+) T cell frequency. Thus, we identify a critical link between UTX in T cells and immunity to infection.	[Cook, Kevin D.; Shpargel, Karl B.; Starmer, Joshua; Magnuson, Terry; Whitmire, Jason K.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Shpargel, Karl B.; Starmer, Joshua; Magnuson, Terry] Univ N Carolina, Sch Med, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Shpargel, Karl B.; Starmer, Joshua; Magnuson, Terry; Su, Maureen A.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Whitfield-Larry, Fatima; Conley, Bridget; Davenport, Marsha L.; Su, Maureen A.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Whitfield-Larry, Fatima; Allard, Denise E.; Whitmire, Jason K.; Su, Maureen A.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Rager, Julia E.; Fry, Rebecca C.] Univ N Carolina, Sch Med, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Whitmire, JK (corresponding author), Univ N Carolina, Sch Med, Dept Genet, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	jwhitmir@email.unc.edu; masu@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Ariel, Pablo/AGJ-4118-2022	Shpargel, Karl/0000-0002-9658-456X; Conley, Bridget/0000-0002-2986-764X; Su, Maureen/0000-0002-3680-9982; Whitmire, Jason/0000-0003-2578-6073; Fry, Rebecca/0000-0003-0899-9018; Cook, Kevin/0000-0003-3079-4174	NCTracs; NIH [R01 NS079683, R01 AI074862, R56 AI110682, T32 AI7273-27, R01 GM10974]; NC TraCS Translational Team Science Award [TTSA004P2]; UNC-Chapel Hill; Cancer Center Core [P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110682, R01AI074862, T32AI007273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079683] Funding Source: NIH RePORTER	NCTracs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NC TraCS Translational Team Science Award; UNC-Chapel Hill; Cancer Center Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Kristian Helin (University of Copenhagen, Denmark) kindly provided the UTX antibody for ChIP analysis. NCTracs (50K Pilot Grant to M.A.S.), NIH (R01 NS079683 to M.A.S.; R01 AI074862 and R56 AI110682 to J.K.W.; T32 AI7273-27 to K.D.C.; and R01 GM10974 to TM, K.B.S. and J.S.), NC TraCS Translational Team Science Award (TTSA004P2), and start-up funds from UNC-Chapel Hill to M.A.S. and J.K.W. funded this work. The UNC Flow Cytometry Core Facility is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; CACCIARI E, 1981, J IMMUNOGENET, V8, P337; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Feng JY, 2012, J GASTROENTEROL, V47, P1048, DOI 10.1007/s00535-012-0568-1; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; JENSEN K, 1976, HUM GENET, V31, P329, DOI 10.1007/BF00270862; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Matloubian M., 1994, J VIROL, V68, P8056; Matsumoto N, 2003, AM J MED GENET C, V117C, P57, DOI 10.1002/ajmg.c.10020; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mock BA, 2000, J INVEST ALLERG CLIN, V10, P312; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Planz O, 1997, P NATL ACAD SCI USA, V94, P6874, DOI 10.1073/pnas.94.13.6874; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Richter K, 2013, EUR J IMMUNOL, V43, P2349, DOI 10.1002/eji.201343566; Schreiber TH, 2013, IMMUNOL RES, V57, P3, DOI 10.1007/s12026-013-8465-0; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Stenberg AE, 1998, HEARING RES, V124, P85, DOI 10.1016/S0378-5955(98)00113-0; Stenberg Annika E, 2004, J Negat Results Biomed, V3, P6, DOI 10.1186/1477-5751-3-6; Su MA, 2009, CLIN IMMUNOL, V131, P139, DOI 10.1016/j.clim.2008.11.007; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; vanderMost RG, 1996, J IMMUNOL, V157, P5543; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Whitmire JK, 2009, J IMMUNOL, V182, P1868, DOI 10.4049/jimmunol.0802501; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	56	50	51	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					703	714		10.1016/j.immuni.2015.09.002	http://dx.doi.org/10.1016/j.immuni.2015.09.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26431949	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000363478700013
J	Panda, S; Nilsson, JA; Gekara, NO				Panda, Swarupa; Nilsson, Jonas A.; Gekara, Nelson O.			Deubiquitinase MYSM1 Regulates Innate Immunity through Inactivation of TRAF3 and TRAF6 Complexes	IMMUNITY			English	Article							NF-KAPPA-B; HISTONE H2A DEUBIQUITINASE; CELL-DEVELOPMENT; EPIGENETIC CONTROL; PROTEIN; A20; DIFFERENTIATION; RESPONSES; CYLD; UBIQUITYLATION	Pattern-recognition receptors (PRRs) including Toll-like receptors, RIG-I-like receptors, and cytoplasmic DNA receptors are essential for protection against pathogens but require tight control to avert inflammatory diseases. The mechanisms underlying this strict regulation are unclear. MYSM1 was previously described as a key component of epigenetic signaling machinery. We found that in response to microbial stimuli, MYSM1 accumulated in the cytoplasm where it interacted with and inactivated TRAF3 and TRAF6 complexes to terminate PRR pathways for pro-inflammatory and type I interferon responses. Consequently, Mysm1 deficiency in mice resulted in hyper-inflammation and enhanced viral clearance but also susceptibility to septic shock. We identified two motifs in MYSM1 that were essential for innate immune suppression: the SWIRM domain that interacted with TRAF3 and TRAF6 and the metalloproteinase domain that removed K63 polyubiquitins. This study identifies MYSM1 as a key negative regulator of the innate immune system that guards against an overzealous self-destructive immune response.	[Panda, Swarupa; Gekara, Nelson O.] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Panda, Swarupa; Gekara, Nelson O.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Panda, Swarupa; Gekara, Nelson O.] Umea Univ, UCMR, S-90187 Umea, Sweden; [Nilsson, Jonas A.] Univ Gothenburg, Inst Clin Sci, Dept Surg, Sahlgrenska Canc Ctr, S-41390 Gothenburg, Sweden	Umea University; Umea University; Umea University; University of Gothenburg	Gekara, NO (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.	nelson.gekara@mims.umu.se	Gekara, Nelson/P-9208-2019; Gekara, Nelson/AAG-7944-2020	Nilsson, Jonas/0000-0003-0346-6837; Gekara, Nelson O./0000-0002-1269-8288	Laboratory for Molecular infection Medicine Sweden (MIMS); Umea University; Swedish Research Council	Laboratory for Molecular infection Medicine Sweden (MIMS); Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by funding from Laboratory for Molecular infection Medicine Sweden (MIMS) to N.O.G., Career grants from Umea University and project grants from Swedish Research Council to N.O.G. and J.A.N.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Belle JI, 2015, BLOOD, V125, P2344, DOI 10.1182/blood-2014-05-574111; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Gatzka M, 2015, CELL DEATH DIFFER, V22, P1451, DOI 10.1038/cdd.2014.231; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Jiang XX, 2011, IMMUNITY, V35, P883, DOI 10.1016/j.immuni.2011.11.010; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Nandakumar V, 2013, P NATL ACAD SCI USA, V110, pE3927, DOI 10.1073/pnas.1308888110; Nijnik A, 2012, BLOOD, V119, P1370, DOI 10.1182/blood-2011-05-352666; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wang T, 2013, BLOOD, V122, P2812, DOI 10.1182/blood-2013-03-489641; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Won H, 2014, BLOOD, V124, P2647, DOI 10.1182/blood-2013-10-534313; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhang MY, 2011, CELL MOL IMMUNOL, V8, P502, DOI 10.1038/cmi.2011.42; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	34	50	54	3	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					647	659		10.1016/j.immuni.2015.09.010	http://dx.doi.org/10.1016/j.immuni.2015.09.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26474655	Bronze			2022-12-18	WOS:000363478700009
J	Sckisel, GD; Bouchlaka, MN; Monjazeb, AM; Crittenden, M; Curti, BD; Wilkins, DEC; Alderson, KA; Sungur, CM; Ames, E; Mirsoian, A; Reddy, A; Alexander, W; Soulika, A; Blazar, BR; Longo, DL; Wiltrout, RH; Murphy, WJ				Sckisel, Gail D.; Bouchlaka, Myriam N.; Monjazeb, Arta M.; Crittenden, Marka; Curti, Brendan D.; Wilkins, Danice E. C.; Alderson, Kory A.; Sungur, Can M.; Ames, Erik; Mirsoian, Annie; Reddy, Abhinav; Alexander, Warren; Soulika, Athena; Blazar, Bruce R.; Longo, Dan L.; Wiltrout, Robert H.; Murphy, William J.			Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity	IMMUNITY			English	Article							PERSISTENT LCMV INFECTION; ANTITUMOR RESPONSES; MEMORY; INTERLEUKIN-2; ACTIVATION; INTERFERON; EXPRESSION; BLOCKADE; NAIVE; HELP	Primary T cell activation involves the integration of three distinct signals delivered in sequence: (1) antigen recognition, (2) costimulation, and (3) cytokine-mediated differentiation and expansion. Strong immunostimulatory events such as immunotherapy or infection induce profound cytokine release causing "bystander" T cell activation, thereby increasing the potential for autoreactivity and need for control. We show that during strong stimulation, a profound suppression of primary CD4(+) T-cell-mediated immune responses ensued and was observed across preclinical models and patients undergoing high-dose interleukin-2 (IL-2) therapy. This suppression targeted naive CD4(+) but not CD8(+) T cells and was mediated through transient suppressor of cytokine signaling-3 (SOCS3) inhibition of the STAT5b transcription factor signaling pathway. These events resulted in complete paralysis of primary CD4(+) T cell activation, affecting memory generation and induction of autoimmunity as well as impaired viral clearance. These data highlight the critical regulation of naive CD4(+) T cells during inflammatory conditions.	[Sckisel, Gail D.; Bouchlaka, Myriam N.; Sungur, Can M.; Ames, Erik; Mirsoian, Annie; Reddy, Abhinav; Soulika, Athena; Murphy, William J.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Monjazeb, Arta M.] Univ Calif Davis, Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Crittenden, Marka; Curti, Brendan D.] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Crittenden, Marka; Curti, Brendan D.] Oregon Clin, Portland, OR 97220 USA; [Wilkins, Danice E. C.; Alderson, Kory A.] Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Alexander, Warren] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Soulika, Athena] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Blazar, Bruce R.] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA; [Longo, Dan L.] NIA, Genet Lab, Baltimore, MD 21224 USA; [Wiltrout, Robert H.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Murphy, William J.] Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; Providence Portland Medical Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; Walter & Eliza Hall Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Davis	Murphy, WJ (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	wmjmurphy@ucdavis.edu	Longo, Dan L./F-6022-2011	Ames, Erik/0000-0002-4522-7319; Bouchlaka, Myriam/0000-0003-2865-0817	NIH [R01 CA 095572, R01 CA 072669]; NATIONAL CANCER INSTITUTE [R01CA072669, R01CA095572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank Monja Metcalf and Weihong Ma for excellent technical assistance with these studies. We would also like to thank Dr. Jonathan Weiss for helpful discussions with the manuscript. We would also like to thank Dr. Fu-Tong Liu for donating his OT-II Tg mouse colony, which was further propagated for studies in this manuscript. This work was funded by grants from the NIH (R01 CA 095572 and R01 CA 072669). Samples from patients undergoing systemic high-dose IL-2 therapy were part of a larger study evaluating combination of radiotherapy with systemic IL-2. This trial is supported in part by Prometheus Laboratories, Inc.	Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Berner V, 2007, NAT MED, V13, P354, DOI 10.1038/nm1554; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; Comin-Anduix B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-22; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Kimura MY, 2013, NAT IMMUNOL, V14, P143, DOI 10.1038/ni.2494; Madiehe AM, 2001, AM J PHYSIOL-REG I, V281, pR2048, DOI 10.1152/ajpregu.2001.281.6.R2048; Maker AV, 2005, ANN SURG ONCOL, V12, P1005, DOI 10.1245/ASO.2005.03.536; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Monjazeb AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102709; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Murphy WJ, 2003, J IMMUNOL, V170, P2727, DOI 10.4049/jimmunol.170.5.2727; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Sauce D, 2013, CURR OPIN HIV AIDS, V8, P125, DOI 10.1097/COH.0b013e32835d08a9; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sckisel GD, 2014, CLIN EXP IMMUNOL, V175, P79, DOI 10.1111/cei.12186; Stevenson PG, 1998, P NATL ACAD SCI USA, V95, P15565, DOI 10.1073/pnas.95.26.15565; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tietze JK, 2012, BLOOD, V119, P3073, DOI 10.1182/blood-2011-07-369736; Tietze JK, 2011, INT REV IMMUNOL, V30, P238, DOI 10.3109/08830185.2011.598977; Tough DF, 1999, IMMUNOL REV, V170, P39, DOI 10.1111/j.1600-065X.1999.tb01327.x; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao J, 2010, CLIN EXP IMMUNOL, V160, P479, DOI 10.1111/j.1365-2249.2010.04089.x	35	50	53	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					240	250		10.1016/j.immuni.2015.06.023	http://dx.doi.org/10.1016/j.immuni.2015.06.023			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26231116	Green Accepted, Bronze			2022-12-18	WOS:000360101200008
J	Gaiha, GD; McKim, KJ; Woods, M; Pertel, T; Rohrbach, J; Barteneva, N; Chin, CR; Liu, DF; Soghoian, DZ; Cesa, K; Wilton, S; Waring, MT; Chicoine, A; Doering, T; Wherry, EJ; Kaufmann, DE; Lichterfeld, M; Brass, AL; Walker, BD				Gaiha, Gaurav D.; McKim, Kevin J.; Woods, Matthew; Pertel, Thomas; Rohrbach, Janine; Barteneva, Natasha; Chin, Christopher R.; Liu, Dongfang; Soghoian, Damien Z.; Cesa, Kevin; Wilton, Shannon; Waring, Michael T.; Chicoine, Adam; Doering, Travis; Wherry, E. John; Kaufmann, Daniel E.; Lichterfeld, Mathias; Brass, Abraham L.; Walker, Bruce D.			Dysfunctional HIV-Specific CD8(+) T Cell Proliferation Is Associated with Increased Caspase-8 Activity and Mediated by Necroptosis	IMMUNITY			English	Article							GENE-EXPRESSION DATA; NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY; PROGRAMMED NECROSIS; DISEASE PROGRESSION; ACTIVATION; INFECTION; DEATH; EXHAUSTION; APOPTOSIS	Decreased HIV-specific CD8(+) T cell proliferation is a hallmark of chronic infection, but the mechanisms of decline are unclear. We analyzed gene expression profiles from antigen-stimulated HIV-specific CD8(+) T cells from patients with controlled and uncontrolled infection and identified caspase-8 as a correlate of dysfunctional CD8(+) T cell proliferation. Caspase-8 activity was upregulated in HIV-specific CD8(+) T cells from progressors and correlated positively with disease progression and programmed cell death-1 (PD-1) expression, but negatively with proliferation. In addition, progressor cells displayed a decreased ability to upregulate membrane-associated caspase-8 activity and increased necrotic cell death following antigenic stimulation, implicating the programmed cell death pathway necroptosis. In vitro necroptosis blockade rescued HIV-specific CD8(+) T cell proliferation in progressors, as did silencing of necroptosis mediator RIPK3. Thus, chronic stimulation leading to upregulated caspase-8 activity contributes to dysfunctional HIV-specific CD8(+) T cell proliferation through activation of necroptosis and increased cell death.	[Gaiha, Gaurav D.; McKim, Kevin J.; Woods, Matthew; Rohrbach, Janine; Chin, Christopher R.; Soghoian, Damien Z.; Cesa, Kevin; Wilton, Shannon; Waring, Michael T.; Chicoine, Adam; Kaufmann, Daniel E.; Lichterfeld, Mathias; Brass, Abraham L.; Walker, Bruce D.] Ragon Inst MGH, Cambridge, MA 02139 USA; [Pertel, Thomas] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Barteneva, Natasha] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Chin, Christopher R.; Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA; [Liu, Dongfang] Baylor Coll Med, Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Waring, Michael T.; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Doering, Travis] Hofstra North Shore LIJ Sch Med, Hempstead, NY 11549 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Kaufmann, Daniel E.] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Lichterfeld, Mathias; Walker, Bruce D.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Massachusetts System; University of Massachusetts Worcester; Baylor College of Medicine; Howard Hughes Medical Institute; Hofstra University; Northwell Health; University of Pennsylvania; Pennsylvania Medicine; Universite de Montreal; Harvard University; Massachusetts General Hospital	Walker, BD (corresponding author), Ragon Inst MGH, Cambridge, MA 02139 USA.	bwalker@partners.org	Lichterfeld, Mathias/B-2042-2008; Wherry, John/ABI-1280-2020; Barteneva, Natalie/V-3826-2019; Barteneva, Natasha/B-9094-2017	Lichterfeld, Mathias/0000-0001-9865-8350; Barteneva, Natalie/0000-0002-8109-1754; Pertel, Thomas/0000-0002-2286-6011; Chin, Christopher/0000-0002-2140-3197; Liu, Dongfang/0000-0002-7295-8088	Howard Hughes Medical Institute; Ragon Institute; NIH [AI30914, AI105343, AI112521, AI082630, AI095608, HHSN266200500030C]; Bill and Melinda Gates Foundation; NIH-funded Center for AIDS Research grant [P30 AI060354]; NIH Co-Funding and Participating Institute and Center: NIAID; NIH Co-Funding and Participating Institute and Center: NCI; NIH Co-Funding and Participating Institute and Center: NICHD; NIH Co-Funding and Participating Institute and Center: NHLBI; NIH Co-Funding and Participating Institute and Center: NIDA; NIH Co-Funding and Participating Institute and Center: NIMH; NIH Co-Funding and Participating Institute and Center: NIA; NIH Co-Funding and Participating Institute and Center: FIC; NIH Co-Funding and Participating Institute and Center: OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095608, R01AI105343, U19AI082630, R01AI030914, P30AI060354, P01AI112521] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ragon Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH-funded Center for AIDS Research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Co-Funding and Participating Institute and Center: NIAID; NIH Co-Funding and Participating Institute and Center: NCI; NIH Co-Funding and Participating Institute and Center: NICHD; NIH Co-Funding and Participating Institute and Center: NHLBI; NIH Co-Funding and Participating Institute and Center: NIDA; NIH Co-Funding and Participating Institute and Center: NIMH; NIH Co-Funding and Participating Institute and Center: NIA; NIH Co-Funding and Participating Institute and Center: FIC; NIH Co-Funding and Participating Institute and Center: OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Judy Lieberman and Jennifer Sims for comments on the manuscript and to Deanna Nguyen for assistance with experiments. This study was supported by funds from the Howard Hughes Medical Institute, the Ragon Institute, the NIH (AI30914, AI105343, AI112521, AI082630, AI095608, HHSN266200500030C), the Bill and Melinda Gates Foundation, and an NIH-funded Center for AIDS Research grant (P30 AI060354), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, and OAR.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Arends JE, 2011, APOPTOSIS, V16, P959, DOI 10.1007/s10495-011-0620-2; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dunkle A, 2013, J IMMUNOL, V190, P940, DOI 10.4049/jimmunol.1103481; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kim HJ, 2010, ARCH PHARM RES, V33, P1813, DOI 10.1007/s12272-010-1114-4; Koenig A, 2008, CELL DEATH DIFFER, V15, P1701, DOI 10.1038/cdd.2008.100; Koenig A, 2014, J BIOL CHEM, V289, P1183, DOI 10.1074/jbc.M113.506428; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Leverrier S, 2011, CELL DEATH DIFFER, V18, P90, DOI 10.1038/cdd.2010.69; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu P, 2012, LEUKEMIA, V26, P1293, DOI 10.1038/leu.2011.357; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; McComb S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015328; McKinnon LR, 2012, IMMUNOL CELL BIOL, V90, P346, DOI 10.1038/icb.2011.44; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; Ndhlovu ZM, 2013, BLOOD, V121, P801, DOI 10.1182/blood-2012-06-436295; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Pacheco Y, 2013, J IMMUNOL, V191, P2072, DOI 10.4049/jimmunol.1300435; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Petrovas C, 2004, J IMMUNOL, V172, P4444, DOI 10.4049/jimmunol.172.7.4444; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; Regamey N, 1999, AIDS RES HUM RETROV, V15, P803, DOI 10.1089/088922299310700; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Weil R, 1999, J VIROL, V73, P3709, DOI 10.1128/JVI.73.5.3709-3717.1999; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Yan JY, 2013, J VIROL, V87, P5170, DOI 10.1128/JVI.02379-12; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571	61	50	51	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1001	1012		10.1016/j.immuni.2014.12.011	http://dx.doi.org/10.1016/j.immuni.2014.12.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526311	Green Accepted, Bronze			2022-12-18	WOS:000346654100017
J	Schmitt, N; Ueno, H				Schmitt, Nathalie; Ueno, Hideki			Blood Tfh Cells Come with Colors	IMMUNITY			English	Editorial Material							T-CELLS	Blood CXCR5(+) CD4(+) T cells share phenotypic and functional similarities with T follicular helper cells. Studies by He et al. (2013) and Locci et al. (2013) in this issue of Immunity provide insight into their ontogeny and functionally distinct subsets.	[Schmitt, Nathalie; Ueno, Hideki] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health; Baylor University Medical Center	Ueno, H (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	hidekiu@baylorhealth.edu	Ueno, Hideki/L-1237-2016	Ueno, Hideki/0000-0001-7747-0738; Schmitt, Nathalie/0000-0001-9993-2788	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082715, U19AI089987, U19AI057234] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI082715, U19 AI057234, U19 AI089987] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012	5	50	52	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					629	630		10.1016/j.immuni.2013.09.011	http://dx.doi.org/10.1016/j.immuni.2013.09.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138878	Green Accepted, Bronze			2022-12-18	WOS:000330950000004
J	Beuneu, H; Lemaitre, F; Deguine, J; Moreau, HD; Bouvier, I; Garcia, Z; Albert, ML; Bousso, P				Beuneu, Helene; Lemaitre, Fabrice; Deguine, Jacques; Moreau, Helene D.; Bouvier, Isabelle; Garcia, Zacarias; Albert, Matthew L.; Bousso, Philippe			Visualizing the Functional Diversification of CD8(+) T Cell Responses in Lymph Nodes	IMMUNITY			English	Article							DENDRITIC CELLS; IN-VIVO; EFFECTOR; MEMORY; DIFFERENTIATION; DYNAMICS; ACTIVATION; INFECTION; PRECURSOR; CONTACTS	CD8(+) T cell responses generate effector cells endowed with distinct functional potentials but the contribution of early events in this process is unclear. Here, we have imaged T cells expressing a fluorescent reporter for the activation of the interferon-gamma (IFN-gamma) locus during priming in lymph nodes. We have demonstrated marked differences in the efficiency of gene activation during stable T cell-dentritic cell (DC) contacts, influenced in part by signal strength. Imaging the first cell division, we have demonstrated that heterogeneity in T cell functional potential was largely apparent as T cells initiated clonal expansion. Moreover, by analyzing the fate of single activated T cells ex vivo, we have provided evidence that these early differences resulted in clonal progenies with distinct functional properties. Thus, the early set of T cell-DC interactions in lymph nodes largely contribute to the heterogeneity of T cell responses through the generation of functionally divergent clonal progenies.	[Beuneu, Helene; Lemaitre, Fabrice; Deguine, Jacques; Moreau, Helene D.; Garcia, Zacarias; Bousso, Philippe] Inst Pasteur, Dept Immunol, Unite Dynam Reponses Immunes, F-75015 Paris, France; [Bouvier, Isabelle; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Unite Immunol Cellules Dendrit, F-75015 Paris, France; [Beuneu, Helene; Lemaitre, Fabrice; Deguine, Jacques; Moreau, Helene D.; Garcia, Zacarias; Bousso, Philippe] INSERM, U668, Equipe Avenir, F-75015 Paris, France; [Bouvier, Isabelle; Albert, Matthew L.] INSERM, U818, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bousso, P (corresponding author), Inst Pasteur, Dept Immunol, Unite Dynam Reponses Immunes, F-75015 Paris, France.	philippe.bousso@pasteur.fr	Albert, Matthew L/C-9782-2009; BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X; Moreau, Helene/0000-0001-5715-6864; Deguine, Jacques/0000-0001-9218-3040	Inserm; Institut Pasteur; ANR; Marie Curie Excellence grant; Fondation pour la Recherche Medicale	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); ANR(French National Research Agency (ANR)); Marie Curie Excellence grant(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The authors wish to thank R. Locksley for the Yeti mouse, members of the P.B. laboratory for comments on the manuscript, and P.H Commere and the Plate-Forme de Cytometrie en flux, Institut Pasteur. This work was supported by Inserm, Institut Pasteur, the ANR, and a Marie Curie Excellence grant. H.B. was supported by the Fondation pour la Recherche Medicale.	Bajenoff M, 2003, J IMMUNOL, V171, P6355, DOI 10.4049/jimmunol.171.12.6355; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Mayer KD, 2005, J IMMUNOL, V174, P7732, DOI 10.4049/jimmunol.174.12.7732; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341	23	50	52	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 24	2010	33	3					412	423		10.1016/j.immuni.2010.08.016	http://dx.doi.org/10.1016/j.immuni.2010.08.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20850354	Bronze			2022-12-18	WOS:000282798500015
J	Barclay, AN; Hatherley, D				Barclay, A. Neil; Hatherley, Deborah			The Counterbalance Theory for Evolution and Function of Paired Receptors	IMMUNITY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; IG-LIKE RECEPTORS; CELL-RECEPTORS; CD200 RECEPTOR; RECOGNITION; PROTEIN; BINDING; ALPHA; CD47; CYTOMEGALOVIRUS	Paired receptors are families of membrane proteins containing similar extracellular regions but differing in their potential for signaling with one type able to give inhibitory signals and the other activating. Inhibitory receptors could be good targets for pathogens to restrict immune responses against them. Here we suggest that activating members may have evolved to counterbalance pathogens utilizing the inhibitory pathway. Thus, if a pathogen utilizes any part of the inhibitory receptor to downregulate responses against itself, it may, because of similarities in structure, also bind the activating receptor and give an opposing signal. We evaluate recent structural data on SIRP alpha (signal regulatory protein) and LILRB1 (leukocyte immunoglobulin-like receptor subfamily B member 1) showing evidence of pathogen pressure in nonligand-binding regions of these receptors together with data on pathogen binding to PIRs (paired Ig-like receptors) to provide support for this theory.	[Barclay, A. Neil; Hatherley, Deborah] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Barclay, AN (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	neil.barclay@path.ox.ac.uk			MRC; Wellcome Trust; MRC [G0400808] Funding Source: UKRI; Medical Research Council [G0400808] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC and the Wellcome Trust. We are grateful to M.H. Brown for helpful comments.	Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Barclay AN, 1997, LEUCOCYTE ANTIGENS F; Carlyle JR, 2008, SEMIN IMMUNOL, V20, P321, DOI 10.1016/j.smim.2008.05.004; Cheng TP, 2008, IMMUNOGENETICS, V60, P565, DOI 10.1007/s00251-008-0313-3; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Foster-Cuevas M, 2004, J VIROL, V78, P7667, DOI 10.1128/JVI.78.14.7667-7676.2004; Hatherley D, 2005, J IMMUNOL, V175, P2469, DOI 10.4049/jimmunol.175.4.2469; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Kuroki K, 2005, HUM MOL GENET, V14, P2469, DOI 10.1093/hmg/ddi247; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 2001, CURR OPIN IMMUNOL, V13, P326, DOI 10.1016/S0952-7915(00)00222-3; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; Nakaishi A, 2008, J MOL BIOL, V375, P650, DOI 10.1016/j.jmb.2007.10.085; Nakayama M, 2007, J IMMUNOL, V178, P4250, DOI 10.4049/jimmunol.178.7.4250; Sano S, 1999, BIOCHEM J, V344, P667, DOI 10.1042/0264-6021:3440667; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Tabata S, 2008, J BIOL CHEM, V283, P8893, DOI 10.1074/jbc.M709793200; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; van den Berg TK, 2005, J IMMUNOL, V175, P7788, DOI 10.4049/jimmunol.175.12.7788; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wilson MD, 2006, PHYSIOL GENOMICS, V27, P201, DOI 10.1152/physiolgenomics.00284.2005; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; YAMADA E, 2008, CURR PROTOC IMMUNOL, pCH1	29	50	50	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					675	678		10.1016/j.immuni.2008.10.004	http://dx.doi.org/10.1016/j.immuni.2008.10.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006692	Bronze, Green Accepted			2022-12-18	WOS:000261036000006
J	Ouchida, R; Yamasaki, S; Hikida, M; Masuda, K; Kawamura, K; Wada, A; Mochizuki, S; Tagawa, M; Sakamoto, A; Hatano, M; Tokuhisa, T; Koseki, H; Saito, T; Kurosaki, T; Wang, JY				Ouchida, Rika; Yamasaki, Sho; Hikida, Masaki; Masuda, Keiji; Kawamura, Kiyoko; Wada, Akihiko; Mochizuki, Shigenobu; Tagawa, Masatoshi; Sakamoto, Akemi; Hatano, Masahiko; Tokuhisa, Takeshi; Koseki, Haruhiko; Saito, Takashi; Kurosaki, Tomohiro; Wang, Ji-Yang			A lysosomal protein negatively regulates surface T cell antigen receptor expression by promoting CD3 zeta-chain degradation	IMMUNITY			English	Article							C-CBL; ADAPTER PROTEIN-2; HEMATOPOIETIC-CELLS; POSITIVE SELECTION; DOWN-MODULATION; COMPLEX; ACTIVATION; MICE; ZETA; DIFFERENTIATION	Modulation of surface T cell antigen receptor (TCR) expression is an important mechanism for the regulation of immune responses and the prevention of T cell hyperactivation and autoimmunity. The TCR is rapidly internalized after antigen stimulation and then degraded in lysosomes. However, few of the molecules involved in this process have been identified. We demonstrate that the lysosomal protein LAPTM5 negatively regulated surface TCR expression by specifically interacting with the invariant signal-transducing CD3 zeta chain and promoting its degradation without affecting other CD3 proteins, CD3 epsilon, CD3 delta, or CD3 gamma. TCR downmodulation required the polyproline-tyrosine motifs and the ubiquitin-interacting motif of LAPTM5. LAPTM5 deficiency resulted in elevated TCR expression on both CD4(+)CD8(+) thymocytes and spleen T cells after CD3 stimulation, as well as enhanced T cell responses in vitro and in vivo. These results identify a lysosomal protein important for CD3 zeta degradation and illustrate a unique mechanism for the control of surface TCR expression and T cell activation.	[Ouchida, Rika; Masuda, Keiji; Wang, Ji-Yang] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Immune Div, Yokohama, Kanagawa 2300045, Japan; [Yamasaki, Sho; Saito, Takashi] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa 2300045, Japan; [Hikida, Masaki; Kurosaki, Tomohiro] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Koseki, Haruhiko] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [Kawamura, Kiyoko; Wada, Akihiko; Mochizuki, Shigenobu; Tagawa, Masatoshi] Chiba Canc Ctr, Res Inst, Div Pathol, Chiba 2608717, Japan; [Sakamoto, Akemi; Hatano, Masahiko; Tokuhisa, Takeshi] Chiba Univ, Grad Sch Med, Dept Dev Genet, Chiba 2608670, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Chiba Cancer Center; Chiba University	Wang, JY (corresponding author), RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Immune Div, Yokohama, Kanagawa 2300045, Japan.	oh@rcai.riken.jp	Saito, Takashi/C-9684-2009; Koseki, Haruhiko/I-3825-2014; Kurosaki, Tomohiro/D-1306-2009	Saito, Takashi/0000-0001-9495-3547; Koseki, Haruhiko/0000-0001-8424-5854; Kurosaki, Tomohiro/0000-0002-6352-304X				Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; D'Oro U, 2002, J IMMUNOL, V169, P6269, DOI 10.4049/jimmunol.169.11.6269; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Hayami Y, 2003, LEUKEMIA, V17, P1650, DOI 10.1038/sj.leu.2403026; Hikida M, 2003, J EXP MED, V198, P581, DOI 10.1084/jem.20030280; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Holland SJ, 2001, J EXP MED, V194, P1263, DOI 10.1084/jem.194.9.1263; Huang F, 2006, IMMUNITY, V25, P571, DOI 10.1016/j.immuni.2006.08.021; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Loreto MP, 2002, MOL CELL BIOL, V22, P4241, DOI 10.1128/MCB.22.12.4241-4255.2002; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pandey A, 2002, J BIOL CHEM, V277, P19131, DOI 10.1074/jbc.M110318200; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Roberts JL, 2007, BLOOD, V109, P3198, DOI 10.1182/blood-2006-08-043166; Schrum AG, 2003, IMMUNOL REV, V196, P7, DOI 10.1046/j.1600-065X.2003.00083.x; Scott LM, 1996, BLOOD, V88, P2517, DOI 10.1182/blood.V88.7.2517.bloodjournal8872517; Seimiya M, 2003, INT J ONCOL, V22, P301; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; von Essen M, 2004, J IMMUNOL, V173, P384, DOI 10.4049/jimmunol.173.1.384; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200	36	50	51	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					33	43		10.1016/j.immuni.2008.04.024	http://dx.doi.org/10.1016/j.immuni.2008.04.024			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18619870	Bronze			2022-12-18	WOS:000257905400008
J	Schraven, B; Kalinke, U				Schraven, Burkhart; Kalinke, Ulrich			CD28 superagonists: What makes the difference in humans?	IMMUNITY			English	Editorial Material							MONOCLONAL-ANTIBODY TGN1412; REGULATORY T-CELLS; CYTOKINE STORM; IMMUNE-SYSTEM; IN-VITRO; PROLIFERATION; STIMULATION; LYMPHOCYTES; ACTIVATION; INDUCTION		[Schraven, Burkhart] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, D-39120 Magdeburg, Germany; [Kalinke, Ulrich] Paul Ehrlich Inst, D-63225 Langen, Germany	Otto von Guericke University; Paul Ehrlich Institute	Schraven, B (corresponding author), Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, Leipziger Str 44, D-39120 Magdeburg, Germany.	burkhart.schraven@med.ovgu.de; kalul@pei.de		Kalinke, Ulrich/0000-0003-0503-9564				Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Bischof A, 2000, EUR J IMMUNOL, V30, P876, DOI 10.1002/1521-4141(200003)30:3<876::AID-IMMU876>3.0.CO;2-M; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dennehy KM, 2007, J IMMUNOL, V178, P1363, DOI 10.4049/jimmunol.178.3.1363; Dennehy KM, 2003, INT IMMUNOL, V15, P655, DOI 10.1093/intimm/dxg063; DUFF GWC, 2008, EXPERT SCI GROUP PHA; EMEA/CHMP, 2007, GUID STRAT ID MIT RI; Hanke T, 2006, LANCET, V368, P1569, DOI 10.1016/S0140-6736(06)69651-7; Hunig T, 2007, ADV IMMUNOL, V95, P111, DOI 10.1016/S0065-2776(07)95004-X; Legrand N, 2006, BLOOD, V108, P238, DOI 10.1182/blood-2006-01-0190; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; MULLER N, 2008, IN PRESS J CLIN INVE; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; Presta L. G., 2005, U. S. Patent, Patent No. [6911321 B2, 6911321]; Schneider CK, 2007, BUNDESGESUNDHEITSBLA, V50, P1213, DOI 10.1007/s00103-007-0331-6; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Sester U, 2007, EUR J IMMUNOL, V37, P2881, DOI 10.1002/eji.200737206; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708	22	50	51	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					591	595		10.1016/j.immuni.2008.04.003	http://dx.doi.org/10.1016/j.immuni.2008.04.003			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18482560	Bronze			2022-12-18	WOS:000256003900001
J	Bezbradica, JS; Gordy, LE; Stanic, AK; Dragovic, S; Hill, T; Hawiger, J; Unutmaz, D; Van Kaer, L; Joyce, S				Bezbradica, Jelena S.; Gordy, Laura E.; Stanic, Aleksandar K.; Dragovic, Srdjan; Hill, Timothy; Hawiger, Jacek; Unutmaz, Derya; Van Kaer, Luc; Joyce, Sebastian			Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny	IMMUNITY			English	Article							NF-KAPPA-B; FACTOR-DEFICIENT MICE; NKT CELLS; CUTTING EDGE; ALPHA-GALACTOSYLCERAMIDE; IN-VIVO; DENDRITIC CELLS; TRANSCRIPTION FACTOR; GLYCOLIPID ANTIGENS; SECRETORY LYSOSOMES	Invariant natural killer T (iNKT) cell-derived cytokines have important functions in inflammation, host defense, and immunoregulation. Yet, when and how iNKT cells undergo effector differentiation, which endows them with the capacity to rapidly secrete cytokines upon activation, remains unknown. We discovered that granulocyte-macrophage colony-stimulating factor (Csf-2)-deficient mice developed iNKT cells that failed to respond to the model antigen m-galactosylceramide because of an intrinsic defect in the fusion of secretory vesicles with the plasma membrane. Exogenous Csf-2 corrected the functional defect only when supplied during the development of thymic, but not mature, splenic Csf-2-deficient iNKT cells. Thus, we ascribe a uniquefunction to Csf-2, which regulates iNKT cell effector differentiation during development by a mechanism that renders them competent for cytokine secretion.	Vanderbilt Univ, Sch Med & Dent, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Joyce, S (corresponding author), Vanderbilt Univ, Sch Med & Dent, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	sebastian.joyce@vanderbilt.edu	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Stanic-Kostic, Aleksandar/0000-0003-1946-6436; JOYCE, Sebastian/0000-0002-3183-1451; Bezbradica, Jelena/0000-0003-1441-1727	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL069542, P01HL068744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042284, R01AI042284, R01AI054206, R01AI061721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044044] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL069542, HL068744] Funding Source: Medline; NIAID NIH HHS [AI061721, AI054206, AI042284, AI050953] Funding Source: Medline; NINDS NIH HHS [NS044044] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; BEZBRADICA JS, 2006, CURR PROTOCOLS IMMUN, DOI UNSP 14.13.11-14.13.27; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Eberl G, 1999, J IMMUNOL, V163, P4091; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; ENZLER T, 2003, CYTOKINE HDB, P503; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gadue P, 2002, J IMMUNOL, V169, P2397, DOI 10.4049/jimmunol.169.5.2397; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Singh N, 1999, J IMMUNOL, V163, P2373; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; Wada H, 1997, P NATL ACAD SCI USA, V94, P12557, DOI 10.1073/pnas.94.23.12557; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Yoshimura Y, 2004, J IMMUNOL, V172, P6666, DOI 10.4049/jimmunol.172.11.6666; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	56	50	51	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					487	497		10.1016/j.immuni.2006.06.017	http://dx.doi.org/10.1016/j.immuni.2006.06.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16949316	Bronze			2022-12-18	WOS:000240862200016
J	Patterson, HCK; Kraus, M; Kim, YM; Ploegh, H; Rajewsky, K				Patterson, Heide Christine K.; Kraus, Manfred; Kim, You-Me; Ploegh, Hidde; Rajewsky, Klaus			The B cell receptor promotes B cell activation and proliferation through a non-ITAM tyrosine in the Ig alpha cytoplasmic domain	IMMUNITY			English	Article							ANTIGEN RECEPTOR; LINKER PROTEIN; MOTIF ITAM; KAPPA-B; BLNK; LYMPHOCYTES; MICE; SLP-65; SYK; PHOSPHORYLATION	In addition to the tyrosines of the Ig alpha and beta immunoreceptor tyrosine-based activation motifs (ITAMs), the evolutionarily conserved Ig alpha non-ITAM tyrosine 204 becomes phosphorylated upon antigen recognition by the B cell receptor (BCR). Here we demonstrate that splenic B cells from mice with a targeted mutation of Ig alpha Y204 exhibited an isolated defect in T cell-independent B cell activation, proliferation, and antibody response upon BCR engagement, yet normal BCR capping, antigen internalization, antigen presentation, and T cell-dependent antibody production. Mutant B cells, present in normal numbers, exhibited unimpaired BCR-induced spleen tyrosine kinase (Syk) phosphorylation but reduced B cell linker protein (BLNK) phosphorylation, calcium flux, and nuclear factor kappa B (NF kappa B), c-jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) activation. These results suggest that Ig alpha non-ITAM tyrosine 204 promotes a distinct cellular response, namely T-independent B cell proliferation and differentiation via phosphorylation of the adaptor BLNK.	CBR Inst Biomed Res, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Massachusetts Institute of Technology (MIT); Whitehead Institute	Rajewsky, K (corresponding author), CBR Inst Biomed Res, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Kim, You-Me/I-5553-2013	Kim, You-Me/0000-0001-8780-704X; Rajewsky, Klaus/0000-0002-6633-6370	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054636] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI054636] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Bishop GA, 2001, CURR OPIN IMMUNOL, V13, P278, DOI 10.1016/S0952-7915(00)00216-8; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Clark MR, 2004, CURR OPIN IMMUNOL, V16, P382, DOI 10.1016/j.coi.2004.03.007; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 2003, NATURE, V423, P452, DOI 10.1038/nature01608; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; King LB, 2000, IMMUNOL REV, V176, P86; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lankar D, 1998, J EXP MED, V188, P819, DOI 10.1084/jem.188.5.819; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pike KA, 2005, J IMMUNOL, V174, P2012, DOI 10.4049/jimmunol.174.4.2012; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHASTRI N, 1986, J IMMUNOL, V137, P911; Siemasko K, 2002, J IMMUNOL, V168, P2127, DOI 10.4049/jimmunol.168.5.2127; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Thyagarajan R, 2003, J IMMUNOL, V170, P6099, DOI 10.4049/jimmunol.170.12.6099; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397	43	50	53	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					55	65		10.1016/j.immuni.2006.04.014	http://dx.doi.org/10.1016/j.immuni.2006.04.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860757	Bronze			2022-12-18	WOS:000239713000010
J	Park, J; Lee, BS; Choi, JK; Means, RE; Choe, J; Jung, JU				Park, J; Lee, BS; Choi, JK; Means, RE; Choe, J; Jung, JU			Herpesviral protein targets a cellular WD repeat endosomal protein to downregulate T lymphocyte receptor expression	IMMUNITY			English	Article							MEDIATED SIGNAL-TRANSDUCTION; BARR-VIRUS LMP2A; TYROSINE KINASE; ANTIGEN RECEPTOR; DOWN-REGULATION; SAIMIRI; TIP; ACTIVATION; P56(LCK); TRANSFORMATION	Herpesvirus saimiri Tip associates with Lck and down-regulates Lck signal transduction. Here we demonstrate that Tip targets a lysosomal protein p80, which consists of an N-terminal WD repeat domain and a C-terminal coiled-coil domain. Interaction of Tip with p80 facilitated lysosomal vesicle formation and subsequent recruitment of Lck into the lysosomes for degradation. Consequently, Tip interactions with Lck and p80 result in downregulation of T cell receptor (TCR) and CD4 surface expression. Remarkably, these actions of Tip are functionally and genetically separable: the N-terminal p80 interaction is responsible for TCR downregulation and the C-terminal Lck interaction is responsible for CD4 downregulation. Thus, lymphotropic herpesvirus has evolved an elaborate mechanism to deregulate lymphocyte receptor expression to disarm host immune control.	Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Harvard University; Korea Advanced Institute of Science & Technology (KAIST)	Jung, JU (corresponding author), Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA.		Choe, Joonho/F-3066-2011		NATIONAL CANCER INSTITUTE [R01CA082057, R01CA031363] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI038131] Funding Source: NIH RePORTER; NCI NIH HHS [CA82057, CA31363] Funding Source: Medline; NCRR NIH HHS [RR00168] Funding Source: Medline; NIAID NIH HHS [AI38131] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlRamadi BK, 1996, J IMMUNOL, V157, P4751; Andre P, 1997, J IMMUNOL, V159, P5253; BIESINGER B, 1995, J BIOL CHEM, V270, P4729, DOI 10.1074/jbc.270.9.4729; BIESINGER B, 1992, P NATL ACAD SCI USA, V89, P3116, DOI 10.1073/pnas.89.7.3116; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURKHARDT AL, 1992, J VIROL, V66, P5161, DOI 10.1128/JVI.66.8.5161-5167.1992; Callan MFC, 1999, SPRINGER SEMIN IMMUN, V21, P37, DOI 10.1007/s002810050051; Cenciarelli C, 1996, J BIOL CHEM, V271, P8709, DOI 10.1074/jbc.271.15.8709; DESROSIERS RC, 1985, SCIENCE, V228, P184, DOI 10.1126/science.2983431; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; Duboise SM, 1998, J VIROL, V72, P1308, DOI 10.1128/JVI.72.2.1308-1313.1998; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Guo J, 1997, J VIROL, V71, P7092, DOI 10.1128/JVI.71.9.7092-7096.1997; Ikeda M, 2000, VIROLOGY, V268, P178, DOI 10.1006/viro.1999.0166; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Isakov N, 2000, EUR J BIOCHEM, V267, P3413, DOI 10.1046/j.1432-1327.2000.01412.x; Jung JU, 1999, SEMIN CANCER BIOL, V9, P231, DOI 10.1006/scbi.1998.0115; JUNG JU, 1995, J VIROL, V69, P7814, DOI 10.1128/JVI.69.12.7814-7822.1995; JUNG JU, 1995, J BIOL CHEM, V270, P20660, DOI 10.1074/jbc.270.35.20660; MITTRUCKER HW, 1992, J EXP MED, V176, P909, DOI 10.1084/jem.176.3.909; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Weil R, 1999, J VIROL, V73, P3709, DOI 10.1128/JVI.73.5.3709-3717.1999; Weil R, 1996, CURR TOP MICROBIOL, V205, P63; WEISS A, 1993, FUNDAMENTAL IMMUNOLO; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000	31	50	56	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2002	17	2					221	233		10.1016/S1074-7613(02)00368-0	http://dx.doi.org/10.1016/S1074-7613(02)00368-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196293	Bronze			2022-12-18	WOS:000177669400010
J	Sullivan, BA; Kraj, P; Weber, DA; Ignatowicz, L; Jensen, PE				Sullivan, BA; Kraj, P; Weber, DA; Ignatowicz, L; Jensen, PE			Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin	IMMUNITY			English	Article							CLASS-I MOLECULES; NATURAL-KILLER-CELLS; LISTERIA-MONOCYTOGENES; HEMATOPOIETIC-CELLS; IMMUNE-RESPONSES; PEPTIDE BINDING; TRANSGENIC MICE; DEFICIENT MICE; MHC MOLECULES; KNOCKOUT MICE	The phenotype and development of T cells from transgenic mice expressing a T cell receptor with specificity for insulin presented by the MHC class Ib molecule Qa-1(b) was investigated. Peripheral T cells from the transgenic mice express CD8 and, after activation, kill Qa-1(b)-positive lymphoid target cells in the presence of soluble insulin. Thymic selection requires expression of Qa-1(b) but not the dominant Qa-1-associated peptide, Qdm. In contrast to conventional T cells, selection is at least as efficient when the selecting ligand is expressed only on hematopoietic lineage cells as compared to expression on epithelial cells in the thymus. Our findings suggest that there is a dedicated population of Qa-1-restricted T cells that are selected by interaction with Qa-1 and that the cellular requirements for selection may differ from conventional T cells.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	Emory University; University System of Georgia; Augusta University	Jensen, PE (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.			Sullivan, Barbara/0000-0003-0969-6131	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033614, R01AI033614, R01AI030554, R21AI030554] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33614, AI30554] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDRICH CJ, 1992, J IMMUNOL, V149, P3773; ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; ALDRICH CJ, 1988, QDM IMMUNOGENETICS, V28, P334; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bai A, 1998, IMMUNITY, V9, P413, DOI 10.1016/S1074-7613(00)80624-X; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Berg RE, 1999, IMMUNITY, V11, P33, DOI 10.1016/S1074-7613(00)80079-5; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; BOUWER HGA, 1994, J IMMUNOL, V152, P5352; Bouwer HGA, 1997, J IMMUNOL, V159, P2795; CARBONE AM, 1988, J IMMUNOL, V141, P1369; Chiu NM, 1999, J EXP MED, V190, P1869, DOI 10.1084/jem.190.12.1869; Cole DN, 2000, US FOR SERV RMRS-P, V1, P1; Cotterill LA, 1997, EUR J IMMUNOL, V27, P2123, DOI 10.1002/eji.1830270902; D'Orazio TJ, 2001, J IMMUNOL, V166, P26, DOI 10.4049/jimmunol.166.1.26; DeCloux A, 1997, J IMMUNOL, V158, P2183; Ernst BB, 1996, J EXP MED, V183, P1235, DOI 10.1084/jem.183.3.1235; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jensen PE, 1998, J IMMUNOL METHODS, V215, P71, DOI 10.1016/S0022-1759(98)00062-3; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; KECK K, 1975, NATURE, V254, P78, DOI 10.1038/254078a0; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Kraft JR, 2000, J EXP MED, V192, P613, DOI 10.1084/jem.192.5.613; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; LINDAHL KF, 1982, EUR J IMMUNOL, V12, P159, DOI 10.1002/eji.1830120211; Lo WF, 2000, NAT MED, V6, P215, DOI 10.1038/72329; Lo WF, 1999, J IMMUNOL, V162, P5398; Lohwasser S, 2001, INT IMMUNOL, V13, P321, DOI 10.1093/intimm/13.3.321; LOWEN LC, 1993, J IMMUNOL, V151, P6155; MARKOWITZ JS, 1993, P NATL ACAD SCI USA, V90, P2779, DOI 10.1073/pnas.90.7.2779; Maurice MM, 2001, P NATL ACAD SCI USA, V98, P7437, DOI 10.1073/pnas.141143298; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Noble A, 1998, J IMMUNOL, V160, P566; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Robinson PJ, 1998, J IMMUNOL, V160, P3217; Salcedo M, 1998, EUR J IMMUNOL, V28, P4356, DOI 10.1002/(SICI)1521-4141(199812)28:12<4356::AID-IMMU4356>3.3.CO;2-8; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; Seaman MS, 2000, J IMMUNOL, V165, P5192, DOI 10.4049/jimmunol.165.9.5192; Seaman MS, 1999, J IMMUNOL, V162, P5429; Sivakumar PV, 1999, J IMMUNOL, V162, P6976; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Tompkins SM, 1998, J EXP MED, V188, P961; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Zerrahn J, 1999, P NATL ACAD SCI USA, V96, P11470, DOI 10.1073/pnas.96.20.11470; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	54	50	53	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					95	105		10.1016/S1074-7613(02)00343-6	http://dx.doi.org/10.1016/S1074-7613(02)00343-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150895	Bronze			2022-12-18	WOS:000177187500010
J	Cauwels, A; Van Molle, W; Janssen, B; Everaerdt, B; Huang, P; Fiers, W; Brouckaert, P				Cauwels, A; Van Molle, W; Janssen, B; Everaerdt, B; Huang, P; Fiers, W; Brouckaert, P			Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase	IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; METHYLENE-BLUE; SEPTIC SHOCK; VASCULAR-RESISTANCE; INDUCED SENSITIZATION; INDUCED HYPOTENSION; RECOMBINANT HUMAN; BLOOD-PRESSURE; SMOOTH-MUSCLE; MICE LACKING	Hypotension and shock observed in sepsis, SIRS, and tumor necrosis factor (TNF) or cytokine-based cancer treatment are the consequence of excessive nitric oxide (NO) production and subsequent soluble guanylate cyclase (sGC)-mediated vascular smooth muscle relaxation. We demonstrate here that, while NO synthase (NOS) inhibitors exacerbated toxicity, inhibitors of sGC activation protected against TNF-induced lethality, bradycardia, and hypotension. Importantly, sGC inhibition did not interfere with the antitumor activity of TNF. Using NOS inhibitors or iNOS-deficient animals, we furthermore observed that no protection against TNF toxicity could be obtained in the absence of NO. These data imply that iNOS- (and not eNOS-) derived NO is an endogenous protective molecule indispensable to survive a TNF challenge and exerting this beneficial effect via sGC-independent mechanisms.	State Univ Ghent VIB, Dept Mol Biol, MPET, B-9000 Ghent, Belgium; Univ Maastricht, Dept Pharmacol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Med Serv, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Flanders Institute for Biotechnology (VIB); Ghent University; Maastricht University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Cauwels, A (corresponding author), State Univ Ghent VIB, Dept Mol Biol, MPET, KL Legeganckstr 35, B-9000 Ghent, Belgium.	anje@dmb.rug.ac.be; peterb@dmb.rug.ac.be		Huang, Paul/0000-0002-5436-8658				ALEXANDER RB, 1991, BIOL THERAPY CANCER, P378; Andresen M, 1998, J CRIT CARE, V13, P164, DOI 10.1016/S0883-9441(98)90001-6; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BROUCKAERT PGG, 1986, INT J CANCER, V38, P763, DOI 10.1002/ijc.2910380521; Cain BS, 1998, J AM COLL SURGEONS, V186, P337, DOI 10.1016/S1072-7515(98)00036-2; CAUWELS A, 1995, J IMMUNOL, V154, P2753; Cauwels A, 1996, J IMMUNOL, V156, P4686; COBB JP, 1992, J EXP MED, V176, P1175, DOI 10.1084/jem.176.4.1175; Dimmeler S, 1997, NITRIC OXIDE-BIOL CH, V1, P275, DOI 10.1006/niox.1997.0133; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Driscoll W, 1996, J PEDIATR-US, V129, P904, DOI 10.1016/S0022-3476(96)70036-7; EGGIMANN P, 1995, CHEST, V107, P1074, DOI 10.1378/chest.107.4.1074; Fiers W, 1995, BIOL THERAPY CANC, P295; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Galili Y, 1997, EUR SURG RES, V29, P390, DOI 10.1159/000129548; GEROULANOS S, 1992, LANCET, V339, P435; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH1449, DOI 10.1152/ajpheart.1996.271.4.H1449; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; Gundersen Y, 1997, SHOCK, V8, P368, DOI 10.1097/00024382-199711000-00009; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; HARE JM, 1995, PROG CARDIOVASC DIS, V38, P155, DOI 10.1016/S0033-0620(05)80004-0; Hock CE, 1997, AM J PHYSIOL-HEART C, V272, pH843, DOI 10.1152/ajpheart.1997.272.2.H843; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Janssen BJA, 2000, AM J PHYSIOL-REG I, V278, pR215, DOI 10.1152/ajpregu.2000.278.1.R215; KEANEY JF, 1994, CIRC RES, V74, P1121, DOI 10.1161/01.RES.74.6.1121; KILBOURN RG, 1990, P NATL ACAD SCI USA, V87, P3629, DOI 10.1073/pnas.87.9.3629; Kubota T, 1998, CIRCULATION, V97, P2499, DOI 10.1161/01.CIR.97.25.2499; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; Li JR, 1999, AM J PHYSIOL-GASTR L, V276, pG1069, DOI 10.1152/ajpgi.1999.276.5.G1069; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Ma JY, 1996, AM J PHYSIOL-HEART C, V271, pH1717, DOI 10.1152/ajpheart.1996.271.4.H1717; MALTA E, 1988, N-S ARCH PHARMACOL, V337, P459; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Oral H, 1997, J BIOL CHEM, V272, P4836, DOI 10.1074/jbc.272.8.4836; Ou JH, 1997, NITRIC OXIDE-BIOL CH, V1, P404, DOI 10.1006/niox.1997.0136; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; PAYA D, 1993, J CARDIOVASC PHARM, V21, P926, DOI 10.1097/00005344-199306000-00012; PREISER JC, 1995, CRIT CARE MED, V23, P259, DOI 10.1097/00003246-199502000-00010; Salvemini D, 1996, J CLIN INVEST, V97, P2562, DOI 10.1172/JCI118704; Schnackenberg CG, 1998, HYPERTENSION, V32, P59, DOI 10.1161/01.HYP.32.1.59; SCHNEIDER F, 1992, INTENS CARE MED, V18, P309, DOI 10.1007/BF01706481; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; THIEMERMANN C, 1995, BRIT J PHARMACOL, V116, P2845, DOI 10.1111/j.1476-5381.1995.tb15935.x; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; Wolkow PP, 1998, INFLAMM RES, V47, P152, DOI 10.1007/s000110050309; Wray GM, 1998, SHOCK, V9, P329, DOI 10.1097/00024382-199805000-00003; Zollner S, 1997, J BIOL CHEM, V272, P23076, DOI 10.1074/jbc.272.37.23076	55	50	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2000	13	2					223	231		10.1016/S1074-7613(00)00022-4	http://dx.doi.org/10.1016/S1074-7613(00)00022-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981965	Bronze			2022-12-18	WOS:000089132100007
J	Combadiere, B; Sousa, CR; Trageser, C; Zheng, LX; Kim, CR; Lenardo, MJ				Combadiere, B; Sousa, CR; Trageser, C; Zheng, LX; Kim, CR; Lenardo, MJ			Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL TISSUE FACTOR; PROGRAMMED CELL-DEATH; MATURE T-CELLS; LYMPHOPROLIFERATIVE SYNDROME; PARTIAL AGONISTS; FACTOR-ALPHA; FAS-LIGAND; ACTIVATION; INDUCTION	Clonal selection theories postulate that lymphocyte fate is regulated by antigen receptor specificity. However, lymphocyte apoptosis is induced through non-antigen-specific receptors such as Fas (CD95/APO-1) or TNFR. We define a selective TCR that controls apoptosis by Fas or TNFR stimulation. Variant ligands can deliver this "competence to die" signal without the full TCR signals necessary for cytokine synthesis. These partial agonists regulate T cell deletion in vivo even when Fas or TNF is provided by T cells of unrelated specificity, but they do not cause the liver necrosis that is associated with T cell elimination by the full agonist. Thus, selective signaling ligands regulate T cell deletion and immune damage in vivo and may be important for peripheral T cell tolerance.	NIAID, Mol Dev Immune Syst Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Combadiere, Behazine/S-8054-2019; Combadiere, Behazine/G-3881-2013	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Combadiere, Behazine/0000-0002-2353-4406; 				AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; BOEHME SA, 1995, J IMMUNOL, V155, P1703; BOEHME SA, 1993, LEUKEMIA, V7, P45; Brocke S, 1996, NATURE, V379, P343, DOI 10.1038/379343a0; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Combadiere B, 1998, J EXP MED, V187, P349, DOI 10.1084/jem.187.3.349; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DELPRETE G, 1995, BLOOD, V86, P250, DOI 10.1182/blood.V86.1.250.bloodjournal861250; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; HECHT TT, 1983, J IMMUNOL, V131, P1049; Hornung F, 1997, J IMMUNOL, V159, P3816; Jaeschke H, 1998, J IMMUNOL, V160, P3480; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Lenardo M J, 1995, Int Rev Immunol, V13, P115, DOI 10.3109/08830189509061742; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; SCHMID EF, 1995, BLOOD, V86, P1836, DOI 10.1182/blood.V86.5.1836.bloodjournal8651836; Schwartz Ronald H., 1993, P677; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wong B, 1997, J EXP MED, V186, P1939, DOI 10.1084/jem.186.11.1939; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zheng LX, 1996, ADV EXP MED BIOL, V406, P229	35	50	51	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1998	9	3					305	313		10.1016/S1074-7613(00)80613-5	http://dx.doi.org/10.1016/S1074-7613(00)80613-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768750	Bronze			2022-12-18	WOS:000076202300003
J	LUESCHER, IF; ANJUERE, F; PEITSCH, MC; JONGENEEL, CV; CEROTTINI, JC; ROMERO, P				LUESCHER, IF; ANJUERE, F; PEITSCH, MC; JONGENEEL, CV; CEROTTINI, JC; ROMERO, P			STRUCTURAL-ANALYSIS OF TCR-LIGAND INTERACTIONS STUDIED ON H-2K(D)-RESTRICTED CLONED CTL SPECIFIC FOR A PHOTOREACTIVE PEPTIDE DERIVATIVE	IMMUNITY			English	Article							T-CELL-RECEPTOR; ALPHA-CHAIN; 3-DIMENSIONAL STRUCTURE; ANTIGEN RECOGNITION; SYNTHETIC PEPTIDES; VIRAL PEPTIDES; MHC; BINDING; COMPLEX; SITE	To study the interaction of the TCR with its ligand, the complex of a MHC molecule and an antigenic peptide, we modified a TCR contact residue of a H-2K(d)-restricted antigenic peptide with photoreactive 4-azidabenzoic acid. The photoreactive group was a critical component of the epitope recognized by CTL clones derived from mice immunized with such a peptide derivative. The majority of these clones expressed V beta 1-encoded beta chains that were paired with J alpha TA28-encoded a chains. For one of these TCR, the photoaffinity labeled sites were mapped on the a chain as a J alpha TA28-encoded tryptophan and on the beta chain as a residue of the C' strand of V beta 1. Molecular modeling of this TCR suggested the presence of a hydrophobic pocket that harbors this tryptophan as well as a tyrosine on the C' strand of V beta 1 between which the photoreactive side chain inserts. It is concluded that this avid binding principle may account for the preferential selection of V beta 1 and J alpha TA28-encoded TCR.	GLAXO INST MOLEC BIOL SA,CH-1228 GENEVA,SWITZERLAND	GlaxoSmithKline	LUESCHER, IF (corresponding author), UNIV LAUSANNE,LUDWIG INST CANC RES,LAUSANNE BRANCH,CH-1066 EPALINGES,SWITZERLAND.		Anjuere-Casile, Fabienne/O-5779-2016; Jongeneel, Cornelis V/B-2135-2012; Romero, Pedro/S-6015-2017; Peitsch, Manuel/J-7416-2017	Anjuere-Casile, Fabienne/0000-0003-3144-8652; Romero, Pedro/0000-0002-9688-2882; Peitsch, Manuel/0000-0001-5324-359X; Jongeneel, Cornelis Victor/0000-0002-3922-1906				BALEY H, 1984, AZIDES NITRENES REAC, P434; BOITEL B, 1992, J EXP MED, V175, P765, DOI 10.1084/jem.175.3.765; BREMS DN, 1980, BIOCHEMISTRY-US, V20, P3711; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; CLAVERIE JM, 1989, IMMUNOL TODAY, V10, P10, DOI 10.1016/0167-5699(89)90058-3; DANSKA JS, 1990, J EXP MED, V172, P27, DOI 10.1084/jem.172.1.27; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; ENGEL I, 1988, CELL, V54, P473, DOI 10.1016/0092-8674(88)90068-2; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GANJU RK, 1992, P NATL ACAD SCI USA, V89, P11552, DOI 10.1073/pnas.89.23.11552; GREER J, 1990, PROTEINS, V7, P315; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KASIBHATLA S, 1993, J IMMUNOL, V151, P3140; Kaye J, 1991, Semin Immunol, V3, P269; LAI MZ, 1990, J IMMUNOL, V144, P4851; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; LUESCHER IF, 1990, J BIOL CHEM, V265, P11177; LUESCHER IF, 1994, J BIOL CHEM, V269, P5574; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MARTIN S, 1992, J IMMUNOL, V149, P2569; MARYANSKI JL, 1991, INT IMMUNOL, V3, P1035, DOI 10.1093/intimm/3.10.1035; MATHESON RR, 1977, BIOCHEMISTRY-US, V16, P396, DOI 10.1021/bi00622a009; MATIS LA, 1990, ANNU REV IMMUNOL, V8, P65; NALEFSKI EA, 1992, J EXP MED, V175, P1553, DOI 10.1084/jem.175.6.1553; NALEFSKI EA, 1993, J IMMUNOL, V150, P3806; ORTMANN B, 1992, J IMMUNOL, V148, P1445; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; ROMERO P, 1992, J IMMUNOL, V148, P1871; ROMERO P, 1993, J EXP MED, V177, P1247, DOI 10.1084/jem.177.5.1247; ROMERO P, 1993, J IMMUNOL, V150, P3825; ROMERO P, 1994, J IMMUNOL METHODS, V171, P73, DOI 10.1016/0022-1759(94)90230-5; SAMELSON LE, 1985, J IMMUNOL, V134, P2529; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SILICIANO RF, 1986, CELL, V47, P161, DOI 10.1016/0092-8674(86)90439-3; STRONG RK, 1991, BIOCHEMISTRY-US, V30, P3749, DOI 10.1021/bi00229a023; TAN KN, 1988, CELL, V54, P247, DOI 10.1016/0092-8674(88)90557-0; TAYLOR AH, 1990, J EXP MED, V172, P1643, DOI 10.1084/jem.172.6.1643	43	50	50	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					51	63		10.1016/1074-7613(95)90158-2	http://dx.doi.org/10.1016/1074-7613(95)90158-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621078				2022-12-18	WOS:A1995RK86800007
J	Mintz, MA; Felce, JH; Chou, MY; Mayya, V; Xu, Y; Shui, W; An, JP; Li, ZM; Marson, A; Okada, T; Ware, CF; Kronenberg, M; Dustin, ML; Cyster, JG				Mintz, Michelle A.; Felce, James H.; Chou, Marissa Y.; Mayya, Viveka; Xu, Ying; Shui, Jr-Wen; An, Jinping; Li, Zhongmei; Marson, Alexander; Okada, Takaharu; Ware, Carl F.; Kronenberg, Mitchell; Dustin, Michael L.; Cyster, Jason G.			The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis	IMMUNITY			English	Article							HERPESVIRUS ENTRY MEDIATOR; SET ENRICHMENT ANALYSIS; LYMPHOCYTE ATTENUATOR; IMMUNOLOGICAL SYNAPSE; FOLLICULAR LYMPHOMA; AFFINITY MATURATION; CENTER SELECTION; C-MYC; RECEPTOR; ACTIVATION	The tumor necrosis factor receptor superfamily member HVEM is one of the most frequently mutated surface proteins in germinal center (GC)-derived B cell lymphomas. We found that HVEM deficiency increased B cell competitiveness during pre-GC and GC responses. The immunoglobulin (Ig) superfamily protein BTLA regulated HVEM-expressing B cell responses independently of B-cell-intrinsic signaling via HVEM or BTLA. BTLA signaling into T cells through the phosphatase SHP1 reduced T cell receptor (TCR) signaling and preformed CD40 ligand mobilization to the immunological synapse, thus diminishing the help delivered to B cells. Moreover, T cell deficiency in BTLA cooperated with B cell Bcl-2 overexpression, leading to GC B cell outgrowth. These results establish that HVEM restrains the T helper signals delivered to B cells to influence GC selection outcomes, and they suggest that BTLA functions as a cell-extrinsic suppressor of GC B cell lymphomagenesis.	[Mintz, Michelle A.; Chou, Marissa Y.; Xu, Ying; An, Jinping; Li, Zhongmei; Marson, Alexander; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Mintz, Michelle A.; Chou, Marissa Y.; Xu, Ying; An, Jinping; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Felce, James H.; Mayya, Viveka; Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Shui, Jr-Wen; Kronenberg, Mitchell] La Jolla Inst Immunol, Div Dev Immunol, La Jolla, CA USA; [Okada, Takaharu] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Ware, Carl F.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Shui, Jr-Wen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Oxford; La Jolla Institute for Immunology; RIKEN; Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Kronenberg, Mitchell/AAT-6078-2021; Dustin, Michael/AAM-4611-2020; Shui, Jr-Wen/Q-2617-2018	Shui, Jr-Wen/0000-0002-5243-3727; Mayya, Viveka/0000-0001-5668-9124; Dustin, Michael/0000-0003-4983-6389; Mintz, Michelle/0000-0002-0300-8126	National Institute of Allergy and Infectious Diseases [5F30AI131496-02]; Burroughs Wellcome Fund; Innovative Genomics Institute; NIH [R01 AI045073, P01 DK46763]; European Research Council Advanced Grant [ERC-2014-AdG_670930]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073, F30AI131496, U01AI125955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Innovative Genomics Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council Advanced Grant(European Research Council (ERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Allen, J. Bluestone, and J. Rubenstein for mice; S. Davis for HVEM-Fc-His and 6x-His PDL1; K. Wucherpfennig for 10x-His-CD58; R. Brink for 2x-HEL; N. Strauli for assistance with running MIXCR; D. Parker and J. Gardell for advice on detecting CD40L; E. Dang, E. Lu, and A. Reboldi for helpful discussions; and M. Meyer-Hermann, O. Bannard, and J. Muppidi for helpful discussions and critical reading of the manuscript. M.A.M. was supported by 5F30AI131496-02 from the National Institute of Allergy and Infectious Diseases, J.G.C. is a Howard Hughes Medical Institute Investigator. J.H.F. is a Wellcome Trust Sir Henry Wellcome Fellow (107375/Z/15/Z), and M.L.D is a Wellcome Trust Principal Research Fellow (100262Z/12/Z). A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund, is an investigator at the Chan Zuckerberg Biohub, is a Parker Institute for Cancer Immunotherapy investigator, and has received funding from the Innovative Genomics Institute. This work was supported in part by NIH grant R01 AI045073 (J.G.C), European Research Council Advanced Grant ERC-2014-AdG_670930 (M.L.D), and NIH grant P01 DK46763 (M.K).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Boice M, 2016, CELL, V167, P405, DOI 10.1016/j.cell.2016.08.032; Boisvert J, 2004, J IMMUNOL, V173, P3647, DOI 10.4049/jimmunol.173.6.3647; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; de Jong D, 2011, BEST PRACT RES CL HA, V24, P135, DOI 10.1016/j.beha.2011.02.007; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Dustin M. L., 2007, CURR PROTOC IMMUNOL, V13; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Gardell JL, 2017, EUR J IMMUNOL, V47, P41, DOI 10.1002/eji.201646504; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; Huet S, 2018, NAT REV CANCER, V18, P224, DOI 10.1038/nrc.2017.127; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Kashiwakuma D, 2010, J IMMUNOL, V185, P2730, DOI 10.4049/jimmunol.0903839; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Koguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031296; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lackraj T, 2018, BEST PRACT RES CL HA, V31, P2, DOI 10.1016/j.beha.2017.10.006; Launay E, 2012, LEUKEMIA, V26, P559, DOI 10.1038/leu.2011.266; LAVOIE TB, 1992, J IMMUNOL, V148, P503; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Manso BA, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.33; Mayya V, 2018, CELL REP, V22, P340, DOI 10.1016/j.celrep.2017.12.052; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Owada T, 2010, J LEUKOCYTE BIOL, V87, P425, DOI 10.1189/jlb.0309138; Oya Y, 2008, ARTHRITIS RHEUM-US, V58, P2498, DOI 10.1002/art.23674; Papa I, 2017, NATURE, V547, P318, DOI 10.1038/nature23013; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Ritthipichai K, 2017, CLIN CANCER RES, V23, P6151, DOI 10.1158/1078-0432.CCR-16-1217; Rota G, 2018, CELL REP, V23, P39, DOI 10.1016/j.celrep.2018.03.026; Ruedl C, 2000, EUR J IMMUNOL, V30, P2056, DOI 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Seo GY, 2018, CELL HOST MICROBE, V24, P249, DOI 10.1016/j.chom.2018.07.008; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shui JW, 2012, NATURE, V488, P222, DOI 10.1038/nature11242; Steinberg MW, 2011, IMMUNOL REV, V244, P169, DOI 10.1111/j.1600-065X.2011.01064.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Verdiere L, 2018, CURR OPIN HEMATOL, V25, P335, DOI 10.1097/MOH.0000000000000440; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wu TH, 2007, IMMUNOL CELL BIOL, V85, P590, DOI 10.1038/sj.icb.7100087; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009; Yeh CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03382-x; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Zaretsky I, 2017, J EXP MED, V214, P3435, DOI 10.1084/jem.20171129; Zhao YB, 2006, MOL THER, V13, P151, DOI 10.1016/j.ymthe.2005.07.688	74	49	51	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					310	+		10.1016/j.immuni.2019.05.022	http://dx.doi.org/10.1016/j.immuni.2019.05.022			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31204070	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-18	WOS:000482088500014
J	Mondor, I; Baratin, M; Lagueyrie, M; Saro, L; Henri, S; Gentek, R; Suerinck, D; Kastenmuller, W; Jiang, JX; Bajenoff, M				Mondor, Isabelle; Baratin, Myriam; Lagueyrie, Marine; Saro, Lisa; Henri, Sandrine; Gentek, Rebecca; Suerinck, Delphine; Kastenmuller, Wolfgang; Jiang, Jean X.; Bajenoff, Marc			Lymphatic Endothelial Cells Are Essential Components of the Subcapsular Sinus Macrophage Niche	IMMUNITY			English	Article							TISSUE-RESIDENT MACROPHAGES; LANGERHANS CELLS; CARDIAC MACROPHAGES; FLUORESCENT PROTEIN; STEADY-STATE; SPI-C; MONOCYTES; ACTIVATION; MICE; MAINTENANCE	In lymph nodes, subcapsular sinus macrophages (SSMs) form an immunological barrier that monitors lymph drained from peripheral tissues. Upon infection, SSMs activate B and natural killer T (NKT) cells while secreting inflammatory mediators. Here, we investigated the mechanisms regulating development and homeostasis of SSMs. Embryonic SSMs originated from yolk sac hematopoiesis and were replaced by a postnatal wave of bone marrow (BM)-derived monocytes that proliferated to establish the adult SSM network. The SSM network self-maintained by proliferation with minimal BM contribution. Upon pathogen-induced transient deletion, BM-derived cells contributed to restoring the SSM network. Lymphatic endothelial cells (LECs) were the main source of CSF-1 within the lymph node and conditional deletion of Csf1 in adult LECs decreased the network of SSMs and medullary sinus macrophages (MSMs). Thus, SSMs have a dual hematopoietic origin, and LECs are essential to the niche supporting these macrophages.	[Mondor, Isabelle; Baratin, Myriam; Lagueyrie, Marine; Saro, Lisa; Henri, Sandrine; Gentek, Rebecca; Suerinck, Delphine; Bajenoff, Marc] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Kastenmuller, Wolfgang] Univ Wurzburg, Inst Syst Immunol, D-97078 Wurzburg, Germany; [Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Wurzburg; University of Texas System; University of Texas Health San Antonio	Bajenoff, M (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.	bajenoff@ciml.univ-mrs.fr	Henri, Sandrine/O-3045-2016	HENRI, Sandrine/0000-0002-8980-9193; Gentek, Rebecca/0000-0001-6574-7242; Jiang, Jean/0000-0002-2185-5716	NIH [AG045040]; Agence National pour la Recherche [ANR-17-CE15-0015-01 STROMAC, ANR-10-INBS-04-01 France Bio Imaging]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [647257-STROMA]; INSERM; CNRS; Aix-Marseille University; NATIONAL INSTITUTE ON AGING [R01AG045040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence National pour la Recherche(French National Research Agency (ANR)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Taija Makinen (Uppsala University, Department Immunology, Genetics and Pathology, Sweden) for providing the Prox1<SUP>CreERT2</SUP> mice, Sahil Adriouch (Normandie University, Institute for Research and Innovation in Biomedicine, France) for providing VSV, and the CIML core facilities for animal housing and flow cytometry. This study was funded by grants from the NIH (AG045040), Agence National pour la Recherche (ANR-10-INBS-04-01 France Bio Imaging and ANR-17-CE15-0015-01 STROMAC) and from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program grant agreement No 647257-STROMA. This work was supported by institutional grants from INSERM, CNRS and Aix-Marseille University to the CIML.	Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Bellomo A, 2018, CELL IMMUNOL, V330, P168, DOI 10.1016/j.cellimm.2018.01.010; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Birling MC, 2012, GENESIS, V50, P482, DOI 10.1002/dvg.20826; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Garcia Z, 2012, BLOOD, V120, P4744, DOI 10.1182/blood-2012-02-408179; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Gordon EJ, 2010, DEVELOPMENT, V137, P3899, DOI 10.1242/dev.050021; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hong YK, 2003, CELL TISSUE RES, V314, P85, DOI 10.1007/s00441-003-0747-8; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kayama H, 2018, P NATL ACAD SCI USA, V115, P8418, DOI 10.1073/pnas.1808426115; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Mondor I, 2016, IMMUNITY, V45, P877, DOI 10.1016/j.immuni.2016.09.017; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Oussoren C, 1998, BBA-BIOMEMBRANES, V1370, P259, DOI 10.1016/S0005-2736(97)00275-7; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Scott CL, 2014, IMMUNOL REV, V262, P9, DOI 10.1111/imr.12220; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; STANLEY ER, 1978, NATURE, V274, P168, DOI 10.1038/274168a0; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018; Zumsteg A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006494	79	49	50	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1453	+		10.1016/j.immuni.2019.04.002	http://dx.doi.org/10.1016/j.immuni.2019.04.002			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31053503	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000471876100016
J	Barbet, G; Sander, LE; Geswell, M; Leonardi, I; Cerutti, A; Iliev, I; Blander, JM				Barbet, Gaetan; Sander, Leif E.; Geswell, Matthew; Leonardi, Irina; Cerutti, Andrea; Iliev, Iliyan; Blander, J. Magarian			Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses	IMMUNITY			English	Article							I IFN; DIFFERENTIATION; EXPRESSION; PROMOTE; MONOCYTES; VACCINES; IMMUNITY; ZBTB46; ROLES	Live vaccines historically afford superior protection, yet the cellular and molecular mechanisms mediating protective immunity remain unclear. Here we found that vaccination of mice with live, but not dead, Gram-negative bacteria heightened follicular T helper cell (Tfh) differentiation, germinal center formation, and protective antibody production through the signaling adaptor TRIF. Complementing the dead vaccine with an innate signature of bacterial viability, bacterial RNA, recapitulated these responses. The interferon (IFN) and inflammasome pathways downstream of TRIF orchestrated Tfh responses extrinsically to B cells and classical dendritic cells. Instead, CX3CR1(+)CCR2(-) monocytes instructed Tfh differentiation through interleukin-1 beta (IL-1 beta), a tightly regulated cytokine secreted upon TRIF-dependent IFN licensing of the inflammasome. Hierarchical production of IFN-beta and IL-1 beta dictated Tfh differentiation and elicited the augmented humoral responses characteristic of live vaccines. These findings identify bacterial RNA, an innate signature of microbial viability, as a trigger for Tfh differentiation and suggest new approaches toward vaccine formulations for coordinating augmented Tfh and B cell responses.	[Barbet, Gaetan; Leonardi, Irina; Iliev, Iliyan; Blander, J. Magarian] Cornell Univ, Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Barbet, Gaetan; Leonardi, Irina; Iliev, Iliyan; Blander, J. Magarian] Cornell Univ, Weill Cornell Med, Gastroenterol & Hepatol Div, Joan & Sanford Weill Dept Med 1, New York, NY 10021 USA; [Iliev, Iliyan; Blander, J. Magarian] Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA; [Blander, J. Magarian] Cornell Univ, Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10021 USA; [Iliev, Iliyan; Blander, J. Magarian] Cornell Univ, Weill Cornell Med, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA; [Sander, Leif E.] Humboldt Univ, Charite Univ Med Berlin, Freie Univ Berlin, Dept Infect Dis & Pulm Med, Berlin, Germany; [Sander, Leif E.] Berlin Inst Hlth, Berlin, Germany; [Geswell, Matthew; Cerutti, Andrea] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA; [Geswell, Matthew; Cerutti, Andrea; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Cerutti, Andrea] Inst Hosp Mar Invest Med, Barcelona Biomed Res Pk, Barcelona, Spain; [Cerutti, Andrea] Catalan Inst Res & Adv Studies ICREA, Barcelona 08003, Spain; [Geswell, Matthew] 21-30 Geisinger Orthoped Surg,100 North Acad Ave, Danville, PA 17821 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pompeu Fabra University; ICREA	Blander, JM (corresponding author), Cornell Univ, Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Weill Cornell Med, Gastroenterol & Hepatol Div, Joan & Sanford Weill Dept Med 1, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Weill Cornell Med, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA.; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.	jmblander@med.cornell.edu	Sander, Leif Erik/AAI-8619-2020; Leonardi, Irina/AAW-7480-2020; Barbet, Gaetan/ABB-5618-2020; Barbet, Gaetan/AAJ-1675-2021	Leonardi, Irina/0000-0002-0369-7371; Barbet, Gaetan/0000-0002-0152-3650; Sander, Leif Erik/0000-0002-0476-9947; Blander, Julie Magarian/0000-0001-9207-1700	National Institutes of Health (NIH) [AI095245, AI127658, DK113136, AI123284, AI073899, DK072201, DK111862, AI57653, AI95613, AI61093, U19096187]; Crohn's and Colitis Foundation; European Advanced Grant [ERC-2011-ADG-20110310]; Ministerio de Ciencia e Innovation [SAF2011-25241]; Marie Curie reintegration grant [PIRG-08-GA-2010-276928]; German Research Council [DFG SA1940-2/1, SFB-TR84 TP C8]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095245, R01AI073899, R21AI080959, R01AI127658, R01AI057653, P01AI061093, U01AI095613, R56AI073899, R01AI123284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111862, P01DK072201, R01DK113136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; European Advanced Grant; Ministerio de Ciencia e Innovation(Ministry of Science and Innovation, Spain (MICINN)); Marie Curie reintegration grant(European Commission); German Research Council(German Research Foundation (DFG)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grants AI095245 and AI127658 to J.M.B. and DK113136 to I.I. J.M.B. and her laboratory were supported by NIH grants AI123284, AI073899, DK072201, and DK111862. A.G. and his laboratory were supported by NIH grants AI57653, AI95613, AI61093, and U19096187. We thank the Crohn's and Colitis Foundation (to G.B.), European Advanced Grant (ERC-2011-ADG-20110310 to A.C.), Ministerio de Ciencia e Innovation (SAF2011-25241 to A.C.), Marie Curie reintegration grant (PIRG-08-GA-2010-276928 to A.C.), the German Research Council (DFG SA1940-2/1 and SFB-TR84 TP C8 to LE.S.), the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society (to J.M.B.).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Detmer A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-23; Diehl G.E., 2013, J IMMUNOL, V494, P116; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Finco O, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00012; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Kanagavelu S., 2016, J CLIN CELL IMMUNOL, V7, P458; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Leonardi I, 2018, SCIENCE, V359, P232, DOI 10.1126/science.aao1503; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Riteau N, 2016, J IMMUNOL, V197, P3884, DOI 10.4049/jimmunol.1600883; Ritvo PGG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan0368; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schmitt N, 2015, CURR OPIN IMMUNOL, V34, P130, DOI 10.1016/j.coi.2015.03.007; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Sprokholt JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006738; Strengell M, 2004, J LEUKOCYTE BIOL, V76, P416, DOI 10.1189/jlb.1003488; Swanson CL, 2013, IMMUNOL RES, V55, P277, DOI 10.1007/s12026-012-8372-9; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53	38	49	49	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					584	+		10.1016/j.immuni.2018.02.015	http://dx.doi.org/10.1016/j.immuni.2018.02.015			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29548673	Green Accepted, Bronze			2022-12-18	WOS:000427916900017
J	Murata, K; Fang, C; Terao, C; Giannopoulou, EG; Lee, YJ; Lee, MJ; Mun, SH; Bae, S; Qiao, Y; Yuan, RX; Furu, M; Ito, H; Ohmura, K; Matsuda, S; Mimori, T; Matsuda, F; Park-Min, KH; Ivashkiv, LB				Murata, Koichi; Fang, Celestia; Terao, Chikashi; Giannopoulou, Eugenia G.; Lee, Ye Ji; Lee, Min Joon; Mun, Se-Hwan; Bae, Seyeon; Qiao, Yu; Yuan, Ruoxi; Furu, Moritoshi; Ito, Hiromu; Ohmura, Koichiro; Matsuda, Shuichi; Mimori, Tsuneyo; Matsuda, Fumihiko; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.			Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis	IMMUNITY			English	Article							RHEUMATOID-ARTHRITIS; MITOCHONDRIAL BIOGENESIS; NEGATIVE REGULATION; JOINT DESTRUCTION; CREATINE-KINASE; BONE-RESORPTION; RNA-SEQ; DIFFERENTIATION; ACTIVATION; MECHANISMS	Hypoxia augments inflammatory responses and osteoclastogenesis by incompletely understood mechanisms. We identified COMMD1 as a cell-intrinsic negative regulator of osteoclastogenesis that is suppressed by hypoxia. In human macrophages, COMMD1 restrained induction of NF-kappa B signaling and a transcription factor E2F1-dependent metabolic pathway by the cytokine RANKL. Downregulation of COMMD1 protein expression by hypoxia augmented RANKL-induced expression of inflammatory and E2F1 target genes and downstream osteoclastogenesis. E2F1 targets included glycolysis and metabolic genes including CKB that enabled cells to meet metabolic demands in challenging environments, as well as inflammatory cytokine-driven target genes. Expression quantitative trait locus analysis linked increased COMMD1 expression with decreased bone erosion in rheumatoid arthritis. Myeloid deletion of Commd1 resulted in increased osteoclastogenesis in arthritis and inflammatory osteolysis models. These results identify COMMD1 and an E2F-metabolic pathway as key regulators of osteoclastogenic responses under pathological inflammatory conditions and provide a mechanism by which hypoxia augments inflammation and bone destruction.	[Murata, Koichi; Fang, Celestia; Giannopoulou, Eugenia G.; Lee, Ye Ji; Lee, Min Joon; Mun, Se-Hwan; Bae, Seyeon; Qiao, Yu; Yuan, Ruoxi; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Murata, Koichi; Fang, Celestia; Giannopoulou, Eugenia G.; Lee, Ye Ji; Lee, Min Joon; Mun, Se-Hwan; Bae, Seyeon; Qiao, Yu; Yuan, Ruoxi; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, New York, NY 10021 USA; [Murata, Koichi; Furu, Moritoshi; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068507, Japan; [Murata, Koichi; Furu, Moritoshi] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Sakyo Ku, Kyoto 6068507, Japan; [Terao, Chikashi; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Sakyo Ku, Kyoto 6068507, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Promot Interdisciplinary Educ & Res, Sakyo Ku, Kyoto 6068507, Japan; [Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Sakyo Ku, Kyoto 6068507, Japan; [Terao, Chikashi] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Terao, Chikashi] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Terao, Chikashi] Harvard Med Sch, Boston, MA 02115 USA; [Terao, Chikashi] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Giannopoulou, Eugenia G.] CUNY, New York City Coll Technol, Biol Sci Dept, Brooklyn, NY 11201 USA	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; City University of New York (CUNY) System	Park-Min, KH; Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA.; Park-Min, KH; Ivashkiv, LB (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, New York, NY 10021 USA.	parkmink@hss.edu; ivashkivl@hss.edu	Giannopoulou, Evgenia/K-9576-2019	Lee, Min Joon/0000-0003-2722-8526; Murata, Koichi/0000-0002-7896-3937; Yuan, Ruoxi/0000-0002-8719-341X	Kyoto University Foundation; JSPS [JP16H06251]; NIAMS [AR061430, AR069562]; NIH [DE019420, AI044938, AR050401]; Mitsubishi Tanabe Pharma Co.; Chugai Pharmaceutical Co. Ltd; UCB Japan Co. Ltd; AYUMI Pharmaceutical Co.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR061430, R01AR069562, R01AR050401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019420] Funding Source: NIH RePORTER	Kyoto University Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitsubishi Tanabe Pharma Co.; Chugai Pharmaceutical Co. Ltd; UCB Japan Co. Ltd(UCB Pharma SA); AYUMI Pharmaceutical Co.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Lyudmila Lukashova for micro-CT analysis, Drs. Steven Goldring, Matthew B. Greenblatt, and Jae-Hyuck Shim for helpful discussions, and Baohong Zhao for critical review of the manuscript. This study was supported by the Kyoto University Foundation to K.M., JSPS KAKENHI Grant Number JP16H06251 to F.M., NIAMS grants to K.-H. P.-M. (AR061430, AR069562), and NIH grants to L.B.I. (DE019420, AI044938, AR050401). Department of Advanced Medicine for Rheumatic Diseases is supported by Nagahama City, Shiga, Japan and four pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Chugai Pharmaceutical Co. Ltd, UCB Japan Co. Ltd, and AYUMI Pharmaceutical Co.). The study contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; Benevolenskaya EV, 2015, CANCER RES, V75, P619, DOI 10.1158/0008-5472.CAN-14-2173; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Cejka D, 2010, ARTHRITIS RHEUM-US, V62, P2294, DOI 10.1002/art.27504; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Ivashkiv LB, 2015, NAT MED, V21, P212, DOI 10.1038/nm.3815; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Nakashima T, 2011, ANN NY ACAD SCI, V1240, pE13, DOI 10.1111/j.1749-6632.2011.06373.x; Nicolay BN, 2013, CURR OPIN CELL BIOL, V25, P735, DOI 10.1016/j.ceb.2013.07.012; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park-Min KH, 2013, J BONE MINER RES, V28, P135, DOI 10.1002/jbmr.1739; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terao C, 2015, ARTHRITIS RHEUMATOL, V67, P3113, DOI 10.1002/art.39306; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zeng R, 2015, J BONE MINER RES, V30, P2287, DOI 10.1002/jbmr.2584; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379	46	49	52	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					66	+		10.1016/j.immuni.2017.06.018	http://dx.doi.org/10.1016/j.immuni.2017.06.018			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723554	Green Accepted, Bronze			2022-12-18	WOS:000405712800010
J	Gras, S; Chadderton, J; Del Campo, CM; Farenc, C; Wiede, F; Josephs, TM; Sng, XYX; Mirams, M; Watson, KA; Tiganis, T; Quinn, KM; Rossjohn, J; La Gruta, NL				Gras, Stephanie; Chadderton, Jesseka; Del Campo, Claudia M.; Farenc, Carine; Wiede, Florian; Josephs, Tracy M.; Sng, Xavier Y. X.; Mirams, Michiko; Watson, Katherine A.; Tiganis, Tony; Quinn, Kylie M.; Rossjohn, Jamie; La Gruta, Nicole L.			Reversed T Cell Receptor Docking on a Major Histocompatibility Class I Complex Limits Involvement in the Immune Response	IMMUNITY			English	Article							ANTIGEN-DRIVEN SELECTION; STRUCTURAL BASIS; REPERTOIRE DIVERSITY; RECOGNITION; MHC; PEPTIDE; BIAS; AVIDITY; SPECIFICITY; POPULATIONS	The anti-viral T cell response is drawn from the naive T cell repertoire. During influenza infection, the CD8(+) T cell response to an H-2D(b)-restricted nucleoprotein epitope (NP366) is characterized by preferential expansion of T cells bearing TRBV13(+) T cell receptors (TCRs) and avoidance of TRBV17(+) T cells, despite the latter dominating the naive precursor repertoire. We found two TRBV17(+) TCRs that bound H-2D(b)-NP366 with a 180 degrees reversed polarity compared to the canonical TCR-pMHC-I docking. The TRBV17 beta-chain dominated the interaction and, whereas the complementarity determining region-3 (CDR3) loops exclusively mediated contacts with the MHC-I, peptide specificity was attributable to germline-encoded recognition. Nevertheless, the TRBV17(+) TCR exhibited moderate affinity toward H-2D(b)-NP366 and was capable of signal transduction. Thus, the naive CD8(+) T cell pool can comprise TCRs adopting reversed pMHC-I docking modes that limit their involvement in the immune response.	[Gras, Stephanie; Chadderton, Jesseka; Del Campo, Claudia M.; Farenc, Carine; Wiede, Florian; Josephs, Tracy M.; Sng, Xavier Y. X.; Tiganis, Tony; Quinn, Kylie M.; Rossjohn, Jamie; La Gruta, Nicole L.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Gras, Stephanie; Chadderton, Jesseka; Del Campo, Claudia M.; Farenc, Carine; Wiede, Florian; Josephs, Tracy M.; Sng, Xavier Y. X.; Tiganis, Tony; Quinn, Kylie M.; Rossjohn, Jamie; La Gruta, Nicole L.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gras, Stephanie; Del Campo, Claudia M.; Josephs, Tracy M.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Chadderton, Jesseka; Sng, Xavier Y. X.; Mirams, Michiko; Watson, Katherine A.; Quinn, Kylie M.; La Gruta, Nicole L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Watson, Katherine A.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia	Monash University; Monash University; Monash University; University of Melbourne; Cardiff University; Walter & Eliza Hall Institute	Rossjohn, J; La Gruta, NL (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J; La Gruta, NL (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia.; La Gruta, NL (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	jamie.rossjohn@monash.edu; nicole.la.gruta@monash.edu	Tiganis, Tony/AAV-3495-2020; Rossjohn, Jamie/F-9032-2013; Quinn, Kylie/AAJ-5066-2021	Tiganis, Tony/0000-0002-8065-9942; Rossjohn, Jamie/0000-0002-2020-7522; Chadderton, Jesseka/0000-0002-2784-3556; gras, stephanie/0000-0001-7416-038X; Sng, Xavier Y. X./0000-0001-7424-2123; La Gruta, Nicole/0000-0001-5358-9363; Quinn, Kylie/0000-0002-0417-3625; Wiede, Florian/0000-0001-5145-7180; Farenc, Carine/0000-0001-6383-3032	Australian National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); University of Melbourne Faculty Research Scholarship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); University of Melbourne Faculty Research Scholarship	The authors wish to thank staff at the National Synchrotron for assistance with data collection and staff at the Monash Macromolecular crystallization facility. This work was supported by Australian National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC) funding. N.L.L.G. is a Sylvia and Charles Viertel Senior Medical Research Fellow. J.C. is funded by University of Melbourne Faculty Research Scholarship. J.R. is an NHMRC Australia Fellow (AF50), T.T. an NHMRC Principal Research Fellow, and S.G. is an ARC Future Fellow (FF120100416).	Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Coles RM, 2003, EUR J IMMUNOL, V33, P1557, DOI 10.1002/eji.200323715; Cukalac T, 2015, IMMUNOL CELL BIOL, V93, P804, DOI 10.1038/icb.2015.44; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; La Gruta NL, 2010, J CLIN INVEST, V120, P1885, DOI 10.1172/JCI41538; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Neller MA, 2015, IMMUNOL CELL BIOL, V93, P625, DOI 10.1038/icb.2015.17; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Rangarajan S, 2014, CELL MOL LIFE SCI, V71, P3059, DOI 10.1007/s00018-014-1600-9; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	43	49	49	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					749	760		10.1016/j.immuni.2016.09.007	http://dx.doi.org/10.1016/j.immuni.2016.09.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27717799	Green Accepted, Bronze			2022-12-18	WOS:000389473200009
J	Wieland, A; Shashidharamurthy, R; Kamphorst, AO; Han, JH; Aubert, RD; Choudhury, BP; Stowell, SR; Lee, J; Punkosdy, GA; Shlomchik, MJ; Selvaraj, P; Ahmed, R				Wieland, Andreas; Shashidharamurthy, Rangaiah; Kamphorst, Alice O.; Han, Jin-Hwan; Aubert, Rachael D.; Choudhury, Biswa P.; Stowell, Sean R.; Lee, Junghwa; Punkosdy, George A.; Shlomchik, Mark J.; Selvaraj, Periasamy; Ahmed, Rafi			Antibody Effector Functions Mediated by Fc gamma-Receptors Are Compromised during Persistent Viral Infection	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IMMUNE-COMPLEX DISEASE; T-CELL RESPONSES; IN-VIVO; B-CELLS; ANTITUMOR ACTIVITIES; DENDRITIC CELLS; BREAST-CANCER; STEM-CELLS; THERAPY	T cell dysfunction is well documented during chronic viral infections but little is known about functional abnormalities in humoral immunity. Here we report that mice persistently infected with lymphocytic choriomeningitis virus (LCMV) exhibit a severe defect in Fc gamma-receptor (Fc gamma R)-mediated antibody effector functions. Using transgenic mice expressing human CD20, we found that chronic LCMV infection impaired the depletion of B cells with rituximab, an anti-CD20 antibody widely used for the treatment of B cell lymphomas. In addition, Fc gamma R-dependent activation of dendritic cells by agonistic anti-CD40 antibody was compromised in chronically infected mice. These defects were due to viral antigen-anti-body complexes and not the chronic infection per se, because Fc gamma R-mediated effector functions were normal in persistently infected mice that lacked LCMV-specific antibodies. Our findings have implications for the therapeutic use of antibodies and suggest that high levels of pre-existing immune complexes could limit the effectiveness of antibody therapy in humans.	[Wieland, Andreas; Kamphorst, Alice O.; Han, Jin-Hwan; Aubert, Rachael D.; Lee, Junghwa; Punkosdy, George A.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Wieland, Andreas; Kamphorst, Alice O.; Han, Jin-Hwan; Aubert, Rachael D.; Lee, Junghwa; Punkosdy, George A.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shashidharamurthy, Rangaiah; Stowell, Sean R.; Selvaraj, Periasamy] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Shlomchik, Mark J.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Choudhury, Biswa P.] Univ Calif San Diego, La Jolla, CA 92093 USA	Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	rahmed@emory.edu	DELGADO, RAFAEL/A-2938-2012; Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Kamphorst, Alice/0000-0002-9230-9501	National Institutes of Health [R01-AI030048, R01-AR044077, R01-CA138993]; Cancer Research Institute's Irvington Institute Fellowship Program; NATIONAL CANCER INSTITUTE [R01CA138993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, T32AI070081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute's Irvington Institute Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank members of the Ahmed laboratory for insightful discussion. We would like to thank Edward Clark for providing us with the 2H7 hybridoma. This work was supported by the National Institutes of Health (Grant R01-AI030048 to R.A., Grant R01-AR044077 to M.J.S., and Grant R01-CA138993 to P.S.), and by the Cancer Research Institute's Irvington Institute Fellowship Program (to A.O.K., and to J.-H.H.).	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Ahuja A, 2011, J IMMUNOL, V187, P3888, DOI 10.4049/jimmunol.1101629; Alduaij W, 2011, BLOOD, V117, P2993, DOI 10.1182/blood-2010-07-298356; Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; BUCHMEIER MJ, 1978, J IMMUNOL, V120, P1297; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hu YP, 2009, IMMUNOLOGY, V128, P260, DOI 10.1111/j.1365-2567.2009.03115.x; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jilani I, 2003, BLOOD, V102, P3514, DOI 10.1182/blood-2003-01-0055; Jing WQ, 2009, BLOOD, V113, P4449, DOI 10.1182/blood-2008-11-190827; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kirimanjeswara GS, 2005, J IMMUNOL, V175, P7504, DOI 10.4049/jimmunol.175.11.7504; Li FB, 2013, P NATL ACAD SCI USA, V110, P19501, DOI 10.1073/pnas.1319502110; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Li YL, 2007, J IMMUNOL, V179, P4263, DOI 10.4049/jimmunol.179.6.4263; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Martin C.E., 2013, BLOOD; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; OLDSTONE MBA, 1980, J IMMUNOL, V124, P831; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Shashidharamurthy R, 2008, BLOOD, V111, P894, DOI 10.1182/blood-2007-04-085944; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; TSAI JF, 1995, CLIN IMMUNOL IMMUNOP, V75, P39, DOI 10.1006/clin.1995.1050; Varchetta S, 2007, CANCER RES, V67, P11991, DOI 10.1158/0008-5472.CAN-07-2068; Yang XM, 2013, MOL THER, V21, P91, DOI 10.1038/mt.2012.184; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232	53	49	50	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					367	378		10.1016/j.immuni.2015.01.009	http://dx.doi.org/10.1016/j.immuni.2015.01.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25680276	Bronze, Green Accepted			2022-12-18	WOS:000349916400019
J	Yamada, DH; Elsaesser, H; Lux, A; Timmerman, JM; Morrison, SL; de la Torre, JC; Nimmerjahn, F; Brooks, DG				Yamada, Douglas H.; Elsaesser, Heidi; Lux, Anja; Timmerman, John M.; Morrison, Sherie L.; de la Torre, Juan Carlos; Nimmerjahn, Falk; Brooks, David G.			Suppression of Fc gamma-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; DENDRITIC CELLS; HIV-INFECTION; T-CELLS; B-CELLS; VIRUS; THERAPY; IGG; EFFICACY; IMMUNITY	Understanding how viruses subvert host immunity and persist is essential for developing strategies to eliminate infection. T cell exhaustion during chronic viral infection is well described, but effects on anti-body- mediated effector activity are unclear. Herein, we show that increased amounts of immune complexes generated in mice persistently infected with lymphocytic choriomeningitis virus (LCMV) suppressed multiple Fc gamma-receptor (Fc gamma R) functions. The high amounts of immune complexes suppressed antibody-mediated cell depletion, therapeutic antibody- killing of LCMV infected cells and human CD20-expressing tumors, as well as reduced immune complex-mediated cross-presentation to T cells. Suppression of Fc gamma R activity was not due to inhibitory Fc gamma Rs or high concentrations of free antibody, and proper Fc gamma R functions were restored when persistently infected mice specifically lacked immune complexes. Thus, we identify a mechanism of immunosuppression during viral persistence with implications for understanding effective antibody activity aimed at pathogen control.	[Yamada, Douglas H.; Elsaesser, Heidi; Morrison, Sherie L.; Brooks, David G.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Timmerman, John M.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Timmerman, John M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [de la Torre, Juan Carlos] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Lux, Anja; Nimmerjahn, Falk] Univ Erlangen Nurnberg, Inst Genet, Dept Biol, D-91058 Erlangen, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Scripps Research Institute; University of Erlangen Nuremberg	Brooks, DG (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	dbrooks@microbio.ucla.edu		Brooks, David/0000-0001-7763-8764; Lux, Anja/0000-0001-9475-2147; Nimmerjahn, Falk/0000-0002-5418-316X	National Institutes of Health (NIH) [AI085043, AI082975, AI109627]; dissertation year fellowship; DFG-TRR [130]; UCLA Center for AIDS Research [P30 AI028697]; NATIONAL CANCER INSTITUTE [R01CA162964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, R21AI109627, R21AI077012, U01AI082975, R01AI085043] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); dissertation year fellowship; DFG-TRR; UCLA Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank past and present members of the Brooks, Kitchen, Bensinger, and Zack Laboratories for helpful discussions and technical assistance. This work was supported by the National Institutes of Health (NIH) grants AI085043, AI082975, and AI109627 to D.G.B., a dissertation year fellowship to D.H.Y., a DFG-TRR 130 grant to F.N., and the UCLA Center for AIDS Research Grant P30 AI028697.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Ahuja A, 2011, J IMMUNOL, V187, P3888, DOI 10.4049/jimmunol.1101629; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Biburger M, 2011, IMMUNITY, V35, P932, DOI 10.1016/j.immuni.2011.11.009; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fahey LM, 2010, CURR OPIN IMMUNOL, V22, P348, DOI 10.1016/j.coi.2010.03.004; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Huber M, 2008, CURR TOP MICROBIOL, V317, P39; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Massabki PS, 1997, AIDS, V11, P1845, DOI 10.1097/00002030-199715000-00009; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Nielsen H, 1998, SCAND J INFECT DIS, V30, P597, DOI 10.1080/00365549850161160; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Osokine I, 2014, P NATL ACAD SCI USA, V111, P7409, DOI 10.1073/pnas.1401662111; Platzer B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00140; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Siragam V, 2005, J CLIN INVEST, V115, P155, DOI 10.1172/JCI200522753; Sparano JA, 2010, BLOOD, V115, P3008, DOI 10.1182/blood-2009-08-231613; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 2008, J VIROL, V82, P1591, DOI 10.1128/JVI.01792-07; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1	46	49	49	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					379	390		10.1016/j.immuni.2015.01.005	http://dx.doi.org/10.1016/j.immuni.2015.01.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25680277	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-18	WOS:000349916400020
J	Mayans, S; Stepniak, D; Palida, SF; Larange, A; Dreux, J; Arlian, BM; Shinnakasu, R; Kronenberg, M; Cheroutre, H; Lambolez, F				Mayans, Sofia; Stepniak, Dariusz; Palida, Sakina F.; Larange, Alexandre; Dreux, Joanna; Arlian, Britni M.; Shinnakasu, Ryo; Kronenberg, Mitchell; Cheroutre, Hilde; Lambolez, Florence			alpha beta T Cell Receptors Expressed by CD4(-)CD8 alpha beta Intraepithelial T Cells Drive Their Fate into a Unique Lineage with Unusual MHC Reactivities	IMMUNITY			English	Article							CLASS-I MOLECULE; IMMUNE SURVEILLANCE; RETROGENIC MICE; LYMPHOCYTES; ANTIGEN; SELECTION; DIFFERENTIATION; CD8-ALPHA-ALPHA; MOUSE; REPERTOIRE	Coreceptor CD4 and CD8 alpha beta double-negative (DN) TCR alpha beta(+) intraepithelial T cells, although numerous, have been greatly overlooked and their contribution to the immune response is not known. Here we used T cell receptor (TCR) sequencing of single cells combined with retrogenic expression of TCRs to study the fate and the major histocompatibility complex (MHC) restriction of DN TCR alpha beta(+) intraepithelial T cells. The data show that commitment of thymic precursors to the DN TCR alpha beta(+) lineage is imprinted by their TCR specificity. Moreover, the TCRs they express display a diverse and unusual pattern of MHC restriction that is nonoverlapping with that of CD4(+) or CD8 alpha beta(+) T cells, indicating that they sense antigens that are not recognized by the conventional T cell subsets. The new insights indicate that DN TCR alpha beta(+) T cells form a third lineage of TCR alpha beta T lymphocytes expressing a variable TCR repertoire, which serve nonredundant immune functions.	[Mayans, Sofia; Stepniak, Dariusz; Palida, Sakina F.; Larange, Alexandre; Dreux, Joanna; Arlian, Britni M.; Shinnakasu, Ryo; Kronenberg, Mitchell; Cheroutre, Hilde; Lambolez, Florence] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Stepniak, Dariusz] eBioscience, San Diego, CA USA; [Palida, Sakina F.] Univ Calif San Diego, HHMI, La Jolla, CA 92093 USA; [Arlian, Britni M.] Scripps Res Inst, La Jolla, CA 92037 USA; [Shinnakasu, Ryo] RIKEN, Ctr Integrat Med Sci, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan	La Jolla Institute for Immunology; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute; RIKEN	Lambolez, F (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	florence@liai.org	Kronenberg, Mitchell/AAT-6078-2021	Mayans, Sofia/0000-0002-9912-8252	NIH [R21 AI090504, R21 AI099726, DP1 OD006433, PO1 DK46763]; Swedish Research Council [6232010-6567]; Amgen Summer Research Program Scholarship; National Institute of Allergy and Infectious Diseases; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064584, R21AI090504, R21AI099726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006433] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Amgen Summer Research Program Scholarship; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Lena and Y. Wang-Zhu for technical help, the LIAI Imaging Core Facility for cell sorting, and the LIAI Department of Laboratory Animal Care for mouse colony management. We thank S. Becart for providing cellular biology expertise, E. Girardi for advice regarding TCR sequences analysis, B. Peters for providing statistical analysis expertise, and B. Lucas for suggestions, advice, and critical reading of the manuscript. We thank M. Cheroutre for her contribution. We thank K. Murphy for the retroviral vector, N. Gascoigne for the 58 alpha beta cell line, P. Marrack and J. Kappler for the BW5147 cell line, and H. Cantor, L. van Kaer, A. Sette, and T. Hansen for providing mice. This work was supported by grants from the NIH (R21 AI090504 and R21 AI099726 to F.L.; DP1 OD006433 to H.C.; PO1 DK46763 to M.K.). S.M. was supported by a fellowship from the Swedish Research Council (Dnr 6232010-6567). B.A. was supported by an Amgen Summer Research Program Scholarship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the NIH, or other funding agencies. This is manuscript number 1626 from the La Jolla Institute for Allergy and Immunology.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Aptsiauri N, 2007, INT REV CYTOL, V256, P139, DOI 10.1016/S0074-7696(07)56005-5; Arnold PY, 2004, J IMMUNOL, V173, P3103, DOI 10.4049/jimmunol.173.5.3103; Bettini ML, 2012, IMMUNOLOGY, V136, P265, DOI 10.1111/j.1365-2567.2012.03574.x; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Das G, 2000, J EXP MED, V192, P1521, DOI 10.1084/jem.192.10.1521; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Engel I, 2012, CURR OPIN IMMUNOL, V24, P184, DOI 10.1016/j.coi.2012.01.012; Fang XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010288; Fujiura Y, 1996, J IMMUNOL, V156, P2710; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Gapin L, 1999, J IMMUNOL, V163, P4100; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; GuyGrand D, 1996, EUR J IMMUNOL, V26, P2248, DOI 10.1002/eji.1830260942; Hofstetter AR, 2012, J IMMUNOL, V188, P3071, DOI 10.4049/jimmunol.1103554; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; KILSHAW PJ, 1990, EUR J IMMUNOL, V20, P2201, DOI 10.1002/eji.1830201008; Lambolez F, 2007, IMMUNOL REV, V215, P178, DOI 10.1111/j.1600-065X.2006.00488.x; Lefranc M.P., 2006, J IMMUNOL, V147, P1746; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851; Medina F, 2009, J IMMUNOL, V183, P4639, DOI 10.4049/jimmunol.0901356; MELLOR AL, 1985, P NATL ACAD SCI USA, V82, P5920, DOI 10.1073/pnas.82.17.5920; Mixter PF, 1999, J IMMUNOL, V162, P5747; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; OHTEKI T, 1993, EUR J IMMUNOL, V23, P1251, DOI 10.1002/eji.1830230609; Oliveira CC, 2013, MOL IMMUNOL, V55, P113, DOI 10.1016/j.molimm.2012.10.005; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; Patel KK, 2013, ANNU REV PHYSIOL, V75, P241, DOI 10.1146/annurev-physiol-030212-183658; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Priatel JJ, 2001, J IMMUNOL, V167, P6188, DOI 10.4049/jimmunol.167.11.6188; REGNAULT A, 1994, J EXP MED, V180, P1345, DOI 10.1084/jem.180.4.1345; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; SYDORA BC, 1993, CELL IMMUNOL, V152, P305, DOI 10.1006/cimm.1993.1293; Sydora BC, 1996, J IMMUNOL, V156, P4209; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Weber DA, 2002, J IMMUNOL, V169, P5708, DOI 10.4049/jimmunol.169.10.5708; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	53	49	51	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					207	218		10.1016/j.immuni.2014.07.010	http://dx.doi.org/10.1016/j.immuni.2014.07.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25131531	Green Accepted, Bronze			2022-12-18	WOS:000341455300009
J	Brennan, AJ; Chia, J; Browne, KA; Ciccone, A; Ellis, S; Lopez, JA; Susanto, O; Verschoor, S; Yagita, H; Whisstock, JC; Trapani, JA; Voskoboinik, I				Brennan, Amelia J.; Chia, Jenny; Browne, Kylie A.; Ciccone, Annette; Ellis, Sarah; Lopez, Jamie A.; Susanto, Olivia; Verschoor, Sandra; Yagita, Hideo; Whisstock, James C.; Trapani, Joseph A.; Voskoboinik, Ilia			Protection from Endogenous Perforin: Glycans and the C Terminus Regulate Exocytic Trafficking in Cytotoxic Lymphocytes	IMMUNITY			English	Article							DIPEPTIDYL PEPTIDASE-I; NATURAL-KILLER-CELLS; GRANZYME-B; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MEDIATED APOPTOSIS; MEMBRANE-BINDING; DEATH PATHWAY; ACTIVATION; INHIBITOR; TRANSPORT	Cytotoxic lymphocyte-mediated apoptosis is dependent on the delivery of perforin to secretory granules and its ability to form calcium-dependent pores in the target cell after granule exocytosis. It is unclear how cytotoxic lymphocytes synthesize and store perforin without incurring damage or death. We discovered that the extreme C terminus of perforin was essential for rapid trafficking from the endoplasmic reticulum to the Golgi compartment. Substitution of the C-terminal tryptophan residue resulted in retention of perforin in the ER followed by calcium-dependent toxic activity that eliminated host cells. We also found that N-linked glycosylation of perforin was critical for transport from the Golgi to secretory granules. Overall, an intact C terminus and N-linked glycosylation provide accurate and efficient export of perforin from the endoplasmic reticulum to the secretory granules and are critical for cytotoxic lymphocyte survival.	[Brennan, Amelia J.; Chia, Jenny; Browne, Kylie A.; Ciccone, Annette; Ellis, Sarah; Lopez, Jamie A.; Susanto, Olivia; Verschoor, Sandra; Trapani, Joseph A.; Voskoboinik, Ilia] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Brennan, Amelia J.; Lopez, Jamie A.; Voskoboinik, Ilia] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Voskoboinik, Ilia] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia	Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Juntendo University; Monash University; Monash University	Voskoboinik, I (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia.	ilia.voskoboinik@petermac.org		Lopez Bernal, Jamie/0000-0002-1301-5653; Ellis, Sarah/0000-0002-5772-6051; Voskoboinik, Ilia/0000-0002-6410-009X; Whisstock, James/0000-0003-4200-5611; Trapani, Joseph/0000-0003-0983-1532; Susanto, Olivia/0000-0001-6360-1952	CCV scholarship; NHMRC	CCV scholarship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	A.J.B. and J.A.L. are NHMRC Training Fellows, J.C. is a recipient of a CCV scholarship, J.C.W. is an ARC Federation Fellow and Honorary NHMRC Principal Research Fellow, J.A.T. was previously an NHMRC Senior Principal Research Fellow, and I.V. is an NHMRC Career Development Fellow. The authors greatly acknowledge the helpful comments of R.H.P. Law and D. Hoke, the technical assistance of the late K. Mitchelhill, and the NHMRC for grant support.	AEBI M, 2010, IMMUNITY, V35, P684; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bolitho P, 2007, CURR OPIN IMMUNOL, V19, P339, DOI 10.1016/j.coi.2007.04.007; Brennan AJ, 2010, CELL DEATH DIFFER, V17, P607, DOI 10.1038/cdd.2009.212; Chia J, 2009, P NATL ACAD SCI USA, V106, P9809, DOI 10.1073/pnas.0903815106; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENKART PA, 1986, J IMMUNOL, V137, P2611; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Katano H, 2005, BRIT J HAEMATOL, V128, P739, DOI 10.1111/j.1365-2141.2004.05305.x; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Pipkin ME, 2007, IMMUNITY, V26, P29, DOI 10.1016/j.immuni.2006.11.009; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Saraste J, 1992, Semin Cell Biol, V3, P343, DOI 10.1016/1043-4682(92)90020-V; SMYTH MJ, 1995, J IMMUNOL, V154, P6299; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2004, J EXP MED, V200, P811, DOI 10.1084/jem.20040776; Voskoboinik I, 2007, BLOOD, V110, P1184, DOI 10.1182/blood-2007-02-072850; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769	42	49	49	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					879	892		10.1016/j.immuni.2011.04.007	http://dx.doi.org/10.1016/j.immuni.2011.04.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21658975	Bronze			2022-12-18	WOS:000292349700009
J	Northrup, DL; Zhao, KJ				Northrup, Daniel L.; Zhao, Keji			Application of ChIP-Seq and Related Techniques to the Study of Immune Function	IMMUNITY			English	Review							REGULATORY T-CELLS; TISSUE-SPECIFIC ENHANCERS; CYTOKINE GENE-EXPRESSION; EMBRYONIC STEM-CELLS; LOCUS-CONTROL REGION; TRANSCRIPTION FACTORS; DNA METHYLATION; HUMAN GENOME; CHROMATIN-STRUCTURE; STAT3-DEPENDENT MANNER	Behaviors observed at the cellular level such as development and acquisition of effector functions by immune cells result from transcriptional changes. The biochemical mediators of transcription are sequence-specific transcription factors (TFs), chromatin modifying enzymes, and chromatin, the complex of DNA and histone proteins. Covalent modification of DNA and histones, also termed epigenetic modification, influences the accessibility of target sequences for transcription factors on chromatin and the expression of linked genes required for immune functions. Genome-wide techniques such as ChIP-Seq have described the entire "cistrome" of transcription factors involved in specific developmental steps of B and T cells and started to define specific immune responses in terms of the binding profiles of critical effectors and epigenetic modification patterns. Current data suggest that both promoters and enhancers are prepared for action at different stages of activation by epigenetic modification through distinct transcription factors in different cells.	[Northrup, Daniel L.; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Northrup, DL (corresponding author), NHLBI, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	northrupd@nhlbi.nih.gov; zhaok@nhlbi.nih.gov		Northrup, Daniel/0000-0002-2665-2686	Division of Intramural Research, National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006030] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Division of Intramural Research, National Heart, Lung and Blood Institute supported the research in the authors' laboratory.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Allis CD, 2011, CHEMBIOCHEM, V12, P264, DOI 10.1002/cbic.201000761; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Aune TM, 2009, IMMUNOLOGY, V126, P299, DOI 10.1111/j.1365-2567.2008.03026.x; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De S, 2011, MOL CELL BIOL, V31, P1512, DOI 10.1128/MCB.00920-10; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/nmeth.1459, 10.1038/NMETH.1459]; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	109	49	51	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 24	2011	34	6					830	842		10.1016/j.immuni.2011.06.002	http://dx.doi.org/10.1016/j.immuni.2011.06.002			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703538	Bronze, Green Accepted			2022-12-18	WOS:000292349700005
J	Back, J; Malchiodi, EL; Cho, S; Scarpellino, L; Schneider, P; Kerzic, MC; Mariuzza, RA; Held, W				Back, Jonathan; Malchiodi, Emilio L.; Cho, Sangwoo; Scarpellino, Leonardo; Schneider, Pascal; Kerzic, Melissa C.; Mariuzza, Roy A.; Held, Werner			Distinct Conformations of Ly49 Natural Killer Cell Receptors Mediate MHC Class I Recognition in Trans and Cis	IMMUNITY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; CRYSTAL-STRUCTURE; INHIBITORY RECEPTORS; TYROSINE PHOSPHATASE; STRUCTURAL BASIS; LIGAND; COMPLEX; MOLECULES; BINDING; SPECIFICITY	Certain cell-surface receptors engage ligands expressed on juxtaposed cells and ligands on the same cell. The structural basis for trans versus cis binding is not known. Here, we showed that Ly49 natural killer (NK) cell receptors bound two MHC class I (MHC-I) molecules in trans when the two ligand-binding domains were backfolded onto the long stalk region. In contrast, dissociation of the ligand-binding domains from the stalk and their reorientation relative to the NK cell membrane allowed monovalent binding of MHC-I in cis. The distinct conformations (backfolded and extended) define the structural basis for cis-trans binding by Ly49 receptors and explain the divergent functional consequences of cis versus trans interactions. Further analyses identified specific stalk segments that were not required for MHC-I binding in trans but were essential for inhibitory receptor function. These data identify multiple distinct roles of stalk regions for receptor function.	[Malchiodi, Emilio L.; Cho, Sangwoo; Kerzic, Melissa C.; Mariuzza, Roy A.] Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Back, Jonathan; Scarpellino, Leonardo; Held, Werner] Ludwig Inst Canc Res Ltd, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University System of Maryland; University of Maryland Baltimore; Ludwig Institute for Cancer Research; University of Lausanne	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Rockville, MD 20850 USA.	mariuzza@carb.nist.gov; werner.held@licr.unil.ch		Malchiodi, Emilio/0000-0001-7501-3330; Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; National Institutes of Health [AI47990]; Fogarty International Center [TW007972]; FOGARTY INTERNATIONAL CENTER [R03TW007972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by grants from the Swiss National Science Foundation and Oncosuisse to W.H. and by the National Institutes of Health (AI47990 to R.A.M.). E.L.M. is supported by the Fogarty International Center (TW007972). We are grateful to P. Guillaume (Ludwig Institute) for tetramers, F. Levy (Ludwig Institute) for MHC-I Abs, S.K. Anderson (National Cancer Institute) and A.P. Makrigiannis (Clinical Research Institute of Montreal) for Ly49L cDNA, and Howard Robinson (Brookhaven National Synchrotron Light Source) for X-ray data collection.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Back J, 2007, P NATL ACAD SCI USA, V104, P3978, DOI 10.1073/pnas.0607418104; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Dam J, 2006, J MOL BIOL, V362, P102, DOI 10.1016/j.jmb.2006.07.005; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Deng L, 2006, SEMIN IMMUNOL, V18, P159, DOI 10.1016/j.smim.2006.03.004; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Treanor B, 2006, J CELL BIOL, V174, P153, DOI 10.1083/jcb.200601108; Velikovsky CA, 2007, IMMUNITY, V27, P572, DOI 10.1016/j.immuni.2007.08.019	29	49	49	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					598	608		10.1016/j.immuni.2009.07.007	http://dx.doi.org/10.1016/j.immuni.2009.07.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19818651	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000271403900011
J	Fukushima, T; Zapata, JM; Singha, NC; Thomas, M; Kress, CL; Krajewska, M; Krajewski, S; Ronai, Z; Reed, JC; Matsuzawa, S				Fukushima, T; Zapata, JM; Singha, NC; Thomas, M; Kress, CL; Krajewska, M; Krajewski, S; Ronai, Z; Reed, JC; Matsuzawa, S			Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpoint	IMMUNITY			English	Article							T-CELL DEVELOPMENT; F-BOX PROTEIN; DNA-DAMAGE RESPONSE; C-MYB; V(D)J REARRANGEMENT; STRUCTURAL-ANALYSIS; TCF-I; P53; CYCLE; ACTIVATION	b-catenin has been implicated in thymocyte development because of its function as a coactivator of Tcf/LEF-family transcription factors. Previously, we discovered a novel pathway for p53-induced beta-catenin degradation through a ubiquitin E3 ligase complex involving Siah1, SIP (CacyBP), Skp1, and Ebi. To gain insights into the physiological relevance of this new degradation pathway in vivo, we generated mutant mice lacking SIP. We demonstrate here that SIP-/- thymocytes have an impaired pre-TCR checkpoint with failure of TCR beta gene rearrangement and increased apoptosis, resulting in reduced cellularity of the thymus. Moreover, the degradation of beta-catenin in response to DNA damage is significantly impaired in SIP-/- cells. SIP-/- embryonic fibroblasts show a growth-rate increase resulting from defects in G1 arrest. Thus, the beta-catenin degradation pathway mediated by SIP defines an essential checkpoint for thymocyte development and cell-cycle progression.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Matsuzawa, S (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	smatsuzawa@burnham.org	Zapata, Juan M/J-6304-2014	Zapata, Juan M/0000-0002-0110-0009; RONAI, ZEEV/0000-0002-3859-0400	NATIONAL CANCER INSTITUTE [R21CA107403, R01CA078419, P01CA069381, R01CA067329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067515] Funding Source: NIH RePORTER; NCI NIH HHS [CA67329, CA107403, CA078419, CA69381] Funding Source: Medline; NIDDK NIH HHS [DK067515] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bogue MA, 1996, GENE DEV, V10, P553, DOI 10.1101/gad.10.5.553; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 1996, BIOCHEM J, V320, P585, DOI 10.1042/bj3200585; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Frew IJ, 2004, J BIOL CHEM, V279, P29583, DOI 10.1074/jbc.M312755200; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Hall PA, 1997, CURR BIOL, V7, pR144, DOI 10.1016/S0960-9822(97)70074-5; HARPER JW, 1993, CELL, V75, P805; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Iwai A, 2004, ONCOGENE, V23, P7593, DOI 10.1038/sj.onc.1208016; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 2003, J BIOL CHEM, V278, P1837, DOI 10.1074/jbc.M210263200; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mulroy T, 2003, INT IMMUNOL, V15, P1485, DOI 10.1093/intimm/dxg146; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Reed JC, 2002, NAT STRUCT BIOL, V9, P8, DOI 10.1038/nsb0102-8; Reed JC, 1996, J CLIN INVEST, V97, P2403, DOI 10.1172/JCI118684; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu L, 2001, NAT IMMUNOL, V2, P823, DOI 10.1038/ni0901-823; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	58	49	50	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					29	39		10.1016/j.immuni.2005.12.002	http://dx.doi.org/10.1016/j.immuni.2005.12.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413921	Bronze			2022-12-18	WOS:000234850200008
J	Racanelli, V; Behrens, SE; Aliberti, J; Rehermann, B				Racanelli, V; Behrens, SE; Aliberti, J; Rehermann, B			Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8(+) T cells and antiviral immunity	IMMUNITY			English	Article							MHC CLASS-I; CHRONIC HEPATITIS-C; EXOGENOUS ANTIGEN; CROSS-PRESENTATION; VIRAL CLEARANCE; RESPONSES; VACCINE; IDENTIFICATION; ACTIVATION; MATURATION	A potential shortcoming of nonlive vaccines is their relative inefficiency in generating T cell responses, thus limiting their application in infections requiring cellular immunity. Here, we present a system to induce cellular immunity and to study the immunological implications of time-delayed dendritic cell (DC) apoptosis and antigen reprocessing in vivo. We generated a self-replicating cytopathic pestivirus RNA to enhance production and presentation of hepatitis C virus (HCV) antigens and to induce apoptosis in DC 24-48 hr after transfection. Replicon-transfected H-2(b) DCs used to immunize HLA-A2 transgenic mice induced protection upon challenge with a vaccinia virus expressing HCV antigens. Induction of cell death enhanced the immunogenicity of DC-associated antigen. Transfer of cellular material from vaccine DCs to endogenous antigen presenting cells was visualized in lymph nodes and spleen, and crossprimed CD8+ T cells were characterized. The findings are relevant for the rational design of vaccines against noncytopathic pathogens like HCV.	NIDDK, Liver Dis Sect, Digest Dis Branch, DHHS,NIH, Bethesda, MD 20892 USA; Univ Giessen, Inst Virol, D-35392 Giessen, Germany; NIAID, Immunobiol Sect, Parasit Dis Lab, DHHS,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Justus Liebig University Giessen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rehermann, B (corresponding author), NIDDK, Liver Dis Sect, Digest Dis Branch, DHHS,NIH, Bethesda, MD 20892 USA.	rehermann@nih.gov	Aliberti, Julio/G-4565-2012; Aliberti, Julio/I-7354-2013; Racanelli, Vito/J-8511-2018	Aliberti, Julio/0000-0003-3420-8478; Racanelli, Vito/0000-0002-8639-1940; Rehermann, Barbara/0000-0001-6832-9951	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054508, Z01DK054508] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARNABA V, 1990, NATURE, V345, P258, DOI 10.1038/345258a0; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Behrens SE, 1998, J VIROL, V72, P2364, DOI 10.1128/JVI.72.3.2364-2372.1998; Berd D, 2001, VACCINE, V19, P2565, DOI 10.1016/S0264-410X(00)00490-4; BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Drexler I, 2003, P NATL ACAD SCI USA, V100, P217, DOI 10.1073/pnas.262668999; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Grassmann CW, 2001, J VIROL, V75, P7791, DOI 10.1128/JVI.75.17.7791-7802.2001; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gurunathan S, 2000, CURR OPIN IMMUNOL, V12, P442, DOI 10.1016/S0952-7915(00)00118-7; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Khromykh AA, 2000, CURR OPIN MOL THER, V2, P555; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; MAJOR ME, 2001, FIELDS VIROLOGY, P1127; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Newberg MH, 1996, J IMMUNOL, V156, P2473; Okada N, 2001, CANCER RES, V61, P7913; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Ramirez MC, 2002, J IMMUNOL, V169, P6733, DOI 10.4049/jimmunol.169.12.6733; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; Saeboe-Larssen S, 2002, J IMMUNOL METHODS, V259, P191, DOI 10.1016/S0022-1759(01)00506-3; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tautz N, 1999, J VIROL, V73, P9422, DOI 10.1128/JVI.73.11.9422-9432.1999; Thiel H.J., 1996, FIELDS VIROLOGY, V1, P1059; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wedemeyer H, 2001, GASTROENTEROLOGY, V121, P1158, DOI 10.1053/gast.2001.29311; WISKERCHEN M, 1991, J VIROL, V65, P4508, DOI 10.1128/JVI.65.8.4508-4514.1991; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Ying H, 1999, NAT MED, V5, P823, DOI 10.1038/10548; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V	53	49	57	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					47	58		10.1016/S1074-7613(03)00353-4	http://dx.doi.org/10.1016/S1074-7613(03)00353-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738764	Bronze			2022-12-18	WOS:000221442200006
J	Natarajan, K; Boyd, LF; Schuck, P; Yokoyama, WM; Eilat, D; Margulies, DH				Natarajan, K; Boyd, LF; Schuck, P; Yokoyama, WM; Eilat, D; Margulies, DH			Interaction of the NK cell inhibitory receptor Ly49A with H-2D(d): Identification of a site distinct from the TCR site	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CLASS-I MHC; SURFACE-PLASMON RESONANCE; T-CELLS; LY-49A RECOGNIZES; ANTIGEN RECEPTOR; VIRAL PEPTIDE; COMPLEX; SPECIFICITY; BINDING	Natural killer cell function is controlled by interaction of NK receptors with MHC I molecules expressed on target cells. We describe the binding of bacterially expressed Ly49A, the prototype murine NK inhibitory receptor, to similarly engineered H-2D(d). Despite its homology to c-type lectins, Ly49A binds independently of carbohydrate and Ca2+ and shows specificity for MHC I but not bound peptide. The affinity of the Ly49A/H-2D(d) interaction as determined by surface plasmon resonance is from 6 to 26 mu M at 25 degrees C and is greater by ultracentrifugation at 4 degrees C. Biotinylated Ly49A stains H-2D(d)-expressing cells. Competition experiments indicate that the Ly49A and T cell receptor (TCR) binding sites on MHC I are distinct, suggesting complex regulation of cells that bear both TCR and NK cell receptors.	NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; NIH, Mol Interact Resource Bioengn & Phys Sci Program, Bethesda, MD 20892 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA; Hadassah Univ Hosp, Div Med, IL-91120 Jerusalem, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Howard Hughes Medical Institute; Washington University (WUSTL); Hebrew University of Jerusalem	Margulies, DH (corresponding author), NIAID, Mol Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Margulies, David/0000-0001-8530-7375	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000394, Z01AI000394] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [Z01OD010485] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andersen PS, 1999, IMMUNITY, V10, P473, DOI 10.1016/S1074-7613(00)80047-3; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1999, J IMMUNOL, V162, P305; Chang CS, 1996, EUR J IMMUNOL, V26, P3219, DOI 10.1002/eji.1830261256; Chang CS, 1998, J IMMUNOL, V160, P4367; Chung DH, 1999, J IMMUNOL, V163, P3699; Ciccone E, 1996, IMMUNOL TODAY, V17, P450, DOI 10.1016/0167-5699(96)30054-V; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fremont DH, 1996, CURR OPIN IMMUNOL, V8, P93, DOI 10.1016/S0952-7915(96)80111-7; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1994, J IMMUNOL, V153, P2407; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Karre K, 1985, MECHANISMS CYTOTOXIC, P81; KHILKO SN, 1993, J BIOL CHEM, V268, P15425; Kim J, 1997, J IMMUNOL, V159, P3875; KURUCZ I, 1993, P NATL ACAD SCI USA, V90, P3830, DOI 10.1073/pnas.90.9.3830; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Laue TM, 1992, ANAL ULTRACENTRIFUGA, P90, DOI [10.1007/s00249-009-0425-1, DOI 10.1007/S00249-009-0425-1]; Li HM, 1998, J MOL BIOL, V283, P179, DOI 10.1006/jmbi.1998.2091; Lian RH, 1998, J IMMUNOL, V161, P2301; Lian RH, 1999, J IMMUNOL, V162, P7271; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MacDonald HR, 1998, J EXP MED, V187, P2109, DOI 10.1084/jem.187.12.2109; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; MAndelboim O, 1996, SCIENCE, V274, P2097, DOI 10.1126/science.274.5295.2097; Margulies DH, 1996, CURR OPIN IMMUNOL, V8, P262, DOI 10.1016/S0952-7915(96)80066-5; Mason LH, 1998, J IMMUNOL, V160, P4148; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; Matsumoto N, 1998, IMMUNITY, V8, P245, DOI 10.1016/S1074-7613(00)80476-8; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; MORETTA A, 1984, EUR J IMMUNOL, V14, P121, DOI 10.1002/eji.1830140204; NAGASAWA R, 1987, J IMMUNOL, V138, P815; Orihuela M, 1996, P NATL ACAD SCI USA, V93, P11792, DOI 10.1073/pnas.93.21.11792; Ortaldo JR, 1998, J IMMUNOL, V160, P1158; PARHAM P, 1997, NK CELLS MHC CLASS 1; Plaksin D, 1997, J IMMUNOL, V158, P2218; ROLAND J, 1992, INT IMMUNOL, V4, P699, DOI 10.1093/intimm/4.6.699; SENTMAN CL, 1989, J EXP MED, V170, P191, DOI 10.1084/jem.170.1.191; Shields MJ, 1998, J IMMUNOL, V160, P2297; Smith KM, 1998, J IMMUNOL, V161, P7; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sugie T, 1996, J IMMUNOL, V157, P3925; Sundback J, 1998, J IMMUNOL, V160, P5971; Svedberg T, 1940, ULTRAZENTRIFUGE; TAKEI F, 1983, J IMMUNOL, V130, P2794; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; TORMO J, 1999, IN PRESS NATURE; Vales-Gomez M, 1998, IMMUNITY, V9, P337, DOI 10.1016/S1074-7613(00)80616-0; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; VALESGOMEZ M, 1998, IMMUNITY, V9, pB890; Valiante NM, 1996, CHEM IMMUNOL, V64, P146; Waldenstrom M, 1998, EUR J IMMUNOL, V28, P2872, DOI 10.1002/(SICI)1521-4141(199809)28:09<2872::AID-IMMU2872>3.0.CO;2-3; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Yokoyama WM, 1997, J EXP MED, V186, P1803, DOI 10.1084/jem.186.11.1803; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	75	49	49	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					591	601		10.1016/S1074-7613(00)80134-X	http://dx.doi.org/10.1016/S1074-7613(00)80134-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591184	Bronze			2022-12-18	WOS:000083952200011
J	Schaefer, BC; Ware, MF; Marrack, P; Fanger, GR; Kappler, JW; Johnson, GL; Monks, CRF				Schaefer, BC; Ware, MF; Marrack, P; Fanger, GR; Kappler, JW; Johnson, GL; Monks, CRF			Live cell fluorescence imaging of T cell MEKK2: Redistribution and activation in response to antigen stimulation of the T cell receptor	IMMUNITY			English	Article							PROTEIN-KINASE-C; MONOCLONAL-ANTIBODY; MAP KINASE; SIGNAL-TRANSDUCTION; DEPENDENT PATHWAY; INTEGRIN FUNCTION; PHOSPHORYLATION; LYMPHOCYTES; COMPLEX; RAF-1	T cell activation requires engagement of the T cell receptor (TCR) at the interface of conjugates formed with antigen-presenting cells, TCR engagement is accompanied by a redistribution of specific signaling molecules to the cytoplasmic region of the TCR complex. In this study, immunocytochemistry and live cell fluorescence imaging demonstrate that T cell MEK kinase 2 (MEKK2) is translocated to the T cell/antigen-presenting cell interface in response to antigen activation. MEKK2 translocation occurs more rapidly as the antigen concentration is increased. Biochemical activation of MEKK2 follows TCR stimulation, and expression of a dominant-negative MEKK2 inhibits TCR-mediated conjugate stabilization and ERK and p38 MAP kinase phosphorylation. Live cell fluorescence imaging thus enables characterization of signal transducers that are dynamically translocated following TCR engagement.	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Program Mol Signal Transduct, Div Basic Sci, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Mol Genet, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80220 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Schaefer, BC (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Schaefer, Brian C/0000-0001-8877-3507	NIAID NIH HHS [AI-18785, AI-17134, AI-22295] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017134, R01AI017134, R37AI018785, R01AI018785, P01AI022295] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; DAVIGNON D, 1981, J IMMUNOL, V127, P590; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Dumont FJ, 1998, J IMMUNOL, V160, P2579; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; GOLDE WT, 1986, CELL IMMUNOL, V103, P73, DOI 10.1016/0008-8749(86)90069-9; GUPTA S, 1994, J BIOL CHEM, V269, P17349; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; IZQUIERDO M, 1994, J EXP MED, V180, P401, DOI 10.1084/jem.180.1.401; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Mobley JL, 1996, J IMMUNOL, V156, P948; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; OTTEN GR, 1991, SCIENCE, V251, P1228, DOI 10.1126/science.1900952; OWAKI H, 1993, EMBO J, V12, P4367, DOI 10.1002/j.1460-2075.1993.tb06121.x; PARDI R, 1992, J CELL BIOL, V116, P1211, DOI 10.1083/jcb.116.5.1211; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Salmon RA, 1997, J IMMUNOL, V159, P5309; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Shi J, 1997, J IMMUNOL, V158, P4688; Shimizu Y, 1996, IMMUNOL TODAY, V17, P565, DOI 10.1016/S0167-5699(96)10061-X; SIEGEL JN, 1990, J BIOL CHEM, V265, P18472; SIEGEL JN, 1993, J IMMUNOL, V151, P4116; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; TROWBRIDGE IS, 1981, J EXP MED, V154, P1517, DOI 10.1084/jem.154.5.1517; Vignali DAA, 1999, J IMMUNOL, V162, P1431; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	47	49	49	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1999	11	4					411	421		10.1016/S1074-7613(00)80116-8	http://dx.doi.org/10.1016/S1074-7613(00)80116-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549623	Bronze			2022-12-18	WOS:000083343100003
J	OShea, CC; Thornell, AP; Rosewell, IR; Hayes, B; Owen, MJ				OShea, CC; Thornell, AP; Rosewell, IR; Hayes, B; Owen, MJ			Exit of the pre-TCR from the ER/cis-Golgi is necessary for signaling differentiation, proliferation, and allelic exclusion in immature thymocytes	IMMUNITY			English	Article							T-CELL-RECEPTOR; SURROGATE LIGHT-CHAIN; ENDOPLASMIC-RETICULUM; ANTIGEN RECEPTOR; BETA-CHAIN; ALPHA-BETA; GENE REARRANGEMENT; MICE LACKING; TRANSGENIC MICE; CD3 COMPONENTS	A major issue is whether surface expression of the pre-TCR is necessary for signaling the development of immature thymocytes. To address this question, we generated transgenic mice expressing a TCR beta chain that had a strong endoplasmic reticulum (ER) retrieval signal (TCR beta(ER)) and that was expressed intracellularly but failed to reach the cell surface. In TCR beta(ER) transgenic mice, there was a failure of allelic exclusion. Also, the transgene failed to rescue the developmental defects observed in TCR beta-null mice. In contrast, TCR beta transgenes with a mutant ER retrieval sequence or lacking this sequence signaled efficient allelic exclusion and suppressed the TCR beta(-/-) defect. These data show that exit of the pre-TCR from the ER/cis-Golgi is required for progression through the double-negative thymocyte checkpoint.	IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; GLAXO WELLCOME MED RES CTR,MOL PATHOL UNIT,STEVENAGE SG1 2NY,HERTS,ENGLAND	Cancer Research UK; GlaxoSmithKline								ALARCON B, 1988, J BIOL CHEM, V263, P2953; BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; Borst J, 1996, CURR OPIN IMMUNOL, V8, P181, DOI 10.1016/S0952-7915(96)80056-2; Brouns GS, 1996, J BIOL CHEM, V271, P19272, DOI 10.1074/jbc.271.32.19272; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGMAN J, 1989, J EXP MED, V169, P1911, DOI 10.1084/jem.169.6.1911; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; HUANG SS, 1988, J BIOL CHEM, V263, P12608; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Jacobs H, 1996, J EXP MED, V184, P1833, DOI 10.1084/jem.184.5.1833; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KRIMPENFORT P, 1989, NATURE, V341, P742, DOI 10.1038/341742a0; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEE BA, 1992, J CELL BIOL, V118, P1057, DOI 10.1083/jcb.118.5.1057; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MAGUIRE JE, 1990, FASEB J, V4, P3131, DOI 10.1096/fasebj.4.13.1698681; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; MASON WT, 1993, FLUORESCENT LUMINESC, P161; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P491; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; PAABO S, 1986, EMBO J, V5, P1921, DOI 10.1002/j.1460-2075.1986.tb04445.x; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SPARKOWSKI J, 1995, EMBO J, V14, P3055, DOI 10.1002/j.1460-2075.1995.tb07308.x; Terhorst Cox, 1995, P369; VINEY JL, 1993, INT IMMUNOL, V5, P1541, DOI 10.1093/intimm/5.12.1541; VINEY JL, 1992, HYBRIDOMA, V11, P701, DOI 10.1089/hyb.1992.11.701; vonBoehmer H, 1995, ANN NY ACAD SCI, V766, P52, DOI 10.1111/j.1749-6632.1995.tb26648.x; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WIEST DL, 1994, J EXP MED, V180, P1375, DOI 10.1084/jem.180.4.1375; WILSON A, 1995, INT IMMUNOL, V7, P1659, DOI 10.1093/intimm/7.10.1659; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; Xu Y, 1996, P NATL ACAD SCI USA, V93, P2169, DOI 10.1073/pnas.93.5.2169	56	49	49	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					591	599		10.1016/S1074-7613(00)80380-5	http://dx.doi.org/10.1016/S1074-7613(00)80380-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390683	Bronze			2022-12-18	WOS:A1997YH55400002
J	Gong, Q; White, L; Johnson, R; White, M; Negishi, I; Thomas, M; Chan, AC				Gong, Q; White, L; Johnson, R; White, M; Negishi, I; Thomas, M; Chan, AC			Restoration of thymocyte development and function in zap-70(-/-) mice by the syk protein tyrosine kinase	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; DELTA-T-CELLS; LYMPHOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; PHOSPHATASE CD45; ACTIVATION; SELECTION; LACKING; LCK	The Syk family of protein tyrosine kinases, consisting of ZAP-70 and Syk, associate with the pre- and alpha beta T cell antigen receptors (TCRs) and undergo tyrosine phosphorylation and activation following receptor engagement. Thymocyte development in zap-70(-/-) mice is blocked at the CD4(+)CD8(+)TCR(lo) stage. The presence of Syk in the thymus has raised the possibility that Syk may be able to mediate TCR function. To determine if Syk can play a role in thymocyte development, we generated zap-70(-/-) mice expressing a human syk cDNA. Syk expression restored both thymocyte development and function. In addition, Syk function required the CD45 transmembrane protein tyrosine phosphatase. Hence, ZAP-70 and Syk can play overlapping functions and exhibit similar regulatory mechanisms in mediating alpha beta T cell development.	WASHINGTON UNIV, SCH MED, CTR IMMUNOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, DIV RHEUMATOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA; NIPPON ROCHE RES CTR, KAMAKURA, KANAGAWA 247, JAPAN	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Roche Holding					NATIONAL CANCER INSTITUTE [R01CA071516] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA71516] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Benatar T, 1996, J EXP MED, V183, P329, DOI 10.1084/jem.183.1.329; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; CHENG AM, 1997, IN PRESS P NATL ACAD; CHENG AM, 1997, IN PRESS CURR OPIN I; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; COSTA TE, 1992, J EXP MED, V175, P1669, DOI 10.1084/jem.175.6.1669; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Fujise S, 1996, J IMMUNOL, V157, P247; GELFAND EW, 1995, J EXP MED, V182, P1057, DOI 10.1084/jem.182.4.1057; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KONG GH, 1995, IMMUNITY, V2, P485, DOI 10.1016/1074-7613(95)90029-2; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; LAW CL, 1994, J BIOL CHEM, V269, P12310; LoGrasso PV, 1996, P NATL ACAD SCI USA, V93, P12165, DOI 10.1073/pnas.93.22.12165; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Malissen B, 1996, CURR OPIN IMMUNOL, V8, P383, DOI 10.1016/S0952-7915(96)80129-4; MallickWood CA, 1996, P NATL ACAD SCI USA, V93, P9704, DOI 10.1073/pnas.93.18.9704; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Page ST, 1997, EUR J IMMUNOL, V27, P554, DOI 10.1002/eji.1830270229; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TESTI R, 1989, J IMMUNOL, V142, P1854; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; VONBOEHMER H, 1992, BONE MARROW TRANSPL, V9, P46; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2	56	49	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1997	7	3					369	377		10.1016/S1074-7613(00)80358-1	http://dx.doi.org/10.1016/S1074-7613(00)80358-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324357	Bronze			2022-12-18	WOS:A1997XY83000006
J	HOWCROFT, TK; PALMER, LA; BROWN, J; RELLAHAN, B; KASHANCHI, F; BRADY, JN; SINGER, DS				HOWCROFT, TK; PALMER, LA; BROWN, J; RELLAHAN, B; KASHANCHI, F; BRADY, JN; SINGER, DS			HIV TAT REPRESSES TRANSCRIPTION THROUGH SP1-LIKE ELEMENTS IN THE BASAL PROMOTER	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECEPTOR GENE-EXPRESSION; BOX-BINDING-PROTEINS; MDR1 PROMOTER; CELLS; SP1; TYPE-1; SEQUENCE; ACTIVATION; INITIATOR	MHC class I genes are potently repressed by HIV Tat, which transactivates the HIV LTR. Tat represses class I transcription by binding to complexes associated with a novel promoter element, consisting of Sp1-like DNA binding sites. Transcription by other Sp1-dependent promoters, such as MDR1 and the minimal SV40 promoters, is also repressed by Tat, whereas the human p-actin promoter is neither activated by Sp1 nor repressed by Tat. Tat repression can be overcome by a strong enhancer element. Thus, the SV40 72 bp enhancer element confers protection from Tat-mediated repression on both the minimal SV40 promoter and the class I promoter. Surprisingly, Tat can activate the class I promoter in the presence of both the HIV TAR element and a strong upstream enhancer. These data demonstrate that Tat differentially affects Sp1-responsive promoters, depending on promoter architecture.	NCI,IMMUNIE CELL BIOL LAB,BIOL RESPONSE MODIFIERS PROGRAM,BETHESDA,MD 20892; NCI,MOLEC VIROL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	HOWCROFT, TK (corresponding author), NCI,EXPTL IMMUNOL BRANCH,BLDG 10,ROOM 4B-17,BETHESDA,MD 20892, USA.							AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; BAYSAL E, 1994, ACTA HAEMATOL-BASEL, V91, P16; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; CHOWDHURY M, 1993, ONCOGENE, V8, P887; COHEN D, 1994, DNA CELL BIOL, V13, P641, DOI 10.1089/dna.1994.13.641; Coleman Timothy A., 1992, Gene Expression, V2, P175; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; CULLEN BR, 1991, FASEB J, V5, P2361, DOI 10.1096/fasebj.5.10.1712325; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219; CUPP C, 1993, ONCOGENE, V8, P2231; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EHRLICH R, 1988, MOL CELL BIOL, V8, P695, DOI 10.1128/MCB.8.2.695; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1992, IMMUNOL REV, V127, P147, DOI 10.1111/j.1600-065X.1992.tb01412.x; ESPESETH AS, 1989, GENE DEV, V3, P1647, DOI 10.1101/gad.3.11.1647; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; GERMINO J, 1995, P NATL ACAD SCI USA, V81, P4692; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HASELTINE WA, 1991, FASEB J, V5, P2349, DOI 10.1096/fasebj.5.10.1829694; HILL A, 1995, P NATL ACAD SCI USA, V92, P341, DOI 10.1073/pnas.92.2.341; HO N, 1991, AIDS RES HUM RETROV, V7, P689; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; KATO H, 1992, GENE DEV, V6, P655, DOI 10.1101/gad.6.4.655; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KOUP RA, 1994, J EXP MED, V180, P779, DOI 10.1084/jem.180.3.779; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; MASOOD R, 1994, BIOCHEM BIOPH RES CO, V202, P374, DOI 10.1006/bbrc.1994.1938; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; POCSIK E, 1992, LYMPHOKINE CYTOK RES, V11, P317; PURVIS SF, 1992, CELL IMMUNOL, V144, P32, DOI 10.1016/0008-8749(92)90223-C; RELLAHAN BL, 1994, J EXP MED, V180, P1529, DOI 10.1084/jem.180.4.1529; SASTRY KJ, 1990, J BIOL CHEM, V265, P20091; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; TADA H, 1990, P NATL ACAD SCI USA, V87, P3479, DOI 10.1073/pnas.87.9.3479; TAYLOR JP, 1992, EMBO J, V11, P3395, DOI 10.1002/j.1460-2075.1992.tb05418.x; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; VAISHNAV YN, 1991, ANNU REV BIOCHEM, V60, P577, DOI 10.1146/annurev.bi.60.070191.003045; VANGROENIGEN M, 1993, BIOCHIM BIOPHYS ACTA, V1172, P138, DOI 10.1016/0167-4781(93)90280-Q; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; WEISSMAN JD, 1991, MOL CELL BIOL, V11, P4217, DOI 10.1128/MCB.11.8.4217; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; YU CY, 1991, J BIOL CHEM, V266, P8907	65	49	49	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					127	138						12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621073				2022-12-18	WOS:A1995RK86800014
J	WALSERKUNTZ, DR; WEYAND, CM; WEAVER, AJ; OFALLON, WM; GORONZY, JJ				WALSERKUNTZ, DR; WEYAND, CM; WEAVER, AJ; OFALLON, WM; GORONZY, JJ			MECHANISMS UNDERLYING THE FORMATION OF THE T-CELL RECEPTOR REPERTOIRE IN RHEUMATOID-ARTHRITIS	IMMUNITY			English	Article							MHC CLASS-II; MONOZYGOTIC TWINS; REGION GENES; CONSTANT-REGION; BETA-CHAIN; LYMPHOCYTES; SUBSETS; THYMUS; RECOMBINATION; ORGANIZATION	The contributions of germline-encoded T cell receptor segments and of HLA-DR polymorphisms in shaping the repertoire of human CD4(+) CD45RO(-) T cells were investigated In healthy unrelated individuals and in patients with rheumatoid arthritis, an HLA-DRB1(*)04-associated disease. By comparing frequencies of V beta-J beta combinations, healthy individuals segregated into independent clusters, which strongly correlated with the HLA-DRB1 allele expression. The repertoire fingerprint imposed by the HLA-DRB1 alleles involved only a selected group of J beta elements, whereas the distribution of the other J beta segments was HLA independent. The HLA-restricted J beta elements are characterized by a Gly-Pro-Gly sequence within the conserved Phe-Gly-X-Gly motif, which induces rigidity in an otherwise more flexible protein backbone. The T cell receptor repertoire distinguished patients with RA from healthy HLA-DR-matched individuals, suggesting that patients share a selection mechanism that significantly distorts the composition of the T cell receptor repertoire.	MAYO CLIN & MAYO FDN,DEPT MED,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,DIV RHEUMATOL,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic	WALSERKUNTZ, DR (corresponding author), MAYO CLIN & MAYO FDN,DEPT IMMUNOL,200 1ST ST SW,ROCHESTER,MN 55905, USA.		Weyand, Cornelia/AAH-3343-2021	Goronzy, Jorg/0000-0001-7670-1856	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527, R01AR041974] Funding Source: NIH RePORTER; NIAMS NIH HHS [R0I AR42527, R0I AR41974] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKBAR AN, 1988, J IMMUNOL, V140, P2171; ALBANI S, 1992, RHEUM DIS CLIN N AM, V18, P729; ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; ANDERBERG MR, 1973, CLUSTER ANAL APPLICA; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V35, P764; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; DAVEY MP, 1994, J IMMUNOL, V152, P315; GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GORONZY JJ, 1994, J CLIN INVEST, V94, P2068, DOI 10.1172/JCI117561; GULWANIAKOLKAR B, 1991, J EXP MED, V174, P1139, DOI 10.1084/jem.174.5.1139; HAWES GE, 1993, J IMMUNOL, V150, P2033; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; KISLELOW P, 1988, NATURE, V335, P730; KOHSAKA H, 1993, ARTHRITIS RHEUM, V36, P213, DOI 10.1002/art.1780360212; KOHSAKA H, 1993, EUR J IMMUNOL, V23, P1895, DOI 10.1002/eji.1830230825; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; MALHOTRA U, 1992, J IMMUNOL, V149, P1802; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; OKUMURA M, 1993, J IMMUNOL, V150, P429; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; SALMON M, 1992, Current Opinion in Rheumatology, V4, P342, DOI 10.1097/00002281-199206000-00011; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; TOYONAGA B, 1985, P NATL ACAD SCI USA, V82, P8624, DOI 10.1073/pnas.82.24.8624; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; WINCHESTER R, 1994, ADV IMMUNOL, V56, P389, DOI 10.1016/S0065-2776(08)60456-3	40	49	51	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					597	605		10.1016/1074-7613(95)90004-7	http://dx.doi.org/10.1016/1074-7613(95)90004-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796293	Bronze			2022-12-18	WOS:A1995RE53800005
J	van der Poll, T; Shankar-Hari, M; Wiersinga, WJ				van der Poll, Tom; Shankar-Hari, Manu; Wiersinga, W. Joost			The immunology of sepsis	IMMUNITY			English	Review							NEUTROPHIL EXTRACELLULAR TRAPS; INTERNATIONAL CONSENSUS DEFINITIONS; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; INNATE IMMUNITY; GUT MICROBIOTA; INTESTINAL MICROBIOTA; INFLAMMASOME ACTIVATION; BACTERIAL-INFECTION; CELL-DEATH	Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection. This recently implemented definition does not capture the heterogeneity or the underlying pathophysiology of the syndrome, which is characterized by concurrent unbalanced hyperinflammation and immune suppression. Here, we review current knowledge of aberrant immune responses during sepsis and recent initiatives to stratify patients with sepsis into subgroups that are more alike from a clinical and/or pathobiological perspective, which could be key for identification of patients who are more likely to benefit from specific immune interventions.	[van der Poll, Tom; Wiersinga, W. Joost] Univ Amsterdam, Ctr Expt & Mol Med, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands; [van der Poll, Tom; Wiersinga, W. Joost] Amsterdam Inst Infect & Immun, Div Infect Dis, Amsterdam, Netherlands; [Shankar-Hari, Manu] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England; [Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, Dept Intens Care Med, London, England	University of Amsterdam; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	van der Poll, T (corresponding author), Univ Amsterdam, Ctr Expt & Mol Med, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands.; van der Poll, T (corresponding author), Amsterdam Inst Infect & Immun, Div Infect Dis, Amsterdam, Netherlands.	t.vanderpoll@amsterdamumc.nl	Shankar-Hari, Manu/I-6948-2012	Shankar-Hari, Manu/0000-0002-5338-2538	Netherlands Organization for Scientific Research (VIDI grant) [91716475]; EU-project Immuno-Sep [847422]; National Institute for Health Research Clinician Scientist Award [NIHR-CS-2016-16-011]	Netherlands Organization for Scientific Research (VIDI grant); EU-project Immuno-Sep; National Institute for Health Research Clinician Scientist Award	We would like to thank Maartje Kunen for preparing the figures. W.J.W. is sup-ported by the Netherlands Organization for Scientific Research (VIDI grant 91716475) . W.J.W. and T.v.d.P. receive funding from the EU-project Immuno-Sep (847422) . M.S.-H. is supported by the National Institute for Health Research Clinician Scientist Award (NIHR-CS-2016-16-011) . The views ex-pressed in this publication are those of the author (s) and not necessarily those of the NHS, the UK National Institute for Health Research, or the Department of Health.	Abraham E, 2016, JAMA-J AM MED ASSOC, V315, P757, DOI 10.1001/jama.2016.0290; Abrams ST, 2019, AM J RESP CRIT CARE, V200, P869, DOI 10.1164/rccm.201811-2111OC; Adelman MW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02989-1; Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Alberelli MA, 2014, VASC PHARMACOL, V62, P72, DOI 10.1016/j.vph.2014.06.001; Aneja RK, 2008, J LEUKOCYTE BIOL, V84, P1326, DOI 10.1189/jlb.0108030; Antcliffe DB, 2019, AM J RESP CRIT CARE, V199, P980, DOI 10.1164/rccm.201807-1419OC; Austermann J, 2014, CELL REP, V9, P2112, DOI 10.1016/j.celrep.2014.11.020; Baggs J, 2018, CLIN INFECT DIS, V66, P1004, DOI 10.1093/cid/cix947; Bhavani SV, 2019, AM J RESP CRIT CARE, V200, P327, DOI 10.1164/rccm.201806-1197OC; Bijlsma MF, 2017, NAT REV GASTRO HEPAT, V14, P333, DOI 10.1038/nrgastro.2017.33; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burnham KL, 2017, AM J RESP CRIT CARE, V196, P328, DOI 10.1164/rccm.201608-1685OC; Cavaillon JM, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201810128; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chang K, 2014, CRIT CARE, V18, DOI 10.1186/cc13176; Chang KC, 2007, FASEB J, V21, P708, DOI 10.1096/fj.06-6805com; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Clarke TB, 2014, INFECT IMMUN, V82, P4596, DOI 10.1128/IAI.02212-14; Czaikoski PG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148142; Danahy DB, 2016, CRIT REV IMMUNOL, V36, P57, DOI 10.1615/CritRevImmunol.2016017098; Darden DB, 2021, J CLIN MED, V10, DOI 10.3390/jcm10081742; Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1; Davis FM, 2019, ARTERIOSCL THROM VAS, V39, P2353, DOI 10.1161/ATVBAHA.119.312754; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; Demaret J, 2015, J LEUKOCYTE BIOL, V98, P1081, DOI 10.1189/jlb.4A0415-168RR; DeMerle KM, 2021, CRIT CARE MED, V49, P748, DOI 10.1097/CCM.0000000000004842; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Dickson RP, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.113, 10.1038/nmicrobiol.2016.113]; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Doster RS, 2018, J INNATE IMMUN, V10, P3, DOI 10.1159/000480373; Dumas A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02656; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Evans L, 2021, INTENS CARE MED, V47, P1181, DOI 10.1007/s00134-021-06506-y; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Francois B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98960; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Funk DJ, 2009, CRIT CARE CLIN, V25, P83, DOI 10.1016/j.ccc.2008.12.003; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Gustave CA, 2018, J IMMUNOL, V200, P2418, DOI 10.4049/jimmunol.1700929; Haak BW, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.01148-20; Haak BW, 2017, LANCET GASTROENTEROL, V2, P135, DOI 10.1016/S2468-1253(16)30119-4; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hoogendijk AJ, 2019, HAEMATOLOGICA, V104, pE233, DOI 10.3324/haematol.2018.201913; Hoogendijk AJ, 2017, CRIT CARE MED, V45, pE524, DOI 10.1097/CCM.0000000000002294; Hotchkiss RS, 2019, INTENS CARE MED, V45, P1360, DOI 10.1007/s00134-019-05704-z; Hotchkiss RS, 2019, CRIT CARE MED, V47, P632, DOI 10.1097/CCM.0000000000003685; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Huang LF, 2010, CRIT CARE, V14, DOI 10.1186/cc8232; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Karakike E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00055; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Keragala CB, 2018, BRIT J HAEMATOL, V180, P782, DOI 10.1111/bjh.15062; Kerris EWJ, 2020, J INVEST MED, V68, P813, DOI 10.1136/jim-2019-001195; Kim S, 2017, IMMUNOL REV, V279, P90, DOI 10.1111/imr.12563; Krezalek MA, 2016, SHOCK, V45, P475, DOI 10.1097/SHK.0000000000000534; Kumar S, 2013, CRIT REV MICROBIOL, V39, P229, DOI 10.3109/1040841X.2012.706249; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Lankelma JM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005548; Lankelma JM, 2017, INTENS CARE MED, V43, P59, DOI 10.1007/s00134-016-4613-z; Leijte GP, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2830-x; Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Machado FR, 2017, LANCET INFECT DIS, V17, P1180, DOI 10.1016/S1473-3099(17)30322-5; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mathias B, 2017, ANN SURG, V265, P827, DOI 10.1097/SLA.0000000000001783; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; McDonald D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00199-16; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Meyer NJ, 2018, CRIT CARE MED, V46, P21, DOI 10.1097/CCM.0000000000002749; Monaghan SF, 2012, SHOCK, V38, P117, DOI 10.1097/SHK.0b013e31825de6a3; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphy K, 2017, JANEWAY'S IMMUNOBIOLOGY, 9TH EDITION, P1; Oami Takehiko, 2017, Crit Care Med, V45, pe77; Ong DSY, 2017, CLIN INFECT DIS, V64, P1204, DOI 10.1093/cid/cix120; Ost M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00037; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; Patera AC, 2016, J LEUKOCYTE BIOL, V100, P1239, DOI 10.1189/jlb.4HI0616-255R; Philippart F, 2012, CRIT CARE MED, V40, P2987, DOI 10.1097/CCM.0b013e31825b8d57; Pierrakos C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02993-5; Prescott HC, 2020, CURR OPIN CRIT CARE, V26, P500, DOI 10.1097/MCC.0000000000000761; Prescott HC, 2018, JAMA-J AM MED ASSOC, V319, P62, DOI 10.1001/jama.2017.17687; Prescott HC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2375; Prescott HC, 2015, AM J RESP CRIT CARE, V192, P581, DOI 10.1164/rccm.201503-0483OC; Prescott HC, 2015, JAMA-J AM MED ASSOC, V313, P1055, DOI 10.1001/jama.2015.1410; Presneill JJ, 2002, AM J RESP CRIT CARE, V166, P138, DOI 10.1164/rccm.2009005; Reddy K, 2020, LANCET RESP MED, V8, P631, DOI 10.1016/S2213-2600(20)30124-7; Reddy RC, 2001, INFECT IMMUN, V69, P1394, DOI 10.1128/IAI.69.3.1394-1401.2001; Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Riche F, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1934-4; Roquilly A, 2020, NAT IMMUNOL, V21, P636, DOI 10.1038/s41590-020-0673-x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rubio I, 2019, LANCET INFECT DIS, V19, pE422, DOI 10.1016/S1473-3099(19)30567-5; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schuijt TJ, 2016, GUT, V65, P575, DOI 10.1136/gutjnl-2015-309728; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Schuurman AR, 2021, INTENS CARE MED EXP, V9, DOI 10.1186/s40635-021-00383-x; Scicluna BP, 2017, LANCET RESP MED, V5, P816, DOI 10.1016/S2213-2600(17)30294-1; Sencio V, 2020, CELL REP, V30, P2934, DOI 10.1016/j.celrep.2020.02.013; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; Seymour CW, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1836-5; Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402; Shankar-Hari M, 2017, BRIT J ANAESTH, V119, P626, DOI 10.1093/bja/aex234; Shankar-Hari M, 2020, INTENS CARE MED, V46, P619, DOI 10.1007/s00134-019-05908-3; Shankar-Hari M, 2019, CURR OPIN CRIT CARE, V25, P489, DOI 10.1097/MCC.0000000000000641; Shankar-Hari M, 2017, CRIT CARE MED, V45, P875, DOI [10.1097/CCM.0000000000002380, 10.1097/ccm.0000000000002380]; Shankar-Hari M, 2016, CRIT CARE MED, V44, P2223, DOI 10.1097/CCM.0000000000001876; Shankar-Hari M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1276-7; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stanski NL, 2020, NAT REV NEPHROL, V16, P20, DOI 10.1038/s41581-019-0199-3; Sweeney TE, 2018, CRIT CARE MED, V46, P915, DOI 10.1097/CCM.0000000000003084; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Uhel F, 2017, AM J RESP CRIT CARE, V196, P315, DOI 10.1164/rccm.201606-1143OC; Vachharajani V, 2014, EXPERT REV CLIN IMMU, V10, P1141, DOI 10.1586/1744666X.2014.943192; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; van der Poll T, 2014, THROMB HAEMOSTASIS, V112, P640, DOI 10.1160/TH14-01-0053; VANDEUREN M, 1994, J INFECT DIS, V169, P157, DOI 10.1093/infdis/169.1.157; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Vigilante K, 2019, NEW ENGL J MED, V380, P1888, DOI 10.1056/NEJMp1815418; Vincent JL, 2019, JAMA-J AM MED ASSOC, V321, P1993, DOI 10.1001/jama.2019.5358; Wakeley ME, 2020, CRIT CARE CLIN, V36, P69, DOI 10.1016/j.ccc.2019.08.006; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang L, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602096; Watanabe E, 2020, SHOCK, V53, P686, DOI 10.1097/SHK.0000000000001443; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Wong HR, 2022, PEDIATR RES, V91, P283, DOI 10.1038/s41390-021-01620-5; Wong HCR, 2021, CRIT CARE MED, V49, pE98, DOI 10.1097/CCM.0000000000004709; Wong HR, 2015, AM J RESP CRIT CARE, V191, P309, DOI 10.1164/rccm.201410-1864OC; Wong HR, 2014, CRIT CARE MED, V42, P781, DOI 10.1097/CCM.0000000000000106; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Wu CQ, 2019, IMMUNITY, V50, P1401, DOI 10.1016/j.immuni.2019.04.003; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang XY, 2019, IMMUNITY, V51, P983, DOI 10.1016/j.immuni.2019.11.005; Yende S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8686; Zador Z, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2486-6; Zhang H, 2020, CELL HOST MICROBE, V27, P556, DOI 10.1016/j.chom.2020.02.004; Zhang ZH, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2279-3; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	172	48	48	50	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2450	2464		10.1016/j.immuni.2021.10.012	http://dx.doi.org/10.1016/j.immuni.2021.10.012		NOV 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34758337	Bronze			2022-12-18	WOS:000718366000006
J	Zeis, P; Lian, M; Fan, XY; Herman, JS; Hernandez, DC; Gentek, R; Elias, S; Symowski, C; Knopper, K; Peltokangas, N; Friedrich, C; Doucet-Ladeveze, R; Kabat, AM; Locksley, RM; Voehringer, D; Bajenoff, M; Rudensky, AY; Romagnani, C; Grun, D; Gasteiger, G				Zeis, Patrice; Lian, Mi; Fan, Xiying; Herman, Josip S.; Hernandez, Daniela C.; Gentek, Rebecca; Elias, Shlomo; Symowski, Cornelia; Knoepper, Konrad; Peltokangas, Nina; Friedrich, Christin; Doucet-Ladeveze, Remi; Kabat, Agnieszka M.; Locksley, Richard M.; Voehringer, David; Bajenoff, Marc; Rudensky, Alexander Y.; Romagnani, Chiara; Gruen, Dominic; Gasteiger, Georg			In Situ Maturation and Tissue Adaptation of Type 2 Innate Lymphoid Cell Progenitors	IMMUNITY			English	Article							TRANSCRIPTION FACTOR BCL11B; NK CELLS; LUNG; PROMOTES; IDENTITY; HETEROGENEITY; IMMUNITY; NICHE; LIVER; STEM	Innate lymphoid cells (ILCs) are generated early during ontogeny and persist predominantly as tissue-resident cells. Here, we examined how ILCs are maintained and renewed within tissues. We generated a single cell atlas of lung ILC2s and found that II8r1(+) ILCs comprise circulating and tissue-resident ILC progenitors (ILCP) and effector-cells with heterogeneous expression of the transcription factors Tcf7 and Zbtb16, and CD103. Our analyses revealed a continuous differentiation trajectory from II18r1(+) ST2 ILCPs to II18r1(-) ST2(+) ILC2s, which was experimentally validated. Upon helminth infection, recruited and BM-derived cells generated the entire spectrum of ILC2s in parabiotic and shield chimeric mice, consistent with their potential role in the renewal of tissue ILC2s. Our findings identify local ILCPs and reveal ILCP in situ differentiation and tissue adaptation as a mechanism of ILC maintenance and phenotypic diversification. Local niches, rather than progenitor origin, or the developmental window during ontogeny, may dominantly imprint ILC phenotypes in adult tissues.	[Zeis, Patrice; Herman, Josip S.; Peltokangas, Nina; Kabat, Agnieszka M.; Gruen, Dominic] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Lian, Mi; Knoepper, Konrad; Friedrich, Christin; Doucet-Ladeveze, Remi; Gasteiger, Georg] Julius Maximilians Univ Wurzburg, Max Planck Res Grp, Wurzburg Inst Syst Immunol, Wurzburg, Germany; [Zeis, Patrice; Herman, Josip S.] Int Max Planck Res Sch Mol & Cellular Biol IMPRS, Freiburg, Germany; [Zeis, Patrice; Lian, Mi; Herman, Josip S.; Peltokangas, Nina] Univ Freiburg, Fac Biol, Freiburg, Germany; [Lian, Mi; Friedrich, Christin; Gasteiger, Georg] Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Fan, Xiying; Elias, Shlomo; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Program Immunol, New York, NY 10021 USA; [Fan, Xiying; Elias, Shlomo; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA; [Gentek, Rebecca; Bajenoff, Marc] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Symowski, Cornelia; Voehringer, David] Univ Hosp Erlangen, Dept Infect Biol, Erlangen, Germany; [Symowski, Cornelia; Voehringer, David] Friedrich Alexander Univ Erlangen Nuremberg FAU, Erlangen, Germany; [Gruen, Dominic] Univ Freiburg, CIBSS Ctr Integrat Biol Signaling Studies, Freiburg, Germany; [Hernandez, Daniela C.; Romagnani, Chiara] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Berlin, Germany; [Hernandez, Daniela C.; Romagnani, Chiara] Charite Univ Med Berlin, Dept Med 1, Berlin, Germany; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Max Planck Society; Max Planck Society; University of Wurzburg; University of Freiburg; University of Freiburg; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Freiburg; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Grun, D (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.; Gasteiger, G (corresponding author), Julius Maximilians Univ Wurzburg, Max Planck Res Grp, Wurzburg Inst Syst Immunol, Wurzburg, Germany.; Gasteiger, G (corresponding author), Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany.; Grun, D (corresponding author), Univ Freiburg, CIBSS Ctr Integrat Biol Signaling Studies, Freiburg, Germany.	gruen@ie-freiburg.mpg.de; georg.gasteiger@uni-wuerzburg.de	Elias, Shlomo/ABF-9933-2021; Romagnani, Chiara/E-4708-2016	Romagnani, Chiara/0000-0002-5167-7463; Knopper, Konrad/0000-0003-2076-2160; Hernandez, Daniela/0000-0001-5960-160X; Fan, Xiying/0000-0003-3090-381X; Gasteiger, Georg/0000-0001-6986-127X; Zeis, Patrice/0000-0001-7615-2201	German Research Foundation (DFG) [GA2129/2-1, SPP1937, GR4980/1-1, RO3565/4-1, VO944/8-2]; European Research Council [647257-STROMA, 759176-TissueLymphoContexts, 818846-ImmuNiche]; DFG Emmy Noether programme [GA2129/1-1]; DFG [GR4980/3-1, GRK2344 MeInBio]; DFG under Germany's Excellence Strategy (CIBSS-EXC-2189) [390939984]; Behrens-Weise-Foundation; Max Planck Society	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); DFG Emmy Noether programme(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy (CIBSS-EXC-2189)(German Research Foundation (DFG)); Behrens-Weise-Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank A. Diefenbach, R. Golub, and W. Kastenm_uller for critically reading the manuscript and G.A. H_acker and T. Gogishvilli for their support. This work was supported by grants through the German Research Foundation (DFG) priority program SPP1937-Innate lymphoid cells (GA2129/2-1 to G.G., GR4980/1-1 to D.G., RO3565/4-1 to C.R., and VO944/8-2 to D.V.) and the European Research Council (647257-STROMA to M.B., 759176-TissueLymphoContexts to G.G., and 818846-ImmuNiche to D.G.). G.G. was further supported by the DFG Emmy Noether programme (GA2129/1-1). D.G. was further supported by the DFG (GR4980/3-1 and GRK2344 MeInBio), the DFG under Germany's Excellence Strategy (CIBSS-EXC-2189-Project 390939984), and by the Behrens-Weise-Foundation. G.G. and D.G. are supported by the Max Planck Society.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bando Jennifer K, 2015, Nat Immunol, V16, P153, DOI 10.1038/ni.3057; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Barletta KE, 2012, J IMMUNOL METHODS, V375, P100, DOI 10.1016/j.jim.2011.09.013; Bielecki P., 2018, BIORXIV, DOI [10.1101/461228, DOI 10.1101/461228]; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Motran CC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00664; Cuff AO, 2016, J IMMUNOL, V197, P4283, DOI 10.4049/jimmunol.1601424; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Ghaedi M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182293; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Harly C, 2019, NAT IMMUNOL, V20, P1150, DOI 10.1038/s41590-019-0445-7; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lun A., 2019, SINGLECELLEXPERIMENT; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mazzurana L, 2018, SEMIN IMMUNOPATHOL, V40, P407, DOI 10.1007/s00281-018-0688-7; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Nagasawa M, 2019, J EXP MED, V216, P1762, DOI 10.1084/jem.20190490; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Ng SS, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1003; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oherle K, 2020, IMMUNITY, V52, P275, DOI [10.1016/j.immuni.7020.01.005, 10.1016/j.immuni.2020.01.005]; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Sagar, 2018, METHODS MOL BIOL, V1766, P257, DOI 10.1007/978-1-4939-7768-0_15; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Silberstein L, 2016, CELL STEM CELL, V19, P530, DOI 10.1016/j.stem.2016.07.004; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Symowski C, 2019, EUR J IMMUNOL, V49, P1421, DOI 10.1002/eji.201948161; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Weiner J, 2017, TRANSPLANTATION, V101, P2449, DOI 10.1097/TP.0000000000001593; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yipp BG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8929; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318	67	48	48	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					775	+		10.1016/j.immuni.2020.09.002	http://dx.doi.org/10.1016/j.immuni.2020.09.002			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33002412	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000581062800011
J	Bartok, E; Hartmann, G				Bartok, Eva; Hartmann, Gunther			Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids	IMMUNITY			English	Review							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; CYCLIC GMP-AMP; PLASMACYTOID DENDRITIC CELLS; IRF3 TRANSCRIPTION FACTOR; INDUCIBLE GENE-I; NF-KAPPA-B; RIG-I; MESSENGER-RNA; ANTIVIRAL IMMUNITY	All lifeforms have developed highly sophisticated systems equipped to detect altered self and non-self nucleic acids (NA). In vertebrates, NA-sensing receptors safeguard the integrity of the organism by detecting pathogens, dyshomeostasis and damage, and inducing appropriate responses to eliminate pathogens and reconstitute homeostasis. Effector mechanisms include i) immune signaling, ii) restriction of NA functions such as inhibition of mRNA translation, and iii) cell death pathways. An appropriate effector response is necessary for host defense, but dysregulated NA-sensing can lead to devastating autoimmune and autoinflammatory disease, Their inherent biochemical similarity renders the reliable distinction between self NA under homeostatic conditions and altered or exogenous NA particularly challenging. In this review, we provide an overview of recent progress in our understanding of the closely coordinated and regulated network of innate immune receptors, restriction factors, and nucleases to effectively respond to pathogens and maintain host integrity.	[Bartok, Eva; Hartmann, Gunther] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Venusberg Campus 1, D-53127 Bonn, Germany	University of Bonn	Hartmann, G (corresponding author), Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Venusberg Campus 1, D-53127 Bonn, Germany.	gunther.hartmann@uni-bonn.de	Bartok, Eva/AAM-6274-2020; Hartmann, Gunther/P-7492-2017	Bartok, Eva/0000-0003-0556-1950; Hartmann, Gunther/0000-0003-1021-2018	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC2151-390873048]; DFG [TRR237, SFB670, GRK 2168]; German Center for Infection Research (DZIF)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); German Center for Infection Research (DZIF)	This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC2151-390873048 of which E.B. and G.H. are members. It was also supported by other grants of the DFG to E.B. and G.H., including TRR237, SFB670, and GRK 2168. G.H. is also supported by the German Center for Infection Research (DZIF).	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Ahn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21722; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alexopoulou L, 2012, M S-MED SCI, V28, P96, DOI 10.1051/medsci/2012281023; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Aly HH, 2016, J BIOL CHEM, V291, P15958, DOI 10.1074/jbc.M116.724641; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Asgarimehr M, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11091048; Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007; Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; Barak M, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1937-3; Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Baum R, 2017, ARTHRITIS RHEUMATOL, V69, P460, DOI 10.1002/art.39863; Bell RAV, 2017, CELL DEATH DIFFER, V24, P1359, DOI 10.1038/cdd.2017.37; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Berkhout B, 2018, CURR OPIN VIROL, V32, P9, DOI 10.1016/j.coviro.2018.07.008; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016; Brault M, 2018, J IMMUNOL, V200, P2748, DOI 10.4049/jimmunol.1701492; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burleigh K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba4219; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Chakrabarti A, 2015, CELL HOST MICROBE, V17, P466, DOI 10.1016/j.chom.2015.02.010; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Coch C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00371; Coch C, 2009, J LEUKOCYTE BIOL, V86, P663, DOI 10.1189/jlb.0509314; Cohen D, 2019, NATURE, V574, P691, DOI 10.1038/s41586-019-1605-5; COLBY C, 1969, P NATL ACAD SCI USA, V63, P160, DOI 10.1073/pnas.63.1.160; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Cushing L, 2017, J BIOL CHEM, V292, P18689, DOI 10.1074/jbc.M117.796912; da Costa LS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1579-0; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Davey GM, 2010, J IMMUNOL, V184, P2243, DOI 10.4049/jimmunol.0903013; de Marcken M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw1347; de Vasconcelos NM, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036392; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dimitrova DG, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020117; Diner BA, 2015, J BIOL CHEM, V290, P26412, DOI 10.1074/jbc.R115.652289; Diner BA, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145808; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; DREW HR, 1984, J MOL BIOL, V176, P535, DOI 10.1016/0022-2836(84)90176-1; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Eaglesham JB, 2019, NATURE, V566, P259, DOI 10.1038/s41586-019-0928-6; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Eigenbrod T, 2015, J IMMUNOL, V195, P411, DOI 10.4049/jimmunol.1500530; El Maadidi S, 2014, J IMMUNOL, V192, P1171, DOI 10.4049/jimmunol.1300842; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elliott D., 2017, MOL BIOL RNA; Loureiro M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007125; FARRELL PJ, 1978, P NATL ACAD SCI USA, V75, P5893, DOI 10.1073/pnas.75.12.5893; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ficarelli M, 2020, J VIROL, V94, DOI 10.1128/JVI.01337-19; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; Fontaine KA, 2018, MBIO, V9, DOI [10.1128/mBio.02126-18, 10.1128/mbio.02126-18]; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Franchi L, 2014, J IMMUNOL, V193, P4214, DOI 10.4049/jimmunol.1400582; Franklin BS, 2018, IMMUNOL REV, V281, P74, DOI 10.1111/imr.12611; Freund I., 2019, GENES, V10, pE92; Gaidt MM, 2018, METHODS MOL BIOL, V1714, P57, DOI 10.1007/978-1-4939-7519-8_4; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Gavin AL, 2018, NAT IMMUNOL, V19, P942, DOI 10.1038/s41590-018-0179-y; Gebhardt A, 2017, J INTERF CYTOK RES, V37, P184, DOI 10.1089/jir.2016.0092; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Gentili M, 2019, CELL REP, V26, P3474, DOI 10.1016/j.celrep.2019.03.049; George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goubau D, 2015, EUR J IMMUNOL, V45, P3386, DOI 10.1002/eji.201545794; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Gowen BB, 2007, J IMMUNOL, V178, P5200, DOI 10.4049/jimmunol.178.8.5200; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Green Michael R, 2020, Cold Spring Harb Protoc, V2020, P100750, DOI 10.1101/pdb.top100750; Greulich W, 2019, CELL, V179, P1264, DOI 10.1016/j.cell.2019.11.001; Grieves JL, 2015, P NATL ACAD SCI USA, V112, P5117, DOI 10.1073/pnas.1423804112; Gringhuis SI, 2017, NAT IMMUNOL, V18, P225, DOI 10.1038/ni.3647; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hagmann CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062872; Hampton HG, 2020, NATURE, V577, P327, DOI 10.1038/s41586-019-1894-8; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartmann BM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02035-9; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hartmann G, 2017, ADV IMMUNOL, V133, P121, DOI 10.1016/bs.ai.2016.11.001; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; HEFTI E, 1976, J VIROL, V17, P149, DOI 10.1128/JVI.17.1.149-159.1976; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heinz LX, 2020, NATURE, V581, P316, DOI 10.1038/s41586-020-2282-0; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; Herzner AM, 2015, NAT IMMUNOL, V16, P1025, DOI 10.1038/ni.3267; Hia FB, 2019, EMBO REP, V20, DOI 10.15252/embr.201948220; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; HILLEMAN MR, 1970, J INFECT DIS, V121, P196, DOI 10.1093/infdis/121.2.196; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Ishida H, 2018, FEBS LETT, V592, P2636, DOI 10.1002/1873-3468.13176; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ito J, 2020, P NATL ACAD SCI USA, V117, P610, DOI 10.1073/pnas.1914183116; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jakobs C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131702; Jiang H, 2019, EMBO J, V38, DOI 10.15252/embj.2019102718; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jonsson KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14391; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Junt T, 2015, NAT REV IMMUNOL, V15, P529, DOI 10.1038/nri3875; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kaneda Y, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23566; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kruger A, 2015, EMBO REP, V16, P1656, DOI 10.15252/embr.201540861; Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321; Kumar S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.122; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2018, CELL, V175, P488, DOI 10.1016/j.cell.2018.08.062; Lee SMY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00516; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; Li MH, 2019, NAT MICROBIOL, V4, P985, DOI 10.1038/s41564-019-0375-z; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li XD, 2012, ELIFE, V1, DOI 10.7554/eLife.00102; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Lian H, 2018, IMMUNITY, V49, P438, DOI 10.1016/j.immuni.2018.08.014; Lian H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05559-w; Lim HK, 2019, J EXP MED, V216, P2038, DOI 10.1084/jem.20181621; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu J, 2020, J MICROBIOL, V58, P153, DOI 10.1007/s12275-020-9289-y; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu ZS, 2019, NAT IMMUNOL, V20, P18, DOI 10.1038/s41590-018-0262-4; Lo Cigno I, 2015, J VIROL, V89, P7506, DOI 10.1128/JVI.00013-15; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu HL, 2012, CLIN CANCER RES, V18, P499, DOI 10.1158/1078-0432.CCR-11-1625; Lu L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01012; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Maelfait J, 2020, J MOL BIOL, V432, P552, DOI 10.1016/j.jmb.2019.11.016; Maelfait J, 2017, EMBO J, V36, P2529, DOI 10.15252/embj.201796476; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Maillard PV, 2016, EMBO J, V35, P2505, DOI 10.15252/embj.201695086; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210; Malireddi RKS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00406; Maltez VI, 2016, J IMMUNOL, V196, P956, DOI 10.4049/jimmunol.1502060; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Massa D, 2020, J BIOL CHEM, V295, P4438, DOI 10.1074/jbc.RA119.011400; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsushima-Miyagi T, 2012, CLIN CANCER RES, V18, P6271, DOI 10.1158/1078-0432.CCR-12-1595; Matyszewski M, 2018, P NATL ACAD SCI USA, V115, pE1963, DOI 10.1073/pnas.1712860115; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Merkl PE, 2019, MBIO, V10, DOI 10.1128/mBio.02621-18; Meunier E, 2016, CELL MICROBIOL, V18, P168, DOI 10.1111/cmi.12546; Michelson A M, 1967, Prog Nucleic Acid Res Mol Biol, V6, P83; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Molleston JM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010002; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Moy RH, 2014, CELL, V158, P764, DOI 10.1016/j.cell.2014.06.023; Ng CS, 2020, CELL DEATH DIFFER, V27, P2363, DOI 10.1038/s41418-020-0509-0; Nguyen TA, 2017, IMMUNITY, V47, P498, DOI 10.1016/j.immuni.2017.08.007; Ning XH, 2019, MOL CELL, V74, P19, DOI 10.1016/j.molcel.2019.02.013; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Ohto U, 2018, IMMUNITY, V48, P649, DOI 10.1016/j.immuni.2018.03.013; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200; Oshiumi H, 2011, J IMMUNOL, V187, P5320, DOI 10.4049/jimmunol.1101503; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Ostendorf T, 2020, IMMUNITY, V52, P591, DOI 10.1016/j.immuni.2020.03.009; Pajak A, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008240; Pattabhi S, 2019, J INTERF CYTOK RES, V39, P331, DOI 10.1089/jir.2018.0163; Pawaria S, 2015, J IMMUNOL, V194, P1403, DOI 10.4049/jimmunol.1402893; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pohar J, 2017, J IMMUNOL, V198, P2093, DOI 10.4049/jimmunol.1600757; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Ren XM, 2019, CELL REP, V26, P2019, DOI 10.1016/j.celrep.2019.01.107; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Roth S, 2014, NAT IMMUNOL, V15, P538, DOI 10.1038/ni.2888; Samuel CE, 2019, J BIOL CHEM, V294, P1710, DOI 10.1074/jbc.TM118.004166; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Sato R, 2018, NAT IMMUNOL, V19, P1071, DOI 10.1038/s41590-018-0203-2; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmid M, 2014, J VIROL, V88, P1404, DOI 10.1128/JVI.02046-13; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schmitt FCF, 2017, RNA, V23, P1344, DOI 10.1261/rna.061952.117; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Sears N, 2011, J BIOL CHEM, V286, P33037, DOI 10.1074/jbc.M111.257022; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen C, 2019, P NATL ACAD SCI USA, V116, P2052, DOI 10.1073/pnas.1817221116; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Shibata T, 2016, INT IMMUNOL, V28, P211, DOI 10.1093/intimm/dxv062; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Singh VV, 2013, J VIROL, V87, P4417, DOI 10.1128/JVI.03282-12; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Song W, 2015, NAT STRUCT MOL BIOL, V22, P782, DOI 10.1038/nsmb.3080; Spackova N, 2018, GENES-BASEL, V9, DOI 10.3390/genes9070324; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stricker RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003796; Su SC, 2018, CELL, V175, P442, DOI 10.1016/j.cell.2018.09.007; Sugimoto N, 2014, P NATL ACAD SCI USA, V111, P7747, DOI 10.1073/pnas.1400139111; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takahashi T, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100511; Takahashi T, 2018, NUCLEIC ACIDS RES, V46, P9134, DOI 10.1093/nar/gky575; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van der Veen AG, 2018, EMBO J, V37, DOI 10.15252/embj.201797479; Volkman HE, 2019, ELIFE, V8, DOI 10.7554/eLife.47491; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Watanabe A, 2011, J BIOL CHEM, V286, P10702, DOI 10.1074/jbc.M110.185793; Weber C, 2012, IMMUNOLOGY, V136, P64, DOI 10.1111/j.1365-2567.2012.03559.x; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wienert B, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005840; Williams G.D., 2020, MSPHERE, V5, P907; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yang SG, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7999; Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111; Ye L, 2019, NAT REV IMMUNOL, V19, P614, DOI 10.1038/s41577-019-0182-z; Yi GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077846; Yi YS, 2018, EBIOMEDICINE, V29, P78, DOI 10.1016/j.ebiom.2018.02.012; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoo J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004544; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011; Zheng M, 2020, CELL, V181, P674, DOI 10.1016/j.cell.2020.03.040; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhu QY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006886; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967; ZILBERSTEIN A, 1978, P NATL ACAD SCI USA, V75, P4734, DOI 10.1073/pnas.75.10.4734; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	329	48	48	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					54	77		10.1016/j.immuni.2020.06.014	http://dx.doi.org/10.1016/j.immuni.2020.06.014			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668228	Bronze, Green Published			2022-12-18	WOS:000551116800010
J	Liu, GQ; Gack, MU				Liu, GuanQun; Gack, Michaela U.			Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity	IMMUNITY			English	Review							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; RIG-I ACTIVATION; INDUCIBLE GENE-I; NUCLEIC-ACID; VIRAL-RNA; ANTIVIRAL RESPONSES	Faithful maintenance of immune homeostasis relies on the capacity of the cellular immune surveillance machinery to recognize "nonself", such as the presence of pathogenic RNA. Several families of pattern-recognition receptors exist that detect immunostimulatory RNA and then induce cytokine-mediated antiviral and proinflammatory responses. Here, we review the distinct features of bona fide RNA sensors, Toll-like receptors and retinoic-acid inducible gene-I (RIG-I)-like receptors in particular, with a focus on their functional specificity imposed by cell-type-dependent expression, subcellular localization, and ligand preference. Furthermore, we highlight recent advances on the roles of nucleotide-binding oligomerization domain (NOD)-like receptors and DEAD-box or DEAH-box RNA helicases in an orchestrated RNA-sensing network and also discuss the relevance of RNA sensor polymorphisms in human disease.	[Liu, GuanQun; Gack, Michaela U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Gack, MU (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	mgack@uchicago.edu	Liu, GuanQun/AAJ-2681-2020	Liu, GuanQun/0000-0003-2520-7625	U.S. National Institutes of Health (NIH) [R01 AI087846, R01 AI127774, R21 AI148082]; ClayCo Foundation, United States	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ClayCo Foundation, United States	We apologize to all whose important contributions could not be discussed and cited due to space constraints. Current research in Dr. Gack's laboratory is supported by U.S. National Institutes of Health (NIH) grants R01 AI087846, R01 AI127774, and R21 AI148082 and an award from the ClayCo Foundation, United States.	Abe T, 2017, IMMUNITY, V46, P621, DOI 10.1016/j.immuni.2017.03.020; Abe Y, 2012, J VIROL, V86, P185, DOI 10.1128/JVI.05245-11; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Askar E, 2010, J MED VIROL, V82, P1859, DOI 10.1002/jmv.21893; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Bruns AM, 2015, CYTOKINE, V74, P198, DOI 10.1016/j.cyto.2015.02.010; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416; Cadena C, 2019, CELL, V177, P1187, DOI 10.1016/j.cell.2019.03.017; Cao LL, 2019, CELL HOST MICROBE, V26, P369, DOI 10.1016/j.chom.2019.08.010; Cao P, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007983; Cen H, 2013, INFLAMMATION, V36, P444, DOI 10.1007/s10753-012-9564-0; Chakrabarti A, 2015, CELL HOST MICROBE, V17, P466, DOI 10.1016/j.chom.2015.02.010; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Chen ST, 2019, CELL HOST MICROBE, V25, P602, DOI 10.1016/j.chom.2019.02.013; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Chiang C, 2017, TRENDS IMMUNOL, V38, P39, DOI 10.1016/j.it.2016.10.008; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Choi SJ, 2016, EMBO J, V35, P429, DOI 10.15252/embj.201592586; Chow KT, 2018, J IMMUNOL, V201, P3036, DOI 10.4049/jimmunol.1800221; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Cui YZ, 2001, GENOMICS, V78, P129, DOI 10.1006/geno.2001.6661; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Engin A, 2010, MICROBES INFECT, V12, P1071, DOI 10.1016/j.micinf.2010.07.012; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Feirer N, 2015, MBIO, V6, DOI 10.1128/mBio.00156-15; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Gono T, 2010, MOD RHEUMATOL, V20, P466, DOI 10.1007/s10165-010-0311-9; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Gringhuis SI, 2017, NAT IMMUNOL, V18, P225, DOI 10.1038/ni.3647; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Herbert A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0237-x; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hipp MM, 2013, IMMUNITY, V39, P711, DOI 10.1016/j.immuni.2013.09.004; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ishii N, 2014, J IMMUNOL, V193, P5118, DOI 10.4049/jimmunol.1401375; Jang MA, 2015, AM J HUM GENET, V96, P266, DOI 10.1016/j.ajhg.2014.11.019; Jiang MH, 2018, CELL, V173, P906, DOI 10.1016/j.cell.2018.03.064; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanno A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7119; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859; Lang XT, 2017, J EXP MED, V214, P459, DOI 10.1084/jem.20160592; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lechtenberg BC, 2014, CURR OPIN STRUC BIOL, V29, P17, DOI 10.1016/j.sbi.2014.08.011; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Li XD, 2012, ELIFE, V1, DOI 10.7554/eLife.00102; Lian H, 2018, IMMUNITY, V49, P438, DOI 10.1016/j.immuni.2018.08.014; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lin HY, 2019, NAT IMMUNOL, V20, P812, DOI 10.1038/s41590-019-0379-0; Liu GQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05745-w; Liu GQ, 2015, J VIROL, V89, P6067, DOI 10.1128/JVI.00232-15; Liu HM, 2016, EBIOMEDICINE, V9, P195, DOI 10.1016/j.ebiom.2016.06.015; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Liu Y, 2014, CELL MOL IMMUNOL, V11, P49, DOI [10.1038/cmi.2013.40, 10.1038/cmi.2014.83]; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu HB, 2014, J IMMUNOL, V193, P1364, DOI 10.4049/jimmunol.1303322; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Luthra P, 2011, P NATL ACAD SCI USA, V108, P2118, DOI 10.1073/pnas.1012409108; Maelfait J, 2017, EMBO J, V36, P2529, DOI 10.15252/embj.201796476; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Majer O, 2019, NATURE, V575, P366, DOI 10.1038/s41586-019-1612-6; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mayer-Barber KD, 2017, CELL MOL IMMUNOL, V14, P22, DOI 10.1038/cmi.2016.25; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Minamitani T, 2011, J VIROL, V85, P4035, DOI 10.1128/JVI.02160-10; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Miyake K, 2017, J LEUKOCYTE BIOL, V101, P135, DOI 10.1189/jlb.4MR0316-108R; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mosallanejad K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004841; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Oh DY, 2009, AIDS, V23, P297, DOI 10.1097/QAD.0b013e32831fb540; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Oshiumi H, 2015, CELL REP, V11, P1193, DOI 10.1016/j.celrep.2015.04.047; Oshiumi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003533; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Pattabhi S, 2019, J INTERF CYTOK RES, V39, P331, DOI 10.1089/jir.2018.0163; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pelka K, 2018, IMMUNITY, V48, P911, DOI 10.1016/j.immuni.2018.04.011; Pelka K, 2016, IMMUNOL REV, V269, P60, DOI 10.1111/imr.12375; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Qin YW, 2017, J VIROL, V91, DOI 10.1128/JVI.01264-17; Quicke KM, 2019, J INTERF CYTOK RES, V39, P669, DOI 10.1089/jir.2019.0059; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Runge S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004081; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sanchez JG, 2018, J MOL BIOL, V430, P5280, DOI 10.1016/j.jmb.2018.10.003; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schott E, 2007, J HEPATOL, V47, P203, DOI 10.1016/j.jhep.2007.03.021; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Song W, 2015, NAT STRUCT MOL BIOL, V22, P782, DOI 10.1038/nsmb.3080; Sridharan H, 2017, EMBO REP, V18, P1429, DOI 10.15252/embr.201743947; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sugimoto N, 2014, P NATL ACAD SCI USA, V111, P7747, DOI 10.1073/pnas.1400139111; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tabeta K., 2006, NAT IMMUNOL; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Tanji H, 2016, P NATL ACAD SCI USA, V113, P3012, DOI 10.1073/pnas.1516000113; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Uchikawa E, 2016, MOL CELL, V62, P586, DOI 10.1016/j.molcel.2016.04.021; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; Vazquez C, 2019, J VIROL, V93, DOI 10.1128/JVI.00725-19; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang Y, 2019, NAT CELL BIOL, V21, P1346, DOI 10.1038/s41556-019-0416-0; Weber M, 2015, CELL HOST MICROBE, V17, P309, DOI 10.1016/j.chom.2015.01.005; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu YS, 2018, EMBO J, V37, DOI 10.15252/embj.201899017; Xu HQ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax6525; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zevini A, 2017, TRENDS IMMUNOL, V38, P194, DOI 10.1016/j.it.2016.12.004; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050; Zhang Y, 2011, BIRD CONSERV INT, V21, P36, DOI 10.1017/S0959270910000201; Zhang YG, 2018, MBIO, V9, DOI 10.1128/mBio.00823-18; Zhang ZK, 2018, CELL REP, V25, P3371, DOI 10.1016/j.celrep.2018.11.081; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhao Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07314-7; Zhu QY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006886; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967	214	48	48	7	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					26	42		10.1016/j.immuni.2020.03.017	http://dx.doi.org/10.1016/j.immuni.2020.03.017			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668226	Bronze, Green Accepted			2022-12-18	WOS:000551116800008
J	Flamar, AL; Klose, CSN; Moeller, JB; Mahlakoiv, T; Bessman, NJ; Zhang, W; Moriyama, S; Stokic-Trtica, V; Rankin, LC; Putzel, GG; Rodewald, HR; He, ZX; Chen, LL; Lira, SA; Karsenty, G; Artis, D				Flamar, Anne-Laure; Klose, Christoph S. N.; Moeller, Jesper B.; Mahlakoiv, Tanel; Bessman, Nicholas J.; Zhang, Wen; Moriyama, Saya; Stokic-Trtica, Vladislava; Rankin, Lucille C.; Putzel, Gregory Garbes; Rodewald, Hans-Reimer; He, Zhengxiang; Chen, Lili; Lira, Sergio A.; Karsenty, Gerard; Artis, David			Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA3; NIPPOSTRONGYLUS-BRASILIENSIS; TYPE-2 IMMUNITY; TISSUE HOMEOSTASIS; TUFT CELLS; SEROTONIN; PATHWAY; HETEROGENEITY; ASSOCIATION; INTERFERON	Group 2 innate lymphoid cells (ILC2s) regulate immunity, inflammation, and tissue homeostasis. Two distinct subsets of ILC2s have been described: steady-state natural ILC2s and inflammatory ILC2s, which are elicited following helminth infection. However, how tissue-specific cues regulate these two subsets of ILC2s and their effector functions remains elusive. Here, we report that interleukin-33 (IL-33) promotes the generation of inflammatory ILC2s (ILC2(INFLAM)) via induction of the enzyme tryptophan hydroxylase 1 (Tph1). Tph1 expression was upregulated in ILC2s upon activation with IL-33 or following helminth infection in an IL-33-dependent manner. Conditional deletion of Tph1 in lymphocytes resulted in selective impairment of ILC2(INFLAM) responses and increased susceptibility to helminth infection. Further, RNA sequencing analysis revealed altered gene expression in Tph1 deficient ILC2s including inducible T cell co-stimulator (Icos). Collectively, these data reveal a previously unrecognized function for IL-33, Tph1, and ICOS in promoting inflammatory ILC2 responses and type 2 immunity at mucosal barriers.	[Flamar, Anne-Laure; Klose, Christoph S. N.; Moeller, Jesper B.; Mahlakoiv, Tanel; Bessman, Nicholas J.; Zhang, Wen; Moriyama, Saya; Rankin, Lucille C.; Putzel, Gregory Garbes; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med,Dept Microbiol & Immunol, New York, NY 10021 USA; [Klose, Christoph S. N.; Stokic-Trtica, Vladislava] Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, D-12203 Berlin, Germany; [Moeller, Jesper B.] Univ Southern Denmark, Dept Mol Med, DK-5000 Odense, Denmark; [Stokic-Trtica, Vladislava] Max Planck Inst Infect Biol, Berlin, Germany; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [He, Zhengxiang; Chen, Lili; Lira, Sergio A.] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Karsenty, Gerard] Columbia Univ, Irving Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Cornell University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southern Denmark; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Icahn School of Medicine at Mount Sinai; Columbia University; NewYork-Presbyterian Hospital	Artis, D (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med,Dept Microbiol & Immunol, New York, NY 10021 USA.	dartis@med.cornell.edu	Klose, Christoph/ABE-6396-2020; Moeller, Jesper B/E-6377-2015; Chen, Lili/AAC-8411-2020; He, Zhengxiang/I-2035-2019	Moeller, Jesper B/0000-0001-8786-8037; Chen, Lili/0000-0003-0026-4877; He, Zhengxiang/0000-0002-8961-859X; Zhang, Wen/0000-0002-9069-3773; Rankin, Lucille/0000-0002-3699-1569; Artis, David/0000-0002-1753-4100	German Research Foundation (DFG) [KL 2963/1-1, KL 2963/2-1, SFB 873-B11]; European Research Council [803087, 742883]; Novo Nordic Foundation [14052]; National Institutes of Health (NIH) fellowship [F32AI124517]; JSPS Overseas Research Fellowships; NIH [AI074878, AI095466, AI095608, AI102942, 2P01AG032959-09]; Burroughs Wellcome Fund; Crohn's and Colitis Foundation of America; Cure for IBD; Rosanne H. Silberman Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Novo Nordic Foundation(Novo Nordisk Foundation); National Institutes of Health (NIH) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Overseas Research Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; Cure for IBD; Rosanne H. Silberman Foundation	We thank the members of the Artis lab for critically reading the manuscript and the epigenomics core at Weill Cornell Medicine for carrying out the RNA sequencing. The work was supported by grants from the German Research Foundation (DFG; KL 2963/1-1 and KL 2963/2-1 to C.S.N.K. and SFB 873-B11 to H.-R.R.), the European Research Council (Starting Grant 803087 to C.S.N.K. and Advanced Grant 742883 to H.-R.R.), the Novo Nordic Foundation (14052 to J.B.M.), a National Institutes of Health (NIH) fellowship (F32AI124517 to N.J.B), JSPS Overseas Research Fellowships (to S.M.), the NIH (AI074878, AI095466, AI095608, and AI102942 to D.A. and 2P01AG032959-09 to G.K.), the Burroughs Wellcome Fund (to D.A.), the Crohn's and Colitis Foundation of America (to T.M. and D.A.), Cure for IBD (to D.A.), and the Rosanne H. Silberman Foundation (to D.A.).	Alvarez F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00522; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Durk T, 2013, AM J RESP CRIT CARE, V187, P476, DOI 10.1164/rccm.201208-1440OC; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Farrelly LA, 2019, NATURE, V567, P535, DOI 10.1038/s41586-019-1024-7; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; He ZX, 2018, CYTOKINE, V111, P146, DOI 10.1016/j.cyto.2018.08.009; Herr N, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00048; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lawrence RA, 1996, EXP PARASITOL, V84, P65, DOI 10.1006/expr.1996.0090; Lechin F, 1998, J CLIN PHARMACOL, V38, P918, DOI 10.1002/j.1552-4604.1998.tb04387.x; Li JY, 2015, CURR OPIN ALLERGY CL, V15, P33, DOI 10.1097/ACI.0000000000000124; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lund ML, 2018, MOL METAB, V11, P70, DOI 10.1016/j.molmet.2018.03.004; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Magrini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022482; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; Margolis KG, 2014, GUT, V63, P928, DOI 10.1136/gutjnl-2013-304901; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Miyahira Y, 2003, IMMUNOL LETT, V89, P193, DOI 10.1016/S0165-2478(03)00137-8; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; MURRAY M, 1971, EXP PARASITOL, V30, P58, DOI 10.1016/0014-4894(71)90070-1; Nagashima H, 2018, J ALLERGY CLIN IMMUN, V141, P1939, DOI 10.1016/j.jaci.2018.01.028; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nowak EC, 2012, J EXP MED, V209, P2127, DOI 10.1084/jem.20120408; Paclik D, 2015, EUR J IMMUNOL, V45, P2766, DOI 10.1002/eji.201545635; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rak GD, 2016, J INVEST DERMATOL, V136, P487, DOI 10.1038/JID.2015.406; Rana BMJ, 2019, J EXP MED, V216, P1999, DOI 10.1084/jem.20190689; Rankin LC, 2018, CELL, V173, P554, DOI 10.1016/j.cell.2018.03.013; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Wang SJ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180027; Wilhelm C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01742; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006453, 10.1371/journal.pone.0004898]; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	91	48	50	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					606	+		10.1016/j.immuni.2020.02.009	http://dx.doi.org/10.1016/j.immuni.2020.02.009			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32160524	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000526782600007
J	Eftychi, C; Schwarzer, R; Vlantis, K; Wachsmuth, L; Basic, M; Wagle, P; Neurath, MF; Becker, C; Bleich, A; Pasparakis, M				Eftychi, Christina; Schwarzer, Robin; Vlantis, Katerina; Wachsmuth, Laurens; Basic, Marijana; Wagle, Prerana; Neurath, Markus F.; Becker, Christoph; Bleich, Andre; Pasparakis, Manolis			Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment	IMMUNITY			English	Article							ROR-GAMMA-T; CROHNS-DISEASE; EXPERIMENTAL COLITIS; GENETIC-BASIS; IFN-GAMMA; MUCOSAL; INTERLEUKIN-12; INNATE; MICE; PERMEABILITY	Epithelial barrier defects are implicated in the pathogenesis of inflammatory bowel disease (IBD); however, the role of microbiome dysbiosis and the cytokine networks orchestrating chronic intestinal inflammation in response to barrier impairment remain poorly understood. Here, we showed that altered Schaedler flora (ASF), a benign minimal microbiota, was sufficient to trigger colitis in a mouse model of intestinal barrier impairment. Colitis development required myeloid-cell-specific adaptor protein MyD88 signaling and was orchestrated by the cytokines IL-12, IL-23, and IFN-gamma. Colon inflammation was driven by IL-12 during the early stages of the disease, but as the mice aged, the pathology shifted toward an IL-23-dependent inflammatory response driving disease chronicity. These findings reveal that IL-12 and IL-23 act in a temporally distinct, biphasic manner to induce microbiota-driven chronic intestinal inflammation. Similar mechanisms might contribute to the pathogenesis of IBD particularly in patients with underlying intestinal barrier defects.	[Eftychi, Christina; Schwarzer, Robin; Vlantis, Katerina; Wachsmuth, Laurens; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Eftychi, Christina; Schwarzer, Robin; Vlantis, Katerina; Wachsmuth, Laurens; Wagle, Prerana; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Eftychi, Christina; Schwarzer, Robin; Vlantis, Katerina; Wachsmuth, Laurens; Pasparakis, Manolis] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Basic, Marijana; Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany; [Neurath, Markus F.; Becker, Christoph] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany	University of Cologne; University of Cologne; University of Cologne; Hannover Medical School; University of Erlangen Nuremberg	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, D-50674 Cologne, Germany.; Pasparakis, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.; Pasparakis, M (corresponding author), Univ Cologne, CMMC, D-50931 Cologne, Germany.	pasparakis@uni-koeln.de	Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Eftychi, Christina/AAB-1135-2020; Becker, Christoph/L-2996-2016; Becker, Christoph/A-6694-2008	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Wachsmuth, Laurens/0000-0003-1701-9384; Becker, Christoph/0000-0002-1388-1041	European Research Council (ERC) [AdG 323040]; Deutsche Forschungsgemeinschaft (DFG) [SFB670, SPP1656]; Humboldt postdoctoral fellowship	European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Humboldt postdoctoral fellowship	We thank E. Stade, C. Uthoff-Hachenberg, E. Gareus, J. Kuth, and B. Kuhnel for technical assistance, as well as P. Frommolt and V.J. Promponas for help on data analysis. Research reported in this publication was supported by funding from the European Research Council (ERC) (AdG 323040) and the Deutsche Forschungsgemeinschaft (DFG) (SFB670 and SPP1656). C.E. was supported by a Humboldt postdoctoral fellowship.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Becker C, 2015, ILAR J, V56, P192, DOI 10.1093/ilar/ilv030; Ben-Horin S, 2014, AUTOIMMUN REV, V13, P24, DOI 10.1016/j.autrev.2013.06.002; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brand MW, 2015, ILAR J, V56, P169, DOI 10.1093/ilar/ilv012; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cox JH, 2012, MUCOSAL IMMUNOL, V5, P99, DOI 10.1038/mi.2011.54; Davidson NJ, 1998, J IMMUNOL, V161, P3143; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Feagan BG, 2017, LANCET, V389, P1699, DOI 10.1016/S0140-6736(17)30570-6; Furfaro F, 2017, EXPERT REV CLIN IMMU, V13, P457, DOI 10.1080/1744666X.2017.1279055; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kugathasan S, 2007, GUT, V56, P1696, DOI 10.1136/gut.2006.116467; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liu ZJ, 2001, EUR J IMMUNOL, V31, P1550, DOI 10.1002/1521-4141(200105)31:5<1550::AID-IMMU1550>3.0.CO;2-3; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moschen AR, 2018, NAT REV GASTRO HEPAT, V16, P185; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neurath M, 2017, NAT REV GASTRO HEPAT, V14, P688, DOI 10.1038/nrgastro.2017.138; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sands BE, 2017, GASTROENTEROLOGY, V153, P77, DOI 10.1053/j.gastro.2017.03.049; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2010, NAT MED, V16, P1195, DOI 10.1038/nm1110-1195; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Uhlig HH, 2009, EUR J IMMUNOL, V39, P2021, DOI 10.1002/eji.200939602; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020; Vlantis K, 2016, GUT, V65, P935, DOI 10.1136/gutjnl-2014-308323; Wagle P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1695-x; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zorzi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054562	61	48	51	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					367	+		10.1016/j.immuni.2019.06.008	http://dx.doi.org/10.1016/j.immuni.2019.06.008			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31350179	Bronze			2022-12-18	WOS:000482088500018
J	Kim, CJ; Lee, CG; Jung, JY; Ghosh, A; Hasan, SN; Hwang, SM; Kang, H; Lee, C; Kim, GC; Rudra, D; Suh, CH; Im, SH				Kim, Chan Johng; Lee, Choong-Gu; Jung, Ju-Yang; Ghosh, Ambarnil; Hasan, Syed Nurul; Hwang, Sung-Min; Kang, Hyeji; Lee, Changhon; Kim, Gi-Cheon; Rudra, Dipayan; Suh, Chang-Hee; Im, Sin-Hyeog			The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus	IMMUNITY			English	Article							IGE PRODUCTION; I INTERFERON; EXPRESSION; PATHOGENESIS; DEFICIENCY; ACTIVATION; LANDSCAPE; ENHANCER; PROMOTE; MICE	Single-nucleotide polymorphisms in ETS1 are associated with systemic lupus erythematosus (SLE). Ets1(-/-) mice develop SLE-like symptoms, suggesting that dysregulation of this transcription factor is important to the onset or progression of SLE. We used conditional deletion approaches to examine the impact of Ets1 expression in different immune cell types. Ets1 deletion on CD4(+) T cells, but not B cells or dendritic cells, resulted in the SLE autoimmunity, and this was associated with the spontaneous expansion of T follicular helper type 2 (Tfh2) cells. Ets1(-/-) Tfh2 cells exhibited increased expression of GATA-3 and interleukin-4 (IL-4), which induced IgE isotype switching in B cells. Neutralization of IL-4 reduced Tfh2 cell frequencies and ameliorated disease parameters. Mechanistically, Ets1 suppressed signature Tfh and Th2 cell genes, including Cxcr5, Bcl6, and Il4ra, thus curbing the terminal Tfh2 cell differentiation process. Tfh2 cell frequencies in SLE patients correlated with disease parameters, providing evidence for the relevance of these findings to human disease.	[Kim, Chan Johng; Lee, Choong-Gu; Ghosh, Ambarnil; Hasan, Syed Nurul; Hwang, Sung-Min; Kang, Hyeji; Lee, Changhon; Kim, Gi-Cheon; Rudra, Dipayan; Im, Sin-Hyeog] Acad Immunol & Microbiol, Inst Basic Sci, Pohang 37673, Gyeongbuk, South Korea; [Kim, Chan Johng; Hasan, Syed Nurul; Hwang, Sung-Min; Lee, Changhon; Im, Sin-Hyeog] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea; [Jung, Ju-Yang; Suh, Chang-Hee] Ajou Univ, Sch Med, Dept Rheumatol, 164 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea	Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Ajou University	Im, SH (corresponding author), Acad Immunol & Microbiol, Inst Basic Sci, Pohang 37673, Gyeongbuk, South Korea.; Im, SH (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea.	iimsh@postech.ac.kr	Lee, Choong-Gu/H-1878-2011; HASAN, SYED NURUL/E-2647-2019; Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013; Rudra, Dipayan/AAZ-5426-2020	Lee, Choong-Gu/0000-0002-7977-0408; HASAN, SYED NURUL/0000-0002-4564-872X; Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Rudra, Dipayan/0000-0002-9667-5891; Kim, Chan Johng/0000-0002-7256-0205; Hwang, Sung-Min/0000-0002-4868-147X; Ghosh, Ambarnil/0000-0002-1400-0963	Korea Health Technology R&D project - Ministry of Health Welfare [HI16C0992]; Institute for Basic Science [IBS-R005]	Korea Health Technology R&D project - Ministry of Health Welfare; Institute for Basic Science	We thank Dr. Meinrad Busslinger for agreeing to provide Gata3 GFP mice and Dr. Maxime Bouchard for providing us with the mice. We also thank Haejin Jung for technical assistance for cell sorting. This work was supported by grants from the Korea Health Technology R&D project funded by the Ministry of Health & Welfare (HI16C0992 to C.-H.S.) and by the Institute for Basic Science (IBS-R005 to S.-H.I.).	Augusto JF, 2018, AUTOIMMUN REV, V17, P361, DOI 10.1016/j.autrev.2017.11.027; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Blanco P, 2016, EUR J IMMUNOL, V46, P281, DOI 10.1002/eji.201545760; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Fonseca VR, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan1487; Fu WW, 2018, J EXP MED, V215, P815, DOI 10.1084/jem.20170901; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Grenningloh K, 2005, J EXP MED, V201, P615, DOI 10.1084/jem.20041330; John SA, 2008, J BIOL CHEM, V283, P951, DOI 10.1074/jbc.M705262200; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaul A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.39; Kim YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137044; Kobayashi T., 2016, J ALLERGY CLIN IMMUN, V137; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Meli AP, 2017, J IMMUNOL, V199, P244, DOI 10.4049/jimmunol.1700141; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mok MY, 2016, EXPERT OPIN BIOL TH, V16, P927, DOI 10.1517/14712598.2016.1171840; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Park S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16037; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reichlin M, 2003, CLIN IMMUNOL, V108, P69, DOI 10.1016/S1521-6616(03)00063-9; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Richards HB, 2001, KIDNEY INT, V60, P2173, DOI 10.1046/j.1523-1755.2001.00045.x; Sage PT, 2015, METHODS MOL BIOL, V1291, P151, DOI 10.1007/978-1-4939-2498-1_13; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tsao HW, 2013, P NATL ACAD SCI USA, V110, P15776, DOI 10.1073/pnas.1304343110; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Weinstein JS, 2018, J EXP MED, V215, P337, DOI 10.1084/jem.20170457; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104; Wu LC, 2014, CURR OPIN IMMUNOL, V31, P8, DOI 10.1016/j.coi.2014.08.001; Wu LC, 2014, NAT REV IMMUNOL, V14, P247, DOI 10.1038/nri3632; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	54	48	50	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1034	+		10.1016/j.immuni.2018.10.012	http://dx.doi.org/10.1016/j.immuni.2018.10.012			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566881	Bronze			2022-12-18	WOS:000453556500010
J	Li, X; Gadzinsky, A; Gong, LY; Tong, HJ; Calderon, V; Li, Y; Kitamura, D; Klein, U; Langdon, WY; Hou, FJ; Zou, YR; Gu, H				Li, Xin; Gadzinsky, Adeline; Gong, Liying; Tong, Haijun; Calderon, Virginie; Li, Yue; Kitamura, Daisuke; Klein, Ulf; Langdon, Wallace Y.; Hou, Fajian; Zou, Yong-Rui; Gu, Hua			Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction	IMMUNITY			English	Article							SECRETING PLASMA-CELLS; CLASS-SWITCH RECOMBINATION; MEMORY B; CLONAL SELECTION; DIFFERENTIATION; GENERATION; DYNAMICS; PROLIFERATION; HYPERMUTATION; ORGANIZATION	Selective expansion of high-affinity antigen-specific B cells in germinal centers (GCs) is a key event in anti-body affinity maturation. GC B cells with improved affinity can either continue affinity-driven selection or exit the GC to differentiate into plasma cells (PCs) or memory B cells. Here we found that deleting E3 ubiquitin ligases Cbl and Cbl-b (Cbls) in GC B cells resulted in the early exit of high-affinity antigen-specific B cells from the GC reaction and thus impaired clonal expansion. Cbls were highly expressed in GC light zone (LZ) B cells, where they promoted the ubiquitination and degradation of Irf4, a transcription factor facilitating PC fate choice. Strong CD40 and BCR stimulation triggered the Cbl degradation, resulting in increased Irf4 expression and exit from GC affinity selection. Thus, a regulatory cascade that is centered on the Cbl ubiquitin ligases ensures affinity-driven clonal expansion by connecting BCR affinity signals with differentiation programs.	[Li, Xin; Gadzinsky, Adeline; Gong, Liying; Tong, Haijun; Calderon, Virginie; Li, Yue; Gu, Hua] Montreal Clin Res Inst, Montreal, PQ H2W 1R7, Canada; [Li, Xin; Tong, Haijun; Gu, Hua] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3T 1J4, Canada; [Gong, Liying; Gu, Hua] McGill Univ, Div Expt Med, Montreal, PQ H3A 0G4, Canada; [Li, Yue] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 0G4, Canada; [Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 1628601, Japan; [Klein, Ulf] Univ Leeds, Leeds Inst Canc & Pathol, Sch Med, Leeds LS9 7TF, W Yorkshire, England; [Langdon, Wallace Y.] Univ Western Australia, Sch Biomed Sci, Crawley, WA 6009, Australia; [Hou, Fajian] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zou, Yong-Rui] Feinstein Inst Med Res, Manhasset, NY 11030 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; McGill University; Tokyo University of Science; University of Leeds; University of Western Australia; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Northwell Health	Gu, H (corresponding author), Montreal Clin Res Inst, Montreal, PQ H2W 1R7, Canada.; Gu, H (corresponding author), Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3T 1J4, Canada.; Gu, H (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ H3A 0G4, Canada.	hua.gu@ircm.qc.ca			Canadian Institute of Health Research [MOP142279]; A. Aisenstadt Chair Fund; Chinese Scholarship Council PhD training grants; National Cancer Institute of the National Institutes of Health [R21 CA175461]; National Health and Medical Research grant [1101318]; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs (CAS/SAFEA); Feinstein Institute for Medical Research; NATIONAL CANCER INSTITUTE [R21CA175461] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); A. Aisenstadt Chair Fund; Chinese Scholarship Council PhD training grants; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research grant; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs (CAS/SAFEA)(Chinese Academy of Sciences); Feinstein Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. Huang (Fudan University Medical College, Shanghai, China) for MSCV-IKB-GFP reporter, R. Chen (Montreal Clinical Research Institute) for HA-Ubiqutin vector, and J. Di Noia, T. Moroy, W.-K. Suh, and A. Veillette for comments. Supported by an operating grant (MOP142279) from the Canadian Institute of Health Research and by the A. Aisenstadt Chair Fund to H.G.; Chinese Scholarship Council PhD training grants to X.L. and H.J.T.; National Cancer Institute of the National Institutes of Health grant (R21 CA175461) to U.K.; a National Health and Medical Research grant (1101318) to W.Y.L.; the Chinese Academy of Sciences/State Administration of Foreign Experts Affairs (CAS/SAFEA) for International Partnership Program for Creative Research Teams to F.J.H. and H.G; and by an Institutional Fund from the Feinstein Institute for Medical Research to Y.R.Z.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Dufaud CR, 2017, CURR OPIN IMMUNOL, V45, P112, DOI 10.1016/j.coi.2017.03.007; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jang IK, 2011, P NATL ACAD SCI USA, V108, P7926, DOI 10.1073/pnas.1016451108; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Meyer-Hermann M, 2012, CELL REP, V2, P162, DOI 10.1016/j.celrep.2012.05.010; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004	51	48	48	4	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					530	+		10.1016/j.immuni.2018.03.006	http://dx.doi.org/10.1016/j.immuni.2018.03.006			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562201	Bronze, Green Accepted			2022-12-18	WOS:000427916900013
J	Banerjee, A; Northrup, D; Boukarabila, H; Jacobsen, SEW; Allman, D				Banerjee, Anupam; Northrup, Daniel; Boukarabila, Hanane; Jacobsen, Sten Erik W.; Allman, David			Transcriptional Repression of Gata3 Is Essential for Early B Cell Commitment	IMMUNITY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; COMMON LYMPHOID PROGENITORS; LINEAGE SPECIFICATION; EXPRESSION; DIFFERENTIATION; PAX5; GENOME; GENE; EBF; NOTCH	The mechanisms underlying the silencing of alternative fate potentials in very early B cell precursors remain unclear. Using gain- and loss-of-function approaches together with a synthetic Zinc-finger polypeptide (6ZFP) engineered to prevent transcription factor binding to a defined cis element, we show that the transcription factor EBF1 promotes B cell lineage commitment by directly repressing expression of the T-cell-lineage-requisite Gata3 gene. Ebf1-deficient lymphoid progenitors exhibited increased T cell lineage potential and elevated Gata3 transcript expression, whereas enforced EBF1 expression inhibited T cell differentiation and caused rapid loss of Gata3 mRNA. Notably, 6ZFP-mediated perturbation of EBF1 binding to a Gata3 regulatory region restored Gata3 expression, abrogated EBF1-driven suppression of T cell differentiation, and prevented B cell differentiation via a GATA3-dependent mechanism. Furthermore, EBF1 binding to Gata3 regulatory sites induced repressive histone modifications across this region. These data identify a transcriptional circuit critical for B cell lineage commitment.	[Banerjee, Anupam; Northrup, Daniel; Allman, David] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Boukarabila, Hanane; Jacobsen, Sten Erik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab,MRC Mol Haematol Unit, Oxford OX3 0LQ, England	University of Pennsylvania; University of Oxford	Allman, D (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	dallman@mail.med.upenn.edu	Jacobsen, Sten Eirik W/D-3974-2018	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Northrup, Daniel/0000-0002-2665-2686	Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource; National Institutes of Health [AI052861]; Medical Research Council, UK [H4RPLK0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052861] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12009/5, G0501838, G0801073] Funding Source: researchfish; MRC [G0501838, MC_UU_12009/5, G0801073] Funding Source: UKRI	Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Bhandoola, R. Sen, and M. De Obaldia for helpful discussions and/or critically reviewing this manuscript and J. Hagman, B. Kee, R. Grosschedl, and M. Busslinger for providing critical reagents and/or mice. We also gratefully acknowledge the expert technical assistance provided by C. Mauvais and support from the Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource. This work was supported by a grant from the National Institutes of Health (AI052861) to D. A. and a program grant (H4RPLK0) from the Medical Research Council, UK, to S.E.W.J.	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hosoya-Ohmura S, 2011, MOL CELL BIOL, V31, P1894, DOI 10.1128/MCB.05065-11; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kikuchi K, 2008, J IMMUNOL, V181, P383, DOI 10.4049/jimmunol.181.1.383; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Schilham MW, 1998, J IMMUNOL, V161, P3984; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Vickers ER, 2002, METHODS, V26, P270, DOI 10.1016/S1046-2023(02)00031-2; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Xu W, 2007, BLOOD, V109, P4406, DOI 10.1182/blood-2006-08-043331; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	50	48	49	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					930	942		10.1016/j.immuni.2013.01.014	http://dx.doi.org/10.1016/j.immuni.2013.01.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23684985	Green Published, hybrid			2022-12-18	WOS:000330942500012
J	Py, BF; Gonzalez, SF; Long, K; Kim, MS; Kim, YA; Zhu, H; Yao, JH; Degauque, N; Villet, R; Ymele-Leki, P; Gadjeva, M; Pier, GB; Carroll, MC; Yuan, JY				Py, Benedicte F.; Gonzalez, Santiago F.; Long, Kai; Kim, Mi-Sung; Kim, Young-A.; Zhu, Hong; Yao, Jianhua; Degauque, Nicolas; Villet, Regis; Ymele-Leki, Patrick; Gadjeva, Mihaela; Pier, Gerald B.; Carroll, Michael C.; Yuan, Junying			Cochlin Produced by Follicular Dendritic Cells Promotes Antibacterial Innate Immunity	IMMUNITY			English	Article							DFNA9 DEAFNESS; A DOMAIN; IDENTIFICATION; SYSTEM; MATRIX; LYMPH; GENE; AGGRECANASES; CHEMOKINES; EXPRESSION	Cochlin, an extracellular matrix protein, shares homologies with the Factor C, a serine protease found in horseshoe crabs, which is critical for antibacterial responses. Mutations in the COCH gene are responsible for human DFNA9 syndrome, a disorder characterized by neurodegeneration of the inner ear that leads to hearing loss and vestibular impairments. The physiological function of cochlin, however, is unknown. Here, we report that cochlin is specifically expressed by follicular dendritic cells and selectively localized in the fine extracellular network of conduits in the spleen and lymph nodes. During inflammation, cochlin was cleaved by aggrecanases and secreted into blood circulation. In models of lung infection with Pseudomonas aeruginosa and Staphylococcus aureus, Coch (-/-) mice show reduced survival linked to defects in local cytokine production, recruitment of immune effector cells, and bacterial clearance. By producing cochlin, FDCs thus contribute to the innate immune response in defense against bacteria.	[Py, Benedicte F.; Long, Kai; Kim, Mi-Sung; Zhu, Hong; Yao, Jianhua; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gonzalez, Santiago F.; Kim, Young-A.; Carroll, Michael C.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Degauque, Nicolas] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Transplant Immunol, Boston, MA 02115 USA; [Degauque, Nicolas] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplant Res Ctr, Boston, MA 02115 USA; [Villet, Regis] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ymele-Leki, Patrick] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Infect Dis, Boston, MA 02115 USA; [Gadjeva, Mihaela; Pier, Gerald B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Py, BF (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	benedicte.py@normalesup.org; junying_yuan@hms.harvard.edu	Py, Benedicte/M-6129-2014; Pier, Gerald/AAO-2692-2021; Degauque, Nicolas/R-4944-2017	Pier, Gerald/0000-0002-9112-2331; Degauque, Nicolas/0000-0003-2990-3513; F. Gonzalez, Santiago/0000-0003-4166-7664; Zhu, Hong/0000-0002-2575-4031; py, benedicte/0000-0001-6716-7807	National Institutes of Health; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Colin L. Stewart (National Cancer Institute, Frederick, MD) for providing Coch<SUP>-/-</SUP> mice; Bjorn R. Olsen and Rodrick Bronson for scientific advices and discussions; Adeline Bernier and Melissa Marinelli for technical assistance; James Kenny, Lisa A. Pitcher, Caroline N. Herndon, Sloan Siegrist, Ying Li, and Michael Boyce for technical advices; Stephanie Bedhomme for statistical analysis; Jennifer Walters and the staff at the Nikon imaging center, Maria Ericsson, and the staff at the electronic microscopy facility and the rodent histology facility (Harvard Medical School) for help with image analysis. This work was supported in part by the National Institutes of Health Director's Pioneer Award (to J.Y.).	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bhattacharya SK, 2005, J BIOL CHEM, V280, P6080, DOI 10.1074/jbc.M411233200; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Cross AK, 2006, BRAIN RES, V1088, P19, DOI 10.1016/j.brainres.2006.02.136; El Shikh MEM, 2007, J IMMUNOL, V179, P4444, DOI 10.4049/jimmunol.179.7.4444; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; Horino T, 2009, MICROBIOL IMMUNOL, V53, P502, DOI 10.1111/j.1348-0421.2009.00143.x; Ikezono T, 2004, BIOCHEM BIOPH RES CO, V314, P440, DOI 10.1016/j.bbrc.2003.12.106; Ikezono T, 2001, BBA-MOL BASIS DIS, V1535, P258, DOI 10.1016/S0925-4439(00)00101-0; IWANAGA S, 1992, THROMB RES, V68, P1, DOI 10.1016/0049-3848(92)90124-S; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Liepinsh E, 2001, EMBO J, V20, P5347, DOI 10.1093/emboj/20.19.5347; Lin EA, 2010, PROTEIN CELL, V1, P33, DOI 10.1007/s13238-010-0002-5; Lokmic Z, 2008, SEMIN IMMUNOL, V20, P4, DOI 10.1016/j.smim.2007.12.009; Manolis EN, 1996, HUM MOL GENET, V5, P1047, DOI 10.1093/hmg/5.7.1047; Mizuta K, 2008, NEUROSCI LETT, V434, P104, DOI 10.1016/j.neulet.2008.01.036; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Nagy I, 2008, FEBS LETT, V582, P4003, DOI 10.1016/j.febslet.2008.10.050; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Robertson NG, 2006, HUM MOL GENET, V15, P1071, DOI 10.1093/hmg/ddl022; Robertson NG, 2003, J MED GENET, V40, P479, DOI 10.1136/jmg.40.7.479; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; Rodriguez CI, 2004, ENDOCRINOLOGY, V145, P1410, DOI 10.1210/en.2003-1361; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Sukumar S, 2006, J IMMUNOL METHODS, V313, P81, DOI 10.1016/j.jim.2006.03.018; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tan NS, 2000, FASEB J, V14, P1801, DOI 10.1096/fj.99-0866com; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Wang ZQ, 2009, J IMMUNOL, V183, P6646, DOI 10.4049/jimmunol.0802348; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; Yao JH, 2010, J BIOL CHEM, V285, P14909, DOI 10.1074/jbc.M110.106724	41	48	48	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					1063	1072		10.1016/j.immuni.2013.01.015	http://dx.doi.org/10.1016/j.immuni.2013.01.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23684986	Bronze, Green Accepted			2022-12-18	WOS:000330942500022
J	Villarino, AV; Katzman, SD; Gallo, E; Miller, O; Jiang, SW; McManus, MT; Abbas, AK				Villarino, Alejandro V.; Katzman, Shoshana D.; Gallo, Eugenio; Miller, Omer; Jiang, Shuwei; McManus, Michael T.; Abbas, Abul K.			Posttranscriptional Silencing of Effector Cytokine mRNA Underlies the Anergic Phenotype of Self-Reactive T Cells	IMMUNITY			English	Article							IN-VIVO; TRANSLATIONAL CONTROL; PERIPHERAL TOLERANCE; GENE-EXPRESSION; AUTOIMMUNITY; DIFFERENTIATION; MECHANISMS; TRISTETRAPROLIN; BIOSYNTHESIS; ACTIVATION	Self-reactive T cell clones that escape negative selection are either deleted or rendered functionally unresponsive (anergic), thus preventing them from propagating host tissue damage. By using an in vivo model, we investigated molecular mechanisms for T cell tolerance, finding that despite a characteristic inability to generate effector cytokine proteins, self-reactive T cells express large amounts of cytokine mRNAs. This disconnect between cytokine message and protein was not observed in T cells mounting productive responses to foreign antigens but, instead, was seen only in those responding to self, where the block in protein translation was shown to involve conserved AU-rich elements within cytokine 3'UTRs. These studies reveal that translation of abundant cytokine mRNAs is limited in self-reactive T cells and, thus, identify posttranscriptional silencing of antigen-driven gene expression as a key mechanism underlying the anergic phenotype of self-reactive T cells.	[Villarino, Alejandro V.; Katzman, Shoshana D.; Gallo, Eugenio; Miller, Omer; Jiang, Shuwei; Abbas, Abul K.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Abbas, AK (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	abul.abbas@ucsf.edu	Villarino, Alejandro/AAE-3517-2020; mcmanus, michael/AAB-1239-2020	Villarino, Alejandro/0000-0001-8068-2176; mcmanus, michael/0000-0003-3013-6569; gallo, eugenio/0000-0003-4708-462X	NIH [PO1-AI35297, RO1-AI64677, PA-05-015, R01-DA026065]; Ruth L. Kirschstein National Research Service [F32-AI077199]; W.M. Keck Award; UCSF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077199, R01AI064677, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026065] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Award; UCSF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank members of the A.K.A., Anderson, Bluestone, Krummel, M.T.M., and Tang laboratories for helpful discussions. We also thank M. Krummel for scientific discussions and C. Benitez for expert animal husbandry. This work was supported by NIH grants PO1-AI35297 and RO1-AI64677 to A.K.A., a minority postdoctoral supplement to A.V.V. (PA-05-015), a Ruth L. Kirschstein National Research Service Award to S.D.K. (F32-AI077199), an NIH grant (R01-DA026065) and W.M. Keck Award to M.T.M, and support from the UCSF Program in Breakthrough Biomedical Research. The authors have no conflicting financial interests.	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; GarciaSanz JA, 1996, J EXP MED, V184, P159, DOI 10.1084/jem.184.1.159; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Houzet L, 2001, BLOOD, V98, P1281, DOI 10.1182/blood.V98.5.1281; Knoechel B, 2006, J IMMUNOL, V176, P6473, DOI 10.4049/jimmunol.176.11.6473; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Lohr J, 2004, J IMMUNOL, V173, P5028, DOI 10.4049/jimmunol.173.8.5028; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Pape KA, 1998, J IMMUNOL, V160, P4719; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Sonnenberg GF, 2010, BLOOD, V115, P2186, DOI 10.1182/blood-2009-08-237438; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Teague RM, 2008, IMMUNITY, V28, P662, DOI 10.1016/j.immuni.2008.03.012; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	39	48	48	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					50	60		10.1016/j.immuni.2010.12.014	http://dx.doi.org/10.1016/j.immuni.2010.12.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21236706	Green Accepted, Bronze			2022-12-18	WOS:000287336600009
J	Jimi, E; Strickland, I; Voll, RE; Long, MX; Ghosh, S				Jimi, Eijiro; Strickland, Ian; Voll, Reinhard E.; Long, Meixiao; Ghosh, Sankar			Differential Role of the Transcription Factor NF-kappa B in Selection and Survival of CD4(+) and CD8(+) Thymocytes	IMMUNITY			English	Article							T-CELL DEVELOPMENT; LINEAGE COMMITMENT; POSITIVE SELECTION; NEGATIVE SELECTION; THYMIC SELECTION; RUNX PROTEINS; LYMPHOCYTE DEVELOPMENT; ANTIGEN RECEPTOR; CLONAL DELETION; TCR SIGNALS	Inhibition of the transcription factor nuclear factor (NF)-kappa B activity leads to a reduction in numbers of CD8(+) single-positive (SP) thymocytes, suggesting a selective role for NF-kappa B in these cells. To further explore the role of NF-kappa B in SP thymocytes, we utilized transgenic models that allowed either inhibition activation of NF-kappa B. We showed that activation of NF-kappa B played an important role in the selection of major histocompatibility complex (MHC) class I-restricted CD8(+) T cells. Surprisingly, NF-kappa B was not activated in positively selected CD4(+) thymocytes, and inhibition of NF-kappa B did not perturb positive or negative selection of CD4(+) cells. However, enforced activation of NF-kappa B via a constitutively active inhibitor of kappa B (I kappa B) kinase transgene led to a nearly complete deletion of CD4 cells by pushing positively selecting CD4(+) cells into negative selection. These studies therefore revealed a surprising difference of NF-kappa B activation in CD4(+) and CD8(+) thymocytes and suggested that NF-kappa B contributes to the establishment of thresholds of signaling that determine positive or negative selection of thymocytes.	[Jimi, Eijiro; Strickland, Ian; Voll, Reinhard E.; Long, Meixiao; Ghosh, Sankar] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Jimi, Eijiro; Strickland, Ian; Voll, Reinhard E.; Long, Meixiao; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	sankar.ghosh@yale.edu			NIH [R37-AI33443, RO1-A168977]; Mochida Memorial Foundation for Medical; Pharmaceutical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068977, R37AI033443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mochida Memorial Foundation for Medical; Pharmaceutical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work in this manuscript was supported by the NIH (R37-AI33443 and RO1-A168977) (S.G.) and Mochida Memorial Foundation for Medical and Pharmaceutical Research (E.J). We would like to thank D. Schatz, X.-H. Sun, and M. Hayden for carefully reading the manuscript.	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Cho HJ, 2003, J IMMUNOL, V170, P10, DOI 10.4049/jimmunol.170.1.10; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Egawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001512; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Hare KJ, 1998, J IMMUNOL, V160, P3666; He X, 2006, CURR OPIN IMMUNOL, V18, P135, DOI 10.1016/j.coi.2006.02.003; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hettmann T, 2000, J IMMUNOL, V165, P5004, DOI 10.4049/jimmunol.165.9.5004; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; Mandal M, 2005, J EXP MED, V201, P603, DOI 10.1084/jem.20041924; MARODON G, 1994, EUR J IMMUNOL, V24, P196, DOI 10.1002/eji.1830240131; Matsui K, 1997, EUR J IMMUNOL, V27, P2269, DOI 10.1002/eji.1830270922; MOORE NC, 1995, J IMMUNOL, V155, P4653; Mora AL, 1999, EUR J IMMUNOL, V29, P2968, DOI 10.1002/(SICI)1521-4141(199909)29:09<2968::AID-IMMU2968>3.3.CO;2-O; Mora AL, 2001, J IMMUNOL, V167, P5628, DOI 10.4049/jimmunol.167.10.5628; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; Viret C, 2001, J IMMUNOL, V166, P4429, DOI 10.4049/jimmunol.166.7.4429; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; VONBOEHMER H, 1992, IMMUNOL TODAY, V13, P454, DOI 10.1016/0167-5699(92)90075-I; WATANABEFUKUNAG.R, 1992, NATURE, V356, P317; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	56	48	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					523	537		10.1016/j.immuni.2008.08.010	http://dx.doi.org/10.1016/j.immuni.2008.08.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957265	Green Accepted, Bronze			2022-12-18	WOS:000260316700007
J	Miyazaki, M; Miyazaki, K; Itoi, M; Katoh, Y; Guo, Y; Kanno, R; Katoh-Fukui, Y; Honda, H; Amagai, T; van Lohuizen, M; Kawamoto, H; Kanno, M				Miyazaki, Masaki; Miyazaki, Kazuko; Itoi, Manarni; Katoh, Yuko; Guo, Yun; Kanno, Rieko; Katoh-Fukui, Yuko; Honda, Hiroaki; Amagai, Takashi; van Lohuizen, Maarten; Kawamoto, Hiroshi; Kanno, Masamoto			Thymocyte proliferation induced by pre-t cell receptor signaling is maintained through polycomb gene product bmi-1-mediated Cdkn2a repression	IMMUNITY			English	Article							ARF TUMOR-SUPPRESSOR; NF-KAPPA-B; BETA-SELECTION CHECKPOINT; HEMATOPOIETIC STEM-CELLS; ALPHA-BETA; METHYLTRANSFERASE ACTIVITY; MOLECULAR-BASIS; SELF-RENEWAL; INK4A LOCUS; ROR-GAMMA	Thymocytes undergo massive proliferation before T cell receptor (TCR) gene rearrangement, ensuring the diversification of the TCR repertoire. Because activated cells are more susceptible to damage, cell-death restraint as well as promotion of cell-cycle progression is considered important for adequate cell growth. Although the molecular mechanism of pre-TCR-induced proliferation has been examined, the mechanisms of protection against cell death during the proliferation phase remain unknown. Here we show that the survival of activated pre-T cells induced by pre-TCR signaling required the Polycomb group (PcG) gene product Bmi-1-mediated repression of Cdkn2A, and that p19Arf expression resulted in thymocyte cell death and inhibited the transition from CD4(-)CD8(-) (DN) to CD4(+)CD8(+) (DIP) stage upstream of the transcriptional factor p53 pathway. The expression of Cdkn2A (the gene encoding p19Arf) in immature thymocytes was directly regulated by PcG complex containing Bmi-1 and M33 through the maintenance of local trimethylated histone H3K27. Our results indicate that this epigenetic regulation critically contributes to the survival of the activated pre-T cells, thereby supporting their proliferation during the DN-DP transition.	[Miyazaki, Masaki; Katoh, Yuko; Guo, Yun; Kanno, Rieko; Kanno, Masamoto] Hiroshima Univ, Grad Sch Biomed Sci, Dept Immunol, Minami Ku, Hiroshima 7348551, Japan; [Miyazaki, Kazuko; Honda, Hiroaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dev Biol, Minami Ku, Hiroshima 7348551, Japan; [Itoi, Manarni] Meiji Univ Oriental Med, Dept Immunol & Microbiol, Kyoto 6290392, Japan; [Katoh-Fukui, Yuko] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Sex Differentiat, Okazaki, Aichi 4448787, Japan; [van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Kawamoto, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan	Hiroshima University; Hiroshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Netherlands Cancer Institute; RIKEN	Miyazaki, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Immunol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	fwnkl228@mb.infoweb.ne.jp; mkanno@hiroshima-u.ac.jp	Katoh-Fukui, Yuko/Y-5383-2019	Kanno, masamoto/0000-0001-9169-3444; Katoh-Fukui, Yuko/0000-0001-6858-3693; Miyazaki, Masaki/0000-0002-9543-624X				Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gallagher SJ, 2006, INT J BIOCHEM CELL B, V38, P1637, DOI 10.1016/j.biocel.2006.02.008; Garbe AI, 2007, TRENDS IMMUNOL, V28, P124, DOI 10.1016/j.it.2007.01.004; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gilley J, 2001, ONCOGENE, V20, P7447, DOI 10.1038/sj.onc.1204933; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Katoh-Fukui Y, 2005, BLOOD, V106, P1612, DOI 10.1182/blood-2004-08-3367; Kawamoto H, 2003, EUR J IMMUNOL, V33, P606, DOI 10.1002/eji.200323461; Kim SH, 2003, P NATL ACAD SCI USA, V100, P211, DOI 10.1073/pnas.0135557100; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; QUELLE DE, 1995, CELL, V83, P993; Raaphorst FM, 2005, INT J HEMATOL, V81, P281, DOI 10.1532/IJH97.05023; Raaphorst FM, 2001, J IMMUNOL, V166, P5925, DOI 10.4049/jimmunol.166.10.5925; Richie ER, 2002, ONCOGENE, V21, P299, DOI 10.1038/sj.onc.1205051; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sato T, 2006, GENE, V379, P166, DOI 10.1016/j.gene.2006.05.006; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Yamasaki S, 2007, TRENDS IMMUNOL, V28, P39, DOI 10.1016/j.it.2006.11.006; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	67	48	49	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					231	245		10.1016/j.immuni.2007.12.013	http://dx.doi.org/10.1016/j.immuni.2007.12.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275833	Bronze			2022-12-18	WOS:000253275000013
J	Jia, YH; Subramanian, KK; Erneux, C; Pouillon, V; Hattori, H; Jo, HY; You, J; Zhu, D; Schurmans, S; Luo, HBR				Jia, Yonghui; Subramanian, Kulandayan K.; Erneux, Christophe; Pouillon, Valerie; Hattori, Hidenori; Jo, Hakryul; You, Jian; Zhu, Daocheng; Schurmans, Stephane; Luo, Hongbo R.			Inositol 1,3,4,5-tetrakisphosphate negatively regulates phosphatidylinositol-3,4,5-trisphosphate signaling in neutrophils	IMMUNITY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; TUMOR-SUPPRESSOR PTEN; HEXAKISPHOSPHATE KINASE; CELL-DEATH; STRUCTURAL BASIS; 1,4,5-TRISPHOSPHATE; CHEMOTAXIS; 3-KINASE; PHOSPHORYLATION; EXPRESSION	Many neutrophil functions are regulated by phosphatidylinositol-3,4,5-trisphosphate (Ptdlns(3,4,5)P3) that mediates protein membrane translocation via binding to pleckstrin homolog (PH) domains within target proteins. Here we show that inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4), a cytosolic small molecule, bound the same PH domain of target proteins and competed for binding to Ptdlns(3,4,5)P3. In neutrophils, chemoattractant stimulation triggered rapid elevation in lns(1,3,4,5)P4 concentration. Depletion of lns(1,3,4,5)P4 by deleting the gene encoding lnsP3KB, which converts Ins(1,4,5)P3 to Ins(1,3,4,5)P4, enhanced membrane translocation of the Ptdins(3,4,5)P3specific PH domain. This led to enhanced sensitivity to chemoattractant stimulation, elevated superoxide production, and enhanced neutrophil recruitment to inflamed peritoneal cavity. On the contrary, augmentation of intracellular Ins(1,3,4,5)P4 concentration blocked PH domainmediated membrane translocation of target proteins and dramatically decreased the sensitivity of neutrophils to chemoattractant stimulation. These findings establish a role for lns(1,3,4,5)P4 in cellular signal transduction pathways and provide another mechanism for modulating Ptdlns(3,4,5)P3 signaling in neutrophils.	Harvard Univ, Sch Med, Dept Pathol,Childrens Hosp, Dana Farber Canc Ctr,Dept Lab Med, Boston, MA 02115 USA; Univ Libre Bruxelles, IRIBHM, B-6041 Gosselies, Belgium	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Universite Libre de Bruxelles	Luo, HBR (corresponding author), Harvard Univ, Sch Med, Dept Pathol,Childrens Hosp, Dana Farber Canc Ctr,Dept Lab Med, Karp Family Res Bldg,Room 10214, Boston, MA 02115 USA.	hongbo.luo@childrens.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, R01HL085100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052200] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL085100, R01 HL085100-01A1, HL066987, R01 HL085100, T32 HL066987] Funding Source: Medline; NIGMS NIH HHS [R01 GM076084-01A1, GM076084, R01 GM076084-02, R01 GM076084] Funding Source: Medline; NINDS NIH HHS [NS052200, R21 NS052200] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; BRADFORD PG, 1986, J BIOL CHEM, V261, P5644; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cantrell DA, 2001, J CELL SCI, V114, P1439; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; Collins P, 2000, NAT REV NEUROSCI, V1, P4, DOI 10.1038/35036157; Cozier G, 2000, BIOCHEM J, V349, P333, DOI 10.1042/0264-6021:3490333; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Dewaste V, 2002, BIOCHEM BIOPH RES CO, V291, P400, DOI 10.1006/bbrc.2002.6456; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; EUROPEFINNER GN, 1991, BIOCHEM BIOPH RES CO, V181, P191, DOI 10.1016/S0006-291X(05)81400-7; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FRENCH PJ, 1991, P ROY SOC B-BIOL SCI, V245, P193, DOI 10.1098/rspb.1991.0109; FRUMAN DA, 1991, AGENTS ACTIONS, V34, P16, DOI 10.1007/BF01993225; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859, DOI 10.1074/jbc.271.31.18859; Huang JHY, 2003, GENE EXPR PATTERNS, V3, P3, DOI 10.1016/s1567-133X(02)00096-0; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; IRVINE RF, 1995, BIOCHEM SOC T, V23, P27, DOI 10.1042/bst0230027; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Jun KS, 1998, LEARN MEMORY, V5, P317; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; MARECHAL Y, 2007, IN PRESS P NATL ACAD; Michell RH, 2002, CURR BIOL, V12, pR313, DOI 10.1016/S0960-9822(02)00827-8; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Nalaskowski MM, 2003, J BIOL CHEM, V278, P19765, DOI 10.1074/jbc.M211059200; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; STUART JA, 1994, BIOCHEM J, V303, P517, DOI 10.1042/bj3030517; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; VANDIJKEN P, 1994, EUR J BIOCHEM, V226, P561; VANWEYENBERG V, 1995, BIOCHEM J, V306, P429, DOI 10.1042/bj3060429; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhu D, 2006, P NATL ACAD SCI USA, V103, P14836, DOI 10.1073/pnas.0605722103; ZIGMOND SH, 1989, AM J RESP CELL MOL, V1, P451, DOI 10.1165/ajrcmb/1.6.451	69	48	52	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					453	467		10.1016/j.immuni.2007.07.016	http://dx.doi.org/10.1016/j.immuni.2007.07.016			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17825589	Green Accepted, Bronze			2022-12-18	WOS:000249843400012
J	Murphy, A; Westwood, JA; Teng, MWL; Moeller, M; Darcy, PK; Kershaw, MH				Murphy, A; Westwood, JA; Teng, MWL; Moeller, M; Darcy, PK; Kershaw, MH			Gene modification strategies to induce tumor immunity	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; T-CELL-RECEPTOR; PROTEIN-10 TRANSGENE EXPRESSION; PERIPHERAL-BLOOD LYMPHOCYTES; DENDRITIC CELLS; ANTITUMOR IMMUNITY; IN-VIVO; NECROSIS-FACTOR; INTERLEUKIN-12 GENE; CD40 LIGAND	The immune system provides an attractive option for use in cancer therapy. Our increasing understanding of the molecular events important in the generation of an effective immune response presents us with the opportunity to manipulate key genes to boost the immune response against cancer. Genetic modification is being employed to enhance a range of immune processes including antigen presentation, activation of specific T cells, and localization of immune effectors to tumors. In this review, we describe how many diverse cell types, including dendritic cells, T cells, and tumor cells, are being modified with a variety of genes, including those encoding antigens, cytokines, and chemokines, in order to enhance tumor immunity.	Peter MacCallum Canc Inst, Canc Immunol Program, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center	Kershaw, MH (corresponding author), Peter MacCallum Canc Inst, Canc Immunol Program, Melbourne, Vic 3002, Australia.	michael.kershaw@petermac.org	Teng, Michele WL/S-5055-2016	Teng, Michele WL/0000-0003-1886-9145; Kershaw, Michael/0000-0002-2697-487X; Darcy, Phillip/0000-0002-5303-9561				Altenschmidt U, 1997, J IMMUNOL, V159, P5509; Andarini S, 2004, CANCER RES, V64, P3281, DOI 10.1158/0008-5472.CAN-03-3911; Armeanu S, 2003, CANCER RES, V63, P2369; Balkir L, 2004, J GENE MED, V6, P537, DOI 10.1002/jgm.545; Bjorkdahl O, 2000, CANCER GENE THER, V7, P1365, DOI 10.1038/sj.cgt.0242; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Bollard CM, 2002, BLOOD, V99, P3179, DOI 10.1182/blood.V99.9.3179; Bowman L, 1998, BLOOD, V92, P1941, DOI 10.1182/blood.V92.6.1941.418k03_1941_1949; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Buelens C, 1997, EUR J IMMUNOL, V27, P1848, DOI 10.1002/eji.1830270805; Carroll MW, 1998, JNCI-J NATL CANCER I, V90, P1881, DOI 10.1093/jnci/90.24.1881; Chamberlain RS, 1996, CANCER RES, V56, P2832; Chamoto K, 2004, CANCER RES, V64, P386, DOI 10.1158/0008-5472.CAN-03-2596; Chen Z, 2002, CANCER GENE THER, V9, P778, DOI 10.1038/sj.cgt.7700498; Clay TM, 1999, J IMMUNOL, V163, P507; Cui Y, 2003, NAT MED, V9, P952, DOI 10.1038/nm882; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Eaton D, 2002, GENE THER, V9, P527, DOI 10.1038/sj.gt.3301685; Engleman EG, 2003, SEMIN ONCOL, V30, P23, DOI 10.1016/S0093-7754(03)00229-X; Finney HM, 2004, J IMMUNOL, V172, P104, DOI 10.4049/jimmunol.172.1.104; Fushimi T, 2000, J CLIN INVEST, V105, P1383, DOI 10.1172/JCI7548; Gao JQ, 2003, CANCER RES, V63, P4420; Gao WT, 2003, J IMMUNOL, V170, P107, DOI 10.4049/jimmunol.170.1.107; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Gnant MFX, 1999, CANCER RES, V59, P4668; Guo J, 2002, GENE THER, V9, P793, DOI 10.1038/sj.gt.3301688; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Haynes NM, 2002, BLOOD, V100, P3155, DOI 10.1182/blood-2002-04-1041; Haynes NM, 2002, J IMMUNOL, V169, P5780, DOI 10.4049/jimmunol.169.10.5780; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; HOCK H, 1993, P NATL ACAD SCI USA, V90, P2774, DOI 10.1073/pnas.90.7.2774; Huang H, 2004, INT J CANCER, V109, P817, DOI 10.1002/ijc.20043; Huang H, 2002, CELL IMMUNOL, V217, P12, DOI 10.1016/S0008-8749(02)00508-7; Huang H, 2002, CANCER RES, V62, P2043; HWU P, 1993, J IMMUNOL, V150, P4104; Irvine KR, 1996, J IMMUNOL, V156, P238; JACOB B, 2004, CANCER GENE THER, V12, P109; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Kang WK, 2001, HUM GENE THER, V12, P671, DOI 10.1089/104303401300057388; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Kershaw MH, 2002, NAT BIOTECHNOL, V20, P1221, DOI 10.1038/nbt756; Kikuchi T, 1999, HUM GENE THER, V10, P1375, DOI 10.1089/10430349950018049; Kikuchi T, 2000, BLOOD, V96, P91, DOI 10.1182/blood.V96.1.91.013k19_91_99; Kim TW, 2003, J CLIN INVEST, V112, P109, DOI 10.1172/JCI200317293; Levitsky HI, 1996, J IMMUNOL, V156, P3858; LI YW, 1994, J IMMUNOL, V153, P421; Lin CM, 2002, CLIN IMMUNOL, V104, P58, DOI 10.1006/clim.2002.5229; Lin TY, 2002, CANCER RES, V62, P3620; Liu YQ, 2002, CANCER GENE THER, V9, P533, DOI 10.1038/sj.cgt.7700466; Loskog A, 2004, J IMMUNOL, V172, P7200, DOI 10.4049/jimmunol.172.11.7200; Mach N, 2000, CANCER RES, V60, P3239; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Melero I, 1998, EUR J IMMUNOL, V28, P1116, DOI 10.1002/(SICI)1521-4141(199803)28:03<1116::AID-IMMU1116>3.0.CO;2-A; Mohr A, 2004, GENE THER, V11, P534, DOI 10.1038/sj.gt.3302154; Morse MA, 2003, CANCER INVEST, V21, P341, DOI 10.1081/CNV-120018224; Narvaiza I, 2000, J IMMUNOL, V164, P3112, DOI 10.4049/jimmunol.164.6.3112; Nishioka Y, 1999, CANCER RES, V59, P4035; Palmer K, 2001, GENE THER, V8, P282, DOI 10.1038/sj.gt.3301386; Parker LL, 2000, HUM GENE THER, V11, P2377, DOI 10.1089/104303400750038480; Pecher G, 2002, CANCER IMMUNOL IMMUN, V51, P669, DOI 10.1007/s00262-002-0317-z; Pinthus JH, 2003, CANCER RES, V63, P2470; Putzer BM, 1997, P NATL ACAD SCI USA, V94, P10889, DOI 10.1073/pnas.94.20.10889; Ribas Antoni, 2002, Current Gene Therapy, V2, P57, DOI 10.2174/1566523023348129; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Rossig C, 2002, BLOOD, V99, P2009, DOI 10.1182/blood.V99.6.2009; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; SARTOR WM, 1995, J SURG RES, V59, P66, DOI 10.1006/jsre.1995.1133; Sharma S, 2003, HUM GENE THER, V14, P1511, DOI 10.1089/104303403322495025; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Simons JW, 1997, CANCER RES, V57, P1537; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Su Z, 2003, CANCER RES, V63, P2127; Sung MW, 2002, HUM GENE THER, V13, P731, DOI 10.1089/104303402317322294; Tatsumi T, 2003, CANCER RES, V63, P6378; Tatsumi T, 2002, CANCER RES, V62, P5853; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; von Mehren M, 2003, ANNU REV MED, V54, P343, DOI 10.1146/annurev.med.54.101601.152442; Wang JJ, 2004, MOL THER, V9, P577, DOI 10.1016/j.ymthe.2003.12.011; Wickham TJ, 2003, NAT MED, V9, P135, DOI 10.1038/nm0103-135; Wierda WG, 2000, BLOOD, V96, P2917; Wiethe C, 2003, J IMMUNOL, V171, P4121, DOI 10.4049/jimmunol.171.8.4121; Yang L, 2002, P NATL ACAD SCI USA, V99, P6204, DOI 10.1073/pnas.092154599; Yang SC, 2004, CLIN CANCER RES, V10, P2891, DOI 10.1158/1078-0432.CCR-03-0380; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Zajac P, 2003, HUM GENE THER, V14, P1497, DOI 10.1089/104303403322495016	92	48	59	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					403	414		10.1016/j.immuni.2005.03.007	http://dx.doi.org/10.1016/j.immuni.2005.03.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845446	Bronze			2022-12-18	WOS:000228909600003
J	Dal Porto, JM; Burke, K; Cambier, JC				Dal Porto, JM; Burke, K; Cambier, JC			Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; ANTIBODY-PRODUCING CELLS; B-CELLS; AUTOANTIBODY PRODUCTION; PERITONEAL-CAVITY; TRANSGENIC MOUSE; RECEPTOR COMPLEX; IMMUNOGLOBULIN-M; IN-VIVO; ANTIGEN	Although found predominantly in the peritoneal and pleural cavities, B-1 cells are also present in other peripheral tissues such as spleen and lung. While similar in surface phenotypes, such as CD5, all B-1 cells are not equivalent in their response to stimuli. Here, we report that the src family kinase Lck is required to confer the BCR hyporesponsiveness typical of CD5(+) B-1 cells and appears involved in the maintenance of their unique function. Splenic B-1 cells express CD5 but not Lck and are not hyporesponsive; however, within the peritoneum, these B-1 cells are induced to express Lck and acquire a hyporesponsive phenotype. Peritoneal B-1 cells from Ick-deficient mice, while CD5(+), no longer exhibit attenuated BCR signaling. Interestingly, Ick-null mice exhibited increased natural antibody levels characteristic of B-1 cells. Taken together, these results demonstrate a key role for Lck in modulating the signaling and cellular fate of B-1 B cells.	Univ Colorado, Sch Med, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Cambier, JC (corresponding author), Univ Colorado, Sch Med, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA.	cambierj@njc.org		Cambier, John/0000-0002-7803-242X	NHLBI NIH HHS [NIHR01 AG13983] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Arnold LW, 2000, J IMMUNOL, V164, P2924, DOI 10.4049/jimmunol.164.6.2924; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Berland R, 1998, J IMMUNOL, V161, P277; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; BURGESS KE, 1992, P NATL ACAD SCI USA, V89, P9311, DOI 10.1073/pnas.89.19.9311; CARMACK CE, 1990, J EXP MED, V172, P371, DOI 10.1084/jem.172.1.371; Chumley MJ, 2000, J IMMUNOL, V164, P4586, DOI 10.4049/jimmunol.164.9.4586; Chumley MJ, 2002, J IMMUNOL, V169, P1735, DOI 10.4049/jimmunol.169.4.1735; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Dennehy KM, 2001, INT IMMUNOL, V13, P149, DOI 10.1093/intimm/13.2.149; Gary-Gouy H, 2002, J IMMUNOL, V168, P232, DOI 10.4049/jimmunol.168.1.232; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HAUGHTON G, 1986, IMMUNOL REV, V93, P35, DOI 10.1111/j.1600-065X.1986.tb01501.x; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Hippen KL, 2000, J EXP MED, V191, P883, DOI 10.1084/jem.191.5.883; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Kawaguchi S, 1998, J IMMUNOL, V160, P4796; Kawahara T, 2003, J IMMUNOL, V171, P5406, DOI 10.4049/jimmunol.171.10.5406; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Majolini MB, 1998, BLOOD, V91, P3390, DOI 10.1182/blood.V91.9.3390.3390_3390_3396; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; MCDANIEL LS, 1984, J IMMUNOL, V133, P3308; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111; NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110; Ochi H, 1999, IMMUNOLOGY, V98, P595, DOI 10.1046/j.1365-2567.1999.00899.x; Ohdan H, 2000, J IMMUNOL, V165, P5518, DOI 10.4049/jimmunol.165.10.5518; Paciorkowski N, 2000, J EXP MED, V191, P731, DOI 10.1084/jem.191.4.731; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Stall A M, 1996, Semin Immunol, V8, P45, DOI 10.1006/smim.1996.0007; Ulivieri C, 2003, EUR J IMMUNOL, V33, P441, DOI 10.1002/immu.200310019; Vila JM, 2001, EUR J IMMUNOL, V31, P1191, DOI 10.1002/1521-4141(200104)31:4<1191::AID-IMMU1191>3.3.CO;2-8; Vyse TJ, 1996, J IMMUNOL, V157, P2719; Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; WORTIS HH, 1995, P NATL ACAD SCI USA, V92, P3348, DOI 10.1073/pnas.92.8.3348	43	48	48	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					443	453		10.1016/j.immuni.2004.07.018	http://dx.doi.org/10.1016/j.immuni.2004.07.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357954	Bronze			2022-12-18	WOS:000224034900014
J	Min, IM; Schrader, CE; Vardo, J; Luby, TM; D'Avirro, N; Stavnezer, J; Selsing, E				Min, IM; Schrader, CE; Vardo, J; Luby, TM; D'Avirro, N; Stavnezer, J; Selsing, E			The S mu tandem repeat region is critical for Ig isotype switching in the absence of Msh2	IMMUNITY			English	Article							MISMATCH REPAIR PROTEINS; CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; SACCHAROMYCES-CEREVISIAE; CIRCULAR DNA; B-CELLS; ANTIBODY DIVERSIFICATION; MSH2-DEFICIENT MICE; DEFICIENT MICE	Deficiencies of the Msh2 protein or the Smu tandem repeat (SmuTR) sequences each reduce isotype switching in mice by about 2- to 3-fold. We find that switching in mice deficient for both Msh2 and SmuTR is nearly ablated. We propose that the SmuTR provides closely spaced cleavage sites that can undergo switch recombination independent of Msh2, whereas cleavages in sequences flanking the SmuTR require Msh2 processing to allow recombinational joining. We also find that changes in Smu sequences alter the focus of switch junctions within Sgamma sequences, indicating that sequences of switch regions act together in the choice of switch recombination junctions. These findings help to explain the conservation of tandemly repeated switch regions associated with heavy chain constant genes in species capable of switching.	Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Immunol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Univ Massachusetts, Sch Med, Program Immunol & Virol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Tufts University; Tufts University; Tufts University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Selsing, E (corresponding author), Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA.		Min, Irene/AAQ-4186-2021	Min, Irene/0000-0002-1057-4804; Schrader, Carol/0000-0001-8920-6803	NATIONAL CANCER INSTITUTE [T32CA065441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023283, R01AI048570, R01AI024465] Funding Source: NIH RePORTER; NCI NIH HHS [CA 65441] Funding Source: Medline; NIAID NIH HHS [R01 AI024465, AI 24465, AI 23283, AI 48570] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; Datta A, 1996, MOL CELL BIOL, V16, P1085; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; GRITZMACHER CA, 1989, CRIT REV IMMUNOL, V9, P173; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Jenab-Wolcott J, 2000, MOL CELL BIOL, V20, P8373, DOI 10.1128/MCB.20.22.8373-8381.2000; Jolly C J, 1996, Semin Immunol, V8, P159, DOI 10.1006/smim.1996.0020; KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Ma LM, 2002, J IMMUNOL, V168, P2835, DOI 10.4049/jimmunol.168.6.2835; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Marsischky GT, 1999, J BIOL CHEM, V274, P7200, DOI 10.1074/jbc.274.11.7200; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Shanmugam A, 2000, J EXP MED, V191, P1365, DOI 10.1084/jem.191.8.1365; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2002, TRENDS GENET, V18, P541, DOI 10.1016/S0168-9525(02)02799-3; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Wuerffel RA, 2001, J IMMUNOL, V166, P4552, DOI 10.4049/jimmunol.166.7.4552	52	48	48	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					515	524		10.1016/S1074-7613(03)00262-0	http://dx.doi.org/10.1016/S1074-7613(03)00262-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563316	Bronze			2022-12-18	WOS:000186051900008
J	Rudolph, MG; Speir, JA; Brunmark, A; Mattsson, N; Jackson, MR; Peterson, PA; Teyton, L; Wilson, IA				Rudolph, MG; Speir, JA; Brunmark, A; Mattsson, N; Jackson, MR; Peterson, PA; Teyton, L; Wilson, IA			The crystal structures of K-bm1 and k(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity	IMMUNITY			English	Article							MHC CLASS-I; T-CELL-RECEPTOR; INDUCED CONFORMATIONAL-CHANGES; CYTOTOXIC LYMPHOCYTES-T; ANTIGEN RECOGNITION; BINDING GROOVE; SELF-PEPTIDE; COMPLEX; PROTEIN; MOLECULES	The K-bm1 and K-bm8 natural mutants of the murine MHC class I molecule H-2K(b) were originally identified by allograft rejection. They also bind viral peptides VSV8 and SEV9 with high affinity, but their peptide complexes have substantially decreased thermostability, and the K-bm1 complexes do not elicit alloreactive T cell responses. Crystal structures of the four mutant complexes at 1.7-1.9 Angstrom resolution are similar to the corresponding wild-type K-b structures, except in the vicinity of the mutated residues, which alter the electrostatic potential, topology, hydrogen bonding, and local water structure of the peptide binding groove. Thus, these natural K-b mutations define the minimal perturbations in the peptide environment that alter antigen presentation to T cells and abolish alloreactivity.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA; Uppsala Univ, Sch Engn, Mol Biotechnol Programme, S-75124 Uppsala, Sweden	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA; Uppsala University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu		Rudolph, Markus/0000-0003-0447-1101	NCI NIH HHS [CA58896] Funding Source: Medline; NIAID NIH HHS [AI42267] Funding Source: Medline; NIMH NIH HHS [MH19185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042267, R21AI142267] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolopoulos V, 1997, J IMMUNOL, V159, P5211; Apostolopoulos V, 1998, J IMMUNOL, V161, P767; Apostolopoulos V, 1997, EUR J IMMUNOL, V27, P2579, DOI 10.1002/eji.1830271017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BLUESTONE JA, 1992, J EXP MED, V176, P1757, DOI 10.1084/jem.176.6.1757; Bon C, 1999, ACTA CRYSTALLOGR D, V55, P978, DOI 10.1107/S0907444998018514; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; CHACKO S, 1995, J MOL BIOL, V245, P261, DOI 10.1006/jmbi.1994.0022; CHATTOPADHYAY S, 1994, J EXP MED, V179, P213, DOI 10.1084/jem.179.1.213; CLARK SS, 1983, SURV IMMUNOL RES, V2, P203; Cook JR, 1998, MOL IMMUNOL, V35, P929, DOI 10.1016/S0161-5890(98)00080-7; Cook JR, 1996, J IMMUNOL, V157, P2256; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; DASER A, 1994, MOL IMMUNOL, V31, P331, DOI 10.1016/0161-5890(94)90110-4; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DEWAAL LP, 1983, J IMMUNOL, V130, P1090; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dyall R, 1996, J EXP MED, V184, P253, DOI 10.1084/jem.184.1.253; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; ELLIOTT TJ, 1990, P NATL ACAD SCI USA, V87, P5213, DOI 10.1073/pnas.87.13.5213; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; GAO LQ, 1995, J IMMUNOL, V155, P5519; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; GRANDEA AG, 1993, J IMMUNOL, V151, P3981; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HUNT HD, 1990, J IMMUNOL, V145, P1456; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JEFFREY PD, 1993, P NATL ACAD SCI USA, V90, P10310, DOI 10.1073/pnas.90.21.10310; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2000, J BIOMOL STRUCT DYN, P79, DOI 10.1080/07391102.2000.10506606; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liu RJ, 2000, J MOL BIOL, V295, P127, DOI 10.1006/jmbi.1999.3300; MANDELBOIM O, 1994, NATURE, V369, P67, DOI 10.1038/369067a0; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NATHENSON SG, 1986, ANNU REV IMMUNOL, V4, P471, DOI 10.1146/annurev.iy.04.040186.002351; NIKOLICZUGIC J, 1990, EUR J IMMUNOL, V20, P2431, DOI 10.1002/eji.1830201111; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PARKER KC, 1992, J IMMUNOL, V149, P1896; PULLEN JK, 1994, J IMMUNOL, V152, P3445; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; ROHREN EM, 1994, J IMMUNOL, V152, P5337; Saito NG, 1999, J IMMUNOL, V162, P5998; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Smith PA, 1997, J EXP MED, V185, P1023, DOI 10.1084/jem.185.6.1023; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Stefanski HE, 2000, J IMMUNOL, V164, P3519, DOI 10.4049/jimmunol.164.7.3519; TALLQUIST MD, 1995, J IMMUNOL, V155, P2419; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Vlassi M, 1999, J MOL BIOL, V285, P817, DOI 10.1006/jmbi.1998.2342; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; YUN TJ, 1994, INT IMMUNOL, V6, P1037, DOI 10.1093/intimm/6.7.1037; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	75	48	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2001	14	3					231	242		10.1016/S1074-7613(01)00105-4	http://dx.doi.org/10.1016/S1074-7613(01)00105-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290333	Bronze			2022-12-18	WOS:000167959500003
J	Wallace, ME; Bryden, M; Cose, SC; Coles, RM; Schumacher, TN; Brooks, A; Carbone, FR				Wallace, ME; Bryden, M; Cose, SC; Coles, RM; Schumacher, TN; Brooks, A; Carbone, FR			Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CELL ANTIGEN RECEPTOR; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CLASS-I; T-CELLS; GENE SEGMENTS; SELECTION; USAGE; INFECTION; RECOGNITION	The enormous diversity of the T cell pool makes it difficult to determine whether inherent biases in the naive TCR repertoire can influence T cell responsiveness. In C57BL/6 mice the cytotoxic T lymphocyte response to an immunodominant HSV-1 determinant (gB) is characterized by a prominent bias in VP element usage, associated with a conserved and preferentially D element-encoded CDR3 sequence. Comparison of naive and gB-specific T cell populations revealed a similar enrichment of germline D element-encoded CDR3 sequences in the preimmune repertoire. Strikingly, eliminating the germline coding of the gs-specific CDR3 sequence caused an almost complete loss of the dominant subset of gB-specific T cells, illustrating that CDR3 biases can significantly alter both the composition and strength of an immune response.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; Monash Med Sch, Dept Pathol & Immunol, Prahran, Vic 3181, Australia; Netherlands Canc Inst, Dept Immunol, NL-1066 CX Amsterdam, Netherlands	University of Melbourne; Monash University; Netherlands Cancer Institute	Carbone, FR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.		Cose, Stephen/H-4851-2019; Carbone, Francis/ABF-2141-2020; Schumacher, Ton/Y-2432-2019	Cose, Stephen/0000-0002-5156-037X; Schumacher, Ton/0000-0003-0517-8804; Brooks, Andrew/0000-0002-4085-9683; Wallace, Morgan/0000-0002-0744-6895				ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; AEBISCHER T, 1990, EUR J IMMUNOL, V20, P523, DOI 10.1002/eji.1830200310; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; BONNEAU RH, 1993, VIROLOGY, V195, P62, DOI 10.1006/viro.1993.1346; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; CANDEIAS S, 1991, J EXP MED, V174, P989, DOI 10.1084/jem.174.5.989; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CHEN WS, 1994, J EXP MED, V180, P1471, DOI 10.1084/jem.180.4.1471; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; Cose SC, 1997, EUR J IMMUNOL, V27, P2310, DOI 10.1002/eji.1830270927; COSE SC, 1995, J VIROL, V69, P5849, DOI 10.1128/JVI.69.9.5849-5852.1995; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; Falk K, 1993, Semin Immunol, V5, P81, DOI 10.1006/smim.1993.1012; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; GILFILLAN S, 1994, INT IMMUNOL, V6, P1681, DOI 10.1093/intimm/6.11.1681; Haanen JBAG, 1999, EUR J IMMUNOL, V29, P1168, DOI 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.0.CO;2-J; HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0; HIRAMA T, 1991, EUR J IMMUNOL, V21, P483, DOI 10.1002/eji.1830210234; IMARAI M, 1995, CELL IMMUNOL, V162, P340; Jones CM, 1997, INT IMMUNOL, V9, P1319, DOI 10.1093/intimm/9.9.1319; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; McNally JM, 1999, CELL IMMUNOL, V194, P103, DOI 10.1006/cimm.1999.1498; NOONAN DJ, 1986, J EXP MED, V163, P644, DOI 10.1084/jem.163.3.644; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SIU G, 1984, NATURE, V311, P344, DOI 10.1038/311344a0; STAERZ UD, 1985, J IMMUNOL, V134, P3994; Turner SJ, 1996, J IMMUNOL, V157, P4979; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; vanderMost RG, 1996, J IMMUNOL, V157, P5543; VASILAKOS JP, 1993, J IMMUNOL, V150, P2346; Vitiello A, 1996, J IMMUNOL, V157, P5555; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; WOODLAND DL, 1990, J IMMUNOL, V144, P379; YANAGI Y, 1990, J VIROL, V64, P5919, DOI 10.1128/JVI.64.12.5919-5926.1990; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	44	48	50	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2000	12	5					547	556		10.1016/S1074-7613(00)80206-X	http://dx.doi.org/10.1016/S1074-7613(00)80206-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843387	Bronze			2022-12-18	WOS:000087356400010
J	Peter, F				Peter, F			HIV nef: The mother of all evil?	IMMUNITY			English	Review							VIRUS TYPE-1 NEF; MAJOR HISTOCOMPATIBILITY COMPLEX; LONG-TERM SURVIVOR; SORTING SIGNALS; DOWN-REGULATION; IN-VIVO; T-CELLS; PROTEIN; CD4; KINASE		Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Peter, F (corresponding author), Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.	mcbpfj@imcb.nus.edu.sg						AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Aldrovandi GM, 1998, J VIROL, V72, P7032, DOI 10.1128/JVI.72.9.7032-7039.1998; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Coates K, 1997, J BIOL CHEM, V272, P12289, DOI 10.1074/jbc.272.19.12289; Collette Y, 1996, J IMMUNOL, V156, P360; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; GOLD MS, 1995, DRUGS ABUSE, V4, P1; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Graziani A, 1996, J BIOL CHEM, V271, P6590, DOI 10.1074/jbc.271.12.6590; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Iafrate AJ, 1997, EMBO J, V16, P673, DOI 10.1093/emboj/16.4.673; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; KEEN JH, 1991, J BIOL CHEM, V266, P7950; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Littman D R, 1996, Curr Top Microbiol Immunol, V205, pv; Liu LX, 1997, J BIOL CHEM, V272, P13779, DOI 10.1074/jbc.272.21.13779; LURIA S, 1991, P NATL ACAD SCI USA, V88, P5326, DOI 10.1073/pnas.88.12.5326; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nunn MF, 1996, J VIROL, V70, P6157, DOI 10.1128/JVI.70.9.6157-6161.1996; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SALGHETTI S, 1995, P NATL ACAD SCI USA, V92, P349, DOI 10.1073/pnas.92.2.349; SANFRIDSON A, 1994, J BIOL CHEM, V269, P3917; SAWAI ET, 1994, P NATL ACAD SCI USA, V91, P1539, DOI 10.1073/pnas.91.4.1539; SCHWARTZ O, 1995, J VIROL, V69, P528, DOI 10.1128/JVI.69.1.528-533.1995; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; SKOWRONSKI J, 1993, EMBO J, V12, P703, DOI 10.1002/j.1460-2075.1993.tb05704.x; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	49	48	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1998	9	4					433	437		10.1016/S1074-7613(00)80626-3	http://dx.doi.org/10.1016/S1074-7613(00)80626-3			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806629	Bronze			2022-12-18	WOS:000076680700001
J	ZHANG, Y; CADO, D; ASARNOW, DM; KOMORI, T; ALT, FW; RAULET, DH; ALLISON, JP				ZHANG, Y; CADO, D; ASARNOW, DM; KOMORI, T; ALT, FW; RAULET, DH; ALLISON, JP			THE ROLE OF SHORT HOMOLOGY REPEATS AND TDT IN GENERATION OF THE INVARIANT GAMMA-DELTA ANTIGEN RECEPTOR REPERTOIRE IN THE FETAL THYMUS	IMMUNITY			English	Article							DENDRITIC EPIDERMAL-CELLS; GENE JUNCTIONAL SEQUENCES; VARIABLE REGION GENES; MURINE T-CELLS; PRE-B-CELLS; N-REGIONS; V(D)J RECOMBINATION; MAMMALIAN-CELLS; SCID MICE; DIVERSITY	Fetal thymic and adult epithelial V gamma 3(+) and V gamma 4(+) T cells express gamma delta antigen receptors (TCR) with invariant junctions lacking N nucleotides. Using transgenic recombination substrates, we show that di- or trinucleotide repeats, either in the coding region or in P elements, have strong effects on the site of recombination. In other mice bearing a terminal deoxynucleotidyl transferase (TdT) transgene under the control of the CD2 promoter, we found that the frequency of canonical junctions was markedly reduced with a concomitant increase in in-frame noncanonical junctions with N nucleotides. Together, our results show that short homology repeats direct the site of rearrangement and thus play a critical role in the generation of gamma delta T cell receptor canonical junctions. Increased TdT activity in V gamma 3(+) T cells has a inhibitory effect on junctional homogeneity in these cells.	BERLEX LABS INC,RICHMOND,CA 94804; HARVARD UNIV,CHILDRENS HOSP,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	ZHANG, Y (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,BERKELEY,CA 94720, USA.			Allison, James/0000-0001-8980-5697; Raulet, David/0000-0002-1257-8649	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031650, R01AI026942] Funding Source: NIH RePORTER; NIAID NIH HHS [AI200047, AI31650, AI26942] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1993, CURR OPIN IMMUNOL, V5, P241, DOI 10.1016/0952-7915(93)90011-G; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; BOUBNOV NV, 1993, MOL CELL BIOL, V13, P6957, DOI 10.1128/MCB.13.11.6957; CHUKWUOCHA RU, 1995, J IMMUNOL, V154, P1246; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DUPLAY P, 1989, J IMMUNOL, V142, P2998; FEENEY AJ, 1991, J EXP MED, V174, P115, DOI 10.1084/jem.174.1.115; FEENEY AJ, 1993, J IMMUNOL, V151, P3094; FEENEY AJ, 1991, J IMMUNOL, V147, P4343; FEENEY AJ, 1992, J IMMUNOL, V149, P222; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GERSTEIN RM, 1993, NATURE, V363, P625, DOI 10.1038/363625a0; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; GU H, 1990, CELL, V65, P47; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; ITOHARA S, 1990, P NATL ACAD SCI USA, V87, P7935, DOI 10.1073/pnas.87.20.7935; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; KIENKER LJ, 1991, J EXP MED, V174, P769, DOI 10.1084/jem.174.4.769; KOIWAI O, 1986, NUCLEIC ACIDS RES, V14, P5777, DOI 10.1093/nar/14.14.5777; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LANDAU NR, 1987, MOL CELL BIOL, V7, P3237, DOI 10.1128/MCB.7.9.3237; LECLERCQ G, 1993, J EXP MED, V178, P309, DOI 10.1084/jem.178.1.309; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LIEBER MR, 1992, CELL, V70, P873, DOI 10.1016/0092-8674(92)90237-7; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MEEK K, 1990, SCIENCE, V250, P820, DOI 10.1126/science.2237433; NANDI D, 1991, J IMMUNOL, V147, P1773; OPSTELTEN D, 1986, J IMMUNOL, V137, P76; OWEN MJ, 1988, EUR J IMMUNOL, V18, P187, DOI 10.1002/eji.1830180129; PANDEY A, 1993, J EXP MED, V177, P329, DOI 10.1084/jem.177.2.329; RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; ROTHENBERG E, 1983, J IMMUNOL, V130, P1627; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULER W, 1991, EUR J IMMUNOL, V21, P589, DOI 10.1002/eji.1830210309; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286	49	48	48	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					439	447		10.1016/1074-7613(95)90173-6	http://dx.doi.org/10.1016/1074-7613(95)90173-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584135	Bronze			2022-12-18	WOS:A1995TB60800005
J	Doerflinger, M; Deng, YX; Whitney, P; Salvamoser, R; Engel, S; Kueh, AJ; Tai, L; Bachem, A; Gressier, E; Geoghegan, ND; Wilcox, S; Rogers, KL; Garnham, AL; Dengler, MA; Bader, SM; Ebert, G; Pearson, JS; De Nardo, D; Wang, N; Yang, CY; Pereira, M; Bryant, CE; Strugnell, RA; Vince, JE; Pellegrini, M; Strasser, A; Bedoui, S; Herold, MJ				Doerflinger, Marcel; Deng, Yexuan; Whitney, Paul; Salvamoser, Ranja; Engel, Sven; Kueh, Andrew J.; Tai, Lin; Bachem, Annabell; Gressier, Elise; Geoghegan, Niall D.; Wilcox, Stephen; Rogers, Kelly L.; Garnham, Alexandra L.; Dengler, Michael A.; Bader, Stefanie M.; Ebert, Gregor; Pearson, Jaclyn S.; De Nardo, Dominic; Wang, Nancy; Yang, Chenying; Pereira, Milton; Bryant, Clare E.; Strugnell, Richard A.; Vince, James E.; Pellegrini, Marc; Strasser, Andreas; Bedoui, Sammy; Herold, Marco J.			Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection	IMMUNITY			English	Article							PSEUDOKINASE MLKL; MOLECULAR SWITCH; INFLAMMASOME; APOPTOSIS; CASPASE-1; ACTIVATION; NECROPTOSIS; MECHANISMS; EFFECTOR; PLATFORM	Programmed cell death contributes to host defense against pathogens. To investigate the relative importance of pyroptosis, necroptosis, and apoptosis during Salmonella infection, we infected mice and macrophages deficient for diverse combinations of caspases-1, -11, -12, and -8 and receptor interacting serine/threonine kinase 3 (RIPK3). Loss of pyroptosis, caspase-8-driven apoptosis, or necroptosis had minor impact on Salmonella control. However, combined deficiency of these cell death pathways caused loss of bacterial control in mice and their macrophages, demonstrating that host defense can employ varying components of several cell death pathways to limit intracellular infections. This flexible use of distinct cell death pathways involved extensive cross-talk between initiators and effectors of pyroptosis and apoptosis, where initiator caspases-1 and -8 also functioned as executioners when all known effectors of cell death were absent. These findings uncover a highly coordinated and flexible cell death system with in-built fail-safe processes that protect the host from intracellular infections.	[Doerflinger, Marcel; Deng, Yexuan; Salvamoser, Ranja; Kueh, Andrew J.; Tai, Lin; Geoghegan, Niall D.; Wilcox, Stephen; Rogers, Kelly L.; Garnham, Alexandra L.; Dengler, Michael A.; Bader, Stefanie M.; Ebert, Gregor; De Nardo, Dominic; Vince, James E.; Pellegrini, Marc; Strasser, Andreas; Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Doerflinger, Marcel; Whitney, Paul; Salvamoser, Ranja; Engel, Sven; Kueh, Andrew J.; Bachem, Annabell; Gressier, Elise; Geoghegan, Niall D.; Wilcox, Stephen; Rogers, Kelly L.; Garnham, Alexandra L.; Dengler, Michael A.; Ebert, Gregor; De Nardo, Dominic; Wang, Nancy; Yang, Chenying; Strugnell, Richard A.; Vince, James E.; Pellegrini, Marc; Strasser, Andreas; Bedoui, Sammy; Herold, Marco J.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Deng, Yexuan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Whitney, Paul; Engel, Sven; Bachem, Annabell; Gressier, Elise; Wang, Nancy; Yang, Chenying; Strugnell, Richard A.; Bedoui, Sammy] Univ Melbourne, Dept Microbiol & Immunol, Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Pearson, Jaclyn S.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Pearson, Jaclyn S.] Monash Univ, Dept Mol & Translat Res, Clayton, Vic, Australia; [Pearson, Jaclyn S.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia; [De Nardo, Dominic] Monash Univ, Monash Biomed Discovery Inst, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Pereira, Milton] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA; [Pereira, Milton; Bryant, Clare E.] Univ Cambridge, Cambridge, England; [Yang, Chenying] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia	Walter & Eliza Hall Institute; University of Melbourne; Nanjing University; University of Melbourne; Hudson Institute of Medical Research; Monash University; Monash University; Monash University; University of Massachusetts System; University of Massachusetts Worcester; University of Cambridge; Griffith University	Strasser, A; Herold, MJ (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Strasser, A; Bedoui, S; Herold, MJ (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Bedoui, S (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Doherty Inst Infect & Immun, Parkville, Vic, Australia.	strasser@wehi.edu.au; sbedoui@unimelb.edu.au; herold@wehi.edu.au	Herold, Marco J/C-8039-2013; Strasser, Andreas/C-7581-2013; Wang, Nancy/C-1518-2016; Dengler, Michael/AFR-3509-2022	Herold, Marco J/0000-0001-7539-7581; Strasser, Andreas/0000-0002-5020-4891; Bachem, Annabell/0000-0002-0047-2097; Dengler, Michael/0000-0002-1693-1761; Whitney, Paul/0000-0003-3836-7601; Engel, Sven/0000-0002-2682-3596; Pereira, Milton/0000-0003-2977-1565; Doerflinger, Marcel/0000-0001-9159-3021; Strugnell, Richard/0000-0003-0614-5641; Mendes Bader, Stefanie/0000-0002-7901-9833; Wang, Nancy/0000-0001-7623-1858	Australian National Health and Medical Research Council (NHMRC) [1186575, 1145728, 1143105, 1159658, 1016701, 1020363, 1156095]; Leukemia and Lymphoma Society of America [LLS SCOR 700113]; Cancer Council of Victoria [1147328, 1052309]; Australian Phenomics Network; Cass Foundation; Wellcome Trust [108045/Z/15/Z]; German Research Council [GRK2168]; Victorian State Government Operational Infrastructure Support Program; Australian Government Independent Research Institute Infrastructure Support Scheme [361646, 9000220]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian Phenomics Network; Cass Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); German Research Council(German Research Foundation (DFG)); Victorian State Government Operational Infrastructure Support Program; Australian Government Independent Research Institute Infrastructure Support Scheme(Australian Government)	We thank M. Patsis and G. Siciliano for expert animal care, B. Helbert and K. Mackwell for genotyping, S. Monard and his team for help with flow cytometry, V. Dixit and N. Kayagaki for insightful discussions, and all the members of the Herold, Strasser, and Bedoui laboratories. We thank Gordon Dougan (University of Cambridge) for the SL1344 GFP-expressing Salmonella strain. This work was supported by grants and fellowships from the Australian National Health and Medical Research Council (NHMRC) (project grants 1186575 and 1145728 to M.J.H., 1143105 to M.J.H. and A.S., 1159658 to M.J.H. and S.B., and 1016701 to A.S.; and fellowships 1020363 to A.S. and 1156095 to M.J.H.), the Leukemia and Lymphoma Society of America (LLS SCOR 700113 to A.S. and M.J.H.), the Cancer Council of Victoria (project grants 1147328 to M.J.H. and 1052309 to A.S., and a venture grant to M.J.H. and A.S.), the Australian Phenomics Network (to M.J.H. and A.J.K.), the Cass Foundation (to M.D.), the Wellcome Trust (investigator award 108045/Z/15/Z to C.E.B.), and the German Research Council (GRK2168 to S.E. and S.B.), as well as by operational infrastructure grants through the AustrYalian Government Independent Research Institute Infrastructure Support Scheme (361646 and 9000220) and the Victorian State Government Operational Infrastructure Support Program. The graphical abstract was created with the help of BioRender.com.	Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bachem A, 2019, IMMUNITY, V51, P285, DOI 10.1016/j.immuni.2019.06.002; Bedoui S, 2010, J IMMUNOL, V184, P2237, DOI 10.4049/jimmunol.0902871; Benoun JM, 2018, P NATL ACAD SCI USA, V115, P10416, DOI 10.1073/pnas.1808339115; Browne AJ, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1443-1; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; De Nardo D, 2018, METHODS MOL BIOL, V1784, P35, DOI 10.1007/978-1-4939-7837-3_4; Dengler MA, 2019, CELL REP, V27, P359, DOI 10.1016/j.celrep.2019.03.040; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Green DR, 2019, CELL, V177, P1094, DOI 10.1016/j.cell.2019.04.024; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Heilig R, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000735; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Korea CG, 2014, INFECT IMMUN, V82, P4144, DOI 10.1128/IAI.01576-14; Kueh AJ, 2016, METHODS MOL BIOL, V1491, P253, DOI 10.1007/978-1-4939-3581-9_18; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kupz A, 2014, INFECT IMMUN, V82, P4997, DOI 10.1128/IAI.02192-14; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lee BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21998-3; Man SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45126; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Ng TM, 2013, CELL HOST MICROBE, V14, P9, DOI 10.1016/j.chom.2013.06.009; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Salvamoser R, 2019, CELL DEATH DIFFER, V26, P1124, DOI 10.1038/s41418-018-0188-2; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schneider KS, 2017, CELL REP, V21, P3846, DOI 10.1016/j.celrep.2017.12.018; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2; Van Opdenbosch N, 2017, CELL REP, V21, P3427, DOI 10.1016/j.celrep.2017.11.088; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Winstel V, 2019, MBIO, V10, DOI 10.1128/mBio.02270-19; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2016, CURR OPIN MICROBIOL, V29, P37, DOI 10.1016/j.mib.2015.10.003	58	47	48	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					533	+		10.1016/j.immuni.2020.07.004	http://dx.doi.org/10.1016/j.immuni.2020.07.004			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32735843	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000569806100012
J	Glass, DR; Tsai, AG; Oliveria, JP; Hartmann, FJ; Kimmey, SC; Calderon, AA; Borges, L; Glass, MC; Wagar, LE; Davis, MM; Bendall, SC				Glass, David R.; Tsai, Albert G.; Oliveria, John Paul; Hartmann, Felix J.; Kimmey, Samuel C.; Calderon, Ariel A.; Borges, Luciene; Glass, Marla C.; Wagar, Lisa E.; Davis, Mark M.; Bendall, Sean C.			An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity	IMMUNITY			English	Article							MEMORY; RECEPTOR; INNATE; MARKER; ACTIVATION; APOPTOSIS; TOOLKIT; BLOOD; NAIVE; BCR	B cells are capable of a wide range of effector functions including antibody secretion, antigen presentation, cytokine production, and generation of immunological memory. A consistent strategy for classifying human B cells by using surface molecules is essential to harness this functional diversity for clinical translation. We developed a highly multiplexed screen to quantify the co-expression of 351 surface molecules on millions of human B cells. We identified differentially expressed molecules and aligned their variance with isotype usage, VDJ sequence, metabolic profile, biosynthesis activity, and signaling response. Based on these analyses, we propose a classification scheme to segregate B cells from four lymphoid tissues into twelve unique subsets, including a CD45RB(+)CD27(-) early memory population, a class-switched CD39(+) tonsil-resident population, and a CD19(hi)CD11(+) memory population that potently responds to immune activation. This classification framework and underlying datasets provide a resource for further investigations of human B cell identity and function.	[Glass, David R.; Calderon, Ariel A.; Bendall, Sean C.] Stanford Univ, Immunol Grad Program, Stanford, CA 94305 USA; [Glass, David R.; Tsai, Albert G.; Oliveria, John Paul; Hartmann, Felix J.; Kimmey, Samuel C.; Calderon, Ariel A.; Borges, Luciene; Bendall, Sean C.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Oliveria, John Paul] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON L8S 4K1, Canada; [Kimmey, Samuel C.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Glass, Marla C.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Wagar, Lisa E.; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; McMaster University; Stanford University; Stanford University; Stanford University	Bendall, SC (corresponding author), Stanford Univ, Immunol Grad Program, Stanford, CA 94305 USA.; Bendall, SC (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	bendall@stanford.edu	Oliveria, John-Paul/AAH-8080-2020; Bendall, Sean/AGG-0126-2022	Oliveria, John-Paul/0000-0002-7192-7634; Calderon, Ariel/0000-0001-9606-2115; Davis, Mark/0000-0001-6868-657X; Kimmey, Samuel/0000-0002-5742-4037; Tsai, Albert/0000-0002-6607-3347; Wagar, Lisa/0000-0001-5980-3586; Hartmann, Felix/0000-0002-4174-2276; Bendall, Sean/0000-0003-1341-2453; Glass, Marla/0000-0003-3763-0842; Glass, David/0000-0001-9924-167X	Stanford Graduate Fellowship; Bio-X Stanford Interdisciplinary Graduate Fellowship; Damon Runyon Cancer Research Foundation (DRCRF) [DRG-118-16]; Stanford Department of Pathology Seed Grant; Canadian Institute of Health Research Postdoctoral Fellowship; EMBO organization (EMBO Long-Term Fellowship); Novartis Foundation for Medical-Biological Research; Swiss National Science Foundation (SNF Early Postdoc Mobility); NIH/NIGMS Cell and Molecular Biology Training Grant [T32GM007276]; NIAID of the National Institutes of Health [5T32AI007290-32]; National Science Foundation Graduate Research Fellowship Program [DGE-1656518]; Molecular and Cellular Immunology NIH Training Grant institutional postdoctoral fellowship [5 T32 AI07290]; NIH [U01AI35947-02, 1DP2OD022550-01, 1R01AG056287-01, 1R01AG057915-01, 1-R00-GM104148-01, 1U24CA224309-01, 5U19AI116484-02, UH3 CA246633, U19 AG065156-01]; DRCRF Fellowship [DRG-2017-09]; Bill and Melinda Gates Foundation	Stanford Graduate Fellowship(Stanford University); Bio-X Stanford Interdisciplinary Graduate Fellowship; Damon Runyon Cancer Research Foundation (DRCRF); Stanford Department of Pathology Seed Grant; Canadian Institute of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); EMBO organization (EMBO Long-Term Fellowship); Novartis Foundation for Medical-Biological Research; Swiss National Science Foundation (SNF Early Postdoc Mobility)(Swiss National Science Foundation (SNSF)); NIH/NIGMS Cell and Molecular Biology Training Grant; NIAID of the National Institutes of Health; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Molecular and Cellular Immunology NIH Training Grant institutional postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DRCRF Fellowship; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Thanks to Leeat Keren and Erin McCaffrey for discussion and comments; to Jennifer Wang, Trevor Bruce, Shirley Greenbaum, and the Stanford Blood Center Flow Cytometry Core for experimental assistance; and to the Stanford Immunology Graduate Program leadership and administration for training and support. D.R.G. was supported by a Stanford Graduate Fellowship and a Bio-X Stanford Interdisciplinary Graduate Fellowship. A.G.T. was supported by a Damon Runyon Cancer Research Foundation (DRCRF) (DRG-118-16) and Stanford Department of Pathology Seed Grant. J.P.O. was supported by a Canadian Institute of Health Research Postdoctoral Fellowship. F.J.H was supported by the EMBO organization (EMBO Long-Term Fellowship), the Novartis Foundation for Medical-Biological Research, and the Swiss National Science Foundation (SNF Early Postdoc Mobility). S.C.K. was supported by the NIH/NIGMS Cell and Molecular Biology Training Grant (T32GM007276). A.A.C. was supported by the NIAID of the National Institutes of Health under award number 5T32AI007290-32 and the National Science Foundation Graduate Research Fellowship Program under grant number DGE-1656518. M.C.G. was supported by the Molecular and Cellular Immunology NIH Training Grant institutional postdoctoral fellowship (5 T32 AI07290) and NIH grant U01AI35947-02. S.C.B. was supported by the DRCRF Fellowship (DRG-2017-09), the NIH 1DP2OD022550-01, 1R01AG056287-01, 1R01AG057915-01, 1-R00-GM104148-01, 1U24CA224309-01, 5U19AI116484-02, UH3 CA246633, U19 AG065156-01, and The Bill and Melinda Gates Foundation. Figures were created using BioRender (http://www.biorender.com) and Illustrator (Adobe).	Abdel-Wahab N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160221; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Boyd SD, 2016, CURR OPIN IMMUNOL, V40, P103, DOI 10.1016/j.coi.2016.03.008; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; DANIEL PT, 1994, J IMMUNOL, V152, P5624; de Vries ARV, 1999, EUR J IMMUNOL, V29, P3160; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Garraud O, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-63; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hafler D.A., 2014, SCI TRANSL MED, V248; Hartmann F.J., 2020, MULTIPLEXED SINGLE C, DOI [10.1101/2020.01.17.909796, DOI 10.1101/2020.01.17.909796]; Hartmann FJ, 2019, CELL REP, V28, P819, DOI 10.1016/j.celrep.2019.06.049; Hartmann FJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28791-2; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jackson SM, 2009, BLOOD, V113, P3999, DOI 10.1182/blood-2008-03-145979; Jimenez-Saiz R, 2019, J ALLERGY CLIN IMMUN, V144, P336, DOI 10.1016/j.jaci.2019.04.001; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Karnell JL, 2017, CELL IMMUNOL, V321, P40, DOI 10.1016/j.cellimm.2017.05.008; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kimmey SC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09128-7; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Koethe S, 2011, J LEUKOCYTE BIOL, V90, P5, DOI 10.1189/jlb.0710404; Kotecha N., 2010, CURR PROTOC CYTOM, V17; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Macardle PJ, 2002, EUR J IMMUNOL, V32, P3736, DOI 10.1002/1521-4141(200212)32:12<3736::AID-IMMU3736>3.0.CO;2-I; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Sun JB, 2015, CELL REP, V13, P1110, DOI 10.1016/j.celrep.2015.09.070; Sutherland CL, 1996, J IMMUNOL, V157, P3381; Thorarinsdottir K, 2016, CLIN EXP IMMUNOL, V185, P252, DOI 10.1111/cei.12795; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Tsubata Takeshi, 2012, Infectious Disorders - Drug Targets, V12, P181; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	57	47	48	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					217	+		10.1016/j.immuni.2020.06.013	http://dx.doi.org/10.1016/j.immuni.2020.06.013			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668225	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000551116800021
J	Camara, A; Cordeiro, OG; Alloush, F; Sponsel, J; Chypre, M; Onder, L; Asano, K; Tanaka, M; Yagita, H; Ludewig, B; Flacher, V; Mueller, CG				Camara, Abdouramane; Cordeiro, Olga G.; Alloush, Farouk; Sponsel, Janina; Chypre, Melanie; Onder, Lucas; Asano, Kenichi; Tanaka, Masato; Yagita, Hideo; Ludewig, Burkhard; Flacher, Vincent; Mueller, Christopher G.			Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR FAMILY-MEMBER; SUBCAPSULAR SINUS; RECEPTOR ACTIVATOR; DENDRITIC CELLS; OSTEOCLAST; EXPRESSION; INFLAMMATION; LYMPHOTOXIN; MAINTENANCE	Tissue-resident macrophages are receptive to specific signals concentrated in cellular niches that direct their cell differentiation and maintenance genetic programs. Here, we found that deficiency of the cytokine RANKL in lymphoid tissue organizers and marginal reticular stromal cells of lymph nodes resulted in the loss of the CD169(+) sinusoidal macrophages (SMs) comprising the subcapsular and the medullary subtypes. Subcapsular SM differentiation was impaired in mice with targeted RANK deficiency in SMs. Temporally controlled RANK removal in lymphatic endothelial cells (LECs) revealed that lymphatic RANK activation during embryogenesis and shortly after birth was required for the differentiation of both SM subtypes. Moreover, RANK expression by LECs was necessary for SM restoration after inflammation-induced cell loss. Thus, cooperation between mesenchymal cells and LECs shapes a niche environment that supports SM differentiation and reconstitution after inflammation.	[Camara, Abdouramane; Cordeiro, Olga G.; Alloush, Farouk; Sponsel, Janina; Chypre, Melanie; Flacher, Vincent; Mueller, Christopher G.] Univ Strasbourg, CNRS UPR 3572, IBMC, F-67000 Strasbourg, France; [Onder, Lucas; Ludewig, Burkhard] Kantonspital St Gallen, Inst Immunobiol, Med Res Ctr, CH-9007 St Gallen, Switzerland; [Asano, Kenichi; Tanaka, Masato] Tokyo Univ Pharm & Life Sci, Lab Immune Regulat, Sch Life Sci, Tokyo 1920392, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kantonsspital St. Gallen; Tokyo University of Pharmacy & Life Sciences; Juntendo University	Mueller, CG (corresponding author), Univ Strasbourg, CNRS UPR 3572, IBMC, F-67000 Strasbourg, France.	c.mueller@ibmc-cnrs.unistra.fr		Camara, Abdouramane/0000-0003-1521-4821; FLACHER, Vincent/0000-0002-8648-2615; Mueller, Christopher/0000-0002-4119-2729	Malian Ministry of Higher Education and Scientific Research; FP7-MC-ITN [289720]; IdEx-Strasbourg; French Ministry for research and international affairs; Prestwick Chemical Inc.; Centre National pour la Recherche Scientifique; l'Agence Nationale pour la Recherche (Program "Investissements d'Avenir") [ANR-10-LABX-0034 MEDALIS, ANR-11-EQPX-022]	Malian Ministry of Higher Education and Scientific Research; FP7-MC-ITN; IdEx-Strasbourg; French Ministry for research and international affairs; Prestwick Chemical Inc.; Centre National pour la Recherche Scientifique; l'Agence Nationale pour la Recherche (Program "Investissements d'Avenir")(French National Research Agency (ANR))	We thank Nathalie Silvestre (Transgene, Illkirch, France) and Sebastian Pfeffer (CNRS UPR9002, Strasbourg, France) for viruses; Philipp Lang (Dusseldorf, Germany) for anti-VSV antibody; Biogen (Cambridge, MA, USA) for providing reagents; and Taija Makinen (Uppsala, Sweden) for Prox1-cre mice. We are indebted to Ingo Hilgendorf (Freiburg, Germany) for help in irradiation, Celine Keime (IGBMC, Illkirch, France), and Benjamin Voisin (NIH, Bethesda, USA) for transcriptome data analysis. We thank Frederic Gros for critical reading of the manuscript, Sophie Guinard and Simon Rauber for assistance, and lab members for discussion. We appreciate the help of Monique Duval, Delphine Lamon, and Fabien Lhericel, acknowledge the CNRS-Chronobiotron UMS 3415 and Sophie Reibel-Foisset for use of the A3 facility, and note the use of the IGBMC flow cytometry facility. The Cd169-cre mice were kindly provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. A.C. was supported by a stipend from the Malian Ministry of Higher Education and Scientific Research, O.G.C. by FP7-MC-ITN 289720 "Stroma,'' F.A. by IdEx-Strasbourg, J.S. by the French Ministry for research and international affairs, M.C. by Prestwick Chemical Inc. and the Centre National pour la Recherche Scientifique, and C.G.M. by l'Agence Nationale pour la Recherche (Program "Investissements d'Avenir,'' ANR-10-LABX-0034 MEDALIS and ANR-11-EQPX-022).	Ahern E, 2018, NAT REV CLIN ONCOL, V15, P676, DOI 10.1038/s41571-018-0095-y; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arai A, 2012, J CELL SCI, V125, P2910, DOI 10.1242/jcs.099986; Bando JK, 2018, IMMUNITY, V48, P1208, DOI 10.1016/j.immuni.2018.04.012; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bovay E, 2018, J EXP MED, V215, P2760, DOI 10.1084/jem.20180217; Buechler MB, 2018, SEMIN IMMUNOL, V35, P48, DOI 10.1016/j.smim.2017.11.001; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chatziandreou N, 2017, CELL REP, V18, P2427, DOI 10.1016/j.celrep.2017.02.026; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Cohen JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087740; Cordeiro OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151848; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Ettinger R, 1998, INT IMMUNOL, V10, P727, DOI 10.1093/intimm/10.6.727; Furuya M, 2010, J IMMUNOL, V185, P5769, DOI 10.4049/jimmunol.1002226; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Guerrini MM, 2015, IMMUNITY, V43, P1174, DOI 10.1016/j.immuni.2015.10.017; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Hoorweg K, 2015, J IMMUNOL, V195, P4257, DOI 10.4049/jimmunol.1402584; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Josien R, 1999, J IMMUNOL, V162, P2562; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kamijo S, 2006, BIOCHEM BIOPH RES CO, V347, P124, DOI 10.1016/j.bbrc.2006.06.098; Karasawa K, 2015, J AM SOC NEPHROL, V26, P896, DOI 10.1681/ASN.2014020195; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Onder L, 2018, TRENDS IMMUNOL, V39, P775, DOI 10.1016/j.it.2018.08.003; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Pucci F, 2016, SCIENCE, V352, P242, DOI 10.1126/science.aaf1328; Remouchamps C, 2011, CYTOKINE GROWTH F R, V22, P301, DOI 10.1016/j.cytogfr.2011.11.007; Rios D, 2016, MUCOSAL IMMUNOL, V9, P907, DOI 10.1038/mi.2015.121; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Sugiyama M, 2012, INT IMMUNOL, V24, P369, DOI 10.1093/intimm/dxs002; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Takeuchi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02196; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zhang Y, 2016, ELIFE, V5, DOI 10.7554/eLife.18156	67	47	47	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1467	+		10.1016/j.immuni.2019.05.008	http://dx.doi.org/10.1016/j.immuni.2019.05.008			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31201093	Bronze, Green Published			2022-12-18	WOS:000471876100017
J	Wei, SC; Sharma, R; Anang, NAAS; Levine, JH; Zhao, Y; Mancuso, JJ; Setty, M; Sharma, P; Wang, J; Pe'er, D; Allison, JP				Wei, Spencer C.; Sharma, Roshan; Anang, Nana-Ama A. S.; Levine, Jacob H.; Zhao, Yang; Mancuso, James J.; Setty, Manu; Sharma, Padmanee; Wang, Jing; Pe'er, Dana; Allison, James P.			Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States	IMMUNITY			English	Article							FOLLICULAR-HELPER; CTLA-4 CONTROLS; MOLECULAR-BASIS; N-REGIONS; RESPONSES; MICE; ACTIVATION; MECHANISMS; DEFICIENT; LYMPHOPROLIFERATION	Co-stimulation regulates T cell activation, but it remains unclear whether co-stimulatory pathways also control T cell differentiation. We used mass cytometry to profile T cells generated in the genetic absence of the negative co-stimulatory molecules CTLA-4 and PD-1. Our data indicate that negative co-stimulation constrains the possible cell states that peripheral T cells can acquire. CTLA-4 imposes major boundaries on CD4(+) T cell phenotypes, whereas PD-1 subtly limits CD8(+)T cell phenotypes. By computationally reconstructing T cell differentiation paths, we identified protein expression changes that underlied the abnormal phenotypic expansion and pinpointed when lineage choice events occurred during differentiation. Similar alterations in T cell phenotypes were observed after anti-CTLA-4 and anti-PD-1 antibody blockade. These findings implicate negative co-stimulation as a key regulator and determinant of T cell differentiation and suggest that checkpoint blockade might work in part by altering the limits of T cell phenotypes.	[Wei, Spencer C.; Anang, Nana-Ama A. S.; Mancuso, James J.; Allison, James P.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sharma, Roshan; Levine, Jacob H.; Setty, Manu; Pe'er, Dana] Sloan Kettering Inst, Computat & Syst Biol Program, New York, NY 10065 USA; [Sharma, Roshan] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; [Zhao, Yang; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Sharma, Padmanee; Allison, James P.] Univ Texas MD Anderson Canc Ctr, Parker Inst Canc Immunotherapy, Houston, TX 77030 USA; [Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10065 USA	University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center	Allison, JP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Allison, JP (corresponding author), Univ Texas MD Anderson Canc Ctr, Parker Inst Canc Immunotherapy, Houston, TX 77030 USA.	jallison@mdanderson.org		Setty, Manu/0000-0002-0344-2627; Mancuso, James/0000-0001-5776-8617; Anang, Nana-Ama/0000-0002-8495-2978; Pe'er, Dana/0000-0002-9259-8817	National Cancer Institute Cancer Center Support Grant (CCSG) [P30CA16672]; Cancer Prevention and Research in Texas [R1203]; MDACC CCSG Bioinformatics Shared Resource, NIH [DP1-HD084071, R01CA164729]; MSK Cancer Center Support Grant/Core Grant [P30CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA164729, P30CA008748, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support Grant (CCSG); Cancer Prevention and Research in Texas; MDACC CCSG Bioinformatics Shared Resource, NIH; MSK Cancer Center Support Grant/Core Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Duncan Mak for providing expert advice in mass-cytometry analysis, members of the Allison and Pe'er labs for helpful discussions, and Caitlin Trasande for critical reading. Mass cytometry was performed at the MD Anderson Cancer Center (MDACC) Flow Cytometry and Cellular Imaging Core Facility, transgenic mouse lines were generated with the MDACC Genetically Engineered Mouse Facility, and sequencing was performed at the MDACC Sequencing and Microarray Facility, all of which are in part funded by National Cancer Institute Cancer Center Support Grant (CCSG) P30CA16672. This work was supported by a grant from Cancer Prevention and Research in Texas to J.P.A. (R1203), the MDACC CCSG Bioinformatics Shared Resource, NIH grants to D.P. (DP1-HD084071 and R01CA164729), and a MSK Cancer Center Support Grant/Core Grant to D.P. (P30CA008748). S.C.W. was an MD Anderson Cancer Center Odyssey postdoctoral fellow.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Bour-Jordan H, 2003, NAT IMMUNOL, V4, P182, DOI 10.1038/ni884; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Coutzac C, 2017, J CROHNS COLITIS, V11, P1238, DOI 10.1093/ecco-jcc/jjx081; CUTLER A, 1994, TECHNOMETRICS, V36, P338, DOI 10.2307/1269949; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Engelhardt JJ, 2006, J IMMUNOL, V177, P1052, DOI 10.4049/jimmunol.177.2.1052; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARDTLE W, 1997, SYNOPSIS PFLANZENGES, P1; Hart Y, 2015, NAT METHODS, V12, P233, DOI [10.1038/NMETH.3254, 10.1038/nmeth.3254]; Hou TZ, 2015, J IMMUNOL, V194, P2148, DOI 10.4049/jimmunol.1401876; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Khattri R, 1999, J IMMUNOL, V162, P5784; Klocke K, 2016, P NATL ACAD SCI USA, V113, pE2383, DOI 10.1073/pnas.1603892113; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Korem Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004224; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Kuhn H.W., 1955, NAV RES LOGIST Q, V2, P83, DOI [10.1002/nav.3800020109, DOI 10.1002/NAV.3800020109]; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778; Melchiotti R, 2017, CYTOM PART A, V91A, P73, DOI 10.1002/cyto.a.23001; Moon K. R., 2019, BIORXIV, DOI [10.1101/120378, DOI 10.1101/120378]; Morup M, 2012, NEUROCOMPUTING, V80, P54, DOI 10.1016/j.neucom.2011.06.033; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nadler B., 2006, ADV NEURAL INF PROCE; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Sheftel H, 2013, ECOL EVOL, V3, P1471, DOI 10.1002/ece3.528; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; van Berkel MEAT, 2005, J IMMUNOL, V175, P182, DOI 10.4049/jimmunol.175.1.182; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Verhagen J, 2013, P NATL ACAD SCI USA, V110, pE221, DOI 10.1073/pnas.1208573110; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterhouse P, 1997, EUR J IMMUNOL, V27, P1887, DOI 10.1002/eji.1830270811; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	86	47	47	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1084	+		10.1016/j.immuni.2019.03.004	http://dx.doi.org/10.1016/j.immuni.2019.03.004			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30926234	Bronze, Green Accepted			2022-12-18	WOS:000464660800024
J	Ghosh, A; Shao, LL; Sampath, P; Zhao, BY; Patel, NV; Zhu, JZ; Behl, B; Parise, RA; Beumer, JH; O'Sullivan, RJ; DeLuca, NA; Thorne, SH; Rathinam, VAK; Li, PW; Sarkar, SN				Ghosh, Arundhati; Shao, Lulu; Sampath, Padmavathi; Zhao, Baoyu; Patel, Nidhi, V; Zhu, Jianzhong; Behl, Bharat; Parise, Robert A.; Beumer, Jan H.; O'Sullivan, Roderick J.; DeLuca, Neal A.; Thorne, Stephen H.; Rathinam, Vijay A. K.; Li, Pingwei; Sarkar, Saumendra N.			Oligoadenylate-Synthetase-Family Protein OASL Inhibits Activity of the DNA Sensor cGAS during DNA Virus Infection to Limit Interferon Production	IMMUNITY			English	Article							GMP-AMP SYNTHASE; HOST; PROMOTES; BETA; REPLICATION; EXPRESSION; MECHANISM; REVEALS; GENES; CELLS	Interferon-inducible human oligoadenylate synthetase-like (OASL) and its mouse ortholog, Oasl2, enhance RNA-sensor RIG-I-mediated type I interferon (IFN) induction and inhibit RNA virus replication. Here, we show that OASL and Oasl2 have the opposite effect in the context of DNA virus infection. In Oasl2(-/-) mice and OASL-deficient human cells, DNA viruses such as vaccinia, herpes simplex, and adenovirus induced increased IFN production, which resulted in reduced virus replication and pathology. Correspondingly, ectopic expression of OASL in human cells inhibited IFN induction through the cGAS-STING DNA-sensing pathway. cGAS was necessary for the reduced DNA virus replication observed in OASL-deficient cells. OASL directly and specifically bound to cGAS independently of double-stranded DNA, resulting in a non-competitive inhibition of the second messenger cyclic GMP-AMP production. Our findings define distinct mechanisms by which OASL differentially regulates host IFN responses during RNA and DNA virus infection and identify OASL as a negative-feedback regulator of cGAS.	[Ghosh, Arundhati; Shao, Lulu; Sampath, Padmavathi; Patel, Nidhi, V; Zhu, Jianzhong; DeLuca, Neal A.; Thorne, Stephen H.; Sarkar, Saumendra N.] Univ Pittsburgh, Canc Inst, Canc Virol Program, Pittsburgh, PA 15213 USA; [Ghosh, Arundhati; Shao, Lulu; Zhu, Jianzhong; DeLuca, Neal A.; Sarkar, Saumendra N.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Sampath, Padmavathi; Thorne, Stephen H.] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA 15261 USA; [Zhao, Baoyu; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Behl, Bharat; Rathinam, Vijay A. K.] Univ Connecticut Hlth, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [Parise, Robert A.; Beumer, Jan H.] Univ Pittsburgh, Dept Pharmaceut Sci, Sch Pharm, Pittsburgh, PA 15213 USA; [O'Sullivan, Roderick J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15219 USA; [Zhu, Jianzhong] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas A&M University System; Texas A&M University College Station; University of Connecticut; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yangzhou University	Sarkar, SN (corresponding author), Univ Pittsburgh, Canc Inst, Canc Virol Program, Pittsburgh, PA 15213 USA.; Sarkar, SN (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.	saumen@pitt.edu	Shao, Lulu/I-4425-2019; Rathinam, Vijay/ABE-7544-2020; Sarkar, Saumendra N/B-5038-2011	Shao, Lulu/0000-0002-1441-4744; Rathinam, Vijay/0000-0002-8009-3977; Sarkar, Saumendra N/0000-0002-2850-6121	NIH [P30CA047904, AI118896, CA178766]; NATIONAL CANCER INSTITUTE [R50CA211241, R01CA178766, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118896] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Dr. Andrea Gambotto, Dr. Chris Benedict, and Dr. Veit Hornung for generously sharing crucial reagents. This work was supported in part by AI118896 and CA178766 from the NIH. This project used a number of University of Pittsburgh Cancer Institute core facilities supported by P30CA047904 from the NIH.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Aguirre S, 2017, J VIROL, V91, DOI 10.1128/JVI.01081-16; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; Busnadiego I, 2014, J VIROL, V88, P7738, DOI 10.1128/JVI.00214-14; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chen S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01006; Chen YA, 2017, NAT STRUCT MOL BIOL, V24, P1124, DOI 10.1038/nsmb.3498; CHOI UY, 2015, EXP MOL MED, V47; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Crow MK, 2016, NAT REV RHEUMATOL, V12, P439, DOI 10.1038/nrrheum.2016.117; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Daugherty MD, 2016, ELIFE, V5, DOI 10.7554/eLife.14228; Detje CN, 2015, J VIROL, V89, P2731, DOI 10.1128/JVI.02044-14; Dhar J, 2015, J VIROL, V89, P10115, DOI 10.1128/JVI.01076-15; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Goulding J, 2012, J IMMUNOL, V189, P2432, DOI 10.4049/jimmunol.1200799; Guo HT, 2016, CELL HOST MICROBE, V19, P515, DOI 10.1016/j.chom.2016.03.001; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartmann G, 2017, ADV IMMUNOL, V133, P121, DOI 10.1016/bs.ai.2016.11.001; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Kirn DH, 2007, PLOS MED, V4, P2001, DOI 10.1371/journal.pmed.0040353; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Lum KK, 2018, CELL SYST, V7, P627, DOI 10.1016/j.cels.2018.10.010; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Nair S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003999; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Oh JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19089; Reeves PM, 2011, J VIROL, V85, P21, DOI 10.1128/JVI.01814-10; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schmidt T, 2016, METHODS MOL BIOL, V1338, P261, DOI 10.1007/978-1-4939-2932-0_19; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tuting T, 1999, J GENE MED, V1, P400, DOI 10.1002/(SICI)1521-2254(199911/12)1:6<400::AID-JGM68>3.0.CO;2-D; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Ye S, 2007, CLIN RHEUMATOL, V26, P186, DOI 10.1007/s10067-006-0260-z; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zheng S, 2016, J MED VIROL, V88, P760, DOI 10.1002/jmv.24397; Zhu JZ, 2014, IMMUNITY, V40, P936, DOI 10.1016/j.immuni.2014.05.007	64	47	50	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					51	+		10.1016/j.immuni.2018.12.013	http://dx.doi.org/10.1016/j.immuni.2018.12.013			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30635239	Green Accepted, Bronze			2022-12-18	WOS:000455661600010
J	O'Reilly, LA; Putoczki, TL; Mielke, LA; Low, JT; Lin, A; Preaudet, A; Herold, MJ; Yaprianto, K; Tai, L; Kueh, A; Pacini, G; Ferrero, RL; Gugasyan, R; Hu, YF; Christie, M; Wilcox, S; Grumont, R; Griffin, MDW; O'Connor, L; Smyth, GK; Ernst, M; Waring, P; Gerondakis, S; Strasser, A				O'Reilly, Lorraine A.; Putoczki, Tracy L.; Mielke, Lisa A.; Low, Jun T.; Lin, Ann; Preaudet, Adele; Herold, Marco J.; Yaprianto, Kelvin; Tai, Lin; Kueh, Andrew; Pacini, Guido; Ferrero, Richard L.; Gugasyan, Raffi; Hu, Yifang; Christie, Michael; Wilcox, Stephen; Grumont, Raelene; Griffin, Michael D. W.; O'Connor, Liam; Smyth, Gordon K.; Ernst, Mathias; Waring, Paul; Gerondakis, Steve; Strasser, Andreas			Loss of NF-kappa B1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner	IMMUNITY			English	Article							NF-KAPPA-B; HELICOBACTER-PYLORI; TARGETED DISRUPTION; NFKB1; PROMOTER; GENES; STAT3; PROLIFERATION; TRANSCRIPTION; POLYMORPHISM	Polymorphisms in NF kappa B1 that diminish its expression have been linked to human inflammatory diseases and increased risk for epithelial cancers. The underlying mechanisms are unknown, and the link is perplexing given that NF-kappa B signaling reportedly typically exerts pro-tumorigenic activity. Here we have shown that NF-kappa B1 deficiency, even loss of a single allele, resulted in spontaneous invasive gastric cancer (GC) in mice that mirrored the histopathological progression of human intestinal-type gastric adenocarcinoma. Bone marrow chimeras revealed that NF-kappa B1 exerted tumor suppressive functions in both epithelial and hematopoietic cells. RNA-seq analysis showed that NF-kappa B1 deficiency resulted in aberrant JAK-STAT signaling, which dysregulated expression of effectors of inflammation, antigen presentation, and immune checkpoints. Concomitant loss of STAT1 prevented these immune abnormalities and GC development. These findings provide mechanistic insight into how polymorphisms that attenuate NF kappa B1 expression predispose humans to epithelial cancers, highlighting the pro-tumorigenic activity of STAT1 and identifying targetable vulnerabilities in GC.	[O'Reilly, Lorraine A.; Putoczki, Tracy L.; Mielke, Lisa A.; Low, Jun T.; Lin, Ann; Preaudet, Adele; Herold, Marco J.; Yaprianto, Kelvin; Tai, Lin; Kueh, Andrew; Pacini, Guido; Hu, Yifang; Wilcox, Stephen; O'Connor, Liam; Smyth, Gordon K.; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [O'Reilly, Lorraine A.; Putoczki, Tracy L.; Mielke, Lisa A.; Low, Jun T.; Herold, Marco J.; Yaprianto, Kelvin; Kueh, Andrew; Wilcox, Stephen; O'Connor, Liam; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Ferrero, Richard L.] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Gugasyan, Raffi] Burnet Inst, Hlth Ageing, Life Sci Discipline, Melbourne, Vic 3004, Australia; [Gugasyan, Raffi] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Christie, Michael] Univ Melbourne, Ctr Translat Pathol, Parkville, Vic 3010, Australia; [Grumont, Raelene; Gerondakis, Steve] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Grumont, Raelene; Gerondakis, Steve] Monash Univ, Biomed Discovery Inst, Canc Program, Clayton, Vic 3800, Australia; [Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Griffin, Michael D. W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Ernst, Mathias] Olivia Newton John Canc Res Inst, Heidelberg, Vic 3084, Australia; [Ernst, Mathias] La Trobe Univ, Sch Canc Med, Heidelberg, Vic 3084, Australia; [Waring, Paul] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Yaprianto, Kelvin] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Walter & Eliza Hall Institute; University of Melbourne; Hudson Institute of Medical Research; Burnet Institute; Monash University; University of Melbourne; Monash University; Monash University; University of Melbourne; University of Melbourne; University of Melbourne; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; University of Melbourne; University of Oxford	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; O'Reilly, LA; Strasser, A (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	oreilly@wehi.edu.au; strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013; Ernst, Matthias/D-5111-2012; Herold, Marco J/C-8039-2013; Ferrero, Richard/U-1332-2017	Strasser, Andreas/0000-0002-5020-4891; Ernst, Matthias/0000-0002-6399-1177; Herold, Marco J/0000-0001-7539-7581; Mielke, Lisa/0000-0002-9522-9320; Ferrero, Richard/0000-0001-6817-6211	Cancer Australia; Cancer Council New South Wales [1047672]; NHMRC; Canberra [1016701, 1055618, 1020363, 1058892, 606476, 1079904, 1046010, 1008614, 1080498, 603713]; WEHI Dyson Bequest Centenary Fellowship; Victorian Cancer Agency Fellowship; Worldwide Cancer Research project [14-1197]; Operational Infrastructure Support Program (Hudson Institute) Australian Postgraduate Award; Top-up Scholarship, Cancer Therapeutics CRC (Australia); NHMRC; Independent Research Institutes Infrastructure Support Scheme Grant [361646]; Victorian State Government (OIS grant); Leukemia and Lymphoma Society (SCOR grant) [7413, 7001-13]; JDRF/NHMRC [466658]; Monash University Faculty of Medicine, Nursing and Health Sciences Outside Studies Program	Cancer Australia; Cancer Council New South Wales(Cancer Council New South Wales); NHMRC; Canberra(National Health and Medical Research Council (NHMRC) of Australia); WEHI Dyson Bequest Centenary Fellowship; Victorian Cancer Agency Fellowship; Worldwide Cancer Research project; Operational Infrastructure Support Program (Hudson Institute) Australian Postgraduate Award; Top-up Scholarship, Cancer Therapeutics CRC (Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Independent Research Institutes Infrastructure Support Scheme Grant; Victorian State Government (OIS grant); Leukemia and Lymphoma Society (SCOR grant)(Leukemia and Lymphoma Society); JDRF/NHMRC(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); Monash University Faculty of Medicine, Nursing and Health Sciences Outside Studies Program	We thank T. Burgess, J. Silke, P. Bouillet, and D. Wortherly for discussions and critical reading of this manuscript, K. Lawlor for advice on flow cytometry, S. Infantino for advice on phospho-flow analysis, G. Siciliano, K. Hughes, and H. Johnston for animal care, B. Helbert, C. Young, and K. Mackwell for genotyping, E. Tsui, B. Tsui, V. Babo, and K. Weston for preparation of histological sections. This work was principally supported by a Cancer Australia and Cancer Council New South Wales project grant #1047672 (L.A.O'R., T.L.P., P.W., M.J.H.). This work was further supported by fellowships and grants from the NHMRC; Canberra; program #1016701 (A.S.), # 1055618 (G.K.S.), fellowships; #1020363 (A.S.), #1058892 (G.S.), #606476 and #1079904 (R.L.F.), and project grants; #1046010 (A.S.), #1008614, #1080498 (T.L.P.), and #603713 (R. Gugasyan), WEHI Dyson Bequest Centenary Fellowship (T.L.P.), Victorian Cancer Agency Fellowship (T.L.P.), Worldwide Cancer Research project grant 14-1197 (T.L.P.), Operational Infrastructure Support Program (Hudson Institute) Australian Postgraduate Award (J.T.L.), Top-up Scholarship, Cancer Therapeutics CRC (Australia) (J.T.L.), and an NHMRC infrastructure grant, Independent Research Institutes Infrastructure Support Scheme Grant #361646, the Victorian State Government (OIS grant), the Leukemia and Lymphoma Society (SCOR grant #7413 and #7001-13) and the JDRF/NHMRC #466658 (A.S.), Monash University Faculty of Medicine, Nursing and Health Sciences Outside Studies Program (R.L.F.).	Arisawa T, 2013, ONCOL REP, V30, P3013, DOI 10.3892/or.2013.2768; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chen Y, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0243-0; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; CORREA P, 1992, CANCER RES, V52, P6735; de Valle E, 2016, J EXP MED, V213, P621, DOI 10.1084/jem.20151182; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Ferrero RL, 2000, J PATHOL, V191, P333; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Joossens JV, 1996, INT J EPIDEMIOL, V25, P494, DOI 10.1093/ije/25.3.494; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Koliaraki V, 2012, J CLIN INVEST, V122, P4231, DOI 10.1172/JCI63917; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lewander A, 2007, SCAND J GASTROENTERO, V42, P1332, DOI 10.1080/00365520701396026; Li D, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317717107; Li PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071604; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lu RQ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-87; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Meissl K, 2017, CYTOKINE, V89, P12, DOI 10.1016/j.cyto.2015.11.011; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Qing Y, 2015, DRUG DES DEV THER, V9, P901, DOI 10.2147/DDDT.S75152; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sunakawa Y, 2015, ANN ONCOL, V26, P332, DOI 10.1093/annonc/mdu542; Sutton P, 2000, INFECT IMMUN, V68, P4802, DOI 10.1128/IAI.68.8.4802-4804.2000; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Hua T, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000279; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; Wilson CL, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms7818, 10.1038/ncomms9901]; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Yang HT, 2011, J IMMUNOL, V186, P1989, DOI 10.4049/jimmunol.1001003; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025	67	47	50	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					570	+		10.1016/j.immuni.2018.03.003	http://dx.doi.org/10.1016/j.immuni.2018.03.003			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562203	Bronze			2022-12-18	WOS:000427916900016
J	Caron, E; Aebersold, R; Banaei-Esfahani, A; Chong, C; Bassani-Sternberg, M				Caron, Etienne; Aebersold, Ruedi; Banaei-Esfahani, Amir; Chong, Chloe; Bassani-Sternberg, Michal			A Case for a Human Immuno-Peptidome Project Consortium	IMMUNITY			English	News Item								A multidisciplinary group of researchers gathered at the Honggerberg Campus at ETH Zurich, Switzerland, for the first meeting on the Human Immuno-Peptidome Project (https://hupo.org/human-immunopeptidome-project/). The long-term goal of this project is to map the entire repertoire of peptides presented by human leukocyte antigen molecules using mass spectrometry technologies, and make its robust analysis accessible to any immunologist. Here we outline the specific challenges identified toward this goal, and within this framework, describe the structure of a multipronged program aimed at addressing these challenges and implementing solutions at a community-wide level. Pillars of that program are: (1) method and technology development, (2) standardization, (3) effective data sharing, and (4) education. If successful, this community-driven endeavor might provide a roadmap toward new paradigms in immunology.	[Caron, Etienne; Aebersold, Ruedi; Banaei-Esfahani, Amir] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Banaei-Esfahani, Amir] Univ Zurich, Life Sci Zurich Grad Sch, PhD Program Syst Biol, Zurich, Switzerland; [Banaei-Esfahani, Amir] Swiss Fed Inst Technol, Zurich, Switzerland; [Chong, Chloe; Bassani-Sternberg, Michal] Univ Lausanne, Univ Hosp Lausanne, Dept Oncol, Lausanne, Switzerland; [Chong, Chloe; Bassani-Sternberg, Michal] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Caron, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland.; Bassani-Sternberg, M (corresponding author), Univ Lausanne, Univ Hosp Lausanne, Dept Oncol, Lausanne, Switzerland.; Bassani-Sternberg, M (corresponding author), Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland.	caron@imsb.biol.ethz.ch; michal.bassani@chuv.ch	Bassani-Sternberg, Michal/AAQ-3413-2020; Banaei-Esfahani, Amir/N-5128-2017	Bassani-Sternberg, Michal/0000-0002-1934-954X; Banaei-Esfahani, Amir/0000-0002-9533-7647	HUPO; Ludwig Cancer Research; Swiss National Science Foundation; SystemsX; Swiss Cancer League; eLife Scientific Publications; Genentech; Novartis; Roche; Biognosys; Merck; ThermoFisher Scientific; EC HOR2020 project TBVAC2020 [2-73838-14]	HUPO; Ludwig Cancer Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX; Swiss Cancer League; eLife Scientific Publications; Genentech(Roche HoldingGenentech); Novartis(Novartis); Roche(Roche Holding); Biognosys; Merck(Merck & Company); ThermoFisher Scientific; EC HOR2020 project TBVAC2020	We thank the Human Immuno-Peptidome Project Working Group, which included Jennifer Abelin (Neon Therapeutics), Arie Admon (Technion Israel Institute of Technology), Ruedi Aebersold, Amir Banaei-Esfahani, Etienne Caron, Patrick Pedrioli and Wenguang Shao (ETH Zurich), Michal Bassani-Sternberg, Chloe Chong, George Coukos, Fabio Marino and Hui Song Pak (CHUV, Lausanne), Ilan Beer (Adicet Bio), Jennifer Busby (Gritstone Oncology Inc.), John Castle, Erin Jeffery and Paisley Myers (Agenus Inc.), Joshua Elias (Stanford University), Tim Fugmann (Philochem), Roger Geiger (Institute for Research in Biomedicine), David Gfeller (University of Lausanne), Albert Heck (Utrecht University), Daniel Kowalewski, Heiko Schuster and Toni Weinschenk (Immatics), Jennie Lill (Genentech), Miguel Marcilla (Spanish National Biotechnology Centre), Geert Mommen (Immunocore), Markus Muller (Swiss Institute of Bioinformatics), Alexey Nesvizhskii (University of Michigan), Morten Nielsen (The Technical University of Denmark), Claude Perreault (University of Montreal), Anthony Purcell (Monash University), Hans-Georg Rammensee (University of Tubingen), Alessandro Sette (La Jolla Institute for Allergy and Immunology), Paul Shannon (eLife Sciences Publications Ltd.), Guido Sonsmann (Thermo Fisher Scientific), Stefan Tenzer (Mainz University), Nicola Ternette (University Oxford), and Peter van Veelen (Leiden University Medical Center). We thank Edita Schroppel, Brigitte Wipfli, Nicole Brand Hortobagyi, Daniel Kottmann, and Betty Friedrich-Grube for logistics and organizational support for the workshop. We also thank Wayne Koff and Ted Schenkelberg for insightful discussions. Financial support for the HUPO-HIPP workshop was provided by HUPO, Ludwig Cancer Research, Swiss National Science Foundation, SystemsX, Swiss Cancer League, eLife Scientific Publications, Genentech, Novartis, Roche, Biognosys, Merck, and ThermoFisher Scientific. R.A. acknowledges funding from EC HOR2020 project TBVAC2020 (2-73838-14).	Admon A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.011833; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Caron E, 2015, ELIFE, V4, DOI 10.7554/eLife.07661; Green ED, 2015, NATURE, V526, P29, DOI 10.1038/526029a; Hassan C, 2014, J PROTEOMICS, V109, P240, DOI 10.1016/j.jprot.2014.07.009; Koff WC, 2014, NAT IMMUNOL, V15, P589, DOI 10.1038/ni.2871; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Sette A, 2016, EXPERT REV VACCINES, V15, P167, DOI 10.1586/14760584.2016.1112743	8	47	47	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					203	208		10.1016/j.immuni.2017.07.010	http://dx.doi.org/10.1016/j.immuni.2017.07.010			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813649	Bronze			2022-12-18	WOS:000407788300003
J	Chu, HH; Chan, SW; Gosling, JP; Blanchard, N; Tsitsiklis, A; Lythe, G; Shastri, N; Molina-Paris, C; Robey, EA				Chu, H. Hamlet; Chan, Shiao-Wei; Gosling, John Paul; Blanchard, Nicolas; Tsitsiklis, Alexandra; Lythe, Grant; Shastri, Nilabh; Molina-Paris, Carmen; Robey, Ellen A.			Continuous Effector CD8(+) T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; TOXOPLASMA-GONDII; VIRUS-INFECTION; ANTIGEN PRESENTATION; MEMORY PHENOTYPE; EOMESODERMIN; REACTIVATION; STIMULATION; RECOGNITION; EXPRESSION	Highly functional CD8(+) effector T (Teff) cells can persist in large numbers during controlled persistent infections, as exemplified by rare HIV-infected individuals who control the virus. Here we examined the cellular mechanisms that maintain ongoing T effector responses using a mouse model for persistent Toxoplasma gondii infection. In mice expressing the protective MHC-I molecule, H-2L(d), a dominant T effector response against a single parasite antigen was maintained without a contraction phase, correlating with ongoing presentation of the dominant antigen. Large numbers of short-lived Teff cells were continuously produced via a proliferative, antigen-dependent intermediate (Tint) population with a memory-effector hybrid phenotype. During an acute, resolved infection, decreasing antigen load correlated with a sharp drop in the Tint cell population and subsequent loss of the ongoing effector response. Vaccination approaches aimed at the development of Tint populations might prove effective against pathogens that lead to chronic infection.	[Chu, H. Hamlet; Chan, Shiao-Wei; Tsitsiklis, Alexandra; Shastri, Nilabh; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Gosling, John Paul] Univ Leeds, Dept Stat, Leeds LS2 9JT, W Yorkshire, England; [Lythe, Grant; Molina-Paris, Carmen] Univ Leeds, Sch Math, Appl Math, Leeds LS2 9JT, W Yorkshire, England; [Blanchard, Nicolas] Univ Toulouse, Ctr Pathophysiol Toulouse Purpan, INSERM, CNRS,UMR1043,UMR5282, F-31024 Toulouse 3, France	University of California System; University of California Berkeley; University of Leeds; University of Leeds; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Chu, HH; Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA.	hamletchu.berkeley@gmail.com; erobey@berkeley.edu	Blanchard, Nicolas/AAD-6601-2020; Molina-Paris, Carmen/ABG-1274-2021; Blanchard, Nicolas/I-5255-2014; molina-paris, carmen/GRN-8674-2022	Blanchard, Nicolas/0000-0002-4924-2161; Blanchard, Nicolas/0000-0002-4924-2161; Lythe, Grant/0000-0001-7966-5571; molina-paris, carmen/0000-0001-9828-6737; Gosling, John Paul/0000-0002-4072-3022	American National Institutes of Health [P01 AI065831, R01 AI065537, AI093132]; American Heart Association; California Institute for Regenerative Medicine; Human Frontier Science Program; UK's National Centre for Replacement, Refinement and Reduction of Animals in Research [NC/K001280/1]; Leeds Fund for International Research Collaborations; Biotechnology and Biological Sciences Research Council [BB/F003811/1, BB/G023395/1]; BBSRC [BB/F003811/1, BB/G023395/1] Funding Source: UKRI; National Centre for the Replacement [NC/K001280/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065537, R01AI093132, P01AI065831] Funding Source: NIH RePORTER	American National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Human Frontier Science Program(Human Frontier Science Program); UK's National Centre for Replacement, Refinement and Reduction of Animals in Research; Leeds Fund for International Research Collaborations; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Kang for generating TG6 transgenic mice, K. Taylor and I. Chou for expert technical assistance, the NIH Tetramer Core for peptide-MHC tetramers, H. Nolla and A. Valero for cell sorting, M. Jenkins (University of Minnesota), M. Prlic (Fred Hutchson Cancer Research Center), and members of the Robey Laboratory for helpful comments. This work was supported by grants from the American National Institutes of Health P01 AI065831 (E.A.R. and N.S.), R01 AI065537 and AI093132 (E.A.R.); the American Heart Association and the California Institute for Regenerative Medicine (H.H.C.); the Human Frontier Science Program (N.B.); the UK's National Centre for Replacement, Refinement and Reduction of Animals in Research NC/K001280/1 (J.P.G.), the Leeds Fund for International Research Collaborations (G.L. and C.M.-P.), the Biotechnology and Biological Sciences Research Council BB/F003811/1 (G.L. and C.M.-P.) and BB/G023395/1 (C.M.-P.).	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; BROWN CR, 1995, IMMUNOLOGY, V85, P419; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Feliu V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003449; FERGUSON DJP, 1989, PARASITOL RES, V75, P599, DOI 10.1007/BF00930955; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Grover HS, 2014, CELL REP, V7, P1716, DOI 10.1016/j.celrep.2014.04.031; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hiramoto RM, 2002, VACCINE, V20, P2072, DOI 10.1016/S0264-410X(02)00054-3; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Leon B, 2014, J EXP MED, V211, P1637, DOI 10.1084/jem.20131692; Lopez J, 2015, CELL REP, V13, P2273, DOI 10.1016/j.celrep.2015.11.001; Mackay LK, 2012, J IMMUNOL, V188, P2173, DOI 10.4049/jimmunol.1102719; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Narayanan S, 2013, J BIOL CHEM, V288, P31784, DOI 10.1074/jbc.M113.478412; Nelson RW, 2013, J IMMUNOL, V190, P2828, DOI 10.4049/jimmunol.1202183; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shah S, 2015, ELIFE, V4, DOI 10.7554/eLife.09017; Simonetta F, 2014, J VIROL, V88, P11861, DOI 10.1128/JVI.02013-14; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Torti N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002313; Turner DL, 2007, J VIROL, V81, P2039, DOI 10.1128/JVI.02167-06; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	45	47	47	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					159	171		10.1016/j.immuni.2016.06.013	http://dx.doi.org/10.1016/j.immuni.2016.06.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27421704	Green Accepted, Bronze			2022-12-18	WOS:000380749000018
J	Xiao, X; Shi, XM; Fan, YH; Wu, CL; Zhang, XL; Minze, L; Liu, WT; Ghobrial, RM; Lan, PX; Li, XC				Xiao, Xiang; Shi, Xiaomin; Fan, Yihui; Wu, Chenglin; Zhang, Xiaolong; Minze, Laurie; Liu, Wentao; Ghobrial, Rafik M.; Lan, Peixiang; Li, Xian Chang			The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways	IMMUNITY			English	Article							TRANSCRIPTION FACTORS; T-CELLS; IMMUNITY; FAMILY; DIFFERENTIATION; METHYLATION; LYMPHOCYTES; INDUCTION; REJECTION; MEMBERS	T helper 17 (Th17) cells are prominently featured in multiple autoimmune diseases, but the regulatory mechanisms that control Th17 cell responses are poorly defined. Here we found that stimulation of OX40 triggered a robust chromatin remodeling response and produced a "closed" chromatin structure at interleukin-17 (IL-17) locus to inhibit Th17 cell function. OX40 activated the NF-kappa B family member RelB, and RelB recruited the histone methyltransferases G9a and SETDB1 to the Il17 locus to deposit "repressive" chromatin marks at H3K9 sites, and consequently repressing IL-17 expression. Unlike its transcriptional activities, RelB acted independently of both p52 and p50 in the suppression of IL-17. In an experimental autoimmune encephalomyelitis (EAE) disease model, we found that OX40 stimulation inhibited IL-17 and reduced EAE. Conversely, RelB-deficient CD4(+) T cells showed enhanced IL-17 induction and exacerbated the disease. Our data uncover a mechanism in the control of Th17 cells that might have important clinic implications.	[Xiao, Xiang; Shi, Xiaomin; Fan, Yihui; Wu, Chenglin; Zhang, Xiaolong; Minze, Laurie; Liu, Wentao; Ghobrial, Rafik M.; Lan, Peixiang; Li, Xian Chang] Texas Med Ctr, Houston Methodist Hosp, Immunobiol & Transplant Sci Ctr, Houston, TX 77030 USA; [Ghobrial, Rafik M.; Li, Xian Chang] Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas Health Science Center Houston; Cornell University	Li, XC (corresponding author), Texas Med Ctr, Houston Methodist Hosp, Immunobiol & Transplant Sci Ctr, Houston, TX 77030 USA.; Li, XC (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA.	xcli@houstonmethodist.org		xiao, xiang/0000-0001-6644-6118	National Institutes of Health [R01AI106200, R01AI070315, R01AI080779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106200, R01AI070315, R01AI080779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Yang-Xin Fu at University of Chicago for providing Nfkb1<SUP>-/-</SUP> and Nfkb2<SUP>-/-</SUP> mice and Dr. Naoto Ishii at Tohoku University for the OX40Ltg mice. We also thank the flow cytometry and the pathology core facilities at Houston Methodist for excellent services and Dr. Roger Sciammas for discussions. This study was supported by grants from the National Institutes of Health (R01AI106200, R01AI070315, and R01AI080779).	Antignano F, 2014, J CLIN INVEST, V124, P1945, DOI 10.1172/JCI69592; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Coursey TG, 2011, J IMMUNOL, V187, P4219, DOI 10.4049/jimmunol.1100826; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Demirci GI, 2004, J IMMUNOL, V172, P1691, DOI 10.4049/jimmunol.172.3.1691; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Falvo JV, 2013, ADV IMMUNOL, V118, P37, DOI 10.1016/B978-0-12-407708-9.00002-9; Fantini MC, 2007, EUR J IMMUNOL, V37, P3155, DOI 10.1002/eji.200737766; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Li J, 2008, CELL IMMUNOL, V253, P31, DOI 10.1016/j.cellimm.2008.04.010; Li P, 2014, IMMUNOL REV, V261, P141, DOI 10.1111/imr.12199; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Millet P, 2013, J LEUKOCYTE BIOL, V94, P941, DOI 10.1189/jlb.0513305; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Sato T, 2002, EUR J IMMUNOL, V32, P3326, DOI 10.1002/1521-4141(200211)32:11<3326::AID-IMMU3326>3.0.CO;2-9; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; So T, 2011, P NATL ACAD SCI USA, V108, P2903, DOI 10.1073/pnas.1008765108; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Xiao X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9266; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Xiao X, 2012, J IMMUNOL, V188, P892, DOI 10.4049/jimmunol.1101373; Xin LJ, 2014, P NATL ACAD SCI USA, V111, P10672, DOI 10.1073/pnas.1402336111; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937; Zhang ZL, 2010, AM J PATHOL, V177, P2912, DOI 10.2353/ajpath.2010.100353	46	47	54	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1271	1283		10.1016/j.immuni.2016.05.013	http://dx.doi.org/10.1016/j.immuni.2016.05.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27317259	Green Accepted, Bronze			2022-12-18	WOS:000378341200008
J	Guerrini, MM; Okamoto, K; Komatsu, N; Sawa, S; Danks, L; Penninger, JM; Nakashima, T; Takayanagi, H				Guerrini, Matteo M.; Okamoto, Kazuo; Komatsu, Noriko; Sawa, Shinichiro; Danks, Lynett; Penninger, Josef M.; Nakashima, Tomoki; Takayanagi, Hiroshi			Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; DENDRITIC-CELL-FUNCTION; MULTIPLE-SCLEROSIS; BONE DESTRUCTION; IN-VITRO; T-CELLS; ACTIVATION; CNS; RECEPTOR; TRANCE	The central nervous system (CNS) is an immunologically privileged site protected from uncontrolled access of T cells by the blood-brain barrier (BBB), which is breached upon autoimmune inflammation. Here we have shown that receptor activator of nuclear factor-kappa B (NF-kappa B) ligand (RANKL) on T cells regulates C-C type chemokine ligand 20 (CCL20) production by astrocytes and T cell localization in the CNS. Importantly, mice specifically lacking RANKL in T cells were resistant to experimental autoimmune encephalomyelitis (EAE) due to altered T cell trafficking. Pharmacological inhibition of RANKL prevented the development of EAE without affecting the peripheral immune response, indicating that RANKL is a potential therapeutic target for treating autoimmune diseases in the CNS.	[Guerrini, Matteo M.; Okamoto, Kazuo; Komatsu, Noriko; Sawa, Shinichiro; Danks, Lynett; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Guerrini, Matteo M.; Okamoto, Kazuo; Komatsu, Noriko; Sawa, Shinichiro; Danks, Lynett; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Guerrini, Matteo M.; Okamoto, Kazuo; Sawa, Shinichiro; Danks, Lynett; Takayanagi, Hiroshi] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1130033, Japan; [Penninger, Josef M.] Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria; [Nakashima, Tomoki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Nakashima, Tomoki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Bunkyo Ku, Tokyo 1138549, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	takayana@m.u-tokyo.ac.jp	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777	Japan Society for Promotion of Science (JSPS) [15H05703]; JSPS [26713015, 15H05653]; grant for the ERATO Takayanagi Osteonetwork Project from JST; Japan Agency for Medical Research and Development [15ek0109106]; Era of Hope; ERC; grant for PRESTO from JST;  [22-00131]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); grant for the ERATO Takayanagi Osteonetwork Project from JST; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Era of Hope; ERC(European Research Council (ERC)European Commission); grant for PRESTO from JST; 	We are grateful to Astellas Pharma and Wakunaga Pharmaceutical Co. for providing the RANKL inhibitor AS2676293, and to Y. Gotoh for advising on strategy for isolating astrocytes. We also thank T. Negishi-Koga, A. Terashima, H. Takaba, T. Ono, M. Ionue, N. Otsuka, Y. Ogiwara, K. Kusubata, and S. Navone for discussion and technical assistance. This work was supported in part by a Grant-in-Aid for Specially Promoted Research from the Japan Society for Promotion of Science (JSPS) (15H05703); Grants-in-Aid for Young Scientists A from JSPS (26713015 and 15H05653); a Grant-in-Aid for JSPS fellows (22-00131); grants for the ERATO Takayanagi Osteonetwork Project and PRESTO from JST; a grant for Practical Research Project for Rare/Intractable Diseases (15ek0109106) from Japan Agency for Medical Research and Development; and the Era of Hope and an Advanced ERC grants (to J.M.P.). M.M.G. and L.D. were supported in part by JSPS Postdoctoral Fellowships for Overseas Researchers.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Ashcroft AJ, 2003, IMMUNITY, V19, P849, DOI 10.1016/S1074-7613(03)00326-1; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Fukumoto N, 2004, J IMMUNOL, V173, P1620, DOI 10.4049/jimmunol.173.3.1620; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kim JK, 2014, CANCER LETT, V353, P194, DOI 10.1016/j.canlet.2014.07.034; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Miyata J, 2012, BIOORG MED CHEM LETT, V22, P5681, DOI 10.1016/j.bmcl.2012.06.087; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Williamson E, 2002, J IMMUNOL, V169, P3606, DOI 10.4049/jimmunol.169.7.3606; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	34	47	48	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1174	1185		10.1016/j.immuni.2015.10.017	http://dx.doi.org/10.1016/j.immuni.2015.10.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26680207	Bronze			2022-12-18	WOS:000366846600020
J	Hanc, P; Fujii, T; Iborra, S; Yamada, Y; Huotari, J; Schulz, O; Ahrens, S; Kjaer, S; Way, M; Sancho, D; Namba, K; Sousa, CRE				Hanc, Pavel; Fujii, Takashi; Iborra, Salvador; Yamada, Yurika; Huotari, Jatta; Schulz, Oliver; Ahrens, Susan; Kjaer, Svend; Way, Michael; Sancho, David; Namba, Keiichi; Reis e Sousa, Caetano			Structure of the Complex of F-Actin and DNGR-1, a C-Type Lectin Receptor Involved in Dendritic Cell Cross-Presentation of Dead Cell-Associated Antigens	IMMUNITY			English	Article							ELECTRON CRYOMICROSCOPY; FILAMENTS; BINDING; CLEC9A; MICE; IDENTIFICATION; PROTEINS; AFFINITY; IMMUNITY; SURFACE	DNGR-1 is a C-type lectin receptor that binds F-actin exposed by dying cells and facilitates cross-presentation of dead cell-associated antigens by dendritic cells. Here we present the structure of DNGR-1 bound to F-actin at 7.7 angstrom resolution. Unusually for F-actin binding proteins, the DNGR-1 ligand binding domain contacts three actin subunits helically arranged in the actin filament, bridging over two protofilaments, as well as two neighboring actin subunits along one protofilament. Mutation of residues predicted to mediate ligand binding led to loss of DNGR-1-dependent cross-presentation of dead cell-associated antigens, formally demonstrating that the latter depends on F-actin recognition. Notably, DNGR-1 has relatively modest affinity for F-actin but multivalent interactions allow a marked increase in binding strength. Our findings shed light on modes of actin binding by cellular proteins and reveal how extracellular detection of cytoskeletal components by dedicated receptors allows immune monitoring of loss of cellular integrity.	[Hanc, Pavel; Huotari, Jatta; Schulz, Oliver; Ahrens, Susan; Reis e Sousa, Caetano] Francis Crick Inst, Lincolns Inn Fields Lab, Immunobiol Lab, London WC2A 3LY, England; [Fujii, Takashi; Namba, Keiichi] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650871, Japan; [Fujii, Takashi; Yamada, Yurika; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Iborra, Salvador; Sancho, David] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Kjaer, Svend] Francis Crick Inst, Lincolns Inn Fields Lab, Struct Biol Sci Technol Platform, London WC2A 3LY, England; [Way, Michael] Francis Crick Inst, Lincolns Inn Fields Lab, Cell Motil Lab, London WC2A 3LY, England	Francis Crick Institute; RIKEN; Osaka University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Francis Crick Institute; Francis Crick Institute	Sousa, CRE (corresponding author), Francis Crick Inst, Lincolns Inn Fields Lab, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@crick.ac.uk	Sancho, David/D-3433-2009; Namba, Keiichi/A-9406-2016; Reis e Sousa, Caetano/ABD-7322-2021; Iborra, Salvador/J-2863-2015	Sancho, David/0000-0003-2890-3984; Reis e Sousa, Caetano/0000-0001-7392-2119; Iborra, Salvador/0000-0002-1607-1749; Schulz, Oliver/0000-0002-1493-3341; Hanc, Pavel/0000-0002-0511-5566; Way, Michael/0000-0001-7207-2722	Cancer Research UK; European Research Council (ERC) [AdG-2010-268670, StG-2010-260414]; JSPS KAKENHI [25000013, 25711010]; CNIC; Spanish Ministry of Economy and Competitiveness [SAF-2013-42920R]; The Francis Crick Institute [10015] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council (ERC)(European Research Council (ERC)European Commission); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CNIC; Spanish Ministry of Economy and Competitiveness(Spanish Government); The Francis Crick Institute	We thank all members of the Immunobiology Laboratory for helpful discussions and suggestions. We thank the Flow Cytometry, Equipment Park, and Structural Biology Science Technology Platforms for assistance. This work was funded by Cancer Research UK, a prize from Fondation Bettencourt-Schueller, and a grant from the European Research Council (ERC Advanced Researcher Grant AdG-2010-268670) to C.R.S., and by JSPS KAKENHI Grant number 25000013 to K.N. and 25711010 to T.F. Work in the D.S. laboratory is funded by the CNIC and grants from the Spanish Ministry of Economy and Competitiveness (SAF-2013-42920R) and the European Research Council (ERC Starting Independent Researcher Grant StG-2010-260414).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Ge P, 2014, NAT STRUCT MOL BIOL, V21, P1075, DOI 10.1038/nsmb.2907; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	30	47	53	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					839	849		10.1016/j.immuni.2015.04.009	http://dx.doi.org/10.1016/j.immuni.2015.04.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25979418	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000354827400011
J	Choi, HW; Brooking-Dixon, R; Neupane, S; Lee, CJ; Miao, EA; Staats, HF; Abraham, SN				Choi, Hae Woong; Brooking-Dixon, Rhea; Neupane, Subham; Lee, Chul-Jin; Miao, Edward A.; Staats, Herman F.; Abraham, Soman N.			Salmonella Typhimurium Impedes Innate Immunity with a Mast-Cell-Suppressing Protein Tyrosine Phosphatase, SptP	IMMUNITY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; HOST-CELLS; NEUTROPHIL INFLUX; III SECRETION; INFECTION; MODULATION; MICE; RESPONSES; MEDIATE; MODEL	The virulence of Salmonella is linked to its invasive capacity and suppression of adaptive immunity. This does not explain, however, the rapid dissemination of the pathogen after it breaches the gut. In our study, S. Typhimurium suppressed degranulation of local mast cells (MCs), resulting in limited neutrophil recruitment and restricting outflow of vascular contents into infection sites, thus facilitating bacterial spread. MC suppression was mediated by secreted effector protein (SptP), which shares structural homology with Yersinia YopH. SptP functioned by dephosphorylating the vesicle fusion protein N-ethylmalemide-sensitive factor and by blocking phosphorylation of Syk. Without SptP, orally challenged S. Typhimurium failed to suppress MC degranulation and exhibited limited colonization of the mesenteric lymph nodes. Administration of SptP to sites of E. coli infection markedly enhanced its virulence. Thus, SptP-mediated inactivation of local MCs is a powerful mechanism utilized by S. Typhimurium to impede early innate immunity.	[Choi, Hae Woong; Brooking-Dixon, Rhea; Staats, Herman F.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Staats, Herman F.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Lee, Chul-Jin] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Staats, Herman F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Neupane, Subham] Duke Univ, Med Ctr, Undergrad Program Biol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore; [Miao, Edward A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Miao, Edward A.] Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; National University of Singapore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	soman.abraham@duke.edu		Miao, Edward/0000-0001-7295-3490; Staats, Herman/0000-0003-1039-1087; Choi, Hae Woong/0000-0001-9372-1875	National Institutes of Health [U01-AI082107, R01-AI096305, R56-DK095198]; Duke-NUS, Singapore; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097518, R01AI096305, U01AI082107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101456, R01DK077159, R56DK095198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke-NUS, Singapore; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Galan and A. Aballay for Salmonella strains, S. Dowdy for plasmids, D. Metcalfe for LAD2 cells, and A. Roers for Cma1-cre mice. We thank M. Kuehn, L. Hale, and M. Gunn for discussions. C. Shelburne provided technical advice. W. Ang and S. Bowen provided critical manuscript review. This work was funded by National Institutes of Health grants U01-AI082107, R01-AI096305, and R56-DK095198 and a block grant from Duke-NUS, Singapore.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Benhamou M, 2010, FEBS LETT, V584, P4941, DOI 10.1016/j.febslet.2010.09.023; Chatterjea D, 2005, IMMUNOL LETT, V99, P122, DOI 10.1016/j.imlet.2005.02.015; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cramer RA, 2006, EUKARYOT CELL, V5, P972, DOI 10.1128/EC.00049-06; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Enoksson M, 2013, BLOOD, V121, P530, DOI 10.1182/blood-2012-05-434209; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Gunn JS, 2000, INFECT IMMUN, V68, P3758, DOI 10.1128/IAI.68.6.3758-3762.2000; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Harrison CA, 2007, BRIT J PHARMACOL, V150, P509, DOI 10.1038/sj.bjp.0707002; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Humphreys D, 2009, CELL HOST MICROBE, V5, P225, DOI 10.1016/j.chom.2009.01.010; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; King CA, 2000, J VIROL, V74, P7146, DOI 10.1128/JVI.74.15.7146-7150.2000; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; Masuda ES, 2008, PULM PHARMACOL THER, V21, P461, DOI 10.1016/j.pupt.2007.06.002; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Narenjkar J, 2006, INT IMMUNOPHARMACOL, V6, P742, DOI 10.1016/j.intimp.2005.11.001; Niide O, 2006, CLIN IMMUNOL, V118, P108, DOI 10.1016/j.clim.2005.08.012; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; Stebbins CE, 2004, CURR OPIN STRUC BIOL, V14, P731, DOI 10.1016/j.sbi.2004.09.011; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Urb M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002619; van der Velden AWM, 2008, J IMMUNOL, V180, P5569, DOI 10.4049/jimmunol.180.8.5569; van der Velden AWM, 2005, P NATL ACAD SCI USA, V102, P17769, DOI 10.1073/pnas.0504382102; Wang XD, 2002, J IMMUNOL, V168, P4612, DOI 10.4049/jimmunol.168.9.4612; Yang KK, 2002, J IMMUNOL, V169, P4475, DOI 10.4049/jimmunol.169.8.4475	55	47	50	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1108	1120		10.1016/j.immuni.2013.11.009	http://dx.doi.org/10.1016/j.immuni.2013.11.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332031	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000330951000016
J	Scott-Browne, JP; Crawford, F; Young, MH; Kappler, JW; Marrack, P; Gapin, L				Scott-Browne, James P.; Crawford, Frances; Young, Mary H.; Kappler, John W.; Marrack, Philippa; Gapin, Laurent			Evolutionarily Conserved Features Contribute to alpha beta T Cell Receptor Specificity	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; ANTIGEN RECEPTOR; AMINO-ACIDS; NEGATIVE SELECTION; ADAPTIVE IMMUNITY; MHC RECOGNITION; PEPTIDE-MHC; NKT CELLS; BINDING	alpha beta T cell receptors (TCRs) bind specifically to foreign antigens presented by major histocompatibility complex proteins (MHC) or MHC-like molecules. Accumulating evidence indicates that the germline-encoded TCR segments have features that promote binding to MHC and MHC-like molecules, suggesting coevolution between TCR and MHC molecules. Here, we assess directly the evolutionary conservation of alpha beta TCR specificity for MHC. Sequence comparisons showed that some V beta s from distantly related jawed vertebrates share amino acids in their complementarity determining region 2 (CDR2). Chimeric TCRs containing amphibian, bony fish, or cartilaginous fish V beta s can recognize antigens presented by mouse MHC class II and CD1d (an MHC-like protein), and this recognition is dependent upon the shared CDR2 amino acids. These results indicate that features of the TCR that control specificity for MHC and MHC-like molecules were selected early in evolution and maintained between species that last shared a common ancestor more than 400 million years ago.	[Scott-Browne, James P.; Crawford, Frances; Young, Mary H.; Kappler, John W.; Marrack, Philippa; Gapin, Laurent] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Scott-Browne, James P.; Crawford, Frances; Young, Mary H.; Kappler, John W.; Marrack, Philippa; Gapin, Laurent] Univ Colorado, Sch Med, Denver, CO 80206 USA; [Crawford, Frances; Kappler, John W.; Marrack, Philippa] Univ Colorado, Sch Med, Howard Hughes Med Inst, Aurora, CO 80220 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado, Sch Med, Program Biomol Struct, Aurora, CO 80220 USA; [Marrack, Philippa] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80220 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Marrack, P (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA.	marrackp@njhealth.org; gapinl@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	National Institutes of Health [AI18785, AI22295, AI078246, AI076463, AI092108-01A1, T32 AI07405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007405, P01AI022295, R01AI018785, R37AI018785, R21AI076463, R01AI092108, R56AI018785, R56AI078246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the J.W.K. and P.M. lab and the L.G. lab for thoughtful discussion and P. Henson (NJH) and M. Kronenberg (LIAI) for comments on the manuscript. We thank the flow cytometry facility at NJH for technical assistance with cell sorting and E. Kushnir and M. MacLeod (NJH) for assistance generating bone marrow chimeras. We thank Y. Refaeli (NJH) for providing stem cell cytokine containing conditioned medium. Rainbow trout fillet was generously provided by J. Campos (NJH). This work was supported by grants from the National Institutes of Health (AI18785 and AI22295 to P.M. and J.W.K. and AI078246, AI076463, and AI092108-01A1 to L.G.). J.P.S.-B. and M.H.Y. were supported by an NIH training grant (T32 AI07405).	Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brossay L, 1998, J IMMUNOL, V160, P3681; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dascher CC, 2007, CURR TOP MICROBIOL, V314, P3; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Hanada KI, 2011, BLOOD, V117, P4816, DOI 10.1182/blood-2010-11-317743; Hansen TH, 2007, NAT IMMUNOL, V8, P563, DOI 10.1038/ni1475; Hawke NA, 1996, J IMMUNOL, V156, P2458; HUNIG T, 1981, NATURE, V294, P460, DOI 10.1038/294460a0; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Morris GP, 2011, P NATL ACAD SCI USA, V108, P3695, DOI 10.1073/pnas.1017015108; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Parra ZE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-111; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; RAST JP, 1995, IMMUNOGENETICS, V42, P204, DOI 10.1007/BF00191226; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; Rubtsova K, 2009, P NATL ACAD SCI USA, V106, P7951, DOI 10.1073/pnas.0902728106; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Seiler M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-144; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; WHITE J, 1983, J IMMUNOL, V130, P1033; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	71	47	48	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					526	535		10.1016/j.immuni.2011.09.005	http://dx.doi.org/10.1016/j.immuni.2011.09.005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	21962492	Green Accepted, Bronze			2022-12-18	WOS:000296657700012
J	Davidson, D; Shi, X; Zhong, MC; Rhee, I; Veillette, A				Davidson, Dominique; Shi, Xiaochu; Zhong, Ming-Chao; Rhee, Inmoo; Veillette, Andre			The Phosphatase PTP-PEST Promotes Secondary T Cell Responses by Dephosphorylating the Protein Tyrosine Kinase Pyk2	IMMUNITY			English	Article							ANTIGEN RECEPTOR; ADHESION; ACTIVATION; INHIBITION; TOLERANCE; BETA; MICE; GENE; PEP; STIMULATION	PTP-PEST (encoded by Ptpn12) is an intracellular protein tyrosine phosphatase belonging to the same family as LYP. LYP inhibits secondary T cell responses by suppressing Src family protein tyrosine kinases and is implicated in human autoimmunity. To determine the function of PTP-PEST in T cells, we generated mice with a conditionally deleted allele of Ptpn12. By removing PIP-PEST in T cells, we determined that PTP-PEST was not necessary for T cell development or primary responses. However, PTP-PEST was required for secondary T cell responses, anergy prevention, and autoimmunity induction. PTP-PEST specifically regulated the phosphorylation of Pyk2, a substrate of the Src family kinase Fyn. It also promoted the formation of T cell homoaggregates, which are known to enhance T cell activation. Thus, PTP-PEST controls Pyk2 activity and is a positive regulator of secondary T cell activation. These data illustrate the critical role of protein tyrosine phosphatases in T cell regulation.	[Davidson, Dominique; Shi, Xiaochu; Zhong, Ming-Chao; Rhee, Inmoo; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Rhee, Inmoo; Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal	Davidson, D (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	dominique.davidson@ircm.qc.ca; andre.veillette@ircm.qc.ca			Canadian Cancer Society Research Institute; Canadian Institutes of Health Research	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank the members of our laboratory for discussions and S. Latour for reading the manuscript. This work was supported by grants from the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute (to A.V.). A.V. holds the Canada Research Chair in Signaling in the Immune System and is an International Scholar of the Howard Hughes Medical Institute.	Arimura Y, 2008, MOL IMMUNOL, V45, P3074, DOI 10.1016/j.molimm.2008.03.019; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bagi CM, 2008, CANCER-AM CANCER SOC, V112, P2313, DOI 10.1002/cncr.23429; Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Gismondi A, 2003, J IMMUNOL, V170, P3065, DOI 10.4049/jimmunol.170.6.3065; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; JENKINS MK, 1990, J IMMUNOL, V144, P16; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mittrucker HW, 1996, J EXP MED, V183, P2481, DOI 10.1084/jem.183.6.2481; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; Stewart MP, 1996, J IMMUNOL, V156, P1810; Utting O, 2001, J IMMUNOL, V166, P1540, DOI 10.4049/jimmunol.166.3.1540; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Zhong MC, 2002, J CLIN INVEST, V110, P81, DOI 10.1172/JCI200215692; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	41	47	48	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					167	180		10.1016/j.immuni.2010.08.001	http://dx.doi.org/10.1016/j.immuni.2010.08.001			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20727793	Bronze			2022-12-18	WOS:000281654900007
J	Victoratos, P; Kollias, G				Victoratos, Panayiotis; Kollias, George			Induction of Autoantibody-Mediated Spontaneous Arthritis Critically Depends on Follicular Dendritic Cells	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; CXC CHEMOKINE RECEPTOR-5; HELPER T-CELLS; GERMINAL-CENTERS; RHEUMATOID-ARTHRITIS; LYMPHOID NEOGENESIS; FACTOR THERAPY; B-LYMPHOCYTES; CUTTING EDGE; EXPRESSION	Follicular dendritic cells (FDCs) are important for the induction of protective T cell-dependent humoral responses, but their contribution to autoimmunity remains elusive. Here, gene-targeted interruption of FDC development was combined with the K/BxN mouse model of arthritis. We found that FDCs were essential for autoantibody production through two distinct but cooperative functions. In a T cell-independent fashion, FDCs loaded with autoantigen-containing immune complexes supported germinal center (GC) B cell development. Additionally, the integrity of FDC networks was required for the recruitment of arthritogenic follicular helper T cells, a process that drove T-B cell interactions and productive GC reactivity. Importantly, pharmacological interference in the maintenance of FDCs ameliorated disease development, suggesting the FDC as a potential target for dampening autoimmunity.	[Victoratos, Panayiotis; Kollias, George] Alexander Fleming, BSRC, Inst Immunol, Vari 16672, Attica, Greece		Victoratos, P (corresponding author), Alexander Fleming, BSRC, Inst Immunol, Vari 16672, Attica, Greece.	p.victoratos@fleming.gr; g.kollias@fleming.gr	Kollias, George/A-7079-2012	Kollias, George/0000-0003-1867-3150	European Commission [LSHG-CT-2005-005203]	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank D. Mathis and C. Benoist (Institut de Genetique et de Biologie Moleculaire et Cellulaire, Strasbourg, France) for KRN and B6.H-2<SUP>g7</SUP>/<SUP>g7</SUP> mouse lines and S. Tzima, M. Apostolaki, K. Kranidioti, and V. Gretsi for helpful comments on the manuscript. This work was supported by European Commission (MUGEN; LSHG-CT-2005-005203) funding to G.K.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Corr M, 2002, J IMMUNOL, V169, P6604, DOI 10.4049/jimmunol.169.11.6604; Cyster JG, 2000, IMMUNOL REV, V176, P181; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Junt T, 2005, J IMMUNOL, V175, P7109, DOI 10.4049/jimmunol.175.11.7109; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim HJ, 1999, J IMMUNOL, V162, P3053; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kyburz D, 2000, ARTHRITIS RHEUM, V43, P2571, DOI 10.1002/1529-0131(200011)43:11<2571::AID-ANR26>3.0.CO;2-4; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lentz VM, 2001, J IMMUNOL, V167, P15, DOI 10.4049/jimmunol.167.1.15; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mandik-Nayak L, 2002, P NATL ACAD SCI USA, V99, P14368, DOI 10.1073/pnas.182549099; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Qin DH, 1998, J IMMUNOL, V161, P4549; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simelyte E, 2005, ARTHRITIS RHEUM-US, V52, P1876, DOI 10.1002/ART.21099; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; VANLENT PLEM, 1995, J RHEUMATOL, V22, P2250; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	53	47	48	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					130	142		10.1016/j.immuni.2008.10.019	http://dx.doi.org/10.1016/j.immuni.2008.10.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19119026	Bronze			2022-12-18	WOS:000262769900016
J	Puga, I; Rao, A; Macian, F				Puga, Irene; Rao, Anjana; Macian, Fernando			Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells	IMMUNITY			English	Article							E3 UBIQUITIN LIGASE; ADAPTER PROTEIN; DEPENDENT CLEAVAGE; ACTIVATION; SUBSTRATE; APOPTOSIS; TRANSCRIPTION; REQUIREMENT; GADS; UNRESPONSIVENESS	T cell receptor (TCR) engagement in the absence of costimulation induces the calcium-dependent upregulation of a program of gene expression that leads to the establishment of T cell anergy. Casp3 is one of the genes activated during anergy induction. Here we show that caspase 3 is required for the induction of T cell unresponsiveness. Suboptimal T cell stimulation induced caspase 3 actvation, which did not result in cell death. Furthermore, caspase 3-deficient T cells showed impaired responses to anergizing stimuli. In anergic T cells, activated caspase 3 associated to the plasma membrane, where it cleaved and inactivated proteins such as the Grb2-related adaptor downstream of shc (GADS) and the guanine-nucleotide exchange factor Vav1, causing a blockade in TCR signaling. Our results identify a role for caspase 3 in nonapoptotic T cells and support that caspase 3-dependent proteolytic inactivation of signaling proteins is essential to maintain T cell tolerance.	[Puga, Irene; Macian, Fernando] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Rao, Anjana] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Macian, F (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA.	fmacianj@aecom.yu.edu		Puga, Irene/0000-0003-2208-3196; Macian, Fernando/0000-0003-2666-035X	National Institutes of Health [AI48213, AI059738]; Irene Diamond Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213, R01AI059738, R56AI059738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of our laboratories for helpful discussions and A.M. Cuervo and L. Santambrogio for critical reading of the manuscript. We thank T.W. Mak for the Casp3<SUP>-/-</SUP> mice and S. Bathia for the CHO-IA<SUP>d</SUP> and CHO-IA<SUP>d</SUP>-B7 cell lines. We also thank C.J. McGlade for the GADS constructs and X.R. Bustelo for the Vav-1 expression plasmid. Human IL-2 and antibodies against murine IL-4 were obtained from the Biological Resources Branch preclinical repository. This work was supported by National Institutes of Health grants AI48213 (A.R.) and AI059738 (F.M.) and by the Irene Diamond Foundation (F. M.).	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Bandyopadhyay S, 2007, SEMIN IMMUNOL, V19, P180, DOI 10.1016/j.smim.2007.02.006; Berry DM, 2001, ONCOGENE, V20, P1203, DOI 10.1038/sj.onc.1204218; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boerth NJ, 2000, J EXP MED, V192, P1047, DOI 10.1084/jem.192.7.1047; Borde M, 2006, IMMUNOL REV, V210, P105, DOI 10.1111/j.0105-2896.2006.00370.x; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Denis F, 1998, CELL MOL LIFE SCI, V54, P1005, DOI 10.1007/s000180050228; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gastman BR, 1999, CANCER RES, V59, P1422; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Heissmeyer Vigo, 2005, Novartis Found Symp, V267, P165; Hofmann TG, 2000, ONCOGENE, V19, P1153, DOI 10.1038/sj.onc.1203406; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kaji T, 2003, J BIOL CHEM, V278, P27836, DOI 10.1074/jbc.M212820200; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McCollum AT, 2002, J NEUROCHEM, V82, P1208, DOI 10.1046/j.1471-4159.2002.01057.x; McGinnis KM, 1999, BIOCHEM BIOPH RES CO, V263, P94, DOI 10.1006/bbrc.1999.1315; Miossec C, 1997, J BIOL CHEM, V272, P13459, DOI 10.1074/jbc.272.21.13459; Misra RS, 2005, J IMMUNOL, V174, P3999, DOI 10.4049/jimmunol.174.7.3999; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; QUILL H, 1987, J IMMUNOL, V138, P3704; RATHMELL JC, 1987, ANNU REV IMMUNOL, V17, P781; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Wong SH, 2004, P NATL ACAD SCI USA, V101, P17783, DOI 10.1073/pnas.0408229102; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Yankee TM, 2004, J IMMUNOL, V173, P1711, DOI 10.4049/jimmunol.173.3.1711; Yankee TM, 2001, P NATL ACAD SCI USA, V98, P6789, DOI 10.1073/pnas.111158598; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	50	47	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					193	204		10.1016/j.immuni.2008.06.010	http://dx.doi.org/10.1016/j.immuni.2008.06.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701083	Green Accepted, Bronze			2022-12-18	WOS:000258610800008
J	Louis, I; Heinonen, KM; Chagraoui, J; Vainio, S; Sauvageau, G; Perreault, C				Louis, Isabelle; Heinonen, Krista M.; Chagraoui, Jalila; Vainio, Seppo; Sauvageau, Guy; Perreault, Claude			The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling	IMMUNITY			English	Article							T-CELL DEVELOPMENT; STEM-CELLS; FLT3 LIGAND; THYMIC PROGENITORS; EXPRESSION; GENE; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; ACTIVATION	Despite studies based on deletion or activation of intracellular components of the canonical Wingless related (Wnt) pathway, the role of Wnts in hemato-lymphopoiesis remains controversial. Using gain-of-function and loss-of-function models, we found that Wnt4 differentially affected diverse subsets of hematopoietic stem and progenitor cells. Bone-marrow and thymic Lin(-)Sca1(+)Kit(hi) cells (LSKs) were the key targets of Wnt4. In adult mice, Wnt4-induced expansion of Flt3(+) bone-marrow LSKs (lymphoid-primed multipotent progenitors) led to a sizeable accumulation of the most immature thymocyte subsets (upstream of beta-selection) and a major increase in thymopoiesis. Conversely, Wnt4(-/-) neonates showed low frequencies of bone-marrow LSKs and thymic hypocellularity. We provide compelling evidence that Wnt4 activates noncanonical (beta-catenin-independent) signaling and that its effects on hematopoietic cells are mainly non-cell-autonomous. Our work shows that Wnt4 overexpression has a unique ability to expand Flt(3+) LSKs in adults and demonstrates that noncanonical Wnt signaling regulates thymopoiesis.	[Louis, Isabelle; Heinonen, Krista M.; Chagraoui, Jalila; Sauvageau, Guy; Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Louis, Isabelle; Heinonen, Krista M.; Chagraoui, Jalila; Sauvageau, Guy; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Vainio, Seppo] Univ Oulu, Dept Med Biochem & Mol Biol, Bioctr Oulu, FIN-90014 Oulu, Finland; [Sauvageau, Guy; Perreault, Claude] Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal; University of Oulu; Universite de Montreal	Perreault, C (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada.	c.perreault@videotron.ca	Heinonen, Krista M/G-9769-2016; Perreault, Claude/A-7220-2008	Heinonen, Krista M/0000-0002-2410-4432; Perreault, Claude/0000-0001-9453-7383; Sauvageau, Guy/0000-0002-4333-7266; Vainio, Seppo/0000-0001-9319-3566				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Chagraoui J, 2006, GENE DEV, V20, P2110, DOI 10.1101/gad.1453406; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Fry TJ, 2004, BLOOD, V104, P2794, DOI 10.1182/blood-2003-11-3789; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Kenins L, 2008, J EXP MED, V205, P523, DOI 10.1084/jem.20072065; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Magnusson M, 2007, BLOOD, V109, P3687, DOI 10.1182/blood-2006-10-054676; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; MONTECINORODRIG.E, 2002, EUR J IMMUNOL, V32, P967; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Park E, 2006, DEV BIOL, V292, P344, DOI 10.1016/j.ydbio.2006.01.011; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Terra R, 2005, BLOOD, V106, P193, DOI 10.1182/blood-2004-12-4886; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605; Zediak VP, 2005, SEMIN IMMUNOL, V17, P337, DOI 10.1016/j.smim.2005.05.004; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	51	47	48	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					57	67		10.1016/j.immuni.2008.04.023	http://dx.doi.org/10.1016/j.immuni.2008.04.023			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18617424	Bronze			2022-12-18	WOS:000257905400010
J	Woellner, C; Schaffer, AA; Pluck, JM; Renner, ED; Knebel, C; Holland, SM; Plebani, A; Grimbacher, B				Woellner, Cristina; Schaeffer, Alejandro A.; Pluck, Jennifer M.; Renner, Eleonore D.; Knebel, Constanze; Holland, Steve M.; Plebani, Alessandro; Grimbacher, Bodo			The hyper IgE syndrome and mutations in TYK2	IMMUNITY			English	Letter							IMMUNITY		UCL, Royal Free Hosp, Dept Immunol & Mol Pathol, London, England; Univ Hosp Freiburg, Div Mol & Clin Rheumatol, D-79106 Freiburg, Germany; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Dept Hlth & Human Serv, Bethesda, MD 20894 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; Tech Univ Munich, Dept Pediat, D-80804 Munich, Germany; NIAID, NIH, Bethesda, MD 20892 USA; Univ Brescia, Pediat Clin, I-25123 Brescia, Italy; Univ Brescia, Inst Med Mol A Novicelli, I-25123 Brescia, Italy	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Freiburg; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California San Francisco; University of Munich; Technical University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Brescia; University of Brescia	Grimbacher, B (corresponding author), UCL, Royal Free Hosp, Dept Immunol & Mol Pathol, London, England.	b.grimbacher@medsch.ucl.ac.uk	Plebani, Alessandro/C-8593-2011; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Renner, Ellen/R-7168-2016	Renner, Ellen/0000-0001-9816-8538	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000646] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000097] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9	4	47	49	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					535	535		10.1016/j.immuni.2007.05.007	http://dx.doi.org/10.1016/j.immuni.2007.05.007			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521577	Bronze			2022-12-18	WOS:000246895900001
J	Mempel, TR; Junt, T; von Andrian, UH				Mempel, Thorsten R.; Junt, Tobias; von Andrian, Ulrich H.			Rulers over randomness: Stroma cells guide lymphocyte migration in lymph nodes	IMMUNITY			English	Editorial Material							CHEMOKINES		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mempel, TR (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.		Junt, Tobias/AAE-4389-2021; von Andrian, Ulrich H/A-5775-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Breart B, 2006, CURR OPIN IMMUNOL, V18, P483, DOI 10.1016/j.coi.2006.05.006; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222	10	47	54	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2006	25	6					867	869		10.1016/j.immuni.2006.11.002	http://dx.doi.org/10.1016/j.immuni.2006.11.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174930	Bronze			2022-12-18	WOS:000243087500006
J	Nikolajczyk, BS; Sanchez, JA; Sen, RJ				Nikolajczyk, BS; Sanchez, JA; Sen, RJ			ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer	IMMUNITY			English	Article							MATRIX-ATTACHMENT REGIONS; TCR-ALPHA ENHANCER; T-CELL DEVELOPMENT; IGH INTRONIC ENHANCER; XENOPUS EGG EXTRACTS; GENE ENHANCER; V(D)J RECOMBINATION; B-CELLS; TARGETED DELETION; IN-VITRO	Directed accessibility mediated by antigen-receptor gene enhancers ensures developmental stage-specific activation of V(D)J recombination. Here, we used a combination of in vitro and in vivo assays to explore the mechanisms that regulate immunoglobulin mu heavy chain gene enhancer-dependent chromatin accessibility. Ets-1 or PU.1 bound to mu enhancer-containing plasmids assembled into chromatin in vitro and increased restriction enzyme access to a proximal site. In complementary analyses, expression of PU.1 in Ets-1-containing 2017 pro-T cells or NIH 3T3 cells induced sterile ly transcripts at the IgH locus and increased accessibility of the endogenous mu enhancer to restriction endonucleases. These observations suggest that one role of PU.1 is to increase accessibility of the mu locus to initiate heavy chain gene expression.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Sen, RJ (corresponding author), Brandeis Univ, Rosenstiel Res Ctr, Waltham, MA 02454 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038925, R01GM038925] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38925] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angelin-Duclos C, 1998, MOL CELL BIOL, V18, P6253, DOI 10.1128/MCB.18.11.6253; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CAPONE M, 1995, J IMMUNOL, V154, P5165; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Clevers H, 1998, CURR OPIN IMMUNOL, V10, P166, DOI 10.1016/S0952-7915(98)80245-8; Dang W, 1998, MOL CELL BIOL, V18, P6870, DOI 10.1128/MCB.18.11.6870; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Demengeot J, 1995, INT IMMUNOL, V7, P1995, DOI 10.1093/intimm/7.12.1995; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FERNEX C, 1994, NUCLEIC ACIDS RES, V22, P792, DOI 10.1093/nar/22.5.792; Ferradini L, 1996, SCIENCE, V271, P1416, DOI 10.1126/science.271.5254.1416; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; HAWLEY RG, 1994, GENE THER, V1, P136; Hernandez-Munain C, 1998, MOL CELL BIOL, V18, P3223, DOI 10.1128/MCB.18.6.3223; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; KALLENBACH S, 1993, EUR J IMMUNOL, V23, P1917, DOI 10.1002/eji.1830230828; LASKEY RA, 1980, NATURE, V286, P763, DOI 10.1038/286763a0; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIBERMANN TA, 1990, MOL ASPECTS CELL REG, V6, P399; Mayall TP, 1997, GENE DEV, V11, P887, DOI 10.1101/gad.11.7.887; MILLS FC, 1983, NATURE, V306, P809, DOI 10.1038/306809a0; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; NELSEN B, 1990, MOL CELL BIOL, V10, P3145, DOI 10.1128/MCB.10.6.3145; Nikolajczyk BS, 1997, MOL CELL BIOL, V17, P3527, DOI 10.1128/MCB.17.7.3527; Nikolajczyk BS, 1996, MOL CELL BIOL, V16, P4544; OKADA A, 1994, J EXP MED, V180, P261, DOI 10.1084/jem.180.1.261; OLTZ EM, 1993, MOL CELL BIOL, V13, P6223, DOI 10.1128/MCB.13.10.6223; PAZIN M, 1998, CHROMATIN PRACTICAL; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; Roberts JL, 1997, J EXP MED, V185, P131, DOI 10.1084/jem.185.1.131; SAKAI E, 1999, IMMUNITY, V96, P1526; SANCHEZ JA, 1995, J BIOL CHEM, V270, P29676; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SEN R, 1986, CELL, V46, P706; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SHEN CKJ, 1986, P NATL ACAD SCI USA, V83, P1641, DOI 10.1073/pnas.83.6.1641; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SPOLSKI R, 1988, EUR J IMMUNOL, V18, P295; WANGH LJ, 1995, J CELL SCI, V108, P2187; WORKMAN JL, 1990, EMBO J, V9, P1299, DOI 10.1002/j.1460-2075.1990.tb08239.x	52	47	47	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1999	11	1					11	20		10.1016/S1074-7613(00)80077-1	http://dx.doi.org/10.1016/S1074-7613(00)80077-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435575	Bronze			2022-12-18	WOS:000081671300002
J	Bertocci, B; Quint, L; Delbos, F; Garcia, C; Reynaud, CA; Weill, JC				Bertocci, B; Quint, L; Delbos, F; Garcia, C; Reynaud, CA; Weill, JC			Probing immunoglobulin gene hypermutation with microsatellites suggests a nonreplicative short patch DNA synthesis process	IMMUNITY			English	Article							SOMATIC HYPERMUTATION; MISMATCH REPAIR; PASSENGER TRANSGENES; B-CELLS; MUTATIONS; KAPPA; ANTIBODY; SEQUENCES; CANCER; MICE	As the rate of Ig gene hypermutation approximates the level of nucleotide discrimination of DNA polymerases (10(-3) to 10(-4)), a local inhibition of proofreading and mismatch repair during semiconservative replication could generate the mutations introduced by the process. To address this question, we have constructed transgenic mice that carry a hypermutation substrate containing a "polymerase slippage trap": an Ig gene with a mono or dinucleotide tract inserted in its V region. The low amount of slippage events as compared to the number of mutations, the absence of transient misalignment mutations at the border of the repeats, and the dissociation between the amount of frameshifts and mutations when the transgene is put on mismatch repair-deficient genetic backgrounds, suggest that Ig gene hypermutation occurs by an error-prone short patch DNA synthesis taking place outside global DNA replication.	INSERM, U373, Fac Med Necker Enfants Malades, F-75730 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Weill, JC (corresponding author), INSERM, U373, Fac Med Necker Enfants Malades, 156 Rue Vaugirard, F-75730 Paris 15, France.	weill@necker.fr	Bertocci, Barbara/L-9115-2018; Cordier, Corinne/F-9966-2018	Cordier, Corinne/0000-0003-4799-6143				BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862; GONZALEZFERNANDEZ A, 1994, EUR J IMMUNOL, V24, P2918, DOI 10.1002/eji.1830241151; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Goyenechea B, 1996, P NATL ACAD SCI USA, V93, P13979, DOI 10.1073/pnas.93.24.13979; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; Hite JM, 1996, NUCLEIC ACIDS RES, V24, P2429, DOI 10.1093/nar/24.12.2429; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; Kim N, 1998, J EXP MED, V187, P1729, DOI 10.1084/jem.187.11.1729; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; OBRIEN RL, 1987, NATURE, V326, P405, DOI 10.1038/326405a0; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reynaud C A, 1996, Semin Immunol, V8, P125, DOI 10.1006/smim.1996.0016; REYNAUD CA, 1992, EMBO J, V11, P4349, DOI 10.1002/j.1460-2075.1992.tb05534.x; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; SHARPE MJ, 1991, EMBO J, V10, P2139, DOI 10.1002/j.1460-2075.1991.tb07748.x; STEELE EJ, 1987, MOL IMMUNOL, V24, P667, DOI 10.1016/0161-5890(87)90049-6; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Wabl M, 1996, CURR TOP MICROBIOL, V217, P203; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953; WU HY, 1995, SCAND J IMMUNOL, V42, P52, DOI 10.1111/j.1365-3083.1995.tb03625.x; YELAMOS J, 1995, NATURE, V376, P225	45	47	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					257	265		10.1016/S1074-7613(00)80608-1	http://dx.doi.org/10.1016/S1074-7613(00)80608-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729046	Bronze			2022-12-18	WOS:000075610300012
J	Cook, JR; Wormstall, EM; Hornell, T; Russell, J; Connolly, JM; Hansen, TH				Cook, JR; Wormstall, EM; Hornell, T; Russell, J; Connolly, JM; Hansen, TH			Quantitation of the cell surface level of L-d resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo	IMMUNITY			English	Article							I-DEFICIENT MICE; BETA(2)-MICROGLOBULIN-DEFICIENT MICE; ANTIGEN RECEPTOR; LYMPHOCYTES-T; PEPTIDE; CD8+; REACTIVITY; EXPRESSION; AGONIST; MODEL	The 2C transgenic TCR is positively selected on K-b and is alloreactive for and negatively selected on L-d. To test an avidity model for positive selection, mice were bred to express different levels of surface L-d by varying the number of gene copies encoding beta(2)-microglobulin (beta(2)m) or L-d heavy chain. Whereas mice expressing 35% L-d (beta(2)m(+/-) Ld+/-) negatively selected the 2C TCR, mice expressing 2% L-d (beta(2)m(-/-) Ld+/-) positively selected the 2C TCR. Furthermore, 2C cytotoxic T lymphocytes selected on 2% L-d showed peptide-specific cytolytic activity against L-d/p2Ca targets. These findings provide clear in vivo evidence that positive selection can occur on very low levels of the same class I antigen capable of negative selection when expressed at higher levels.	WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL)	Cook, JR (corresponding author), WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110, USA.			Russell, John/0000-0002-3680-9587	NATIONAL CANCER INSTITUTE [R01CA028533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027568, R01AI019687] Funding Source: NIH RePORTER; NCI NIH HHS [CA-28533] Funding Source: Medline; NIAID NIH HHS [AI-27568, AI-19687] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; APASOV S, 1993, P NATL ACAD SCI USA, V90, P2837, DOI 10.1073/pnas.90.7.2837; APASOV SG, 1994, J IMMUNOL, V152, P2087; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; COOK JR, 1995, J IMMUNOL, V154, P47; GLAS R, 1994, J EXP MED, V179, P661, DOI 10.1084/jem.179.2.661; GORKA J, 1989, Peptide Research, V2, P376; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; Sprent Jonathan, 1993, P75; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UDAKA K, 1994, J IMMUNOL, V153, P2843; VONBOEHMER H, 1992, IMMUNOL TODAY, V13, P454, DOI 10.1016/0167-5699(92)90075-I; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	23	47	48	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					233	241		10.1016/S1074-7613(00)80526-9	http://dx.doi.org/10.1016/S1074-7613(00)80526-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285408	Bronze			2022-12-18	WOS:A1997XT49200007
J	Muller, KM; Luedecker, CJ; Udey, MC; Farr, AG				Muller, KM; Luedecker, CJ; Udey, MC; Farr, AG			Involvement of E-cadherin in thymus organogenesis and thymocyte maturation	IMMUNITY			English	Article							EPITHELIAL-CELLS; MONOCLONAL-ANTIBODY; ADHESION MOLECULES; EMBRYONIC HISTOGENESIS; IMMATURE THYMOCYTES; STROMAL CELLS; EXPRESSION; INTEGRIN; MORPHOGENESIS; RECEPTOR	We examined the role of E-cadherin expressed by thymic epithelial cells and immature thymocytes in thymus organogenesis and thymocyte development. ECCD-1 MAb, which blocks homotypic E-cadherin interactions, inhibited epithelial organization and thymocyte development in reaggregate fetal thymic organ cultures. It also interfered with the differentiation of fetal liver cells or fetal thymocytes within deoxyguanosine-treated thymic lobes, but did not affect thymocyte development in intact cultured fetal thymic lobes. In contrast, antibodies that selectively inhibit interactions between E-cadherin and alpha(E) beta(7) integrins did not perturb thymic epithelial organization or thymocyte development, suggesting that homotypic E-cadherin interactions play an important role in thymus development and function.	UNIV WASHINGTON,SCH MED,DEPT BIOL STRUCT,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT IMMUNOL,SEATTLE,WA 98195; NCI,DERMATOL BRANCH,BETHESDA,MD 20892	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)					NIAID NIH HHS [AI 24137] Funding Source: Medline; NIA NIH HHS [AG 04360] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG004360] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrew DP, 1996, EUR J IMMUNOL, V26, P897, DOI 10.1002/eji.1830260427; ARMEANU S, 1995, J CELL BIOL, V131, P243, DOI 10.1083/jcb.131.1.243; Cepek KL, 1996, P NATL ACAD SCI USA, V93, P6567, DOI 10.1073/pnas.93.13.6567; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CHANG AC, 1993, J IMMUNOL, V151, P1789; DENNING SM, 1987, J IMMUNOL, V139, P2573; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; FARR A, 1993, J IMMUNOL, V150, P1160; FARR AG, 1988, CELL IMMUNOL, V116, P135, DOI 10.1016/0008-8749(88)90216-X; FARR AG, 1981, J IMMUNOL METHODS, V47, P129, DOI 10.1016/0022-1759(81)90114-9; FINE JS, 1991, J IMMUNOL, V147, P2852; FUJITA M, 1992, ARCH DERMATOL RES, V284, P159, DOI 10.1007/BF00372710; GLIMCHER LH, 1983, SCAND J IMMUNOL, V17, P1, DOI 10.1111/j.1365-3083.1983.tb00759.x; Grunwald GB, 1993, CURR OPIN CELL BIOL, V5, P797, DOI 10.1016/0955-0674(93)90028-O; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HIRAI Y, 1989, DEVELOPMENT, V105, P271; HIRAI Y, 1989, DEVELOPMENT, V105, P263; HUEBER AO, 1992, J IMMUNOL, V148, P3692; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333; KINGSTON R, 1985, NATURE, V317, P811, DOI 10.1038/317811a0; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; LANNESVIEIRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P1539, DOI 10.1177/39.11.1918928; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; LEE MG, 1994, J IMMUNOL, V152, P5653; LEFRANCOIS L, 1994, EUR J IMMUNOL, V24, P635, DOI 10.1002/eji.1830240322; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; Munro SB, 1996, CELL IMMUNOL, V169, P309, DOI 10.1006/cimm.1996.0123; Nelson AJ, 1996, EUR J IMMUNOL, V26, P401, DOI 10.1002/eji.1830260220; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P649, DOI 10.1002/eji.1830190412; NIKOLICZUGIC J, 1988, P NATL ACAD SCI USA, V85, P8633, DOI 10.1073/pnas.85.22.8633; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; RAMSDELL F, 1992, CURRENT PROTOCOLS IM; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; SAWADA M, 1992, J IMMUNOL, V149, P3517; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; STAERZ UD, 1985, J IMMUNOL, V134, P3994; TAKAHAMA Y, 1994, J EXP MED, V179, P1495, DOI 10.1084/jem.179.5.1495; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.bi.59.070190.001321; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; UTSUMI K, 1991, P NATL ACAD SCI USA, V88, P5685, DOI 10.1073/pnas.88.13.5685; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; WADSWORTH S, 1992, J IMMUNOL, V149, P421; WEE SF, 1994, CELL IMMUNOL, V158, P353, DOI 10.1006/cimm.1994.1282; YOSHIDANORO C, 1984, DEV BIOL, V101, P19, DOI 10.1016/0012-1606(84)90112-X	51	47	47	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					257	264		10.1016/S1074-7613(00)80328-3	http://dx.doi.org/10.1016/S1074-7613(00)80328-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075926	Bronze			2022-12-18	WOS:A1997XC61800005
J	Lineburg, KE; Grant, EJ; Swaminathan, S; Chatzileontiadou, DSM; Szeto, C; Sloane, H; Panikkar, A; Raju, J; Crooks, P; Rehan, S; Nguyen, AT; Lekieffre, L; Neller, MA; Tong, ZWM; Jayasinghe, D; Chew, KY; Lobos, CA; Halim, H; Burrows, JM; Riboldi-Tunnicliffe, A; Chen, WS; D'Orsogna, L; Khanna, R; Short, KR; Smith, C; Gras, S				Lineburg, Katie E.; Grant, Emma J.; Swaminathan, Srividhya; Chatzileontiadou, Demetra S. M.; Szeto, Christopher; Sloane, Hannah; Panikkar, Archana; Raju, Jyothy; Crooks, Pauline; Rehan, Sweera; Nguyen, Andrea T.; Lekieffre, Lea; Neller, Michelle A.; Tong, Zhen Wei Marcus; Jayasinghe, Dhilshan; Chew, Keng Yih; Lobos, Christian A.; Halim, Hanim; Burrows, Jacqueline M.; Riboldi-Tunnicliffe, Alan; Chen, Weisan; D'Orsogna, Lloyd; Khanna, Rajiv; Short, Kirsty R.; Smith, Corey; Gras, Stephanie			CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses	IMMUNITY			English	Article							COVID-19; ESCAPE; IMPACT; TCR	Efforts are beingmade worldwide to understand the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, including the impact of T cell immunity and cross-recognition with seasonal coronaviruses. Screening of SARS-CoV-2 peptide pools revealed that the nucleocapsid (N) protein induced an immunodominant response in HLA-B7(+) COVID-19-recovered individuals that was also detectable in unexposed donors. A single N-encoded epitope that was highly conserved across circulating coronaviruses drove this immunodominant response. In vitro peptide stimulation and crystal structure analyses revealed T cell-mediated cross-reactivity toward circulating OC43 and HKU-1 betacoronaviruses but not 229E or NL63 alphacoronaviruses because of different peptide conformations. T cell receptor (TCR) sequencing indicated that cross-reactivity was driven by private TCR repertoires with a bias for TRBV27 and a long CDR3b loop. Our findings demonstrate the basis of selective T cell cross-reactivity for an immunodominant SARS-CoV-2 epitope and its homologs from seasonal coronaviruses, suggesting long-lasting protective immunity.	[Lineburg, Katie E.; Swaminathan, Srividhya; Panikkar, Archana; Raju, Jyothy; Crooks, Pauline; Rehan, Sweera; Lekieffre, Lea; Neller, Michelle A.; Burrows, Jacqueline M.; Khanna, Rajiv; Smith, Corey] QIMR Berghofer Med Res Inst, QIMR Berghofer Ctr Immunotherapy & Vaccine Dev, Dept Immunol, Brisbane, Qld 4006, Australia; [Lineburg, Katie E.; Swaminathan, Srividhya; Panikkar, Archana; Raju, Jyothy; Crooks, Pauline; Rehan, Sweera; Lekieffre, Lea; Neller, Michelle A.; Burrows, Jacqueline M.; Khanna, Rajiv; Smith, Corey] QIMR Berghofer Med Res Inst, Translat & Human Immunol Lab, Dept Immunol, Brisbane, Qld 4006, Australia; [Grant, Emma J.; Chatzileontiadou, Demetra S. M.; Szeto, Christopher; Sloane, Hannah; Nguyen, Andrea T.; Jayasinghe, Dhilshan; Lobos, Christian A.; Halim, Hanim; Gras, Stephanie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Grant, Emma J.; Chatzileontiadou, Demetra S. M.; Szeto, Christopher; Sloane, Hannah; Nguyen, Andrea T.; Jayasinghe, Dhilshan; Lobos, Christian A.; Chen, Weisan; Gras, Stephanie] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Swaminathan, Srividhya; Smith, Corey] Univ Queensland, Fac Med, Brisbane, Qld 4072, Australia; [Tong, Zhen Wei Marcus; Chew, Keng Yih; Short, Kirsty R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Riboldi-Tunnicliffe, Alan] ANSTO, Australian Synchrotron, Clayton, Vic 3168, Australia; [D'Orsogna, Lloyd] Fiona Stanley Hosp, Dept Clin Immunol, PathWest Lab Med, Murdoch, WA 6150, Australia; [D'Orsogna, Lloyd] Univ Western Australia, Sch Med, Nedlands, WA 6009, Australia; [Short, Kirsty R.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Monash University; La Trobe University; University of Queensland; University of Queensland; Australian Nuclear Science & Technology Organisation; University of Western Australia; University of Queensland	Smith, C (corresponding author), QIMR Berghofer Med Res Inst, QIMR Berghofer Ctr Immunotherapy & Vaccine Dev, Dept Immunol, Brisbane, Qld 4006, Australia.; Smith, C (corresponding author), QIMR Berghofer Med Res Inst, Translat & Human Immunol Lab, Dept Immunol, Brisbane, Qld 4006, Australia.; Gras, S (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Gras, S (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	corey.smith@qimrberghofer.edu.au; s.gras@latrobe.edu.au	Grant, Emma/AAR-3766-2021; Khanna, Rajiv/A-7691-2008; D'Orsogna, Lloyd/ABE-9573-2021; Lineburg, Katie E/L-3268-2018	Khanna, Rajiv/0000-0003-2241-0353; D'Orsogna, Lloyd/0000-0002-6824-4189; Lineburg, Katie E/0000-0002-5712-2610; Szeto, Christopher/0000-0003-3784-5210; Grant, Emma/0000-0001-7193-9427	QIMR Berghofer COVID-19 appeal; Monash University; Australian Nuclear Science and Technology Organisation (ANSTO); AINSE; ECR; Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) [GNT1132519]; Medical Research Future Fund (MRFF) [APP2005654]; Australian Government Research Training Program scholarship; NHMRC C.J. Martin fellowship [1110429]; Australian Research Council DECRA [DE210101479, DE180100512]; NHMRC SRF [1159272]	QIMR Berghofer COVID-19 appeal; Monash University(Monash University); Australian Nuclear Science and Technology Organisation (ANSTO); AINSE; ECR(European CommissionEuropean Commission Joint Research Centre); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Future Fund (MRFF)(Medical Research Future Fund (MRFF)); Australian Government Research Training Program scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); NHMRC C.J. Martin fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council DECRA(Australian Research Council); NHMRC SRF(National Health and Medical Research Council (NHMRC) of Australia)	The authors would like to thank Queensland Health Forensic & Scientific Services, Queensland Department of Health who provided the SARS-CoV-2 isolate QLD02; Monash facilities (Flow Core, Macromolecular Crystallization Facility, Imaging Facility); VTIS, PathWest Laboratory Medicine and CareDx for HLA Typing; and the MX team for assistance at the Australian Synchrotron. The authors would also like to thank all participants who took part in the study. This work was supported by generous donations from the QIMR Berghofer COVID-19 appeal and financial contributions from Monash University, the Australian Nuclear Science and Technology Organisation (ANSTO; AINSE ECR grants), the Australian Research Council (ARC), the National Health and Medical Research Council (NHMRC, GNT1132519), and the Medical Research Future Fund (MRFF, APP2005654). S.S. and H.S. are supported by an Australian Government Research Training Program scholarship. E.J.G. was supported by an NHMRC C.J. Martin fellowship (1110429) and is supported by an Australian Research Council DECRA (DE210101479). K.R.S. is supported by an Australian Research Council DECRA (DE180100512). S.G. is supported by an NHMRC SRF (1159272).	Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Brennan RM, 2012, J IMMUNOL, V188, P2742, DOI 10.4049/jimmunol.1102675; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Canete PF, 2020, CELL, V183, P13, DOI 10.1016/j.cell.2020.09.013; Chan KF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03321-w; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davis BH, 2013, CYTOM PART B-CLIN CY, V84, P286, DOI 10.1002/cyto.b.21105; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Du VY, 2016, J IMMUNOL, V196, P3276, DOI 10.4049/jimmunol.1502411; Ellis JM, 2000, HUM IMMUNOL, V61, P334, DOI 10.1016/S0198-8859(99)00155-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Geldmacher C, 2009, BLOOD, V114, P1553, DOI 10.1182/blood-2009-02-206193; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Gonzalez-Galarza FF, 2020, NUCLEIC ACIDS RES, V48, pD783, DOI 10.1093/nar/gkz1029; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Grant EJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07815-5; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Jarjour NN, 2021, IMMUNITY, V54, P14, DOI 10.1016/j.immuni.2020.12.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kared Hassen, 2020, bioRxiv, DOI 10.1101/2020.10.08.330688; Karlsson AC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe8063; Kloverpris HN, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0149-5; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lineburg KE, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1219; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Ng Kevin W, 2020, Science, V370, P1339, DOI 10.1126/science.abe1107; Peacock T.P., 2021, MEDRXIV, DOI [10.1101/2021.01.12.426407v1, DOI 10.1093/CID/CIAA344, 10.1101/2021.05.28.446163]; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Rowntree LC, 2020, J IMMUNOL, V205, P1524, DOI 10.4049/jimmunol.2000249; Rowntree LC, 2018, J IMMUNOL, V200, P3993, DOI 10.4049/jimmunol.1800010; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Smart O. S., 2011, GRADE VERSION 1 2 20; Smith C, 2014, SCI REP-UK, V4, DOI 10.1038/srep03993; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Szeto C, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102096; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647	49	46	47	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					1055	+		10.1016/j.immuni.2021.04.006	http://dx.doi.org/10.1016/j.immuni.2021.04.006		MAY 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33945786	Bronze, Green Published			2022-12-18	WOS:000652019500019
J	Chong, WP; Mattapallil, MJ; Raychaudhuri, K; Bing, SJ; Wu, SH; Zhong, YJ; Wang, WW; Chen, ZL; Silver, PB; Jittayasothorn, Y; Chan, CC; Chen, J; Horai, R; Caspi, RR				Chong, Wai Po; Mattapallil, Mary J.; Raychaudhuri, Kumarkrishna; Bing, So Jin; Wu, Sihan; Zhong, Yajie; Wang, WeiWei; Chen, Zilin; Silver, Phyllis B.; Jittayasothorn, Yingyos; Chan, Chi-Chao; Chen, Jun; Horai, Reiko; Caspi, Rachel R.			The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24	IMMUNITY			English	Article							T-CELLS; CUTTING EDGE; T(H)17 CELLS; MICE; AUTOIMMUNITY; EXPRESSION; PROTEIN; INFLAMMATION; MECHANISMS; PSORIASIS	Dysregulated Th17 cell responses underlie multiple inflammatory and autoimmune diseases, including autoimmune uveitis and its animal model, EAU. However, clinical trials targeting IL-17A in uveitis were not successful. Here, we report that Th17 cells were regulated by their own signature cytokine, IL-17A. Loss of IL17A in autopathogenic Th17 cells did not reduce their pathogenicity and instead elevated their expression of the Th17 cytokines GM- CSF and IL-17F. Mechanistic in vitro studies revealed a Th17 cell-intrinsic autocrine loop triggered by binding of IL-17A to its receptor, leading to activation of the transcription factor NF-kappa B and induction of IL-24, which repressed the Th17 cytokine program. In vivo, IL-24 treatment ameliorated Th17-induced EAU, whereas silencing of IL-24 in Th17 cells enhanced disease. This regulatory pathway also operated in human Th17 cells. Thus, IL-17A limits pathogenicity of Th17 cells by inducing IL-24. These findings may explain the disappointing therapeutic effect of targeting IL-17A in uveitis.	[Chong, Wai Po; Wu, Sihan; Zhong, Yajie; Wang, WeiWei; Chen, Zilin; Chen, Jun] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Peoples R China; [Chong, Wai Po; Mattapallil, Mary J.; Raychaudhuri, Kumarkrishna; Bing, So Jin; Silver, Phyllis B.; Jittayasothorn, Yingyos; Chan, Chi-Chao; Horai, Reiko; Caspi, Rachel R.] NIH, Lab Immunol, Natl Eye Inst, Bethesda, MD 20892 USA	Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Caspi, RR (corresponding author), NIH, Lab Immunol, Natl Eye Inst, Bethesda, MD 20892 USA.	caspir@nei.nih.gov	Raychaudhuri, Kumarkrishna/AAB-4589-2021; Chong, Wai Po/HCI-1030-2022	Raychaudhuri, Kumarkrishna/0000-0001-5198-8651; Chen, Jun/0000-0002-4059-3512; Chong, Wai Po/0000-0001-9640-199X; Mattapallil, Mary/0000-0003-0615-7343	NIH/National Eye Institute (NEI) [EY000184]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center; Natural Science Foundation of Guangdong Province [201604020082, 2017A030313836, 2019A1515010956]	NIH/National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Fundamental Research Funds of the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	We thank Dr. Yoichiro Iwakura for Il17a<SUP>-/-</SUP>, Il17f<SUP>-/-</SUP>, and Il17a<SUP>-/-</SUP> Il17f<SUP>-/-</SUP> mice and Dr. Renee de Waal Malefyt of Merck (formerly DNAX) for his gift of Il24<SUP>-/-</SUP> mice. We are grateful to Matthew Brooks, BS, of N-NRL, NEI, for performing RNA-seq. We thank the staff of the Zhongshan Ophthalmic Center Flow Cytometry Core and the NEI Flow Cytometry Core for flow cytometry support. This study was funded by NIH/National Eye Institute (NEI) intramural funding (project number EY000184); the Fundamental Research Funds of the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center; and the Natural Science Foundation of Guangdong Province (grants 201604020082, 2017A030313836, and 2019A1515010956).	Agarwal RK, 2004, METH MOLEC MED, V102, P395; Al Omar S, 2013, CYTOKINE, V62, P123, DOI 10.1016/j.cyto.2013.02.005; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Andoh A, 2009, J IMMUNOL, V183, P687, DOI 10.4049/jimmunol.0804169; Anuradha R, 2016, J INFECT DIS, V213, P811, DOI 10.1093/infdis/jiv497; Bing SJ, 2020, J AUTOIMMUN, V114, DOI 10.1016/j.jaut.2020.102507; Brooks Matthew J, 2012, Methods Mol Biol, V884, P319, DOI 10.1007/978-1-61779-848-1_23; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chen J, 2018, J LEUKOCYTE BIOL, V104, P953, DOI 10.1002/JLB.MR1117-471R; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chong WP, 2015, J EXP MED, V212, P1739, DOI 10.1084/jem.20141678; Chong WP, 2014, J AUTOIMMUN, V50, P12, DOI 10.1016/j.jaut.2013.08.003; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dick AD, 2013, OPHTHALMOLOGY, V120, P777, DOI 10.1016/j.ophtha.2012.09.040; Dincses E, 2019, OXF MED CASE REP, P239, DOI 10.1093/omcr/omz041; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Golan H, 2018, STEM CELL REP, V11, P795, DOI 10.1016/j.stemcr.2018.07.010; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; Horai R, 2015, CURR MOL MED, V15, P511, DOI 10.2174/1566524015666150731095201; Horai R, 2013, J AUTOIMMUN, V44, P21, DOI 10.1016/j.jaut.2013.06.003; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mattapallil MJ, 2019, J AUTOIMMUN, V102, P65, DOI 10.1016/j.jaut.2019.04.017; Mattapallil MJ, 2015, INVEST OPHTH VIS SCI, V56, P5439, DOI 10.1167/iovs.15-17280; McGinley AM, 2020, IMMUNITY, V52, P342, DOI 10.1016/j.immuni.2020.01.002; Messenger W., 2015, NEUROLOGY REV, V23, P9; Milovanovic M, 2010, J INVEST DERMATOL, V130, P2621, DOI 10.1038/jid.2010.175; Mozaffari S, 2015, EXPERT OPIN INV DRUG, V24, P949, DOI 10.1517/13543784.2015.1035432; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sandquist Ivy, 2018, F1000Res, V7, P205, DOI 10.12688/f1000research.13020.1; Schaefer G, 2001, J IMMUNOL, V166, P5859, DOI 10.4049/jimmunol.166.10.5859; Shiga H, 2017, INFLAMM BOWEL DIS, V23, pE38, DOI 10.1097/MIB.0000000000001142; SILVER PB, 1995, INVEST OPHTH VIS SCI, V36, P946; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; von Vietinghoff S, 2009, J IMMUNOL, V183, P865, DOI 10.4049/jimmunol.0804080; Wahl C, 2009, J IMMUNOL, V182, P802, DOI 10.4049/jimmunol.182.2.802; Wang CK, 2012, INVEST OPHTH VIS SCI, V53, P4668, DOI 10.1167/iovs.12-9863; Wasilewska A, 2016, POSTEP DERM ALERGOL, V33, P247, DOI 10.5114/ada.2016.61599; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	61	46	47	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					384	+		10.1016/j.immuni.2020.06.022	http://dx.doi.org/10.1016/j.immuni.2020.06.022			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32673565	Green Published, Bronze			2022-12-18	WOS:000561190600016
J	Soni, C; Perez, OA; Voss, WN; Pucella, JN; Serpas, L; Mehl, J; Ching, KL; Goike, J; Georgiou, G; Ippolito, GC; Sisirak, V; Reizis, B				Soni, Chetna; Perez, Oriana A.; Voss, William N.; Pucella, Joseph N.; Serpas, Lee; Mehl, Justin; Ching, Krystal L.; Goike, Jule; Georgiou, George; Ippolito, Gregory C.; Sisirak, Vanja; Reizis, Boris			Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; T-CELLS; CUTTING EDGE; MURINE MODEL; AUTOANTIBODY PRODUCTION; GERMINAL-CENTERS; INTRINSIC TLR7; NUCLEIC-ACID; AUTOIMMUNITY; DISEASE	Class-switched antibodies to double-stranded DNA (dsDNA) are prevalent and pathogenic in systemic lupus erythematosus (SLE), yet mechanisms of their development remain poorly understood. Humans and mice lacking secreted DNase DNASE1L3 develop rapid anti-dsDNA antibody responses and SLE-like disease. We report that anti-DNA responses in Dnase1/3(-/-) mice require CD4OL-mediated T cell help, but proceed independently of germinal center formation via short-lived antibody-forming cells (AFCs) localized to extrafollicular regions. Type I interferon (IFN-I) signaling and IFN-I-producing plasmacytoid dendritic cells (pDCs) facilitate the differentiation of DNA-reactive AFCs in vivo and in vitro and are required for downstream manifestations of autoimmunity. Moreover, the endosomal DNA sensor TLR9 promotes anti-dsDNA responses and SLE-like disease in Dnase1/3(-/-) mice redundantly with another nucleic acid-sensing receptor, TLR7. These results establish extrafollicular B cell differentiation into short-lived AFCs as a key mechanism of anti-DNA autoreactivity and reveal a major contribution of pDCs, endosomal Toll-like receptors (TLRs), and IFN-I to this pathway.	[Soni, Chetna; Perez, Oriana A.; Pucella, Joseph N.; Serpas, Lee; Mehl, Justin; Ching, Krystal L.; Reizis, Boris] NYU, Dept Pathol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Voss, William N.; Georgiou, George; Ippolito, Gregory C.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Goike, Jule; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ippolito, Gregory C.] Univ Texas Austin, Med Sch, Dept Oncol, Austin, TX 78712 USA; [Sisirak, Vanja] Univ Bordeaux, ImmunoConcEpt, CNRS UMR 5164, F-33076 Bordeaux, France; [Reizis, Boris] NYU, Dept Med, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA	New York University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; New York University	Reizis, B (corresponding author), NYU, Dept Pathol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.; Sisirak, V (corresponding author), Univ Bordeaux, ImmunoConcEpt, CNRS UMR 5164, F-33076 Bordeaux, France.; Reizis, B (corresponding author), NYU, Dept Med, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.	vsisirak@immuconcept.org; boris.reizis@nyulangone.org	Ippolito, Gregory C./AAR-2930-2021; Soni, Chetna/E-8386-2018; Sisirak, Vanja/GRJ-7805-2022; Sisirak, Vanja/O-9393-2016	Ippolito, Gregory C./0000-0002-7565-7002; Soni, Chetna/0000-0001-7800-2338; Pucella, Joseph/0000-0003-0875-8046; Sisirak, Vanja/0000-0003-3070-6533; Ching, Krystal/0000-0002-1181-0119; Reizis, Boris/0000-0003-1140-7853	NIH [AI072571, AR071703, AR070591, CA232666, AI100853, AR069515, HL145997, CA009161, CA110624]; Lupus Research Alliance; Colton Center for Autoimmunity; Idex Junior Chair program from Bordeaux University; Cancer Research Institute CLIP grant	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Alliance; Colton Center for Autoimmunity; Idex Junior Chair program from Bordeaux University; Cancer Research Institute CLIP grant	This work was supported by NIH grants AI072571 (B.R.), AR071703 (B.R. and G.C.I.), AR070591 (B.R.), CA232666 (O.A.P.), AI100853 (O.A.P. and L.S.), AR069515 (L.S.), HL145997 (J.N.P), CA009161 (J.N.P.), CA110624 (G.C.I.), and AR071703 (G.C.I.); and by the Lupus Research Alliance (B.R.), the Colton Center for Autoimmunity (B.R.), the Idex Junior Chair program from Bordeaux University (V.S.), and a Cancer Research Institute CLIP grant (V.S.).	Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2019, J EXP MED, V216, P1974, DOI 10.1084/jem.20181359; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bruschi M., 2019, J RHEUMATOL; Buechler MB, 2013, J IMMUNOL, V190, P886, DOI 10.4049/jimmunol.1202739; Caielli S, 2019, NAT MED, V25, P75, DOI 10.1038/s41591-018-0254-9; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Das A, 2017, IMMUNITY, V46, P106, DOI 10.1016/j.immuni.2016.12.014; Degn SE, 2017, CELL, V170, P913, DOI 10.1016/j.cell.2017.07.026; Deng RS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00880-2; Domeier PP, 2018, CELL REP, V24, P406, DOI 10.1016/j.celrep.2018.06.046; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finke D, 2001, J IMMUNOL, V166, P6266, DOI 10.4049/jimmunol.166.10.6266; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Hale M, 2018, CURR OPIN IMMUNOL, V55, P81, DOI 10.1016/j.coi.2018.10.008; Hamilton JA, 2017, J IMMUNOL, V199, P2618, DOI 10.4049/jimmunol.1700888; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jenks SA, 2019, IMMUNOL REV, V288, P136, DOI 10.1111/imr.12741; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kuriakose J, 2019, J CLIN INVEST, V129, P2251, DOI 10.1172/JCI125116; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Mathian A, 2011, EUR J IMMUNOL, V41, P863, DOI 10.1002/eji.201040649; Muskardin TLW, 2018, NAT REV RHEUMATOL, V14, P214, DOI 10.1038/nrrheum.2018.31; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Nielsen CT, 2011, ARTHRITIS RHEUM-US, V63, P3067, DOI 10.1002/art.30499; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ozcakar ZB, 2013, ARTHRITIS RHEUM-US, V65, P2183, DOI 10.1002/art.38010; Pawaria S, 2015, CLIN EXP RHEUMATOL, V33, pS70; Pisetsky DS, 2016, NAT REV RHEUMATOL, V12, P102, DOI 10.1038/nrrheum.2015.151; Pisetsky DS, 2011, IMMUNOL RES, V49, P227, DOI 10.1007/s12026-010-8184-8; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Sawai CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02475; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; Serpas L, 2019, P NATL ACAD SCI USA, V116, P641, DOI 10.1073/pnas.1815031116; Sharma S, 2015, J IMMUNOL, V195, P3507, DOI 10.4049/jimmunol.1500964; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shibata T, 2016, INT IMMUNOL, V28, P211, DOI 10.1093/intimm/dxv062; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Soni C, 2018, CURR OPIN IMMUNOL, V55, P31, DOI 10.1016/j.coi.2018.09.009; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Sweet RA, 2011, P NATL ACAD SCI USA, V108, P7932, DOI 10.1073/pnas.1018571108; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Weisenburger T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01551; Westra HJ, 2018, NAT GENET, V50, P1366, DOI 10.1038/s41588-018-0216-7; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yung S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00475; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zochling J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0438-8	69	46	46	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1022	+		10.1016/j.immuni.2020.04.015	http://dx.doi.org/10.1016/j.immuni.2020.04.015			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32454024	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000541890000016
J	Xu, W; Zhao, XH; Wang, XS; Feng, H; Gou, MT; Jin, W; Wang, XH; Liu, XD; Dong, C				Xu, Wei; Zhao, Xiaohong; Wang, Xiaoshuang; Feng, Han; Gou, Mengting; Jin, Wei; Wang, Xiaohu; Liu, Xindong; Dong, Chen			The Transcription Factor Tox2 Drives T Follicular Helper Cell Development via Regulating Chromatin Accessibility	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; BINDING FACTOR TOX; DIFFERENTIATION; BCL6; EXPRESSION; GENERATION	T follicular helper (Tfh) cells provide essential help to B cells in germinal center (GC) reactions. Bcl6 is the obligatory lineage transcription factor in Tfh cells. Here, we examined the molecular pathways that induce Bcl6 gene expression and underscore Bcl6-dependent function during Tfh cell commitment. Integration of genome-wide Bcl6 occupancy in Tfh cells and differential gene expression analyses suggested an important role for the transcription factor Tox2 in Tfh cell differentiation. Ectopic expression of Tox2 was sufficient to drive Bcl6 expression and Tfh development. In genome-wide ChIP-seq analyses, Tox2-bound loci associated with Tfh cell differentiation and function, including Bcl6. Tox2 binding was associated with increased chromatin accessibility at these sites, as measured by ATAC-seq. Tox2(-/-) mice exhibited defective Tfh differentiation, and inhibition of both Tox2 and the related transcription factor Tox abolished Tfh differentiation. Thus, a Tox2-Bcl6 axis establishes a transcriptional feed-forward loop that promotes the Tfh program.	[Xu, Wei] Peking Univ, Coll Life Sci, Beijing, Peoples R China; [Xu, Wei] Peking Univ, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing, Peoples R China; [Xu, Wei; Zhao, Xiaohong; Wang, Xiaoshuang; Feng, Han; Gou, Mengting; Jin, Wei; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Xu, Wei; Zhao, Xiaohong; Wang, Xiaoshuang; Feng, Han; Gou, Mengting; Jin, Wei; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Liu, Xindong] Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Liu, Xindong] Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Peking University; Peking University; Tsinghua University; Tsinghua University; Tsinghua University; Army Medical University; Army Medical University	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing, Peoples R China.	chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Liu, Xindong/0000-0002-2465-0337	National Natural Science Foundation of China [91642201, 31630022]; Beijing Municipal Science and Technology [Z171100000417005]; Ministry of Science and Technology of China [2016YFC0906200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank the Tsinghua University Genetic Engineering Facility for assistance in the generation of Tox2 KO mice and the Immunology Core facility for FACS sorting. The work was supported in part by National Natural Science Foundation of China (91642201 and 31630022 to C.D.), Beijing Municipal Science and Technology (Z171100000417005 to C.D.), and Ministry of Science and Technology of China (2016YFC0906200 to C.D.). C.D. is a FViL Investigator.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2011, J IMMUNOL, V187, P5931, DOI 10.4049/jimmunol.1101474; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Auderset F, 2013, J IMMUNOL, V191, P2344, DOI 10.4049/jimmunol.1300643; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chae WJ, 2018, TRENDS IMMUNOL, V39, P830, DOI 10.1016/j.it.2018.08.006; Chen XY, 2020, CELL MOL IMMUNOL, V17, P247, DOI 10.1038/s41423-019-0219-z; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Lahmann A, 2019, J IMMUNOL, V202, P2229, DOI 10.4049/jimmunol.1801400; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Page N, 2018, IMMUNITY, V48, P937, DOI 10.1016/j.immuni.2018.04.005; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Vong QP, 2014, BLOOD, V124, P3905, DOI 10.1182/blood-2014-06-582965; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weinstein JS, 2014, BLOOD, V124, P3719, DOI 10.1182/blood-2014-06-582700; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	36	46	49	6	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					826	+		10.1016/j.immuni.2019.10.006	http://dx.doi.org/10.1016/j.immuni.2019.10.006			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31732165	Bronze			2022-12-18	WOS:000497811300008
J	Kimball, AS; Davis, FM; DenDekker, A; Joshi, AD; Schaller, MA; Bermick, J; Xing, XY; Burant, CF; Obi, AT; Nysz, D; Robinson, S; Allen, R; Lukacs, NW; Henke, PK; Gudjonsson, JE; Moore, BB; Kunkel, SL; Gallagher, KA				Kimball, Andrew S.; Davis, Frank M.; DenDekker, Aaron; Joshi, Amrita D.; Schaller, Matthew A.; Bermick, Jennifer; Xing, Xianying; Burant, Charles F.; Obi, Andrea T.; Nysz, Dylan; Robinson, Scott; Allen, Ron; Lukacs, Nicholas W.; Henke, Peter K.; Gudjonsson, Johann E.; Moore, Bethany B.; Kunkel, Steve L.; Gallagher, Katherine A.			The Histone Methyltransferase Setdb2 Modulates Macrophage Phenotype and Uric Acid Production in Diabetic Wound Repair	IMMUNITY			English	Article							TISSUE-REPAIR; FOOT ULCERS; INFLAMMATION; ACTIVATION; CELLS; POLARIZATION; PLASTICITY; INDUCTION; RESPONSES; BETA	Macrophage plasticity is critical for normal tissue repair to ensure transition from the inflammatory to the proliferative phase of healing. We examined macrophages isolated from wounds of patients afflicted with diabetes and of healthy controls and found differential expression of the methyltransferase Setdb2. Myeloid-specific deletion of Setdb2 impaired the transition of macrophages from an inflammatory phenotype to a reparative one in normal wound healing. Mechanistically, Setdb2 trimethylated histone 3 at NF-kappa B binding sites on inflammatory cytokine gene promoters to suppress transcription. Setdb2 expression in wound macrophages was regulated by interferon (IFN) beta, and under diabetic conditions, this IFN beta-Setdb2 axis was impaired, leading to a persistent inflammatory macrophage phenotype in diabetic wounds. Setdb2 regulated the expression of xanthine oxidase and thereby the uric acid (UA) pathway of purine catabolism in macrophages, and pharmacologic targeting of Setdb2 or the UA pathway improved healing. Thus, Setdb2 regulates macrophage plasticity during normal and pathologic wound repair and is a target for therapeutic manipulation.	[Kimball, Andrew S.; Davis, Frank M.; DenDekker, Aaron; Joshi, Amrita D.; Obi, Andrea T.; Nysz, Dylan; Robinson, Scott; Henke, Peter K.; Gallagher, Katherine A.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [DenDekker, Aaron; Allen, Ron; Lukacs, Nicholas W.; Kunkel, Steve L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Schaller, Matthew A.] Univ Florida, Dept Immunol, Gainesville, FL USA; [Bermick, Jennifer] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Xing, Xianying; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Burant, Charles F.; Moore, Bethany B.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Moore, Bethany B.; Gallagher, Katherine A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gallagher, KA (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.; Gallagher, KA (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	kgallag@med.umich.edu	Lukacs, Nicholas W/ABH-5583-2020; Burant, Charles/GPC-5690-2022; Schaller, Matthew/AAL-7640-2020; Robinson, Scott/M-9491-2016	Burant, Charles/0000-0001-9189-5003; denDekker, Aaron/0000-0001-9604-0557; Robinson, Scott/0000-0002-2911-439X; Bermick, Jennifer/0000-0002-0245-946X	NIH [RO1-HL137919, NIH-T32 HL076123, NIH-F32 DK-117545-01]; Doris Duke Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076123, R01HL137919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR075043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK117545] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Robin G. Kunkel, research associate in the Pathology Department, University of Michigan, for her artistic work. This study was supported by NIH (RO1-HL137919, NIH-T32 HL076123, and NIH-F32 DK-117545-01) and the Doris Duke Foundation.	Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; Barres R, 2013, CELL REP, V3, P1020, DOI 10.1016/j.celrep.2013.03.018; Beischlag TV, 2018, METHODS MOL BIOL, V1689, P103, DOI 10.1007/978-1-4939-7380-4_9; Boniakowski AE, 2017, J IMMUNOL, V199, P17, DOI 10.4049/jimmunol.1700223; Braga TT, 2017, SCI REP-UK, V7, DOI 10.1038/srep39884; Carson WF, 2017, J IMMUNOL, V199, P1865, DOI 10.4049/jimmunol.1601272; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coomes SM, 2010, J IMMUNOL, V184, P5130, DOI 10.4049/jimmunol.0901871; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Davis FM, 2019, J IMMUNOL, V202, P1777, DOI 10.4049/jimmunol.1801258; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Faglia E, 2001, DIABETES CARE, V24, P78, DOI 10.2337/diacare.24.1.78; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fislova T, 2005, ACTA VIROL, V49, P243; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gallagher KA, 2015, DIABETES, V64, P1420, DOI 10.2337/db14-0872; Ghanassia E, 2008, DIABETES CARE, V31, P1288, DOI 10.2337/dc07-2145; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Hicks CW, 2016, ANN VASC SURG, V33, P149, DOI 10.1016/j.avsg.2015.11.025; Hubbard LLN, 2008, EXP LUNG RES, V34, P263, DOI 10.1080/01902140802022518; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Izumi Y, 2009, DIABETES RES CLIN PR, V83, P126, DOI 10.1016/j.diabres.2008.09.005; Kimball A, 2018, ARTERIOSCL THROM VAS, V38, P1102, DOI 10.1161/ATVBAHA.118.310703; Kimball AS, 2017, DIABETES, V66, P2459, DOI 10.2337/db17-0194; Kittan NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078045; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kroetz DN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005338; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza RE, 2015, J PATHOL, V236, P433, DOI 10.1002/path.4548; Mirza RE, 2014, DIABETES, V63, P1103, DOI 10.2337/db13-0927; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Porta C, 2015, SEMIN IMMUNOL, V27, P237, DOI 10.1016/j.smim.2015.10.003; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Sato Y, 2010, ANAL CHEM, V82, P9858, DOI 10.1021/ac102211r; Schliehe C, 2015, NAT IMMUNOL, V16, P67, DOI 10.1038/ni.3046; Schrementi ME, 2008, WOUND REPAIR REGEN, V16, P80, DOI 10.1111/j.1524-475X.2007.00320.x; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Uratsuji H, 2012, J IMMUNOL, V188, P436, DOI 10.4049/jimmunol.1003746; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	56	46	47	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					258	+		10.1016/j.immuni.2019.06.015	http://dx.doi.org/10.1016/j.immuni.2019.06.015			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31350176	Green Accepted, Bronze			2022-12-18	WOS:000482088500010
J	Stewart, I; Radtke, D; Phillips, B; McGowan, SJ; Bannard, O				Stewart, Isabelle; Radtke, Daniel; Phillips, Bethan; McGowan, Simon J.; Bannard, Oliver			Germinal Center B Cells Replace Their Antigen Receptors in Dark Zones and Fail Light Zone Entry when Immunoglobulin Gene Mutations are Damaging	IMMUNITY			English	Article							CLASS SWITCH RECOMBINATION; TRANSCRIPTION FACTOR; AFFINITY MATURATION; CLONAL SELECTION; IMMUNE-RESPONSE; TRANSGENIC MICE; PI3 KINASE; LYMPHOCYTES; EXPRESSION; ANTIBODIES	A daptive immunity involves the development of bespoke antibodies in germinal centers (GCs) through immunoglobulin somatic hypermutation (SHM) in GC dark zones (DZs) and clonal selection in light zones (LZs). Accurate selection requires that cells fully replace surface B cell receptors (BCRs) following SHM, but whether this happens before LZ entry is not clear. We found that most GC B cells degrade pre-SHM receptors before leaving the DZ, and that B cells acquiring crippling mutations during SHM rarely reached the LZ. Instead, apoptosis was triggered preferentially in late G1, a stage wherein cells with functional BCRs re-entered cell cycle or reduced surface expression of the chemokine receptor CXCR4 to enable LZ migration. Ectopic expression of the anti-apoptotic gene Bcl2 was not sufficient for cells with damaging mutations to reach the LZ, suggesting that BCR-dependent cues may actively facilitate the transition. Thus, BCR replacement and pre-screening in DZs prevents the accumulation of clones with non-functional receptors and facilitates selection in the LZ.	[Stewart, Isabelle; Radtke, Daniel; Phillips, Bethan; Bannard, Oliver] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [McGowan, Simon J.] Univ Oxford, MRC Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England	University of Oxford; University of Oxford	Bannard, O (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	oliver.bannard@ndm.ox.ac.uk	Radtke, Daniel/AHD-2173-2022	Radtke, Daniel/0000-0003-3241-4542; Stewart, Isabelle/0000-0001-8204-0687; McGowan, Simon/0000-0001-9720-1914	Sir Henry Dale Fellowship from The Wellcome Trust/Royal Society [105654/Z/14/Z]; Medical Research Council (UK); MRC WIMM [MC_UU_12010/3]; MRC [MC_UU_12010/3] Funding Source: UKRI	Sir Henry Dale Fellowship from The Wellcome Trust/Royal Society; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC WIMM(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to C. Anzilloti, R. Brink, R. Cornall, T. Honjo, S. Jayaram, C. Rada, and S. Srinivas for kindly providing, or allowing use of, various mouse strains. We thank T. Fujimori and RIKEN BDR Laboratories for Animal Resource Development and Genetic Engineering (LARGE) for R26p-Fucci2 mice. We also thank G. Kelsoe and M. Kuraoka for generously allowing use of NB21 cells and for help with protocols, and J. Cyster, J. Muppidi, and A. Re-boldi for critical reading of the manuscript. N. Ashley (WIMM single cell core) provided technical advice and T. Rostron (WIMM sequencing core) provided sequencing services. Cell sorts were performed in the WIMM FACS facility with expert assistance from C. Waugh and S. Clarke. This work was funded by a Sir Henry Dale Fellowship from The Wellcome Trust/Royal Society (O.B., 105654/Z/14/Z) and by the Medical Research Council (UK) through core funding to the MRC Human Immunology Unit and the MRC WIMM (MC_UU_12010/3).	Abe T, 2013, DEVELOPMENT, V140, P237, DOI 10.1242/dev.084111; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ANDERSSON J, 1974, EUR J IMMUNOL, V4, P170, DOI 10.1002/eji.1830040305; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kelsoe G, 2017, IMMUNOL REV, V275, P79, DOI 10.1111/imr.12508; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Le Q, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005411; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Peperzak V, 2012, IMMUNOL REV, V247, P93, DOI 10.1111/j.1600-065X.2012.01123.x; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Thaunat O, 2012, SCIENCE, V335, P475, DOI 10.1126/science.1214100; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang Q, 2017, J EXP MED, V214, P49, DOI 10.1084/jem.20161649; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042	53	46	46	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					477	+		10.1016/j.immuni.2018.08.025	http://dx.doi.org/10.1016/j.immuni.2018.08.025			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231983	hybrid, Green Published			2022-12-18	WOS:000444909600015
J	Mowel, WK; McCright, SJ; Kotzin, JJ; Collet, MA; Uyar, A; Chen, X; DeLaney, A; Spencer, SP; Virtue, AT; Yang, EJ; Villarino, A; Kurachi, M; Dunagin, MC; Pritchard, GH; Stein, J; Hughes, C; Fonseca-Pereira, D; Veiga-Fernandes, H; Raj, A; Kambayashi, T; Brodsky, IE; O'Shea, JJ; Wherry, EJ; Goff, LA; Rinn, JL; Williams, A; Flavell, RA; Henao-Mejia, J				Mowel, Walter K.; McCright, Sam J.; Kotzin, Jonathan J.; Collet, Magalie A.; Uyar, Asli; Chen, Xin; DeLaney, Alexandra; Spencer, Sean P.; Virtue, Anthony T.; Yang, EnJun; Villarino, Alejandro; Kurachi, Makoto; Dunagin, Margaret C.; Pritchard, Gretchen Harms; Stein, Judith; Hughes, Cynthia; Fonseca-Pereira, Diogo; Veiga-Fernandes, Henrique; Raj, Arjun; Kambayashi, Taku; Brodsky, Igor E.; O'Shea, John J.; Wherry, E. John; Goff, Loyal A.; Rinn, John L.; Williams, Adam; Flavell, Richard A.; Henao-Mejia, Jorge			Group 1 Innate Lymphoid Cell Lineage Identity Is Determined by a cis-Regulatory Element Marked by a Long Non-coding RNA	IMMUNITY			English	Article							TRANSCRIPTION; DIFFERENTIATION; EXPRESSION; MATURATION; PROGENITOR; EVOLUTION; COHESIN; CTCF	Commitment to the innate lymphoid cell (ILC) lineage is determined by Id2, a transcriptional regulator that antagonizes T and B cell-specific gene expression programs. Yet how Id2 expression is regulated in each ILC subset remains poorly understood. We identified a cis-regulatory element demarcated by a long non-coding RNA (lncRNA) that controls the function and lineage identity of group 1 ILCs, while being dispensable for early ILC development and homeostasis of ILC2s and ILC3s. The locus encoding this lncRNA, which we termed Rroid, directly interacted with the promoter of its neighboring gene, Id2, in group 1 ILCs. Moreover, the Rroid locus, but not the lncRNA itself, controlled the identity and function of ILC1s by promoting chromatin accessibility and deposition of STAT5 at the promoter of Id2 in response to interleukin (IL)-15. Thus, non-coding elements responsive to extracellular cues unique to each ILC subset represent a key regulatory layer for controlling the identity and function of ILCs.	[Mowel, Walter K.; McCright, Sam J.; Kotzin, Jonathan J.; Spencer, Sean P.; Virtue, Anthony T.; Yang, EnJun; Kambayashi, Taku; Henao-Mejia, Jorge] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mowel, Walter K.; McCright, Sam J.; Kotzin, Jonathan J.; Spencer, Sean P.; Virtue, Anthony T.; Yang, EnJun; Kurachi, Makoto; Kambayashi, Taku; Wherry, E. John; Henao-Mejia, Jorge] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Collet, Magalie A.; Uyar, Asli; Chen, Xin; Williams, Adam] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Chen, Xin] Univ Connecticut, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [DeLaney, Alexandra; Pritchard, Gretchen Harms; Brodsky, Igor E.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Villarino, Alejandro; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Kurachi, Makoto; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Dunagin, Margaret C.; Raj, Arjun; Flavell, Richard A.] Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; [Stein, Judith; Hughes, Cynthia; Flavell, Richard A.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Stein, Judith; Hughes, Cynthia] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Fonseca-Pereira, Diogo; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Med Mol, Av Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal; [Veiga-Fernandes, Henrique] Champalimaud Ctr Unknown, Champalimaud Res, P-1400038 Lisbon, Portugal; [Goff, Loyal A.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Goff, Loyal A.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Rinn, John L.] Harvard Med Sch, Biol & Biomed Sci, Boston, MA 02115 USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Williams, Adam] Univ Connecticut, Dept Genet & Genom Sci, Hlth Ctr, Farmington, CT 06032 USA; [Henao-Mejia, Jorge] Univ Penn, Div Transplant Immunol, Dept Pathol & Lab Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Jackson Laboratory; University of Connecticut; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Yale University; Howard Hughes Medical Institute; Yale University; Universidade de Lisboa; Fundacao Champalimaud; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Harvard University; University of Connecticut; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Henao-Mejia, J (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Henao-Mejia, J (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Williams, A (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Flavell, RA (corresponding author), Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA.; Flavell, RA (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.; Williams, A (corresponding author), Univ Connecticut, Dept Genet & Genom Sci, Hlth Ctr, Farmington, CT 06032 USA.; Henao-Mejia, J (corresponding author), Univ Penn, Div Transplant Immunol, Dept Pathol & Lab Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	adam.williams@jax.org; richard.flavell@yale.edu; jhena@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; da Fonseca Pereira, Diogo/O-9894-2019; Fonseca-Pereira, Diogo/U-1275-2018; Villarino, Alejandro/AAE-3517-2020	Fonseca-Pereira, Diogo/0000-0002-7400-9804; Villarino, Alejandro/0000-0001-8068-2176; Chen, Xin/0000-0002-5310-5426; Goff, Loyal/0000-0003-2875-451X; Rinn, John/0000-0002-7231-7539; Mowel, Walter/0000-0003-2393-4300; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Spencer, Sean/0000-0002-7328-5399; McCright, Sam/0000-0002-4295-9290	CHOP; UPenn IFI; IDOM; PEW Foundation; NIH [R21AI128060, R21DK111755, R01HL136572, R21AI110776, R01AI103062, R01AI128530, T32AI055428, F31AI124538, T32DK007780, F30DK094708, R33EB019767]; Howard Hughes Medical Institute; New Innovator NIH [DP2OD008514]; NSF CAREER [1350601]; ERC, EU [647274]; Kenneth Rainin Foundation, US; Crohn's and Colitis Foundation of America, US; FCT, Portugal; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428, R21AI128060, R01AI128530, R01AI103062, R21AI110776, F31AI124538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041207, ZIAAR041159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB019767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK111755, F30DK094708, T32DK007780] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	CHOP; UPenn IFI; IDOM; PEW Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New Innovator NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); ERC, EU; Kenneth Rainin Foundation, US; Crohn's and Colitis Foundation of America, US; FCT, Portugal(Portuguese Foundation for Science and Technology); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Hunter for providing Tbx21<SUP>-/-</SUP> mice and J. Kurachi for technical support. The work in this manuscript was supported by funds from CHOP, UPenn IFI and IDOM pilot projects, the PEW Foundation, and NIH R21AI128060, R21DK111755, and R01HL136572 (J.H.-M.). A.W. and R.A.F. were supported by NIH R21AI110776; R.A.F. by the Howard Hughes Medical Institute; I.E.B. by NIH R01AI103062 and R01AI128530; W.K.M. by NIH T32AI055428 and F31AI124538; J.J.K. by NIH T32DK007780; S.P.S. by NIH F30DK094708; and A.R. and M.C.D. by New Innovator NIH DP2OD008514, NIH R33EB019767, and NSF CAREER 1350601. E.J.W. is a member of the Parker Institute for Cancer Immunotherapy, which supports the Penn Cancer Immunotherapy Program. H.V.-F. is funded by ERC (647274), EU; Kenneth Rainin Foundation, US; Crohn's and Colitis Foundation of America, US; and FCT, Portugal. A.R. receives royalty and consulting income related to Stellaris RNA FISH probes from LGC/Biosearch Technologies.	Anderson KM, 2016, NATURE, V539, P433, DOI 10.1038/nature20128; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henao-Mejia J, 2016, COLD SPRING HARB PRO, V2016; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Ogawa N, 2012, METHODS MOL BIOL, V786, P51, DOI 10.1007/978-1-61779-292-2_3; Polansky JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19699; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; TAKADA H, 1994, IMMUNOLOGY, V82, P106; Villarino A, 2016, ELIFE, V5, DOI 10.7554/eLife.08384; Vivier E, 2016, NAT IMMUNOL, V17, P790, DOI 10.1038/ni.3459; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	39	46	49	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					435	+		10.1016/j.immuni.2017.08.012	http://dx.doi.org/10.1016/j.immuni.2017.08.012			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930659	Bronze, Green Accepted			2022-12-18	WOS:000411128200010
J	Iwata, S; Mikami, Y; Sun, HW; Brooks, SR; Jankovic, D; Hirahara, K; Onodera, A; Shih, HY; Kawabe, T; Jiang, K; Nakayama, T; Sher, A; O'Shea, JJ; Davis, FP; Kanno, Y				Iwata, Shigeru; Mikami, Yohei; Sun, Hong-Wei; Brooks, Stephen R.; Jankovic, Dragana; Hirahara, Kiyoshi; Onodera, Atsushi; Shih, Han-Yu; Kawabe, Takeshi; Jiang, Kan; Nakayama, Toshinori; Sher, Alan; O'Shea, John J.; Davis, Fred P.; Kanno, Yuka			The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells	IMMUNITY			English	Article							PERSISTENT LCMV INFECTION; CELLULAR-RESPONSES; INTERFERON-GAMMA; INDUCTION; IMMUNITY; DIFFERENTIATION; POPULATIONS; RESISTANCE; COOPERATE; BLOCKADE	Host defense requires the specification of CD4(+) helper T (Th) cells into distinct fates, including Th1 cells that preferentially produce interferon-gamma (IFN-gamma). IFN-gamma, a member of a large family of antipathogenic and anti-tumor IFNs, induces T-bet, a lineage-defining transcription factor for Th1 cells, which in turn supports IFN-gamma production in a feed-forward manner. Herein, we show that a cellintrinsic role of T-bet influences how T cells perceive their secreted product in the environment. In the absence of T-bet, IFN-gamma aberrantly induced a type I IFN transcriptomic program. T-bet preferentially repressed genes and pathways ordinarily activated by type I IFNs to ensure that its transcriptional response did not evoke an aberrant amplification of type I IFN signaling circuitry, otherwise triggered by its own product. Thus, in addition to promoting Th1 effector commitment, T-bet acts as a repressor in differentiated Th1 cells to prevent abberant autocrine type I IFN and downstream signaling.	[Iwata, Shigeru; Mikami, Yohei; Shih, Han-Yu; Jiang, Kan; O'Shea, John J.; Davis, Fred P.; Kanno, Yuka] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei; Brooks, Stephen R.] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Jankovic, Dragana; Kawabe, Takeshi; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hirahara, Kiyoshi; Onodera, Atsushi; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba 2608670, Japan; [Onodera, Atsushi] Chiba Univ, Inst Global Prominent Res, Chiba 2608670, Japan; [Nakayama, Toshinori] AMED, AMED CREST, Chiba 2608670, Japan; [Kawabe, Takeshi] NIAID, Cytokine Biol Unit, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Iwata, Shigeru] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chiba University; Chiba University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Occupational & Environmental Health - Japan	O'Shea, JJ; Davis, FP; Kanno, Y (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	john.oshea@nih.gov; fred.davis@nih.gov; kannoy@mail.nih.gov	MIKAMI, YOHEI/GRJ-8133-2022; Nakayama, Toshinori/E-1067-2017; Kanno, Yuka/B-5802-2013; Hirahara, Kiyoshi/E-2460-2017	MIKAMI, YOHEI/0000-0001-5104-4415; Nakayama, Toshinori/0000-0002-1434-2007; Kanno, Yuka/0000-0001-5668-9319; Davis, Fred/0000-0001-8294-1610; Shih, Han-Yu/0000-0002-7525-5433; Hirahara, Kiyoshi/0000-0002-9128-9449	Intramural Research Program of NIAMS; Intramural Research Program of NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041159] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26221305] Funding Source: KAKEN	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural Research Program of NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Simone, J. Lay, and K. Tinsley from NIAMS and T. Moyer from NIAID for expert assistance in flow cytometry and the NIAMS LACU staff for their excellent technical support in handling mice. We thank G. Gutierrez-Cruz for deep-sequencing support. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of NIAMS and NIAID.	Arimoto K, 2017, NAT STRUCT MOL BIOL, V24, P279, DOI 10.1038/nsmb.3378; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; GAZZINELLI RT, 1993, INFECT AGENT DIS, V2, P139; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu CF, 2016, P NATL ACAD SCI USA, V113, pE6572, DOI 10.1073/pnas.1613914113; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Pimentel H, 2016, BIORXIV; Pritchard GH, 2015, J IMMUNOL, V194, P1131, DOI 10.4049/jimmunol.1401617; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sallusto F, 2016, ANNU REV IMMUNOL, V34, P317, DOI 10.1146/annurev-immunol-032414-112056; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suzuki R, 2014, SCIENCE, V343, P1021, DOI 10.1126/science.1246976; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yosef N, 2016, SCIENCE, V354, P64, DOI 10.1126/science.aaf5453; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	45	46	48	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					983	+		10.1016/j.immuni.2017.05.005	http://dx.doi.org/10.1016/j.immuni.2017.05.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28623086	Green Accepted, Bronze			2022-12-18	WOS:000403665900012
J	Choi, HW; Bowen, SE; Miao, YX; Chan, CY; Miao, EA; Abrink, M; Moeser, AJ; Abraham, SN				Choi, Hae Woong; Bowen, Samantha E.; Miao, Yuxuan; Chan, Cheryl Y.; Miao, Edward A.; Abrink, Magnus; Moeser, Adam J.; Abraham, Soman N.			Loss of Bladder Epithelium Induced by Cytolytic Mast Cell Granules	IMMUNITY			English	Article							URINARY-TRACT; BARRIER DYSFUNCTION; BACTERIAL CLEARANCE; MIGRATION; PROLIFERATION; PYROPTOSIS; APOPTOSIS; ALPHA; DEATH	Programmed death and shedding of epithelial cells is a powerful defense mechanism to reduce bacterial burden during infection but this activity cannot be indiscriminate because of the critical barrier function of the epithelium. We report that during cystitis, shedding of infected bladder epithelial cells (BECs) was preceded by the recruitment of mast cells (MCs) directly underneath the superficial epithelium where they docked and extruded their granules. MCs were responding to interleukin-1 beta (IL-1 beta) secreted by BECs after inflammasome and caspase-1 signaling. Upon uptake of granule-associated chymase (mouse MC protease 4 [mMCPT4]), BECs underwent caspase-1-associated cytolysis and exfoliation. Thus, infected epithelial cells require a specific cue for cytolysis from recruited sentinel inflammatory cells before shedding.	[Choi, Hae Woong; Abraham, Soman N.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Bowen, Samantha E.; Miao, Yuxuan; Abraham, Soman N.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Dept Immunol, Durham, NC 27710 USA; [Chan, Cheryl Y.; Abraham, Soman N.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore 169857, Singapore; [Miao, Edward A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Miao, Edward A.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA; [Miao, Edward A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, S-75007 Uppsala, Sweden; [Moeser, Adam J.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Moeser, Adam J.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Duke University; Duke University; Duke University; National University of Singapore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Swedish University of Agricultural Sciences; Michigan State University; Michigan State University	Choi, HW (corresponding author), Duke Univ, Dept Pathol, Durham, NC 27710 USA.	haewoong.choi@duke.edu	Åbrink, Magnus/AAK-8346-2020	Moeser, Adam/0000-0003-3068-627X; Choi, Hae Woong/0000-0001-9372-1875; Bowen, Samantha/0000-0002-0937-6990; Abrink, Magnus/0000-0002-1335-3927	NIH grants [U01-AI082107, R01-AI096305, R56-DK095198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082107, R01AI096305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK095198] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Roers for the Mcpt5-Cre<SUP>+</SUP>iDTR<SUP>+</SUP> mice. We thank L. Hellman for providing the Mcpt4 clone and S. Dowdy for the pTAT-2.1 vector. We thank J. Shipley-Phillips and M. Dykstra for assistance with electron microscopy. J. Hart is gratefully acknowledged for critical review of this manuscript. We thank R. Valdivia, P. Seed, G. Taylor, and T. Lechler for helpful suggestions and comments. S.N.A. is the cofounder and chief scientific officer for Mastezellen Bio Inc. This work was funded by NIH grants U01-AI082107, R01-AI096305, and R56-DK095198.	BAGGIOLINI M, 1982, INT ARCH ALLER A IMM, V67, P219, DOI 10.1159/000233022; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Chen MC, 2006, J UROLOGY, V175, P754, DOI 10.1016/S0022-5347(05)00171-0; Chen MC, 2007, AM J PHYSIOL-RENAL, V292, pF1372, DOI 10.1152/ajprenal.00472.2006; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Jones NL, 1997, AM J PATHOL, V151, P1695; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Malaviya R, 2004, IMMUNOL LETT, V91, P103, DOI 10.1016/j.imlet.2003.10.005; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; McDermott JR, 2003, P NATL ACAD SCI USA, V100, P7761, DOI 10.1073/pnas.1231488100; Mehershahi K.S., 2015, SCIENCE, V3, P3; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; White SR, 2008, AM J PHYSIOL-LUNG C, V295, pL1018, DOI 10.1152/ajplung.00065.2008; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	34	46	46	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1258	1269		10.1016/j.immuni.2016.11.003	http://dx.doi.org/10.1016/j.immuni.2016.11.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27939674	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000392918100012
J	Meli, AP; Fontes, G; Avery, DT; Leddon, SA; Tam, M; Elliot, M; Ballesteros-Tato, A; Miller, J; Stevenson, MM; Fowell, DJ; Tangye, SG; King, IL				Meli, Alexandre P.; Fontes, Ghislaine; Avery, Danielle T.; Leddon, Scott A.; Tam, Mifong; Elliot, Michael; Ballesteros-Tato, Andre; Miller, Jim; Stevenson, Mary M.; Fowell, Deborah J.; Tangye, Stuart G.; King, Irah L.			The Integrin LFA-1 Controls T Follicular Helper Cell Generation and Maintenance	IMMUNITY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; B-CELLS; LYMPHOCYTE EGRESS; IN-VIVO; HELMINTH INFECTION; DENDRITIC CELLS; FH CELLS; DIFFERENTIATION; ACTIVATION; RESPONSES	T follicular helper (Tfh) cells are a CD4(+) T cell subset critical for long-lived humoral immunity. We hypothesized that integrins play a decisive role in Tfh cell biology. Here we show that Tfh cells expressed a highly active form of leukocyte function-associated antigen-1 (LFA-1) that was required for their survival within the germinal center niche. In addition, LFA-1 promoted expression of Bcl-6, a transcriptional repressor critical for Tfh cell differentiation, and inhibition of LFA-1 abolished Tfh cell generation and prevented protective humoral immunity to intestinal helminth infection. Furthermore, we demonstrated that expression of Talin-1, an adaptor protein that regulates LFA-1 affinity, dictated Tfh versus Th2 effector cell differentiation. Collectively, our results define unique functions for LFA-1 in the Tfh cell effector program and suggest that integrin activity is important in lineage decision-making events in the adaptive immune system.	[Meli, Alexandre P.; Fontes, Ghislaine; Tam, Mifong; Stevenson, Mary M.; King, Irah L.] McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ H3A 2B4, Canada; [Avery, Danielle T.; Tangye, Stuart G.] Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW 2010, Australia; [Leddon, Scott A.; Miller, Jim; Fowell, Deborah J.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol,Aab Inst, Rochester, NY 14642 USA; [Elliot, Michael] Sydney Head & Neck Canc Inst, Camperdown, NSW 2050, Australia; [Ballesteros-Tato, Andre] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	McGill University; Garvan Institute of Medical Research; University of Rochester; University of Alabama System; University of Alabama Birmingham	King, IL (corresponding author), McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ H3A 2B4, Canada.	irah.king@mcgill.ca	Tangye, Stuart G/H-4023-2014	Tangye, Stuart G/0000-0002-5360-5180; Ballesteros-Tato, Andre/0000-0002-4833-593X; Meli, Alexandre/0000-0002-6199-3531	Canadian Institute of Health Research (CIHR) [MOP-130579]; McGill University Faculty of Medicine; Fonds de recherche du Quebec-Sante; Fonds de recherche du Quebec - Nature et Technologies; Canada Research Chair in Humoral Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill University Faculty of Medicine; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Fonds de recherche du Quebec - Nature et Technologies; Canada Research Chair in Humoral Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank Camille Stegen for her management of the MIMM flow cytometry facility and members of the King laboratory for their technical input. This work was supported by the Canadian Institute of Health Research (CIHR) operating grant (MOP-130579) and McGill University Faculty of Medicine. I.L.K. also holds a Canada Research Chair in Humoral Immunity. A.P.M. received support from the Fonds de recherche du Quebec-Sante and Fonds de recherche du Quebec - Nature et Technologies.	Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; DUBEY C, 1995, J IMMUNOL, V155, P45; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; FISCHER A, 1986, J IMMUNOL, V136, P3198; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hewitson JP, 2011, J IMMUNOL, V187, P4764, DOI 10.4049/jimmunol.1004140; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Kinashi T, 2011, METHODS MOL BIOL, V757, P261, DOI 10.1007/978-1-61779-166-6_17; King IL, 2010, J IMMUNOL, V185, P6138, DOI 10.4049/jimmunol.1001703; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; KOOPMAN G, 1991, J EXP MED, V173, P1297, DOI 10.1084/jem.173.6.1297; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Lee JE, 1997, J IMMUNOL, V159, P61; Linterman MA, 2014, ELIFE, V3, DOI 10.7554/eLife.03180; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meli AP, 2015, METHODS MOL BIOL, V1291, P3, DOI 10.1007/978-1-4939-2498-1_1; Morrison VL, 2015, J IMMUNOL, V195, P105, DOI 10.4049/jimmunol.1402741; Nolte MA, 2002, IMMUNOLOGY, V106, P299, DOI 10.1046/j.1365-2567.2002.01443.x; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Peters T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/450738; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; PRITCHARD DI, 1983, IMMUNOLOGY, V49, P353; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reichardt P, 2013, EMBO J, V32, P829, DOI 10.1038/emboj.2013.33; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Valanparambil RM, 2014, NAT PROTOC, V9, P2740, DOI 10.1038/nprot.2014.184; Wang XM, 2014, J IMMUNOL, V192, P4601, DOI 10.4049/jimmunol.1400090; Winter SS, 2001, BRIT J HAEMATOL, V115, P862, DOI 10.1046/j.1365-2141.2001.03182.x; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	55	46	47	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					831	846		10.1016/j.immuni.2016.09.018	http://dx.doi.org/10.1016/j.immuni.2016.09.018			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760339	Green Accepted, Bronze			2022-12-18	WOS:000389473200015
J	Stienne, C; Michieletto, MF; Benamar, M; Carrie, N; Bernard, I; Nguyen, XH; Lippi, Y; Duguet, F; Liblau, RS; Hedrick, SM; Saoudi, A; Dejean, AS				Stienne, Caroline; Michieletto, Michael F.; Benamar, Mehdi; Carrie, Nadege; Bernard, Isabelle; Xuan-Hung Nguyen; Lippi, Yannick; Duguet, Fanny; Liblau, Roland S.; Hedrick, Stephen M.; Saoudi, Abdelhadi; Dejean, Anne S.			Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes	IMMUNITY			English	Article							T-CELL DIFFERENTIATION; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; GM-CSF; AUTOIMMUNE NEUROINFLAMMATION; IMMUNE-RESPONSES; INTERFERON-GAMMA; HELPER-CELLS; EOMESODERMIN; RECEPTOR	The transcription factor Foxo3 plays a crucial role in myeloid cell function but its role in lymphoid cells remains poorly defined. Here, we have shown that Foxo3 expression was increased after T cell receptor engagement and played a specific role in the polarization of CD4(+) T cells toward pathogenic T helper 1 (Th1) cells producing interferon-gamma (IFN-gamma) and granulocyte monocyte colony stimulating factor (GMCSF). Consequently, Foxo3-deficient mice exhibited reduced susceptibility to experimental autoimmune encephalomyelitis. At the molecular level, we identified Eomes as a direct target gene for Foxo3 in CD4(+) T cells and we have shown that lentiviral-based overexpression of Eomes in Foxo3-deficient CD4(+) T cells restored both IFN-gamma and GM-CSF production. Thus, the Foxo3-Eomes pathway is central to achieve the complete specialized gene program required for pathogenic Th1 cell differentiation and development of neuroinflammation.	[Stienne, Caroline; Michieletto, Michael F.; Benamar, Mehdi; Bernard, Isabelle; Xuan-Hung Nguyen; Duguet, Fanny; Liblau, Roland S.; Saoudi, Abdelhadi; Dejean, Anne S.] UMR Inserm U1043, F-31300 Toulouse, France; [Stienne, Caroline; Michieletto, Michael F.; Benamar, Mehdi; Bernard, Isabelle; Xuan-Hung Nguyen; Duguet, Fanny; Liblau, Roland S.; Saoudi, Abdelhadi; Dejean, Anne S.] UMR CNRS, U5282, F-31300 Toulouse, France; [Stienne, Caroline; Michieletto, Michael F.; Benamar, Mehdi; Bernard, Isabelle; Xuan-Hung Nguyen; Duguet, Fanny; Liblau, Roland S.; Saoudi, Abdelhadi; Dejean, Anne S.] Univ Toulouse, UPS, CPTP, F-31300 Toulouse, France; [Carrie, Nadege] Oncopole, UGM 4127, F-31059 Toulouse, France; [Lippi, Yannick] Univ Toulouse, Toxalim Res Ctr Food Toxicol, INRA, ENVT,INP Purpan,UPS, F-31024 Toulouse, France; [Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California San Diego; University of California System; University of California San Diego	Dejean, AS (corresponding author), UMR Inserm U1043, F-31300 Toulouse, France.; Dejean, AS (corresponding author), UMR CNRS, U5282, F-31300 Toulouse, France.; Dejean, AS (corresponding author), Univ Toulouse, UPS, CPTP, F-31300 Toulouse, France.	anne.dejean@inserm.fr	Hedrick, Stephen M/E-9171-2010; SAOUDI, Abdelhadi/K-6719-2014; lippi, yannick/AAG-2774-2019; Dejean, Anne S/K-6739-2014; Liblau, Roland/J-3530-2014	SAOUDI, Abdelhadi/0000-0001-7015-8178; lippi, yannick/0000-0003-4717-078X; Xuan-Hung, Nguyen/0000-0002-2216-8598; Bernard, Isabelle/0000-0002-5847-1281; LIBLAU, Roland/0000-0001-5477-5475; Dejean, Anne S./0000-0002-8846-1113; Benamar, Mehdi/0000-0003-1532-8642; DEJEAN, Sebastien/0000-0001-9610-5306	Inserm Dotation (Nouveau-recrute); ANR [ANR-09-RPDOC-015-01]; ARSEP Foundation [R112195BB]; Midi-Pyrenees Region; ARSEP Fondation [R14067BB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103440] Funding Source: NIH RePORTER	Inserm Dotation (Nouveau-recrute); ANR(French National Research Agency (ANR)); ARSEP Foundation; Midi-Pyrenees Region(Region Occitanie); ARSEP Fondation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Dr. B. Li (Institut Pasteur of Shanghai, China) for providing us the pGL3-Eomes-Luc reporter construct; Dr. C. Charvet (Institut Cochin, Paris, France) for FOXO3 plasmids; A. Thouard and Dr. M. Szelechowski for advice in lentiviral production; Dr. V. Adoue and Dr. O. Joffre for their help on ChIP experiments; Dr. S. Kassem for her expertise on EAE experiments; Dr. L.T. Mars for his help with funding; and Dr. D. Dunia, Dr. N. Fazilleau, and Dr. R. Lesourne for their critical comments on the manuscript. We would also like to thank the flow cytometry and microscopy core facility (CPTP) and the animal house staff members for their technical assistance (UMS 06). This work was supported financially by grants from Inserm Dotation (Nouveau-recrute), the ANR (project ANR-09-RPDOC-015-01), ARSEP Foundation (project R112195BB) and Midi-Pyrenees Region. C.S. was the recipient of a doctoral fellowship from ARSEP Fondation (R14067BB).	Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Charvet C, 2003, ONCOGENE, V22, P4557, DOI 10.1038/sj.onc.1206778; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Codarri L, 2010, CURR OPIN NEUROL, V23, P205, DOI 10.1097/WCO.0b013e3283391feb; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Dejean AS, 2011, ANTIOXID REDOX SIGN, V14, P663, DOI 10.1089/ars.2010.3414; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Eijkelenboom A, 2013, CELL REP, V5, P1664, DOI 10.1016/j.celrep.2013.11.031; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Herndler-Brandstetter D, 2014, CELL RES, V24, P1379, DOI 10.1038/cr.2014.155; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laine A, 2015, J IMMUNOL, V195, P1791, DOI 10.4049/jimmunol.1500849; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Li CR, 2013, J BIOL CHEM, V288, P19127, DOI 10.1074/jbc.M113.453357; Li YY, 2013, J BIOL CHEM, V288, P15537, DOI 10.1074/jbc.M112.430207; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Obsil T, 2011, BBA-MOL CELL RES, V1813, P1946, DOI 10.1016/j.bbamcr.2010.11.025; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Parnell GP, 2014, CLIN IMMUNOL, V151, P16, DOI 10.1016/j.clim.2014.01.003; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Raveney BJE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9437; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Sullivan JA, 2012, J VIROL, V86, P9025, DOI 10.1128/JVI.00942-12; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	51	46	46	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					774	787		10.1016/j.immuni.2016.09.010	http://dx.doi.org/10.1016/j.immuni.2016.09.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27742544	Green Accepted, Bronze			2022-12-18	WOS:000389473200011
J	Hsiao, HW; Liu, WH; Wang, CJ; Lo, YH; Wu, YH; Jiang, ST; Lai, MZ				Hsiao, Huey-Wen; Liu, Wen-Hsien; Wang, Chen-Jhe; Lo, Yu-Hsun; Wu, Yung-Hsuan; Jiang, Si-Tse; Lai, Ming-Zong			Deltex1 Is a Target of the Transcription Factor NFAT that Promotes T Cell Anergy	IMMUNITY			English	Article							E3 UBIQUITIN LIGASE; LYMPHOCYTE DEVELOPMENT; CBL-B; NOTCH; ACTIVATION; MECHANISMS; EXPRESSION; INDUCTION; REGULATOR; LINEAGE	The molecular process underlying T cell anergy is incompletely understood. Deltex1 (DTX1) is a Notch target with unknown physiological function. Here we show that Dtx1 was a transcription target of nuclear factor of activated T cells (NFAT) and participated in T cell anergy. DTX1 protein was upregulated during T cell anergy, and transgenic expression of Dtx1 attenuated T cell activation. DTX1 inhibited T cell activation by both E3-dependent and E3-independent mechanisms. In addition, DTX1 suppressed T cell activation in the absence of its Notch-binding domain. Importantly, DTX1 regulated the expression of two anergy-associated molecules, growth arrest and DNA-damage-inducible 45 beta (Gadd45 beta) and Cbl-b. DTX1 interacted with early growth response 2 (Egr-2) for optimum expression of Cbl-b. Furthermore, deficiency of DTX1 augmented T cell activation, conferred resistance to anergy induction, enhanced autoantibody generation, and increased inflammation. DTX1 therefore represents a component downstream of calcium-NFAT signaling that regulates T cell anergy.	[Hsiao, Huey-Wen; Wu, Yung-Hsuan; Lai, Ming-Zong] Natl Yang Ming Univ, Grad Inst Microbiol & Immunol, Taipei 11221, Taiwan; [Hsiao, Huey-Wen; Liu, Wen-Hsien; Wang, Chen-Jhe; Lo, Yu-Hsun; Wu, Yung-Hsuan; Jiang, Si-Tse; Lai, Ming-Zong] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Lai, Ming-Zong] Natl Taiwan Univ, Grad Inst Immunol, Taipei 10002, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University	Lai, MZ (corresponding author), Natl Yang Ming Univ, Grad Inst Microbiol & Immunol, Taipei 11221, Taiwan.	mblai@gate.sinica.edu.tw	Lai, Ming-Zong/AAA-4408-2021	Wu, Yung-Hsuan/0000-0001-7491-2596; Lai, Ming-Zong/0000-0002-3237-4803; Jiang, Si-Tse/0000-0002-5145-258X	National Science Council, Taiwan [NSC97-2321-B001-024]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We would like to thank D. Littman, H. Okano, G. Costa, and G. Nolan for providing key materials used in this study and H. Wilson for editing the manuscript. This work was supported by grant NSC97-2321-B001-024 from National Science Council, Taiwan, and Deep Root (Shen-Gen) Grant from Academia Sinica, Taiwan. The authors declare that they have no competing financial interests.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Fuwa TJ, 2006, MOL GENET GENOMICS, V275, P251, DOI 10.1007/s00438-005-0087-3; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kishi N, 2001, INT J DEV NEUROSCI, V19, P21, DOI 10.1016/S0736-5748(00)00071-X; Lehar SM, 2006, MOL CELL BIOL, V26, P7358, DOI 10.1128/MCB.00149-06; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Liu L, 2005, J EXP MED, V202, P1341, DOI 10.1084/jem.20051359; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MAILLARD I, 2005, ANNU REV IMMUNOL, V23, P781; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Sabil SD, 2007, CURR OPIN IMMUNOL, V19, P658, DOI 10.1016/j.coi.2007.08.005; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Storck S, 2005, MOL CELL BIOL, V25, P1437, DOI 10.1128/MCB.25.4.1437-1445.2005; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zweifel ME, 2005, STRUCTURE, V13, P1599, DOI 10.1016/j.str.2005.07.015	40	46	47	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					72	83		10.1016/j.immuni.2009.04.017	http://dx.doi.org/10.1016/j.immuni.2009.04.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19592273	Bronze			2022-12-18	WOS:000268219900013
J	Silva, E; Au-Yeung, HW; Van Goethem, E; Burden, J; Franc, NC				Silva, Elizabeth; Au-Yeung, Hiu Wan; Van Goethem, Emeline; Burden, Jemima; Franc, Nathalie C.			Requirement for a Drosophila E3-ubiquitin ligase in phagocytosis of apoptotic cells	IMMUNITY			English	Article							F-BOX PROTEINS; C-ELEGANS; CORPSE ENGULFMENT; CAENORHABDITIS-ELEGANS; CRKII/DOCK180/RAC PATHWAY; UBIQUITIN; PROTEASOME; CLEARANCE; RECEPTOR; DEATH	Many cells die by apoptosis during animal development. Apoptotic cells are rapidly removed through phagocytosis by their neighbors or by macrophages. To genetically dissect this process, we performed an in vivo screen for genes required for efficient phagocytosis of apoptotic cells by Drosophila macrophages and identified pallbearer (pall)l, which encodes an F box protein. F box proteins generally provide substrate specificity to Skp Cullin F box (SCIF) complexes, acting as E3 ligases that target phosphorylated proteins to ubiquitylation and degradation via the 26S proteasome. We showed that Pallbearer functions in an SCF-dependent manner and provided direct evidence of a role for ubiquitylation and proteasomal degradation in phagocytosis of apoptotic corpses in vivo. This work might further our understanding of the regulation of apoptotic cell engulfment and thus our understanding of innate immunity as a whole.	UCL, MRC, Cell Biol Unit, MRC Lab Mol Cell Biol & Anat, London WC1E 6BT, England; UCL, Dept Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Franc, NC (corresponding author), UCL, MRC, Cell Biol Unit, MRC Lab Mol Cell Biol & Anat, Mortimer St, London WC1E 6BT, England.	n.franc@ucl.ac.uk	Franc, Nathalie/C-2208-2009; Burden, Jemima/Q-1228-2017; Silva, Elizabeth/C-1495-2008	Burden, Jemima/0000-0001-5894-7043; Silva, Elizabeth/0000-0002-0684-9473; Silva, Elizabeth/0000-0002-0524-929X; Franc, Nathalie/0000-0002-1617-385X	Medical Research Council [MC_U122665005] Funding Source: Medline; MRC [MC_U122665005] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Bocca SN, 2001, BIOCHEM BIOPH RES CO, V286, P357, DOI 10.1006/bbrc.2001.5394; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Friedman J, 2004, DEV CELL, V6, P460, DOI 10.1016/S1534-5807(04)00104-2; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Khush RS, 2002, CURR BIOL, V12, P1728, DOI 10.1016/S0960-9822(02)01214-9; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lee WL, 2005, MOL BIOL CELL, V16, P2077, DOI 10.1091/mbc.E04-06-0464; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Pittoni Valerio, 2002, Autoimmunity Reviews, V1, P154, DOI 10.1016/S1568-9972(02)00032-0; RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; White K, 2001, METHOD CELL BIOL, V66, P321; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2004, CURR TOP DEV BIOL, V63, P91, DOI 10.1016/S0070-2153(04)63004-3; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	49	46	48	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT	2007	27	4					585	596		10.1016/j.immuni.2007.08.016	http://dx.doi.org/10.1016/j.immuni.2007.08.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17936033	Bronze			2022-12-18	WOS:000250490700010
J	Koralov, SB; Novobrantseva, TI; Konigsmann, J; Ehlich, A; Rajewsky, K				Koralov, Sergei B.; Novobrantseva, Tatiana I.; Koenigsmann, Jessica; Ehlich, Andreas; Rajewsky, Klaus			Antibody repertoires generated by V-H replacement and direct V-H to J(H) joining	IMMUNITY			English	Article							VARIABLE REGION GENE; STRAND BREAK REPAIR; HUMAN-B-LYMPHOCYTES; HEAVY-CHAIN LOCUS; V(D)J RECOMBINATION; SEQUENCE HOMOLOGIES; RECEPTOR REVISION; SOMATIC MUTATION; MAMMALIAN-CELLS; IMMUNE-RESPONSE	The immunoglobulin heavy chain repertoire is generated by somatic rearrangement of variable (V-H), diversity (D-H), and joining (J(H)) elements. It can be further diversified by V-H replacement, where nonrearranged V-H genes invade preexisting V(H)D(H)J(H) joints. To study the impact and mechanism of V-H replacement, we generated mice in which antibody production depends on the replacement of a nonproductive V(H)D(H)J(H) rearrangement inserted into its physiological position in the immunoglobulin heavy chain locus. In these mice a highly diverse heavy chain repertoire resulted from V-H replacement and a second process of noncanonical V(D)J recombination, direct V-H to J(H) joining. V-H replacement rarely generated detectable sequence duplications but often proceeded through recombination between the conserved homologous sequences at the 3' end of V-H. Thus, V-H replacement is an efficient mechanism of antibody diversification, and its impact on the overall antibody repertoire could be greater than anticipated because it frequently leaves no molecular footprint.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Cologne	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu		Rajewsky, Klaus/0000-0002-6633-6370; Koralov, Sergei/0000-0002-4843-3791	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI052343, R37AI054636] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054636, AI052343] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACCALA R, 1989, P NATL ACAD SCI USA, V86, P4624, DOI 10.1073/pnas.86.12.4624; BLANKENSTEIN T, 1989, MOL IMMUNOL, V26, P319, DOI 10.1016/0161-5890(89)90086-2; Bogue MA, 1997, IMMUNITY, V7, P37, DOI 10.1016/S1074-7613(00)80508-7; BROKAW JL, 1992, INT IMMUNOL, V4, P197, DOI 10.1093/intimm/4.2.197; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COVEY LR, 1990, INT IMMUNOL, V2, P579, DOI 10.1093/intimm/2.6.579; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Feeney A J, 1992, Int Rev Immunol, V8, P113, DOI 10.3109/08830189209055567; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Itoh K, 2000, J EXP MED, V192, P1151, DOI 10.1084/jem.192.8.1151; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Koralov SB, 2005, J EXP MED, V201, P341, DOI 10.1084/jem.20041577; Li J, 2005, MOL IMMUNOL, V42, P1475, DOI 10.1016/j.molimm.2005.01.010; Madan MK, 2000, EUR J IMMUNOL, V30, P2404, DOI 10.1002/1521-4141(2000)30:8&lt;2404::AID-IMMU2404&gt;3.0.CO;2-9; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nussenzweig MC, 1998, CELL, V95, P875, DOI 10.1016/S0092-8674(00)81711-0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHATZ DG, 1988, CELL, V53, P107, DOI 10.1016/0092-8674(88)90492-8; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sekiguchi DR, 2003, J EXP MED, V197, P27, DOI 10.1084/jem.20020737; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; TAKI S, 1995, EUR J IMMUNOL, V25, P1888, DOI 10.1002/eji.1830250715; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; USUDA S, 1992, EMBO J, V11, P611, DOI 10.1002/j.1460-2075.1992.tb05093.x; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhang ZX, 2003, IMMUNITY, V19, P21, DOI 10.1016/S1074-7613(03)00170-5; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200	50	46	47	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					43	53		10.1016/j.immuni.2006.04.016	http://dx.doi.org/10.1016/j.immuni.2006.04.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860756	Bronze			2022-12-18	WOS:000239713000009
J	Hermiston, ML; Tan, AL; Gupta, VA; Majeti, R; Weiss, A				Hermiston, ML; Tan, AL; Gupta, VA; Majeti, R; Weiss, A			The juxtamembrane wedge negatively regulates CD45 function in B cells	IMMUNITY			English	Article							SRC-FAMILY KINASES; TYROSINE-PHOSPHATASE-ALPHA; LYN-DEFICIENT MICE; ANTIGEN-RECEPTOR; T-CELL; POSITIVE SELECTION; STRUCTURAL BASIS; LYMPHOCYTES; EXPRESSION; PHOSPHORYLATION	CD45 is a receptor-like protein tyrosine phosphatase highly expressed on all nucleated hematopoietic cells. We previously generated mice containing a point mutation in the juxtamembrane wedge of CD45. Demonstrating the critical negative regulatory function of the wedge, the CD45 E613R mutation led to a lymphoproliferative disorder (LPD) and a lupus-like autoimmune syndrome. Here we show the central role of B cells in this phenotype. Genetic elimination of B cells, but not T cells, ablates the LPD. In contrast to CD45-deficient B cells, the E613R mutation generates hyperresponsive B cells. Comparison of CD45-deficient and CD45 E613R mice reveals dichotomous effects of these mutations on B cell development. Together, the results support a role for CD45 as a rheostat, with both positive and negative regulatory functions, that fine-tunes the signal transduction threshold at multiple checkpoints in B cell development.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu		Gupta, Vikas/0000-0002-8980-2338	NCI NIH HHS [K08 CA098418-01] Funding Source: Medline; NIAID NIH HHS [P01 AI35297-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA098418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashwell JD, 1999, IMMUNOL TODAY, V20, P412, DOI 10.1016/S0167-5699(99)01505-4; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Felberg J, 1998, J BIOL CHEM, V273, P17839, DOI 10.1074/jbc.273.28.17839; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KATAGIRI T, 1995, J BIOL CHEM, V270, P27987; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kung C, 2000, NAT MED, V6, P343; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Monroe JG, 2004, CURR OPIN IMMUNOL, V16, P288, DOI 10.1016/j.coi.2004.03.010; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Shrivastava P, 2004, BLOOD, V103, P1425, DOI 10.1182/blood-2003-03-0716; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; TAKEDA A, 1992, J BIOL CHEM, V267, P16651; Tan J, 2000, J BIOL CHEM, V275, P37224, DOI 10.1074/jbc.M002006200; Tchilian EZ, 2004, INT IMMUNOL, V16, P1323, DOI 10.1093/intimm/dxh135; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573	48	46	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2005	23	6					635	647		10.1016/j.immuni.2005.11.001	http://dx.doi.org/10.1016/j.immuni.2005.11.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356861	Bronze			2022-12-18	WOS:000234316900010
J	Notidis, E; Heltemes, L; Manser, T				Notidis, E; Heltemes, L; Manser, T			Dominant, hierarchical induction of peripheral tolerance during foreign antigen-driven B cell development	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY IMMUNE-RESPONSE; DOUBLE-STRANDED DNA; TRANSGENIC MICE; MOLECULAR MIMICRY; GERMINAL-CENTERS; SELF-TOLERANCE; LYMPHOCYTE-B; IN-SITU; ANTIBODIES	We created mice expressing transgene-encoded BCRs with "dual reactivity" for the hapten Ars and nuclear autoantigens. Expression of transgene-encoded BCRs was not evident in the memory compartment despite observation of transgene-expressing B cells in germinal centers following Ars immunization. In contrast, dual reactive mAbs were readily obtained from mice with enforced expression of Bcl-2 following secondary Ars immunization. However, while these mAbs were hypermutated and displayed increased affinity for Ars, all had reduced avidity for DNA and intracellular autoantigens. Thus, Bcl-2 alters dominant-negative selection of dual reactive B cells during the Ars response, but this is restricted to those with lowered autoreactivity, demonstrating a hierarchy of peripheral tolerance during memory B cell development.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Manser, T (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.			Heltemes Harris, Lynn/0000-0002-2668-8005	NATIONAL CANCER INSTITUTE [T32CA072318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038965, R56AI038965, T32AI007492] Funding Source: NIH RePORTER; NCI NIH HHS [CA-72318] Funding Source: Medline; NIAID NIH HHS [AI38965, AI-07492] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; BORRETZEN M, 1994, P NATL ACAD SCI USA, V91, P12917, DOI 10.1073/pnas.91.26.12917; CASSON LP, 1995, J EXP MED, V182, P743, DOI 10.1084/jem.182.3.743; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; DIRKES G, 1994, IMMUNOGENETICS, V40, P379, DOI 10.1007/BF01246680; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FOWLER E, 1983, J IMMUNOL METHODS, V62, P297, DOI 10.1016/0022-1759(83)90173-4; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GIUSTI AM, 1992, P NATL ACAD SCI USA, V89, P10321, DOI 10.1073/pnas.89.21.10321; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Hande S, 1998, IMMUNITY, V8, P189, DOI 10.1016/S1074-7613(00)80471-9; Hande S, 1997, MOL IMMUNOL, V34, P1281, DOI 10.1016/S0161-5890(98)00005-4; Heltemes LM, 2002, J IMMUNOL, V169, P1283, DOI 10.4049/jimmunol.169.3.1283; HIERNAUX J, 1983, ANN NY ACAD SCI, V418, P9, DOI 10.1111/j.1749-6632.1983.tb18049.x; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Karlsen AE, 1998, SEMIN IMMUNOL, V10, P25, DOI 10.1006/smim.1997.0102; KRISHNAN MR, 1993, J IMMUNOL, V150, P4948; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; LINTON PJ, 1991, J IMMUNOL, V146, P4099; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; LOSMAN MJ, 1993, INT IMMUNOL, V5, P513, DOI 10.1093/intimm/5.5.513; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; MANSER T, 1989, J EXP MED, V170, P1211, DOI 10.1084/jem.170.4.1211; MANSER T, 1986, EUR J IMMUNOL, V16, P1439, DOI 10.1002/eji.1830161120; MANSER T, 1987, IMMUNOL REV, V96, P141, DOI 10.1111/j.1600-065X.1987.tb00513.x; MANSER T, 1991, SOMATIC HYPERMUTATIO, P42; MARSHAKROTHSTEIN A, 1980, P NATL ACAD SCI-BIOL, V77, P1120, DOI 10.1073/pnas.77.2.1120; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Moens U, 1995, P NATL ACAD SCI USA, V92, P12393, DOI 10.1073/pnas.92.26.12393; Monroe JG, 1998, IMMUNOL RES, V17, P155, DOI 10.1007/BF02786440; MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0; NAPARSTEK Y, 1986, J EXP MED, V164, P614, DOI 10.1084/jem.164.2.614; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nguyen KAT, 1997, J IMMUNOL, V159, P2633; Noorchashm H, 1999, INT IMMUNOL, V11, P765, DOI 10.1093/intimm/11.5.765; NOSSAL GJV, 1993, ANN NY ACAD SCI, V690, P34; Notidis E, 2001, Dev Immunol, V8, P223, DOI 10.1155/2001/83595; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; PARKER DC, 1991, FASEB J, V5, P2777, DOI 10.1096/fasebj.5.13.1916102; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Radmacher MD, 1998, IMMUNOL CELL BIOL, V76, P373, DOI 10.1046/j.1440-1711.1998.00753.x; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Reed AJ, 2000, J EXP MED, V192, P1763, DOI 10.1084/jem.192.12.1763; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; ROSEN A, 1995, J EXP MED, V181, P1557, DOI 10.1084/jem.181.4.1557; ROTHSTEIN TL, 1983, MOL IMMUNOL, V20, P161, DOI 10.1016/0161-5890(83)90127-X; ROUSSEAU PG, 1989, MOL IMMUNOL, V26, P993, DOI 10.1016/0161-5890(89)90118-1; Sater RA, 1998, INT IMMUNOL, V10, P1673, DOI 10.1093/intimm/10.11.1673; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; Shapiro GS, 1999, J IMMUNOL, V163, P259; SHARON J, 1989, J IMMUNOL, V142, P596; SHARON J, 1984, NATURE, V309, P364, DOI 10.1038/309364a0; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Vora KA, 1999, J IMMUNOL, V163, P4315; WALKER SM, 1985, CELL IMMUNOL, V90, P331, DOI 10.1016/0008-8749(85)90198-4; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; WEISSMAN D, 1985, HYBRIDOMA, V4, P329, DOI 10.1089/hyb.1985.4.329	67	46	46	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2002	17	3					317	327		10.1016/S1074-7613(02)00392-8	http://dx.doi.org/10.1016/S1074-7613(02)00392-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354384	Bronze			2022-12-18	WOS:000178163100008
J	Garefalaki, A; Coles, M; Hirschberg, S; Mavria, G; Norton, T; Hostert, A; Kioussis, D				Garefalaki, A; Coles, M; Hirschberg, S; Mavria, G; Norton, T; Hostert, A; Kioussis, D			Variegated expression of CD8 alpha resulting from in situ deletion of regulatory sequences	IMMUNITY			English	Article							LOCUS-CONTROL REGION; T-CELL DEVELOPMENT; GENE-EXPRESSION; TRANSGENIC MICE; STEM-CELLS; CD4 GENE; LYT-2; LINEAGE; THYMOCYTES; COMMITMENT	The developmental and subset-specific expression of the CD8 genes is under the control of a complex array of regulatory elements distributed along the locus and characterized by DNasel hypersensitivity. Here we describe the phenotype of mice in which hypersensitive sites 1 and 2 (HSS1 and 2) of DNasel hypersensitive Cluster II (CII), which are located upstream of the CD8alpha gene, were deleted by targeted homologous recombination of the endogenous locus. Knockout mice exhibit a variegated expression of the CD8alpha gene, particularly among the immature CD4(+)8(+) TCRlo thymocyte population. We propose that HSS Cluster II regulatory elements are essential in ensuring initiation of chromatin remodeling and establishment of an open configuration in all developing thymocytes that undergo the double-negative to double-positive transition. Furthermore, these sequences contribute to the levels of expression of the CD8alpha gene.	Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Kioussis, D (corresponding author), Natl Inst Med Res, Ridgeway, London NW7 1AA, England.	dkioussis@nimr.mrc.ac.uk						Banan M, 1997, J BIOL CHEM, V272, P18440, DOI 10.1074/jbc.272.29.18440; Bender MA, 2000, BLOOD, V95, P3600, DOI 10.1182/blood.V95.11.3600.011k42_3600_3604; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Duncan DD, 1996, IMMUNITY, V4, P301, DOI 10.1016/S1074-7613(00)80438-0; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; GAREFALAKI A, 2002, THESIS U LONDON LOND; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; JAY G, 1982, P NATL ACAD SCI-BIOL, V79, P2654, DOI 10.1073/pnas.79.8.2654; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; LEDBETTER JA, 1981, J EXP MED, V153, P1503, DOI 10.1084/jem.153.6.1503; LEDBETTER JA, 1982, IMMUNOL REV, V68, P197, DOI 10.1111/j.1600-065X.1982.tb01065.x; LEE WH, 1994, INT IMMUNOL, V6, P1307, DOI 10.1093/intimm/6.9.1307; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mei Q, 2000, EXP CELL RES, V260, P304, DOI 10.1006/excr.2000.5030; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; PARO R, 1995, TRENDS GENET, V11, P295, DOI 10.1016/S0168-9525(00)89081-2; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Ramirez A, 2001, GENETICS, V158, P341; Ronai D, 1999, MOL CELL BIOL, V19, P7031; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Zhang XL, 1998, J IMMUNOL, V161, P2254; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	35	46	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2002	16	5					635	647		10.1016/S1074-7613(02)00308-4	http://dx.doi.org/10.1016/S1074-7613(02)00308-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049716	Bronze			2022-12-18	WOS:000175820400003
J	Bosselut, R; Feigenbaum, L; Sharrow, SO; Singer, A				Bosselut, R; Feigenbaum, L; Sharrow, SO; Singer, A			Strength of signaling by CD4 and CD8 coreceptor tails determines the number but not the lineage direction of positively selected thymocytes	IMMUNITY			English	Article							IMMATURE CD4+CD8+ THYMOCYTES; T-CELL DEVELOPMENT; CYTOPLASMIC DOMAIN; TYROSINE PHOSPHORYLATION; CD4(+)CD8(+) THYMOCYTES; THYMIC MATURATION; TCR-ZETA; RECEPTOR; EXPRESSION; KINASE	The present study has assessed the impact of the intracellular domains of CD4 and CD8 on positive selection and lineage direction of MHC class I-restricted thymocytes. Contrary to current presumption, we found that the CD4 tail promotes the generation of both CD4' and CD8(+) T cells without preference for the CD4' T cell lineage. We also found that the identity of the coreceptor tail and hence the strength of coreceptor signaling determine the number of thymocytes undergoing positive selection but not their ultimate CD4/ CD8 phenotype. These findings demonstrate that the strength of coreceptor signaling has a significant quantitative but not qualitative impact on positive selection and provide a simple explanation for the greater numbers of CD4(+) than CD8(+) T cells selected in the normal thymus.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	singera@nih.gov						BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Basson MA, 1998, J EXP MED, V187, P1249; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CROOKS MEC, 1994, IMMUNITY, V1, P277; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; DUTZ JP, 1995, J IMMUNOL, V154, P2588; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Irie HY, 1998, J IMMUNOL, V161, P183; IRIE HY, 1995, J EXP MED, V181, P1267, DOI 10.1084/jem.181.4.1267; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; JANEWAY CA, 1988, NATURE, V335, P208, DOI 10.1038/335208a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; LOVE PE, 1994, J EXP MED, V179, P1485, DOI 10.1084/jem.179.5.1485; MURPHY RF, 1985, CYTOMETRY, V6, P302, DOI 10.1002/cyto.990060405; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SEONG RH, 1992, NATURE, V356, P718, DOI 10.1038/356718a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; Singer A, 1999, SEMIN IMMUNOL, V11, P273, DOI 10.1006/smim.1999.0183; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	46	46	46	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2001	14	4					483	494		10.1016/S1074-7613(01)00128-5	http://dx.doi.org/10.1016/S1074-7613(01)00128-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336693	Bronze			2022-12-18	WOS:000168246700015
J	McSorley, SJ; Soldera, S; Malherbe, L; Carnaud, C; Locksley, RM; Flavell, RA; Glaichenhaus, N				McSorley, SJ; Soldera, S; Malherbe, L; Carnaud, C; Locksley, RM; Flavell, RA; Glaichenhaus, N			Immunological tolerance to a pancreatic antigen as a result of local expression of TNF alpha by islet beta cells	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; DEPENDENT DIABETES-MELLITUS; LEISHMANIA-MAJOR; T-CELLS; TRANSGENIC MICE; MONOCLONAL-ANTIBODY; BALB/C MICE; NOD MICE; AUTOIMMUNITY; LYMPHOTOXIN	Recent experiments have suggested that tumor necrosis factor alpha (TNF alpha) can down-regulate islet-specific T cells and prevent the development of autoimmune diabetes. Here we demonstrate that transgenic mice expressing both TNF alpha and the Leishmania major LACK antigen in the pancreas (RIP-TNF alpha/RIP-LACK) exhibit an impaired ability to mount a CD4(+) T cell response against LACK. In addition, peripheral CD4(+) T cells from TCR transgenic mice (TCR-LACK/RIP-TNF alpha/RIP-LACK) produced reduced interleukin-2 but elevated levels of T helper 2 cytokines in response to LACK peptide in vitro. Taken together, our data suggest that TNF alpha may act in vivo to modulate a potentially damaging self-reactive T cell response by inducing tolerance to pancreatic antigens.	INST PHARMACOL MOL & CELLULAIRE,CNRS,UPR 411,F-06560 VALBONNE,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U25,F-75743 PARIS,FRANCE; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Yale University				McSorley, Stephen/0000-0002-6363-3222				Brown DR, 1997, J EXP MED, V185, P31, DOI 10.1084/jem.185.1.31; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; FORSTER I, 1995, IMMUNITY, V2, P573, DOI 10.1016/1074-7613(95)90002-0; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P5138, DOI 10.1073/pnas.91.11.5138; HELD W, 1990, P NATL ACAD SCI USA, V87, P2239, DOI 10.1073/pnas.87.6.2239; HIGUCHI Y, 1992, J EXP MED, V176, P1719, DOI 10.1084/jem.176.6.1719; Hogan B., 1986, MANIPULATING MOUSE E; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Hunger RE, 1997, EUR J IMMUNOL, V27, P255, DOI 10.1002/eji.1830270138; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; JACOB CO, 1992, IMMUNOL TODAY, V13, P122, DOI 10.1016/0167-5699(92)90107-I; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; LANE JR, 1992, J EXP MED, V175, P1123, DOI 10.1084/jem.175.4.1123; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; McSorley SJ, 1997, INFECT IMMUN, V65, P171, DOI 10.1128/IAI.65.1.171-178.1997; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; OHASHI PS, 1993, J IMMUNOL, V150, P5185; Pape KA, 1997, J IMMUNOL, V159, P591; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PICARELLA DE, 1993, J IMMUNOL, V150, P4136; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; SARIN A, 1995, J IMMUNOL, V155, P3716; SATOH J, 1989, J CLIN INVEST, V84, P1345, DOI 10.1172/JCI114304; SCOTT P, 1990, J IMMUNOL, V144, P1075; SHALABY MR, 1988, J IMMUNOL, V141, P499; Soldera S, 1997, EUR J IMMUNOL, V27, P848, DOI 10.1002/eji.1830270407; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TOMONARI K, 1990, IMMUNOGENETICS, V31, P333, DOI 10.1007/BF02115007; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Vieira LQ, 1996, J IMMUNOL, V157, P827; XU D, 1995, IMMUNOLOGY, V85, P1; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995; YOKOTA S, 1988, J IMMUNOL, V140, P531; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhou T, 1996, J IMMUNOL, V156, P2661	42	46	46	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					401	409		10.1016/S1074-7613(00)80361-1	http://dx.doi.org/10.1016/S1074-7613(00)80361-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324360	hybrid			2022-12-18	WOS:A1997XY83000009
J	HARTON, JA; VANHAGEN, AE; BISHOP, GA				HARTON, JA; VANHAGEN, AE; BISHOP, GA			THE CYTOPLASMIC AND TRANSMEMBRANE DOMAINS OF MHC CLASS-II BETA-CHAINS DELIVER DISTINCT SIGNALS REQUIRED FOR MHC CLASS II-MEDIATED B-CELL ACTIVATION	IMMUNITY			English	Article							SITE-DIRECTED MUTAGENESIS; LYMPHOCYTES-B; MONOCLONAL-ANTIBODIES; ANTIGEN PRESENTATION; SURFACE EXPRESSION; MOLECULES; CLONE; PROTEIN; DIFFERENTIATION; ADHESION	Class II-mediated signals play potential roles in B cell activation and antigen presentation. The regions of the class II molecule participating in B cell signaling are incompletely defined. Our prior analysis of structural requirements of the cytoplasmic domain of A(beta) revealed that only the eight membrane-proximal residues are required for signaling. Here, we report that the sequence and position of two of these are critical, and present direct evidence that the A(beta) transmembrane domain is also involved in signaling, via a pathway distinct from the cytoplasmic domain. These results demonstrate that specific regions in both the cytoplasmic and transmembrane domains of the class II molecule have distinct signaling functions.	UNIV IOWA,DEPT INTERNAL MED,IOWA CITY,IA 52242; VET ADM MED CTR,DIV RES,IOWA CITY,IA 52246	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	HARTON, JA (corresponding author), UNIV IOWA,DEPT MICROBIOL,IOWA CITY,IA 52242, USA.		Harton, Jonathan/F-2848-2010; Harton, Jonathan A/AAW-5283-2021	Harton, Jonathan/0000-0002-0350-1877; Harton, Jonathan A/0000-0002-0350-1877; Bishop, Gail/0000-0002-1291-5078	NIAID NIH HHS [AI28847] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI028847, R29AI028847, R01AI028847] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRE P, 1994, J EXP MED, V179, P763, DOI 10.1084/jem.179.2.763; BALUYUT AR, 1988, J MOL CELL IMMUNOL, V4, P45; BERG W, 1993, BIOTECHNIQUES, V15, P56; BISHOP GA, 1987, J IMMUNOL, V138, P3308; BISHOP GA, 1993, J IMMUNOL, V150, P2565; BISHOP GA, 1994, INT IMMUNOL, V6, P1049, DOI 10.1093/intimm/6.7.1049; BISHOP GA, 1989, P NATL ACAD SCI USA, V86, P5933, DOI 10.1073/pnas.86.15.5933; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; BISHOP GA, 1991, J IMMUNOL, V147, P1107; BRAUNSTEIN NS, 1987, P NATL ACAD SCI USA, V84, P2921, DOI 10.1073/pnas.84.9.2921; BUERSTEDDE JM, 1988, J EXP MED, V168, P823, DOI 10.1084/jem.168.3.823; CAMBIER JC, 1989, J EXP MED, V170, P877, DOI 10.1084/jem.170.3.877; CAMBIER JC, 1987, NATURE, V327, P629, DOI 10.1038/327629a0; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; CUNNINGHAM AJ, 1968, IMMUNOLOGY, V14, P599; FULEIHAN R, 1992, J IMMUNOL, V149, P1853; HAMANO T, 1990, J IMMUNOL, V144, P811; HARTON JA, 1993, J IMMUNOL, V151, P5282; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KANSAS GS, 1992, EUR J IMMUNOL, V22, P147, DOI 10.1002/eji.1830220122; KANSAS GS, 1991, J IMMUNOL, V147, P4094; LANE PJL, 1990, J IMMUNOL, V144, P3684; Maniatis T., 1982, MOL CLONING; MARSHALL LS, 1994, J IMMUNOL, V152, P4816; MATSUYAMA S, 1993, EUR J IMMUNOL, V23, P3194, DOI 10.1002/eji.1830231223; MERCOLINO TJ, 1986, J EXP MED, V163, P155, DOI 10.1084/jem.163.1.155; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MORIO T, 1994, EUR J IMMUNOL, V24, P651, DOI 10.1002/eji.1830240325; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; NABAVI N, 1989, J IMMUNOL, V142, P1444; NEWELL MK, 1993, P NATL ACAD SCI USA, V90, P10459, DOI 10.1073/pnas.90.22.10459; OZATO K, 1980, J IMMUNOL, V124, P533; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; PALACIOS R, 1983, P NATL ACAD SCI-BIOL, V80, P3456, DOI 10.1073/pnas.80.11.3456; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCHOLL PR, 1994, IMMUNOL TODAY, V15, P418, DOI 10.1016/0167-5699(94)90271-2; SIDNEY J, 1995, J IMMUNOL, V154, P247; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STPIERRE Y, 1991, J IMMUNOL, V147, P2875; TAKAHAMA Y, 1989, EUR J IMMUNOL, V19, P2227, DOI 10.1002/eji.1830191208; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TRUMAN JP, 1994, INT IMMUNOL, V6, P887, DOI 10.1093/intimm/6.6.887; WADE WF, 1994, INT IMMUNOL, V6, P1457, DOI 10.1093/intimm/6.10.1457; WADE WF, 1989, P NATL ACAD SCI USA, V86, P6297, DOI 10.1073/pnas.86.16.6297	45	46	46	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					349	358		10.1016/1074-7613(95)90119-1	http://dx.doi.org/10.1016/1074-7613(95)90119-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552999	Bronze			2022-12-18	WOS:A1995RX64500009
J	Shi, H; Chapman, NM; Wen, J; Guy, C; Long, LY; Dhungana, Y; Rankin, S; Pelletier, S; Vogel, P; Wang, H; Peng, JM; Guan, KL; Chi, HB				Shi, Hao; Chapman, Nicole M.; Wen, Jing; Guy, Cliff; Long, Lingyun; Dhungana, Yogesh; Rankin, Sherri; Pelletier, Stephane; Vogel, Peter; Wang, Hong; Peng, Junmin; Guan, Kun-Liang; Chi, Hongbo			Amino Acids License Kinase mTORC1 Activity and Treg Cell Function via Small G Proteins Rag and Rheb	IMMUNITY			English	Article							REGULATORY T-CELLS; DIFFERENTIATION; RECEPTOR; EFFECTOR; FOXP3; MAINTENANCE; HOMEOSTASIS; QUIESCENCE; GLUTAMINE; SIGNALS	Regulatory T (Treg) cells are critical mediators of immune tolerance whose activity depends upon T cell receptor (TCR) and mTORC1 kinase signaling, but the mechanisms that dictate functional activation of these pathways are incompletely understood. Here, we showed that amino acids license Treg cell function by priming and sustaining TCR-induced mTORC1 activity. mTORC1 activation was induced by amino acids, especially arginine and leucine, accompanied by the dynamic lysosomal localization of the mTOR and Tsc complexes. Rag and Rheb GTPases were central regulators of amino acid-dependent mTORC1 activation in effector Treg (eTreg) cells. Mice bearing RagA-RagB- or Rheb1-Rheb2-deficient Treg cells developed a fatal autoimmune disease and had reduced eTreg cell accumulation and function. RagA-RagB regulated mitochondrial and lysosomal fitness, while Rheb1-Rheb2 enforced eTreg cell suppressive gene signature. Together, these findings reveal a crucial requirement of amino acid signaling for licensing and sustaining mTORC1 activation and functional programming of Treg cells.	[Shi, Hao; Chapman, Nicole M.; Wen, Jing; Guy, Cliff; Long, Lingyun; Dhungana, Yogesh; Rankin, Sherri; Pelletier, Stephane; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Hong; Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol & Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Hong; Peng, Junmin] St Jude Childrens Res Hosp, Ctr Prote & Metab, 332 N Lauderdale St, Memphis, TN 38105 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; Peng, Junmin/N-2614-2018; Guan, Kun-Liang/ADK-7088-2022; SHI, HAO/ABE-4662-2020; Vogel, Peter/N-2490-2018; Wang, Hong/AAE-2340-2019	Chi, Hongbo/0000-0002-9997-2496; Peng, Junmin/0000-0003-0472-7648; SHI, HAO/0000-0002-2796-629X; Vogel, Peter/0000-0002-7535-0545; Wang, Hong/0000-0002-6215-6348; Dhungana, Yogesh/0000-0002-4021-0075	NIH [5R01AG053987, CA196878, AI105887, AI131703, AI140761, CA176624, CA221290]; NATIONAL CANCER INSTITUTE [R01CA221290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI150241, R01AI150514, R37AI105887, R01AI131703, R01AI140761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG053987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge A. Rudensky for the Foxp3Cre mice (Chinen et al., 2016), Y. Wang for editing the manuscript, M. Hendren and A. KC for animal colony management, the St. Jude Immunology FACS core facility for cell sorting, The Hartwell Center for microarray analysis, and Transgenic and Gene Knockout Shared Resources for generation of mice. This work was supported by NIH grants 5R01AG053987 (to J.P.), CA196878 (to K.-L.G.), and AI105887, AI131703, AI140761, CA176624, and CA221290 (to H.C.).	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Castellano BM, 2017, SCIENCE, V355, P1306, DOI 10.1126/science.aag1417; Chapman NM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04392-5; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Du XR, 2018, NATURE, V558, P141, DOI 10.1038/s41586-018-0177-0; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Goberdhan DCI, 2016, CELL METAB, V23, P580, DOI 10.1016/j.cmet.2016.03.013; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Ikeda K, 2017, CELL REP, V21, P1824, DOI 10.1016/j.celrep.2017.10.082; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kalaitzidis D, 2017, J CLIN INVEST, V127, P1405, DOI 10.1172/JCI89452; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kim YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5241; Klysz D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2610; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Metzler B, 2016, J IMMUNOL, V196, P3618, DOI 10.4049/jimmunol.1501756; Mossmann D, 2018, NAT REV CANCER, V18, P744, DOI 10.1038/s41568-018-0074-8; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Shen K, 2016, CELL REP, V14, P547, DOI 10.1016/j.celrep.2015.12.055; Shi HZ, 2018, ENVIRON SCI POLLUT R, V25, P10771, DOI 10.1007/s11356-018-1288-8; Shi H, 2018, IMMUNITY, V49, P899, DOI 10.1016/j.immuni.2018.10.010; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Tyagi R, 2015, CELL REP, V10, P684, DOI 10.1016/j.celrep.2015.01.014; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Zeng H, 2017, CURR OPIN IMMUNOL, V46, P103, DOI 10.1016/j.coi.2017.04.005; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	61	45	46	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1012	+		10.1016/j.immuni.2019.10.001	http://dx.doi.org/10.1016/j.immuni.2019.10.001			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31668641	Green Accepted, Bronze			2022-12-18	WOS:000503162900009
J	Van Gool, F; Nguyen, MLT; Mumbach, MR; Satpathy, AT; Rosenthal, WL; Giacometti, S; Le, DT; Liu, WH; Brusko, TM; Anderson, MS; Rudensky, AY; Marson, A; Chang, HY; Bluestone, JA				Van Gool, Frederic; Nguyen, Michelle L. T.; Mumbach, Maxwell R.; Satpathy, Ansuman T.; Rosenthal, Wendy L.; Giacometti, Simone; Le, Duy T.; Liu, Weihong; Brusko, Todd M.; Anderson, Mark S.; Rudensky, Alexander Y.; Marson, Alexander; Chang, Howard Y.; Bluestone, Jeffrey A.			A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells	IMMUNITY			English	Article							X-LINKED SYNDROME; IMMUNE DYSREGULATION; TARGET GENES; ENTEROPATHY; EXPRESSION; GENOME; POLYENDOCRINOPATHY; CHROMATIN; PROTEIN; SYSTEM	Regulatory T (Treg) cells maintain immune tolerance through the master transcription factor forkhead box P3 (FOXP3), which is crucial for Treg cell function and homeostasis. We identified an IPEX (immune dysregulation polyendocrinopathy enteropathy X-linked) syndrome patient with a FOXP3 mutation in the domain swap interface of the protein. Recapitulation of this Foxp3 variant in mice led to the development of an autoimmune syndrome consistent with an unrestrained T helper type 2 (Th2) immune response. Genomic analysis of Treg cells by RNA-sequencing, Foxp3 chromatin immunoprecipitation followed by high-throughput DNA sequencing (ChIP-sequencing), and H3K27ac-HiChIP revealed a specific de-repression of the Th2 transcriptional program leading to the generation of Th2-like Treg cells that were unable to suppress extrinsic Th2 cells. Th2-like Treg cells showed increased intra-chromosomal interactions in the Th2 locus, leading to type 2 cytokine production. These findings identify a direct role for Foxp3 in suppressing Th2-like Treg cells and implicate additional pathways that could be targeted to restrain Th2 trans-differentiated Treg cells.	[Van Gool, Frederic; Nguyen, Michelle L. T.; Rosenthal, Wendy L.; Giacometti, Simone; Le, Duy T.; Liu, Weihong; Anderson, Mark S.; Marson, Alexander; Bluestone, Jeffrey A.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Van Gool, Frederic; Rosenthal, Wendy L.; Le, Duy T.; Liu, Weihong; Bluestone, Jeffrey A.] Univ Calif San Francisco, Sean N Parker Autoimmune Res Lab, San Francisco, CA 94143 USA; [Mumbach, Maxwell R.; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Sch Med, Stanford, CA 94305 USA; [Brusko, Todd M.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Le, Duy T.] Baylor Coll Med, Dept Pediat, Immunol Grad Program, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; State University System of Florida; University of Florida; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University; Baylor College of Medicine	Bluestone, JA (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Bluestone, JA (corresponding author), Univ Calif San Francisco, Sean N Parker Autoimmune Res Lab, San Francisco, CA 94143 USA.	jeff.bluestone@ucsf.edu	Van Gool, Frederic/V-4638-2019; Anderson, Mark/AAZ-4992-2020	Anderson, Mark/0000-0002-3093-4758; Brusko, Todd/0000-0003-2878-9296; Le, Duy/0000-0003-3399-1376	NIH [P50-HG007735]; DRC Center Grant [NIH P30 DK063720]; Sean N. Parker Autoimmune Research Laboratory; Burroughs Wellcome Fund; Innovative Genomics Institute (IGI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DRC Center Grant; Sean N. Parker Autoimmune Research Laboratory; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Innovative Genomics Institute (IGI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We deeply appreciate the support, cooperation, and trust of the patient's family. In addition, this work would not be possible without the help of the clinical teams treating the patient. The authors thank Linda Vo and Jessica Barragan for helpful comments on the manuscript and A. Arvey, H. Bandukwala, A. Rao, R. Bacchetta, and M.G. Roncarolo for discussions and research insights. We thank D. Erle, A. Barczak, R. Barbeau, and W. Eckalbar of the UCSF Sandler Center Functional Genomics Core for assistance with RNA-seq data; Jennifer Bolen and the UCSF immunohistochemistry core facility; M. Lee, V. Nguyen, and UCSF Flow Core for assisting with flow cytometry; D. Simeonov for help with sgRNA design; and Yanli Wang for animal care. This work was supported by NIH P50-HG007735 (H.Y.C.), DRC Center Grant NIH P30 DK063720, and the Sean N. Parker Autoimmune Research Laboratory (J.A.B.). A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund, has received support from the Innovative Genomics Institute (IGI), and is an investigator at the Chan Zuckerberg Biohub. J.A.B. is the A.W. and Mary Margaret Clausen Distinguished Professor in Metabolism and Endocrinology. A.Y.R. and H.Y.C. are investigators of the Howard Hughes Medical Institute.	An YF, 2011, SCAND J IMMUNOL, V74, P304, DOI 10.1111/j.1365-3083.2011.02574.x; Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bin Dhuban K, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai9297; Birjandi SZ, 2016, AM J PATHOL, V186, P2008, DOI 10.1016/j.ajpath.2016.03.020; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; d'Hennezel E, 2012, J MED GENET, V49, P291, DOI 10.1136/jmedgenet-2012-100759; d'Hennezel E, 2009, NEW ENGL J MED, V361, P1710, DOI 10.1056/NEJMc0907093; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Halim L, 2017, CELL REP, V20, P757, DOI 10.1016/j.celrep.2017.06.079; Hansmann L, 2012, J IMMUNOL, V188, P1275, DOI 10.4049/jimmunol.1102288; Harakal J, 2016, J IMMUNOL, V197, P27, DOI 10.4049/jimmunol.1502344; Hayatsu N, 2017, IMMUNITY, V47, P268, DOI 10.1016/j.immuni.2017.07.008; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Kwon HK, 2018, P NATL ACAD SCI USA, V115, pE253, DOI 10.1073/pnas.1718599115; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee GR, 2014, IMMUNOLOGY, V141, P498, DOI 10.1111/imm.12216; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Lu L, 2017, NAT REV IMMUNOL, V17, P703, DOI 10.1038/nri.2017.75; Moes N, 2010, GASTROENTEROLOGY, V139, P770, DOI 10.1053/j.gastro.2010.06.006; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Restori KH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01249; Reubsaet L, 2013, J ALLERGY CLIN IMMUN, V132, P1440, DOI 10.1016/j.jaci.2013.06.028; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	56	45	45	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					362	+		10.1016/j.immuni.2018.12.016	http://dx.doi.org/10.1016/j.immuni.2018.12.016			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30709738	Green Accepted, Bronze			2022-12-18	WOS:000459006700012
J	Pape, KA; Maul, RW; Dileepan, T; Paustian, AS; Gearhart, PJ; Jenkins, MK				Pape, Kathryn A.; Maul, Robert W.; Dileepan, Thamotharampillai; Paustian, Amanda Schmidt; Gearhart, Patricia J.; Jenkins, Marc K.			Naive B Cells with High-Avidity Germline-Encoded Antigen Receptors Produce Persistent IgM(+) and Transient IgG(+) Memory B Cells	IMMUNITY			English	Article							GERMINAL-CENTERS; IMMUNE-RESPONSE; PLASMA-CELLS; V-H; IMMUNOGLOBULIN; LOCUS; MICE; EXPRESSION; STRAIN; REGION	Although immune memory often lasts for life, this is not the case for certain vaccines in some individuals. We sought a mechanism for this phenomenon by studying B cell responses to phycoerythrin (PE). PE immunization of mouse strains with Igh(b) immunoglobulin (Ig) variable heavy chain (V-H) genes elicited affinity-matured switched Ig memory B cells that declined with time, while the comparable population from an Igh(a) strain was numerically stable. Igh(b) strains had larger numbers of PE-specific naive B cells and generated smaller germinal center responses and larger numbers of IgM memory cells than the Igh(a) strain. The properties of PE-specific B cells in Igh(b) mice correlated with usage of a single V-H that afforded high-affinity PE binding in its germline form. These results suggest that some individuals may be genetically predisposed to generate non-canonical memory B cell responses to certain antigens because of avid antigen binding via germline-encoded V-H elements.	[Pape, Kathryn A.; Dileepan, Thamotharampillai; Jenkins, Marc K.] Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Sch Med, Minneapolis, MN 55455 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Paustian, Amanda Schmidt] AbbVie Pharmaceut, N Chicago, IL 60064 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); AbbVie	Jenkins, MK (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Sch Med, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Jenkins, Marc K/G-1063-2012; Gearhart, Patricia/Y-7227-2019; Maul, Robert W./Y-6818-2019	Jenkins, Marc K/0000-0001-8009-7655; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996	US National Institutes of Health [R37 AI027998, R01 AI039614]; Intramural Research Program of the National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027998, R37AI027998, R01AI039614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000732] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the US National Institutes of Health (R37 AI027998 and R01 AI039614) to M.K.J. and the Intramural Research Program of the National Institutes of Health, National Institute on Aging to P.J.G. The authors acknowledge technical assistance from David Wu, Madeline Pape, and Jennifer Walter.	Benson MJ, 2007, CURR OPIN IMMUNOL, V19, P275, DOI 10.1016/j.coi.2007.04.009; BOSMA MJ, 1974, J EXP MED, V139, P512, DOI 10.1084/jem.139.3.512; Collins AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0236; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Feeney AJ, 1996, J CLIN INVEST, V97, P2277, DOI 10.1172/JCI118669; Field LL, 2002, GENES IMMUN, V3, P338, DOI 10.1038/sj.gene.6363857; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Herzenberg L A, 1974, Contemp Top Immunobiol, V3, P41; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jones DD, 2015, J IMMUNOL, V195, P4753, DOI 10.4049/jimmunol.1501365; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; PAWLAK LL, 1973, J EXP MED, V137, P22, DOI 10.1084/jem.137.1.22; Rapoport B, 2010, GENES IMMUN, V11, P254, DOI 10.1038/gene.2010.8; Raposo B, 2014, J EXP MED, V211, P405, DOI 10.1084/jem.20130968; SAKKAS LI, 1987, J IMMUNOGENET, V14, P189; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; SIEKEVITZ M, 1982, EUR J IMMUNOL, V12, P1023, DOI 10.1002/eji.1830121208; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stenger RM, 2010, VACCINE, V28, P6637, DOI 10.1016/j.vaccine.2010.06.118; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Van Braeckel-Budimir N, 2017, IMMUNITY, V47, P835; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	36	45	46	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1135	+		10.1016/j.immuni.2018.04.019	http://dx.doi.org/10.1016/j.immuni.2018.04.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29884459	Green Accepted, Bronze			2022-12-18	WOS:000436456900013
J	Cao, W; Kayama, H; Chen, ML; Delmas, A; Sun, A; Kim, SY; Rangarajan, ES; McKevitt, K; Beck, AP; Jackson, CB; Crynen, G; Oikonomopoulos, A; Lacey, PN; Martinez, GJ; Izard, T; Lorenz, RG; Rodriguez-Palacios, A; Cominelli, F; Abreu, MT; Hommes, DW; Koralov, SB; Takeda, K; Sundrud, MS				Cao, Wei; Kayama, Hisako; Chen, Mei Lan; Delmas, Amber; Sun, Amy; Kim, Sang Yong; Rangarajan, Erumbi S.; McKevitt, Kelly; Beck, Amanda P.; Jackson, Cody B.; Crynen, Gogce; Oikonomopoulos, Angelos; Lacey, Precious N.; Martinez, Gustavo J.; Izard, Tina; Lorenz, Robin G.; Rodriguez-Palacios, Alex; Cominelli, Fabio; Abreu, Maria T.; Hommes, Daniel W.; Koralov, Sergei B.; Takeda, Kiyoshi; Sundrud, Mark S.			The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; MICE; CD4(+); TRAFFICKING; ACTIVATION; MECHANISMS; MICROBIOTA; BACTERIA	CD4(+) T cells are tightly regulated by microbiota in the intestine, but whether intestinal T cells interface with host-derived metabolites is less clear. Here, we show that CD4(+) T effector (Teff) cells upregulated the xenobiotic transporter, Mdr1, in the ileum to maintain homeostasis in the presence of bile acids. Whereas wild-type Teff cells upregulated Mdr1 in the ileum, those lacking Mdr1 displayed mucosal dysfunction and induced Crohn's disease-like ileitis following transfer into Rag1(-/-) hosts. Mdr1 mitigated oxidative stress and enforced homeostasis in Teff cells exposed to conjugated bile acids (CBAs), a class of liver-derived emulsifying agents that actively circulate through the ileal mucosa. Blocking ileal CBA reabsorption in transferred Rag1(-/-) mice restored Mdr1-deficient Teff cell homeostasis and attenuated ileitis. Further, a subset of ileal Crohn's disease patients displayed MDR1 loss of function. Together, these results suggest that coordinated interaction between mucosal Teff cells and CBAs in the ileum regulate intestinal immune homeostasis.	[Cao, Wei; Chen, Mei Lan; Delmas, Amber; McKevitt, Kelly; Jackson, Cody B.; Sundrud, Mark S.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA; [Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Osaka 5650871, Japan; [Sun, Amy; Koralov, Sergei B.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Kim, Sang Yong] NYU, Sch Med, Rodent Genet Engn Core, New York, NY 10016 USA; [Rangarajan, Erumbi S.; Izard, Tina] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Jupiter, FL 33458 USA; [Beck, Amanda P.] MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA; [Crynen, Gogce] Scripps Res Inst, Bioinformat Core Facil, Jupiter, FL 33458 USA; [Oikonomopoulos, Angelos; Lacey, Precious N.; Hommes, Daniel W.] Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA; [Martinez, Gustavo J.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, N Chicago, IL 60064 USA; [Lorenz, Robin G.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Rodriguez-Palacios, Alex; Cominelli, Fabio] Case Western Reserve Univ, Sch Med, Digest Hlth Res Inst, Cleveland, OH 44106 USA; [Abreu, Maria T.] Univ Miami, Miller Sch Med, Dept Med, Div Gastroenterol, Miami, FL 33136 USA; [Beck, Amanda P.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Scripps Research Institute; Osaka University; New York University; New York University; Scripps Research Institute; University of Texas System; UTMD Anderson Cancer Center; Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chicago Medical School; Rosalind Franklin University Medical & Science; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; University of Miami; Yeshiva University; Albert Einstein College of Medicine	Sundrud, MS (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.	msundrud@scripps.edu	Lorenz, Robin G/AAJ-1499-2021; Jackson, Cody/ACN-5204-2022	Lorenz, Robin G/0000-0002-2514-9819; Jackson, Cody/0000-0002-0686-9423; Kim, Sang Yong/0000-0001-7326-7505; Abreu, Maria T./0000-0002-7294-0574; Takeda, Kiyoshi/0000-0002-1778-6332; Sun, Amy/0000-0002-9219-9509; Koralov, Sergei/0000-0002-4843-3791; Eliason, Amber/0000-0001-8765-686X	TSRI Florida via the State of Florida; National Institute of Allergy and Infectious Diseases [R21AI119728, R21AI124129]; National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK099076-07, P01DK071176]; National Heart, Lung, and Blood Institute [RO1HL125816]; Crohn's and Colitis Foundation of America [422515, 3786, 26971]; Broad Medical Foundation [IBD-0389R]; Colton Center for Autoimmunity; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [JPMJCR10J2]; Ministry of Education, Culture, Sports, Science and Technology [T15K15152, A15H02511]; Ministry of Health, Labour, and Welfare [201324001B]; Lotte Research Promotion Grant; Nagao Memorial Fund; AbbVie; Amgen; Asana Medical; Ferring Pharmaceuticals; Focus Medical Communications; Genentech; Genova Diagnostics; GI Health Foundation; Gilead; GSK Holding Americas; Hospira; Janssen; Mucosal Health Board; Pfizer; Prometheus Laboratories; Prova Education; Sanofi Aventis; Shire; Takeda; UCB; WebMD Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124129, R21AI119728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, P30DK097948, P01DK071176, R01DK099076, R01DK042191] Funding Source: NIH RePORTER	TSRI Florida via the State of Florida; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Crohn's and Colitis Foundation of America; Broad Medical Foundation; Colton Center for Autoimmunity; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Lotte Research Promotion Grant; Nagao Memorial Fund; AbbVie(AbbVie); Amgen(Amgen); Asana Medical; Ferring Pharmaceuticals(Ferring Pharmaceuticals); Focus Medical Communications; Genentech(Roche HoldingGenentech); Genova Diagnostics; GI Health Foundation; Gilead(Gilead Sciences); GSK Holding Americas; Hospira; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Mucosal Health Board; Pfizer(Pfizer); Prometheus Laboratories; Prova Education; Sanofi Aventis(Sanofi-Aventis); Shire; Takeda(Takeda Pharmaceutical Company Ltd); UCB(UCB Pharma SA); WebMD Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Core Facilities at The Scripps Research Institute (TSRI) Florida for technical support and Dr. Paul Dawson for critical discussions. This work was funded by TSRI Florida via the State of Florida (to M.S.S.), the National Institute of Allergy and Infectious Diseases (R21AI119728, to M.S.S.; R21AI124129, to S.B.K.), the National Institute of Diabetes and Digestive and Kidney Diseases (5R01DK099076-07, to M.T.A.; P01DK071176, to R.G.L.), the National Heart, Lung, and Blood Institute (RO1HL125816, to S.B.K.), the Crohn's and Colitis Foundation of America (#422515, to M.S.S.; #3786, to M.T.A.; #26971, to R.G.L.), the Broad Medical Foundation (#IBD-0389R, to M.T.A.), and the Colton Center for Autoimmunity (to S.B.K.), as well as the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (JPMJCR10J2, to K.T.); the Ministry of Education, Culture, Sports, Science and Technology (T15K15152 and A15H02511, to K.T.); and the Ministry of Health, Labour, and Welfare (201324001B, to K.T.). H.K. was supported by a Lotte Research Promotion Grant and the Nagao Memorial Fund. M.T.A. and D.W.H. have received research grants and consultancy fees from AbbVie, Amgen, Asana Medical, Ferring Pharmaceuticals, Focus Medical Communications, Genentech, Genova Diagnostics, GI Health Foundation, Gilead, GSK Holding Americas, Hospira, Janssen, Mucosal Health Board, Pfizer, Prometheus Laboratories, Prova Education, Sanofi Aventis, Shire, Takeda, UCB, and WebMD Health. M.S.S. and A.D. hold a provisional patent on screening IBD patients for MDR1 loss of function.	Albenberg LG, 2012, CURR OPIN GASTROEN, V28, P314, DOI 10.1097/MOG.0b013e328354586f; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Annese V, 2006, WORLD J GASTROENTERO, V12, P3636, DOI 10.3748/wjg.v12.i23.3636; Arnold MA, 2014, AM J SURG PATHOL, V38, P1530, DOI 10.1097/PAS.0000000000000260; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Bhat BG, 2003, J LIPID RES, V44, P1614, DOI 10.1194/jlr.M200469-JLR200; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Ho G. T., 2017, MUCOSAL IMMUNOL; Hofmann AF, 2014, J LIPID RES, V55, P1553, DOI 10.1194/jlr.R049437; HYAFIL F, 1993, CANCER RES, V53, P4595; Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x; Jones-Hall Yava L, 2014, Pathophysiology, V21, P267, DOI 10.1016/j.pathophys.2014.05.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim IW, 2006, BIOCHEMISTRY-US, V45, P7605, DOI 10.1021/bi060308o; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Lorenzo-Zuniga V, 2003, HEPATOLOGY, V37, P551, DOI 10.1053/jhep.2003.50116; LUDESCHER C, 1992, BRIT J HAEMATOL, V82, P161, DOI 10.1111/j.1365-2141.1992.tb04608.x; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Panwala CM, 1998, J IMMUNOL, V161, P5733; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; Pavlidis P, 2015, J CROHNS COLITIS, V9, P210, DOI 10.1093/ecco-jcc/jju020; Poupon R, 2000, J HEPATOL, V32, P129, DOI 10.1016/S0168-8278(00)80421-3; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	49	45	48	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1182	+		10.1016/j.immuni.2017.11.012	http://dx.doi.org/10.1016/j.immuni.2017.11.012			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262351	Bronze, Green Accepted			2022-12-18	WOS:000418486500020
J	Dominguez-Andres, J; Feo-Lucas, L; de la Escalera, MM; Gonzalez, L; Lopez-Bravo, M; Ardavin, C				Dominguez-Andres, Jorge; Feo-Lucas, Lidia; Minguito de la Escalera, Maria; Gonzalez, Leticia; Lopez-Bravo, Maria; Ardavin, Carlos			Inflammatory Ly6C(high) Monocytes Protect against Candidiasis through IL-15-Driven NK Cell/Neutrophil Activation	IMMUNITY			English	Article							DENDRITIC CELLS; INTERLEUKIN-15; IMMUNITY; RECEPTOR; DEFENSE; INFECTION; ALBICANS; IL-15	Neutrophils play a crucial role in defense against systemic candidiasis, a disease associated with a high mortality rate in patients receiving immunosuppressive therapy, although the early immune mechanisms that boost the candidacidal activity of neutrophils remain to be defined in depth. Here, we used a murine model of systemic candidiasis to explore the role of inflammatory Ly6C(high) monocytes in NK cell-mediated neutrophil activation during the innate immune response against C. albicans. We found that efficient anti-Candida immunity required a collaborative response between the spleen and kidney, which relied on type I interferon-dependent IL-15 production by spleen inflammatory Ly6C(high) monocytes to drive efficient activation and GM-CSF release by spleen NK cells; this in turn was necessary to boost the Candida killing potential of kidney neutrophils. Our findings unveil a role for IL-15 as a critical mediator in defense against systemic candidiasis and hold promise for the design of IL-15-based antifungal immunotherapies.	[Dominguez-Andres, Jorge; Feo-Lucas, Lidia; Minguito de la Escalera, Maria; Gonzalez, Leticia; Lopez-Bravo, Maria; Ardavin, Carlos] Ctr Nacl Biotecnol CSIC, Dept Inmunol & Oncol, Darwin 3, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Ardavin, C (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Inmunol & Oncol, Darwin 3, Madrid 28049, Spain.	ardavin@cnb.csic.es	Dominguez-Andres, Jorge/S-6211-2017	Dominguez-Andres, Jorge/0000-0002-9091-1961; Lopez-Bravo, Maria/0000-0002-1898-9465	Spanish Ministerio de Economia y Competitividad [SAF 2012-35670, SAF2015-69905]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	We thank C. Gil for C. albicans SC5314 strain and experimental advice. F. Tacke for Ccr2<SUP>-/-</SUP> mice, J. di Santo for Il15<SUP>-/-</SUP> mice, U. Kalinke for Ifnar1<SUP>-/-</SUP> mice, G. Brown for Clec7a<SUP>-/-</SUP> bone marrow, I. Udalova for Irf5<SUP>-/-</SUP> bone marrow and S. Colpitts, C. del Fresno, S. Leibundgut-Landmann, A. Marcais, L. Puddington, D. Sancho, and T. Walzer for scientific advice. J. D.-A. received a La Caixa Foundation PhD fellowship. This work was supported by the Spanish Ministerio de Economia y Competitividad (Grants SAF 2012-35670 and SAF2015-69905) to C.A.	Reales-Calderon JA, 2012, J PROTEOMICS, V75, P4734, DOI 10.1016/j.jprot.2012.01.037; Bar E, 2014, IMMUNITY, V40, P117, DOI 10.1016/j.immuni.2013.12.002; Colpitts SL, 2012, J IMMUNOL, V188, P2483, DOI 10.4049/jimmunol.1103609; del Fresno C, 2013, IMMUNITY, V38, P1176, DOI 10.1016/j.immuni.2013.05.010; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Frenz T, 2010, EUR J IMMUNOL, V40, P2769, DOI 10.1002/eji.201040453; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Horowitz A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00088; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Majer O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002811; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; McCarthy MW, 2017, EXPERT REV ANTI-INFE, V15, P577, DOI 10.1080/14787210.2017.1328279; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Musso T, 1998, INFECT IMMUN, V66, P2640, DOI 10.1128/IAI.66.6.2640-2647.1998; Naglik JR., 2014, NEW J SCI, V2014; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Ngo LY, 2014, J INFECT DIS, V209, P109, DOI 10.1093/infdis/jit413; Perera PY, 2012, MICROBES INFECT, V14, P247, DOI 10.1016/j.micinf.2011.10.006; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Vazquez N, 1998, INFECT IMMUN, V66, P145; Whitney PG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004276; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017	33	45	47	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					1059	+		10.1016/j.immuni.2017.05.009	http://dx.doi.org/10.1016/j.immuni.2017.05.009			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636955	Bronze			2022-12-18	WOS:000403665900018
J	Bhattacharya, A; Hegazy, AN; Deigendesch, N; Kosack, L; Cupovic, J; Kandasamy, RK; Hildebrandt, A; Merkler, D; Kuhl, AA; Vilagos, B; Schliehe, C; Panse, I; Khamina, K; Baazim, H; Arnold, I; Flatz, L; Xu, HFC; Lang, PA; Aderem, A; Takaoka, A; Superti-Furga, G; Colinge, J; Ludewig, B; Lohning, M; Bergthaler, A				Bhattacharya, Anannya; Hegazy, Ahmed N.; Deigendesch, Nikolaus; Kosack, Lindsay; Cupovic, Jovana; Kandasamy, Richard K.; Hildebrandt, Andrea; Merkler, Doron; Kuehl, Anja A.; Vilagos, Bojan; Schliehe, Christopher; Panse, Isabel; Khamina, Kseniya; Baazim, Hatoon; Arnold, Isabelle; Flatz, Lukas; Xu, Haifeng C.; Lang, Philipp A.; Aderem, Alan; Takaoka, Akinori; Superti-Furga, Giulio; Colinge, Jacques; Ludewig, Burkhard; Loehning, Max; Bergthaler, Andreas			Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage	IMMUNITY			English	Article							T-CELLS; VIRAL-INFECTION; VIRUS-INFECTION; FUNCTIONAL-ROLE; LIVER FIBROSIS; STRESS; ALPHA; DISEASE; PATHOGENESIS; MACROPHAGES	Tissue damage caused by viral hepatitis is a major cause of morbidity and mortality worldwide. Using a mouse model of viral hepatitis, we identified virus-induced early transcriptional changes in the redox pathways in the liver, including downregulation of superoxide dismutase 1 (Sod1). Sod1(-/-) mice exhibited increased inflammation and aggravated liver damage upon viral infection, which was independent of T and NK cells and could be ameliorated by antioxidant treatment. Type I interferon (IFN-I) led to a downregulation of Sod1 and caused oxidative liver damage in Sod1(-/-) and wild-type mice. Genetic and pharmacological ablation of the IFN-I signaling pathway protected against virus-induced liver damage. These results delineate IFN-I mediated oxidative stress as a key mediator of virus-induced liver damage and describe a mechanism of innate-immunity-driven pathology, linking IFN-I signaling with antioxidant host defense and infection-associated tissue damage.	[Bhattacharya, Anannya; Kosack, Lindsay; Kandasamy, Richard K.; Hildebrandt, Andrea; Vilagos, Bojan; Schliehe, Christopher; Khamina, Kseniya; Baazim, Hatoon; Superti-Furga, Giulio; Colinge, Jacques; Bergthaler, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Hegazy, Ahmed N.; Panse, Isabel; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, Expt Immunol, D-10117 Berlin, Germany; [Hegazy, Ahmed N.; Panse, Isabel; Loehning, Max] Leibniz Inst, German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Hegazy, Ahmed N.; Arnold, Isabelle] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Div Expt Med,Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Deigendesch, Nikolaus] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Cupovic, Jovana; Flatz, Lukas; Ludewig, Burkhard] Cantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, CH-1211 Geneva, Switzerland; [Merkler, Doron] Univ Med Gottingen, Dept Neuropathol, D-37099 Gottingen, Germany; [Kuehl, Anja A.] Charite, Dept Med Gastroenterol Infect Dis & Rheumatol 1, D-12200 Berlin, Germany; [Xu, Haifeng C.; Lang, Philipp A.] Univ Dusseldorf, Dept Gastroenterol, D-40225 Dusseldorf, Germany; [Lang, Philipp A.] Univ Dusseldorf, Dept Mol Med 2, D-40225 Dusseldorf, Germany; [Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido 0600815, Japan; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Oxford; Max Planck Society; Kantonsspital St. Gallen; University of Geneva; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Center for Infectious Disease Research; Hokkaido University; Medical University of Vienna	Bergthaler, A (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14 AKH BT25-3, A-1090 Vienna, Austria.	abergthaler@cemm.oeaw.ac.at	Bergthaler, Andreas/ABG-5047-2020; Colinge, Jacques/D-1578-2017; Merkler, Doron/N-9157-2016; Colinge, Jacques/Z-2613-2019; Kandasamy, Richard Kumaran/C-8981-2009; Superti-Furga, Giulio/AAE-5681-2019; Bhattacharya, Anannya/J-4555-2019; Löhning, Max/AAL-2967-2021	Bergthaler, Andreas/0000-0003-0597-1976; Colinge, Jacques/0000-0003-2466-4824; Merkler, Doron/0000-0002-0247-2007; Colinge, Jacques/0000-0003-2466-4824; Kandasamy, Richard Kumaran/0000-0002-0894-1222; Löhning, Max/0000-0001-6382-7281; Hegazy, Ahmed N./0000-0002-2946-8251; Kuhl, Anja/0000-0003-2293-5387; Bhattacharya, Anannya/0000-0001-6385-4028; Arnold, Isabelle C./0000-0001-8679-9666; /0000-0003-4243-4950	DOC fellowships of the Austrian Academy of Sciences; European Molecular Biology Organization (EMBO) long-term fellowship [ALTF 116-2012, ALTF 314-2012]; German Academic Exchange Service (DAAD); Swiss National Science Foundation [PP00P3_152928]; Klaus-Tschira Foundation; Gebert-Ruf Foundation; DAAD; Alexander von Humboldt Foundation (SKA); German Research Council [SFB974, LA2558/5-1]; ERC; German Federal Ministry of Education and Research (BMBF, T-Sys); German Research Foundation [SFB618, TPC3, SFB650, TP28, LO1542/3-1]; Volkswagen Foundation; Austrian Academy of Sciences; Austrian Science Foundation (FWF) [23991]; Grants-in-Aid for Scientific Research [25253030] Funding Source: KAKEN	DOC fellowships of the Austrian Academy of Sciences; European Molecular Biology Organization (EMBO) long-term fellowship(European Molecular Biology Organization (EMBO)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Klaus-Tschira Foundation; Gebert-Ruf Foundation; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander von Humboldt Foundation (SKA)(Alexander von Humboldt Foundation); German Research Council(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research (BMBF, T-Sys)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Austrian Academy of Sciences; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A. Bhattacharya and K.K. are supported by DOC fellowships of the Austrian Academy of Sciences. A.N.H. and R.K.K. were supported by a European Molecular Biology Organization (EMBO) long-term fellowship (ALTF 116-2012 and ALTF 314-2012). A.N.H. is currently a Marie Sklodowska-Curie Research Fellow (Proposal 330621). A.H. was supported by a stipend of the German Academic Exchange Service (DAAD). D.M. was supported by the Swiss National Science Foundation (PP00P3_152928), the Klaus-Tschira Foundation and the Gebert-Ruf Foundation. C.S. was supported by a fellowship within the Postdoc-Program of DAAD. P.A.L. was supported by the Alexander von Humboldt Foundation (SKA2010) and the German Research Council (SFB974, LA2558/5-1). G.S.-F. was supported by the ERC advanced grant i-FIVE. M.L. was supported by the German Federal Ministry of Education and Research (BMBF, T-Sys), the German Research Foundation (SFB618, TPC3; SFB650, TP28; LO1542/3-1), and the Volkswagen Foundation (Lichtenberg program). A. Bergthaler was supported by the Austrian Academy of Sciences and by a stand-alone grant #23991 of the Austrian Science Foundation (FWF).	Bergthaler A, 2007, J GEN VIROL, V88, P592, DOI 10.1099/vir.0.82428-0; Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Boelsterli UA, 2008, DRUG DISCOV TODAY, V13, P982, DOI 10.1016/j.drudis.2008.08.002; Bolukbas C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-95; Bonilla WV, 2002, J VIROL, V76, P3810, DOI 10.1128/JVI.76.8.3810-3818.2002; CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Crouse J, 2014, IMMUNITY, V40, P961, DOI 10.1016/j.immuni.2014.05.003; Diamond DL, 2012, HEPATOLOGY, V56, P28, DOI 10.1002/hep.25649; Dillon ST, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-239; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Janowska-Wieczorek A, 2001, BLOOD, V98, P3143, DOI 10.1182/blood.V98.10.3143; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kim HS, 2005, MOL CELL BIOL, V25, P6821, DOI 10.1128/MCB.25.15.6821-6833.2005; Kim W, 2003, CLIN CANCER RES, V9, P5493; Koike K, 2005, J GASTROENTEROL, V40, P329, DOI 10.1007/s00535-005-1586-z; Lalazar G. I. Y., 2014, LIVER IMMUNOLOGY, P115; Lang PA, 2013, CELL DEATH DIFFER, V20, P649, DOI 10.1038/cdd.2012.167; Laurent A, 2004, HEPATOLOGY, V39, P1277, DOI 10.1002/hep.20177; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-25; Louten J, 2006, J IMMUNOL, V177, P3266, DOI 10.4049/jimmunol.177.5.3266; MARKLUND SL, 1984, BIOCHEM J, V222, P649, DOI 10.1042/bj2220649; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Megger DA, 2013, MOL CELL PROTEOMICS, V12, P2006, DOI 10.1074/mcp.M113.028027; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Reder AT, 2014, J INTERF CYTOK RES, V34, P589, DOI 10.1089/jir.2013.0158; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; von Marschall Z, 2003, J NATL CANCER I, V95, P437, DOI 10.1093/jnci/95.6.437; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Xu HC, 2014, IMMUNITY, V40, P949, DOI 10.1016/j.immuni.2014.05.004	66	45	45	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					974	986		10.1016/j.immuni.2015.10.013	http://dx.doi.org/10.1016/j.immuni.2015.10.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588782	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000366846000017
J	Bhutia, YD; Ganapathy, V				Bhutia, Yangzom D.; Ganapathy, Vadivel			Short, but Smart: SCFAs Train T Cells in the Gut to Fight Autoimmunity in the Brain	IMMUNITY			English	Editorial Material							CHAIN FATTY-ACIDS; TRANSPORTER; MICROBIOTA	In this issue of Immunity, Haghikia and colleagues (2015) demonstrate that dietary fatty acids, by modulating gut microbes and their metabolism, regulate mucosal immune cells to impact systemic immunity. Using this mechanism, dietary and bacteria-derived medium-chain and long-chain fatty acids exacerbate, whereas short-chain fatty acids ameliorate, autoimmunity in the brain.	[Bhutia, Yangzom D.; Ganapathy, Vadivel] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Ganapathy, V (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	vadivel.ganapathy@ttuhsc.edu			NCI NIH HHS [CA190710, R01 CA190710] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA190710] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ganapathy V, 2013, CURR OPIN PHARMACOL, V13, P869, DOI 10.1016/j.coph.2013.08.006; Gurav A, 2015, BIOCHEM J, V469, P267, DOI 10.1042/BJ20150242; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Kim Chang H, 2014, Immune Netw, V14, P277, DOI 10.4110/in.2014.14.6.277; Kuhn KA, 2013, SEMIN IMMUNOL, V25, P364, DOI 10.1016/j.smim.2013.10.002; Longman RS, 2015, CURR OPIN RHEUMATOL, V27, P381, DOI 10.1097/BOR.0000000000000190; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Singh N, 2010, J BIOL CHEM, V285, P27601, DOI 10.1074/jbc.M110.102947; Vieira SM, 2014, LUPUS, V23, P518, DOI 10.1177/0961203313501401	9	45	51	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					629	631		10.1016/j.immuni.2015.09.014	http://dx.doi.org/10.1016/j.immuni.2015.09.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488813	Bronze, Green Accepted			2022-12-18	WOS:000363478700006
J	Wiehe, K; Easterhoff, D; Luo, K; Nicely, NI; Bradley, T; Jaeger, FH; Dennison, SM; Zhang, RJ; Lloyd, KE; Stolarchuk, C; Parks, R; Sutherland, LL; Scearce, RM; Morris, L; Kaewkungwal, J; Nitayaphan, S; Pitisuttithum, P; Rerks-Ngarm, S; Sinangil, F; Phogat, S; Michael, NL; Kim, JH; Kelsoe, G; Montefiori, DC; Tomaras, GD; Bonsignori, M; Santra, S; Kepler, TB; Alam, SM; Moody, MA; Liao, HX; Haynes, BF				Wiehe, Kevin; Easterhoff, David; Luo, Kan; Nicely, Nathan I.; Bradley, Todd; Jaeger, Frederick H.; Dennison, S. Moses; Zhang, Ruijun; Lloyd, Krissey E.; Stolarchuk, Christina; Parks, Robert; Sutherland, Laura L.; Scearce, Richard M.; Morris, Lynn; Kaewkungwal, Jaranit; Nitayaphan, Sorachai; Pitisuttithum, Punnee; Rerks-Ngarm, Supachai; Sinangil, Faruk; Phogat, Sanjay; Michael, Nelson L.; Kim, Jerome H.; Kelsoe, Garnett; Montefiori, David C.; Tomaras, Georgia D.; Bonsignori, Mattia; Santra, Sampa; Kepler, Thomas B.; Alam, S. Munir; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.			Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved	IMMUNITY			English	Article							MONOCLONAL-ANTIBODIES; REACTIVITY; EFFICACY; AFFINITY; BINDING; GP41; IDENTIFICATION; MATURATION; INDUCTION; PHENIX	In HIV-1, the ability to mount antibody responses to conserved, neutralizing epitopes is critical for protection. Here we have studied the light chain usage of human and rhesus macaque antibodies targeted to a dominant region of the HIV-1 envelope second variable (V2) region involving lysine (K) 169, the site of immune pressure in the RV144 vaccine efficacy trial. We found that humans and rhesus macaques used orthologous lambda variable gene segments encoding a glutamic acid-aspartic acid (ED) motif for K169 recognition. Structure determination of an unmutated ancestor antibody demonstrated that the V2 binding site was preconfigured for ED motifmediated recognition prior to maturation. Thus, light chain usage for recognition of the site of immune pressure in the RV144 trial is highly conserved across species. These data indicate that the HIV-1 K169-recognizing ED motif has persisted over the diversification between rhesus macaques and humans, suggesting an evolutionary advantage of this antibody recognition mode.	[Wiehe, Kevin; Easterhoff, David; Luo, Kan; Nicely, Nathan I.; Bradley, Todd; Jaeger, Frederick H.; Dennison, S. Moses; Zhang, Ruijun; Lloyd, Krissey E.; Stolarchuk, Christina; Parks, Robert; Sutherland, Laura L.; Scearce, Richard M.; Kelsoe, Garnett; Montefiori, David C.; Tomaras, Georgia D.; Bonsignori, Mattia; Alam, S. Munir; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Morris, Lynn] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa; [Morris, Lynn] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Kaewkungwal, Jaranit; Pitisuttithum, Punnee] Mahidol Univ, Dept Trop Med, Bangkok 10400, Thailand; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi 11000, Thailand; [Sinangil, Faruk] Sanofi Pasteur Inc, Swiftwater, PA 18370 USA; [Phogat, Sanjay] Global Solut Infect Dis, San Francisco, CA 94080 USA; [Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil Res Program, Silver Spring, MD 20910 USA; [Santra, Sampa] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02118 USA	Duke University; National Institute for Communicable Diseases (NICD); Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Sanofi-Aventis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Wiehe, K (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.	kevin.wiehe@dm.duke.edu; barton.haynes@dm.duke.edu	Moody, M/AAB-6947-2020; Alam, S. Munir/AAC-6711-2019; , PEP-MX Core/AGV-4051-2022; Morris, Lynn/V-3941-2018; Bonsignori, Mattia/AAE-7678-2019; Zhang, RUIJUN/AAD-6887-2021; Bradley, Todd/AAB-3550-2020; Tomaras, Georgia/J-5041-2016	Moody, M/0000-0002-3890-5855; Morris, Lynn/0000-0003-3961-7828; Bonsignori, Mattia/0000-0003-2973-2101; Kaewkungwal, Jaranit/0000-0001-7916-8460; Kelsoe, Garnett/0000-0002-8770-040X	Collaboration for AIDS Vaccine Discovery from the Bill & Melinda Gates Foundation [OPP1033098]; Center for HIV/AIDS Vaccine Immunology-Immuongen Discovery (CHAVI-ID) from NIH/NIAID/DAIDS [UMI-AI100645]; Duke University Center for AIDS Research Flow Cytometry core (NIAID, NIH) [P30-AI-64518]; U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NIAID (NIH) [5T32-AI007392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, T32AI007392, P30AI064518] Funding Source: NIH RePORTER	Collaboration for AIDS Vaccine Discovery from the Bill & Melinda Gates Foundation; Center for HIV/AIDS Vaccine Immunology-Immuongen Discovery (CHAVI-ID) from NIH/NIAID/DAIDS; Duke University Center for AIDS Research Flow Cytometry core (NIAID, NIH); U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIAID (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Collaboration for AIDS Vaccine Discovery grants from the Bill & Melinda Gates Foundation (grant ID OPP1033098) and by the Center for HIV/AIDS Vaccine Immunology-Immuongen Discovery (CHAVI-ID; UMI-AI100645) grant from NIH/NIAID/DAIDS. This work was also supported by grant number 5T32-AI007392 from the NIAID (NIH). Flow cytometry work was additionally supported by The Duke University Center for AIDS Research Flow Cytometry core (NIAID, NIH, CFAR grant P30-AI-64518). Funding was also provided by Interagency Agreement Y1-AI-2642-12 between U.S. Army Medical Research and Material Command (USAMRMC) and the (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The views expressed in this article are those of the authors and should not be construed as official or as representing the views of the Department of Defense or the Department of the Army. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. We thank A. Foulger for expert technical assistance in antibody production; D. Marshall and J. Whitesides for expert technical assistance in flow cytometry; A. Martelli for expert technical assistance in neutralization assays; and K. Soderberg and S. Bowen for project management.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Compton AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003135; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; de Wildt RMT, 1999, J MOL BIOL, V285, P895, DOI 10.1006/jmbi.1998.2396; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRIPPIAT JP, 1994, MOL IMMUNOL, V31, P657, DOI 10.1016/0161-5890(94)90175-9; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Jayaram N, 2012, PROTEIN ENG DES SEL, V25, P523, DOI 10.1093/protein/gzs043; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; McLinden RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077756; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Munshaw S, 2010, BIOINFORMATICS, V26, P867, DOI 10.1093/bioinformatics/btq056; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	43	45	45	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					909	918		10.1016/j.immuni.2014.11.014	http://dx.doi.org/10.1016/j.immuni.2014.11.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526306	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000346654100010
J	Angiari, S; Donnarumma, T; Rossi, B; Dusi, S; Pietronigro, E; Zenaro, E; Della Bianca, V; Toffali, L; Piacentino, G; Budui, S; Rennert, P; Xiao, S; Laudanna, C; Casasnovas, JM; Kuchroo, VK; Constantin, G				Angiari, Stefano; Donnarumma, Tiziano; Rossi, Barbara; Dusi, Silvia; Pietronigro, Enrica; Zenaro, Elena; Della Bianca, Vittorina; Toffali, Lara; Piacentino, Gennj; Budui, Simona; Rennert, Paul; Xiao, Sheng; Laudanna, Carlo; Casasnovas, Jose M.; Kuchroo, Vijay K.; Constantin, Gabriela			TIM-1 Glycoprotein Binds the Adhesion Receptor P-Selectin and Mediates T Cell Trafficking during Inflammation and Autoimmunity	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; RECRUITMENT; RECOGNITION; MECHANISMS; ROLES; ACTIVATION; IMMUNITY; FAMILY; LIGAND; SITE	Selectins play a central role in leukocyte trafficking by mediating tethering and rolling on vascular surfaces. Here we have reported that T cell immunoglobulin and mucin domain 1 (TIM-1) is a P-selectin ligand. We have shown that human and murine TIM-1 binds to P-selectin, and that TIM-1 mediates tethering and rolling of T helper 1 (Th1) and Th17, but not Th2 and regulatory T cells on P-selectin. Th1 and Th17 cells lacking the TIM-1 mucin domain showed reduced rolling in thrombin-activated mesenteric venules and inflamed brain microcirculation. Inhibition of TIM-1 had no effect on naive T cell homing, but it reduced T cell recruitment in a skin hypersensitivity model and blocked experimental autoimmune encephalomyelitis. Uniquely, the TIM-1 immunoglobulin variable domain was also required for P-selectin binding. Our data demonstrate that TIM-1 is a major P-selectin ligand with a specialized role in T cell trafficking during inflammatory responses and the induction of autoimmune disease.	[Angiari, Stefano; Donnarumma, Tiziano; Rossi, Barbara; Dusi, Silvia; Pietronigro, Enrica; Zenaro, Elena; Della Bianca, Vittorina; Toffali, Lara; Piacentino, Gennj; Budui, Simona; Laudanna, Carlo; Constantin, Gabriela] Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, Str Le Grazie 8, I-37134 Verona, Italy; [Rennert, Paul] Biogen Idec Inc, Dept Mol Discovery & Immunobiol, Brookline, MA 02146 USA; [Xiao, Sheng; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Toffali, Lara; Laudanna, Carlo] Univ Verona, Ctr Biomed Comp CBMC, I-37134 Verona, Italy; [Casasnovas, Jose M.] CNB CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	University of Verona; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Verona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Constantin, G (corresponding author), Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, Str Le Grazie 8, I-37134 Verona, Italy.	gabriela.constantin@univr.it	Casasnovas, Jose M/L-6299-2014	Casasnovas, Jose M/0000-0002-2873-6410; Zenaro, Elena/0000-0003-3928-6272; Constantin, Gabriela/0000-0001-8978-3539; ROSSI, Barbara/0000-0003-4711-1528; DUSI, SILVIA/0000-0002-5241-9394; Angiari, Stefano/0000-0003-4434-2224; Pietronigro, Enrica Caterina/0000-0001-7661-2247	European Research Council [261079- NEUROTRAFFICKING]; Fondazione Italiana Sclerosi Multipla (FISM); National Multiple Sclerosis Society (NMSS), New York; Ministry of Education and Research (MIUR); Fondazione Cariverona; National Institutes of Health [2P01AI054456-06A1]; Fondazione Italiana Sclerosi Multipla; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); National Multiple Sclerosis Society (NMSS), New York; Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariverona(Fondazione Cariverona); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the European Research Council grant 261079- NEUROTRAFFICKING (G. C.); Fondazione Italiana Sclerosi Multipla (FISM) (G. C. and B. R.); National Multiple Sclerosis Society (NMSS), New York (G. C.); PRIN 2009 grant from the Ministry of Education and Research (MIUR) (C. L., G. C.), Fondazione Cariverona (C. L., G. C.), and National Institutes of Health, grant 2P01AI054456-06A1 (J.M.C.). S. D. is a fellowship recipient from the Fondazione Italiana Sclerosi Multipla.	Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Balasubramanian S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003200; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; D Sizing I, 2007, J IMMUNOL, V178, P2249, DOI 10.4049/jimmunol.178.4.2249; D'Ambrosio D, 2004, TRENDS IMMUNOL, V25, P411, DOI 10.1016/j.it.2004.05.010; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Degauque N, 2008, J CLIN INVEST, V118, P735, DOI 10.1172/JCI32562; DeKrey GK, 1999, J IMMUNOL METHODS, V228, P1, DOI 10.1016/S0022-1759(99)00085-X; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Lees JR, 2008, J IMMUNOL, V180, P8066, DOI 10.4049/jimmunol.180.12.8066; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Rennert PD, 2011, IMMUNOL LETT, V141, P28, DOI 10.1016/j.imlet.2011.08.003; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Wilker PR, 2007, INT IMMUNOL, V19, P763, DOI 10.1093/intimm/dxm044; Xiao S, 2007, J EXP MED, V204, P1691, DOI 10.1084/jem.20062498; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	29	45	50	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					542	553		10.1016/j.immuni.2014.03.004	http://dx.doi.org/10.1016/j.immuni.2014.03.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24703780	Bronze, Green Accepted			2022-12-18	WOS:000334849400012
J	Yatim, N; Albert, ML				Yatim, Nader; Albert, Matthew L.			Dying to Replicate: The Orchestration of the Viral Life Cycle, Cell Death Pathways, and Immunity	IMMUNITY			English	Article							INFLUENZA-A VIRUS; NF-KAPPA-B; MURINE CYTOMEGALOVIRUS-INFECTION; CD8(+) T-CELLS; DENDRITIC CELLS; NS1 PROTEIN; APOPTOTIC CELLS; IN-VIVO; MITOCHONDRIAL PROTEIN; ANTIGEN PRESENTATION	Manipulation of cell death pathways has been identified as a common feature of host-microbe interactions. We examine two examples: influenza A as a representative acute infection and cytomegalovirus as an example of chronic infection. From the perspective of viral entry, replication, and transmission, we identify points of interconnection with the host response to infection, namely the induction of host cell death, inflammation, and immunity. Following from this analysis, we argue that the evolution and fine-tuned regulation of death-associated genes may result from constant microbial pressure-past and present-that helped to support and coordinate cell death programs within the host. Interestingly, the delay in host cell death allows time for the virus to replicate while perturbations in cell death allow the host cell to initiate an immune response. This may represent a genetically encoded trade-off ensuring survival of both host and virus, or it may be a part of the complex agenda of infectious microbes.	[Yatim, Nader; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Unite Immunol Cellules Dendrit, F-75724 Paris, France; [Yatim, Nader; Albert, Matthew L.] INSERM, U818, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Albert, ML (corresponding author), Inst Pasteur, Dept Immunol, Unite Immunol Cellules Dendrit, F-75724 Paris, France.	albertm@pasteur.fr	Albert, Matthew L/C-9782-2009	Yatim, Nader/0000-0001-5326-1624	Agence National de Recherche (ANR); Immuno-Oncology LabEx Project	Agence National de Recherche (ANR)(French National Research Agency (ANR)); Immuno-Oncology LabEx Project	We would like to dedicate this review to the memory of R. Steinman, the consummate mentor and a leader in the field of dendritic cell biology and host response to infection. Far ahead of his time, he informed the dendritic cell community in 2000 that we must always consider the microbes agenda if we are going to understand how to vaccinate the host. His insights and support will be sorely missed. We would like to thank A. Oberst, O. Schwartz, and M. Laird for their careful read of the manuscript. We also acknowledge helpful discussions with L. Quintana-Murci, D. Green and members of his lab, and the Laboratory of Dendritic Cell Biology. Funding support is from the Agence National de Recherche (ANR) and the Immuno-Oncology LabEx Project.	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Ameisen JC, 2004, CELL DEATH DIFFER, V11, P4, DOI 10.1038/sj.cdd.4401356; Andreansky SS, 2005, J VIROL, V79, P4329, DOI 10.1128/JVI.79.7.4329-4339.2005; Arkhipova I, 2005, BIOESSAYS, V27, P76, DOI 10.1002/bies.20159; Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P700; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Bender A, 1998, IMMUNOBIOLOGY, V198, P552, DOI 10.1016/S0171-2985(98)80078-8; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Britt W, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P737; Brune W, 2003, J VIROL, V77, P11633, DOI 10.1128/JVI.77.21.11633-11643.2003; Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Cam M, 2010, CELL DEATH DIFFER, V17, P655, DOI 10.1038/cdd.2009.147; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Cicin-Sain L, 2008, J VIROL, V82, P2056, DOI 10.1128/JVI.01803-07; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Correia-Silva JF, 2007, ORAL DIS, V13, P163, DOI 10.1111/j.1601-0825.2006.01240.x; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; de la Calle C, 2011, AUTOPHAGY, V7, P1045, DOI 10.4161/auto.7.9.16252; DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Ehrhardt C, 2007, J VIROL, V81, P12097, DOI 10.1128/JVI.01216-07; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Giodini A, 2010, CURR OPIN IMMUNOL, V22, P94, DOI 10.1016/j.coi.2010.01.023; Green DR, 2011, IMMUNITY, V35, P441, DOI 10.1016/j.immuni.2011.10.003; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Holtappels R, 2004, J EXP MED, V199, P131, DOI 10.1084/jem.20031582; IBANEZ CE, 1991, J VIROL, V65, P6581, DOI 10.1128/JVI.65.12.6581-6588.1991; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Jurak I, 2008, J VIROL, V82, P4812, DOI 10.1128/JVI.02570-07; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kamps BS, 2006, INFLUENZA REPORT; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lagunoff M, 2003, INT REV IMMUNOL, V22, P373, DOI 10.1080/08830180305218; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lederberg J, 1999, GENETICS, V153, P1; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McCormick AL, 2010, J VIROL, V84, P5108, DOI 10.1128/JVI.01345-09; McCormick AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000063; McCormick AL, 2005, J VIROL, V79, P12205, DOI 10.1128/JVI.79.19.12205-12217.2005; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Miller-Kittrell M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-4; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Mochizuki A, 2006, GENETICS, V172, P1309, DOI 10.1534/genetics.105.042895; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Nencioni L, 2009, J BIOL CHEM, V284, P16004, DOI 10.1074/jbc.M900146200; Nosek J, 2006, BIOESSAYS, V28, P182, DOI 10.1002/bies.20355; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Rivett AJ, 2004, CURR PROTEIN PEPT SC, V5, P153, DOI 10.2174/1389203043379774; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Slobedman B, 2010, FUTURE MICROBIOL, V5, P883, DOI 10.2217/FMB.10.58; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Szomolanyi-Tsuda E, 2006, J VIROL, V80, P4286, DOI 10.1128/JVI.80.9.4286-4291.2006; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tomkinson A, 2010, ALLERGY, V65, P69, DOI 10.1111/j.1398-9995.2009.02156.x; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y; Ziegler H, 2000, EMBO J, V19, P870, DOI 10.1093/emboj/19.5.870	113	45	47	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 28	2011	35	4					478	490		10.1016/j.immuni.2011.10.010	http://dx.doi.org/10.1016/j.immuni.2011.10.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035840	Bronze			2022-12-18	WOS:000296657700005
J	Stadinski, B; Kappler, J; Eisenbarth, GS				Stadinski, Brian; Kappler, John; Eisenbarth, George S.			Molecular Targeting of Islet Autoantigens	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; T-CELL-CLONES; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN BASIC-PROTEIN; GLUTAMIC-ACID DECARBOXYLASE; NOD MICE; PANCREATIC-ISLETS; TRANSGENIC MICE; IMMUNODOMINANT EPITOPE; INSULIN AUTOANTIBODIES	Type 1 diabetes of man and animal models results from immune-mediated specific beta cell destruction. Multiple islet antigens are targets of autoimmunity and most of these are not beta cell specific. Immune responses to insulin appear to be essential for the development of diabetes of the NOD mouse. In this review, we will emphasize the unusual manner in which selected autoantigenic peptides (particularly the recently discovered target of BDC2.5 T cells [chromagranin A]) are presented and recognized by autoreactive CD4(+) T cell receptors. We hypothesize that "unusual" structural interactions of specific trimolecular complexes (MHC class II, peptide, and T cell receptors) are fundamental to the escape from the thymus of autoreactive T cells able to cause type 1 diabetes.	[Eisenbarth, George S.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80045 USA; [Stadinski, Brian; Kappler, John] Natl Jewish Hlth, Denver, CO 80206 USA	University of Colorado System; University of Colorado Denver; National Jewish Health	Eisenbarth, GS (corresponding author), Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80045 USA.							Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Arnold PY, 2004, J IMMUNOL, V173, P3103, DOI 10.4049/jimmunol.173.5.3103; Bergman B, 2000, J AUTOIMMUN, V14, P343, DOI 10.1006/jaut.2000.0377; BERGMAN B, 1994, DIABETES, V43, P197, DOI 10.2337/diabetes.43.2.197; BLASCHKO H, 1967, NATURE, V215, P58, DOI 10.1038/215058a0; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Burton AR, 2010, J IMMUNOL, V184, P4863, DOI 10.4049/jimmunol.0903728; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; CASTANO L, 1993, DIABETES, V42, P1202, DOI 10.2337/diabetes.42.8.1202; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; COLLE E, 1981, J EXP MED, V154, P1237, DOI 10.1084/jem.154.4.1237; Congia M, 1998, P NATL ACAD SCI USA, V95, P3833, DOI 10.1073/pnas.95.7.3833; Coon B, 1999, J CLIN INVEST, V104, P189, DOI 10.1172/JCI7209; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; de Marquesini LGP, 2008, EUR J IMMUNOL, V38, P240, DOI 10.1002/eji.2007377621; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Du W, 2006, J CLIN INVEST, V116, P1360, DOI 10.1172/JCI27030; DUNNOVICBELLO I, 2010, GENES IMMUN, V11, P188; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; FRITZ RB, 1983, J IMMUNOL, V130, P191; GAUTAM AM, 1992, J EXP MED, V176, P605, DOI 10.1084/jem.176.2.605; GEPTS W, 1981, AM J MED, V70, P105, DOI 10.1016/0002-9343(81)90417-4; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Greeley SAW, 2002, NAT MED, V8, P399, DOI 10.1038/nm0402-399; Groen Herman, 2003, Clin Dev Immunol, V10, P141, DOI 10.1080/10446670310001626508; HANENBERG H, 1989, DIABETOLOGIA, V32, P126, DOI 10.1007/BF00505185; Hanninen A, 2000, IMMUNOL REV, V173, P109, DOI 10.1034/j.1600-065X.2000.917303.x; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Hassainya Y, 2005, DIABETES, V54, P2053, DOI 10.2337/diabetes.54.7.2053; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; IKEHARA S, 1985, P NATL ACAD SCI USA, V82, P2483, DOI 10.1073/pnas.82.8.2483; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; Jaeckel E, 2003, J EXP MED, V197, P1635, DOI 10.1084/jem.20030215; Jarpe A J, 1990, Reg Immunol, V3, P305; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kash SF, 1999, HORM METAB RES, V31, P340, DOI 10.1055/s-2007-978750; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kim SK, 2004, P NATL ACAD SCI USA, V101, P14204, DOI 10.1073/pnas.0405500101; Kobayashi M, 2008, P NATL ACAD SCI USA, V105, P10090, DOI 10.1073/pnas.0801648105; Krishnamurthy B, 2008, J IMMUNOL, V180, P4458, DOI 10.4049/jimmunol.180.7.4458; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kubosaki A, 2004, DIABETOLOGIA, V47, P149, DOI 10.1007/s00125-003-1252-z; Lee C, 1998, J EXP MED, V187, P1505, DOI 10.1084/jem.187.9.1505; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; LIKE AA, 1986, J EXP MED, V164, P1145, DOI 10.1084/jem.164.4.1145; LIPES MA, 1993, SCIENCE, V259, P1165, DOI 10.1126/science.8267690; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Martin-Pagola A, 2009, SCAND J IMMUNOL, V70, P439, DOI 10.1111/j.1365-3083.2009.02316.x; MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; MONYAMA H, 2003, P NATL ACAD SCI USA, V100, P10376; MUIR A, 1995, J CLIN INVEST, V95, P628, DOI 10.1172/JCI117707; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nakayama M, 2007, J CLIN INVEST, V117, P1835, DOI 10.1172/JCI31368; OGAWA M, 1985, BIOMED RES-TOKYO, V6, P103; Orr DF, 2002, PROTEOMICS, V2, P1586, DOI 10.1002/1615-9861(200211)2:11<1586::AID-PROT1586>3.0.CO;2-K; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pinkse GGM, 2006, ANN NY ACAD SCI, V1079, P19, DOI 10.1196/annals.1375.003; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; Seamons A, 2003, J EXP MED, V197, P1391, DOI 10.1084/jem.20022226; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; SUN A, 2002, J IMMUNOL, V168, P1235; Tarbell KV, 2002, J EXP MED, V196, P481, DOI 10.1084/jem.20011845; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Thrower SL, 2009, CLIN EXP IMMUNOL, V155, P156, DOI 10.1111/j.1365-2249.2008.03814.x; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1988, TRENDS GENET, V4, P129, DOI 10.1016/0168-9525(88)90135-7; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Walter M, 2009, DIABETES CARE, V32, P2036, DOI 10.2337/dc09-0449; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; WHALEN BJ, 1994, J AUTOIMMUN, V7, P819, DOI 10.1006/jaut.1994.1065; Wong FS, 2009, DIABETES, V58, P1156, DOI 10.2337/db08-0800; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Yamamoto T, 2004, DIABETOLOGIA, V47, P221, DOI 10.1007/s00125-003-1296-0; Yoon JW, 1998, AUTOIMMUNITY, V27, P109, DOI 10.3109/08916939809008041; Yoshida K, 2002, INT IMMUNOL, V14, P1439, DOI 10.1093/intimm/dxf106; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878; Zekzer D, 1997, DIABETES, V46, P1124, DOI 10.2337/diabetes.46.7.1124; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008; Zhang Y, 2009, CHINESE PHYS C, V33, P42, DOI 10.1088/1674-1137/33/1/009; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	114	45	46	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					446	456		10.1016/j.immuni.2010.04.008	http://dx.doi.org/10.1016/j.immuni.2010.04.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412755	Bronze			2022-12-18	WOS:000277171900002
J	Damdinsuren, B; Zhang, YQ; Khalil, A; Wood, WH; Becker, KG; Shlomchik, MJ; Sen, R				Damdinsuren, Bazarragchaa; Zhang, Yongqing; Khalil, Ashraf; Wood, William H., III; Becker, Kevin G.; Shlomchik, Mark J.; Sen, Ranjan			Single Round of Antigen Receptor Signaling Programs Naive B Cells to Receive T Cell Help	IMMUNITY			English	Article							UP-REGULATION; G1 PHASE; LYMPHOCYTES; ACTIVATION; SURVIVAL; IG; PROLIFERATION; EXPRESSION; SUBSTRATE; MIGRATION	To simulate transient B cell activation that is the likely initiator of T-dependent responses, we examined the molecular and functional consequences of a single round of immunoglobulin M (IgM) signaling. This form of activation triggered early cytosolic signaling and the transcription factor NF-kappa B activation indistinguishably from conventional continuous IgM crosslinking but did not induce G1 progression. However, single round IgM signaling changed the expression of chemokine and chemokine receptor genes implicated in initiating T-dependent responses, as well as accentuated responsiveness to CD40 signaling. Several features of single-round IgM signaling in vitro were recapitulated in B cells after short-term exposure to antigen in vivo. We propose that transient BCR signals prime B cells to receive T cell help by increasing the probability of B-T encounter and creating a cellular environment that is hyper-responsive to CD40 signaling.	[Damdinsuren, Bazarragchaa; Sen, Ranjan] NIA, Gene Regulat Sect, Cellular & Mol Biol Lab, Baltimore, MD 21224 USA; [Zhang, Yongqing; Wood, William H., III; Becker, Kevin G.] NIA, Res Resources Branch, Baltimore, MD 21224 USA; [Khalil, Ashraf; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Khalil, Ashraf; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Yale University; Yale University	Sen, R (corresponding author), NIA, Gene Regulat Sect, Cellular & Mol Biol Lab, 251 Bayview Blvd, Baltimore, MD 21224 USA.	rs465z@nih.gov	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Becker, Kevin/0000-0002-6794-6656	National Institute on Aging; NIH [R01-AI43603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000376] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Kokkonen for sorting of follicular B cells; Drs. T. Kurosaki and Y. Aiba for providing reagents; Drs. J. Cerny, A. Roy, S. Gerondakis, D. Parker, P. Gearhart, S. Fugmann, and R. Wersto for comments on the manuscript; and V. Martin for editorial assistance. This work was supported by the Intramural Research Program of the National Institute on Aging and by NIH grant R01-AI43603 to M.J.S.	Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DEFRANCO AL, 1985, J IMMUNOL, V135, P87; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; FERRARINI M, 1976, EUR J IMMUNOL, V6, P372, DOI 10.1002/eji.1830060513; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUROSAKI T, 2009, ANNU REV IMMUNOL, DOI DOI 10.1146/ANNUREV.IMMUNOL.021908.132541; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Marshall-Clarke S, 2003, IMMUNOLOGY, V109, P102, DOI 10.1046/j.1365-2567.2003.01638.x; Meyer-Bahlburg A, 2009, J IMMUNOL, V182, P4065, DOI 10.4049/jimmunol.0802961; Niiro H, 2002, J EXP MED, V195, P143, DOI 10.1084/jem.20011524; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; Piatelli MJ, 2003, IMMUNOL RES, V27, P31, DOI 10.1385/IR:27:1:31; PROUST JJ, 1985, J IMMUNOL, V135, P3056; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Soeiro I, 2006, MOL CELL BIOL, V26, P6170, DOI 10.1128/MCB.02182-05; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337	30	45	46	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					355	366		10.1016/j.immuni.2010.02.013	http://dx.doi.org/10.1016/j.immuni.2010.02.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20226693	Green Accepted, Bronze			2022-12-18	WOS:000276125400009
J	Haining, WN; Wherry, EJ				Haining, W. Nicholas; Wherry, E. John			Integrating Genomic Signatures for Immunologic Discovery	IMMUNITY			English	Article							GENE-EXPRESSION PROFILES; YELLOW-FEVER VACCINE; T-CELL RESPONSES; MEMORY DIFFERENTIATION; EFFECTOR; PATTERNS; NAIVE; IDENTIFICATION; MICROARRAYS; PROGRAM	Understanding heterogeneity in adaptive immune responses is essential to dissect pathways of memory B and T cell differentiation and to define correlates of protective immunity. Traditionally, immunologists have deconvoluted this heterogeneity with flow cytometry-with combinations of markers to define signatures that represent specific lineages, differentiation states, and functions. Genome-scale technologies have become widely available and provide the ability to define expression signatures-sets of genes-that represent discrete biological properties of cell populations. Because genomic signatures can serve as surrogates of a phenotype, function, or cell state, they can integrate phenotypic information between experiments, cell types, and species. Here, we discuss how integration of well-defined expression signatures across experimental conditions together with functional analysis of their component genes could provide new opportunities to dissect the complexity of the adaptive immune response and map the immune response to vaccines and pathogens.	[Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wherry, E. John] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; The Wistar Institute	Haining, WN (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	nicholas_haining@dfci.harvard.edu; jwherry@wistar.org	Wherry, John/ABI-1280-2020		NIH [AI082630, AI071309, HHSN266200500030C]; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071309, U19AI082630] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	W.N.H. and E.J.W. are supported by grants from the NIH (AI082630 to both W.N.H. and E.J.W.; AI071309 and HHSN266200500030C to E.J.W.) and from the Dana Foundation.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Alizadeh A, 1998, J CLIN IMMUNOL, V18, P373, DOI 10.1023/A:1023293621057; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Bild A, 2005, P NATL ACAD SCI USA, V102, P15278, DOI 10.1073/pnas.0507477102; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Chattopadhyay PK, 2008, IMMUNOLOGY, V125, P441, DOI 10.1111/j.1365-2567.2008.02989.x; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Hamalainen H, 2001, GENOME BIOL, V2; Heltzer ML, 2009, J LEUKOCYTE BIOL, V85, P1036, DOI 10.1189/jlb.1108710; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hess K, 2004, INT IMMUNOL, V16, P1711, DOI 10.1093/intimm/dxh172; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hyatt G, 2006, NAT IMMUNOL, V7, P686, DOI 10.1038/ni0706-686; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lee MS, 2004, INT IMMUNOL, V16, P1109, DOI 10.1093/intimm/dxh112; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; MALYS V, 2003, NUCLEIC ACIDS RES, V31, P374; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarwal MM, 2009, CURR OPIN ORGAN TRAN, V14, P544, DOI 10.1097/MOT.0b013e32833068fb; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Tilford CA, 2009, METHODS MOL BIOL, V563, P99, DOI 10.1007/978-1-60761-175-2_6; Vinuesa CG, 2002, ANN NY ACAD SCI, V975, P33, DOI 10.1111/j.1749-6632.2002.tb05939.x; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang L, 2005, J IMMUNOL, V175, P6458, DOI 10.4049/jimmunol.175.10.6458; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	82	45	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					152	161		10.1016/j.immuni.2010.02.001	http://dx.doi.org/10.1016/j.immuni.2010.02.001			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20189480	Bronze			2022-12-18	WOS:000275346000006
J	Antunes, I; Tolaini, M; Kissenpfennig, A; Iwashiro, M; Kuribayashi, K; Malissen, B; Hasenkrug, K; Kassiotis, G				Antunes, Ines; Tolaini, Mauro; Kissenpfennig, Adrien; Iwashiro, Michihiro; Kuribayashi, Kagemasa; Malissen, Bernard; Hasenkrug, Kim; Kassiotis, George			Retrovirus-Specificity of Regulatory T Cells Is Neither Present nor Required in Preventing Retrovirus-Induced Bone Marrow Immune Pathology	IMMUNITY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; HIV-1 SUBTYPE-C; APLASTIC-ANEMIA; EFFECTOR FUNCTION; STEM-CELLS; IN-VITRO; INFECTION; CD4(+); MICE; VIRUS	Chronic viral infections of the hematopoietic system are associated with bone marrow dysfunction, to which both virus-mediated and immune-mediated effects may contribute. Using unresolving noncytopathic Friend virus (FV) infection in mice, we showed that unregulated CD4+ T cell response to FV caused IFN-gamma-mediated bone marrow pathology and anemia. Importantly, bone marrow pathology was triggered by relative insufficiency in regulatory T (Treg) cells and was prevented by added Treg cells, which suppressed the local IFN-gamma production by FV-specific CD4(+) T cells. We further showed that the T cell receptor (TCR) repertoire of transgenic Treg cells expressing the beta chain of an FV-specific TCR was virtually devoid of FV-specific clones. Moreover, anemia induction by virus-specific CD4(+) T cells was efficiently suppressed by virus-nonspecific Treg cells. Thus, sufficient numbers of polyclonal Treg cells may provide substantial protection against bone marrow pathology in chronic viral infections.	[Antunes, Ines; Kassiotis, George] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Tolaini, Mauro] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Hasenkrug, Kim] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Kissenpfennig, Adrien; Malissen, Bernard] Univ Aix Marseille 2, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; [Kuribayashi, Kagemasa] Tazuke Kofukai Med Res Inst, Osaka 5308480, Japan; [Iwashiro, Michihiro] Kyoto Univ, Fac Med, Dept Oral & Maxillofacial Surg, Kyoto 6068507, Japan	MRC National Institute for Medical Research; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Kyoto University	Kassiotis, G (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England.	gkassio@nimr.mrc.ac.uk	Malissen, Bernard/AAK-4659-2020	Malissen, Bernard/0000-0003-1340-9342; Kassiotis, George/0000-0002-8457-2633; Kissenpfennig, Adrien/0000-0002-9633-3111	Intramural NIH HHS Funding Source: Medline; Medical Research Council [MC_U117581330] Funding Source: Medline; MRC [MC_U117581330] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000753, ZIAAI001100, ZIAAI000753] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Binder D, 1998, J EXP MED, V187, P1903, DOI 10.1084/jem.187.11.1903; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen J, 2004, BLOOD, V104, P1671, DOI 10.1182/blood-2004-03-1115; Chen JC, 2007, J IMMUNOL, V178, P4159, DOI 10.4049/jimmunol.178.7.4159; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hasenkrug KJ, 1997, P NATL ACAD SCI USA, V94, P7811, DOI 10.1073/pnas.94.15.7811; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; IWASHIRO M, 1993, J VIROL, V67, P4533, DOI 10.1128/JVI.67.8.4533-4542.1993; Iwashiro M, 2001, J VIROL, V75, P52, DOI 10.1128/JVI.75.1.52-60.2001; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kulkosky J, 2000, LEUKEMIA LYMPHOMA, V37, P497, DOI 10.3109/10428190009058502; MacLeod M, 2006, J EXP MED, V203, P897, DOI 10.1084/jem.20050711; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mlisana K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001626; MOLINA JM, 1990, BLOOD, V76, P2476; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Picca CC, 2006, IMMUNOL REV, V212, P74, DOI 10.1111/j.0105-2896.2006.00416.x; RAEFSKY EL, 1985, J IMMUNOL, V135, P2507; Redd AD, 2007, BLOOD, V110, P3143, DOI 10.1182/blood-2007-04-086314; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Solomou EE, 2007, BLOOD, V110, P1603, DOI 10.1182/blood-2007-01-066258; SPRENT J, 1994, J EXP MED, V180, P307, DOI 10.1084/jem.180.1.307; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; Zinkernagel RM, 2002, VACCINE, V20, P1913, DOI 10.1016/S0264-410X(02)00066-X; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005	52	45	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2008	29	5					782	794		10.1016/j.immuni.2008.09.016	http://dx.doi.org/10.1016/j.immuni.2008.09.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006695	Green Published, hybrid			2022-12-18	WOS:000261036000015
J	Le, Y; Zhu, BM; Harley, B; Park, SY; Kobayashi, T; Manis, JP; Luo, HR; Yoshimura, A; Hennighausen, L; Silberstein, LE				Le, Yi; Zhu, Bing-Mei; Harley, Brendan; Park, Shin-Young; Kobayashi, Takashi; Manis, John P.; Luo, Hongbo R.; Yoshimura, Akihiko; Hennighausen, Lothar; Silberstein, Leslie E.			SOCS3 protein developmentally regulates the chemokine receptor CXCR4-FAK signaling pathway during B lymphopoiesis	IMMUNITY			English	Article							FOCAL ADHESION KINASE; HUMAN BONE-MARROW; PRECURSOR CELLS; NEGATIVE REGULATION; MUTATIONAL ANALYSES; MEMBRANE DOMAINS; CYTOKINE; MICE; RESPONSES; ACTIVATION	The chemokine CXCL12 induces prolonged focal adhesion kinase (FAK) phosphorylation and sustained proadhesive responses in progenitor bone-marrow (BM) B cells, but not in mature peripheral B cells. Here we demonstrate that suppressor of cytokine signaling 3 (SOCS3) regulated CXCL12-induced FAK phosphorylation through the ubiquitin-proteasome pathway. CXCL12 triggered increased FAK ubiquitination in mature B cells, but not in progenitor B cells. Accordingly, SOCS3 expression was low in progenitor B cells, increased in immature B cells, and highest in mature B cells. SOCS3 overexpression in pro-B cells impaired CXCL12-induced FAK phosphorylation and proadhesive responses. Conversely, SOCS3-deficient mature B cells from Cre(MMTV)Socs3(fl/fl) mice exhibited prolonged FAK phosphorylation and adhesion to VCAM-1. In contrast to wild-type mice, Cre(MMTV)Socs3(fl/fl) mice had a 2-fold increase in immature B cells, which were evenly distributed in endosteal and perisinusoidal BM compartments. We propose that the developmental regulation of CXCR4-FAK signaling by SOCS3 is an important mechanism to control the lodgement of B cell precursors in the BM microenvironment.	Childrens Hosp, Harvard Med Sch, Joint Program Transfusion Med, Boston, MA 02115 USA; NIH, NIDDK, Lab Genet & Physiol, Bethesda, MD 20892 USA; Kyushu Univ, Div Mol & Cellular Immunol, Fukuoka, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kyushu University	Silberstein, LE (corresponding author), Childrens Hosp, Harvard Med Sch, Joint Program Transfusion Med, Boston, MA 02115 USA.	leslie.silberstein@childrens.harvard.edu	Yoshimura, Akihiko/K-5515-2013	Harley, Brendan/0000-0001-5458-154X; Le, Yi/0000-0002-7734-3808; Park, Shin-Young/0000-0001-6385-4132; Hennighausen, Lothar/0000-0001-8319-9841	NHLBI NIH HHS [HL074355, HL56949] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK061002] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Chang HC, 2005, IMMUNITY, V23, P661, DOI 10.1016/j.immuni.2005.11.002; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Garzon R, 2004, J BIOL CHEM, V279, P44460, DOI 10.1074/jbc.M408010200; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Hardy RR, 2003, CURR OPIN IMMUNOL, V15, P158, DOI 10.1016/S0952-7915(03)00012-8; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1983, NATURE, V306, P270, DOI 10.1038/306270a0; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Honczarenko M, 1999, BLOOD, V94, P2990, DOI 10.1182/blood.V94.9.2990.421k36_2990_2998; Honczarenko M, 2002, BLOOD, V100, P2321, DOI 10.1182/blood-2002-01-0248; JACOBSEN K, 1990, EUR J IMMUNOL, V20, P2395, DOI 10.1002/eji.1830201106; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Kapur R, 2001, BLOOD, V97, P1975, DOI 10.1182/blood.V97.7.1975; Kobayashi T, 2006, NAT IMMUNOL, V7, P123, DOI 10.1038/ni0206-123; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lane WJ, 2000, BLOOD, V96, P4152; Le Y, 2005, J IMMUNOL, V174, P2582, DOI 10.4049/jimmunol.174.5.2582; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; OSMOND DG, 1992, BLOOD, V79, P1695; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Palmesino E, 2006, IMMUNOBIOLOGY, V211, P377, DOI 10.1016/j.imbio.2005.12.003; Paolini R, 2001, P NATL ACAD SCI USA, V98, P9611, DOI 10.1073/pnas.161298098; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Pello OM, 2006, BLOOD, V108, P3928, DOI 10.1182/blood-2006-02-006353; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sandel PC, 2001, J IMMUNOL, V166, P5935, DOI 10.4049/jimmunol.166.10.5935; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Takahira H, 1997, BLOOD, V89, P1574, DOI 10.1182/blood.V89.5.1574.1574_1574_1584; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zanin-Zhorov A, 2005, J IMMUNOL, V175, P276, DOI 10.4049/jimmunol.175.1.276	56	45	47	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	2007	27	5					811	823		10.1016/j.immuni.2007.09.011	http://dx.doi.org/10.1016/j.immuni.2007.09.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031698	Bronze			2022-12-18	WOS:000251269000014
J	Long, EO				Long, Eric O.			Ready for prime time: NK cell priming by dendritic cells	IMMUNITY			English	Editorial Material							NATURAL-KILLER-CELLS; MHC CLASS-I; TOLERANCE; RESPONSES; SELF	Natural killer (NK) cells were long thought to respond directly to infected cells and tumor cells. In this issue of Immunity, Lucas et al. (2007) repeal this view by showing that NK cells acquire functionality through priming by dendritic cells.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Long, EO (corresponding author), NIAID, Immunogenet Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	elong@nih.gov	Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000842] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006	10	45	50	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					385	387		10.1016/j.immuni.2007.04.001	http://dx.doi.org/10.1016/j.immuni.2007.04.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17459805	Bronze			2022-12-18	WOS:000246126400002
J	Alugupalli, KR; Gerstein, RM				Alugupalli, KR; Gerstein, RM			Divide and conquer: Division of labor by B-1B cells	IMMUNITY			English	Editorial Material							SPLENIC MARGINAL ZONE; B-CELLS; LYMPHOCYTES	Capsular polysaccharides enhance bacterial virulence. In this issue of Immunity, Haas et al. (2005) demonstrate a division of labor between the B-1 B cell subsets: natural antibodies from B-1a cells limit infection by Streptococcus pneumoniae, whereas B-1b cells generate the anticapsule-induced response that prevents fatal infection.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Alugupalli, KR (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, 55 Lake Ave N, Worcester, MA 01605 USA.							Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Carsetti R, 2005, J ALLERGY CLIN IMMUN, V115, P412, DOI 10.1016/j.jaci.2004.10.048; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Kantor AB, 1997, J IMMUNOL, V158, P1175; Knoops L, 2004, J IMMUNOL, V172, P6101, DOI 10.4049/jimmunol.172.10.6101; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Peltola H, 2004, EUR J PEDIATR, V163, P509, DOI 10.1007/s00431-004-1430-0; Vos Q, 2000, IMMUNOL REV, V176, P154; Zandvoort A, 2001, TISSUE ANTIGENS, V58, P234, DOI 10.1034/j.1399-0039.2001.580403.x	11	45	45	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					1	2		10.1016/j.immuni.2005.07.001	http://dx.doi.org/10.1016/j.immuni.2005.07.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039572	Bronze			2022-12-18	WOS:000231024800001
J	Wang, YH; Liu, YJ				Wang, YH; Liu, YJ			Mysterious origin of plasmacytoid dendritic cell precursors	IMMUNITY			English	Editorial Material							MOUSE; ICSBP; GENERATION	The origin of plasmacytoid dendritic cell precursors (pDC) has been controversial. This manuscript shows that CLP and CMP both can give rise to pDCs. pDCs derived from CMP express RAG gene products and show lgHD-J rearrangement, suggesting that pDC represent a unique lineage whose gene expression program shows substantial plasticity.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wang, YH (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.							Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Comeau MR, 2002, J IMMUNOL, V169, P75, DOI 10.4049/jimmunol.169.1.75; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; DARMICO A, 2003, J EXP MED, V198, P293; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131	17	45	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					1	2		10.1016/j.immuni.2004.07.003	http://dx.doi.org/10.1016/j.immuni.2004.07.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345213	Bronze			2022-12-18	WOS:000222975500001
J	Shaw, AS				Shaw, AS			FERMing up the synapse	IMMUNITY			English	Article							T-CELL ACTIVATION; ANTIGEN; MOTILITY; POLARITY	The immunological synapse is characterized by the reorganization of membrane proteins at the immunological synapse. Active cytoskeletal mechanisms are involved in recruiting the TCR, accessory molecules, and the integrin LFA-1 to the contact area. Other molecules like CD43 are excluded from the contact area, but the mechanism of exclusion is unknown. Three papers in this issue of Immunity demonstrate that CD43 exclusion involves the ERM family of cytoskeletal proteins.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.			Shaw, Andrey/0000-0001-5685-0272				Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; MCINTYRE JA, 1976, J IMMUNOL, V116, P1582; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Sperling AI, 1998, J IMMUNOL, V161, P6459; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	20	45	45	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					683	686		10.1016/S1074-7613(01)00237-0	http://dx.doi.org/10.1016/S1074-7613(01)00237-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728330	Bronze			2022-12-18	WOS:000172528200001
J	Torres, RM; Hafen, K				Torres, RM; Hafen, K			A negative regulatory role for Ig-alpha during B cell development	IMMUNITY			English	Article							ANTIGEN-RECEPTOR COMPLEX; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAINS; ALLELIC EXCLUSION; ACTIVATION MOTIF; CLONAL SELECTION; TYROSINE KINASE; LYMPHOCYTES-B; BETA; ANTIBODY	The development of B cells requires the expression of an antigen receptor at distinct points during maturation. The Ig-alpha/beta heterodimer signals for these receptors, and mice harboring a truncation of the Ig-alpha intracellular domain (mb-1(Delta c/Delta c)) have severely reduced peripheral B cell numbers. Here we report that immature mb-1(Delta c/Delta c) B cells are activated despite tacking a critical Ig-alpha-positive signaling motif. As a consequence of abnormal activation, transitional immature IgM(high)IgD(low) B cells are largely absent in mb-1(Delta c/Delta c) mutants, accounting for the paucity of mature B cells. Thus, Ig-alpha cytoplasmic tail truncation yields an antigen receptor complex on immature B cells that signals constitutively. These data illustrate a role for Ig-alpha in negatively regulating antigen receptor signaling during B cell development.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Torres, RM (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.							ALLMAN DM, 1993, J IMMUNOL, V151, P4431; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; CAMBIER JC, 1993, IMMUNOL REV, V132, P85, DOI 10.1111/j.1600-065X.1993.tb00838.x; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Cassard S, 1998, J IMMUNOL, V160, P1767; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; Clements JL, 1999, J CLIN INVEST, V103, P925, DOI 10.1172/JCI6562; CYSTER JG, 1995, IMMUNITY, V2, P1; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; FRIEDRICH RJ, 1993, J IMMUNOL, V150, P2814; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LAW DA, 1993, CURR BIOL, V3, P645, DOI 10.1016/0960-9822(93)90062-S; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; Luisiri P, 1996, J BIOL CHEM, V271, P5158; Maas A, 1999, J IMMUNOL, V162, P6526; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pao LI, 1998, J IMMUNOL, V160, P3305; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; TADDIE JA, 1994, J BIOL CHEM, V269, P13529; Teh YM, 1997, J EXP MED, V185, P1753, DOI 10.1084/jem.185.10.1753; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474	44	45	46	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					527	536		10.1016/S1074-7613(00)80128-4	http://dx.doi.org/10.1016/S1074-7613(00)80128-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591178	Bronze			2022-12-18	WOS:000083952200005
J	Lercher, A; Bhattacharya, A; Popa, AM; Caldera, M; Schlapansky, MF; Baazim, H; Agerer, B; Gurtl, B; Kosack, L; Majek, P; Brunner, JS; Vitko, D; Pinter, T; Genger, JW; Orlova, A; Pikor, N; Reil, D; Ozsvar-Kozma, M; Kalinke, U; Ludewig, B; Moriggl, R; Bennett, KL; Menche, J; Cheng, PN; Schabbauer, G; Trauner, M; Klavins, K; Bergthaler, A				Lercher, Alexander; Bhattacharya, Anannya; Popa, Alexandra M.; Caldera, Michael; Schlapansky, Moritz F.; Baazim, Hatoon; Agerer, Benedikt; Guertl, Bettina; Kosack, Lindsay; Majek, Peter; Brunner, Julia S.; Vitko, Dijana; Pinter, Theresa; Genger, Jakob-Wendelin; Orlova, Anna; Pikor, Natalia; Reil, Daniela; Ozsvar-Kozma, Maria; Kalinke, Ulrich; Ludewig, Burkhard; Moriggl, Richard; Bennett, Keiryn L.; Menche, Joerg; Cheng, Paul N.; Schabbauer, Gernot; Trauner, Michael; Klavins, Kristaps; Bergthaler, Andreas			Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ARGININOSUCCINATE SYNTHETASE; VIVO PROLIFERATION; SAMPLE PREPARATION; LIVER; INFLAMMATION; HEPATOCYTES; VITRO; HOMEOSTASIS; ACTIVATION	Infections induce complex host responses linked to antiviral defense, inflammation, and tissue damage and repair. We hypothesized that the liver, as a central metabolic hub, may orchestrate systemic metabolic changes during infection. We infected mice with chronic lymphocytic choriomeningitis virus (LCMV), performed RNA sequencing and proteomics of liver tissue, and integrated these data with serum metabolomics at different infection phases. Widespread reprogramming of liver metabolism occurred early after infection, correlating with type I interferon (IFN-I) responses. Viral infection induced metabolic alterations of the liver that depended on the interferon alpha/beta receptor (IFNAR1). Hepatocyte-intrinsic IFNAR1 repressed the transcription of metabolic genes, including Otc and Ass1, which encode urea cycle enzymes. This led to decreased arginine and increased ornithine concentrations in the circulation, resulting in suppressed virus-specific CD8(+) T cell responses and ameliorated liver pathology. These findings establish IFN-I-induced modulation of hepatic metabolism and the urea cycle as an endogenous mechanism of immunoregulation.	[Lercher, Alexander; Bhattacharya, Anannya; Popa, Alexandra M.; Caldera, Michael; Schlapansky, Moritz F.; Baazim, Hatoon; Agerer, Benedikt; Guertl, Bettina; Kosack, Lindsay; Majek, Peter; Vitko, Dijana; Pinter, Theresa; Genger, Jakob-Wendelin; Reil, Daniela; Ozsvar-Kozma, Maria; Bennett, Keiryn L.; Menche, Joerg; Klavins, Kristaps; Bergthaler, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14 AKH BT25.3, A-1090 Vienna, Austria; [Brunner, Julia S.; Schabbauer, Gernot; Trauner, Michael] Med Univ Vienna, Dept Thrombosis Res & Vasc Biol, A-1090 Vienna, Austria; [Brunner, Julia S.; Schabbauer, Gernot] Christian Doppler Lab Arginine Metab Rheumatoid A, A-1090 Vienna, Austria; [Vitko, Dijana] Harvard Med Sch, Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Pinter, Theresa] Vienna BioCtr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Orlova, Anna] Univ Vet Med Vienna, Inst Anim Breeding & Genet, A-1210 Vienna, Austria; [Pikor, Natalia; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Ozsvar-Kozma, Maria] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Kalinke, Ulrich] Helmholtz Ctr Infect Res, TWINCORE, Inst Expt Infect Res, Ctr Expt & Clin Infect Res,Helmholtz Ctr, D-30625 Braunschweig, Germany; [Moriggl, Richard] Med Univ Vienna, A-1090 Vienna, Austria; [Cheng, Paul N.] Biocanc Treatment Int Ltd, Hong Kong, Peoples R China; [Trauner, Michael] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol Hepatol, A-1090 Vienna, Austria; [Bhattacharya, Anannya] Merck Res Labs, 33 Ave Louis Pasteur, Boston, MA 02115 USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Harvard University; Boston Children's Hospital; Harvard Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Veterinary Medicine Vienna; Kantonsspital St. Gallen; Medical University of Vienna; Helmholtz Association; Helmholtz-Center for Infection Research; Medical University of Vienna; Medical University of Vienna; Merck & Company	Bergthaler, A (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14 AKH BT25.3, A-1090 Vienna, Austria.	abergthaler@cemm.oeaw.ac.at	Klavins, Kristaps/AAJ-1644-2020; Caldera, Michael/AAG-5808-2019; Bhattacharya, Anannya/J-4555-2019; Menche, Jörg/G-3994-2015; Bergthaler, Andreas/ABG-5047-2020; Menche, Jörg/AAB-7008-2021	Klavins, Kristaps/0000-0001-9577-9990; Caldera, Michael/0000-0003-3218-6324; Menche, Jörg/0000-0002-1583-6404; Bergthaler, Andreas/0000-0003-0597-1976; Menche, Jörg/0000-0002-1583-6404; Bhattacharya, Anannya/0000-0001-6385-4028; Orlova, Anna/0000-0001-9262-7529; Lercher, Alexander/0000-0003-3478-5304; Moriggl, Richard/0000-0003-0918-9463; Trauner, Michael/0000-0002-1275-6425; Pikor, Natalia/0000-0002-6564-4232; Popa, Alexandra Mariela/0000-0001-7156-272X; /0000-0003-4243-4950; Agerer, Benedikt/0000-0002-0044-8396	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [677006]; Austrian Academy of Sciences; Ambizione grant - Swiss National Science Foundation [PZ00P3_180011/1]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Austrian Academy of Sciences; Ambizione grant - Swiss National Science Foundation	We want to thank Sarah Niggemeyer, Jenny Riede, Sabine Jungwirth, Nicole Fleischmann, and Patricia Schittenhelm for animal caretaking; Safia Zahma for histopathology and immunohistochemistry processing; Thomas Penz, Michael Schuster, Martin Senekowitsch, Daniele Barreca, and Christoph Bock from the Biomedical Sequencing Facility at CeMM; Katja Parapatics from the Proteomics Facility at CeMM; Jacques Colinge for initial data analyses; and Christoph J. Binder from CeMM and Medical University of Vienna and Roger Geiger from the Institute for Research in Biomedicine, Bellinzona, for support and feedback. The following reagents were obtained through the NIH Tetramer Core Facility: LCMV MHCI tetramers GP33 (in Phycoerythrin [PE]) and NP396 (in Allophycocyanin [APC]). This project was funded with support of the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 677006, "CMIL" to A. Bergthaler). A.L., A. Bhattacharya, and J.S.B. were supported by aDOC fellowship of the Austrian Academy of Sciences. N.P. was supported by an Ambizione grant awarded by the Swiss National Science Foundation (PZ00P3_180011/1).	Adams DH, 2006, AM J PATHOL, V168, P1057, DOI 10.2353/ajpath.2006.051296; Ah Mew N, 2003, GENEREVIEWS; [Anonymous], LIVER IMMUNOLOGY; Baazim H, 2019, NAT IMMUNOL, V20, P701, DOI 10.1038/s41590-019-0397-y; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breitwieser FP, 2013, J PROTEOMICS, V90, P77, DOI 10.1016/j.jprot.2013.02.022; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Cheng PNM, 2007, CANCER RES, V67, P309, DOI 10.1158/0008-5472.CAN-06-1945; Crispe IN, 2016, J IMMUNOL, V196, P17, DOI 10.4049/jimmunol.1501668; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; De Santo C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0612-6; Diez-Fernandez C, 2016, J MED GENET, V53, P710, DOI 10.1136/jmedgenet-2016-103937; Dumas ME, 2014, GASTROENTEROLOGY, V146, P46, DOI 10.1053/j.gastro.2013.11.001; Feun LG, 2012, BRIT J CANCER, V106, P1481, DOI 10.1038/bjc.2012.106; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Guidotti LG, 1999, J EXP MED, V189, P1555, DOI 10.1084/jem.189.10.1555; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kosack L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10637-y; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lam TL, 2011, PIGM CELL MELANOMA R, V24, P366, DOI 10.1111/j.1755-148X.2010.00798.x; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee JS, 2018, CELL, V174, P1559, DOI 10.1016/j.cell.2018.07.019; Li H, 2011, J PROTEOME RES, V10, P2797, DOI 10.1021/pr200047c; Li L, 2019, NATURE, V567, P253, DOI 10.1038/s41586-019-0996-7; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Metzger D, 2004, METH MOL B, V289, P329; Miyajima M, 2017, NAT IMMUNOL, V18, P1342, DOI 10.1038/ni.3867; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pallett LJ, 2015, NAT MED, V21, P591, DOI 10.1038/nm.3856; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Poillet-Perez L, 2018, NATURE, V563, P569, DOI 10.1038/s41586-018-0697-7; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sanchez KK, 2018, CELL, V175, P146, DOI 10.1016/j.cell.2018.07.016; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; St John-Williams L, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.140; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; STURMAN LS, 1972, INFECT IMMUN, V6, P501, DOI 10.1128/IAI.6.4.501-507.1972; Tranah TH, 2013, METAB BRAIN DIS, V28, P1, DOI 10.1007/s11011-012-9370-2; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van de Velde LA, 2016, J BIOL CHEM, V291, P25815, DOI 10.1074/jbc.C116.763623; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Watford M, 2003, BIOCHEM MOL BIOL EDU, V31, P289, DOI 10.1002/bmb.2003.494031050249; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zehn D, 2015, ADV EXP MED BIOL, V850, P137, DOI 10.1007/978-3-319-15774-0_10; Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	89	44	44	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1074	+		10.1016/j.immuni.2019.10.014	http://dx.doi.org/10.1016/j.immuni.2019.10.014			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31784108	Green Published, hybrid			2022-12-18	WOS:000503162900013
J	Montecino-Rodriguez, E; Fice, M; Casero, D; Berent-Maoz, B; Barber, CL; Dorshkind, K				Montecino-Rodriguez, Encarnacion; Fice, Michael; Casero, David; Berent-Maoz, Beata; Barber, Chad L.; Dorshkind, Kenneth			Distinct Genetic Networks Orchestrate the Emergence of Specific Waves of Fetal and Adult B-1 and B-2 Development	IMMUNITY			English	Article							B-CELL-DEVELOPMENT; HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR PU.1; INTERLEUKIN-7 RECEPTOR-ALPHA; CIS-REGULATORY ELEMENTS; BONE-MARROW; PROGENITOR CELLS; LYMPHOID PROGENITORS; LINEAGE COMMITMENT; YOLK-SAC	B cell development is often depicted as a linear process initiating in the fetus and continuing postnatally. Using a PU.1 hypomorphic mouse model, we found that B-1 and B-2 lymphopoiesis occurred in distinct fetal and adult waves differentially dependent on the Sfpi1 14 kB upstream regulatory element. The initial wave of fetal B-1 development was absent in PU.1 hypomorphic mice, while subsequent fetal and adult waves emerged. In contrast, B-2 lymphopoiesis occurred in distinct fetal and adult waves. Whole-transcriptome profiling of fetal and adult B cell progenitors supported the existence of three waves of B-1 and two waves of B-2 development and revealed that the network of transcription factors governing B lineage specification and commitment was highly divergent between B-1 and B-2 progenitors. These findings support the view that the B-1 and B-2 lineages are distinct and provide a genetic basis for layering of immune system development.	[Montecino-Rodriguez, Encarnacion; Fice, Michael; Casero, David; Dorshkind, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Berent-Maoz, Beata] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Barber, Chad L.] Calif Lutheran Univ, Dept Biol, Thousand Oaks, CA 91360 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Lutheran University	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu	Casero, David/E-7365-2010	Casero, David/0000-0002-7347-3330; Fice, Michael/0000-0002-6406-1211; Montecino Rodriguez, Encarnacion/0000-0002-2826-7503	NIH grant [AI021256, CA16042, AI28697]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021256, R37AI021256, P30AI028697] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI021256 (K.D.). The Jonsson Comprehensive Cancer Center flow core is supported by NIH grants CA16042 and AI28697.	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Barber CL, 2011, P NATL ACAD SCI USA, V108, P13700, DOI 10.1073/pnas.1107172108; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berent-Maoz B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125414; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Choukrallah MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00156; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Dakic A, 2007, TRENDS IMMUNOL, V28, P108, DOI 10.1016/j.it.2007.01.006; de Andres B., 2002, BLOOD, V100, P4074; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Esplin BL, 2009, P NATL ACAD SCI USA, V106, P5773, DOI 10.1073/pnas.0811632106; Ghosn EEB, 2012, P NATL ACAD SCI USA, V109, P5394, DOI 10.1073/pnas.1121632109; Ghosn EEB, 2011, P NATL ACAD SCI USA, V108, P2879, DOI 10.1073/pnas.1019764108; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Holodick NE, 2014, J IMMUNOL, V192, P2432, DOI 10.4049/jimmunol.1300247; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jensen CT, 2008, BLOOD, V112, P2297, DOI 10.1182/blood-2008-04-150508; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; Kearney JF, 2005, SPRINGER SEMIN IMMUN, V26, P377, DOI 10.1007/s00281-004-0184-0; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; Kobayashi M, 2014, P NATL ACAD SCI USA, V111, P12151, DOI 10.1073/pnas.1407370111; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Manning J, 2013, ANTIOXID REDOX SIGN, V19, P2054, DOI 10.1089/ars.2012.4988; Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2014, J IMMUNOL, V192, P5171, DOI 10.4049/jimmunol.1303170; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Rothenberg EV, 2002, IMMUNOL REV, V187, P96, DOI 10.1034/j.1600-065X.2002.18709.x; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Turro E, 2014, BIOINFORMATICS, V30, P180, DOI 10.1093/bioinformatics/btt624; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Wei N, 2014, DEV COMP IMMUNOL, V44, P315, DOI 10.1016/j.dci.2014.01.015; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10	58	44	44	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					527	539		10.1016/j.immuni.2016.07.012	http://dx.doi.org/10.1016/j.immuni.2016.07.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27566938	Green Accepted, Bronze			2022-12-18	WOS:000388454300011
J	Ross, SH; Rollings, C; Anderson, KE; Hawkins, PT; Stephens, LR; Cantrell, DA				Ross, Sarah H.; Rollings, Christina; Anderson, Karen E.; Hawkins, Phillip T.; Stephens, Len R.; Cantrell, Doreen A.			Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8(+) T Cells	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; IL-2 RECEPTOR; QUANTITATIVE PHOSPHOPROTEOMICS; FAMILY PROTEIN; PHOSPHORYLATION; PATHWAY; SRC; ANTIGEN; ACTIVATION; MECHANISMS	Interleukin-2 (IL-2) is a fundamental cytokine that controls proliferation and differentiation of T cells. Here, we used high-resolution mass spectrometry to generate a comprehensive and detailed map of IL-2 protein phosphorylations in cytotoxic T cells (CTL). The data revealed that Janus kinases (JAKs) couple IL-2 receptors to the coordinated phosphorylation of transcription factors, regulators of chromatin, mRNA translation, GTPases, vesicle trafficking, and the actin and microtubule cytoskeleton. We identified an IL-2-JAK-independent SRC family Tyr-kinase-controlled signaling network that regulates similar to 10% of the CTL phosphoproteome, the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), and the activity of the serine/threonine kinase AKT. These data reveal a signaling framework wherein IL-2-JAK-controlled pathways coordinate with IL-2-independent networks of kinase activity and provide a resource toward the further understanding of the networks of protein phosphorylation that program CTL fate.	[Ross, Sarah H.; Rollings, Christina; Cantrell, Doreen A.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland; [Anderson, Karen E.; Hawkins, Phillip T.; Stephens, Len R.] Babraham Inst, Inositide Lab, Babraham Res Campus, Cambridge CB22 3AT, England	University of Dundee; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Cantrell, DA (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland.	d.a.cantrell@dundee.ac.uk		Ross, Sarah/0000-0001-7302-6875; Hawkins, Phillip/0000-0002-6979-0464; Anderson, Karen/0000-0002-7394-6660; stephens, len/0000-0002-2771-3487	Wellcome Trust (Principal Research Fellowship) [097418/Z/11/Z]; Tenovus Scotland; Biotechnology and Biological Sciences Research Council (BBSRC) and GlaxoSmithKline; BBSRC [BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1252752, BBS/E/B/000C0415] Funding Source: researchfish	Wellcome Trust (Principal Research Fellowship)(Wellcome Trust); Tenovus Scotland; Biotechnology and Biological Sciences Research Council (BBSRC) and GlaxoSmithKline; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge members of the Cantrell group for critical data discussion. We thank the Biological Resources unit, flow cytometry (A. Whigham and R. Clarke) and Proteomics (D. Lamont and team) at the University of Dundee. We thank D. Bensaddek, A. Lamond, R. Gourlay, and M. Trost for assistance with phosphoproteomic protocols. Work was supported by the Wellcome Trust (Principal Research Fellowship 097418/Z/11/Z to D.A.C.) and Tenovus Scotland (S.H.R.). C.R. is the recipient of a studentship from the Biotechnology and Biological Sciences Research Council (BBSRC) and GlaxoSmithKline.	Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003; Arneja A, 2014, J IMMUNOL, V192, P123, DOI 10.4049/jimmunol.1302291; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Chamorro M, 2001, BMC Immunol, V2, P3, DOI 10.1186/1471-2172-2-3; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; Clark DE, 2005, J BIOL CHEM, V280, P24175, DOI 10.1074/jbc.M414044200; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; deAos I, 1997, J BIOL CHEM, V272, P25310, DOI 10.1074/jbc.272.40.25310; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Giansanti P, 2015, CELL REP, V11, P1834, DOI 10.1016/j.celrep.2015.05.029; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996; Hukelmann JL, 2016, NAT IMMUNOL, V17, P104, DOI 10.1038/ni.3314; John S, 1996, EMBO J, V15, P5627, DOI 10.1002/j.1460-2075.1996.tb00947.x; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; KOBAYASHI N, 1993, P NATL ACAD SCI USA, V90, P4201, DOI 10.1073/pnas.90.9.4201; Lee S, 2014, P NATL ACAD SCI USA, V111, pE4315, DOI 10.1073/pnas.1320477111; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Maksumova L, 2005, J IMMUNOL, V175, P7947, DOI 10.4049/jimmunol.175.12.7947; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; Navarro MN, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005477; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Osinalde N, 2015, PROTEOMICS, V15, P520, DOI 10.1002/pmic.201400194; Osinalde N, 2011, J PROTEOMICS, V75, P177, DOI 10.1016/j.jprot.2011.06.007; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Safari F, 2011, P NATL ACAD SCI USA, V108, P14938, DOI 10.1073/pnas.1107740108; Smith GA, 2016, NAT CHEM BIOL, V12, P373, DOI [10.1038/NCHEMBIO.2056, 10.1038/nchembio.2056]; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; TANAKA M, 1995, J BIOCHEM-TOKYO, V117, P554, DOI 10.1093/oxfordjournals.jbchem.a124743; Titz B, 2010, ONCOGENE, V29, P5895, DOI 10.1038/onc.2010.331; Vindis C, 2004, J BIOL CHEM, V279, P27965, DOI 10.1074/jbc.M401295200; Zhang ZS, 2003, J BIOL CHEM, V278, P4668, DOI 10.1074/jbc.M210028200; Zhou YJ, 2000, MOL CELL BIOL, V20, P4371, DOI 10.1128/MCB.20.12.4371-4380.2000	57	44	45	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					685	700		10.1016/j.immuni.2016.07.022	http://dx.doi.org/10.1016/j.immuni.2016.07.022			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27566939	hybrid, Green Published			2022-12-18	WOS:000388454300022
J	Chang, X; Liu, F; Wang, XF; Lin, AP; Zhao, HY; Su, B				Chang, Xing; Liu, Fang; Wang, Xiaofang; Lin, Aiping; Zhao, Hongyu; Su, Bing			The Kinases MEKK2 and MEKK3 Regulate Transforming Growth Factor-beta-Mediated Helper T Cell Differentiation	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR; TGF-BETA; SMAD3; PHOSPHORYLATION; ACTIVATION; PATHWAYS; MICE; JNK; IDENTIFICATION; GENERATION	Mitogen-activated protein kinases (MAPKs) are key mediators of the T cell receptor (TCR) signals but their roles in T helper (Th) cell differentiation are unclear. Here we showed that the MAPK kinase kinases MEKK2 (encoded by Map3k2) and MEKK3 (encoded by Map3k3) negatively regulated transforming growth factor-beta(TGF-beta)-mediated Th cell differentiation. Map3k2(-/-)Map3k3(Lck-Cre/-) mice showed an abnormal accumulation of regulatory T (Treg) and Th17 cells in the periphery, consistent with Map3k2(-/-)Map3k3(Lck-Cre/-) naive CD4(+) T cells' differentiation into Treg and Th17 cells with a higher frequency than wild-type (WT) cells after TGF-beta stimulation in vitro. In addition, Map3k2(-/-)Map3k3(Lck-Cre/-) mice developed more severe experimental autoimmune encephalomyelitis. Map3k2(-/-)Map3k3(Lck-Cre/-) T cells exhibited impaired phosphorylation of SMAD2 and SMAD3 proteins at their linker regions, which negatively regulated the TGF-beta responses in T cells. Thus, the crosstalk between TCR-induced MAPK and the TGF-beta signaling pathways is important in regulating Th cell differentiation.	[Chang, Xing; Wang, Xiaofang; Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Chang, Xing; Wang, Xiaofang; Su, Bing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06519 USA; [Lin, Aiping; Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06519 USA; [Liu, Fang] Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA; [Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Yale University; Yale University; Yale University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Su, B (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06519 USA.	bing.su@yale.edu	wang, xiaofang/A-9967-2015	wang, xiaofang/0000-0002-2911-0161; Chang, Xing/0000-0002-5072-9225	NIH [AI063348, HL070225]; Yale University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044016, R01AI063348] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Flavell, J. Pober, J. Craft, M.S. Kluger, and A. Lazorchak for critical reading of the manuscript and for their many insightful suggestions during the course of this work, Y. Zhuang and P. Zhang for targeting vector construction and generation of targeted mice, M.O. Li for sharing the unpublished cDNA array data, W. Ouyang for initial involvement in the characterization of Map3k2<SUP>-/-</SUP>Map3k3<SUP>Lck-Cre/-</SUP> mice, N. Ruddle and C. Bergman for help with the EAE study, and D. Liu, A. Lazorchak, and other members in B.S. laboratory for helpful suggestions and technical helps. This work is supported in part by grant AI063348 and HL070225 (NIH) (to B.S.). X.C. is a recipient of Gershon and Trudeau Fellowship from Yale University.	Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Gorham JD, 1998, J IMMUNOL, V161, P1664; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Kim K, 2007, IMMUNOLOGY, V120, P242, DOI 10.1111/j.1365-2567.2006.02495.x; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Shinohara H, 2009, INT IMMUNOL, V21, P393, DOI 10.1093/intimm/dxp007; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang XF, 2009, J IMMUNOL, V182, P3597, DOI 10.4049/jimmunol.0803738; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	47	44	48	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					201	212		10.1016/j.immuni.2011.01.017	http://dx.doi.org/10.1016/j.immuni.2011.01.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21333552	Green Accepted, Bronze			2022-12-18	WOS:000287989500010
J	Mora, JR; von Andrian, UH				Mora, JR; von Andrian, UH			Retinoic acid: An educational "vitamin elixir" for gut-seeking T cells	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; TISSUE; EXPRESSION; MIGRATION	T cell priming by dendritic cells (DC) from gut-associated lymphoid tissues gives rise to effector cells with pronounced gut tropism. The mechanism for DC-dependent imprinting of gut specificity has remained unknown. New findings point to retinoic acid, which is uniquely produced by intestinal DC, but not by DC from other lymphoid organs (Iwata et al., 2004; this issue of Immunity).	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Mora, JR (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.		von Andrian, Ulrich H/A-5775-2008					Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Carramolino L, 2001, BLOOD, V97, P850, DOI 10.1182/blood.V97.4.850; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kuenzli S, 2001, Curr Opin Investig Drugs, V2, P625; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407	10	44	46	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2004	21	4					458	460		10.1016/j.immuni.2004.10.002	http://dx.doi.org/10.1016/j.immuni.2004.10.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485623	Bronze			2022-12-18	WOS:000224744400002
J	Hughes, EA; Galan, JE				Hughes, EA; Galan, JE			Immune response to Salmonella: Location, location, location?	IMMUNITY			English	Review							IFN-GAMMA; ORAL CHALLENGE; T-CELLS; TYPHIMURIUM INFECTION; VIRULENT SALMONELLAE; BACTERIAL CLEARANCE; ACQUIRED-RESISTANCE; INTERFERON-GAMMA; PEYERS-PATCHES; MICE	Successful immunity against Salmonella infections is dependent on the generation of CD4(+) T helper cells and to a lesser extent on antibody production and CD8(+) T cells. The cells within the lymphatic tissue of the gut are likely to be central for the orchestration of a proper and rapid response. The anatomical restriction of the pathogen may also determine the distribution of effector cells. In this issue of Immunity, McSorley et al. address both of these processes using identifiable CD4 T cells that are specific for Salmonella typhimurium. Such cells localize to the Peyer's patches of the small intestine when the bacteria are delivered orally.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.							Adams P, 2001, PROTEOMICS, V1, P597, DOI 10.1002/1615-9861(200104)1:4<597::AID-PROT597>3.3.CO;2-G; Eichelberg K, 2000, INFECT IMMUN, V68, P2735, DOI 10.1128/IAI.68.5.2735-2743.2000; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan J.E., 1996, ESCHERICHIA COLI SAL, P2757; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; George A, 1996, INFECT IMMUN, V64, P4606, DOI 10.1128/IAI.64.11.4606-4611.1996; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Hess J, 1996, J IMMUNOL, V156, P3321; Huleatt JW, 2001, J IMMUNOL, V166, P4065, DOI 10.4049/jimmunol.166.6.4065; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Lalmanach AC, 1999, MICROBES INFECT, V1, P719, DOI 10.1016/S1286-4579(99)80073-2; Mahan MJ, 2000, ANNU REV GENET, V34, P139, DOI 10.1146/annurev.genet.34.1.139; Makela PH, 1997, HOST RESPONSE INTRAC, P143; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; MATSUMURA H, 1990, INT J IMMUNOPHARMACO, V12, P49, DOI 10.1016/0192-0561(90)90067-W; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; OBRIEN AD, 1979, INFECT IMMUN, V25, P513, DOI 10.1128/IAI.25.2.513-520.1979; OBRIEN AD, 1980, NATURE, V287, P440, DOI 10.1038/287440a0; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; Pie S, 1997, INFECT IMMUN, V65, P4509, DOI 10.1128/IAI.65.11.4509-4514.1997; RAMARATHINAM L, 1991, MICROB PATHOGENESIS, V11, P347, DOI 10.1016/0882-4010(91)90020-B; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; TAKEUCHI A, 1967, AM J PATHOL, V50, P109; THATTE J, 1993, INT IMMUNOL, V5, P1431, DOI 10.1093/intimm/5.11.1431; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Yrlid U, 2001, MICROBES INFECT, V3, P1239, DOI 10.1016/S1286-4579(01)01484-8	31	44	46	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2002	16	3					325	328		10.1016/S1074-7613(02)00293-5	http://dx.doi.org/10.1016/S1074-7613(02)00293-5			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911817	Bronze			2022-12-18	WOS:000174572800001
J	Lee, DS; Ahn, C; Ernst, B; Sprent, J; Surh, CD				Lee, DS; Ahn, C; Ernst, B; Sprent, J; Surh, CD			Thymic selection by a single MHC/peptide ligand: Autoreactive T cells are low-affinity cells	IMMUNITY			English	Article							VERSUS-HOST-DISEASE; SKIN ALLOGRAFT-REJECTION; POSITIVE SELECTION; SUPRALETHAL IRRADIATION; ANTIGEN PRESENTATION; TRANSGENIC MICE; SELF-PEPTIDES; FAS-LIGAND; REPERTOIRE; GRAFT	In H2-M- mice, the presence of a single peptide, CLIP, bound to MHC class II molecules generates a diverse repertoire of CD4(+) cells. In these mice, typical self-peptides are not bound to class II molecules, with the result that a very high proportion of H2-M- CD4(+) cells are responsive to the various peptides displayed on normal MHC-compatible APC. We show here, however, that such "self" reactivity is controlled by low-affinity CD4(+) cells. These cells give spectacularly high proliferative responses but are virtually unreactive in certain other assays, e.g., skin graft rejection; responses to MHC alloantigens, by contrast, are intense in all assays. Possible explanations for why thymic selection directed to a single peptide curtails self specificity without affecting alloreactivity are discussed.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Seoul Natl Univ, Med Res Ctr, Seoul 110744, South Korea	Scripps Research Institute; Seoul National University (SNU)	Surh, CD (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Lee, Dong-Sup/J-2777-2012; Ahn, Curie/J-5527-2012		NCI NIH HHS [CA38355] Funding Source: Medline; NIAID NIH HHS [AI41079, AI38385] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA038355, R01CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038385, R01AI041079] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baker MB, 1997, P NATL ACAD SCI USA, V94, P1366, DOI 10.1073/pnas.94.4.1366; Benoist C, 1997, CURR OPIN IMMUNOL, V9, P245, DOI 10.1016/S0952-7915(97)80143-4; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Bevan MJ, 1997, IMMUNITY, V7, P175, DOI 10.1016/S1074-7613(00)80520-8; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Braun MY, 1996, J EXP MED, V183, P657, DOI 10.1084/jem.183.2.657; ELIE R, 1976, CELL IMMUNOL, V21, P31, DOI 10.1016/0008-8749(76)90324-5; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hattori K, 1998, BLOOD, V91, P4051, DOI 10.1182/blood.V91.11.4051.411k16_4051_4055; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KOSAKA H, 1993, J EXP MED, V177, P367, DOI 10.1084/jem.177.2.367; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mishell B.B., 1980, SELECTED METHODS CEL; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; ROSENBERG AS, 1987, J EXP MED, V165, P1296, DOI 10.1084/jem.165.5.1296; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; ROSENBERG AS, 1989, J IMMUNOL, V143, P2452; ROSENBERG AS, 1990, J IMMUNOL, V144, P4648; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SIMONSEN M, 1962, PROG ALLERGY, V6, P349, DOI 10.1159/000313805; SPRENT J, 1990, J IMMUNOL, V144, P2946; SPRENT J, 1994, J EXP MED, V180, P307, DOI 10.1084/jem.180.1.307; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Teraki Y, 1997, J IMMUNOL, V159, P6018; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Waldmann H, 1998, ANNU REV IMMUNOL, V16, P619, DOI 10.1146/annurev.immunol.16.1.619; WIDERA G, 1987, CELL, V51, P175, DOI 10.1016/0092-8674(87)90145-0	38	44	44	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1999	10	1					83	92		10.1016/S1074-7613(00)80009-6	http://dx.doi.org/10.1016/S1074-7613(00)80009-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023773	Bronze			2022-12-18	WOS:000078428700009
J	Duncan, DD; Adlam, M; Siu, G				Duncan, DD; Adlam, M; Siu, G			Asymmetric redundancy in CD4 silencer function	IMMUNITY			English	Article							SODIUM-CHANNEL GENE; T-CELL DEVELOPMENT; TRANSGENIC MICE; ANTIGEN RECEPTOR; MHC CLASS; EXPRESSION; ENHANCER; ELEMENTS; LINEAGE; PROTEIN	We and others have defined a transcriptional silencer critical for the proper expression of the CD4 gene at all stages of T cell development. In this report, we use biochemical techniques to identify three different factor-binding sites within the CD4 silencer, denoted sites I, II, and III. Using transgenic analyses, we determine that although all three factor-binding sites are important for silencer activity, there is significant redundancy in that the presence of either site II alone, or the combination of sites I and III permits silencer function. Thus, our data indicate that the mechanism of function of the CD4 silencer is extremely complex. Further biochemical analyses indicate that the factor binding to site II has the same sequence specificity as a factor binding to an E box site in the CD4 enhancer; thus, a member of the bHLH factor family may be important in mediating silencer function.			Duncan, DD (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT MICROBIOL, 701 W 168TH ST, NEW YORK, NY 10032 USA.							ARTANDI SE, 1994, MOL CELL BIOL, V14, P7704, DOI 10.1128/MCB.14.12.7704; BANIAHMAD A, 1987, EMBO J, V6, P2297, DOI 10.1002/j.1460-2075.1987.tb02504.x; BENOIST C, 1994, CURR BIOL, V4, P821, DOI 10.1016/S0960-9822(00)00182-2; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; CHAMBERLAIN JW, 1988, P NATL ACAD SCI USA, V85, P7690, DOI 10.1073/pnas.85.20.7690; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DUNCAN DD, 1995, MOL CELL BIOL, V15, P3179; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hogan B., 1986, MANIPULATING MOUSE E; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; KRUISBEEK AM, 1985, J EXP MED, V161, P1029, DOI 10.1084/jem.161.5.1029; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LITTMAN DR, 1987, ANNU REV IMMUNOL, V5, P561, DOI 10.1146/annurev.iy.05.040187.003021; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; PERLMUTTER RM, 1989, BIOCHIM BIOPHYS ACTA, V948, P245, DOI 10.1016/0304-419X(89)90001-2; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SHORE D, 1995, TELOMERES, P139; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SIU G, 1992, MOL CELL BIOL, V12, P1592, DOI 10.1128/MCB.12.4.1592; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WATERMAN M L, 1990, New Biologist, V2, P621; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; WURSTER AL, 1994, MOL CELL BIOL, V14, P6452, DOI 10.1128/MCB.14.10.6452	46	44	44	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1996	4	3					301	311		10.1016/S1074-7613(00)80438-0	http://dx.doi.org/10.1016/S1074-7613(00)80438-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624820	Bronze			2022-12-18	WOS:A1996UC01800011
J	Ferreira, DP; Silva, JG; Wyss, T; Marraco, SAF; Scarpellino, L; Charmoy, M; Maas, R; Siddiqui, I; Tang, L; Joyce, JA; Delorenzi, M; Luther, SA; Speiser, DE; Held, W				Ferreira, Daniela Pais; Silva, Joana Gomes; Wyss, Tania; Marraco, Silvia A. Fuertes; Scarpellino, Leonardo; Charmoy, Melanie; Maas, Roeltje; Siddiqui, Imran; Tang, Li; Joyce, Johanna A.; Delorenzi, Mauro; Luther, Sanjiv A.; Speiser, Daniel E.; Held, Werner			Central memory CD8(+) T cells derive from stem-like Tcf7(hi) effector cells in the absence of cytotoxic differentiation	IMMUNITY			English	Article							CHROMATIN ACCESSIBILITY; INFLAMMATORY CYTOKINES; EPIGENETIC CONTROL; QUALITY-CONTROL; EXPRESSION; PATHWAY; SET; REPRESSION; GENERATION; PRECURSOR	Central memory CD8(+) T cells (Tcm) control systemic secondary infections and can protect from chronic infection and cancer as a result of their stem-cell-like capacity to expand, differentiate, and self-renew. Central memory is generally thought to emerge following pathogen clearance and to form based on the de-differentiation of cytolytic effector cells. Here, we uncovered rare effector-phase CD8(+) T cells expressing high amounts of the transcription factor Tcf7 (Tcf1) that showed no evidence of prior cytolytic differentiation and that displayed key hallmarks of Tcm cells. These effector-phase Tcf7(hi) cells quantitatively yielded Tcm cells based on lineage tracing. Mechanistically, Tcf1 counteracted the differentiation of Tcf7(hi) cells and sustained the expression of conserved adult stem-cell genes that were critical for CD8(+) T cell stemness. The discovery of stem-cell-like CD8(+) T cells during the effector response to acute infection provides an opportunity to optimize Tcm cell formation by vaccination.	[Ferreira, Daniela Pais; Silva, Joana Gomes; Marraco, Silvia A. Fuertes; Charmoy, Melanie; Maas, Roeltje; Siddiqui, Imran; Joyce, Johanna A.; Delorenzi, Mauro; Speiser, Daniel E.; Held, Werner] Univ Lausanne, Dept Oncol, CH-1066 Epalinges, Switzerland; [Wyss, Tania; Delorenzi, Mauro] SIB Swiss Inst Bioinformat, Bioinformat Core Facil, CH-1015 Lausanne, Switzerland; [Scarpellino, Leonardo; Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Maas, Roeltje; Joyce, Johanna A.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Maas, Roeltje] CHU Vaudois, Neurosci Res Ctr, Dept Neurosci, Lausanne, Switzerland; [Tang, Li] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Held, W (corresponding author), Univ Lausanne, Dept Oncol, CH-1066 Epalinges, Switzerland.	werner.held@unil.ch	Luther, Sanjiv/AAP-6525-2020	Luther, Sanjiv/0000-0002-8758-957X; Pais Ferreira, Daniela/0000-0003-2277-5563; Silva, Joana/0000-0003-2318-3893; Siddiqui, Imran/0000-0002-6792-8730; Tang, Li/0000-0002-6393-982X; Maas, Roeltje/0000-0002-1040-6560	Swiss National Science Foundation (SNSF) [310030B_179570]; Swiss Cancer League (SCL) [KFS-4407-02-2018]; SCL [KFS-3390-08-2016, KFS-4600-08-2018, KFS-3971-08-2016]; Breast Cancer Research Foundation; SNSF [310030_179459, 31003A-166161]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Cancer League (SCL); SCL; Breast Cancer Research Foundation; SNSF(Swiss National Science Foundation (SNSF))	This research was supported in part by grants from the Swiss National Science Foundation (SNSF) (310030B_179570) and the Swiss Cancer League (SCL) (KFS-4407-02-2018) to W.H., a Swiss Bridge Award from the SCL (KFS-3390-08-2016) and the Breast Cancer Research Foundation to J.A.J., a grant from the SCL (KFS-4600-08-2018) to L.T., grants from the SCL (KFS-3971-08-2016) and the SNSF (310030_179459) to D.E.S. and S.A.F.M., and a grant from the SNSF (31003A-166161) to S.A.L.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Boudousquie C, 2014, J IMMUNOL, V193, P2784, DOI 10.4049/jimmunol.1400465; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; DILLON SR, 1994, J IMMUNOL, V152, P1790; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gullicksrud JA, 2017, J IMMUNOL, V199, P911, DOI 10.4049/jimmunol.1700595; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kakaradov B, 2017, NAT IMMUNOL, V18, P422, DOI 10.1038/ni.3688; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Ladle BH, 2016, P NATL ACAD SCI USA, V113, P10631, DOI 10.1073/pnas.1524490113; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Pace L, 2018, SCIENCE, V359, P177, DOI 10.1126/science.aah6499; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tiemessen MM, 2014, J IMMUNOL, V193, P5480, DOI 10.4049/jimmunol.1303417; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	68	43	43	7	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					985	+		10.1016/j.immuni.2020.09.005	http://dx.doi.org/10.1016/j.immuni.2020.09.005			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33128876	Green Published, Bronze			2022-12-18	WOS:000599348200011
J	Weulersse, M; Asrir, A; Pichler, AC; Lemaitre, L; Braun, M; Carrie, N; Joubert, MV; Le Moine, M; Do Souto, L; Gaud, G; Das, I; Brauns, E; Scarlata, CM; Morandi, E; Sundarrajan, A; Cuisinier, M; Buisson, L; Maheo, S; Kassem, S; Agesta, A; Peres, M; Verhoeyen, E; Martinez, A; Mazieres, J; Dupre, L; Gossye, T; Pancaldi, V; Guillerey, C; Ayyoub, M; Dejean, AS; Saoudi, A; Goriely, S; Avet-Loiseau, H; Bald, T; Smyth, MJ; Martinet, L				Weulersse, Marianne; Asrir, Assia; Pichler, Andrea C.; Lemaitre, Lea; Braun, Matthias; Carrie, Nadege; Joubert, Marie-Veronique; Le Moine, Marie; Do Souto, Laura; Gaud, Guillaume; Das, Indrajit; Brauns, Elisa; Scarlata, Clara M.; Morandi, Elena; Sundarrajan, Ashmitha; Cuisinier, Marine; Buisson, Laure; Maheo, Sabrina; Kassem, Sahar; Agesta, Arantxa; Peres, Michael; Verhoeyen, Els; Martinez, Alejandra; Mazieres, Julien; Dupre, Loic; Gossye, Thomas; Pancaldi, Vera; Guillerey, Camille; Ayyoub, Maha; Dejean, Anne S.; Saoudi, Abdelhadi; Goriely, Stanislas; Avet-Loiseau, Herve; Bald, Tobias; Smyth, Mark J.; Martinet, Ludovic			Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8(+) T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy	IMMUNITY			English	Article							LIPID RAFT RECRUITMENT; MOLECULAR-MECHANISMS; NEGATIVE SELECTION; MULTIPLE-MYELOMA; PD-1 BLOCKADE; DNAM-1 CD226; TUMOR-GROWTH; CHECKPOINT; THERAPY; LFA-1	CD8(+) T cells within the tumor microenvironment (TME) are exposed to various signals that ultimately determine functional outcomes. Here, we examined the role of the co-activating receptor CD226 (DNAM-1) in CD8(+) T cell function. The absence of CD226 expression identified a subset of dysfunctional CD8(+) T cells present in peripheral blood of healthy individuals. These cells exhibited reduced LFA-1 activation, altered TCR signaling, and a distinct transcriptomic program upon stimulation. CD226(neg) CD8(+) T cells accumulated in human and mouse tumors of diverse origin through an antigen-specific mechanism involving the transcriptional regulator Eomesodermin (Eomes). Despite similar expression of co-inhibitory receptors, CD8(+) tumor-infiltrating lymphocyte failed to respond to anti-PD-1 in the absence of CD226. Immune checkpoint blockade efficacy was hampered in Cd226(-/-) mice. Anti-CD137 (4-1 BB) agonists also stimulated Eomes-dependent CD226 loss that limited the anti-tumor efficacy of this treatment. Thus, CD226 loss restrains CD8(+) T cell function and limits the efficacy of cancer immunotherapy.	[Weulersse, Marianne; Asrir, Assia; Pichler, Andrea C.; Lemaitre, Lea; Carrie, Nadege; Joubert, Marie-Veronique; Do Souto, Laura; Scarlata, Clara M.; Cuisinier, Marine; Buisson, Laure; Maheo, Sabrina; Kassem, Sahar; Peres, Michael; Martinez, Alejandra; Mazieres, Julien; Gossye, Thomas; Pancaldi, Vera; Ayyoub, Maha; Avet-Loiseau, Herve; Martinet, Ludovic] Univ Paul Sabatier, CNRS, INSERM, CRCT,UMR1037, Toulouse, France; [Braun, Matthias; Das, Indrajit; Sundarrajan, Ashmitha; Guillerey, Camille; Bald, Tobias; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Joubert, Marie-Veronique; Do Souto, Laura; Scarlata, Clara M.; Cuisinier, Marine; Buisson, Laure; Maheo, Sabrina; Peres, Michael; Martinez, Alejandra; Mazieres, Julien; Ayyoub, Maha; Avet-Loiseau, Herve; Martinet, Ludovic] CHU Toulouse, Inst Univ Canc, Toulouse, France; [Le Moine, Marie; Brauns, Elisa; Goriely, Stanislas] Univ Libre Bruxelles, Inst Med Immunol, Ctr Res Immunol, UCR 1, B-6041 Gosselies, Belgium; [Gaud, Guillaume; Morandi, Elena; Agesta, Arantxa; Dupre, Loic; Dejean, Anne S.; Saoudi, Abdelhadi] UPS, CNRS, INSERM, CPTP,UMR 1043,UMR 5282, Toulouse, France; [Verhoeyen, Els] Univ Cote Azur, INSERM, C3M, Nice, France; [Verhoeyen, Els] Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, INSERM, CIRI,U1111,CNRS,UMR5308, Lyon, France; [Dupre, Loic] Ludwig Boltzmann Inst Rare & Undiagnosed Dis LBI, Vienna, Austria; [Pancaldi, Vera] Barcelona Supercomp Ctr, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; QIMR Berghofer Medical Research Institute; CHU de Toulouse; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Martinet, L (corresponding author), Univ Paul Sabatier, CNRS, INSERM, CRCT,UMR1037, Toulouse, France.; Martinet, L (corresponding author), CHU Toulouse, Inst Univ Canc, Toulouse, France.	ludovic.martinet@inserm.fr	asrir, Assia/GWC-6514-2022; Pancaldi, Vera/I-2555-2015; Peres, Michaël/AAP-2399-2021; Martinet, ludovic/O-9693-2014; Verhoeyen, Els/AAW-4853-2021; dupre, loic/L-8174-2014; MAZIERES, JULIEN/M-3986-2014; Morandi, Elena/AAF-8466-2021; Martinez, Alejandra/A-4097-2015; Ayyoub, Maha/A-2074-2017; Scarlata, Clara Maria/A-2397-2017; peres, michael/P-1219-2014; Guillerey, Camille/N-1061-2014; Abdelhadi, SAOUDI/K-6719-2014	Pancaldi, Vera/0000-0002-7433-624X; Martinet, ludovic/0000-0002-0867-7724; Verhoeyen, Els/0000-0001-9224-5491; dupre, loic/0000-0002-7278-6503; Martinez, Alejandra/0000-0002-7633-3536; Ayyoub, Maha/0000-0003-2022-0898; Scarlata, Clara Maria/0000-0003-3429-2825; peres, michael/0000-0001-8827-1347; Lemaitre, Lea/0000-0003-1940-1018; Morandi, Elena/0000-0002-8222-1514; Agesta, Arantxa/0000-0002-0441-4687; Guillerey, Camille/0000-0002-7917-2432; Dejean, Anne S./0000-0002-8846-1113; Abdelhadi, SAOUDI/0000-0001-7015-8178	Fondation ARC [PGA1-20160203788, 20180206911, 20190208630]; Institut National du Cancer (INCA) [PLBIO R16100BB, 2017-155]; Cancer Research Institute/Bristol-Myers Squibb CLIP Grant; Fondation Toulouse cancer sante; Ligue contre le cancer; European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Fondation Recherche Medicale [FRM DEQ20170336727]; "Dr. Mildred Scheel Stiftung fuer Krebsforschung'' of the "Deutsche Krebshilfe"; EMBO [ALT945-2015]; National Health and Medical Research Council of Australia grant (NHMRC) [1124690]; NHMRC [1078671, 1173958, 1132519]; Cancer Council of Queensland Project Grant [1157048]; "Fonds National de la Recherche Scientifique'' (FRS-FNRS, Belgium); European Regional Development Fund (ERDF) of the Walloon Region (Wallonia-Biomed portfolio) [411132-957270]; IUCT-O translational research program	Fondation ARC; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Cancer Research Institute/Bristol-Myers Squibb CLIP Grant; Fondation Toulouse cancer sante; Ligue contre le cancer(Ligue nationale contre le cancer); European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Fondation Recherche Medicale; "Dr. Mildred Scheel Stiftung fuer Krebsforschung'' of the "Deutsche Krebshilfe"; EMBO(European Molecular Biology Organization (EMBO)); National Health and Medical Research Council of Australia grant (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland Project Grant; "Fonds National de la Recherche Scientifique'' (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); European Regional Development Fund (ERDF) of the Walloon Region (Wallonia-Biomed portfolio); IUCT-O translational research program	We are grateful to our healthcare professionals during the COVID-19 crisis. We thank M. Tosolini, L. Ligat, L. Town, B. Quine, N. Rufer, C. Colacios, C. Costa, D. Negre, G. Froment, B. Couderc, the pole technologique du CRCT, and the lentivector production facility/SFR BioSciences Lyon. L.M. was supported by the Fondation ARC (PGA1-20160203788, 20180206911, and 20190208630), by the Institut National du Cancer (INCA; PLBIO R16100BB and 2017-155), a Cancer Research Institute/Bristol-Myers Squibb CLIP Grant, and the Fondation Toulouse cancer sante and IUCT-O translational research program. M.W. and A.C.P. were supported by la Ligue contre le cancer. A.S., A.S.D and E.M. were supported by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Fondation Recherche Medicale (FRM DEQ20170336727). M.B. was supported by the "Dr. Mildred Scheel Stiftung fuer Krebsforschung'' of the "Deutsche Krebshilfe.'' T.B. was supported by EMBO (ALT945-2015) and a National Health and Medical Research Council of Australia grant (NH & MRC; 1124690). M.J.S. was supported by NH&MRC (1078671, 1173958, and 1132519) and Cancer Council of Queensland Project Grant (1157048). S.G., M.L.M., and E.B. were supported by "Fonds National de la Recherche Scientifique'' (FRS-FNRS, Belgium) and the European Regional Development Fund (ERDF) of the Walloon Region (Wallonia-Biomed portfolio, 411132-957270). The results shown here are in part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga	Attal M, 2017, NEW ENGL J MED, V376, P1311, DOI 10.1056/NEJMoa1611750; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Bertrand F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02358-7; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Blake SJ, 2016, CLIN CANCER RES, V22, P5183, DOI 10.1158/1078-0432.CCR-16-0933; Blake SJ, 2016, CANCER DISCOV, V6, P446, DOI 10.1158/2159-8290.CD-15-0944; Chan CJ, 2014, CELL DEATH DIFFER, V21, P5, DOI 10.1038/cdd.2013.26; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Chester C, 2018, BLOOD, V131, P49, DOI 10.1182/blood-2017-06-741041; Comrie WA, 2015, J CELL BIOL, V208, P475, DOI 10.1083/jcb.201406121; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; Danisch S, 2013, IMMUNOBIOLOGY, V218, P152, DOI 10.1016/j.imbio.2012.02.010; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Effern M, 2020, IMMUNITY, V53, P564, DOI 10.1016/j.immuni.2020.07.007; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Gaud G, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar3083; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Girard-Gagnepain A, 2014, BLOOD, V124, P1221, DOI 10.1182/blood-2014-02-558163; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Guillerey C, 2018, BLOOD, V132, P1689, DOI 10.1182/blood-2018-01-825265; Guillerey C, 2015, J CLIN INVEST, V125, P2077, DOI 10.1172/JCI77181; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Istaces N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11233-6; Jin HS, 2020, CANCER IMMUNOL RES, V8, P912, DOI 10.1158/2326-6066.CIR-19-0877; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kamran N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054406; Koyama M, 2013, BLOOD, V121, P3511, DOI 10.1182/blood-2012-07-444026; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lee SH, 2012, MBIO, V3, DOI 10.1128/mBio.00411-12; Levy C, 2017, BLOOD ADV, V1, P2088, DOI 10.1182/bloodadvances.2017007773; Li J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02981; Li XY, 2018, J CLIN INVEST, V128, P2613, DOI 10.1172/JCI98769; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozano E, 2013, J IMMUNOL, V191, P3673, DOI 10.4049/jimmunol.1300945; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Maiti AK, 2010, RHEUMATOLOGY, V49, P1239, DOI 10.1093/rheumatology/kep470; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Nakamura K, 2018, CANCER CELL, V33, P634, DOI 10.1016/j.ccell.2018.02.007; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Petit AE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12242; PORGADOR A, 1989, J IMMUNOGENET, V16, P291; Qiu Q, 2010, J IMMUNOL, V184, P1681, DOI 10.4049/jimmunol.0900062; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2019, CANCER CELL, V36, P579, DOI 10.1016/j.ccell.2019.11.005; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Schoenfeld AJ, 2020, CANCER CELL, V37, P443, DOI 10.1016/j.ccell.2020.03.017; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Shirakawa J, 2005, INT IMMUNOL, V17, P217, DOI 10.1093/intimm/dxh199; Shirakawa J, 2006, INT IMMUNOL, V18, P951, DOI 10.1093/intimm/dxl031; Song GG, 2012, LUPUS, V21, P1522, DOI 10.1177/0961203312458840; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Varet H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157022; von Scheidt B, 2014, CANCER RES, V74, P2412, DOI 10.1158/0008-5472.CAN-13-1646; Wang B, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7061; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Zhang ZG, 2015, J EXP MED, V212, P2165, DOI 10.1084/jem.20150792; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749; Zhu YW, 2016, J EXP MED, V213, P167, DOI 10.1084/jem.20150785; Zumwalde NA, 2013, J IMMUNOL, V191, P3681, DOI 10.4049/jimmunol.1201954	79	43	45	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					824	+		10.1016/j.immuni.2020.09.006	http://dx.doi.org/10.1016/j.immuni.2020.09.006			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053331	Green Submitted, Bronze			2022-12-18	WOS:000581062800014
J	Li, WT; Qiu, SZ; Chen, J; Jiang, ST; Chen, WD; Jiang, JW; Wang, F; Si, W; Shu, YL; Wei, P; Fan, GF; Tian, RJ; Wu, HT; Xu, CQ; Wang, HP				Li, Wentao; Qiu, Shizhen; Chen, Jian; Jiang, Shutan; Chen, Wendong; Jiang, Jingwei; Wang, Fei; Si, Wen; Shu, Yilai; Wei, Ping; Fan, Gaofeng; Tian, Ruijun; Wu, Haitao; Xu, Chenqi; Wang, Haopeng			Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy	IMMUNITY			English	Article							T-CELL MEMORY; SPARE RESPIRATORY CAPACITY; OXIDATIVE STRESS; C-CBL; CAR; COSTIMULATION; LYMPHOCYTES; EXPRESSION; IMMUNOTHERAPY; THERAPY	Clinical evidence suggests that poor persistence of chimeric antigen receptor-T cells (CAR-T) in patients limits therapeutic efficacy. Here, we designed a CAR with recyclable capability to promote in vivo persistence and to sustain antitumor activity. We showed that the engagement of tumor antigens induced rapid ubiquitination of CARs, causing CAR downmodulation followed by lysosomal degradation. Blocking CAR ubiquitination by mutating all lysines in the CAR cytoplasmic domain (CAR(KR)) markedly repressed CAR downmodulation by inhibiting lysosomal degradation while enhancing recycling of internalized CARs back to the cell surface. Upon encountering tumor antigens, CAR(KR)-T cells ameliorated the loss of surface CARs, which promoted their long-term killing capacity. Moreover, CAR(KR)-T cells containing 4-1BB signaling domains displayed elevated endosomal 4-1BB signaling that enhanced oxidative phosphorylation and promoted memory T cell differentiation, leading to superior persistence in vivo. Collectively, our study provides a straightforward strategy to optimize CAR-T antitumor efficacy by redirecting CAR trafficking.	[Li, Wentao; Qiu, Shizhen; Jiang, Jingwei; Wang, Fei; Fan, Gaofeng; Wang, Haopeng] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Li, Wentao; Jiang, Shutan; Jiang, Jingwei; Wang, Fei; Xu, Chenqi] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Li, Wentao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Chen, Jian; Shu, Yilai; Wu, Haitao] Fudan Univ, Eye & ENT Hosp, ENT Inst & Dept Otorhinolaryngol, Shanghai 200031, Peoples R China; [Chen, Wendong; Tian, Ruijun] Southern Univ Sci & Technol, Dept Chem, Shenzhen 518055, Peoples R China; [Si, Wen; Wei, Ping] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol & Peking Tsinghua Joint Ctr Li, Beijing 100871, Peoples R China; [Xu, Chenqi] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Hangzhou 310024, Peoples R China	ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Southern University of Science & Technology; Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, HP (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Xu, CQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.; Wu, HT (corresponding author), Fudan Univ, Eye & ENT Hosp, ENT Inst & Dept Otorhinolaryngol, Shanghai 200031, Peoples R China.; Xu, CQ (corresponding author), Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Hangzhou 310024, Peoples R China.	eentwuhaitao@163.com; cqxu@sibcb.ac.cn; wanghp@shanghaitech.edu.cn	; Fan, Gaofeng/H-2996-2013	Chen, Jian/0000-0002-0578-9675; Shu, Yilai/0000-0001-8893-434X; Jiang, Jingwei/0000-0001-6618-6993; Wang, Haopeng/0000-0002-4995-0838; Wei, Ping/0000-0002-1275-7145; Fan, Gaofeng/0000-0002-6729-2867	National Key R&D Program of China, China [2019YFA0111000]; National Natural Science Foundation of China, China [31670919, 31530022, 31861133009, 31621003]; Science and Technology Commission of Shanghai Municipality of China, China [17411962000]; Health and Family Planning Commission of Shanghai Municipality of China, China [2019SY059]; Fountain-Valley Life Sciences Fund from Chinese Academy of Sciences, China;  [XDB29000000];  [QYZDB-SSW-SMC048]	National Key R&D Program of China, China; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality of China, China; Health and Family Planning Commission of Shanghai Municipality of China, China; Fountain-Valley Life Sciences Fund from Chinese Academy of Sciences, China; ; 	We are grateful for advice from A. Weiss (UCSF), T. Chi, Z. Lin (ShanghaiTech), and B.B. Au-Yeung (Emory). We thank the staff members of the Animal Facility at the National Facility for Protein Science in Shanghai, Zhangjiang Lab for providing the support in mouse housing and care, and the staff members of the FACS, Mass Spectrometry and Image Facility of ShanghaiTech for technical supports. This work was supported by 2019YFA0111000 from National Key R&D Program of China, China (H. Wang); 31670919 (H. Wang), 31530022 (C.X.), 31861133009 (C.X.), and 31621003 (C.X.) from National Natural Science Foundation of China, China; 17411962000 from Science and Technology Commission of Shanghai Municipality of China, China (H. Wu); 2019SY059 from Health and Family Planning Commission of Shanghai Municipality of China, China (H. Wu). C.X. is also funded by XDB29000000, QYZDBSSW-SMC048, and Fountain-Valley Life Sciences Fund from Chinese Academy of Sciences, China.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Bakker J, 2017, J CELL SCI, V130, P4087, DOI 10.1242/jcs.209197; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Caruso HG, 2015, CANCER RES, V75, P3505, DOI 10.1158/0008-5472.CAN-15-0139; Choi BK, 2017, CELL MOL IMMUNOL, V14, P748, DOI 10.1038/cmi.2016.02; Compeer EB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04088-w; Davenport AJ, 2015, CANCER IMMUNOL RES, V3, P483, DOI 10.1158/2326-6066.CIR-15-0048; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Foster JB, 2019, MOL THER, V27, P747, DOI 10.1016/j.ymthe.2019.01.018; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Guedan S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96976; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Hamieh M, 2019, NATURE, V568, P112, DOI 10.1038/s41586-019-1054-1; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Jensen MC, 2010, BIOL BLOOD MARROW TR, V16, P1245, DOI 10.1016/j.bbmt.2010.03.014; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kim DK, 2009, EUR J IMMUNOL, V39, P2617, DOI 10.1002/eji.200939292; Klammt C, 2015, NAT IMMUNOL, V16, P961, DOI 10.1038/ni.3231; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Lamers C.H.J., 2006, J CLIN ONCOL, V24, pe20, DOI [DOI 10.1200/JCO.2006.05.9964, 10.1200/JCO.2006.05.9964]; Lamers CHJ, 2005, HUM GENE THER, V16, P1452, DOI 10.1089/hum.2005.16.1452; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Li GB, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121322; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Martinez-Forero I, 2013, J IMMUNOL, V190, P6694, DOI 10.4049/jimmunol.1203010; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Menk AV, 2018, J EXP MED, V215, P1091, DOI 10.1084/jem.20171068; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nicholson IC, 1997, MOL IMMUNOL, V34, P1157, DOI 10.1016/S0161-5890(97)00144-2; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Rossig C, 2001, INT J CANCER, V94, P228, DOI 10.1002/ijc.1457; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Schmidts A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02593; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Sun C, 2020, CANCER CELL, V37, P216, DOI 10.1016/j.ccell.2019.12.014; Teijeira A, 2018, CANCER IMMUNOL RES, V6, P798, DOI 10.1158/2326-6066.CIR-17-0767; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Walker AJ, 2017, MOL THER, V25, P2189, DOI 10.1016/j.ymthe.2017.06.008; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Watanabe K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02486; Watts TH, 2011, ADV EXP MED BIOL, V691, P177, DOI 10.1007/978-1-4419-6612-4_19; Wortzman ME, 2013, IMMUNOL REV, V255, P125, DOI 10.1111/imr.12086; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052; Zapata JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02618; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	65	43	45	5	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					456	+		10.1016/j.immuni.2020.07.011	http://dx.doi.org/10.1016/j.immuni.2020.07.011			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32758419	Bronze			2022-12-18	WOS:000561190600021
J	Liu, ZH; Wang, CP; Yang, J; Chen, YH; Zhou, BW; Abbott, DW; Xiao, TS				Liu, Zhonghua; Wang, Chuanping; Yang, Jie; Chen, Yinghua; Zhou, Bowen; Abbott, Derek W.; Xiao, Tsan Sam			Caspase-1 Engages Full-Length Gasdermin D through Two Distinct Interfaces That Mediate Caspase Recruitment and Substrate Cleavage	IMMUNITY			English	Article							CRYSTAL-STRUCTURE; PROTEIN STRUCTURES; PYROPTOSIS; GSDMD; ACTIVATION; MECHANISM; INHIBITION; EXOSITE; PORE; INFLAMMATION	The recognition and cleavage of gasdermin D (GSDMD) by inflammatory caspases-1, 4, 5, and 11 are essential steps in initiating pyroptosis after inflammasome activation. Previous work has identified cleavage site signatures in substrates such as GSDMD, but it is unclear whether these are the sole determinants for caspase engagement. Here we report the crystal structure of a complex between human caspase-1 and the fulllength murine GSDMD. In addition to engagement of the GSDMD N- and C-domain linker by the caspase-1 active site, an anti-parallel beta sheet at the caspase-1 L2 and L2' loops bound a hydrophobic pocket within the GSDMD C-terminal domain distal to its N-terminal domain. This "exosite" interface endows an additional function for the GSDMD C-terminal domain as a caspase-recruitment module besides its role in autoinhibition. Our study thus reveals dual-interface engagement of GSDMD by caspase-1, which may be applicable to other physiological substrates of caspases.	[Liu, Zhonghua; Wang, Chuanping; Yang, Jie; Zhou, Bowen; Abbott, Derek W.; Xiao, Tsan Sam] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Yang, Jie] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Yang, Jie] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd,TRY 21, La Jolla, CA 92037 USA; [Chen, Yinghua] Case Western Reserve Univ, Dept Physiol & Biophys, Prot Express Purificat Crystallizat & Mol Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Scripps Research Institute; Case Western Reserve University	Xiao, TS (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	tsx@case.edu		Zhou, Bowen/0000-0003-4421-9787; YANG, JIE/0000-0001-6662-4236	American Association of Immunologists; NIH [R01GM127609, T32AI089474, P01DK091222, R01GM086550]; National Institute of General Medical Sciences from the NIH [P30 GM124165]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]	American Association of Immunologists; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences from the NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE))	Z.L. is supported by a Careers in Immunology postdoctoral fellowship from the American Association of Immunologists. B.Z. is supported by NIH grant T32AI089474, D.W.A. is supported by NIH grants P01DK091222 and R01GM086550, and T.S.X. is supported by NIH grant R01GM127609. We would like to thank the Xiao, Abbott, Dubyak, Ramakrishnan, and Adoro laboratories for insightful discussions. X-ray diffraction data were collected at the Advanced Photon Source (APS) NE-CAT (24-ID) beamline funded by the National Institute of General Medical Sciences from the NIH (P30 GM124165) and GM/CA-CAT (23-ID) beamline funded in whole or in part by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the APS, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Clark AC, 2016, CHEM REV, V116, P6666, DOI 10.1021/acs.chemrev.5b00540; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez DJ, 2015, BIOL CHEM, V396, P193, DOI 10.1515/hsz-2014-0253; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Fulcher YG, 2011, BIOCHEMISTRY-US, V50, P9488, DOI 10.1021/bi2009807; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Jabaiah AM, 2012, BIOL CHEM, V393, P933, DOI 10.1515/hsz-2012-0162; Julien O, 2017, CELL DEATH DIFFER, V24, P1380, DOI 10.1038/cdd.2017.44; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Liu Z, 2018, STRUCTURE, V26, P778, DOI 10.1016/j.str.2018.03.002; Lu M, 2006, CHEM BIOL, V13, P117, DOI 10.1016/j.chembiol.2005.12.007; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Rathkey JK, 2020, J BIOL CHEM, V295, P3228, DOI 10.1074/jbc.RA119.010604; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Roschitzki-Voser H, 2012, PROTEIN EXPRES PURIF, V84, P236, DOI 10.1016/j.pep.2012.05.009; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115	48	43	46	5	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					106	+		10.1016/j.immuni.2020.06.007	http://dx.doi.org/10.1016/j.immuni.2020.06.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32553275	Green Accepted, Bronze			2022-12-18	WOS:000551116800013
J	Karagiannis, F; Masouleh, SK; Wunderling, K; Surendar, J; Schmitt, V; Kazakov, A; Michla, M; Holzel, M; Thiele, C; Wilhelm, C				Karagiannis, Fotios; Masouleh, Schekufe Kharabi; Wunderling, Klaus; Surendar, Jayagopi; Schmitt, Vanessa; Kazakov, Alexander; Michla, Marcel; Hoelzel, Michael; Thiele, Christoph; Wilhelm, Christoph			Lipid-Droplet Formation Drives Pathogenic Group 2 Innate Lymphoid Cells in Airway Inflammation	IMMUNITY			English	Article							MAMMALIAN TARGET; METABOLISM; PROTECTS; ASTHMA; BIOGENESIS; ACTIVATION; MECHANISMS; INDUCTION; DISEASE; ALLERGY	Innate lymphoid cells (ILCs) play an important role in the control and maintenance of barrier immunity. However, chronic activation of ILCs results in immune-mediated pathology. Here, we show that tissue-resident type 2 ILCs (ILC2s) display a distinct metabolic signature upon chronic activation. In the context of allergen-driven airway inflammation, ILC2s increase their uptake of both external lipids and glucose. Externally acquired fatty acids are transiently stored in lipid droplets and converted into phospholipids to promote the proliferation of ILC2s. This metabolic program is imprinted by interleukin-33 (IL-33) and regulated by the genes Pparg and Dgat1, which are both controlled by glucose availability and mTOR signaling. Restricting dietary glucose by feeding mice a ketogenic diet largely ablated ILC2-mediated airway inflammation by impairing fatty acid metabolism and the formation of lipid droplets. Together, these results reveal that pathogenic ILC2 responses require lipid metabolism and identify ketogenic diet as a potent intervention strategy to treat airway inflammation.	[Karagiannis, Fotios; Masouleh, Schekufe Kharabi; Surendar, Jayagopi; Schmitt, Vanessa; Kazakov, Alexander; Michla, Marcel; Wilhelm, Christoph] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Immunopathol Unit,Med Fac, D-53127 Bonn, Germany; [Hoelzel, Michael] Univ Bonn, Inst Expt Oncol, Med Fac, D-53127 Bonn, Germany; [Wunderling, Klaus; Thiele, Christoph] Univ Bonn, Life & Med Sci Inst LIMES, D-53115 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Wilhelm, C (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Immunopathol Unit,Med Fac, D-53127 Bonn, Germany.	christoph.wilhelm@uni-bonn.de	Wilhelm, Christoph/ABE-7176-2020	Wilhelm, Christoph/0000-0002-9839-0291	Ministry for Science and Education of North-Rhine-Westphalia; Human Frontiers Science Program (HFSP); Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany's Excellence Strategy [EXC2151-390873048, SPP1937]	Ministry for Science and Education of North-Rhine-Westphalia; Human Frontiers Science Program (HFSP)(Human Frontier Science Program); Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG))	This work was supported by the Ministry for Science and Education of North-Rhine-Westphalia and the Human Frontiers Science Program (HFSP). C.W., C.T., and M.H. were further supported by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany's Excellence Strategy (EXC2151-390873048 and SPP1937; C.W.). We thank Dr. Richard Locksley providing Red5 mice and Dr. Andrew McKenzie for Il1r1<SUP>-/-</SUP> mice; the animal facility staff for animal care at the UKB (HET); staff from the UKB flow core facility; Andreas Dolf, Peter Wurst, and Maximilian Germer for expert cell sorting; and the UKB Imaging Core Facility. We thank Drs. Meghan Campbell, Bernardo Franklin, and Florian Schmidt; the Wilhelm lab; and Emma Bawden for critical discussions regarding the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Angela M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13683; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; Benador IY, 2018, CELL METAB, V27, P869, DOI 10.1016/j.cmet.2018.03.003; Bendixen AC, 2001, P NATL ACAD SCI USA, V98, P2443, DOI 10.1073/pnas.041493198; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chitraju C, 2017, CELL METAB, V26, P407, DOI 10.1016/j.cmet.2017.07.012; Everaere L, 2016, J ALLERGY CLIN IMMUN, V138, P1309, DOI 10.1016/j.jaci.2016.03.019; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Futatsugi K, 2015, J MED CHEM, V58, P7173, DOI 10.1021/acs.jmedchem.5b01006; Gaebler A, 2016, J LIPID RES, V57, P1934, DOI 10.1194/jlr.D070565; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Herms A, 2013, CURR BIOL, V23, P1489, DOI 10.1016/j.cub.2013.06.032; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Iturralde M, 2003, BBA-MOL CELL BIOL L, V1634, P40, DOI 10.1016/j.bbalip.2003.08.005; Kassan A, 2013, J CELL BIOL, V203, P985, DOI 10.1083/jcb.201305142; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; King AJ, 2010, EUR J PHARMACOL, V637, P155, DOI 10.1016/j.ejphar.2010.03.056; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Marcelin G, 2010, CURR OPIN PHARMACOL, V10, P588, DOI 10.1016/j.coph.2010.05.008; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Neal EG, 2009, EPILEPSIA, V50, P1109, DOI 10.1111/j.1528-1167.2008.01870.x; Nguyen TB, 2017, DEV CELL, V42, P9, DOI 10.1016/j.devcel.2017.06.003; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pelgrom LR, 2017, EUR J IMMUNOL, V47, P1266, DOI 10.1002/eji.201646728; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Salmond RJ, 2012, J ALLERGY CLIN IMMUN, V130, P1159, DOI 10.1016/j.jaci.2012.05.018; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Thiele C, 2019, NAT METHODS, V16, P1123, DOI 10.1038/s41592-019-0593-6; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Yamaguchi M, 2018, MUCOSAL IMMUNOL, V11, P615, DOI 10.1038/mi.2017.99; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007	55	43	45	5	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					620	+		10.1016/j.immuni.2020.03.003	http://dx.doi.org/10.1016/j.immuni.2020.03.003			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32268121	Bronze			2022-12-18	WOS:000526782600008
J	Ostendorf, T; Zillinger, T; Andryka, K; Schlee-Guimaraes, TM; Schmitz, S; Marx, S; Bayrak, K; Linke, R; Salgert, S; Wegner, J; Grasser, T; Bauersachs, S; Soltesz, L; Hubner, MP; Nastaly, M; Coch, C; Kettwig, M; Roehl, I; Henneke, M; Hoerauf, A; Barchet, W; Gartner, J; Schlee, M; Hartmann, G; Bartok, E				Ostendorf, Thomas; Zillinger, Thomas; Andryka, Katarzyna; Schlee-Guimaraes, Thais Marina; Schmitz, Saskia; Marx, Samira; Bayrak, Kubra; Linke, Rebecca; Salgert, Sarah; Wegner, Julia; Grasser, Tatjana; Bauersachs, Sonja; Soltesz, Leon; Huebner, Marc P.; Nastaly, Maximilian; Coch, Christoph; Kettwig, Matthias; Roehl, Ingo; Henneke, Marco; Hoerauf, Achim; Barchet, Winfried; Gaertner, Jutta; Schlee, Martin; Hartmann, Gunther; Bartok, Eva			Immune Sensing of Synthetic, Bacterial, and Protozoan RNA by Toll-like Receptor 8 Requires Coordinated Processing by RNase T2 and RNase 2	IMMUNITY			English	Article							CYSTIC LEUKOENCEPHALOPATHY; STRANDED-RNA; TLR8; RECOGNITION; RIBONUCLEASES; FAMILY; EVOLUTION; MONOCYTES; ALPHA; CELLS	Human toll-like receptor 8 (TLR8) activation induces a potent T helper-1 (Th1) cell response critical for defense against intracellular pathogens, including protozoa. The receptor harbors two distinct binding sites, uridine and di- and/or trinucleotides, but the RNases upstream of TLR8 remain poorly characterized. We identified two endolysosomal endoribonucleases, RNase T2 and RNase 2, that act synergistically to release uridine from oligoribonucleotides. RNase T2 cleaves preferentially before, and RNase 2 after, uridines. Live bacteria, P. falciparum-infected red blood cells, purified pathogen RNA, and synthetic oligoribonucleotides all required RNase 2 and T2 processing to activate TLR8. Uridine supplementation restored RNA recognition in RNASE2(-/-) or RNASET2(-/-) but not RNASE2(-/-) RNASET2(-/-) cells. Primary immune cells from RNase T2-hypomorphic patients lacked a response to bacterial RNA but responded robustly to small-molecule TLR8 ligands. Our data identify an essential function of RNase T2 and RNase 2 upstream of TLR8 and provide insight into TLR8 activation.	[Ostendorf, Thomas; Zillinger, Thomas; Andryka, Katarzyna; Schlee-Guimaraes, Thais Marina; Schmitz, Saskia; Marx, Samira; Bayrak, Kubra; Linke, Rebecca; Salgert, Sarah; Wegner, Julia; Soltesz, Leon; Nastaly, Maximilian; Coch, Christoph; Barchet, Winfried; Schlee, Martin; Hartmann, Gunther; Bartok, Eva] Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, Bonn, Germany; [Grasser, Tatjana; Bauersachs, Sonja; Roehl, Ingo] Axolabs GmbH, Fritz Hornschuch Str 9, D-95326 Kulmbach, Germany; [Huebner, Marc P.; Hoerauf, Achim] Univ Hosp Bonn, IMMIP, Bonn, Germany; [Coch, Christoph] Miltenyi Biotech, Biomed Div, Bergisch Gladbach, Germany; [Kettwig, Matthias; Henneke, Marco; Gaertner, Jutta] Georg August Univ, Univ Med Ctr Gottingen, Div Pediat Neurol, Dept Pediat & Adolescent Med, Gottingen, Germany; [Hoerauf, Achim; Barchet, Winfried; Hartmann, Gunther] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany	University of Bonn; University of Bonn; Miltenyi Biotec; University of Gottingen; German Center for Infection Research; University of Cologne	Bartok, E (corresponding author), Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, Bonn, Germany.	ebartok@uni-bonn.de	Zillinger, Thomas/AAD-7320-2020; Coch, Christoph/AAW-5336-2021; Hübner, Marc P/W-9529-2018; Bartok, Eva/AAM-6274-2020; Schlee, Martin/AAL-1238-2021; Hartmann, Gunther/P-7492-2017	Zillinger, Thomas/0000-0002-0866-4835; Hübner, Marc P/0000-0001-8885-418X; Bartok, Eva/0000-0003-0556-1950; Wegner, Julia/0000-0001-8103-8040; Hartmann, Gunther/0000-0003-1021-2018; Barchet, Winfried/0000-0002-6745-6606; Kettwig, Matthias/0000-0003-4804-7716; Schlee, Martin/0000-0003-3671-7639	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC2151-390873048]; DFG [TRR237, SFB670, SCHL1930/1-1, GA 354/14-1, GRK 2168]; BONFOR (Uni Bonn); BonnNI (Uni Bonn)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); BONFOR (Uni Bonn); BonnNI (Uni Bonn)	We thank the Core Facilities of the Medical Faculty, Microscopy, NGS, and Flow Cytometry for their support of our work. We thank Meghan Campbell for her critical reading of the manuscript. Wethank Waldemar Kolanus, Jerome Mertens, Sven Burgdorf, and Eicke Latz for lending us imaging antibodies on exceptionally short notice. We thank the CLWM patients and their families for their extraordinary willingness to assist with our research. This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC2151-390873048 of which A.H., E.B., G.H., and M.S. are members. It was also supported by other grants of the DFG, including TRR237 (K.A., T.M.S.-G., E.B., G.H., M.N., and M.S.), SFB670 (E.B., W.B., G.H., and M.S.), SCHL1930/1-1 (M.S.), GA 354/14-1 (J.G.), and Bo&MeRanG GRK 2168 (G.H., E.B., and M.S.). E.B., M.N., T.O., and T.Z. received financial support from BONFOR (Uni Bonn). T.O. also received support from BonnNI (Uni Bonn). This work is part of the thesis of T.O. at the University of Bonn.	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Acquati F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02587; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Alexopoulou L, 2012, M S-MED SCI, V28, P96, DOI 10.1051/medsci/2012281023; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boix E, 2013, BIOCHIMIE, V95, P1087, DOI 10.1016/j.biochi.2012.12.015; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Cervantes JL, 2012, CELL MOL IMMUNOL, V9, P434, DOI 10.1038/cmi.2012.38; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Coch C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00371; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Dice J.F., 2006, REV CELL BIOL MOL ME, DOI [10.1002/ 3527600906.mcb.200300122, DOI 10.1002/3527600906.MCB.200300122]; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eigenbrod T, 2015, J IMMUNOL, V195, P1092, DOI 10.4049/jimmunol.1403173; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Freund I, 2019, RNA, V25, P869, DOI 10.1261/rna.070243.118; Freund I, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020092; Fujiwara Y, 2017, J BIOCHEM, V161, P145, DOI 10.1093/jb/mvw085; Gaidt MM, 2018, METHODS MOL BIOL, V1714, P57, DOI 10.1007/978-1-4939-7519-8_4; Greulich W, 2019, CELL, V179, P1264, DOI 10.1016/j.cell.2019.11.001; Haladyj Ewa, 2018, Reumatologia (Warsaw), V56, P164, DOI 10.5114/reum.2018.76904; Hartmann G., 2018, EP 3263707 A1,Divisional application: EP20170168762, Patent No. 3263707; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Ishii N, 2014, J IMMUNOL, V193, P5118, DOI 10.4049/jimmunol.1401375; Jung S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120498; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lu HL, 2012, CLIN CANCER RES, V18, P499, DOI 10.1158/1078-0432.CCR-11-1625; Lu L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01012; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; MacIntosh GC, 2011, NUCLEIC ACIDS MOL BI, V26, P89, DOI 10.1007/978-3-642-21078-5_4; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Prats-Ejarque G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01170; Rainsford KD, 2015, INFLAMMOPHARMACOLOGY, V23, P231, DOI 10.1007/s10787-015-0239-y; Rapino F, 2013, CELL REP, V3, P1153, DOI 10.1016/j.celrep.2013.03.003; Rimbach K, 2015, J INNATE IMMUN, V7, P482, DOI 10.1159/000375460; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; ROSENBERG HF, 1995, NAT GENET, V10, P219, DOI 10.1038/ng0695-219; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Schwartz L, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040076; Shibata T, 2016, INT IMMUNOL, V28, P211, DOI 10.1093/intimm/dxv062; SORRENTINO S, 1991, FEBS LETT, V288, P23, DOI 10.1016/0014-5793(91)80994-E; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; Stauffer W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33592-8; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Thorn A, 2012, NUCLEIC ACIDS RES, V40, P8733, DOI 10.1093/nar/gks614; Uchida T., 1971, ENZYMES, V4, P205; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	63	43	44	5	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					591	+		10.1016/j.immuni.2020.03.009	http://dx.doi.org/10.1016/j.immuni.2020.03.009			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294405	Bronze			2022-12-18	WOS:000526782600006
J	Pioli, PD; Casero, D; Montecino-Rodriguez, E; Morrison, SL; Dorshkind, K				Pioli, Peter D.; Casero, David; Montecino-Rodriguez, Encarnacion; Morrison, Sherie L.; Dorshkind, Kenneth			Plasma Cells Are Obligate Effectors of Enhanced Myelopoiesis in Aging Bone Marrow	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; B-CELL; PROGENITOR CELLS; SURVIVAL NICHE; MYELOID DIFFERENTIATION; TRANSCRIPTION FACTORS; LYMPHOID PROGENITOR; SELF-RENEWAL; PRO-B; LYMPHOPOIESIS	Aging results in increased myelopoiesis, which is linked to the increased incidence of myeloid leukemias and production of myeloid-derived suppressor cells. Here, we examined the contribution of plasma cells (PCs) to age-related increases in myelopoiesis, as PCs exhibit immune regulatory function and sequester in bone marrow (BM). PC number was increased in old BM, and they exhibited high expression of genes encoding inflammatory cytokines and pathogen sensors. Antibody-mediated depletion of PCs from old mice reduced the number of myeloid-biased hematopoietic stem cells and mature myeloid cells to levels in young animals, but lymphopoiesis was not rejuvenated, indicating that redundant mechanisms inhibit that process. PCs also regulated the production of inflammatory factors from BM stromal cells, and disruption of the PC-stromal cell circuitry with inhibitors of the cytokines IL-1 and TNF-alpha attenuated myelopoiesis in old mice. Thus, the age-related increase in myelopoiesis is driven by an inflammatory network orchestrated by PCs.	[Pioli, Peter D.; Casero, David; Montecino-Rodriguez, Encarnacion; Dorshkind, Kenneth] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Morrison, Sherie L.] UCLA, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu	Pioli, Peter Dion/GRR-3563-2022; Casero, David/E-7365-2010; Pioli, Peter/AAU-3614-2021	Casero, David/0000-0002-7347-3330; Montecino Rodriguez, Encarnacion/0000-0002-2826-7503; Pioli, Peter/0000-0002-3321-2216	NIH [CA16042, AI28697, AG056480, CA009056, HL086345, CA162964]; NATIONAL CANCER INSTITUTE [T32CA009056, P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056480] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant AG056480 to K.D. S.L.M. was supported by NIH grant CA162964. P.D.P. was supported by NIH T32 training grants in tumor cell biology (CA009056) and hematology (HL086345). The Jonsson Comprehensive Cancer Center flow cytometry core is supported by NIH grants CA16042 and AI28697.	Alter-Wolf S, 2009, MECH AGEING DEV, V130, P401, DOI 10.1016/j.mad.2009.04.001; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Baratono SR, 2015, EUR J IMMUNOL, V45, P1313, DOI 10.1002/eji.201445319; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Buford TW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0296-0; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chen XW, 2017, CELL STEM CELL, V21, P747, DOI 10.1016/j.stem.2017.11.003; Chernova I, 2014, J IMMUNOL, V193, P4971, DOI 10.4049/jimmunol.1401264; Choi JS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600455; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Cocco C, 2011, J LEUKOCYTE BIOL, V89, P729, DOI 10.1189/jlb.1210660; CONLEY ME, 1981, NEW ENGL J MED, V305, P495, DOI 10.1056/NEJM198108273050905; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Das A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00916-z; de Haan G, 2018, BLOOD, V131, P479, DOI 10.1182/blood-2017-06-746412; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DORSHKIND K, 1991, J IMMUNOL, V146, P4204; DORSHKIND K, 1988, BLOOD, V72, P2053; DORSHKIND K, 1988, J IMMUNOL, V141, P531; Dykstra B, 2008, CELL TISSUE RES, V331, P91, DOI 10.1007/s00441-007-0529-9; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Fang MM, 2018, J IMMUNOL, V201, P2414, DOI 10.4049/jimmunol.1800252; Flores RR, 2017, AGING CELL, V16, P480, DOI 10.1111/acel.12571; Fowler T, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0012-x; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Guidi N, 2017, EMBO J, V36, P840, DOI 10.15252/embj.201694969; Guidi N, 2017, SEMIN HEMATOL, V54, P51, DOI 10.1053/j.seminhematol.2016.10.005; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Hardy RR, 1995, ANN NY ACAD SCI, V764, P19; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Henry CJ, 2015, J CLIN INVEST, V125, P4666, DOI 10.1172/JCI83024; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Hoggatt J, 2016, ANNU REV PATHOL-MECH, V11, P555, DOI 10.1146/annurev-pathol-012615-044414; Hu XB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13095; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayaba A, 2018, INT IMMUNOL, V30, P241, DOI 10.1093/intimm/dxy018; Kennedy DE, 2017, J IMMUNOL, V198, P3471, DOI 10.4049/jimmunol.1601643; Kennedy DE, 2015, J IMMUNOL, V195, P2666, DOI 10.4049/jimmunol.1500957; Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983; Kim HM, 2011, FEBS LETT, V585, P579, DOI 10.1016/j.febslet.2011.01.011; Kim KA, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0625-7; Kim MS, 2014, J LEUKOCYTE BIOL, V95, P461, DOI 10.1189/jlb.0613310; King AM, 2009, MECH AGEING DEV, V130, P384, DOI 10.1016/j.mad.2009.03.002; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kovtonyuk LV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00502; Kunisawa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2718; Lam WY, 2018, CELL REP, V24, P2479, DOI 10.1016/j.celrep.2018.07.084; Lemke A, 2016, MUCOSAL IMMUNOL, V9, P83, DOI 10.1038/mi.2015.38; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Lopez D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4167-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo Y, 2018, BLOOD ADV, V2, P859, DOI 10.1182/bloodadvances.2018015685; Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Mokhtari Z, 2015, CYTOM PART A, V87A, P503, DOI 10.1002/cyto.a.22641; Montecino-Rodriguez E, 2019, STEM CELL REP, V12, P584, DOI 10.1016/j.stemcr.2019.01.016; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nakamura-Ishizu A, 2014, BIOCHEM BIOPH RES CO, V454, P353, DOI 10.1016/j.bbrc.2014.10.095; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Nilsson ALK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163213; O'Reilly SM, 2003, BIOCHEM BIOPH RES CO, V303, P586, DOI 10.1016/S0006-291X(03)00389-9; Oduro KA, 2012, BLOOD, V120, P2203, DOI 10.1182/blood-2011-11-391342; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Poulos MG, 2017, J CLIN INVEST, V127, P4163, DOI 10.1172/JCI93940; Puchta A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005368; Qi YF, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.05.018; Qureshi ST, 1999, INFLAMM RES, V48, P613, DOI 10.1007/s000110050511; Ratliff M, 2013, AGING CELL, V12, P303, DOI 10.1111/acel.12055; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schepers K, 2012, BLOOD, V120, P3425, DOI 10.1182/blood-2011-11-395418; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Signer RAJ, 2007, BLOOD, V110, P1831, DOI 10.1182/blood-2007-01-069401; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suzuki-Yamazaki N, 2017, EUR J IMMUNOL, V47, P493, DOI 10.1002/eji.201646549; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang DZ, 2016, J EXP MED, V213, P535, DOI 10.1084/jem.20151100; Tang QQ, 2013, AGING-US, V5, P643, DOI 10.18632/aging.100588; Taubenheim N, 2012, J IMMUNOL, V189, P3328, DOI 10.4049/jimmunol.1201042; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tsujimoto T, 1996, BLOOD, V87, P3375, DOI 10.1182/blood.V87.8.3375.bloodjournal8783375; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Dang VD, 2014, CURR OPIN IMMUNOL, V28, P77, DOI 10.1016/j.coi.2014.02.009; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Yazdani R, 2017, SCAND J IMMUNOL, V85, P3, DOI 10.1111/sji.12499; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313; Zhang J, 2004, EXP GERONTOL, V39, P239, DOI 10.1016/j.exger.2003.10.024; Zhou A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2898-5; Ziegler P, 2016, ANN HEMATOL, V95, P173, DOI 10.1007/s00277-015-2550-5	128	43	43	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					351	+		10.1016/j.immuni.2019.06.006	http://dx.doi.org/10.1016/j.immuni.2019.06.006			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31303400	Bronze, Green Accepted			2022-12-18	WOS:000482088500017
J	Zhai, ZZ; Boquete, JP; Lemaitre, B				Zhai, Zongzhao; Boquete, Jean-Philippe; Lemaitre, Bruno			Cell-Specific Imd-NF-kappa B Responses Enable Simultaneous Antibacterial Immunity and Intestinal Epithelial Cell Shedding upon Bacterial Infection	IMMUNITY			English	Article							DROSOPHILA-MELANOGASTER; PGRP-LE; HOMEOSTASIS; GUT; APOPTOSIS; ACTIVATION; MICROBIOTA; EXTRUSION; SHAPES; MIDGUT	Intestinal infection triggers potent immune responses to combat pathogens and concomitantly drives epithelial renewal to maintain barrier integrity. Current models propose that epithelial renewal is primarily driven by damage caused by reactive oxygen species (ROS). Here we found that in Drosophila, the Imd-NF-kappa B pathway controlled enterocyte (EC) shedding upon infection, via a mechanism independent of ROS-associated apoptosis. Mechanistically, the Imd pathway synergized with JNK signaling to induce epithelial cell shedding specifically in the context of bacterial infection, requiring also the reduced expression of the transcription factor GATAe. Furthermore, cell-specific NF-kappa B responses enabled simultaneous production of antimicrobial peptides (AMPs) and epithelial shedding in different EC populations. Thus, the Imd-NF-kappa B pathway is central to the intestinal antibacterial response by mediating both AMP production and the maintenance of barrier integrity. Considering the similarities between Drosophila Imd signaling and mammalian TNFR pathway, our findings suggest the existence of an evolutionarily conserved genetic program in immunity-induced epithelial shedding.	[Zhai, Zongzhao; Boquete, Jean-Philippe; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland; [Lemaitre, Bruno] Hunan Normal Univ, Sch Life Sci, Anim Nutr & Human Hlth Lab, Changsha 410081, Hunan, Peoples R China	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Hunan Normal University	Zhai, ZZ; Lemaitre, B (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland.; Lemaitre, B (corresponding author), Hunan Normal Univ, Sch Life Sci, Anim Nutr & Human Hlth Lab, Changsha 410081, Hunan, Peoples R China.	zongzhao.zhai@foxmail.com; bruno.lemaitre@epfl.ch	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667	SNSF grant [3100A0-12079/1]; Hunan Natural Science Foundation [2018JJ1015]; Marie-Curie IEF fellowship (gutENCODE) [330852]	SNSF grant; Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province); Marie-Curie IEF fellowship (gutENCODE)	We thank Drs. Claudine Neyen, Zheng Guo, and Mark Hanson for comments on the manuscript; Won-Jae Lee, Julien Royet, Sara Cherry, Luis Teixeira, Leanne Jones, Mirka Uhlirova, BDSC, DGRC, and VDRC for fly stocks; DSHB for antibodies; and the FCCF and BIOP platforms at EPFL for technical help. This project was supported by the SNSF grant 3100A0-12079/1 (to B.L.) and the Hunan Natural Science Foundation grant 2018JJ1015 (to Z.Z.). Z.Z. was also supported by a Marie-Curie IEF fellowship (gutENCODE) (330852).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Combe BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094729; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dutta D., 2013, CURR PROTOC STEM C F, V27, P2; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Guo Z, 2016, CURR OPIN GENET DEV, V40, P81, DOI 10.1016/j.gde.2016.06.009; Jiang HQ, 2012, CURR OPIN GENET DEV, V22, P354, DOI 10.1016/j.gde.2012.04.002; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Lee KZ, 2016, CELL HOST MICROBE, V20, P716, DOI 10.1016/j.chom.2016.10.010; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Liang J, 2017, NATURE, V548, P588, DOI 10.1038/nature23678; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Matsuoka Y, 2015, GENES CELLS, V20, P11, DOI 10.1111/gtc.12193; McGuire SE, 2004, SCI STKE, V2004; Meyer SN, 2014, SCIENCE, V346, P1199, DOI 10.1126/science.1258236; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Mistry R, 2017, GENETICS, V206, P889, DOI 10.1534/genetics.116.190215; Neyen C, 2014, METHODS, V68, P116, DOI 10.1016/j.ymeth.2014.02.023; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; Ohsawa S, 2018, DEV CELL, V44, P284, DOI 10.1016/j.devcel.2018.01.009; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Pastor-Pareja JC, 2004, DEV CELL, V7, P387, DOI 10.1016/j.devcel.2004.07.022; Patel PH, 2015, NAT CELL BIOL, V17, P1182, DOI 10.1038/ncb3214; Patterson AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00841; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Resnik-Docampo M, 2017, NAT CELL BIOL, V19, P52, DOI 10.1038/ncb3454; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sellin ME, 2015, TRENDS IMMUNOL, V36, P442, DOI 10.1016/j.it.2015.06.002; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vereecke L, 2011, TRENDS MOL MED, V17, P584, DOI 10.1016/j.molmed.2011.05.011; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Zhai ZZ, 2018, DEV COMP IMMUNOL, V83, P51, DOI 10.1016/j.dci.2017.11.008; Zhai ZZ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006854; Zhai ZZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10219; Zhou J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14289	65	43	45	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					897	+		10.1016/j.immuni.2018.04.010	http://dx.doi.org/10.1016/j.immuni.2018.04.010			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29752064	Green Submitted, Bronze			2022-12-18	WOS:000432488600011
J	Gurung, P; Fan, GF; Lukens, JR; Vogel, P; Tonks, NK; Kanneganti, TD				Gurung, Prajwal; Fan, Gaofeng; Lukens, John R.; Vogel, Peter; Tonks, Nicholas K.; Kanneganti, Thirumala-Devi			Tyrosine Kinase SYK Licenses MyD88 Adaptor Protein to Instigate IL-1 alpha-Mediated Inflammatory Disease	IMMUNITY			English	Article							NF-KAPPA-B; MOTH-EATEN MICE; APOPTOTIC CELL-DEATH; IN-VIVO; AUTOINFLAMMATORY DISEASE; STERILE INFLAMMATION; SIGNALING PATHWAYS; SHP-1; GENE; PHOSPHATASE	Mice carrying a hypomorphic point mutation in the Ptpn6 gene (Ptpn6 spin mice) develop an inflammatory skin disease that resembles neutrophilic dermatosis in humans. Here, we demonstrated that interleukin-1 alpha (IL-1 alpha) signaling through IL-1R and MyD88 in both stromal and immune cells drive inflammation in Ptpn6 spin mice. We further identified SYK as a critical kinase that phosphorylates MyD88, promoted MyD88-dependent signaling and mediates dermatosis in Ptpn6 spin mice. Our studies further demonstrated that SHP1 encoded by Ptpn6 binds and suppresses SYK activation to inhibit MyD88 phosphorylation. Downstream of SHP1 and SYK-dependent counterregulation of MyD88 tyrosine phosphorylation, we have demonstrated that the scaffolding function of receptor interacting protein kinase 1 (RIPK1) and tumor growth factor-beta activated kinase 1 (TAK1)-mediating signaling were required to spur inflammatory disease. Overall, these studies identify SHP1 and SYK crosstalk as a critical regulator of MyD88 post-translational modifications and IL-1-driven inflammation.	[Gurung, Prajwal; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Fan, Gaofeng; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lukens, John R.] Univ Virginia, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Res Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Cold Spring Harbor Laboratory; University of Virginia; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Vogel, Peter/N-2490-2018; Fan, Gaofeng/H-2996-2013	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Gurung, Prajwal/0000-0002-7451-9433; Fan, Gaofeng/0000-0002-6729-2867; Lukens, John/0000-0002-6795-0866	National Institutes of Health [CA53840, GM55989, CA163507, AR056296, AI124346, AI101935]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA053840, R37CA053840, R01CA163507, P30CA045508, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124346, R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B.A. Buetler, V.M. Dixit, M. Kelliher, and D.R. Green for generously supplying mutant mice. We also thank members of the Kanneganti laboratory for their helpful discussion and reviewing of the manuscript. We thank the Hartwell Center for Bioinformatics and Biotechnology and the Department of Computational Biology at St. Jude for help with Microbiome studies. Images were acquired at the SJCRH Cell & Tissue Imaging Center, which is supported by SJCRH and NCI P30 CA021765-35. This work was supported by the National Institutes of Health Grants CA53840 and GM55989 to N.K.T., and Grants CA163507, AR056296, AI124346, and AI101935 and the American Lebanese Syrian Associated Charities (ALSAC) to T.-D.K.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barton G. M., 2014, F1000PRIME REP, V6, P97; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cao HN, 2002, J HUM GENET, V47, P445, DOI 10.1007/s100380200062; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Elefteriou F, 2011, BONE, V49, P1242, DOI 10.1016/j.bone.2011.08.021; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lamothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051228; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Martin A, 1999, MOL IMMUNOL, V36, P1029, DOI 10.1016/S0161-5890(99)00126-1; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nesterovitch AB, 2011, AM J PATHOL, V178, P1701, DOI 10.1016/j.ajpath.2010.12.053; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Wishcamper CA, 2001, J COMP NEUROL, V441, P118; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	45	43	44	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					635	648		10.1016/j.immuni.2017.03.014	http://dx.doi.org/10.1016/j.immuni.2017.03.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28410990	Green Accepted, Bronze			2022-12-18	WOS:000399451100016
J	Zhang, Y; Li, WN; Li, LF; Li, YB; Fu, R; Zhu, Y; Li, J; Zhou, YF; Xiong, SD; Zhang, HM				Zhang, Yun; Li, Wenna; Li, Linfeng; Li, Yuanbao; Fu, Rong; Zhu, Yi; Li, Jie; Zhou, Yanfeng; Xiong, Sidong; Zhang, Huimin			Structural Damage in the C. elegans Epidermis Causes Release of STA-2 and Induction of an Innate Immune Response	IMMUNITY			English	Article							ANTIMICROBIAL PEPTIDE EXPRESSION; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEIN; SIGNALING PATHWAY; CELL ADHESION; ENCODES; COMPONENT; FILAMENTS; FAMILY; LINKS	The epidermis constantly encounters invasions that disrupt its architecture, yet whether the epidermal immune system utilizes damaged structures as danger signals to activate self-defense is unclear. Here, we used a C. elegans epidermis model in which skin-penetrating infection or injury activates immune defense and antimicrobial peptide (AMP) production. By systemically disrupting each architectural component, we found that only disturbance of the apical hemidesmosomes triggered an immune response and robust AMP expression. The epidermis recognized structural damage through hemidesmosomes associated with a STAT-like protein, whose disruption led to detachment of STA-2 molecules from hemidesmosomes and transcription of AMPs. This machinery enabled the epidermis to bypass certain signaling amplification and directly trigger AMP production when subjected to extensive architectural damage. Together, our findings uncover an evolutionarily conserved mechanism for the epithelial barriers to detect danger and activate immune defense.	[Zhang, Yun; Li, Wenna; Li, Linfeng; Li, Yuanbao; Fu, Rong; Zhu, Yi; Li, Jie; Zhou, Yanfeng; Xiong, Sidong; Zhang, Huimin] Soochow Univ, Inst Biol Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Yun; Li, Wenna; Li, Linfeng; Li, Yuanbao; Fu, Rong; Zhu, Yi; Li, Jie; Zhou, Yanfeng; Xiong, Sidong; Zhang, Huimin] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Xiong, SD (corresponding author), Soochow Univ, Inst Biol Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China.	sdxiong@suda.edu.cn; zhanghuimin@suda.edu.cn	Zhou, Yanfeng/AAY-2047-2020	Zhang, Huimin/0000-0002-2167-9644	Major State Basic Research Development Program of China [2013CB530501]; National Natural Science Foundation of China [31271429, 31471265]; Jiangsu Provincial Innovative Research Team; Program for Changjiang Scholars and Innovative Research Team in University; Priority Academic Development Program of Jiangsu Province Higher Education Institutions	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Innovative Research Team; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Development Program of Jiangsu Province Higher Education Institutions	We are grateful to Michel Labouesse, Hong Zhang, Xiaochen Wang, Shiqing Cai, the Caenorhabditis Genetics Center, and NBP-Japan for reagents, as well as Shuai Wang, Ming Zhu, Yiling Zhang, and Yanmei Li for technical support. We thank Min Han for discussion and members of the H.Z. lab (He Wang, Xiaoran Dong, Lin Sun, and Qin Wang) for help with the manuscript. This work was supported by grants from Major State Basic Research Development Program of China (2013CB530501), National Natural Science Foundation of China (31271429 and 31471265), Jiangsu Provincial Innovative Research Team, the Program for Changjiang Scholars and Innovative Research Team in University, and the Priority Academic Development Program of Jiangsu Province Higher Education Institutions.	Bercher M, 2001, J CELL BIOL, V154, P415, DOI 10.1083/jcb.200103035; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BRENNER S, 1974, GENETICS, V77, P71; Chisholm AD, 2012, WIRES DEV BIOL, V1, P879, DOI 10.1002/wdev.77; Costa M, 1997, DEV BIOL, V184, P373, DOI 10.1006/dbio.1997.8530; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dierking K, 2011, CELL HOST MICROBE, V9, P425, DOI 10.1016/j.chom.2011.04.011; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Lee KZ, 2010, VIRULENCE, V1, P113, DOI 10.4161/viru.1.3.10974; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Lints R., 2009, THE CUTICLE; McKeown C, 1998, DEVELOPMENT, V125, P2087; McMahon L, 2003, MOL BIOL CELL, V14, P1366, DOI 10.1091/mbc.E02-08-0479; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Niculescu C, 2011, EUR J CELL BIOL, V90, P270, DOI 10.1016/j.ejcb.2010.09.003; Ozawa T, 2010, J INVEST DERMATOL, V130, P1624, DOI 10.1038/jid.2009.439; Pasti G., 2014, WORMBOOK; Patterson RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061773; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perez-Moreno M, 2008, P NATL ACAD SCI USA, V105, P15399, DOI 10.1073/pnas.0807301105; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Xu SH, 2011, CURR BIOL, V21, P1960, DOI 10.1016/j.cub.2011.10.050; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765; Zhang HM, 2010, DEV DYNAM, V239, P1465, DOI 10.1002/dvdy.22255; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006; Zugasti O, 2014, NAT IMMUNOL, V15, P833, DOI 10.1038/ni.2957; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	39	43	50	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					309	320		10.1016/j.immuni.2015.01.014	http://dx.doi.org/10.1016/j.immuni.2015.01.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692704	Bronze			2022-12-18	WOS:000349916400014
J	St John, AL; Ang, WXG; Huang, MN; Kunder, CA; Chan, EW; Gunn, MD; Abraham, SN				St John, Ashley L.; Ang, W. X. Gladys; Huang, Min-Nung; Kunder, Christian A.; Chan, Elizabeth W.; Gunn, Michael D.; Abraham, Soman N.			S1P-Dependent Trafficking of Intracellular Yersinia pestis through Lymph Nodes Establishes Buboes and Systemic Infection	IMMUNITY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; DENDRITIC-CELL TRAFFICKING; THORACIC-DUCT LYMPH; FLEA-BORNE PLAGUE; PLASMINOGEN-ACTIVATOR; CHEMOKINE RECEPTORS; THERAPEUTIC TARGETS; PASTEURELLA-PESTIS; BUBONIC PLAGUE; MACROPHAGES	Pathologically swollen lymph nodes (LNs), or buboes, characterize Yersinia pestis infection, yet how they form and function is unknown. We report that colonization of the draining LN (dLN) occurred due to trafficking of infected dendritic cells and monocytes in temporally distinct waves in response to redundant chemotactic signals, including through CCR7, CCR2, and sphingosine-1-phospate (S1P) receptors. Retention of multiple subsets of phagocytes within peripheral LNs using the S1P receptor agonist FTY720 or S1P1-specific agonist SEW2871 increased survival, reduced colonization of downstream LNs, and limited progression to transmission-associated septicemic or pneumonic disease states. Conditional deletion of S1P1 in mononuclear phagocytes abolished node-to-node trafficking of infected cells. Thus, Y. pestis-orchestrated LN remodeling promoted its dissemination via host cells through the lymphatic system but can be blocked by prevention of leukocyte egress from DLNs. These findings define a novel trafficking route of mononuclear phagocytes and identify S1P as a therapeutic target during infection.	[St John, Ashley L.; Abraham, Soman N.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore 169857, Singapore; [St John, Ashley L.; Kunder, Christian A.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Ang, W. X. Gladys; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Huang, Min-Nung; Chan, Elizabeth W.; Gunn, Michael D.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Gunn, Michael D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	National University of Singapore; Duke University; Duke University; Duke University; Duke University	St John, AL (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore 169857, Singapore.	ashley.st.john@duke-nus.edu.sg	StJohn, Ashley/AAE-4378-2021; Kunder, Christian/AAW-5377-2021; Kunder, Christian/K-3212-2019	StJohn, Ashley/0000-0001-5098-1044; Kunder, Christian/0000-0003-1514-7550; Chan, Elizabeth/0000-0002-5602-9991; Ang, Wei Xin Gladys/0000-0002-9105-0550	NIH [R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814, R21 AI056101]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035678, T32AI052077, R01AI096305, R21AI056101, R01AI050021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077307, R01DK101456, R56DK095198, R37DK050814, R01DK077159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank W. Zhang for providing antibody 2C11 for T cell depletion experiments and A.P.S. Rathore for critical manuscript review. The authors' work is supported by NIH grants R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814, and R21 AI056101.	ANDERSON AO, 1981, TRANSPL P, V13, P1460; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; BELL EB, 1979, IMMUNOLOGY, V38, P797; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BUTLER T, 1994, CLIN INFECT DIS, V19, P655, DOI 10.1093/clinids/19.4.655; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cross AK, 1997, CYTOKINE, V9, P521, DOI 10.1006/cyto.1996.0196; DEMARTINI JC, 1983, INT ARCH ALLER A IMM, V72, P110, DOI 10.1159/000234851; FINEGOLD MJ, 1969, AM J PATHOL, V54, P167; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Jawetz E, 1944, J INFECT DIS, V74, P1, DOI 10.1093/infdis/74.1.1; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Lonnbro P, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-35; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rathinasamy A, 2010, J IMMUNOL, V185, P4072, DOI 10.4049/jimmunol.1000568; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Saikh KU, 2004, J IMMUNOL, V173, P7426, DOI 10.4049/jimmunol.173.12.7426; SAINTEMARIE G, 1983, LAB INVEST, V49, P420; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Shelburne CP, 2009, CELL HOST MICROBE, V6, P331, DOI 10.1016/j.chom.2009.09.004; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Turner JK, 2008, INFECT IMMUN, V76, P4092, DOI 10.1128/IAI.00488-08; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang SS, 2008, J BIOL CHEM, V283, P31511, DOI 10.1074/jbc.M804646200	44	43	43	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					440	450		10.1016/j.immuni.2014.07.013	http://dx.doi.org/10.1016/j.immuni.2014.07.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238098	Green Accepted, Bronze			2022-12-18	WOS:000342626500014
J	Hedl, M; Lahiri, A; Ning, K; Cho, JH; Abraham, C				Hedl, Matija; Lahiri, Amit; Ning, Kaida; Cho, Judy H.; Abraham, Clara			Pattern Recognition Receptor Signaling in Human Dendritic Cells is Enhanced by ICOS Ligand and Modulated by the Crohn's Disease ICOSLG Risk Allele	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE-C; TOLL-LIKE RECEPTORS; MURAMYL DIPEPTIDE; INDUCIBLE COSTIMULATOR; CYTOKINE SECRETION; NOD2; ACTIVATION; EXPRESSION; MACROPHAGES	Inflammatory bowel disease (IBD) is characterized by dysregulated intestinal immune homeostasis and cytokine secretion. Multiple loci are associated with IBD, but a functional explanation is missing for most. Here we found that pattern-recognition receptor (PRR)-induced cytokine secretion was diminished in human monocyte-derived dendritic cells (MDDC) from rs7282490 ICOSLG GG risk carriers. Homotypic interactions between the costimulatory molecule ICOS and the ICOS ligand on MDDCs amplified nucleotide-binding oligomerization domain 2 (NOD2)-initiated cytokine secretion. This amplification required arginine residues in the ICOSL cytoplasmic tail that recruited the adaptor protein RACK1 and the kinases PKC and JNK leading to PKC, MAPK, and NF-kappa B activation. MDDC from rs7282490 GG risk-carriers had reduced ICOSL expression and PRR-initiated signaling and this loss-of-function ICOSLG risk allele associated with an ileal Crohn's disease phenotype, similar to polymorphisms in NOD2. Taken together, ICOSL amplifies PRR-initiated outcomes, which might contribute to immune homeostasis.	[Hedl, Matija; Lahiri, Amit; Ning, Kaida; Cho, Judy H.; Abraham, Clara] Yale Univ, Sect Digest Dis, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Abraham, C (corresponding author), Yale Univ, Sect Digest Dis, Dept Internal Med, New Haven, CT 06510 USA.	clara.abraham@yale.edu		LAHIRI, AMIT/0000-0003-0307-3478	Broad Foundation; NIH [R01DK099097, R01DK077905, R56AI089789, U01 DK062422, U01 DK62429, DK099097, R01 DK092235, DK-P30-34989, U19-AI082713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713, R56AI089789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092235, U01DK062422, R01DK099097, P30DK034989, U01DK062429, R01DK077905] Funding Source: NIH RePORTER	Broad Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Broad Foundation and the NIH: R01DK099097, R01DK077905, R56AI089789, U01 DK062422, U01 DK62429, DK099097, R01 DK092235, DK-P30-34989, U19-AI082713, U01 DK62429, U01 DK062422, R01 DK092235.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hedl M, 2012, J IMMUNOL, V188, P5348, DOI 10.4049/jimmunol.1103319; Hedl M, 2011, J BIOL CHEM, V286, P26440, DOI 10.1074/jbc.M111.237495; Hedl M, 2011, GASTROENTEROLOGY, V140, P231, DOI 10.1053/j.gastro.2010.09.009; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; LEVENTHAL PS, 1993, J BIOL CHEM, V268, P13906; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; Ling V, 2001, J IMMUNOL, V166, P7300, DOI 10.4049/jimmunol.166.12.7300; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nguyen GC, 2006, AM J GASTROENTEROL, V101, P1012, DOI 10.1111/j.1572-0241.2006.00504.x; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Sato T, 2004, GASTROENTEROLOGY, V126, P829, DOI 10.1053/j.gastro.2003.12.011; Sharpe A. H., 2009, CURR OPIN IMMUNOL, V229, P5; Tang GS, 2009, CELL MOL LIFE SCI, V66, P3067, DOI 10.1007/s00018-009-0090-7; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Vidal VF, 2001, EUR J IMMUNOL, V31, P1962, DOI 10.1002/1521-4141(200107)31:7<1962::AID-IMMU1962>3.0.CO;2-V; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Webb BLJ, 2000, BRIT J PHARMACOL, V130, P1433, DOI 10.1038/sj.bjp.0703452; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	44	43	47	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					734	746		10.1016/j.immuni.2014.04.011	http://dx.doi.org/10.1016/j.immuni.2014.04.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837102	Green Accepted, Bronze			2022-12-18	WOS:000336026100012
J	Figgett, WA; Fairfax, K; Vincent, FB; Le Page, MA; Katik, I; Deliyanti, D; Quah, PS; Verma, P; Grumont, R; Gerondakis, S; Hertzog, P; O'Reilly, LA; Strasser, A; Mackay, F				Figgett, William A.; Fairfax, Kirsten; Vincent, Fabien B.; Le Page, Melanie A.; Katik, Indzi; Deliyanti, Devy; Pin Shie Quah; Verma, Pali; Grumont, Raelene; Gerondakis, Steve; Hertzog, Paul; O'Reilly, Lorraine A.; Strasser, Andreas; Mackay, Fabienne			The TACI Receptor Regulates T-Cell-Independent Marginal Zone B Cell Responses through Innate Activation-Induced Cell Death	IMMUNITY			English	Article							TRANSMEMBRANE ACTIVATOR; BAFF; EXPRESSION; APOPTOSIS; DIFFERENTIATION; LIGAND; ROLES; MICE; CD40	Activation-induced cell death (AICD) plays a critical role in immune homeostasis and tolerance. In T-cell-dependent humoral responses, AICD of B cells is initiated by Fas ligand (FasL) on T cells, stimulating the Fas receptor on B cells. In contrast, T-cell-independent B cell responses involve innate-type B lymphocytes, such as marginal zone (MZ) B cells, and little is known about the mechanisms that control AICD during innate B cell responses to Toll-like receptor (TLR) activation. Here, we show that MZ B cells undergo AICD in response to TLR4 activation in vivo. The transmembrane activator, calcium modulator, and cyclophilin ligand interactor (TACI) receptor and TLR4 cooperate to upregulate expression of both FasL and Fas on MZ B cells and also to repress inhibitors of Fas-induced apoptosis signaling. These findings demonstrate an unappreciated role for TACI and its ligands in the regulation of AICD during T-cell-independent B cell responses.	[Figgett, William A.; Fairfax, Kirsten; Vincent, Fabien B.; Le Page, Melanie A.; Katik, Indzi; Deliyanti, Devy; Pin Shie Quah; Mackay, Fabienne] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Figgett, William A.] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Verma, Pali] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Grumont, Raelene; Gerondakis, Steve] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Hertzog, Paul] Monash Inst Med Res, Clayton, Vic 3168, Australia; [O'Reilly, Lorraine A.; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [O'Reilly, Lorraine A.; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	Monash University; University of New South Wales Sydney; Griffith University; Monash University; Monash University; Walter & Eliza Hall Institute; University of Melbourne	Mackay, F (corresponding author), Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia.	fabienne.mackay@monash.edu	Deliyanti, Devy/I-1562-2014; Hertzog, Paul J/I-7053-2013; Mackay, Fabienne/B-7440-2008; Vincent, Fabien B./A-2834-2012; Strasser, Andreas/C-7581-2013	Deliyanti, Devy/0000-0002-0390-3454; Hertzog, Paul J/0000-0002-1373-8472; Mackay, Fabienne/0000-0002-6074-2693; Vincent, Fabien B./0000-0001-7220-0800; Strasser, Andreas/0000-0002-5020-4891; Figgett, William/0000-0003-2947-478X; Fairfax, Kirsten/0000-0002-8394-137X; Quah, Pin Shie/0000-0003-1684-5799	National Health and Medical Research Council; Leukemia and Lymphoma Society of America; Australian Government IRISS; Victorian State Government OIS	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Australian Government IRISS(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government OIS	We thank C. Mackay, R. Brink, and S. Jane for critical reading of the manuscript; C. Brownlee and BTF staff (Garvan Institute), G. Paulkovics, J. Le Masurier (Monash AMREP flow cytometry), D. Saulep-Easton, M. Taylor, A. Lin, and R. Piganis for technical assistance; and S. Cody and I. Carmichael (Monash Micro Imaging). F. M., A. S., P. H., K. F., L.A.O'R., and S. G. are supported by grants and fellowships from the National Health and Medical Research Council and the Leukemia and Lymphoma Society of America and operational infrastructure grants through the Australian Government IRISS and the Victorian State Government OIS.	Acosta-Rodriguez EV, 2007, EUR J IMMUNOL, V37, P990, DOI 10.1002/eji.200636698; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; Chu VT, 2007, J IMMUNOL, V179, P5947, DOI 10.4049/jimmunol.179.9.5947; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hyer ML, 2006, CLIN CANCER RES, V12, P5929, DOI 10.1158/1078-0432.CCR-06-2098; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Mizuno T, 2003, APOPTOSIS, V8, P451, DOI 10.1023/A:1025534223168; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Ozcan E, 2009, J ALLERGY CLIN IMMUN, V123, P1277, DOI 10.1016/j.jaci.2009.03.019; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; SCHATTNER EJ, 1995, J EXP MED, V182, P1557, DOI 10.1084/jem.182.5.1557; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Zhang HB, 2009, J IMMUNOL, V182, P207, DOI 10.4049/jimmunol.182.1.207	41	43	44	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					573	583		10.1016/j.immuni.2013.05.019	http://dx.doi.org/10.1016/j.immuni.2013.05.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24012421	Bronze			2022-12-18	WOS:000330949600019
J	Van Belle, TL; Nierkens, S; Arens, R; von Herrath, MG				Van Belle, Tom L.; Nierkens, Stefan; Arens, Ramon; von Herrath, Matthias G.			Interleukin-21 Receptor-Mediated Signals Control Autoreactive T Cell Infiltration in Pancreatic Islets	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; DEPENDENT DIABETES-MELLITUS; DENDRITIC CELLS; NOD MOUSE; ANTIGEN; IL-21; MICE; AUTOIMMUNITY; LYMPHOCYTES; EXPANSION	It remains unclear how interleukin-21 receptor (IL-21R) contributes to type 1 diabetes. Here we have shown that dendritic cells (DCs) in the pancreas required IL-21R not for antigen uptake, but to acquire the chemokine receptor CCR7 and migrate into the draining lymph node. Consequently, less antigen, major histocompatibility complex (MHC) class II, and CD86 was provided to autoreactive effector cells in II21r(-/-) mice, impairing CD4(+) T cell activation, CD40:CD40L interactions, and pancreatic infiltration by autoreactive T cells. CD40 crosslinking restored defective CD4(+) cell expansion and CD4 independently expanded autoreactive CD8(+) cells, but CD8(+) cells still required CD4(+) cells to reach the pancreas and induce diabetes. Diabetes induction by transferred T cells required IL-21R-sufficient host antigen-presenting cells. Transferring IL-21R-sufficient DCs broke diabetes resistance in II21r(-/-) mice. We conclude that IL-21R controls both antigen transport by DCs and the crucial beacon function of CD4(+) cells for autoreactive CD8(+) cells to reach the islets.	[Van Belle, Tom L.; von Herrath, Matthias G.] La Jolla Inst Allergy & Immunol LIAI, Type Diabet Ctr 1, La Jolla, CA 92037 USA; [Nierkens, Stefan; Arens, Ramon] La Jolla Inst Allergy & Immunol LIAI, Dept Cellular Immunol, La Jolla, CA 92037 USA; [Van Belle, Tom L.] Univ Louvain, B-3000 Louvain, Belgium; [Nierkens, Stefan] Utrecht Univ Med Ctr, Dept Immunol, NL-3584 CX Utrecht, Netherlands; [Arens, Ramon] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	von Herrath, MG (corresponding author), La Jolla Inst Allergy & Immunol LIAI, Type Diabet Ctr 1, La Jolla, CA 92037 USA.	matthias@liai.org	Arens, Ramon/V-4010-2018; Nierkens, Stefan/AAQ-5564-2021	Arens, Ramon/0000-0001-5058-4110; Nierkens, Stefan/0000-0003-3406-817X	American Diabetes Association; Brehm Center for T1D Research and Analysis;  [P01 AI058105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058105] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Brehm Center for T1D Research and Analysis; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is dedicated to J.F. Purton for his invaluable contribution to life, as a friend, a scientist, and a colleague. We thank J. Liao, T. Juntti, M. McClure, and the staff at LIAI Animal Facility and P. Colby for administrative assistance. This work is funded by a Mentor-Based Postdoctoral Fellowship Award from the American Diabetes Association, The Brehm Center for T1D Research and Analysis, and Program grant P01 AI058105.	Asano K, 2007, HUM IMMUNOL, V68, P384, DOI 10.1016/j.humimm.2007.01.009; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Clough LE, 2008, J IMMUNOL, V180, P5393, DOI 10.4049/jimmunol.180.8.5393; Datta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003118; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eshima K, 2003, INT IMMUNOL, V15, P351, DOI 10.1093/intimm/dxg035; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Homann D, 2002, IMMUNITY, V16, P403, DOI 10.1016/S1074-7613(02)00290-X; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jin HL, 2009, J CLIN INVEST, V119, P47, DOI 10.1172/JCI32310; KANTWERKFUNKE G, 1991, CLIN EXP IMMUNOL, V86, P266; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Martinic MM, 2007, DIABETES, V56, P1059, DOI 10.2337/db05-0062; MILLER BJ, 1988, J IMMUNOL, V140, P52; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Van Belle TL, 2010, J AUTOIMMUN, V34, P445, DOI 10.1016/j.jaut.2009.11.010; VanParijs L, 1997, J IMMUNOL, V158, P3738; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194	37	43	43	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					1060	1072		10.1016/j.immuni.2012.04.005	http://dx.doi.org/10.1016/j.immuni.2012.04.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22579473	Bronze, Green Accepted			2022-12-18	WOS:000306097100021
J	van Loo, PF; Dingjan, GM; Maas, A; Hendriks, RW				van Loo, Pieter Fokko; Dingjan, Gemma M.; Maas, Alex; Hendriks, Rudi W.			Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling	IMMUNITY			English	Article							BRUTONS TYROSINE KINASE; ADAPTER PROTEIN SLP-65; DEVELOPMENTAL-STAGE; POSITIVE SELECTION; TUMOR-SUPPRESSOR; LAMBDA-5 PROTEIN; TRANSGENIC MICE; DEFICIENT MICE; HEAVY-CHAINS; RECEPTOR	The pre-B cell receptor (pre-BCR), composed of immunoglobulin mu heavy chain and the surrogate light chain (SLC) proteins lambda 5 and Vpreb, signals for proliferation and maturation of developing pre-B cells. It has been assumed that pre-B cells stop cycling by the pre-BCR-mediated downregulation of SLC transcription. We generated transgenic mice expressing SLC throughout B cell development and, remarkably, found that enforced SLC expression had no effect on pre-B cell proliferation or differentiation. However, in the presence of conventional immunoglobulin light chains, SLC components had the capacity to induce constitutive BCR internalization, secondary immunoglobulin light-chain rearrangement, and a severe developmental arrest of immature B cells, dependent on the adaptor protein Slp65. Residual B cells in the spleen showed increased expression of surface CD5, which is a negative regulator of BCR signaling, and differentiated spontaneously into IgM(+) plasma cells. Thus, the silencing of SLC genes is not essential for the limitation of pre-B cell proliferation, but is required for the prevention of constitutive activation of B cells.	Erasmus MC, Dept Immunol, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hendriks, RW (corresponding author), Erasmus MC, Dept Immunol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	r.hendriks@erasmusmc.nl						Bradl H, 2001, J IMMUNOL, V167, P6403, DOI 10.4049/jimmunol.167.11.6403; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Dingjan GM, 1998, EMBO J, V17, P5309, DOI 10.1093/emboj/17.18.5309; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hippen KL, 2000, J EXP MED, V191, P883, DOI 10.1084/jem.191.5.883; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Kersseboom R, 2003, J EXP MED, V198, P91, DOI 10.1084/jem.20030615; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; Kouro T, 2001, INT IMMUNOL, V13, P485, DOI 10.1093/intimm/13.4.485; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Maas A, 1999, J IMMUNOL, V162, P6526; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Mundt C, 2006, INT IMMUNOL, V18, P163, DOI 10.1093/intimm/dxh359; Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Parker MJ, 2005, EMBO J, V24, P3895, DOI 10.1038/sj.emboj.7600850; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Seidl T, 2001, EUR J IMMUNOL, V31, P1999, DOI 10.1002/1521-4141(200107)31:7<1999::AID-IMMU1999>3.0.CO;2-K; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007	41	43	53	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	2007	27	3					468	480		10.1016/j.immuni.2007.07.018	http://dx.doi.org/10.1016/j.immuni.2007.07.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17869135	Bronze			2022-12-18	WOS:000249843400013
J	Xue, HH; Bollenbacher-Reilley, J; Wu, Z; Spolski, R; Jing, X; Zhang, YC; McCoy, JP; Leonard, WJ				Xue, Hai-Hui; Bollenbacher-Reilley, Julie; Wu, Zheng; Spolski, Rosanne; Jing, Xuefang; Zhang, Yi-Chen; McCoy, J. Philip; Leonard, Warren J.			The transcription factor GABP is a critical regulator of B lymphocyte development	IMMUNITY			English	Article							CELL-DEVELOPMENT; MARGINAL-ZONE; INTERLEUKIN-7 RECEPTOR; GENE-EXPRESSION; CHAIN GENE; PAX-5; ACTIVATION; BSAP; DIFFERENTIATION; PROTEINS	GA binding protein (GABP) is a ubiquitously expressed Ets-family transcription factor that critically regulates the expression of the interleukin-7 receptor alpha chain (IL-7R alpha) in T cells, whereas it is dispensable for IL-7R alpha expression in fetal liver B cells. Here we showed that deficiency of GABP alpha, the DNA-binding subunit of GABP, resulted in profoundly defective B cell development and a compromised humoral immune response, in addition to thymic developmental defects. Furthermore, the expression of Pax5 and Pax5 target genes such as Cd79a was greatly diminished in GABP alpha-deficient B cell progenitors, pro-B, and mature B cells. GABP could bind to the regulatory regions of Pax5 and Cd79a in vivo. Thus, GABP is a key regulator of B cell development, maturation, and function.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; NHLBI, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA; Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Iowa	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	mccoy, john philip/ABD-9348-2021; Leonard, Warren/AAA-1397-2022	Xue, Hai-Hui/0000-0002-9163-7669	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005402, ZIAHL005402] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akerblad P, 1999, MOL CELL BIOL, V19, P392; Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; Bartholdy B, 2004, GENE, V327, P1, DOI 10.1016/j.gene.2003.11.008; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; de Andres B, 2002, BLOOD, V100, P4074, DOI 10.1182/blood-2002-03-0809; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fortunel NO, 2003, SCIENCE, V302, P393; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Hagman J, 2005, TRENDS IMMUNOL, V26, P455, DOI 10.1016/j.it.2005.07.001; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 2000, IMMUNOL REV, V175, P94, DOI 10.1034/j.1600-065X.2000.017503.x; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	41	43	43	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2007	26	4					421	431		10.1016/j.immuni.2007.03.010	http://dx.doi.org/10.1016/j.immuni.2007.03.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17442597	Bronze			2022-12-18	WOS:000246126400008
J	Stunz, LL; Busch, LK; Munroe, ME; Sigmund, CD; Tygrett, LT; Waldschmidt, TJ; Bishop, GA				Stunz, LL; Busch, LK; Munroe, ME; Sigmund, CD; Tygrett, LT; Waldschmidt, TJ; Bishop, GA			Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture	IMMUNITY			English	Article							MEMBRANE-PROTEIN 1; NF-KAPPA-B; PRIMARY IMMUNE-RESPONSE; BARR-VIRUS LMP1; LATENT MEMBRANE-PROTEIN-1; TRANSFORMING PROTEIN; IL-6 PRODUCTION; ANTI-DSDNA; IN-SITU; CD40	The oncogenic EBV protein LMP1 mimics a dysregulated CD40 receptor in vitro. To compare CD40 and LMP1-mediated events in vivo, transgenic mice were engineered to express mouse CD40 (mCD40tg) or a protein with extracellular mCD40 and cytoplasmic LMP1 (mCD40-LMP1tg). Transgenic and CD40(-/-) mice were bred so that only the transgenic CD40 molecule is expressed in B cells, macrophages, and dendritic cells. mCD40-LMP1tg mice had normal lymphocyte subsets, and immunization elicited an antibody response featuring normal isotype switching, affinity maturation, and germinal center (GC) formation. However, unimmunized mCD40-LMP1tg mice had expanded immature and germinal center B cells, produced autoantibodies, exhibited marked splenomegaly and lymphadenopathy, and elevated serum IL-6. Thus, signaling through the LMP1 cytoplasmic tail results in amplified and abnormal mimicry of CD40 functions in vivo, indicating possible ways in which LMP1 contributes to the pathogenesis of EBV-associated human disease.	Univ Iowa, Grad Program Mol Biol, Iowa City, IA 52242 USA; Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; VA Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Grad Program Mol Biol, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu	Sigmund, Curt D./W-1611-2019; Busch, Lisa/K-6195-2018	Sigmund, Curt D./0000-0002-1453-0921; Busch, Lisa/0000-0002-7493-7547; Munroe, Melissa/0000-0002-6933-9745; Bishop, Gail/0000-0002-1291-5078; Waldschmidt, Thomas/0000-0001-6147-6991	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260] Funding Source: NIH RePORTER; NCI NIH HHS [CA09997] Funding Source: Medline; NIAID NIH HHS [T32 AI007260] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AARDEN LA, 1975, ANN NY ACAD SCI, V254, P505, DOI 10.1111/j.1749-6632.1975.tb29197.x; Ardila-Osorio H, 1999, INT J CANCER, V81, P645, DOI 10.1002/(SICI)1097-0215(19990517)81:4<645::AID-IJC22>3.0.CO;2-0; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; BISHOP GA, 1995, EUR J IMMUNOL, V25, P1230, DOI 10.1002/eji.1830250515; Bishop GA, 2001, CURR OPIN IMMUNOL, V13, P278, DOI 10.1016/S0952-7915(00)00216-8; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; FENNEWALD S, 1984, J VIROL, V51, P411, DOI 10.1128/JVI.51.2.411-419.1984; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Hsing Y, 1999, J IMMUNOL, V162, P2804; HUEN DS, 1995, ONCOGENE, V10, P549; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; James JA, 1998, IMMUNOL REV, V164, P185, DOI 10.1111/j.1600-065X.1998.tb01220.x; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KIBERD BA, 1993, J AM SOC NEPHROL, V4, P58; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Kurzrock R, 2001, BIOMED PHARMACOTHER, V55, P543, DOI 10.1016/S0753-3322(01)00140-8; LIEBOWITZ D, 1986, J VIROL, V58, P233, DOI 10.1128/JVI.58.1.233-237.1986; LONG EO, 1991, HUM IMMUNOL, V31, P229, DOI 10.1016/0198-8859(91)90092-N; Lorenz HM, 2001, SCAND J CLIN LAB INV, V61, P16, DOI 10.1080/003655101753352004; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Marai I., 2003, Human Antibodies, V12, P57; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nishimoto N, 2000, BLOOD, V95, P56, DOI 10.1182/blood.V95.1.56; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Rhodus NL, 1999, QUINTESSENCE INT, V30, P689; Rolink AG, 2001, CURR OPIN IMMUNOL, V13, P202, DOI 10.1016/S0952-7915(00)00205-3; Sanders RW, 1997, J ORTHOP TRAUMA, V11, P1, DOI 10.1097/00005131-199701000-00001; Schiffer LE, 2002, LUPUS, V11, P885, DOI 10.1191/0961203302lu311rr; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Shoenfeld Y, 2003, TRENDS IMMUNOL, V24, P2, DOI 10.1016/S1471-4906(02)00007-8; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; TANG B, 1991, INT IMMUNOL, V3, P273, DOI 10.1093/intimm/3.3.273; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Waldschmidt TJ, 2002, BLOOD, V100, P4557, DOI 10.1182/blood-2002-04-1232; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255	59	43	45	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					255	266		10.1016/j.immuni.2004.07.008	http://dx.doi.org/10.1016/j.immuni.2004.07.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308105	Bronze			2022-12-18	WOS:000223441900013
J	Thomas, RM; Schmedt, C; Novelli, M; Choi, BK; Skok, J; Tarakhovsky, A; Roes, J				Thomas, RM; Schmedt, C; Novelli, M; Choi, BK; Skok, J; Tarakhovsky, A; Roes, J			C-terminal Src kinase controls acute inflammation and granulocyte adhesion	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; FAMILY KINASES; SIGNAL-TRANSDUCTION; CONSTITUTIVE ACTIVATION; EXTRACELLULAR-MATRIX; INTEGRIN; CSK; NEUTROPHILS; DEFICIENT; PAXILLIN	To establish whether the widely expressed regulator of Src family kinases Csk contributes to the control of acute inflammation in vivo, we inactivated csk in granulocytes by conditional mutagenesis (Cre/IoxP). Mutant mice (Csk-GEcre) developed acute multifocal inflammation in skin and lung. Animals were protected from the disease in a microbiologically controlled environment, but remained hypersensitive to LPS-induced shock. Csk-deficient granulocytes showed enhanced spontaneous and ligand-induced degranulation with hyperinduction of integrins. This hyperresponsiveness was associated with hyperadhesion and impaired migratory responses in vitro. Hyperphosphorylation of key signaling proteins such as Syk and Paxillin in mutant granulocytes further supported breakdown of the activation threshold set by Csk. By enforcing the need for ligand engagement Csk thus prevents premature granulocyte recruitment while supporting the motility of stimulated cells through negative regulation of cell adhesion.	UCL, Dept Immunol & Mol Pathol, Windeyer Inst Med Sci, London W1T 4JF, England; Dept Histopathol, London WC1E 6JJ, England; Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA	University of London; University College London; Rockefeller University	Roes, J (corresponding author), UCL, Dept Immunol & Mol Pathol, Windeyer Inst Med Sci, 46 Cleveland St, London W1T 4JF, England.	j.roes@ucl.ac.uk	Skok, Jane/ABF-7249-2020	Skok, Jane/0000-0002-4145-1516; Roes, Jurgen/0000-0003-3235-2345				BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; BERGMAN M, 1995, MOL CELL BIOL, V15, P711; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; JOHNSON MML, 1994, ARCH DERMATOL, V130, P77, DOI 10.1001/archderm.130.1.77; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kohara Y, 2001, IMMUNOGENETICS, V53, P15, DOI 10.1007/s002510000286; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; METCALF D, 1995, BLOOD, V85, P2364, DOI 10.1182/blood.V85.9.2364.bloodjournal8592364; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 1999, J IMMUNOL, V162, P1120; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; NADA S, 1994, ONCOGENE, V9, P3571; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Shultz L D, 1991, Semin Immunol, V3, P397; Suen PW, 1999, J CELL SCI, V112, P4067; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Turner CE, 2000, J CELL SCI, V113, P4139; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Vestergaard C, 2000, MOL MED TODAY, V6, P209, DOI 10.1016/S1357-4310(00)01683-X; Wang B, 2001, MOL CELL BIOL, V21, P1077, DOI 10.1128/MCB.21.4.1077-1088.2001; WEEDON D, 1997, SKIN PATHOLOGY; Zhou XM, 2001, J BIOL CHEM, V276, P44762, DOI 10.1074/jbc.M104029200	47	43	45	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					181	191		10.1016/S1074-7613(04)00023-8	http://dx.doi.org/10.1016/S1074-7613(04)00023-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975240	Bronze			2022-12-18	WOS:000221442400007
J	Achour, A; Michaelsson, J; Harris, RA; Odeberg, J; Grufman, P; Sandberg, JK; Levitsky, V; Karre, K; Sandalova, T; Schneider, G				Achour, A; Michaelsson, J; Harris, RA; Odeberg, J; Grufman, P; Sandberg, JK; Levitsky, V; Karre, K; Sandalova, T; Schneider, G			A structural basis for LCMV immune evasion: Subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure analyses	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ESCAPE VIRAL VARIANTS; CLASS-I MOLECULES; 3-DIMENSIONAL STRUCTURE; ANTIGENIC PEPTIDES; BINDING-SITE; COMPLEX; SELECTION; AMINO; VIVO	LCMV infection of H-2(b) mice generates a CD8(+) CTL response mainly directed toward three immunodominant epitopes. One of these, gp33, is presented by both H-2D(b) and H-2K(b) MHC class I molecules. The virus can escape immune recognition in the context of both these MHC class I molecules through single mutations of the peptide. In order to understand the underlying structural mechanism, we determined the crystal structures of both complexes. The structures reveal that the peptide is presented in two diametrically opposed manners by H-2D(b) and H-21K(b), with residues used as anchor positions in one MHC class I molecule interacting with the TCR in the other. Importantly, the peptide's N-terminal residue p1K protrudes from the binding cleft in H-2K(b). We present structural evidence that explains the functional consequences of single mutations found in escape variants.	Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; Karolinska Hosp, Ctr Mol Med, S-10401 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Royal Sch Technol, Dept Biochem, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Royal Institute of Technology	Achour, A (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden.		Harris, Robert A./I-6234-2019; Odeberg, Jacob/I-8314-2016; Odeberg, Jacob O/O-3336-2014	Harris, Robert A./0000-0003-4990-509X; Odeberg, Jacob/0000-0003-0996-1644; Odeberg, Jacob O/0000-0003-0996-1644; Schneider, Gunter/0000-0003-0622-5713; Sandalova, Tatyana/0000-0002-7694-6420; Sandberg, Johan/0000-0002-6275-0750; Achour, Adnane/0000-0003-0432-710X				AEBISCHER T, 1991, P NATL ACAD SCI USA, V88, P11047, DOI 10.1073/pnas.88.24.11047; Bachmann MF, 1998, EUR J IMMUNOL, V28, P3110; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Borrow P, 1998, IMMUNOL REV, V164, P37, DOI 10.1111/j.1600-065X.1998.tb01206.x; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; FAHNESTOCK ML, 1994, BIOCHEMISTRY-US, V33, P8149, DOI 10.1021/bi00192a020; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Glithero A, 1999, IMMUNITY, V10, P63, DOI 10.1016/S1074-7613(00)80007-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hudrisier D, 1996, J BIOL CHEM, V271, P17829, DOI 10.1074/jbc.271.30.17829; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEWICKI H, 1995, VIROLOGY, V210, P29, DOI 10.1006/viro.1995.1314; Lucas M, 2001, INT J EXP PATHOL, V82, P269, DOI 10.1046/j.1365-2613.2001.00204.x; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MOSKOPHIDIS D, 1995, J VIROL, V69, P2187, DOI 10.1128/JVI.69.4.2187-2193.1995; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Connor D, 2001, IMMUNOL LETT, V79, P77, DOI 10.1016/S0165-2478(01)00268-1; OTWINOWSKI Z, 1993, OSCILLATION DATA RED; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Stryhn A, 2000, EUR J IMMUNOL, V30, P3089, DOI 10.1002/1521-4141(200011)30:11<3089::AID-IMMU3089>3.0.CO;2-5; Tissot AC, 2000, J MOL BIOL, V302, P873, DOI 10.1006/jmbi.2000.4501; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu XN, 2001, IMMUNITY, V15, P867, DOI 10.1016/S1074-7613(01)00255-2; Yague J, 2001, J BIOL CHEM, V276, P43699, DOI 10.1074/jbc.M105981200; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zinkernagel RM, 1999, IMMUNOL REV, V168, P305, DOI 10.1111/j.1600-065X.1999.tb01300.x	46	43	45	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					757	768		10.1016/S1074-7613(02)00478-8	http://dx.doi.org/10.1016/S1074-7613(02)00478-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479822	Bronze			2022-12-18	WOS:000179985500008
J	Minegishi, Y; Conley, ME				Minegishi, Y; Conley, ME			Negative selection at the pre-BCR checkpoint elicited by human mu heavy chains with unusual CDR3 regions	IMMUNITY			English	Article							B-CELL DEVELOPMENT; SURROGATE LIGHT-CHAIN; REACTIVE LYMPHOCYTES-B; BINDING-PROTEIN; PREFERENTIAL UTILIZATION; SOMATIC HYPERMUTATION; V(D)J RECOMBINATION; SURFACE EXPRESSION; ANTIGEN RECEPTOR; V REGIONS	Approximately 9% of in-frame mu heavy chain transcripts found in normal human pro-B cells encode proteins that can be expressed on the cell surface in the absence of surrogate or conventional light chains. These unusual mu heavy chains demonstrate preferential use of certain VH genes (VH3-23), frequent expression of DH regions in underrepresented reading frames, and an increased number of positively charged amino acids within the CDR3 region. Transcripts for these proteins are not found in pre-B cells or in mature B cells. When expressed in Jurkat T cells with the Ig alpha /Ig beta signal transduction module, these aberrant mu heavy chains induce cell activation and apoptosis. These results suggest that some mu heavy chains elicit negative selection at the pro-B cell to pre-B cell transition.	St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Conley, ME (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale, Memphis, TN 38105 USA.				NCI NIH HHS [P30 CA21765] Funding Source: Medline; NIAID NIH HHS [AI25129] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025129, R56AI025129, R01AI025129] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; BAKHSHI A, 1986, P NATL ACAD SCI USA, V83, P2689, DOI 10.1073/pnas.83.8.2689; BRAUN J, 1992, J CLIN INVEST, V89, P1395, DOI 10.1172/JCI115728; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; Conley ME, 1998, AM J HUM GENET, V62, P1034, DOI 10.1086/301828; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; COSTA TE, 1992, J EXP MED, V175, P1669, DOI 10.1084/jem.175.6.1669; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.biochem.59.1.439; DECKER DJ, 1995, J IMMUNOL, V154, P4924; FRANKLIN EC, 1976, J IMMUNOL, V116, P1194; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; Horne MC, 1996, IMMUNITY, V4, P145, DOI 10.1016/S1074-7613(00)80679-2; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KEYNA U, 1995, J IMMUNOL, V155, P5536; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; Klein U, 1998, IMMUNOL REV, V162, P261; Lassoued K, 1996, J EXP MED, V183, P421, DOI 10.1084/jem.183.2.421; LAWLER AM, 1987, P NATL ACAD SCI USA, V84, P2454, DOI 10.1073/pnas.84.8.2454; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Milili M, 1996, EUR J IMMUNOL, V26, P63, DOI 10.1002/eji.1830260110; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Papavasiliou F, 1996, J EXP MED, V184, P2025, DOI 10.1084/jem.184.5.2025; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; POLLOK BA, 1987, P NATL ACAD SCI USA, V84, P9199, DOI 10.1073/pnas.84.24.9199; RAAPHORST FM, 1992, EUR J IMMUNOL, V22, P247, DOI 10.1002/eji.1830220136; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; Rohrer J, 1999, BLOOD, V94, P3358, DOI 10.1182/blood.V94.10.3358.422k04_3358_3365; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; STEWART AK, 1994, BLOOD, V83, P1717; ten Boekel E, 1998, IMMUNITY, V8, P199; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tornberg UC, 1998, J EXP MED, V187, P703, DOI 10.1084/jem.187.5.703; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003	59	43	43	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2001	14	5					631	641		10.1016/S1074-7613(01)00131-5	http://dx.doi.org/10.1016/S1074-7613(01)00131-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371364	Bronze			2022-12-18	WOS:000168880900014
J	Baker, JE; Cado, D; Raulet, DH				Baker, JE; Cado, D; Raulet, DH			Developmentally programmed rearrangement of T cell receptor V gamma genes is controlled by sequences immediately upstream of the V gamma genes	IMMUNITY			English	Article							V(D)J RECOMBINATION; ANTIGEN RECEPTORS; ALPHA-BETA; TCR-BETA; LOCUS; CHAIN; THYMOCYTES; EXPRESSION; ENHANCER; REPERTOIRE	Distinct subsets of gamma delta T cells expressing different V gamma and V delta chains arise in ordered waves during thymic development. In the murine J gamma 1-C gamma 1 cluster, the V gamma 3 gene segment is utilized earliest in fetal thymic development, in progenitors of dendritic epidermal T cells (DECs). The V gamma 2 gene segment predominates in the late fetal stages and beyond, in cells destined for the secondary lymphoid organs. Using transgenic TCR gamma recombination substrates, we demonstrate that this restricted V gamma gene usage is determined by developmentally targeted gene rearrangement. We show that sequences immediately upstream of the V gamma 2 and V gamma 3 genes direct the rearrangement pattern in adult thymocytes. Thus, the choice of V gamma gene for recombination is coordinated with distinct differentiation programs in gamma delta subsets.	Univ Calif Berkeley, Canc Res Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Canc Res Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.			Raulet, David/0000-0002-1257-8649	NIAID NIH HHS [R01-AI31650] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031650] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; ALVAREZ JD, 1995, J IMMUNOL, V155, P1191; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CLAUSELL A, 1994, MOL CELL BIOL, V14, P803, DOI 10.1128/MCB.14.1.803; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DILLON N, 1991, NATURE, V350, P252, DOI 10.1038/350252a0; ELLIOTT JF, 1988, NATURE, V331, P627; EZEKIEL UR, 1995, IMMUNITY, V2, P381, DOI 10.1016/1074-7613(95)90146-9; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; HEYBORNE K, 1993, J IMMUNOL, V151, P4523; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; KALLENBACH S, 1993, EUR J IMMUNOL, V23, P1917, DOI 10.1002/eji.1830230828; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; KAPPES DJ, 1991, P NATL ACAD SCI USA, V88, P2204, DOI 10.1073/pnas.88.6.2204; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Marshall AJ, 1996, J IMMUNOL, V156, P2077; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; MARUSICGALESIC S, 1988, J IMMUNOL, V140, P411; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SPENCER DM, 1991, P NATL ACAD SCI USA, V88, P800, DOI 10.1073/pnas.88.3.800; SPERLING AI, 1992, J IMMUNOL, V149, P3200; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; SULLIVAN S, 1985, J INVEST DERMATOL, V84, P491, DOI 10.1111/1523-1747.ep12273454; tenBoekel E, 1997, IMMUNITY, V7, P357; VERNOOIJ BTM, 1993, GENOMICS, V17, P566, DOI 10.1006/geno.1993.1373; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	43	43	43	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1998	9	2					159	168		10.1016/S1074-7613(00)80598-1	http://dx.doi.org/10.1016/S1074-7613(00)80598-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729036	Bronze			2022-12-18	WOS:000075610300002
J	CHERVONSKY, AV; XU, JC; BARLOW, AK; KHERY, M; FLAVELL, RA; JANEWAY, CA				CHERVONSKY, AV; XU, JC; BARLOW, AK; KHERY, M; FLAVELL, RA; JANEWAY, CA			DIRECT PHYSICAL INTERACTION INVOLVING CD40 LIGAND ON T-CELLS AND CD40 ON B-CELLS IS REQUIRED TO PROPAGATE MMTV	IMMUNITY			English	Article							MAMMARY-TUMOR VIRUS; CLONAL DELETION; MOUSE; SUPERANTIGEN; ACTIVATION; ANTIGEN; INFECTION; EXPRESSION; RECEPTOR; GENE	The propagation of mouse mammary tumor virus (MMTV) has been analyzed in mice defective for expression of CD40 ligand (CD40L). Mice with endogenous viral superantigen (SAG) delete T cells with cognate Vp independent of CD40L expression. Nevertheless, CD40L(-) mice do not show deletion of cognate T cells after being exposed to infectious MMTV and have greatly diminished viral replication. The response of CD40L(-) T cells to SAG in vitro is also impaired, but can be reconstituted by adding B cells activated by recombinant CD40L to express costimulatory molecules. Thus, direct CD40L-dependent B cell activation appears to be a critical step in the life cycle of MMTV. The initial step in SAG-dependent T cell activation, and hence the MMTV life cycle, may be mediated by non-B cells, because splenocytes from B cell-deficient SAG-transgenic mice are able to activate cognate T cells.	BOEHRINGER INGELHEIM PHARMACEUT INC,RIDGEFIELD,CT 06877	Boehringer Ingelheim	CHERVONSKY, AV (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.			Chervonsky, Alexander/0000-0001-7547-871X	NIAID NIH HHS [AI-14579] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014579, R37AI014579] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1991, NATURE, V350, P207, DOI 10.1038/350207a0; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BEUTNER U, 1994, J EXP MED, V179, P1457, DOI 10.1084/jem.179.5.1457; CHOI YW, 1991, NATURE, V350, P203, DOI 10.1038/350203a0; COFFMAN RL, 1983, IMMUNOL REV, V69, P5, DOI 10.1111/j.1600-065X.1983.tb00446.x; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; GOLOVKINA TV, 1994, J EXP MED, V179, P439, DOI 10.1084/jem.179.2.439; GOLOVKINA TV, 1992, CELL, V69, P637, DOI 10.1016/0092-8674(92)90227-4; HALLENBAUGH D, 1994, J CLIN INVEST, V94, P616; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HELD W, 1993, J EXP MED, V177, P359, DOI 10.1084/jem.177.2.359; HELD W, 1993, CELL, V74, P529, DOI 10.1016/0092-8674(93)80054-I; HELD W, 1994, IMMUNOL TODAY, V15, P184, DOI 10.1016/0167-5699(94)90317-4; HELD W, 1994, J EXP MED, V180, P2347, DOI 10.1084/jem.180.6.2347; HODGKIN PD, 1990, J IMMUNOL, V145, P2025; IGNATOWICZ L, 1992, J EXP MED, V175, P917, DOI 10.1084/jem.175.4.917; JONES LA, 1993, INT IMMUNOL, V5, P503, DOI 10.1093/intimm/5.5.503; KAISERLIAN D, 1993, EUR J IMMUNOL, V23, P2717, DOI 10.1002/eji.1830231053; KANAGAWA O, 1989, J EXP MED, V170, P1513, DOI 10.1084/jem.170.5.1513; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KARAPETIAN O, 1994, J EXP MED, V180, P1511, DOI 10.1084/jem.180.4.1511; Kehry M R, 1994, Semin Immunol, V6, P287, DOI 10.1006/smim.1994.1037; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LIAO NS, 1989, J EXP MED, V170, P135, DOI 10.1084/jem.170.1.135; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LIU H, 1991, P NATL ACAD SCI USA, V88, P8705, DOI 10.1073/pnas.88.19.8705; MARRACK P, 1991, NATURE, V349, P525; MARSHAKROTHSTEI.A, 1979, J IMMUNOL, V122, P2491; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOELLE RJ, 1990, J IMMUNOL, V146, P1118; SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SQUARTINI F, 1970, CANCER RES, V30, P2069; TSUBURA A, 1988, CANCER RES, V48, P6555; WAANDERS GA, 1993, J EXP MED, V177, P1359, DOI 10.1084/jem.177.5.1359; WEBB SR, 1993, IMMUNOL REV, V131, P168; WEBER GF, 1994, J IMMUNOL, V152, P4433; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	43	43	43	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					139	146		10.1016/1074-7613(95)90166-3	http://dx.doi.org/10.1016/1074-7613(95)90166-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7542547	Bronze			2022-12-18	WOS:A1995RK86800015
J	Kreutmair, S; Unger, S; Nunez, NG; Ingelfinger, F; Alberti, C; De Feo, D; Krishnarajah, S; Kauffmann, M; Friebel, E; Babaei, S; Gaborit, B; Lutz, M; Jurado, NP; Malek, NP; Goepel, S; Rosenberger, P; Haberle, HA; Ayoub, I; Al-Hajj, S; Nilsson, J; Claassen, M; Liblau, R; Martin-Blondel, G; Bitzer, M; Roquilly, A; Becher, B				Kreutmair, Stefanie; Unger, Susanne; Nunez, Nicolas Gonzalo; Ingelfinger, Florian; Alberti, Chiara; De Feo, Donatella; Krishnarajah, Sinduya; Kauffmann, Manuel; Friebel, Ekaterina; Babaei, Sepideh; Gaborit, Benjamin; Lutz, Mirjam; Jurado, Nicole Puertas; Malek, Nisar P.; Goepel, Siri; Rosenberger, Peter; Haeberle, Helene A.; Ayoub, Ikram; Al-Hajj, Sally; Nilsson, Jakob; Claassen, Manfred; Liblau, Roland; Martin-Blondel, Guillaume; Bitzer, Michael; Roquilly, Antoine; Becher, Burkhard			Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia	IMMUNITY			English	Article							T-CELLS; INFECTION; CYTOMETRY; RESPONSES; IMMUNE; MILD	Immune profiling of COVID-19 patients has identified numerous alterations in both innate and adaptive immunity. However, whether those changes are specific to SARS-CoV-2 or driven by a general inflammatory response shared across severely ill pneumonia patients remains unknown. Here, we compared the immune profile of severe COVID-19 with non-SARS-CoV-2 pneumonia ICU patients using longitudinal, high-dimensional single-cell spectral cytometry and algorithm-guided analysis. COVID-19 and non-SARS-CoV-2 pneumonia both showed increased emergency myelopoiesis and displayed features of adaptive immune paralysis. However, pathological immune signatures suggestive of T cell exhaustion were exclusive to COVID-19. The integration of single-cell profiling with a predicted binding capacity of SARS-CoV-2 peptides to the patients' HLA profile further linked the COVID-19 immunopathology to impaired virus recognition. Toward clinical translation, circulating NKT cell frequency was identified as a predictive biomarker for patient outcome. Our comparative immune map serves to delineate treatment strategies to interfere with the immunopathologic cascade exclusive to severe COVID-19.	[Kreutmair, Stefanie; Unger, Susanne; Nunez, Nicolas Gonzalo; Ingelfinger, Florian; Alberti, Chiara; De Feo, Donatella; Krishnarajah, Sinduya; Kauffmann, Manuel; Friebel, Ekaterina; Lutz, Mirjam; Jurado, Nicole Puertas; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Kreutmair, Stefanie] German Canc Consortium DKTK, D-79106 Freiburg, Germany; [Kreutmair, Stefanie] German Canc Res Ctr, Partner Site Freiburg, D-79106 Freiburg, Germany; [Babaei, Sepideh; Malek, Nisar P.; Goepel, Siri; Claassen, Manfred; Bitzer, Michael] Eberhard Karls Univ Tubingen, Dept Internal Med 1, D-72076 Tubingen, Germany; [Gaborit, Benjamin; Roquilly, Antoine] Univ Nantes, Serv Anesthesie Reanimat Chirurg, CHU Nantes, Pole Anesthesie Reanimat, F-44093 Nantes, France; [Goepel, Siri] German Ctr Infect Res DZIF, Partner Site Tuebingen, D-72076 Tubingen, Germany; [Rosenberger, Peter; Haeberle, Helene A.] Eberhard Karls Univ Tubingen, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany; [Ayoub, Ikram; Al-Hajj, Sally; Liblau, Roland; Martin-Blondel, Guillaume] Univ Toulouse, CNRS, Toulouse Inst Infect & Inflammatory Dis, Inst Natl Sante & Rech Med,UPS, F-31024 Toulouse, France; [Nilsson, Jakob] Univ Hosp Zurich, Dept Immunol, CH-8006 Zurich, Switzerland; [Martin-Blondel, Guillaume] Toulouse Univ Hosp, Dept Infect & Trop Dis, F-31059 Toulouse, France	University of Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Nantes Universite; CHU de Nantes; German Center for Infection Research; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Zurich; University Zurich Hospital; CHU de Toulouse	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020; Martin-Blondel, Guillaume/K-6762-2014; Friebel, Ekaterina/ABF-1308-2021; Kreutmair, Stefanie/AAE-6952-2022; Kreutmair, Stefanie/GOK-2757-2022	Becher, Burkhard/0000-0002-1541-7867; Martin-Blondel, Guillaume/0000-0002-8363-7028; Friebel, Ekaterina/0000-0003-1419-2376; Kreutmair, Stefanie/0000-0001-8466-6675; Gaborit, Benjamin/0000-0002-6076-9722; De Feo, Donatella/0000-0003-0121-5364; Roquilly, Antoine/0000-0002-1029-6242; Bitzer, Michael/0000-0002-4463-8263; Ingelfinger, Florian/0000-0001-6890-9753; Krishnarajah, Sinduya/0000-0003-2348-1751	biological resource center for biobanking (CHU Nantes, Nantes Universite', Centre de Ressources Biologiques, Nantes, France) [BB-0033-00040]; Swiss National Science Foundation [733 310030_170320, 310030_188450, CRSII5_183478, 31CA30_195883]; LOOP Zurich; Vontobel Foundation; European Union [847782]; European Research Council (ERC) [882424]; Agence National de la Recherche (ANR); Region Pays de la Loire -Flash COVID-19:COVARDS project; French Ministry of Health; Deutsche Forschungsgemeinschaft (DFG); University Research Priority Program (URPP) postdoctoral fellowship; Studienstiftung des Deutschen Volkes	biological resource center for biobanking (CHU Nantes, Nantes Universite', Centre de Ressources Biologiques, Nantes, France); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); LOOP Zurich; Vontobel Foundation; European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Region Pays de la Loire -Flash COVID-19:COVARDS project; French Ministry of Health; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University Research Priority Program (URPP) postdoctoral fellowship; Studienstiftung des Deutschen Volkes	We thank the patients and blood donors who contributed to this study and the hospitals at Nantes, Toulouse, and T_ubingen for sample and data collection. Regarding specifically the COVID-BioToul biobank (ClinicalTrials.gov identifier NCT04385108), we thank the CRB TBR, the Clinical Research Center 1436, and the delegation for clinical research and innovation of Toulouse University Hospital for their highly valuable implication. We thank the biological resource center for biobanking (CHU Nantes, Nantes Universite ', Centre de Ressources Biologiques [BB-0033-00040], Nantes, France). This work was supported by the Swiss National Science Foundation (733 310030_170320, 310030_188450, and CRSII5_183478 to B.B.; 31CA30_195883 to S. Kreutmair, M.C., M.B., and B.B.), The LOOP Zurich, the Vontobel Foundation (to B.B.), the European Union's Horizon 2020 research and innovation program under grant 847782 (to B.B. and A.R.) and the European Research Council (ERC; 882424) to B.B., Agence National de la Recherche (ANR) and Region Pays de la Loire -Flash COVID-19:COVARDS project (to A.R.) and the French Ministry of Health with the participation of Groupement Interregional de Recherche Clinique et d'Innovation Sud-Ouest Outre-Mer (PHRCI 2020 IMMUNOMARK-COV) (to R.L. and G.M.-B.). S. Kreutmair is a recipient of a postdoctoral fellowship from Deutsche Forschungsgemeinschaft (DFG). N.G.N. is a recipient of a University Research Priority Program (URPP) postdoctoral fellowship. F.I. received a PhD fellowship from Studienstiftung des Deutschen Volkes. We thank Dr. Lucy Robinson from Insight Editing London for critical review and editing of the manuscript.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bonaventura A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01625; Bosteels C, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04451-7; Bravo E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0266-y; Breillat P., 2020, IMPAIRED TYPE INTERF, DOI [10.1101/2020.04.19, DOI 10.1101/2020.04.19]; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; Cohen J., 1977, PREFACE ORIGINAL, pxiii, DOI [10.1016/B978-0-12-179060-8.50005-0, DOI 10.1016/B978-0-12-179060-8.50005-0]; Cook H, 2015, J IMMUNOL, V194; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; De Biasi S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17292-4; De Luca G, 2020, LANCET RHEUMATOL, V2, pE465, DOI 10.1016/S2665-9913(20)30170-3; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Dempsey LA, 2018, NAT IMMUNOL, V19, P99, DOI 10.1038/s41590-017-0039-1; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Erokhina SA, 2021, J LEUKOCYTE BIOL, V109, P327, DOI 10.1002/JLB.3RU0420-668RR; Feng Z., 2020, MEDRXIV, p2020.03.27.20045427, DOI 10.1101/2020.03.27.20045427; Fergusson JR, 2016, MUCOSAL IMMUNOL, V9, P401, DOI 10.1038/mi.2015.69; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Flament H, 2021, EUR J IMMUNOL, V51, P298, DOI 10.1038/s41590-021-00870-z; Fontana MF, 2018, IMMUNITY, V48, P198, DOI 10.1016/j.immuni.2018.02.008; Galli E, 2019, EUR J IMMUNOL, V49, P212, DOI 10.1002/eji.201847758; Han MF, 2020, MED MICROBIOL IMMUN, V209, P657, DOI 10.1007/s00430-020-00693-z; Hartmann FJ, 2016, J EXP MED, V213, P2621, DOI 10.1084/jem.20160897; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang HH, 2019, CELL MOL IMMUNOL, V16, P602, DOI 10.1038/s41423-018-0164-2; Iadecola C, 2020, CELL, V183, P16, DOI 10.1016/j.cell.2020.08.028; Idzikowski E., 2020, MEDRXIV PREPR SERV H; Iturrieta-Zuazo I, 2020, CLIN IMMUNOL, V219, DOI 10.1016/j.clim.2020.108572; Iype E., 2020, UNDERSTANDING ASYMME, DOI [10.1101/2020.04.21.20073791, DOI 10.1101/2020.04.21.20073791]; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jouan Y, 2020, J EXP MED, V217, DOI 10.1084/jem.20200872; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Korol C., SCIENCE, V370; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kvedaraite E, PERTURBATIONS MONONU, DOI [10.1101/2020.08.25.20181404, DOI 10.1101/2020.08.25.20181404]; Lang FM, 2020, NAT REV IMMUNOL, V20, P507, DOI 10.1038/s41577-020-0357-7; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Leone M, 2018, ANAESTH CRIT CARE PA, V37, P83, DOI 10.1016/j.accpm.2017.11.006; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3981; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Nakano H, 2017, J LEUKOCYTE BIOL, V101, P1143, DOI 10.1189/jlb.1A0616-285R; Nguyen A, 2020, J VIROL, V94, DOI 10.1128/JVI.00510-20; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1; R Development Core Team, 2018, R LANG ENV STAT COMP; Roquilly A, 2019, LANCET RESP MED, V7, P710, DOI 10.1016/S2213-2600(19)30140-7; Roquilly A, 2017, IMMUNITY, V47, P135, DOI 10.1016/j.immuni.2017.06.021; RStudio Team, 2015, RSTUDIO INT DEV ENV; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002; Souza, 2020, 20200728225912 BIORX; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Thwaites RS, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg9873; Tian WM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19706-9; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vella L., 2020, BIORXIV PREPR SERV B; Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069; World Health Organization, WHO R D BLU NOV COR; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu X, 2014, BRIT J CANCER, V111, P1391, DOI 10.1038/bjc.2014.416; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zhao Y, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf6692; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zingaropoli MA, 2021, CLIN IMMUNOL, V222, DOI 10.1016/j.clim.2020.108630	86	42	42	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1578	+		10.1016/j.immuni.2021.05.002	http://dx.doi.org/10.1016/j.immuni.2021.05.002		JUL 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34051147	hybrid, Green Published			2022-12-18	WOS:000672812100019
J	da Silva, HB; Peng, CW; Wang, HG; Wanhainen, KM; Ma, CY; Lopez, S; Khoruts, A; Zhang, N; Jameson, SC				da Silva, Henrique Borges; Peng, Changwei; Wang, Haiguang; Wanhainen, Kelsey M.; Ma, Chaoyu; Lopez, Sharon; Khoruts, Alexander; Zhang, Nu; Jameson, Stephen C.			Sensing of ATP via the Purinergic Receptor P2RX7 Promotes CD8(+) Trm Cell Generation by Enhancing Their Sensitivity to the Cytokine TGF-beta	IMMUNITY			English	Article							MEMORY T-CELLS; RESIDENT MEMORY; P2X7 RECEPTOR; CUTTING EDGE; ACTIVATION; EXPRESSION; MIGRATION; DIFFERENTIATION; MAINTENANCE; HOMEOSTASIS	Tissue-resident memory (Trm) CD8(+) T cells mediate protective immunity in barrier tissues, but the cues promoting Trm cell generation are poorly understood. Sensing of extracellular adenosine triphosphate (eATP) by the purinergic receptor P2RX7 is needed for recirculating CD8(+) T cell memory, but its role for Trm cells is unclear. Here we showed that P2RX7 supported Trm cell generation by enhancing CD8(+) T cell sensing of TGF-beta, which was necessary for tissue residency. P2RX7-deficient Mtn cells progressively decayed in nonlymphoid tissues and expressed dysregulated Trm-specific markers. P2RX7 was required for efficient reexpression of the receptor TGF-beta RII through calcineurin signaling. Forced Tgfbr2 expression rescued P2RX7-deficient Trm cell generation, and TGF-beta sensitivity was dictated by P2RX7 agonists and antagonists. Forced Tgfbr2 also rescued P2RX7-deficient Trm cell mitochondrial function. Sustained P2RX7 signaling was required for long-term Trm cell maintenance, indicating that P2RX7 signaling drives induction and CD8(+ )T cell durability in barrier sites.	[da Silva, Henrique Borges; Peng, Changwei; Wang, Haiguang; Wanhainen, Kelsey M.; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Ma, Chaoyu; Zhang, Nu] Univ Texas Hlth San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA; [Lopez, Sharon; Khoruts, Alexander] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health San Antonio; University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013; Khoruts, Alexander/ABF-5119-2020	Jameson, Stephen C/0000-0001-9137-1146; Khoruts, Alexander/0000-0002-3205-3188; Borges da Silva, Henrique/0000-0001-9424-3326	NIAID [K99/R00 AI139381, R01 AI038903, AI145147]; Paul C. Shiverick/CRI Irvington fellowship	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul C. Shiverick/CRI Irvington fellowship	We thank Wanjun Chen (NIDCR) for providing the MiT-Tgfbr2 overexpression vector. We also thank the members of the Jamequist lab for critically reviewing the manuscript. S.C.J. was funded by NIAID (R01 AI038903 and AI145147). H.B.d.S. was funded by NIAID (K99/R00 AI139381) and a Paul C. Shiverick/CRI Irvington fellowship.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Alanio C, 2018, J IMMUNOL, V200, P139, DOI 10.4049/jimmunol.1700564; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chu C, 2019, NATURE, V574, P543, DOI 10.1038/s41586-019-1644-y; da Silva HB, 2019, J IMMUNOL, V202, P2153, DOI 10.4049/jimmunol.1801613; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Dosch M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041222; Farber DL, 2016, NAT REV IMMUNOL, V16, P124, DOI 10.1038/nri.2016.13; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Ferrari D, 1996, J IMMUNOL, V156, P1531; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Iijima N, 2015, TRENDS IMMUNOL, V36, P556, DOI 10.1016/j.it.2015.07.002; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jung YW, 2016, P NATL ACAD SCI USA, V113, P8278, DOI 10.1073/pnas.1602899113; Khadra A, 2013, BIOPHYS J, V104, P2612, DOI 10.1016/j.bpj.2013.05.006; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li CF, 2019, IMMUNITY, V51, P491, DOI 10.1016/j.immuni.2019.08.013; Ma CY, 2017, J IMMUNOL, V198, P749, DOI 10.4049/jimmunol.1601500; Ma CY, 2015, P NATL ACAD SCI USA, V112, P11013, DOI 10.1073/pnas.1510119112; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mani V, 2019, SCIENCE, V366, P202, DOI 10.1126/science.aav5728; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Milner JJ, 2018, CURR OPIN IMMUNOL, V51, P162, DOI 10.1016/j.coi.2018.03.017; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nath AP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210495; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Perruzza L, 2017, CELL REP, V18, P2566, DOI 10.1016/j.celrep.2017.02.061; Priyadharshini B, 2018, J IMMUNOL, V201, P2215, DOI 10.4049/jimmunol.1800311; Proietti M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08156-z; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Renkema KR, 2016, J EXP MED, V213, P1319, DOI 10.1084/jem.20151359; Rissiek B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01580; Rissiek B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00204; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schwartzkopff S, 2015, EUR J IMMUNOL, V45, P2212, DOI 10.1002/eji.201545634; Seki A, 2018, J EXP MED, V215, P985, DOI 10.1084/jem.20171626; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Stark R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau1022; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tu E, 2018, IMMUNITY, V48, P745, DOI 10.1016/j.immuni.2018.03.025; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wanhainen K.M., 2019, IMMUNOMETABOLISM, V1; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	59	42	42	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					158	+		10.1016/j.immuni.2020.06.010	http://dx.doi.org/10.1016/j.immuni.2020.06.010			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32640257	Green Accepted, Bronze			2022-12-18	WOS:000551116800017
J	Tummers, B; Mari, L; Guy, CS; Heckmann, BL; Rodriguez, DA; Ruhl, S; Moretti, J; Crawford, JC; Fitzgerald, P; Kanneganti, TD; Janke, LJ; Pelletier, S; Blander, JM; Green, DR				Tummers, Bart; Mari, Luigi; Guy, Clifford S.; Heckmann, Bradlee L.; Rodriguez, Diego A.; Ruhl, Sebastian; Moretti, Julien; Crawford, Jeremy Chase; Fitzgerald, Patrick; Kanneganti, Thirumala-Devi; Janke, Laura J.; Pelletier, Stephane; Blander, J. Magarian; Green, Douglas R.			Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis	IMMUNITY			English	Article							NF-KAPPA-B; NLRP3 INFLAMMASOME; PSEUDOKINASE MLKL; MOLECULAR SWITCH; CASPASE-8; IL-1-BETA; APOPTOSIS; ACTIVATION; MATURATION; ROLES	Cell death pathways regulate various homeostatic processes. Autoimmune lymphoproliferative syndrome (ALPS) in humans and lymphoproliferative (LPR) disease in mice result from abrogated CD95-induced apoptosis. Because caspase-8 mediates CD95 signaling, we applied genetic approaches to dissect the roles of caspase-8 in cell death and inflammation. Here, we describe oligomerization-deficient Caspase-8(F122GL123G/F122GL123G) and non-cleavable CaSPaSe-8(D387A)(/D3)(87A) mutant mice with defective caspase-8-mediated apoptosis. Although neither mouse developed LPR disease, removal of the necroptosis effector MIkl from CaSPaSe-8(D387A/D387A) mice revealed an inflammatory role of caspase-8. Ablation of one allele of Fasl, Fadd, or Ripk1 prevented the pathology of Casp8(D387A/D387A )Mlkl(-/-) animals. Removing both Fadd alleles from these mice resulted in early lethality prior to post-natal day 15 (P15), which was prevented by co-ablation of either Ripk1 or Caspase-1. Our results suggest an in vivo role of the inflammatory RIPK1-caspase-8-FADD (FADDosome) complex and reveal a FADD-independent inflammatory role of caspase-8 that involves activation of an inflammasome.	[Tummers, Bart; Mari, Luigi; Guy, Clifford S.; Heckmann, Bradlee L.; Rodriguez, Diego A.; Ruhl, Sebastian; Crawford, Jeremy Chase; Fitzgerald, Patrick; Kanneganti, Thirumala-Devi; Pelletier, Stephane; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Janke, Laura J.] St Jude Childrens Res Hosp, Dept Pathol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Moretti, Julien; Blander, J. Magarian] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA; [Blander, J. Magarian] Cornell Univ, Joan & Sanford I Weill Dept Med, Gastroenterol & Hepatol Div, Weill Cornell Med, New York, NY 10021 USA; [Blander, J. Magarian] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA; [Blander, J. Magarian] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10021 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Cornell University; Cornell University; Cornell University; Cornell University	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	douglas.green@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Crawford, Jeremy Chase/G-5711-2013	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Crawford, Jeremy Chase/0000-0003-4096-6048; Moretti, Julien/0000-0002-3415-9058; Rodriguez, Diego/0000-0003-4771-0221; Mari, Luigi/0000-0002-2903-7689	National Institutes of Health [AI44828, CA231620, AI127658]; Paul Barrett Endowed Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Barrett Endowed Fellowship	The authors thank Dr. David Boyd and Dr. Marie Wehenkel for thoughtful discussions, suggestions, and technical assistance. This work was supported by National Institutes of Health AI44828 and CA231620 (to D.R.G.) and AI127658 (to J.M.B.), and the Paul Barrett Endowed Fellowship (to B.T.).	Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Chauhan D, 2018, CELL REP, V25, P2354, DOI 10.1016/j.celrep.2018.10.087; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Fu TM, 2016, MOL CELL, V64, P236, DOI 10.1016/j.molcel.2016.09.009; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gong YT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1029-8; Grunert M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.154; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hartwig T, 2017, MOL CELL, V65, P730, DOI 10.1016/j.molcel.2017.01.021; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee KH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091057; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Manda P, 2018, IMMUNITY, V49, P42, DOI 10.1016/j.immuni.2018.06.011; Meynier S, 2019, IMMUNOL REV, V287, P50, DOI 10.1111/imr.12720; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Newton K, 2019, NATURE, V574, P428, DOI 10.1038/s41586-019-1548-x; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Philip NH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005910; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Ruan ZH, 2019, CURR MED SCI, V39, P513, DOI 10.1007/s11596-019-2067-6; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Sellin ME, 2015, TRENDS IMMUNOL, V36, P442, DOI 10.1016/j.it.2015.06.002; Shen C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35153-5; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Stammler D, 2015, J IMMUNOL, V195, P5421, DOI 10.4049/jimmunol.1501195; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Vince JE, 2018, CELL REP, V25, P2339, DOI 10.1016/j.celrep.2018.10.103; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang CJ, 2018, J CLIN INVEST, V128, P5399, DOI 10.1172/JCI121901	57	42	44	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					994	+		10.1016/j.immuni.2020.04.010	http://dx.doi.org/10.1016/j.immuni.2020.04.010			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32428502	Green Accepted, Bronze			2022-12-18	WOS:000541890000014
J	Pokrovskii, M; Hall, JA; Ochayon, DE; Yi, R; Chaimowitz, NS; Seelamneni, H; Carriero, N; Watters, A; Waggoner, SN; Littman, DR; Bonneau, R; Miraldi, ER				Pokrovskii, Maria; Hall, Jason A.; Ochayon, David E.; Yi, Ren; Chaimowitz, Natalia S.; Seelamneni, Harsha; Carriero, Nicholas; Watters, Aaron; Waggoner, Stephen N.; Littman, Dan R.; Bonneau, Richard; Miraldi, Emily R.			Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells	IMMUNITY			English	Article							T-BET; EXPRESSION DATA; READ ALIGNMENT; NK; DIFFERENTIATION; PLASTICITY; FATE; BCL6; HETEROGENEITY; INFLAMMATION	Innate lymphoid cells (ILCs) promote tissue homeostasis and immune defense but also contribute to inflammatory diseases. ILCs exhibit phenotypic and functional plasticity in response to environmental stimuli, yet the transcriptional regulatory networks (TRNs) that control ILC function are largely unknown. Here, we integrate gene expression and chromatin accessibility data to infer regulatory interactions between transcription factors (TFs) and genes within intestinal type 1, 2, and 3 ILC subsets. We predicted the "core'' TFs driving ILC identities, organized TFs into cooperative modules controlling distinct gene programs, and validated roles for c-MAF and BCL6 as regulators affecting type 1 and type 3 ILC lineages. The ILC network revealed alternative-lineage-gene repression, a mechanism that may contribute to reported plasticity between ILC subsets. By connecting TFs to genes, the TRNs suggest means to selectively regulate ILC effector functions, while our network approach is broadly applicable to identifying regulators in other in vivo cell populations.	[Pokrovskii, Maria; Hall, Jason A.; Littman, Dan R.] NYU, Skirball Inst, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Ochayon, David E.; Chaimowitz, Natalia S.; Seelamneni, Harsha; Waggoner, Stephen N.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Ochayon, David E.; Chaimowitz, Natalia S.; Seelamneni, Harsha; Waggoner, Stephen N.; Miraldi, Emily R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Yi, Ren; Bonneau, Richard] NYU, Dept Biol, New York, NY 10003 USA; [Yi, Ren; Bonneau, Richard] NYU, Dept Comp Sci, New York, NY 10003 USA; [Carriero, Nicholas; Watters, Aaron; Bonneau, Richard] Flatiron Inst, Ctr Computat Biol, New York, NY 10010 USA; [Littman, Dan R.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA; [Miraldi, Emily R.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Miraldi, Emily R.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	New York University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; New York University; New York University; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Littman, DR (corresponding author), NYU, Skirball Inst, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA.; Bonneau, R (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.; Bonneau, R (corresponding author), NYU, Dept Comp Sci, New York, NY 10003 USA.; Bonneau, R (corresponding author), Flatiron Inst, Ctr Computat Biol, New York, NY 10010 USA.; Littman, DR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA.	dan.littman@med.nyu.edu; bonneau@nyu.edu	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022	Waggoner, Stephen/0000-0001-9658-2874; Ohayon, David/0000-0002-5226-5110	Cincinnati Children's Research Foundation; Simons Foundation; NIH [5T32AI100853, R01-DK103358-01, DA038017, R01-GM112192-01, T32 CA009161, AR47363, DK78392, DK90971]; Howard Hughes Medical Institute; Damon Runyon Cancer Research Foundation (Dale and Betty Frey Fellowship); Colton Center for Autoimmunity; NIH cancer center support grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NATIONAL CANCER INSTITUTE [T32CA009161, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103358, P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122515, R01GM112192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA038017] Funding Source: NIH RePORTER	Cincinnati Children's Research Foundation; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Damon Runyon Cancer Research Foundation (Dale and Betty Frey Fellowship); Colton Center for Autoimmunity; NIH cancer center support grant at the Laura and Isaac Perlmutter Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Flatiron Institute Scientific Computing Core (I. Fisk) and the NYU School of Medicine Genome Technology Core (GTC) (A. Heguy and P. Zappile). This work was supported by the Cincinnati Children's Research Foundation (Trustee Award to E.R.M., Research Innovation Award to S.N.W., Research In Residency Award to N.S.C., and Arnold P. Strauss Fellowship to D.O.), the Simons Foundation (E.R.M., A.W., N.D., N.C., and R.B.), the NIH (5T32AI100853 to M.P.; R01-DK103358-01 to R.B. and D.R.L.; DA038017 to S.N.W.; and R01-GM112192-01 to R.B., and T32 CA009161 [Levy] to J.A.H.), Howard Hughes Medical Institute (D.R.L.), Damon Runyon Cancer Research Foundation (Dale and Betty Frey Fellowship to J.A.H.), and the Colton Center for Autoimmunity (D.R.L). The NYU GTC was supported by NIH cancer center support grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. Cell sorting and flow cytometric data acquired atCincinnati Children's relied on equipment maintained by the Research Flow Cytometry Core, which is supported in part by NIH grants AR47363, DK78392, and DK90971.	Adams NM, 2018, IMMUNITY, V48, P1172, DOI 10.1016/j.immuni.2018.04.018; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arrieta-Ortiz ML, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156236; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Blatti C, 2015, NUCLEIC ACIDS RES, V43, P3998, DOI 10.1093/nar/gkv195; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P277, DOI 10.1016/j.coi.2012.03.011; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gray J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9412; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Gustafsson M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2722; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Held W, 2003, EUR J IMMUNOL, V33, P1393, DOI 10.1002/eji.200323840; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim AI, 2017, CURR OPIN IMMUNOL, V44, P61, DOI 10.1016/j.coi.2017.03.010; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Liu Han, 2010, Adv Neural Inf Process Syst, V24, P1432; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy MT, 2014, BIOINFORMATICS, V30, P1302, DOI 10.1093/bioinformatics/btt774; Melo-Gonzalez F, 2017, IMMUNOLOGY, V150, P265, DOI 10.1111/imm.12697; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Miraldi ER, 2019, GENOME RES, V29, P449, DOI 10.1101/gr.238253.118; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Pope SD, 2018, MOL CELL, V71, P389, DOI 10.1016/j.molcel.2018.07.017; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabacal W, 2016, P NATL ACAD SCI USA, V113, P5370, DOI 10.1073/pnas.1521491113; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Studham ME, 2014, BIOINFORMATICS, V30, P130, DOI 10.1093/bioinformatics/btu285; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van de Pavert SA, 2016, INT IMMUNOL, V28, P35, DOI 10.1093/intimm/dxv052; Verrier T, 2016, J IMMUNOL, V196, P4731, DOI 10.4049/jimmunol.1502673; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wojno EDT, 2016, J EXP MED, V213, P2229, DOI 10.1084/jem.20160525; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	84	42	42	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					185	+		10.1016/j.immuni.2019.06.001	http://dx.doi.org/10.1016/j.immuni.2019.06.001			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31278058	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000475561000020
J	Lim, HY; Lim, SY; Tan, CK; Thiam, CH; Goh, CC; Carbajo, D; Chew, SHS; See, P; Chakarov, S; Wang, XN; Lim, LH; Johnson, LA; Lum, J; Fong, CY; Bongso, A; Biswas, A; Goh, C; Evrard, M; Yeo, KP; Basu, R; Wang, JK; Tan, YR; Jain, R; Tikoo, S; Choong, C; Weninger, W; Poidinger, M; Stanley, ER; Collin, M; Tan, NS; Ng, LG; Jackson, DG; Ginhoux, F; Angeli, V				Lim, Hwee Ying; Lim, Sheau Yng; Tan, Chek Kun; Thiam, Chung Hwee; Goh, Chi Ching; Carbajo, Daniel; Chew, Samantha Hui Shang; See, Peter; Chakarov, Svetoslav; Wang, Xiao Nong; Lim, Li Hui; Johnson, Louise A.; Lum, Josephine; Fong, Chui Yee; Bongso, Ariff; Biswas, Arijit; Goh, Chern; Evrard, Maximilien; Yeo, Kim Pin; Basu, Ranu; Wang, Jun Kit; Tan, Yingrou; Jain, Rohit; Tikoo, Shweta; Choong, Cleo; Weninger, Wolfgang; Poidinger, Michael; Stanley, E. Richard; Collin, Matthew; Tan, Nguan Soon; Ng, Lai Guan; Jackson, David G.; Ginhoux, Florent; Angeli, Veronique			Hyaluronan Receptor LYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen(vol 49, 326, 2018)	IMMUNITY			English	Correction												micva@nus.edu.sg	Tikoo, Shweta/AAX-1902-2021; Chakarov, Svetoslav/AAC-9283-2019; Stanley, Evan R/J-9154-2013	Tikoo, Shweta/0000-0001-5850-8075; Chakarov, Svetoslav/0000-0002-0665-5417; Stanley, Evan R/0000-0002-2910-2065; Jain, Rohit/0000-0002-4905-462X; Johnson, Louise/0000-0001-6667-8912	MRC [MC_UU_00008/2, MC_UU_12010/2] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.12.009, 10.1016/j.immuni.2018.06.008]	1	42	42	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1191	1191		10.1016/j.immuni.2018.12.009	http://dx.doi.org/10.1016/j.immuni.2018.12.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX		Green Submitted, Bronze			2022-12-18	WOS:000453556500021
J	Spidale, NA; Sylvia, K; Narayan, K; Miu, B; Frascoli, M; Melichar, HJ; Wu, ZH; Kisielow, J; Palin, A; Serwold, T; Love, P; Kobayashi, M; Yoshimoto, M; Jain, N; Kang, J				Spidale, Nicholas A.; Sylvia, Katelyn; Narayan, Kavitha; Miu, Bing; Frascoli, Michela; Melichar, Heather J.; Wu Zhihao; Kisielow, Jan; Palin, Amy; Serwold, Thomas; Love, Paul; Kobayashi, Michihiro; Yoshimoto, Momoko; Jain, Nitya; Kang, Joonsoo			Interleukin-17-Producing gamma delta T Cells Originate from SOX13(+) Progenitors that Are Independent of gamma delta TCR Signaling	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; INNATE LYMPHOID-CELLS; LINEAGE COMMITMENT; ALPHA-BETA; DENDRITIC CELLS; FETAL THYMUS; INKT CELLS; ADULT MICE; EXPRESSION; DIFFERENTIATION	Lineage-committed alpha beta and gamma delta T cells are thought to originate from common intrathymic multipotent progenitors following instructive T cell receptor (TCR) signals. A subset of lymph node and mucosal V gamma 2(+) gamma delta T cells is programmed intrathymically to produce IL-17 (T gamma delta 17 cells), however the role of the gamma delta TCR in development of these cells remains controversial. Here we generated reporter mice for the T gamma delta 17 lineage-defining transcription factor SOX13 and identified fetal-origin, intrathymic Sox13(+) progenitors. In organ culture developmental assays, T gamma delta 17 cells derived primarily from Sox13(+) progenitors, and not from other known lymphoid progenitors. Single cell transcriptome assays of the progenitors found in TCR-deficient mice demonstrated that T gamma delta 17 lineage programming was independent of gamma delta TCR. Instead, generation of the lineage committed progenitors and T gamma delta 17 cells was controlled by TCF1 and SOX13. Thus, T lymphocyte lineage fate can be prewired cell-intrinsically and is not necessarily specified by clonal antigen receptor signals.	[Spidale, Nicholas A.; Sylvia, Katelyn; Narayan, Kavitha; Miu, Bing; Frascoli, Michela; Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 02135 USA; [Melichar, Heather J.] Hop Maison Neuve Rosemont, Ctr Rech, Immunooncol Res Axis, Montreal, PQ H1T 2M4, Canada; [Wu Zhihao] Nanyang Technol Univ, Sch Biol Sci, Div Genom & Genet, SBS 04n-23,60 Nanyang Dr, Singapore 637551, Singapore; [Kisielow, Jan] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Palin, Amy; Love, Paul] Natl Inst Child Hlth & Human Dev NICHD, NIH, Bethesda, MD 20892 USA; [Serwold, Thomas] Harvard Med Sch, Immunobiol Sect, Joslin Diabet Ctr, Boston, MA 02215 USA; [Kobayashi, Michihiro; Yoshimoto, Momoko] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med Stem Cell Res, McGovern Med Sch, Houston, TX 77030 USA; [Jain, Nitya] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Jain, Nitya] Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA	University of Massachusetts System; University of Massachusetts Worcester; Universite de Montreal; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kang, J (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 02135 USA.	joonsoo.kang@umassmed.edu	Yoshimoto, Momoko/AFP-3523-2022	Yoshimoto, Momoko/0000-0002-7272-6682; Palin, Amy/0000-0002-7724-9563; Kisielow, Jan/0000-0002-4482-5202	NIH/NCI [CA100382, AI101301, AR071269]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA100382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121197, R01AI101301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071269] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Bhandoola for reagents, N. Malhotra, S. Kumar, and H.J. Felhing for unpublished data, K. Richards-Hrdlicka and K. Tanriverdi for assistance with C1/BioMark assays, P. Wang and H. Wang for assistance with RNA-seq data analysis, Y.M. Morillon II for critical reading of the manuscript, and UMMS FACS Core for cell sorting. Supported by NIH/NCI grants CA100382, AI101301, and AR071269 to J.K.	Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Buus TB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01963-w; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chien YH, 2013, TRENDS IMMUNOL, V34, P151, DOI 10.1016/j.it.2012.11.004; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Coffey F, 2014, J EXP MED, V211, P329, DOI 10.1084/jem.20131540; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; de Andres B, 2002, BLOOD, V100, P4074, DOI 10.1182/blood-2002-03-0809; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Grigoriadou K, 2003, J IMMUNOL, V171, P2413, DOI 10.4049/jimmunol.171.5.2413; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; Hwang S, 2012, J EXP MED, V209, P1781, DOI 10.1084/jem.20120058; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; Kang J, 2015, ANNU REV IMMUNOL, V33, P505, DOI 10.1146/annurev-immunol-032414-112025; Kashani E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7477; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee SY, 2014, IMMUNITY, V41, P934, DOI 10.1016/j.immuni.2014.10.021; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Luche H, 2011, EUR J IMMUNOL, V41, P2165, DOI 10.1002/eji.201141728; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Mair F, 2015, ELIFE, V4, DOI 10.7554/eLife.10087; Malhotra N, 2018, J EXP MED, V215, P2887, DOI 10.1084/jem.20172021; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Munoz-Ruiz M, 2016, NAT IMMUNOL, V17, P721, DOI 10.1038/ni.3424; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Narayan K, 2010, SEMIN IMMUNOL, V22, P222, DOI 10.1016/j.smim.2010.04.003; Nitta T, 2015, EMBO REP, V16, P638, DOI 10.15252/embr.201540096; Park K, 2010, EMBO J, V29, P2329, DOI 10.1038/emboj.2010.113; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2014, J IMMUNOL, V192, P2210, DOI 10.4049/jimmunol.1302145; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Veinotte LL, 2006, BLOOD, V107, P2673, DOI 10.1182/blood-2005-07-2797; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wei YL, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00118; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557	64	42	42	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					857	+		10.1016/j.immuni.2018.09.010	http://dx.doi.org/10.1016/j.immuni.2018.09.010			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30413363	Bronze, Green Accepted			2022-12-18	WOS:000450752200012
J	Gilchuk, P; Kuzmina, N; Ilinykh, PA; Huang, K; Gunn, BM; Bryan, A; Davidson, E; Doranz, BJ; Turner, HL; Fusco, ML; Bramble, MS; Hoff, NA; Binshtein, E; Kose, N; Flyak, AI; Flinko, R; Orlandi, C; Carnahan, R; Parrish, EH; Sevy, AM; Bombardi, RG; Singh, PK; Mukadi, P; Muyembe-Tamfum, JJ; Ohi, MD; Saphire, EO; Lewis, GK; Alter, G; Ward, AB; Rimoin, AW; Bukreyev, A; Crowe, JE				Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A.; Huang, Kai; Gunn, Bronwyn M.; Bryan, Aubrey; Davidson, Edgar; Doranz, Benjamin J.; Turner, Hannah L.; Fusco, Marnie L.; Bramble, Matthew S.; Hoff, Nicole A.; Binshtein, Elad; Kose, Nurgun; Flyak, Andrew I.; Flinko, Robin; Orlandi, Chiara; Carnahan, Robert; Parrish, Erica H.; Sevy, Alexander M.; Bombardi, Robin G.; Singh, Prashant K.; Mukadi, Patrick; Muyembe-Tamfum, Jean Jacques; Ohi, Melanie D.; Saphire, Erica Ollmann; Lewis, George K.; Alter, Galit; Ward, Andrew B.; Rimoin, Anne W.; Bukreyev, Alexander; Crowe, James E., Jr.			Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein	IMMUNITY			English	Article							NIEMANN-PICK C1; CRYO-EM STRUCTURE; VIRUS-INFECTION; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODIES; HUMAN SURVIVOR; DISEASE; BINDING; HIV; FILOVIRUSES	Ebolaviruses cause severe disease in humans, and identification of monoclonal antibodies (mAbs) that are effective against multiple ebolaviruses are important for therapeutics development. Here we describe a distinct class of broadly neutralizing human mAbs with protective capacity against three ebolaviruses infectious for humans: Ebola (EBOV), Sudan (SUDV), and Bundibugyo (BDBV) viruses. We isolated mAbs from human survivors of ebolavirus disease and identified a potent mAb, EBOV-520, which bound to an epitope in the glycoprotein (GP) base region. EBOV-520 efficiently neutralized EBOV, BDBV, and SUDV and also showed protective capacity in relevant animal models of these infections. EBOV-520 mediated protection principally by direct virus neutralization and exhibited multifunctional properties. This study identified a potent naturally occurring mAb and defined key features of the human antibody response that may contribute to broad protection. This multifunctional mAb and related clones are promising candidates for development as broadly protective pan-ebolavirus therapeutic molecules.	[Gilchuk, Pavlo; Carnahan, Robert; Parrish, Erica H.; Bombardi, Robin G.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Flyak, Andrew I.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Sevy, Alexander M.; Crowe, James E., Jr.] Vanderbilt Univ, Chem & Phys Biol Program, Nashville, TN 37232 USA; [Binshtein, Elad; Singh, Prashant K.; Ohi, Melanie D.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Kuzmina, Natalia; Ilinykh, Philipp A.; Huang, Kai; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Kuzmina, Natalia; Ilinykh, Philipp A.; Huang, Kai; Bukreyev, Alexander] Galveston Natl Lab, Galveston, TX 77550 USA; [Bukreyev, Alexander] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gunn, Bronwyn M.; Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Bryan, Aubrey; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA 19104 USA; [Turner, Hannah L.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Fusco, Marnie L.; Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Bramble, Matthew S.; Hoff, Nicole A.; Rimoin, Anne W.] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Bramble, Matthew S.; Rimoin, Anne W.] Childrens Natl Med Ctr, Dept Genet Med Res, Childrens Res Inst, Washington, DC 20010 USA; [Flinko, Robin; Orlandi, Chiara; Lewis, George K.] Univ Maryland, Sch Med, Div Vaccine Res, Inst Human Virol, Baltimore, MD 21201 USA; [Mukadi, Patrick; Muyembe-Tamfum, Jean Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California Los Angeles; Children's National Health System; University System of Maryland; University of Maryland Baltimore; Institute Nacional de Recherche Biomedical	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Chem & Phys Biol Program, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.; Bukreyev, A (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Bukreyev, A (corresponding author), Galveston Natl Lab, Galveston, TX 77550 USA.; Bukreyev, A (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	alexander.bukreyev@utmb.edu; james.crowe@vanderbilt.edu	Ward, Andrew B/F-9203-2014; Crowe, James/B-5549-2009; Ward, Andrew/ABD-7728-2021; Hoff, Nicole/ABE-9171-2021; Huang, Kai/H-9309-2018; Carnahan, Robert H/N-7429-2013; Kuzmina, Natalia/AAY-8589-2020	Ward, Andrew B/0000-0001-7153-3769; Crowe, James/0000-0002-0049-1079; Ward, Andrew/0000-0001-7153-3769; Huang, Kai/0000-0002-3373-5594; Carnahan, Robert H/0000-0001-5230-1532; Kuzmina, Natalia/0000-0001-6650-9369; Bramble, Matthew/0000-0003-1216-7134; Flyak, Andrew/0000-0002-8722-479X; Mukadi, Patrick/0000-0001-9312-9345; Binshtein, Elad/0000-0003-2745-104X; Ohi, Melanie/0000-0003-1750-4793	U.S. NIH [U19 AI109711, R01 AI067927, U19 AI109762]; Defense Threat Reduction Agency [HDTRA1-13-1-0034]; HHS [HHSN272201400058C]; Defense Advanced Research Project Agency [W31P4Q-14-1-0010]; Fogarty International Center of the National Institutes of Health (NIH) [D43TW009343]; University of California Global Health Institute (UCGHI); Bill and Melinda Gates Foundation; Atreca, Inc.; NCRR [UL1 RR024975-01, 2 UL1 TR000445-06]; NIH [P30 CA68485, DK058404, 5UC7AI094660-07, 1S10OD021737]; Animal Resource Center of the Galveston National Laboratory; FOGARTY INTERNATIONAL CENTER [D43TW009343] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002243, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109711, U19AI109762, R01AI067927, UC7AI094660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021737] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); HHS(United States Department of Health & Human Services); Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Fogarty International Center of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute (UCGHI); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Atreca, Inc.; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Animal Resource Center of the Galveston National Laboratory; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Emile Okitolonda Wemakoy and Benoit Kebela Illunga who oversaw sample collection in DRC. We thank Drs. Morris Ibeawuchi, Ada Igonoh, and Benjamin Ohiaeri for advice and assistance with human subject matters related to the Nigerian outbreak. We thank Cinque Soto and Andre Branchizio for assistance with data visualization. The Jurkat-EBOV GP cell line and the protocol for cell surface GP cleavage were a kind gift from Carl Davis and Rafi Ahmed. This work was supported by U.S. NIH grants U19 AI109711 (to J.E.C. and A. Bukreyev), R01 AI067927 (to E.O.S.), and U19 AI109762 (to E.O.S. and A.B.W.), Defense Threat Reduction Agency grant HDTRA1-13-1-0034 (to J.E.C. and A. Bukreyev), HHS contract HHSN272201400058C (to J.E.C. and B.J.D.), Defense Advanced Research Project Agency grant W31P4Q-14-1-0010 (to J.E.C.), Fogarty International Center of the National Institutes of Health (NIH) under award number D43TW009343 and the University of California Global Health Institute (UCGHI) (to M.S.B.), and funding from the Bill and Melinda Gates Foundation (to J.E.C. and A.W.R. by subcontract from Atreca, Inc.). E.O.S. is an Investigator in the Pathogenesis of Infectious Disease of the Burroughs Welcome Fund. The project was supported by NCRR grant UL1 RR024975-01, which is now at the National Center for Advancing Translational Sciences, grant 2 UL1 TR000445-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Flow cytometry experiments were performed in the VUMC Flow Cytometry Shared Resource, supported by NIH grants P30 CA68485 and DK058404. The Intellicyt iQue is managed within the Vanderbilt Antibody and Protein Resource and was funded by NIH Shared Instrumentation Grant 1S10OD021737. The EM work was conducted at The Scripps Research Institute electron microscopy facility. Work in BSL-4/ABSL-4 containment of the Galveston National Laboratory was supported by NIH grant 5UC7AI094660-07. Animal studies were supported by the Animal Resource Center of the Galveston National Laboratory.	Bornholdt ZA, 2016, MBIO, V7, DOI 10.1128/mBio.02154-15; Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; CDC, 2017, EB VIR DIS; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Domi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19041-y; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Flyak AI, 2018, NAT MICROBIOL, V3, P670, DOI 10.1038/s41564-018-0157-z; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Howell KA, 2017, CELL REP, V19, P413, DOI 10.1016/j.celrep.2017.03.049; Howell KA, 2016, CELL REP, V15, P1514, DOI 10.1016/j.celrep.2016.04.026; Ilinykh PA, 2016, J VIROL, V90, P3890, DOI 10.1128/JVI.00101-16; Keck ZY, 2016, J VIROL, V90, P279, DOI 10.1128/JVI.02172-15; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kozak R, 2016, J VIROL, V90, P9209, DOI 10.1128/JVI.01033-16; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Orlandi C, 2016, J IMMUNOL METHODS, V433, P51, DOI 10.1016/j.jim.2016.03.002; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Raymond J, 2011, J INFECT DIS, V204, pS986, DOI 10.1093/infdis/jir335; Sanchez A, 2005, VIRUS RES, V113, P16, DOI 10.1016/j.virusres.2005.03.028; Saphire EO, 2016, TRENDS MICROBIOL, V24, P684, DOI 10.1016/j.tim.2016.05.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Spence JS, 2016, MBIO, V7, DOI 10.1128/mBio.01857-15; Thornburg NJ, 2016, J CLIN INVEST, V126, P1482, DOI 10.1172/JCI85317; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Wong G, 2016, J VIROL, V90, P392, DOI 10.1128/JVI.02331-15; World Health Organization, 2017, 2016 EB VIR DIS FACT; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Zhao XL, 2017, CELL, V169, P891, DOI 10.1016/j.cell.2017.04.038	52	42	43	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					363	+		10.1016/j.immuni.2018.06.018	http://dx.doi.org/10.1016/j.immuni.2018.06.018			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30029854	Green Published, hybrid			2022-12-18	WOS:000442354500020
J	Leonard, JD; Gilmore, DC; Dileepan, T; Nawrocka, WI; Chao, JL; Schoenbach, MH; Jenkins, MK; Adams, EJ; Savage, PA				Leonard, John D.; Gilmore, Dana C.; Dileepan, Thamotharampillai; Nawrocka, Wioletta I.; Chao, Jaime L.; Schoenbach, Mary H.; Jenkins, Marc K.; Adams, Erin J.; Savage, Peter A.			Identification of Natural Regulatory T Cell Epitopes Reveals Convergence on a Dominant Autoantigen	IMMUNITY			English	Article							SELF-ANTIGEN; EXPRESSION; REPERTOIRE; POPULATION; SELECTION; PEPTIDE; TCR; TOLERANCE; DIVERSITY; MAINTAIN	Regulatory T (Treg) cells expressing the transcription factor Foxp3 are critical for the prevention of autoimmunity and the suppression of anti-tumor immunity. The major self-antigens recognized by Treg cells remain undefined, representing a substantial barrier to the understanding of immune regulation. Here, we have identified natural Treg cell ligands in mice. We found that two recurrent Treg cell clones, one prevalent in prostate tumors and the other associated with prostatic autoimmune lesions, recognized distinct non-overlapping MHC-class-II-restricted peptides derived from the same prostate-specific protein. Notably, this protein is frequently targeted by autoantibodies in experimental models of prostatic autoimmunity. On the basis of these findings, we propose a model in which Treg cell responses at peripheral sites converge on those self-proteins that are most susceptible to autoimmune attack, and we suggest that this link could be exploited as a generalizable strategy for identifying the Treg cell antigens relevant to human autoimmunity.	[Leonard, John D.; Nawrocka, Wioletta I.; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Gilmore, Dana C.; Chao, Jaime L.; Schoenbach, Mary H.; Savage, Peter A.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Dileepan, Thamotharampillai; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Chicago; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; Savage, PA (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ejadams@uchicago.edu; psavage@bsd.uchicago.edu	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Nawrocka, Wioletta/0000-0001-5019-7196; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996	National Institute of Allergy and Infectious Diseases [R21-AI112758, R01-AI126756, P01-AI035296, T32-AI007090]; National Cancer Institute [T32-CA009594]; NATIONAL CANCER INSTITUTE [T32CA009594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126756, T32AI007090, P01AI035296, R01AI110507, R21AI112758] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Albert Bendelac and Daniel Leventhal for critical reading of the manuscript, Xiufen Chen and Dave Klawon for technical assistance, Ben McDonald and Jeff Bunker for technical assistance, and Stephen Sansom and Georg Hollander for unpublished data. This work was funded by the National Institute of Allergy and Infectious Diseases (R21-AI112758 to P.A.S., R01-AI126756 to E.J.A. and P.A.S., P01-AI035296 to M.J.K., and T32-AI007090 to J.L.C.) and the National Cancer Institute (T32-CA009594 to D.C.G.). J.D.L. is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-2251-16).	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen J, 2015, CURR MOL MED, V15, P550, DOI 10.2174/1566524015666150731100318; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fujimoto N, 2006, J ENDOCRINOL, V190, P793, DOI 10.1677/joe.1.06733; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kieback E, 2016, IMMUNITY, V44, P1114, DOI 10.1016/j.immuni.2016.04.018; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Landegren N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20104; Landegren N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9186; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Legoux FP, 2012, JOVE-J VIS EXP, DOI 10.3791/4420; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; McDonald BD, 2015, IMMUNITY, V43, P859, DOI 10.1016/j.immuni.2015.09.009; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Meng Jing, 2011, Hormones & Cancer, V2, P145, DOI 10.1007/s12672-010-0063-1; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Setiady YY, 2006, BLOOD, V107, P1056, DOI 10.1182/blood-2005-08-3088; Silver P, 2015, J IMMUNOL, V194, P3011, DOI 10.4049/jimmunol.1402650; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Su LF, 2016, P NATL ACAD SCI USA, V113, pE6192, DOI 10.1073/pnas.1611723113; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Tungatt K, 2015, J IMMUNOL, V194, P463, DOI 10.4049/jimmunol.1401785; Turner VM, 2010, J IMMUNOL METHODS, V360, P162, DOI 10.1016/j.jim.2010.06.007; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	54	42	42	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					107	+		10.1016/j.immuni.2017.06.015	http://dx.doi.org/10.1016/j.immuni.2017.06.015			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28709804	Green Accepted, Bronze			2022-12-18	WOS:000405712800013
J	Keppler, SJ; Gasparrini, F; Burbage, M; Aggarwal, S; Frederico, B; Geha, RS; Way, M; Bruckbauer, A; Batista, FD				Keppler, Selina Jessica; Gasparrini, Francesca; Burbage, Marianne; Aggarwal, Shweta; Frederico, Bruno; Geha, Raif S.; Way, Michael; Bruckbauer, Andreas; Batista, Facundo D.			Wiskott-Aldrich Syndrome Interacting Protein Deficiency Uncovers the Role of the Co-receptor CD19 as a Generic Hub for PI3 Kinase Signaling in B Cells	IMMUNITY			English	Article							T-CELL; ACTIN POLYMERIZATION; N-WASP; ANTIGEN RECEPTOR; WIP; ACTIVATION; MICE; TRANSDUCTION; CYTOSKELETON; DIFFERENTIATION	Humans with Wiskott-Aldrich syndrome display a progressive immunological disorder associated with compromised Wiskott-Aldrich Syndrome Interacting Protein (WIP) function. Mice deficient in WIP recapitulate such an immunodeficiency that has been attributed to T cell dysfunction; however, any contribution of B cells is as yet undefined. Here we have shown that WIP deficiency resulted in defects in B cell homing, chemotaxis, survival, and differentiation, ultimately leading to diminished germinal center formation and antibody production. Furthermore, in the absence of WIP, several receptors, namely the BCR, BAFFR, CXCR4, CXCR5, CD40, and TLR4, were impaired in promoting CD19 co-receptor activation and subsequent PI3 kinase (PI3K) signaling. The underlying mechanism was due to a distortion in the actin and tetraspanin networks that lead to altered CD19 cell surface dynamics. In conclusion, our findings suggest that, by regulating the cortical actin cytoskeleton, WIP influences the function of CD19 as a general hub for PI3K signaling.	[Keppler, Selina Jessica; Gasparrini, Francesca; Burbage, Marianne; Aggarwal, Shweta; Frederico, Bruno; Bruckbauer, Andreas; Batista, Facundo D.] Francis Crick Inst, Lymphocyte Interact Lab, London WC2A 3LY, England; [Geha, Raif S.] Harvard Univ, Sch Med, Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Way, Michael] Francis Crick Inst, Cell Motil Lab, London WC2A 3LY, England	Francis Crick Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Francis Crick Institute	Batista, FD (corresponding author), Francis Crick Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	facundo.batista@crick.ac.uk	Burbage, Marianne/GLQ-7327-2022	Burbage, Marianne/0000-0003-0686-2608; Keppler, Selina Jessica/0000-0002-9010-8044; Way, Michael/0000-0001-7207-2722; Frederico, Bruno/0000-0002-6985-3090	Francis Crick Institute; German Research Foundation (DFG) [Ke1737/1-1]; Institute Pasteur-Fondazione Cenci Bolognetti; long-term EMBO fellowship; Royal Society Wolfson Research Merit Award; Cancer Research UK [15691] Funding Source: researchfish; The Francis Crick Institute [10035] Funding Source: researchfish	Francis Crick Institute; German Research Foundation (DFG)(German Research Foundation (DFG)); Institute Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); long-term EMBO fellowship(European Molecular Biology Organization (EMBO)); Royal Society Wolfson Research Merit Award(Royal Society of London); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank all members of the Lymphocyte Interaction Laboratory, Beatriz Montaner for managing the animal colony, Julia Coleman for critical reading of the manuscript, and Jan Sodenkamp and Sabine Zoellner for help with graphics. All the work presented here was supported by The Francis Crick Institute, the German Research Foundation (DFG) grant Ke1737/1-1 (S.J.K.), the Institute Pasteur-Fondazione Cenci Bolognetti (F.G.), a long-term EMBO fellowship (S.A.), and a Royal Society Wolfson Research Merit Award (F.D.B).	Anton IM, 1998, J BIOL CHEM, V273, P20992, DOI 10.1074/jbc.273.33.20992; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Banon-Rodriguez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070364; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Becker-Herman S, 2011, J EXP MED, V208, P2033, DOI 10.1084/jem.20110200; Burbage M, 2015, J EXP MED, V212, P53, DOI 10.1084/jem.20141143; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Curcio C, 2007, J PATHOL, V211, P67, DOI 10.1002/path.2088; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Donnelly SK, 2013, CURR BIOL, V23, P999, DOI 10.1016/j.cub.2013.04.051; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Freeman S.A., 2015, NATURE COMMUNICATION, V6, P1; Fried S, 2014, J LEUKOCYTE BIOL, V96, P713, DOI 10.1189/jlb.2RU0314-162R; Fujimoto M, 1999, J IMMUNOL, V162, P7088; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; Hojer C, 2014, CANCER RES, V74, P4318, DOI 10.1158/0008-5472.CAN-13-3274; Jellusova J, 2013, CELL REP, V5, P1022, DOI 10.1016/j.celrep.2013.10.022; Kumari S, 2015, ELIFE, V4, DOI 10.7554/eLife.04953; Lanzi G, 2012, J EXP MED, V209, P29, DOI 10.1084/jem.20110896; Liu CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001704; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Massaad MJ, 2014, MOL CELL BIOL, V34, P4343, DOI 10.1128/MCB.00533-14; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Otero DC, 2001, J BIOL CHEM, V276, P1474, DOI 10.1074/jbc.M003918200; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Recher M, 2012, BLOOD, V119, P2819, DOI 10.1182/blood-2011-09-379412; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Stewart DM, 1999, J IMMUNOL, V162, P5019; Thrasher Adrian J, 2009, Hematology Am Soc Hematol Educ Program, P132, DOI 10.1182/asheducation-2009.1.132; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Vijayakumar V, 2015, J CELL SCI, V128, P251, DOI 10.1242/jcs.154880; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Westerberg LS, 2012, BLOOD, V119, P3966, DOI 10.1182/blood-2010-09-308197	48	42	43	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					660	673		10.1016/j.immuni.2015.09.004	http://dx.doi.org/10.1016/j.immuni.2015.09.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26453379	hybrid, Green Published			2022-12-18	WOS:000363478700010
J	Joo, H; Li, DP; Dullaers, M; Kim, TW; Duluc, D; Upchurch, K; Xue, YM; Zurawski, S; Le Grand, R; Liu, YJ; Kuroda, M; Zurawski, G; Oh, S				Joo, HyeMee; Li, Dapeng; Dullaers, Melissa; Kim, Tae-Whan; Duluc, Dorothee; Upchurch, Katherine; Xue, Yaming; Zurawski, Sandy; Le Grand, Roger; Liu, Yong-Jun; Kuroda, Marcelo; Zurawski, Gerard; Oh, SangKon			C-Type Lectin-like Receptor LOX-1 Promotes Dendritic Cell-Mediated Class-Switched B Cell Responses	IMMUNITY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TARGETING ANTIGENS; ENDOTHELIAL-CELLS; CCR10 EXPRESSION; SECRETING CELLS; LAMINA PROPRIA; UP-REGULATION; T-CELLS; IGA	Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a pattern-recognition receptor for a variety of endogenous and exogenous ligands. However, LOX-1 function in the host immune response is not fully understood. Here, we report that LOX-1 expressed on dendritic cells (DCs) and B cells promotes humoral responses. On B cells LOX-1 signaling upregulated CCR7, promoting cellular migration toward lymphoid tissues. LOX-1 signaling on DCs licensed the cells to promote B cell differentiation into class-switched plasmablasts and led to downregulation of chemokine receptor CXCR5 and upregulation of chemokine receptor CCR10 on plasmablasts, enabling their exit from germinal centers and migration toward local mucosa and skin. Finally, we found that targeting influenza hemagglutinin 1 (HA1) subunit to LOX-1 elicited HA1-specific protective antibody responses in rhesus macaques. Thus, LOX-1 expressed on B cells and DC cells has complementary functions to promote humoral immune responses.	[Joo, HyeMee; Li, Dapeng; Dullaers, Melissa; Kim, Tae-Whan; Duluc, Dorothee; Upchurch, Katherine; Xue, Yaming; Zurawski, Sandy; Liu, Yong-Jun; Zurawski, Gerard; Oh, SangKon] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Upchurch, Katherine; Zurawski, Gerard; Oh, SangKon] Baylor Univ, Inst Biomed Studies, Waco, TX 76706 USA; [Le Grand, Roger] Commissariat Energie Atom, Div Immunovirol, Inst Emerging Dis & Innovat Therapies, F-922655 Paris, France; [Kuroda, Marcelo] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	Baylor Scott & White Health; Baylor University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Cite; Tulane University	Oh, S (corresponding author), Baylor Inst Immunol Res, 3434 Live Oak St, Dallas, TX 75204 USA.	sangkono@baylorhealth.edu	Li, Dapeng/HGE-1586-2022	Li, Dapeng/0000-0003-0571-5876; Upchurch-Ange, Katherine/0000-0002-9813-3949; Dullaers, Melissa/0000-0003-0223-230X	BHCS Foundation; NIH [U19 AI057234]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	BHCS Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Andres M. Salazar (Oncovir) and Adolfo Garcia-Sastre (Icahn School of Medicine at Mount Sinai) for providing Poly ICLC and influenza viruses, respectively. We thank the FACS Core, Cell Processing Core, Biobank & Project Management Core, Imaging Core, and Luminex Core at the Baylor Institute for Immunology Research. We thank Amy O'Bar and Xiao-Hua Li for providing monoclonal antibodies specific for lectins. We thank Carson Harrod and Jerome Ellis for editing the manuscript. We also thank Jacques Banchereau, Andrew Lackner, and Michael Ramsay for supporting this study. This study was funded by the BHCS Foundation and NIH U19 AI057234.	ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Bassi N, 2009, AUTOIMMUNITY, V42, P289, DOI 10.1080/08916930902828247; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Duluc D, 2014, J IMMUNOL, V192, P5776, DOI 10.4049/jimmunol.1301661; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Kakutani M, 2000, P NATL ACAD SCI USA, V97, P360, DOI 10.1073/pnas.97.1.360; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704; McMahon M, 2007, CURR OPIN IMMUNOL, V19, P633, DOI 10.1016/j.coi.2007.11.001; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; Ni L, 2010, J IMMUNOL, V185, P3504, DOI 10.4049/jimmunol.1000999; Nickel T, 2009, ATHEROSCLEROSIS, V205, P442, DOI 10.1016/j.atherosclerosis.2009.01.002; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Shimaoka T, 2001, J IMMUNOL, V166, P5108, DOI 10.4049/jimmunol.166.8.5108; Shirakawa AK, 2008, J IMMUNOL, V180, P2786, DOI 10.4049/jimmunol.180.5.2786; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Xie J, 2010, J IMMUNOL, V185, P2306, DOI 10.4049/jimmunol.0903214; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x	54	42	42	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					592	604		10.1016/j.immuni.2014.09.009	http://dx.doi.org/10.1016/j.immuni.2014.09.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25308333	Green Accepted, Bronze			2022-12-18	WOS:000345504300013
J	Van Kaer, L; Algood, HMS; Singh, K; Parekh, VV; Greer, MJ; Piazuelo, MB; Weitkamp, JH; Matta, P; Chaturvedi, R; Wilson, KT; Olivares-Villagomez, D				Van Kaer, Luc; Algood, Holly M. Scott; Singh, Kshipra; Parekh, Vrajesh V.; Greer, Michael J.; Piazuelo, M. Blanca; Weitkamp, Joern-Hendrik; Matta, Pranathi; Chaturvedi, Rupesh; Wilson, Keith T.; Olivares-Villagomez, Danyvid			CD8 alpha alpha(+) Innate-Type Lymphocytes in the Intestinal Epithelium Mediate Mucosal Immunity	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; LYMPHOID-CELLS; T-CELLS; INTRAEPITHELIAL LYMPHOCYTES; DENDRITIC CELLS; DIFFERENTIATION; IDENTIFICATION; OSTEOPONTIN; PROGENITORS; PRECURSORS	Innate immune responses are critical for mucosal immunity. Here we describe an innate lymphocyte population, iCD8 alpha cells, characterized by expression of CD8 alpha homodimers. iCD8 alpha cells exhibit innate functional characteristics such as the capacity to engulf and kill bacteria. Development of iCD8 alpha cells depends on expression of interleukin-2 receptor gamma chain (IL-2R gamma c), IL-15, and the major histocompatibility complex (MHC) class Ib protein H2-T3, also known as the thymus leukemia antigen or TL. While lineage tracking experiments indicated that iCD8 alpha cells have a lymphoid origin, their development was independent of the transcriptional suppressor Id2, suggesting that these cells do not belong to the family of innate lymphoid cells. Finally, we identified cells with a similar phenotype in humans, which were profoundly depleted in newborns with necrotizing enterocolitis. These findings suggest a critical role of iCD8 alpha cells in immune responses associated with the intestinal epithelium.	[Van Kaer, Luc; Algood, Holly M. Scott; Parekh, Vrajesh V.; Greer, Michael J.; Wilson, Keith T.; Olivares-Villagomez, Danyvid] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Algood, Holly M. Scott; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA; [Algood, Holly M. Scott; Singh, Kshipra; Piazuelo, M. Blanca; Chaturvedi, Rupesh; Wilson, Keith T.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Weitkamp, Joern-Hendrik; Matta, Pranathi] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Wilson, Keith T.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University	Van Kaer, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.	luc.van.kaer@vanderbilt.edu; danyvid.olivares-villagomez@vanderbilt.edu	Weitkamp, Joern-Hendrik/AAZ-8272-2020; Van Kaer, Luc/H-1033-2015	Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Van Kaer, Luc/0000-0001-5275-2309; Wilson, Keith/0000-0003-4421-1830	Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine - NIH [P30DK058404]; NIH [P30DK058404, R01AI072471, R01AI070305, R01HL089667, R01DK081536, HD061607, R01AT004821]; Office of Medical Research, Department of Veterans Affairs; National Multiple Sclerosis Society of America;  [1K01AT007324]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD061607] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA190612, P01CA028842, P01CA116087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K01AT007324] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765, R01HL089667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070305, R21AI072417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, R01DK081536, P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453, I01BX000915] Funding Source: NIH RePORTER	Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine - NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); National Multiple Sclerosis Society of America(National Multiple Sclerosis Society); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Sebastian Joyce for providing IL-15-deficient mice, Hilde Cheroutre for Cd8a<SUP>tm1.1Litt</SUP>-deficient mice, Kenneth Murphy for Batf3-deficient mice, the NIH Tetramer Core Facility (Emory University) for H2-T3-tetramers, and Marc Jenkins for the GFP-E alpha construct. We also thank Paul Love and LiQi Li for providing intestines from Rag1<SUP>Cre</SUP>ROSA26<SUP>YFP</SUP> mice. This work was supported by a pilot grant from the Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine, funded by NIH grant P30DK058404 (D.O.-V.); by NIH grants R01AI072471, R01AI070305, R01HL089667, and R01DK081536 (L.V.K.); HD061607 (J.H.W.), and R01AT004821 (K.T.W.), and Merit Review Grants from the Office of Medical Research, Department of Veterans Affairs (H.M.S.A. and K.T.W.). V.V.P was supported by a postdoctoral fellowship from the National Multiple Sclerosis Society of America. R.C. was supported by 1K01AT007324. Core Services performed through Vanderbilt University Medical Center's Digestive Disease Research Center are supported by NIH grant P30DK058404.	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Dagur PK, 2011, J AUTOIMMUN, V37, P319, DOI 10.1016/j.jaut.2011.09.003; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inagaki-Ohara K, 2004, J IMMUNOL, V173, P1390, DOI 10.4049/jimmunol.173.2.1390; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kourepini E, 2014, P NATL ACAD SCI USA, V111, pE856, DOI 10.1073/pnas.1316447111; Lambolez F, 2007, IMMUNOL REV, V215, P178, DOI 10.1111/j.1600-065X.2006.00488.x; Lepage AC, 1998, J IMMUNOL, V161, P4902; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Ohteki T, 1997, J IMMUNOL, V159, P5931; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; OLD LJ, 1963, JNCI-J NATL CANCER I, V31, P977; Olivares-Villagomez D, 2011, J IMMUNOL, V187, P4051, DOI 10.4049/jimmunol.1101052; Olivares-Villagomez D, 2010, IMMUNOL LETT, V134, P1, DOI 10.1016/j.imlet.2010.09.004; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Page ST, 1998, P NATL ACAD SCI USA, V95, P9459, DOI 10.1073/pnas.95.16.9459; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; ROCHA B, 1995, CURR OPIN IMMUNOL, V7, P235, DOI 10.1016/0952-7915(95)80008-5; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Seillet C, 2013, ADV IMMUNOL, V120, P185, DOI 10.1016/B978-0-12-417028-5.00007-7; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Weber DA, 2002, J IMMUNOL, V169, P5708, DOI 10.4049/jimmunol.169.10.5708; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Woodward J, 2001, EUR J IMMUNOL, V31, P3329, DOI 10.1002/1521-4141(200111)31:11<3329::AID-IMMU3329>3.0.CO;2-W; Wu Y, 2009, J IMMUNOL, V183, P5622, DOI 10.4049/jimmunol.0901772; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	46	42	42	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					451	464		10.1016/j.immuni.2014.08.010	http://dx.doi.org/10.1016/j.immuni.2014.08.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25220211	Green Accepted, Bronze			2022-12-18	WOS:000342626500015
J	Huang, GH; Wang, YY; Shi, LZ; Kanneganti, TD; Chi, HB				Huang, Gonghua; Wang, Yanyan; Shi, Lewis Z.; Kanneganti, Thirumala-Devi; Chi, Hongbo			Signaling by the Phosphatase MKP-1 in Dendritic Cells Imprints Distinct Effector and Regulatory T Cell Fates	IMMUNITY			English	Article							INNATE IMMUNE-RESPONSES; PATTERN-RECOGNITION RECEPTORS; TRANSCRIPTION FACTOR FOXP3; ADAPTIVE IMMUNITY; TGF-BETA; RETINOIC-ACID; TH17 CELLS; REG-CELLS; MICE; DIFFERENTIATION	Naive T cells respond to antigens by differentiating into effector and regulatory lineages. Whereas the roles of T cell-intrinsic pathways have been extensively studied, how T cell lineage choices are controlled by innate immune signals remains elusive. Here we report that dendritic cell (DC)-expressed phosphatase MKP-1, a negative regulator of the MAP kinases, programmed reciprocal T helper 1 (Th1) and Th17 cell differentiation by modulating IL-12-STAT4 and IL-6-STAT3 axes and cytokine receptor expression at the DC-T cell interface. MKP-1 was regulated by innate recognition signals and its deficiency disrupted antimicrobial responses and promoted T cell-mediated inflammation. Moreover, MKP-1 inhibited induction of regulatory T cells by downregulating TGF-beta 2 production from DCs. Our findings identify a regulatory circuit linking MKP-1 signaling in DCs, production of polarizing cytokines, and integration of DC-derived signals in responding T cells, that bridges innate and adaptive immunity to coordinate protective immunity and immunopathology.	[Huang, Gonghua; Wang, Yanyan; Shi, Lewis Z.; Kanneganti, Thirumala-Devi; Chi, Hongbo] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019	Chi, Hongbo/0000-0002-9997-2496; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Shi, Lewis/0000-0002-5351-8730; Huang, Gonghua/0000-0003-1579-5478	NIH [R01 NS064599]; National Multiple Sclerosis Society [RG4180-A-1]; Cancer Research Institute; Hartwell Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Cancer Research Institute; Hartwell Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge A. Bennett for advice on phosphatase activity measurement, S. Shrestha for the excellent technical support, R.K. Subbarao Malireddi for help with fungal infection, and R. Cross, G. Lennon, and S. Morgan for cell sorting. This work was supported by NIH R01 NS064599, National Multiple Sclerosis Society RG4180-A-1, Cancer Research Institute, and The Hartwell Foundation (all to H.C.).	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MERCAN F, 2010, CURR PROTOC MOL BIOL, V18; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	41	42	45	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					45	58		10.1016/j.immuni.2011.05.014	http://dx.doi.org/10.1016/j.immuni.2011.05.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21723158	Bronze, Green Accepted			2022-12-18	WOS:000293107300009
J	D'Argenio, DA; Wilson, CB				D'Argenio, David A.; Wilson, Christopher B.			A Decade of Vaccines: Integrating Immunology and Vaccinology for Rational Vaccine Design	IMMUNITY			English	Editorial Material							STRATEGIES; DIARRHEA; IMMUNITY; FUTURE	Vaccination stands as one of the most successful public health measures of the last century New approaches will be needed, however, to develop highly effective vaccines to prevent tuberculosis, HIV-AIDS, and malaria and to eradicate polio Current advances in immunology and technology have set the stage for rational vaccine design to begin a "Decade of Vaccines"	[D'Argenio, David A.; Wilson, Christopher B.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Wilson, CB (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, POB 23350, Seattle, WA 98102 USA.							Allen PM, 1999, IMMUNITY, V11, P649, DOI 10.1016/S1074-7613(00)80139-9; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Germain RN, 2010, IMMUNITY, V33, P441, DOI 10.1016/j.immuni.2010.09.014; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; SERAZIN AC, 2010, NAT IMMUNOL, V11, P551; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017	16	42	45	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					437	440		10.1016/j.immuni.2010.10.011	http://dx.doi.org/10.1016/j.immuni.2010.10.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029955	Bronze			2022-12-18	WOS:000284300200001
J	Nakahira, M; Tanaka, T; Robson, BE; Mizgerd, JP; Grusby, MJ				Nakahira, Masakiyo; Tanaka, Takashi; Robson, Bryanne E.; Mizgerd, Joseph P.; Grusby, Michael J.			Regulation of signal transducer and activator of transcription signaling by the tyrosine phosphatase PTP-BL	IMMUNITY			English	Article							NEGATIVE REGULATOR; GAMMA-INTERFERON; IFN-GAMMA; RESPONSES; STAT4; SHP-2; IDENTIFICATION; INHIBITION; PROTEINS; BINDING	Signal Transducer and Activator of Transcription (STAT) proteins are a family of latent cytoplasmic transcription factors that are activated by tyrosine phosphorylation after cytokine stimulation. One mechanism by which STAT signaling is regulated is by dephosphorylation through the action of protein tyrosine phosphatases (PTP). We have identified PTP-Basophil like (PTP-BL) as a STAT PTP. PTP-BL dephosphorylates STAT proteins in vitro and in vivo, resulting in attenuation of STAT-mediated gene activation. In CD4(+) T cells, PTP-BL deficiency leads to increased and prolonged activation of STAT4 and STAT6, and consequently enhanced T helper 1 (Th1) and Th2 cell differentiation. Taken together, our findings demonstrate that PTP-BL is a physiologically important negative regulator of the STAT signaling pathway.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Grusby, MJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	mgrusby@hsph.harvard.edu	Tanaka, Takashi/O-8254-2015; Mizgerd, Joseph/GRY-6369-2022	Mizgerd, Joseph/0000-0002-4042-3169	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079392, R01HL068153] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-79392, HL-68153] Funding Source: Medline; NIAID NIH HHS [AI-506296] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Andrews RP, 2002, J BIOL CHEM, V277, P36563, DOI 10.1074/jbc.M200986200; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Arora T, 2003, J BIOL CHEM, V278, P21327, DOI 10.1074/jbc.C300119200; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; CHIDA D, 1995, FEBS LETT, V358, P233, DOI 10.1016/0014-5793(94)01432-Z; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Collum RG, 2000, P NATL ACAD SCI USA, V97, P10120, DOI 10.1073/pnas.170192197; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Deng JC, 2004, J IMMUNOL, V173, P4075, DOI 10.4049/jimmunol.173.6.4075; Erdmann KS, 2000, ONCOGENE, V19, P3894, DOI 10.1038/sj.onc.1203725; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Fujimoto M, 2002, INT IMMUNOL, V14, P1343, DOI 10.1093/intimm/dxf094; Herrmann L, 2003, MOL BIOL CELL, V14, P230, DOI 10.1091/mbc.E02-04-0191; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Kamata T, 2003, J CLIN INVEST, V111, P109, DOI 10.1172/JCI200315719; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu ZH, 1998, ACTA POLYM SIN, P1; Lorber B, 2005, EUR J NEUROSCI, V21, P2375, DOI 10.1111/j.1460-9568.2005.04065.x; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakahira M, 2001, J IMMUNOL, V167, P1306, DOI 10.4049/jimmunol.167.3.1306; Nakai Y, 2000, EUR J BIOCHEM, V267, P7170, DOI 10.1046/j.1432-1327.2000.01818.x; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Ruan SB, 2006, PULM PHARMACOL THER, V19, P251, DOI 10.1016/j.pupt.2005.07.002; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; SHIMADA M, 2000, GEOMECH RES SER, V2, P1; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Shuai K, 1996, MOL CELL BIOL, V16, P4932; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sugimoto N, 2003, EUR J IMMUNOL, V33, P243, DOI 10.1002/immu.200390027; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Wansink DG, 2004, PHYSIOL GENOMICS, V19, P50, DOI 10.1152/physiolgenomics.00079.2004; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	57	42	44	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					163	176		10.1016/j.immuni.2007.01.010	http://dx.doi.org/10.1016/j.immuni.2007.01.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17306571	Bronze			2022-12-18	WOS:000244628600008
J	Baum, LG				Baum, LG			Developing a taste for sweets	IMMUNITY			English	Review							T-CELLS; THYMOCYTES; EXPRESSION; RECOGNITION; GALECTIN-1; PHENOTYPE; LECTIN; ROLES; CD8	Lymphocytes are covered with sugars. Some of the oligosaccharides on lymphocytes may be recognized by specific lectins such as the selectins, but what other functions do all of these oligosaccharides serve? Two recent papers in Cell (Moody et al., 2001) and Immunity (Daniels et al., 2001) describe a novel role for glycosylation in the thymus - regulating the interaction of MHC class I molecules with CD8 during thymocyte maturation.	Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baum, LG (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, 10833 LeConte Ave, Los Angeles, CA 90095 USA.							Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dennis JW, 2001, CURR OPIN STRUC BIOL, V11, P601, DOI 10.1016/S0959-440X(00)00254-2; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Ellis DS, 1996, IEEE T ULTRASON FERR, V43, P88, DOI 10.1109/58.484468; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Galvan M, 1998, J IMMUNOL, V161, P641; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Pace KE, 1999, J IMMUNOL, V163, P3801; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; SHARON N, 1994, NAT STRUCT BIOL, V1, P843, DOI 10.1038/nsb1294-843; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wu WY, 1996, J EXP MED, V184, P759, DOI 10.1084/jem.184.2.759	28	42	43	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					5	8		10.1016/S1074-7613(02)00265-0	http://dx.doi.org/10.1016/S1074-7613(02)00265-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825561	Bronze			2022-12-18	WOS:000173575700002
J	Gomez, M; Kioussis, D; Cantrell, DA				Gomez, M; Kioussis, D; Cantrell, DA			The GTPase Rac-1 controls cell fate in the thymus by diverting thymocytes from positive to negative selection	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR TRANSGENIC MICE; EXCHANGE FACTOR VAV; T-CELL; RHO-FAMILY; IN-VIVO; CYCLE PROGRESSION; CD4+8+ THYMOCYTES; DEFICIENT MICE; NUCLEAR FACTOR	The positive selection of CD4 or CD8 single-positive mature peripheral T lymphocytes and the deletion of self-reactive cells are crucial for central tolerance in the peripheral immune system. Previously, the guanine nucleotide binding protein Rac-1 has been shown to control pre-T cell development. The present report now describes the actions of Rac-1 in thymocyte selection. The study reveals that this molecule has the striking and unique ability to efficiently divert cells from positive selection into a pathway of negative selection and deletion. The ability of Rac-1 to switch thymocytes from a destiny of positive to negative selection identifies this molecule as a critical regulator of the developmental processes in T cells that are essential for immune homeostasis.	Imperial Canc Res Fund, Lymphocyte Activat Lab, London WC2A 3PX, England; Natl Inst Med Res, London NW7 1AA, England	Cancer Research UK; MRC National Institute for Medical Research	Cantrell, DA (corresponding author), Imperial Canc Res Fund, Lymphocyte Activat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.							Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brennan P, 1999, MOL CELL BIOL, V19, P4729; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cleverley S, 1999, CURR BIOL, V9, P657, DOI 10.1016/S0960-9822(99)80289-9; CORRE I, 2001, IN PRESS J EXP MED; Costello PS, 2000, J EXP MED, V192, P77, DOI 10.1084/jem.192.1.77; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Diehl NL, 2000, J EXP MED, V191, P321, DOI 10.1084/jem.191.2.321; DUTZ JP, 1995, J IMMUNOL, V154, P2588; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; GALLANDRINI R, 1997, IMMUNITY, V7, P163; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hare KJ, 1998, J IMMUNOL, V160, P3666; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; Kaga S, 1998, J IMMUNOL, V160, P24; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Li RX, 2001, J IMMUNOL, V166, P6050, DOI 10.4049/jimmunol.166.10.6050; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; MAMALAKI C, 1993, INT IMMUNOL, V5, P1285, DOI 10.1093/intimm/5.10.1285; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; McKean DJ, 2001, J IMMUNOL, V166, P3468, DOI 10.4049/jimmunol.166.5.3468; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; Page DM, 1999, J IMMUNOL, V163, P3577; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; Rausch O, 1999, J BIOL CHEM, V274, P4096, DOI 10.1074/jbc.274.7.4096; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; SALOMON DR, 1994, J EXP MED, V179, P1573, DOI 10.1084/jem.179.5.1573; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sen J, 1996, J IMMUNOL, V156, P4535; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; SWAT W, 1992, EUR J IMMUNOL, V22, P2367, DOI 10.1002/eji.1830220928; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	73	42	43	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					703	713		10.1016/S1074-7613(01)00235-7	http://dx.doi.org/10.1016/S1074-7613(01)00235-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728333	Bronze			2022-12-18	WOS:000172528200004
J	Morita, CT; Li, HM; Lamphear, JG; Rich, RR; Fraser, JD; Mariuzza, RA; Lee, HK				Morita, CT; Li, HM; Lamphear, JG; Rich, RR; Fraser, JD; Mariuzza, RA; Lee, HK			Superantigen recognition by gamma delta T cells: SEA recognition site for human V gamma 2 T cell receptors	IMMUNITY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-A; PRENYL PYROPHOSPHATE ANTIGENS; BACTERIAL SUPERANTIGENS; PERIPHERAL-BLOOD; BETA-CHAIN; NONPEPTIDE ANTIGENS; LYMPHOCYTES BEARING; MULTIPLE-SCLEROSIS; CRYSTAL-STRUCTURE; BINDING-SITES	Human gamma delta T cells expressing the V gamma 2V delta2 antigen receptors recognize nonpeptide prenyl pyrophosphate and alkylamine antigens. We find that they also recognize staphylococcal enterotoxin A superantigens in a manner distinct from the recognition of nonpeptide antigens. Using chimeric and mutant toxins, SEA amino acid residues 20-27 were shown to be required for gamma delta TCR recognition of SEA. Residues at 200-207 that are critical for specific alpha beta TCR recognition of SEA do not affect gamma delta TCR recognition. SEA residues 20-27 are located in an area contiguous with the binding site of V beta chains. This study defines a superantigen recognition site for a gamma delta T cell receptor and demonstrates the differences between V gamma 2V delta2(+) T cell recognition of superantigens and nonpeptide antigens.	Univ Iowa, Coll Med, Dept Internal Med, Div Rheumatol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Interdisciplinary Grp Immunol, Iowa City, IA 52242 USA; Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA; Emory Univ, Sch Med, Dept Med Microbiol & Immunol, Atlanta, GA 30322 USA; Univ Auckland, Sch Med, Dept Mol Med, Auckland 1, New Zealand	University of Iowa; University of Iowa; University System of Maryland; University of Maryland Baltimore; Baylor College of Medicine; Emory University; University of Auckland	Morita, CT (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Div Rheumatol, Iowa City, IA 52242 USA.	craig-morita@uiowa.edu	Li, Hongmin/ABI-2439-2020; Morita, Craig T/C-1365-2011	Li, Hongmin/0000-0002-8684-5308; Morita, Craig T/0000-0001-8496-8294				BALBI B, 1993, AM REV RESPIR DIS, V148, P1685, DOI 10.1164/ajrccm/148.6_Pt_1.1685; BERTOTTO A, 1993, EUR J IMMUNOL, V23, P1177, DOI 10.1002/eji.1830230531; Bieganowska KD, 1997, J EXP MED, V185, P1585, DOI 10.1084/jem.185.9.1585; Boismenu R, 1997, CURR OPIN IMMUNOL, V9, P57, DOI 10.1016/S0952-7915(97)80159-8; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Bukowski JF, 1998, J IMMUNOL, V161, P286; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; CALDWELL CW, 1995, AM J CLIN PATHOL, V103, P761; Carena I, 1997, J EXP MED, V186, P1769, DOI 10.1084/jem.186.10.1769; CHANDLER P, 1995, IMMUNOLOGY, V85, P531; CHINTAGUMPALA MM, 1991, J IMMUNOL, V147, P3876; COLLIN JF, 1993, P ISI 49 SESS FIR FI, P87; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; DomiatiSaad R, 1996, J IMMUNOL, V156, P3608; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Esin S, 1996, SCAND J IMMUNOL, V43, P593, DOI 10.1046/j.1365-3083.1996.d01-79.x; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Halary F, 1997, EUR J IMMUNOL, V27, P2812, DOI 10.1002/eji.1830271111; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; HERMAN A, 1990, J EXP MED, V172, P709, DOI 10.1084/jem.172.3.709; HO M, 1990, IMMUNOL LETT, V25, P139, DOI 10.1016/0165-2478(90)90105-Y; HOCHSTENBACH F, 1989, NATURE, V340, P562, DOI 10.1038/340562a0; Huber BT, 1996, MICROBIOL REV, V60, P473, DOI 10.1128/MMBR.60.3.473-482.1996; HUDSON KR, 1993, J EXP MED, V177, P175, DOI 10.1084/jem.177.1.175; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; JANEWAY CA, 1988, NATURE, V333, P804, DOI 10.1038/333804a0; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; KABELITZ D, 1990, J EXP MED, V171, P667, DOI 10.1084/jem.171.3.667; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Kunzmann V, 2000, BLOOD, V96, P384; LADEL CH, 1995, EUR J IMMUNOL, V25, P2877, DOI 10.1002/eji.1830251025; Lamphear JG, 1996, J IMMUNOL, V156, P2178; LANG F, 1995, J IMMUNOL, V154, P5986; Li HM, 1998, IMMUNOL REV, V163, P177, DOI 10.1111/j.1600-065X.1998.tb01196.x; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; LOH EY, 1994, J IMMUNOL, V152, P3324; MAHANA W, 1995, INFECT IMMUN, V63, P2826, DOI 10.1128/IAI.63.8.2826-2832.1995; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MIOSSEC C, 1990, J EXP MED, V171, P1171, DOI 10.1084/jem.171.4.1171; MOLLICK JA, 1993, J EXP MED, V177, P283, DOI 10.1084/jem.177.2.283; MORITA CT, 1994, J IMMUNOL, V153, P3979; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; MORITA CT, 1991, EUR J IMMUNOL, V21, P2999, DOI 10.1002/eji.1830211215; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Morita CT, 1996, RES IMMUNOL, V147, P347, DOI 10.1016/0923-2494(96)89649-0; OBRIEN RL, 1989, CELL, V57, P667, DOI 10.1016/0092-8674(89)90135-9; PANCHAMOORTHY G, 1991, J IMMUNOL, V147, P3360; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; PERERA MK, 1994, J EXP MED, V179, P311, DOI 10.1084/jem.179.1.311; PFEFFER K, 1992, J IMMUNOL, V148, P575; Poccia F, 1997, J IMMUNOL, V159, P6009; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; RAMESH N, 1995, IMMUNOL INVEST, V24, P713, DOI 10.3109/08820139509060700; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; RHODES J, 1995, NATURE, V377, P71, DOI 10.1038/377071a0; RHODES J, 1989, J IMMUNOL, V143, P1482; RONCAROLO MG, 1988, J EXP MED, V168, P2139, DOI 10.1084/jem.168.6.2139; RUST C, 1993, SCAND J IMMUNOL, V38, P89, DOI 10.1111/j.1365-3083.1993.tb01698.x; RUST CJJ, 1990, NATURE, V346, P572, DOI 10.1038/346572a0; RUST CJJ, 1993, CELL IMMUNOL, V151, P467, DOI 10.1006/cimm.1993.1255; SAITO S, 1991, MICROBIOL IMMUNOL, V35, P661, DOI 10.1111/j.1348-0421.1991.tb01598.x; SCALISE F, 1992, IMMUNOLOGY, V76, P668; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; SPITS H, 1991, J IMMUNOL, V147, P1180; STINISSEN P, 1995, J IMMUNOL, V154, P4883; STINISSEN P, 1995, CELL IMMUNOL, V166, P227, DOI 10.1006/cimm.1995.9975; SUMIDA T, 1992, INFECT IMMUN, V60, P2554, DOI 10.1128/IAI.60.6.2554-2558.1992; SURMAN S, 1994, J IMMUNOL, V152, P4893; SWAMINATHAN S, 1995, NAT STRUCT BIOL, V2, P680, DOI 10.1038/nsb0895-680; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; Tiedemann RE, 1995, P NATL ACAD SCI USA, V92, P12156, DOI 10.1073/pnas.92.26.12156; UETA C, 1994, INFECT IMMUN, V62, P5434, DOI 10.1128/IAI.62.12.5434-5441.1994	84	42	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2001	14	3					331	344		10.1016/S1074-7613(01)00113-3	http://dx.doi.org/10.1016/S1074-7613(01)00113-3			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290341	Bronze			2022-12-18	WOS:000167959500011
J	Zuberi, AR; Christianson, GJ; Mendoza, LM; Shastri, N; Roopenian, DC				Zuberi, AR; Christianson, GJ; Mendoza, LM; Shastri, N; Roopenian, DC			Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex	IMMUNITY			English	Article							VERSUS-HOST DISEASE; Y-CHROMOSOME; ANTIGEN; GENE; PEPTIDE; REGION; IDENTIFICATION; LOCUS; MICE; TRANSPLANTATION	Immune responses to minor histocompatibility antigens are poorly understood and present substantial barriers to successful solid tissue and bone marrow transplantation among MHC-matched individuals. We exploited a unique positional cloning approach relying on the potent negative selection capability of cytotoxic T cells to identify the H3a gene responsible for immunodominant H2-D-b-restricted determinants of the classically defined mouse autosomal H3 complex. The allelic basis for reciprocal H3a antigens is two amino acid changes within a single nonamer H2-D-b-binding peptide. The H3a gene, now called Zfp106, encodes a 1888-amino acid protein with three zinc fingers and a beta-transducin domain consistent with DNA/protein binding. A region of ZFP106 is identical to a 600-amino acid sequence implicated in the insulin receptor signaling pathway.	Jackson Lab, Bar Harbor, ME 04609 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Jackson Laboratory; University of California System; University of California Berkeley	Roopenian, DC (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.			Christianson, Gregory/0000-0001-5532-342X	NCI NIH HHS [CA34196] Funding Source: Medline; NIAID NIH HHS [AI24544, R01-AI28802] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024544, R29AI024544, R01AI028802] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY DW, 1975, IMMUNOGENETICS, V2, P249, DOI 10.1007/BF01572293; BAILEY DW, 1970, TRANSPLANT P, V2, P32; Bhuyan PK, 1997, J IMMUNOL, V158, P3753; CHIANNILKULCHAI N, 1995, HUM MOL GENET, V4, P717, DOI 10.1093/hmg/4.4.717; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; denHaan JMM, 1996, EUR J IMMUNOL, V26, P2680, DOI 10.1002/eji.1830261120; FRANCIS F, 1994, GENET ANAL-BIOMOL E, V11, P148, DOI 10.1016/1050-3862(94)90035-3; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; GRAFF RJ, 1973, TRANSPLANT REV-DENMA, V15, P26; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Hudrisier D, 1996, J BIOL CHEM, V271, P17829, DOI 10.1074/jbc.271.30.17829; KentFirst MG, 1996, NAT GENET, V14, P128, DOI 10.1038/ng1096-128; KING TR, 1994, GENOMICS, V24, P159, DOI 10.1006/geno.1994.1593; KURTZ ME, 1985, J IMMUNOL, V135, P2847; LINDAHL KF, 1991, TRENDS GENET, V7, P219, DOI 10.1016/0168-9525(91)90368-Z; LIPPOLIS JD, 1995, J VIROL, V69, P3134, DOI 10.1128/JVI.69.5.3134-3146.1995; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Malarkannan S, 1998, J IMMUNOL, V161, P3501; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Mendoza LM, 1997, IMMUNITY, V7, P461, DOI 10.1016/S1074-7613(00)80368-4; MICHAELSON J, 1983, IMMUNOGENETICS, V17, P219, DOI 10.1007/BF00364409; Morse MC, 1996, J IMMUNOL, V156, P3301; Perreault C, 1996, J CLIN INVEST, V98, P622, DOI 10.1172/JCI118832; Rammensee H G, 1994, Behring Inst Mitt, P11; RAMMENSEE HG, 1983, J IMMUNOL, V130, P2926; RAMMENSEE HG, 1983, IMMUNOGENETICS, V17, P637, DOI 10.1007/BF00366131; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Richard I, 1996, MAMM GENOME, V7, P377, DOI 10.1007/s003359900108; ROOPENIAN DC, 1980, IMMUNOGENETICS, V10, P333, DOI 10.1007/BF01561583; ROOPENIAN DC, 1989, IMMUNOGENETICS, V30, P335, DOI 10.1007/BF02425273; ROOPENIAN DC, 1993, J IMMUNOL, V1561, P4595; ROOPENIAN DC, 1999, IN PRESS MINOR HISTO; Salvatore P, 1998, J BIOL CHEM, V273, P6989, DOI 10.1074/jbc.273.12.6989; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Simpson E, 1998, IMMUNOL TODAY, V19, P108, DOI 10.1016/S0167-5699(97)01213-9; SNELL GD, 1958, JNCI-J NATL CANCER I, V21, P843; VANELS CACM, 1992, IMMUNOGENETICS, V35, P161, DOI 10.1007/BF00185109; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; ZUBERI AR, 1994, GENOMICS, V19, P273, DOI 10.1006/geno.1994.1058	45	42	43	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					687	698		10.1016/S1074-7613(00)80666-4	http://dx.doi.org/10.1016/S1074-7613(00)80666-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846490	Bronze			2022-12-18	WOS:000077298300011
J	van der Stoep, N; Gorman, JR; Alt, FW				van der Stoep, N; Gorman, JR; Alt, FW			Reevaluation of 3 ' E-kappa function in stage- and lineage-specific rearrangement and somatic hypermutation	IMMUNITY			English	Article							IMMUNOGLOBULIN-KAPPA-GENE; IMMUNE-RESPONSE; GERMINAL-CENTERS; IG-KAPPA; B-CELL; 3'-ENHANCER REGION; ATTACHMENT REGION; MATURATION; MUTATION; ENHANCER	Transgenic studies have led to the conclusion that the 3'E-kappa enhancer functions to suppress kappa variable region gene assembly in T lineage cells and in progenitor B cells and have also implicated 3'E-kappa as a critical element in promoting somatic hypermutation of kappa variable region genes. To assess the role of the endogenous 3'E-kappa, we assayed these processes in mice homozygous for mutations in which the 3'E-kappa sequences were deleted by the loxP/Cre method (3'E(kappa)Delta/Delta mice). In contrast to transgenic findings, we found that deletion of the endogenous 3'E-kappa did not deregulate kappa gene rearrangement in T lineage cells or in pro-B cells. Furthermore, immunization of the 3'E(kappa)Delta/Delta mice led to the generation of specific antibodies with mutation patterns typical of affinity maturation, showing that there is no absolute requirement for the 3'E-kappa with respect to somatic mutation of endogenous kappa genes.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Res Labs, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Alt, FW (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI020047] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 20047] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALZARI PM, 1990, EMBO J, V9, P3807, DOI 10.1002/j.1460-2075.1990.tb07598.x; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BLASQUEZ VC, 1992, J BIOL CHEM, V267, P23888; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; Cavelier P, 1997, EUR J IMMUNOL, V27, P1626, DOI 10.1002/eji.1830270706; EMORINE L, 1983, NATURE, V304, P447, DOI 10.1038/304447a0; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GORMAN JR, 1998, IN PRESS ADV IMMUNOL; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; Hayashi R, 1997, J IMMUNOL, V159, P4145; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; KAARTINEN M, 1983, J IMMUNOL, V130, P937; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANSFORD R, 1996, MOL IMMUNOLOGY; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Meyer KB, 1996, INT IMMUNOL, V8, P1561, DOI 10.1093/intimm/8.10.1561; MEYER KB, 1990, NUCLEIC ACIDS RES, V18, P5609, DOI 10.1093/nar/18.19.5609; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; Milstein C, 1996, ADV PROTEIN CHEM, V49, P451, DOI 10.1016/S0065-3233(08)60494-5; MILSTEIN C, 1992, EUR J IMMUNOL, V22, P1627, DOI 10.1002/eji.1830220642; MULLER B, 1990, EUR J IMMUNOL, V20, P1409, DOI 10.1002/eji.1830200631; Okada A, 1994, Semin Immunol, V6, P185, DOI 10.1006/smim.1994.1024; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; PICARD D, 1984, NATURE, V307, P80, DOI 10.1038/307080a0; QUEEN C, 1984, MOL CELL BIOL, V4, P1042, DOI 10.1128/MCB.4.6.1042; RADA C, 1991, P NATL ACAD SCI USA, V88, P5508, DOI 10.1073/pnas.88.13.5508; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SHARPE MJ, 1990, EUR J IMMUNOL, V20, P1379, DOI 10.1002/eji.1830200625; SHARPE MJ, 1991, EMBO J, V10, P2139, DOI 10.1002/j.1460-2075.1991.tb07748.x; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2	38	42	43	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1998	8	6					743	750		10.1016/S1074-7613(00)80579-8	http://dx.doi.org/10.1016/S1074-7613(00)80579-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655488	Bronze			2022-12-18	WOS:000074396300010
J	Sebzda, E; Choi, M; FungLeung, WP; Mak, TW; Ohashi, PS				Sebzda, E; Choi, M; FungLeung, WP; Mak, TW; Ohashi, PS			Peptide-induced positive selection of TCR transgenic thymocytes in a coreceptor-independent manner	IMMUNITY			English	Article							T-CELL RECEPTOR; MICE LACKING CD4; THYMIC SELECTION; NEGATIVE SELECTION; BETA-CHAIN; CYTOPLASMIC DOMAINS; CD4-DEFICIENT MICE; ANTIGEN RECEPTOR; HELPER; MHC	T cell receptor (TCR) transgenic thymocytes specific for the LCMV gp peptide are normally positively selected to the CD8 lineage. Transgenic thymocyte development was substantially reduced in the absence of these CD8 coreceptors. However, efficient positive selection was restored when TCR transgenic CD8(-/-) fetal thymic lobes were cultured with a peptide variant of the wild-type ligand. These mature thymocytes were functional, as shown by their ability to respond against strong peptide agonists. Additional experiments demonstrated that transgenic positive selection was peptide-specific. These results prove that CD8 does not possess essential signaling properties that are necessary for T cell development. In addition, the unilateral commitment of transgenic thymocytes to mature CD4(-)TCR(hi) T cells expressing intracellular perforin suggests that there must be some instructive component to CD4 down-regulation and lineage commitment during thymocyte selection.	ONTARIO CANC INST,DEPT IMMUNOL,TORONTO,ON M5G 2M9,CANADA; RW JOHNSON PHARMACEUT RES INST,SAN DIEGO,CA 92121; AMGEN INST,TORONTO,ON M5G 2C1,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Johnson & Johnson; Johnson & Johnson USA	Sebzda, E (corresponding author), ONTARIO CANC INST,DEPT MED BIOPHYS,TORONTO,ON M5G 2M9,CANADA.			Ohashi, Pamela S./0000-0003-2915-9317; Fung-Leung, Wai-Ping/0000-0001-7013-8855				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALDRICH CJ, 1991, NATURE, V352, P718, DOI 10.1038/352718a0; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; Chan S H, 1994, Semin Immunol, V6, P241, DOI 10.1006/smim.1994.1031; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; CROOKS MEC, 1994, IMMUNITY, V1, P277; Dalloul AH, 1996, EUR J IMMUNOL, V26, P213, DOI 10.1002/eji.1830260133; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P212, DOI 10.1002/eji.1830230133; HAMMERLING GJ, 1979, IMMUNOGENETICS, V8, P433, DOI 10.1007/BF01561454; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOGQUIST KA, 1995, IMMUNITY, V3, P78; Ignatowicz L, 1996, J IMMUNOL, V157, P1827; INGOLD AL, 1991, NATURE, V352, P721, DOI 10.1038/352721a0; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; KAWAI K, 1995, NATURE, V374, P68, DOI 10.1038/374068a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KILLEEN N, 1992, J EXP MED, V176, P89, DOI 10.1084/jem.176.1.89; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KNOBLOCH M, 1992, INT IMMUNOL, V4, P1169, DOI 10.1093/intimm/4.10.1169; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; Liu CP, 1996, J EXP MED, V184, P1619, DOI 10.1084/jem.184.5.1619; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; LUCAS B, 1995, J EXP MED, V181, P1623, DOI 10.1084/jem.181.5.1623; MANNIE MD, 1991, J THEOR BIOL, V151, P169, DOI 10.1016/S0022-5193(05)80360-1; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; PAGE DM, 1994, P NATL ACAD SCI USA, V91, P4057, DOI 10.1073/pnas.91.9.4057; PENNINGER JM, 1995, EUR J IMMUNOL, V25, P2115, DOI 10.1002/eji.1830250748; RAHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213, DOI 10.1002/eji.1830240942; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Robey E A, 1994, Semin Immunol, V6, P209, DOI 10.1006/smim.1994.1027; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHERMAN LA, 1992, SCIENCE, V258, P815, DOI 10.1126/science.1439792; SPAIN LM, 1994, J IMMUNOL, V152, P1709; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VANDEKERCKHOVE BAE, 1994, J IMMUNOL, V152, P1738; VANMEERWIJK JP, 1983, SCIENCE, V261, P911; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; VONHERRATH MG, 1994, J EXP MED, V180, P1901, DOI 10.1084/jem.180.5.1901; WALLACE VA, 1992, J EXP MED, V176, P1459, DOI 10.1084/jem.176.5.1459; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Williams O, 1996, EUR J IMMUNOL, V26, P532, DOI 10.1002/eji.1830260305	68	42	42	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					643	653		10.1016/S1074-7613(00)80352-0	http://dx.doi.org/10.1016/S1074-7613(00)80352-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175842	Bronze			2022-12-18	WOS:A1997XB81900015
J	Xu, CL; Lee, SK; Zhang, DC; Frenette, PS				Xu, Chunliang; Lee, Sung Kyun; Zhang, Dachuan; Frenette, Paul S.			The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation	IMMUNITY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; VASOOCCLUSIVE EVENTS; T-CELLS; GLUCOCORTICOIDS; HEALTH; PAIN; MICRODOMAINS; NEUTROPHILS; MODULATION; HEMOGLOBIN	Psychological stress has adverse effects on various human diseases, including those of the cardiovascular system. However, the mechanisms by which stress influences disease activity remain unclear. Here, using vaso-occlusive episodes (VOEs) of sickle cell disease as a vascular disease model, we show that stress promotes VOEs by eliciting a glucocorticoid hormonal response that augments gut permeability, leading to microbiota-dependent interleukin-17A (IL-17A) secretion from T helper 17 (Th17) cells of the lamina propria, followed by the expansion of the circulating pool of aged neutrophils that trigger VOEs. We identify segmented filamentous bacteria as the commensal essential for the stress-induced expansion of aged neutrophils that enhance VOEs in mice. Importantly, the inhibition of glucocorticoids synthesis, blockade of IL-17A, or depletion of the Th17 cell-inducing gut microbiota markedly reduces stress-induced VOEs. These results offer potential therapeutic targets to limit the impact of psychological stress on acute vascular occlusion.	[Xu, Chunliang; Lee, Sung Kyun; Zhang, Dachuan; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Xu, Chunliang; Lee, Sung Kyun; Zhang, Dachuan; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	paul.frenette@einsteinmed.org	Zhang, Dachuan/GZA-8781-2022	Lee, Sung Kyun/0000-0001-8130-7431; Xu, Chunliang/0000-0002-4514-8477; Zhang, Dachuan/0000-0002-1746-275X	National Institutes of Health [HL069438, DK056638, DK116312, DK112976]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Dan Littman for providing SFB-monocolonized intestinal flora. We are grateful to Colette Prophete and George Amatuni for technical assistance and other lab members for discussion. This work was supported by R01 grants from the National Institutes of Health (HL069438, DK056638, DK116312, and DK112976 to P.S.F.).	Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Ataga KI, 2017, NEW ENGL J MED, V376, P429, DOI 10.1056/NEJMoa1611770; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bernini JC, 1998, BLOOD, V92, P3082, DOI 10.1182/blood.V92.9.3082.421k15_3082_3089; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Darbari DS, 2008, J NATL MED ASSOC, V100, P948, DOI 10.1016/S0027-9684(15)31410-3; Dessap AM, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000280; Franklin TB, 2017, NAT NEUROSCI, V20, P260, DOI 10.1038/nn.4470; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gil KM, 2004, HEALTH PSYCHOL, V23, P267, DOI 10.1037/0278-6133.23.3.267; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Gouin JP, 2012, ANN BEHAV MED, V44, P287, DOI 10.1007/s12160-012-9386-1; GRIFFIN TC, 1994, NEW ENGL J MED, V330, P733, DOI 10.1056/NEJM199403173301101; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kivimaki M, 2018, NAT REV CARDIOL, V15, P215, DOI 10.1038/nrcardio.2017.189; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lutgendorf SK, 1999, J GERONTOL A-BIOL, V54, pM434, DOI 10.1093/gerona/54.9.M434; Mahdi N, 2010, J PEDIAT HEMATOL ONC, V32, P345, DOI 10.1097/MPH.0b013e3181d869d5; Mohanan V, 2018, SCIENCE, V359, P1161, DOI 10.1126/science.aan0814; Nesse RM, 2016, STRESS CONCEPTS COGN, P95, DOI [10.1016/B978-0-12-800951-2.00011-X, DOI 10.1016/B978-0-12-800951-2.00011-X]; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; Porter L S, 2000, J Health Psychol, V5, P53, DOI 10.1177/135910530000500109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rohleder N, 2014, PSYCHOSOM MED, V76, P181, DOI 10.1097/PSY.0000000000000049; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; Shen CJ, 2019, NAT MED, V25, P337, DOI 10.1038/s41591-018-0299-9; Sheridan JF, 1998, ANN NY ACAD SCI, V840, P803, DOI 10.1111/j.1749-6632.1998.tb09618.x; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sundd P, 2019, ANNU REV PATHOL-MECH, V14, P263, DOI 10.1146/annurev-pathmechdis-012418-012838; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Telen MJ, 2015, BLOOD, V125, P2656, DOI 10.1182/blood-2014-06-583351; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VANEEDEN SF, 1997, AM J PHYSIOL, V272, pH40; Vecchiarelli HA, 2016, BRAIN BEHAV IMMUN, V51, P70, DOI 10.1016/j.bbi.2015.07.026; von Kanel R, 2008, GERONTOLOGY, V54, P131, DOI 10.1159/000113649; Ware RE, 2017, LANCET, V390, P311, DOI 10.1016/S0140-6736(17)30193-9; Wu L, 2016, CELL METAB, V23, P735, DOI 10.1016/j.cmet.2016.01.014; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434; Xu CL, 2019, NAT MED, V25, P536, DOI 10.1038/s41591-019-0409-3; Xu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04726-3; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yeral M, 2017, TRANSFUS APHER SCI, V56, P717, DOI 10.1016/j.transci.2017.08.005; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zheng PY, 2009, GUT, V58, P1473, DOI 10.1136/gut.2009.181701	72	41	42	6	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					417	+		10.1016/j.immuni.2020.06.025	http://dx.doi.org/10.1016/j.immuni.2020.06.025			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	NC4NX	32735844	Green Accepted, Bronze			2022-12-18	WOS:000561190600018
J	Tu, E; Chia, CPZ; Chen, WW; Zhang, DF; Park, SA; Jin, WW; Wang, DD; Alegre, ML; Zhang, YE; Sun, LY; Chen, WJ				Tu, Eric; Chia, Cheryl P. Z.; Chen, Weiwei; Zhang, Dunfang; Park, Sang A.; Jin, Wenwen; Wang, Dandan; Alegre, Maria-Luisa; Zhang, Ying E.; Sun, Lingyun; Chen, WanJun			T Cell Receptor-Regulated TGF-beta Type I Receptor Expression Determines T Cell Quiescence and Activation	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; NF-KAPPA-B; TRANSCRIPTION FACTOR FOXP3; TARGETED DISRUPTION; MECHANISMS; DIFFERENTIATION; HOMEOSTASIS; MICE; IMMUNOSUPPRESSION; AUTOIMMUNITY	It is unclear how quiescence is enforced in naive T cells, but activation by foreign antigens and self-antigens is allowed, despite the presence of inhibitory signals. We showed that active transforming growth factor beta (TGF-beta) signaling was present in naive T cells, and T cell receptor (TCR) engagement reduced TGF-beta signaling during T cell activation by downregulating TGF-beta type 1 receptor (T beta RI) through activation of caspase recruitment domain-containing protein 11 (CARD11) and nuclear factor kappa B (NF-kappa B). TGF-beta prevented TCR-mediated T beta RI downregulation, but this was abrogated by interleukin-6 (IL-6). Mitigation of TCR-mediated T beta RI downregulation through overexpression of T beta RI in naive and activated T cells rendered T cells less responsive and suppressed autoimmunity. Naive T cells in autoimmune patients exhibited reduced T beta RI expression and increased TCR-driven proliferation compared to healthy subjects. Thus, TCR-mediated regulation of T beta RI-TGF-beta signaling acts as a crucial criterion to determine T cell quiescence and activation.	[Tu, Eric; Chia, Cheryl P. Z.; Zhang, Dunfang; Park, Sang A.; Jin, Wenwen; Chen, WanJun] NIDCR, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA; [Chen, Weiwei; Wang, Dandan; Sun, Lingyun] Nanjing Univ, Dept Rheumatol & Immunol, Med Sch, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Alegre, Maria-Luisa] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Nanjing University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, WJ (corresponding author), NIDCR, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA.; Sun, LY (corresponding author), Nanjing Univ, Dept Rheumatol & Immunol, Med Sch, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	lingyunsun@nju.edu.cn; wchen@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Zhang, Dunfang/0000-0001-7545-9930	Intramural Research Program of NIDCR, NIH; National Science Foundation of China [81120108021, 81720108020]; Jiangsu Province Major Research and Development Program, China [BE2015062]; A*STAR International Fellowship, Singapore; Korean Biomedical Scientist Fellowship Program; NATIONAL CANCER INSTITUTE [ZIABC010419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097113] Funding Source: NIH RePORTER	Intramural Research Program of NIDCR, NIH; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Major Research and Development Program, China; A*STAR International Fellowship, Singapore(Agency for Science Technology & Research (A*STAR)); Korean Biomedical Scientist Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. M. Diaz, U. Siebenlist, R. Sen, and G. Altan-Bonnet (NIH) for providing gene-mutated mice and reagents. We thank N. Goldberg, NIDCR, and the FACS core of NIDCR for their technical assistance. This research was supported by the Intramural Research Program of NIDCR, NIH; the National Science Foundation of China projects #81120108021 and #81720108020 (L.S.); and the Jiangsu Province Major Research and Development Program, China #BE2015062 (L.S.). C.P.Z.C. was supported in part by the A*STAR International Fellowship, Singapore. S.A.P. was supported in part by the Korean Biomedical Scientist Fellowship Program.	Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Giroux M, 2010, J IMMUNOL, V185, P1568, DOI 10.4049/jimmunol.1000137; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kasagi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008895; Konkel JE, 2017, IMMUNITY, V46, P660, DOI 10.1016/j.immuni.2017.03.015; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Molinero LL, 2011, J IMMUNOL, V186, P4609, DOI 10.4049/jimmunol.1002361; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakatsukasa H, 2015, NAT IMMUNOL, V16, P1077, DOI 10.1038/ni.3252; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; RUEGEMER JJ, 1990, J IMMUNOL, V144, P1767; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Tu E, 2014, CYTOKINE GROWTH F R, V25, P423, DOI 10.1016/j.cytogfr.2014.07.014; Tu E, 2013, EUR J IMMUNOL, V43, P1286, DOI 10.1002/eji.201242771; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	46	41	46	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					745	+		10.1016/j.immuni.2018.03.025	http://dx.doi.org/10.1016/j.immuni.2018.03.025			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669252	Bronze, Green Accepted			2022-12-18	WOS:000430198900020
J	Kleino, A; Ramia, NF; Bozkurt, G; Shen, YF; Nailwal, H; Huang, J; Napetschnig, J; Gangloff, M; Chan, FKM; Wu, H; Li, JX; Silverman, N				Kleino, Anni; Ramia, Nancy F.; Bozkurt, Gunes; Shen, Yanfang; Nailwal, Himani; Huang, Jing; Napetschnig, Johanna; Gangloff, Monique; Chan, Francis Ka-Ming; Wu, Hao; Li, Jixi; Silverman, Neal			Peptidoglycan-Sensing Receptors Trigger the Formation of Functional Amyloids of the Adaptor Protein Imd to Initiate Drosophila NF-kappa B Signaling	IMMUNITY			English	Article							INNATE IMMUNE RECOGNITION; GRAM-NEGATIVE INFECTION; PGRP-LC; ANTIBACTERIAL DEFENSE; DEFICIENCY IMD; CASPASE DREDD; HOST-DEFENSE; COMPLEX; ACTIVATION; BINDING	In the Drosophila immune response, bacterial derived diaminopimelic acid-type peptidoglycan binds the receptors PGRP-LC and PGRP-LE, which through interaction with the adaptor protein Imd leads to activation of the NF-kappa B homolog Relish and robust antimicrobial peptide gene expression. PGRP-LC, PGRP-LE, and Imd each contain a motif with some resemblance to the RIP Homotypic Interaction Motif (RHIM), a domain found in mammalian RIPK proteins forming functional amyloids during necroptosis. Here we found that despite sequence divergence, these Drosophila cryptic RHIMs formed amyloid fibrils in vitro and in cells. Amyloid formation was required for signaling downstream of Imd, and in contrast to the mammalian RHIMs, was not associated with cell death. Furthermore, amyloid formation constituted a regulatable step and could be inhibited by Pirk, an endogenous feedback regulator of this pathway. Thus, diverse sequence motifs are capable of forming amyloidal signaling platforms, and the formation of these platforms may present a regulatory point in multiple biological processes.	[Kleino, Anni; Silverman, Neal] Univ Massachusetts, Med Sch, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Ramia, Nancy F.; Nailwal, Himani; Chan, Francis Ka-Ming] Univ Massachusetts, Med Sch, Program Immunol & Microbiol, Dept Pathol, Worcester, MA 01605 USA; [Bozkurt, Gunes; Wu, Hao] Harvard Med Sch, Program Cellular & Mol Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Bozkurt, Gunes; Li, Jixi] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Shen, Yanfang; Huang, Jing; Wu, Hao] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Napetschnig, Johanna] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Gangloff, Monique] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Fudan University; Cornell University; University of Cambridge	Silverman, N (corresponding author), Univ Massachusetts, Med Sch, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.; Wu, H (corresponding author), Harvard Med Sch, Program Cellular & Mol Med, Boston Childrens Hosp, Boston, MA 02115 USA.; Li, JX (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Wu, H (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.	wu@crystal.harvard.edu; lijixi@fudan.edu.cn; neal.silverman@umassmed.edu	Chan, Francis/ABB-1895-2021; Chan, Francis Ka-Ming/E-9647-2014; Bozkurt, Gunes/I-6453-2019	Chan, Francis Ka-Ming/0000-0002-4803-8353; Bozkurt, Gunes/0000-0002-6025-3582; Kleino, Anni/0000-0001-8919-9404; Gangloff, Monique/0000-0001-6131-0115	NIH [AI045937, AI119030, AI060025]; EMBO Long-Term Fellowship [ALTF 357-2011]; Sigrid Juselius Foundation; K. Albin Johansson Foundation; Maud Kuistila Memorial Foundation; National Key Research and Development Program [2016YFA0500600, 2015CB943300]; National Natural Science Foundation of China [31670878, 31470724]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [TP2014010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050872, R01AI045937, R56AI060025, R01AI060025, R01AI119030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); K. Albin Johansson Foundation; Maud Kuistila Memorial Foundation; National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Ericsson (Harvard Medical School, Boston) for EM technical assistance and T. McQuade for protocols and advice. This work was supported by the NIH AI045937 to H.W., AI119030 to F.K.-M.C., and AI060025 to N.S., the EMBO Long-Term Fellowship (ALTF 357-2011), Sigrid Juselius Foundation, K. Albin Johansson Foundation, and Maud Kuistila Memorial Foundation to A.K., and the National Key Research and Development Program (2016YFA0500600, 2015CB943300), the National Natural Science Foundation of China (31670878, 31470724), and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (TP2014010) to J.L.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Akbar MA, 2016, IMMUNITY, V45, P267, DOI 10.1016/j.immuni.2016.07.010; Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Chen L, 2017, J BIOL CHEM, V292, P8738, DOI 10.1074/jbc.M117.788158; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; COOKSON BT, 1989, INFECT IMMUN, V57, P2223, DOI 10.1128/IAI.57.7.2223-2229.1989; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gendrin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069742; Gentle IE, 2017, FEBS J, V284, P1987, DOI 10.1111/febs.14091; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kajava AV, 2014, SCI REP-UK, V4, DOI 10.1038/srep07436; Kaneko T, 2005, J ENDOTOXIN RES, V11, P383, DOI 10.1179/096805105X76823; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kim CH, 2014, J BIOL CHEM, V289, P20092, DOI 10.1074/jbc.M113.544841; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Mompean M, 2016, J PHYS CHEM LETT, V7, P1859, DOI 10.1021/acs.jpclett.6b00699; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Neyen C, 2016, NAT IMMUNOL, V17, P1150, DOI 10.1038/ni.3536; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; Paik D, 2017, J IMMUNOL, V199, P263, DOI 10.4049/jimmunol.1600409; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258	68	41	43	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					635	+		10.1016/j.immuni.2017.09.011	http://dx.doi.org/10.1016/j.immuni.2017.09.011			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045898	Bronze, Green Accepted			2022-12-18	WOS:000413091600010
J	Boudreau, JE; Liu, XR; Zhao, ZG; Zhang, AR; Shultz, LD; Greiner, DL; Dupont, B; Hsu, KC				Boudreau, Jeanette E.; Liu, Xiao-Rong; Zhao, Zeguo; Zhang, Aaron; Shultz, Leonard D.; Greiner, Dale L.; Dupont, Bo; Hsu, Katharine C.			Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MISSING SELF-RECOGNITION; INHIBITORY RECEPTORS; EFFECTOR FUNCTION; CIS ASSOCIATION; MOUSE MODEL; TRANS; EXPRESSION; TRANSPLANTATION; ENGRAFTMENT	The effector potential of NK cells is counterbalanced by their sensitivity to inhibition by "self'' MHC class I molecules in a process called "education.'' In humans, interactions between inhibitory killer immunoglobulin-like receptors (KIR) and human MHC (HLA) mediate NK cell education. In HLA-B*27:05(+) transgenic mice and in patients undergoing HLA-mismatched hematopoietic cell transplantation (HCT), NK cells derived from human CD34(+) stem cells were educated by HLA from both donor hematopoietic cells and host stromal cells. Furthermore, mature human KIR3DL1(+) NK cells gained reactivity after adoptive transfer to HLA-B*27: 05(+) mice or bone marrow chimeric mice where HLA-B* 27: 05 was restricted to either the hematopoietic or stromal compartment. Silencing of HLA in primary NK cells diminished NK cell reactivity, while acquisition of HLA from neighboring cells increased NK cell reactivity. Altogether, these findings reveal roles for cell-extrinsic HLA in driving NK cell reactivity upward, and cell-intrinsic HLA in maintaining NK cell education.	[Boudreau, Jeanette E.; Liu, Xiao-Rong; Zhao, Zeguo; Zhang, Aaron; Dupont, Bo; Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10065 USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Greiner, Dale L.] Univ Massachusetts, Dept Med, Program Mol Med Diabet, Sch Med,Ctr Excellence, Worcester, MA 01655 USA; [Dupont, Bo; Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hsu, Katharine C.] Weill Cornell Med Coll, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Jackson Laboratory; University of Massachusetts System; University of Massachusetts Worcester; Memorial Sloan Kettering Cancer Center; Cornell University	Hsu, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10065 USA.; Hsu, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Hsu, KC (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	hsuk@mskcc.org		Boudreau, Jeanette/0000-0003-0203-2180; Zhao, Zeguo/0000-0002-2901-5033	NIH P01 [CA23766]; NIH [R01 HL088134, R24OOD018259, UC4DK104218]; NIH NCI [CA08747, CA023766]; William H. Goodwin and Alice T. Goodwin and the Commonwealth Foundation for Cancer Research; Helmsley Charitable Trust [2012PG-T1D018]; Jackson Laboratory;  [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196, P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD018259] Funding Source: NIH RePORTER	NIH P01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); William H. Goodwin and Alice T. Goodwin and the Commonwealth Foundation for Cancer Research; Helmsley Charitable Trust; Jackson Laboratory; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Thomas A. Waldmann (National Cancer Institute) for cDNA clones for human IL-15 and human IL-15R alpha. We thank Dr. Stuart Tangye (Garvan Institute) for providing the mouse pre-B cell line Ba/F3, immortalized with mouse IL-3 gene. The authors thank Drs. Joseph Sun and Alan Hanash (MSKCC) for helpful comments on the manuscript. We are grateful to Chi-Hang Cheung, Jean-Benoit Le Luduec, Shajoti Rahman, and Mimi Tang for technical assistance. This work was supported by NIH P01 (CA23766) and NIH R01 HL088134 to K.C.H.; NIH NCI CA08747 and CA023766 to B.D.; and core grant (CA034196) and NIH R24OOD018259 and UC4DK104218 to L.D.S. and D.L.G.. Additional support was provided from the William H. Goodwin and Alice T. Goodwin and the Commonwealth Foundation for Cancer Research and the Helmsley Charitable Trust 2012PG-T1D018 (B.D.). D.L.G. receives grant support and is a consultant for The Jackson Laboratory.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; Boudreau JE, 2011, CANCER RES, V71, P2497, DOI 10.1158/0008-5472.CAN-10-3025; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chow T, 2013, STEM CELLS, V31, P2242, DOI 10.1002/stem.1458; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Li NL, 2013, EUR J IMMUNOL, V43, P1042, DOI 10.1002/eji.201242607; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Miner CA, 2015, J IMMUNOL, V194, P1945, DOI 10.4049/jimmunol.1402408; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pek EA, 2011, IMMUNOBIOLOGY, V216, P218, DOI 10.1016/j.imbio.2010.04.008; Pittari G, 2013, J IMMUNOL, V190, P4650, DOI 10.4049/jimmunol.1202120; Pradeu T, 2013, NAT REV IMMUNOL, V13, P764, DOI 10.1038/nri3521; Purtill D, 2014, BLOOD, V124, P2905, DOI 10.1182/blood-2014-03-566216; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; Sharkey AM, 2015, J IMMUNOL, V195, P3026, DOI 10.4049/jimmunol.1501229; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; Strowig T, 2010, BLOOD, V116, P4158, DOI 10.1182/blood-2010-02-270678; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; TAUROG JD, 1990, TRANSGENIC MICE AND MUTANTS IN MHC RESEARCH, P268; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; van Bergen J, 2013, J IMMUNOL, V190, P2880, DOI 10.4049/jimmunol.1200650; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Xie XF, 2010, P NATL ACAD SCI USA, V107, P8754, DOI 10.1073/pnas.0913126107; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yu JL, 2009, BLOOD, V113, P3875, DOI 10.1182/blood-2008-09-177055	45	41	41	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					280	291		10.1016/j.immuni.2016.07.005	http://dx.doi.org/10.1016/j.immuni.2016.07.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27496730	Bronze, Green Accepted			2022-12-18	WOS:000382267300011
J	Champagne, DP; Hatle, KM; Fortner, KA; D'Alessandro, A; Thornton, TM; Yang, R; Torralba, D; Tomas-Cortazar, J; Jun, YW; Ahn, KH; Hansen, KC; Haynes, L; Anguita, J; Rincon, M				Champagne, Devin P.; Hatle, Ketki M.; Fortner, Karen A.; D'Alessandro, Angelo; Thornton, Tina M.; Yang, Rui; Torralba, Daniel; Tomas-Cortazar, Julen; Jun, Yong Woong; Ahn, Kyo Han; Hansen, Kirk C.; Haynes, Laura; Anguita, Juan; Rincon, Mercedes			Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus	IMMUNITY			English	Article							GENE-EXPRESSION; MEMORY; METHYLATION; EFFECTOR; DIFFERENTIATION; MCJ/DNAJC15	Mitochondrial respiration is regulated in CD8(+) T cells during the transition from naive to effector and memory cells, but mechanisms controlling this process have not been defined. Here we show that MCJ (methylation-controlled J protein) acted as an endogenous break for mitochondrial respiration in CD8(+) T cells by interfering with the formation of electron transport chain respiratory supercomplexes. Metabolic profiling revealed enhanced mitochondrial metabolism in MCJ-deficient CD8(+) T cells. Increased oxidative phosphorylation and subcellular ATP accumulation caused by MCJ deficiency selectively increased the secretion, but not expression, of interferon-gamma. MCJ also adapted effector CD8(+) T cell metabolism during the contraction phase. Consequently, memory CD8(+) T cells lacking MCJ provided superior protection against influenza virus infection. Thus, MCJ offers a mechanism for fine-tuning CD8(+) T cell mitochondrial metabolism as an alternative to modulating mitochondrial mass, an energetically expensive process. MCJ could be a therapeutic target to enhance CD8(+) T cell responses.	[Champagne, Devin P.; Hatle, Ketki M.; Fortner, Karen A.; Thornton, Tina M.; Yang, Rui; Torralba, Daniel; Rincon, Mercedes] Univ Vermont, Dept Med, Program Immunobiol, Burlington, VT 05405 USA; [D'Alessandro, Angelo; Hansen, Kirk C.] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Tomas-Cortazar, Julen; Anguita, Juan] Ctr Cooperat Res Biosci CIC bioGUNE, Derio 48160, Bizkaia, Spain; [Jun, Yong Woong; Ahn, Kyo Han] Pohang Univ Sci & Technol POSTECH, Ctr Electrophoto Behav Adv Mol Syst, Dept Chem, Pohang 790784, Gyeongbuk, South Korea; [Haynes, Laura] Univ Connecticut, Ctr Hlth, Ctr Aging, Farmington, CT 06030 USA; [Haynes, Laura] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Anguita, Juan] Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain	University of Vermont; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; CIC bioGUNE; Pohang University of Science & Technology (POSTECH); University of Connecticut; University of Connecticut; Basque Foundation for Science	Rincon, M (corresponding author), Univ Vermont, Dept Med, Program Immunobiol, Burlington, VT 05405 USA.	mrincon@uvm.edu	Yang, Rui/N-8972-2016; Yang, Rui/G-4917-2015; D'Alessandro, Angelo/AAA-4695-2019; Anguita, Juan/D-5432-2011; Yang, Rui/AAX-2516-2021; Tomás-Cortázar, Julen/AAN-8237-2021	Yang, Rui/0000-0003-4427-2158; Yang, Rui/0000-0003-4427-2158; D'Alessandro, Angelo/0000-0002-2258-6490; Anguita, Juan/0000-0003-2061-7182; Yang, Rui/0000-0003-4427-2158; Champagne, Devin/0000-0002-1958-7433; Tomas Cortazar, Julen/0000-0002-0812-0395	NIH [AI110016, GM103496]; Spanish Ministry of Economy Plan Nacional grant [SAF2012-34610]; AAI Careers in Immunology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055402, R21AI110016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy Plan Nacional grant; AAI Careers in Immunology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the University of Vermont DNA Analysis Facility, Flow Cytometry and Cell Sorting Facility and Microscopy Imaging Center. We thank E. Atondo, I. Martin-Ruiz, P. Gummadidala, and B. Silverstrim for technical support. This work was supported by NIH grants AI110016 (M.R.) and GM103496 (M.R. and K.M.H.). J.A. was partially funded by the Spanish Ministry of Economy Plan Nacional grant SAF2012-34610. R.Y. was supported by an AAI Careers in Immunology Fellowship.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Hatle KM, 2007, MOL CELL BIOL, V27, P2952, DOI 10.1128/MCB.01804-06; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jena Bhanu P, 2013, Methods Mol Biol, V931, P345, DOI 10.1007/978-1-62703-056-4_17; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; La Gruta NL, 2014, TRENDS IMMUNOL, V35, P396, DOI 10.1016/j.it.2014.06.004; MACDONALD HR, 1977, J EXP MED, V146, P699, DOI 10.1084/jem.146.3.698; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Morlino G, 2014, MOL CELL BIOL, V34, P1412, DOI 10.1128/MCB.01177-13; Navasa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep14692; Navasa N, 2015, J INFECT DIS, V211, DOI 10.1093/infdis/jiu389; O'Brien S, 2014, J IMMUNOL, V192, P5118, DOI 10.4049/jimmunol.1301992; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schusdziarra C, 2013, HUM MOL GENET, V22, P1348, DOI 10.1093/hmg/dds541; Shridhar V, 2001, CANCER RES, V61, P4258; Strathdee G, 2005, GYNECOL ONCOL, V97, P898, DOI 10.1016/j.ygyno.2005.03.023; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Yang R, 2015, ELIFE, V4, DOI 10.7554/eLife.06376	36	41	41	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1299	1311		10.1016/j.immuni.2016.02.018	http://dx.doi.org/10.1016/j.immuni.2016.02.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27234056	Green Accepted, Bronze			2022-12-18	WOS:000378341200010
J	Xu, RH; Wong, EB; Rubio, D; Roscoe, F; Ma, XY; Nair, S; Remakus, S; Schwendener, R; John, S; Shlomchik, M; Sigal, LJ				Xu, Ren-Huan; Wong, Eric B.; Rubio, Daniel; Roscoe, Felicia; Ma, Xueying; Nair, Savita; Remakus, Sanda; Schwendener, Reto; John, Shinu; Shlomchik, Mark; Sigal, Luis J.			Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; ADAPTIVE IMMUNE-RESPONSES; VIRAL-INFECTION; NUCLEIC-ACIDS; INNATE; MACROPHAGES; MONOCYTES; SYSTEM; RECEPTORS; DEFENSE	Toll-like receptor 9 (TLR9), its adaptor MyD88, the downstream transcription factor interferon regulatory factor 7 (IRF7), and type I interferons (IFN-I) are all required for resistance to infection with ectromelia virus (ECTV). However, it is not known how or in which cells these effectors function to promote survival. Here, we showed that after infection with ECTV, the TLR9-MyD88-IRF7 pathway was necessary in CD11c(+) cells for the expression of proinflammatory cytokines and the recruitment of inflammatory monocytes (iMos) to the draining lymph node (dLN). In the dLN, the major producers of IFN-I were infected iMos, which used the DNA sensor-adaptor STING to activate IRF7 and nuclear factor kappa B (NF-kappa B) signaling to induce the expression of IFN-alpha and IFN-beta, respectively. Thus, in vivo, two pathways of DNA pathogen sensing act sequentially in two distinct cell types to orchestrate resistance to a viral disease.	[Xu, Ren-Huan; Wong, Eric B.; Rubio, Daniel; Roscoe, Felicia; Ma, Xueying; Nair, Savita; Remakus, Sanda; Sigal, Luis J.] Fox Chase Canc Ctr, Res Inst, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Schwendener, Reto] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [John, Shinu] Yale Univ, Dept Lab Med, New Haven, CT 06520 USA; [Shlomchik, Mark] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Fox Chase Cancer Center; University of Zurich; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sigal, LJ (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, BLSB 730,233 South 10th St, Philadelphia, PA 19107 USA.	luis.sigal@jefferson.edu	Sigal, Luis/AAL-1849-2021; Schwendener, Reto A/F-6373-2011; Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Sigal, Luis/0000-0001-6642-5472	NIH [R01AI065544, R01AI110457, U19AI083008, P30CA006927]; Kirby Foundation;  [T32 CA-009035036]; NATIONAL CANCER INSTITUTE [P30CA006927, T32CA009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110457, R01AI048849, R01AI065544, U19AI083008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirby Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Ms. Holly Gillin for assistance in the preparation of the manuscript and Dr. Siddharth Balachandran for critical reading. We also thank the Fox Chase Cancer Center (FCCC) Laboratory Animal, Flow Cytometry, and Tissue Culture Facilities for their services. This work was supported by NIH grants R01AI065544, R01AI110457, and U19AI083008 to L.J.S. and P30CA006927 to the FCCC. S.R. was supported by T32 CA-009035036 to FCCC. A generous gift form the Kirby Foundation also contributed to funding this work.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Cao WP, 2012, J IMMUNOL, V189, P2257, DOI 10.4049/jimmunol.1200168; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dai PH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003989; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2; Flint SJ, 2009, PRINCIPLES VIROLOGY; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Giunti S, 2006, KIDNEY INT, V69, P856, DOI 10.1038/sj.ki.5000197; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Han SJ, 2014, IMMUNOL CELL BIOL, V92, P872, DOI 10.1038/icb.2014.70; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Johansson C, 2007, J EXP MED, V204, P1349, DOI 10.1084/jem.20061587; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lopez-Guerrero DV, 2010, J VIROL, V84, P1856, DOI 10.1128/JVI.02640-08; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Myskiw C, 2011, VIROLOGY, V413, P183, DOI 10.1016/j.virol.2011.01.034; Orzalli MH, 2014, ANNU REV MICROBIOL, V68, P477, DOI 10.1146/annurev-micro-091313-103409; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Radtke AJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004637; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rubio D, 2013, CELL HOST MICROBE, V13, P701, DOI 10.1016/j.chom.2013.04.015; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Seiler P, 1997, EUR J IMMUNOL, V27, P2626, DOI 10.1002/eji.1830271023; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Sutherland DB, 2011, IMMUNOL CELL BIOL, V89, P706, DOI 10.1038/icb.2010.157; Swiecki M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003728; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tahiliani V, 2013, J VIROL, V87, P3852, DOI 10.1128/JVI.03038-12; Vabret N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00468; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Virgin HW, 2007, FIELDS VIROLOGY, P335; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854; Xu RH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002475; Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768	58	41	43	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1148	1159		10.1016/j.immuni.2015.11.015	http://dx.doi.org/10.1016/j.immuni.2015.11.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682986	Green Accepted, Bronze			2022-12-18	WOS:000366846600018
J	Zlotnikov-Klionsky, Y; Bar Nathansohn-Levi; Shezen, E; Rosen, C; Kagan, S; Bar-On, L; Jung, S; Shifrut, E; Reich-Zeliger, S; Friedman, N; Aharoni, R; Arnon, R; Yifa, O; Aronovich, A; Reisner, Y				Zlotnikov-Klionsky, Yael; Bar Nathansohn-Levi; Shezen, Elias; Rosen, Chava; Kagan, Sivan; Bar-On, Liat; Jung, Steffen; Shifrut, Eric; Reich-Zeliger, Shlomit; Friedman, Nir; Aharoni, Rina; Arnon, Ruth; Yifa, Oren; Aronovich, Anna; Reisner, Yair			Perforin-Positive Dendritic Cells Exhibit an Immuno-regulatory Role in Metabolic Syndrome and Autoimmunity	IMMUNITY			English	Article							DIET-INDUCED OBESITY; ADIPOSE-TISSUE INFLAMMATION; CARDIAC ALLOGRAFT SURVIVAL; LINKED INSULIN-RESISTANCE; NATURAL-KILLER-CELLS; T-CELLS; MACROPHAGE POLARIZATION; ADAPTIVE IMMUNITY; MICE; FAT	Emerging evidence suggests that immunological mechanisms underlie metabolic control of adipose tissue. Here, we have shown the regulatory impact of a rare subpopulation of dendritic cells, rich in perforin-containing granules (perf-DCs). Using bone marrow transplantation to generate animals selectively lacking perf-DCs, we found that these chimeras progressively gained weight and exhibited features of metabolic syndrome. This phenotype was associated with an altered repertoire of T cells residing in adipose tissue and could be completely prevented by T cell depletion in vivo. A similar impact of perf-DCs on inflammatory T cells was also found in a well-defined model of multiple sclerosis, experimental autoimmune encephlalomyelitis (EAE). Thus, perf-DCs probably represent a regulatory cell subpopulation critical for protection from metabolic syndrome and autoimmunity.	[Zlotnikov-Klionsky, Yael; Bar Nathansohn-Levi; Shezen, Elias; Rosen, Chava; Kagan, Sivan; Bar-On, Liat; Jung, Steffen; Shifrut, Eric; Reich-Zeliger, Shlomit; Friedman, Nir; Aharoni, Rina; Arnon, Ruth; Yifa, Oren; Aronovich, Anna; Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reisner, Y (corresponding author), Weizmann Inst Sci, Dept Immunol, Herzel St 1, IL-76100 Rehovot, Israel.	yair.reisner@weizmann.ac.il	Shifrut, Eric/AAK-9263-2021; Jung, Steffen/K-1409-2012; Reisner, Yair/AAA-4772-2019	Shifrut, Eric/0000-0001-6827-0128; Jung, Steffen/0000-0003-4290-5716; Reisner, Yair/0000-0002-3354-6945	BIRAX (Britain-Israel Research and Academic Exchange) Regenerative Medicine Initiative; ISF [1346/14]; Roberto and Renata Ruhman	BIRAX (Britain-Israel Research and Academic Exchange) Regenerative Medicine Initiative; ISF(Israel Science Foundation); Roberto and Renata Ruhman	The authors wish to thank Dr. Eran Elinav for reviewing the manuscript and Dr. Hagit Shapiro, Dr. Yael Kuperman, and Dr. Michael Tsoory for professional advice. Y.R. holds the Henry Drake Professorial Chair in Transplantation Immunology. This work was supported in part by grants from BIRAX (Britain-Israel Research and Academic Exchange) Regenerative Medicine Initiative and ISF (no. 1346/14) and from Roberto and Renata Ruhman.	Aharoni R, 2013, EXPERT REV CLIN IMMU, V9, P423, DOI [10.1586/ECI.13.21, 10.1586/eci.13.21]; Bar-On L, 2010, IMMUNOL REV, V234, P76, DOI 10.1111/j.0105-2896.2009.00875.x; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lu LN, 1997, J IMMUNOL, V158, P5676; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Ndifon W, 2012, P NATL ACAD SCI USA, V109, P15865, DOI 10.1073/pnas.1203916109; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2013, CELL METAB; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Revelo XS, 2015, DIABETES, V64, P90, DOI 10.2337/db13-1524; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Sadys M, 2015, INT J BIOMETEOROL, V59, P25, DOI 10.1007/s00484-014-0818-4; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tiao MM, 2005, ANN SURG, V241, P497, DOI 10.1097/01.sla.0000154267.42933.5d; Trinite B, 2005, J IMMUNOL, V175, P2408, DOI 10.4049/jimmunol.175.4.2408; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; Yu P, 2009, IMMUNOLOGY, V127, P500, DOI 10.1111/j.1365-2567.2009.03057.x; Zangi L, 2012, BLOOD, V120, P1647, DOI 10.1182/blood-2012-02-410803	55	41	43	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					776	787		10.1016/j.immuni.2015.08.015	http://dx.doi.org/10.1016/j.immuni.2015.08.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26384546	Bronze			2022-12-18	WOS:000363478700019
J	Relloso, M; Cheng, TY; Im, JS; Parisini, E; Roura-Mir, C; DeBono, C; Zajonc, DM; Murga, LF; Ondrechen, MJ; Wilson, IA; Porcelli, SA; Moody, DB				Relloso, Miguel; Cheng, Tan-Yun; Im, Jin S.; Parisini, Emilio; Roura-Mir, Carme; DeBono, Charles; Zajonc, Dirk M.; Murga, Leonel F.; Ondrechen, Mary Jo; Wilson, Ian A.; Porcelli, Steven A.; Moody, D. Branch			pH-dependent interdomain tethers of CD1b regulate its antigen capture	IMMUNITY			English	Article							DIFFERENT CELLULAR COMPARTMENTS; T-CELLS; CRYSTAL-STRUCTURE; LIPOGLYCAN ANTIGENS; LIPID ANTIGENS; FORCE-FIELD; CONFORMATIONAL FLEXIBILITY; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR RECOGNITION; PRESENTING MOLECULES	As CD1 proteins recycle between the cell surface and endosomes, they show altered receptiveness to lipid antigen loading. We hypothesized that changes in proton concentration encountered within distinct endosomal compartments influence the charge state of residues near the entrance to the CD1 groove and thereby control antigen loading. Molecular dynamic models identified flexible areas of the CD1b heavy chain in the superior and lateral walls of the A' pocket. In these same areas, residues that carry charge in a pH-dependent manner (D60, E62) were found to tether the rigid alpha 1 helix to flexible areas of the alpha 2 helix and the 50-60 loop. After disruption of these tethers with acid pH or mutation, we observed increased association and dissociation of lipids with CD1b and preferential presentation of antigens with bulky lipid tails. We propose that ionic tethers act as molecular switches that respond to pH fluxes during endosomal recycling and regulate the conformation of the CD1 heavy chain to control the size and rate of antigens captured.	[Relloso, Miguel; Cheng, Tan-Yun; Roura-Mir, Carme; DeBono, Charles; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Relloso, Miguel; Cheng, Tan-Yun; Roura-Mir, Carme; DeBono, Charles; Moody, D. Branch] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Im, Jin S.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Parisini, Emilio] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Lab Immunobiol,Dept Med Oncol, Boston, MA 02115 USA; [Murga, Leonel F.; Ondrechen, Mary Jo] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Zajonc, Dirk M.; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northeastern University; Scripps Research Institute	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Smith Bldg Room 514,1 Jimmy Fund Way, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu	Roura-Mir, Carme/D-4538-2013; Relloso, Miguel/K-2238-2014	Roura-Mir, Carme/0000-0003-0514-337X; Relloso, Miguel/0000-0002-9181-2244; Ondrechen, Mary Jo/0000-0003-2456-4313; PARISINI, Emilio/0000-0002-5529-0039	NCI NIH HHS [CA58896, R01 CA058896] Funding Source: Medline; NIAID NIH HHS [R01 AI049313, R01 AI071155, R01 AI045889-07, P01 AI063537, R01 AI045889, AI45889, R01 AI045889-06, AI 071155, R01 AI045889-08, AI063537] Funding Source: Medline; NIAMS NIH HHS [AR048632, R01 AR048632] Funding Source: Medline; NIGMS NIH HHS [GM62116, U54 GM062116] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889, R01AI071155, P01AI063537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Baaden M, 2004, BIOPHYS J, V87, P2942, DOI 10.1529/biophysj.104.046987; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Briken V, 2000, SEMIN IMMUNOL, V12, P517, DOI 10.1006/smim.2000.0274; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Dascher Christopher C, 2003, Contrib Microbiol, V10, P164; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Lawton AP, 2005, J IMMUNOL, V174, P3179, DOI 10.4049/jimmunol.174.6.3179; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; Melancon JM, 2004, J VIROL, V78, P7329, DOI 10.1128/JVI.78.14.7329-7343.2004; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Rapaport D.C, 2004, ART MOL DYNAMICS SIM, DOI [DOI 10.1017/CBO9780511816581, 10.1017/CBO9780511816581]; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; Roura-Mir C, 2005, J IMMUNOL, V174, P3773, DOI 10.4049/jimmunol.174.6.3773; Scott SD, 2002, GENE THER, V9, P1396, DOI 10.1038/sj.gt.3301822; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Sullivan BA, 2005, TRENDS IMMUNOL, V26, P282, DOI 10.1016/j.it.2005.03.002; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	70	41	41	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					774	786		10.1016/j.immuni.2008.04.017	http://dx.doi.org/10.1016/j.immuni.2008.04.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18538591	Green Accepted, Bronze			2022-12-18	WOS:000256760200009
J	Velikovsky, CA; Deng, L; Chlewicki, LK; Fernandez, MM; Kumar, V; Mariuzza, RA				Velikovsky, C. Alejandro; Deng, Lu; Chlewicki, Lukasz K.; Fernandez, Marisa M.; Kumar, Vinay; Mariuzza, Roy A.			Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family	IMMUNITY			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; YEAST SURFACE-DISPLAY; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN SUPERFAMILY; DIRECTED EVOLUTION; SELF-TOLERANCE; CELL RECEPTORS; CUTTING EDGE; LOW-AFFINITY; CD58 LFA-3	Natural killer (NK) cells eliminate virally infected and tumor cells. Among the receptors regulating INK cell function is 2B4 (CD244), a member of the signaling lymphocyte-activation molecule (SLAM) family that binds CD48. 2B4 is the only heterophilic receptor of the SLAM family, whose other members, e.g., NK-T-B-antigen (NTB-A), are self-ligands. We determined the structure of the complex between the N-terminal domains of mouse 2B4 and CD48, as well as the structures of unbound 2B4 and CD48. The complex displayed an association mode related to, yet distinct from, that of the NTB-A dimer. Binding was accompanied by the rigidification of flexible 2B4 regions containing most of the polymorphic residues across different species and receptor isoforms. We propose a model for 2B4-CD48 interactions that permits the intermixing of SLAM receptors with major histocompatibility complex-specific receptors in the NK cell immune synapse. This analysis revealed the basis for heterophilic recognition within the SLAM family.	Univ Maryland, WM Kect Lab Struct Biol, Ctr Adv Res Biotechnol, Inst Biotechnol, Rockville, MD 20850 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University System of Maryland; University of Maryland Baltimore; University of Chicago	Mariuzza, RA (corresponding author), Univ Maryland, WM Kect Lab Struct Biol, Ctr Adv Res Biotechnol, Inst Biotechnol, Rockville, MD 20850 USA.	mariuzza@carb.nist.gov	Deng, Lu/AAE-1635-2021	Fernandez, Marisa/0000-0002-7480-5907	NIAID NIH HHS [AI47990, R01 AI047990-08, R01 AI047990] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047990] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ames JB, 2005, BIOCHEMISTRY-US, V44, P6416, DOI 10.1021/bi050139s; Assarsson E, 2005, J IMMUNOL, V175, P2045, DOI 10.4049/jimmunol.175.4.2045; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Cao E, 2006, IMMUNITY, V25, P559, DOI 10.1016/j.immuni.2006.06.020; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Deng L, 2006, SEMIN IMMUNOL, V18, P159, DOI 10.1016/j.smim.2006.03.004; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Esteban O, 2004, J MOL BIOL, V340, P81, DOI 10.1016/j.jmb.2004.04.054; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; KILLEEN N, 1988, EMBO J, V7, P3087, DOI 10.1002/j.1460-2075.1988.tb03174.x; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Kumaresan PR, 2000, IMMUNOGENETICS, V51, P306, DOI 10.1007/s002510050624; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Latchman Y, 1998, J IMMUNOL, V161, P5809; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Li YL, 2003, BIOCHEMISTRY-US, V42, P11, DOI 10.1021/bi020589+; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Mathew SO, 2005, J IMMUNOL, V175, P1005, DOI 10.4049/jimmunol.175.2.1005; McNerney ME, 2005, BLOOD, V106, P1337, DOI 10.1182/blood-2005-01-0357; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Roda-Navarro P, 2004, J IMMUNOL, V173, P3640, DOI 10.4049/jimmunol.173.6.3640; Schatzle JD, 1999, P NATL ACAD SCI USA, V96, P3870, DOI 10.1073/pnas.96.7.3870; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Vyas YM, 2001, J IMMUNOL, V167, P4358, DOI 10.4049/jimmunol.167.8.4358; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Yan QR, 2007, P NATL ACAD SCI USA, V104, P10583, DOI 10.1073/pnas.0703893104; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	60	41	46	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					572	584		10.1016/j.immuni.2007.08.019	http://dx.doi.org/10.1016/j.immuni.2007.08.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17950006	Green Accepted, Bronze			2022-12-18	WOS:000250490700009
J	Wu, C; Bassing, CH; Jung, D; Woodman, BB; Foy, D; Alt, FW				Wu, C; Bassing, CH; Jung, D; Woodman, BB; Foy, D; Alt, FW			Dramatically increased rearrangement and peripheral representation of V beta 14 driven by the 3 ' D beta 1 recombination signal sequence	IMMUNITY			English	Article							T-CELL-RECEPTOR; GENE SEGMENT USAGE; V(D)J RECOMBINATION; BETA LOCUS; INCREASED SUSCEPTIBILITY; MEDIATE RECOMBINATION; SOMATIC RECOMBINATION; ALLELIC EXCLUSION; B-LYMPHOCYTES; CHAIN GENES	V(D)J recombination is targeted by short recombination signal (RS) sequences that are relatively conserved but exhibit natural sequence variations. To evaluate the potential of RS sequence variations to determine the primary and peripheral TCRbeta repertoire, we generated mice containing specific replacement of the endogenous Vbeta14 RS with the 3'Dbeta1 RS (Vbeta14/3'DbetadRS). These mice exhibited a dramatic increase in Vbeta14(+) thymocyte numbers at the expense of thymocytes expressing other Vbetas. In addition, the percentage of peripheral Vbeta14(+) cip T lymphocytes was similarly increased. Strikingly, this altered Vbeta repertoire resulted predominantly from a higher relative level of primary Vbeta14/3'DORS rearrangement to DbetaJbeta complexes, despite the ability of the 3'Dbeta1 RS to break B12/23 restriction and allow direct rearrangement of Vbeta14/3'DbetaRS to Jbeta segments.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Ctr Blood Res, Boston, MA 02115 USA.				NIAID NIH HHS [AI 20047] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI020047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aifantis I, 1999, J EXP MED, V190, P1093, DOI 10.1084/jem.190.8.1093; Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; AKAMATSU Y, 1994, J IMMUNOL, V153, P4520; AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CONNOR AM, 1995, J IMMUNOL, V155, P5268; EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; EZEKIEL UR, 1995, IMMUNITY, V2, P381, DOI 10.1016/1074-7613(95)90146-9; Fanning L, 1996, IMMUNOGENETICS, V44, P146, DOI 10.1007/BF02660064; Feeney AJ, 1996, J CLIN INVEST, V97, P2277, DOI 10.1172/JCI118669; Feeney AJ, 2000, IMMUNOL REV, V175, P59, DOI 10.1111/j.1600-065X.2000.imr017508.x; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Larijani M, 1999, NUCLEIC ACIDS RES, V27, P2304, DOI 10.1093/nar/27.11.2304; Livak F, 2000, J EXP MED, V192, P1191, DOI 10.1084/jem.192.8.1191; MALISSEN M, 1986, NATURE, V319, P28, DOI 10.1038/319028a0; Marshall AJ, 1996, J IMMUNOL, V156, P2077; MAX EE, 1979, P NATL ACAD SCI USA, V76, P3450, DOI 10.1073/pnas.76.7.3450; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; Nadel B, 1998, J IMMUNOL, V161, P6068; POSNETT DN, 1994, J EXP MED, V179, P1707, DOI 10.1084/jem.179.5.1707; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sawchuk DJ, 1997, J EXP MED, V185, P2025, DOI 10.1084/jem.185.11.2025; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sleckman BP, 2000, P NATL ACAD SCI USA, V97, P7975, DOI 10.1073/pnas.130190597; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; tenBoekel E, 1997, IMMUNITY, V7, P357; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; WEI Z, 1993, J BIOL CHEM, V268, P3180; WHITE J, 1989, J IMMUNOL, V143, P1822; Williams GS, 2001, J IMMUNOL, V167, P257, DOI 10.4049/jimmunol.167.1.257; Wilson A, 2001, J IMMUNOL, V166, P51, DOI 10.4049/jimmunol.166.1.51; Yu KF, 2002, J BIOL CHEM, V277, P5040, DOI 10.1074/jbc.M109772200	48	41	42	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					75	85		10.1016/S1074-7613(02)00515-0	http://dx.doi.org/10.1016/S1074-7613(02)00515-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530977	Bronze			2022-12-18	WOS:000180860600008
J	Tang, H; Sharp, PA				Tang, H; Sharp, PA			Transcriptional regulation of the murine 3 ' IgH enhancer by OCT-2	IMMUNITY			English	Article							HEAVY-CHAIN LOCUS; PROTEIN-KINASE-C; B-CELL PROLIFERATION; CONTROL REGION; DNA-BINDING; POU DOMAIN; IMMUNOGLOBULIN PROMOTERS; ACTIVATION DOMAINS; GENE-EXPRESSION; OCTAMER SITE	Targeted disruption of either of the B cell-specific transcription factors Oct-2 or OCA-B/BOB-1/OBF-1 dramatically affects B cell terminal differentiation. The 3' enhancer of immunoglobulin heavy chain (IgH) locus is important for transcription of the locus in terminal plasma cells. Allele-specific suppression of mutant Oct-2 binding sites in this enhancer by a variant Oct-2 protein revealed that in a mature B cell line this enhancer was specifically dependent upon Oct-2, as contrasted to the closely related Oct-1 transcription factor. Phosphorylation of the Oct-2 protein was important for this activation and was synergistic for coactivation by the OCA-B factor. These results indicate that Oct-2 and OCA-B interact with the 3' enhancer in regulation of the IgH locus during B cell activation.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.				NATIONAL CANCER INSTITUTE [P30CA014051, P01CA042063] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA42063, P30-CA14051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANNWEILER A, 1993, J BIOL CHEM, V268, P2525; ANNWEILER A, 1994, NUCLEIC ACIDS RES, V22, P4250, DOI 10.1093/nar/22.20.4250; ARULAMPALAM V, 1994, EUR J IMMUNOL, V24, P1671, DOI 10.1002/eji.1830240732; Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; Cepek KL, 1996, GENE DEV, V10, P2079, DOI 10.1101/gad.10.16.2079; CHASMAN D, 1999, IN PRESS GENES DEV; Chauveau C, 1998, EUR J IMMUNOL, V28, P3048, DOI 10.1002/(SICI)1521-4141(199810)28:10<3048::AID-IMMU3048>3.3.CO;2-M; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; CORCORAN LM, 1994, IMMUNITY, V1, P635, DOI 10.1016/1074-7613(94)90035-3; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; DEARDENBADET MT, 1993, IMMUNOLOGY, V80, P658; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; FELDHAUS AL, 1993, EMBO J, V12, P2763, DOI 10.1002/j.1460-2075.1993.tb05937.x; FRIEDL EM, 1995, EUR J BIOCHEM, V234, P308, DOI 10.1111/j.1432-1033.1995.308_c.x; Grant JB, 1996, J AM MED INFORM ASSN, V3, P15, DOI 10.1136/jamia.1996.96342646; GRANT PA, 1995, EMBO J, V14, P4501, DOI 10.1002/j.1460-2075.1995.tb00129.x; GREGOR PD, 1986, MOL CELL BIOL, V6, P1903, DOI 10.1128/MCB.6.6.1903; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; GUPTA S, 1988, CELL IMMUNOL, V117, P425, DOI 10.1016/0008-8749(88)90131-1; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Humbert PO, 1997, J IMMUNOL, V159, P5273; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; KEARNEY JF, 1976, J IMMUNOL, V116, P1664; KEARNEY JF, 1975, J IMMUNOL, V115, P677; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; LASKOV R, 1981, EUR J IMMUNOL, V11, P462, DOI 10.1002/eji.1830110605; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Li Y S, 1992, Eur Cytokine Netw, V3, P103; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; Linderson Y, 1997, EUR J IMMUNOL, V27, P468, DOI 10.1002/eji.1830270218; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; Matthias P, 1998, SEMIN IMMUNOL, V10, P155, DOI 10.1006/smim.1998.0117; Mey A, 1998, INFECT IMMUN, V66, P2547, DOI 10.1128/IAI.66.6.2547-2552.1998; Michaelson JS, 1996, J IMMUNOL, V156, P2828; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; NATKUNAM Y, 1994, J IMMUNOL, V153, P3476; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ong J, 1998, J IMMUNOL, V160, P4896; PETTERSSON S, 1990, NATURE, V344, P165, DOI 10.1038/344165a0; PFISTERER P, 1994, EMBO J, V13, P1655; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; POMERANTZ JL, 1994, BIOCHEMISTRY-US, V33, P10851, DOI 10.1021/bi00202a001; RUSH JS, 1987, BIOCHEM BIOPH RES CO, V145, P1315, DOI 10.1016/0006-291X(87)91581-6; Saleque S, 1999, J IMMUNOL, V162, P2791; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shah PC, 1997, EMBO J, V16, P7105, DOI 10.1093/emboj/16.23.7105; TANAKA M, 1994, MOL CELL BIOL, V14, P6046, DOI 10.1128/MCB.14.9.6046; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tang H, 1996, P NATL ACAD SCI USA, V93, P1119, DOI 10.1073/pnas.93.3.1119; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; VANDERGEER P, 1994, ELECTROPHORESIS, V15, P544, DOI 10.1002/elps.1150150173; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; XIE HJ, 1995, J IMMUNOL, V154, P1717; YUAN D, 1992, J IMMUNOL, V48, P3652	64	41	42	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					517	526		10.1016/S1074-7613(00)80127-2	http://dx.doi.org/10.1016/S1074-7613(00)80127-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591177	Bronze			2022-12-18	WOS:000083952200004
J	Sayaman, RW; Saad, M; Thorsson, V; Hu, DL; Hendrickx, W; Roelands, J; Porta-Pardo, E; Mokrab, Y; Farshidfar, F; Kirchhoff, T; Sweis, RF; Bathe, OF; Heimann, C; Campbell, MJ; Stretch, C; Huntsman, S; Graff, RE; Syed, N; Radvanyi, L; Shelley, S; Wolf, D; Marincola, FM; Ceccarelli, M; Galon, J; Ziv, E; Bedognetti, D				Sayaman, Rosalyn W.; Saad, Mohamad; Thorsson, Vesteinn; Hu, Donglei; Hendrickx, Wouter; Roelands, Jessica; Porta-Pardo, Eduard; Mokrab, Younes; Farshidfar, Farshad; Kirchhoff, Tomas; Sweis, Randy F.; Bathe, Oliver F.; Heimann, Carolina; Campbell, Michael J.; Stretch, Cynthia; Huntsman, Scott; Graff, Rebecca E.; Syed, Najeeb; Radvanyi, Laszlo; Shelley, Simon; Wolf, Denise; Marincola, Francesco M.; Ceccarelli, Michele; Galon, Jerome; Ziv, Elad; Bedognetti, Davide			Germline genetic contribution to the immune landscape of cancer	IMMUNITY			English	Article							GENOME-WIDE ASSOCIATION; REPAIR DEFICIENCY; CLINICAL-RESPONSE; PD-1; VARIANTS; BLOCKADE; TUMORS; IDENTIFICATION; VISUALIZATION; HERITABILITY	Understanding the contribution of the host's genetic background to cancer immunity may lead to improved stratification for immunotherapy and to the identification of novel therapeutic targets. We investigated the effect of common and rare germline variants on 139 well-defined immune traits in similar to 9000 cancer patients enrolled in TCGA. High heritability was observed for estimates of NK cell and T cell subset infiltration and for interferon signaling. Common variants of IFIH1, TMEM173 (STING1), and TMEM108 were associated with differential interferon signaling and variants mapping to RBL1 correlated with T cell subset abundance. Pathogenic or likely pathogenic variants in BRCA1 and in genes involved in telomere stabilization and Wnt-bcatenin also acted as immune modulators. Our findings provide evidence for the impact of germline genetics on the composition and functional orientation of the tumor immune microenvironment. The curated datasets, variants, and genes identified provide a resource toward further understanding of tumor-immune interactions.	[Sayaman, Rosalyn W.] City Hope Comprehens Canc Ctr, Dept Populat Sci, Beckman Res Inst, Duarte, CA 91010 USA; [Sayaman, Rosalyn W.; Wolf, Denise] Univ Calif San Francisco, Dept Lab Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Sayaman, Rosalyn W.] Lawrence Berkeley Natl Lab, Biol Sci & Engn Div, Berkeley, CA 94720 USA; [Saad, Mohamad] Hamad Bin Khalifa Univ, Qatar Comp Res Inst, Doha, Qatar; [Saad, Mohamad] Lebanese Univ, Fac Med Sci, Neurosci Res Ctr, Beirut, Lebanon; [Thorsson, Vesteinn; Heimann, Carolina] Inst Syst Biol, Seattle, WA 98109 USA; [Hu, Donglei; Huntsman, Scott; Ziv, Elad] Univ Calif San Francisco, Dept Med, Inst Human Genet, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Hendrickx, Wouter; Roelands, Jessica; Mokrab, Younes; Syed, Najeeb; Bedognetti, Davide] Sidra Med, Res Branch, POB 26999, Doha, Qatar; [Hendrickx, Wouter; Mokrab, Younes; Bedognetti, Davide] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar; [Roelands, Jessica] Leiden Univ Med Ctr, Dept Surg, NL-2333 ZA Leiden, Netherlands; [Porta-Pardo, Eduard] Barcelona Supercomp Ctr BSC, Barcelona, Spain; [Porta-Pardo, Eduard] Josep Carreras Leukaemia Res Inst IJC, Barcelona 08034, Spain; [Mokrab, Younes] Weill Cornell Med, Doha, Qatar; [Farshidfar, Farshad; Bathe, Oliver F.; Stretch, Cynthia] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Farshidfar, Farshad; Bathe, Oliver F.; Stretch, Cynthia] Arnie Charbonneau Canc Inst, Calgary, AB T2N 4N1, Canada; [Farshidfar, Farshad] Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA; [Farshidfar, Farshad] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Farshidfar, Farshad] Tenaya Therapeut, San Francisco, CA 94080 USA; [Kirchhoff, Tomas] NYU, Perlmutter Canc Ctr, NYU Langone Hlth, Sch Med, New York, NY 10016 USA; [Sweis, Randy F.] Univ Chicago, Dept Med, Sect Hematol Oncol, Comm Clin Pharmacol & Pharmacogen,Comm Immunol, Chicago, IL 60637 USA; [Bathe, Oliver F.] Univ Calgary, Dept Surg, Calgary, AB T2N 4N1, Canada; [Campbell, Michael J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Graff, Rebecca E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Syed, Najeeb] Univ Sannio, Dept Sci & Technol, I-82100 Benevento, Italy; [Radvanyi, Laszlo] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Shelley, Simon] Leukemia Therapeut LLC, Dept Res & Dev, Hull, MA 02045 USA; [Marincola, Francesco M.] Refuge Biotechnol Inc, Menlo Pk, CA 94025 USA; [Ceccarelli, Michele] Univ Naples Federico II, Dept Elect Engn & Informat Technol, I-80128 Naples, Italy; [Ceccarelli, Michele] Biogem Scarl, Ist Ric Genet G Salvatore, I-83031 Ariano Irpino, Italy; [Galon, Jerome] Sorbonne Univ, Univ Paris, INSERM,Equipe Labellisee Ligue Canc, Lab Integrat Canc Immunol,Ctr Rech Cordeliers, Paris, France; [Bedognetti, Davide] Univ Genoa, Dept Internal Med & Med Specialties DiMI, I-16132 Genoa, Italy	City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; Lebanese University; Institute for Systems Biology (ISB); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Sidra Medical & Research Center; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Leiden University; Leiden University Medical Center (LUMC); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Calgary; Stanford University; Stanford University; New York University; NYU Langone Medical Center; University of Chicago; University of Calgary; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Sannio; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Genoa	Ziv, E (corresponding author), Univ Calif San Francisco, Dept Med, Inst Human Genet, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Bedognetti, D (corresponding author), Sidra Med, Res Branch, POB 26999, Doha, Qatar.; Bedognetti, D (corresponding author), Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar.	rwsayaman@gmail.com; elad.ziv@ucsf.edu; dbedognetti@sidra.org	Roelands, Jessica/X-8518-2019; Bedognetti, Davide/GLQ-9410-2022; Ceccarelli, Michele/AGP-1739-2022; Hendrickx, Wouter Renaat Leo/A-1447-2010; Porta-Pardo, Eduard/K-9162-2016; Farshidfar, Farshad/B-7317-2008	Roelands, Jessica/0000-0003-3631-2041; Hendrickx, Wouter Renaat Leo/0000-0002-7649-5092; Porta-Pardo, Eduard/0000-0001-7900-4239; Heimann, Carolina/0000-0002-1322-6813; Sayaman, Rosalyn/0000-0003-1343-0619; Stretch, Cynthia/0000-0002-5152-2728; Kirchhoff, Tomas/0000-0002-9055-2364; Farshidfar, Farshad/0000-0003-3674-7336; Sweis, Randy/0000-0002-0497-9637	National Institutes of Health [R01CA227466, K24CA169004, T32CA221709]; Qatar National Research Fund (QNRF) [NPRP11S-0121-180351]; Sidra Precision Medicine Program internal grant [SDR100035, SDR400023]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG2018-21846]; Cancer Research Institute fund; Fundacio Bancaria La Caixa, a La Caixa Junior Leader Fellowship [LCF/BQ/PI18/11630003]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF)); Sidra Precision Medicine Program internal grant; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cancer Research Institute fund; Fundacio Bancaria La Caixa, a La Caixa Junior Leader Fellowship	We are grateful to the Society for Immunotherapy of Cancer (SITC) for the logistical support of the investigator meeting within the SITC Cancer Immune Responsiveness Workshop (San Francisco CA, US, April 2018; Houston, TX, US, May 2019). We are also grateful to Noah Zaitlen and Andy Dahl for useful discussions on heritability interaction analyses. This work was funded in part by the National Institutes of Health R01CA227466 and K24CA169004 to E.Z. and T32CA221709 Cancer Metabolism Training Program Postdoctoral Fellowship to R.W. S., Qatar National Research Fund (QNRF) NPRP11S-0121-180351 grant and the Sidra Precision Medicine Program internal grant (SDR100035 and SDR400023) to D.B., Associazione Italiana per la Ricerca sul Cancro (AIRC) grant IG2018-21846 to M.C., the Cancer Research Institute funding to V.T., and the Fundacio Bancaria La Caixa, a La Caixa Junior Leader Fellowship (LCF/BQ/PI18/11630003) to E.P-P.	Amara D, 2017, BREAST CANCER RES TR, V161, P41, DOI 10.1007/s10549-016-4041-3; Angelova M, 2018, CELL, V175, P751, DOI 10.1016/j.cell.2018.09.018; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bedognetti D, 2013, BRIT J CANCER, V109, P2412, DOI 10.1038/bjc.2013.557; Bedognetti D, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0602-4; Bedognetti D, 2016, CURR OPIN IMMUNOL, V39, P150, DOI 10.1016/j.coi.2016.02.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bruni D, 2020, NAT REV CANCER, V20, P662, DOI 10.1038/s41568-020-0285-7; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Carrot-Zhang J, 2020, CANCER CELL, V37, P639, DOI 10.1016/j.ccell.2020.04.012; Chamoto K, 2020, INT J CLIN ONCOL, V25, P790, DOI 10.1007/s10147-019-01588-7; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chat V, 2019, CANCER IMMUNOL IMMUN, V68, P897, DOI 10.1007/s00262-019-02318-8; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Cook R, 2015, CELL REP, V10, P2006, DOI 10.1016/j.celrep.2015.02.059; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Flood BA, 2019, IMMUNOL REV, V290, P24, DOI 10.1111/imr.12765; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Galon J, 2020, IMMUNITY, V52, P55, DOI 10.1016/j.immuni.2019.12.018; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Garfin PM, 2013, J EXP MED, V210, P1087, DOI 10.1084/jem.20121716; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gorman JA, 2017, NAT IMMUNOL, V18, P744, DOI 10.1038/ni.3766; Haslam A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2535; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Helmink BA, 2019, NAT MED, V25, P377, DOI 10.1038/s41591-019-0377-7; Hendrickx W, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1253654; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jezequel P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0550-y; Jiang Y, 2013, 2013 CROSS STRAIT QUAD-REGIONAL RADIO SCIENCE AND WIRELESS TECHNOLOGY CONFERENCE (CSQRWC), P5, DOI 10.1109/CSQRWC.2013.6657336; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Kalbasi A, 2020, NAT REV IMMUNOL, V20, P25, DOI 10.1038/s41577-019-0218-4; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Keller MF, 2014, HUM MOL GENET, V23, P6944, DOI 10.1093/hmg/ddu401; Kennedy RB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.567348; Kim Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40527-4; Knijnenburg TA, 2018, CELL REP, V23, P239, DOI 10.1016/j.celrep.2018.03.076; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11664; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Luke J.J., 2019, CLIN CANC RES OFF J, DOI [10.1158/1078-0432, DOI 10.1158/1078-0432]; Mahajan A, 2018, NAT GENET, V50, P559, DOI 10.1038/s41588-018-0084-1; Mandal R, 2019, SCIENCE, V364, P485, DOI 10.1126/science.aau0447; Marcus L, 2019, CLIN CANCER RES, V25, P3753, DOI 10.1158/1078-0432.CCR-18-4070; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Miller LD, 2016, CANCER IMMUNOL RES, V4, P600, DOI 10.1158/2326-6066.CIR-15-0149; Mulligan GJ, 1998, MOL CELL BIOL, V18, P206, DOI 10.1128/MCB.18.1.206; Munn DH, 2016, TRENDS IMMUNOL, V37, P193, DOI 10.1016/j.it.2016.01.002; Ng SR, 2020, P NATL ACAD SCI USA, V117, P513, DOI 10.1073/pnas.1821893117; Ogawa Y, 2010, MOL BIOL CELL, V21, P630, DOI 10.1091/mbc.E09-05-0374; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Patel S, 2019, GENES IMMUN, V20, P82, DOI 10.1038/s41435-018-0029-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Queirolo P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00386; Rashkin S.R., 2019, BIORXIV, DOI [10.1101/635367, DOI 10.1101/635367]; Rice C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14928; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Roelands J, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000617corr1; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rozenblit M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42784-9; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Senbabaoglu Y, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004765; Shahamatdar S, 2020, CELL REP, V30, P2900, DOI 10.1016/j.celrep.2020.02.039; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Sweis RF, 2017, PHARMACOL RES, V120, P1, DOI 10.1016/j.phrs.2017.03.012; Taura M, 2012, MOL CELL BIOL, V32, P1581, DOI 10.1128/MCB.06454-11; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Uccellini L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-170; Ugurel S, 2008, CANCER IMMUNOL IMMUN, V57, P685, DOI 10.1007/s00262-007-0407-z; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Wolf DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088309; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang JYC, 2017, NAT REV GENET, V18, P309, DOI 10.1038/nrg.2017.12; Yao DW, 2020, NAT GENET, V52, P626, DOI 10.1038/s41588-020-0625-2; Ye J, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080377; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yu Z, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0272-4; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	113	40	40	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					367	+		10.1016/j.immuni.2021.01.011	http://dx.doi.org/10.1016/j.immuni.2021.01.011		FEB 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567262	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000627407700018
J	DiToro, D; Harbour, SN; Bando, JK; Benavides, G; Witte, S; Laufer, VA; Moseley, C; Singer, JR; Frey, B; Turner, H; Bruning, J; Darley-Usmar, V; Gao, M; Conover, C; Hatton, RD; Frank, S; Colonna, M; Weaver, CT				DiToro, Daniel; Harbour, Stacey N.; Bando, Jennifer K.; Benavides, Gloria; Witte, Steven; Laufer, Vincent A.; Moseley, Carson; Singer, Jeffery R.; Frey, Blake; Turner, Henrietta; Bruning, Jens; Darley-Usmar, Victor; Gao, Min; Conover, Cheryl; Hatton, Robin D.; Frank, Stuart; Colonna, Marco; Weaver, Casey T.			Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity	IMMUNITY			English	Article							FACTOR-I RECEPTOR; FACTOR BINDING-PROTEINS; CYTOKINE GM-CSF; TH17 CELLS; GRAVES-DISEASE; BONE-MARROW; MULTIPLE-SCLEROSIS; MAMMALIAN TARGET; TGF-BETA; IGF-I	Appropriate balance of T helper 17 (Th17) and regulatory T (Treg) cells maintains immune tolerance and host defense. Disruption of Th17-Treg cell balance is implicated in a number of immune-mediated diseases, many of which display dysregulation of the insulin-like growth factor (IGF) system. Here, we show that, among effector T cell subsets, Th17 and Treg cells selectively expressed multiple components of the IGF system. Signaling through IGF receptor (IGF1R) activated the protein kinase B-mammalian target of rapamycin (AKT-mTOR) pathway, increased aerobic glycolysis, favored Th17 cell differentiation over that of Treg cells, and promoted a heightened pro-inflammatory gene expression signature. Group 3 innate lymphoid cells (ILC3s), but not ILC1s or ILC2s, were similarly responsive to IGF signaling. Mice with deficiency of IGF1R targeted to T cells failed to fully develop disease in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis. Thus, the IGF system represents a previously unappreciated pathway by which type 3 immunity is modulated and immune-mediated pathogenesis controlled.	[DiToro, Daniel; Harbour, Stacey N.; Witte, Steven; Laufer, Vincent A.; Moseley, Carson; Singer, Jeffery R.; Frey, Blake; Turner, Henrietta; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35203 USA; [Bando, Jennifer K.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Benavides, Gloria; Darley-Usmar, Victor] Univ Alabama Birmingham, Dept Pathol, Mitochondrial Med Lab, Birmingham, AL 35294 USA; [Bruning, Jens] Max Plank Inst Metab Res, Dept Neuronal Control Metab, Cologne, Germany; [Bruning, Jens] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Cologne, Germany; [Bruning, Jens] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Cologne, Germany; [Bruning, Jens] Univ Cologne, CMMC, Cologne, Germany; [Gao, Min] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35203 USA; [Gao, Min] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35203 USA; [Conover, Cheryl] Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA; [Frank, Stuart; Weaver, Casey T.] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Dept Med, Birmingham, AL 35203 USA; [Frank, Stuart; Weaver, Casey T.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35203 USA	University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; University of Cologne; University of Cologne; University of Cologne; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Mayo Clinic; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35203 USA.; Weaver, CT (corresponding author), Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Dept Med, Birmingham, AL 35203 USA.; Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35203 USA.	cweaver@uabc.edu	Singer, Jeffrey/AAO-7314-2020	Singer, Jeffrey/0000-0001-7033-3001; Bando, Jennifer/0000-0002-1331-7424	NIH [T32 AI007051, K99 DK118110]; UAB Institutional Funds	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Institutional Funds	The authors thank Drs. Etty Beneveniste, Laurie Harrington, Lou Justement, and Robin Lorenz (University of Alabama Birmingham [UAB]), and members of the Weaver laboratory for their helpful comments and suggestions. We gratefully acknowledge Jeremy Day (La Jolla Institute of Allergy and Immunology) for assistance with gene expression studies. Wealso thank Jon Wright, Brenda Dale, and Alanna Smith for expert technical assistance, Connie Rutledge for editorial assistance, and the UAB Center for AIDS Research Flow Cytometry Core and UAB Epitope Recognition and Immunoreagent Core Facility flow cytometric sorting and antibody preparations, respectively. This work was supported by an NIH training grant T32 AI007051 to D.D.; NIH K99 DK118110 to J.K.B.; NIH R01 grants to C.H.C., S.J.F., R.D.H., and C.T.W.; and UAB Institutional Funds to C.T.W.	ABBOUD SL, 1991, J CLIN INVEST, V88, P470, DOI 10.1172/JCI115327; Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Allard JB, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00117; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bando JK, 2018, IMMUNITY, V48, P1208, DOI 10.1016/j.immuni.2018.04.012; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilbao D, 2014, EMBO MOL MED, V6, P1423, DOI 10.15252/emmm.201303376; Cai WK, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14892, 10.1038/s41467-017-00417-7]; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chesik D, 2006, EUR J NEUROSCI, V24, P1645, DOI 10.1111/j.1460-9568.2006.05034.x; Chu YW, 2008, BLOOD, V112, P2836, DOI 10.1182/blood-2008-04-149435; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clark R, 1997, ENDOCR REV, V18, P157, DOI 10.1210/er.18.2.157; CLARK R, 1993, J CLIN INVEST, V92, P540, DOI 10.1172/JCI116621; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Conover CA, 2010, AM J PHYSIOL-HEART C, V299, pH284, DOI 10.1152/ajpheart.00904.2009; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Douglas RS, 2007, J IMMUNOL, V178, P3281, DOI 10.4049/jimmunol.178.5.3281; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Duplomb L, 2003, ENDOCRINOLOGY, V144, P5381, DOI 10.1210/en.2003-0607; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gan YJ, 2013, MOL ENDOCRINOL, V27, P1969, DOI 10.1210/me.2013-1178; Gan YJ, 2010, MOL ENDOCRINOL, V24, P644, DOI 10.1210/me.2009-0357; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guvakova MA, 2007, INT J BIOCHEM CELL B, V39, P890, DOI 10.1016/j.biocel.2006.10.013; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Himpe E, 2009, BIOFACTORS, V35, P76, DOI 10.1002/biof.20; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang Y, 2004, MOL ENDOCRINOL, V18, P1471, DOI 10.1210/me.2003-0418; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; JARDIEU P, 1994, J IMMUNOL, V152, P4320; Johannesson B, 2014, DIS MODEL MECH, V7, P977, DOI 10.1242/dmm.015362; JOHNSON EW, 1992, J IMMUNOL, V148, P63; Joseph AM, 2018, IMMUNOL REV, V286, P137, DOI 10.1111/imr.12703; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kecha O, 2000, ENDOCRINOLOGY, V141, P1209, DOI 10.1210/en.141.3.1209; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim EY, 2017, CYTOKINE, V98, P87, DOI 10.1016/j.cyto.2017.04.012; Kineman RD, 2018, J MOL ENDOCRINOL, V61, pT187, DOI 10.1530/JME-18-0076; King H, 2014, CANCER TREAT REV, V40, P1096, DOI 10.1016/j.ctrv.2014.07.004; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; KOOIJMAN R, 1992, ENDOCRINOLOGY, V131, P2244, DOI 10.1210/en.131.5.2244; Kooijman R, 1997, J ENDOCRINOL, V155, P165, DOI 10.1677/joe.0.1550165; KOZAK RW, 1987, CELL IMMUNOL, V109, P318, DOI 10.1016/0008-8749(87)90315-7; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; LANDRETH KS, 1992, BLOOD, V80, P1207; Lanzillo R, 2011, EUR J NEUROL, V18, P1402, DOI 10.1111/j.1468-1331.2011.03433.x; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P16, DOI 10.1097/00054725-200102000-00003; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Li C, 2016, CELL PHYSIOL BIOCHEM, V40, P245, DOI 10.1159/000452541; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LIU X, 1994, MOL CELL NEUROSCI, V5, P418, DOI 10.1006/mcne.1994.1052; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovett-Racke AE, 1998, J CLIN INVEST, V101, P1797, DOI 10.1172/JCI1486; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; MERCHAV S, 1988, J CLIN INVEST, V81, P791, DOI 10.1172/JCI113385; Michaux H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00338; Miyagawa I, 2017, J IMMUNOL, V199, P1616, DOI 10.4049/jimmunol.1600230; Miyagawa S, 2000, BRIT J HAEMATOL, V109, P555, DOI 10.1046/j.1365-2141.2000.02047.x; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Na G, 2013, MOL BIOTECHNOL, V54, P504, DOI 10.1007/s12033-012-9591-y; Nanba T, 2009, THYROID, V19, P495, DOI 10.1089/thy.2008.0423; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Pritchard J, 2004, J IMMUNOL, V173, P3564, DOI 10.4049/jimmunol.173.5.3564; Pritchard J, 2003, J IMMUNOL, V170, P6348, DOI 10.4049/jimmunol.170.12.6348; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Rajan A, 2014, LANCET ONCOL, V15, P191, DOI 10.1016/S1470-2045(13)70596-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Robinette ML, 2016, J ALLERGY CLIN IMMUN, V138, P1243, DOI 10.1016/j.jaci.2016.09.006; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; SCHILLACI R, 1995, IMMUNOL CELL BIOL, V73, P340, DOI 10.1038/icb.1995.52; SCHILLACI R, 1994, IMMUNOL CELL BIOL, V72, P300, DOI 10.1038/icb.1994.45; Schillaci R, 1998, CELL IMMUNOL, V183, P157, DOI 10.1006/cimm.1997.1237; Segretin ME, 2003, HORM RES, V59, P276, DOI 10.1159/000070625; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; SIDDLE K, 1994, HORM RES, V41, P56, DOI 10.1159/000183962; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Ueno A, 2015, WORLD J GASTROENTERO, V21, P12283, DOI 10.3748/wjg.v21.i43.12283; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; VANBUULOFFERS SC, 1995, J IMMUNOL, V154, P5736; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vogel TP, 2015, J CLIN IMMUNOL, V35, P615, DOI 10.1007/s10875-015-0187-8; Walker LSK, 2016, CLIN EXP IMMUNOL, V183, P16, DOI 10.1111/cei.12672; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WOLFF HL, 1990, J IMMUNOL, V144, P1215; Yang Y, 2002, J MOL ENDOCRINOL, V28, P207, DOI 10.1677/jme.0.0280207; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	130	40	41	5	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					650	+		10.1016/j.immuni.2020.03.013	http://dx.doi.org/10.1016/j.immuni.2020.03.013			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294406	Green Accepted, Bronze			2022-12-18	WOS:000526782600010
J	Fu, YY; Egorova, A; Sobieski, C; Kuttiyara, J; Calafiore, M; Takashima, S; Clevers, H; Hanash, AM				Fu, Ya-Yuan; Egorova, Anastasiya; Sobieski, Catherine; Kuttiyara, Jason; Calafiore, Marco; Takashima, Shuichiro; Clevers, Hans; Hanash, Alan M.			T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation	IMMUNITY			English	Article							VERSUS-HOST-DISEASE; MUCOSAL VASCULAR ADDRESSIN; LYMPHOCYTE MIGRATION; MAINTENANCE THERAPY; DENDRITIC CELLS; LAMINA PROPRIA; INTEGRIN; ADHESION; GUT; INFLAMMATION	The key sites within the gastrointestinal (GI) tract where T cells mediate effector responses and the impact of these responses on intestinal stem cells (ISCs) remain unclear. Using experimental bone marrow transplantation to model immune-mediated GI damage and 3D imaging to analyze T cell localization, we found that the ISC compartment is the primary intestinal site targeted by T cells after transplantation. Recruitment to the crypt base region resulted in direct T cell engagement with the stem cell compartment and loss of crypt base columnar ISCs, which expressed both MHC classes I and II. Vasculature expressing the adhesion molecule MAd-CAM-1 clustered near the crypt base, preferentially regulating crypt compartment invasion and ISC reduction without affecting T cell migration to villi. These findings indicate that allogeneic T cells rapidly access the stem cell niche after transplantation, and this targeted recruitment to the stem cell compartment results in ISC loss during immune-mediated GI damage.	[Fu, Ya-Yuan; Egorova, Anastasiya; Sobieski, Catherine; Kuttiyara, Jason; Calafiore, Marco; Takashima, Shuichiro; Hanash, Alan M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAVV, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Hanash, Alan M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cornell University	Hanash, AM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Hanash, AM (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	hanasha@mskcc.org		Fu, Ya-Yuan/0000-0002-3894-0490	NIH [K08-HL115355, R01-HL125571, R01-HL146338, P30CA008748]; Susan and Peter Solomon Divisional Genomics Program; Parker Institute for Cancer Immunotherapy; Ludwig Center for Cancer Immunotherapy; Anna Fuller Fund; Amy Strelzer Manasevit Research Program; American Society of Hematology; American Society for Transplantation and Cellular Therapy; Sanofi Genzyme; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL146338, R01HL125571, K08HL115355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan and Peter Solomon Divisional Genomics Program; Parker Institute for Cancer Immunotherapy; Ludwig Center for Cancer Immunotherapy; Anna Fuller Fund; Amy Strelzer Manasevit Research Program; American Society of Hematology; American Society for Transplantation and Cellular Therapy; Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Jennifer Tsai for her helpful advice, and we thank Jarrod Dudakov for his expert review of our manuscript. We gratefully acknowledge the Memorial Sloan Kettering Cancer Center (MSKCC) Gastroenterology and Nutrition Service and the endoscopy unit staff for their collection of patient biopsies. We also gratefully acknowledge the technical assistance of the MSKCC Molecular Cytology Core Facility and the MSKCC Research Animal Resource Center. This research was supported by NIH award numbers K08-HL115355 (A.M.H.), R01-HL125571 (A.M.H), R01-HL146338 (A.M.H), and P30CA008748 (MSKCC Core Grant). Support was also received from the Susan and Peter Solomon Divisional Genomics Program, the Parker Institute for Cancer Immunotherapy, the Ludwig Center for Cancer Immunotherapy, and the Anna Fuller Fund (A.M.H.). A.M.H. was also supported by the Amy Strelzer Manasevit Research Program and a Scholar Award from the American Society of Hematology. Y.-Y.F. was supported by a New Investigator Award from the American Society for Blood and Marrow Transplantation (now renamed as the American Society for Transplantation and Cellular Therapy) and Sanofi Genzyme.	Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Akcora D, 2013, STEM CELL RES, V10, P203, DOI 10.1016/j.scr.2012.12.001; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bernier-Latmani J, 2016, NAT PROTOC, V11, P1617, DOI 10.1038/nprot.2016.092; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Cheroutre H, 2004, NAT REV IMMUNOL, V4, P290, DOI 10.1038/nri1333; Davidson LA, 2012, BBA-MOL BASIS DIS, V1822, P1600, DOI 10.1016/j.bbadis.2012.06.011; Dotti I, 2017, GUT, V66, P2069, DOI 10.1136/gutjnl-2016-312609; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Floisand Y, 2017, BIOL BLOOD MARROW TR, V23, P172, DOI 10.1016/j.bbmt.2016.10.009; Fu YY, 2013, AM J PHYSIOL-GASTR L, V304, pG1, DOI 10.1152/ajpgi.00209.2012; Fu YY, 2010, MICROVASC RES, V80, P512, DOI 10.1016/j.mvr.2010.06.003; Fu YY, 2010, GASTROENTEROLOGY, V139, P1100, DOI 10.1053/j.gastro.2010.08.025; Fu YY, 2009, GASTROENTEROLOGY, V137, P453, DOI 10.1053/j.gastro.2009.05.008; Fujimori H, 2002, GASTROENTEROLOGY, V122, P734, DOI 10.1053/gast.2002.31899; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; JEURISSEN SHM, 1987, IMMUNOLOGY, V62, P273; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Koseki S, 2001, INT IMMUNOL, V13, P1165, DOI 10.1093/intimm/13.9.1165; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Levine JE, 2013, BLOOD, V122, P1505, DOI 10.1182/blood-2013-02-485813; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; MAYER L, 1991, GASTROENTEROLOGY, V100, P3, DOI 10.1016/0016-5085(91)90575-6; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; NAKACHE M, 1989, NATURE, V337, P179, DOI 10.1038/337179a0; Nakanishi Y, 2016, CELL REP, V16, P3297, DOI 10.1016/j.celrep.2016.08.054; Nalle SC, 2015, MUCOSAL IMMUNOL, V8, P720, DOI 10.1038/mi.2015.40; Neurath MF, 2017, NAT REV GASTRO HEPAT, V14, P269, DOI 10.1038/nrgastro.2016.208; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; Perera L, 2007, INFLAMM BOWEL DIS, V13, P298, DOI 10.1002/ibd.20026; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; PODOLSKY DK, 1993, J CLIN INVEST, V92, P372, DOI 10.1172/JCI116575; Reshef R, 2012, NEW ENGL J MED, V367, P135, DOI 10.1056/NEJMoa1201248; Sackstein R, 1995, ANN NY ACAD SCI, V770, P177, DOI 10.1111/j.1749-6632.1995.tb31054.x; Sale GE, 1996, MOL MED TODAY, V2, P114, DOI 10.1016/1357-4310(96)88721-1; Salmi M, 2005, IMMUNOL REV, V206, P100, DOI 10.1111/j.0105-2896.2005.00285.x; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Shimoji S, 2017, BLOOD, V129, P1216, DOI 10.1182/blood-2016-07-728337; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; Waldman E, 2006, BLOOD, V107, P1703, DOI 10.1182/blood-2005-08-3445; Wosen JE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02144; Wysocki CA, 2005, BLOOD, V105, P4191, DOI 10.1182/blood-2004-12-4726	71	40	40	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					90	+		10.1016/j.immuni.2019.06.003	http://dx.doi.org/10.1016/j.immuni.2019.06.003			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31278057	Green Accepted, Bronze			2022-12-18	WOS:000475561000013
J	Page, N; Klimek, B; De Roo, M; Steinbach, K; Soldati, H; Lemeille, S; Wagner, I; Kreutzfeldt, M; Di Liberto, G; Vincenti, I; Lingner, T; Salinas, G; Bruck, W; Simons, M; Murr, R; Kaye, J; Zehn, D; Pinschewer, DD; Merkler, D				Page, Nicolas; Klimek, Bogna; De Roo, Mathias; Steinbach, Karin; Soldati, Hadrien; Lemeille, Sylvain; Wagner, Ingrid; Kreutzfeldt, Mario; Di Liberto, Giovanni; Vincenti, Ilena; Lingner, Thomas; Salinas, Gabriela; Brueck, Wolfgang; Simons, Mikael; Murr, Rabih; Kaye, Jonathan; Zehn, Dietmar; Pinschewer, Daniel D.; Merkler, Doron			Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8(+) T Cells	IMMUNITY			English	Article							MULTIPLE-SCLEROSIS LESIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; VIRAL-INFECTION; TERMINAL DIFFERENTIATION; CLONAL EXPANSIONS; MEMORY FORMATION; EFFECTOR; BET; FATE	Infections are thought to trigger CD8(+) cytotoxic T lymphocyte (CTL) responses during autoimmunity. However, the transcriptional programs governing the tissue-destructive potential of CTLs remain poorly defined. In a model of central nervous system (CNS) inflammation, we found that infection with lymphocytic choriomeningitis virus (LCMV), but not Listeria monocytogenes (Lm), drove autoimmunity. The DNA-binding factor TOX was induced in CTLs during LCMV infection and was essential for their encephalitogenic properties, and its expression was inhibited by interleukin-12 during Lm infection. TOX repressed the activity of several transcription factors (including Id2, TCF-1, and Notch) that are known to drive CTL differentiation. TOX also reduced immune checkpoint sensitivity by restraining the expression of the inhibitory checkpoint receptor CD244 on the surface of CTLs, leading to increased CTL-mediated damage in the CNS. Our results identify TOX as a transcriptional regulator of tissue-destructive CTLs in autoimmunity, offering a potential mechanistic link to microbial triggers.	[Page, Nicolas; Klimek, Bogna; Steinbach, Karin; Lemeille, Sylvain; Wagner, Ingrid; Kreutzfeldt, Mario; Di Liberto, Giovanni; Vincenti, Ilena; Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [De Roo, Mathias] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland; [De Roo, Mathias] Univ Geneva, Med Sch, Dept Basic Neurosci, Geneva, Switzerland; [Soldati, Hadrien; Murr, Rabih] Univ Geneva, Dept Genet Med & Dev, Med Sch, Geneva, Switzerland; [Lingner, Thomas; Salinas, Gabriela] Univ Med Ctr Gottingen, Microarray & Deep Sequencing Core Facil, Gottingen, Germany; [Brueck, Wolfgang] Georg August Univ Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany; [Simons, Mikael] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany; [Simons, Mikael] German Ctr Neurodegenerat Dis, D-6250 Munich, Germany; [Simons, Mikael] Munich Cluster Syst Neurol, D-81377 Munich, Germany; [Murr, Rabih] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Kaye, Jonathan] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA; [Kaye, Jonathan] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Los Angeles, CA 90048 USA; [Zehn, Dietmar] Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany; [Pinschewer, Daniel D.] Univ Basel, Dept Biomed, Div Expt Virol, Haus Peterspl, Basel, Switzerland; [Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Gottingen; University of Gottingen; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Geneva; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Technical University of Munich; University of Basel; University of Geneva	Merkler, D (corresponding author), Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland.; Merkler, D (corresponding author), Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland.	doron.merkler@unige.ch	Merkler, Doron/N-9157-2016	Merkler, Doron/0000-0002-0247-2007; Kaye, Jonathan/0000-0002-1634-9069; Vincenti, Ilena/0000-0003-1061-6071; Kreutzfeldt, Mario/0000-0003-0335-2733; Di Liberto, Giovanni/0000-0001-6788-0215; Simons, Mikael/0000-0001-5329-192X	Klaus-Tschira Foundation; Swiss National Science Foundation [310030_173010, CRSII3_160772, PP00P3_150712]; Swiss MS Society; Helmut Horten Foundation; Gebert-Ruf Foundation [GRS-049/13]; Fondation Ernst et Lucie Schmidheiny; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054977] Funding Source: NIH RePORTER	Klaus-Tschira Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss MS Society; Helmut Horten Foundation; Gebert-Ruf Foundation; Fondation Ernst et Lucie Schmidheiny; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D.M., D.D.P., and M.S. are supported by the Klaus-Tschira Foundation. D.M. and D.D.P. are supported by the Swiss National Science Foundation (310030_173010 to D.M. and CRSII3_160772 to D.P. and D.M.). D.M., N.P., and K.S. are supported by the Swiss MS Society. D.M. is supported by the Helmut Horten Foundation, Gebert-Ruf Foundation (GRS-049/13), and Fondation Ernst et Lucie Schmidheiny. R.M. is supported by the Swiss National Science Foundation (PP00P3_150712). The plasmids for pMIG-T-bet and pMIG-Eomes were kindly provided by Gabrielle Belz (WEHI, Australia). ODC-OVA mice were kindly provided by T. Hunig (University of Wurzburg).	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Backer RA, 2014, NAT IMMUNOL, V15, P1143, DOI 10.1038/ni.3027; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Bos SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117403; Cao Y, 2006, EUR J IMMUNOL, V36, P207, DOI 10.1002/eji.200535211; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; Fukuoka N, 2016, GENES CELLS, V21, P146, DOI 10.1111/gtc.12328; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallert SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15327; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kim JR, 2010, CLIN EXP IMMUNOL, V160, P348, DOI 10.1111/j.1365-2249.2010.04116.x; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; MAKGOBA MW, 1989, IMMUNOL TODAY, V10, P417, DOI 10.1016/0167-5699(89)90039-X; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Na SY, 2012, IMMUNITY, V37, P134, DOI 10.1016/j.immuni.2012.04.009; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Oberle SG, 2016, CELL REP, V17, P627, DOI 10.1016/j.celrep.2016.09.072; Oertle T, 2003, J NEUROSCI, V23, P5393; ORANGE JS, 1995, J EXP MED, V181, P901, DOI 10.1084/jem.181.3.901; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; Sandusky MM, 2006, EUR J IMMUNOL, V36, P3268, DOI 10.1002/eji.200636146; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Stienne C, 2016, IMMUNITY, V45, P774, DOI 10.1016/j.immuni.2016.09.010; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; von Jonquieres G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065646; Waggoner SN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00377; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	63	40	41	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					937	+		10.1016/j.immuni.2018.04.005	http://dx.doi.org/10.1016/j.immuni.2018.04.005			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768177	Green Accepted, Bronze			2022-12-18	WOS:000432488600014
J	Ranasinghe, S; Lamothe, PA; Soghoian, DZ; Kazer, SW; Cole, MB; Shalek, AK; Yosef, N; Jones, RB; Donaghey, F; Nwonu, C; Jani, P; Clayton, GM; Crawford, F; White, J; Montoya, A; Power, K; Allen, TM; Streeck, H; Kaufmann, DE; Picker, LJ; Kappler, JW; Walker, BD				Ranasinghe, Srinika; Lamothe, Pedro A.; Soghoian, Damien Z.; Kazer, Samuel W.; Cole, Michael B.; Shalek, Alex K.; Yosef, Nir; Jones, R. Brad; Donaghey, Faith; Nwonu, Chioma; Jani, Priya; Clayton, Gina M.; Crawford, Frances; White, Janice; Montoya, Alana; Power, Karen; Allen, Todd M.; Streeck, Hendrik; Kaufmann, Daniel E.; Picker, Louis J.; Kappler, John W.; Walker, Bruce D.			Antiviral CD8(+) T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion	IMMUNITY			English	Article							HLA CLASS-I; DISCORDANT ASSOCIATIONS; IMMUNE CONTROL; VIRAL LOAD; RESPONSES; COMPLEX; MOLECULES; CD4; MICE; DETERMINANTS	CD8(+) T cell recognition of virus-infected cells is characteristically restricted by major histocompatibility complex (MHC) class I, although rare examples of MHC class II restriction have been reported in Cd4-deficient mice and a macaque SIV vaccine trial using a recombinant cytomegalovirus vector. Here, we demonstrate the presence of human leukocyte antigen (HLA) class II-restricted CD8(+) T cell responses with antiviral properties in a small subset of HIV-infected individuals. In these individuals, T cell receptor beta (TCR beta) analysis revealed that class II-restricted CD8(+) T cells underwent clonal expansion and mediated killing of HIV-infected cells. In one case, these cells comprised 12% of circulating CD8(+) T cells, and TCR alpha analysis revealed two distinct co-expressed TCRa chains, with only one contributing to binding of the class II HLA-peptide complex. These data indicate that class II-restricted CD8(+) T cell responses can exist in a chronic human viral infection, and may contribute to immune control.	[Ranasinghe, Srinika; Lamothe, Pedro A.; Soghoian, Damien Z.; Kazer, Samuel W.; Shalek, Alex K.; Yosef, Nir; Jones, R. Brad; Donaghey, Faith; Nwonu, Chioma; Jani, Priya; Power, Karen; Allen, Todd M.; Kaufmann, Daniel E.; Walker, Bruce D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 01239 USA; [Lamothe, Pedro A.; Walker, Bruce D.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Lamothe, Pedro A.; Clayton, Gina M.; Crawford, Frances; Kappler, John W.; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Kazer, Samuel W.; Shalek, Alex K.; Walker, Bruce D.] MIT, Inst Med Engn & Sci, Cambridge, MA 01239 USA; [Kazer, Samuel W.; Shalek, Alex K.; Walker, Bruce D.] Broad Inst, Cambridge, MA 01239 USA; [Cole, Michael B.; Yosef, Nir] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Jones, R. Brad] George Washington Univ, Washington, DC 20052 USA; [Clayton, Gina M.; Crawford, Frances; White, Janice; Montoya, Alana; Kappler, John W.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Streeck, Hendrik] Univ Duisburg Essen, Univ Hosp, Inst HIV Res, D-45147 Essen, Germany; [Streeck, Hendrik] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD 20910 USA; [Kaufmann, Daniel E.] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 3J4, Canada; [Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; George Washington University; National Jewish Health; University of Duisburg Essen; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Universite de Montreal; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Ranasinghe, S; Walker, BD (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 01239 USA.; Walker, BD (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Walker, BD (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Walker, BD (corresponding author), MIT, Inst Med Engn & Sci, Cambridge, MA 01239 USA.; Walker, BD (corresponding author), Broad Inst, Cambridge, MA 01239 USA.	sranasinghe@mgh.harvard.edu; bwalker@mgh.harvard.edu	Allen, Todd/F-5473-2011; Shalek, Alex/Y-2434-2019	Allen, Todd/0000-0002-6609-1318; Shalek, Alex/0000-0001-5670-8778; Lamothe, Pedro/0000-0001-9262-2920; Kazer, Samuel/0000-0002-7380-9594	Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [APP1108533]; CFAR Developmental Award (NIH/NIAID) [5P30AI060354]; HHMI International Student Research Fellowship; Research Scholar Career Award of the Quebec Health Research Fund; NIAID [AI104715]; NSF Graduate Research Fellowship; Ragon Institute; Searle Scholars Program; Beckman Young Investigator Program; NIH New Innovator Award [DP2 OD020839]; NIH from NIAID [U24 AI11862-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, U24AI118672, R21AI125085, P01AI104715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM119419] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); CFAR Developmental Award (NIH/NIAID); HHMI International Student Research Fellowship; Research Scholar Career Award of the Quebec Health Research Fund; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Ragon Institute; Searle Scholars Program; Beckman Young Investigator Program; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all study participants, as well as A. Sette and J. Sidney for the LCL, M.C. Carrington for HLA typing, and M. Nakayama for 5KC mouse hybridomas. This study was funded by the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grant APP1108533 to L.J.P., B.D.W, and S.R. S.R. is also supported by a CFAR Developmental Award (NIH/NIAID 5P30AI060354). P.A.L. is supported by a HHMI International Student Research Fellowship. D.E.K. is supported by a Research Scholar Career Award of the Quebec Health Research Fund. T.M.A. and K.P. are supported by NIAID grant AI104715. S.W.K. is supported by a NSF Graduate Research Fellowship. A.K.S. is supported by the Ragon Institute, the Searle Scholars Program, the Beckman Young Investigator Program, the NIH New Innovator Award (DP2 OD020839), and NIH U24 AI11862-01 from NIAID. L.J.P. and OHSU have a significant financial interest in Vir Bio, Inc., a company that may have a commercial interest in the results of this research and technology. The potential individual and institutional conflicts of interest have been reviewed and are being managed by OHSU. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, U.S. Army, or Department of Defense, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Benati D, 2016, J CLIN INVEST, V126, P2093, DOI 10.1172/JCI83792; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carrington M, 2012, ANNU REV MED, V63, P131, DOI 10.1146/annurev-med-062909-130018; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Heemskerk MHM, 2001, P NATL ACAD SCI USA, V98, P6806, DOI 10.1073/pnas.111162298; Hirosawa T, 2011, CANCER SCI, V102, P1281, DOI 10.1111/j.1349-7006.2011.01949.x; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; MASON D, 1994, INT IMMUNOL, V6, P881, DOI 10.1093/intimm/6.6.881; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Mendoza D, 2012, J VIROL, V86, P4014, DOI 10.1128/JVI.06982-11; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; MIZUOCHI T, 1988, J EXP MED, V168, P437, DOI 10.1084/jem.168.1.437; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Pearce EL, 2004, J IMMUNOL, V173, P2494, DOI 10.4049/jimmunol.173.4.2494; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Ranasinghe S, 2013, NAT BIOTECHNOL, V31, P811, DOI 10.1038/nbt.2688; Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Riou C, 2014, J VIROL, V88, P1819, DOI 10.1128/JVI.02968-13; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Shimizu T, 1997, EUR J IMMUNOL, V27, P500, DOI 10.1002/eji.1830270222; Southwood S, 1998, J IMMUNOL, V160, P3363; SUZUKI H, 1994, J IMMUNOL, V153, P4496; TROMBETTA JJ, 2014, CURR PROTOC MOL BIOL, V107, P1, DOI DOI 10.1002/0471142727.MB0422S107; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; White J, 2000, METH MOL B, V134, P185	39	40	41	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					917	930		10.1016/j.immuni.2016.09.015	http://dx.doi.org/10.1016/j.immuni.2016.09.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760342	Green Published, hybrid			2022-12-18	WOS:000389473200021
J	Shu, HB; Wang, YY				Shu, Hong-Bing; Wang, Yan-Yi			Adding to the STING	IMMUNITY			English	Editorial Material							PROTEIN; ADAPTER		[Shu, Hong-Bing] Wuhan Univ, Med Res Inst, Coll Life Sci, Wuhan 430072, Peoples R China; [Wang, Yan-Yi] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Shu, HB (corresponding author), Wuhan Univ, Med Res Inst, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn; wangyy@wh.iov.cn						Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Qin Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004358; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhou Q, 2014, CELL HOST MICROBE, V16, P450, DOI 10.1016/j.chom.2014.09.006	10	40	44	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					871	873		10.1016/j.immuni.2014.12.002	http://dx.doi.org/10.1016/j.immuni.2014.12.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526298	Bronze			2022-12-18	WOS:000346654100002
J	Katz, HR; Austen, KF				Katz, Howard R.; Austen, K. Frank			Mast Cell Deficiency, A Game of Kit and Mouse	IMMUNITY			English	Editorial Material							MICE; TISSUE	Defining mast cell (MC) function has been clouded by use of mice with Kit mutations. In this and a previous issue of Immunity, two studies (Dudeck et al., 2011; Feyerabend et al., 2011) clarify MC function by using two unique mouse models.	[Katz, Howard R.; Austen, K. Frank] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Katz, Howard R.; Austen, K. Frank] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Austen, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	fausten@rics.bwh.harvard.edu						Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Charles N, 2009, IMMUNITY, V30, P533, DOI 10.1016/j.immuni.2009.02.008; Cozzi E, 2011, P NATL ACAD SCI USA, V108, P12787, DOI 10.1073/pnas.1106582108; Du T, 1996, CLIN EXP IMMUNOL, V103, P316, DOI 10.1046/j.1365-2249.1996.d01-610.x; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Mancardi DA, 2011, J IMMUNOL, V186, P1899, DOI 10.4049/jimmunol.1003642; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	10	40	40	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					668	670		10.1016/j.immuni.2011.11.004	http://dx.doi.org/10.1016/j.immuni.2011.11.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118523	Bronze			2022-12-18	WOS:000297390800007
J	Vinuesa, CG; Cook, MC				Vinuesa, Carole G.; Cook, Matthew C.			Blood Relatives of Follicular Helper T Cells	IMMUNITY			English	Editorial Material								Expression of the chemokine receptor CXCR5 identifies B follicular helper T cells. In this issue of Immunity, Morita et al. (2011) describe a heterogeneous circulating CXCR5(+)CD4(+) B cell helper population overrepresented in juvenile dermatomyositis patients.	[Vinuesa, Carole G.; Cook, Matthew C.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; [Cook, Matthew C.] Canberra Hosp, Dept Immunol & Translat Res, Canberra, ACT 2606, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, GPO Box 4, Canberra, ACT 0200, Australia.	carola.vinuesa@anu.edu.au	Cook, matthew/F-4151-2019; Vinuesa, Carola G/B-1108-2010	Cook, matthew/0000-0002-3331-9363; Vinuesa, Carola G/0000-0001-9799-0298				Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001	9	40	41	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					10	12		10.1016/j.immuni.2011.01.006	http://dx.doi.org/10.1016/j.immuni.2011.01.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21272784	Bronze			2022-12-18	WOS:000287336600005
J	Pan, H; Shively, JE				Pan, Hao; Shively, John E.			Carcinoembryonic Antigen-Related Cell Adhesion Molecule-1 Regulates Granulopoiesis by Inhibition of Granulocyte Colony-Stimulating Factor Receptor	IMMUNITY			English	Article							SHORT CYTOPLASMIC DOMAIN; NEGATIVE REGULATOR; CEACAM1; STAT3; NEUTROPHILS; PROLIFERATION; DEFICIENCY; ACTIVATION; APOPTOSIS; IMMUNITY	Although carcinoembryonic antigen-related cell adhesion moclecule-1 (CEACAM1) is an activation marker for neutrophils and delays neutrophil apoptosis, the role of CEACAM1 in granulopoiesis and neutrophil-dependent host immune responses has not been investigated CEACAM1 expression correlated with granulocytic differentiation, and Ceacam1(-/-) mice developed neutrophilia because of loss of the Src-homology-phosphatase-1 (SHP-1)-dependent inhibition of granulocyte colony-stimulating factor receptor (G-CSFR) signal transducer and activator of transcription (Stat3) pathway provided by CEACAM1 Moreover, Ceacam1(-/-) mice were hypersensitive to Listeria Monocyto genes (LM) infection with an accelerated mortality Reintroduction of CEACAM1 into Ceacam1(-/-) bone marrow restored normal granulopoiesis and host sensitivity to LM infection, while mutation of its immunoreceptor tyrosine-based inhibitory motifs (ITIMs) abrogated this restoration shRNA-mediated reduction of Stat3 amounts rescued normal granulopoiesis, attenuating host sensitivity to LM infection in Ceacam1(-/-) mice Thus, CEACAM1 acted as a coinhibitory receptor for G-CSFR regulating granuloporesis and host innate immune response to bacterial infections	[Pan, Hao; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA; [Pan, Hao] City Hope Natl Med Ctr, Beckman Res Inst, City Hope Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, 1450 E Duarte Rd, Duarte, CA 91010 USA.				NIH [CA 84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Z Sun for retroviral vectors N Beauchemin for Ceacam1<SUP>-/-</SUP> mice and S Loera for histology This work is supported by NIH grant CA 84202 H P designed and performed research analyzed data and wrote the manu script J E S supervised research and revised the manuscript	Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Chakraborty A, 1996, BLOOD, V88, P2442, DOI 10.1182/blood.V88.7.2442.bloodjournal8872442; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen ZG, 2008, J IMMUNOL, V180, P6085, DOI 10.4049/jimmunol.180.9.6085; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; GRAY OSD, 2006, NAT REV IMMUNOL, V6, P433; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Lobo EO, 2009, J LEUKOCYTE BIOL, V86, P205, DOI 10.1189/jlb.0109037; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Roberts AW, 1997, BLOOD, V89, P2736, DOI 10.1182/blood.V89.8.2736; Singer BB, 2005, EUR J IMMUNOL, V35, P1949, DOI 10.1002/eji.200425691; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; TIAN SS, 1994, BLOOD, V84, P1760; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhu GF, 2009, BLOOD, V113, P1759, DOI 10.1182/blood-2008-01-133223	28	40	42	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					620	631		10.1016/j.immuni.2010.10.009	http://dx.doi.org/10.1016/j.immuni.2010.10.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029969	Green Accepted, Bronze			2022-12-18	WOS:000284300200018
J	Ebert, PJR; Ehrlich, LIR; Davis, MM				Ebert, Peter J. R.; Ehrlich, Lauren I. Richie; Davis, Mark M.			Low Ligand Requirement for Deletion and Lack of Synapses in Positive Selection Enforce the Gauntlet of Thymic T Cell Maturation	IMMUNITY			English	Article							IMMUNOLOGICAL SYNAPSE; NEGATIVE SELECTION; PEPTIDE-MHC; THYMOCYTE DEVELOPMENT; CUTTING EDGE; LYMPH-NODE; CLASS-II; RECEPTOR; SENSITIVITY; ANTIGEN	Immature double-positive (CD4(+)CD8(+)) thymocytes respond to negatively selecting peptide-MHC ligands by forming an immune synapse that sustains contact with the antigen-presenting cell (APC). Using fluorescently labeled peptides, we showed that as few as two agonist ligands could promote APC contact and subsequent apoptosis in reactive thymocytes. Furthermore, we showed that productive signaling for positive selection, as gauged by nuclear translocation of a green fluorescent protein (GFP)-labeled NFATc construct, did not involve formation of a synapse between thymocytes and selecting epithelial cells in reaggregate thymus cultures. Antibody blockade of endogenous positively selecting ligands prevented NFAT nuclear accumulation in such cultures and reversed NFAT accumulation in previously stimulated thymocytes. Together, these data suggest a "gauntlet" model in which thymocytes mature by continually acquiring and reacquiring positively selecting signals without sustained contact with epithelial cells, thereby allowing them to sample many cell surfaces for potentially negatively selecting ligands.	[Ebert, Peter J. R.; Ehrlich, Lauren I. Richie; Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ebert, Peter J. R.; Ehrlich, Lauren I. Richie; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Ehrlich, Lauren/0000-0002-1697-1755; Davis, Mark/0000-0001-6868-657X	Howard Hughes Medical Institute predoctoral fellowships; US National institutes of Health [R01 A1022511]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022511, R01AI022511] Funding Source: NIH RePORTER	Howard Hughes Medical Institute predoctoral fellowships(Howard Hughes Medical Institute); US National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M.F. Krummel for the original NFATc1-GFP construct; G. Nolan, K. Kripke-Skillern, and R. Wolkowitz for the CKHGppSin vector; and M. Kuhns for the modified pMSCV vector. We also thank J.J.T. Owen for his guidance, Q.-J. Li and F. Tynan for critical reading and J.R. Neilson, M. Winslow, and E. Gallo for productive discussions. This work was supported by Howard Hughes Medical Institute predoctoral fellowships (P.J.R.E. and L.I.R.E.) and by the US National institutes of Health (R01 A1022511) and Howard Hughes Medical Institute (M.M.D.).	Amasaki Y, 2002, J BIOL CHEM, V277, P25640, DOI 10.1074/jbc.M201860200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baldwin KK, 1999, J EXP MED, V189, P13, DOI 10.1084/jem.189.1.13; Barton GM, 1999, SEMIN IMMUNOL, V11, P417, DOI 10.1006/smim.1999.0199; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Chmielowski B, 2000, INT IMMUNOL, V12, P67, DOI 10.1093/intimm/12.1.67; Correia-Neves M, 2001, EUR J IMMUNOL, V31, P2583, DOI 10.1002/1521-4141(200109)31:9<2583::AID-IMMU2583>3.0.CO;2-Z; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Graham DB, 2006, J IMMUNOL, V177, P6098, DOI 10.4049/jimmunol.177.9.6098; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hare KJ, 1999, SEMIN IMMUNOL, V11, P3, DOI 10.1006/smim.1998.0151; Hayden-Martinez K, 2000, J IMMUNOL, V165, P3713, DOI 10.4049/jimmunol.165.7.3713; Hogquist KA, 2003, CURR BIOL, V13, pR239, DOI 10.1016/S0960-9822(03)00161-1; Hooijberg E, 2000, BLOOD, V96, P459; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JENKINSON EJ, 1994, CURR OPIN IMMUNOL, V6, P293, DOI 10.1016/0952-7915(94)90104-X; JERABEK L, 2001, METHODS MOL MED, P161; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; KRIPKESKILLERN K, 2002, THESIS STANFORD U ST; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Merkenschlager M, 1996, EUR J IMMUNOL, V26, P892, DOI 10.1002/eji.1830260426; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Peterson DA, 1999, J IMMUNOL, V162, P3117; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; Sprent J, 2001, PHILOS T R SOC B, V356, P609, DOI 10.1098/rstb.2001.0846; Starr TK, 2003, J IMMUNOL, V171, P4512, DOI 10.4049/jimmunol.171.9.4512; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; TOURNE S, 1995, EUR J IMMUNOL, V25, P1851, DOI 10.1002/eji.1830250709; Venanzi ES, 2004, CURR OPIN IMMUNOL, V16, P197, DOI 10.1016/j.coi.2004.01.008; Villunger A, 2003, NAT IMMUNOL, V4, P717, DOI 10.1038/ni0803-717; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	62	40	40	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					734	745		10.1016/j.immuni.2008.09.014	http://dx.doi.org/10.1016/j.immuni.2008.09.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18993085	Bronze, Green Accepted			2022-12-18	WOS:000261036000011
J	Dinarello, CA				Dinarello, CA			Unraveling the NALP-3/IL-1 beta inflammasome: A big lesson from a small mutation	IMMUNITY			English	Editorial Material							MUCKLE-WELLS-SYNDROME	Cytokine-mediated inflammation is a target for novel therapies as well as for fundamental research. A single amino acid mutation in the NALP-3 gene controlling the activation of caspase-1 results in increased processing of the inactive IL-1beta precursor and release of the active cytokine. Blocking IL-1 receptors arrests inflammation in humans with the mutation.	Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Dinarello, CA (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Infect Dis, B168,4200 E 9th Ave, Denver, CO 80262 USA.		Dinarello, Charles/C-8524-2013					Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019	6	40	47	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2004	20	3					243	244		10.1016/S1074-7613(04)00055-X	http://dx.doi.org/10.1016/S1074-7613(04)00055-X			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030767	Bronze			2022-12-18	WOS:000221442600001
J	Li, H; Jiang, YF; Cao, H; Radic, M; Prak, EL; Weigert, M				Li, H; Jiang, YF; Cao, H; Radic, M; Prak, EL; Weigert, M			Regulation of anti-phosphatidylserine antibodies	IMMUNITY			English	Article							REACTIVE LYMPHOCYTES-B; STRUCTURAL BASIS; DNA-BINDING; CELLS; MICE; RECOGNITION; DELETION; AUTOANTIBODIES; EXPRESSION; MECHANISM	The degree of heavy chain (H) editing, the types of Vkappa editors, and the pattern of Jkappa usage are correlated with a range of the affinity of anti-DNA. This range was determined by the number and location of arginine (R) residues in the VH. We, here, changed a key arginine residue in the VH of anti-DNA transgene to glycine, which sharply reduces the affinity for dsDNA. However, complete reversion of this anti-DNA to germline enhances the affinity for phosphatidylserine (PS). The B cells of this low-affinity anti-DNA and anti-PS transgenic mouse are tightly regulated by receptor editing. Thus, anti-PS B cells are another example of a constitutive self-antigen regulated in the bone marrow.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19404 USA	Princeton University; University of Tennessee System; University of Tennessee Health Science Center; University of Pennsylvania	Weigert, M (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Radic, Marko/0000-0002-8004-282X				Brard F, 1999, J EXP MED, V190, P691, DOI 10.1084/jem.190.5.691; CASIOLAROSEN LA, 1994, J EXP MED, V179, P1317; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; Cocca BA, 2001, P NATL ACAD SCI USA, V98, P13826, DOI 10.1073/pnas.241510698; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FADOK VA, 1992, J IMMUNOL, V148, P2207; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Jang YJ, 1998, MOL IMMUNOL, V35, P1207, DOI 10.1016/S0161-5890(98)00095-9; KOHLER G, 1980, P NATL ACAD SCI-BIOL, V77, P2197, DOI 10.1073/pnas.77.4.2197; LAFER EM, 1981, J EXP MED, V153, P897, DOI 10.1084/jem.153.4.897; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; LUNINGPRAK E, 1995, J EXP MED, V182, P541; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Tanner JJ, 2001, J MOL BIOL, V314, P807, DOI 10.1006/jmbi.2001.5178; WINTER E, 1985, EMBO J, V4, P2861, DOI 10.1002/j.1460-2075.1985.tb04015.x; WOOD DL, 1984, P NATL ACAD SCI-BIOL, V81, P4756, DOI 10.1073/pnas.81.15.4756; WU AM, 1978, CARBOHYD RES, V66, P113, DOI 10.1016/S0008-6215(00)83244-9; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247	28	40	41	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2003	18	2					185	192		10.1016/S1074-7613(03)00026-8	http://dx.doi.org/10.1016/S1074-7613(03)00026-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594946	Bronze			2022-12-18	WOS:000181138100003
J	Baker, BM; Wiley, DC				Baker, BM; Wiley, DC			alpha beta T cell receptor ligand-specific oligomerization revisited	IMMUNITY			English	Article							MHC CLASS-II; PEPTIDE-MHC; SIGNAL-TRANSDUCTION; ANTIGEN RECOGNITION; CRYSTAL-STRUCTURE; BINDING; COMPLEX; ACTIVATION; MOLECULE; THERMODYNAMICS	The mechanism of T cell receptor signaling is unclear. Included among models for TCR signaling is ligand-induced oligomerization in a fashion analogous to other cell surface receptors. Published kinetic, saturation binding, and light scattering experiments have been interpreted to suggest a propensity for soluble alpha beta TCR/peptide/MHC ectodomain complexes to oligomerize. Upon performing these experiments with soluble ectodomains of human class I and class II restricted alpha beta TCRs, we find no evidence for dimerization or oligomerization of complexes. Apparently, oligomerization in solution to a detectable extent is not a general property of soluble alpha beta TCRs or their complexes with ligand. Our results suggest that membrane-anchored, fully assembled TCRs should be studied to determine the role oligomerization plays in T cell signaling.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Wiley, DC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Baker, Brian/B-4584-2009	Baker, Brian/0000-0002-0864-0964				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; AUNE KC, 1971, BIOCHEMISTRY-US, V10, P1609; Bachmann MF, 1999, IMMUNOL TODAY, V20, P568, DOI 10.1016/S0167-5699(99)01543-1; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Baker BM, 1999, COLD SPRING HARB SYM, V64, P235, DOI 10.1101/sqb.1999.64.235; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Myszka DG, 1996, PROTEIN SCI, V5, P2468, DOI 10.1002/pro.5560051209; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; TAKEDA Y, 1992, P NATL ACAD SCI USA, V89, P8180, DOI 10.1073/pnas.89.17.8180; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Vulevic B, 1997, BIOPHYS J, V72, P1357, DOI 10.1016/S0006-3495(97)78782-4; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	42	40	40	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					681	692		10.1016/S1074-7613(01)00160-1	http://dx.doi.org/10.1016/S1074-7613(01)00160-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420039	Bronze			2022-12-18	WOS:000169495100005
J	Williams, GT; Jolly, CJ; Kohler, J; Neuberger, MS				Williams, GT; Jolly, CJ; Kohler, J; Neuberger, MS			The contribution of somatic hypermutation to the diversity of serum immunoglobulin: Dramatic increase with age	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; MEMORY B-CELLS; ANTIGEN-FREE DIET; GERMINAL-CENTERS; PASSENGER TRANSGENES; AFFINITY MATURATION; ANTIBODY-RESPONSES; DIFFERENT STRAINS; GENE-EXPRESSION; PLASMA-CELLS	Although somatic mutation contributes to the diversity of only a minor fraction of B cells in mouse spleen or blood, its contribution to the diversity of serum immunoglobulin is unknown. We have devised an immunoassay to monitor mutated antibodies in serum using a monoclonal antibody that recognizes a Vie only when mutated at its major intrinsic hot spot. Mutation makes essentially no contribution to the diversity of endogenous serum IgM, IgG, or IgA in young mice. However, in response to environmental antigens, the titer of mutated immunoglobulin in T cell-proficient mice rises strikingly with age, such that the major proportion of serum immunoglobulin in adults is somatically mutated, with the mutation load in IgG being some 10-fold greater than in IgM.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Jolly, Christopher/G-5261-2011	Jolly, Christopher/0000-0002-9307-1056				BEREK C, 1987, EUR J IMMUNOL, V17, P1121, DOI 10.1002/eji.1830170808; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Boes M, 1998, J IMMUNOL, V160, P4776; BOS NA, 1989, EUR J IMMUNOL, V19, P1817, DOI 10.1002/eji.1830191009; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; EVEN J, 1985, EMBO J, V4, P3439, DOI 10.1002/j.1460-2075.1985.tb04102.x; GILKESON GS, 1993, J IMMUNOL, V151, P1353; GONZALEZFERNANDEZ A, 1994, EUR J IMMUNOL, V24, P2918, DOI 10.1002/eji.1830241151; Goyenechea B, 1996, P NATL ACAD SCI USA, V93, P13979, DOI 10.1073/pnas.93.24.13979; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Hodes RJ, 1997, IMMUNOL REV, V160, P5, DOI 10.1111/j.1600-065X.1997.tb01022.x; HOOIJKAAS H, 1985, J IMMUNOL, V134, P2223; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; HUANG CC, 1992, J CLIN INVEST, V89, P1331, DOI 10.1172/JCI115719; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; KAARTINEN M, 1989, EMBO J, V8, P1743, DOI 10.1002/j.1460-2075.1989.tb03567.x; KAARTINEN M, 1987, J IMMUNOL, V138, P1613; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KLEIN U, 1994, J EXP MED, V180, P1383, DOI 10.1084/jem.180.4.1383; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;317::AID-IMMU317&gt;3.0.CO;2-S; Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406; MANSER T, 1987, J IMMUNOL, V139, P234; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MORTARI F, 1993, J IMMUNOL, V150, P1348; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; PEREIRA P, 1986, EUR J IMMUNOL, V16, P685, DOI 10.1002/eji.1830160616; RADA C, 1991, P NATL ACAD SCI USA, V88, P5508, DOI 10.1073/pnas.88.13.5508; Razanajaona D, 1997, J IMMUNOL, V159, P3347; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; Ridings J, 1997, CLIN EXP IMMUNOL, V108, P366, DOI 10.1046/j.1365-2249.1997.3631264.x; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; SHARPE MJ, 1991, EMBO J, V10, P2139, DOI 10.1002/j.1460-2075.1991.tb07748.x; SIEKEVITZ M, 1987, CELL, V48, P757, DOI 10.1016/0092-8674(87)90073-0; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Zan H, 1999, J IMMUNOL, V162, P3437; ZOU XG, 1995, EUR J IMMUNOL, V25, P2154, DOI 10.1002/eji.1830250806	46	40	41	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					409	417		10.1016/S1074-7613(00)00040-6	http://dx.doi.org/10.1016/S1074-7613(00)00040-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021538	Bronze			2022-12-18	WOS:000089616400013
J	Fournier, S; Rathmell, JC; Goodnow, CC; Allison, JP				Fournier, S; Rathmell, JC; Goodnow, CC; Allison, JP			T cell-mediated elimination of B7.2 transgenic B cells	IMMUNITY			English	Article							B7-2 COSTIMULATORY MOLECULES; ANTIGEN-PRESENTING CELLS; ACTIVATED LYMPHOCYTES-T; LIGANDS CD80 B7-1; IN-VIVO; CD28-B7 INTERACTIONS; MONOCLONAL-ANTIBODY; ADDITIONAL LIGAND; COUNTER-RECEPTOR; CLONAL EXPANSION	Transgenic mice were generated to explore the effects on lymphoid development and immune function of constitutive expression of murine B7.2 on B and T cells. The number of B lymphocytes in primary and secondary lymphoid tissues is normal in B7.2 transgenic lines expressing low levels of B7.2 on B cells, but markedly reduced in transgenic lines expressing moderate to high levels of the transgene on B cells. This reduction is not due to an intrinsic abnormality of the transgenic B cells, but is rather the consequence of an elimination by an immune mechanism requiring the engagement of CD28 on T cells. Interestingly, during cognate antigen-specific interaction with T cells in vivo, B7.2 transgenic B cells are not eliminated, but proliferate and differentiate normally. Our findings suggest that, in the absence of high affinity ligand for the ICR, the CD2-B7.2 system participates in the regulation of B cell homeostasis.	STANFORD UNIV,BECKMAN CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,BECKMAN CTR,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University; Stanford University	Fournier, S (corresponding author), UNIV CALIF BERKELEY,DEPT MOL & CELLULAR BIOL,BERKELEY,CA 94720, USA.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155; Allison, James/0000-0001-8980-5697	NATIONAL CANCER INSTITUTE [R01CA040041, R37CA040041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI019512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020610] Funding Source: NIH RePORTER; NCI NIH HHS [CA40041] Funding Source: Medline; NIAID NIH HHS [P01 AI19512] Funding Source: Medline; NIAMS NIH HHS [P060 AR20610] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BAROJA ML, 1988, J IMMUNOL, V141, P1502; BASKAR S, 1993, P NATL ACAD SCI USA, V90, P5687, DOI 10.1073/pnas.90.12.5687; Brinkmann V, 1996, J IMMUNOL, V156, P4100; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; CHEN CY, 1994, J IMMUNOL, V152, P4929; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; CONSTANT S, 1995, J IMMUNOL, V155, P3734; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; DAS MRP, 1995, EUR J IMMUNOL, V25, P207, DOI 10.1002/eji.1830250134; FINKELMAN FD, 1995, J EXP MED, V181, P515, DOI 10.1084/jem.181.2.515; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GHLOTTORAGUENEA.M, 1996, EUR J IMMUNOL, V26, P34; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; GUERDER S, 1995, J IMMUNOL, V155, P5167; GUERDER S, 1994, IMMUNITY, V1, P155; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P5138, DOI 10.1073/pnas.91.11.5138; HARDING FA, 1993, J EXP MED, V177, P1791, DOI 10.1084/jem.177.6.1791; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; HARPER K, 1991, J IMMUNOL, V147, P1037; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Jaiswal AI, 1996, INT IMMUNOL, V8, P275, DOI 10.1093/intimm/8.2.275; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Kariv I, 1996, J IMMUNOL, V157, P29; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LANIER LL, 1995, J IMMUNOL, V154, P97; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LEVINE BL, 1995, INT IMMUNOL, V7, P891, DOI 10.1093/intimm/7.6.891; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1993, J IMMUNOL, V150, P3161; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Miller SD, 1995, IMMUNITY, V3, P739, DOI 10.1016/1074-7613(95)90063-2; MOMBAERTS P, 1991, P NATL ACAD SCI USA, V88, P3084, DOI 10.1073/pnas.88.8.3084; Morton PA, 1996, J IMMUNOL, V156, P1047; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; Perkins D, 1996, J IMMUNOL, V156, P4154; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; RAZIWOLF Z, 1993, P NATL ACAD SCI USA, V90, P11182, DOI 10.1073/pnas.90.23.11182; RONCHESE F, 1994, J EXP MED, V179, P809, DOI 10.1084/jem.179.3.809; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; Rubio CF, 1996, J IMMUNOL, V157, P65; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SETHNA MP, 1994, IMMUNITY, V1, P415, DOI 10.1016/1074-7613(94)90072-8; SHARPE AH, 1995, CURR OPIN IMMUNOL, V7, P389, DOI 10.1016/0952-7915(95)80115-4; STACK RM, 1994, J IMMUNOL, V152, P5723; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; Truneh A, 1996, MOL IMMUNOL, V33, P321, DOI 10.1016/0161-5890(95)00077-1; UEDA Y, 1995, INT IMMUNOL, V7, P957, DOI 10.1093/intimm/7.6.957; VERWILGHEN J, 1993, J IMMUNOL, V150, P835; WU Y, 1993, J EXP MED, V178, P1789, DOI 10.1084/jem.178.5.1789; YANG GC, 1995, J IMMUNOL, V154, P2794; Yuschenkoff VN, 1996, J IMMUNOL, V157, P1987; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	90	40	40	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					327	339		10.1016/S1074-7613(00)80335-0	http://dx.doi.org/10.1016/S1074-7613(00)80335-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075933	Bronze			2022-12-18	WOS:A1997XC61800012
J	Dugan, HL; Stamper, CT; Li, L; Changrob, S; Asby, NW; Halfmann, PJ; Zheng, NY; Huang, M; Shaw, DG; Cobb, MS; Erickson, SA; Guthmiller, JJ; Stovicek, O; Wang, JL; Winkler, ES; Madariaga, ML; Shanmugarajah, K; Jansen, MO; Amanat, F; Stewart, I; Utset, HA; Huang, J; Nelson, CA; Dai, YN; Hall, PD; Jedrzejczak, RP; Joachimiak, A; Krammer, F; Diamond, MS; Fremont, DH; Kawaoka, Y; Wilson, PC				Dugan, Haley L.; Stamper, Christopher T.; Li, Lei; Changrob, Siriruk; Asby, Nicholas W.; Halfmann, Peter J.; Zheng, Nai-Ying; Huang, Min; Shaw, Dustin G.; Cobb, Mari S.; Erickson, Steven A.; Guthmiller, Jenna J.; Stovicek, Olivia; Wang, Jiaolong; Winkler, Emma S.; Madariaga, Maria Lucia; Shanmugarajah, Kumaran; Jansen, Maud O.; Amanat, Fatima; Stewart, Isabelle; Utset, Henry A.; Huang, Jun; Nelson, Christopher A.; Dai, Ya-Nan; Hall, Paige D.; Jedrzejczak, Robert P.; Joachimiak, Andrzej; Krammer, Florian; Diamond, Michael S.; Fremont, Daved H.; Kawaoka, Yoshihiro; Wilson, Patrick C.			Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets	IMMUNITY			English	Article							GERMINAL CENTER; MARGINAL ZONE; ACTIVATION; EXPRESSION; MEMORY; IDENTIFICATION; PROLIFERATION; MATURATION; SIGNATURES; SURVIVAL	Dissecting the evolution of memory B cells (MBCs) against SARS-CoV-2 is critical for understanding antibody recallupon secondary exposure. Here, we usedsingle-cell sequencing to profile SARS-CoV-2-reactive B cells in 38 COVID-19 patients. Using oligo-tagged antigen baits, we isolated B cells specific to the SARS-CoV-2 spike, nucleoprotein (NP), open reading frame 8 (ORF8), and endemic human coronavirus (HCoV) spike proteins. SARS-CoV-2 spike-specific cells were enriched in the memory compartment of acutely infected and convalescent patients several months post symptom onset. With severe acute infection, substantial populations of endemic HCoV-reactive antibody-secreting cells were identified and possessed highlymutated variable genes, signifying preexisting immunity. Finally, MBCs exhibited pronounced maturation to NP and ORF8 over time, especially in older patients. Monoclonal antibodies against these targets were non-neutralizing and non-protective in vivo. These findings reveal antibody adaptation to non-neutralizing intracellular antigens during infection, emphasizing the importance of vaccination for inducing neutralizing spike-specific MBCs.	[Dugan, Haley L.; Stamper, Christopher T.; Shaw, Dustin G.; Huang, Jun; Wilson, Patrick C.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Li, Lei; Changrob, Siriruk; Zheng, Nai-Ying; Huang, Min; Erickson, Steven A.; Guthmiller, Jenna J.; Stovicek, Olivia; Wang, Jiaolong; Stewart, Isabelle; Utset, Henry A.; Wilson, Patrick C.] Univ Chicago, Sect Rheumatol, Dept Med, Chicago, IL 60637 USA; [Asby, Nicholas W.; Huang, Jun] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA; [Halfmann, Peter J.; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, Influenza Res Inst, Madison, WI 53711 USA; [Cobb, Mari S.] Univ Chicago, Sect Genet Med, Chicago, IL 60637 USA; [Winkler, Emma S.; Nelson, Christopher A.; Dai, Ya-Nan; Hall, Paige D.; Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63130 USA; [Winkler, Emma S.; Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA; [Diamond, Michael S.] Washington Univ, Dept Mol Immunol, Sch Med, St Louis, MO 63130 USA; [Madariaga, Maria Lucia; Shanmugarajah, Kumaran] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Jansen, Maud O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Amanat, Fatima; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Jedrzejczak, Robert P.; Joachimiak, Andrzej] Univ Chicago, Ctr Struct Genom Infect Dis, Consortium Adv Sci & Engn, Chicago, IL 60439 USA; [Jedrzejczak, Robert P.; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Xray Sci Div, Lemont, IL 60439 USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Stewart, Isabelle] Victoria Univ Wellington, Sch Biol Sci, Wellington 6012, New Zealand	University of Chicago; University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Chicago; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Chicago; University of Chicago; Icahn School of Medicine at Mount Sinai; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Tokyo; Victoria University Wellington	Wilson, PC (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.; Wilson, PC (corresponding author), Univ Chicago, Sect Rheumatol, Dept Med, Chicago, IL 60637 USA.	wilsonp@uchicago.edu	Changrob, Siriruk/AAZ-6282-2021; Krammer, Florian/H-3237-2019; Li, Lei/AGZ-4207-2022; Wilson, Patrick/HGC-3157-2022	Changrob, Siriruk/0000-0002-1826-4333; Krammer, Florian/0000-0003-4121-776X; Li, Lei/0000-0002-8828-5199; Shaw, Dustin/0000-0003-3961-7588; Joachimiak, Andrzej/0000-0003-2535-6209; Shiratori, Mari/0000-0001-9641-0343; Stewart, Isabelle/0000-0001-8204-0687; Halfmann, Peter/0000-0002-1648-1625; Stovicek, Olivia/0000-0001-6413-855X; Asby, Nicholas/0000-0002-1675-7601; Fremont, Daved/0000-0002-8544-2689	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [U19AI082724, U19AI109946, U19AI057266]; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400005C]; Multi-disciplinary Training program in Cancer Research (MTCR) (NIH) [T32 CA009594]; NIAID, NIH; U.S. Department of Health and Human Services [HHSN272201700060C]; NIAID CEIRS [HHSN272201400008C]; Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]; JPB Foundation; Open Philanthropy Project [2020-215611]; Research Program on Emerging and Re-emerging Infectious Disease grant [JP19fk0108113]; Japan Program for Infectious Diseases Research and Infrastructure of the Japan Agency for Medical Research and Development (AMED) [JP20fk0108272]; NIAID CEIRS contract [HHSN272201400008C]; CIVIC contract [75N93019C00051]; NIAID [HHSN272201700060C, 75N93019C00062]; NIH [R01 AI157155, F30 AI152327]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS); Multi-disciplinary Training program in Cancer Research (MTCR) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Health and Human Services; NIAID CEIRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Collaborative Influenza Vaccine Innovation Centers (CIVIC); JPB Foundation; Open Philanthropy Project; Research Program on Emerging and Re-emerging Infectious Disease grant; Japan Program for Infectious Diseases Research and Infrastructure of the Japan Agency for Medical Research and Development (AMED); NIAID CEIRS contract; CIVIC contract; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded in part by the National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) grant numbers U19AI082724 (P.C.W.), U19AI109946 (P.C.W.), and U19AI057266 (P.C.W.); and NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) grant HHSN272201400005C (P.C.W.). N.W.A. was supported by the Multi-disciplinary Training program in Cancer Research (MTCR) (NIH grant T32 CA009594). A.J. and R.P.J. were supported by federal funds from NIAID, NIH, and the U.S. Department of Health and Human Services under contract HHSN272201700060C. F.K. and F.A. were funded by NIAID CEIRS contract HHSN272201400008C and Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051 and the generous support of the JPB Foundation, the Open Philanthropy Project (2020-215611), and other philanthropic donations. Y.K. and P.J.H. were funded by the Research Program on Emerging and Re-emerging Infectious Disease grant (JP19fk0108113) and the Japan Program for Infectious Diseases Research and Infrastructure (JP20fk0108272) of the Japan Agency for Medical Research and Development (AMED), NIAID CEIRS contract HHSN272201400008C, and CIVIC contract 75N93019C00051. D.H.F., C.A.N., Y.-N.D., and P.D.H. were supported by NIAID contracts HHSN272201700060C and 75N93019C00062. M.S.D. and E.S.W. were supported by NIH grants R01 AI157155 and F30 AI152327, respectively. We kindly thank the University of Chicago CAT Facility (RRID: SCR_017760) for their assistance and allowing us to use their facilities. We thank Dr. Nicholas Chevrier for allowing us to use the Pritzker School of Molecular Engineering's sequencing facility. We are thankful to the University of Chicago Genomics Facility (RRID: SCR_019196) for their assistance with sequencing several samples. We thank John Bivona and the staff of the Howard Taylor Ricketts Laboratory for prompt training in BSL-3 practices and procedures and for use of their facilities for severe acute infected sample collection. Last, we are appreciative of the patients who donated samples for our research purposes. The Graphical abstract was created with Biorender.com.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; Atyeo C, 2020, IMMUNITY, V53, P524, DOI 10.1016/j.immuni.2020.07.020; Axelsson S, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-00343-2; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Dugan HL, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3601; Dugan HL, 2020, CELL IMMUNOL, V348, DOI 10.1016/j.cellimm.2019.103998; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guthmiller JJ, 2021, MBIO, V12, DOI 10.1128/mBio.02940-20; Guthmiller JJ, 2020, IMMUNITY, V53, P1230, DOI 10.1016/j.immuni.2020.10.005; Guthmiller JJ, 2019, METHODS MOL BIOL, V1904, P109, DOI 10.1007/978-1-4939-8958-4_5; Hartley GE, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abf8891; Henry C, 2019, CELL HOST MICROBE, V25, P357, DOI 10.1016/j.chom.2019.01.002; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Kim CC, 2019, CELL REP, V27, P1446, DOI 10.1016/j.celrep.2019.04.019; Krzyzak L, 2016, J IMMUNOL, V196, P3581, DOI 10.4049/jimmunol.1502163; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lee K, 2009, GLOB INST, P1; Lightman SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00965; Liu B., 2020, NAT COMMUN, V11, P3155, DOI DOI 10.1038/S41467-020-16904-3; Lu S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20768-y; Mabbott NA, 2014, IMMUNOLOGY, V141, P79, DOI 10.1111/imm.12171; Macias-Garcia A, 2016, J BIOL CHEM, V291, P9073, DOI 10.1074/jbc.M115.704239; Moroney JB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19242-6; Nelson CA, 2005, STRUCTURE, V13, P75, DOI 10.1016/j.str.2004.10.010; Nelson CA, 2014, METHODS MOL BIOL, V1140, P145, DOI 10.1007/978-1-4939-0354-2_11; Ng Kevin W, 2020, Science, V370, P1339, DOI 10.1126/science.abe1107; Ochiai K, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108517; Palm AKE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01787; Patzelt T, 2018, P NATL ACAD SCI USA, V115, P3120, DOI 10.1073/pnas.1711335115; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.21203/rs.3.rs-57112/v1, 10.1101/2020.08.11.20171843]; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Said JW, 2001, LAB INVEST, V81, P555, DOI 10.1038/labinvest.3780264; Sakharkar M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6916; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Smulski CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02285; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Stuart T., 2019, CELL, V177, P1888, DOI [DOI 10.1016/j.cell.2019.05.031, DOI 10.1016/J.CELL.2019.05.031]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Villa M, 2017, EMBO J, V36, P116, DOI 10.15252/embj.201695027; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wohner M, 2016, J EXP MED, V213, P1201, DOI 10.1084/jem.20152002; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yi CY, 2020, CELL MOL IMMUNOL, V17, P621, DOI 10.1038/s41423-020-0458-z; Zhao C, 2008, ONCOGENE, V27, P63, DOI 10.1038/sj.onc.1210637	65	39	39	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1290	+		10.1016/j.immuni.2021.05.001	http://dx.doi.org/10.1016/j.immuni.2021.05.001		JUN 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34022127	Green Published, Bronze			2022-12-18	WOS:000659882900018
J	Pulido, AD; Hanggi, K; Celias, DP; Gardner, A; Li, J; Batista-Bittencourt, B; Mohamed, E; Trillo-Tinoco, J; Osunmakinde, O; Pena, R; Onimus, A; Kaisho, T; Kaufmann, J; McEachern, K; Soliman, H; Luca, VC; Rodriguez, PC; Yu, XQ; Ruffell, B				Pulido, Alvaro de Mingo; Hanggi, Kay; Celias, Daiana P.; Gardner, Alycia; Li, Jie; Batista-Bittencourt, Bruna; Mohamed, Eslam; Trillo-Tinoco, Jimena; Osunmakinde, Olabisi; Pena, Reymi; Onimus, Alexis; Kaisho, Tsuneyasu; Kaufmann, Johanna; McEachern, Kristen; Soliman, Hatem; Luca, Vincent C.; Rodriguez, Paulo C.; Yu, Xiaoqing; Ruffell, Brian			The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake	IMMUNITY			English	Article							ANTITUMOR IMMUNITY; CHEMOTHERAPY; RESPONSES; BLOCKADE; CANCER; INFLAMMATION; BREAST; DEATH	Blockade of the inhibitory receptor TIM-3 shows efficacy in cancer immunotherapy clinical trials. TIM-3 inhibits production of the chemokine CXCL9 by XCR1(+) classical dendritic cells (cDC1), thereby limiting antitumor immunity in mammary carcinomas. We found that increased CXCL9 expression by splenic cDC1s upon TIM-3 blockade required type I interferons and extracellular DNA. Chemokine expression as well as combinatorial efficacy of TIM-3 blockade and paclitaxel chemotherapy were impaired by deletion of Cgas and Sting. TIM-3 blockade increased uptake of extracellular DNA by cDC1 through an endocytic process that resulted in cytoplasmic localization. DNA uptake and efficacy of TIM-3 blockade required DNA binding by HMGB1, while galectin-9-induced cell surface clustering of TIM-3 was necessary for its suppressive function. Human peripheral blood cDC1s also took up extracellular DNA upon TIM-3 blockade. Thus, TIM-3 regulates endocytosis of extracellular DNA and activation of the cytoplasmic DNA sensing cGAS-STING pathway in cDC1s, with implications for understanding the mechanisms underlying TIM-3 immunotherapy.	[Pulido, Alvaro de Mingo; Hanggi, Kay; Celias, Daiana P.; Gardner, Alycia; Li, Jie; Batista-Bittencourt, Bruna; Mohamed, Eslam; Trillo-Tinoco, Jimena; Osunmakinde, Olabisi; Pena, Reymi; Onimus, Alexis; Soliman, Hatem; Rodriguez, Paulo C.; Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Gardner, Alycia; Li, Jie; Batista-Bittencourt, Bruna; Osunmakinde, Olabisi] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA; [Osunmakinde, Olabisi] Aalborg Univ, Dept Hlth Sci & Technol, DK-29220 Aalborg, Denmark; [Onimus, Alexis] Univ S Florida, Mol Med PhD Program, Tampa, FL 33620 USA; [Kaisho, Tsuneyasu] Wakayama Med Univ, Inst Adv Med, Wakayama 6418509, Japan; [Kaufmann, Johanna] GSK, Immunooncol & Combinat Res Unit, Waltham, MA 02451 USA; [McEachern, Kristen] TESARO, Waltham, MA 02451 USA; [Soliman, Hatem; Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Dept Breast Oncol, Tampa, FL 33612 USA; [Luca, Vincent C.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Yu, Xiaoqing] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA; [McEachern, Kristen] Ribon Therapeut, Cambridge, MA 02140 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Aalborg University; State University System of Florida; University of South Florida; Wakayama Medical University; GlaxoSmithKline; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Ruffell, B (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	brian.ruffell@moffitt.org	de Mingo Pulido, Alvaro/AAU-7552-2021; Rodríguez, Paulo/HDM-9539-2022	Rodriguez, Paulo/0000-0001-7480-6566; Batista Bittencourt, Bruna/0000-0002-2205-6051; Li, Jie/0000-0002-7282-2009; Hanggi, Kay/0000-0003-1435-3707; Trillo-Tinoco, Jimena/0000-0002-1240-9650; Osunmakinde, Olabisi/0000-0001-8513-7011; Gardner, Alycia/0000-0003-2185-5174; Ruffell, Brian/0000-0002-3846-6872; Celias, Daiana/0000-0002-5122-6718	National Cancer Institute [P30-CA076292]; Swiss National Science Foundation; NIH NRSA predoctoral fellowship [F31CA224963]; NIH/NCI [F99CA245807, R00CA185325, R01CA230610]; Florida Breast Cancer Foundation; Shula Fund at Moffitt Cancer Center; Florida Department of Health Bankhead-Coley Cancer Research Program [8BC02]; Department of Defense Breast Cancer Research Program [W81XWH-20-1-0012]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH NRSA predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Breast Cancer Foundation; Shula Fund at Moffitt Cancer Center; Florida Department of Health Bankhead-Coley Cancer Research Program; Department of Defense Breast Cancer Research Program(United States Department of Defense)	This work was supported by the Moffitt Cancer Center Flow Cytometry, Molecular Genomics, Analytic Microscopy, Chemical Biology, and Tissue Core Facilities, all comprehensive cancer center facilities designated by the National Cancer Institute (P30-CA076292). The authors would like to thank Matthew F. Krummel, Miranda Broz, Kathy Yang, Vivian Lee, Leenil Noel, and Aysenur Keske for scientific/technical assistance, along with Melissa A. Meyer and David G. DeNardo for the PyMT-B6 cell line. K.H. was supported by a postdoctoral fellowship from the Swiss National Science Foundation. A.G. was supported by a NIH NRSA predoctoral fellowship (F31CA224963) and a NIH/NCI Predoctoral to Postdoctoral Fellow Transition Award (F99CA245807). The research reported herein was supported by the Florida Breast Cancer Foundation, the Shula Fund at Moffitt Cancer Center, the Florida Department of Health Bankhead-Coley Cancer Research Program (8BC02), the Department of Defense Breast Cancer Research Program (W81XWH-20-1-0012), and the NIH/NCI (R00CA185325 and R01CA230610), all to B.R.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ahn J, 2018, CANCER CELL, V33, P862, DOI 10.1016/j.ccell.2018.03.027; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Cardinal J, 2009, HEPATOLOGY, V50, P565, DOI 10.1002/hep.23021; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Diamond JM, 2018, CANCER IMMUNOL RES, V6, P910, DOI 10.1158/2326-6066.CIR-17-0581; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gardner A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00924; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Larkin B, 2017, J IMMUNOL, V199, P397, DOI 10.4049/jimmunol.1601999; Li TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19049; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; Mender I, 2020, CANCER CELL, V38, P400, DOI 10.1016/j.ccell.2020.05.020; Meyer MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03600-6; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Phong BL, 2015, J EXP MED, V212, P2289, DOI 10.1084/jem.20150388; Pulido AD, 2018, CANCER CELL, V33, P60, DOI 10.1016/j.ccell.2017.11.019; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sabatos-Peyton CA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1385690; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Wolf Y, 2020, NAT REV IMMUNOL, V20, P173, DOI 10.1038/s41577-019-0224-6; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Zhou HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006087; Zhou Y, 2020, IMMUNITY, V52, P357, DOI 10.1016/j.immuni.2020.01.014	50	39	39	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1154	+	e7	10.1016/j.immuni.2021.04.019	http://dx.doi.org/10.1016/j.immuni.2021.04.019		JUN 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33979578	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000659882900009
J	Nguyen, THO; Rowntree, LC; Petersen, J; Chua, BY; Hensen, L; Kedzierski, L; van de Sandt, CE; Chaurasia, P; Tan, HX; Habel, JR; Zhang, WJ; Allen, LF; Earnest, LD; Mak, KY; Juno, JA; Wragg, K; Mordant, FL; Amanat, F; Krammer, F; Mifsud, NA; Doolan, DL; Flanagan, KL; Sonda, S; Kaur, J; Wakim, LM; Westall, GP; James, F; Mouhtouris, E; Gordon, CL; Holmes, NE; Smibert, OC; Trubiano, JA; Cheng, AC; Harcourt, P; Clifton, P; Crawford, JC; Thomas, PG; Wheatley, AK; Kent, SJ; Rossjohn, J; Torresi, J; Kedzierska, K				Nguyen, Thi H. O.; Rowntree, Louise C.; Petersen, Jan; Chua, Brendon Y.; Hensen, Luca; Kedzierski, Lukasz; van de Sandt, Carolien E.; Chaurasia, Priyanka; Tan, Hyon-Xhi; Habel, Jennifer R.; Zhang, Wuji; Allen, Lilith F.; Earnest, Linda; Mak, Kai Yan; Juno, Jennifer A.; Wragg, Kathleen; Mordant, Francesca L.; Amanat, Fatima; Krammer, Florian; Mifsud, Nicole A.; Doolan, Denise L.; Flanagan, Katie L.; Sonda, Sabrina; Kaur, Jasveen; Wakim, Linda M.; Westall, Glen P.; James, Fiona; Mouhtouris, Effie; Gordon, Claire L.; Holmes, Natasha E.; Smibert, Olivia C.; Trubiano, Jason A.; Cheng, Allen C.; Harcourt, Peter; Clifton, Patrick; Crawford, Jeremy Chase; Thomas, Paul G.; Wheatley, Adam K.; Kent, Stephen J.; Rossjohn, Jamie; Torresi, Joseph; Kedzierska, Katherine			CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity	IMMUNITY			English	Article							ACUTE RESPIRATORY SYNDROME; RESPONSES; DIVERSITY; KINETICS; AVIDITY; IMMUNE	To better understand primary and recall T cell responses during coronavirus disease 2019 (COVID-19), it is important to examine unmanipulated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells. By using peptide-human leukocyte antigen (HLA) tetramers for direct ex vivo analysis, we characterized CD8(+) T cells specific for SARS-CoV-2 epitopes in COVID-19 patients and unexposed individuals. Unlike CD8(+) T cells directed toward subdominant epitopes (B7/N-257, A2/S-269, and A24/S-1,S-208) CD8(+) T cells specific for the immunodominant B7/N-105 epitope were detected at high frequencies in pre-pandemic samples and at increased frequencies during acute COVID-19 and convalescence. SARS-CoV-2-specific CD8(+) T cells in pre-pandemic samples from children, adults, and elderly individuals predominantly displayed a naive phenotype, indicating a lack of previous cross-reactive exposures. T cell receptor (TCR) analyses revealed diverse TCR alpha beta repertoires and promiscuous alpha beta-TCR pairing within B7/N(105)(+)CD8(+) T cells. Our study demonstrates high naive precursor frequency and TCR alpha beta diversity within immunodominant B7/N-105-specific CD8(+) T cells and provides insight into SARS-CoV-2-specific T cell origins and subsequent responses.	[Nguyen, Thi H. O.; Rowntree, Louise C.; Chua, Brendon Y.; Hensen, Luca; Kedzierski, Lukasz; van de Sandt, Carolien E.; Tan, Hyon-Xhi; Habel, Jennifer R.; Zhang, Wuji; Allen, Lilith F.; Earnest, Linda; Mak, Kai Yan; Juno, Jennifer A.; Wragg, Kathleen; Mordant, Francesca L.; Wakim, Linda M.; Holmes, Natasha E.; Wheatley, Adam K.; Kent, Stephen J.; Torresi, Joseph; Kedzierska, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Petersen, Jan; Chaurasia, Priyanka; Mifsud, Nicole A.; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Petersen, Jan; Chaurasia, Priyanka; Mifsud, Nicole A.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Petersen, Jan; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Chua, Brendon Y.; Kedzierska, Katherine] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo, Hokkaido 0600808, Japan; [Kedzierski, Lukasz] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic 3000, Australia; [van de Sandt, Carolien E.] Univ Amsterdam, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam UMC, NL-1066 CX Amsterdam, Netherlands; [Amanat, Fatima; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Amanat, Fatima] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Doolan, Denise L.] James Cook Univ, Ctr Mol Therapeut, Australian Inst Trop Hlth & Med, Cairns, Qld 4870, Australia; [Flanagan, Katie L.; Sonda, Sabrina; Kaur, Jasveen] Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7248, Australia; [Flanagan, Katie L.; Sonda, Sabrina; Kaur, Jasveen] Univ Tasmania, Sch Med, Launceston, Tas 7248, Australia; [Flanagan, Katie L.] Monash Univ, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia; [Flanagan, Katie L.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic 3000, Australia; [Flanagan, Katie L.; Kaur, Jasveen] Launceston Gen Hosp, Clifford Craig Fdn, Tasmanian Vaccine Trial Ctr, Launceston, Tas 7250, Australia; [Westall, Glen P.] Alfred Hosp, Lung Transplant Unit, Melbourne, Vic 3004, Australia; [James, Fiona; Mouhtouris, Effie; Gordon, Claire L.; Holmes, Natasha E.; Smibert, Olivia C.; Trubiano, Jason A.] Austin Hosp, Dept Infect Dis, Heidelberg, Vic 3084, Australia; [Smibert, Olivia C.] Univ Melbourne, Dept Med & Radiol, Parkville, Vic 3000, Australia; [Smibert, Olivia C.] Austin Hlth, Data Analyt Res & Evaluat Dare Ctr, Heidelberg, Vic 3084, Australia; [Smibert, Olivia C.] Univ Melbourne, Heidelberg, Vic 3084, Australia; [Trubiano, Jason A.; Cheng, Allen C.] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic 3000, Australia; [Trubiano, Jason A.; Cheng, Allen C.] Peter MacCallum Canc Ctr, Natl Ctr Infect Canc, Melbourne, Vic 3000, Australia; [Cheng, Allen C.] Austin Hlth, Ctr Antibiot Allergy & Res, Dept Infect Dis, Heidelberg, Vic 3084, Australia; [Cheng, Allen C.] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia; [Harcourt, Peter] Alfred Hlth, Infect Prevent & Healthcare Epidemiol Unit, Melbourne, Vic 3004, Australia; [Harcourt, Peter] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Clifton, Patrick] AFL House, Melbourne, Vic 3001, Australia; [Crawford, Jeremy Chase; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wheatley, Adam K.; Kent, Stephen J.] Univ Melbourne, Arc Ctr Excellence Convergent Bionano Sci & Techn, Melbourne, Vic 3000, Australia; [Kent, Stephen J.] Monash Univ, Melbourne Sexual Hlth Ctr, Cent Clin Sch, Infect Dis Dept,Alfred Hlth, Melbourne, Vic 3004, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales	University of Melbourne; Monash University; Monash University; Monash University; Hokkaido University; University of Melbourne; University of Amsterdam; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; James Cook University; University of Tasmania; University of Tasmania; Monash University; Royal Melbourne Institute of Technology (RMIT); Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; St Jude Children's Research Hospital; University of Melbourne; Monash University; Cardiff University	Kedzierska, K (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.; Kedzierska, K (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo, Hokkaido 0600808, Japan.	kkedz@unimelb.edu.au	Crawford, Jeremy Chase/G-5711-2013; Krammer, Florian/H-3237-2019; Chua, Brendon/A-9755-2012; Rossjohn, Jamie/F-9032-2013	Crawford, Jeremy Chase/0000-0003-4096-6048; Krammer, Florian/0000-0003-4121-776X; Hensen, Luca/0000-0001-8467-8537; Gordon, Claire/0000-0001-5172-4728; Mifsud, Nicole/0000-0001-8647-2102; Kent, Stephen/0000-0002-8539-4891; Mordant, Francesca/0000-0002-3754-2642; Flanagan, Katie/0000-0002-1575-1953; Doolan, Denise/0000-0001-7354-8817; Kedzierski, Lukasz/0000-0003-0203-1057; Chua, Brendon/0000-0001-5654-1293; Rowntree, Louise/0000-0002-0649-5089; Habel, Jennifer/0000-0003-0380-1527; Rossjohn, Jamie/0000-0002-2020-7522	Clifford Craig Foundation; NHMRC Leadership Investigator Grant [1173871]; NHMRC Emerging Leadership Level 1 Investigator Grant [1194036]; NHMRC program [1132975]; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-712/19-N]; Victorian government; MRFF [2002073, 1202445, 2005544]; NHMRC [1149990, 1162760, 1137285, 1136322]; NIH [HHS-NIH-NIAID-BAA2018]; Emerging Leadership 1 Investigator Grant [1173433]; NHMRC Early Career Fellowship (ECF) [1123673]; European Union [792532]; Doherty Collaborative Seed Grant; ARC Laureate fellowship; Melbourne Research Scholarship from the University of Melbourne; Melbourne International Research Scholarship (MIRS); Melbourne International Fee Remission Scholarship (MIFRS) from The University of Melbourne; NIH NIAID [R01 AI136514-03]; ALSAC at St. Jude	Clifford Craig Foundation; NHMRC Leadership Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Emerging Leadership Level 1 Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Victorian government; MRFF(Medical Research Future Fund (MRFF)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerging Leadership 1 Investigator Grant; NHMRC Early Career Fellowship (ECF)(National Health and Medical Research Council (NHMRC) of Australia); European Union(European Commission); Doherty Collaborative Seed Grant; ARC Laureate fellowship(Australian Research Council); Melbourne Research Scholarship from the University of Melbourne; Melbourne International Research Scholarship (MIRS); Melbourne International Fee Remission Scholarship (MIFRS) from The University of Melbourne; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC at St. Jude	We thank all the participants involved in the study, as well as Robyn Esterbauer, Hannah Kelly, Jane Batten, Helen Kent, and Kanta Subbarao for support with the cohorts and assays. We thank Jill Garlick, Janine Roney, Anne Paterson, and the research nurses at the Alfred Hospital. We acknowledge all DRASTIC (The use of cytokines as a preDictoR of disease Severity in criTically Ill Covid-patients) investigators from Austin Health and thank the participants involved. We thank Ana Copaescu for laboratory work and study coordination for the DRASTIC study. We thank Thomas Loudovaris and Stuart I. Mannering from St Vincent's Institute of Medical Research for access to spleen samples. This work was supported by the Clifford Craig Foundation to K.L.F. and K.K.; an NHMRC Leadership Investigator Grant to K.K. (1173871); an NHMRC Emerging Leadership Level 1 Investigator Grant to THON (1194036); an NHMRC program grant to D.L.D. (1132975); the Research Grants Council of the Hong Kong Special Administrative Region, China (T11-712/19-N) to K.K.; the Victorian government to S.J.K. and A.K.W.; an MRFF award (2002073) to S.J.K. and A.K.W.; an MRFF award (1202445) to K.K.; an MRFF award (2005544) to K.K., S.J.K., J.A.J., and A.K.W.; an NHMRC program grant (1149990) to S.J.K.; an NHMRC project grant (1162760) to A.K.W.; and NIH contract CIVR-HRP (HHS-NIH-NIAID-BAA2018) to P.G.T. and K.K. A.K.W. is supported by an Emerging Leadership 1 Investigator Grant (1173433), J.A.J. by an NHMRC Early Career Fellowship (ECF) (1123673), D.L.D. by an NHMRC Principal Research Fellowship (1137285), and S.J.K. by an NHMRC Senior Principal Research Fellowship (1136322). C.E.S. has received funding from the European Union's Horizon 2020 research, innovation program under the Marie Sk1odowska-Curie grant agreement (792532) and the Doherty Collaborative Seed Grant. J.R. is supported by an ARC Laureate fellowship. J.R.H. and W.Z. are supported by the Melbourne Research Scholarship from the University of Melbourne. L.H. is supported by the Melbourne International Research Scholarship (MIRS) and the Melbourne International Fee Remission Scholarship (MIFRS) from The University of Melbourne. J.C.C. and P.G.T. are supported by NIH NIAID (R01 AI136514-03) and ALSAC at St. Jude.	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Caly L, 2020, MED J AUSTRALIA, V212, P459, DOI 10.5694/mja2.50569; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Clemens EB, 2016, IMMUNOL CELL BIOL, V94, P367, DOI 10.1038/icb.2015.93; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Gonzalez-Galarza FF, 2020, NUCLEIC ACIDS RES, V48, pD783, DOI 10.1093/nar/gkz1029; Griffiths SJ, 2013, J IMMUNOL, V190, P5363, DOI 10.4049/jimmunol.1203267; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Kedzierska K, 2020, VIRAL IMMUNOL, V33, P160, DOI 10.1089/vim.2019.0184; Koutsakos M, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100208; Koutsakos M, 2019, NAT IMMUNOL, V20, P613, DOI 10.1038/s41590-019-0320-6; Koutsakos M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8405; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; LeMaoult J, 2000, J IMMUNOL, V165, P2367, DOI 10.4049/jimmunol.165.5.2367; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Messaoudi I, 2006, J IMMUNOL, V176, P301, DOI 10.4049/jimmunol.176.1.301; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Nguyen THO, 2018, J LEUKOCYTE BIOL, V103, P321, DOI 10.1189/jlb.5MA0517-207R; Nguyen THO, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.4; Peng H, 2006, VIROLOGY, V351, P466, DOI 10.1016/j.virol.2006.03.036; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Rowntree LC, 2020, J IMMUNOL, V205, P1524, DOI 10.4049/jimmunol.2000249; Sant S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01453; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Nguyen TH, 2017, IMMUNOL CELL BIOL, V95, P77, DOI 10.1038/icb.2016.71; Valkenburg SA, 2016, P NATL ACAD SCI USA, V113, P4440, DOI 10.1073/pnas.1603106113; Valkenburg SA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002544; Wang ZF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03243-7; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393	48	39	41	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					1066	+		10.1016/j.immuni.2021.04.009	http://dx.doi.org/10.1016/j.immuni.2021.04.009		MAY 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33951417	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-18	WOS:000652019500020
J	Han, RT; Kim, RD; Molofsky, AV; Liddelow, SA				Han, Rafael T.; Kim, Rachel D.; Molofsky, Anna, V; Liddelow, Shane A.			Astrocyte-immune cell interactions in physiology and pathology	IMMUNITY			English	Review							DYSTROPHIN-GLYCOPROTEIN COMPLEX; MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; GROWTH-FACTOR-BETA; HUNTINGTONS-DISEASE; GLUTAMATE TRANSPORT; ALZHEIMERS-DISEASE; CNS SYNAPTOGENESIS; POTASSIUM CHANNEL; MICE LACKING	Astrocytes play both physiological and pathological roles in maintaining central nervous system (CNS) function. Here, we review the varied functions of astrocytes and how these might change in subsets of reactive astrocytes. We review the current understanding of astrocyte interactions with microglia and the vasculature and protective barriers in the central nervous system as well as highlight recent insights into physiologic and reactive astrocyte sub-states identified by transcriptional profiling. Our goal is to stimulate inquiry into how these molecular identifiers link to specific functional changes in astrocytes and to define the implications of these heterogeneous molecular and functional changes in brain function and pathology. Defining these complex interactions has the potential to yield new therapies in CNS injury, infection, and disease.	[Han, Rafael T.; Molofsky, Anna, V] Univ Calif San Francisco, Dept Psychiat & Behav Sci, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Kim, Rachel D.; Liddelow, Shane A.] NYU Grossman Sch Med, Neurosci Inst, New York, NY 10016 USA; [Molofsky, Anna, V] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA; [Liddelow, Shane A.] NYU Grossman Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Liddelow, Shane A.] NYU Grossman Sch Med, Dept Ophthalmol, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Han, RT; Molofsky, AV (corresponding author), Univ Calif San Francisco, Dept Psychiat & Behav Sci, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Kim, RD; Liddelow, SA (corresponding author), NYU Grossman Sch Med, Neurosci Inst, New York, NY 10016 USA.; Molofsky, AV (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.; Liddelow, SA (corresponding author), NYU Grossman Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA.; Liddelow, SA (corresponding author), NYU Grossman Sch Med, Dept Ophthalmol, New York, NY 10016 USA.	taeho.han@ucsf.edu; rachel.kim2@nyulangone.org; anna.molofsky@ucsf.edu; shane.liddelow@nyulangone.org		Han, Rafael Taeho/0000-0002-0127-2396; Han, Rafael/0000-0002-0123-877X; Liddelow, Shane/0000-0002-0840-1437				Abbott NJ, 2018, ACTA NEUROPATHOL, V135, P387, DOI 10.1007/s00401-018-1812-4; ALEXANDER WS, 1949, BRAIN, V72, P373, DOI 10.1093/brain/72.3.373; Allen NJ, 2017, NEURON, V96, P697, DOI 10.1016/j.neuron.2017.09.056; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arnold TD, 2014, DEVELOPMENT, V141, P4489, DOI 10.1242/dev.107193; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Avalos CB, 2019, ELIFE, V8, DOI 10.7554/eLife.50354; Avey D, 2018, CELL REP, V24, P3619, DOI 10.1016/j.celrep.2018.08.080; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Bayraktar OA, 2020, NAT NEUROSCI, V23, P500, DOI 10.1038/s41593-020-0602-1; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Blanco-Suarez E, 2018, NEURON, V100, P1116, DOI 10.1016/j.neuron.2018.09.043; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Cekanaviciute E, 2014, J IMMUNOL, V193, P139, DOI 10.4049/jimmunol.1303284; Cekanaviciute E, 2014, GLIA, V62, P1227, DOI 10.1002/glia.22675; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P450, DOI 10.1038/jcbfm.2013.217; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Favuzzi E, 2017, NEURON, V95, P639, DOI 10.1016/j.neuron.2017.06.028; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Garcia VJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00669; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Goldsmith J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1090-2; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Grubman A, 2019, NAT NEUROSCI, V22, P2087, DOI 10.1038/s41593-019-0539-4; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Guillemaud O, 2020, NEUROBIOL AGING, V90, P135, DOI 10.1016/j.neurobiolaging.2020.02.010; Guttenplan KA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17514-9; Guttenplan KA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107776; Guttenplan KA, 2019, J EXP MED, V216, P71, DOI 10.1084/jem.20180200; Habib N, 2020, NAT NEUROSCI, V23, P701, DOI 10.1038/s41593-020-0624-8; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Han CZ, 2016, NATURE, V539, P570, DOI 10.1038/nature20141; Hassel B, 2008, NEUROCHEM RES, V33, P232, DOI 10.1007/s11064-007-9463-1; Hill SA, 2019, ELIFE, V8, DOI 10.7554/eLife.45545; Horng S, 2017, J CLIN INVEST, V127, P3136, DOI 10.1172/JCI91301; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Kaiser M, 2006, J NEUROCHEM, V99, P900, DOI 10.1111/j.1471-4159.2006.04131.x; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kelley KW, 2018, NAT NEUROSCI, V21, P1171, DOI 10.1038/s41593-018-0216-z; Kelley KW, 2018, NEURON, V98, P306, DOI 10.1016/j.neuron.2018.03.010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Koh S., 2019, BIORXIV, DOI [10.1101/866590, DOI 10.1101/866590]; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Li MS, 2017, P NATL ACAD SCI USA, V114, pE396, DOI 10.1073/pnas.1612930114; Liddelow SA, 2020, TRENDS IMMUNOL, V41, P820, DOI 10.1016/j.it.2020.07.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Liu WT, 2020, NEUROBIOL DIS, V141, DOI 10.1016/j.nbd.2020.104877; Lu TY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14355; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Masliah E, 2000, EXP NEUROL, V163, P381, DOI 10.1006/exnr.2000.7386; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mattei D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217944; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mayo L, 2016, BRAIN, V139, P1939, DOI 10.1093/brain/aww113; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; McQuade A, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0297-x; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MILSTED A, 1990, P NATL ACAD SCI USA, V87, P5720, DOI 10.1073/pnas.87.15.5720; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Molumby MJ, 2017, CELL REP, V18, P2702, DOI 10.1016/j.celrep.2017.02.060; Munji RN, 2019, NAT NEUROSCI, V22, P1892, DOI 10.1038/s41593-019-0497-x; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Profaci CP, 2020, J EXP MED, V217, DOI 10.1084/jem.20190062; Punal VM, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000492; Qian K, 2017, STEM CELL REP, V8, P843, DOI 10.1016/j.stemcr.2017.03.003; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Reeves BC, 2020, TRENDS MOL MED, V26, P285, DOI 10.1016/j.molmed.2019.11.008; Reichenbach N, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809665; Rojas F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00024; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Sheng LH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba9869; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Sigal YM, 2019, P NATL ACAD SCI USA, V116, P7071, DOI 10.1073/pnas.1817222116; Singh SK, 2016, CELL, V164, P183, DOI 10.1016/j.cell.2015.11.034; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sterling JK, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108271; Stogsdill JA, 2017, NATURE, V551, P192, DOI 10.1038/nature24638; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113; TCW Julia., 2019, SSRN ELECT J, DOI [10.2139/ssrn.3435267, DOI 10.2139/SSRN.3435267]; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tonnesen J, 2018, CELL, V172, P1108, DOI 10.1016/j.cell.2018.02.007; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Tyler CM, 2012, NEURON, V74, P597, DOI 10.1016/j.neuron.2012.05.002; Vainchtein ID, 2020, TRENDS NEUROSCI, V43, P144, DOI 10.1016/j.tins.2020.01.003; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Van Deijk ALF, 2017, GLIA, V65, P670, DOI 10.1002/glia.23120; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wheeler MA, 2019, CELL, V176, P581, DOI 10.1016/j.cell.2018.12.012; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yao MJ, 2020, CELL, V180, P502, DOI 10.1016/j.cell.2019.12.024; Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zamboni M, 2020, CELL STEM CELL, V27, P605, DOI 10.1016/j.stem.2020.07.006; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhou HB, 2020, CELL, V181, P590, DOI 10.1016/j.cell.2020.03.024	167	39	40	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					211	224		10.1016/j.immuni.2021.01.013	http://dx.doi.org/10.1016/j.immuni.2021.01.013		FEB 2021	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567261	Bronze			2022-12-18	WOS:000627407700007
J	Kim, JS; Kolesnikov, M; Peled-Hajaj, S; Scheyltjens, I; Xia, Y; Trzebanski, S; Haimon, Z; Shemer, A; Lubart, A; Van Hove, H; Chappell-Maor, L; Boura-Halfon, S; Movahedi, K; Blinder, P; Jung, S				Kim, Jung-Seok; Kolesnikov, Masha; Peled-Hajaj, Shany; Scheyltjens, Isabelle; Xia, Yuan; Trzebanski, Sebastien; Haimon, Zhana; Shemer, Anat; Lubart, Alisa; Van Hove, Hannah; Chappell-Maor, Louise; Boura-Halfon, Sigalit; Movahedi, Kiavash; Blinder, Pablo; Jung, Steffen			A Binary Cre Transgenic Approach Dissects Microglia and CNS Border-Associated Macrophages	IMMUNITY			English	Article							EXPRESSION PROFILES; TISSUE MACROPHAGES; GENE-EXPRESSION; CELL; RNA; RECOMBINASE; MONOCYTES; BARRIER; HEALTH; FATE	The developmental and molecular heterogeneity of tissue macrophages is unravelling, as are theft diverse contributions to physiology and pathophysiology. Moreover, also given tissues harbor macrophages in discrete anatomic locations. Functional contributions of specific cell populations can in mice be dissected using Cre recombinase-mediated mutagenesis. However, single promoter-based Cre models show limited specificity for cell types. Focusing on macrophages in the brain, we establish here a binary transgenic system involving complementation-competent NCre and CCre fragments whose expression is driven by distinct promoters: Sall1(ncre): Cx3cr1(ccre) mice specifically target parenchymal microglia and compound transgenic Lyve1(ccre): Cx3cr1(ccre) animals target vasculature-associated macrophages, in the brain, as well as other tissues. We imaged the respective cell populations and retrieved their specific translatomes using the RiboTag in order to define them and analyze their differential responses to a challenge. Collectively, we establish the value of binary transgenesis to dissect tissue macrophage compartments and their functions.	[Kim, Jung-Seok; Kolesnikov, Masha; Xia, Yuan; Trzebanski, Sebastien; Haimon, Zhana; Shemer, Anat; Chappell-Maor, Louise; Boura-Halfon, Sigalit; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Peled-Hajaj, Shany; Lubart, Alisa; Blinder, Pablo] Tel Aviv Univ, George S Wise Fac Life Sci, Sagol Sch Neurosci, Tel Aviv, Israel; [Blinder, Pablo] Tel Aviv Univ, George S Wise Fac Life Sci, Neurobiol Biochem & Biophys Sch, Tel Aviv, Israel; [Scheyltjens, Isabelle; Van Hove, Hannah; Movahedi, Kiavash] VIB Ctr Inflammat Res, Myeloid Cell Immunol Lab, Brussels, Belgium; [Scheyltjens, Isabelle; Van Hove, Hannah; Movahedi, Kiavash] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium	Weizmann Institute of Science; Tel Aviv University; Tel Aviv University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Blinder, Pablo/GQI-2237-2022; Movahedi, Kiavash/AAQ-4942-2020; Jung, Steffen/K-1409-2012	Movahedi, Kiavash/0000-0002-0826-4399; Jung, Steffen/0000-0003-4290-5716; Scheyltjens, Isabelle/0000-0002-2260-2921; Trzebanski, Sebastien/0000-0002-0647-6814; Van Hove, Hannah/0000-0002-0412-6474; Kim, Jung-Seok/0000-0003-0284-1658	Israel Science Foundation [887/11]; European Research Council [Adv ERC 340345]; International Progressive MS Alliance (PMSA); Minerva Foundation; Deutsche Forschungsgemeinschaft (DFG) [CRC/TRR167]; American Brain Foundation; Blythe Brenden-Mann Foundation; Estate of David Levinson; Innoviris [Attract BB2B 2015-2]; FWO fellowships; Roland N. Karlen Foundation	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); International Progressive MS Alliance (PMSA); Minerva Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); American Brain Foundation; Blythe Brenden-Mann Foundation; Estate of David Levinson; Innoviris(Innoviris); FWO fellowships(FWO); Roland N. Karlen Foundation	We would like to thank all members of the Jung Laboratory, as well as the staff of the Weizmann Animal facility, the FACS facility, and the Weizmann Veterinary Services for expert technical help. We thank J. Hirrlinger and F. Kirchhoff for sharing split Cre reagents. A special thanks goes to S. Ben-Dor and R. Haffner for help with the CRISPR/Cas9 design and generation of the transgenic animals. S. Jung is the Incumbent of the Henry. H. Drake Professional Chair of Immunology. The Jung laboratory was supported by the Israel Science Foundation (887/11), the European Research Council (Adv ERC 340345), a collaborative network grant of the International Progressive MS Alliance (PMSA), the Minerva Foundation, the Deutsche Forschungsgemeinschaft (DFG) (CRC/TRR167 'NeuroMac'), the American Brain Foundation, the Roland N. Karlen Foundation, the Blythe Brenden-Mann Foundation, and the Estate of David Levinson. K. Movahedi was supported by Innoviris (Attract BB2B 2015-2), I. Scheyltjens and H. Van Hove are supported by FWO fellowships.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chappell-Maor L, 2020, EUR J IMMUNOL, V50, P353, DOI 10.1002/eji.201948342; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Coureuil M, 2017, NAT REV MICROBIOL, V15, P149, DOI 10.1038/nrmicro.2016.178; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Foulquier S, 2020, HYPERTENS RES, V43, P148, DOI 10.1038/s41440-019-0359-7; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; Hermann M, 2014, NUCLEIC ACIDS RES, V42, P3894, DOI 10.1093/nar/gkt1361; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008354; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaiser T, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0448-18.2019; Kohen R, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2728-2; Kolter J, 2019, IMMUNITY, V50, P1482, DOI 10.1016/j.immuni.2019.05.009; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lim HY, 2018, IMMUNITY, V49, P1191, DOI 10.1016/j.immuni.2018.12.009; Lun Aaron T L, 2016, F1000Res, V5, P2122; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masuda T, 2020, NAT IMMUNOL, V21, P802, DOI 10.1038/s41590-020-0707-4; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; McDonough A, 2020, GLIA, V68, P76, DOI 10.1002/glia.23701; McKinsey GL, 2020, ELIFE, V9, DOI 10.7554/eLife.54590; Miron VE, 2020, TRENDS IMMUNOL, V41, P785, DOI 10.1016/j.it.2020.07.002; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Nayak Debasis, 2012, Intravital, V1, P95, DOI 10.4161/intv.22823; Nishida-Fukuda H, 2016, J BIOL CHEM, V291, P10490, DOI 10.1074/jbc.M115.683201; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rua R, 2018, TRENDS MOL MED, V24, P542, DOI 10.1016/j.molmed.2018.04.003; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Shemer A, 2020, IMMUNITY, V53, P1033, DOI 10.1016/j.immuni.2020.09.018; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tebaldi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-220; Tonon S, 2019, EUR J IMMUNOL, V49, P1213, DOI 10.1002/eji.201848025; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Utz SG, 2020, CELL, V181, P557, DOI 10.1016/j.cell.2020.03.021; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Verbeek E, 2012, EUR J HUM GENET, V20, P844, DOI 10.1038/ejhg.2012.20; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Willis CL, 2007, NEUROSCIENCE, V150, P498, DOI 10.1016/j.neuroscience.2007.09.023; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Ydens E, 2020, NAT NEUROSCI, V23, P676, DOI 10.1038/s41593-020-0618-6; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	77	39	39	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					176	+		10.1016/j.immuni.2020.11.007	http://dx.doi.org/10.1016/j.immuni.2020.11.007		JAN 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33333014	Bronze			2022-12-18	WOS:000607814000018
J	Wang, LT; Pereira, LS; Flores-Garcia, Y; O'Connor, J; Flynn, BJ; Schon, A; Hurlburt, NK; Dillon, M; Yang, ASP; Fabra-Garcia, A; Idris, AH; Mayer, BT; Gerber, MW; Gottardo, R; Mason, RD; Cavett, N; Ballard, RB; Kisalu, NK; Molina-Cruz, A; Nelson, J; Vistein, R; Barillas-Mury, C; Amino, R; Baker, D; King, NP; Sauerwein, RW; Pancera, M; Cockburn, IA; Zavala, F; Francica, JR; Seder, RA				Wang, Lawrence T.; Pereira, Lais S.; Flores-Garcia, Yevel; O'Connor, James; Flynn, Barbara J.; Schon, Arne; Hurlburt, Nicholas K.; Dillon, Marlon; Yang, Annie S. P.; Fabra-Garcia, Amanda; Idris, Azza H.; Mayer, Bryan T.; Gerber, Monica W.; Gottardo, Raphael; Mason, Rosemarie D.; Cavett, Nicole; Ballard, Reid B.; Kisalu, Neville K.; Molina-Cruz, Alvaro; Nelson, Jorgen; Vistein, Rachel; Barillas-Mury, Carolina; Amino, Rogerio; Baker, David; King, Neil P.; Sauerwein, Robert W.; Pancera, Marie; Cockburn, Ian A.; Zavala, Fidel; Francica, Joseph R.; Seder, Robert A.			A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver	IMMUNITY			English	Article							HOST-CELL TRAVERSAL; PLASMODIUM-FALCIPARUM; MALARIA PARASITE; INFECTION; PROTECTION; MIGRATION; EFFICACY; BINDING; BERGHEI; MOTIFS	Discovering potent human monoclonal antibodies (mAbs) targeting the Plasmodium falciparum circumsporozoite protein (PfCSP) on sporozoites (SPZ) and elucidating their mechanisms of neutralization will facilitate translation for passive prophylaxis and aid next-generation vaccine development. Here, we isolated a neutralizing human mAb, L9 that preferentially bound NVDP minor repeats of PfCSP with high affinity while cross-reacting with NANP major repeats. L9 was more potent than six published neutralizing human PfCSP mAbs at mediating protection against mosquito bite challenge in mice. Isothermal titration calorimetry and multiphoton microscopy showed that L9 and the other most protective mAbs bound PfCSP with two binding events and mediated protection by killing SPZ in the liver and by preventing their egress from sinusoids and traversal of hepatocytes. This study defines the subdominant PfCSP minor repeats as neutralizing epitopes, identifies an in vitro biophysical correlate of SPZ neutralization, and demonstrates that the liver is an important site for antibodies to prevent malaria.	[Wang, Lawrence T.; Pereira, Lais S.; Flynn, Barbara J.; Dillon, Marlon; Idris, Azza H.; Mason, Rosemarie D.; Cavett, Nicole; Ballard, Reid B.; Kisalu, Neville K.; Vistein, Rachel; Francica, Joseph R.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Flores-Garcia, Yevel; Zavala, Fidel] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [O'Connor, James; Cockburn, Ian A.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 0200, Australia; [O'Connor, James] Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia; [Schon, Arne] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21205 USA; [Hurlburt, Nicholas K.; Mayer, Bryan T.; Gerber, Monica W.; Gottardo, Raphael; Pancera, Marie] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Yang, Annie S. P.; Fabra-Garcia, Amanda; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Molina-Cruz, Alvaro; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Nelson, Jorgen; Baker, David; King, Neil P.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Nelson, Jorgen; Baker, David; King, Neil P.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Amino, Rogerio] Inst Pasteur, Unit Malaria Infect & Immun, 25-28 Rue Dr Roux, F-75015 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Australian National University; John Curtin School of Medical Research; Australian National University; Johns Hopkins University; Fred Hutchinson Cancer Center; Radboud University Nijmegen; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	rseder@mail.nih.gov	O'Connor, James/ABC-6060-2021; Gottardo, Raphael/HCH-3169-2022	O'Connor, James/0000-0002-4857-8114; Gottardo, Raphael/0000-0002-3867-0232; Cockburn, Ian/0000-0001-8220-9294; Hurlburt, Nicholas/0000-0001-9891-916X; Gerber, Monica/0000-0001-9878-9166; Nelson, Jorgen/0000-0002-0202-2460	National Institute of Allergy and Infectious Diseases; National Cancer Institute [HHSN261200800001E]; Dutch Research Council (NWO) talent program veni [VI.Veni.192.171]; Bill & Melinda Gates Foundation [OPP1156262]; Bloomberg Philanthropies	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dutch Research Council (NWO) talent program veni; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bloomberg Philanthropies	We thank B. Kim Lee Sim and Stephen L. Hoffman (Sanaria, Inc.) for providing the PfSPZ Vaccine, Youri van Waardenburg and Geert-Jan van Gemert for generating PfSPZ-infected mosquitoes and processing FRG-huHep mice samples, and DavidAmbrozak (Vaccine Research Center) for assistance with sorting memory B cells. Thisworkwas supported by the National Institute of Allergy and Infectious Diseases, the National Cancer Institute (HHSN261200800001E to A.S.), the Dutch Research Council (NWO) talent program veni (VI.Veni.192.171 to A.S.P.Y.), the Bill & Melinda Gates Foundation for N.K.H and M.P. (OPP1156262) and Y.F.-G. and F.Z., who also thank the Bloomberg Philanthropies for continued support.	Alcoser SY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-124; Aliprandini E, 2018, NAT MICROBIOL, V3, P1224, DOI 10.1038/s41564-018-0254-z; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chevalier A, 2017, NATURE, V550, P74, DOI 10.1038/nature23912; Cockburn IA, 2018, NAT IMMUNOL, V19, P1199, DOI 10.1038/s41590-018-0228-6; Delemarre-van de Waal H A, 1981, Ned Tijdschr Geneeskd, V125, P375; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P7828, DOI 10.1021/bi00486a008; Espinosa DA, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0011-y; Espinosa DA, 2015, J INFECT DIS, V212, P1111, DOI 10.1093/infdis/jiv154; Flores-Garcia Y, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3055-9; Flores-Garcia Y, 2018, MBIO, V9, DOI [10.1128/mBio.02194-18, 10.1128/mbio.02194-18]; Foquet L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00524; Foquet L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-430; Frischknecht F., 2017, COLD SPRING HARB PER, V7; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Hester J., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, J STAT SOFTW, V28, P1; Imkeller K, 2018, SCIENCE, V360, P1358, DOI 10.1126/science.aar5304; Julien JP, 2019, NAT REV IMMUNOL, V19, P761, DOI 10.1038/s41577-019-0209-5; Kennedy M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-421; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Kosmidis I, 2009, BIOMETRIKA, V96, P793, DOI 10.1093/biomet/asp055; Krettli AU, 2001, CURR BIOL, V11, pR409, DOI 10.1016/S0960-9822(01)00221-4; Liang Q., 2020, PLOS PATHOG, V16; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; McCall MBB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2490; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Murugan R, 2020, NAT MED, V26, P1135, DOI 10.1038/s41591-020-0881-9; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Oyen D, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008373; Oyen D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8529; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; R Core Team, 2018, R LANG ENV STAT COMP, P10, DOI [DOI 10.1038/SJ.HDY.6800737, 10.1108/eb003648]; Raghunandan R, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03181-0; Rodriguez-Galan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17274-5; Sallberg M, 2002, INTERVIROLOGY, V45, P350, DOI 10.1159/000067928; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Scally SW, 2018, IMMUNITY, V48, P851, DOI 10.1016/j.immuni.2018.04.037; Scally SW, 2018, J EXP MED, V215, P63, DOI 10.1084/jem.20170869; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tavares J, 2013, J EXP MED, V210, P905, DOI 10.1084/jem.20121130; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; VANDERBERG J, 1969, MIL MED, V134, P1183; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; VERHAVE JP, 1988, PARASITE IMMUNOL, V10, P17, DOI 10.1111/j.1365-3024.1988.tb00200.x; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; White MT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0117-2; WHO, 2018, WORLD MAL REP 2018; Wilke CO., 2020, COWPLOT STREAMLINED; Yang ASP, 2017, CELL REP, V18, P3105, DOI 10.1016/j.celrep.2017.03.017; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947	63	39	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					733	+		10.1016/j.immuni.2020.08.014	http://dx.doi.org/10.1016/j.immuni.2020.08.014			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	32946741	Bronze, Green Accepted			2022-12-18	WOS:000581062800008
J	Yu, SY; Balasubramanian, I; Laubitz, D; Tong, K; Bandyopadhyay, S; Lin, X; Flores, J; Singh, R; Liu, Y; Macazana, C; Zhao, YL; Beguet-Crespel, F; Patil, K; Midura-Kiela, MT; Wang, D; Yap, GS; Ferraris, RP; Wei, Z; Bonder, EM; Haggblom, MM; Zhang, LJ; Douard, V; Verzi, MP; Cadwell, K; Kiela, PR; Gao, N				Yu, Shiyan; Balasubramanian, Iyshwarya; Laubitz, Daniel; Tong, Kevin; Bandyopadhyay, Sheila; Lin, Xiang; Flores, Juan; Singh, Rajbir; Liu, Yue; Macazana, Carlos; Zhao, Yanlin; Beguet-Crespel, Fabienne; Patil, Karuna; Midura-Kiela, Monica T.; Wang, Daniel; Yap, George S.; Ferraris, Ronaldo P.; Wei, Zhi; Bonder, Edward M.; Haggblom, Max M.; Zhang, Lanjing; Douard, Veronique; Verzi, Michael P.; Cadwell, Ken; Kiela, Pawel R.; Gao, Nan			Paneth Cell-Derived Lysozyme Defines the Composition of Mucolytic Microbiota and the Inflammatory Tone of the Intestine	IMMUNITY			English	Article							EGG-WHITE LYSOZYME; TYPE-2 IMMUNITY; TUFT CELLS; ULCERATIVE-COLITIS; MOUSE; EXPRESSION; BACTERIA; IL-4; AUTOPHAGY; RESPONSES	Paneth cells are the primary source of C-type lysozyme, a beta-1,4-N-acetylmuramoylhydrolase that enzymatically processes bacterial cell walls. Paneth cells are normally present in human cecum and ascending colon, but are rarely found in descending colon and rectum; Paneth cell metaplasia in this region and aberrant lysozyme production are hallmarks of inflammatory bowel disease (IBD) pathology. Here, we examined the impact of aberrant lysozyme production in colonic inflammation. Targeted disruption of Paneth cell lysozyme (Lyz1) protected mice from experimental colitis. Lyz1-deficiency diminished intestinal immune responses to bacterial molecular patterns and resulted in the expansion of lysozyme-sensitive mucolytic bacteria, including Ruminococcus gnavus, a Crohn's disease-associated pathobiont. Ectopic lysozyme production in colonic epithelium suppressed lysozyme-sensitive bacteria and exacerbated colitis. Transfer of R. gnavus into Lyz1(-/-) hosts elicited a type 2 immune response, causing epithelial reprograming and enhanced anti-colitogenic capacity. In contrast, in lysozyme-intact hosts, processed R. gnavus drove pro-inflammatory responses. Thus, Paneth cell lysozyme balances intestinal anti- and pro-inflammatory responses, with implications for IBD.	[Yu, Shiyan; Balasubramanian, Iyshwarya; Bandyopadhyay, Sheila; Flores, Juan; Singh, Rajbir; Liu, Yue; Macazana, Carlos; Wang, Daniel; Bonder, Edward M.; Zhang, Lanjing; Gao, Nan] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07103 USA; [Laubitz, Daniel; Patil, Karuna; Midura-Kiela, Monica T.; Kiela, Pawel R.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Tong, Kevin; Verzi, Michael P.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Lin, Xiang; Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Zhao, Yanlin; Yap, George S.] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ USA; [Beguet-Crespel, Fabienne; Douard, Veronique] Univ Paris Saclay, Micalis Inst, Inst Natl Rech Agronom INRA, AgroParisTech, Jouy En Josas, France; [Ferraris, Ronaldo P.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Haggblom, Max M.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ USA; [Zhang, Lanjing] Med Ctr Princeton, Dept Pathol, Plainsboro, NJ USA; [Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Cadwell, Ken] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Kiela, Pawel R.] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Gao, Nan] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University of Arizona; Rutgers State University New Brunswick; New Jersey Institute of Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; New York University; New York University; University of Arizona; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Gao, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07103 USA.; Gao, N (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	ngao@newark.rutgers.edu	Haggblom, Max M/E-7597-2010; Zhang, Lanjing/GZB-0260-2022; Zhang, Lanjing/AGY-7838-2022	Haggblom, Max M/0000-0001-6307-7863; Zhang, Lanjing/0000-0001-5436-887X; Cadwell, Ken/0000-0002-5860-0661; Wang, Daniel/0000-0003-4825-4547; singh, RAJBIR/0000-0002-2307-2360; Laubitz, Daniel/0000-0002-7482-8500; Bandyopadhyay, Sheila/0000-0002-1827-9324; Kiela, Pawel/0000-0002-0014-3517	NIH [R01CA190558, R01AI134040, F31 DK121428, 5R01DK109711, DK102934, DK119198, AT010243, CA178599]; NSF/BIO/IDBR [1353890, 1952823]; ACS Scholar Award [RSG-15-060-01-TBE]; Rutgers IMRT award; Rutgers Chancellor's SEED grant; PANDA Endowment in Autoimmune Diseases; NSF [IOS-1456673, IOS-1754783]; NJCCR fellowship [DCHS19PPC038]; CCFA Career Development Award [406794]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF/BIO/IDBR; ACS Scholar Award; Rutgers IMRT award; Rutgers Chancellor's SEED grant; PANDA Endowment in Autoimmune Diseases; NSF(National Science Foundation (NSF)); NJCCR fellowship; CCFA Career Development Award	The authors are indebted to Ivaylo I. Ivanov (Columbia University) and Mi-Na Kweon (University of Ulsan College of Medicine) for helpful discussion. We thank Peter Romanienko and Ghassan Yehia (Rutgers Cancer Institute of New Jersey Genome Editing Shared Resource P30CA072720-5922) for deriving Lyz1<SUP>-/-</SUP> and Villin-Lyz1 mice, Luke Fritzk (Digital Imaging and Histology Core) for histology, Sukhwinder Singh and Tammy Mui-Galenkamp (Flow Cytometry and Immunology Core) for FACS analysis, Seema Husain (The Genomics Center) for scRNA sequencing, and the excellent technical support from PrimBio Research Institute (Exton, PA). This work was supported by NIH (DK102934, DK119198, AT010243, and CA178599), NSF/BIO/IDBR (1353890 and 1952823), ACS Scholar Award (RSG-15-060-01-TBE), Rutgers IMRT award (to N.G.); Rutgers Chancellor's SEED grant (to E.M.B.); NIH (R01CA190558 to M.P.V., R01AI134040 to G.S.Y., F31 DK121428 to S.B., and 5R01DK109711 to P.R.K.); PANDA Endowment in Autoimmune Diseases (to P.R.K.); NSF (IOS-1456673 and IOS-1754783 to R.P.F.); NJCCR fellowship (DCHS19PPC038 to J.F.); and a CCFA Career Development Award (406794 to S.Y.).	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; [Anonymous], 2016, HYDROBIOLOGIA, DOI DOI 10.1007/s10750-015-2543-3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramanian I, 2017, AM J PHYSIOL-GASTR L, V313, pG7, DOI 10.1152/ajpgi.00330.2016; Bel S, 2017, SCIENCE, V357, P1047, DOI 10.1126/science.aal4677; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; BROOK I, 1989, REV INFECT DIS, V11, P361; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; CANFIELD RE, 1965, J BIOL CHEM, V240, P1997; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Chen FD, 2018, J IMMUNOL, V201, P2492, DOI 10.4049/jimmunol.1800003; Chua HH, 2018, GASTROENTEROLOGY, V154, P154, DOI 10.1053/j.gastro.2017.09.006; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Di Ruscio M, 2018, INFLAMM BOWEL DIS, V24, P78, DOI 10.1093/ibd/izx011; Doran E, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00139; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Ericsson AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21986-7; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Ganz T, 2003, BLOOD, V101, P2388, DOI 10.1182/blood-2002-07-2319; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Girnius S, 2012, AMYLOID, V19, P182, DOI 10.3109/13506129.2012.723074; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Hadley W., 2016, GGPLOT2 ELEGRANT GRA, V2; Hall AB, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0490-5; Harrison CA, 2018, MUCOSAL IMMUNOL, V11, P1329, DOI 10.1038/s41385-018-0035-2; Herbert DR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092276; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huaux F, 2003, J IMMUNOL, V170, P2083, DOI 10.4049/jimmunol.170.4.2083; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Ibrahim HR, 1998, NAHRUNG, V42, P187, DOI 10.1002/(SICI)1521-3803(199808)42:03/04<187::AID-FOOD187>3.3.CO;2-6; Ibrahim HR, 2001, FEBS LETT, V506, P27, DOI 10.1016/S0014-5793(01)02872-1; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; Jean E, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-159; Jia ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137782; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabata H, 2018, IMMUNOL REV, V286, P37, DOI 10.1111/imr.12706; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Katz JP, 2002, DEVELOPMENT, V129, P2619; KLASS HJ, 1978, GUT, V19, P233, DOI 10.1136/gut.19.3.233; Kurakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126226; LAIBLE NJ, 1985, INFECT IMMUN, V48, P720, DOI 10.1128/IAI.48.3.720-728.1985; Laurent Paoline, 2017, Front Immunol, V8, P454, DOI 10.3389/fimmu.2017.00454; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Liu TC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91917; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; Markart P, 2004, AM J RESP CRIT CARE, V169, P454, DOI 10.1164/rccm.200305-669OC; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; MEYER K, 1947, P SOC EXP BIOL MED, V65, P221, DOI 10.3181/00379727-65-15917P; MEYER K, 1948, AM J MED, V5, P496, DOI 10.1016/0002-9343(48)90100-4; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Proust B, 2003, CLIN EXP ALLERGY, V33, P119, DOI 10.1046/j.1365-2222.2003.01560.x; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rael EL, 2011, WORLD ALLERGY ORGAN, V4, P54, DOI 10.1097/WOX.0b013e31821188e0; Ragland SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006512; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Randall L, 2010, J MED MICROBIOL, V59, P172, DOI 10.1099/jmm.0.014415-0; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Singh R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00280; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Stahl M, 2018, AM J PHYSIOL-GASTR L, V315, pG195, DOI 10.1152/ajpgi.00264.2017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tailford LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8624; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Tan CM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.49; Tanaka M, 2001, J GASTROEN HEPATOL, V16, P1353, DOI 10.1046/j.1440-1746.2001.02629.x; VanDussen KL, 2014, GASTROENTEROLOGY, V146, P200, DOI 10.1053/j.gastro.2013.09.048; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yu SY, 2018, CELL STEM CELL, V23, P46, DOI 10.1016/j.stem.2018.05.002; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhang Q, 2015, NAT IMMUNOL, V16, P918, DOI 10.1038/ni.3233	101	39	40	4	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					398	+		10.1016/j.immuni.2020.07.010	http://dx.doi.org/10.1016/j.immuni.2020.07.010			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814028	Green Accepted, Bronze			2022-12-18	WOS:000561190600017
J	Lou, FZ; Sun, Y; Xu, ZY; Niu, LM; Wang, ZK; Deng, SY; Liu, ZY; Zhou, H; Bai, J; Yin, QQ; Cai, XJ; Sun, LB; Wang, H; Li, Q; Wu, ZW; Chen, X; Gu, J; Shi, YL; Tao, WF; Ginhoux, F; Wang, HL				Lou, Fangzhou; Sun, Yang; Xu, Zhenyao; Niu, Liman; Wang, Zhikai; Deng, Siyu; Liu, Zhaoyuan; Zhou, Hong; Bai, Jing; Yin, Qianqian; Cai, Xiaojie; Sun, Libo; Wang, Hong; Li, Qun; Wu, Zhouwei; Chen, Xiang; Gu, Jun; Shi, Yu-Ling; Tao, Wufan; Ginhoux, Florent; Wang, Honglin			Excessive Polyamine Generation in Keratinocytes Promotes Self-RNA Sensing by Dendritic Cells in Psoriasis	IMMUNITY			English	Article							GENE-EXPRESSION; C/EBP-BETA; ARGINASE-1 OVEREXPRESSION; NITRIC-OXIDE; RECOGNITION; INDUCTION; COMPLEXES; TOPHAT; TLR7	Psoriasis is a chronic inflammatory disease whose etiology is multifactorial. The contributions of cellular metabolism to psoriasis are unclear. Here, we report that interleukin-17 (IL-17) downregulated Protein Phosphatase 6 (PP6) in psoriatic keratinocytes, causing phosphorylation and activation of the transcription factor C/EBP-beta and subsequent generation of arginase-1. Mice lacking Pp6 in keratinocytes were predisposed to psoriasis-like skin inflammation. Accumulation of arginase-1 in Pp6-deficient keratinocytes drove polyamine production from the urea cycle. Polyamines protected self-RNA released by psoriatic keratinocytes from degradation and facilitated the endocytosis of self-RNA by myeloid dendritic cells to promote toll-like receptor-7 (TLR7)-dependent RNA sensing and IL-6 production. An arginase inhibitor improved skin inflammation in murine and non-human primate models of psoriasis. Our findings suggest that urea cycle hyperreactivity and excessive polyamine generation in psoriatic keratinocytes promote self-RNA sensation and PP6 deregulation in keratinocytes is a pivotal event that amplifies the inflammatory circuits in psoriasis.	[Lou, Fangzhou; Sun, Yang; Xu, Zhenyao; Niu, Liman; Wang, Zhikai; Deng, Siyu; Liu, Zhaoyuan; Zhou, Hong; Bai, Jing; Yin, Qianqian; Cai, Xiaojie; Sun, Libo; Wang, Hong; Ginhoux, Florent; Wang, Honglin] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Translat Med Ctr,Chinese Minist Educ, Shanghai Inst Immunol,Sch Med,Key Lab Cell Differ, Shanghai 200025, Peoples R China; [Li, Qun] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hypertens, Sch Med, Shanghai 200020, Peoples R China; [Wu, Zhouwei] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Dermatol, Sch Med, Shanghai 200080, Peoples R China; [Chen, Xiang] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha 410008, Peoples R China; [Gu, Jun; Shi, Yu-Ling] Tongji Univ, Shanghai Peoples Hosp 10, Inst Psoriasis, Dept Dermatol,Sch Med, Shanghai 200072, Peoples R China; [Tao, Wufan] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Tao, Wufan] Fudan Univ, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Central South University; Tongji University; Fudan University; Fudan University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Ginhoux, F; Wang, HL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Translat Med Ctr,Chinese Minist Educ, Shanghai Inst Immunol,Sch Med,Key Lab Cell Differ, Shanghai 200025, Peoples R China.; Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.	florent_ginhoux@immunol.a-star.edu.sg; honglin.wang@sjtu.edu.cn	WANG, Honglin/AAJ-2708-2020; SUN, Libo/G-7016-2019	WANG, Honglin/0000-0001-6302-6927; SUN, Libo/0000-0002-3805-5870; Lou, Fangzhou/0000-0002-7127-1743; Cai, Xiaojie/0000-0001-7297-4865	National Natural Science Foundation of China [81725018, 81930088, 81703118, 81803123]; Shanghai Collaborative Innovation Center for Translational Medicine [TM201925]; Innovative Research Team of High-Level Local Universities in Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Collaborative Innovation Center for Translational Medicine; Innovative Research Team of High-Level Local Universities in Shanghai	The authors would like to thank Ms. C. Gao, Ms. M. Zhang, Ms. L. Ding, and Dr. L. Chen (Sequencing Core of Shanghai Institute of Immunology) for single-cell cDNA library generation; Dr. L. Xia and Dr. L. Meng (Proteomics Core of College of Basic Medical Sciences, SJTU-SM) for protein LC-MS analyses; Dr. D. Han, Dr. J. Fang, and Dr. M. Liu (Metabolomics Core of College of Basic Medical Sciences, SJTU-SM) for metabolite quantitation analyses; and Insight Editing London for proofreading the manuscript prior to publication. This work is supported by grants from the National Natural Science Foundation of China (81725018, 81930088, 81703118, and 81803123) and Shanghai Collaborative Innovation Center for Translational Medicine (TM201925), Innovative Research Team of High-Level Local Universities in Shanghai.	Abeyakirthi S, 2010, BRIT J DERMATOL, V163, P193, DOI 10.1111/j.1365-2133.2010.09766.x; Arakawa A, 2015, J EXP MED, V212, P2203, DOI 10.1084/jem.20151093; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Bruch-Gerharz D, 2003, AM J PATHOL, V162, P203, DOI 10.1016/S0002-9440(10)63811-4; Celhar T, 2015, P NATL ACAD SCI USA, V112, pE6195, DOI 10.1073/pnas.1507052112; Cheung KL, 2016, J EXP MED, V213, P2399, DOI 10.1084/jem.20160258; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Guarneri C, 2018, J DTSCH DERMATOL GES, V16, P1103, DOI 10.1111/ddg.13631; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Herbert D, 2018, J INVEST DERMATOL, V138, P1999, DOI 10.1016/j.jid.2018.03.1522; Jones DA, 2004, J INVEST DERMATOL, V123, P93, DOI 10.1111/j.0022-202X.2004.22709.x; Kamleh MA, 2015, J PROTEOME RES, V14, P557, DOI 10.1021/pr500782g; Kang H, 2017, BRIT J DERMATOL, V176, P713, DOI 10.1111/bjd.15008; Kovamees O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103260; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Leavesley HB, 2008, TOXICOL SCI, V101, P101, DOI 10.1093/toxsci/kfm254; Li H, 2016, AMINO ACIDS, V48, P2401, DOI 10.1007/s00726-016-2256-6; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mao Chun-Ming, 2003, Acta Genetica Sinica, V30, P407; Moon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103048; Mousavi A, 2005, APPL BIOCHEM BIOTECH, V120, P169, DOI 10.1385/ABAB:120:3:169; Nerlich A, 2015, BBA-GENE REGUL MECH, V1849, P966, DOI 10.1016/j.bbagrm.2015.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Rusin SF, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3138; Sarti P., 2012, INT J CELL BIOL, V2012; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schnorr O, 2005, FREE RADICAL BIO MED, V38, P1073, DOI 10.1016/j.freeradbiomed.2005.01.005; Schoenen H, 2014, J IMMUNOL, V193, P3664, DOI 10.4049/jimmunol.1301593; Sioud M, 2006, TRENDS MOL MED, V12, P167, DOI 10.1016/j.molmed.2006.02.004; Song XY, 2013, CYTOKINE, V62, P175, DOI 10.1016/j.cyto.2013.03.014; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Swindell WR, 2016, J INVEST DERMATOL, V136, P1820, DOI 10.1016/j.jid.2016.04.035; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wolf M, 2006, BIOORG MED CHEM LETT, V16, P3193, DOI 10.1016/j.bmcl.2006.03.046; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zavradashvili N, 2019, ACS OMEGA, V4, P2090, DOI 10.1021/acsomega.8b02977; Zhang ZZ, 2018, NAT MED, V24, P617, DOI 10.1038/s41591-018-0003-0	48	39	41	10	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					204	+		10.1016/j.immuni.2020.06.004	http://dx.doi.org/10.1016/j.immuni.2020.06.004			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32553276	Green Submitted, Bronze			2022-12-18	WOS:000551116800020
J	Nutt, SL; Chopin, M				Nutt, Stephen L.; Chopin, Michael			Transcriptional Networks Driving Dendritic Cell Differentiation and Function	IMMUNITY			English	Review							CD34(+) STEM-CELLS; CROSS-PRESENTATION; BONE-MARROW; GM-CSF; IN-VITRO; MONOCYTE DIFFERENTIATION; REGULATORY FACTOR-4; SUBSET DEVELOPMENT; SIGNALING CONTROLS; FACTOR E2-2	Dendritic cells (DCs) are the sentinels of the immune system, sensing a diverse array of pathogens to stimulate a robust and appropriate immune response. To initiate responses to highly disparate challenges, DCs have diversified into multiple phenotypically, anatomically, and functionally distinct cell types. As a result of the application of new single-cell technologies, the full extent of this diversity, as well as the developmental relationships of the DC lineages, is currently undergoing reassessment. Here, we review the cellular and molecular evidence that underpins current models of DC differentiation and functional diversification in the murine and human systems. We discuss these models in the context of the diversity revealed by single-cell studies and propose that understanding DC identity will require defining the regulatory interactions that control gene expression in these cells.	[Nutt, Stephen L.; Chopin, Michael] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Nutt, Stephen L.; Chopin, Michael] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne	Nutt, SL; Chopin, M (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Nutt, SL; Chopin, M (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	nutt@wehi.edu.au; chopin@wehi.edu.au	Nutt, Stephen/C-9256-2013	Nutt, Stephen/0000-0002-0020-6637	National Health and Medical Research Council of Australia [1155342]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Joanna Groom for critical comments on the manuscript. S.L.N. is supported by the National Health and Medical Research Council of Australia (1155342).	Alcantara-Hernandez M, 2017, IMMUNITY, V47, P1037, DOI 10.1016/j.immuni.2017.11.001; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Balan S, 2018, CELL REP, V24, P1902, DOI 10.1016/j.celrep.2018.07.033; Bao MS, 2016, J EXP MED, V213, P2383, DOI 10.1084/jem.20160438; Bennett RL, 2018, ANNU REV PHARMACOL, V58, P187, DOI 10.1146/annurev-pharmtox-010716-105106; Bigley V, 2019, SEMIN CELL DEV BIOL, V86, P50, DOI 10.1016/j.semcdb.2018.02.020; Bigley V, 2018, J ALLERGY CLIN IMMUN, V141, P2234, DOI 10.1016/j.jaci.2017.08.044; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bornstein C, 2014, MOL CELL, V56, P749, DOI 10.1016/j.molcel.2014.10.014; Boukhaled GM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01119; Breton G, 2016, J EXP MED, V213, P2861, DOI 10.1084/jem.20161135; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Cabeza-Cabrerizo M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw1941; Cancel JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00009; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chauvistre H, 2014, EUR J IMMUNOL, V44, P2478, DOI 10.1002/eji.201344150; Chopin M, 2019, IMMUNITY, V50, P77, DOI 10.1016/j.immuni.2018.11.010; Chopin M, 2016, CELL REP, V15, P866, DOI 10.1016/j.celrep.2016.03.066; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Clark GJ, 2019, SEMIN CELL DEV BIOL, V86, P3, DOI 10.1016/j.semcdb.2018.02.013; Coillard A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01907; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; Cytlak U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02977-8; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Durai V, 2018, J EXP MED, V215, P1417, DOI 10.1084/jem.20171784; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Durand M, 2019, J EXP MED, V216, P1561, DOI 10.1084/jem.20181994; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grajkowska LT, 2017, IMMUNITY, V46, P65, DOI 10.1016/j.immuni.2016.11.006; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hammerich L, 2019, NAT MED, V25, P814, DOI 10.1038/s41591-019-0410-x; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hossain MK, 2019, CANCERS, V11, DOI 10.3390/cancers11030418; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Ippolito GC, 2014, P NATL ACAD SCI USA, V111, pE998, DOI 10.1073/pnas.1319228111; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Keles S, 2014, J ALLERGY CLIN IMMUN, V133, P1753, DOI 10.1016/j.jaci.2014.03.032; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kirkling ME, 2018, CELL REP, V23, P3658, DOI 10.1016/j.celrep.2018.05.068; Kong XF, 2018, NAT IMMUNOL, V19, P973, DOI 10.1038/s41590-018-0178-z; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kurotaki D, 2019, BLOOD, V133, P1803, DOI 10.1182/blood-2018-06-857789; Kurotaki D, 2016, J INTERF CYTOK RES, V36, P433, DOI 10.1089/jir.2015.0138; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lau CM, 2018, J EXP MED, V215, P2265, DOI 10.1084/jem.20172323; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Leylek R, 2019, CELL REP, V29, P3736, DOI 10.1016/j.celrep.2019.11.042; Lin DS, 2018, CELL REP, V22, P2557, DOI 10.1016/j.celrep.2018.02.046; Lin Q, 2015, NUCLEIC ACIDS RES, V43, P9680, DOI 10.1093/nar/gkv1056; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Ma WJ, 2019, BMC MOL CELL BIOL, V20, DOI 10.1186/s12860-019-0199-y; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Maraskovsky E, 2000, BLOOD, V96, P878, DOI 10.1182/blood.V96.3.878.015k15_878_884; Mastio J, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007485; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Mittal D, 2017, CANCER IMMUNOL RES, V5, P1098, DOI 10.1158/2326-6066.CIR-17-0341; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nizzoli G, 2013, BLOOD, V122, P932, DOI 10.1182/blood-2013-04-495424; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; O'Brien LJ, 2019, CANCERS, V11, DOI 10.3390/cancers11060875; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Pacis A, 2019, P NATL ACAD SCI USA, V116, P6938, DOI 10.1073/pnas.1814700116; Pacis A, 2015, GENOME RES, V25, P1801, DOI 10.1101/gr.192005.115; Paul F, 2014, CURR OPIN IMMUNOL, V30, P1, DOI 10.1016/j.coi.2014.04.004; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Prandini A, 2016, BLOOD, V127, P3382, DOI 10.1182/blood-2015-06-650689; Proietto AI, 2012, CELL MOL IMMUNOL, V9, P446, DOI 10.1038/cmi.2012.48; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Sander J, 2017, IMMUNITY, V47, P1051, DOI 10.1016/j.immuni.2017.11.024; Sasaki I, 2012, BLOOD, V120, P4733, DOI 10.1182/blood-2012-06-436527; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Satpathy AT, 2014, BLOOD, V123, P2968, DOI 10.1182/blood-2013-11-539643; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Sawai CM, 2013, J EXP MED, V210, P2151, DOI 10.1084/jem.20130443; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Seillet C, 2013, BLOOD, V121, P1574, DOI 10.1182/blood-2012-07-445650; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Thomas GD, 2016, IMMUNITY, V45, P975, DOI 10.1016/j.immuni.2016.10.011; Tsapogas P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061115; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vento-Tormo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0863-2; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Welner RS, 2013, BLOOD, V121, P4073, DOI 10.1182/blood-2012-10-463448; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Willis SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01605-1; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114; Wu XD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064800, 10.1371/journal.pone.0071258]; Yasuda K, 2013, INT IMMUNOL, V25, P295, DOI 10.1093/intimm/dxs114; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhan YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep25060; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540; Zhang X, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-21	170	39	42	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					942	956		10.1016/j.immuni.2020.05.005	http://dx.doi.org/10.1016/j.immuni.2020.05.005			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553180	Bronze			2022-12-18	WOS:000541890000010
J	Fenton, TM; Jorgensen, PB; Niss, K; Rubin, SJS; Morbe, UM; Riis, LB; Da Silva, C; Plumb, A; Vandamme, J; Jakobsen, HL; Brunak, S; Habtezion, A; Nielsen, OH; Johansson-Lindbom, B; Agace, WW				Fenton, Thomas M.; Jorgensen, Peter B.; Niss, Kristoffer; Rubin, Samuel J. S.; Morbe, Urs M.; Riis, Lene B.; Da Silva, Clement; Plumb, Adam; Vandamme, Julien; Jakobsen, Henrik L.; Brunak, Soren; Habtezion, Aida; Nielsen, Ole H.; Johansson-Lindbom, Bengt; Agace, William W.			Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity	IMMUNITY			English	Article							IGA-PRODUCING CELLS; PEYERS-PATCHES; SMALL-INTESTINE; SWITCH RECOMBINATION; LAMINA PROPRIA; MUCOSAL; EXPRESSION; COLON; LYMPHOCYTES; MICROBIOTA	The intestine contains some of the most diverse and complex immune compartments in the body. Here we describe a method for isolating human gut-associated lymphoid tissues (GALTs) that allows unprecedented profiling of the adaptive immune system in submucosal and mucosal isolated lymphoid follicles (SM-ILFs and M-ILFs, respectively) as well as in GALT-free intestinal lamina propria (LP). SM-ILF and M-ILF showed distinct patterns of distribution along the length of the intestine, were linked to the systemic circulation through MAdCAM-1(+) high endothelial venules and efferent lymphatics, and had immune profiles consistent with immune-inductive sites. IgA sequencing analysis indicated that human ILFs are sites where intestinal adaptive immune responses are initiated in an anatomically restricted manner. Our findings position ILFs as key inductive hubs for regional immunity in the human intestine, and the methods presented will allow future assessment of these compartments in health and disease.	[Fenton, Thomas M.; Jorgensen, Peter B.; Vandamme, Julien; Agace, William W.] Tech Univ Denmark, Dept Hlth Technol, Mucosal Immunol Grp, DK-2800 Lyngby, Denmark; [Niss, Kristoffer; Brunak, Soren] Univ Copenhagen, Translat Dis Syst Biol, DK-2200 Copenhagen, Denmark; [Rubin, Samuel J. S.; Habtezion, Aida] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Med, Stanford, CA 94305 USA; [Morbe, Urs M.; Da Silva, Clement; Johansson-Lindbom, Bengt; Agace, William W.] Lund Univ, Immunol Sect, BMC D14, S-22184 Lund, Sweden; [Riis, Lene B.] Univ Copenhagen, Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Plumb, Adam; Johansson-Lindbom, Bengt] Tech Univ Denmark, Dept Hlth Technol, Immunol Memory Grp, DK-2800 Lyngby, Denmark; [Jakobsen, Henrik L.] Univ Copenhagen, Herlev Hosp, Surg Sect, Dept Gastroenterol, DK-2730 Herlev, Denmark; [Nielsen, Ole H.] Univ Copenhagen, Herlev Hosp, Med Sect, Dept Gastroenterol, DK-2730 Herlev, Denmark	Technical University of Denmark; University of Copenhagen; Stanford University; Lund University; University of Copenhagen; Herlev & Gentofte Hospital; Technical University of Denmark; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Fenton, TM; Agace, WW (corresponding author), Tech Univ Denmark, Dept Hlth Technol, Mucosal Immunol Grp, DK-2800 Lyngby, Denmark.; Agace, WW (corresponding author), Lund Univ, Immunol Sect, BMC D14, S-22184 Lund, Sweden.	thomas.m.fenton@gmail.com; wiag@dtu.dk	Mörbe, Urs/GPX-7383-2022; Jørgensen, Peter/AAJ-7092-2021; Nielsen, Ole Haagen/AAK-2482-2021; Mörbe, Urs Michael/AAM-2757-2020	Jørgensen, Peter/0000-0001-5262-0074; Nielsen, Ole Haagen/0000-0003-4612-8635; Mörbe, Urs Michael/0000-0001-8747-437X; Niss, Kristoffer/0000-0001-5910-1525; Agace, william/0000-0003-3823-5772; Fenton, Thomas/0000-0002-6200-6403; Da Silva, Clement/0000-0002-5587-7438; Rubin, Samuel/0000-0001-7335-3868	Stanford Human Immune Monitoring Center (NIH S10 Shared Instrumentation) [S10RR027431-01]; Swedish Research Council; Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation [NNF14CC0001]; Lundbeck Foundation [R155-2014-4184]; Swedish Research Council [2017-02072]; Swedish Cancerfonden [18 0598]; NIH [R01 DK101119]	Stanford Human Immune Monitoring Center (NIH S10 Shared Instrumentation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancerfonden; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all patients and collaborating staff at Herlev hospital, in particular the gastroenterology team (Department of Pathology), for help with providing tissue samples; the Core Facility for Integrated Microscopy (University of Copenhagen) for scanning electron microscopy; the Stanford Human Immune Monitoring Center (NIH S10 Shared Instrumentation Grant S10RR027431-01) for access to mass cytometers; and H. Maecker and S. Gupta for mass cytometry expertise. Sequencing was performed at the National Genomics Infrastructure (NGI) and Science for Life Laboratory SNP&SEQ Technology Platform in Uppsala (supported by the Swedish Research Council and the Knut and Alice Wallenberg Foundation). The Centre for Protein Research is supported by a core grant from the Novo Nordisk Foundation (NNF14CC0001). We thank Dr. A. Mowat (Glasgow University) for valuable feedback during preparation of the manuscript. This work was supported by grants from the Lundbeck Foundation (R155-2014-4184), the Swedish Research Council (2017-02072), the Swedish Cancerfonden (18 0598) (to W.W.A.), and the NIH (R01 DK101119 to A.H.).	Agace WW, 2017, IMMUNITY, V46, P532, DOI 10.1016/j.immuni.2017.04.004; Barone F, 2009, MUCOSAL IMMUNOL, V2, P495, DOI 10.1038/mi.2009.106; Bergqvist P, 2010, J IMMUNOL, V184, P3545, DOI 10.4049/jimmunol.0901895; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Boursier L, 2005, GASTROENTEROLOGY, V128, P1879, DOI 10.1053/j.gastro.2005.03.047; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; BRANDTZAEG P, 1990, DIGESTION, V46, P262, DOI 10.1159/000200396; Buettner M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00342; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; CORNES JS, 1965, GUT, V6, P225, DOI 10.1136/gut.6.3.225; CRAGO SS, 1983, ANN NY ACAD SCI, V409, P803, DOI 10.1111/j.1749-6632.1983.tb26928.x; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Dukes C, 1926, J PATHOL BACTERIOL, V29, P111, DOI 10.1002/path.1700290113; DunnWalters DK, 1997, EUR J IMMUNOL, V27, P463, DOI 10.1002/eji.1830270217; Durack J, 2019, J EXP MED, V216, P20, DOI 10.1084/jem.20180448; Elgbratt K, 2010, CLIN EXP IMMUNOL, V162, P325, DOI 10.1111/j.1365-2249.2010.04230.x; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Farstad IN, 2000, IMMUNOLOGY, V101, P354, DOI 10.1046/j.1365-2567.2000.00118.x; Finlay WJJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00342; FUJIMURA Y, 1992, DIGEST DIS SCI, V37, P1089, DOI 10.1007/BF01300292; Gullberg E, 2006, ANN NY ACAD SCI, V1072, P218, DOI 10.1196/annals.1326.028; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Hoorweg K, 2008, SEMIN IMMUNOL, V20, P164, DOI 10.1016/j.smim.2008.02.003; Horje CSHT, 2017, CLIN EXP IMMUNOL, V188, P163, DOI 10.1111/cei.12918; Houston SA, 2016, MUCOSAL IMMUNOL, V9, P468, DOI 10.1038/mi.2015.77; JACOB E, 1987, HISTOPATHOLOGY, V11, P941, DOI 10.1111/j.1365-2559.1987.tb01900.x; Junker Y, 2009, CLIN EXP IMMUNOL, V156, P232, DOI 10.1111/j.1365-2249.2009.03883.x; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; KETT K, 1986, J IMMUNOL, V136, P3631; Knoop KA, 2011, AM J PATHOL, V179, P1861, DOI 10.1016/j.ajpath.2011.06.004; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lin M, 2014, MUCOSAL IMMUNOL, V7, P511, DOI 10.1038/mi.2013.68; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Macpherson AJ, 2018, ANNU REV IMMUNOL, V36, P359, DOI 10.1146/annurev-immunol-042617-053238; Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Meier D, 2014, AM J TRANSPLANT, V14, P2148, DOI 10.1111/ajt.12797; Moghaddami M, 1998, GASTROENTEROLOGY, V115, P1414, DOI 10.1016/S0016-5085(98)70020-4; Nguyen LP, 2015, NAT IMMUNOL, V16, P207, DOI 10.1038/ni.3079; OLEARY AD, 1986, HISTOPATHOLOGY, V10, P267, DOI 10.1111/j.1365-2559.1986.tb02481.x; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189, DOI 10.1016/s0016-5085(74)80102-2; Pabst O, 2006, J IMMUNOL, V177, P6824, DOI 10.4049/jimmunol.177.10.6824; Pakkanen SH, 2010, CLIN VACCINE IMMUNOL, V17, P393, DOI 10.1128/CVI.00475-09; R Core Team, 2018, R LANG ENV STAT COMP; RICKERT RR, 1980, J CLIN GASTROENTEROL, V2, P11, DOI 10.1097/00004836-198003000-00003; Rubin SJS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10387-7; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Senda T, 2019, MUCOSAL IMMUNOL, V12, P378, DOI 10.1038/s41385-018-0110-8; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Spencer J, 2016, MUCOSAL IMMUNOL, V9, P1113, DOI 10.1038/mi.2016.59; Spencer J, 2019, MUCOSAL IMMUNOL, V12, P296, DOI 10.1038/s41385-018-0120-6; Spencer J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00108; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Wang CH, 2006, AM J PHYSIOL-GASTR L, V291, pG595, DOI 10.1152/ajpgi.00525.2005; Warnes GR, 2016, VARIOUS R PROGRAMMIN; Wickham H., 2017, BLOOD; Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358; Zhao Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06089-1	64	39	39	4	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					557	+		10.1016/j.immuni.2020.02.001	http://dx.doi.org/10.1016/j.immuni.2020.02.001			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32160523	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000520600200016
J	Gilchuk, P; Murin, CD; Milligan, JC; Cross, RW; Mire, CE; Ilinykh, PA; Huang, K; Kuzmina, N; Altman, PX; Hui, S; Gunn, BM; Bryan, AL; Davidson, E; Doranz, BJ; Turner, HL; Alkutkar, T; Flinko, R; Orlandi, C; Carnahan, R; Nargi, R; Bombardi, RG; Vodzak, ME; Li, S; Okoli, A; Ibeawuchi, M; Ohiaeri, B; Lewis, GK; Alter, G; Bukreyev, A; Saphire, EO; Geisbert, TW; Ward, AB; Crowe, JE				Gilchuk, Pavlo; Murin, Charles D.; Milligan, Jacob C.; Cross, Robert W.; Mire, Chad E.; Ilinykh, Philipp A.; Huang, Kai; Kuzmina, Natalia; Altman, Pilar X.; Hui, Sean; Gunn, Bronwyn M.; Bryan, Aubrey L.; Davidson, Edgar; Doranz, Benjamin J.; Turner, Hannah L.; Alkutkar, Tanwee; Flinko, Robin; Orlandi, Chiara; Carnahan, Robert; Nargi, Rachel; Bombardi, Robin G.; Vodzak, Megan E.; Li, Sheng; Okoli, Adaora; Ibeawuchi, Morris; Ohiaeri, Benjamin; Lewis, George K.; Alter, Galit; Bukreyev, Alexander; Saphire, Erica Ollmann; Geisbert, Thomas W.; Ward, Andrew B.; Crowe, James E., Jr.			Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization	IMMUNITY			English	Article							CRYO-EM STRUCTURE; HUMAN MONOCLONAL-ANTIBODIES; CROSS-REACTIVITY; STRUCTURAL BASIS; VIRUS; GLYCOPROTEIN; PROTECTION; MECHANISM; SURVIVOR; MODELS	Structural principles underlying the composition of protective antiviral monoclonal antibody (mAb) cocktails are poorly defined. Here, we exploited antibody cooperativity to develop a therapeutic mAb cocktail against Ebola virus. We systematically analyzed the antibody repertoire in human survivors and identified a pair of potently neutralizing mAbs that cooperatively bound to the ebolavirus glycoprotein (GP). High-resolution structures revealed that in a two antibody cocktail, molecular mimicry was a major feature of mAb-GP interactions. Broadly neutralizing mAb rEBOV-520 targeted a conserved epitope on the GP base region. mAb rEBOV-548 bound to a glycan cap epitope, possessed neutralizing and Fc-mediated effector function activities, and potentiated neutralization by rEBOV-520. Remodeling of the glycan cap structures by the cocktail enabled enhanced GP binding and virus neutralization. The cocktail demonstrated resistance to virus escape and protected non-human primates (NHPs) against Ebola virus disease. These data illuminate structural principles of antibody cooperativity with implications for development of antiviral immunotherapeutics.	[Gilchuk, Pavlo; Carnahan, Robert; Nargi, Rachel; Bombardi, Robin G.; Vodzak, Megan E.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Murin, Charles D.; Turner, Hannah L.; Alkutkar, Tanwee; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Milligan, Jacob C.; Altman, Pilar X.; Hui, Sean; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Cross, Robert W.; Mire, Chad E.; Ilinykh, Philipp A.; Huang, Kai; Kuzmina, Natalia; Bukreyev, Alexander; Geisbert, Thomas W.] Galveston Natl Lab, Galveston, TX 77550 USA; [Cross, Robert W.; Mire, Chad E.; Bukreyev, Alexander; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol Immunol, Galveston, TX 77555 USA; [Ilinykh, Philipp A.; Huang, Kai; Kuzmina, Natalia; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Gunn, Bronwyn M.; Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Gunn, Bronwyn M.; Bryan, Aubrey L.; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA 19104 USA; [Flinko, Robin; Orlandi, Chiara; Lewis, George K.] Univ Maryland, Sch Med, Inst Human Virol, Div Vaccine Res, Baltimore, MD 21201 USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Okoli, Adaora; Ibeawuchi, Morris; Ohiaeri, Benjamin] First Consultants Med Ctr, Lagos, Nigeria; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Vanderbilt University; Scripps Research Institute; Scripps Research Institute; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego; Scripps Research Institute; Vanderbilt University; Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	james.crowe@vumc.org	cross, bob/AAB-9461-2021; Crowe, James/B-5549-2009; Huang, Kai/H-9309-2018; Kuzmina, Natalia/AAY-8589-2020; Ward, Andrew/ABD-7728-2021; Murin, Charles Daniel/ABA-2861-2020; Cross, PhD, MPH, Robert W/ABD-6575-2021; Carnahan, Robert H/N-7429-2013	Crowe, James/0000-0002-0049-1079; Huang, Kai/0000-0002-3373-5594; Kuzmina, Natalia/0000-0001-6650-9369; Ward, Andrew/0000-0001-7153-3769; Cross, PhD, MPH, Robert W/0000-0001-7718-1522; Carnahan, Robert H/0000-0001-5230-1532; Hui, Sean/0000-0002-9870-6823	US NIH [U19 AI109711, U19 AI142785, R01 AI067927, U19 AI109762]; U.S. Department of Health and Human Services (HHS) [HHSN272201400058C]; Defense Threat Reduction Agency (DTRA) grant [HDTRA1-13-1-0034]; Defense Advanced Reseach Projects Agency (DARPA) [W31P4Q-14-1-0010]; Fogarty International Center of the NIH [D43TW009343]; University of California Global Health Institute (UCGHI); Bill and Melinda Gates Foundation; Atreca, Inc.; NCRR grant [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; NIH [5UC7AI094660-07]; Animal Resource Center of the Galveston National Laboratory	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services (HHS); Defense Threat Reduction Agency (DTRA) grant; Defense Advanced Reseach Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Fogarty International Center of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute (UCGHI); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Atreca, Inc.; NCRR grant; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Animal Resource Center of the Galveston National Laboratory	We thank J. Slaughter, C. Schoeder, N. Kose, S. Smith, K. Schey, W. White, J.D. Laughlin, J. Geisbert, K. Agans, D. Deer, and V. Borisevich for technical assistance. The Jurkat-EBOV, Jurkat-BDBV, and Jurkat-SUDV GP cell lines were a kind gift from C. Davis and R. Ahmed. This work was supported by US NIH grants U19 AI109711 to J.E.C. and A.B., U19 AI142785 to J.E.C. and T.G., R01 AI067927 to E.O.S., and U19 AI109762 to E.O.S. and A.B.W.); the U.S. Department of Health and Human Services (HHS) contract HHSN272201400058C to J.E.C. and B.J.D.; Defense Threat Reduction Agency (DTRA) grant HDTRA1-13-1-0034 to J.E.C. and A.B.; Defense Advanced Reseach Projects Agency (DARPA) grant W31P4Q-14-1-0010 to J.E.C.; Fogarty International Center of the NIH under award number D43TW009343; and the University of California Global Health Institute (UCGHI) to M.S.B.; and funding from the Bill and Melinda Gates Foundation to. J.E.C. by subcontract from Atreca, Inc. E.O.S. is an Investigator in the Pathogenesis of Infectious Disease of the Burroughs Welcome Fund. The project was supported by NCRR grant UL1 RR024975-01, which is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Work in BSL-4 and ABSL-4 was supported by NIH grant 5UC7AI094660-07 and by the Animal Resource Center of the Galveston National Laboratory.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; [Anonymous], 2019, NATURE NEWS; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/nmeth.3541, 10.1038/NMETH.3541]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bendell CJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-82; Bennett RS, 2017, CURR TOP MICROBIOL, V411, P171, DOI 10.1007/82_2017_20; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Bornholdt ZA, 2019, CELL HOST MICROBE, V25, P49, DOI 10.1016/j.chom.2018.12.005; Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Carlsen THR, 2014, HEPATOLOGY, V60, P1551, DOI 10.1002/hep.27298; CDC, 2019, EB DEM REP CONG; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297; Corti D, 2016, J INFECT PUBLIC HEAL, V9, P231, DOI 10.1016/j.jiph.2016.04.003; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Crowe JE, 2017, CELL HOST MICROBE, V22, P193, DOI 10.1016/j.chom.2017.07.013; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/NMETH.3286, 10.1038/nmeth.3286]; Domi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19041-y; Doria-Rose NA, 2012, J VIROL, V86, P3393, DOI 10.1128/JVI.06745-11; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Geisbert TW, 2015, J INFECT DIS, V212, pS91, DOI 10.1093/infdis/jiv284; Geisbert TW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008929; Gilchuk I, 2016, CELL, V167, P684, DOI 10.1016/j.cell.2016.09.049; Gilchuk P, 2018, IMMUNITY, V49, P363, DOI 10.1016/j.immuni.2018.06.018; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634; Howell KA, 2017, CELL REP, V19, P413, DOI 10.1016/j.celrep.2017.03.049; Ilinykh PA, 2016, J VIROL, V90, P3890, DOI 10.1128/JVI.00101-16; Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031; King LB, 2019, CURR OPIN VIROL, V34, P140, DOI 10.1016/j.coviro.2019.01.003; Kuhn JH, 2017, CURR TOP MICROBIOL, V411, P447, DOI 10.1007/82_2017_7; Kuzmina NA, 2018, CELL REP, V24, P1802, DOI 10.1016/j.celrep.2018.07.035; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Mascola JR, 1997, J VIROL, V71, P7198, DOI 10.1128/JVI.71.10.7198-7206.1997; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Murin CD, 2018, CELL REP, V24, P2723, DOI 10.1016/j.celrep.2018.08.009; NIH, 2019, INV THER TREATM PEOP; Orlandi C, 2016, J IMMUNOL METHODS, V433, P51, DOI 10.1016/j.jim.2016.03.002; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Pascal KE, 2018, J INFECT DIS, V218, pS612, DOI 10.1093/infdis/jiy285; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Raymond J, 2011, J INFECT DIS, V204, pS986, DOI 10.1093/infdis/jir335; Robinson JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10512; Sanchez A, 2005, VIRUS RES, V113, P16, DOI 10.1016/j.virusres.2005.03.028; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Turchaninova MA, 2016, NAT PROTOC, V11, P1599, DOI 10.1038/nprot.2016.093; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wec AZ, 2019, CELL HOST MICROBE, V25, P39, DOI 10.1016/j.chom.2018.12.004; Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037; West BR, 2019, NAT STRUCT MOL BIOL, V26, P204, DOI 10.1038/s41594-019-0191-4; West BR, 2018, MBIO, V9, DOI [10.1128/mBio.01674-18, 10.1128/mbio.01674-18]; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615; Zhao ZZ, 2014, J STRUCT BIOL, V186, P153, DOI 10.1016/j.jsb.2014.03.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	81	39	39	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					388	+		10.1016/j.immuni.2020.01.001	http://dx.doi.org/10.1016/j.immuni.2020.01.001			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32023489	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000515082000018
J	Tyrkalska, SD; Perez-Oliva, AB; Rodriguez-Ruiz, L; Martinez-Morcillo, FJ; Alcaraz-Perez, F; Martinez-Navarro, FJ; Lachaud, C; Ahmed, N; Schroeder, T; Pardo-Sanchez, I; Candel, S; Lopez-Munoz, A; Choudhuri, A; Rossmann, MP; Zon, LI; Cayuela, ML; Garcia-Moreno, D; Mulero, V				Tyrkalska, Sylwia D.; Perez-Oliva, Ana B.; Rodriguez-Ruiz, Lola; Martinez-Morcillo, Francisco J.; Alcaraz-Perez, Francisca; Martinez-Navarro, Francisco J.; Lachaud, Christophe; Ahmed, Nouraiz; Schroeder, Timm; Pardo-Sanchez, Irene; Candel, Sergio; Lopez-Munoz, Azucena; Choudhuri, Avik; Rossmann, Marlies P.; Zon, Leonard, I; Cayuela, Maria L.; Garcia-Moreno, Diana; Mulero, Victoriano			Inflammasome Regulates Hematopoiesis through Cleavage of the Master Erythroid Transcription Factor GATA1	IMMUNITY			English	Article							MOLECULAR-MECHANISMS; PROGENITOR CELLS; STEM-CELLS; ZEBRAFISH; ACTIVATION; CASPASE-1; ABLATION; BIOLOGY; TOOLS; PU.1	Chronic inflammatory diseases are associated with altered hematopoiesis that could result in neutrophilia and anemia. Here we report that genetic or chemical manipulation of different inflammasome components altered the differentiation of hematopoietic stem and progenitor cells (HSPC) in zebrafish. Although the inflammasome was dispensable for the emergence of HSPC, it was intrinsically required for their myeloid differentiation. In addition, Gata1 transcript and protein amounts increased in inflammasome-deficient larvae, enforcing erythropoiesis and inhibiting myelopoiesis. This mechanism is evolutionarily conserved, since pharmacological inhibition of the inflammasome altered erythroid differentiation of human erythro-leukemic K562 cells. In addition, caspase-1 inhibition rapidly upregulated GATA1 protein in mouse HSPC promoting their erythroid differentiation. Importantly, pharmacological inhibition of the inflammasome rescued zebrafish disease models of neutrophilic inflammation and anemia. These results indicate that the inflammasome plays a major role in the pathogenesis of neutrophilia and anemia of chronic diseases and reveal druggable targets for therapeutic interventions.	[Tyrkalska, Sylwia D.; Perez-Oliva, Ana B.; Rodriguez-Ruiz, Lola; Martinez-Morcillo, Francisco J.; Martinez-Navarro, Francisco J.; Pardo-Sanchez, Irene; Candel, Sergio; Lopez-Munoz, Azucena; Garcia-Moreno, Diana; Mulero, Victoriano] Univ Murcia, Dept Biol Celular & Histol, Fac Biol, IMIB Arrixaca, Murcia, Spain; [Alcaraz-Perez, Francisca; Cayuela, Maria L.] Hosp Clin Univ Virgen de la Arrixaca, IMIB Arrixaca, Murcia, Spain; [Lachaud, Christophe] Aix Marseille Univ, INSERM, CNRS, Inst Paoli Calmettes,CRCM, Marseille, France; [Ahmed, Nouraiz; Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Choudhuri, Avik; Rossmann, Marlies P.; Zon, Leonard, I] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Choudhuri, Avik; Rossmann, Marlies P.; Zon, Leonard, I] Childrens Hosp Boston, Stem Cell Program, Howard Hughes Med Inst, Boston, MA 02115 USA; [Choudhuri, Avik; Rossmann, Marlies P.; Zon, Leonard, I] Childrens Hosp Boston, Div Hematol Oncol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zon, Leonard, I] Dana Farber Canc Inst, Boston, MA 02215 USA; [Zon, Leonard, I] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zon, Leonard, I] Harvard Med Sch, Boston, MA 02115 USA; [Tyrkalska, Sylwia D.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Candel, Sergio] Univ Cambridge, Dept Med, MRC Lab Mol Biol, Cambridge CB2 0QH, England	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge	Perez-Oliva, AB; Garcia-Moreno, D; Mulero, V (corresponding author), Univ Murcia, Dept Biol Celular & Histol, Fac Biol, IMIB Arrixaca, Murcia, Spain.	anabpo@um.es; dianagm@um.es; vmulero@um.es	Rossmann, Marlies/AAJ-1943-2021; Tyrkalska, Sylwia/AAH-9664-2019; Lachaud, Christophe/ABC-8596-2021; Garcia-Moreno, Diana/ABG-2131-2020; FJ, Martínez-Navarro/AAO-9928-2020; Perez-Oliva, Ana Belen/GNW-3708-2022	Rossmann, Marlies/0000-0003-2056-6792; Lachaud, Christophe/0000-0003-2762-1619; FJ, Martínez-Navarro/0000-0002-2093-0040; Martinez Morcillo, Francisco Javier/0000-0002-9025-5191; Schroeder, Timm/0000-0001-9320-0252; Garcia, Diana/0000-0002-1521-2327; Mulero, Victoriano/0000-0001-9527-0211; Tyrkalska, Sylwia/0000-0001-6654-0163	Spanish Ministry of Science, Innovation and Universities [BIO2014-52655-R, BIO2017-84702-R, PI13/0234]; Spanish Ministry of Science, Innovation and Universities (Juan de la Cierva postdoctoral contract); Fondos Europeos de Desarrollo Regional/European Regional Development Funds; Fundacion Seneca-Murcia [19400/PI/14]; University of Murcia; SNF [179490]; European 7th Framework Initial Training Network FishForPharma [PITG-GA-2011-289209]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL144780] Funding Source: NIH RePORTER	Spanish Ministry of Science, Innovation and Universities; Spanish Ministry of Science, Innovation and Universities (Juan de la Cierva postdoctoral contract); Fondos Europeos de Desarrollo Regional/European Regional Development Funds; Fundacion Seneca-Murcia(Fundacion Seneca); University of Murcia; SNF; European 7th Framework Initial Training Network FishForPharma; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We strongly acknowledge I. Fuentes and P. Martinez for their excellent technical assistance with the zebrafish experiments. We also thank Profs.S.A. Renshaw, P. Crosier, G. Lieschke, M. Hammerschmidt, and M. Halpern for the zebrafish lines, N. Inohara for the zebrafish Asc-Myc and Caspa constructs, C. Hall for the zebrafish Gcsfa construct, D. Holden for the ST strain, and P. Pelegrin and A. Baroja-Mazo for critical reading of the manuscript. This work was supported by the Spanish Ministry of Science, Innovation and Universities (grants BIO2014-52655-R and BIO2017-84702-R to V.M. and PI13/0234 to M.L.C., PhD fellowship to F.J.M.-M. and Juan de la Cierva postdoctoral contract to F.A.-P.), all co-funded with Fondos Europeos de Desarrollo Regional/European Regional Development Funds), Fundacion Seneca-Murcia (grant 19400/PI/14 to M.L.C.), the University of Murcia (postdoctoral contracts to A.B.-P.O. and D.G.-M., and PhD fellowship to F.J.M.-M.), SNF grant 179490 to T.S., and the European 7th Framework Initial Training Network FishForPharma (PhD fellowship to S.D.T., PITG-GA-2011-289209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Angosto D, 2012, INNATE IMMUN-LONDON, V18, P815, DOI 10.1177/1753425912441956; Basiorka AA, 2016, BLOOD, V128, P2960, DOI 10.1182/blood-2016-07-730556; Berman Jason, 2012, Adv Hematol, V2012, P425345, DOI 10.1155/2012/425345; Birbrair A, 2016, ANN NY ACAD SCI, V1370, P82, DOI 10.1111/nyas.13016; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Danilova N, 2015, DIS MODEL MECH, V8, P1013, DOI 10.1242/dmm.020529; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Elias HK, 2017, SEMIN HEMATOL, V54, P4, DOI 10.1053/j.seminhematol.2016.11.002; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Espin-Palazon R, 2018, TRENDS CELL BIOL, V28, P58, DOI 10.1016/j.tcb.2017.08.003; Etzrodt M, 2019, BLOOD, V133, P816, DOI 10.1182/blood-2018-02-832998; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Gore AV, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.312; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hall CJ, 2012, CELL STEM CELL, V10, P198, DOI 10.1016/j.stem.2012.01.007; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Hilsenbeck O, 2017, BIOINFORMATICS, V33, P2020, DOI 10.1093/bioinformatics/btx107; Hilsenbeck O, 2016, NAT BIOTECHNOL, V34, P703, DOI 10.1038/nbt.3626; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Jagannathan-Bogdan M, 2013, DEVELOPMENT, V140, P2463, DOI 10.1242/dev.083147; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KOEFFLER HP, 1980, BLOOD, V56, P344; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 2010, IMMUNOL REV, V238, P37, DOI 10.1111/j.1600-065X.2010.00963.x; Kuri P, 2017, J CELL BIOL, V216, P2891, DOI 10.1083/jcb.201703103; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Liongue C, 2009, BLOOD, V113, P2535, DOI 10.1182/blood-2008-07-171967; Lopez-Castejon G, 2008, MOL IMMUNOL, V45, P49, DOI 10.1016/j.molimm.2007.05.015; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Marzano AV, 2018, CLIN REV ALLERG IMMU, V54, P114, DOI 10.1007/s12016-017-8621-8; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Masumoto J, 2003, J BIOL CHEM, V278, P4268, DOI 10.1074/jbc.M203944200; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Prajsnar TK, 2012, CELL MICROBIOL, V14, P1600, DOI 10.1111/j.1462-5822.2012.01826.x; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Ray A, 2017, TRENDS IMMUNOL, V38, P942, DOI 10.1016/j.it.2017.07.003; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Santos JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798089; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Smith RD, 2000, NUCLEIC ACIDS RES, V28, P4998, DOI 10.1093/nar/28.24.4998; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Strasser MK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05037-3; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Testa U, 2015, EXPERT OPIN INV DRUG, V24, P1433, DOI 10.1517/13543784.2015.1085505; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tyrkalska SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01375; Tyrkalska SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12077; Wallet P, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006630; Wannamaker W, 2007, J PHARMACOL EXP THER, V321, P509, DOI 10.1124/jpet.106.111344; Weiss G, 2015, SEMIN HEMATOL, V52, P313, DOI 10.1053/j.seminhematol.2015.07.004; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Whyatt D, 2000, NATURE, V406, P519, DOI 10.1038/35020086; Whyatt David J., 1997, Genes and Function, V1, P11; Wu WC, 2014, P NATL ACAD SCI USA, V111, P4221, DOI 10.1073/pnas.1320753111; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Zwack EE, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00778-16	83	39	40	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					50	+		10.1016/j.immuni.2019.05.005	http://dx.doi.org/10.1016/j.immuni.2019.05.005			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31174991	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000475561000010
J	Krebs, SJ; Kwon, YD; Schramm, CA; Law, WH; Donofrio, G; Zhou, KH; Gift, S; Dussupt, V; Georgiev, IS; Schatzle, S; McDaniel, JR; Lai, YT; Sastry, M; Zhang, BS; Jarosinski, MC; Ransier, A; Chenine, AL; Asokan, M; Bailer, RT; Bose, M; Cagigi, A; Cale, EM; Chuang, GY; Darko, S; Driscoll, JI; Druz, A; Gorman, J; Laboune, F; Louder, MK; McKee, K; Mendez, L; Moody, MA; O'Sullivan, AM; Owen, C; Peng, DJ; Rawi, R; Sanders-Buell, E; Shen, CH; Shiakolas, AR; Stephens, T; Tsybovsky, Y; Tucker, C; Verardi, R; Wang, KY; Zhou, J; Zhou, TQ; Georgiou, G; Alam, SM; Haynes, BF; Rolland, M; Matyas, GR; Polonis, VR; McDermott, AB; Douek, DC; Shapiro, L; Tovanabutra, S; Michael, NL; Mascola, JR; Robb, ML; Kwong, PD; Doria-Rose, NA				Krebs, Shelly J.; Kwon, Young D.; Schramm, Chaim A.; Law, William H.; Donofrio, Gina; Zhou, Kenneth H.; Gift, Syna; Dussupt, Vincent; Georgiev, Ivelin S.; Schatzle, Sebastian; McDaniel, Jonathan R.; Lai, Yen-Ting; Sastry, Mallika; Zhang, Baoshan; Jarosinski, Marissa C.; Ransier, Amy; Chenine, Agnes L.; Asokan, Mangaiarkarasi; Bailer, Robert T.; Bose, Meera; Cagigi, Alberto; Cale, Evan M.; Chuang, Gwo-Yu; Darko, Samuel; Driscoll, Jefferson, I; Druz, Aliaksandr; Gorman, Jason; Laboune, Farida; Louder, Mark K.; McKee, Krisha; Mendez, Letzibeth; Moody, M. Anthony; O'Sullivan, Anne Marie; Owen, Christopher; Peng, Dongjun; Rawi, Reda; Sanders-Buell, Eric; Shen, Chen-Hsiang; Shiakolas, Andrea R.; Stephens, Tyler; Tsybovsky, Yaroslav; Tucker, Courtney; Verardi, Raffaello; Wang, Keyun; Zhou, Jing; Zhou, Tongqing; Georgiou, George; Alam, S. Munir; Haynes, Barton F.; Rolland, Morgane; Matyas, Gary R.; Polonis, Victoria R.; McDermott, Adrian B.; Douek, Daniel C.; Shapiro, Lawrence; Tovanabutra, Sodsai; Michael, Nelson L.; Mascola, John R.; Robb, Merlin L.; Kwong, Peter D.; Doria-Rose, Nicole A.			Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; HIV-1-NEUTRALIZING ANTIBODIES; HIV-1 NEUTRALIZATION; AFFINITY MATURATION; VACCINE DEVELOPMENT; IDENTIFICATION; MEMBRANE; EPITOPE; BROAD	Lineage-based vaccine design is an attractive approach for eliciting broadly neutralizing antibodies (bNAbs) against HIV-1. However, most bNAb lineages studied to date have features indicative of unusual recombination and/or development. From an individual in the prospective RV217 cohort, we identified three lineages of bNAbs targeting the membrane-proximal external region (MPER) of the HIV-1 envelope. Antibodies RV217-VRC42.01, -VRC43.01, and -VRC46.01 used distinct modes of recognition and neutralized 96%, 62%, and 30%, respectively, of a 208-strain virus panel. All three lineages had modest levels of somatic hypermutation and normal antibody-loop lengths and were initiated by the founder virus MPER. The broadest lineage, VRC42, was similar to the known bNAb 4E10. A multimeric immunogen based on the founder MPER activated B cells bearing the unmutated common ancestor of VRC42, with modest maturation of early VRC42 intermediates imparting neutralization breadth. These features suggest that VRC42 may be a promising template for lineage-based vaccine design.	[Krebs, Shelly J.; Donofrio, Gina; Gift, Syna; Dussupt, Vincent; Chenine, Agnes L.; Bose, Meera; Mendez, Letzibeth; O'Sullivan, Anne Marie; Owen, Christopher; Sanders-Buell, Eric; Tucker, Courtney; Rolland, Morgane; Matyas, Gary R.; Polonis, Victoria R.; Tovanabutra, Sodsai; Michael, Nelson L.; Robb, Merlin L.] WRAIR, US Mil HIV Res Program, Silver Spring, MD USA; [Krebs, Shelly J.; Donofrio, Gina; Gift, Syna; Dussupt, Vincent; Chenine, Agnes L.; Bose, Meera; Mendez, Letzibeth; O'Sullivan, Anne Marie; Owen, Christopher; Sanders-Buell, Eric; Tucker, Courtney; Rolland, Morgane; Tovanabutra, Sodsai; Robb, Merlin L.] Henry Jackson Fdn, Bethesda, MD USA; [Kwon, Young D.; Schramm, Chaim A.; Law, William H.; Zhou, Kenneth H.; Lai, Yen-Ting; Sastry, Mallika; Zhang, Baoshan; Jarosinski, Marissa C.; Ransier, Amy; Asokan, Mangaiarkarasi; Bailer, Robert T.; Cagigi, Alberto; Cale, Evan M.; Chuang, Gwo-Yu; Darko, Samuel; Driscoll, Jefferson, I; Druz, Aliaksandr; Gorman, Jason; Laboune, Farida; Louder, Mark K.; McKee, Krisha; Peng, Dongjun; Rawi, Reda; Shen, Chen-Hsiang; Shiakolas, Andrea R.; Verardi, Raffaello; Wang, Keyun; Zhou, Jing; Zhou, Tongqing; McDermott, Adrian B.; Douek, Daniel C.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.; Doria-Rose, Nicole A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA; [Schatzle, Sebastian; McDaniel, Jonathan R.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Moody, M. Anthony; Alam, S. Munir; Haynes, Barton F.] Duke Univ, Sch Med, Durham, NC USA; [Moody, M. Anthony; Alam, S. Munir; Haynes, Barton F.] Ctr HIV AIDS Vaccine Immunol Immunogen Discovery, Durham, NC USA; [Stephens, Tyler; Tsybovsky, Yaroslav] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Canc Res Technol Program, Frederick, MD USA; [Shapiro, Lawrence; Kwong, Peter D.] Columbia Univ, New York, NY 10027 USA	Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University; University of Texas System; University of Texas Austin; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University	Kwong, PD; Doria-Rose, NA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Kwong, PD (corresponding author), Columbia Univ, New York, NY 10027 USA.	pdkwong@nih.gov; nicole.doriarose@nih.gov	Zhou, Tongqing/A-6880-2010; Moody, M/AAB-6947-2020; McDermott, Adrian B/E-7306-2011; Mascola, John/AAI-7193-2021; Do Kwon, Young/A-6957-2010; Shapiro, Lawrence/AAE-7172-2019; Alam, S. Munir/AAC-6711-2019; Matyas, Gary/AAK-6785-2021; Gorman, Jason/AGG-9417-2022; Krebs, Shelly/D-8015-2016	Zhou, Tongqing/0000-0002-3935-4637; Moody, M/0000-0002-3890-5855; Do Kwon, Young/0000-0002-1188-7458; Owen, Christopher/0000-0003-0293-8601; McDaniel, Jonathan/0000-0001-8575-3535; Shiakolas, Andrea/0000-0001-9391-5434; Zhou, Kenneth/0000-0001-5295-2693; Gorman, Jason/0000-0002-3775-6560; Dussupt, Vincent/0000-0002-8579-6356; McDermott, Adrian/0000-0003-0616-9117; Krebs, Shelly/0000-0003-1136-1760	Henry M. Jack-son Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067, W81XWH-11-2-0174, W81XWH-18-2-0040]; U.S.Department of Defense (DOD), United States [W81XWH-07-2-0067, W81XWH-11-2-0174, W81XWH-18-2-0040]; Leidos Biomedical Research Inc. [15X219]; DTRA [HDTRA1-12C-0105]; Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health, United States; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38];  [R01 AI131722]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005111, ZICAI005133, ZIAAI005143, ZICAI005114, ZIAAI005024, ZIAAI005033, R01AI131722, ZIAAI005095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	Henry M. Jack-son Foundation for the Advancement of Military Medicine, Inc.; U.S.Department of Defense (DOD), United States; Leidos Biomedical Research Inc.; DTRA(United States Department of DefenseDefense Threat Reduction Agency); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health, United States; United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Gurley, E. Viox, L. Armand, and the MHRP Viral Sequencing Core for technical contributions; J. Stuckey for assistance with graphics; and M. Zwick and members of the Structural Biology Section and the Structural Bioinformatics Core Section of the Vaccine Research Center for helpful comments. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Moris, J. Overbaugh, E. Sanders-Buell, G. Shae, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing HIV-1 Env plasmids for our neutralization panel. This work was supported by cooperative agreements (W81XWH-07-2-0067, W81XWH-11-2-0174, and W81XWH-18-2-0040) between The Henry M. Jack-son Foundation for the Advancement of Military Medicine, Inc. and the U.S.Department of Defense (DOD), United States; R01 AI131722 to I.S.G.; Leidos Biomedical Research Inc. contract 15X219 and DTRA contract HDTRA1-12C-0105 to G.G.; Frederick National Laboratory for Cancer Research contract #HHSN261200800001E to Y.T. and T.S.; and the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health, United States. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. Use of insertion device 22 (SER-CAT) at the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Boutz DR, 2014, ANAL CHEM, V86, P4758, DOI 10.1021/ac4037679; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; DeLano W. L, 2002, PYMOL MOL GENETICS G; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Doria-Rose NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006148; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2015, CURR OPIN VIROL, V11, P137, DOI 10.1016/j.coviro.2015.04.002; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Excler JL, 2015, VACCINE, V33, pD4, DOI 10.1016/j.vaccine.2015.03.059; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Irimia A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006212; Irimia A, 2016, IMMUNITY, V44, P21, DOI 10.1016/j.immuni.2015.12.001; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kulp DW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01549-6; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Landais E, 2017, IMMUNITY, V47, P990, DOI 10.1016/j.immuni.2017.11.002; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Longo NS, 2016, J VIROL, V90, P10574, DOI 10.1128/JVI.01012-16; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montefiori D.C., 2005, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1211S64; Moody MA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag0851; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Musen MA, 2015, J AM MED INFORM ASSN, V22, P1148, DOI 10.1093/jamia/ocv048; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Robb ML, 2016, NEW ENGL J MED, V374, P2120, DOI 10.1056/NEJMoa1508952; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Rubelt F, 2017, NAT IMMUNOL, V18, P1274, DOI 10.1038/ni.3873; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Saunders KO, 2015, J VIROL, V89, P8334, DOI 10.1128/JVI.00908-15; Scherer EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004461; Schramm CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00372; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Sekigawa I, 2002, J INFECTION, V44, P67, DOI 10.1053/jinf.2001.0959; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Soto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157409; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Wagh K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006860; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weaver GC, 2016, NAT PROTOC, V11, P193, DOI 10.1038/nprot.2016.009; Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200; Xu K, 2018, NAT MED, V24, P857, DOI 10.1038/s41591-018-0042-6; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	83	39	40	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					677	+		10.1016/j.immuni.2019.02.008	http://dx.doi.org/10.1016/j.immuni.2019.02.008			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30876875	Green Accepted, Bronze			2022-12-18	WOS:000461660500018
J	Wolski, D; Foote, PK; Chen, DY; Lewis-Ximenez, LL; Fauvelle, C; Aneja, J; Walker, A; Tonnerre, P; Torres-Cornejo, A; Kvistad, D; Imam, S; Waring, MT; Tully, DC; Allen, TM; Chung, RT; Timm, J; Haining, WN; Kim, AY; Baumert, TF; Lauer, GM				Wolski, David; Foote, Peter K.; Chen, Diana Y.; Lewis-Ximenez, Lia L.; Fauvelle, Catherine; Aneja, Jasneet; Walker, Andreas; Tonnerre, Pierre; Torres-Cornejo, Almudena; Kvistad, Daniel; Imam, Sabrina; Waring, Michael T.; Tully, Damien C.; Allen, Todd M.; Chung, Raymond T.; Timm, Joerg; Haining, W. Nicholas; Kim, Arthur Y.; Baumert, Thomas F.; Lauer, Georg M.			Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8(+) T Cells in Chronic versus Acute Infection	IMMUNITY			English	Article							HEPATITIS-C INFECTION; IMMUNE-RESPONSES; GENE-EXPRESSION; CLASS-I; CLEARANCE; ENCYCLOPEDIA; PERSISTENCE; BINDING; ESCAPE; MODULE	Distinct molecular pathways govern the differentiation of CD8(+) effector T cells into memory or exhausted T cells during acute and chronic viral infection, but these are not well studied in humans. Here, we employed an integrative systems immunology approach to identify transcriptional commonalities and differences between virus-specific CD8(+) T cells from patients with persistent and spontaneously resolving hepatitis C virus (HCV) infection during the acute phase. We observed dysregulation of metabolic processes during early persistent infection that was linked to changes in expression of genes related to nucleosomal regulation of transcription, T cell differentiation, and the inflammatory response and correlated with subject age, sex, and the presence of HCV-specific CD4(+) T cell populations. These early changes in HCV-specific CD8(+) T cell transcription preceded the overt establishment of T cell exhaustion, making this signature a prime target in the search for the regulatory origins of T cell dysfunction in chronic viral infection.	[Wolski, David; Foote, Peter K.; Chen, Diana Y.; Aneja, Jasneet; Tonnerre, Pierre; Torres-Cornejo, Almudena; Kvistad, Daniel; Chung, Raymond T.; Lauer, Georg M.] Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Wolski, David; Foote, Peter K.; Chen, Diana Y.; Aneja, Jasneet; Tonnerre, Pierre; Torres-Cornejo, Almudena; Kvistad, Daniel; Chung, Raymond T.; Lauer, Georg M.] Harvard Med Sch, Massachusetts Gen Hosp, Liver Ctr, Boston, MA 02114 USA; [Wolski, David; Fauvelle, Catherine; Baumert, Thomas F.] Inst Rech Malad Virales & Hepat, INSERM, U1110, F-67000 Strasbourg, France; [Wolski, David; Fauvelle, Catherine; Baumert, Thomas F.] Univ Strasbourg, F-67081 Strasbourg, France; [Lewis-Ximenez, Lia L.] Fiocruz MS, Oswaldo Cruz Inst, Lab Viral Hepatitis, BR-21040 Rio De Janeiro, Brazil; [Walker, Andreas; Timm, Joerg] Heinrich Heine Univ, Univ Hosp Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Imam, Sabrina; Haining, W. Nicholas] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Waring, Michael T.; Tully, Damien C.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Waring, Michael T.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Kim, Arthur Y.] Harvard Med Sch, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Baumert, Thomas F.] Nouvel Hop Civil, Inst Hosp Univ, Pole Hepato Digestif, F-67000 Strasbourg, France	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Fundacao Oswaldo Cruz; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; CHU Strasbourg	Lauer, GM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Lauer, GM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Liver Ctr, Boston, MA 02114 USA.	glauer@mgh.harvard.edu	Baumert, Thomas/ABF-4718-2020; Tonnerre, Pierre/AAA-1631-2020; Allen, Todd/F-5473-2011; Timm, Jörg/P-7652-2019; Lauer, Georg/J-1467-2018	Baumert, Thomas/0000-0002-8864-2168; Tonnerre, Pierre/0000-0002-1719-9736; Allen, Todd/0000-0002-6609-1318; Timm, Jörg/0000-0001-7799-3045; Lewis-Ximenez, Lia Laura/0000-0002-3447-4621; Walker, Andreas/0000-0002-8736-0863; Lauer, Georg/0000-0002-9792-4271; Tully, Damien/0000-0002-7620-9340	NIH [U19 AI066345/U01 AI131314, U19 AI082630, R01 AI105035/R01 DA016017]; ARC, Paris; IHU Strasbourg/TheraHCC IHUARC [IHU201301187]; European Union [ERC-AdG-2014-671231-HEPCIR]; EU [H2020-667273HEPCAR, FP7 HEPAMAB GAN 305600]; ANR/LABEX [ANR-10-LABX-0028_HEPSYS]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, U01AI131314, R01AI105035, U19AI066345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC, Paris; IHU Strasbourg/TheraHCC IHUARC; European Union(European Commission); EU(European Commission); ANR/LABEX(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Brad Rosenberg, Naglaa Shoukry, Paul Klenerman, and Kate Jeffrey for constructive discussions. This work was funded by the NIH through U19 AI066345/U01 AI131314 (G.M.L., L.L. L.-X., A.Y.K.), U19 AI082630 (G.M.L., A.Y.K., R.T.C., W.N.H.), and R01 AI105035/R01 DA016017 (G.M.L.) and by ARC, Paris, IHU Strasbourg/TheraHCC IHUARC IHU201301187 and the European Union/ERC-AdG-2014-671231-HEPCIR, EU H2020-667273HEPCAR, FP7 HEPAMAB GAN 305600, and ANR/LABEX ANR-10-LABX-0028_HEPSYS (all to T.F.B.).	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakr I, 2006, GUT, V55, P1183, DOI [10.1136/gut.2006.078147, 10.1136/gut.2005.078147]; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P5; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; ERNST P, 1995, IMMUNITY, V2, P311, DOI 10.1016/1074-7613(95)90139-6; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Gaiha GD, 2014, IMMUNITY, V41, P1001, DOI 10.1016/j.immuni.2014.12.011; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasprowicz V, 2010, J VIROL, V84, P1656, DOI 10.1128/JVI.01499-09; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Liu ZP, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav095; Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239; Marbach D, 2016, NAT METHODS, V13, P366, DOI [10.1038/NMETH.3799, 10.1038/nmeth.3799]; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Munoz-Fontela C, 2016, NAT REV IMMUNOL, V16, P741, DOI 10.1038/nri.2016.99; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Oytam Y, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1212-5; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Zhang HM, 2015, NUCLEIC ACIDS RES, V43, pD76, DOI 10.1093/nar/gku887; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	55	39	40	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					648	+		10.1016/j.immuni.2017.09.006	http://dx.doi.org/10.1016/j.immuni.2017.09.006			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045899	Bronze, Green Accepted			2022-12-18	WOS:000413091600011
J	Voss, OH; Murakami, Y; Pena, MY; Lee, HN; Tian, LJ; Margulies, DH; Street, JM; Yuen, PST; Qi, CF; Krzewski, K; Coligan, JE				Voss, Oliver H.; Murakami, Yousuke; Pena, Mirna Y.; Lee, Ha-Na; Tian, Linjie; Margulies, David H.; Street, Jonathan M.; Yuen, Peter S. T.; Qi, Chen-Feng; Krzewski, Konrad; Coligan, John E.			Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock	IMMUNITY			English	Article							APOPTOTIC CELLS; AMPLIFIES INFLAMMATION; ACTIVATING RECEPTOR; IL-10 PRODUCTION; IMMUNE-SYSTEM; PROTECTS MICE; CD14; LPS; SEPSIS; MACROPHAGES	Receptor CD300b is implicated in regulating the immune response to bacterial infection by an unknown mechanism. Here, we identified CD300b as a lipopolysaccharide (LPS)-binding receptor and determined the mechanism underlying CD300b augmentation of septic shock. In vivo depletion and adoptive transfer studies identified CD300b-expressing macrophages as the key cell type augmenting sepsis. We showed that CD300b, and its adaptor DAP12, associated with Toll-like receptor 4 (TLR4) upon LPS binding, thereby enhancing TLR4-adaptor MyD88- and TRIF-dependent signaling that resulted in an elevated pro-inflammatory cytokine storm. LPS engagement of the CD300b-TLR4 complex led to the recruitment and activation of spleen tyrosine kinase (Syk) and phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K). This resulted in an inhibition of the ERK1/2 protein kinase-and NF-kappa B transcription factor-mediated signaling pathways, which subsequently led to a reduced interleukin-10 (IL-10) production. Collectively, our data describe a mechanism of TLR4 signaling regulated by CD300b in myeloid cells in response to LPS.	[Voss, Oliver H.; Murakami, Yousuke; Pena, Mirna Y.; Lee, Ha-Na; Tian, Linjie; Krzewski, Konrad; Coligan, John E.] NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Margulies, David H.] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20814 USA; [Street, Jonathan M.; Yuen, Peter S. T.] NIDDK, Renal Diagnost & Therapeut Unit, NIH, Bethesda, MD 20814 USA; [Qi, Chen-Feng] NIAID, Pathol Core, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Coligan, JE (corresponding author), NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	jcoligan@niaid.nih.gov	ST Yuen, Peter/B-1954-2008	ST Yuen, Peter/0000-0001-9557-3909	intramural programs of the National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000622, ZIAAI000962, ZIAAI000964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043403] Funding Source: NIH RePORTER	intramural programs of the National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Robert Star (NIAID/NIH) for providing us with the CLP methodology. We further thank Kannan Natarajan and Lisa Boyd for assistance with the SPR analyses. We also thank Herbert Morse III, Susan Pierce, and Louis Thomas for their critical comments and advice. This study was supported by the intramural programs of the National Institute of Allergy and Infectious Diseases (NIAID).	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Henson PM, 2013, J CLIN INVEST, V123, P2773, DOI 10.1172/JCI69344; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kim SH, 2004, PHARMACOL RES, V49, P433, DOI 10.1016/j.phrs.2003.11.004; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Moshkovits I, 2015, P NATL ACAD SCI USA, V112, P8708, DOI 10.1073/pnas.1507625112; Murakami Y, 2014, CELL DEATH DIFFER, V21, P1746, DOI 10.1038/cdd.2014.86; Muroi M, 2002, J BIOL CHEM, V277, P42372, DOI 10.1074/jbc.M205966200; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shin HJ, 2007, MOL CELLS, V24, P119; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Totsuka N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5710; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Wenzel RP, 2012, NEW ENGL J MED, V366, P2122, DOI 10.1056/NEJMe1203412; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2012, J IMMUNOL, V189, P1773, DOI 10.4049/jimmunol.1201139; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	40	39	40	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1365	1378		10.1016/j.immuni.2016.05.005	http://dx.doi.org/10.1016/j.immuni.2016.05.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27261276	Green Accepted, Bronze			2022-12-18	WOS:000378341200015
J	Riteau, N; Sher, A				Riteau, Nicolas; Sher, Alan			Chitosan: An Adjuvant with an Unanticipated STING	IMMUNITY			English	Editorial Material							INTERFERON; IMMUNITY	Adjuvants promote adaptive immunity through the triggering of innate signals that are largely poorly understood. In this issue of Immunity, Lavelle and colleagues describe an unexpected role for the DNA sensing cGAS-STING pathway in the mechanism of action of the Th1 cell-promoting polysaccharide adjuvant chitosan.	[Riteau, Nicolas; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sher, A (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	asher@niaid.nih.gov	Riteau, Nicolas/ABC-1764-2020	Riteau, Nicolas/0000-0003-1306-6466	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001186, ZIAAI001044] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Dubensky Thomas W Jr, 2013, Ther Adv Vaccines, V1, P131, DOI 10.1177/2051013613501988; Hoffman SL, 2015, VACCINE, V33, pD13, DOI 10.1016/j.vaccine.2015.07.091; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156	10	39	40	5	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					522	524		10.1016/j.immuni.2016.03.002	http://dx.doi.org/10.1016/j.immuni.2016.03.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982361	Bronze			2022-12-18	WOS:000372784200010
J	Zhang, BJ; Liu, SQ; Li, CR; Lykken, E; Jiang, S; Wong, E; Gong, ZH; Tao, ZF; Zhu, B; Wan, Y; Li, QJ				Zhang, Baojun; Liu, Si-Qi; Li, Chaoran; Lykken, Erik; Jiang, Shan; Wong, Elizabeth; Gong, Zhihua; Tao, Zhongfen; Zhu, Bo; Wan, Ying; Li, Qi-Jing			MicroRNA-23a Curbs Necrosis during Early T Cell Activation by Enforcing Intracellular Reactive Oxygen Species Equilibrium	IMMUNITY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CYCLOPHILIN-D; INFLAMMATORY RESPONSE; LISTERIA-MONOCYTOGENES; MOLECULAR-MECHANISMS; MESSENGER-RNA; DEATH; APOPTOSIS; PORE; NECROPTOSIS	Upon antigen engagement, augmented cytosolic reactive oxygen species (ROS) are needed to achieve optimal T cell receptor (TCR) signaling. However, uncontrolled ROS production is a prominent cause of necrosis, which elicits hyper-inflammation and tissue damage. Hence, it is critical to program activated T cells to achieve ROS equilibrium. Here, we determined that miR-23a is indispensable for effector CD4(+) T cell expansion, particularly by providing early protection from excessive necrosis. Mechanistically, miR-23a targeted PPIF, gatekeeper of the mitochondria permeability transition pore, thereby restricting ROS flux and maintaining mitochondrial integrity. Upon acute Listeria monocytogenes infection, deleting miR-23a in T cells resulted in excessive inflammation, massive liver damage, and a marked mortality increase, which highlights the essential role of miR-23a in maintaining immune homeostasis.	[Zhang, Baojun; Liu, Si-Qi; Li, Chaoran; Lykken, Erik; Jiang, Shan; Wong, Elizabeth; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27705 USA; [Gong, Zhihua; Zhu, Bo] Xinqiao Hosp, Inst Canc, 83 Xinqiao St, Chongqing 400037, Peoples R China; [Tao, Zhongfen; Wan, Ying] Third Mil Med Univ, Biomed Anal Ctr, Chongqing 400037, Peoples R China	Duke University; Army Medical University; Army Medical University	Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27705 USA.	qi-jing.li@duke.edu	Zhang, Baojun/AAN-8246-2020; Liu, Siqi/AAL-6891-2020	Liu, Siqi/0000-0001-9727-9498; Zhu, Bo/0000-0002-5829-9581; Lykken, Erik/0000-0002-1458-5885	NIH [RO1 AI091878]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052077, R01AI091878] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our colleagues for their suggestions in the progress of this project. We thank Drs. Mari Shinohara (Duke), You-wen He (Duke), Ming-Xiao He (Duke), Garry Nolan (Stanford), and Dan Portnoy (UC Berkeley) for generously providing us with reagents. This work was supported by NIH grant RO1 AI091878.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cliff JM, 2004, J IMMUNOL, V173, P485, DOI 10.4049/jimmunol.173.1.485; CROMPTON M, 1987, BIOCHEM SOC T, V15, P408, DOI 10.1042/bst0150408; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kursar M, 2002, J IMMUNOL, V168, P6382, DOI 10.4049/jimmunol.168.12.6382; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Li CR, 2014, P NATL ACAD SCI USA, V111, pE2807, DOI 10.1073/pnas.1401505111; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin R, 2014, J CLIN INVEST, V124, P5352, DOI 10.1172/JCI76561; Liu J, 2011, J CELL MOL MED, V15, P1474, DOI 10.1111/j.1582-4934.2010.01104.x; Liu SQ, 2014, J BIOL CHEM, V289, P12446, DOI 10.1074/jbc.M114.550723; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; McKinstry KK, 2010, IMMUNOL REV, V236, P110, DOI 10.1111/j.1600-065X.2010.00921.x; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Narducci MG, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.32; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sharifi Mohammadreza, 2014, Adv Biomed Res, V3, P61, DOI 10.4103/2277-9175.125826; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Ye HS, 2012, NUCLEIC ACIDS RES, V40, P5201, DOI 10.1093/nar/gks175; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	59	39	41	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					568	581		10.1016/j.immuni.2016.01.007	http://dx.doi.org/10.1016/j.immuni.2016.01.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26921109	Green Accepted, Bronze			2022-12-18	WOS:000372784200015
J	Pinnell, N; Yan, R; Cho, HJ; Keeley, T; Murai, MJ; Liu, YR; Alarcon, AS; Qin, J; Wang, Q; Kuick, R; Elenitoba-Johnson, KSJ; Maillard, I; Samuelson, LC; Cierpicki, T; Chiang, MY				Pinnell, Nancy; Yan, Ran; Cho, Hyo Je; Keeley, Theresa; Murai, Marcelo J.; Liu, Yiran; Alarcon, Amparo Serna; Qin, Jason; Wang, Qing; Kuick, Rork; Elenitoba-Johnson, Kojo S. J.; Maillard, Ivan; Samuelson, Linda C.; Cierpicki, Tomasz; Chiang, Mark Y.			The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia	IMMUNITY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ETS-1 TRANSCRIPTION FACTOR; ADVANCED SOLID TUMORS; STEM-CELLS; PHASE-I; MICE; MYC; DIFFERENTIATION; TRANSFORMATION; INACTIVATION	Pan-NOTCH inhibitors are poorly tolerated in clinical trials because NOTCH signals are crucial for intestinal homeostasis. These inhibitors might also promote cancer because NOTCH can act as a tumor suppressor. We previously reported that the PIAS-like coactivator ZMIZ1 is frequently co-expressed with activated NOTCH1 in T cell acute lymphoblastic leukemia (T-ALL). Here, we show that similar to Notch1, Zmiz1 was important for T cell development and controlled the expression of certain Notch target genes, such as Myc. However, unlike Notch, Zmiz1 had no major role in intestinal homeostasis or myeloid suppression. Deletion of Zmiz1 impaired the initiation and maintenance of Notch-induced T-ALL. Zmiz1 directly interacted with Notch1 via a tetratricopeptide repeat domain at a special class of Notch-regulatory sites. In contrast to the Notch cofactor Maml, which is nonselective, Zmiz1 was selective. Thus, targeting the NOTCH1-ZMIZ1 interaction might combat leukemic growth while avoiding the intolerable toxicities of NOTCH inhibitors.	[Pinnell, Nancy] Univ Michigan, Canc Biol Grad Program, Ann Arbor, MI 48109 USA; [Yan, Ran; Liu, Yiran; Alarcon, Amparo Serna; Qin, Jason; Wang, Qing; Maillard, Ivan; Samuelson, Linda C.; Chiang, Mark Y.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cho, Hyo Je; Murai, Marcelo J.; Cierpicki, Tomasz] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Keeley, Theresa; Samuelson, Linda C.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kuick, Rork] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Elenitoba-Johnson, Kojo S. J.] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Maillard, Ivan] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; University of Michigan System; University of Michigan	Chiang, MY (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	markchia@umich.edu		Liu, Yiran/0000-0001-7964-712X; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Maillard, Ivan/0000-0003-1312-6748; Chiang, Mark/0000-0003-2099-0956	American Cancer Society [RSG-11-189-01-TBG]; NCI [R01-CA196604]; Elsa U. Pardee Foundation; Rally Foundation for Childhood Cancer Research; Vs. Cancer Foundation; Bear Necessities Pediatric Cancer Foundation; Concern Foundation; American Society of Hematology;  [P30-CA46592];  [T32-CA009676-22];  [R01-AI091627];  [R01-DK078927]; NATIONAL CANCER INSTITUTE [T32CA009676, P30CA046592, R01CA196604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078927, R01DK096972] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa U. Pardee Foundation; Rally Foundation for Childhood Cancer Research; Vs. Cancer Foundation; Bear Necessities Pediatric Cancer Foundation; Concern Foundation; American Society of Hematology; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Warren Pear, Andrew Weng, Adolfo Ferrando, Raphael Kopan, Jon Aster, Stephen Blacklow, Kelly Arnett, Venkatesha Basrur, Weisheng Wu, Manjusha Pande, Jeanne Geskes, Choi Li, Jordan McHugh, Amanda Day, Paula Jeon, Zijie Sun, Maria Figueroa, Jay Hess, and Cailin Collins for invaluable assistance. M.Y.C. was supported by the American Cancer Society (RSG-11-189-01-TBG), NCI (R01-CA196604), Elsa U. Pardee Foundation, Rally Foundation for Childhood Cancer Research, Vs. Cancer Foundation, Bear Necessities Pediatric Cancer Foundation, Concern Foundation, and the American Society of Hematology. Other support was provided to R.K. (P30-CA46592), N.P. (T32-CA009676-22), I.M. (R01-AI091627), and L.C.S. (R01-DK078927).	Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Geimer Le Lay AS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004545; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rakowski LA, 2013, CANCER RES, V73, P930, DOI 10.1158/0008-5472.CAN-12-1389; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	33	39	43	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					870	883		10.1016/j.immuni.2015.10.007	http://dx.doi.org/10.1016/j.immuni.2015.10.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26522984	Green Accepted, Bronze			2022-12-18	WOS:000366846000009
J	Teichmann, LL; Cullen, JL; Kashgarian, M; Dong, C; Craft, J; Shlomchik, MJ				Teichmann, Lino L.; Cullen, Jaime L.; Kashgarian, Michael; Dong, Chen; Craft, Joe; Shlomchik, Mark J.			Local Triggering of the ICOS Coreceptor by CD11c(+) Myeloid Cells Drives Organ Inflammation in Lupus	IMMUNITY			English	Article							HELPER T-CELLS; CHRONIC ALLOGRAFT-REJECTION; B-CELLS; SYSTEMIC AUTOIMMUNITY; DENDRITIC CELLS; EFFECTOR FUNCTION; TISSUE-DAMAGE; MURINE LUPUS; ACTIVATION; COSTIMULATION	The inducible T cell costimulator (ICOS) is a potent promoter of organ inflammation in murine lupus. ICOS stimulates T follicular helper cell differentiation in lymphoid tissue, suggesting that it might drive autoimmunity by enhancing autoantibody production. Yet the pathogenic relevance of this mechanism remains unclear. It is also unknown whether other ICOS-induced processes might contribute to lupus pathology. Here we show that selective ablation of ICOS ligand (ICOSL) in CD11c(+) cells, but not in B cells, dramatically ameliorates kidney and lung inflammation in lupus-prone MRL.Fas(lpr) mice. Autoantibody formation was largely unaffected by ICOSL deficiency in CD11c(+) cells. However, ICOSL display by CD11c(+) cells in inflamed organs had a nonredundant role in protecting invading T cells from apoptosis by elevating activity of the PI3K-Akt signaling pathway, thereby facilitating T cell accrual. These findings reveal a mechanism that locally sustains organ inflammation in lupus.	[Teichmann, Lino L.] Univ Bonn, Sch Med, Dept Med 3, D-53127 Bonn, Germany; [Cullen, Jaime L.; Craft, Joe; Shlomchik, Mark J.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06519 USA; [Kashgarian, Michael] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06519 USA; [Craft, Joe] Yale Univ, Dept Internal Med, Rheumatol Sect, Sch Med, New Haven, CT 06519 USA; [Shlomchik, Mark J.] Yale Univ, Dept Lab Med, Sch Med, New Haven, CT 06519 USA; [Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Shlomchik, Mark J.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	University of Bonn; Yale University; Yale University; Yale University; Yale University; Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Teichmann, LL (corresponding author), Univ Bonn, Sch Med, Dept Med 3, D-53127 Bonn, Germany.	lino.teichmann@uni-bonn.de	Teichmann, Lino/GQA-4636-2022; dong, chen/B-3181-2009; Shlomchik, Mark J./AAN-6189-2020	dong, chen/0000-0002-0084-9130; Shlomchik, Mark J./0000-0002-2152-0959; Teichmann, Lino/0000-0001-9489-7282	Deutsche Forschungsgemeinschaft [TE 785/3-1]; BONFOR [2013-1-25]; NIH [R01-AR044077, R01-AR40072, R01-AI106654]; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044077, R01AR040072] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Jason Weinstein, Kevin Nickerson, and Kevin Cieslak for helpful comments and technical expertise. L.L.T. is supported by Deutsche Forschungsgemeinschaft (TE 785/3-1) and BONFOR (2013-1-25). M.J.S. is supported by NIH (R01-AR044077). J.C. is supported by NIH (R01-AR40072) and Alliance for Lupus Research. C.D. is supported by NIH (R01-AI106654).	Bagavant H, 2009, CURR OPIN RHEUMATOL, V21, P489, DOI 10.1097/BOR.0b013e32832efff1; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chan O, 1998, J IMMUNOL, V160, P51; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; de Haij S, 2005, KIDNEY INT, V68, P2091, DOI 10.1111/j.1523-1755.2005.00665.x; Fos C, 2008, J IMMUNOL, V181, P1969, DOI 10.4049/jimmunol.181.3.1969; Hawiger D, 2008, J IMMUNOL, V180, P3140, DOI 10.4049/jimmunol.180.5.3140; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Iwai H, 2002, J IMMUNOL, V169, P4332, DOI 10.4049/jimmunol.169.8.4332; Jacob N, 2011, J IMMUNOL, V186, P4984, DOI 10.4049/jimmunol.1000466; Katsumata Y, 2007, J IMMUNOL, V179, P3772, DOI 10.4049/jimmunol.179.6.3772; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nurieva RI, 2003, P NATL ACAD SCI USA, V100, P14163, DOI 10.1073/pnas.2335041100; Odegard JM, 2009, J IMMUNOL, V182, P4076, DOI 10.4049/jimmunol.0800758; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Van Belle TL, 2012, IMMUNITY, V36, P1060, DOI 10.1016/j.immuni.2012.04.005; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wallin JJ, 2001, J IMMUNOL, V167, P132, DOI 10.4049/jimmunol.167.1.132; Wong FS, 2004, DIABETES, V53, P2581, DOI 10.2337/diabetes.53.10.2581; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zeller GC, 2006, J AM SOC NEPHROL, V17, P122, DOI 10.1681/ASN.2005080802; Zeng Q, 2014, J CLIN INVEST, V124, P1052, DOI 10.1172/JCI70084	36	39	40	2	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					552	565		10.1016/j.immuni.2015.02.015	http://dx.doi.org/10.1016/j.immuni.2015.02.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786178	Bronze, Green Accepted			2022-12-18	WOS:000351301900018
J	Hong, CW; Luckey, MA; Ligons, DL; Waickman, AT; Park, JY; Kim, GY; Keller, HR; Etzensperger, R; Tai, XG; Lazarevic, V; Feigenbaum, L; Catalfamo, M; Walsh, STR; Park, JH				Hong, Changwan; Luckey, Megan A.; Ligons, Davinna L.; Waickman, Adam T.; Park, Joo-Young; Kim, Grace Y.; Keller, Hilary R.; Etzensperger, Ruth; Tai, Xuguang; Lazarevic, Vanja; Feigenbaum, Lionel; Catalfamo, Marta; Walsh, Scott T. R.; Park, Jung-Hyun			Activated T Cells Secrete an Alternatively Spliced Form of Common gamma-Chain that Inhibits Cytokine Signaling and Exacerbates Inflammation	IMMUNITY			English	Article							SOLUBLE FORM; IN-VIVO; INTERLEUKIN-7 RECEPTOR; IL-7; MICE; LINEAGE; DEFICIENT; DISTINCT; DIFFERENTIATION; TRANSCRIPTION	The common gamma-chain (gamma c) plays a central role in signaling by IL-2 and other gamma c-dependent cytokines. Here we report that activated T cells produce an alternatively spliced form of gc mRNA that results in protein expression and secretion of the gamma c extracellular domain. The soluble form of gamma c (s gamma c) is present in serum and directly binds to IL-2R beta and IL-7R alpha proteins on T cells to inhibit cytokine signaling and promote inflammation. s gamma c suppressed IL-7 signaling to impair naive T cell survival during homeostasis and exacerbated Th17-cell-mediated inflammation by inhibiting IL-2 signaling upon T cell activation. Reciprocally, the severity of Th17-cell-mediated inflammatory diseases was markedly diminished in mice lacking s gamma c. Thus, s gamma c expression is a naturally occurring immunomodulator that regulates gamma c cytokine signaling and controls T cell activation and differentiation.	[Hong, Changwan; Luckey, Megan A.; Ligons, Davinna L.; Waickman, Adam T.; Park, Joo-Young; Kim, Grace Y.; Keller, Hilary R.; Etzensperger, Ruth; Tai, Xuguang; Lazarevic, Vanja; Park, Jung-Hyun] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] Leidos Biomedical Res Inc, Frederick Natl Lab Canc Res, Ft Detrick, MD 21702 USA; [Catalfamo, Marta] NIAID, Clin & Mol Retrovirol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Walsh, Scott T. R.] Univ Maryland, WM Keck Lab Struct Biol, Inst Biosci & Biotechnol Res, Dept Cell Biol & Mol Genet, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Park, JH (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	parkhy@mail.nih.gov	Waickman, Adam/AHB-5028-2022; Gombolay, Grace/GXH-9077-2022; Hong, Changwan/AAO-2460-2020; Gombolay, Grace/AAR-6626-2021; Davis, Megan/F-5339-2015; Park, Jung Hyun/B-5712-2015; Hong, Changwan/R-5683-2019	Gombolay, Grace/0000-0003-4830-7792; Hong, Changwan/0000-0003-2567-2973; Park, Jung Hyun/0000-0002-9547-9055; Waickman, Adam/0000-0002-4536-6714; Lazarevic, Vanja/0000-0002-5783-7130; Walsh, Scott/0000-0002-9288-8443; Davis, Megan/0000-0002-9674-0753; Park, Joo-Young/0000-0002-0333-6349	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NIH [AI072142]; NATIONAL CANCER INSTITUTE [ZIABC011214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072142, R01AI072142] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Singer, C. Mackall, and M. Kimura for critical review of this manuscript. This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; and the NIH (AI072142 to S.T.R.W.).	BARAN D, 1988, J IMMUNOL, V141, P539; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; HWANG CD, 1993, J IMMUNOL, V151, P5631; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; McElroy CA, 2012, P NATL ACAD SCI USA, V109, P2503, DOI 10.1073/pnas.1116582109; Meissner U, 2001, BLOOD, V97, P183; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.iy.11.040193.001333; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Nielsen OH, 1998, AM J GASTROENTEROL, V93, P323, DOI 10.1111/j.1572-0241.1998.00323.x; Nishio J, 2001, J RHEUMATOL, V28, P240; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; Tai XG, 2007, P NATL ACAD SCI USA, V104, P13756, DOI 10.1073/pnas.0706509104; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	43	39	40	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					910	923		10.1016/j.immuni.2014.04.020	http://dx.doi.org/10.1016/j.immuni.2014.04.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24909888	Green Accepted, Bronze			2022-12-18	WOS:000341440200013
J	Brechmann, M; Mock, T; Nickles, D; Kiessling, M; Weit, N; Breuer, R; Muller, W; Wabnitz, G; Frey, F; Nicolay, JP; Booken, N; Samstag, Y; Klemke, CD; Herling, M; Boutros, M; Krammer, PH; Arnold, R				Brechmann, Markus; Mock, Thomas; Nickles, Dorothee; Kiessling, Michael; Weit, Nicole; Breuer, Rebecca; Mueller, Wolfgang; Wabnitz, Guido; Frey, Felice; Nicolay, Jan P.; Booken, Nina; Samstag, Yvonne; Klemke, Claus-Detlev; Herling, Marco; Boutros, Michael; Krammer, Peter H.; Arnold, Ruediger			A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes	IMMUNITY			English	Article							INDUCED CELL-DEATH; ANTIGEN RECEPTORS; PHOSPHATASE 4; ACTIVATION; LYMPHOMA; COMPLEX; SUPPRESSION; PATHWAY; RECRUITMENT; SENSITIVITY	Signal transduction to nuclear factor-kappa B (NE-kappa B) involves multiple kinases and phosphorylated target proteins, but little is known about signal termination by dephosphorylation. By RNAi screening, we have identified protein phosphatase 4 regulatory subunit 1 (PP4R1) as a negative regulator of NF-kappa B activity in T lymphocytes. PP4R1 formed part of a distinct PP4 holoenzyme and bridged the inhibitor of NF-kappa B kinase (IKK) complex and the phosphatase PP4c, thereby directing PP4c activity to dephosphorylate and inactivate the IKK complex. PP4R1 expression was triggered upon activation and proliferation of primary human T lymphocytes and deficiency for PP4R1 caused sustained and increased IKK activity, T cell hyperactivation, and aberrant NF-kappa B signaling in NF-kappa B-addicted T cell lymphomas. Collectively, our results unravel PP4R1 as a previously unknown activation-associated negative regulator of IKK activity in lymphocytes whose downregulation promotes oncogenic NE-kappa B signaling in a subgroup of T cell lymphomas.	[Brechmann, Markus; Mock, Thomas; Kiessling, Michael; Breuer, Rebecca; Mueller, Wolfgang; Nicolay, Jan P.; Krammer, Peter H.; Arnold, Ruediger] German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, D-69120 Heidelberg, Germany; [Nickles, Dorothee; Frey, Felice; Boutros, Michael] German Canc Res Ctr, Med Fac Mannheim, Dept Cell & Mol Biol, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany; [Weit, Nicole; Herling, Marco] Univ Hosp Cologne, Dept Internal Med, Lab Lymphocyte Signaling & Oncoproteome, D-50937 Cologne, Germany; [Wabnitz, Guido; Samstag, Yvonne] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany; [Nicolay, Jan P.; Booken, Nina; Klemke, Claus-Detlev] Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol Venerol & Allergol, D-68167 Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Cologne; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Arnold, R (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	r.arnold@dkfz.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Wabnitz, Guido/0000-0001-5101-9885	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israeli Ministry of Science, Culture and Sport (MOST); Deutsche Krebshilfe; Wilhelm Sander Stiftung; Tumorzentrum Heidelberg/Mannheim; Helmholtz Alliance for Systems Biology; Emmy-Noet her Grant of the Deutsche Forschungsgemeinschaft; Jose Carreras Leukarnie-Stiftung; Helmholtz Alliance for Immunotherapy of Cancer; Max-Eder Junior Group Program of the German Cancer Aid;  [SFB 405]	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israeli Ministry of Science, Culture and Sport (MOST); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander Stiftung; Tumorzentrum Heidelberg/Mannheim; Helmholtz Alliance for Systems Biology; Emmy-Noet her Grant of the Deutsche Forschungsgemeinschaft; Jose Carreras Leukarnie-Stiftung; Helmholtz Alliance for Immunotherapy of Cancer; Max-Eder Junior Group Program of the German Cancer Aid; 	We thank N. Oberle and E.-M. Weiss for technical advice, D. Brenner for critical discussion of the data, and H. Sauter for excellent secretarial work. This work was supported in part by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and the Israeli Ministry of Science, Culture and Sport (MOST), the Deutsche Krebshilfe, the Wilhelm Sander Stiftung, the SFB 405, and the Tumorzentrum Heidelberg/Mannheim. M.Boutros acknowledges support of the Helmholtz Alliance for Systems Biology and by an Emmy-Noet her Grant of the Deutsche Forschungsgemeinschaft. HA., M.Brechmann, T.M., M.H., and N.W. are supported by the Jose Carreras Leukarnie-Stiftung, J.P.N. received funding from the Helmholtz Alliance for Immunotherapy of Cancer, and M.H. receives funding through the Max-Eder Junior Group Program of the German Cancer Aid.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hwang ST, 2008, LANCET, V371, P945, DOI 10.1016/S0140-6736(08)60420-1; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Kiessling MK, 2009, CANCER RES, V69, P2365, DOI 10.1158/0008-5472.CAN-08-3221; Kim KE, 2000, ONCOGENE, V19, P1334, DOI 10.1038/sj.onc.1203432; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Peter ME, 1997, EUR J IMMUNOL, V27, P1207, DOI 10.1002/eji.1830270523; Ruland J, 2003, SEMIN IMMUNOL, V15, P177, DOI 10.1016/S1044-5323(03)00034-4; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Shui JW, 2007, MOL CELL BIOL, V27, P79, DOI 10.1128/MCB.00799-06; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Swerdlow S, 2008, TUMOURS HEMATOPOIETI; Swift S, 2001, CURR PROTOC IMMUNOL; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Yeh PY, 2004, J BIOL CHEM, V279, P26143, DOI 10.1074/jbc.M402362200; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	39	39	41	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					697	708		10.1016/j.immuni.2012.07.014	http://dx.doi.org/10.1016/j.immuni.2012.07.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23084358	Bronze			2022-12-18	WOS:000310185400014
J	Zhu, JW; Doan, K; Park, J; Chau, AH; Zhang, H; Lowell, CA; Weiss, A				Zhu, Jing W.; Doan, Kristin; Park, Jason; Chau, Angela H.; Zhang, Hong; Lowell, Clifford A.; Weiss, Arthur			Receptor-like Tyrosine Phosphatases CD45 and CD148 Have Distinct Functions in Chemoattractant-Mediated Neutrophil Migration and Response to S. aureus	IMMUNITY			English	Article							SRC-FAMILY KINASES; LYN-DEFICIENT MICE; CHRONIC GRANULOMATOUS-DISEASE; B-CELL; PHOSPHOINOSITIDE-3 KINASE; THYMOCYTE DEVELOPMENT; LEUKOCYTE CHEMOTAXIS; REGULATE NEUTROPHIL; AUTOIMMUNE-DISEASE; IMMUNE CELLS	Neutrophils, critical innate immune effectors, use bacterial-derived chemoattractant-induced G protein-coupled receptor (GPCR) signaling for their pursuit of bacteria. Tyrosine phosphorylation pathways and receptor-like tyrosine phosphatases (RPTPs) are rarely considered in chemoattractant-mediated GPCR signaling. Here, we report that two RPTPs, CD45 and CD148, previously shown to share redundant roles in positively regulating Src family kinases (SFKs) in immunoreceptor signaling pathways in B cells and macrophages, are critical in the neutrophil response to S. aureus infection and, surprisingly, in chemoattractant-mediated chemotaxis. Remarkably, deficiency in either of these RPTPs influenced neutrophil GPCR responses in unique ways. Our results reveal that CD45 positively while CD148 positively and negatively regulate GPCR function and proximal signals including Ca(2+), phosphatidylinositol 3'OH kinase (PI3K), and phospho-extracellular regulated kinase (pERK) activity. Moreover, our results suggest that CD45 and CD148 preferentially target different SFK members (Hck and Fgr versus Lyn, respectively) to positively and negatively regulate GPCR pathways.	[Zhu, Jing W.; Doan, Kristin; Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Zhu, Jing W.; Doan, Kristin; Weiss, Arthur] Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Park, Jason; Chau, Angela H.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Park, Jason; Chau, Angela H.] UCSF, UC Berkeley Joint Grad Grp Bioengn, San Francisco, CA 94143 USA; [Zhang, Hong] BioLegend Inc, Dept Res & Dev, San Diego, CA 92121 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu			NIH [AI066120, AI065495, AI068150]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068150, P01AI091580, R01AI065495, R01AI066120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Roque for excellent assistance with animal husbandry and A.W. lab members for advice and helpful discussions. We thank A. Millius and O. Weiner for helping us with the EZ-TAXIScan. This work is supported by NIH grant AI066120. C.A.L. is supported by NIH grants AI065495 and AI068150.	Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Liese J, 2000, J PEDIATR-US, V137, P687, DOI 10.1067/mpd.2000.109112; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 1999, J IMMUNOL, V162, P1120; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Zhang H, 2005, IMMUNITY, V22, P235, DOI 10.1016/j.immuni.2005.01.004; Zhang ZS, 2003, J BIOL CHEM, V278, P4668, DOI 10.1074/jbc.M210028200; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	45	39	40	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					757	769		10.1016/j.immuni.2011.09.011	http://dx.doi.org/10.1016/j.immuni.2011.09.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22078799	Green Accepted, Bronze			2022-12-18	WOS:000297390800015
J	Hatton, RD				Hatton, Robin D.			TGF-beta in Th17 Cell Development: The Truth Is Out There	IMMUNITY			English	Editorial Material							T-CELLS; LINEAGE; DIFFERENTIATION; DISTINCT	As Th17 cell developmental requirements continue to be studied, Gutcher et al. (2011) demonstrate in this issue of Immunity that autocrine TGF-beta cytokine promotes Th17 cell development and maintenance.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Hatton, RD (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	rdzialo@uab.edu		Hatton, Robin/0000-0002-4797-9899	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI077574, R01 AI077574-03] Funding Source: Medline; NIDDK NIH HHS [P01 DK071176-07, P01 DK071176] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	11	39	43	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 25	2011	34	3					288	290		10.1016/j.immuni.2011.03.009	http://dx.doi.org/10.1016/j.immuni.2011.03.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435582	Bronze, Green Accepted			2022-12-18	WOS:000289014500004
J	Hoek, KL; Gordy, LE; Collins, PL; Parekh, VV; Aune, TM; Joyce, S; Thomas, JW; Van Kaer, L; Sebzda, E				Hoek, Kristen L.; Gordy, Laura E.; Collins, Patrick L.; Parekh, Vrajesh V.; Aune, Thomas M.; Joyce, Sebastian; Thomas, James W.; Van Kaer, Luc; Sebzda, Eric			Follicular B Cell Trafficking within the Spleen Actively Restricts Humoral Immune Responses	IMMUNITY			English	Article							MARGINAL-ZONE; TRANSCRIPTION FACTOR; FUNCTIONALLY DISTINCT; BORRELIA-BURGDORFERI; ANTIBODY-RESPONSES; GENE-EXPRESSION; LYME-DISEASE; IN-VIVO; LYMPHOCYTES; ACTIVATION	Follicular (FO) and marginal zone (MZ) B cells are maintained in distinct locations within the spleen, but the genetic basis for this separation is still enigmatic. We now report that B cell sequestration requires lineage-specific regulation of migratory receptors by the transcription factor KIf2. Moreover, using gene-targeted mice we show that altered splenic B cell migration confers a significant in vivo gain-of-function phenotype to FO B cells, including the ability to quickly respond to MZ-associated antigens and pathogens in a T cell-dependent manner. This work demonstrates that in wild-type animals, naive FO B cells are actively removed from the MZ, thus restricting their capacity to respond to blood-borne pathogens.	[Hoek, Kristen L.; Gordy, Laura E.; Collins, Patrick L.; Parekh, Vrajesh V.; Aune, Thomas M.; Joyce, Sebastian; Thomas, James W.; Van Kaer, Luc; Sebzda, Eric] Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Aune, Thomas M.; Thomas, James W.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Sebzda, E (corresponding author), Vanderbilt Univ, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	eric.sebzda@vanderbilt.edu	Van Kaer, Luc/H-1033-2015; Collins, Patrick/AAN-7599-2020	Van Kaer, Luc/0000-0001-5275-2309; Collins, Patrick/0000-0003-4550-4272; JOYCE, Sebastian/0000-0002-3183-1451; Thomas, James/0000-0002-2098-6458	National Multiple Sclerosis Society; NIH [HL069765, AI44924, AI042284, AI061721, AI051448, HL089667, HL094773]; Edward Mallinckrodt, Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089667, R01HL094773, T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051448, R01AI042284, R21AI042284, R21AI051448, R56AI044924, R01AI061721, R01AI044924] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Gherardini and E.P. Skaar for supplying B. burgdorferi stocks, H.M. Jack for supplying rabbit polyclonal Klf2 antibody, and J. Hawiger, M. Boothby, and D. Ballard for helpful comments. The VMC Immunohistochemistry Core Laboratory and the VMC SDRC Molecular Genetics Core provided technical assistance. Flow cytometry and cell sorting was performed in the VMC Flow Cytometry Shared Resource. This research was supported by a postdoctoral fellowship from the National Multiple Sclerosis Society (V.V.P.), NIH training grant HL069765 NIH grant AI44924 (T.M.A.), NIH grant AI042284 and AI061721 (S.J.), NIH grant AI051448 (J.W.T), NIH grant HL089667 (L.V.K.), and NIH grant HL094773 and an Edward Mallinckrodt, Jr. Foundation award (E.S.).	Acevedo-Suarez CA, 2005, J IMMUNOL, V174, P827, DOI 10.4049/jimmunol.174.2.827; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Belperron AA, 2007, INFECT IMMUN, V75, P3354, DOI 10.1128/IAI.00422-07; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; Cariappa A, 2007, J IMMUNOL, V179, P2270, DOI 10.4049/jimmunol.179.4.2270; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Dammers PM, 2000, J IMMUNOL, V165, P6156, DOI 10.4049/jimmunol.165.11.6156; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Fagarasan S, 2000, IMMUNOL REV, V176, P205; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Ferreri AJM, 2007, CRIT REV ONCOL HEMAT, V63, P245, DOI 10.1016/j.critrevonc.2007.04.009; Fruman DA, 2002, P NATL ACAD SCI USA, V99, P359, DOI 10.1073/pnas.012605099; Glynne R, 2000, IMMUNOL REV, V176, P216; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Hoek KL, 2009, J IMMUNOL, V183, P5630, DOI 10.4049/jimmunol.0901100; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Lopes-Carvalho Thiago, 2005, V8, P91; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; McKisic MD, 2000, INFECT IMMUN, V68, P5190, DOI 10.1128/IAI.68.9.5190-5197.2000; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2006, NAT PROTOC, V1, P1140, DOI 10.1038/nprot.2006.163; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pihlgren M, 2003, J IMMUNOL, V170, P2824, DOI 10.4049/jimmunol.170.6.2824; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Schuh W, 2008, MOL IMMUNOL, V45, P362, DOI 10.1016/j.molimm.2007.06.154; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; VANEWIJK W, 1980, CELL TISSUE RES, V212, P497, DOI 10.1007/BF00236513; Viau M, 2005, CLIN IMMUNOL, V114, P17, DOI 10.1016/j.clim.2004.08.019; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Yan J, 2006, J IMMUNOL, V177, P4481, DOI 10.4049/jimmunol.177.7.4481	50	39	41	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					254	265		10.1016/j.immuni.2010.07.016	http://dx.doi.org/10.1016/j.immuni.2010.07.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20691614	Green Accepted, Bronze			2022-12-18	WOS:000281654900014
J	Conche, C; Boulla, G; Trautmann, A; Randriamampita, C				Conche, Claire; Boulla, Genevieve; Trautmann, Alain; Randriamampita, Clotilde			T Cell Adhesion Primes Antigen Receptor-Induced Calcium Responses through a Transient Rise in Adenosine 3 ',5 '-Cyclic Monophosphate	IMMUNITY			English	Article							PROTEIN-KINASE-A; TYROSINE-PHOSPHATASE HEPTP; CYCLIC-AMP; DENDRITIC CELLS; LYMPHOCYTE ACTIVATION; MAP KINASE; CAMP; INHIBITION; INTEGRINS; ERK	It is well established that sustained increases in cyclic AMP (cAMP) such as those triggered by forskolin inhibit T cell activation. We describe here an unexpected phenomenon: in T cells, a transient cAMP increase triggered by the interaction with a dendritic cell strongly potentiates T cell receptor (TCR) signaling. We discovered this effect by examining the molecular basis of the adhesion-dependent sensitization of T cells. T cell adhesion caused extracellular-signal-regulated kinase (ERK) activation, which was necessary for the sensitization process. T cell sensitization could be mimicked in suspended cells by the uncaging of caged cAMP upon ultraviolet illumination. Calcium responses occurring in T cells upon interaction with dendritic cells were strongly inhibited when protein kinase A activation was blocked. Thus, whereas sustained cAMP increases are well known to inhibit TCR signaling transient cAMP increases occurring physiologically upon formation of an immunological synapse facilitate antigen detection.	[Conche, Claire; Boulla, Genevieve; Trautmann, Alain; Randriamampita, Clotilde] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Conche, Claire; Boulla, Genevieve; Trautmann, Alain; Randriamampita, Clotilde] INSERM, U567, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Randriamampita, C (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	clotilde.randriamampita@inserm.fr		Randriamampita, Clotilde/0000-0001-8594-7831	Centre National de la Recherche Scientifique; INSERM; Ligue Nationale Contre le Cancer; Ministere de la Recherche et de l'Enseignement Superieur	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Ministere de la Recherche et de l'Enseignement Superieur	We thank R.Y. Tsien for helpful suggestions and for providing the AKAR2 probe, A. Lellouch for 3A9 cells, and J.-L. Guillaume and G. Bismuth for help with the HTRF and phosphatase assay experiments. We thank T. Pozzan, M. Sixt, D. Fruman, and J. Delon for their comments on the manuscript. This work was supported by the Centre National de la Recherche Scientifique, INSERM, and Ligue Nationale Contre le Cancer (Equipe labellisee LIGUE 2007). For her Ph.D., C.C. was supported by the Ministere de la Recherche et de l'Enseignement Superieur.	ALAVA MA, 1992, BIOCHEM J, V284, P189, DOI 10.1042/bj2840189; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Aplin AE, 1998, PHARMACOL REV, V50, P197; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bodor J, 2001, J LEUKOCYTE BIOL, V69, P1053; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Burzyn D, 2002, J LEUKOCYTE BIOL, V72, P93; Chetoui N, 2006, MOL IMMUNOL, V43, P1687, DOI 10.1016/j.molimm.2005.09.010; Choudhry MA, 1999, AM J PHYSIOL-REG I, V277, pR1741, DOI 10.1152/ajpregu.1999.277.6.R1741; Doucey MA, 2003, J BIOL CHEM, V278, P26983, DOI 10.1074/jbc.M302709200; Feuillet V, 2005, EUR J IMMUNOL, V35, P2563, DOI 10.1002/eji.200526127; Fong JHJ, 1996, BIOCHEM BIOPH RES CO, V221, P19, DOI 10.1006/bbrc.1996.0537; HENNEY CS, 1971, J IMMUNOL, V107, P610; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kanda N, 2001, J INVEST DERMATOL, V117, P1635, DOI 10.1046/j.0022-202x.2001.01566.x; Laakko T, 2003, J BIOL CHEM, V278, P31621, DOI 10.1074/jbc.M304700200; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nika K, 2004, BIOCHEM J, V378, P335, DOI 10.1042/BJ20031244; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; PARK DJ, 1992, J BIOL CHEM, V267, P1496; Randriamampita C, 2003, EUR J IMMUNOL, V33, P1215, DOI 10.1002/eji.200323844; Real E, 2004, J IMMUNOL, V173, P50, DOI 10.4049/jimmunol.173.1.50; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tamir A, 1996, J IMMUNOL, V157, P1514; Trautmann A, 2003, TRENDS IMMUNOL, V24, P425, DOI 10.1016/S1471-4906(03)00182-0; Vang T, 2003, J BIOL CHEM, V278, P17597, DOI 10.1074/jbc.C300077200; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Venkataraman C, 1998, MOL IMMUNOL, V35, P997, DOI 10.1016/S0161-5890(98)00068-6; Whittard JD, 2001, J CELL SCI, V114, P3265; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	42	39	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					33	43		10.1016/j.immuni.2008.10.020	http://dx.doi.org/10.1016/j.immuni.2008.10.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144315	Bronze			2022-12-18	WOS:000262769900008
J	Nekrep, N; Fontes, JD; Geyer, M; Peterlin, BM				Nekrep, N; Fontes, JD; Geyer, M; Peterlin, BM			When the lymphocyte loses its clothes	IMMUNITY			English	Article							CLASS-II TRANSACTIVATOR; TRANSCRIPTION FACTOR XBP-1; DNA-BINDING; REGULATORY FACTOR; RFX-B; MHC; COMPLEX; CIITA; DEFICIENCY; GENES	The type II bare lymphocyte syndrome (BLS) or major histocompatibility complex class II (MHCII) deficiency is a severe combined immunodeficiency (SCID) that is characterized by the absence of constitutive and inducible expression of MHCII determinants on immune cells. Four complementation groups of BLS have been defined, and they result from mutations in DNA-bound activators and the coactivator for MHCII transcription. Recently, all complementation groups of BLS patients have been accounted for. Studies of the syndrome and specific mutations reveal important lessons for the genetics of the immune response.	Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Ljubljana, Inst Biochem, Fac Med, SI-1000 Ljubljana, Slovenia; Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Ljubljana; University System of Ohio; Cleveland State University; Max Planck Society	Peterlin, BM (corresponding author), Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA.			Fontes, Joseph/0000-0003-4796-343X; Geyer, Matthias/0000-0002-7718-5002				Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Douhan J, 1997, J EXP MED, V185, P1885, DOI 10.1084/jem.185.11.1885; Douhan J, 1996, J EXP MED, V183, P1063, DOI 10.1084/jem.183.3.1063; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Fontes JD, 1997, J MOL BIOL, V270, P336, DOI 10.1006/jmbi.1997.1121; Fontes JD, 1999, MICROBES INFECT, V1, P863, DOI 10.1016/S1286-4579(99)80529-2; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P6269, DOI 10.1093/nar/19.22.6269; Jabrane-Ferrat N, 2002, MOL CELL BIOL, V22, P5616, DOI 10.1128/MCB.22.15.5616-5625.2002; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KLEIN C, 1993, J PEDIATR-US, V123, P921, DOI 10.1016/S0022-3476(05)80388-9; LEVINE F, 1984, J IMMUNOL, V132, P959; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2002, EMBO J, V21, P1379, DOI 10.1093/emboj/21.6.1379; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Mudhasani R, 2002, MOL CELL BIOL, V22, P5019, DOI 10.1128/MCB.22.14.5019-5026.2002; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; Nagarajan UM, 2000, J IMMUNOL, V164, P3666, DOI 10.4049/jimmunol.164.7.3666; Nekrep N, 2000, MOL CELL BIOL, V20, P4455, DOI 10.1128/MCB.20.12.4455-4461.2000; Nekrep N, 2002, NAT IMMUNOL, V3, P1075, DOI 10.1038/ni840; Nekrep N, 2001, MOL CELL BIOL, V21, P5566, DOI 10.1128/MCB.21.16.5566-5576.2001; Peijnenburg A, 1999, J IMMUNOL, V163, P794; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; Villard J, 2001, MEDICINE, V80, P405, DOI 10.1097/00005792-200111000-00006	33	39	46	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2003	18	4					453	457		10.1016/S1074-7613(03)00086-4	http://dx.doi.org/10.1016/S1074-7613(03)00086-4			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705848	Bronze			2022-12-18	WOS:000182353900001
J	Adlam, M; Siu, G				Adlam, M; Siu, G			Hierarchical interactions control CD4 gene expression during thymocyte development	IMMUNITY			English	Article							T-CELL DEVELOPMENT; POSITIVE SELECTION; PRECURSOR CELLS; TRANSGENIC MICE; PROMOTER FUNCTION; COMMITMENT; ALPHA; DIFFERENTIATION; SPECIFICITY; CHROMATIN	CD4 gene regulation provides an ideal model for understanding the molecular events that drive T cell development. In this paper we use a transgenic approach to identify a CD4 LCR containing a stage-specific thymocyte enhancer (TE) and a region that protects against position effect variegation. Surprisingly, the TE acts indirectly through the previously defined proximal enhancer and is strongly induced upon commitment to the T cell lineage. We also describe a complex series of hierarchical control element interactions that orchestrate CD4 expression throughout thymopoiesis. These data provide a framework for understanding how CD4 gene expression is regulated in response to lineage commitment decisions.	Columbia Univ Coll Phys & Surg, Dept Microbiol, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University	Adlam, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, Integrated Program Cellular Mol & Biophys Studies, 630 W 168th St, New York, NY 10032 USA.				NIAID NIH HHS [2R01 AI34925] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034925] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adlam M, 1997, INT IMMUNOL, V9, P877, DOI 10.1093/intimm/9.6.877; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; Boyer O, 1997, J IMMUNOL, V159, P3383; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; Duncan DD, 1996, IMMUNITY, V4, P301, DOI 10.1016/S1074-7613(00)80438-0; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; FREDRICKSON GG, 1989, J EXP MED, V169, P1473, DOI 10.1084/jem.169.4.1473; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; Guidos CJ, 1996, CURR OPIN IMMUNOL, V8, P225, DOI 10.1016/S0952-7915(96)80061-6; HANNA Z, 1994, MOL CELL BIOL, V14, P1084, DOI 10.1128/MCB.14.2.1084; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; MacDonald HR, 2001, CURR OPIN IMMUNOL, V13, P219, DOI 10.1016/S0952-7915(00)00207-7; Merli C, 1996, GENE DEV, V10, P1260, DOI 10.1101/gad.10.10.1260; Michie AM, 1998, J IMMUNOL, V160, P1735; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Salmon P, 1996, J IMMUNOL, V156, P1873; Sarafova S, 1999, J BIOL CHEM, V274, P16126, DOI 10.1074/jbc.274.23.16126; Sarafova S, 2000, NUCLEIC ACIDS RES, V28, P2664, DOI 10.1093/nar/28.14.2664; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Siu G, 2002, SEMIN IMMUNOL, V14, P441, DOI 10.1016/S1044532302000799; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; Uematsu Y, 1997, INT IMMUNOL, V9, P179, DOI 10.1093/intimm/9.1.179; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; WINEMAN JP, 1992, BLOOD, V80, P1717; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	40	39	40	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2003	18	2					173	184		10.1016/S1074-7613(03)00021-9	http://dx.doi.org/10.1016/S1074-7613(03)00021-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594945	Bronze			2022-12-18	WOS:000181138100002
J	Hu, CJ; Rao, S; Ramirez-Bergeron, DL; Garrett-Sinha, LA; Gerondakis, S; Clark, MR; Simon, MC				Hu, CJ; Rao, S; Ramirez-Bergeron, DL; Garrett-Sinha, LA; Gerondakis, S; Clark, MR; Simon, MC			PU.1/Spi-B regulation of c-rel is essential for mature B cell survival	IMMUNITY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR PU.1; SPI-B; DNA-BINDING; NUCLEAR-FACTOR; ETS PROTEIN; SUBUNIT COMPOSITION; MICE LACKING; CHAIN GENE; EXPRESSION	PU.1(+/-)Spi-B-/- mice exhibit reduced numbers of immature and mature B lymphocytes, which exhibit severe defects in response to BCR-mediated stimulation and poor survival. We found that expression of c-rel, a member of the Rel/NF-kappaB family, is dramatically reduced in PU.1(+/-)Spi-B-/- splenic B cells. Analysis of the murine c-rel promoter identified three PU.1/Spi-B binding sites critical for c-rel promoter activity. Furthermore, reintroduction of Rel protein restored wild-type B cell numbers to mice reconstituted with PU.1(+/-)Spi-B-/- bone marrow. These findings are the first to demonstrate that a member of the Rel/NF-kappaB family is directly regulated by Ets proteins and dissect the molecular basis for the function of two Ets factors, PU.1 and Spi-B, in promoting B lymphocyte survival.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Chicago; University of Chicago; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Simon, MC (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021; Garrett-Sinha, Lee Ann/K-5911-2019	Garrett-Sinha, Lee Ann/0000-0001-7806-4352; Hu, Cheng-Jun/0000-0003-0985-1285	PHS HHS [52094] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bemark M, 1999, J BIOL CHEM, V274, P10259, DOI 10.1074/jbc.274.15.10259; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731; GRUMONT RJ, 1990, ONCOGENE RES, V5, P245; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; Himmelmann A, 1996, BLOOD, V87, P1036, DOI 10.1182/blood.V87.3.1036.bloodjournal8731036; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; HROMAS R, 1993, BLOOD, V82, P2998; Hu CJ, 2000, VIROLOGY, V268, P517, DOI 10.1006/viro.1999.0176; Kistler B, 1998, J IMMUNOL, V160, P2308; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Omori SA, 1997, J IMMUNOL, V159, P1800; OMORI SA, 1993, P NATL ACAD SCI USA, V90, P11723, DOI 10.1073/pnas.90.24.11723; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Rao S, 1999, J BIOL CHEM, V274, P34245, DOI 10.1074/jbc.274.48.34245; Rao S, 1999, J BIOL CHEM, V274, P11115, DOI 10.1074/jbc.274.16.11115; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; RAYGALLET D, 1995, ONCOGENE, V11, P303; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Su GH, 1996, J EXP MED, V184, P203, DOI 10.1084/jem.184.1.203; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Viswanathan M, 1996, GENE, V170, P271, DOI 10.1016/0378-1119(95)00773-3; WEIH F, 1994, ONCOGENE, V9, P3289; Ying H, 1998, J IMMUNOL, V161, P4760; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	55	39	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					545	555		10.1016/S1074-7613(01)00219-9	http://dx.doi.org/10.1016/S1074-7613(01)00219-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672537	Bronze			2022-12-18	WOS:000171757800006
J	ALAM, SM; CRISPE, IN; GASCOIGNE, NRJ				ALAM, SM; CRISPE, IN; GASCOIGNE, NRJ			ALLELIC EXCLUSION OF MOUSE T-CELL RECEPTOR-ALPHA CHAINS OCCURS AT THE TIME OF THYMOCYTE TCR UP-REGULATION	IMMUNITY			English	Article							POSITIVE SELECTION; TRANSGENIC MICE; ANTIGEN RECEPTOR; V-ALPHA; CD4+8+ THYMOCYTES; BETA-CHAINS; EXPRESSION; GENE; REPERTOIRE; ASSOCIATION	We report a detailed analysis of TCR V alpha and V beta chain expression on immature versus mature thymocytes of normal, TCR beta-transgenic, and TCR alpha-hemizygous mice. Chain pairing between TCR V alpha and V beta chains is random on immature thymocytes, but individual chain pairs are selected in mature thymocytes. This indicates that V alpha-V beta chain pairing preferences are determined during thymic selection, and not as a result of structural constraints. Dual V alpha chain expression is found frequently on immature, but not mature thymocytes. It is not found in TCR alpha-hemizygous mice, showing that cell surface expression of dual alpha chains is caused by lack of allelic exclusion in immature thymocytes. Down-regulation of one of the alpha chains occurs concurrently with differentiation from TCR(lo), CD69(-) to TCR(hi), CD69(+) phenotype, suggesting that it is associated with positive selection of the functional TCR.	YALE UNIV, SCH MED, IMMUNOBIOL SECT, NEW HAVEN, CT 06520 USA	Yale University	ALAM, SM (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		Alam, S. Munir/AAC-6711-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037759] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48002, GM37759] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALAM SM, 1995, INT IMMUNOL, V7, P1311, DOI 10.1093/intimm/7.8.1311; BALOMENOS D, 1995, IN PRESS J IMMUNOL, V155; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BILL J, 1989, NATURE, V341, P649, DOI 10.1038/341649a0; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; CRISPE IN, 1987, J IMMUNOL, V139, P3585; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DAVODEAU F, 1995, J EXP MED, V181, P1391, DOI 10.1084/jem.181.4.1391; DELAU WBM, 1991, J IMMUNOL, V146, P906; HAMEL PA, 1987, J IMMUNOL, V139, P3012; HAMEL PA, 1986, MOL IMMUNOL, V23, P503, DOI 10.1016/0161-5890(86)90113-6; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; HEATH WR, 1993, J EXP MED, V178, P1807, DOI 10.1084/jem.178.5.1807; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; JAMESON SC, 1991, J IMMUNOL, V147, P3185; KANAGAWA O, 1989, CELL IMMUNOL, V119, P412, DOI 10.1016/0008-8749(89)90255-4; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; KOUSKOFF V, 1995, EUR J IMMUNOL, V25, P54, DOI 10.1002/eji.1830250111; KRIMPENFORT P, 1989, NATURE, V341, P742, DOI 10.1038/341742a0; KUIDA K, 1991, INT IMMUNOL, V3, P75, DOI 10.1093/intimm/3.1.75; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MAROLLEAU JP, 1988, CELL, V55, P291, DOI 10.1016/0092-8674(88)90052-9; MASON D, 1994, INT IMMUNOL, V6, P881, DOI 10.1093/intimm/6.6.881; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PENIT C, 1990, INT IMMUNOL, V2, P629, DOI 10.1093/intimm/2.7.629; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; PIRCHER H, 1992, EUR J IMMUNOL, V22, P399, DOI 10.1002/eji.1830220217; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SAITO T, 1989, J IMMUNOL, V143, P3379; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TOMONARI K, 1989, EUR J IMMUNOL, V19, P1131, DOI 10.1002/eji.1830190625; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; UEMATSU Y, 1992, EUR J IMMUNOL, V22, P603, DOI 10.1002/eji.1830220247; UTSUNOMIYA Y, 1989, J IMMUNOL, V143, P2602; VACCHIO MS, 1993, J IMMUNOL, V151, P1322; WAANDERS GA, 1993, INT IMMUNOL, V5, P55, DOI 10.1093/intimm/5.1.55	49	39	40	1	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					449	458						10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584136				2022-12-18	WOS:A1995TB60800006
J	CURNOW, SJ; BOYER, C; BUFERNE, M; SCHMITTVERHULST, AM				CURNOW, SJ; BOYER, C; BUFERNE, M; SCHMITTVERHULST, AM			TCR-ASSOCIATED ZETA-FC-EPSILON-RI-GAMMA HETERODIMERS ON CD4(-)CD8(-) NK1.1(+) T-CELLS SELECTED BY SPECIFIC CLASS-I MHC ANTIGEN	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; MONOCLONAL-ANTIBODY; NEGATIVE SELECTION; GENE REARRANGEMENTS; POSITIVE SELECTION; SURFACE EXPRESSION; LYMPHOCYTES-T; ALPHA-CHAIN; ETA-CHAIN; THYMOCYTES	The origin of autoreactive CD4(-)CD8(-) T cells is largely unknown. In TCR transgenic (Tg) mice expressing the cognate class I MHC antigen, CD4(-)CD8(-) T cells differed depending on characteristics of Tg-TCR/antigen interaction. Tg-TCR/CD3(lo) CD4(-)CD8(-) T cells expressing the NK1.1 marker were observed only for a Tg-TCR whose stimulation by antigen was independent of CD8. Unlike normal T cells, which have essentially TCR-associated zeta homodimers, these cells had a high proportion of TCR-associated zeta-Fc epsilon Rl gamma heterodimers. They were also characterized by an unusually high content of Fc epsilon Rl gamma mRNA and low content of mRNA encoding CD3 epsilon, CD3 gamma, CD3 delta, and zeta. Based on their phenotype and selection requirements, it is proposed that CD4(-)CD8(-) thymic precursor cells can be driven along the CD4(-)CD8(-)NK1.1(+) pathway following coreceptor-independent TCR signaling at an intrathymic stage when Fc epsilon Rl gamma and CD3 components are coexpressed.			CURNOW, SJ (corresponding author), CNRS,INSERM,CTR IMMUNOL,PARC SCI LUMINY,CASE 906,F-13288 MARSEILLE 09,FRANCE.			Schmitt-Verhulst, Anne-Marie/0000-0002-1296-2739				ACE T, 1995, J EXP MED, V181, P1884; AUPHAN N, 1994, EUR J IMMUNOL, V24, P1572, DOI 10.1002/eji.1830240718; AUPHAN N, 1992, INT IMMUNOL, V4, P541, DOI 10.1093/intimm/4.4.541; BANIYASH M, 1988, J BIOL CHEM, V263, P9874; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901; BUFERNE M, 1992, J IMMUNOL, V148, P657; CAPONE M, 1995, J IMMUNOL, V154, P5165; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; COFFMAN RL, 1981, NATURE, V281, P681; COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; CURNOW SJ, 1994, EUR J IMMUNOL, V24, P2401, DOI 10.1002/eji.1830241021; CURNOW SJ, 1994, THYMUS, V22, P255; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P212, DOI 10.1002/eji.1830230133; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GUIMEZANES A, 1992, EUR J IMMUNOL, V22, P1651, DOI 10.1002/eji.1830220647; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; HANKE T, 1994, J EXP MED, V180, P1629, DOI 10.1084/jem.180.5.1629; HUA C, 1986, J IMMUNOL, V136, P1937; JUTILA MA, 1988, EUR J IMMUNOL, V18, P1814; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; KOYASU S, 1994, J EXP MED, V179, P1957, DOI 10.1084/jem.179.6.1957; KOYASU S, 1992, J EXP MED, V175, P203, DOI 10.1084/jem.175.1.203; KUBO RT, 1989, J IMMUNOL, V142, P2736; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LETOURNEUR F, 1989, IMMUNOGENETICS, V29, P265, DOI 10.1007/BF00717911; MAKINO Y, 1993, J EXP MED, V177, P1399, DOI 10.1084/jem.177.5.1399; MALISSEN B, 1993, CURR OPIN IMMUNOL, V5, P324, DOI 10.1016/0952-7915(93)90049-X; MALISSEN M, 1986, NATURE, V319, P28, DOI 10.1038/319028a0; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; RA C, 1989, J BIOL CHEM, V264, P15323; ROZDZIAL MM, 1994, J IMMUNOL, V153, P1563; RUSSELL JH, 1990, J IMMUNOL, V144, P3318; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SEKI S, 1991, CELL IMMUNOL, V137, P46, DOI 10.1016/0008-8749(91)90055-G; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; TANAKA T, 1991, J IMMUNOL, V147, P2222; TAUPIN JL, 1994, EUR J IMMUNOL, V24, P3000, DOI 10.1002/eji.1830241212; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VANBLEEK GM, 1991, P NATL ACAD SCI USA, V88, P11032, DOI 10.1073/pnas.88.24.11032; VIVIER E, 1991, J IMMUNOL, V147, P4263; VONBOEHMER H, 1992, IMMUNOL TODAY, V13, P454, DOI 10.1016/0167-5699(92)90075-I; VONBOEHMER H, 1991, J EXP MED, V174, P1001, DOI 10.1084/jem.174.5.1001	61	39	39	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					427	438						12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584134				2022-12-18	WOS:A1995TB60800004
J	WINSLOW, GM; MARRACK, P; KAPPLER, JW				WINSLOW, GM; MARRACK, P; KAPPLER, JW			PROCESSING AND MAJOR HISTOCOMPATIBILITY COMPLEX BINDING OF THE MTV7 SUPERANTIGEN	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RECEPTOR; OPEN READING FRAME; INVARIANT CHAIN; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; CLONAL DELETION; MICE LACKING; SOLUBLE CD4; IA ANTIGENS	Mouse mammary tumor viruses produce superantigens (vSAGs) which interact with class II major histocompatibility complex (MHC) proteins and stimulate T cells. vSAGs are synthesized as Type II membrane proteins, but at least one of these proteins (VSAG7) is found on the cell surface in a proteolytically processed form. Monoclonal antibodies (MAbs) were used to characterize VSAG7 and its binding to class II molecules. vSAG7 is synthesized in the endoplasmic reticulum (ER) as a 45 kd glycoprotein containing N-asparagine-linked oligomannosyl carbohydrates. vSAG7 transits the golgi complex, where it is modified by the addition of complex-type glycans and proteolysed at three positions. After proteolysis, the amino and carboxyl termini remain noncovalently associated. The ER, golgi, and surface forms of vSAG7 are stably bound to class II, but one of the proteolysed forms comprises the majority of the class II-bound material.	UNIV COLORADO, HLTH SCI CTR, DEPT MICROBIOL & IMMUNOL & MED, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT BIOCHEM BIOPHYS & GENET, DENVER, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	WINSLOW, GM (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED, HOWARD HUGHES MED INST, DEPT MED, DIV BASIC IMMUNOL, DENVER, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017134, R01AI017134, P01AI022295, R56AI017134, R01AI018785, R37AI018785] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-17134, AI-22295, AI-18785] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1992, J EXP MED, V176, P1769, DOI 10.1084/jem.176.6.1769; ACHAORBEA H, 1993, IMMUNOL REV, V131, P5, DOI 10.1111/j.1600-065X.1993.tb01527.x; ANDERSON GD, 1989, J IMMUNOL, V143, P3757; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BEUTNER U, 1992, P NATL ACAD SCI USA, V89, P5432, DOI 10.1073/pnas.89.12.5432; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; CHOI YW, 1992, J EXP MED, V175, P847, DOI 10.1084/jem.175.3.847; DEWAR RL, 1989, J VIROL, V63, P2452, DOI 10.1128/JVI.63.6.2452-2456.1989; DICKSON C, 1980, J VIROL, V35, P349, DOI 10.1128/JVI.35.2.349-361.1980; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HAMMERLING GJ, 1979, IMMUNOGENETICS, V8, P433, DOI 10.1007/BF01561454; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; JANEWAY CA, 1985, J IMMUNOL, V134, P2057; JANEWAY CA, 1991, ADV IMMUNOL, V50, P1; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; JENSEN PE, 1990, J EXP MED, V171, P1779, DOI 10.1084/jem.171.5.1779; JULIUS MH, 1984, EUR J IMMUNOL, V14, P753, DOI 10.1002/eji.1830140816; KNIGHT AM, 1992, EUR J IMMUNOL, V22, P879, DOI 10.1002/eji.1830220339; KORMAN AJ, 1992, EMBO J, V11, P1901, DOI 10.1002/j.1460-2075.1992.tb05242.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; LAMB CA, 1992, J IMMUNOL, V148, P3478; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MARRACK P, 1993, IMMUNOL REV, V131, P79, DOI 10.1111/j.1600-065X.1993.tb01531.x; MOHAN N, 1993, J EXP MED, V177, P351, DOI 10.1084/jem.177.2.351; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MORIKAWA Y, 1993, J VIROL, V67, P3601, DOI 10.1128/JVI.67.6.3601-3604.1993; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; OZATO K, 1980, J IMMUNOL, V124, P533; PECK AB, 1977, NATURE, V266, P840, DOI 10.1038/266840a0; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SPEISER DE, 1989, J EXP MED, V170, P595, DOI 10.1084/jem.170.2.595; STEIN BS, 1990, J BIOL CHEM, V265, P2640; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; SUBRAMANYAM M, 1993, IMMUNOL REV, V131, P117, DOI 10.1111/j.1600-065X.1993.tb01533.x; THOMAS DJ, 1991, J VIROL, V65, P3797, DOI 10.1128/JVI.65.7.3797-3803.1991; TORRES BA, 1993, NATURE, V364, P152, DOI 10.1038/364152a0; TSAI WP, 1988, J VIROL, V62, P3167, DOI 10.1128/JVI.62.9.3167-3174.1988; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; WINSLOW GM, 1992, CELL, V71, P719, DOI 10.1016/0092-8674(92)90549-R; YAZDANBAKHSH K, 1993, J EXP MED, V178, P737, DOI 10.1084/jem.178.2.737	50	39	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1994	1	1					23	33		10.1016/1074-7613(94)90006-X	http://dx.doi.org/10.1016/1074-7613(94)90006-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889395				2022-12-18	WOS:A1994PK15400004
J	Friscic, J; Bottcher, M; Reinwald, C; Bruns, H; Wirth, B; Popp, SJ; Walker, KI; Ackermann, JA; Chen, X; Turner, J; Zhu, HL; Seyler, L; Euler, M; Kirchner, P; Kruger, R; Ekici, AB; Major, T; Aust, O; Weidner, D; Fischer, A; Andes, FT; Stanojevic, Z; Trajkovic, V; Herrmann, M; Korb-Pap, A; Wank, I; Hess, A; Winter, J; Wixler, V; Distler, J; Steiner, G; Kiener, HP; Frey, B; Kling, L; Raza, K; Frey, S; Kleyer, A; Bauerle, T; Hughes, TR; Gruneboom, A; Steffen, U; Kronke, G; Croft, AP; Filer, A; Koehl, J; Klein, K; Buckley, CD; Schett, G; Mougiakakos, D; Hoffmann, MH				Friscic, Jasna; Bottcher, Martin; Reinwald, Christiane; Bruns, Heiko; Wirth, Benjamin; Popp, Samantha-Josefine; Walker, Kellie Irene; Ackermann, Jochen A.; Chen, Xi; Turner, Jason; Zhu, Honglin; Seyler, Lisa; Euler, Maximilien; Kirchner, Philipp; Krueger, Rene; Ekici, Arif B.; Major, Triin; Aust, Oliver; Weidner, Daniela; Fischer, Anita; Andes, Fabian T.; Stanojevic, Zeljka; Trajkovic, Vladimir; Herrmann, Martin; Korb-Pap, Adelheid; Wank, Isabel; Hess, Andreas; Winter, Johnathan; Wixler, Viktor; Distler, Jorg; Steiner, Guenter; Kiener, Hans P.; Frey, Benjamin; Kling, Lasse; Raza, Karim; Frey, Silke; Kleyer, Arnd; Baeuerle, Tobias; Hughes, Timothy R.; Grueneboom, Anika; Steffen, Ulrike; Kroenke, Gerhard; Croft, Adam P.; Filer, Andrew; Koehl, Joerg; Klein, Kerstin; Buckley, Christopher D.; Schett, Georg; Mougiakakos, Dimitrios; Hoffmann, Markus H.			The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts	IMMUNITY			English	Article							NLRP3 INFLAMMASOME; RHEUMATOID-ARTHRITIS; CELL HOMEOSTASIS; READ ALIGNMENT; RECEPTOR; IL-1-BETA; MICE; ACTIVATION; EXPRESSION; C3A	Arthritis typically involves recurrence and progressive worsening at specific predilection sites, but the checkpoints between remission and persistence remain unknown. Here, we defined themolecular and cellular mechanisms of this inflammation-mediated tissue priming. Re-exposure to inflammatory stimuli caused aggravated arthritis in rodent models. Tissue priming developed locally and independently of adaptive immunity. Repeatedly stimulated primed synovial fibroblasts (SFs) exhibited enhanced metabolic activity inducing functional changes with intensified migration, invasiveness and osteoclastogenesis. Meanwhile, human SF from patients with established arthritis displayed a similar primed phenotype. Transcriptomic and epigenomic analyses as well as genetic and pharmacological targeting demonstrated that inflammatory tissue priming relies on intracellular complement C3- and C3a receptor-activation and downstream mammalian target of rapamycin- and hypoxia-inducible factor 1 alpha-mediated metabolic SF invigoration that prevents activation-induced senescence, enhances NLRP3 inflammasome activity, and in consequence sensitizes tissue for inflammation. Our study suggests possibilities for therapeutic intervention abrogating tissue priming without immunosuppression.	[Friscic, Jasna; Reinwald, Christiane; Wirth, Benjamin; Ackermann, Jochen A.; Chen, Xi; Zhu, Honglin; Euler, Maximilien; Aust, Oliver; Weidner, Daniela; Andes, Fabian T.; Herrmann, Martin; Distler, Jorg; Frey, Silke; Kleyer, Arnd; Grueneboom, Anika; Steffen, Ulrike; Kroenke, Gerhard; Schett, Georg; Hoffmann, Markus H.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany; [Friscic, Jasna; Bottcher, Martin; Reinwald, Christiane; Bruns, Heiko; Wirth, Benjamin; Popp, Samantha-Josefine; Ackermann, Jochen A.; Chen, Xi; Zhu, Honglin; Seyler, Lisa; Euler, Maximilien; Kirchner, Philipp; Krueger, Rene; Ekici, Arif B.; Aust, Oliver; Weidner, Daniela; Andes, Fabian T.; Herrmann, Martin; Distler, Jorg; Frey, Silke; Kleyer, Arnd; Baeuerle, Tobias; Grueneboom, Anika; Steffen, Ulrike; Kroenke, Gerhard; Schett, Georg; Mougiakakos, Dimitrios; Hoffmann, Markus H.] Univ Klinikum Erlangen, D-91054 Erlangen, Germany; [Friscic, Jasna; Bottcher, Martin; Reinwald, Christiane; Bruns, Heiko; Wirth, Benjamin; Popp, Samantha-Josefine; Ackermann, Jochen A.; Chen, Xi; Zhu, Honglin; Euler, Maximilien; Aust, Oliver; Weidner, Daniela; Andes, Fabian T.; Herrmann, Martin; Distler, Jorg; Frey, Silke; Kleyer, Arnd; Grueneboom, Anika; Steffen, Ulrike; Kroenke, Gerhard; Schett, Georg; Mougiakakos, Dimitrios; Hoffmann, Markus H.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Deutsch Zentrum Immuntherapie, D-91054 Erlangen, Germany; [Bottcher, Martin; Bruns, Heiko; Popp, Samantha-Josefine; Mougiakakos, Dimitrios] Friedrich Alexander Univ Erlangen Nurnberg, Dept Med Hematol & Oncol 5, D-91054 Erlangen, Germany; [Walker, Kellie Irene; Klein, Kerstin] Univ Zurich, Univ Hosp Zurich, Ctr Expt Rheumatol, Dept Rheumatol, CH-8091 Zurich, Switzerland; [Turner, Jason; Major, Triin; Raza, Karim; Croft, Adam P.; Filer, Andrew; Buckley, Christopher D.] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, NIHR Birmingham Biomed Res Ctr, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England; [Zhu, Honglin] Cent South Univ, Xiangya Hosp, Dept Rheumatol, Changsha 410008, Hunan, Peoples R China; [Seyler, Lisa; Baeuerle, Tobias] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Radiol, D-91054 Erlangen, Germany; [Kirchner, Philipp; Krueger, Rene; Ekici, Arif B.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Human Genet, D-91054 Erlangen, Germany; [Krueger, Rene] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Nephrol & Hypertens, D-91054 Erlangen, Germany; [Fischer, Anita; Steiner, Guenter; Kiener, Hans P.] Med Univ Vienna, Div Rheumatol, Dept Med 3, A-1090 Vienna, Austria; [Fischer, Anita; Steiner, Guenter] Ludwig Boltzmann Inst Arthrit & Rehabil, A-1090 Vienna, Austria; [Stanojevic, Zeljka] Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade 11000, Serbia; [Trajkovic, Vladimir] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade 11000, Serbia; [Korb-Pap, Adelheid] Univ Hosp Muenster, Inst Musculoskeletal Med, Albert Schweitzer Campus 1,D3, D-48149 Munster, Germany; [Wank, Isabel; Hess, Andreas] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Winter, Johnathan; Hughes, Timothy R.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF10 3AT, Wales; [Wixler, Viktor] Westfaelische Wilhelms Univ Muenster, Ctr Mol Biol Inflammat ZMBE, Inst Mol Virol IMV, D-48149 Munster, Germany; [Frey, Benjamin] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Kling, Lasse] Innovat Inst Nanotechnol & Korrelat Mikroskopie, D-91301 Forchheim, Germany; [Raza, Karim] City Hosp, Dept Rheumatol, Birmingham B18 7QH, W Midlands, England; [Koehl, Joerg] Univ Lubeck, Inst Syst Inflammat Res, D-23562 Lubeck, Germany; [Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Joerg] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Buckley, Christopher D.] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Zurich; University Zurich Hospital; University of Birmingham; Central South University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Medical University of Vienna; University of Belgrade; University of Belgrade; University of Munster; University of Erlangen Nuremberg; Cardiff University; University of Erlangen Nuremberg; University of Birmingham; University of Lubeck; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Oxford	Hoffmann, MH (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany.; Hoffmann, MH (corresponding author), Univ Klinikum Erlangen, D-91054 Erlangen, Germany.; Hoffmann, MH (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Deutsch Zentrum Immuntherapie, D-91054 Erlangen, Germany.	markus.hoffmann@uk-erlangen.de	Buckley, Christopher/AAN-6378-2021; Raza, Karim/AAN-3089-2021; Ekici, Arif B/C-3971-2013; Filer, Andrew/AAP-9179-2021; Croft, Adam/AAN-1900-2021; Krönke, Gerhard/C-6615-2014; Kleyer, Arnd/AAU-2689-2021; Koehl, Joerg/HGU-9500-2022; Böttcher, Martin/AFQ-7409-2022; Koehl, Joerg/C-8531-2011	Buckley, Christopher/0000-0001-6924-6402; Raza, Karim/0000-0003-1570-1232; Ekici, Arif B/0000-0001-6099-7066; Filer, Andrew/0000-0001-8164-6249; Croft, Adam/0000-0002-9487-0511; Krönke, Gerhard/0000-0002-7566-4325; Kleyer, Arnd/0000-0002-2026-7728; Böttcher, Martin/0000-0003-2911-8830; Frey, Silke/0000-0001-9411-8357; Fischer, Anita/0000-0001-6728-7649; Hoffmann, Markus/0000-0001-9698-9922; Kirchner, Philipp/0000-0002-7972-2318; Bauerle, Tobias/0000-0002-0206-6199; Turner, Jason/0000-0002-5423-5302; Friscic, Jasna/0000-0001-6136-1967; Koehl, Joerg/0000-0003-1121-3178; Klein, Kerstin/0000-0001-5303-8027	DFG [FG 2886-TP04, FG 2886-TP08, CRC1181-B03, CRC1181-A05, CRC1181-Z2, EXC2167, TI-3]; European Union (ERC) [810316 4DnanoSCOPE]; EU/EFPIA IMI 2 RTCure [77735]; Chinese Scholarship Council	DFG(German Research Foundation (DFG)); European Union (ERC)(European Research Council (ERC)European Commission); EU/EFPIA IMI 2 RTCure; Chinese Scholarship Council(China Scholarship Council)	This work was supported by the DFG (FG 2886-TP04 to U.S., TP08 to D.M. and M.H.H., Z-project [A.K.]; CRC1181-B03 to M.H.H., A05 to S.F., and Z2 to T.B.; EXC2167 PMI, TI-3 to J.K.), the European Union (ERC Synergy grant 810316 4DnanoSCOPE to G.S.), the EU/EFPIA IMI 2 RTCure (77735). X.C. was supported by the Chinese Scholarship Council. We thank the Optical imaging center Erlangen and the Precinical imaging platform Erlangen. We further thank U. Appelt, M. Mroz, H. Danzer, D. Beckmann, K. von Dalwigk, A. Rauschenberg and L. Moller for technical assistance, F. Hartmann for collation of patient characteristics, and M. Goksu for recruitment of human synovial tissue. We also thank G. Kollias, BSRC Alexander Fleming, for sharing Col6a1cre mice. The graphical abstract was created by Sundary Sormendi using Biorender.com.	Akins NS, 2018, CURR TOP MED CHEM, V18, P494, DOI 10.2174/1568026618666180523111351; Alivernini S, 2020, NAT MED, V26, P1295, DOI 10.1038/s41591-020-0939-8; An LL, 2014, EUR J IMMUNOL, V44, P3669, DOI 10.1002/eji.201444560; Arbore G, 2016, EUR J IMMUNOL, V46, P1563, DOI 10.1002/eji.201546131; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; BAXTER AG, 1993, DIABETES, V42, P1574, DOI 10.2337/diabetes.42.11.1574; Bottcher M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1445454; BOSMA GC, 1989, IMMUNOGENETICS, V29, P54, DOI 10.1007/BF02341614; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Buckley CD, 2017, RHEUMATOLOGY, V56, P863, DOI 10.1093/rheumatology/kew289; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Bustamante MF, 2018, ANN RHEUM DIS, V77, P1636, DOI 10.1136/annrheumdis-2018-213103; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cambre I, 2019, ANN RHEUM DIS, V78, P787, DOI 10.1136/annrheumdis-2018-214627; Cambre I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06933-4; Carta S, 2015, P NATL ACAD SCI USA, V112, P2835, DOI 10.1073/pnas.1424741112; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Christensen AD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00213; Cimmino MA, 2011, ANN RHEUM DIS, V70, P2238, DOI 10.1136/ard.2011.153353; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Croft AP, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1156-1; Crowley T, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1248-6; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Cumpelik A, 2016, ANN RHEUM DIS, V75, P1236, DOI 10.1136/annrheumdis-2015-207338; Czegley C, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.034041; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Del Rey MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03921-4; Dominguez-Andres J, 2020, CURR OPIN CELL BIOL, V63, P68, DOI 10.1016/j.ceb.2019.12.006; Donlin LT, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1631-y; Falconer J, 2018, ARTHRITIS RHEUMATOL, V70, P984, DOI 10.1002/art.40504; Fearon U, 2016, NAT REV RHEUMATOL, V12, P385, DOI 10.1038/nrrheum.2016.69; Filer A, 2017, ANN RHEUM DIS, V76, P2105, DOI 10.1136/annrheumdis-2017-211286; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Fromm S, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-2088-3; Gallagher L, 2020, ARTHRITIS RHEUMATOL, V72, P896, DOI 10.1002/art.41190; Garcia-Carbonell R, 2016, ARTHRITIS RHEUMATOL, V68, P1614, DOI 10.1002/art.39608; Gruneboom A, 2019, NAT METAB, V1, P236, DOI 10.1038/s42255-018-0016-5; HEREMANS H, 1990, J EXP MED, V171, P1853, DOI 10.1084/jem.171.6.1853; Holers VM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01057; Hu FL, 2016, EUR J IMMUNOL, V46, P742, DOI 10.1002/eji.201545784; Huber R, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9570129; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; Khameneh HJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00010; Kiener HP, 2010, ARTHRITIS RHEUM-US, V62, P742, DOI 10.1002/art.27285; Kiener HP, 2009, ARTHRITIS RHEUM-US, V60, P1305, DOI 10.1002/art.24453; Kienhofer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115474; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; Klein K, 2017, J AUTOIMMUN, V83, P122, DOI 10.1016/j.jaut.2017.07.001; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Laumonnier Y, 2017, MOL IMMUNOL, V89, P44, DOI 10.1016/j.molimm.2017.05.019; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubbers R, 2017, CLIN EXP IMMUNOL, V188, P183, DOI 10.1111/cei.12952; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; Maueroder C, 2015, J MOL MED, V93, P727, DOI 10.1007/s00109-015-1295-x; McGarry T, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43165; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Montero-Melendez T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14421-x; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Neumann E, 2002, ARTHRITIS RHEUM, V46, P934, DOI 10.1002/art.10183; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Nguyen HN, 2017, IMMUNITY, V46, P220, DOI 10.1016/j.immuni.2017.01.004; Ospelt C, 2017, SEMIN IMMUNOPATHOL, V39, P409, DOI 10.1007/s00281-017-0621-5; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pearson T, 2003, J IMMUNOL, V171, P185, DOI 10.4049/jimmunol.171.1.185; POSTIGO AA, 1993, AUTOIMMUNITY, V16, P69, DOI 10.3109/08916939309010649; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Retser E, 2013, ARTHRITIS RHEUM-US, V65, P2290, DOI 10.1002/art.38026; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosengren Sanna, 2007, V135, P365; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schett G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05800-6; Schett G, 2018, RHEUMATOLOGY, V57, P43, DOI 10.1093/rheumatology/kex513; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Seeley JJ, 2017, J LEUKOCYTE BIOL, V101, P107, DOI 10.1189/jlb.3MR0316-118RR; SERREZE DV, 1993, P NATL ACAD SCI USA, V90, P9625, DOI 10.1073/pnas.90.20.9625; Seya T, 1998, INT J MOL MED, V1, P809; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Stebulis JA, 2005, J RHEUMATOL, V32, P301; Steffen Ulrike, 2019, Curr Protoc Immunol, V125, pe74, DOI 10.1002/cpim.74; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Trouw LA, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.125; Tuncel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155936; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Wei KV, 2020, NATURE, V582, P259, DOI 10.1038/s41586-020-2222-z; West EE, 2020, IMMUNOL REV, V295, P68, DOI 10.1111/imr.12852; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Wunrau C, 2009, ARTHRITIS RHEUM-US, V60, P2606, DOI 10.1002/art.24782; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Zelek W.M., 2020, IMMUNOLOGY; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	115	38	38	4	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					1002	+		10.1016/j.immuni.2021.03.003	http://dx.doi.org/10.1016/j.immuni.2021.03.003		MAY 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33761330	Green Submitted, Bronze			2022-12-18	WOS:000652019500016
J	Lerner, AM; Eisinger, RW; Lowy, DR; Petersen, LR; Humes, R; Hepburn, M; Cassetti, MC				Lerner, Andrea M.; Eisinger, Robert W.; Lowy, Douglas R.; Petersen, Lyle R.; Humes, Rosemary; Hepburn, Matthew; Cassetti, M. Cristina			The COVID-19 Serology Studies Workshop: Recommendations and Challenges	IMMUNITY			English	News Item								The development, validation, and appropriate application of serological assays to detect antibodies to SARS-CoV-2 are essential to determining seroprevalence of this virus in the United States and globally and in guiding government leadership and the private sector on back-to-work policies. An interagency working group of the US Department of Health and Human Services convened a virtual workshop to identify knowledge gaps and key outstanding scientific issues and to develop strategies to fill them. Key outcomes of the workshop included recommendations for (1) advancing serology assays as a tool to better understand SARS-CoV-2 infection and (2) conducting crucial serology field studies to advance an understanding of immunity to SARS-CoV-2, leading to protection and duration of protection, including the correlation between serological test results and risk of reinfection.	[Lerner, Andrea M.; Eisinger, Robert W.] NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lowy, Douglas R.] NCI, Off Director, NIH, Bethesda, MD 20892 USA; [Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [Humes, Rosemary] US Dept HHS, Biomed Adv Res & Dev Author, Washington, DC 20201 USA; [Hepburn, Matthew] US Dept Def, Def Adv Res Projects Agcy, Arlington, VA 22203 USA; [Cassetti, M. Cristina] NIAID, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA; United States Department of Defense; Defense Advanced Research Projects Agency (DARPA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lerner, AM; Eisinger, RW (corresponding author), NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Cassetti, MC (corresponding author), NIAID, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	andrea.lerner@nih.gov; robert.eisinger@nih.gov; CCassetti@niaid.nih.gov		Petersen, Lyle/0000-0002-3902-0565				[Anonymous], NAT MED; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1; Huang Angkana T, 2020, medRxiv, DOI [10.1038/s41467-020-18450-4, 10.1101/2020.04.14.20065771]; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; US FDA, 2020, POL COR DIS 2019 TES; Vitalant Research Institute, 2020, BLOOD IND COLL CDC N; Vitalant Research Institute, 2020, REDS EP SURV PREP NO; Wajnberg A., 2020, HUMORAL IMMUNE RESPO, DOI [10.1101/2020.04.30.20085613, DOI 10.1101/2020.04.30.20085613]	10	38	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					1	5		10.1016/j.immuni.2020.06.012	http://dx.doi.org/10.1016/j.immuni.2020.06.012			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32610080	Bronze, Green Published			2022-12-18	WOS:000551116800001
J	Schmidleithner, L; Thabet, Y; Schonfeld, E; Kohne, M; Sommer, D; Abdullah, Z; Sadlon, T; Osei-Sarpong, C; Subbaramaiah, K; Copperi, F; Haendler, K; Varga, T; Schanz, O; Bourry, S; Bassler, K; Krebs, W; Peters, AE; Baumgart, AK; Schneeweiss, M; Klee, K; Schmidt, SV; Nussing, S; Sander, J; Ohkura, N; Waha, A; Sparwasser, T; Wunderlich, FT; Forster, I; Ulas, T; Weighardt, H; Sakaguchi, S; Pfeifer, A; Bluher, M; Dannenberg, AJ; Ferreiros, N; Muglia, LJ; Wickenhauser, C; Barry, SC; Schultze, JL; Beyer, M				Schmidleithner, Lisa; Thabet, Yasser; Schoenfeld, Eva; Koehne, Maren; Sommer, Daniel; Abdullah, Zeinab; Sadlon, Timothy; Osei-Sarpong, Collins; Subbaramaiah, Kotha; Copperi, Francesca; Haendler, Kristian; Varga, Tamas; Schanz, Oliver; Bourry, Svenja; Bassler, Kevin; Krebs, Wolfgang; Peters, Annika E.; Baumgart, Ann-Kathrin; Schneeweiss, Maria; Klee, Kathrin; Schmidt, Susanne V.; Nuessing, Simone; Sander, Jil; Ohkura, Naganari; Waha, Andreas; Sparwasser, Tim; Wunderlich, F. Thomas; Foerster, Irmgard; Ulas, Thomas; Weighardt, Heike; Sakaguchi, Shimon; Pfeifer, Alexander; Blueher, Matthias; Dannenberg, Andrew J.; Ferreiros, Nerea; Muglia, Louis J.; Wickenhauser, Claudia; Barry, Simon C.; Schultze, Joachim L.; Beyer, Marc			Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction	IMMUNITY			English	Article							REGULATORY T-CELLS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; PPAR-GAMMA; REG CELLS; EXPRESSION; INHIBITION; FAT; ACCUMULATION; METHYLATION; MECHANISMS	Regulatory T cells (Treg cells) are important for preventing autoimmunity and maintaining tissue homeostasis, but whether Treg cells can adopt tissue- or immune-context-specific suppressive mechanisms is unclear. Here, we found that the enzyme hydroxyprostaglandin dehydrogenase (HPGD), which catabolizes prostaglandin E-2 (PGE(2)) into the metabolite 15-keto PGE(2), was highly expressed in Treg cells, particularly those in visceral adipose tissue (VAT). Nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR gamma)-induced HPGD expression in VAT Treg cells, and consequential Treg-cell-mediated generation of 15-keto PG E2 suppressed conventional T cell activation and proliferation. Conditional deletion of Hpgd in mouse Treg cells resulted in the accumulation of functionally impaired Treg cells specifically in VAT, causing local inflammation and systemic insulin resistance. Consistent with this mechanism, humans with type 2 diabetes showed decreased HPGD expression in Treg cells. These data indicate that HPGD-mediated suppression is a tissue- and context-dependent suppressive mechanism used by Treg cells to maintain adipose tissue homeostasis.	[Schmidleithner, Lisa; Koehne, Maren; Osei-Sarpong, Collins; Varga, Tamas; Bourry, Svenja; Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, Sigmund Freud Str 27, D-53127 Bonn, Germany; [Schmidleithner, Lisa; Thabet, Yasser; Schoenfeld, Eva; Koehne, Maren; Sommer, Daniel; Osei-Sarpong, Collins; Haendler, Kristian; Bassler, Kevin; Krebs, Wolfgang; Peters, Annika E.; Baumgart, Ann-Kathrin; Schneeweiss, Maria; Klee, Kathrin; Schmidt, Susanne V.; Nuessing, Simone; Sander, Jil; Ulas, Thomas; Schultze, Joachim L.; Beyer, Marc] Univ Bonn, Lab Genom & Immunoregulat, LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany; [Abdullah, Zeinab; Peters, Annika E.; Baumgart, Ann-Kathrin] Univ Hosp Bonn, Inst Expt Immunol, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Sadlon, Timothy; Barry, Simon C.] Univ Adelaide, Norwich Ctr, Robinson Res Inst, Mol Immunol, 55 King William St, Adelaide, SA 5006, Australia; [Subbaramaiah, Kotha; Dannenberg, Andrew J.] Weill Cornell Med Coll, Dept Med, 525 E 68th St, New York, NY 10065 USA; [Copperi, Francesca; Pfeifer, Alexander] Univ Bonn, Inst Pharmacol & Toxicol, D-53127 Bonn, Germany; [Haendler, Kristian; Schultze, Joachim L.; Beyer, Marc] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, PRECISE, Sigmund Freud Str 27, D-53127 Bonn, Germany; [Haendler, Kristian; Schultze, Joachim L.; Beyer, Marc] Univ Bonn, Sigmund Freud Str 27, D-53127 Bonn, Germany; [Schanz, Oliver; Foerster, Irmgard; Weighardt, Heike] Univ Bonn, LIMES Inst Immunol & Environm, Carl Troll Str 31, D-53115 Bonn, Germany; [Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, WPI Immunol Frontier Res Ctr, Expt Immunol Lab, Osaka, Japan; [Waha, Andreas] Univ Hosp Bonn, Dept Neuropathol, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Sparwasser, Tim] Johannes Gutenberg Univ Mainz, IMMH, Obere Zahlbacherstr 67, D-55131 Mainz, Germany; [Wunderlich, F. Thomas] Max Planck Inst Metab Res, Ctr Endocrinol Diabet & Prevent Med CEDP, Gleueler Str 50, D-50931 Cologne, Germany; [Blueher, Matthias] Univ Leipzig, Dept Med, Liebigstr 20, D-04103 Leipzig, Germany; [Ferreiros, Nerea] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Muglia, Louis J.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Muglia, Louis J.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Wickenhauser, Claudia] Martin Luther Univ Halle Wittenberg, Inst Pathol, Magdeburger Str 14, D-06112 Halle, Saale, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Robinson Research Institute; University of Adelaide; Cornell University; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Osaka University; University of Bonn; Johannes Gutenberg University of Mainz; University of Cologne; Leipzig University; Goethe University Frankfurt; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Martin Luther University Halle Wittenberg	Beyer, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, Sigmund Freud Str 27, D-53127 Bonn, Germany.; Beyer, M (corresponding author), Univ Bonn, Lab Genom & Immunoregulat, LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany.; Beyer, M (corresponding author), German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, PRECISE, Sigmund Freud Str 27, D-53127 Bonn, Germany.; Beyer, M (corresponding author), Univ Bonn, Sigmund Freud Str 27, D-53127 Bonn, Germany.	marc.beyer@dzne.de	Sparwasser, Tim D/AAA-4306-2022; Osei-Sarpong, Collins/AAM-9117-2020; Beyer, Marc/ABE-1408-2021; Schmidt, Susanne/AAU-6827-2021; Schultze, Joachim L./ABA-8176-2020; Sakaguchi, Shimon/C-9535-2009; Sparwasser, Tim/AAF-7085-2019; barry, simon/Y-4529-2019	Beyer, Marc/0000-0001-9704-148X; Schultze, Joachim L./0000-0003-2812-9853; Sparwasser, Tim/0000-0001-5645-902X; barry, simon/0000-0002-0597-7609; Copperi, Francesca/0000-0001-8050-6439; Handler, Kristian/0000-0001-5273-5277; Klee, Kathrin/0000-0003-2408-1282	Wilhelm-Sander-Foundation; German Research Foundation (GRF) [SFB 832, BE 4427/3-1]; GRF [SFB 832, SFB 704, INST 217/576-1, INST 217/577-1]; LOEWE program from the state of Hesse (Translational Medicine and Pharmacology); NHMRC project [339123, 565314]; Breast Cancer Research Foundation	Wilhelm-Sander-Foundation; German Research Foundation (GRF)(German Research Foundation (DFG)); GRF; LOEWE program from the state of Hesse (Translational Medicine and Pharmacology); NHMRC project(National Health and Medical Research Council (NHMRC) of Australia); Breast Cancer Research Foundation	We thank M. Schell, H. Theis, and M. Kraut for technical assistance; J. Oldenburg for blood samples from healthy individuals; B. Balderas and N. Warner for providing HPGD antibody; C. Benoist for microarray and clinical data from T2D patients; A. Rudensky for Foxp3-Cre-YFP mice; and W. Kastenmuller for critical discussions. CD1d tetramer and unloaded control tetramer were kindly provided by the NIH tetramer core facility. M. Beyer was funded by the Wilhelm-Sander-Foundation and the German Research Foundation (GRF) (SFB 832 and BE 4427/3-1). J.L.S. was funded by the GRF (SFB 832, SFB 704, INST 217/576-1, and INST 217/577-1). I.F. was funded by the GRF (SFB 704). M. Beyer, J.L.S., W.K., and I.F. are members of the excellence cluster ImmunoSensation2 (EXC2151-390873048). N.F. is supported by the LOEWE program from the state of Hesse (Translational Medicine and Pharmacology). S.C.B. is supported by NHMRC project grants 339123 and 565314. K.S. and A.J.D. received support from the Breast Cancer Research Foundation.	Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Beyer M, 2016, NAT IMMUNOL, V17, P593, DOI 10.1038/ni.3399; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cipolletta D, 2015, P NATL ACAD SCI USA, V112, P482, DOI 10.1073/pnas.1423486112; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Deng T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15725; Eruslanov E, 2009, J IMMUNOL, V182, P7548, DOI 10.4049/jimmunol.0802358; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaizer EC, 2007, J CLIN ENDOCR METAB, V92, P3705, DOI 10.1210/jc.2007-0979; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Schmitz K, 2014, EMBO MOL MED, V6, P1398, DOI 10.15252/emmm.201404168; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Subbaramaiah K, 2012, CANCER PREV RES, V5, P1183, DOI 10.1158/1940-6207.CAPR-12-0201; Tai HH, 2006, CURR PHARM DESIGN, V12, P955, DOI 10.2174/138161206776055958; Tangen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084002; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; Uppal S, 2008, NAT GENET, V40, P789, DOI 10.1038/ng.153; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340; 2009, J EXP MED, V206, P535, DOI DOI 10.1084/JEM.20082293; 2009, NAT MED, V15, P633, DOI DOI 10.1038/NM.1968; 2006, CANCER RES, V66, P1114, DOI DOI 10.1158/0008-5472.CAN-05-3252; 2013, NAT METHODS, V10, P1096, DOI DOI 10.1038/NMETH.2639; 2015, NAT IMMUNOL, V16, P376, DOI DOI 10.1038/NI.3120	52	38	39	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1232	+		10.1016/j.immuni.2019.03.014	http://dx.doi.org/10.1016/j.immuni.2019.03.014			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31027998	Bronze			2022-12-18	WOS:000468429500014
J	Kobayashi, T; Naik, S; Nagao, K				Kobayashi, Tetsuro; Naik, Shruti; Nagao, Keisuke			Choreographing Immunity in the Skin Epithelial Barrier	IMMUNITY			English	Review							REGULATORY T-CELLS; INNATE LYMPHOID-CELLS; HAIR FOLLICLE REGENERATION; DERMAL DENDRITIC CELLS; LANGERHANS CELLS; STAPHYLOCOCCUS-AUREUS; ATOPIC-DERMATITIS; STEM-CELLS; SENSORY NEURONS; ADAPTIVE IMMUNITY	The skin interfaces with the external environment and is home to a myriad of immune cells that patrol the barrier to ward off harmful agents and aid in tissue repair. The formation of the cutaneous immune arsenal begins before birth and evolves throughout our lifetime, incorporating exogenous cues from microbes and inflammatory encounters, to achieve optimal fitness and function. Here, we discuss the context-specific signals that drive productive immune responses in the skin epithelium, highlighting key modulators of these reactions, including hair follicles, neurons, and commensal microbes. We thus also discuss the causal and mechanistic underpinning of inflammatory skin diseases that have been revealed in recent years. Finally, we discuss the non-canonical functions of cutaneous immune cells including their burgeoning role in epithelial regeneration and repair. The rapidly growing field of cutaneous immunity is revealing immune mechanisms and functions that can be harnessed to boost skin health and treat disease.	[Kobayashi, Tetsuro; Nagao, Keisuke] NIAMSD, Cutaneous Leukocyte Biol Sect, NIH, Bethesda, MD 20892 USA; [Naik, Shruti] NYU, Sch Med, Dept Pathol, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA; [Naik, Shruti] NYU, Sch Med, Dept Med, New York, NY 10003 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); New York University; New York University	Nagao, K (corresponding author), NIAMSD, Cutaneous Leukocyte Biol Sect, NIH, Bethesda, MD 20892 USA.; Naik, S (corresponding author), NYU, Sch Med, Dept Pathol, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA.; Naik, S (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	shruti.naik@nyumc.org; keisuke.nagao@nih.gov	Nagao, Keisuke/P-3837-2018	Nagao, Keisuke/0000-0002-7005-3138; Kobayashi, Tetsuro/0000-0003-2316-4748	Division of Intramural Research of NIAMS; NIAID [1K22AI135099-01]; Damon Runyon Cancer Foundation [DFS-30-18]; NATIONAL CANCER INSTITUTE [ZIABC011561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI135099] Funding Source: NIH RePORTER	Division of Intramural Research of NIAMS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Damon Runyon Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We apologize to our colleagues in immunology and skin biology whose work we could not cite due to space constraints. This work was supported by the Division of Intramural Research of NIAMS and by grants from NIAID (1K22AI135099-01 S.N.) and the Damon Runyon Cancer Foundation (DFS-30-18 S.N.).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Adam C, 2017, J INVEST DERMATOL, V137, P367, DOI 10.1016/j.jid.2016.10.003; Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Amsen D, 2018, NAT IMMUNOL, V19, P538, DOI 10.1038/s41590-018-0114-2; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Boulakirba S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18433-4; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Castellana D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002002; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chen CC, 2015, CELL, V161, P277, DOI 10.1016/j.cell.2015.02.016; Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dainichi T, 2018, NAT IMMUNOL, V19, P1286, DOI 10.1038/s41590-018-0256-2; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Doebel T, 2017, TRENDS IMMUNOL, V38, P817, DOI 10.1016/j.it.2017.06.008; Doehl JSP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00103-8; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Guerrero-Juarez CF, 2018, NAT REV ENDOCRINOL, V14, P163, DOI 10.1038/nrendo.2017.162; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kabashima K, 2019, NAT REV IMMUNOL, V19, P19, DOI 10.1038/s41577-018-0084-5; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kashiwagi M, 2017, NAT IMMUNOL, V18, P334, DOI 10.1038/ni.3661; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lay K, 2018, ELIFE, V7, DOI 10.7554/eLife.41661; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Li H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03704-z; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Liu HY, 2017, CELL HOST MICROBE, V22, P653, DOI 10.1016/j.chom.2017.10.006; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay-Wiggan J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89790; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; Matsumoto R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121175; Meisel JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0404-9; Menon GK, 2002, ADV DRUG DELIVER REV, V54, pS3, DOI 10.1016/S0169-409X(02)00121-7; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Myles IA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120608; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik S, 2018, CELL, V175, P908, DOI 10.1016/j.cell.2018.08.071; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakagawa S, 2017, CELL HOST MICROBE, V22, P667, DOI 10.1016/j.chom.2017.10.008; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Otberg N, 2004, J INVEST DERMATOL, V122, P14, DOI 10.1046/j.0022-202X.2003.22110.x; Park S. L, 2018, NATURE; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; Paus Ralf, 2013, J Investig Dermatol Symp Proc, V16, pS25, DOI 10.1038/jidsymp.2013.7; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Pratt CH, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.11; Rak GD, 2016, J INVEST DERMATOL, V136, P487, DOI 10.1038/JID.2015.406; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Richmond JM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7710; Ridaura VK, 2018, J EXP MED, V215, P785, DOI 10.1084/jem.20171079; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Robertson K, 2010, ACTA DERM-VENEREOL, V90, P368, DOI 10.2340/00015555-0875; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sanford JA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah4609; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Scharschmidt TC, 2017, CELL HOST MICROBE, V21, P467, DOI 10.1016/j.chom.2017.03.001; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Shen W, 2014, P NATL ACAD SCI USA, V111, pE2977, DOI 10.1073/pnas.1401820111; Shipman WD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9527; Shook BA, 2018, SCIENCE, V362, P909, DOI 10.1126/science.aar2971; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takamori A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25094-4; Tong PL, 2015, J INVEST DERMATOL, V135, P84, DOI 10.1038/jid.2014.289; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Veiga-Fernandes H, 2018, SCIENCE, V359, P1465, DOI 10.1126/science.aap9598; Vivier E, 2016, NAT IMMUNOL, V17, P790, DOI 10.1038/ni.3459; Wang MC, 2018, IMMUNITY, V49, P66, DOI 10.1016/j.immuni.2018.05.012; Wang XS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14091; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Xu M, 2018, IMMUNITY, V48, P787, DOI 10.1016/j.immuni.2018.03.019; Yang J, 2016, NAT IMMUNOL, V17, P48, DOI 10.1038/ni.3312; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852; Zwick RK, 2018, CELL METAB, V27, P68, DOI 10.1016/j.cmet.2017.12.002	155	38	38	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					552	565		10.1016/j.immuni.2019.02.023	http://dx.doi.org/10.1016/j.immuni.2019.02.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893586	Green Accepted, Bronze			2022-12-18	WOS:000461660500008
J	Dingens, AS; Arenz, D; Weight, H; Overbaugh, J; Bloom, JD				Dingens, Adam S.; Arenz, Dana; Weight, Haidyn; Overbaugh, Julie; Bloom, Jesse D.			An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 BINDING-SITE; CRYO-EM STRUCTURE; GLYCAN RECOGNITION; ENVELOPE TRIMERS; POTENT; THERAPY; GP41; SENSITIVITY; MUTATIONS	Anti-HIV broadly neutralizing antibodies (bnAbs) have revealed vaccine targets on the virus's envelope (Env) protein and are themselves promising immunotherapies. The efficacy of bnAb-based therapies and vaccines depends in part on how readily the virus can escape neutralization. Although structural studies can define contacts between bnAbs and Env, only functional studies can define mutations that confer escape. Here, we mapped how all possible single amino acid mutations in Env affect neutralization of HIV by nine bnAbs targeting five epitopes. For most bnAbs, mutations at only a small fraction of structurally defined contact sites mediated escape, and most escape occurred at sites near, but not in direct contact with, the antibody. The Env mutations selected by two pooled bnAbs were similar to those expected from the combination of the bnAbs's independent action. Overall, our mutation-level antigenic atlas provides a comprehensive dataset for understanding viral immune escape and refining therapies and vaccines.	[Dingens, Adam S.; Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA; [Dingens, Adam S.; Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Computat Biol Program, Seattle, WA 98109 USA; [Dingens, Adam S.] Univ Washington, Mol & Cellular Biol PhD Program, Seattle, WA 98195 USA; [Dingens, Adam S.; Arenz, Dana; Weight, Haidyn; Overbaugh, Julie] Div Human Biol, Seattle, WA 98109 USA; [Dingens, Adam S.; Arenz, Dana; Weight, Haidyn; Overbaugh, Julie] Epidemiol Program, Seattle, WA 98109 USA; [Bloom, Jesse D.] Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Bloom, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA.; Bloom, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Computat Biol Program, Seattle, WA 98109 USA.; Overbaugh, J (corresponding author), Div Human Biol, Seattle, WA 98109 USA.; Overbaugh, J (corresponding author), Epidemiol Program, Seattle, WA 98109 USA.; Bloom, JD (corresponding author), Howard Hughes Med Inst, Seattle, WA 98109 USA.	joverbau@fredhutch.org; jbloom@fredhutch.org			NSF Graduate Research Fellowship [DGE-1256082]; NIH [R01AI127893, R01AI141707, DA039543, R01AI120961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127893, R01AI120961, R01AI140891, R01AI141707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA039543] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	A.S.D. was supported by an NSF Graduate Research Fellowship (DGE-1256082). This work was supported by NIH grants R01AI127893 and R01AI141707 to J.D.B. and by grants DA039543 and R01AI120961 to J.O. J.D.B. is an investigator of the Howard Hughes Medical Institute.	Adams R. M, 2017, ARXIV171204000; BACK NKT, 1993, J VIROL, V67, P6897, DOI 10.1128/JVI.67.11.6897-6902.1993; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bar-On Y, 2018, NAT MED, V24, P1701, DOI 10.1038/s41591-018-0186-4; Barton JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11660; Benki S, 2006, J CLIN MICROBIOL, V44, P4357, DOI 10.1128/JCM.01481-06; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Bloom JD, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0590-4; Boyd DF, 2015, J VIROL, V89, P894, DOI 10.1128/JVI.02680-14; Bradley T, 2016, EBIOMEDICINE, V12, P196, DOI 10.1016/j.ebiom.2016.08.045; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Crooks ET, 2017, VIROLOGY, V505, P193, DOI 10.1016/j.virol.2017.02.024; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Dingens AS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007159; Dingens AS, 2017, CELL HOST MICROBE, V21, P777, DOI 10.1016/j.chom.2017.05.003; Doud MB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03665-3; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Foley B, 2017, NON TRADITIONAL REF; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Haddox HK, 2018, ELIFE, V7, DOI 10.7554/eLife.34420; Haddox HK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006114; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Kim AS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004271; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liang Y, 2016, J VIROL, V90, P9224, DOI 10.1128/JVI.01116-16; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Louie RHY, 2018, P NATL ACAD SCI USA, V115, pE564, DOI 10.1073/pnas.1717765115; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Margolis DM, 2017, IMMUNOL REV, V275, P313, DOI 10.1111/imr.12506; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; O'Rourke SM, 2012, J VIROL, V86, P12105, DOI 10.1128/JVI.01352-12; Otsuka Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007238; Pegu A, 2017, IMMUNOL REV, V275, P296, DOI 10.1111/imr.12511; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Poss M, 1999, J VIROL, V73, P5255, DOI 10.1128/JVI.73.7.5255-5264.1999; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Sethi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003046; Shekhar K, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062705; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Townsley S, 2016, J VIROL, V90, P829, DOI 10.1128/JVI.02321-15; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Verkerke HP, 2016, J VIROL, V90, P9471, DOI 10.1128/JVI.01351-16; Wagh K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006860; Wagh K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005520; Wagih O, 2017, BIOINFORMATICS, V33, P3645, DOI 10.1093/bioinformatics/btx469; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang HN, 2017, J ADV CERAM, V6, P73, DOI 10.1007/s40145-016-0214-0; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wu NC, 2017, CELL HOST MICROBE, V22, P246, DOI 10.1016/j.chom.2017.07.001; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yoon H, 2015, NUCLEIC ACIDS RES, V43, pW213, DOI 10.1093/nar/gkv404; Zanini F, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex003	79	38	38	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					520	+		10.1016/j.immuni.2018.12.017	http://dx.doi.org/10.1016/j.immuni.2018.12.017			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30709739	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000459006700023
J	Treger, RS; Pope, SD; Kong, Y; Tokuyama, M; Taura, M; Iwasaki, A				Treger, Rebecca S.; Pope, Scott D.; Kong, Yong; Tokuyama, Maria; Taura, Manabu; Iwasaki, Akiko			The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV	IMMUNITY			English	Article							MURINE LEUKEMIA-VIRUS; DNA METHYLATION; ANTIBODY REACTIVITY; READ ALIGNMENT; TRANSCRIPTION; ERYTHEMATOSUS; CELLS; PATHOGENESIS; SEQUENCES; PROTEINS	Elevated endogenous retrovirus (ERV) transcription and anti-ERV antibody reactivity are implicated in lupus pathogenesis. Overproduction of non-ecotropic ERV (NEERV) envelope glycoprotein gp70 and resultant nephritis occur in lupus-prone mice, but whether NEERV mis-expression contributes to lupus etiology is unclear. Here we identified suppressor of NEERV (Snerv) 1 and 2, Kruppel-associated box zinc-finger proteins (KRAB-ZFPs) that repressed NEERV by binding the NEERV long terminal repeat to recruit the transcriptional regulator KAP1. Germline Snerv1/Snerv2 deletion increased activating chromatin modifications, transcription, and gp70 expression from NEERV loci. F1 crosses of lupus-prone New Zealand Black (NZB) and 129 mice to Snerv1/Snerv2(-/-) mice failed to restore NEERV repression, demonstrating that loss of SNERV underlies the lupus autoantigen gp70 overproduction that promotes nephritis in susceptible mice and that SNERV encodes for Sgp3 (in NZB mice) and Gv-1 loci (in 129 mice). Increased ERV expression in lupus patients inversely correlated with three putative ERV-suppressing KRAB-ZFPs, suggesting that loss of KRAB-ZFP-mediated ERV control may contribute to human lupus pathogenesis.	[Treger, Rebecca S.; Pope, Scott D.; Kong, Yong; Tokuyama, Maria; Taura, Manabu; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Kong, Yong] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA; [Iwasaki, Akiko] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	akiko.iwasaki@yale.edu	Kong, Yong/B-5105-2014; Iwasaki, Akiko/Z-1591-2019; Taura, Manabu/Y-6844-2019	Kong, Yong/0000-0002-2881-5274; Iwasaki, Akiko/0000-0002-7824-9856; Taura, Manabu/0000-0001-9577-8007	Howard Hughes Medical Institute; NIH [R01 AI054359, R01 AI127429, T32 GM00720540, F30 AI129265]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI129265, R01AI054359, R01AI127429] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Huiping Dong for maintaining the mouse strains used in this study. This work was supported in part by Howard Hughes Medical Institute (to A. I.) and by NIH awards R01 AI054359 and R01 AI127429 (to A.I.). R.T. was supported by NIH training grant T32 GM00720540 and F30 (F30 AI129265). M. Taura was a Japan Society for the Promotion of Science fellow and was in part supported by Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Baudino L, 2008, J IMMUNOL, V181, P2846, DOI 10.4049/jimmunol.181.4.2846; Bengtsson A, 1996, ARTHRITIS RHEUM-US, V39, P1654, DOI 10.1002/art.1780391007; BLOMBERG J, 1994, ARTHRITIS RHEUM-US, V37, P57, DOI 10.1002/art.1780370109; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Celhar T, 2017, RHEUMATOLOGY, V56, P88, DOI 10.1093/rheumatology/kew400; COFFIN JM, 1989, ANN NY ACAD SCI, V567, P39, DOI 10.1111/j.1749-6632.1989.tb16457.x; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Crampton SP, 2014, DIS MODEL MECH, V7, P1033, DOI 10.1242/dmm.016451; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; Ecco G, 2016, DEV CELL, V36, P611, DOI 10.1016/j.devcel.2016.02.024; ELDER JH, 1980, CLIN IMMUNOL IMMUNOP, V15, P493, DOI 10.1016/0090-1229(80)90061-6; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; FRANKEL WN, 1992, MAMM GENOME, V2, P110, DOI 10.1007/BF00353859; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Groger V, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00265; Groh S, 2017, CELL MOL LIFE SCI, V74, P2055, DOI 10.1007/s00018-017-2454-8; Guzeloglu-Kayisli O, 2012, BIOCHEM J, V446, P47, DOI 10.1042/BJ20120467; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Hishikawa T, 1997, VIRAL IMMUNOL, V10, P137, DOI 10.1089/vim.1997.10.137; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Ito K, 2013, J AUTOIMMUN, V43, P10, DOI 10.1016/j.jaut.2013.01.014; IZUI S, 1979, J EXP MED, V149, P1099, DOI 10.1084/jem.149.5.1099; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Kalunian KC, 2016, ANN RHEUM DIS, V75, P196, DOI 10.1136/annrheumdis-2014-206090; Kassiotis G, 2014, J IMMUNOL, V192, P1343, DOI 10.4049/jimmunol.1302972; Kazazian HH, 2017, NEW ENGL J MED, V377, P361, DOI 10.1056/NEJMra1510092; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KEMPLER G, 1993, VIROLOGY, V193, P690, DOI 10.1006/viro.1993.1177; Kihara M, 2011, J AUTOIMMUN, V37, P311, DOI 10.1016/j.jaut.2011.09.001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Kozak CA, 2015, VIRUSES-BASEL, V7, P1, DOI 10.3390/v7010001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laporte C, 2003, J IMMUNOL, V171, P3872, DOI 10.4049/jimmunol.171.7.3872; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2017, CURR OPIN RHEUMATOL, V29, P434, DOI 10.1097/BOR.0000000000000412; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Markopoulos G, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0066-8; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; MELLORS RC, 1976, P NATL ACAD SCI USA, V73, P233, DOI 10.1073/pnas.73.1.233; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; Nakkuntod J, 2013, J HUM GENET, V58, P241, DOI 10.1038/jhg.2013.6; Nelson P, 2014, LUPUS, V23, P596, DOI 10.1177/0961203314531637; Oliver PL, 1999, J VIROL, V73, P8227, DOI 10.1128/JVI.73.10.8227-8234.1999; ONEILL RR, 1986, J VIROL, V58, P359, DOI 10.1128/JVI.58.2.359-366.1986; ONEILL RR, 1985, J VIROL, V53, P100, DOI 10.1128/JVI.53.1.100-106.1985; Ottina E, 2018, CANCER IMMUNOL RES, V6, P1292, DOI 10.1158/2326-6066.CIR-18-0038; PERL A, 1995, ARTHRITIS RHEUM, V38, P1660, DOI 10.1002/art.1780381119; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2013, DEVELOPMENT, V140, P519, DOI 10.1242/dev.087585; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schmitt K, 2013, J VIROL, V87, P13837, DOI 10.1128/JVI.02388-13; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Stein Paula, 2011, J Vis Exp, DOI 10.3791/2851; Steiner Sebastian, 2009, V479, P273, DOI 10.1007/978-1-59745-289-2_18; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tomonaga K, 1998, J VIROL, V72, P8289, DOI 10.1128/JVI.72.10.8289-8300.1998; Veselovska L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0769-z; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Wu ZW, 2015, J DERMATOL SCI, V77, P110, DOI 10.1016/j.jdermsci.2014.12.004; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; YOSHIKI T, 1974, J EXP MED, V140, P1011, DOI 10.1084/jem.140.4.1011; Yoshinobu K, 2009, J IMMUNOL, V182, P8094, DOI 10.4049/jimmunol.0900263; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018	84	38	38	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					334	+		10.1016/j.immuni.2018.12.022	http://dx.doi.org/10.1016/j.immuni.2018.12.022			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30709743	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000459006700010
J	zu Horste, GM; Przybylski, D; Schramm, MA; Wang, C; Schnell, A; Lee, Y; Sobel, R; Regev, A; Kuchroo, VK				zu Horste, Gerd Meyer; Przybylski, Dariusz; Schramm, Markus A.; Wang, Chao; Schnell, Alexandra; Lee, Youjin; Sobel, Raymond; Regev, Aviv; Kuchroo, Vijay K.			Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1	IMMUNITY			English	Article							ROR-GAMMA-T; TH17 CELLS; T(H)17; ACTIVATION; MICE; GENERATION; EXPRESSION; INDUCTION; CYTOKINE; IL-17	The death receptor Fas removes activated lymphocytes through apoptosis. Previous transcriptional profiling predicted that Fas positively regulates inter-leukin-17 (IL-17)-producing T helper 17 (Th17) cells. Here, we demonstrate that Fas promoted the generation and stability of Th17 cells and prevented their differentiation into Th1 cells. Mice with T-cell-and Th17-cell-specific deletion of Fas were protected from induced autoimmunity, and Th17 cell differentiation and stability were impaired. Fas-deficient Th17 cells instead developed a Th1-cell-like transcriptional profile, which a new algorithm predicted to depend on STAT1. Experimentally, Fas indeed bound and sequestered STAT1, and Fas deficiency enhanced IL-6-induced STAT1 activation and nuclear translocation, whereas deficiency of STAT1 reversed the transcriptional changes induced by Fas deficiency. Thus, our computational and experimental approach identified Fas as a regulator of the Th17-to-Th1 cell balance by controlling the availability of opposing STAT1 and STAT3 to have a direct impact on autoimmunity.	[zu Horste, Gerd Meyer; Schramm, Markus A.; Wang, Chao; Schnell, Alexandra; Lee, Youjin; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [zu Horste, Gerd Meyer; Schramm, Markus A.; Wang, Chao; Schnell, Alexandra; Lee, Youjin; Kuchroo, Vijay K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [zu Horste, Gerd Meyer; Schramm, Markus A.; Wang, Chao; Schnell, Alexandra; Lee, Youjin; Kuchroo, Vijay K.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [zu Horste, Gerd Meyer] Univ Hosp Munster, Dept Neurol, Munster, Germany; [Przybylski, Dariusz; Regev, Aviv; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sobel, Raymond] Stanford Univ, Sch Med, Palo Alto Vet Adm Hlth Care Syst, Stanford, CA 94305 USA; [Sobel, Raymond] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Munster; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Stanford University	Kuchroo, VK (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.; Regev, A; Kuchroo, VK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	aregev@broadinstitute.org; vkuchroo@evergrande.hms.harvard.edu	Wang, Chao/GYD-5103-2022; Horste, Gerd Meyer zu/O-9549-2016	Wang, Chao/0000-0003-3084-6093; Horste, Gerd Meyer zu/0000-0002-4341-4719; Schramm, Markus/0000-0003-3513-3842; Schnell, Alexandra/0000-0003-3442-7750; Sobel, Raymond/0000-0002-0477-9002	Deutsche Forschungsgemeinschaft (DFG) [ME4050/1-1]; National Multiple Sclerosis Society postdoctoral fellowship [FG20118-A-1]; DFG [SCHR 1481/1-1]; Klarman Cell Observatory at the Broad Institute; Howard Hughes Medical Institute; NIH [RO1 NS30843, P01 AI0562999, P01 NS076410, P01 AI039671, P01 AI045757, P01 AI073748]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, P01AI073748, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS076410, R01NS030843] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Multiple Sclerosis Society postdoctoral fellowship(National Multiple Sclerosis Society); DFG(German Research Foundation (DFG)); Klarman Cell Observatory at the Broad Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Deneen Kozoriz for cell sorting. We thank Dr. Jin Wang (Department of Pharmacology, Baylor College of Medicine) for providing us with the Fas<SUP>flox</SUP> mouse line. We thank Leslie Gaffney (Broad Institute of MIT and Harvard) for helping with figure editing. G.M.z.H. was funded in part by the Deutsche Forschungsgemeinschaft (DFG; grant ME4050/1-1) and a National Multiple Sclerosis Society postdoctoral fellowship (grant FG20118-A-1). M.A.S. was funded in part by DFG grant SCHR 1481/1-1. Work was supported by the Klarman Cell Observatory at the Broad Institute (to A.R. and V.K.K.) and the Howard Hughes Medical Institute (to AR.). V.K.K. received funding from NIH grants RO1 NS30843, P01 AI0562999, P01 NS076410, P01 AI039671, P01 AI045757, and P01 AI073748.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Benjamini Y, 2001, ANN STAT, V29, P1165; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Brucklacher-Waldert V, 2016, J IMMUNOL, V196, P4893, DOI 10.4049/jimmunol.1600137; Cencioni MT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.100; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duhen R, 2013, J IMMUNOL, V190, P4478, DOI 10.4049/jimmunol.1203172; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fortner KA, 2005, J IMMUNOL, V175, P4374, DOI 10.4049/jimmunol.175.7.4374; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee Y, 2015, J CLIN INVEST, V125, P4011, DOI 10.1172/JCI75933; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Paulsen M, 2011, CELL DEATH DIFFER, V18, P619, DOI 10.1038/cdd.2010.134; Peters A, 2015, J IMMUNOL, V195, P4144, DOI 10.4049/jimmunol.1302246; Sabelko KA, 1997, J IMMUNOL, V159, P3096; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Waldner H, 1997, J IMMUNOL, V159, P3100; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	61	38	38	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					556	+		10.1016/j.immuni.2018.03.008	http://dx.doi.org/10.1016/j.immuni.2018.03.008			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562202	Bronze			2022-12-18	WOS:000427916900015
J	Whang, MI; Tavares, RM; Benjamin, DI; Kattah, MG; Advincula, R; Nomura, DK; Debnath, J; Malynn, BA; Ma, A				Whang, Michael I.; Tavares, Rita M.; Benjamin, Daniel I.; Kattah, Michael G.; Advincula, Rommel; Nomura, Daniel K.; Debnath, Jayanta; Malynn, Barbara A.; Ma, Averil			The Ubiquitin Binding Protein TAX1BP1 Mediates Autophagasome Induction and the Metabolic Transition of Activated T Cells	IMMUNITY			English	Article							NF-KAPPA-B; AMINO-ACID; LYMPHOCYTE ACTIVATION; SELECTIVE AUTOPHAGY; ENERGY-METABOLISM; MAMMALIAN TARGET; MTORC1 PATHWAY; RAPAMYCIN; CYSTEINE; PHOSPHORYLATION	During immune responses, naive T cells transition from small quiescent cells to rapidly cycling cells. We have found that T cells lacking TAX1BP1 exhibit delays in growth of cell size and cell cycling. TAX1BP1-deficient T cells exited G(0) but stalled in S phase, due to both bioenergetic and biosynthetic defects. These defects were due to deficiencies in mTOR complex formation and activation. These mTOR defects in turn resulted from defective autophagy induction. TAX1BP1 binding of LC3 and GABARAP via its LC3-interacting region (LIR), but not its ubiquitin-binding domain, supported T cell proliferation. Supplementation of TAX1BP1-deficient T cells with metabolically active L-cysteine rescued mTOR activation and proliferation but not autophagy. These studies reveal that TAX1BP1 drives a specialized form of autophagy, providing critical amino acids that activate mTOR and enable the metabolic transition of activated T cells.	[Whang, Michael I.; Tavares, Rita M.; Kattah, Michael G.; Advincula, Rommel; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Benjamin, Daniel I.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Benjamin, Daniel I.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Benjamin, Daniel I.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu		Debnath, Jayanta/0000-0002-8745-4069; Whang, Michael/0000-0002-6695-6799; Kattah, Michael/0000-0002-6067-6585; Tavares, Rita/0000-0002-1654-4454	NIH [DK095693, P30 DK026743, P30 DK063720, T32 DK007007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI124457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095693, T32DK007007, P30DK026743, P30DK063720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH DK095693, P30 DK026743, and P30 DK063720. M.I.W. and M.K. were partially supported by NIH T32 DK007007. We thank Kevan Shokat, Emin Maltepe, and Jeroen Roose for helpful comments and advice. We thank Priscilia Tanbun, Yenny Rosli, and Julio Barrera for general laboratory assistance.	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; CALNE RY, 1989, LANCET, V2, P227; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; CHAWLA RK, 1984, GASTROENTEROLOGY, V87, P770; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; ECK HP, 1989, BIOL CHEM H-S, V370, P101, DOI 10.1515/bchm3.1989.370.1.101; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GMUNDER H, 1991, EUR J BIOCHEM, V201, P113, DOI 10.1111/j.1432-1033.1991.tb16263.x; GMUNDER H, 1990, CELL IMMUNOL, V129, P32, DOI 10.1016/0008-8749(90)90184-S; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Ling L, 2000, P NATL ACAD SCI USA, V97, P9567, DOI 10.1073/pnas.170279097; Louie SM, 2016, CELL CHEM BIOL, V23, P567, DOI 10.1016/j.chembiol.2016.03.017; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin P, 2006, EMBO J, V25, P3524, DOI 10.1038/sj.emboj.7601250; Matsuzawa Y, 2015, AUTOPHAGY, V11, P1052, DOI 10.1080/15548627.2015.1055439; Morris R.E., 1992, TRANSPLANT REV-ORLAN, P39; Nakano S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073205; Newman AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050672; Okayasu T, 1997, AMINO ACIDS, V13, P379, DOI 10.1007/BF01372601; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Ren T, 2015, ONCOGENE, V34, P373, DOI 10.1038/onc.2013.552; Ren T, 2012, J BIOL CHEM, V287, P34683, DOI 10.1074/jbc.M112.377143; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; SAETRE R, 1978, ANAL BIOCHEM, V90, P684, DOI 10.1016/0003-2697(78)90161-6; Salmond RJ, 2015, J IMMUNOL, V195, P4615, DOI 10.4049/jimmunol.1501473; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Tumbarello DA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005174; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674	48	38	41	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					405	420		10.1016/j.immuni.2017.02.018	http://dx.doi.org/10.1016/j.immuni.2017.02.018			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28314591	Green Accepted, Bronze			2022-12-18	WOS:000396818100013
J	Irving, AT; Wang, D; Vasilevski, O; Latchoumanin, O; Kozer, N; Clayton, AHA; Szczepny, A; Morimoto, H; Xu, DK; Williams, BRG; Sadler, AJ				Irving, Aaron T.; Wang, Die; Vasilevski, Oliver; Latchoumanin, Olivier; Kozer, Noga; Clayton, Andrew H. A.; Szczepny, Anette; Morimoto, Hiroyuki; Xu, Dakang; Williams, Bryan R. G.; Sadler, Anthony J.			Regulation of Actin Dynamics by Protein Kinase R Control of Gelsolin Enforces Basal Innate Immune Defense	IMMUNITY			English	Article							BINDING PROTEINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CA-2+ CONTROL; POLYMERIZATION; MICE; CYTOSKELETON; MECHANISMS; FILAMENTS; HOMOLOGY; MOTILITY	Primary resistance to pathogens is reliant on both basal and inducible immune defenses. To date, research has focused upon inducible innate immune responses. In contrast to resistance via cytokine induction, basal defense mechanisms are less evident. Here we showed that the antiviral protein kinase R (PKR) inhibited the key actin-modifying protein gelsolin to regulate actin dynamics and control cytoskeletal cellular functions under homeostatic conditions. Through this mechanism, PKR controlled fundamental innate immune, actin-dependent processes that included membrane ruffling and particle engulfment. Accordingly, PKR counteracted viral entry into the cell. These findings identify a layer of host resistance, showing that the regulation of actin-modifying proteins during the innate immune response bolsters first-line defense against intracellular pathogens and has a sustained effect on virus production. Moreover, these data provide proof of principle for a concept in which the cell cytoskeleton could be targeted to elicit broad antiviral protection.	[Irving, Aaron T.; Wang, Die; Vasilevski, Oliver; Latchoumanin, Olivier; Szczepny, Anette; Morimoto, Hiroyuki; Xu, Dakang; Williams, Bryan R. G.; Sadler, Anthony J.] Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Kozer, Noga; Clayton, Andrew H. A.] Swinburne Univ Technol, Ctr Microphoton, Fac Engn & Ind Sci, Hawthorn, Vic 3122, Australia; [Morimoto, Hiroyuki] Univ Occupat & Environm Hlth, Dept Anat, Sch Med, Kitakyushu, Fukuoka 8078555, Japan	Monash University; Swinburne University of Technology; University of Occupational & Environmental Health - Japan	Sadler, AJ (corresponding author), Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic 3168, Australia.	anthony.sadler@monash.edu	Wang, Die/H-8860-2017; sadler, anthony/ABA-5572-2020; Irving, Aaron/AAE-8874-2021; Williams, Bryan R. G./A-5021-2009; irving, aaron/I-6754-2013	Wang, Die/0000-0001-7628-7309; sadler, anthony/0000-0002-7970-8030; Irving, Aaron/0000-0002-0196-1570; Williams, Bryan R. G./0000-0002-4969-1151; irving, aaron/0000-0002-0196-1570; Xu, Dakang/0000-0003-2415-4920	Victorian Government; NIH [R01AI034039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034039] Funding Source: NIH RePORTER	Victorian Government; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank F. Cribbin for editorial assistance in preparing this manuscript, C. Lo for assistance in preparing image data, M. Kinter for mass spectrometry, J. Bamburg for fluorescent actin constructs, S. Michnick and J.-F. Paradis for split Venus plasmids, and P. Faber for genetic constructs. We are also very grateful to N. De Weerd and P. Hertzog for purified recombinant IFN-alpha, B. Thomas and P. Bardin for the HRV-16, N. McMillan for the HSV-1 isolate, F. Carbone for the GFP HSV-1 isolate, M. Behlke (Integrated DNA Technologies) for the siRNA targeting GSN, and N. Watkins for the recombinant adenovirus and procedures to use this virus in vivo. This work was supported by the Victorian Government's Operational Infrastructure Support Program and by an NIH grant (R01AI034039) to B.R.G.W.	Aidinis V, 2005, PLOS GENET, V1, P455, DOI 10.1371/journal.pgen.0010048; Arora PD, 2005, MOL BIOL CELL, V16, P5175, DOI 10.1091/mbc.E05-07-0648; Asch HL, 1996, CANCER RES, V56, P4841; Bar S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000126; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Campbell JJ, 2007, MICROSC RES TECHNIQ, V70, P1034, DOI 10.1002/jemt.20513; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Crowley MR, 2000, DEV BIOL, V225, P407, DOI 10.1006/dbio.2000.9844; DeCorte V, 1997, FEBS LETT, V401, P191, DOI 10.1016/S0014-5793(96)01471-8; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Ferjani I, 2006, BIOCHEM J, V396, P461, DOI 10.1042/BJ20051690; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Halavatyi AA, 2009, BIOPHYS CHEM, V140, P24, DOI 10.1016/j.bpc.2008.11.006; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Hoffmeister KM, 2001, J BIOL CHEM, V276, P24751, DOI 10.1074/jbc.M011642200; Ke HN, 2010, CELL RES, V20, P458, DOI 10.1038/cr.2010.21; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Lin KM, 1997, J BIOL CHEM, V272, P20443, DOI 10.1074/jbc.272.33.20443; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; MAURY CPJ, 1990, FEBS LETT, V260, P85, DOI 10.1016/0014-5793(90)80072-Q; Mazur AJ, 2010, EUR J CELL BIOL, V89, P402, DOI 10.1016/j.ejcb.2009.10.017; McGhie EJ, 2004, MOL CELL, V13, P497, DOI 10.1016/S1097-2765(04)00053-X; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Safiejko-Mroczka B, 2001, CELL MOTIL CYTOSKEL, V50, P13, DOI 10.1002/cm.1038; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Sun HQ, 1997, J CELL BIOL, V138, P811, DOI 10.1083/jcb.138.4.811; Wang TY, 2006, J IMMUNOL, V176, P1355, DOI 10.4049/jimmunol.176.3.1355; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; YIN HL, 1980, J BIOL CHEM, V255, P9494; YIN HL, 1981, J BIOL CHEM, V256, P9693; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076	40	38	41	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					795	806		10.1016/j.immuni.2012.02.020	http://dx.doi.org/10.1016/j.immuni.2012.02.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22633459	Bronze			2022-12-18	WOS:000304976000013
J	Teague, RM; Greenberg, PD; Fowler, C; Huang, MZ; Tan, X; Morimoto, J; Dossett, ML; Huseby, ES; Ohlen, C				Teague, Ryan M.; Greenberg, Philip D.; Fowler, Carla; Huang, Maria Z.; Tan, Xiaoxia; Morimoto, Junko; Dossett, Michelle L.; Huseby, Eric S.; Oehlen, Claes			Peripheral CD8(+) T cell tolerance to self-proteins is regulated proximally at the T cell receptor	IMMUNITY			English	Article							IN-VIVO; ADAPTIVE TOLERANCE; TCR ANTAGONISM; CLONAL ANERGY; LIPID RAFTS; MULTIPLE-SCLEROSIS; ALLELIC EXCLUSION; EFFECTOR FUNCTION; ANTIGEN RECEPTOR; NEGATIVE SIGNAL	CD8(+) T cell tolerance, although essential for preventing autoimmunity, poses substantial obstacles to eliciting immune responses to tumor antigens, which are generally overexpressed normal proteins. Development of effective strategies to overcome tolerance for clinical applications would benefit from elucidation of the immunologic mechanism(s) regulating T cell tolerance to self. To examine how tolerance is maintained in vivo, we engineered dual-T cell receptor (TCR) transgenic mice in which CD8(+) T cells recognize two distinct antigens: a foreign viral-protein and a tolerizing self-tumor protein. Encounter with peripheral self-antigen rendered dual-TCR T cells tolerant to self, but these cells responded normally through the virus-specific TCR. Moreover, proliferation induced by virus rescued function of tolerized self-tumor-reactive TCR, restoring anti-tumor activity. These studies demonstrate that peripheral CD8(+) T cell tolerance to self-proteins can be regulated at the level of the self-reactive TCR complex rather than by central cellular inactivation and suggest an alternate strategy to enhance adoptive T cell immunotherapy.	[Teague, Ryan M.; Greenberg, Philip D.; Fowler, Carla; Huang, Maria Z.; Tan, Xiaoxia; Morimoto, Junko; Dossett, Michelle L.; Huseby, Eric S.; Oehlen, Claes] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Teague, Ryan M.; Greenberg, Philip D.; Fowler, Carla; Tan, Xiaoxia; Morimoto, Junko; Dossett, Michelle L.; Oehlen, Claes] Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Greenberg, PD (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	pgreen@u.washington.edu	Dossett, Michelle/U-1166-2019	Huang, Maria/0000-0001-6881-4754; Teague, Ryan/0000-0002-8426-2870	NCI NIH HHS [R37 CA033084, P01 CA018029, CA18029, CA33084, R01 CA033084] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033084, R37CA033084, P01CA018029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Cheng LE, 2002, J IMMUNOL, V169, P4990, DOI 10.4049/jimmunol.169.9.4990; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Daniels MA, 1999, J IMMUNOL, V162, P3761; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; DESILVA DR, 1991, J IMMUNOL, V147, P3261; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gascoigne NRJ, 2004, CURR OPIN IMMUNOL, V16, P114, DOI 10.1016/j.coi.2003.11.008; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gladow M, 2004, EUR J IMMUNOL, V34, P1882, DOI 10.1002/eji.200425041; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Guillaume S, 2003, EUR J IMMUNOL, V33, P2551, DOI 10.1002/eji.200324196; Hah C, 2005, J BIOCHEM MOL BIOL, V38, P334; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; Lohman BL, 1996, J VIROL, V70, P8199, DOI 10.1128/JVI.70.11.8199-8203.1996; MORAHAN G, 1989, NATURE, V339, P622, DOI 10.1038/339622a0; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morimoto J, 2007, J IMMUNOL, V178, P6849, DOI 10.4049/jimmunol.178.11.6849; Murtaza A, 2001, INT IMMUNOL, V13, P1085, DOI 10.1093/intimm/13.8.1085; Niederberger N, 2003, J IMMUNOL, V170, P4557, DOI 10.4049/jimmunol.170.9.4557; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Ohlen C, 2001, J IMMUNOL, V166, P2863, DOI 10.4049/jimmunol.166.4.2863; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; RAMSDELL F, 1992, SCIENCE, V257, P1130, DOI 10.1126/science.257.5073.1130; Robertson JM, 1999, J IMMUNOL, V163, P1750; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; Roszkowski JJ, 2005, CANCER RES, V65, P1570, DOI 10.1158/0008-5472.CAN-04-2076; Rouquette-Jazdanian AK, 2005, J IMMUNOL, V175, P5637, DOI 10.4049/jimmunol.175.9.5637; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Yang W, 2003, J IMMUNOL, V170, P4532, DOI 10.4049/jimmunol.170.9.4532; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102	51	38	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					662	674		10.1016/j.immuni.2008.03.012	http://dx.doi.org/10.1016/j.immuni.2008.03.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18424189	Bronze, Green Accepted			2022-12-18	WOS:000256003900013
J	Vela, JL; Aft-Azzouzene, D; Duong, BH; Ota, T; Nemazee, D				Vela, Jose Luis; Aft-Azzouzene, Djernel; Duong, Bao Hoa; Ota, Takayuki; Nemazee, David			Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production	IMMUNITY			English	Article							CHAIN GENE REARRANGEMENTS; LIGHT-CHAIN; ANTIBODY-RESPONSES; BCL-2 EXPRESSION; PRE-B; MECHANISM; MICE; TRANSCRIPTION; ELIMINATION; LYMPHOCYTES	The recombining sequence (RS) of mouse and its human equivalent, the immunoglobulin (Ig) kappa deleting element (IGKDE), are sequences found at the 3' end of the Ig kappa locus (Igk) that rearrange to inactivate Igk in developing B cells. RS recombination correlates with Ig lambda (Ig lambda) light (L) chain expression and likely plays a role in receptor editing by eliminating Igk genes encoding autoantibodies. A mouse strain was generated in which the recombination signal of RS was removed, blocking RS-mediated Igk inactivation. In RS mutant mice, receptor editing and self-tolerance were impaired, in some cases leading to autoantibody formation. Surprisingly, mutant mice also made fewer B cells expressing lambda chain, whereas lambda versus kappa isotype exclusion was only modestly affected. These results provide insight into the mechanism of L chain isotype exclusion and indicate that RS has a physiological role in promoting the formation of lambda L chain-expressing B cells.	[Vela, Jose Luis; Duong, Bao Hoa] Kellogg Sch Sci & Technol, Scripps Res Inst, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA; [Vela, Jose Luis; Aft-Azzouzene, Djernel; Duong, Bao Hoa; Ota, Takayuki; Nemazee, David] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Nemazee, D (corresponding author), Kellogg Sch Sci & Technol, Scripps Res Inst, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA.	nemazee@scripps.edu	Ota, Takayuki/Q-5528-2017	Ota, Takayuki/0000-0001-6249-0664	NIAID NIH HHS [F31 AI052484-01, T32 AI007606-03, R01 AI 33608, R01 AI 059714, T32 AI007606, F31 AI052484, T32 AI 007606, R01 AI033608-15, R01 AI033608-13, T32 AI007606-05, T32 AI 052484, F31 AI052484-02, T32 AI007606-04, T32 AI007606-06, R01 AI033608-13S1, R01 AI033608, R01 AI033608-12, R01 AI033608-11, F31 AI052484-03, R01 AI033608-14, R01 AI059714] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI052484, T32AI007606, R01AI033608, R01AI059714] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ait-Azzouzene D, 2005, J EXP MED, V201, P817, DOI 10.1084/jem.20041854; APEL TW, 1995, GENE, V156, P191, DOI 10.1016/0378-1119(94)00901-4; Berg J, 1990, Dev Immunol, V1, P53, DOI 10.1155/1990/56014; Brauninger A, 2001, EUR J IMMUNOL, V31, P3631; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Casellas R, 2007, J EXP MED, V204, P153, DOI 10.1084/jem.20061918; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; DAITCH LE, 1992, J IMMUNOL, V149, P832; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Diaw L, 2000, MOL IMMUNOL, V37, P775, DOI 10.1016/S0161-5890(00)00100-0; Dunda O, 1997, J IMMUNOL, V159, P4362; DURDIK J, 1984, NATURE, V307, P749, DOI 10.1038/307749a0; EISEN HN, 1985, ANNU REV IMMUNOL, V3, P337, DOI 10.1146/annurev.iy.03.040185.002005; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; GIACHINO C, 1995, J EXP MED, V181, P1245, DOI 10.1084/jem.181.3.1245; GOLLAHON KA, 1988, J IMMUNOL, V141, P2771; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Klein F, 2005, J IMMUNOL, V174, P367, DOI 10.4049/jimmunol.174.1.367; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; Li YJ, 2004, J EXP MED, V199, P337, DOI 10.1084/jem.20031712; MOORE MW, 1985, P NATL ACAD SCI USA, V82, P6211, DOI 10.1073/pnas.82.18.6211; Morel L, 1997, J IMMUNOL, V158, P6019; MULLER B, 1990, EUR J IMMUNOL, V20, P1409, DOI 10.1002/eji.1830200631; MULLER B, 1988, J EXP MED, V168, P2131, DOI 10.1084/jem.168.6.2131; NADEL B, 1990, EMBO J, V9, P435, DOI 10.1002/j.1460-2075.1990.tb08128.x; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; PAUZA ME, 1993, J EXP MED, V178, P139, DOI 10.1084/jem.178.1.139; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PERSIANI DM, 1987, J EXP MED, V165, P1655, DOI 10.1084/jem.165.6.1655; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SELSING E, 1995, IMMUNOGLOBULIN GENES, P194; SHAPIRO MA, 1987, J IMMUNOL, V139, P3834; SHIMIZU T, 1991, J EXP MED, V173, P1065, DOI 10.1084/jem.173.5.1065; SIMINOVITCH KA, 1987, NUCLEIC ACIDS RES, V15, P2699, DOI 10.1093/nar/15.6.2699; SIMINOVITCH KA, 1985, NATURE, V316, P260, DOI 10.1038/316260a0; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; WOOD C, 1983, P NATL ACAD SCI-BIOL, V80, P3030, DOI 10.1073/pnas.80.10.3030; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	52	38	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					161	170		10.1016/j.immuni.2007.12.011	http://dx.doi.org/10.1016/j.immuni.2007.12.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18261939	Green Accepted, Bronze			2022-12-18	WOS:000253275000007
J	Metcalf, D				Metcalf, Donald			On hematopoietic stem cell fate	IMMUNITY			English	Article							PROGENITORS; IDENTIFICATION; ENGRAFTMENT; MICE	Multipotential hematopoietic stem cells (HSCs) maintain blood-cell formation throughout life. Here, Metcalf considers the origin and heterogeneity of HSCs, their ability to self-generate, and their commitment to the various hematopoietic lineages.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Metcalf, D (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	metcalf@wehi.edu.au						Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brummendorf TH, 1999, ANN NY ACAD SCI, V872, P265, DOI 10.1111/j.1749-6632.1999.tb08471.x; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; MAY G, 2001, HEMATOPOIESIS DEV AP; Metcalf D., 1971, HEMATOPOIETIC CELLS; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Payne KJ, 2007, IMMUNITY, V26, P674, DOI 10.1016/j.immuni.2007.05.011; Quesenberry PJ, 2005, EXP HEMATOL, V33, P389, DOI 10.1016/j.exphem.2004.11.005; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Stein MI, 2004, EXP HEMATOL, V32, P1129, DOI 10.1016/j.exphem.2004.08.012; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; Taschner S, 2007, BLOOD, V109, P971, DOI 10.1182/blood-2006-04-020552.7; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Yoder MC, 1997, BLOOD, V89, P2176, DOI 10.1182/blood.V89.6.2176	31	38	40	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					669	673		10.1016/j.immuni.2007.05.012	http://dx.doi.org/10.1016/j.immuni.2007.05.012			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582339	Bronze			2022-12-18	WOS:000247646900001
J	Watford, WT; O'Shea, JJ				Watford, Wendy T.; O'Shea, John J.			Human Tyk2 kinase deficiency: Another primary immunodeficiency syndrome	IMMUNITY			English	Editorial Material									NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Watford, WT (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, ZIAAR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Reichenbach J, 2001, CURR OPIN ALLERGY CL, V1, P503, DOI 10.1097/00130832-200112000-00003; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L	10	38	57	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					695	697		10.1016/j.immuni.2006.10.007	http://dx.doi.org/10.1016/j.immuni.2006.10.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17098200	Bronze			2022-12-18	WOS:000242063100003
J	Mariuzza, RA				Mariuzza, RA			Multiple paths to multispecificity	IMMUNITY			English	Editorial Material							IMMUNORECEPTOR; NKG2D	The limited primary antibody repertoire uses multiple mechanisms to account for the large number of potential antigens. In this issue of Immunity, Sethi et al. (2006) describe a new means for expanding the antibody repertoire, whereby a single antibody isomer binds diverse antigens at different regions of the binding site.	Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Rockville, MD 20850 USA		Mariuzza, RA (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Rockville, MD 20850 USA.							DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4	9	38	38	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2006	24	4					359	361		10.1016/j.immuni.2006.03.009	http://dx.doi.org/10.1016/j.immuni.2006.03.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618592	Bronze			2022-12-18	WOS:000237153000003
J	Nicholson, MJ; Hahn, M; Wucherpfennig, KW				Nicholson, MJ; Hahn, M; Wucherpfennig, KW			Unusual features of self-peptide/MHC binding by autoimmune T cell receptors	IMMUNITY			English	Review							MYELIN BASIC-PROTEIN; MHC CLASS-II; THYMIC EPITHELIAL-CELLS; MULTIPLE-SCLEROSIS; STRUCTURAL BASIS; AFFINITY MATURATION; CRYSTAL-STRUCTURE; TRANSGENIC MICE; AMINO-ACIDS; RECOGNITION	Structural studies on T cell receptors (TCRs) specific for foreign antigens demonstrated a remarkably similar topology characterized by a central, diagonal TCR binding mode that maximizes interactions with the MHC bound peptide. However, three recent structures involving autoimmune TCRs demonstrated unusual interactions with self-peptide/MHC complexes. Two TCRs from multiple sclerosis patients bind with unconventional topologies, and both TCRs are shifted toward the peptide N terminus and the MHC class II beta chain helix. A TCR from the experimental autoimmune encephalomyelitis (EAE) model binds in a conventional orientation, but the structure is unusual because the self-peptide only partially fills the binding site. For all three TCRs, interaction with the MHC bound self-peptide is suboptimal, and only two or three TCR loops contact the peptide. Optimal TCR binding modes confer a competitive advantage for antimicrobial T cells during an infection, whereas altered binding properties may permit survival of a subset of autoreactive T cells during thymic selection.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu			NIAID NIH HHS [P01 AI045757, R01 AI064177, P01 AI45757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI064177] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Appel H, 2000, J BIOL CHEM, V275, P312, DOI 10.1074/jbc.275.1.312; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Ellmerich S, 2004, EUR J IMMUNOL, V34, P1839, DOI 10.1002/eji.200324044; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Grogan JL, 1999, J IMMUNOL, V163, P3764; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hausmann S, 1999, J IMMUNOL, V162, P338; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Hemmer B, 2000, J IMMUNOL, V164, P861, DOI 10.4049/jimmunol.164.2.861; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hill Jonathan D., 1994, IDENTITIES-GLOB STUD, V1, P7; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Liston A, 2004, IMMUNITY, V21, P817, DOI 10.1016/S1074-7613(04)00313-9; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Pribyl TM, 1996, J NEUROSCI RES, V45, P812; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; SUN R, 1995, IMMUNITY, V3, P573, DOI 10.1016/1074-7613(95)90128-0; VALLI A, 1993, J CLIN INVEST, V91, P616, DOI 10.1172/JCI116242; VOGT AB, 1994, J IMMUNOL, V153, P1665; WALL M, 1992, INT IMMUNOL, V4, P773, DOI 10.1093/intimm/4.7.773; WEDDERBURN LR, 1995, EUR J IMMUNOL, V25, P1654, DOI 10.1002/eji.1830250627; Wilson IA, 2005, NAT IMMUNOL, V6, P434, DOI 10.1038/ni0505-434; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	61	38	39	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					351	360		10.1016/j.immuni.2005.09.009	http://dx.doi.org/10.1016/j.immuni.2005.09.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226501	Green Accepted, Bronze			2022-12-18	WOS:000232995800004
J	NAKAJIMA, PB; MENETSKI, JP; ROTH, DB; GELLERT, M; BOSMA, MJ				NAKAJIMA, PB; MENETSKI, JP; ROTH, DB; GELLERT, M; BOSMA, MJ			V-D-J REARRANGEMENTS AT THE T-CELL RECEPTOR DELTA-LOCUS IN MOUSE THYMOCYTES OF THE ALPHA-BETA LINEAGE	IMMUNITY			English	Article							GAMMA-DELTA; ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODIES; GENE REARRANGEMENTS; GENOMIC ORGANIZATION; V(D)J RECOMBINATION; CD4+8+ THYMOCYTES; TRANSGENIC MICE; CHAIN GENES; SCID MICE	The T cell receptor (TCR) delta locus lies within the TCR alpha locus and is excised from the chromosome by V alpha-J alpha rearrangement. We show here that delta sequences persist in a large fraction of the DNA from mature CD4(+)CD8(-)alpha beta(+) mouse thymocytes. Virtually all delta loci in these cells are rearranged and present in extrachromosomal DNA. In immature alpha beta lineage thymocytes (CD3(-/lo)CD4(+)CD8(+)) and in CD4(+)CD8(-)alpha beta(+) thymocytes expressing a transgene-encoded alpha beta receptor, rearranged delta genes are present both in chromosomal and extrachromosomal DNA. Thus, contrary to earlier proposals, commitment to the alpha beta lineage does not require recombinational silencing of the delta locus or its deletion by a site-specific mechanism prior to V alpha-J alpha rearrangement.	NIDDKD,MOLEC BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	NAKAJIMA, PB (corresponding author), FOX CHASE CANC CTR,INST CANC RES,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.				NATIONAL CANCER INSTITUTE [R01CA004946, R37CA004946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013323] Funding Source: NIH RePORTER; NCI NIH HHS [CA-04946] Funding Source: Medline; NCRR NIH HHS [RR-05539] Funding Source: Medline; NIAID NIH HHS [AI-13323] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERTS B, 1994, MOL BIOL CELL, P359; ALLISON JP, 1987, IMMUNOL TODAY, V8, P293, DOI 10.1016/0167-5699(87)90014-4; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BERG LJ, 1988, MOL CELL BIOL, V8, P5459, DOI 10.1128/MCB.8.12.5459; BONNEVILLE M, 1989, NATURE, V342, P931, DOI 10.1038/342931a0; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; CARROLL AM, 1991, GENE DEV, V5, P1357, DOI 10.1101/gad.5.8.1357; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; ELLIOTT JF, 1988, NATURE, V331, P627; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HAAS W, 1992, CURR OPIN IMMUNOL, V4, P147, DOI 10.1016/0952-7915(92)90004-X; HARDY RR, 1985, HDB EXPT IMMUNOLOGY, V1; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HAYDAY AC, 1985, NATURE, V316, P828, DOI 10.1038/316828a0; HELD W, 1990, EUR J IMMUNOL, V20, P2133, DOI 10.1002/eji.1830200936; HOCKETT RD, 1988, P NATL ACAD SCI USA, V85, P9694, DOI 10.1073/pnas.85.24.9694; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; IWASHIMA M, 1988, P NATL ACAD SCI USA, V85, P6161; JOUVINMARCHE E, 1990, EMBO J, V9, P2141, DOI 10.1002/j.1460-2075.1990.tb07383.x; KERSH GJ, 1995, J IMMUNOL, V154, P5706; KORMAN AJ, 1989, P NATL ACAD SCI USA, V86, P267, DOI 10.1073/pnas.86.1.267; KUBO RT, 1989, J IMMUNOL, V142, P2736; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEW AM, 1986, SCIENCE, V234, P1401, DOI 10.1126/science.3787252; LEWIS S, 1989, CELL, V59, P585, DOI 10.1016/0092-8674(89)90002-0; LINDSTEN T, 1987, J EXP MED, V166, P761, DOI 10.1084/jem.166.3.761; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; LUCAS B, 1993, J IMMUNOL, V153, P53; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MEUER SC, 1983, J EXP MED, V157, P705, DOI 10.1084/jem.157.2.705; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; OKAZAKI K, 1988, EMBO J, V7, P1669, DOI 10.1002/j.1460-2075.1988.tb02994.x; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x; RAULET DH, 1985, NATURE, V314, P103, DOI 10.1038/314103a0; Roth D B, 1992, Curr Top Microbiol Immunol, V182, P115; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; Sambrook J., 1989, MOL CLONING LAB MANU; SAMELSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P6972, DOI 10.1073/pnas.80.22.6972; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHULER W, 1988, EMBO J, V7, P2019, DOI 10.1002/j.1460-2075.1988.tb03041.x; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SIM GK, 1995, J IMMUNOL, V154, P5821; TAKAGAKI Y, 1989, J IMMUNOL, V142, P2112; TAKESHITA S, 1989, EMBO J, V11, P3261; THOMPSON SD, 1990, P NATL ACAD SCI USA, V87, P5583, DOI 10.1073/pnas.87.14.5583; THOMPSON SD, 1991, EUR J IMMUNOL, V21, P1939, DOI 10.1002/eji.1830210824; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; WANG K, 1994, GENOMICS, V20, P419, DOI 10.1006/geno.1994.1196; WILSON RK, 1992, GENOMICS, V13, P1198, DOI 10.1016/0888-7543(92)90038-T; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WOOLF T, 1988, NUCLEIC ACIDS RES, V16, P3863, DOI 10.1093/nar/16.9.3863; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844	68	38	38	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					609	621		10.1016/1074-7613(95)90132-9	http://dx.doi.org/10.1016/1074-7613(95)90132-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584151	Bronze			2022-12-18	WOS:A1995TG28100009
J	Guc, E; Pollard, JW				Guc, Esra; Pollard, Jeffrey W.			Redefining macrophage and neutrophil biology in the metastatic cascade	IMMUNITY			English	Review							TUMOR-ASSOCIATED MACROPHAGES; BREAST-CANCER METASTASIS; STIMULATING FACTOR-I; MYELOID CELLS; PREMETASTATIC NICHE; ANGIOGENIC SWITCH; LUNG METASTASIS; BONE-MARROW; INFLAMMATORY MONOCYTES; PULMONARY METASTASIS	Tumor cells metastasize to distant organs through a complex series of events that are driven by tumor intrinsic and extrinsic factors. In particular, non-malignant stromal cells, including immune cells, modify tumor metastatic behavior. Of these cells, tumor-associated innate immune cells, particularly macrophages and neutrophils, suppress the cytotoxic activity of innate and adaptive killer cells and interact with tumor cells to promote their growth and malignancy. These findings in mouse cancer models suggest that targeting these sub-populations of immune cells holds therapeutic promise in treating metastatic disease. In this review, we describe the origin and role of the macrophages, neutrophils, and their progenitors in the metastatic cascade and suggest strategies that might enhance cancer therapy.	[Guc, Esra; Pollard, Jeffrey W.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh	Pollard, JW (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	jeff.pollard@ed.ac.uk			Wellcome Trust [101067/Z/13/Z]; CRUK [C17950/A26783]; MRC Centre grant [MR/N022556/1]	Wellcome Trust(Wellcome Trust); CRUK(Cancer Research UK); MRC Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding supporting the work in this review was from the Wellcome Trust 101067/Z/13/Z, CRUK C17950/A26783, and MRC Centre grant MR/N022556/1 (to J.W.P.). We thank members of the Pollard lab, particularly Dr. Luca Cassetta, for suggestions and discussions about the origins of macrophages and nomenclature.	Adams DL, 2014, P NATL ACAD SCI USA, V111, P3514, DOI 10.1073/pnas.1320198111; Aharinejad S, 2013, ENDOCR-RELAT CANCER, V20, P777, DOI 10.1530/ERC-13-0198; Akkari L, 2014, GENE DEV, V28, P2134, DOI 10.1101/gad.249599.114; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Arlauckas SP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3604; Arwert EN, 2018, CELL REP, V23, P1239, DOI 10.1016/j.celrep.2018.04.007; Baghel KS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1196299; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ballesteros I, 2020, CELL, V183, P1282, DOI 10.1016/j.cell.2020.10.003; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Beffinger M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97792; Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; BENNETT JA, 1978, P NATL ACAD SCI USA, V75, P5142, DOI 10.1073/pnas.75.10.5142; Bian ZL, 2020, NATURE, V582, P571, DOI 10.1038/s41586-020-2316-7; Bieniasz-Krzywiec P, 2019, CELL METAB, V30, P917, DOI 10.1016/j.cmet.2019.07.015; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Blattner C, 2018, CANCER RES, V78, P157, DOI 10.1158/0008-5472.CAN-17-0348; Blomberg OS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036236; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Bragado Paloma, 2012, Recent Results Cancer Res, V195, P25, DOI 10.1007/978-3-642-28160-0_3; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Cabrera RM, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0960-8; Calcinotto A, 2018, NATURE, V559, P363, DOI 10.1038/s41586-018-0266-0; Cane S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01786; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Cassetta L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001223; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Cassetta L, 2019, CANCER IMMUNOL IMMUN, V68, P687, DOI 10.1007/s00262-019-02302-2; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Celus W, 2017, CELL REP, V21, P2842, DOI 10.1016/j.celrep.2017.11.034; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chen ZH, 2017, CANCER RES, V77, P2266, DOI 10.1158/0008-5472.CAN-16-2310; Cheng SJ, 2021, CELL, V184, P792, DOI 10.1016/j.cell.2021.01.010; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; CORVESE JS, 1980, CELL IMMUNOL, V49, P293, DOI 10.1016/0008-8749(80)90031-3; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croucher PI, 2016, NAT REV CANCER, V16, P373, DOI 10.1038/nrc.2016.44; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; Devalaraja S, 2020, CELL, V180, P1098, DOI 10.1016/j.cell.2020.02.042; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Di Mitri D, 2019, CELL REP, V28, P2156, DOI 10.1016/j.celrep.2019.07.068; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Entenberg David, 2015, Intravital, V4; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Ferjancic S, 2013, BLOOD, V121, P3289, DOI 10.1182/blood-2012-08-449819; Finotello F, 2019, NAT REV GENET, V20, P724, DOI 10.1038/s41576-019-0166-7; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gangoso E, 2021, CELL, V184, P2454, DOI 10.1016/j.cell.2021.03.023; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Georgoudaki AM, 2016, CELL REP, V15, P2000, DOI 10.1016/j.celrep.2016.04.084; GERRARD TL, 1981, J NATL CANCER I, V66, P483; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginter PS, 2019, CANCERS, V11, DOI 10.3390/cancers11101507; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guleria I, 2001, INFECT IMMUN, V69, P1795, DOI 10.1128/IAI.69.3.1795-1807.2001; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Harney AS, 2015, CANCER DISCOV, V5, P932, DOI 10.1158/2159-8290.CD-15-0012; Hawila E, 2017, CELL REP, V21, P2212, DOI 10.1016/j.celrep.2017.10.104; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Hernandez L, 2009, CANCER RES, V69, P3221, DOI 10.1158/0008-5472.CAN-08-2871; HILDENBRAND R, 1995, BRIT J CANCER, V72, P818, DOI 10.1038/bjc.1995.419; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; Hsu BE, 2019, CELL REP, V27, P3902, DOI 10.1016/j.celrep.2019.05.091; Hu Z, 2020, NAT GENET, V52, P701, DOI 10.1038/s41588-020-0628-z; Hughes R, 2015, CANCER RES, V75, P3479, DOI 10.1158/0008-5472.CAN-14-3587; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jahchan NS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01611; Jayasingam SD, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01512; Jenkins RW, 2018, BRIT J CANCER, V118, P9, DOI 10.1038/bjc.2017.434; Jing WQ, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106012; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplanov I, 2019, P NATL ACAD SCI USA, V116, P1361, DOI 10.1073/pnas.1812266115; Keeley EC, 2010, ADV CANCER RES, V106, P91, DOI 10.1016/S0065-230X(10)06003-3; Keklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kersten K, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1334744; Kitamura T, 2019, CANCER IMMUNOL RES, V7, P2052, DOI 10.1158/2326-6066.CIR-19-0234; Kitamura T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.02004; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klemm F, 2020, CELL, V181, P1643, DOI 10.1016/j.cell.2020.05.007; Koscielny S, 2010, NAT REV CANCER, V10, DOI 10.1038/nrc2627-c1; Kuil LE, 2020, ELIFE, V9, DOI 10.7554/eLife.53403; Kumar V, 2016, IMMUNITY, V44, P303, DOI 10.1016/j.immuni.2016.01.014; Labelle M, 2014, P NATL ACAD SCI USA, V111, pE3053, DOI 10.1073/pnas.1411082111; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lawson MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9983; Lee W, 2019, J EXP MED, V216, P176, DOI 10.1084/jem.20181170; Lerman I, 2018, STEROIDS, V133, P96, DOI 10.1016/j.steroids.2017.11.006; Leung E, 2017, ONCOGENE, V36, P2680, DOI 10.1038/onc.2016.421; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Linde N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02481-5; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Lu ZH, 2020, NATURE, V579, P284, DOI 10.1038/s41586-020-2054-x; Lugini L, 2012, J IMMUNOL, V189, P2833, DOI 10.4049/jimmunol.1101988; Ma RY, 2020, J EXP MED, V217, DOI 10.1084/jem.20191820; Madsen DH, 2017, CELL REP, V21, P3662, DOI 10.1016/j.celrep.2017.12.011; Maisonneuve C, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108677; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Mascaux C, 2019, NATURE, V571, P570, DOI 10.1038/s41586-019-1330-0; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Miller BW, 2015, EMBO MOL MED, V7, P1063, DOI 10.15252/emmm.201404827; Mitchem JB, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3149; Mori K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1587-0; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Na YR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107643; Najmeh S, 2017, INT J CANCER, V140, P2321, DOI 10.1002/ijc.30635; Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340; Nosaka T, 2018, J IMMUNOL, V200, P1839, DOI 10.4049/jimmunol.1700544; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Okubo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27548; Ombrato L, 2019, NATURE, V572, P603, DOI 10.1038/s41586-019-1487-6; Palumbo JS, 2007, BLOOD, V110, P133, DOI 10.1182/blood-2007-01-065995; Park J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1711; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Patsialou Antonia, 2013, Intravital, V2, pe25294; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pereira ER, 2015, SEMIN CELL DEV BIOL, V38, P98, DOI 10.1016/j.semcdb.2015.01.008; Pfirschke C, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108164; Qian BZ, 2015, J EXP MED, V212, P1433, DOI 10.1084/jem.20141555; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qian JB, 2020, CELL RES, V30, P745, DOI 10.1038/s41422-020-0355-0; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Rafat M, 2018, CANCER RES, V78, P4241, DOI 10.1158/0008-5472.CAN-17-3623; Regan DP, 2019, J IMMUNOL, V202, P3087, DOI 10.4049/jimmunol.1800619; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rohan TE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju136; RUSSELL SW, 1976, J IMMUNOL, V116, P164; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Salvagno C, 2019, NAT CELL BIOL, V21, P511, DOI 10.1038/s41556-019-0298-1; Santarpia M, 2015, CANCER BIOL MED, V12, P74, DOI 10.7497/j.issn.2095-3941.2015.0022; Schalper KA, 2020, NAT MED, V26, P688, DOI 10.1038/s41591-020-0856-x; Scholl SM, 1996, BREAST CANCER RES TR, V39, P275, DOI 10.1007/BF01806155; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schulz D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38127-9; Seliger B, 2008, TRENDS MOL MED, V14, P550, DOI 10.1016/j.molmed.2008.09.010; Seubert B, 2015, HEPATOLOGY, V61, P238, DOI 10.1002/hep.27378; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma SK, 2015, J IMMUNOL, V194, P5529, DOI 10.4049/jimmunol.1403215; Sidibe A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02610-0; SMITH HO, 1995, CLIN CANCER RES, V1, P313; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Suarez-Carmona M, 2017, MOL ONCOL, V11, P805, DOI 10.1002/1878-0261.12095; Sun L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126853; Swierczak A, 2014, CANCER IMMUNOL RES, V2, P765, DOI 10.1158/2326-6066.CIR-13-0190; Szczerba BM, 2019, NATURE, V566, P553, DOI 10.1038/s41586-019-0915-y; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tan KW, 2013, BLOOD, V122, P3666, DOI 10.1182/blood-2012-11-466532; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; TOTTERMAN TH, 1980, CELL IMMUNOL, V55, P219, DOI 10.1016/0008-8749(80)90153-7; Trinh A, 2021, MOL CANCER RES, V19, P623, DOI 10.1158/1541-7786.MCR-20-0949; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang DZ, 2017, CANCER RES, V77, P3655, DOI 10.1158/0008-5472.CAN-16-3199; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weichand B, 2017, J EXP MED, V214, P2695, DOI 10.1084/jem.20160392; Wellenstein MD, 2019, NATURE, V572, P538, DOI 10.1038/s41586-019-1450-6; Wortzel I, 2019, DEV CELL, V49, P347, DOI 10.1016/j.devcel.2019.04.011; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xiao YS, 2021, CANCER CELL, V39, P423, DOI 10.1016/j.ccell.2020.12.012; Yan DY, 2016, CELL REP, V16, P2914, DOI 10.1016/j.celrep.2016.08.035; Yang LB, 2020, NATURE, V583, P133, DOI 10.1038/s41586-020-2394-6; Yang M, 2018, CANCER RES, V78, P5492, DOI 10.1158/0008-5472.CAN-18-1367; Yeo EJ, 2014, CANCER RES, V74, P2962, DOI 10.1158/0008-5472.CAN-13-2421; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang MY, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-19; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946; Zheng W, 2019, CELL REP, V29, P1747, DOI 10.1016/j.celrep.2019.10.016; Zhu Y, 2017, IMMUNITY, V47, P597, DOI 10.1016/j.immuni.2017.08.018	212	37	38	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					885	902		10.1016/j.immuni.2021.03.022	http://dx.doi.org/10.1016/j.immuni.2021.03.022		MAY 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979586	Bronze, Green Submitted			2022-12-18	WOS:000652019500008
J	Wong, R; Belk, JA; Govero, J; Uhrlaub, JL; Reinartz, D; Zhao, HY; Errico, JM; D'Souza, L; Ripperger, TJ; Nikolich-Zugich, J; Shlomchik, MJ; Satpathy, AT; Fremont, DH; Diamond, MS; Bhattacharya, D				Wong, Rachel; Belk, Julia A.; Govero, Jennifer; Uhrlaub, Jennifer L.; Reinartz, Dakota; Zhao, Haiyan; Errico, John M.; D'Souza, Lucas; Ripperger, Tyler J.; Nikolich-Zugich, Janko; Shlomchik, Mark J.; Satpathy, Ansuman T.; Fremont, Daved H.; Diamond, Michael S.; Bhattacharya, Deepta			Affinity-Restricted Memory B Cells Dominate Recall Responses to Heterologous Flaviviruses	IMMUNITY			English	Article							JAPANESE ENCEPHALITIS VACCINE; HUMAN MONOCLONAL-ANTIBODIES; LIVED PLASMA-CELLS; GERMINAL-CENTER; ZIKA VIRUS; NEUTRALIZING ANTIBODIES; NONHUMAN-PRIMATES; STRUCTURAL BASIS; SHOCK SYNDROME; MURINE MEMORY	Memory B cells (MBCs) can respond to heterologous antigens either by molding new specificities through secondary germinal centers (GCs) or by selecting preexisting clones without further affinity maturation. To distinguish these mechanisms in flavivirus infections and immunizations, we studied recall responses to envelope protein domain III (DIII). Conditional deletion of activation-induced cytidine deaminase (AID) between heterologous challenges of West Nile, Japanese encephalitis, Zika, and dengue viruses did not affect recall responses. DIII-specific MBCs were contained mostly within the plasma-cell-biased CD80(+) subset, and few GCs arose following heterologous boosters, demonstrating that recall responses are confined by preexisting clonal diversity. Measurement of monoclonal antibody (mAb) binding affinity to DIII proteins, timed AID deletion, single-cell RNA sequencing, and lineage tracing experiments point to selection of relatively low-affinity MBCs as a mechanism to promote diversity. Engineering immunogens to avoid this MBC diversity may facilitate flavivirus-type-specific vaccines with minimized potential for infection enhancement.	[Wong, Rachel; Zhao, Haiyan; Errico, John M.; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Wong, Rachel; Uhrlaub, Jennifer L.; Reinartz, Dakota; D'Souza, Lucas; Ripperger, Tyler J.; Nikolich-Zugich, Janko; Bhattacharya, Deepta] Univ Arizona, Dept Immunobiol, Tucson, AZ 85724 USA; [Belk, Julia A.; Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA	Washington University (WUSTL); University of Arizona; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bhattacharya, D (corresponding author), Univ Arizona, Dept Immunobiol, Tucson, AZ 85724 USA.	deeptab@arizona.edu		Errico, John/0000-0002-4452-8152; Uhrlaub, Jennifer/0000-0002-7745-0179; Belk, Julia/0000-0003-4724-6158; Fremont, Daved/0000-0002-8544-2689; Zhao, Haiyan/0000-0001-5123-5537	NIH [R01AI099108, K08230188, P01AI106695, R01AI132186, R01AI127828, R01AI073755, P30AR048335]; NSF Graduate Research Fellowship Program [DGE-1143954]; NSF Graduate Research Fellowship; Stanford Graduate Fellowship; NIH predoctoral training grant [T32AG058503]; Parker Institute for Cancer Immunotherapy; Cancer Research Institute; Burroughs Wellcome Fund; National Cancer Institute of the NIH [P30CA023074]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); NIH predoctoral training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01AI099108 (D.B.), K08230188 (A.T.S), P01AI106695 (M.S.D.), R01AI132186 (M.S.D.), R01AI127828 (M.S.D.), and R01AI073755 (D.H.F. and M.S.D.). R.W. was supported by the NSF Graduate Research Fellowship Program (DGE-1143954). J.A.B. was supported by an NSF Graduate Research Fellowship and a Stanford Graduate Fellowship. T.J.R. was supported by NIH predoctoral training grant T32AG058503. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Technology Impact Award from the Cancer Research Institute, and a Career Award for Medical Scientists from the Burroughs Wellcome Fund. We thank the Speed Congenics Facility of the Rheumatic Diseases Core, supported by NIH grant P30AR048335. Flow cytometry experiments reported in this publication were supported by the National Cancer Institute of the NIH under award number P30CA023074. We thank Chris Nelson and Melissa Edeling for technical support. We thank the Bioinformatics Shared Resource at the University of Arizona for assistance in bioinformatics analysis.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Andrews SF, 2019, IMMUNITY, V51, P398, DOI 10.1016/j.immuni.2019.06.024; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Castro CD, 2013, EUR J IMMUNOL, V43, P3061, DOI 10.1002/eji.201343416; Cui Y, 2016, BIOINFORMATICS, V32, P1740, DOI 10.1093/bioinformatics/btw041; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dubischar-Kastner K, 2010, VACCINE, V28, P5197, DOI 10.1016/j.vaccine.2010.05.069; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Fernandez E, 2018, MBIO, V9, DOI [10.1128/mBio.00008-18, 10.1128/mbio.00008-18]; Frei JC, 2018, J VIROL, V92, DOI [10.1128/JVI.01023-18, 10.1128/jvi.01023-18]; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Havenar-Daughton C, 2019, CELL REP, V29, P1756, DOI 10.1016/j.celrep.2019.10.008; Ho IY, 2016, J IMMUNOL METHODS, V438, P67, DOI 10.1016/j.jim.2016.09.001; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Jagger BW, 2019, J INFECT DIS, V220, P1577, DOI 10.1093/infdis/jiz338; Jash A, 2016, J IMMUNOL, V197, P1159, DOI 10.4049/jimmunol.1600882; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Lam WY, 2018, CELL REP, V24, P2479, DOI 10.1016/j.celrep.2018.07.084; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11; Makhluf H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054220; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Martinez RJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13848; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; MCNEARNEY T, 1992, P NATL ACAD SCI USA, V89, P10247, DOI 10.1073/pnas.89.21.10247; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Pape KA, 2018, IMMUNITY, V48, P1135, DOI 10.1016/j.immuni.2018.04.019; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Polo JM, 2008, BLOOD, V112, P644, DOI 10.1182/blood-2008-01-131813; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Shen WF, 2018, ELIFE, V7, DOI 10.7554/eLife.38970; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Silver J, 2018, J EXP MED, V215, P77, DOI 10.1084/jem.20171022; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Slon-Campos JL, 2019, NAT IMMUNOL, V20, P1291, DOI 10.1038/s41590-019-0477-z; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Song BH, 2012, J MICROBIOL, V50, P698, DOI 10.1007/s12275-012-2336-6; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wan ZP, 2015, ELIFE, V4, DOI 10.7554/eLife.06925; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Wong R, 2019, IMMUNOLOGY, V156, P120, DOI 10.1111/imm.13019; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zaretsky I, 2017, J EXP MED, V214, P3435, DOI 10.1084/jem.20171129; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhao HY, 2020, J EXP MED, V217, DOI 10.1084/jem.20191792; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	111	37	38	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1078	+		10.1016/j.immuni.2020.09.001	http://dx.doi.org/10.1016/j.immuni.2020.09.001			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33010224	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000599348200017
J	Wang, F; Kim, BS				Wang, Fang; Kim, Brian S.			Itch: A Paradigm of Neuroimmune Crosstalk	IMMUNITY			English	Review							GASTRIN-RELEASING-PEPTIDE; SEVERE ATOPIC-DERMATITIS; QUALITY-OF-LIFE; SUBSTANCE-P; MAST-CELL; SENSORY NEURONS; KALLIKREIN 5; SPINAL-CORD; SCRATCHING BEHAVIOR; DUPILUMAB TREATMENT	Although the medical definition of itch has been in existence for 360 years, only in the last 20 years have we begun to understand the basic mechanisms that underlie this unique sensation. Therapeutics that specifically target chronic itch as a pathologic entity are currently still not available. Recent seminal advances in itch circuitry within the nervous system have intersected with discoveries in immunology in unexpected ways to rapidly inform emerging treatment strategies. The current review aims to introduce these basic concepts in itch biology and highlight how distinct immunologic pathways integrate with recently identified itchsensory circuits in the nervous system to inform a major new paradigm of neuroimmunology and therapeutic development for chronic itch.	[Wang, Fang; Kim, Brian S.] Washington Univ, Dept Med, Div Dermatol, Sch Med, St Louis, MO 63110 USA; [Wang, Fang; Kim, Brian S.] Washington Univ, Ctr Study Itch & Sensory Disorders, Sch Med, St Louis, MO 63110 USA; [Wang, Fang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Dermatol, Guangzhou 510080, Guangdong, Peoples R China; [Kim, Brian S.] Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Sun Yat Sen University; Washington University (WUSTL); Washington University (WUSTL)	Kim, BS (corresponding author), Washington Univ, Dept Med, Div Dermatol, Sch Med, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Ctr Study Itch & Sensory Disorders, Sch Med, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.	briankim@wustl.edu	Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161; Wang, Fang/0000-0002-3327-4177	Doris Duke Charitable Foundation; LEO Pharma; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health [R01AR070116]	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); LEO Pharma(LEO Pharma); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank all members of the Kim lab for helpful comments and discussion. This work is supported by the Doris Duke Charitable Foundation, LEO Pharma, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (R01AR070116).	Akiyama T, 2010, J NEUROPHYSIOL, V104, P2442, DOI 10.1152/jn.00563.2010; Akiyama T, 2016, J INVEST DERMATOL, V136, P154, DOI 10.1038/JID.2015.388; Akiyama T, 2014, PAIN, V155, P80, DOI 10.1016/j.pain.2013.09.011; Akiyama T, 2013, J NEUROPHYSIOL, V109, P742, DOI 10.1152/jn.00539.2012; ANASTASI A, 1972, ARCH BIOCHEM BIOPHYS, V148, P443, DOI 10.1016/0003-9861(72)90162-2; Andersen HH, 2018, PAIN, V159, P1185, DOI 10.1097/j.pain.0000000000001220; Andoh T, 1998, EUR J PHARMACOL, V353, P93, DOI 10.1016/S0014-2999(98)00440-3; Andoh T, 2015, EXP DERMATOL, V24, P978, DOI 10.1111/exd.12828; Aresh B, 2017, PAIN, V158, P945, DOI 10.1097/j.pain.0000000000000861; Assas BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00023; Bickford RG, 1938, CLIN SCI, V3, P377; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; Caberlotto L, 2003, EUR J NEUROSCI, V17, P1736, DOI 10.1046/j.1460-9568.2003.02600.x; Calugareanu A, 2020, J EUR ACAD DERMATOL, V34, pE74, DOI 10.1111/jdv.15957; Campion M, 2019, EXP DERMATOL, V28, P1501, DOI 10.1111/exd.14034; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chen YL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax2945; Chen Y, 2016, J BIOL CHEM, V291, P10252, DOI 10.1074/jbc.M116.716464; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Cork MJ, 2020, J DERMATOL TREAT, V31, P606, DOI 10.1080/09546634.2019.1612836; Dale HH, 1910, J PHYSIOL-LONDON, V41, P318; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; DIMITRIADOU V, 1994, CLIN SCI, V87, P151, DOI 10.1042/cs0870151; Ding WH, 2008, J IMMUNOL, V181, P6020, DOI 10.4049/jimmunol.181.9.6020; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; EEDY DJ, 1991, J INVEST DERMATOL, V96, P434, DOI 10.1111/1523-1747.ep12469898; Egan CL, 1998, J CUTAN PATHOL, V25, P20, DOI 10.1111/j.1600-0560.1998.tb01685.x; Fernandes ES, 2013, FASEB J, V27, P1664, DOI 10.1096/fj.12-221218; Fishbane S, 2020, NEW ENGL J MED, V382, P222, DOI 10.1056/NEJMoa1912770; FJELLNER B, 1979, ACTA DERM-VENEREOL, V59, P505; Flier J, 1999, J INVEST DERMATOL, V113, P574, DOI 10.1046/j.1523-1747.1999.00730.x; Furio L, 2014, J EXP MED, V211, P499, DOI 10.1084/jem.20131797; Giura MT, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13201; Giustizieri ML, 2004, J ALLERGY CLIN IMMUN, V114, P1176, DOI 10.1016/j.jaci.2004.07.054; Glatte P, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00970; Glatzer F, 2013, J ALLERGY CLIN IMMUN, V132, P1358, DOI 10.1016/j.jaci.2013.06.023; GMEREK DE, 1983, BRIT J DERMATOL, V109, P239, DOI 10.1111/j.1365-2133.1983.tb07091.x; Goebeler M, 2001, AM J PATHOL, V158, P431, DOI 10.1016/S0002-9440(10)63986-7; Gooderham MJ, 2019, JAMA DERMATOL, V155, P1371, DOI 10.1001/jamadermatol.2019.2855; Granstein RD, 2015, ACTA PHYSIOL, V213, P586, DOI 10.1111/apha.12442; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Guarneri F, 2015, EUR ANN ALLERGY CLIN, V47, P156; Guo C.J., 2019, J INVEST DERMATOL; Guttman-Yassky E, 2020, JAMA DERMATOL, V156, P411, DOI 10.1001/jamadermatol.2020.0079; Guttman-Yassky E, 2020, J ALLERGY CLIN IMMUN, V145, P877, DOI 10.1016/j.jaci.2019.11.025; Guttman-Yassky E, 2019, J AM ACAD DERMATOL, V80, P913, DOI 10.1016/j.jaad.2018.01.018; HAGERMARK O, 1977, ACTA DERM-VENEREOL, V57, P37; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; He A, 2018, J AM ACAD DERMATOL, V79, P92, DOI 10.1016/j.jaad.2017.12.077; Huang J, 2018, NAT NEUROSCI, V21, P707, DOI 10.1038/s41593-018-0119-z; Ikoma A, 2004, NEUROLOGY, V62, P212, DOI 10.1212/WNL.62.2.212; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Inagaki N, 1999, EUR J PHARMACOL, V367, P361, DOI 10.1016/S0014-2999(98)00974-1; Inan S, 2004, EUR J PHARMACOL, V502, P233, DOI 10.1016/j.ejphar.2004.09.010; Jang H, 2016, J INVEST DERMATOL, V136, P127, DOI 10.1038/JID.2015.363; Jian TY, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1682972; Jiang HW, 2019, BRAIN BEHAV IMMUN, V80, P464, DOI 10.1016/j.bbi.2019.04.026; Kabashima K, 2018, J ALLERGY CLIN IMMUN, V142, P1121, DOI 10.1016/j.jaci.2018.03.018; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kim BS, 2020, J AM ACAD DERMATOL, V82, P1305, DOI 10.1016/j.jaad.2020.02.009; Kim BS, 2020, J ALLERGY CLIN IMMUN, V145, P572, DOI 10.1016/j.jaci.2019.08.042; Kim BS, 2019, J AM ACAD DERMATOL, V81, P1223, DOI 10.1016/j.jaad.2019.06.038; Kim S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1047; Kini SP, 2011, ARCH DERMATOL, V147, P1153, DOI 10.1001/archdermatol.2011.178; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Letourneau R, 1996, BRIT J UROL, V77, P41, DOI 10.1046/j.1464-410X.1996.08178.x; Li CL, 2016, CELL RES, V26, P967, DOI 10.1038/cr.2016.90; Li CL, 2018, NEUROSCI BULL, V34, P200, DOI 10.1007/s12264-017-0147-9; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Luo JL, 2018, J ALLERGY CLIN IMMUN, V141, P608, DOI 10.1016/j.jaci.2017.05.051; Mack MR, 2018, TRENDS IMMUNOL, V39, P980, DOI 10.1016/j.it.2018.10.001; MANTYH PW, 1989, J NEUROSCI, V9, P258; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; Mishra SK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.036; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mizumoto N, 2001, IMMUNOBIOLOGY, V204, P477, DOI 10.1078/0171-2985-00057; Morizane S, 2012, J ALLERGY CLIN IMMUN, V130, P259, DOI 10.1016/j.jaci.2012.03.006; MULDERRY PK, 1985, REGUL PEPTIDES, V12, P133, DOI 10.1016/0167-0115(85)90194-6; Murata Y, 2015, J DERMATOL, V42, P129, DOI 10.1111/1346-8138.12726; Nakagawa H, 2018, BRIT J DERMATOL, V178, P424, DOI 10.1111/bjd.16014; Nakagawa H, 2019, J ALLERGY CLIN IMMUN, V144, P1575, DOI 10.1016/j.jaci.2019.08.004; Nakagawa H, 2018, J DERMATOL, V45, P701, DOI 10.1111/1346-8138.14322; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Napolitano M, 2020, DERMATITIS, V31, P81, DOI 10.1097/DER.0000000000000517; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Nemoto O, 2016, BRIT J DERMATOL, V174, P296, DOI 10.1111/bjd.14207; Nguyen MQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185543; Niyonsaba F, 2010, J IMMUNOL, V184, P3526, DOI 10.4049/jimmunol.0900712; Nygaard U, 2016, J EUR ACAD DERMATOL, V30, P1930, DOI 10.1111/jdv.13679; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Pariser DM, 2020, J AM ACAD DERMATOL, V82, P1314, DOI 10.1016/j.jaad.2020.01.056; Park K, 2011, EUR J DERMATOL, V21, P135, DOI 10.1684/ejd.2010.1196; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; PAYAN DG, 1983, J IMMUNOL, V131, P1613; Pereira MP, 2018, EXPERT OPIN PHARMACO, V19, P443, DOI 10.1080/14656566.2018.1444752; Petra AI, 2018, ALLERGY ASTHMA PROC, V39, P153, DOI 10.2500/aap.2018.38.4105; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Qu LT, 2015, PAIN, V156, P1737, DOI 10.1097/j.pain.0000000000000208; Raap M, 2015, EXP DERMATOL, V24, P557, DOI 10.1111/exd.12717; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Reddy VB, 2010, J INVEST DERMATOL, V130, P1468, DOI 10.1038/jid.2009.430; Ringkamp M, 2011, J NEUROSCI, V31, P14841, DOI 10.1523/JNEUROSCI.3005-11.2011; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rossbach K, 2011, NEUROSCIENCE, V190, P89, DOI 10.1016/j.neuroscience.2011.06.002; Ru F, 2017, J PHYSIOL-LONDON, V595, P3651, DOI 10.1113/JP273795; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Sakata D, 2019, J ALLERGY CLIN IMMUN, V144, P1130, DOI 10.1016/j.jaci.2019.06.031; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Serrano A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-90; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Silverberg JI, 2020, J AM ACAD DERMATOL, V82, P1328, DOI 10.1016/j.jaad.2020.02.060; Silverberg JI, 2020, J ALLERGY CLIN IMMUN, V145, P173, DOI 10.1016/j.jaci.2019.08.013; Silverberg JI, 2018, ANN ALLERG ASTHMA IM, V121, P340, DOI 10.1016/j.anai.2018.07.006; Simpson EL, 2020, BRIT J DERMATOL, V183, P242, DOI 10.1111/bjd.18898; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson EL, 2019, J AM ACAD DERMATOL, V80, P1013, DOI 10.1016/j.jaad.2018.11.059; Snyder LM, 2018, NEURON, V99, P1274, DOI 10.1016/j.neuron.2018.08.044; Solinski HJ, 2014, PHARMACOL REV, V66, P570, DOI 10.1124/pr.113.008425; Solinski HJ, 2019, CELL REP, V26, P3561, DOI 10.1016/j.celrep.2019.02.089; Sollmann T, 1917, J PHARMACOL EXP THER, V9, P309; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Stander S, 2020, NEW ENGL J MED, V382, P706, DOI 10.1056/NEJMoa1908316; Stanger R, 2020, BRIT J DERMATOL, V182, P1494, DOI 10.1111/bjd.18852; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Strakhova MI, 2009, BRAIN RES, V1250, P41, DOI 10.1016/j.brainres.2008.11.018; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Sun SH, 2016, SEMIN IMMUNOPATHOL, V38, P293, DOI 10.1007/s00281-015-0530-4; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Takeda M, 2018, NEUROSCI RES, V128, P25, DOI 10.1016/j.neures.2017.07.008; Tanis R, 2019, J DRUGS DERMATOL, V18, P940; Trier AM, 2019, J IMMUNOL, V202, P2829, DOI 10.4049/jimmunol.1801473; Tsianakas A, 2018, BRIT J DERMATOL, V178, P406, DOI 10.1111/bjd.15905; UNDEM BJ, 1995, INT ARCH ALLERGY IMM, V107, P199, DOI 10.1159/000236976; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Walsh R, 2019, CHIN CLIN ONCOL, V8, DOI 10.21037/cco.2019.05.01; Wan L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15756-0; Wang F, 2020, J INVEST DERMATOL, V140, P945, DOI 10.1016/j.jid.2019.12.011; Wang F, 2019, JAMA DERMATOL, V155, P1426, DOI 10.1001/jamadermatol.2019.2804; Weisshaar E, 1997, INFLAMM RES, V46, P412, DOI 10.1007/s000110050213; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662; Werfel T, 2019, J ALLERGY CLIN IMMUN, V143, P1830, DOI 10.1016/j.jaci.2018.07.047; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Wollenberg A, 2019, J ALLERGY CLIN IMMUN, V143, P135, DOI 10.1016/j.jaci.2018.05.029; Yang TLB, 2019, J ALLERGY CLIN IMMUN, V144, P353, DOI 10.1016/j.jaci.2019.06.016; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhai LL, 2019, MEDICINES BASEL, V6, pE72; Zhao ZQ, 2014, J NEUROSCI, V34, P12402, DOI 10.1523/JNEUROSCI.1709-14.2014	169	37	38	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					753	766		10.1016/j.immuni.2020.04.008	http://dx.doi.org/10.1016/j.immuni.2020.04.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433948	Bronze			2022-12-18	WOS:000535371100010
J	Morris, AB; Farley, CR; Pinelli, DF; Adams, LE; Cragg, MS; Boss, JM; Scharer, CD; Fribourg, M; Cravedi, P; Heeger, PS; Ford, ML				Morris, Anna B.; Farley, Clara R.; Pinelli, David F.; Adams, Layne E.; Cragg, Mark S.; Boss, Jeremy M.; Scharer, Christopher D.; Fribourg, Miguel; Cravedi, Paolo; Heeger, Peter S.; Ford, Mandy L.			Signaling through the Inhibitory Fc Receptor Fc gamma RIIB Induces CD8(+) T Cell Apoptosis to Limit T Cell Immunity	IMMUNITY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SHIP; HETEROGENEITY; BIOCONDUCTOR; LYMPHOCYTES; RESPONSES; MOUSE; IGG; AID	Effector CD8(+) T cells are important mediators of adaptive immunity, and receptor-ligand interactions that regulate their survival may have therapeutic potential. Here, we identified a subset of effector CD8(+) T cells that expressed the inhibitory fragment crystallizable (Fc) receptor Fc gamma RIIB following activation and multiple rounds of division. CD8(+) T cell-intrinsic genetic deletion of Fcgr2b increased CD8(+) effector T cell accumulation, resulting in accelerated graft rejection and decreased tumor volume in mouse models. Immunoglobulin G (IgG) antibody was not required for Fc gamma RIIB-mediated control of CD8(+) T cell immunity, and instead, the immunosuppressive cytokine fibrinogen-like 2 (Fgl2) was a functional ligand for Fc gamma RIIB on CD8(+) T cells. Fgl2 induced caspase-3/7-mediated apoptosis in Fcgr2b(+), but not Fcgr2b(-/-), CD8(+) T cells. Increased expression of Fc gamma RIIB correlated with freedom from rejection following withdrawal from immunosuppression in a clinical trial of kidney transplant recipients. Together, these findings demonstrate a cell-intrinsic coinhibitory function of Fc gamma RIIB in regulating CD8(+) T cell immunity.	[Morris, Anna B.; Farley, Clara R.; Pinelli, David F.; Adams, Layne E.; Ford, Mandy L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Cragg, Mark S.] Univ Southampton, Fac Med, Canc Sci Unit, Antibody & Vaccine Grp, Southampton, Hants, England; [Boss, Jeremy M.; Scharer, Christopher D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA USA; [Fribourg, Miguel; Cravedi, Paolo; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Translat Transplant Res Ctr, New York, NY 10029 USA; [Fribourg, Miguel; Cravedi, Paolo; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Precis Inst Immunol, New York, NY 10029 USA; [Pinelli, David F.] Northwestern Univ, Feinberg Sch Med, Comprehens Transplant Ctr, Div Transplant Surg, Chicago, IL 60611 USA	Emory University; University of Southampton; Emory University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Northwestern University; Feinberg School of Medicine	Ford, ML (corresponding author), Emory Univ, Dept Surg, Atlanta, GA 30322 USA.	mandy.ford@emory.edu	Fribourg, Miguel/AAO-2186-2020; Cragg, Mark S/E-5965-2010	Cragg, Mark S/0000-0003-2077-089X	NIH [AI073707, AI104699]; NIH (NIAID) grant [U01 AI63594]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (NIAID) grant	The authors would like to acknowledge the contributions of the NIAID Clinical Trials in Organ Transplantation Consortium, including CTOT09 investigators Donald E. Hricik (University Hospitals Case Medical Center, Cleveland, OH, USA), Richard N. Formica (Yale University School of Medicine, New Haven, CT, USA), Peter Nickerson and David Rush (University of Manitoba, Winnipeg, Manitoba, Canada), Emilio D. Poggio, (Cleveland Clinic, Cleveland OH), Kathryn Tinckam (University of Toronto, Toronto, Canada), Suphamai Bunnapradist and Milagros Samaniego-Picota (University of Michigan Medical Center, Ann Arbor, MI, USA), Daniel C. Brennan (Washington University, St. Louis, MO, USA), Bernd Schroppel (Icahn School of Medicine at Mount Sinai, NY, NY, USA), Osama Gaber (Houston Methodist Hospital, Houston TX and Weil Cornell Medical College, NY, NY, USA), and Nancy D. Bridges (National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD). The arrays on CTOT samples were performed by the late Dr. Dan Salomon (Scripps Research Institute, La Jolla, CA, USA). We also acknowledge Dr. Aaron Rae and the Emory Pediatrics Flow Core, Dr. Jennifer Robertson (Emory University), Ms. Lisa Anderson (Mt. Sinai School of Medicine), and Dr. Marvi Tariq (Emory University) for assistance with flow cytometry and the NYU Genome Technology Center for Illumina sequencing. The study was funded by NIH awards AI073707 and AI104699 to M.L.F. The CTOT09 trial was supported by NIH (NIAID) grant U01 AI63594 awarded to P.S.H.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Altman MC, 2019, NAT IMMUNOL, V20, P637, DOI 10.1038/s41590-019-0347-8; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; ANDERSON CL, 1974, J EXP MED, V139, P1175, DOI 10.1084/jem.139.5.1175; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Brown DM, 2001, IMMUNOLOGY, V102, P486, DOI 10.1046/j.1365-2567.2001.01213.x; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Foerster K, 2010, J HEPATOL, V53, P608, DOI 10.1016/j.jhep.2010.04.020; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartmann BM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02035-9; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hricik DE, 2015, J AM SOC NEPHROL, V26, P3114, DOI 10.1681/ASN.2014121234; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Latha K, 2019, JNCI-J NATL CANCER I, V111, P292, DOI 10.1093/jnci/djy107; Lee HJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3619; Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934; Liu C, 2019, IMMUNITY, V51, P381, DOI 10.1016/j.immuni.2019.06.017; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Smith KGC, 2010, NAT REV IMMUNOL, V10, P328, DOI 10.1038/nri2762; Starbeck-Miller GR, 2014, J IMMUNOL, V192, P35, DOI 10.4049/jimmunol.1302232; STOUT RD, 1975, J EXP MED, V142, P611, DOI 10.1084/jem.142.3.611; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13149-x; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Williams EL, 2012, EUR J IMMUNOL, V42, P2109, DOI 10.1002/eji.201142302; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Yan J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08271-x; Yan J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv137; Yoshida T O, 1972, Scand J Immunol, V1, P401, DOI 10.1111/j.1365-3083.1972.tb03306.x; Zhu Y, 2017, INT J BIOL SCI, V13, P804, DOI 10.7150/ijbs.19398	45	37	39	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					136	+		10.1016/j.immuni.2019.12.006	http://dx.doi.org/10.1016/j.immuni.2019.12.006			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940267	Green Accepted, Bronze			2022-12-18	WOS:000507384600014
J	Mariani, SA; Li, ZA; Rice, S; Krieg, C; Fragkogianni, S; Robinson, M; Vink, CS; Pollard, JW; Dzierzak, E				Mariani, Samanta Antonella; Li, Zhuan; Rice, Siobhan; Krieg, Carsten; Fragkogianni, Stamatina; Robinson, Mark; Vink, Chris Sebastiaan; Pollard, Jeffrey William; Dzierzak, Elaine			Pro-inflammatory Aorta-Associated Macrophages Are Involved in Embryonic Development of Hematopoietic Stem Cells	IMMUNITY			English	Article							DEFINITIVE HEMATOPOIESIS; MYELOID PROGENITORS; UP-REGULATION; YOLK-SAC; RECEPTOR; ACTIVATION; SYSTEM; LOCALIZATION; REQUIREMENT; EXPRESSION	Hematopoietic stem cells (HSCs) are generated from specialized endothelial cells of the embryonic aorta. Inflammatory factors are implicated in regulating mouse HSC development, but which cells in the aorta-gonad-mesonephros (AGM) microenvironment produce these factors is unknown. In the adult, macrophages play both pro- and anti-inflammatory roles. We sought to examine whether macrophages or other hematopoietic cells found in the embryo prior to HSC generation were involved in the AGM HSC-generative microenvironment. CyTOF analysis of CD45(+) AGM cells revealed predominance of two hematopoietic cell types, mannose-receptor positive macrophages and mannose-receptor negative myeloid cells. We show here that macrophage appearance in the AGM was dependent on the chemokine receptor Cx3cr1. These macrophages expressed a pro-inflammatory signature, localized to the aorta, and dynamically interacted with nascent and emerging intra-aortic hematopoietic cells (IAHCs). Importantly, upon macrophage depletion, no adult-repopulating HSCs were detected, thus implicating a role for pro-inflammatory AGM-associated macrophages in regulating the development of HSCs.	[Mariani, Samanta Antonella; Li, Zhuan; Rice, Siobhan; Vink, Chris Sebastiaan; Dzierzak, Elaine] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Krieg, Carsten] Med Univ South Carolina, Charleston, SC 29425 USA; [Robinson, Mark] Univ Zurich, Zurich, Switzerland; [Fragkogianni, Stamatina; Pollard, Jeffrey William] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; Medical University of South Carolina; University of Zurich; University of Edinburgh	Mariani, SA (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	s.mariani@ed.ac.uk; elaine.dzierzak@ed.ac.uk	Fragkogianni, Stamatina/Y-8935-2019; Robinson, Mark D./O-2254-2019; Krieg, Carsten/ABA-6734-2020	Robinson, Mark D./0000-0002-3048-5518; Krieg, Carsten/0000-0002-5145-7591; Mariani, Samanta Antonella/0000-0003-4950-0607; FRAGKOGIANNI, STAMATINA/0000-0002-5960-8921; Vink, Chris S./0000-0002-3202-8361	ERC [AdG 341096]; MRC [MR/N022556/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank lab members for critical comments, C. Rodriguez-Seoane for technical assistance; C. Eich for vital imaging support; M.T. Fontan-Yanes for helping with the time-course experiment; the QMRI flow cytometry and cell sorting facility (S. Johnston, W. Ramsay, and M. Pattison); and T. Gillespie and D. Soong for microscopy expertise. Support provided by ERC AdG 341096 to E.D.	Bardina SV, 2015, J IMMUNOL, V195, P4306, DOI 10.4049/jimmunol.1500352; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Charbord P, 2014, CELL STEM CELL, V15, P376, DOI 10.1016/j.stem.2014.06.005; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Crisan M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9040; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Dube PR, 2017, BIOCHEM BIOPH RES CO, V491, P154, DOI 10.1016/j.bbrc.2017.07.065; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fitch SR, 2012, CELL STEM CELL, V11, P554, DOI 10.1016/j.stem.2012.07.002; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Godin I, 1995, Semin Immunol, V7, P131, DOI 10.1016/1044-5323(95)90041-1; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kadri Z, 2015, GENE DEV, V29, P2603, DOI 10.1101/gad.267633.115; Kartalaei PS, 2015, J EXP MED, V212, P93, DOI 10.1084/jem.20140767; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kim PG, 2016, BLOOD, V128, P204, DOI 10.1182/blood-2016-01-689281; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Lampinen M, 2004, ALLERGY, V59, P793, DOI 10.1111/j.1398-9995.2004.00469.x; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Manwani D, 2008, CURR TOP DEV BIOL, V82, P23, DOI 10.1016/S0070-2153(07)00002-6; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mei HE, 2015, J IMMUNOL, V194, P2022, DOI 10.4049/jimmunol.1402661; MOKOENA T, 1985, J CLIN INVEST, V75, P624, DOI 10.1172/JCI111740; Munro DAD, 2019, ELIFE, V8, DOI 10.7554/eLife.43271; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Orelio C, 2008, BLOOD, V112, P4895, DOI 10.1182/blood-2007-12-123836; Palis J, 1999, DEVELOPMENT, V126, P5073; Peeters M, 2009, DEVELOPMENT, V136, P2613, DOI 10.1242/dev.034728; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Spadaro O, 2017, CELL REP, V19, P225, DOI 10.1016/j.celrep.2017.03.046; Stremmel C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02492-2; Takahashi K, 1998, CELL TISSUE RES, V292, P311, DOI 10.1007/s004410051062; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tober J, 2007, BLOOD, V109, P1433, DOI 10.1182/blood-2006-06-031898; Travnickova J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7227; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; Yang ZF, 2004, J IMMUNOL, V173, P2507, DOI 10.4049/jimmunol.173.4.2507; Yokomizo T, 2011, BLOOD, V117, P6132, DOI 10.1182/blood-2011-02-334037; Yumine A, 2017, BLOOD RES, V52, P10, DOI 10.5045/br.2017.52.1.10; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	77	37	39	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1439	+		10.1016/j.immuni.2019.05.003	http://dx.doi.org/10.1016/j.immuni.2019.05.003			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31178352	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000471876100015
J	Uchimura, T; Oyama, Y; Deng, M; Guo, HT; Wilson, JE; Rampanelli, E; Cook, KD; Misumi, I; Tan, XM; Chen, L; Johnson, B; Tam, J; Chou, WC; Brickey, WJ; Petrucelli, A; Whitmire, JK; Ting, JPY				Uchimura, Toru; Oyama, Yoshitaka; Deng, Meng; Guo, Haitao; Wilson, Justin E.; Rampanelli, Elena; Cook, Kevin D.; Misumi, Ichiro; Tan, Xianming; Chen, Liang; Johnson, Brandon; Tam, Jason; Chou, Wei-Chun; Brickey, W. June; Petrucelli, Alex; Whitmire, Jason K.; Ting, Jenny P. Y.			The Innate Immune Sensor NLRC3 Acts as a Rheostat that Fine-Tunes T Cell Responses in Infection and Autoimmunity	IMMUNITY			English	Article							NF-KAPPA-B; COLON INFLAMMATION; INHIBITORS; REGULATOR; MECHANISM; DISEASE; TRAF6; TBK1	Appropriate immune responses require a fine balance between immune activation and attenuation. NLRC3, a non-inflammasome-forming member of the NLR innate immune receptor family, attenuates inflammation in myeloid cells and proliferation in epithelial cells. T lymphocytes express the highest amounts of Nlrc3 transcript where its physiologic relevance is unknown. We show that NLRC3 attenuated interferon-gamma and TNF expression by CD4(+) T cells and reduced T helper 1 (Th1) and Th17 cell proliferation. Nlrc3(-/-) mice exhibited increased and prolonged CD4(+) T cell responses to lymphocytic choriomeningitis virus infection andworsened experimental autoimmune encephalomyelitis (EAE). These functions of NLRC3 were executed in a T-cell-intrinsic fashion: NLRC3 reduced K63-linked ubiquitination of TNF-receptor-associated factor 6 (TRAF6) to limit NF-kappa B activation, lowered phosphorylation of eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), and diminished glycolysis and oxidative phosphorylation. This study reveals an unappreciated role for NLRC3 in attenuating CD4(+) T cell signaling and metabolism.	[Uchimura, Toru; Oyama, Yoshitaka; Guo, Haitao; Wilson, Justin E.; Rampanelli, Elena; Cook, Kevin D.; Misumi, Ichiro; Chen, Liang; Johnson, Brandon; Tam, Jason; Chou, Wei-Chun; Brickey, W. June; Petrucelli, Alex; Whitmire, Jason K.; Ting, Jenny P. Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Uchimura, Toru; Oyama, Yoshitaka; Deng, Meng; Guo, Haitao; Wilson, Justin E.; Rampanelli, Elena; Tan, Xianming; Chen, Liang; Johnson, Brandon; Tam, Jason; Chou, Wei-Chun; Brickey, W. June; Petrucelli, Alex; Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Whitmire, Jason K.; Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Deng, Meng] Univ N Carolina, Sch Dent, Oral & Craniofacial Biomed Program, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Whitmire, JK; Ting, JPY (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.; Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Whitmire, JK; Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	jwhitmir@email.unc.edu; jenny_ting@med.unc.edu	Rampanelli, Elena/AAJ-9119-2020; Misumi, Ichiro/H-8573-2019; deng, meng/X-8242-2019; , UNC Flow Cytometry Core/AGU-9839-2022	Rampanelli, Elena/0000-0002-7742-0092; Misumi, Ichiro/0000-0003-3892-7605; deng, meng/0000-0002-9051-7534; Whitmire, Jason/0000-0003-2578-6073; Cook, Kevin/0000-0003-3079-4174	NIH [AI029564, CA156330, DK094779, CA10068, U19AI109965]; Japanese vaccine research fellowship (Japan Foundation for Pediatric Research); NATIONAL CANCER INSTITUTE [R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109965, R01AI029564, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK094779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese vaccine research fellowship (Japan Foundation for Pediatric Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Flow Cytometry Core Facility at University of North Carolina at Chapel Hill for providing core and technical support. This work was supported by NIH grants AI029564, CA156330, DK094779, and CA10068 (the last to the National Multiple Sclerosis Society) to J.P.-Y.T. and U19AI109965 to J.P.-Y.T. and J.K.W. T.U. was supported by the Japanese vaccine research fellowship (Japan Foundation for Pediatric Research). We thank Dr. Shumpei Yokota and Dr. Shuichi Ito for editing the manuscript and Dr. Vijay Kuchroo for generously providing the 2D2 transgenic strain.	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00169; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Cao Y., 2015, SCI TRANSL MED, V7, P287; Cao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104104; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Friedman CF, 2016, JAMA ONCOL, V2, P1346, DOI 10.1001/jamaoncol.2016.1051; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; Gharagozloo M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0414-5; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hu SF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007266; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; Karki R, 2016, NATURE, V540, P583, DOI 10.1038/nature20597; Lechtenberg BC, 2014, CURR OPIN STRUC BIOL, V29, P17, DOI 10.1016/j.sbi.2014.08.011; Lin M, 2016, MOL CELL, V64, P267, DOI 10.1016/j.molcel.2016.08.029; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Qin XY, 2016, CELL CYCLE, V15, P781, DOI 10.1080/15384101.2016.1151581; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010	35	37	39	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1049	+		10.1016/j.immuni.2018.10.008	http://dx.doi.org/10.1016/j.immuni.2018.10.008			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566882	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000453556500011
J	Brazin, KN; Mallis, RJ; Boeszoermenyi, A; Feng, Y; Yoshizawa, A; Reche, PA; Kaur, P; Bi, K; Hussey, RE; Duke-Cohan, JS; Song, L; Wagner, G; Arthanari, H; Lang, MJ; Reinherz, EL				Brazin, Kristine N.; Mallis, Robert J.; Boeszoermenyi, Andras; Feng, Yinnian; Yoshizawa, Akihiro; Reche, Pedro A.; Kaur, Pavanjeet; Bi, Kevin; Hussey, Rebecca E.; Duke-Cohan, Jonathan S.; Song, Likai; Wagner, Gerhard; Arthanari, Haribabu; Lang, Matthew J.; Reinherz, Ellis L.			The T Cell Antigen Receptor alpha Transmembrane Domain Coordinates Triggering through Regulation of Bilayer Immersion and CD3 Subunit Associations	IMMUNITY			English	Article							TCR-CD3 COMPLEX; BETA-CHAIN; TCR; MEMBRANE; PEPTIDES; LYSINE; CD3-EPSILON-GAMMA; IDENTIFICATION; RECOGNITION; TRANSITION	Initial molecular details of cellular activation following alpha beta T cell antigen receptor (TCR) ligation by peptide-major histocompatibility complexes (pMHC) remain unexplored. We determined the nuclear magnetic resonance (NMR) structure of the TCR alpha subunit transmembrane (TM) domain revealing a bipartite helix whose segmentation fosters dynamic movement. Positively charged TM residues Arg251 and Lys256 project from opposite faces of the helix, with Lys256 controlling immersion depth. Their modification caused stepwise reduction in TCR associations with CD3 zeta zeta homodimers and CD3 epsilon gamma plus CD3 epsilon delta heterodimers, respectively, leading to an activated transcriptome. Optical tweezers revealed that Arg251 and Lys256 mutations altered alpha beta TCR-pMHC bond lifetimes, while mutations within interacting TCR alpha connecting peptide and CD3 delta CxxC motif juxtamembrane elements selectively attenuated signal transduction. Our findings suggest that mechanical forces applied during pMHC ligation initiate T cell activation via a dissociative mechanism, shifting disposition of those basic sidechains to rearrange TCR complex membrane topology and weaken TCR alpha beta and CD3 associations.	[Brazin, Kristine N.; Yoshizawa, Akihiro; Hussey, Rebecca E.; Duke-Cohan, Jonathan S.; Reinherz, Ellis L.] Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; [Brazin, Kristine N.; Yoshizawa, Akihiro; Hussey, Rebecca E.; Duke-Cohan, Jonathan S.; Reinherz, Ellis L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Brazin, Kristine N.; Yoshizawa, Akihiro; Hussey, Rebecca E.; Duke-Cohan, Jonathan S.; Reinherz, Ellis L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Mallis, Robert J.; Boeszoermenyi, Andras; Wagner, Gerhard; Arthanari, Haribabu] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Boeszoermenyi, Andras; Arthanari, Haribabu] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Feng, Yinnian; Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Reche, Pedro A.] Univ Complutense Madrid, Fac Med, Dept Immunol, E-28040 Madrid, Spain; [Kaur, Pavanjeet; Song, Likai] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Kaur, Pavanjeet] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Bi, Kevin] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Bi, Kevin] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Lang, Matthew J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University; Complutense University of Madrid; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Vanderbilt University	Reinherz, EL (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA.; Reinherz, EL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Reinherz, EL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Reche, Pedro A/B-1881-2013; Duke-Cohan, Jonathan/A-5812-2010; Boeszoermenyi, Andras/AAD-9808-2020	Reche, Pedro A/0000-0003-3966-5838; Duke-Cohan, Jonathan/0000-0002-9478-9609; Boeszoermenyi, Andras/0000-0001-9810-7241; Yoshizawa, Akihiro/0000-0001-9941-6038; Arthanari, Haribabu/0000-0002-7281-1289	NIH [PO1 GM047467, AI037581, R56 AI138489, R01AI100643]; FWF [J3872-B21]; NSF DMR [1157490]; NHMFL UCGP [5080]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI138489, R01AI136960, R01AI100643, R01AI037581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FWF(Austrian Science Fund (FWF)); NSF DMR(National Science Foundation (NSF)); NHMFL UCGP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Dr. Derin Keskin, Zahra Hayati, and Dr. Vlado Gelev for technical assistance and Dr. Jia-huai Wang for scientific discussions. This work is supported by NIH grants PO1 GM047467 to G.W. and E.L.R., AI037581 to G.W., and R56 AI138489 and R01AI100643 to E.L.R. and M.J.L. Funding is also provided by the FWF project J3872-B21 to A.B., NSF DMR 1157490 to the NHMFL, and the NHMFL UCGP 5080 grant to L.S.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Baniyash M, 2014, CANCER IMMUNOL IMMUN, V63, P11, DOI 10.1007/s00262-013-1468-9; Bhatnagar A, 2003, MOL IMMUNOL, V39, P953, DOI 10.1016/S0161-5890(03)00027-0; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Blazquez-Moreno A, 2017, P NATL ACAD SCI USA, V114, pE5645, DOI 10.1073/pnas.1706483114; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; DeFord-Watts LM, 2009, J IMMUNOL, V183, P1055, DOI 10.4049/jimmunol.0900404; Fajer PG, 2007, BIOL MAGN RESON, V27, P95; Feng YN, 2017, P NATL ACAD SCI USA, V114, pE8204, DOI 10.1073/pnas.1703559114; Franzmann M, 2009, CHEMBIOCHEM, V10, P2339, DOI 10.1002/cbic.200900347; Guo XD, 2017, CELL RES, V27, P505, DOI 10.1038/cr.2017.42; Hartmann J, 2017, EMBO MOL MED, V9, P1183, DOI 10.15252/emmm.201607485; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; KISHIMOTO H, 1995, J EXP MED, V182, P1997, DOI 10.1084/jem.182.6.1997; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Krshnan L, 2016, P NATL ACAD SCI USA, V113, pE6649, DOI 10.1073/pnas.1611445113; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MEUER SC, 1983, SCIENCE, V222, P1239, DOI 10.1126/science.6606228; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Roberts G. C. K., 1993, NMR MACROMOLECULES P; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; WEISSMAN AM, 1986, NATURE, V324, P480, DOI 10.1038/324480a0	44	37	37	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					829	+		10.1016/j.immuni.2018.09.007	http://dx.doi.org/10.1016/j.immuni.2018.09.007			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30389415	Green Accepted, Bronze			2022-12-18	WOS:000450752200010
J	Labed, SA; Wani, KA; Jagadeesan, S; Hakkim, A; Najibi, M; Irazoqui, JE				Labed, Sid Ahmed; Wani, Khursheed A.; Jagadeesan, Sakthimala; Hakkim, Abdul; Najibi, Mehran; Irazoqui, Javier Elbio			Intestinal Epithelial Wnt Signaling Mediates Acetylcholine-Triggered Host Defense against Infection	IMMUNITY			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NONNEURONAL CHOLINERGIC SYSTEM; MUSCARINIC RECEPTORS; INNATE IMMUNITY; C. ELEGANS; SYNAPTIC-TRANSMISSION; TRANSCRIPTION FACTORS; PATHOGEN RECOGNITION; ULCERATIVE-COLITIS; GENETIC-ANALYSIS	Regulated antimicrobial peptide expression in the intestinal epithelium is key to defense against infection and to microbiota homeostasis. Understanding the mechanisms that regulate such expression is necessary for understanding immune homeostasis and inflammatory disease and for developing safe and effective therapies. We used Caenorhabditis elegans in a preclinical approach to discover mechanisms of antimicrobial gene expression control in the intestinal epithelium. We found an unexpected role for the cholinergic nervous system. Infection-induced acetylcholine release from neurons stimulated muscarinic signaling in the epithelium, driving downstream induction of Wnt expression in the same tissue. Wnt induction activated the epithelial canonical Wnt pathway, resulting in the expression of C-type lectin and lysozyme genes that enhanced host defense. Furthermore, the muscarinic and Wnt pathways are linked by conserved transcription factors. These results reveal a tight connection between the nervous system and the intestinal epithelium, with important implications for host defense, immune homeostasis, and cancer.	[Labed, Sid Ahmed; Najibi, Mehran; Irazoqui, Javier Elbio] Harvard Med Sch, Massachusetts Gen Hosp, Res Inst, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Jagadeesan, Sakthimala; Hakkim, Abdul] Harvard Med Sch, Massachusetts Gen Hosp, Res Inst, Dept Mol Biol, Boston, MA 02114 USA; [Labed, Sid Ahmed; Wani, Khursheed A.; Najibi, Mehran; Irazoqui, Javier Elbio] Univ Massachusetts, Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester	Irazoqui, JE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Res Inst, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.; Irazoqui, JE (corresponding author), Univ Massachusetts, Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.	javier.irazoqui@umassmed.edu	Najibi, Mehran/AAT-8275-2020; Wani, Khursheed/AAH-9203-2021	Irazoqui, Javier/0000-0001-6553-1329	National Institute of General Medical Sciences of the National Institutes of Health [GM101056]; National Science Foundation [NSF1457055]; NIH Office of Research Infrastructure Programs [P40 OD010440]; Direct For Biological Sciences [1656925] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101056] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Frederick Ausubel and his laboratory provided generous intellectual input and shared laboratory space and equipment. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number GM101056 and by the National Science Foundation under award number NSF1457055 (to J.E.I.). Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Amaral Flavio Almeida, 2016, Curr Neurovasc Res, V13, P4; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Bloes DA, 2015, NAT REV MICROBIOL, V13, P95, DOI 10.1038/nrmicro3390; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Carroll R. K., 2013, GENOME ANNOUNC, V1, P1; Chatterjee S, 2016, J AM GERIATR SOC, V64, P394, DOI 10.1111/jgs.13932; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Darby M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004636; Dhawan S, 2015, ACTA PHYSIOL, V213, P846, DOI 10.1111/apha.12469; Dhawan S, 2016, AM J PHYSIOL-GASTR L, V311, pG920, DOI 10.1152/ajpgi.00114.2016; Dhawan S, 2012, LIFE SCI, V91, P1038, DOI 10.1016/j.lfs.2012.04.042; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Sales ME, 2010, CURR OPIN INVEST DR, V11, P1239; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Foong JPP, 2014, J PHYSIOL-LONDON, V592, P777, DOI 10.1113/jphysiol.2013.265686; Gautron L, 2013, J COMP NEUROL, V521, P3741, DOI 10.1002/cne.23376; Gilani AH, 2004, LIFE SCI, V75, P2377, DOI 10.1016/j.lfs.2004.03.035; Grando SA, 2015, INT IMMUNOPHARMACOL, V29, P1, DOI 10.1016/j.intimp.2015.08.023; Harrington AM, 2010, NEUROGASTROENT MOTIL, V22, P999, DOI 10.1111/j.1365-2982.2009.01456.x; Head B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004609; Hirota CL, 2006, BRIT J PHARMACOL, V149, P463, DOI 10.1038/sj.bjp.0706889; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Hooper LV, 2015, ADV IMMUNOL, V126, P129, DOI 10.1016/bs.ai.2014.11.003; Hwang JM, 1999, RECEPTOR CHANNEL, V6, P415; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Jeremias IC, 2016, MOL NEUROBIOL, V53, P6635, DOI 10.1007/s12035-015-9538-y; Jonsson M, 2007, INFLAMM BOWEL DIS, V13, P1347, DOI 10.1002/ibd.20224; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Khan MRI, 2014, BBA-MOL BASIS DIS, V1842, P635, DOI 10.1016/j.bbadis.2013.12.007; Khan MRI, 2013, J GASTROENTEROL, V48, P885, DOI 10.1007/s00535-012-0718-5; Kini AT, 2015, INFLAMM BOWEL DIS, V21, P2549, DOI 10.1097/MIB.0000000000000523; Koslowski MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002523; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Lackner MR, 1998, GENETICS, V150, P103; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lehner B, 2006, NAT PROTOC, V1, P1617, DOI 10.1038/nprot.2006.245; Luallen RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124065; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Matera MG, 2014, EXPERT OPIN PHARMACO, V15, P961, DOI 10.1517/14656566.2014.899581; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; McGhee James D, 2007, WormBook, P1; McLean LP, 2015, INFLAMM BOWEL DIS, V21, P1860, DOI 10.1097/MIB.0000000000000408; McMullan R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002530; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Najibi M, 2016, CELL REP, V15, P1728, DOI 10.1016/j.celrep.2016.04.052; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oettgen P, 2006, CIRC RES, V99, P1159, DOI 10.1161/01.RES.0000251056.85990.db; Peng ZS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-204; Pereira L, 2015, ELIFE, V4, DOI 10.7554/eLife.12432; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pochini L, 2012, BBA-BIOMEMBRANES, V1818, P559, DOI 10.1016/j.bbamem.2011.12.014; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Rand J. B., 2007, WORMBOOK, DOI [10.1895/worm-book.1.131.1, DOI 10.1895/WORM-BOOK.1.131.1]; Raufman JP, 2008, CANCER RES, V68, P3573, DOI 10.1158/0008-5472.CAN-07-6810; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rossler OG, 2008, ARCH BIOCHEM BIOPHYS, V470, P93, DOI 10.1016/j.abb.2007.11.008; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sarkar A, 2016, TRENDS NEUROSCI, V39, P763, DOI 10.1016/j.tins.2016.09.002; Sawa Hitoshi, 2013, WormBook, P1, DOI 10.1895/wormbook.1.7.2; Silva-Garcia O, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/310183; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Steger KA, 2004, GENETICS, V167, P633, DOI 10.1534/genetics.103.020230; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tracey KJ, 2014, COLD SPRING HARB PER, V7, DOI [10.1101/cshperspect.a016360, DOI 10.1101/CSHPERSPECT.A01636025376836]; Tsoyi K, 2015, J LEUKOCYTE BIOL, V97, P171, DOI 10.1189/jlb.4A0214-087R; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Verbout Norah G, 2012, Handb Exp Pharmacol, P403, DOI 10.1007/978-3-642-23274-9_17; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Xu ZJ, 2001, J IMMUNOL, V167, P6975, DOI 10.4049/jimmunol.167.12.6975; Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	88	37	39	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					963	+		10.1016/j.immuni.2018.04.017	http://dx.doi.org/10.1016/j.immuni.2018.04.017			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768179	Green Accepted, Bronze			2022-12-18	WOS:000432488600016
J	Burrack, KS; Huggins, MA; Taras, E; Dougherty, P; Henzler, CM; Yang, RD; Alter, S; Jeng, EK; Wong, HC; Felices, M; Cichocki, F; Miller, JS; Hart, GT; Johnson, AJ; Jameson, SC; Hamilton, SE				Burrack, Kristina S.; Huggins, Matthew A.; Taras, Emily; Dougherty, Philip; Henzler, Christine M.; Yang, Rendong; Alter, Sarah; Jeng, Emily K.; Wong, Hing C.; Felices, Martin; Cichocki, Frank; Miller, Jeffrey S.; Hart, Geoffrey T.; Johnson, Aaron J.; Jameson, Stephen C.; Hamilton, Sara E.			Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells	IMMUNITY			English	Article							CD8(+) T-CELLS; NK CELLS; IN-VIVO; IL-10 PRODUCTION; FUSION COMPLEX; BRAIN; SUPERAGONIST; PATHOGENESIS; RESPONSES; ANTIBODY	Cerebral malaria is a deadly complication of Plasmodium infection and involves blood brain barrier (BBB) disruption following infiltration of white blood cells. During experimental cerebral malaria (ECM), mice inoculated with Plasmodium berghei ANKA-infected red blood cells develop a fatal CM-like disease caused by CD8(+) T cell-mediated pathology. We found that treatment with interleukin-15 complex (IL-15C) prevented ECM, whereas IL-2C treatment had no effect. IL-15C-expanded natural killer (NK) cells were necessary and sufficient for protection against ECM. IL-15C treatment also decreased CD8(+) T cell activation in the brain and prevented BBB breakdown without influencing parasite load. IL-15C induced NK cells to express IL-10, which was required for IL-15C-mediated protection against ECM. Finally, we show that ALT-803, a modified human IL-15C, mediates similar induction of IL-10 in NK cells and protection against ECM. These data identify a regulatory role for cytokine-stimulated NK cells in the prevention of a pathogenic immune response.	[Burrack, Kristina S.; Huggins, Matthew A.; Jameson, Stephen C.; Hamilton, Sara E.] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA; [Huggins, Matthew A.; Johnson, Aaron J.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Taras, Emily; Dougherty, Philip; Felices, Martin; Cichocki, Frank; Miller, Jeffrey S.] Univ Minnesota, Dept Med, Minneapolis, MN 55414 USA; [Henzler, Christine M.; Yang, Rendong] Univ Minnesota, Supercomp Inst Adv Computat Res, Minneapolis, MN 55414 USA; [Alter, Sarah; Jeng, Emily K.; Wong, Hing C.] Altor BioSci Corp, Miramar, FL 33025 USA; [Hart, Geoffrey T.] Univ Minnesota, Ctr Immunol, Dept Med, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hamilton, SE (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA.	hamil062@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Wong, Hing C./0000-0002-6865-4313; Huggins, Matthew/0000-0003-2964-8719	University of Minnesota Office of the Vice President for Research [108127]; NIH [R21-AI100088, F32-AI120312-01, R56-NS094150, T32-AI7425-19]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI120312, R21AI100088, T32AI007425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS094150] Funding Source: NIH RePORTER	University of Minnesota Office of the Vice President for Research(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Susan Pierce, PhD for parasites and advice. We thank Kristin Hogquist, PhD, and Thomas Morrison, PhD, for advice and critical review of the manuscript. This project was supported by a Grant-in-Aid from the University of Minnesota Office of the Vice President for Research (108127 to S.E.H.) and NIH grants R21-AI100088 (S.C.J. and S.E.H.), F32-AI120312-01 (K.S.B.), R56-NS094150 (A.J.J.), and T32-AI7425-19 (M.A.H.).	Basher F, 2016, ONCOTARGET, V7, P814, DOI 10.18632/oncotarget.6416; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Biron CA, 2012, P NATL ACAD SCI USA, V109, P1814, DOI 10.1073/pnas.1120528109; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cichocki F., 2010, PLOS PATHOG, V612, P15; Claser C, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00941-16; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; Crouse J, 2015, TRENDS IMMUNOL, V36, P49, DOI 10.1016/j.it.2014.11.001; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; de Oca Marcela Montes, 2013, Methods Mol Biol, V1031, P203, DOI 10.1007/978-1-62703-481-4_23; Dende C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12671; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Fauconnier M, 2012, J IMMUNOL, V188, P1905, DOI 10.4049/jimmunol.1101978; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; Floros T, 2015, SEMIN ONCOL, V42, P539, DOI 10.1053/j.seminoncol.2015.05.015; Gleissner CA, 2007, EUR J IMMUNOL, V37, P177, DOI 10.1002/eji.200636498; Gordon EB, 2015, P NATL ACAD SCI USA, V112, P13075, DOI 10.1073/pnas.1516544112; Hamilton SE, 2010, J IMMUNOL, V185, P6584, DOI 10.4049/jimmunol.1001215; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hora R, 2016, METAB BRAIN DIS, V31, P225, DOI 10.1007/s11011-015-9787-5; Howland SW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004963; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Howland SW, 2015, SEMIN IMMUNOPATHOL, V37, P221, DOI 10.1007/s00281-015-0476-6; Huggins MA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00985-16; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; Kelley, 2014, CUMMERBUND VISUALIZA; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim PS, 2016, ONCOTARGET, V7, P16130, DOI 10.18632/oncotarget.7470; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; Mathios D, 2016, INT J CANCER, V138, P187, DOI 10.1002/ijc.29686; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Niikura M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/383962; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Onkoba WN, 2016, J HELMINTHOL, V90, P547, DOI 10.1017/S0022149X15000723; Park JY, 2011, MOL CELLS, V32, P265, DOI 10.1007/s10059-011-1057-8; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Potchen MJ, 2012, AM J NEURORADIOL, V33, P1740, DOI 10.3174/ajnr.A3035; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Renia L, 2006, PARASITE IMMUNOL, V28, P589, DOI 10.1111/j.1365-3024.2006.00903.x; Rosario M, 2016, CLIN CANCER RES, V22, P596, DOI 10.1158/1078-0432.CCR-15-1419; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Ryg-Cornejo V, 2013, IMMUNOBIOLOGY, V218, P263, DOI 10.1016/j.imbio.2012.05.018; Shaw TN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005210; Specht S, 2010, MICROBES INFECT, V12, P635, DOI 10.1016/j.micinf.2010.04.006; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Storm J, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00100; Swanson PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006022; Tarrio ML, 2014, J IMMUNOL, V193, P354, DOI 10.4049/jimmunol.1302999; Tomala J, 2009, J IMMUNOL, V183, P4904, DOI 10.4049/jimmunol.0900284; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Verdeil G, 2008, P NATL ACAD SCI USA, V105, P16683, DOI 10.1073/pnas.0805054105; Votavova P, 2014, IMMUNOL LETT, V159, P1, DOI 10.1016/j.imlet.2014.01.017; Welsh RM, 2013, VIROLOGY, V435, P37, DOI 10.1016/j.virol.2012.10.005; WHO, 2016, WORLD MAL REP 2016; Xu WX, 2013, CANCER RES, V73, P3075, DOI 10.1158/0008-5472.CAN-12-2357; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zhao H, 2014, CELL HOST MICROBE, V15, P551, DOI 10.1016/j.chom.2014.04.008	70	37	38	9	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					760	+		10.1016/j.immuni.2018.03.012	http://dx.doi.org/10.1016/j.immuni.2018.03.012			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29625893	Bronze, Green Accepted			2022-12-18	WOS:000430198900021
J	Gunther, S; Deredge, D; Bowers, AL; Luchini, A; Bonsor, DA; Beadenkopf, R; Liotta, L; Wintrode, PL; Sundberg, EJ				Gunther, Sebastian; Deredge, Daniel; Bowers, Amanda L.; Luchini, Alessandra; Bonsor, Daniel A.; Beadenkopf, Robert; Liotta, Lance; Wintrode, Patrick L.; Sundberg, Eric J.			IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor	IMMUNITY			English	Article							INTERLEUKIN-1 RECEPTOR; STRUCTURAL INSIGHTS; ST2; ANTAGONIST; ACTIVATION; AGONIST; SYSTEM; REQUIRES; FEATURES; LIGAND	Within the interleukin 1 (IL-1) cytokine family, IL-1 receptor accessory protein (IL-1RAcP) is the co-receptor for eight receptor-cytokine pairs, including those involving cytokines IL-1 beta and IL-33. Unlike IL-1 beta, IL-33 does not have a signaling complex that includes both its cognate receptor, ST2, and the shared co-receptor IL-1RAcP, which we now present here. Although the IL-1 beta and IL-33 complexes shared structural features and engaged identical molecular surfaces of IL-1RAcP, these cytokines had starkly different strategies for co-receptor engagement and signal activation. Our data suggest that IL-1 beta binds to IL-1RI to properly present the cytokine to IL-1RAcP, whereas IL-33 binds to ST2 in order to conformationally constrain the cognate receptor in an IL-1RAcP-receptive state. These findings indicate that members of the IL-1 family of cytokines use distinct molecular mechanisms to signal through their shared co-receptor, and they provide the foundation from which to design new therapies to target IL-33 signaling.	[Gunther, Sebastian; Bowers, Amanda L.; Bonsor, Daniel A.; Beadenkopf, Robert; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Deredge, Daniel; Wintrode, Patrick L.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Luchini, Alessandra; Liotta, Lance] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; George Mason University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.; Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	esundberg@ihv.umaryland.edu	Luchini, Alessandra/M-5340-2014; Guenther, Sebastian/GON-7207-2022	Luchini, Alessandra/0000-0003-1599-0214; Guenther, Sebastian/0000-0002-7329-6653; Sundberg, Eric/0000-0003-0478-3033	American Asthma Foundation [13-0066]; National Institutes of Health (NIH) [R01AR068436, R33CA206937]; Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; National Science Foundation [DMR-0936384]; NIH [GM-103485]; University of Maryland School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NATIONAL CANCER INSTITUTE [R33CA206937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068436] Funding Source: NIH RePORTER	American Asthma Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland School of Pharmacy Mass Spectrometry Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were supported by an American Asthma Foundation Scholar Award (13-0066) to E.J.S. and National Institutes of Health (NIH) awards (R01AR068436 and R33CA206937) to L.L. This research used resources of the Advanced Photon Source, operated for the Department of Energy Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357, and the Cornell High Energy Synchrotron Source, supported by National Science Foundation award DMR-0936384 and NIH award GM-103485. This work was supported in part by the University of Maryland School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014).	Acerbo AS, 2015, J SYNCHROTRON RADIAT, V22, P180, DOI 10.1107/S1600577514020360; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Gunther S, 2014, J IMMUNOL, V193, P921, DOI 10.4049/jimmunol.1400538; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; JU G, 1991, P NATL ACAD SCI USA, V88, P2658, DOI 10.1073/pnas.88.7.2658; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Lott JM, 2015, J LEUKOCYTE BIOL, V97, P1037, DOI 10.1189/jlb.3RI1214-595R; Luchini A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5413; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendoza JL, 2017, IMMUNITY, V46, P379, DOI 10.1016/j.immuni.2017.02.017; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Moraga I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2677; Nagata A, 2012, CELL MOL IMMUNOL, V9, P399, DOI 10.1038/cmi.2012.29; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Sattler S, 2013, ARCH IMMUNOL THER EX, V61, P107, DOI 10.1007/s00005-012-0208-8; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Takegawa K, 1997, ARCH BIOCHEM BIOPHYS, V338, P22, DOI 10.1006/abbi.1996.9803; Takezako N, 2006, BIOCHEM BIOPH RES CO, V341, P425, DOI 10.1016/j.bbrc.2005.12.206; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Vyncke L, 2016, STRUCTURE, V24, P437, DOI 10.1016/j.str.2015.12.018; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Wilkins MR, 1999, METH MOL B, V112, P531; Yang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146522	58	37	41	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					510	+		10.1016/j.immuni.2017.08.004	http://dx.doi.org/10.1016/j.immuni.2017.08.004			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930661	Bronze, Green Accepted			2022-12-18	WOS:000411128200015
J	Church, SE; Galon, J				Church, Sarah E.; Galon, Jerome			Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a Glimpse	IMMUNITY			English	Editorial Material							IMMUNE CELLS; CANCER	Predicting cancer patients' response to therapy is essential for curing disease and improving quality of life. Garraway and colleagues demonstrate that the frequency and number of neoantigens, non-synonymous mutations, and adaptive immune genes, but not the assessment of individual recurrent neoantigens or mutations, predicts patient responses to immunotherapy.	[Church, Sarah E.; Galon, Jerome] INSERM, UMRS1138, Lab Integrat Canc Immunol, F-75006 Paris, France; [Church, Sarah E.; Galon, Jerome] Univ Paris 05, F-75006 Paris, France; [Church, Sarah E.; Galon, Jerome] Univ Paris 06, Cordeliers Res Ctr, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Galon, J (corresponding author), INSERM, UMRS1138, Lab Integrat Canc Immunol, F-75006 Paris, France.	jerome.galon@crc.jussieu.fr	Galon, Jerome/G-9838-2019	Galon, Jerome/0000-0001-9635-1339				Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Cobbold M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006061; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Koster B.D., 2015, CURR OPIN ONCOL; Madsen CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050139; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Van Allen E.M., 2015, SCIENCE; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522	10	37	38	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					631	633		10.1016/j.immuni.2015.10.004	http://dx.doi.org/10.1016/j.immuni.2015.10.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488814	Bronze			2022-12-18	WOS:000363478700007
J	Whibley, N; Gaffen, SL				Whibley, Natasha; Gaffen, Sarah L.			Gut-Busters: IL-17 Ain't Afraid of No IL-23	IMMUNITY			English	Editorial Material							INTERLEUKIN-17; INFLAMMATION; COLITIS	Interleukin-23 (IL-23) is considered a critical regulator of IL-17 in lymphocytes. Whereas antibodies targeting IL-23 ameliorate colitis, IL-17 neutralization exacerbates disease. In this issue, Cua and colleagues and Maxwell and colleagues show that IL-17 maintains intestinal barrier integrity, helping explain this dichotomy (Lee et al., 2015; Maxwell et al., 2015).	[Whibley, Natasha] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Gaffen, Sarah L.] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, 930 Scaife Hall, Pittsburgh, PA 15261 USA	University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gaffen, SL (corresponding author), Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, 930 Scaife Hall, Pittsburgh, PA 15261 USA.	sarah.gaffen@pitt.edu			NIAID NIH HHS [R01 AI107825] Funding Source: Medline; NIDCR NIH HHS [R01 DE023815, R01 DE022550] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023815, R01DE022550] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018139; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; Sanford M, 2015, DRUGS, V75, P329, DOI 10.1007/s40265-015-0359-0; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	11	37	38	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					620	622		10.1016/j.immuni.2015.10.001	http://dx.doi.org/10.1016/j.immuni.2015.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488809	Green Accepted, Bronze			2022-12-18	WOS:000363478700002
J	Gorenshteyn, D; Zaslavsky, E; Fribourg, M; Park, CY; Wong, AK; Tadych, A; Hartmann, BM; Albrecht, RA; Garcia-Sastre, A; Kleinstein, SH; Troyanskaya, OG; Sealfon, SC				Gorenshteyn, Dmitriy; Zaslavsky, Elena; Fribourg, Miguel; Park, Christopher Y.; Wong, Aaron K.; Tadych, Alicja; Hartmann, Boris M.; Albrecht, Randy A.; Garcia-Sastre, Adolfo; Kleinstein, Steven H.; Troyanskaya, Olga G.; Sealfon, Stuart C.			Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases	IMMUNITY			English	Article							INFLUENZA-A VIRUS; GENE-EXPRESSION; I INTERFERON; V-PROTEIN; INTEGRATION; RESPONSES; NETWORKS; GENOME; ENRICHMENT; REPOSITORY	Many functionally important interactions between genes and proteins involved in immunological diseases and processes are unknown. The exponential growth in public high-throughput data offers an opportunity to expand this knowledge. To unlock human-immunology-relevant insight contained in the global biomedical research effort, including all public high-throughput datasets, we performed immunological-pathway-focused Bayesian integration of a comprehensive, heterogeneous compendium comprising 38,088 genome-scale experiments. The distillation of this knowledge into immunological networks of functional relationships between molecular entities (ImmuNet), and tools to mine this resource, are accessible to the public at http://immunet.princeton.edu. The predictive capacity of ImmuNet, established by rigorous statistical validation, is easily accessed by experimentalists to generate data-driven hypotheses. We demonstrate the power of this approach through the identification of unique host-virus interaction responses, and we show how ImmuNet complements genetic studies by predicting disease-associated genes. ImmuNet should be widely beneficial for investigating the mechanisms of the human immune system and immunological diseases.	[Gorenshteyn, Dmitriy; Tadych, Alicja; Troyanskaya, Olga G.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Zaslavsky, Elena; Fribourg, Miguel; Hartmann, Boris M.; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Park, Christopher Y.] New York Genome Ctr, New York, NY 10013 USA; [Wong, Aaron K.; Troyanskaya, Olga G.] Simons Fdn, Simons Ctr Data Anal, New York, NY 10010 USA; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06511 USA; [Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA	Princeton University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; Yale University; Yale University; Princeton University	Troyanskaya, OG (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ogt@cs.princeton.edu; stuart.sealfon@mssm.edu	Albrecht, Randy A./H-5119-2019; Fribourg, Miguel/AAO-2186-2020; Hartmann, Boris M./A-6121-2010	Albrecht, Randy A./0000-0003-4008-503X; Hartmann, Boris M./0000-0002-5649-6776; Zaslavsky, Elena/0000-0002-4828-7771; Fribourg, Miguel/0000-0003-1804-8136; Troyanskaya, Olga/0000-0002-5676-5737; Tadych, Alicja/0000-0001-8645-0739; Wong, Aaron/0000-0002-7294-0646; SEALFON, Stuart/0000-0001-5791-1217; Garcia-Sastre, Adolfo/0000-0002-6551-1827	NIH [HHSN272201000054C, 1U19AI117873];  [T32 MH096678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Judy Cho and Gareth John for helpful discussions or manuscript comments, Nada Marjanovic for technical support, and the Icahn School of Medicine qPCR Core Facility. Supported by NIH Contract HHSN272201000054C and Grant 1U19AI117873. O.G.T. is a Senior Fellow of CIFAR. M.F. was supported by T32 MH096678.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Briggs RC, 2006, CANCER RES, V66, P4645, DOI 10.1158/0008-5472.CAN-06-0229; Connolly DJ, 2014, BIOCHEM PHARMACOL, V92, P405, DOI 10.1016/j.bcp.2014.08.031; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Geisser S., 1993, PREDICTIVE INFERENCE; Guan YF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000991; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hartmann B., 2014, J IMMUNOL S, V192, P75; Hastie T., 2013, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7_16; Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Mok CKP, 2007, J GEN VIROL, V88, P1275, DOI 10.1099/vir.0.82423-0; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neurath MF, 2009, IMMUNITY, V31, P357, DOI 10.1016/j.immuni.2009.08.016; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Park CY, 2015, BIOINFORMATICS, V31, P1093, DOI 10.1093/bioinformatics/btu786; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Platt JC, 2000, ADV NEUR IN, P61; Pradhan A, 2004, LEUKEMIA, V18, P449, DOI 10.1038/sj.leu.2403265; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tasan M, 2012, G3-GENES GENOM GENET, V2, P223, DOI 10.1534/g3.111.000828; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Wong AK, 2012, NUCLEIC ACIDS RES, V40, pW484, DOI 10.1093/nar/gks458; Zaslavsky E, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S1; Zaslavsky E, 2010, J IMMUNOL, V184, P2908, DOI 10.4049/jimmunol.0903453	57	37	37	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					605	614		10.1016/j.immuni.2015.08.014	http://dx.doi.org/10.1016/j.immuni.2015.08.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26362267	Bronze, Green Accepted			2022-12-18	WOS:000361575300012
J	Ballesteros-Tato, A; Leon, B; Lee, BO; Lund, FE; Randall, TD				Ballesteros-Tato, Andre; Leon, Beatriz; Lee, Byung O.; Lund, Frances E.; Randall, Troy D.			Epitope-Specific Regulation of Memory Programming by Differential Duration of Antigen Presentation to Influenza-Specific CD8(+) T Cells	IMMUNITY			English	Article							CD40 LIGAND; CROSS-PRESENTATION; DENDRITIC CELL; VIRUS; RESPONSES; HELP; IMMUNODOMINANCE; INFECTION; EFFECTOR; SIGNALS	Memory CD8(+) T cells are programmed during the primary response for robust secondary responsiveness. Here we show that CD8(+) T cells responding to different epitopes of influenza virus received qualitatively different signals during the primary response that altered their secondary responsiveness. Nucleoprotein (NP)-specific CD8(+) T cells encountered antigen on CD40-licensed, CD70-expressing, CD103(-)CD11b(hi) dendritic cells (DCs) at later times in the primary response. As a consequence, they maintained CD25 expression and responded to interleukin-2 (IL-2) and CD27, which together programmed their robust secondary proliferative capacity and interferon-gamma (IFN-gamma)-producing ability. In contrast, polymerase (PA)-specific CD8(+) T cells did not encounter antigen-bearing, CD40-activated DCs at later times in the primary response, did not receive CD27 and CD25 signals, and were not programmed to become memory CD8(+) T cells with strong proliferative and cytokine-\producing ability. As a result, CD8(+) T cells responding to abundant antigens, like NP, dominated the secondary response.	[Ballesteros-Tato, Andre; Leon, Beatriz; Lund, Frances E.; Randall, Troy D.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Med, Birmingham, AL 35294 USA; [Lee, Byung O.] Vaccine Res Inst San Diego, San Diego, CA 92109 USA	University of Alabama System; University of Alabama Birmingham	Randall, TD (corresponding author), Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Med, Birmingham, AL 35294 USA.	randallt@uab.edu		Ballesteros-Tato, Andre/0000-0002-4833-593X	UR; UAB; NIH [AI061511, AI072689, HL069409, AR048311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072689, R01AI061511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	UR; UAB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to thank Louise Hartson for the preparation of vial stocks and personnel from the University of Rochester Flow Cytometry Core for assistance with cell sorting. This work was supported by UR, UAB, and NIH grants AI061511, AI072689, HL069409, and AR048311.	BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; Ballesteros-Tato A, 2013, J EXP MED, V210, P1591, DOI 10.1084/jem.20130097; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Borrow P, 1998, J VIROL, V72, P7440, DOI 10.1128/JVI.72.9.7440-7449.1998; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Dimopoulos N, 2009, J IMMUNOL METHODS, V340, P90, DOI 10.1016/j.jim.2008.09.023; Dolfi DV, 2008, J IMMUNOL, V180, P2912, DOI 10.4049/jimmunol.180.5.2912; Feau S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1948; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Hamilton SE, 2001, J IMMUNOL, V167, P5603, DOI 10.4049/jimmunol.167.10.5603; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Huang JP, 2006, J IMMUNOL, V176, P7726, DOI 10.4049/jimmunol.176.12.7726; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; La Gruta NL, 2010, J CLIN INVEST, V120, P1885, DOI 10.1172/JCI41538; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Otahal P, 2005, J IMMUNOL, V175, P700, DOI 10.4049/jimmunol.175.2.700; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wolkers MC, 2011, IMMUNOL LETT, V139, P25, DOI 10.1016/j.imlet.2011.04.011; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	35	37	37	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					127	140		10.1016/j.immuni.2014.06.007	http://dx.doi.org/10.1016/j.immuni.2014.06.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035957	Green Accepted, Bronze			2022-12-18	WOS:000341444200016
J	Garcia-Bernal, D; Parmo-Cabanas, M; Dios-Esponera, A; Samaniego, R; de la Ossa, DHP; Teixido, J				Garcia-Bernal, David; Parmo-Cabanas, Marisa; Dios-Esponera, Ana; Samaniego, Rafael; Hernan-P de la Ossa, Dolores; Teixido, Joaquin			Chemokine-Induced Zap70 Kinase-Mediated Dissociation of the Vav1-Talin Complex Activates alpha 4 beta 1 Integrin for T Cell Adhesion	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; LYMPHOCYTE ADHESION; LEUKOCYTE ADHESION; CYTOPLASMIC DOMAIN; VINCULIN BINDING; STRUCTURAL BASIS; PHOSPHOLIPASE-C; UP-REGULATION; FERM DOMAIN; TALIN	Lymphocyte integrins mediate cell arrest on endothelium during immune surveillance after activation by chemokine-stimulated inside-out signals. Here we show that a Vav1-talin complex in T cells is a key target for chemokine-triggered inside-out signaling leading to integrin alpha 4 beta 1 activation. Thus, Vav1 dissociation from talin was required to generate high-affinity alpha 4 beta 1 conformations. Assembly of the Vav1-talin complex required PtdIns(4,5)P-2, which was provided by talin-bound phosphatidylinositol phosphate kinase I gamma. Chemokine-promoted Vav1 dissociation from talin followed an initial increase in talin binding to alpha 4 beta 1. This process was dependent on ZAP-70, which binds to and phosphorylates Vav1 in the complex, leading to further alpha 4 beta 1 activation and cell adhesion strengthening. Moreover, Vav1-talin dissociation was needed for Rac1 activation, thus indicating that alpha 4 beta 1 and Rac1 activation can be coupled by chemokine-stimulated ZAP-70 function. Our data suggest that Vav1 might function as a repressive adaptor of talin that must dissociate from alpha 4 beta 1-talin complexes for efficient integrin activation.	[Garcia-Bernal, David; Parmo-Cabanas, Marisa; Dios-Esponera, Ana; Hernan-P de la Ossa, Dolores; Teixido, Joaquin] CSIC, Ctr Invest Biol, Cellular & Mol Med Program, Madrid 28040, Spain; [Samaniego, Rafael] Hosp Gen Univ Gregorio Maranon, Unidad Microscopia Confocal, Madrid 28009, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); General University Gregorio Maranon Hospital	Teixido, J (corresponding author), CSIC, Ctr Invest Biol, Cellular & Mol Med Program, Madrid 28040, Spain.		García-Bernal, David/W-2868-2019; Teixidó, Joaquin/J-8543-2014; Samaniego, Rafa/ABE-3558-2021	García-Bernal, David/0000-0001-6610-8442; Samaniego, Rafael/0000-0002-3081-7332	Ministerio de Ciencia e Innovacion [SAF2005-02119, SAF2008-00479]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We thank J Miguel Rodriguez-Frade for his initial help in flow adhesion experiments and P Lastres; for flow cytometry We also thank A Garcia Pardo, Xose Bustelo, and S Ruiz for Vav1 reagents and helpful discussions This work was supported by grant SAF2005-02119 and SAF2008-00479 from Ministerio de Ciencia e Innovacion	Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Garcia-Bernal D, 2006, J IMMUNOL, V177, P5215, DOI 10.4049/jimmunol.177.8.5215; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Inngjerdingen M, 2002, BLOOD, V99, P4318, DOI 10.1182/blood.V99.12.4318; Jarquin-Pardo M, 2007, J CELL BIOCHEM, V100, P112, DOI 10.1002/jcb.21027; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Manevich E, 2007, J BIOL CHEM, V282, P25338, DOI 10.1074/jbc.M700089200; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Ottoson NC, 2001, J IMMUNOL, V167, P1857, DOI 10.4049/jimmunol.167.4.1857; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740	51	37	38	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					953	964		10.1016/j.immuni.2009.09.021	http://dx.doi.org/10.1016/j.immuni.2009.09.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20005136	Bronze			2022-12-18	WOS:000273616400015
J	Herroeder, S; Reichardt, P; Sassmann, A; Zimmermann, B; Jaeneke, D; Hoeckner, J; Hollmann, MW; Fischer, KD; Vogt, S; Grosse, R; Hogg, N; Gunzer, M; Offermanns, S; Wettschureck, N				Herroeder, Susanne; Reichardt, Peter; Sassmann, Antonia; Zimmermann, Barbara; Jaeneke, Dagmar; Hoeckner, Jana; Hollmann, Markus W.; Fischer, Klaus-Dieter; Vogt, Stephan; Grosse, Robert; Hogg, Nancy; Gunzer, Matthias; Offermanns, Stefan; Wettschureck, Nina			Guanine Nucleotide-Binding Proteins of the G(12) Family Shape Immune Functions by Controlling CD4(+) T Cell Adhesiveness and Motility	IMMUNITY			English	Article							HETEROTRIMERIC G-PROTEINS; INTEGRIN ACTIVATION; DIFFERENTIAL REGULATION; LYMPHOCYTE MIGRATION; SMALL GTPASES; IN-VIVO; B-CELLS; LFA-1; ADHESION; RAP1	Integrin-mediated adhesion plays a central role in T cell trafficking and activation. Genetic inactivation of the guanine nucleotide-binding (G) protein alpha-subunits G alpha(12) and G alpha(13) resulted in an increased activity of integrin leukocyte-function-antigen-1 in murine CD4(+) T cells. The interaction with allogeneic dendritic cells was enhanced, leading to an abnormal proliferative response in vitro. In vivo, T cell-specific inactivation of G alpha(12) and G alpha(13) caused lymphadenopathy due to increased lymph node entry and enhanced T cell proliferation, and the susceptibility toward T cell-mediated diseases was enhanced. Mechanistically, we show that in the absence of G alpha(12) and G alpha(13) the activity of the small GTPases Rac1 and Rap1 was increased, whereas signaling of the small GTPase RhoA was strongly reduced. Our data indicate that locally produced mediators signal through G alpha(12)- and G alpha(13)-coupled receptors to negatively regulate cell polarization and adhesiveness, thereby fine-tuning T cell trafficking, proliferation, and susceptibility toward T cell-mediated diseases.	[Herroeder, Susanne; Sassmann, Antonia; Zimmermann, Barbara; Jaeneke, Dagmar; Hoeckner, Jana; Grosse, Robert; Offermanns, Stefan; Wettschureck, Nina] Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; [Herroeder, Susanne] Univ Heidelberg, Dept Anesthesiol, D-69120 Heidelberg, Germany; [Reichardt, Peter; Gunzer, Matthias] Univ Magdeburg, Inst Mol & Clin Immunol, D-39120 Magdeburg, Germany; [Hollmann, Markus W.] Univ Amsterdam AMC, Dept Anesthesiol, NL-1105 DD Amsterdam, Netherlands; [Fischer, Klaus-Dieter] Inst Biochem & Cell Biol, D-39120 Magdeburg, Germany; [Fischer, Klaus-Dieter] Dept Funct Genom & Med Topon, D-39120 Magdeburg, Germany; [Vogt, Stephan] Tech Univ Munich, Dept Orthopaed & Trauma Surg, D-81675 Munich, Germany; [Hogg, Nancy] London Res Inst, Canc Res UK, Leukocyte Adhes Lab, London WC2A 3PX, England; [Herroeder, Susanne] Univ Amsterdam, Acad Med Ctr, LEICA, NL-1105 DD Amsterdam, Netherlands; [Offermanns, Stefan; Wettschureck, Nina] Max Planck Inst Heart & Lund Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Otto von Guericke University; University of Amsterdam; Academic Medical Center Amsterdam; Technical University of Munich; Cancer Research UK; University of Amsterdam; Academic Medical Center Amsterdam; Max Planck Society	Wettschureck, N (corresponding author), Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany.	nina.wettschureck@pharma.uni-heidelberg.de	Wettschureck, Nina/L-3651-2017; Gunzer, Matthias/AAW-7026-2021; Vogt, Stephan/AAQ-7456-2021; Offermanns, Stefan/L-3313-2017	Wettschureck, Nina/0000-0001-6858-1460; Gunzer, Matthias/0000-0002-5534-6055; Offermanns, Stefan/0000-0001-8676-6805; Grosse, Robert/0000-0002-3380-5273	Deutsche Forschungsgemeinschaft [405]; Medical Faculty of the University of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Heidelberg	We thank M. Bernhard, M. Hillesheim, and Y. Teschner for expert technical assistance; J. Marth for the LckGre line; and B. Arnold, R. Arnold, and B. Schraven for helpful advice. This work was funded by the collaborative research center 405 of the Deutsche Forschungsgemeinschaft and the Young Investigator Award of the Medical Faculty of the University of Heidelberg.	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Cherry LK, 2004, NAT IMMUNOL, V5, P961, DOI 10.1038/ni1103; Chun J, 2006, CURR PHARM DESIGN, V12, P161, DOI 10.2174/138161206775193109; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Gratacap MP, 2001, J BIOL CHEM, V276, P47906, DOI 10.1074/jbc.M104442200; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Honing H, 2004, J LEUKOCYTE BIOL, V75, P523, DOI 10.1189/jlb.0203054; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KURIMOTO I, 1993, J INVEST DERMATOL, V101, P132, DOI 10.1111/1523-1747.ep12363616; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Rieken S, 2006, J BIOL CHEM, V281, P36985, DOI 10.1074/jbc.M605287200; Rieken S, 2006, J IMMUNOL, V177, P2985, DOI 10.4049/jimmunol.177.5.2985; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rodriguez-Fernandez JL, 2001, J BIOL CHEM, V276, P40518, DOI 10.1074/jbc.M102896200; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhang WY, 2003, J BIOL CHEM, V278, P23978, DOI 10.1074/jbc.M212671200	49	37	39	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 22	2009	30	5					708	720		10.1016/j.immuni.2009.02.010	http://dx.doi.org/10.1016/j.immuni.2009.02.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19409815	Bronze			2022-12-18	WOS:000266356900013
J	Malaviya, R; Navara, C; Uckun, FM				Malaviya, R; Navara, C; Uckun, FM			Role of janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria	IMMUNITY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; FIMH-EXPRESSING ENTEROBACTERIA; TUMOR-NECROSIS-FACTOR; MICE LACKING JAK3; ESCHERICHIA-COLI; HYPERSENSITIVITY REACTIONS; NEUTROPHIL RECRUITMENT; PERITONITIS; CLEARANCE; INFECTION	Mast cells play a pivotal role in innate host immune response to gram-negative bacteria. We report that Janus kinase 3 plays a role in mast cell-mediated bacterial clearance and neutrophil recruitment by regulating the release of tumor necrosis factor from mast cells. The role of JAK3 in mast cell-facilitated neutrophil recruitment and bacterial clearance was investigated by comparing the neutrophil influxes and bacterial clearance in mast cell-deficient W/W-v mice reconstituted with JAK3(+/+) or JAK(-/-) mast cells. The neutrophil influx, bacterial clearance, and survival outcome in W/W-v mice reconstituted with JAK3(+/+) mast cells was better than in W/Wv mice reconstituted with JAK3(-/-) mast cells. These findings provide evidence that JAK3 is a key regulator of mast cell-mediated innate immunity against gram-negative bacteria.	Parker Hughes Inst, Dept Allergy & Inflammatory Dis, St Paul, MN 55113 USA; Parker Hughes Inst, Drug Discovery Program, St Paul, MN 55113 USA; Parker Hughes Inst, Dept Immunol, St Paul, MN 55113 USA		Malaviya, R (corresponding author), Parker Hughes Inst, Dept Allergy & Inflammatory Dis, 2665 Long Lake Rd, St Paul, MN 55113 USA.		Navara, Christopher/C-2813-2011	Uckun, Fatih M./0000-0001-9334-183X	NIAID NIH HHS [R01-AI 45013] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045013] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; Bunting KD, 1999, P NATL ACAD SCI USA, V96, P232, DOI 10.1073/pnas.96.1.232; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; GALLI SJ, 1992, ANN NY ACAD SCI, V664, P69, DOI 10.1111/j.1749-6632.1992.tb39750.x; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; KITAMURA Y, 1979, J EXP MED, V150, P482, DOI 10.1084/jem.150.3.482; Malaviya R, 2000, J PHARMACOL EXP THER, V295, P912; Malaviya R, 1999, BIOCHEM BIOPH RES CO, V257, P807, DOI 10.1006/bbrc.1999.0513; MALAVIYA R, 1995, METHOD ENZYMOL, V253, P27; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; Malaviya R, 1998, J MOL MED, V76, P617, DOI 10.1007/s001090050259; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malaviya R, 1999, J BIOL CHEM, V274, P27028, DOI 10.1074/jbc.274.38.27028; MALAVIYA R, 1994, J CLIN INVEST, V93, P1645, DOI 10.1172/JCI117146; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; Takano M, 1998, INFECT IMMUN, V66, P3270, DOI 10.1128/IAI.66.7.3270-3278.1998; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Villa A, 1996, BLOOD, V88, P817; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922	25	37	39	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					313	321		10.1016/S1074-7613(01)00184-4	http://dx.doi.org/10.1016/S1074-7613(01)00184-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520465	Bronze			2022-12-18	WOS:000170717200012
J	Berg, RE; Princiotta, MF; Irion, S; Moticka, JA; Dahl, KR; Staerz, UD				Berg, RE; Princiotta, MF; Irion, S; Moticka, JA; Dahl, KR; Staerz, UD			Positive selection of an H2-M3 restricted T cell receptor	IMMUNITY			English	Article							CLASS-IB MOLECULE; CLASS-II MOLECULES; ANTIGEN PRESENTATION; TRANSGENIC MICE; HISTOCOMPATIBILITY ANTIGENS; THYMOCYTE SELECTION; MONOCLONAL-ANTIBODY; SELF-PEPTIDES; LYMPHOCYTES-T; H-2 ANTIGENS	Thymocytes are positively selected for alpha beta T cell antigen receptors (TCR) that recognize antigen in conjunction with self-major histocompatibility complex (MHC) molecules. MHC bound peptides participate in positive selection; however, their role has remained controversial. A TCR transgenic mouse was established using a TCR restricted to the MHC class Ib molecule, H2-M3. Having defined H2-M3 as the positively selecting MHC molecule, the severely limited number of H2-M3 binding peptides allowed us to characterize an NADH dehydrogenase subunit 1 (ND1)-derived peptide as the physiological ligand of positive selection. This peptide bears no apparent sequence homology to the cognate peptide, is expressed ubiquitously, and yet does not interfere with peripheral T cells. Our studies also suggest that positive selection becomes promiscuous at high epitope densities.	Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Ctr Canc, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80220 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Staerz, UD (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA.				NIAID NIH HHS [AI22295, AI35194] Funding Source: Medline; NICHD NIH HHS [HD26841] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035194, P01AI022295] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; BEVAN MJ, 1994, SCIENCE, V264, P796, DOI 10.1126/science.8171333; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Byers DE, 1998, J IMMUNOL, V161, P90; Dabhi VM, 1998, J IMMUNOL, V161, P5171; Dabhi VM, 1998, EUR J IMMUNOL, V28, P3773; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gulden PH, 1996, IMMUNITY, V5, P73, DOI 10.1016/S1074-7613(00)80311-8; HERMEL E, 1991, INT IMMUNOL, V3, P407, DOI 10.1093/intimm/3.4.407; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu QH, 1997, IMMUNITY, V7, P221, DOI 10.1016/S1074-7613(00)80525-7; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KUBO RT, 1989, J IMMUNOL, V142, P2736; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; LINDAHL KF, 1983, NATURE, V306, P383, DOI 10.1038/306383a0; Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851; LINDAHL KF, 1981, SCAND J IMMUNOL, V14, P643, DOI 10.1111/j.1365-3083.1981.tb00607.x; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; OZATO K, 1983, P NATL ACAD SCI-BIOL, V80, P2040, DOI 10.1073/pnas.80.7.2040; Pawlowski TJ, 1996, EUR J IMMUNOL, V26, P851, DOI 10.1002/eji.1830260419; Princiotta MF, 1998, J EXP MED, V187, P1711, DOI 10.1084/jem.187.10.1711; Rajagopalan PTR, 1997, BIOCHEMISTRY-US, V36, P13910, DOI 10.1021/bi971155v; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; Seaman MS, 1999, J IMMUNOL, V162, P5429; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SMITH GP, 1994, INT IMMUNOL, V6, P1917, DOI 10.1093/intimm/6.12.1917; STAERZ UD, 1985, J IMMUNOL, V134, P3994; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; VYAS JM, 1994, J EXP MED, V179, P155, DOI 10.1084/jem.179.1.155; VYAS JM, 1992, J IMMUNOL, V149, P3605; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; Xiao H, 1997, IMMUNOGENETICS, V45, P274, DOI 10.1007/s002510050203; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	57	37	37	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1999	11	1					33	43		10.1016/S1074-7613(00)80079-5	http://dx.doi.org/10.1016/S1074-7613(00)80079-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435577	Bronze			2022-12-18	WOS:000081671300004
J	EZEKIEL, UR; ENGLER, P; STERN, D; STORB, U				EZEKIEL, UR; ENGLER, P; STERN, D; STORB, U			ASYMMETRIC PROCESSING OF CODING ENDS AND THE EFFECT OF CODING END NUCLEOTIDE COMPOSITION ON V(D)J RECOMBINATION	IMMUNITY			English	Article							SITE-SPECIFIC RECOMBINATION; T-CELL; B-CELL; CHROMOSOMAL TRANSLOCATION; JUNCTIONAL SEQUENCES; GENE; REARRANGEMENT; SEGMENTS; NEOPLASIA; MISTAKES	The products of V(D)J recombination are coding and signal joints, We show that the nucleotide composition of the coding ends affects V(D)J recombination. The presence of Ts at the 5' end of either the 12 mer or the 23 mer recombination signal sequence (RSS) greatly decreases coding and signal joint formation, and Ts at the 5' ends of bath RSSs eliminate recombination, suggesting that a step during the initiation phase of the recombination is affected. A 5' T coding end can be rescued if the other end contains 5' G, C, or A, implying that synapsis may be required. Furthermore, the presence of As at the 5' end of the 12 mer, but not the 23 mer, RSS affects coding but not signal joint formation, This observation of asymmetric processing of coding ends suggests that different protein complexes are bound to the two RSSs, and become transferred to the aligned coding ends during processing.			EZEKIEL, UR (corresponding author), UNIV CHICAGO,DEPT MOLEC GENET & CELL BIOL,920 E 58TH ST,CHICAGO,IL 60637, USA.							ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; BECK E, 1982, GENE, V19, P327, DOI 10.1016/0378-1119(82)90023-3; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; BOUBNOV NV, 1993, MOL CELL BIOL, V13, P6957, DOI 10.1128/MCB.13.11.6957; BROSIUS J, 1987, METHOD ENZYMOL, V153, P55; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; ENGLER P, 1987, P NATL ACAD SCI USA, V84, P4949, DOI 10.1073/pnas.84.14.4949; FINGER LR, 1986, SCIENCE, V234, P982, DOI 10.1126/science.3490692; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; KALLENBACH S, 1992, RES IMMUNOL, V143, P873, DOI 10.1016/0923-2494(92)80110-7; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; PERSIANI DM, 1987, J EXP MED, V165, P1655, DOI 10.1084/jem.165.6.1655; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; ROSE RE, 1988, NUCLEIC ACIDS RES, V16, P355, DOI 10.1093/nar/16.1.355; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SHOWE LC, 1987, ANNU REV IMMUNOL, V5, P253, DOI 10.1146/annurev.iy.05.040187.001345; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; TACCIOLI GE, 1994, J BIOL CHEM, V269, P7439; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; ZHU CM, 1995, IMMUNITY, V2, P101, DOI 10.1016/1074-7613(95)90082-9	34	37	37	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					381	389		10.1016/1074-7613(95)90146-9	http://dx.doi.org/10.1016/1074-7613(95)90146-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719940	Bronze			2022-12-18	WOS:A1995QU61600008
J	Ullah, I; Prevost, J; Ladinsky, MS; Stone, H; Lu, ML; Anand, SP; Beaudoin-Bussieres, G; Symmes, K; Benlarbi, M; Ding, SL; Gasser, R; Fink, C; Chen, YZ; Tauzin, A; Goyette, G; Bourassa, C; Medjahed, H; Mack, M; Chung, KO; Wilen, CB; Dekaban, GA; Dikeakos, JD; Bruce, EA; Kaufmann, DE; Stamatatos, L; McGuire, AT; Richard, J; Pazgier, M; Bjorkman, PJ; Mothes, W; Finzi, A; Kumar, P; Uchil, PD				Ullah, Irfan; Prevost, Jeremie; Ladinsky, Mark S.; Stone, Helen; Lu, Maolin; Anand, Sai Priya; Beaudoin-Bussieres, Guillaume; Symmes, Kelly; Benlarbi, Mehdi; Ding, Shilei; Gasser, Romain; Fink, Corby; Chen, Yaozong; Tauzin, Alexandra; Goyette, Guillaume; Bourassa, Catherine; Medjahed, Halima; Mack, Matthias; Chung, Kunho; Wilen, Craig B.; Dekaban, Gregory A.; Dikeakos, Jimmy D.; Bruce, Emily A.; Kaufmann, Daniel E.; Stamatatos, Leonidas; McGuire, Andrew T.; Richard, Jonathan; Pazgier, Marzena; Bjorkman, Pamela J.; Mothes, Walther; Finzi, Andres; Kumar, Priti; Uchil, Pradeep D.			Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy	IMMUNITY			English	Article							EFFECTOR FUNCTIONS; CONFORMATIONAL DYNAMICS; CORONAVIRUS; TOMOGRAPHY; PROTECTION; RECEPTOR; SPIKES	Neutralizing antibodies (NAbs) are effective in treating COVID-19, but the mechanism of immune protection is not fully understood. Here, we applied live bioluminescence imaging (BLI) to monitor the real-time effects of NAb treatment during prophylaxis and therapy of K18-hACE2 mice intranasally infected with SARS-CoV-2-nanoluciferase. Real-time imaging revealed that the virus spread sequentially from the nasal cavity to the lungs in mice and thereafter systemically to various organs including the brain, culminating in death. Highly potent NAbs from a COVID-19 convalescent subject prevented, and also effectively resolved, established infection when administered within three days. In addition to direct neutralization, depletion studies indicated that Fc effector interactions of NAbs with monocytes, neutrophils, and natural killer cells were required to effectively dampen inflammatory responses and limit immunopathology. Our study highlights that both Fab and Fc effector functions of NAbs are essential for optimal in vivo efficacy against SARS-CoV-2.	[Ullah, Irfan; Symmes, Kelly; Chung, Kunho; Kumar, Priti] Yale Univ, Dept Internal Med, Sect Infect Dis, Sch Med, New Haven, CT 06520 USA; [Prevost, Jeremie; Anand, Sai Priya; Beaudoin-Bussieres, Guillaume; Benlarbi, Mehdi; Ding, Shilei; Gasser, Romain; Tauzin, Alexandra; Goyette, Guillaume; Bourassa, Catherine; Medjahed, Halima; Kaufmann, Daniel E.; Richard, Jonathan; Finzi, Andres] Ctr Rech Chum, Montreal, PQ H2X 0A9, Canada; [Prevost, Jeremie; Beaudoin-Bussieres, Guillaume; Gasser, Romain; Tauzin, Alexandra; Kaufmann, Daniel E.; Richard, Jonathan; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H2X 0A9, Canada; [Ladinsky, Mark S.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Stone, Helen; Lu, Maolin; Mothes, Walther; Uchil, Pradeep D.] Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT 06510 USA; [Anand, Sai Priya; Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Fink, Corby; Dekaban, Gregory A.; Dikeakos, Jimmy D.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5B7, Canada; [Chen, Yaozong; Pazgier, Marzena] Uniformed Serv Univ Hlth Sci, Dept Med, Infect Dis Div, Bethesda, MD 20814 USA; [Mack, Matthias] Univ Klinikum Regensburg, Innere Med Nephrol 2, D-93042 Regensburg, Germany; [Wilen, Craig B.] Yale Univ, Dept Lab Med, Sch Med, New Haven, CT 06520 USA; [Wilen, Craig B.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Bruce, Emily A.] Univ Vermont, Lamer Coll Med, Dept Med, Div Immunobiol, Burlington, VT 05405 USA; [Stamatatos, Leonidas; McGuire, Andrew T.] Fred Hutchinson Ctr, Vaccine & Infect Dis Div, Seattle, WA 98195 USA; [Dekaban, Gregory A.] Univ Western Ontario, Robarts Res Inst, Mol Med Res Labs, London, ON N6A 5B7, Canada; [Stamatatos, Leonidas; McGuire, Andrew T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [McGuire, Andrew T.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Lu, Maolin] Univ Texas Hlth Sci Ctr Tyler, Cellular & Mol Biol, Tyler, TX 75708 USA	Yale University; Universite de Montreal; Universite de Montreal; California Institute of Technology; Yale University; McGill University; Western University (University of Western Ontario); Uniformed Services University of the Health Sciences - USA; University of Regensburg; Yale University; Yale University; University of Vermont; Western University (University of Western Ontario); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Kumar, P (corresponding author), Yale Univ, Dept Internal Med, Sect Infect Dis, Sch Med, New Haven, CT 06520 USA.; Finzi, A (corresponding author), Ctr Rech Chum, Montreal, PQ H2X 0A9, Canada.; Finzi, A (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H2X 0A9, Canada.; Mothes, W; Uchil, PD (corresponding author), Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT 06510 USA.	walther.mothes@yale.edu; andres.finzi@umontreal.ca; priti.kumar@yale.edu; pradeep.uchil@yale.edu	Dekaban, Gregory/L-1987-2013; Tauzin, Alexandra/GWM-4542-2022; Richard, Jonathan/AAB-5185-2022; Lu, Maolin/U-7778-2017	Dekaban, Gregory/0000-0002-3087-4660; Prevost, Jeremie/0000-0002-5260-5154; Lu, Maolin/0000-0002-8099-6447; Tauzin, Alexandra/0000-0001-9153-3600; Chen, Yaozong/0000-0001-5380-2339	NIH [R01AI163395, P20GM125498]; le Ministe re de l'Economie et de l'Innovation du Quebec, Programme de soutien aux organismes de recherche et d'innovation, Foundation du CHUM; Canadian Institutes of Health Research (CIHR) [352417]; Rapid Research Funding Opportunity [FRN440388]; Canada's COVID-19 Immunity Task Force (CITF); Canada Foundation for Innovation (CFI) [41027, 36287]; FRQS Merit Research Scholarship; MITACS Acceleration postdoctoral fellowship; Fred Hutch COVID-19 Research Fund; Canada Research Chair on Retroviral Entry [RCHS0235 950-232424]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); le Ministe re de l'Economie et de l'Innovation du Quebec, Programme de soutien aux organismes de recherche et d'innovation, Foundation du CHUM; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Rapid Research Funding Opportunity; Canada's COVID-19 Immunity Task Force (CITF); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); FRQS Merit Research Scholarship; MITACS Acceleration postdoctoral fellowship; Fred Hutch COVID-19 Research Fund; Canada Research Chair on Retroviral Entry	This work was supported by NIH grant R01AI163395 to W.M.; George Mason University Fast Grants to M.S.L. and P.J.B.; P20GM125498 (awarded to UVM Translational Global Infectious Disease Research Center) to E.A.B.; le Ministe re de l'Economie et de l'Innovation du Quebec, Programme de soutien aux organismes de recherche et d'innovation, Foundation du CHUM, Canadian Institutes of Health Research (CIHR) foundation grant 352417 and Rapid Research Funding Opportunity FRN440388 to J.D.D. and G.A.D.; Canada Research Chair on Retroviral Entry no. RCHS0235 950-232424 to A.F.; Canada's COVID-19 Immunity Task Force (CITF) and Canada Foundation for Innovation (CFI) 41027 to A.F. and D.E.K. and 36287 to J.D.D. and G.A.D.; FRQS Merit Research Scholarship to D.E. K.; CIHR fellowships to J.P., S.P.A., and G.B.-B.; MITACS Acceleration postdoctoral fellowship to R.G.; Fred Hutch COVID-19 Research Fund to L.S. and A.T.M. The views expressed in this presentation are those of the authors and do not reflect the official policy or position of the Uniformed Services University, US Army, the Department of Defense, or the US Government.	Alsoussi WB, 2020, J IMMUNOL, V205, P915, DOI 10.4049/jimmunol.2000583; Amanat Fatima, 2020, Curr Protoc Microbiol, V58, pe108, DOI 10.1002/cpmc.108; Anand SP, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100290; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Beaudoin-Bussieres G, 2020, MBIO, V11, DOI 10.1128/mBio.02590-20; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Bournazos S, 2019, P NATL ACAD SCI USA, V116, P20054, DOI 10.1073/pnas.1911842116; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Calomeni E, 2020, KIDNEY INT, V98, P233, DOI 10.1016/j.kint.2020.05.003; Carossino Mariano, 2021, bioRxiv, DOI 10.1101/2021.01.13.425144; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Dekkers G, 2017, MABS-AUSTIN, V9, P767, DOI 10.1080/19420862.2017.1323159; Del Valle D.M., 2020, NAT MED, V26, P1636, DOI DOI 10.1038/s41591-020-1051-9; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Ding SL, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12111214; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Falzarano D, 2014, ANTIVIR RES, V103, P78, DOI 10.1016/j.antiviral.2014.01.003; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Golden JW, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142032; Gorman Matthew J, 2021, bioRxiv, DOI 10.1101/2021.02.05.429759; Graham RL, 2020, IMMUNITY, V52, P734, DOI 10.1016/j.immuni.2020.04.016; Halstead SB, 2020, J INFECT DIS, V222, P1946, DOI 10.1093/infdis/jiaa518; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hsieh Ching-Lin, 2020, Science, V369, P1501, DOI [10.1101/2020.05.30.125484, 10.1126/science.abd0826]; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Jennewein MF, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109353; Johansen MD, 2020, MUCOSAL IMMUNOL, V13, P877, DOI 10.1038/s41385-020-00340-z; Juette MF, 2016, NAT METHODS, V13, P341, DOI [10.1038/NMETH.3769, 10.1038/nmeth.3769]; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Klasse PJ, 2020, ELIFE, V9, DOI 10.7554/eLife.57877; Klein S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19619-7; Ladinsky MS, 2012, MOL BIOL CELL, V23, P2537, DOI 10.1091/mbc.E12-02-0093; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Leist SR, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.046581; Li Dapeng, 2021, bioRxiv, DOI 10.1101/2020.12.31.424729; Li W, 2020, P NATL ACAD SCI USA, V117, P29832, DOI 10.1073/pnas.2010197117; Li WW, 2022, CELL REP, V38, DOI [10.1016/j.celrep.2021.110210, 10.1101/2021.08.02.454546]; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Lu Maolin, 2020, bioRxiv, DOI 10.1101/2020.09.10.286948; Lu ML, 2019, NATURE, V568, P415, DOI 10.1038/s41586-019-1101-y; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Noy-Porat T, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102479; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Prevost J, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100126; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Ruckwardt TJ, 2019, IMMUNITY, V51, P429, DOI 10.1016/j.immuni.2019.08.007; Sauer MM, 2021, NAT STRUCT MOL BIOL, V28, P478, DOI [10.1038/s41594-021-00596-4, 10.1101/2020.12.29.424482]; Saunders KO, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01296; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Seydoux E, 2020, IMMUNITY, V53, P98, DOI 10.1016/j.immuni.2020.06.001; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Silvas JA, 2021, J VIROL, V95, DOI 10.1128/JVI.00402-21; Solomon T, 2021, NAT REV NEUROL, V17, P65, DOI 10.1038/s41582-020-00453-w; Stamatatos Leonidas, 2021, medRxiv, DOI 10.1101/2021.02.05.21251182; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Turonova B, 2020, SCIENCE, V370, P203, DOI 10.1126/science.abd5223; Ventura JD, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008161; Voss WN, 2021, SCIENCE, V372, P1108, DOI 10.1126/science.abg5268; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Xie Xuping, 2020, Nat Commun, V11, P5214, DOI [10.1101/2020.06.22.165712, 10.1038/s41467-020-19055-7]; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Yang AC, 2021, NATURE, V595, P565, DOI 10.1038/s41586-021-03710-0; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zost SJ., 2020, NAT MED, V26, P1422, DOI [10.1038/s41591-020-0998-x, DOI 10.1038/s41591-020-0998-x]	87	36	36	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2143	+		10.1016/j.immuni.2021.08.015	http://dx.doi.org/10.1016/j.immuni.2021.08.015		SEP 2021	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34453881	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000695789800020
J	Routhu, NK; Cheedarla, N; Gangadhara, S; Bollimpelli, VS; Boddapati, AK; Shiferaw, A; Rahman, SA; Sahoo, A; Edara, VV; Lai, LL; Floyd, K; Wang, S; Fischinger, S; Atyeo, C; Shin, SA; Gumber, S; Kirejczyk, S; Cohen, J; Jean, SM; Wood, JS; Connor-Stroud, F; Stammen, RL; Upadhyay, AA; Pellegrini, K; Montefiori, D; Shi, PY; Menachery, VD; Alter, G; Vanderford, TH; Bosinger, SE; Suthar, MS; Amara, RR				Routhu, Nanda Kishore; Cheedarla, Narayanaiah; Gangadhara, Sailaja; Bollimpelli, Venkata Satish; Boddapati, Arun K.; Shiferaw, Ayalnesh; Rahman, Sheikh Abdul; Sahoo, Anusmita; Edara, Venkata Viswanadh; Lai, Lilin; Floyd, Katharine; Wang, Shelly; Fischinger, Stephanie; Atyeo, Caroline; Shin, Sally A.; Gumber, Sanjeev; Kirejczyk, Shannon; Cohen, Joyce; Jean, Sherrie M.; Wood, Jennifer S.; Connor-Stroud, Fawn; Stammen, Rachelle L.; Upadhyay, Amit A.; Pellegrini, Kathryn; Montefiori, David; Shi, Pei-Yong; Menachery, Vineet D.; Alter, Galit; Vanderford, Thomas H.; Bosinger, Steven E.; Suthar, Mehul S.; Amara, Rama Rao			A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs	IMMUNITY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; ANTIBODY-RESPONSES; MUCOSAL CHALLENGE; HIGH-THROUGHPUT; IMMUNOGENICITY; HIV-1; ANTIGEN; MVA; DNA; CELLS	A combination of vaccination approaches will likely be necessary to fully control the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Here, we show that modified vaccinia Ankara (MVA) vectors expressing membrane-anchored pre-fusion stabilized spike (MVA/S) but not secreted S1 induced strong neutralizing antibody responses against SARS-CoV-2 in mice. In macaques, the MVA/S vaccination induced strong neutralizing antibodies and CD8(+) T cell responses, and conferred protection from SARS-CoV-2 infection and virus replication in the lungs as early as day 2 following intranasal and intratracheal challenge. Single-cell RNA sequencing analysis of lung cells on day 4 after infection revealed that MVA/S vaccination also protected macaques from infection-induced inflammation and B cell abnormalities and lowered induction of interferon-stimulated genes. These results demonstrate that MVA/S vaccination induces neutralizing antibodies and CD8(+) T cells in the blood and lungs and is a potential vaccine candidate for SARS-CoV-2.	[Routhu, Nanda Kishore; Cheedarla, Narayanaiah; Gangadhara, Sailaja; Bollimpelli, Venkata Satish; Boddapati, Arun K.; Shiferaw, Ayalnesh; Rahman, Sheikh Abdul; Sahoo, Anusmita; Edara, Venkata Viswanadh; Lai, Lilin; Floyd, Katharine; Wang, Shelly; Upadhyay, Amit A.; Pellegrini, Kathryn; Vanderford, Thomas H.; Bosinger, Steven E.; Suthar, Mehul S.; Amara, Rama Rao] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Div Microbiol & Immunol, Atlanta, GA 30329 USA; [Routhu, Nanda Kishore; Cheedarla, Narayanaiah; Gangadhara, Sailaja; Bollimpelli, Venkata Satish; Shiferaw, Ayalnesh; Rahman, Sheikh Abdul; Sahoo, Anusmita; Amara, Rama Rao] Emory Univ, Emory Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Boddapati, Arun K.; Bosinger, Steven E.] Emory Univ, Emory Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Edara, Venkata Viswanadh; Lai, Lilin; Floyd, Katharine; Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; [Fischinger, Stephanie; Atyeo, Caroline; Shin, Sally A.; Alter, Galit] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA; [Gumber, Sanjeev; Kirejczyk, Shannon] Emory Univ, Yerkes Natl Primate Res Ctr, Div Pathol, Atlanta, GA 30329 USA; [Cohen, Joyce; Jean, Sherrie M.; Wood, Jennifer S.; Connor-Stroud, Fawn; Stammen, Rachelle L.] Emory Univ, Yerkes Natl Primate Res Ctr, Div Anim Resources, Atlanta, GA 30329 USA; [Montefiori, David] Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Menachery, Vineet D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	Emory University; Emory University; Emory University; Emory University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Emory University; Emory University; Duke University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Amara, RR (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Div Microbiol & Immunol, Atlanta, GA 30329 USA.; Amara, RR (corresponding author), Emory Univ, Emory Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	ramara@emory.edu	Sahoo, Anusmita/AAY-6675-2021; Cheedarla, Narayanaiah/ABC-5652-2021; Boddapati, Arun/AIA-0658-2022; Routhu, Nanda Kishore/U-4106-2019; Amara, Rama/AAO-8136-2021; Upadhyay, Amit/R-5056-2019	Sahoo, Anusmita/0000-0001-6903-969X; Routhu, Nanda Kishore/0000-0003-2080-819X; Upadhyay, Amit/0000-0002-0952-4164; Cohen, Joyce/0000-0001-9194-6640; Floyd, Katharine/0000-0002-0866-6961; Shin, Sally/0000-0002-9306-2264; Gumber, Sanjeev/0000-0001-9048-2717	Emory University Integrated Cellular Imaging Microscopy Core; National Institutes of Health [RO1 AI148378-01S1]; Fast Grants award [2166]; NCRR/NIH [P51 OD011132]; NIH [P51 OD011132, S10 OD026799]	Emory University Integrated Cellular Imaging Microscopy Core; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fast Grants award; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Traci H. Legere, Brenda Wehrle, and Zeba S. Momin for help with processing blood and tissue samples, Drs. Bernard Moss and Lynda Wyatt for providing the pLW73 transfer plasmid, the Yerkes Division of Pathology and Research Resources for outstanding animal care during the pandemic, and the Histology and Molecular Pathology Lab for help with tissue sectioning. The following reagent was produced under HHSN272201400008C and obtained through BEI Resources, NIAID, NIH: vector pCAGGS containing the SARS-related coronavirus 2, Wuhan-Hu-1 spike glycoprotein RBD, NR-52309. Imaging for this research project was supported in part by the Emory University Integrated Cellular Imaging Microscopy Core. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institute of Health. This work was supported in part by National Institutes of Health grant RO1 AI148378-01S1 and Fast Grants award 2166 (to R.R.A.) and NCRR/NIH base grant P51 OD011132 to YNPRC. Nextgeneration sequencing services were provided by the Yerkes NHP Genomics Core, which is supported in part by NIH P51 OD011132. Sequencing data were acquired on an Illumina NovaSeq6000 funded by NIH S10 OD026799 (to S.E.B.).	Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Aid M, 2020, CELL, V183, P1354, DOI 10.1016/j.cell.2020.10.005; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; Bradley AJ, 1999, BBA-BIOMEMBRANES, V1418, P19, DOI 10.1016/S0005-2736(99)00013-9; Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8; Brouwer P.J.M., 2021, NATURE, DOI [10.1038/s41586-021-03275-y, DOI 10.1038/S41586-021-03275-Y]; Brown EP, 2017, J IMMUNOL METHODS, V443, P33, DOI 10.1016/j.jim.2017.01.010; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chamcha V, 2015, J IMMUNOL, V195, P5025, DOI 10.4049/jimmunol.1501243; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chea LS, 2019, J VIROL, V93, DOI 10.1128/JVI.01648-18; Chea LS, 2017, EXPERT REV VACCINES, V16, P973, DOI 10.1080/14760584.2017.1371594; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Domi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19041-y; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Fischinger S, 2019, J IMMUNOL METHODS, V473, DOI 10.1016/j.jim.2019.07.002; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; Goepfert PA, 2014, J INFECT DIS, V210, P99, DOI 10.1093/infdis/jiu003; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Haagmans BL, 2016, SCIENCE, V351, P77, DOI 10.1126/science.aad1283; Hoang TN, 2021, CELL, V184, P460, DOI 10.1016/j.cell.2020.11.007; Iyer SS, 2014, VACCINES, V2, P160, DOI 10.3390/vaccines2010160; Kannanganat S, 2016, J IMMUNOL, V197, P3586, DOI 10.4049/jimmunol.1600629; Karsten CB, 2019, J IMMUNOL METHODS, V471, P46, DOI 10.1016/j.jim.2019.05.006; Katzelnick LC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006862; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; McDavid A., R PACKAGE VERSION 12; McInnes L., 2018, ARXIV180203426; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nigam P, 2007, VIROLOGY, V366, P73, DOI 10.1016/j.virol.2007.04.010; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0; Speranza Emily, 2020, bioRxiv, DOI 10.1101/2020.08.20.258087; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Thompson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163164; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; Tostanoski LH, 2020, NAT MED, V26, P1694, DOI 10.1038/s41591-020-1070-6; van Doremalen N., 2020, NATURE, DOI DOI 10.1038/S41586-020-2608-Y; Waggoner JJ, 2020, EMERG INFECT DIS, V26, P1633, DOI 10.3201/eid2607.201285; Walls AC, 2020, CELL, V183, P1367, DOI 10.1016/j.cell.2020.10.043; Wiley JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007142; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Woodland DL, 2004, SEMIN IMMUNOL, V16, P163, DOI 10.1016/j.smim.2004.02.003; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wyatt LS, 2004, AIDS RES HUM RETROV, V20, P645, DOI 10.1089/0889222041217428; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Xu JY, 2019, EMERG MICROBES INFEC, V8, P841, DOI 10.1080/22221751.2019.1624482; Yong CY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01781; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang ZZ, 2007, CHEM RES CHINESE U, V23, P329	69	36	37	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					542	+		10.1016/j.immuni.2021.02.001	http://dx.doi.org/10.1016/j.immuni.2021.02.001		MAR 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33631118	Bronze, Green Published			2022-12-18	WOS:000627409300019
J	Chen, ZJ; Luo, JL; Li, J; Kim, G; Stewart, A; Urban, JF; Huang, YF; Chen, S; Wu, LG; Chesler, A; Trinchieri, G; Li, W; Wu, C				Chen, Zuojia; Luo, Jialie; Li, Jian; Kim, Girak; Stewart, Andy; Urban, Joseph F., Jr.; Huang, Yuefeng; Chen, Shan; Wu, Ling-Gang; Chesler, Alexander; Trinchieri, Giorgio; Li, Wei; Wu, Chuan			Interleukin-33 Promotes Serotonin Release from Enterochromaffin Cells for Intestinal Homeostasis	IMMUNITY			English	Article							IL-13 PRODUCTION; IL-33; RECEPTOR; DYSFUNCTION; RESPONSES; NEURONS; SYSTEM; MODEL; DIFFERENTIATION; CHEMOTHERAPY	The gastrointestinal tract is known as the largest endocrine organ that encounters and integrates various immune stimulations and neuronal responses due to constant environmental challenges. Enterochromaffin (EC) cells, which function as chemosensors on the gut epithelium, are known to translate environmental cues into serotonin (5-HT) production, contributing to intestinal physiology. However, how immune signals participate in gut sensation and neuroendocrine response remains unclear. Interleukin-33 (IL-33) acts as an alarmin cytokine by alerting the system of potential environmental stresses. We here demonstrate that IL-33 induced instantaneous peristaltic movement and facilitated Trichuris muris expulsion. We found that IL-33 could be sensed by EC cells, inducing release of 5-HT. IL-33-mediated 5-HT release activated enteric neurons, subsequently promoting gut motility. Mechanistically, IL-33 triggered calcium influx via a non canonical signaling pathway specifically in EC cells to induce 5-HT secretion. Our data establish an immune-neuroendocrine axis in calibrating rapid 5-HT release for intestinal homeostasis.	[Chen, Zuojia; Luo, Jialie; Li, Jian; Kim, Girak; Wu, Chuan] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Stewart, Andy; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA; [Huang, Yuefeng] NIAID, Lab Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chen, Shan; Li, Wei] NEI, Retinal Neurophysiol Sect, NIH, Bethesda, MD 20892 USA; [Wu, Ling-Gang] NINDS, Synapt Transmiss Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Chesler, Alexander] NIH, Sensory Cells & Circuits Sect, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA; [Huang, Yuefeng] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; Columbia University	Wu, C (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	chuan.wu@nih.gov	Li, Jian/AGV-0996-2022	Li, Jian/0000-0002-7076-3332; Urban, Joseph/0000-0002-1590-8869; KIM, Girak/0000-0003-2613-1140	National Multiple Sclerosis Society Career Transition Award [TA 3059-A-2]	National Multiple Sclerosis Society Career Transition Award(National Multiple Sclerosis Society)	We thank Dr. Susumu Nakae (The University of Tokyo, Japan) for Il33<SUP>-/-</SUP>mice, Dr. Xinzhong Dong (Johns Hopkins School of Medicine) for the Pirt<SUP>GCaMP3</SUP> and Pirt<SUP>cre</SUP> mice, Dr. David Ginty (Harvard Medical School) for the Ret<SUP>creER</SUP> mice, Dr. Cheryl L. Stucky (Medical College of Wisconsin) for the Trpa1<SUP>flox</SUP> mice, Dr. David E. Clouthier (University of Colorado Denver) for the Hand2<SUP>cre</SUP> mice, Dr. Gerard Karsenty (Columbia University) for the Tph1<SUP>flox</SUP> mice, Dr. Andrew B. Leiter (University of Massachusetts Medical School) for the Tph1<SUP>CFP</SUP> mice, and Dr. Axel Roers (Dresden University of Technology, Germany) for the Mcpt5<SUP>cre</SUP> mice. We thank Mr. Eric Chen and Dr. Jagan Muppidi (NIH/NCI) for editing the manuscript. This work was supported by a National Multiple Sclerosis Society Career Transition Award (TA 3059-A-2 to C.W.).	Alcaino C, 2018, P NATL ACAD SCI USA, V115, pE7632, DOI 10.1073/pnas.1804938115; Antignano F, 2011, JOVE-J VIS EXP, DOI 10.3791/2774; Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b; Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001; Bellono NW, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.034; Bercik P, 2002, GASTROENTEROLOGY, V123, P1205, DOI 10.1053/gast.2002.36024; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Gregory RE, 1998, DRUGS, V55, P173, DOI 10.2165/00003495-199855020-00002; Guabiraba R, 2014, MUCOSAL IMMUNOL, V7, P1079, DOI 10.1038/mi.2013.124; Han P, 2013, NEUROSCIENCE, V241, P59, DOI 10.1016/j.neuroscience.2013.03.019; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Knutson K, 2018, JOVE-J VIS EXP, DOI 10.3791/58112; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Lopetuso LR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00181; Lott JM, 2015, J LEUKOCYTE BIOL, V97, P1037, DOI 10.1189/jlb.3RI1214-595R; Mahapatro M, 2016, CELL REP, V15, P1743, DOI 10.1016/j.celrep.2016.04.049; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; Molofsky AB, 2015, IMMUNITY, V42, P1005, DOI 10.1016/j.immuni.2015.06.006; Motomura Y, 2008, GUT, V57, P475, DOI 10.1136/gut.2007.129296; O'Malley D, 2011, AM J PHYSIOL-GASTR L, V300, pG241, DOI 10.1152/ajpgi.00385.2010; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Putney James W, 2012, Adv Biol Regul, V52, P152; Racke K, 1996, BEHAV BRAIN RES, V73, P83; Rakhilin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11800; Rehn M, 2004, ACTA PHYSIOL SCAND, V181, P13, DOI 10.1111/j.1365-201X.2004.01269.x; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Spencer NJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00184; Stasi C, 2014, TECH COLOPROCTOL, V18, P613, DOI 10.1007/s10151-013-1106-8; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Vallance BA, 1998, PARASITE IMMUNOL, V20, P249, DOI 10.1046/j.1365-3024.1998.00155.x; Vallance BA, 1998, AM J PHYSIOL-GASTR L, V275, pG1157, DOI 10.1152/ajpgi.1998.275.5.G1157; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang HQ, 2007, GUT, V56, P949, DOI 10.1136/gut.2006.103226; Wang HQ, 2019, J IMMUNOL, V202, P3041, DOI 10.4049/jimmunol.1801034; Xia Y, 1999, J CLIN INVEST, V103, P1309, DOI 10.1172/JCI5823; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yang ZH, 2013, AM J PHYSIOL-GASTR L, V304, pG381, DOI 10.1152/ajpgi.00357.2012; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146; Zhang L, 2013, DIGEST DIS SCI, V58, P2187, DOI 10.1007/s10620-013-2656-3; Zhou XK, 2015, MOL CELL BIOL, V35, P2729, DOI 10.1128/MCB.00256-15; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	65	36	36	4	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					151	+		10.1016/j.immuni.2020.10.014	http://dx.doi.org/10.1016/j.immuni.2020.10.014		JAN 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33220232	Bronze, Green Accepted			2022-12-18	WOS:000607814000016
J	Diskin, C; Ryan, TAJ; O'Neill, LAJ				Diskin, C.; Ryan, T. A. J.; O'Neill, L. A. J.			Modification of Proteins by Metabolites in Immunity	IMMUNITY			English	Review							PYRUVATE-KINASE M2; DNA SENSOR CGAS; POSTTRANSLATIONAL MODIFICATION; SUCCINATE-DEHYDROGENASE; T-CELLS; CHEMICAL-MODIFICATION; HISTONE DEACETYLASES; LYSINE SUCCINYLATION; NLRP3 INFLAMMASOME; IL-1-BETA	Immunometabolism has emerged as a key focus for immunologists, with metabolic change in immune cells becoming as important a determinant for specific immune effector responses as discrete signaling pathways. A key output for these changes involves post-translational modification (PTM) of proteins by metabolites. Products of glycolysis and Krebs cycle pathways can mediate these events, as can lipids, amino acids, and polyamines. A rich and diverse set of PTMs in macrophages and T cells has been uncovered, altering phenotype and modulating immunity and inflammation in different contexts. We review the recent findings in this area and speculate whether they could be of use in the effort to develop therapeutics for immune-related diseases.	[Diskin, C.; Ryan, T. A. J.; O'Neill, L. A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; ALLAND L, 1994, J BIOL CHEM, V269, P16701; Angiari S, 2020, CELL METAB, V31, P391, DOI 10.1016/j.cmet.2019.10.015; Artyomov H., 2020, COMP EVALUATION ITAC; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; Bononi A, 2017, NATURE, V546, P549, DOI 10.1038/nature22798; Bowman CE, 2017, CELL CHEM BIOL, V24, P673, DOI 10.1016/j.chembiol.2017.04.009; Bruning U, 2018, CELL METAB, V28, P866, DOI 10.1016/j.cmet.2018.07.019; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chen SY, 2020, CELL MOL IMMUNOL, V17, P36, DOI 10.1038/s41423-019-0315-0; Chesarino NM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0091-3; Colak G, 2015, MOL CELL PROTEOMICS, V14, P3056, DOI 10.1074/mcp.M115.048850; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Colvin SC, 2013, J BIOL CHEM, V288, P36226, DOI 10.1074/jbc.M113.473942; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dai J, 2019, CELL, V176, P1447, DOI 10.1016/j.cell.2019.01.016; Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017; Das Gupta K, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.46; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Galvan-Pena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08187-6; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; He M, 2020, CELL METAB, V31, P580, DOI 10.1016/j.cmet.2020.01.009; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Nguyen KT, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0097-y; Kim YC, 2019, NAT CHEM BIOL, V15, P907, DOI 10.1038/s41589-019-0344-0; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lauterbach MA, 2019, IMMUNITY, V51, P997, DOI 10.1016/j.immuni.2019.11.009; LEE CGL, 1995, IMMUNOGENETICS, V41, P263, DOI 10.1007/BF00172150; Lee HH, 2019, CANCER CELL, V36, P168, DOI 10.1016/j.ccell.2019.06.008; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Liao ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13078-5; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Liu BY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00235-x; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Lu Y, 2019, SCIENCE, V366, P460, DOI 10.1126/science.aau6391; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Makowski L, 2020, IMMUNOL REV, V295, P5, DOI 10.1111/imr.12858; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Nakanishi S, 2016, AMINO ACIDS, V48, P2353, DOI 10.1007/s00726-016-2275-3; Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; Park SY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01135; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pilarski R, 2014, GENE CHROMOSOME CANC, V53, P177, DOI 10.1002/gcc.22129; Pucino V, 2019, CELL METAB, V30, P1055, DOI 10.1016/j.cmet.2019.10.004; Puleston D.J., 2020, BIORXIV, DOI [10.1101/2020.01.24.918094, DOI 10.1101/2020.01.24.918094]; Puleston DJ, 2019, CELL METAB, V30, P352, DOI 10.1016/j.cmet.2019.05.003; Qin W, 2020, J AM CHEM SOC, V142, P10894, DOI 10.1021/jacs.9b11962; Qin W, 2019, NAT CHEM BIOL, V15, P983, DOI 10.1038/s41589-019-0323-5; Qiu J, 2019, CELL REP, V27, P2063, DOI 10.1016/j.celrep.2019.04.022; Rahman-Roblick R, 2007, P NATL ACAD SCI USA, V104, P5401, DOI 10.1073/pnas.0700794104; Rampoldi F, 2015, J IMMUNOL, V195, P4228, DOI 10.4049/jimmunol.1500622; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Ryan DG, 2020, ANNU REV IMMUNOL, V38, P289, DOI 10.1146/annurev-immunol-081619-104850; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Song BK, 2020, MOL CELL PROTEOMICS, V19, P1193, DOI 10.1074/mcp.RA120.001981; Soupene E, 2016, J LIPID RES, V57, P288, DOI 10.1194/jlr.M065003; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Su MG, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0506-1; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; TOWLER D, 1986, BIOCHEMISTRY-US, V25, P878, DOI 10.1021/bi00352a021; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; Vats D, 2006, CELL METAB, V4, P255, DOI 10.1016/j.cmet.2006.08.006; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang F, 2017, CELL REP, V19, P2331, DOI 10.1016/j.celrep.2017.05.065; Wang YC, 2014, CELL RES, V24, P143, DOI 10.1038/cr.2013.151; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wen ZK, 2019, NAT IMMUNOL, V20, P313, DOI 10.1038/s41590-018-0296-7; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Xiong Z, 2020, J EXP MED, V217, DOI 10.1084/jem.20190974; Yang M, 2014, METABOLITES, V4, P640, DOI 10.3390/metabo4030640; Yao H, 2019, NAT BIOMED ENG, V3, P306, DOI 10.1038/s41551-019-0375-6; Ye XY, 2017, ONCOTARGET, V8, P6984, DOI 10.18632/oncotarget.14346; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhang HL, 2019, MOL CELL, V76, P110, DOI 10.1016/j.molcel.2019.08.005; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003; Zingler P, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0405-8	122	36	36	5	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					19	31		10.1016/j.immuni.2020.09.014	http://dx.doi.org/10.1016/j.immuni.2020.09.014		JAN 2021	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33220233	Bronze			2022-12-18	WOS:000607814000007
J	Hirai, T; Zenke, Y; Yang, Y; Bartholin, L; Beura, LK; Masopust, D; Kaplan, DH				Hirai, Toshiro; Zenke, Yukari; Yang, Yi; Bartholin, Laurent; Beura, Lalit K.; Masopust, David; Kaplan, Daniel H.			Keratinocyte-Mediated Activation of the Cytokine TGF-beta Maintains Skin Recirculating Memory CD8(+) T Cells	IMMUNITY			English	Article							ANTIGEN; INFECTION; MIGRATION; CD4(+); MICE; DIFFERENTIATION; IMMUNIZATION; INFLAMMATION; MAINTENANCE; GENERATION	Regulated activation of the cytokine TGF-beta by integrins alpha(v)beta(6) and alpha(v)beta(8) expressed on keratinocytes is required for residence of epidermal-resident memory T cells, but whether skin-derived signals also affect recirculating memory cells in the skin remains unclear. Here, we show that after resolution of skin vaccinia virus (VV) infection, antigen-specific circulating memory CD8(+) T cells migrated into skin. In mice lacking alpha(v)beta(6) and alpha(v)beta(8) integrins (Itgb6(-/-)Itgb8(fl/fl)-K14-cre), the absence of epidermal-activated TGF-beta resulted in a gradual loss of E- or P-selectin-binding central and peripheral memory populations, which were rescued when skin entry was inhibited. Skin recirculating memory cells were required for optimal host defense against skin VV infection. These data demonstrate that skin migration can persist after resolution of local skin infection and that the cytokine environment within this non-lymphoid tissue shapes the differentiation state and persistence of the central and peripheral memory-T-cell pool.	[Hirai, Toshiro; Zenke, Yukari; Yang, Yi; Kaplan, Daniel H.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15261 USA; [Hirai, Toshiro; Zenke, Yukari; Yang, Yi; Kaplan, Daniel H.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Zenke, Yukari] St Lukes Int Hosp, Dept Dermatol, Tokyo, Japan; [Yang, Yi] Cent S Univ, Dept Dermatol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Yang, Yi] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Bartholin, Laurent] Univ Claude Bernard Lyon 1, Univ Lyon, INSERM 1052, Ctr Leon Berard,CRCL,CNRS 5286, F-69008 Lyon, France; [Beura, Lalit K.; Masopust, David] Univ Minnesota, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St. Luke's International Hospital; Central South University; Central South University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); University of Minnesota System; University of Minnesota Twin Cities	Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15261 USA.; Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.	dankaplan@pitt.edu	Yang, Ye/GZM-4812-2022; Beura, Lalit/W-6281-2019; yang, yang/HGT-7999-2022; masopust, david/B-5027-2008; Hirai, Toshiro/N-8057-2016; Bartholin, Laurent/Q-6655-2017	Hirai, Toshiro/0000-0002-9212-1664; Bartholin, Laurent/0000-0002-5637-3223	JSPS Overseas Research Fellowships; NIH [R01AR060744, 1S10OD011925-01]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060744] Funding Source: NIH RePORTER	JSPS Overseas Research Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the members of the Kaplan laboratory and Vignali laboratory and members throughout the departments of Dermatology and Immunology for helpful discussions. We also thank the Division of Laboratory Animal Resources of the University of Pittsburgh for excellent animal care. This work benefitted from a SPECIAL BD LSRFortessa funded by NIH 1S10OD011925-01. T.H. was supported by JSPS Overseas Research Fellowships and D.H.K. by NIH R01AR060744.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Bartholin L, 2008, GENESIS, V46, P724, DOI 10.1002/dvg.20425; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Freyschmidt EJ, 2007, J ALLERGY CLIN IMMUN, V119, P671, DOI 10.1016/j.jaci.2006.12.645; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gehad A, 2018, BLOOD ADV, V2, P292, DOI 10.1182/bloodadvances.2017011346; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Ma CY, 2015, P NATL ACAD SCI USA, V112, P11013, DOI 10.1073/pnas.1510119112; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Muschaweckh A, 2016, J EXP MED, V213, P3075, DOI 10.1084/jem.20160888; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Sanjabi S, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022236; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Takamura S, 2016, J EXP MED, V213, P3057, DOI 10.1084/jem.20160938; Wakim LM, 2015, MUCOSAL IMMUNOL, V8, P1060, DOI 10.1038/mi.2014.133; Ward SG, 1998, IMMUNITY, V9, P1, DOI 10.1016/S1074-7613(00)80583-X; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zaric M, 2017, J CONTROL RELEASE, V268, P166, DOI 10.1016/j.jconrel.2017.10.026; 2009, J CELL SCI, V122, P227, DOI DOI 10.1242/JCS.035246	40	36	37	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1249	+		10.1016/j.immuni.2019.03.002	http://dx.doi.org/10.1016/j.immuni.2019.03.002			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	30952606	Bronze, Green Accepted			2022-12-18	WOS:000468429500015
J	Janela, B; Patel, AA; Lau, MC; Goh, CC; Msallam, R; Kong, WT; Fehlings, M; Hubert, S; Lum, J; Simoni, Y; Malleret, B; Zolezzi, F; Chen, JM; Poidinger, M; Satpathy, AT; Briseno, C; Wohn, C; Malissen, B; Murphy, KM; Maini, AA; Vanhoutte, L; Guilliams, M; Vial, E; Hennequin, L; Newell, E; Ng, LG; Musette, P; Yona, S; Hacini-Rachinel, F; Ginhoux, F				Janela, Baptiste; Patel, Amit A.; Lau, Mai Chan; Goh, Chi Ching; Msallam, Rasha; Kong, Wan Ting; Fehlings, Michael; Hubert, Sandra; Lum, Josephine; Simoni, Yannick; Malleret, Benoit; Zolezzi, Francesca; Chen, Jinmiao; Poidinger, Michael; Satpathy, Ansuman T.; Briseno, Carlos; Wohn, Christian; Malissen, Bernard; Murphy, Kenneth M.; Maini, Alexander A.; Vanhoutte, Leen; Guilliams, Martin; Vial, Emmanuel; Hennequin, Laurent; Newell, Evan; Ng, Lai Guan; Musette, Philippe; Yona, Simon; Hacini-Rachinel, Feriel; Ginhoux, Florent			A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGF alpha-Mediated Recruitment of Neutrophils	IMMUNITY			English	Article							HIGH-DIMENSIONAL ANALYSIS; PROPIONIBACTERIUM-ACNES; LANGERHANS CELLS; STEADY-STATE; SKIN; MIGRATION; RESPONSES; IMMUNE; MODEL; IDENTIFICATION	Skin conventional dendritic cells (cDCs) exist as two distinct subsets, cDC1s and cDC2s, which maintain the balance of immunity to pathogens and tolerance to self and microbiota. Here, we examined the roles of dermal cDC1s and cDC2s during bacterial infection, notably Propionibacterium acnes (P. acnes). cDC1s, but not cDC2s, regulated the magnitude of the immune response to P. acnes in the murine dermis by controlling neutrophil recruitment to the inflamed site and survival and function therein. Single-cell mRNA sequencing revealed that this regulation relied on secretion of the cytokine vascular endothelial growth factor alpha (VEGF-alpha) by a minor subset of activated EpCAM(+)CD59(+) Ly-6D(+) cDC1s. Neutrophil recruitment by dermal cDC1s was also observed during S. aureus, bacillus Calmette-Guerin (BCG), or E. coli infection, as well as in a model of bacterial insult in human skin. Thus, skin cDC1s are essential regulators of the innate response in cutaneous immunity and have roles beyond classical antigen presentation.	[Janela, Baptiste; Lau, Mai Chan; Goh, Chi Ching; Msallam, Rasha; Kong, Wan Ting; Fehlings, Michael; Hubert, Sandra; Lum, Josephine; Simoni, Yannick; Malleret, Benoit; Zolezzi, Francesca; Chen, Jinmiao; Poidinger, Michael; Newell, Evan; Ng, Lai Guan; Musette, Philippe; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove, Singapore 138648, Singapore; [Janela, Baptiste; Ginhoux, Florent] ASTAR, SRIS, 11 Mandalay Rd, Singapore 308232, Singapore; [Patel, Amit A.; Maini, Alexander A.; Yona, Simon] Univ London, Univ Coll London, Div Med, London WC1E 6BT, England; [Malleret, Benoit] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117545, Singapore; [Zolezzi, Francesca; Vial, Emmanuel; Hennequin, Laurent; Hacini-Rachinel, Feriel] Nestle Skin Hlth R&D GALDERMA, CH-1814 La Tour De Peilz, Switzerland; [Satpathy, Ansuman T.; Briseno, Carlos; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA; [Wohn, Christian; Malissen, Bernard] Aix Marseille Univ, INSERM, CNRS, Ctr Immunol Marseille Luminy,UMR, F-13288 Marseille, France; [Malissen, Bernard] Aix Marseille Univ, INSERM, CNRS, Ctr Immunophenom, F-13288 Marseille, France; [Vanhoutte, Leen] VIB UGnet Ctr Inflammat Res, Transgen Mouse Core Facil, Technol Pk 71, B-9052 Ghent, Belgium; [Vanhoutte, Leen; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Technol Pk 71, B-9052 Ghent, Belgium; [Guilliams, Martin] VIB UGnet Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specia, Technol Pk 71, B-9052 Ghent, Belgium; [Musette, Philippe] Avicenne Hosp, Dept Dermatol, F-93000 Bobigny, France; [Musette, Philippe] INSERM, U1125, F-93000 Bobigny, France	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); University of London; University College London; National University of Singapore; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove, Singapore 138648, Singapore.; Ginhoux, F (corresponding author), ASTAR, SRIS, 11 Mandalay Rd, Singapore 308232, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Malleret, Benoit/E-9159-2011; Guilliams, Martin/N-7803-2013; Musette, Philippe/AAY-9916-2021; Ng, Lai Guan/E-5673-2011; Ng, Lai Guan/N-6980-2019; Yona, Simon/ABE-6572-2020; Newell, Evan W/F-9711-2012; Chen, Jinmiao/ABE-5601-2021; Lau, Mai Chan/L-5186-2019; Malissen, Bernard/AAK-4659-2020	Malleret, Benoit/0000-0001-9658-7528; Guilliams, Martin/0000-0003-3525-7570; Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Newell, Evan W/0000-0002-2889-243X; Lau, Mai Chan/0000-0002-7698-4697; Malissen, Bernard/0000-0003-1340-9342; Kong, Wan Ting/0000-0002-9271-841X; Wohn, Christian/0000-0002-8276-4658; Yona, Simon/0000-0002-3984-2008; Poidinger, Michael/0000-0002-1047-2277; SIMONI, Yannick/0000-0002-9086-3680	Singapore Immunology Network (SIgN) core grant; Nestle Skin Health RD/GALDERMA; DCBiol Labex [ANR-11-LABEX-0043, ANR-10-IDEX-0001-02 PSL]; PHENOMIN; Biomedical Research Council Industry Alignment Fund (BMRC IAF) [311006]; BMRC transition funds [H16/99/b0/011]	Singapore Immunology Network (SIgN) core grant(Agency for Science Technology & Research (A*STAR)); Nestle Skin Health RD/GALDERMA(Nestle SA); DCBiol Labex; PHENOMIN; Biomedical Research Council Industry Alignment Fund (BMRC IAF); BMRC transition funds(Agency for Science Technology & Research (A*STAR))	This work was supported by the Singapore Immunology Network (SIgN) core grant and in part by a grant from Nestle Skin Health R&D/GALDERMA. We thank L. Robinson for critical review and editing of the manuscript. Generation and validation of the Xcr1-IRES-iCre-GSG-2A-TEAL gene-targeted mice were supported by the DCBiol Labex (ANR-11-LABEX-0043 and ANR-10-IDEX-0001-02 PSL) and PHENOMIN. We thank the SIgN Immunomonitoring platform, supported by Biomedical Research Council Industry Alignment Fund (BMRC IAF) grant 311006 and BMRC transition funds #H16/99/b0/011.	Aguilo N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.313; Akamatsu H, 2003, INT J DERMATOL, V42, P366, DOI 10.1046/j.1365-4362.2003.01540.x; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bojar RA, 2004, CLIN DERMATOL, V22, P375, DOI 10.1016/j.clindermatol.2004.03.005; Boros DL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00345; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Briseno CG, 2014, CURR OPIN IMMUNOL, V29, P69, DOI 10.1016/j.coi.2014.04.006; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; del Fresno C, 2018, SCIENCE, V362, P351, DOI 10.1126/science.aan8423; Desai J, 2016, EUR J IMMUNOL, V46, P223, DOI 10.1002/eji.201545605; DEYOUNG LM, 1984, J INVEST DERMATOL, V83, P394, DOI 10.1111/1523-1747.ep12264715; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Elbim Carole, 2009, Open Virol J, V3, P52, DOI 10.2174/1874357900903010052; Ericson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108553; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kistowska M, 2015, J INVEST DERMATOL, V135, P110, DOI 10.1038/jid.2014.290; Kumar S, 2012, BLOOD, V120, P3563, DOI 10.1182/blood-2012-04-426981; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Lu J, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-015-0109-9; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Massena S, 2015, BLOOD, V126, P2016, DOI 10.1182/blood-2015-03-631572; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Motwani MP, 2016, J PATHOL CLIN RES, V2, P154, DOI 10.1002/cjp2.43; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Olekhnovitch R, 2015, TRENDS PARASITOL, V31, P653, DOI 10.1016/j.pt.2015.08.001; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reichel CA, 2006, J LEUKOCYTE BIOL, V79, P114, DOI 10.1189/jlb.0605337; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Salvi V, 2016, ONCOTARGET, V7, P39256, DOI 10.18632/oncotarget.9684; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Scheiermann C, 2015, CARDIOVASC RES, V107, P340, DOI 10.1093/cvr/cvv099; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Stock AT, 2014, J EXP MED, V211, P751, DOI 10.1084/jem.20132183; Szulwach KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135007; Terhorst D, 2015, J IMMUNOL, V195, P4953, DOI 10.4049/jimmunol.1500551; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Wang YM, 2016, EUR J IMMUNOL, V46, P552, DOI 10.1002/eji.201545917; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496	54	36	36	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1069	1083		10.1016/j.immuni.2019.03.001	http://dx.doi.org/10.1016/j.immuni.2019.03.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30926233	Bronze			2022-12-18	WOS:000464660800023
J	Chopin, M; Lun, AT; Zhan, Y; Schreuder, J; Coughlan, H; D'Amico, A; Mielke, LA; Almeida, FF; Kueh, AJ; Dickins, RA; Belz, GT; Naik, SH; Lew, AM; Bouillet, P; Herold, MJ; Smyth, GK; Corcoran, LM; Nutt, SL				Chopin, Michael; Lun, Aaron T.; Zhan, Yifan; Schreuder, Jaring; Coughlan, Hannah; D'Amico, Angela; Mielke, Lisa A.; Almeida, Francisca F.; Kueh, Andrew J.; Dickins, Ross A.; Belz, Gabrielle T.; Naik, Shalin H.; Lew, Andrew M.; Bouillet, Phillipe; Herold, Marco J.; Smyth, Gordon K.; Corcoran, Lynn M.; Nutt, Stephen L.			Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC-SCRIPT	IMMUNITY			English	Article							FACTOR E2-2; FACTOR ZDC; EXPRESSION; IDENTIFICATION; PROGENITORS; REVEALS; FAMILY; MACROPHAGES; COMMITMENT; ACTIVATION	Dendritic cells (DCs) are can be broadly divided into conventional (cDC) and plasmacytoid (pDC) subsets. Despite the importance of this lineage diversity, its genetic basis is not fully understood. We found that conditional ablation of the Ets-family transcription factor PU.1 in DC-restricted progenitors led to increased pDC production at the expense of cDCs. PU.1 controlled many of the cardinal functions of DCs, such as antigen presentation by cDCs and type I interferon production by pDCs. Conditional ablation of PU.1 de-repressed the pDC transcriptional signature in cDCs. The combination of genome-wide mapping of PU.1 binding and gene expression analysis revealed a key role for PU.1 in maintaining cDC identity through the induction of the transcriptional regulator DC-SCRIPT. PU.1 activated DC-SCRIPT expression, which in turn promoted cDC formation, particularly of cDC1s, and repressed pDC development. Thus, cDC identity is regulated by a transcriptional node requiring PU.1 and DC-SCRIPT.	[Chopin, Michael; Lun, Aaron T.; Zhan, Yifan; Schreuder, Jaring; Coughlan, Hannah; D'Amico, Angela; Mielke, Lisa A.; Almeida, Francisca F.; Kueh, Andrew J.; Belz, Gabrielle T.; Naik, Shalin H.; Lew, Andrew M.; Bouillet, Phillipe; Herold, Marco J.; Smyth, Gordon K.; Corcoran, Lynn M.; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Chopin, Michael; Lun, Aaron T.; Zhan, Yifan; Schreuder, Jaring; Coughlan, Hannah; D'Amico, Angela; Mielke, Lisa A.; Almeida, Francisca F.; Kueh, Andrew J.; Belz, Gabrielle T.; Naik, Shalin H.; Lew, Andrew M.; Bouillet, Phillipe; Herold, Marco J.; Corcoran, Lynn M.; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Mielke, Lisa A.] Olivia Newton John Canc Res Inst, Heidelberg, Vic 3084, Australia; [Mielke, Lisa A.] La Trobe Univ, Sch Canc Med, Heidelberg, Vic 3084, Australia; [Dickins, Ross A.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Lew, Andrew M.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Smyth, Gordon K.] Univ Melbourne, Sch Math & Stat, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; Monash University; University of Melbourne; University of Melbourne	Chopin, M; Nutt, SL (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Chopin, M; Nutt, SL (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	chopin@wehi.edu.au; nutt@wehi.edu.au	Naik, Shalin/AFD-5605-2022; Chopin, Michael/AAD-3661-2020; Nutt, Stephen L/C-9256-2013; Herold, Marco J/C-8039-2013; Dickins, Ross A/K-2852-2012; Belz, Gabrielle T/C-9350-2013	Nutt, Stephen L/0000-0002-0020-6637; Herold, Marco J/0000-0001-7539-7581; Dickins, Ross A/0000-0003-4112-5304; Belz, Gabrielle T/0000-0002-9660-9587; Michael, Chopin/0000-0001-8812-2763; Mielke, Lisa/0000-0002-9522-9320; Naik, Shalin/0000-0003-0299-3301; Zhan, Yifan/0000-0001-6974-0486; Schreuder, Jaring/0000-0002-7579-0006	National Health and Medical Research Council of Australia [5575500, 1054925, 1048278, 1054618, 1058892, 1037321, 1043414, 1080321, 1105209]; Cancer Council Victoria Venture Grant; Victorian Cancer Agency [TRP13041]; Australian Phenomics Network	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria Venture Grant(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Cancer Agency; Australian Phenomics Network	We thank S. O'Connor, T. Kratina, T. Camilleri, A. Hilton, and A. Jarratt for excellent technical assistance and A. Stock for comments on the manuscript draft. This work benefitted from data assembled by the ImmGen consortium. This research was supported by the National Health and Medical Research Council of Australia (5575500, 1054925, and 1048278 to S.L.N.; 1054618 and 1058892 to G.K.S.; 1037321, 1043414, 1080321, and 1105209 to A.M.L.) and the Cancer Council Victoria Venture Grant and Victorian Cancer Agency (TRP13041 to M.J.H.). This work was made possible through support from the Australian Phenomics Network.	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Carrington EM, 2015, P NATL ACAD SCI USA, V112, P4044, DOI 10.1073/pnas.1417620112; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chopin M, 2016, CELL REP, V15, P866, DOI 10.1016/j.celrep.2016.03.066; Chopin M, 2013, J EXP MED, V210, P2967, DOI 10.1084/jem.20130930; Chopin M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00026; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hontelez S, 2013, J IMMUNOL, V190, P3172, DOI 10.4049/jimmunol.1201776; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin Q, 2015, NUCLEIC ACIDS RES, V43, P9680, DOI 10.1093/nar/gkv1056; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Lun ATL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku351; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pandey G, 2013, J IMMUNOL METHODS, V387, P71, DOI 10.1016/j.jim.2012.09.012; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROBINSON MD, 2010, GENOME BIOL, V11; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sawai CM, 2013, J EXP MED, V210, P2151, DOI 10.1084/jem.20130443; Schenk RL, 2017, CELL DEATH DIFFER, V24, P534, DOI 10.1038/cdd.2016.156; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Triantis V, 2006, J IMMUNOL, V176, P1081, DOI 10.4049/jimmunol.176.2.1081; Triantis V, 2006, J LEUKOCYTE BIOL, V79, P1083, DOI 10.1189/jlb.1005588; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113	61	36	37	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					77	+		10.1016/j.immuni.2018.11.010	http://dx.doi.org/10.1016/j.immuni.2018.11.010			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30611612	Bronze			2022-12-18	WOS:000455661600012
J	Lin, CD; Zhang, YH; Zhang, K; Zheng, YJ; Lu, L; Chang, HS; Yang, H; Yang, YR; Wan, YY; Wang, SH; Yuan, MY; Yan, ZJ; Zhang, RG; He, YN; Ge, GX; Wu, DQ; Chen, JF				Lin, ChangDong; Zhang, YouHua; Zhang, Kun; Zheng, YaJuan; Lu, Ling; Chang, HaiShuang; Yang, Hui; Yang, YanRong; Wan, YaoYing; Wang, ShiHui; Yuan, MengYa; Yan, ZhanJun; Zhang, RongGuang; He, YongNing; Ge, GaoXiang; Wu, Dianqing; Chen, JianFeng			Fever Promotes T Lymphocyte Trafficking via a Thermal Sensory Pathway Involving Heat Shock Protein 90 and alpha 4 Integrins	IMMUNITY			English	Article							HIGH ENDOTHELIAL VENULES; FOCAL ADHESION KINASE; IN-VIVO; BINDING; MIGRATION; PAXILLIN; HSP90; CELLS; PHOSPHORYLATION; DIMERIZATION	Fever is an evolutionarily conserved response that confers survival benefits during infection. However, the underlying mechanism remains obscure. Here, we report that fever promoted T lymphocyte trafficking through heat shock protein 90 (Hsp90)-induced alpha 4 integrin activation and signaling in T cells. By inducing selective binding of Hsp90 to alpha 4 integrins, but not beta 2 integrins, fever increased alpha 4-integrin-mediated T cell adhesion and transmigration. Mechanistically, Hsp90 bound to the alpha 4 tail and activated alpha 4 integrins via inside-out signaling. Moreover, the N and C termini of one Hsp90 molecule simultaneously bound to two alpha 4 tails, leading to dimerization and clustering of alpha 4 integrins on the cell membrane and subsequent activation of the FAK-RhoA pathway. Abolishment of Hsp90-alpha 4 interaction inhibited fever-induced T cell trafficking to draining lymph nodes and impaired the clearance of bacterial infection. Our findings identify the Hsp90-alpha 4-]integrin axis as a thermal sensory pathway that promotes T lymphocyte trafficking and enhances immune surveillance during infection.	[Lin, ChangDong; Zhang, YouHua; Zhang, Kun; Zheng, YaJuan; Lu, Ling; Yang, YanRong; Wan, YaoYing; Wang, ShiHui; Yuan, MengYa; Yan, ZhanJun; Ge, GaoXiang; Chen, JianFeng] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, Shanghai 200031, Peoples R China; [Chang, HaiShuang; Yang, Hui; Zhang, RongGuang; He, YongNing] Univ Chinese Acad Sci, State Key Lab Mol Biol, CAS Ctr Excellence Mol Cell Sci,Natl Ctr Prot Sci, Shanghai Inst Biochem & Cell Biol,Chinese Acad Sc, Shanghai 201203, Peoples R China; [Wu, Dianqing] Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Wu, Dianqing] Yale Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Yan, ZhanJun] First Peoples Hosp Wujiang Dist, Dept Orthoped, Suzhou 215000, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Yale University; Yale University	Chen, JF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, Shanghai 200031, Peoples R China.	jfchen@sibcb.ac.cn		Lin, ChangDong/0000-0002-6766-3699; chen, jian feng/0000-0002-2892-1691; Zhang, Youhua/0000-0002-2577-8340	National Natural Science Foundation of China [31525016, 31830112, 31601129, 31701219, 31190061]; National Basic Research Program of China [2014CB541905]; Personalized Medicines-Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12010101]; China Postdoctoral Science Foundation [2016M601670]; CAS/SAFEA International Partnership Program for Creative Research Teams; SA-SIBS scholarship program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135805] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Personalized Medicines-Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); SA-SIBS scholarship program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Natural Science Foundation of China (31525016, 31830112, 31601129, 31701219, and 31190061), National Basic Research Program of China (2014CB541905), Personalized Medicines-Molecular Signature-based Drug Discovery and Development, the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010101), China Postdoctoral Science Foundation (2016M601670), and the CAS/SAFEA International Partnership Program for Creative Research Teams. The authors gratefully acknowledge the support of SA-SIBS scholarship program. We thank the Genome Tagging Project (GTP) Center, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences for technical support.	Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Evans SS, 2000, INT J HYPERTHER, V16, P45, DOI 10.1080/026567300285411; Evans SS, 2001, BLOOD, V97, P2727, DOI 10.1182/blood.V97.9.2727; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; HAHNE M, 1993, EUR J CELL BIOL, V61, P290; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Infante E, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0013; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; Kobayakawa T, 2008, CELL STRESS CHAPERON, V13, P97, DOI 10.1007/s12192-008-0017-5; KUIJPERS TW, 1995, SPRINGER SEMIN IMMUN, V16, P379; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; Lu L, 2016, J BIOL CHEM, V291, P10363, DOI 10.1074/jbc.M116.717694; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MAY MJ, 1993, J CELL SCI, V106, P109; Meng X, 1996, J CELL SCI, V109, P1677; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sun H, 2014, DEV CELL, V30, P61, DOI 10.1016/j.devcel.2014.05.002; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Xiong XY, 2014, EXP CELL RES, V326, P78, DOI 10.1016/j.yexcr.2014.05.018	43	36	42	6	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					137	+		10.1016/j.immuni.2018.11.013	http://dx.doi.org/10.1016/j.immuni.2018.11.013			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650373	Green Accepted, Bronze			2022-12-18	WOS:000455661600016
J	Clemente-Casares, X; Hosseinzadeh, S; Barbu, I; Dick, SA; Macklin, JA; Wang, YM; Momen, A; Kantores, C; Aronoff, L; Farno, M; Lucas, TM; Avery, J; Zarrin-Khat, D; Elsaesser, HJ; Razani, B; Lavine, KJ; Husain, M; Brooks, DG; Robbins, CS; Cybulsky, M; Epelman, S				Clemente-Casares, Xavier; Hosseinzadeh, Siyavash; Barbu, Iulia; Dick, Sarah A.; Macklin, Jillian A.; Wang, Yiming; Momen, Abdul; Kantores, Crystal; Aronoff, Laura; Farno, Maylis; Lucas, Tiffany M.; Avery, Joan; Zarrin-Khat, Dorrin; Elsaesser, Heidi J.; Razani, Babak; Lavine, Kory J.; Husain, Mansoor; Brooks, David G.; Robbins, Clinton S.; Cybulsky, Myron; Epelman, Slava			A CD103(+) Conventional Dendritic Cell Surveillance System Prevents Development of Overt Heart Failure during Subclinical Viral Myocarditis	IMMUNITY			English	Article							HIGH-DIMENSIONAL ANALYSIS; TARGETED DELETION; MACROPHAGES; IRF8; EXPRESSION; MONOCYTES; REVEALS; PROGENITORS; INTERFERON; IMMUNITY	Innate and adaptive immune cells modulate heart failure pathogenesis during viral myocarditis, yet their identities and functions remain poorly defined. We utilized a combination of genetic fate mapping, parabiotic, transcriptional, and functional analyses and demonstrated that the heart contained two major conventional dendritic cell (cDC) subsets, CD103(+) and CD11b(+), which differentially relied on local proliferation and precursor recruitment to maintain their tissue residency. Following viral infection of the myocardium, cDCs accumulated in the heart coincident with monocyte infiltration and loss of resident reparative embryonic-derived cardiac macrophages. cDC depletion abrogated antigen-specific CD8(+) T cell proliferative expansion, transforming subclinical cardiac injury to overt heart failure. These effects were mediated by CD103(+) cDCs, which are dependent on the transcription factor BATF3 for their development. Collectively, our findings identified resident cardiac cDC subsets, defined their origins, and revealed an essential role for CD103(+) cDCs in antigen-specific T cell responses during subclinical viral myocarditis.	[Clemente-Casares, Xavier; Hosseinzadeh, Siyavash; Barbu, Iulia; Dick, Sarah A.; Macklin, Jillian A.; Wang, Yiming; Momen, Abdul; Kantores, Crystal; Aronoff, Laura; Zarrin-Khat, Dorrin; Husain, Mansoor; Robbins, Clinton S.; Cybulsky, Myron; Epelman, Slava] UHN, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 1L7, Canada; [Hosseinzadeh, Siyavash; Macklin, Jillian A.; Aronoff, Laura; Husain, Mansoor; Robbins, Clinton S.; Cybulsky, Myron; Epelman, Slava] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Barbu, Iulia; Brooks, David G.; Robbins, Clinton S.; Epelman, Slava] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada; [Farno, Maylis] AgroParisTech, Paris, France; [Lucas, Tiffany M.; Avery, Joan; Razani, Babak; Lavine, Kory J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Elsaesser, Heidi J.; Brooks, David G.] UHN, Princess Margaret Canc Ctr, Immune Therapy Program, Toronto, ON M5G 1L7, Canada; [Husain, Mansoor; Robbins, Clinton S.; Epelman, Slava] Peter Munk Cardiac Ctr, Toronto, ON M5G 1L7, Canada; [Zarrin-Khat, Dorrin; Husain, Mansoor; Epelman, Slava] Ted Rogers Ctr Heart Res, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; AgroParisTech; Washington University (WUSTL); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Peter Munk Cardiac Centre	Epelman, S (corresponding author), UHN, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 1L7, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada.; Epelman, S (corresponding author), Peter Munk Cardiac Ctr, Toronto, ON M5G 1L7, Canada.; Epelman, S (corresponding author), Ted Rogers Ctr Heart Res, Toronto, ON M5G 1L7, Canada.	slava.epelman@uhn.ca	Cybulsky, Myron I./AAD-6539-2019; Farno, Maylis/AAU-6989-2020; Epelman, Slava/AAO-1728-2020	Epelman, Slava/0000-0003-3400-4475; Brooks, David/0000-0001-7763-8764; Clemente-Casares, Xavier/0000-0002-8627-4971; Husain, Mansoor/0000-0002-3740-6739; Aronoff, Laura/0000-0001-5156-9326; Wang, Yiming/0000-0001-8031-6184; Robbins, Clinton/0000-0001-9848-1495; Cybulsky, Myron/0000-0002-1696-2867	Canadian Institutes of Health Research [PJT364831, FDN148386]; Heart and Stroke Foundation (Ontario Provincial Office); March of Dimes; Ted Rogers Centre for Heart Research; Heart and Stroke Richard Lewar Centre; Peter Munk Cardiac Centre; NIH [K08HL112826, AI085043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL112826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085043] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (Ontario Provincial Office)(Heart & Stroke Foundation of Ontario); March of Dimes(March of Dimes); Ted Rogers Centre for Heart Research; Heart and Stroke Richard Lewar Centre; Peter Munk Cardiac Centre(University of Toronto); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Canadian Institutes of Health Research (S.E., PJT364831, J.A.M. and D.G.B., FDN148386). S.E. was supported by a Heart and Stroke Foundation (Grant-in-Aid, CP has Heart Cardiovascular Award, and personnel award from the Ontario Provincial Office), March of Dimes (S.E.), Ted Rogers Centre for Heart Research (S.E., S.A.D, J.A.M.), Heart and Stroke Richard Lewar Centre (S.E., S.A.D.), the Peter Munk Cardiac Centre (S.E.), and the NIH (S.E. K08HL112826, D.G.B. AI085043). We would like to thank Dr. Tania Watts, Dr. Michael Diamond, and Dr. Marco Colonna for their advice and provision of EMCV-D, and Dr. Douglas Mann and Dr. Gwen Randolph for their insights. We thank the NIH tetramer facility for supplying the VP2-tetramer.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Blyszczuk P, 2013, BBA-MOL CELL RES, V1833, P934, DOI 10.1016/j.bbamcr.2012.10.008; Bock C, 2010, NEW ENGL J MED, V362, P1248, DOI 10.1056/NEJMc0911362; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Dieterlen MT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5946807; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fairweather D, 2003, J IMMUNOL, V170, P4731, DOI 10.4049/jimmunol.170.9.4731; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Gebhardt T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00340; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hochheiser K, 2013, J CLIN INVEST, V123, P4242, DOI 10.1172/JCI70143; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Holm GH, 2010, J VIROL, V84, P6900, DOI 10.1128/JVI.01742-09; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Leuschner F, 2015, EUR HEART J, V36, P1478, DOI 10.1093/eurheartj/ehu225; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Maekawa Y, 2009, CIRCULATION, V120, P1401, DOI 10.1161/CIRCULATIONAHA.109.865956; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Ponikowski P., 2014, HEART FAILURE PREVEN, P1; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Valaperti A, 2013, CIRCULATION, V128, P1542, DOI 10.1161/CIRCULATIONAHA.113.002275; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang Y, 2010, WORLD J CARDIOL, V2, P357, DOI 10.4330/wjc.v2.i11.357	57	36	39	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					974	+		10.1016/j.immuni.2017.10.011	http://dx.doi.org/10.1016/j.immuni.2017.10.011			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166591	Bronze			2022-12-18	WOS:000416483700019
J	Fattahi, F; Ward, PA				Fattahi, Fatemeh; Ward, Peter A.			Understanding Immunosuppression after Sepsis	IMMUNITY			English	Editorial Material							IMMUNE DYSFUNCTION; IMPROVES SURVIVAL; MICE	Following a severe primary infection or trauma, the risk of developing pneumonia increases due to acquired immune defects collectively known as sepsis-induced immunosuppression. In this issue of Immunity, Roquilly et al. (2017) show that dendritic cells and macrophages developing in the lung after the resolution of a severe infection acquire tolerogenic properties that contribute to persistent immunosuppression and susceptibility to secondary infections.	[Fattahi, Fatemeh; Ward, Peter A.] Univ Michigan, Med Sch, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Med Sch, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@med.umich.edu						Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Grailer JJ, 2015, J IMMUNOL, V194, P868, DOI 10.4049/jimmunol.1401193; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Patera AC, 2016, J LEUKOCYTE BIOL, V100, P1239, DOI 10.1189/jlb.4HI0616-255R; Roquilly A, 2017, IMMUNITY, V47, P135, DOI 10.1016/j.immuni.2017.06.021; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375	10	36	39	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					3	5		10.1016/j.immuni.2017.07.007	http://dx.doi.org/10.1016/j.immuni.2017.07.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723551	Bronze			2022-12-18	WOS:000405712800002
J	De Palma, M; Jain, RK				De Palma, Michele; Jain, Rakesh K.			CD4(+) T Cell Activation and Vascular Normalization: Two Sides of the Same Coin?	IMMUNITY			English	Editorial Material							IMMUNOTHERAPY	Normalization of tumor blood vessels enhances the infiltration and functions of T cells. Tian et al. (2017) report that effector CD4(+) T cells, in turn, support vascular normalization, highlighting intertwined roles for blood vessels and T cells in cancer.	[De Palma, Michele] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Jain, Rakesh K.] Harvard Med Sch, Dept Radiat Oncol, Steele Labs Tumor Biol, Boston, MA 02114 USA; [Jain, Rakesh K.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	De Palma, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.; Jain, RK (corresponding author), Harvard Med Sch, Dept Radiat Oncol, Steele Labs Tumor Biol, Boston, MA 02114 USA.; Jain, RK (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	michele.depalma@epfl.ch; jain@steele.mgh.harvard.edu	De Palma, Michele/L-5350-2016; Jain, Rakesh K/I-1384-2017	De Palma, Michele/0000-0001-9128-5459; Jain, Rakesh K/0000-0001-7571-3548				Allen E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9679; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Kammertoens T., 2017, NATURE; Qin L, 2017, NEURORADIOLOGY, V59, P135, DOI 10.1007/s00234-016-1769-8; Schmittnaegel M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9670; Schoenfeld J, 2010, CANCER RES, V70, P10150, DOI 10.1158/0008-5472.CAN-10-1852; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724	10	36	37	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					773	775		10.1016/j.immuni.2017.04.015	http://dx.doi.org/10.1016/j.immuni.2017.04.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514684	Bronze			2022-12-18	WOS:000401316300013
J	Fujikado, N; Mann, AO; Bansal, K; Romito, KR; Ferre, EMN; Rosenzweig, SD; Lionakis, MS; Benoist, C; Mathis, D				Fujikado, Noriyuki; Mann, Alexander O.; Bansal, Kushagra; Romito, Kimberly R.; Ferre, Elise M. N.; Rosenzweig, Sergio D.; Lionakis, Michail S.; Benoist, Christophe; Mathis, Diane			Aire Inhibits the Generation of a Perinatal Population of Interleukin-17A-Producing gamma delta T Cells to Promote Immunologic Tolerance	IMMUNITY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; THYMIC EPITHELIAL-CELLS; ECTODERMAL DYSTROPHY; INTERFERON-GAMMA; IL-17 PRODUCTION; GENE-EXPRESSION; SELF-TOLERANCE; TCR REPERTOIRE; RNA-SEQ; SELECTION	Aire's primary mechanism of action is to regulate transcription of a battery of genes in medullary thymic epithelial cells ( mTECs) and, consequently, negative selection of effector T cells and positive selection of regulatory T cells. We found that Aire-deficient mice had expanded thymic and peripheral populations of perinatally generated IL-17A(+)V gamma 6(+) V delta 1(+)T cells, considered to be "early responders'' to tissue stress and drivers of inflammatory reactions. Aire-dependent control of Ii7 expression in mTECs regulated the size of thymic IL-17A(+)V gamma 6(+) V delta 1(+)T compartments. In mice lacking Aire and gd T cells, certain tissues typically targeted in the `` Aire-less'' disease, notably the retina, were only minimally infiltrated. IL-17A(+)V gamma 6(+) V delta 1(+)T cells were present in the retina of wild-type mice and expanded very early in Aire-deficientmice. A putatively parallel population of IL-17A(+)V gamma 6(+) V delta 1(+)T cells was increased in humans lacking Aire. Thus, Aire exerts multi-faceted autoimmune control that extends to a population of innate-like T cells.	[Fujikado, Noriyuki; Mann, Alexander O.; Bansal, Kushagra; Benoist, Christophe; Mathis, Diane] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Romito, Kimberly R.; Rosenzweig, Sergio D.] NIH, Dept Lab Med, NIH Clin Ctr, Bethesda, MD 20892 USA; [Ferre, Elise M. N.; Lionakis, Michail S.] NIAID, Fungal Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Fujikado, Noriyuki] Eli Lilly Japan KK, Minato Ku, Tokyo 1070052, Japan	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Eli Lilly	Benoist, C; Mathis, D (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	cb@hms.harvard.edu; dm@hms.harvard.edu	Lionakis, Michail/J-8840-2017	Lionakis, Michail/0000-0003-4994-9500; Fujikado, Noriyuki/0000-0002-3183-5866; Fujikado, Noriyuki/0000-0002-0415-5929	NIH [R01 DK060027, T32 AI118692]; NIH NIAID Division of Intramural Research; Japan Society for the Promotion of Science; Uehara Memorial Foundation; American Diabetes Association [7-12-MN-51]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001122, T32AI118692, ZIAAI001175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060027] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAID Division of Intramural Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	We would like to thank Drs. V. Kuchroo, P. Love, and M. Anderson for mice; Drs. R. Tigelaar and J. Lewis for the 17D1 hybridoma; K. Hattori for expert assistance with mice; Dr. A. Ortiz-Lopez for histological scoring; the NIH Tetramer Core Facility for provision of tetramer reagents; Dr. N. Asinovski for hybridoma culture; and Drs. H. Yoshida and S. Yang for insightful discussions. This work was supported by NIH grant R01 DK060027 to D.M. and in part by the NIH NIAID Division of Intramural Research. N.F. received fellowships from the Japan Society for the Promotion of Science and the Uehara Memorial Foundation, K.B. received a fellowship from the American Diabetes Association (7-12-MN-51), and A.O.M. received a fellowship from the NIH (T32 AI118692).	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Deknuydt F, 2009, IMMUNOL LETT, V127, P8, DOI 10.1016/j.imlet.2009.08.003; Dimova T, 2015, P NATL ACAD SCI USA, V112, pE556, DOI 10.1073/pnas.1412058112; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Jin Y, 2010, J IMMUNOL, V185, P5723, DOI 10.4049/jimmunol.1001612; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kisand K, 2015, J CLIN IMMUNOL, V35, P463, DOI 10.1007/s10875-015-0176-y; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Koh AS, 2010, P NATL ACAD SCI USA, V107, P13016, DOI 10.1073/pnas.1004436107; Laakso SM, 2011, J IMMUNOL, V187, P2023, DOI 10.4049/jimmunol.1100212; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Nitta T, 2015, EMBO REP, V16, P638, DOI 10.15252/embr.201540096; O'Brien RL, 2015, CELL IMMUNOL, V296, P62, DOI 10.1016/j.cellimm.2015.01.011; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Paget C., 2015, CELL BIOL, V93, P198; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Pereira P, 2004, J IMMUNOL, V173, P3261, DOI 10.4049/jimmunol.173.5.3261; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pitt LA, 2008, EUR J IMMUNOL, V38, P2689, DOI 10.1002/eji.200838553; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rei M, 2014, P NATL ACAD SCI USA, V111, pE3562, DOI 10.1073/pnas.1403424111; Ribeiro AR, 2013, J IMMUNOL, V191, P1200, DOI 10.4049/jimmunol.1203042; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Sato K, 2004, BIOCHEM BIOPH RES CO, V318, P935, DOI 10.1016/j.bbrc.2004.04.116; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; SIM GK, 1995, J IMMUNOL, V154, P5821; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; TROMBETTA JJ, 2014, CURR PROTOC MOL BIOL, V107, P1, DOI DOI 10.1002/0471142727.MB0422S107; Tuovinen H, 2009, CELL IMMUNOL, V257, P5, DOI 10.1016/j.cellimm.2009.01.012; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011	65	36	37	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					999	1012		10.1016/j.immuni.2016.10.023	http://dx.doi.org/10.1016/j.immuni.2016.10.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851927	Bronze, Green Accepted			2022-12-18	WOS:000389473500012
J	Ford, ML				Ford, Mandy L.			T Cell Cosignaling Molecules in Transplantation	IMMUNITY			English	Review							ANTI-CD40 MONOCLONAL-ANTIBODY; ISLET ALLOGRAFT SURVIVAL; RESPONSES IN-VIVO; MISMATCHED CARDIAC ALLOGRAFTS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LONG-TERM ACCEPTANCE; IFN-GAMMA PRODUCTION; COSTIMULATION BLOCKADE; ALLOIMMUNE RESPONSES; NONHUMAN-PRIMATES	The ultimate outcome of alloreactivity versus tolerance following transplantation is potently influenced by the constellation of cosignaling molecules expressed by immune cells during priming with alloantigen, and the net sum of costimulatory and coinhibitory signals transmitted via ligation of these molecules. Intense investigation over the last two decades has yielded a detailed understanding of the kinetics, cellular distribution, and intracellular signaling networks of cosignaling molecules such as the CD28, TNF, and TIM families of receptors in alloimmunity. More recent work has better defined the cellular and molecular mechanisms by which engagement of cosignaling networks serve to either dampen or augment alloimmunity. These findings will likely aid in the rational development of novel immunomodulatory strategies to prolong graft survival and improve outcomes following transplantation.	[Ford, Mandy L.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Ford, Mandy L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA	Emory University; Emory University	Ford, ML (corresponding author), Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.; Ford, ML (corresponding author), Emory Univ, Dept Surg, Atlanta, GA 30322 USA.	mandy.ford@emory.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104699, R01AI073707] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI104699, R01 AI073707] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams AB, 2005, J IMMUNOL, V174, P542, DOI 10.4049/jimmunol.174.1.542; Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Aoyagi T, 2009, AM J TRANSPLANT, V9, P1732, DOI 10.1111/j.1600-6143.2009.02693.x; AZUMA M, 1993, J IMMUNOL, V150, P1147; Badell IR, 2012, AM J TRANSPLANT, V12, P126, DOI 10.1111/j.1600-6143.2011.03736.x; Badell IR, 2010, J CLIN INVEST, V120, P4520, DOI 10.1172/JCI43895; Batliwalla F, 1996, HUM IMMUNOL, V48, P68, DOI 10.1016/0198-8859(96)00077-8; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boenisch O, 2010, J IMMUNOL, V185, P5806, DOI 10.4049/jimmunol.0903435; Brimhall AK, 2008, BRIT J DERMATOL, V159, P274, DOI 10.1111/j.1365-2133.2008.08673.x; Brown DR, 2011, J IMMUNOL, V187, P21, DOI 10.4049/jimmunol.1100510; Burghuber C. K., 2015, AM J TRANSPLANT; Burrell BE, 2009, J IMMUNOL, V182, P379, DOI 10.4049/jimmunol.182.1.379; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Cai LJ, 2013, TRANSPLANTATION, V96, P379, DOI 10.1097/TP.0b013e31829b07b5; Chadha R, 2011, TRANSPLANTATION, V91, P939, DOI 10.1097/TP.0b013e3182126eeb; Charbonnier LM, 2012, AM J TRANSPLANT, V12, P2313, DOI 10.1111/j.1600-6143.2012.04184.x; Chen J, 2013, AM J TRANSPLANT, V13, P2280, DOI 10.1111/ajt.12350; Daley SR, 2008, AM J TRANSPLANT, V8, P2265, DOI 10.1111/j.1600-6143.2008.02382.x; Degauque N, 2008, J CLIN INVEST, V118, P735, DOI 10.1172/JCI32562; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Ezzelarab MB, 2014, TRANSPLANTATION, V97, P502, DOI 10.1097/TP.0000000000000042; Ferrer IR, 2012, J IMMUNOL, V189, P4387, DOI 10.4049/jimmunol.1201757; Ferrer IR, 2011, P NATL ACAD SCI USA, V108, P20701, DOI 10.1073/pnas.1105500108; Flies DB, 2015, J IMMUNOL, V194, P5294, DOI 10.4049/jimmunol.1402648; Flies DB, 2014, J CLIN INVEST, V124, P1966, DOI 10.1172/JCI74589; Flies DB, 2011, J IMMUNOL, V187, P1537, DOI 10.4049/jimmunol.1100660; Ford ML, 2010, CURR OPIN ORGAN TRAN, V15, P405, DOI 10.1097/MOT.0b013e32833b7916; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Gorbacheva V, 2015, J IMMUNOL, V194, P1347, DOI 10.4049/jimmunol.1401573; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; Haanstra KG, 2003, TRANSPLANTATION, V75, P637, DOI 10.1097/01.TP.0000054835.58014.C2; He WT, 2009, TRANSPLANTATION, V88, P782, DOI 10.1097/TP.0b013e3181b47f25; Higginbotham L, 2015, XENOTRANSPLANTATION, V22, P221, DOI 10.1111/xen.12166; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Imai A, 2007, TRANSPLANTATION, V84, P1020, DOI 10.1097/01.tp.0000286058.79448.c7; Ito T, 2005, J IMMUNOL, V174, P6648, DOI 10.4049/jimmunol.174.11.6648; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kim EJ, 2014, AM J TRANSPLANT, V14, P59, DOI 10.1111/ajt.12526; Kim JR, 2010, CLIN EXP IMMUNOL, V160, P348, DOI 10.1111/j.1365-2249.2010.04116.x; Kinnear G, 2013, J IMMUNOL, V191, P1465, DOI 10.4049/jimmunol.1300553; Kinnear G, 2010, TRANSPLANTATION, V90, P1265, DOI 10.1097/TP.0b013e3181fe5396; Kirk AD, 2001, TRANSPLANTATION, V72, P377, DOI 10.1097/00007890-200108150-00005; Kitchens W. H., 2012, AM J TRANSPLANT; Koehn BH, 2008, J IMMUNOL, V181, P5313, DOI 10.4049/jimmunol.181.8.5313; Krummey SM, 2014, AM J TRANSPLANT, V14, P607, DOI 10.1111/ajt.12600; Krummey SM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00036; Lacha J, 2002, J LEUKOCYTE BIOL, V71, P311; Laouar A, 2007, J IMMUNOL, V178, P652, DOI 10.4049/jimmunol.178.2.652; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Li W, 2005, AM J TRANSPLANT, V5, P978, DOI 10.1111/j.1600-6143.2005.00823.x; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Liu DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130490; Liu DY, 2014, J EXP MED, V211, P297, DOI 10.1084/jem.20130902; Liu DY, 2013, J IMMUNOL, V191, P1957, DOI 10.4049/jimmunol.1300267; Liu Y, 2015, AM J TRANSPLANT, V15, P954, DOI 10.1111/ajt.13067; Liu YX, 2015, J HEPATOL, V62, P563, DOI 10.1016/j.jhep.2014.10.034; Lo DJ, 2015, AM J TRANSPLANT, V15, P984, DOI 10.1111/ajt.13100; Lo DJ, 2013, AM J TRANSPLANT, V13, P320, DOI 10.1111/j.1600-6143.2012.04342.x; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; Lowe M, 2012, AM J TRANSPLANT, V12, P2079, DOI 10.1111/j.1600-6143.2012.04054.x; Lowe MC, 2013, AM J TRANSPLANT, V13, P312, DOI 10.1111/j.1600-6143.2012.04341.x; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; Monk NJ, 2003, NAT MED, V9, P1275, DOI 10.1038/nm931; Nanji SA, 2006, DIABETES, V55, P27, DOI 10.2337/diabetes.55.01.06.db04-1154; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Okwor I, 2015, J IMMUNOL, V195, P3218, DOI 10.4049/jimmunol.1500922; Oura T, 2012, AM J TRANSPLANT, V12, P1740, DOI 10.1111/j.1600-6143.2012.04014.x; Ozkaynak E, 2002, J IMMUNOL, V169, P6546, DOI 10.4049/jimmunol.169.11.6546; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Page A, 2012, AM J TRANSPLANT, V12, P115, DOI 10.1111/j.1600-6143.2011.03737.x; PEARSON TC, 1994, TRANSPLANTATION, V57, P1701, DOI 10.1097/00007890-199457120-00002; Pearson TC, 2002, TRANSPLANTATION, V74, P933, DOI 10.1097/00007890-200210150-00006; Pearson TC, 1997, TRANSPLANTATION, V63, P1463, DOI 10.1097/00007890-199705270-00016; Pinelli DF, 2013, AM J TRANSPLANT, V13, P3021, DOI 10.1111/ajt.12417; Pinelli DF, 2015, IMMUNOTHERAPY-UK, V7, P399, DOI [10.2217/IMT.15.1, 10.2217/imt.15.1]; Poirier N, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000116; Ponciano VC, 2007, TRANSPL IMMUNOL, V17, P215, DOI 10.1016/j.trim.2006.11.003; Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x; Poston RS, 2000, TRANSPLANTATION, V69, P2005, DOI 10.1097/00007890-200005270-00006; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rabant M, 2013, AM J TRANSPLANT, V13, P2831, DOI 10.1111/ajt.12432; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Rayat GR, 2005, DIABETES, V54, P443, DOI 10.2337/diabetes.54.2.443; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Reisman NM, 2011, BLOOD, V118, P5851, DOI 10.1182/blood-2011-04-347252; Renesto PG, 2007, AM J TRANSPLANT, V7, P1661, DOI 10.1111/j.1600-6143.2007.01795.x; Rey J, 2006, EUR J IMMUNOL, V36, P2359, DOI 10.1002/eji.200635935; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, pS564; Sandborn WJ, 2012, GASTROENTEROLOGY, V143, P62, DOI 10.1053/j.gastro.2012.04.010; SANDERS ME, 1988, J IMMUNOL, V140, P1401; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Sarraj B, 2014, P NATL ACAD SCI USA, V111, P12145, DOI 10.1073/pnas.1303676111; Schenk AD, 2009, AM J TRANSPLANT, V9, P64, DOI 10.1111/j.1600-6143.2008.02460.x; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Setoguchi K, 2011, AM J TRANSPLANT, V11, P923, DOI 10.1111/j.1600-6143.2011.03492.x; Shin JS, 2015, AM J TRANSPLANT, V15, P2837, DOI 10.1111/ajt.13345; Singh K, 2012, AM J TRANSPLANT, V12, P1441, DOI 10.1111/j.1600-6143.2011.03963.x; Suchard SJ, 2013, J IMMUNOL, V191, P4599, DOI 10.4049/jimmunol.1300470; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tanaka K, 2007, J IMMUNOL, V179, P5204, DOI 10.4049/jimmunol.179.8.5204; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thompson P, 2012, AM J TRANSPLANT, V12, P1765, DOI 10.1111/j.1600-6143.2012.04031.x; Thompson P, 2011, AM J TRANSPLANT, V11, P947, DOI 10.1111/j.1600-6143.2011.03509.x; Thornley TB, 2014, J CLIN INVEST, V124, P3443, DOI 10.1172/JCI73527; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Turgeon NA, 2010, AM J TRANSPLANT, V10, P2082, DOI 10.1111/j.1600-6143.2010.03212.x; Uchida Y, 2010, GASTROENTEROLOGY, V139, P2195, DOI 10.1053/j.gastro.2010.07.003; Ueno T, 2008, J CLIN INVEST, V118, P742, DOI 10.1172/JCI32451; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; van der Merwe PA, 1999, J EXP MED, V190, P1371, DOI 10.1084/jem.190.10.1371; Vanrenterghem Y, 2011, TRANSPLANTATION, V91, P976, DOI 10.1097/TP.0b013e31820c10eb; Venner JM, 2014, AM J TRANSPLANT, V14, P2565, DOI 10.1111/ajt.12946; Vincenti F, 2007, AM J TRANSPLANT, V7, P1770, DOI 10.1111/j.1600-6143.2007.01845.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Vincenti F, 2016, NEW ENGL J MED, V374, P333, DOI 10.1056/NEJMoa1506027; Vu MD, 2006, J IMMUNOL, V176, P1394, DOI 10.4049/jimmunol.176.3.1394; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; Wang LQ, 2007, EUR J IMMUNOL, V37, P2983, DOI 10.1002/eji.200737583; Wang NH, 2010, J IMMUNOL, V185, P5683, DOI 10.4049/jimmunol.1001974; Weaver TA, 2009, NAT MED, V15, P746, DOI 10.1038/nm.1993; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Wherry E. J., 2007, IMMUNITY, V27, pCD8; Willecke F, 2014, THROMB HAEMOSTASIS, V112, P379, DOI 10.1160/TH13-08-0653; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yamada A, 2001, J IMMUNOL, V167, P140, DOI 10.4049/jimmunol.167.1.140; Yang J, 2008, CIRCULATION, V117, P660, DOI 10.1161/CIRCULATIONAHA.107.741025; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Yao S, 2011, IMMUNITY, V34, P729, DOI 10.1016/j.immuni.2011.03.014; Yeung MY, 2011, AM J TRANSPLANT, V11, P2012, DOI 10.1111/j.1600-6143.2011.03727.x; Yeung MY, 2013, J IMMUNOL, V191, P4447, DOI 10.4049/jimmunol.1300992; Yuan XL, 2009, P NATL ACAD SCI USA, V106, P10734, DOI 10.1073/pnas.0812538106; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zhang T, 2011, AM J TRANSPLANT, V11, P1599, DOI 10.1111/j.1600-6143.2011.03624.x; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	163	36	38	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1020	1033		10.1016/j.immuni.2016.04.012	http://dx.doi.org/10.1016/j.immuni.2016.04.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192567	Bronze, Green Accepted			2022-12-18	WOS:000376478500005
J	Cruse, G; Beaven, MA; Ashmole, I; Bradding, P; Gilfillan, AM; Metcalfe, DD				Cruse, Glenn; Beaven, Michael A.; Ashmole, Ian; Bradding, Peter; Gilfillan, Alasdair M.; Metcalfe, Dean D.			A Truncated Splice-Variant of the Fc epsilon RI beta Receptor Subunit Is Critical for Microtubule Formation and Degranulation in Mast Cells	IMMUNITY			English	Article							HIGH-AFFINITY RECEPTOR; IMMUNOGLOBULIN-E; SIGNALING PATHWAYS; IGE; KINASE; ASSOCIATION; ACTIVATION; CHAIN; ATOPY; POLYMORPHISMS	Human linkage analyses have implicated the MS4A2-containing gene locus (encoding Fc epsilon RI beta) as a candidate for allergy susceptibility. We have identified a truncation of Fc epsilon RI beta (t-Fc epsilon RI beta) in humans that contains a putative calmodulin-binding domain and thus, we sought to identify the role of this variant in mast cell function. We determined that t-Fc epsilon RI beta is critical for microtubule formation and degranulation and that it may perform this function by trafficking adaptor molecules and kinases to the pericentrosomal and Golgi region in response to Ca2+ signals. Mutagenesis studies suggest that calmodulin binding to t-Fc epsilon RI beta in the presence of Ca2+ could be critical for t-Fc epsilon RI beta function. In addition, gene targeting of t-Fc epsilon RI beta attenuated microtubule formation, degranulation, and IL-8 production downstream of Ca2+ signals. Therefore, t-Fc epsilon RI beta mediates Ca2+-dependent microtubule formation, which promotes degranulation and cytokine release. Because t-Fc epsilon RI beta has this critical function, it represents a therapeutic target for the downregulation of allergic inflammation.	[Cruse, Glenn; Gilfillan, Alasdair M.; Metcalfe, Dean D.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Beaven, Michael A.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Ashmole, Ian; Bradding, Peter] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Glenfield Hosp, Leicester LE3 9QP, Leics, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Cruse, G (corresponding author), NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA.	glenncruse@hotmail.com	Cruse, Glenn/AAZ-1093-2021	Cruse, Glenn/0000-0002-7511-0082; Bradding, Peter/0000-0001-8403-0319	Division of Intramural Research of NIAID; NHLBI within the National Institutes of Health; Novartis Pharmaceuticals; ERDF [05567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000965] Funding Source: NIH RePORTER	Division of Intramural Research of NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI within the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Novartis Pharmaceuticals(Novartis); ERDF(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Biological Imaging Section, Research Technologies Branch, NIAID, NIH for expert advice in the acquisition and analysis of the confocal imaging. We also thank J. Rivera (NIAMS, NIH) for the generous gifts of Fc epsilon RI beta JRK Ab and Ms4a2<SUP>-/-</SUP> mice. Financial support was provided by the Division of Intramural Research of NIAID and NHLBI within the National Institutes of Health and in part from an unrestricted predoctoral fellowship from Novartis Pharmaceuticals (GC). Work in Leicester was conducted in laboratories partly funded by ERDF #05567.	Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; COOKSON WOCM, 1989, LANCET, V1, P1292; Cruse G, 2010, FASEB J, V24, P4047, DOI 10.1096/fj.10-158378; Donnadieu E, 2000, J IMMUNOL, V165, P3917, DOI 10.4049/jimmunol.165.7.3917; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; Draber P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00130; Funaba M, 2003, CELL BIOL INT, V27, P879, DOI 10.1016/S1065-6995(03)00177-X; Furumoto Y, 2004, J BIOL CHEM, V279, P49177, DOI 10.1074/jbc.M404730200; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gimborn K, 2005, J IMMUNOL, V174, P507, DOI 10.4049/jimmunol.174.1.507; Hong H, 2007, BLOOD, V110, P2511, DOI 10.1182/blood-2007-01-066092; Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631; Hurtado L, 2011, J CELL BIOL, V193, P917, DOI 10.1083/jcb.201011014; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kim SH, 2006, CLIN EXP ALLERGY, V36, P877, DOI 10.1111/j.1365-2222.2006.02443.x; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kuehn Hye Sun, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0738s91; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Laprise C, 2000, IMMUNOGENETICS, V51, P695, DOI 10.1007/s002510000185; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Lorentz A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00143; Ma HT, 2011, ADV EXP MED BIOL, V716, P62, DOI 10.1007/978-1-4419-9533-9_5; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Nishida K, 2011, J IMMUNOL, V187, P932, DOI 10.4049/jimmunol.1100360; Nishiyama C, 2004, J IMMUNOL, V173, P6458, DOI 10.4049/jimmunol.173.10.6458; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Psatha M, 2004, CELL CALCIUM, V36, P51, DOI 10.1016/j.ceca.2003.11.009; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; Singleton TE, 2009, MOL IMMUNOL, V46, P2333, DOI 10.1016/j.molimm.2009.03.023; Smrz D, 2010, EUR J IMMUNOL, V40, P3557, DOI 10.1002/eji.201040573; Suzuki R, 2010, J LEUKOCYTE BIOL, V88, P863, DOI 10.1189/jlb.0510253; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Vonakis BM, 1997, J BIOL CHEM, V272, P24072, DOI 10.1074/jbc.272.38.24072	41	36	41	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					906	917		10.1016/j.immuni.2013.04.007	http://dx.doi.org/10.1016/j.immuni.2013.04.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23643722	Green Accepted, Bronze			2022-12-18	WOS:000330942500010
J	Herda, S; Raczkowski, F; Mittrucker, HW; Willimsky, G; Gerlach, K; Kuhl, AA; Breiderhoff, T; Willnow, TE; Dorken, B; Hopken, UE; Rehm, A				Herda, Stefanie; Raczkowski, Friederike; Mittruecker, Hans-Willi; Willimsky, Gerald; Gerlach, Kerstin; Kuehl, Anja A.; Breiderhoff, Tilman; Willnow, Thomas E.; Doerken, Bernd; Hoepken, Uta E.; Rehm, Armin			The Sorting Receptor Sortilin Exhibits a Dual Function in Exocytic Trafficking of Interferon-gamma and Granzyme A in T Cells	IMMUNITY			English	Article							MICE; NK; LYMPHOCYTES; TNF; INFLAMMATION; REQUIREMENTS; ACTIVATION; CYTOLYSIS; SECRETION; IMMUNITY	Immunological control of infections or tumors depends on the release of effector cytokines and polarized secretion of cytotoxic granules from T cells and natural killer cells. Here we show that the sorting receptor Sortilin controlled both processes. In murine Sortilin-deficient cytotoxic T lymphocytes, regulated secretion of granzyme A and cytotoxic killing was enhanced and correlated with increased vesicle-associated membrane protein 7 availability. In contrast, loss of Sortilin reduced the release of interferon-gamma upon infections and in autoimmune colitis. Exit of interferon-gamma from the Golgi apparatus required the presence of Sortilin. Furthermore, we tracked the transport route of interferon-gamma beyond this Sortilin-dependent Golgi to early endosome step. In wild-type T cells, trafficking of interferon-gamma from the endosomal sorting platform to the plasma membrane proceeded independently of recycling endosomes, and interferon-gamma remained excluded from late endosomes. Our results suggest that Sortilin modulates systemic immune responses through exocytic sorting of immunological effector molecules.	[Herda, Stefanie; Gerlach, Kerstin; Doerken, Bernd; Rehm, Armin] Max Delbruck Ctr Mol Med, Dept Hematol Oncol & Tumorimmunol, D-13125 Berlin, Germany; [Breiderhoff, Tilman; Willnow, Thomas E.] Max Delbruck Ctr Mol Med, Dept Mol Cardiovasc Res, D-13125 Berlin, Germany; [Hoepken, Uta E.] Max Delbruck Ctr Mol Med, Dept Tumor & Immunogenet, D-13125 Berlin, Germany; [Raczkowski, Friederike; Mittruecker, Hans-Willi] Univ Med Ctr, Inst Immunol, D-20246 Hamburg, Germany; [Willimsky, Gerald] Charite, Inst Immunol, D-12200 Berlin, Germany; [Kuehl, Anja A.] Charite, Dept Pathol, Res Ctr Immuno Sci, D-12200 Berlin, Germany; [Doerken, Bernd; Rehm, Armin] Charite, Dept Hematol Oncol & Tumorimmunol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rehm, A (corresponding author), Max Delbruck Ctr Mol Med, Dept Hematol Oncol & Tumorimmunol, D-13125 Berlin, Germany.	arehm@mdc-berlin.de	Breiderhoff, Tilman/X-9364-2019; Willimsky, Gerald/AAA-2445-2021	Breiderhoff, Tilman/0000-0002-1676-7498; Willimsky, Gerald/0000-0002-9693-948X; Kuhl, Anja/0000-0003-2293-5387; Willnow, Thomas/0000-0001-9515-7921				Andersson A, 1998, J IMMUNOL, V161, P5600; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Carrero JA, 2008, J IMMUNOL, V181, P1365, DOI 10.4049/jimmunol.181.2.1365; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; FORTIER AH, 1989, CELL IMMUNOL, V124, P64, DOI 10.1016/0008-8749(89)90112-3; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Ito H, 1997, J AUTOIMMUN, V10, P455, DOI 10.1016/S0896-8411(97)90152-9; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Krzewski K, 2011, EUR J IMMUNOL, V41, P3323, DOI 10.1002/eji.201141582; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Marcet-Palacios M, 2008, BIOCHEM BIOPH RES CO, V366, P617, DOI 10.1016/j.bbrc.2007.11.079; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; POE M, 1991, ARCH BIOCHEM BIOPHYS, V284, P215, DOI 10.1016/0003-9861(91)90286-R; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Ruder C, 2009, J CLIN INVEST, V119, P2184, DOI 10.1172/JCI37760; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Sung RS, 2001, MOL THER, V3, P757, DOI 10.1006/mthe.2001.0318; Trapani JA, 2001, GENOME BIOL, V2; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Wirtz S, 1999, J IMMUNOL, V162, P1884; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	39	36	37	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					854	866		10.1016/j.immuni.2012.07.012	http://dx.doi.org/10.1016/j.immuni.2012.07.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23084031	Bronze			2022-12-18	WOS:000311460000012
J	McDonald, B; Kubes, P				McDonald, Braedon; Kubes, Paul			Chemokines: Sirens of Neutrophil Recruitment-but Is It Just One Song?	IMMUNITY			English	Editorial Material							INFLAMMATION; CHEMOTAXIS	Neutrophil trafficking to inflamed tissues requires the integration of multiple chemoattractant guidance signals. In this issue of Immunity, Chou et al. (2010) demonstrate that collaborative "cascades" of chemoattractant mediators control neutrophil recruitment to arthritic joints in mice.	[McDonald, Braedon; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada	University of Calgary	Kubes, P (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada.	pkubes@ucalgary.ca	Sawant, Kirti V/H-3778-2013					Bonecchi R, 1999, J IMMUNOL, V162, P474; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006	9	36	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					148	149		10.1016/j.immuni.2010.08.006	http://dx.doi.org/10.1016/j.immuni.2010.08.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20732637	Bronze			2022-12-18	WOS:000281654900004
J	Cassatella, MA; Locati, M; Mantovani, A				Cassatella, Marco A.; Locati, Massimo; Mantovani, Alberto			Never Underestimate the Power of a Neutrophil	IMMUNITY			English	Editorial Material							CELLS	Polymorphonuclear neutrophil leukocytes (PMNS) have long been viewed as short-lived effector cells capable of phagocytosing pathogens and mediating tissue damage. In this issue of Immunity, Zhang et al. (2009) shed fresh light on the plasticity and immunoregulatory functions of PMNs.	[Locati, Massimo; Mantovani, Alberto] Univ Milan, Dept Translat Med, I-20089 Rozzano, Italy; [Cassatella, Marco A.] Univ Verona, Div Gen Pathol, Dept Pathol, I-37134 Verona, Italy; [Locati, Massimo; Mantovani, Alberto] Carattere Sci Ist Clin Humanitas, Ist Ricovero & Cura, I-20089 Rozzano, Italy	University of Milan; University of Verona; IRCCS Humanitas Research Hospital	Mantovani, A (corresponding author), Univ Milan, Dept Translat Med, Via Manzoni 56, I-20089 Rozzano, Italy.	alberto.mantovani@humanitas.it	Locati, Massimo/ABF-6807-2021; Mantovani, Alberto/HCI-7449-2022; Cassatella, M A/B-8037-2013; Locati, Massimo/H-8404-2015	Mantovani, Alberto/0000-0001-5578-236X; Cassatella, M A/0000-0001-7824-1806; Locati, Massimo/0000-0003-3077-590X				Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Boudaly S, 2009, FRONT BIOSCI-LANDMRK, V14, P1589, DOI 10.2741/3326; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Tamassia N, 2007, J IMMUNOL, V178, P7344, DOI 10.4049/jimmunol.178.11.7344; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	9	36	39	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					698	700		10.1016/j.immuni.2009.10.003	http://dx.doi.org/10.1016/j.immuni.2009.10.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19932068	Bronze			2022-12-18	WOS:000272097900003
J	Zindl, CL; Kim, TH; Zeng, MQ; Archambault, AS; Grayson, MH; Choi, K; Schreiber, RD; Chaplin, DD				Zindl, Carlene L.; Kim, Tea Hyun; Zeng, Meiqin; Archambault, Angela S.; Grayson, Mitchell H.; Choi, Kyunghee; Schreiber, Robert D.; Chaplin, David D.			The Lymphotoxin LT alpha(1)beta(2) Controls Postnatal and Adult Spleen Marginal Sinus Vascular Structure and Function	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ALPHA-DEFICIENT MICE; PEYERS PATCH ORGANOGENESIS; SECONDARY LYMPHOID-TISSUES; BETA-RECEPTOR; MOUSE SPLEEN; SPLENIC ARCHITECTURE; ENDOTHELIAL-CELLS; HOMING CHEMOKINES	The lymphotoxin LT alpha(1)beta(2) supports the development and maintenance of several aspects of spleen structure, but its significance for marginal sinus (MS) vascular organization is unclear. We showed here that, in early postnatal lymphotoxin-deficient mice, the developing Flk-1(+) white pulp vessels failed to organize or upregulate MAdCAM-1, leading to altered spatial rearrangement of both the white pulp endothelial cells and the smooth muscle actin-expressing cells. In vitro, MAdCAM-1 directed the reorganization of LT beta receptor(+) endothelial cells grown on Matrigel. LT alpha(1)beta(2) 2 also regulated the maintenance of both MAdCAM-1 expression and mature MS structure in adult mice, contributing importantly to normal trafficking of CD11b(+) cells in response to bacterial antigens. Together, our studies demonstrate that LT alpha(1)beta(2) and LT beta receptor signals control proper development and maintenance of the mature MS structure and implicate MAdCAM-1 in the structuring of the MS endothelial cells that is important for the movement of immune cells within the spleen.	[Zindl, Carlene L.; Kim, Tea Hyun; Zeng, Meiqin; Chaplin, David D.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Zindl, Carlene L.; Archambault, Angela S.; Choi, Kyunghee; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Grayson, Mitchell H.] Washington Univ, Sch Med, Dept Med, Div Allergy & Immunol, St Louis, MO 63110 USA	University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Washington University (WUSTL)	Chaplin, DD (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	dchaplin@uab.edu	Grayson, Mitchell/AAX-3674-2020; Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Grayson, Mitchell/0000-0002-4673-2122; Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341; Zindl, Carlene/0000-0003-4841-3552; Chaplin, David/0000-0002-1354-3069	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI034580] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI034580-080007] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Balazs M, 2001, CELL IMMUNOL, V212, P126, DOI 10.1006/cimm.2001.1847; Balogh P, 2007, CELL TISSUE RES, V328, P473, DOI 10.1007/s00441-007-0378-6; BANKS TA, 1995, J IMMUNOL, V155, P1685; BOHNSACK JF, 1986, ANNU REV MED, V37, P49, DOI 10.1146/annurev.me.37.020186.000405; Browning JL, 1997, J IMMUNOL, V159, P3288; BROWNING JL, 1995, J IMMUNOL, V154, P33; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; DE TP, 1994, SCIENCE, V264, P703; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Ejstrud P, 2000, SCAND J INFECT DIS, V32, P521, DOI 10.1080/003655400458811; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Girkontaite I, 2004, J EXP MED, V200, P1491, DOI 10.1084/jem.20041483; Grayson MH, 2001, J IMMUNOL METHODS, V256, P55, DOI 10.1016/S0022-1759(01)00437-9; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Koike R, 1996, EUR J IMMUNOL, V26, P669, DOI 10.1002/eji.1830260324; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KRAAL G, 1986, IMMUNOLOGY, V58, P665; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; KRAAL G, 1995, AM J PATHOL, V147, P763; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Mandik-Nayak L, 2001, J IMMUNOL, V167, P1920, DOI 10.4049/jimmunol.167.4.1920; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mebius RE, 2004, CRIT REV IMMUNOL, V24, P449, DOI 10.1615/CritRevImmunol.v24.i6.40; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; SCHMIDT EE, 1985, J MORPHOL, V186, P17, DOI 10.1002/jmor.1051860103; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; Steiniger B., 2000, ADV ANAT EMBRYOL, DOI [10.1007/978-3-642-57088-9, DOI 10.1007/978-3-642-57088-9]; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453	48	36	36	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					408	420		10.1016/j.immuni.2009.01.010	http://dx.doi.org/10.1016/j.immuni.2009.01.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303389	Green Accepted, Bronze			2022-12-18	WOS:000264405500013
J	Rueda, D; Thome, M				Rueda, D; Thome, M			Phosphorylation of CARMA1: The link(er) to NF-kappa B activation	IMMUNITY			English	Editorial Material							KINASE-C-THETA; BETA; RECRUITMENT	Antigen receptor-induced NF-KB activation depends on receptor-proximal and -distal signaling events. Two papers in this issue of Immunity demonstrate that PKC-dependent phosphorylation of CARMA1 is the critical molecular link that controls the activation of the IKK signalosome and NF-KB.	Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne	Rueda, D (corresponding author), Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.		Thome, Margot/F-8167-2011; Rueda, Daniel/I-1176-2015	Thome, Margot/0000-0002-5656-2139; Rueda, Daniel/0000-0002-5377-8890				Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; THORNE M, 2004, NAT REV IMMUNOL, V4, P348; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003	9	36	37	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2005	23	6					551	553		10.1016/j.immuni.2005.11.007	http://dx.doi.org/10.1016/j.immuni.2005.11.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356853	Bronze			2022-12-18	WOS:000234316900001
J	Kirk, P; Bazan, JF				Kirk, P; Bazan, JF			Pathogen recognition: TLRs throw us a curve	IMMUNITY			English	Review							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION; NOGO RECEPTOR; ECTODOMAIN; SEQUENCE; IDENTIFICATION; EVOLUTION; BINDING; DNA	Toll-like receptors (TLRs) are the archetypal pattern recognition receptors (PRRs) envisioned by Janeway (1989) as innate sensors of pathogen attack and host triggers of an adaptive immune response. Two recent papers (Choe et al., 2005; Bell et al., 2005) reveal the distinctive architecture of a TLR sensor domain and hint at how this structural design facilitates the recognition of a wide array of pathogen molecules.	Genentech Inc, Dept Mol Biol, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Bazan, JF (corresponding author), Genentech Inc, Dept Mol Biol, Dept Prot Engn, MS 37,1 DNA Way, San Francisco, CA 94080 USA.	jfbazan@gene.com	Bazan, J. Fernando/B-4562-2010					Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Cornelie S, 2004, J BIOL CHEM, V279, P15124, DOI 10.1074/jbc.M313406200; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Grabiec A, 2004, J BIOL CHEM, V279, P48004, DOI 10.1074/jbc.M405311200; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mizel SB, 2003, J BIOL CHEM, V278, P23624, DOI 10.1074/jbc.M303481200; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schimmele B, 2005, J MOL BIOL, V352, P229, DOI 10.1016/j.jmb.2005.06.073; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	28	36	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					347	350		10.1016/j.immuni.2005.09.008	http://dx.doi.org/10.1016/j.immuni.2005.09.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226500	Bronze			2022-12-18	WOS:000232995800003
J	Ishii, KJ; Akira, S				Ishii, KJ; Akira, S			TLR ignores methylated RNA?	IMMUNITY			English	Editorial Material							TOLL-LIKE RECEPTOR-3; DENDRITIC CELLS; STRANDED-RNA	CpG methylation of DNA silences TLR9-mediated innate immune recognition. In this issue of Immunity, Kariko et al. (2005) suggest that the innate immune recognition of RNA by TLR3, TLR7, or TLR8 is in fact controlled by modification of nucleotides, including methylation.	Osaka Univ, JST, ERATO, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University	Ishii, KJ (corresponding author), Osaka Univ, JST, ERATO, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.		Ishii, Ken J/B-1685-2012	Ishii, Ken J/0000-0002-6728-3872				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; ISAACS A, 1963, LANCET, V2, P113; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955	11	36	37	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2005	23	2					111	113		10.1016/j.immuni.2005.08.003	http://dx.doi.org/10.1016/j.immuni.2005.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111629	Bronze			2022-12-18	WOS:000231721700001
J	Kang, JS; Fehling, HJ; Laplace, C; Malissen, M; Cado, D; Raulet, DH				Kang, JS; Fehling, HJ; Laplace, C; Malissen, M; Cado, D; Raulet, DH			T cell receptor gamma gene regulatory sequences prevent the function of a novel TCR gamma/pT alpha pre-T cell receptor	IMMUNITY			English	Article							BETA-LINEAGE THYMOCYTES; DEFICIENT MICE; CD4(+)8(+) THYMOCYTES; CD4(+)CD8(+) STAGE; SCID MICE; REARRANGEMENT; DELTA; EXPRESSION; CHAIN; DIFFERENTIATION	Expression of a TCR gamma transgene in RAG-1(-/-) mice resulted in the development of a limited number of CD4(+)CD8(+) (DP) thymocytes. In vivo treatments with anti-TCR gamma antibody enhanced the number of DP thymocytes, demonstrating that TCR gamma chains were expressed on the cell surface in the absence of delta, alpha, or beta chains. Mutations in pT alpha or CD3 epsilon genes abolished transgene-induced DP cell development, indicating that TCR gamma can associate with pT alpha and CD3 to form a novel pre-TCR. With a transgene containing additional regulatory sequences, TCR gamma expression was downregulated in DP cells, and little DP cell development occurred. Thus, the function of the endogenous TCR gamma/pT alpha is limited by the transcriptional down-regulation of TCR gamma genes that normally accompanies DP cell development.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Div Immunol, Berkeley, CA 94720 USA; Basel Inst Immunol, CH-4005 Basel, Switzerland; CNRS, INSERM, Ctr Immunol, F-13288 Marseille 9, France	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu		kang, joonsoo/0000-0001-8419-7995; Malissen, Marie/0000-0003-2331-1445; Raulet, David/0000-0002-1257-8649	NIAID NIH HHS [R01-AI 30171] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030171] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1987, IMMUNOL TODAY, V8, P293, DOI 10.1016/0167-5699(87)90014-4; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DANSKA JS, 1994, SCIENCE, V266, P450, DOI 10.1126/science.7524150; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; IWASHIMA M, 1991, J EXP MED, V174, P293, DOI 10.1084/jem.174.1.293; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; KERSH GJ, 1995, J IMMUNOL, V154, P5706; KRIMPENFORT P, 1989, NATURE, V341, P742, DOI 10.1038/341742a0; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Livak F, 1997, EUR J IMMUNOL, V27, P2948, DOI 10.1002/eji.1830271130; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mertsching E, 1997, EUR J IMMUNOL, V27, P389, DOI 10.1002/eji.1830270208; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Norment AM, 1997, J EXP MED, V185, P121, DOI 10.1084/jem.185.1.121; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PENIT C, 1995, J IMMUNOL, V154, P5103; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; ROTHENBERG EV, 1993, J IMMUNOL, V151, P3530; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; ZUNIGAPFLUCKER JC, 1994, J EXP MED, V180, P1517, DOI 10.1084/jem.180.4.1517	47	36	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1998	8	6					713	721		10.1016/S1074-7613(00)80576-2	http://dx.doi.org/10.1016/S1074-7613(00)80576-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655485	Bronze			2022-12-18	WOS:000074396300007
J	Hilbert, DM; Migone, TS; Kopf, M; Leonard, WJ; Rudikoff, S				Hilbert, DM; Migone, TS; Kopf, M; Leonard, WJ; Rudikoff, S			Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway	IMMUNITY			English	Article							MULTIPLE-MYELOMA PATIENTS; MONOCLONAL LYMPHOCYTES-B; MALIGNANT PLASMA-CELL; BONE-MARROW; HUMAN INTERLEUKIN-6; PERIPHERAL-BLOOD; LINEAGE CELLS; V-ABL; C-ABL; MURINE PLASMACYTOMAGENESIS	The development of murine plasma cell tumors induced by raf/myc containing retroviruses is facilitated by T cells and completely dependent on IL-6. To determine whether kinases with differing specificities reflect alternative biochemical pathways in B cell tumorigenesis, we have employed an abl/myc containing retrovirus to assess neoplastic development. In contrast with raf/myc, abl/myc disease is T cell and IL-6 independent. An examination of the IL-6 signal transduction pathway reveals that this pathway, as defined by activation of Stat3, is inducible by IL-6 in raf/myc tumors but constitutively activated in abl/myc tumors. These findings provide a mechanism for the derivation of cytokine-independent plasma cell tumors and suggest that both IL-6-dependent and independent tumors may arise in vivo depending on the particular mutational events incurred during tumorigenesis.	NHLBI,LAB MOL IMMUNOL,NIH,BETHESDA,MD 20892; BASEL INST IMMUNOBIOL,CH-4005 BASEL,SWITZERLAND	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hilbert, DM (corresponding author), NCI,GENET LAB,NIH,BETHESDA,MD 20892, USA.		Leonard, Warren/AAA-1397-2022; Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140				AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0; BAST EJEG, 1982, CLIN EXP IMMUNOL, V47, P677; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; BERGUI L, 1989, J EXP MED, V170, P613, DOI 10.1084/jem.170.2.613; BILLADEAU D, 1992, BLOOD, V80, P1818; BILLADEAU D, 1993, J EXP MED, V178, P1023, DOI 10.1084/jem.178.3.1023; BROSH N, 1995, J BIOL CHEM, V270, P29594, DOI 10.1074/jbc.270.49.29594; CASSEL A, 1990, EXP HEMATOL, V18, P1171; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DEGRASSI A, 1993, P NATL ACAD SCI USA, V90, P2060, DOI 10.1073/pnas.90.5.2060; DEHON FD, 1994, J EXP MED, V180, P2395, DOI 10.1084/jem.180.6.2395; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; HARTMAN DA, 1995, INFLAMM RES, V44, P269, DOI 10.1007/BF02032567; HENTTINEN T, 1995, J IMMUNOL, V155, P4582; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HILBERT DM, 1989, J IMMUNOL, V143, P4019; HILBERT DM, 1993, ONCOGENE, V8, P1993; HILBERT DM, 1995, P NATL ACAD SCI USA, V92, P649, DOI 10.1073/pnas.92.3.649; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; HITZLER JK, 1991, BLOOD, V78, P1996, DOI 10.1182/blood.V78.8.1996.1996; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JENSEN GS, 1993, AM J HEMATOL, V43, P29, DOI 10.1002/ajh.2830430108; JENSEN GS, 1991, BLOOD, V78, P711, DOI 10.1182/blood.V78.3.711.bloodjournal783711; JENSEN GS, 1992, AM J HEMATOL, V41, P199, DOI 10.1002/ajh.2830410311; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KING MA, 1989, BLOOD, V73, P1925; KLEIN B, 1989, BLOOD, V73, P517; KLEIN B, 1991, BLOOD, V78, P1198; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KUBAGAWA H, 1979, J EXP MED, V150, P792, DOI 10.1084/jem.150.4.792; KURIE JM, 1990, ONCOGENE, V5, P577; Lapena P, 1996, EXP HEMATOL, V24, P26; LARGAESPADA DA, 1992, ONCOGENE, V7, P811; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LOKHORST HM, 1994, BLOOD, V84, P2269; MAEDA M, 1987, BLOOD, V70, P1407; MARTIN F, 1996, J MOL BIOL, V255, P96; MATSUDA T, 1994, BIOCHEM BIOPH RES CO, V200, P821, DOI 10.1006/bbrc.1994.1525; MERWIN RM, 1959, P SOC EXP BIOL MED, V101, P437; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MOCK BA, 1993, P NATL ACAD SCI USA, V90, P9499, DOI 10.1073/pnas.90.20.9499; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; Nakajima K, 1995, ANN NY ACAD SCI, V762, P55; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; OKANO A, 1989, TRANSPLANTATION, V48, P495, DOI 10.1097/00007890-198909000-00028; OSTERBORG A, 1991, BLOOD, V78, P2642; PALUMBO A, 1995, LEUKEMIA LYMPHOMA, V18, P215, DOI 10.3109/10428199509059610; POTTER M, 1983, J NATL CANCER I, V71, P391; POTTER M, 1994, J NATL CANCER I, V86, P1058, DOI 10.1093/jnci/86.14.1058; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; POTTER M, 1994, CANCER RES, V54, P969; POTTER M, 1984, CANCER SURV, V3, P247; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; SAVINO R, 1994, EMBO J, V13, P5863, DOI 10.1002/j.1460-2075.1994.tb06931.x; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; SAWYERS CL, 1992, CANCER SURV, V15, P37; SHIMIZU S, 1989, J EXP MED, V169, P339, DOI 10.1084/jem.169.1.339; SILVA S, 1991, INT J CANCER, V49, P224, DOI 10.1002/ijc.2910490214; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; SUGIYAMA H, 1991, INT J CANCER, V48, P234, DOI 10.1002/ijc.2910480214; SUZUKI H, 1992, EUR J IMMUNOL, V22, P1989, DOI 10.1002/eji.1830220806; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAKATSUKI F, 1988, J IMMUNOL, V141, P3072; TROPPMAIR J, 1989, P NATL ACAD SCI USA, V86, P9941, DOI 10.1073/pnas.86.24.9941; UCHIYAMA H, 1993, BLOOD, V82, P3712; VANRIET I, 1989, BRIT J HAEMATOL, V73, P289; VANSNICK J, 1987, J EXP MED, V165, P641, DOI 10.1084/jem.165.3.641; VINK A, 1990, J EXP MED, V172, P997, DOI 10.1084/jem.172.3.997; WANG YP, 1995, BLOOD, V86, P1671, DOI 10.1182/blood.V86.5.1671.bloodjournal8651671; WIENER F, 1995, CANCER RES, V55, P1181; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; ZHANG XG, 1994, BLOOD, V83, P3654; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	77	36	36	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1996	5	1					81	89		10.1016/S1074-7613(00)80312-X	http://dx.doi.org/10.1016/S1074-7613(00)80312-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758897	Bronze			2022-12-18	WOS:A1996UZ45400009
J	McFarland, AP; Yalin, A; Wang, SY; Cortez, VS; Landsberger, T; Sudan, R; Peng, V; Miller, HL; Ricci, B; David, E; Faccio, R; Amit, I; Colonna, M				McFarland, Adelle P.; Yalin, Adam; Wang, Shuang-Yin; Cortez, Victor S.; Landsberger, Tomer; Sudan, Raki; Peng, Vincent; Miller, Hannah L.; Ricci, Biancamaria; David, Eyal; Faccio, Roberta; Amit, Ido; Colonna, Marco			Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation	IMMUNITY			English	Article							T-BET; NK CELLS; RNA-SEQ; DIFFERENTIATION; DIVERSITY; MELANOMA; INFLAMMATION; CONVERSION; EXPRESSION; RESPONSES	Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1s) are heterogenous innate lymphocytes broadly defined in mice as Lin(-) NK1.1(+)NKp46(+) cells that express the transcription factor T-BET and produce interferon-gamma. The ILC1 definition primarily stems from studies on liver and small intestinal populations. However, NK1.1(+)NKp46(+) cells in the salivary glands, uterus, adipose, and other tissues exhibit nonuniform programs that differ from those of liver or intestinal ILC1s or NK cells. Here, we performed single-cell RNA sequencing on murine NK1.1(+)NKp46(+) cells from blood, spleen, various tissues, and solid tumors. We identified gene expression programs of tissue-specific ILC1s, tissue-specific NK cells, and non-tissue-specific populations in blood, spleen, and other tissues largely corresponding to circulating cells. Moreover, we found that circulating NK cell programs were reshaped in tumor-bearing mice. Core programs of circulating and tumor NK cells paralleled conserved human NK cells signatures, advancing our understanding of the human NK-ILC1 spectrum.	[McFarland, Adelle P.; Cortez, Victor S.; Sudan, Raki; Peng, Vincent; Miller, Hannah L.; Ricci, Biancamaria; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Yalin, Adam; Wang, Shuang-Yin; Landsberger, Tomer; David, Eyal; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Faccio, Roberta] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO USA; [Faccio, Roberta] Shriners Childrens Hosp St Louis, St Louis, MO USA	Washington University (WUSTL); Weizmann Institute of Science; Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	ido.amit@weizmann.ac.il; mcolonna@wustl.edu	Sudan, Raki/AFK-6979-2022	McFarland, Adelle/0000-0001-7534-1158; Peng, Vincent/0000-0002-0301-2985; Ricci, Biancamaria/0000-0003-1574-6043; Wang, Shuang-Yin/0000-0001-9683-4103; Sudan, Raki/0000-0002-9101-818X	NIH [T32 DK077653-27, R01 DE025884, 1R01 AI134236-01, R01 124699, R01 AI134035]; Merck KGaA (Darmstadt, Germany); Chan Zuckerberg Initiative (CZI); HHMI International Scholar award; European Research Council consolidator grant (ERCCOG) [724471]; ISF Israel Precision Medicine Program (IPMP) [607/20, P128245]; SCA award of the Wolfson Foundation and Family Charitable Trust; Thompson Family Foundation, an MRA Established Investigator Award [509044]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center Grant; International Progressive MS Alliance/NMSS [PA-1604 08459]; Abney Foundation grant; NWO [019.181EN.038]; Cancer Research Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck KGaA (Darmstadt, Germany); Chan Zuckerberg Initiative (CZI); HHMI International Scholar award(Howard Hughes Medical Institute); European Research Council consolidator grant (ERCCOG); ISF Israel Precision Medicine Program (IPMP); SCA award of the Wolfson Foundation and Family Charitable Trust; Thompson Family Foundation, an MRA Established Investigator Award; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center Grant; International Progressive MS Alliance/NMSS; Abney Foundation grant; NWO(Netherlands Organization for Scientific Research (NWO)); Cancer Research Institute	We thank the Flow Cytometry & FACS Core at the WUSM Department of Pathology & Immunology for cell sorting assistance and guidance, as well as Susan Gilfillan for helpful suggestions. M.C. is supported by the NIH (grants R01 DE025884, 1R01 AI134236-01, R01 124699 and R01 AI134035). I.A. is an Eden and Steven Romick Professorial Chair and is supported by Merck KGaA (Darmstadt, Germany), the Chan Zuckerberg Initiative (CZI), an HHMI International Scholar award, European Research Council consolidator grant (ERCCOG) 724471-HemTree2.0, the ISF Israel Precision Medicine Program (IPMP) 607/20 (grant P128245), an SCA award of the Wolfson Foundation and Family Charitable Trust, the Thompson Family Foundation, an MRA Established Investigator Award (509044), the Israel Science Foundation (703/15), the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine, the Helen and Martin Kimmel award for innovative investigation, the NeuroMac DFG/Transregional Collaborative Research Center Grant, the International Progressive MS Alliance/NMSS (PA-1604 08459), and an Abney Foundation grant. A.P.M was supported by NIH grant T32 DK077653-27. S.Y.W. is an EMBO long-term fellow (ALTF 263-2018) and is supported by an NWO Rubicon award (019.181EN.038). V.S.C. is supported by the Cancer Research Institute.	Adams NM, 2018, IMMUNOL REV, V286, P23, DOI 10.1111/imr.12710; Adams NM, 2018, IMMUNITY, V48, P1172, DOI 10.1016/j.immuni.2018.04.018; Bald T, 2020, NAT IMMUNOL, V21, P835, DOI 10.1038/s41590-020-0728-z; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Cella M, 2019, NAT IMMUNOL, V20, P980, DOI 10.1038/s41590-019-0425-y; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNOL LETT, V179, P19, DOI 10.1016/j.imlet.2016.07.005; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Di Santo JP, 2006, IMMUNOL REV, V214, P35, DOI 10.1111/j.1600-065X.2006.00461.x; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Filipovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06918-3; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gibbons DL, 2011, J IMMUNOL, V187, P2067, DOI 10.4049/jimmunol.1100833; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hu JM, 2016, INT REV IMMUNOL, V35, P325, DOI 10.3109/08830185.2014.956360; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jarret A, 2020, CELL, V180, P813, DOI 10.1016/j.cell.2020.02.004; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; Johnstone CN, 2015, DIS MODEL MECH, V8, P237, DOI 10.1242/dmm.017830; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Leppilampi M, 2005, P NATL ACAD SCI USA, V102, P15247, DOI 10.1073/pnas.0508007102; Liu MF, 2006, J IMMUNOL, V176, P7028, DOI 10.4049/jimmunol.176.11.7028; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mah AY, 2016, CRIT REV IMMUNOL, V36, P131, DOI 10.1615/CritRevImmunol.2016017387; Montaldo E, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00646; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Nabekura T, 2020, IMMUNITY, V52, P96, DOI 10.1016/j.immuni.2019.11.004; Nakamura K, 2002, LIFE SCI, V70, P791, DOI 10.1016/S0024-3205(01)01454-0; Ni J, 2020, IMMUNITY, V52, P1075, DOI 10.1016/j.immuni.2020.05.001; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Nunn C, 2011, CELL SIGNAL, V23, P1375, DOI 10.1016/j.cellsig.2011.03.020; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Pomaznoy M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2533-3; Rabacal W, 2016, P NATL ACAD SCI USA, V113, P5370, DOI 10.1073/pnas.1521491113; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Raulet DH, 2017, IMMUNOL REV, V280, P93, DOI 10.1111/imr.12600; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Safe S, 2016, J STEROID BIOCHEM, V157, P48, DOI 10.1016/j.jsbmb.2015.04.016; Shui JW, 2012, NATURE, V488, P222, DOI 10.1038/nature11242; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spinner CA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16269; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; Terren I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02278; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481; Zou JR, 2015, MOL MED REP, V12, P6399, DOI 10.3892/mmr.2015.4243	74	35	35	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1320	+		10.1016/j.immuni.2021.03.024	http://dx.doi.org/10.1016/j.immuni.2021.03.024		JUN 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33945787	Bronze, Green Accepted			2022-12-18	WOS:000659882900020
J	Lavaert, M; Liang, KL; Vandamme, N; Park, JE; Roels, J; Kowalczyk, MS; Li, B; Ashenberg, O; Tabaka, M; Dionne, D; Tickle, TL; Slyper, M; Rozenblatt-Rosen, O; Vandekerckhove, B; Leclercq, G; Regev, A; Van Vlierberghe, P; Guilliams, M; Teichmann, SA; Saeys, Y; Taghon, T				Lavaert, Marieke; Liang, Kai Ling; Vandamme, Niels; Park, Jong-Eun; Roels, Juliette; Kowalczyk, Monica S.; Li, Bo; Ashenberg, Orr; Tabaka, Marcin; Dionne, Danielle; Tickle, Timothy L.; Slyper, Michal; Rozenblatt-Rosen, Orit; Vandekerckhove, Bart; Leclercq, Georges; Regev, Aviv; Van Vlierberghe, Pieter; Guilliams, Martin; Teichmann, Sarah A.; Saeys, Yvan; Taghon, Tom			Integrated scRNA-Seq Identifies Human Postnatal Thymus Seeding Progenitors and Regulatory Dynamics of Differentiating Immature Thymocytes	IMMUNITY			English	Article							KILLER-CELL DEVELOPMENT; T-CELL; NATURAL-KILLER; LINEAGE COMMITMENT; IN-VITRO; HEMATOPOIETIC PROGENITORS; DENDRITIC CELLS; B-CELLS; EXPRESSION; INNATE	During postnatal life, thymopoiesis depends on the continuous colonization of the thymus by bone-marrow-derived hematopoietic progenitors that migrate through the bloodstream. The current understanding of the nature of thymic immigrants is largely based on datafrom pre-clinical models. Here, we employed single-cell RNA sequencing (scRNA-seq) to examine the immature postnatal thymocyte population in humans. Integration of bone marrow and peripheral blood precursor datasets identified two putative thymus seeding progenitors that varied in expression of CD7; CD10; and the homing receptors CCR7, CCR9, and ITGB7. Whereas both precursors supported T cell development, only one contributed to intrathymic dendritic cell (DC) differentiation, predominantly of plasmacytoid dendritic cells. Trajectory inference delineated the transcriptional dynamics underlying early human T lineage development, enabling prediction of transcription factor (TF) modules that drive stage-specific steps of human T cell development. This comprehensive dataset defines the expression signature of immature human thymocytes and provides a resource for the further study of human thymopoiesis.	[Lavaert, Marieke; Liang, Kai Ling; Roels, Juliette; Vandekerckhove, Bart; Leclercq, Georges; Taghon, Tom] Univ Ghent, Fac Med & Hlth Sci, Dept Diagnost Sci, C Heymanslaan 10,MRB2,Entrance 38, B-9000 Ghent, Belgium; [Vandamme, Niels; Saeys, Yvan] VIB Ctr Inflammat Res, Data Min & Modeling Biomed, Ghent, Belgium; [Vandamme, Niels; Vandekerckhove, Bart; Leclercq, Georges; Van Vlierberghe, Pieter; Saeys, Yvan; Taghon, Tom] Univ Ghent, Canc Res Inst Ghent CRIG, Ghent, Belgium; [Park, Jong-Eun; Teichmann, Sarah A.] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Roels, Juliette; Van Vlierberghe, Pieter] Univ Ghent, Dept Biomol Med, Ghent, Belgium; [Kowalczyk, Monica S.; Li, Bo; Ashenberg, Orr; Tabaka, Marcin; Dionne, Danielle; Tickle, Timothy L.; Slyper, Michal; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA USA; [Li, Bo] Broad Inst Harvard & MIT, Data Sci Platform, Cambridge, MA USA; [Tickle, Timothy L.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Haematol Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Regev, Aviv] MIT, Koch Inst Integrat Canc Res, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA; [Guilliams, Martin] VIB Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium; [Teichmann, Sarah A.] Univ Cambridge, Cavendish Lab, Dept Phys, Theory Condensed Matter Grp, Cambridge CB3 0HE, England	Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Wellcome Trust Sanger Institute; Ghent University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Cambridge	Taghon, T (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Diagnost Sci, C Heymanslaan 10,MRB2,Entrance 38, B-9000 Ghent, Belgium.; Taghon, T (corresponding author), Univ Ghent, Canc Res Inst Ghent CRIG, Ghent, Belgium.	tom.taghon@ugent.be	Li, Bo/AAS-8773-2021; Roels, juliette/AAJ-6841-2021; Guilliams, Martin/N-7803-2013; Rozenblatt-Rosen, Orit/HDN-4182-2022; Liang, Kai Ling/K-2125-2019; Leclercq, Georges/H-9659-2017; Saeys, Yvan/C-1311-2009; Van Vlierberghe, Pieter/G-8894-2013	Li, Bo/0000-0003-0668-1620; Roels, juliette/0000-0001-7230-3690; Guilliams, Martin/0000-0003-3525-7570; Liang, Kai Ling/0000-0002-8534-2362; Leclercq, Georges/0000-0002-1691-5294; Saeys, Yvan/0000-0002-0415-1506; Tabaka, Marcin/0000-0002-6166-2820; Taghon, Tom/0000-0002-5781-0288; Lavaert, Marieke/0000-0002-5814-7940; Van Vlierberghe, Pieter/0000-0001-9063-7205; Tickle, Timothy/0000-0002-6592-6272; Vandekerckhove, Bart/0000-0003-3828-4195	Fund for Scientific Research Flanders (FWO); Concerted Research Action of Ghent University Research Fund (GOA); Chan Zuckerberg Initiative [CZF2019-002445]; Foundation against Cancer (STK); European Research Council [StG-639784]; Stand up to Cancer (Flemish Cancer Society); Belgian Cancer Society; EMBO Long-Term Fellowship; ERC Consolidator [646794]; EU MRG-Grammar awards; Wellcome [WT206194]	Fund for Scientific Research Flanders (FWO)(FWO); Concerted Research Action of Ghent University Research Fund (GOA); Chan Zuckerberg Initiative; Foundation against Cancer (STK); European Research Council(European Research Council (ERC)European Commission); Stand up to Cancer (Flemish Cancer Society); Belgian Cancer Society; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); ERC Consolidator; EU MRG-Grammar awards; Wellcome	We wish to thank Sophie Vermaut and Katia Reynvoet for flow cytometry help, Juan-Carlos Zuniga-Pflucker (University of Toronto) for OP9 stromal cells, Dr. Katrien Francois and Dr. Guido Van Nooten (Department of Cardiac Surgery; University Hospital Ghent) for thymus tissue, and the Red Cross Flanders for peripheral blood. This work was supported by the Fund for Scientific Research Flanders (FWO), the Concerted Research Action of Ghent University Research Fund (GOA), the Chan Zuckerberg Initiative (CZF2019-002445), the Foundation against Cancer (STK), the European Research Council (StG-639784 to P.V.V.), Stand up to Cancer (the Flemish Cancer Society), and the Belgian Cancer Society. J.-E.P. is supported by an EMBO Long-Term Fellowship. S.A.T. was funded by Wellcome (WT206194), ERC Consolidator (646794), and EU MRG-Grammar awards.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Awong G, 2009, BLOOD, V114, P972, DOI 10.1182/blood-2008-10-187013; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Bergen V, 2019, GEN RNA VELOCITY TRA, DOI 10.1101/820936; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cannoodt R., 2016, BIORXIV, DOI [10.1101/079509, DOI 10.1101/079509]; Cante-Barrett K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00032; Chen ELY, 2019, NAT IMMUNOL, V20, P1456, DOI 10.1038/s41590-019-0518-7; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; De Smedt M, 2007, BLOOD, V110, P2696, DOI 10.1182/blood-2007-03-082206; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2014, SEMIN IMMUNOL, V26, P132, DOI 10.1016/j.smim.2014.02.008; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Garcia-Peydro M, 2018, J CLIN INVEST, V128, P2802, DOI 10.1172/JCI92981; Ha VL, 2017, LEUKEMIA, V31, P2503, DOI 10.1038/leu.2017.70; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Harly C, 2019, NAT IMMUNOL, V20, P1150, DOI 10.1038/s41590-019-0445-7; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Hussen KA, 2017, IMMUNITY, V47, P680, DOI 10.1016/j.immuni.2017.09.009; Ishizuka IE, 2016, ANNU REV IMMUNOL, V34, P299, DOI 10.1146/annurev-immunol-041015-055549; Kirkling ME, 2018, CELL REP, V23, P3658, DOI 10.1016/j.celrep.2018.05.068; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MARQUEZ C, 1995, J EXP MED, V181, P475, DOI 10.1084/jem.181.2.475; Martin-Gayo E, 2017, J EXP MED, V214, P3361, DOI 10.1084/jem.20161564; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McInnes L, 2018, 180203426 ARXIV; Moerman T, 2019, BIOINFORMATICS, V35, P2159, DOI 10.1093/bioinformatics/bty916; Perraudeau Fanny, 2017, F1000Res, V6, P1158, DOI 10.12688/f1000research.12122.1; Plum J, 1999, J IMMUNOL, V162, P60; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saelens W, 2019, NAT BIOTECHNOL, V37, P547, DOI 10.1038/s41587-019-0071-9; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Scoville SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00360; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/NMETH.4612, 10.1038/nmeth.4612]; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Taghon T, 2002, BLOOD, V99, P1197, DOI 10.1182/blood.V99.4.1197; Taghon T, 2009, BLOOD, V113, P3254, DOI 10.1182/blood-2008-07-168906; Tung PY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39921; Van de Walle I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11171; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zeng Y, 2019, IMMUNITY, V51, P930, DOI 10.1016/j.immuni.2019.09.008; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	71	35	35	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1088	+		10.1016/j.immuni.2020.03.019	http://dx.doi.org/10.1016/j.immuni.2020.03.019			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32304633	Bronze			2022-12-18	WOS:000541890000020
J	Xiao, J; Li, WY; Zheng, X; Qi, LL; Wang, H; Zhang, C; Wan, XP; Zheng, YX; Zhong, RY; Zhou, X; Lu, Y; Li, ZQ; Qiu, Y; Liu, C; Zhang, F; Zhang, YB; Xu, XY; Yang, ZZ; Chen, HL; Zhai, QW; Wei, B; Wang, HY				Xiao, Jun; Li, Weiyun; Zheng, Xin; Qi, Linlin; Wang, Hui; Zhang, Chi; Wan, Xiaopeng; Zheng, Yuxiao; Zhong, Ruiyue; Zhou, Xin; Lu, Yao; Li, Zhiqi; Qiu, Ying; Liu, Chang; Zhang, Fang; Zhang, Yanbo; Xu, Xiaoyan; Yang, Zhongzhou; Chen, Hualan; Zhai, Qiwei; Wei, Bin; Wang, Hongyan			Targeting 7-Dehydrocholesterol Reductase Integrates Cholesterol Metabolism and IRF3 Activation to Eliminate Infection	IMMUNITY			English	Article							LEMLI-OPITZ-SYNDROME; IMMUNE-RESPONSE; IN-VITRO; REVEALS; 25-HYDROXYCHOLESTEROL; INTERFERES; MODEL	Recent work suggests that cholesterol metabolism impacts innate immune responses against infection. However, the key enzymes or the natural products and mechanisms involved are not well elucidated. Here, we have shown that upon DNA and RNA viral infection, macrophages reduced 7-dehydrocholesterol reductase (DHCR7) expression. DHCR7 deficiency or treatment with the natural product 7-dehydrocholesterol (7-DHC) could specifically promote phosphorylation of IRF3 (not TBK1) and enhance type I interferon (IFN-I) production in macrophages. We further elucidated that viral infection or 7-DHC treatment enhanced AKT3 expression and activation. AKT3 directly bound and phosphorylated IRF3 at Ser385, together with TBK1-induced phosphorylation of IRF3 Ser386, to achieve IRF3 dimerization. Deletion of DHCR7 and the DHCR7 inhibitors including AY9944 and the chemotherapy drug tamoxifen promoted clearance of Zika virus and multiple viruses in vitro or in vivo. Taken together, we propose that the DHCR7 inhibitors and 7-DHC are potential therapeutics against emerging or highly pathogenic viruses.	[Xiao, Jun; Li, Weiyun; Zheng, Xin; Zhang, Chi; Zheng, Yuxiao; Zhong, Ruiyue; Zhou, Xin; Lu, Yao; Qiu, Ying; Liu, Chang; Zhang, Yanbo; Xu, Xiaoyan; Wang, Hongyan] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,Innovat Ctr Cel, State Key Lab Cell Biol,Key Lab Syst Biol,CAS Ctr, Shanghai 200031, Peoples R China; [Qi, Linlin; Zhang, Fang; Wei, Bin] Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Qi, Linlin; Zhang, Fang; Wei, Bin] Shanghai Univ, Sch Life Sci, Shangda Rd, Shanghai, Peoples R China; [Wang, Hui; Zhai, Qiwei] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai, Peoples R China; [Wan, Xiaopeng; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Li, Zhiqi] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China; [Zhang, Yanbo] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Xu, Xiaoyan] NCI, Expt Immunol Branch, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA; [Yang, Zhongzhou] Nanjing Univ, Model Anim Res Ctr, Nanjing Biomed Res Inst, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Peoples R China; [Yang, Zhongzhou] Nanjing Univ, Model Anim Res Ctr, Nanjing Biomed Res Inst, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Wei, Bin; Wang, Hongyan] Tongji Univ, Shanghai Peoples Hosp 10, Canc Ctr, Sch Med, Shanghai 200072, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Shanghai University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fudan University; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nanjing University; Nanjing University; Tongji University	Wang, HY (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,Innovat Ctr Cel, State Key Lab Cell Biol,Key Lab Syst Biol,CAS Ctr, Shanghai 200031, Peoples R China.; Wei, B (corresponding author), Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.; Wei, B (corresponding author), Shanghai Univ, Sch Life Sci, Shangda Rd, Shanghai, Peoples R China.; Wei, B; Wang, HY (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Canc Ctr, Sch Med, Shanghai 200072, Peoples R China.	weibinwhy@shu.edu.cn; hongyanwang@sibcb.ac.cn	zhou, xin/AAY-4100-2021; Xiao, Jun/AAH-5238-2020; , 肖俊/AAO-9118-2020; Zhang, Yanbo/B-3047-2011	zhou, xin/0000-0001-9281-3612; Zhang, Yanbo/0000-0002-6201-7970; WEI, BIN/0000-0002-2731-489X; Zhai, Qiwei/0000-0002-9617-7403	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; Ministry of Science and Technology of China [2016YFD0500207, 2016YFD0500407, 2018YFA0800702, 2016YFC0905902]; National Natural Science Foundation of China [81930038, 81825011, 81630043, 81671572, 81571552, 81701569, 31700781, 81801575]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000) for support. We thank Dr. Zhong Zhou Yang for providing Akt2<SUP>-/-</SUP> and Akt3<SUP>-/-</SUP> mice, Dr. Xiaolong Liu for CD45.1 mice, Drs. Qibin Leng and Jin Zhong for AG6 mice, and Dr. Deyin Guo, Daming Gao, and Bing Sun for providing the plasmids. We thank the staff, especially Chao Peng, Yue Yin, and Chaohua Zheng from the National Centre for Protein Science, Shanghai for MS analysis and mice irradiance. This work was supported by grants from the Ministry of Science and Technology of China (2016YFD0500207, 2016YFD0500407, 2018YFA0800702, and 2016YFC0905902), National Natural Science Foundation of China (81930038, 81825011, 81630043, 81671572, 81571552, 81701569, 31700781, and 81801575). We thank the Genome Tagging Project (GTP) Centre and Shanghai Institute of Biochemistry and Cell Biology, CAS for technical support.	Achour A, 1998, ANTIMICROB AGENTS CH, V42, P2482, DOI 10.1128/AAC.42.10.2482; Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Babovic-Vuksanovic D, 2005, J INHERIT METAB DIS, V28, P181, DOI 10.1007/s10545-005-5515-3; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Boland MR, 2016, PHARMACOGENOMICS J, V16, P411, DOI 10.1038/tpj.2016.48; Bonneau L, 2010, BBA-BIOMEMBRANES, V1798, P2150, DOI 10.1016/j.bbamem.2010.07.026; Corriden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9369; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Ezella SA, 2012, P NATL ACAD SCI USA, V109, pE613, DOI 10.1073/pnas.1115029109; Francis KR, 2016, NAT MED, V22, P388, DOI 10.1038/nm.4067; Gerrick KY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208602; Hiscott J, 2004, NAT STRUCT MOL BIOL, V11, P1028, DOI 10.1038/nsmb1104-1028; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kandasamy RK, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.27; Keller RK, 2004, J LIPID RES, V45, P347, DOI 10.1194/jlr.M300232-JLR200; Khodabandehlou N, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5286-0; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; OSTERGAARD GZ, 1992, EUR J PEDIATR, V151, P291, DOI 10.1007/BF02072232; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Phung TL, 2015, CANCER RES, V75, P40, DOI 10.1158/0008-5472.CAN-13-2961; Ramstedt B, 1999, BIOPHYS J, V77, P1498, DOI 10.1016/S0006-3495(99)76997-3; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Sonnino S, 2013, CURR MED CHEM, V20, P4; Sponne I, 2004, FASEB J, V18, P836, DOI 10.1096/fj.03-0372fje; Sunshine H, 2017, CURR OPIN LIPIDOL, V28, P408, DOI 10.1097/MOL.0000000000000443; TEO CC, 1992, J MED CHEM, V35, P1330, DOI 10.1021/jm00086a002; Wang Q, 2016, CANCER CELL, V29, P523, DOI 10.1016/j.ccell.2016.02.008; Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200; Wu SY, 2019, NAT CELL BIOL, V21, P1027, DOI 10.1038/s41556-019-0352-z; Xu LB, 2011, J LIPID RES, V52, P1810, DOI 10.1194/jlr.M018366; Xu XY, 2017, J EXP MED, V214, P209, DOI 10.1084/jem.20160068; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhang YB, 2014, IMMUNITY, V40, P501, DOI 10.1016/j.immuni.2014.01.013; Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005	49	35	36	11	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					109	+		10.1016/j.immuni.2019.11.015	http://dx.doi.org/10.1016/j.immuni.2019.11.015			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31882361	Bronze			2022-12-18	WOS:000507384600012
J	Bonsignori, M; Scott, E; Wiehe, K; Easterhoff, D; Alam, SM; Hwang, KK; Cooper, M; Xia, SM; Zhang, RJ; Montefiori, DC; Henderson, R; Nie, XY; Kelsoe, G; Moody, MA; Chen, XJ; Joyce, MG; Kwong, PD; Connors, M; Mascola, JR; McGuire, AT; Stamatatos, L; Medina-Ramirez, M; Sanders, RW; Saunders, KO; Kepler, TB; Haynes, BF				Bonsignori, Mattia; Scott, Eric; Wiehe, Kevin; Easterhoff, David; Alam, S. Munir; Hwang, Kwan-Ki; Cooper, Melissa; Xia, Shi-Mao; Zhang, Ruijun; Montefiori, David C.; Henderson, Rory; Nie, Xiaoyan; Kelsoe, Garnett; Moody, M. Anthony; Chen, Xuejun; Joyce, M. Gordon; Kwong, Peter D.; Connors, Mark; Mascola, John R.; McGuire, Andrew T.; Stamatatos, Leonidas; Medina-Ramirez, Max; Sanders, Rogier W.; Saunders, Kevin O.; Kepler, Thomas B.; Haynes, Barton F.			Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; MOLECULAR-DYNAMICS; SOMATIC HYPERMUTATION; MATURATION PATHWAY; IMMUNOGEN DESIGN; STRUCTURAL BASIS; CELL-LINES; B-CELLS; GERMLINE	Elicitation of VRC01-class broadly neutralizing antibodies (bnAbs) is an appealing approach for a preventative HIV-1 vaccine. Despite extensive investigations, strategies to induce VRC01-class bnAbs and overcome the barrier posed by the envelope N276 glycan have not been successful. Here, we inferred a high-probability unmutated common ancestor (UCA) of the VRC01 lineage and reconstructed the stages of lineage maturation. Env immunogens designed on reverted VRC01-class bnAbs bound to VRC01 UCA with affinity sufficient to activate naive B cells. Early mutations defined maturation pathways toward limited or broad neutralization, suggesting that focusing the immune response is likely required to steer B cell maturation toward the development of neutralization breadth. Finally, VRC01 lineage bnAbs with long CDR H3s overcame the HIV-1 N276 glycan barrier without shortening their CDR L1, revealing a solution for broad neutralization in which the heavy chain, not CDR L1, is the determinant to accommodate the N276 glycan.	[Bonsignori, Mattia; Scott, Eric; Wiehe, Kevin; Easterhoff, David; Alam, S. Munir; Hwang, Kwan-Ki; Cooper, Melissa; Xia, Shi-Mao; Zhang, Ruijun; Montefiori, David C.; Henderson, Rory; Kelsoe, Garnett; Moody, M. Anthony; Saunders, Kevin O.; Haynes, Barton F.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Bonsignori, Mattia; Wiehe, Kevin; Easterhoff, David; Alam, S. Munir; Haynes, Barton F.] Duke Univ, Dept Med, Durham, NC 27708 USA; [Montefiori, David C.; Saunders, Kevin O.] Duke Univ, Dept Surg, Durham, NC USA; [Nie, Xiaoyan; Haynes, Barton F.] Duke Univ, Dept Immunol, Durham, NC 27708 USA; [Moody, M. Anthony] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Chen, Xuejun; Joyce, M. Gordon; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [McGuire, Andrew T.; Stamatatos, Leonidas] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [McGuire, Andrew T.; Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Medina-Ramirez, Max; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Zhang, Ruijun] Sanofi, Framingham, MA USA; [Joyce, M. Gordon] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Joyce, M. Gordon] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA	Duke University; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; Boston University; Sanofi-Aventis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Bonsignori, M; Haynes, BF (corresponding author), Duke Univ, Duke Human Vaccine Inst, Durham, NC 27708 USA.; Bonsignori, M; Haynes, BF (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.; Haynes, BF (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27708 USA.	mattia.bonsignori@duke.edu; barton.haynes@duke.edu	Zhang, RUIJUN/AAD-6887-2021; Moody, M/AAB-6947-2020; Bonsignori, Mattia/AAE-7678-2019; Mascola, John/AAI-7193-2021; Alam, S. Munir/AAC-6711-2019	Moody, M/0000-0002-3890-5855; Bonsignori, Mattia/0000-0003-2973-2101; McGuire, Andrew/0000-0003-1841-6859; Kelsoe, Garnett/0000-0002-8770-040X; Henderson, Rory/0000-0002-4301-6382	Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery grant from the National Institutes of Health (NIH), National Institutes of Allergy and Infectious Diseases (NIAID) [UM1AI100645]; NIH, NIAID [R01AI081625]; Ruth L. Kirschstein National Research Service Award (NRSA) [T32AI007392]; Aids Fonds Netherlands grant [20160192]; Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill & Melinda Gates Foundation [OPP1132237]; NIAID Division of Intramural Research; NIAID Vaccine Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, R01AI081625, ZIAAI005023, ZIAAI001090, T32AI007392, P01AI131251] Funding Source: NIH RePORTER	Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery grant from the National Institutes of Health (NIH), National Institutes of Allergy and Infectious Diseases (NIAID); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aids Fonds Netherlands grant; Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill & Melinda Gates Foundation; NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Vaccine Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Kelly Soderberg and Ashley Trama for project management; Amanda Eaton, Morgan Gladden, Anthony Monroe, Kara Anasti, Andrew Foulger, Giovanna Hernandez, Maggie Barr, and Robert Parks for technical support; and Wes Rountree for statistical analysis. This study was supported by the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery grant UM1AI100645 from the National Institutes of Health (NIH), National Institutes of Allergy and Infectious Diseases (NIAID) to B.F.H. Additional support to this study was provided by the NIH, NIAID grant R01AI081625 to L.S.; by the Ruth L. Kirschstein National Research Service Award (NRSA) grant T32AI007392 to E.S.; the Aids Fonds Netherlands grant 20160192 and the Collaboration for AIDS Vaccine Discovery (CAVD) grant OPP1132237 from the Bill & Melinda Gates Foundation to R.W.S.; and the intramural research programs of the NIAID Vaccine Research Center and the NIAID Division of Intramural Research to P.D.K., J.R.M and M. Connors.	Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Bonsignori M, 2014, J CLIN INVEST, V124, P1835, DOI 10.1172/JCI73441; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Davenport TM, 2016, STRUCTURE, V24, P1346, DOI 10.1016/j.str.2016.06.012; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Felsenstein J, 2005, PHYLIP PHYLOGENY INF; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gray ES, 2011, J VIROL, V85, P7719, DOI 10.1128/JVI.00563-11; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabat E. A., 1991, SEQUENCES PROTEINS I; Kepler TB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00170; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; Montefiori D.C., 2005, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1211S64; Ota T, 2012, J IMMUNOL, V189, P4816, DOI 10.4049/jimmunol.1202165; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weaver GC, 2016, NAT PROTOC, V11, P193, DOI 10.1038/nprot.2016.009; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wiehe K, 2018, CELL HOST MICROBE, V23, P759, DOI 10.1016/j.chom.2018.04.018; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yacoob C, 2016, CELL REP, V17, P1560, DOI 10.1016/j.celrep.2016.10.017; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012	75	35	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1162	+		10.1016/j.immuni.2018.10.015	http://dx.doi.org/10.1016/j.immuni.2018.10.015			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30552024	Green Published, hybrid			2022-12-18	WOS:000453556500019
J	Goldberg, MF; Roeske, EK; Ward, LN; Pengo, T; Dileepan, T; Kotov, DI; Jenkins, MK				Goldberg, Michael F.; Roeske, Elizabeth K.; Ward, Lauren N.; Pengo, Thomas; Dileepan, Thamotharampillai; Kotov, Dmitri I.; Jenkins, Marc K.			Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells	IMMUNITY			English	Article							NITRIC-OXIDE; MEDIATED-IMMUNITY; INFECTION; EXPRESSION; MICE; RESISTANCE; ANTIGEN; DIFFERENTIATION; SUSCEPTIBILITY; DIVERSITY	Salmonella enterica (Se) bacteria cause persistent intracellular infections while stimulating a robust interferon-gamma-producing CD4(+) T (Th1) cell response. We addressed this paradox of concomitant infection and immunity by tracking fluorescent Se organisms in mice. Se bacteria persisted in nitric oxide synthase (iNOS)-producing resident and recruited macrophages while inducing genes related to protection from nitric oxide. Se-infected cells occupied iNOS(+) splenic granulomas that excluded T cells but were surrounded by mononuclear phagocytes producing the chemokines CXCL9 and CXCL10, and Se epitope-specific Th1 cells expressing CXCR3, the receptor for these chemokines. Blockade of CXCR3 inhibited Th1 occupancy of CXCL9/10-dense regions, reduced activation of the Th1 cells, and led to increased Se growth. Thus, intracellular Se bacteria survive in their hosts by counteracting toxic products of the innate immune response and by residing in T cell-sparse granulomas, away from abundant Th1 cells positioned via CXCR3 in a bordering region that act to limit infection.	[Goldberg, Michael F.; Roeske, Elizabeth K.; Ward, Lauren N.; Dileepan, Thamotharampillai; Kotov, Dmitri I.; Jenkins, Marc K.] Univ Minnesota, Med Sch, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA; [Pengo, Thomas] Univ Minnesota, Informat Inst, Off Vice President Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Med Sch, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Pengo, Thomas/D-5867-2013; Jenkins, Marc/G-1063-2012	Pengo, Thomas/0000-0002-9632-918X; Jenkins, Marc/0000-0001-8009-7655; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996	US National Institutes of Health [R01 AI039614, R01 AI103760, T32 AI83196, T32 HL007062]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196, R01AI103760, T35AI118620, R01AI039614] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the US National Institutes of Health R01 AI039614 and R01 AI103760 to M.K.J., T32 AI83196 to D.I.K., and T32 HL007062 to M.F.G. The authors acknowledge Roman Gerlach (Robert Koch Instituit, Berlin) for the kind provision of plasmids and technical advice on generation of the Se-Tomato strain, Antonio Pagan (Cambridge University, England) for critical advice on the manuscript, Jason Mitchell at the UMN-CFI imaging core facility for technical expertise and training, Jennifer Walter for general technical assistance, and the University of Minnesota University Flow Cytometry Resource for cell sorting and analysis support.	Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966; Bayer-Santos E, 2016, CELL HOST MICROBE, V20, P584, DOI 10.1016/j.chom.2016.10.007; Behnsen J, 2015, TRENDS IMMUNOL, V36, P112, DOI 10.1016/j.it.2014.12.003; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Blank K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015763; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Bumann D, 2017, CURR OPIN MICROBIOL, V39, P57, DOI 10.1016/j.mib.2017.09.008; Burton NA, 2014, CELL HOST MICROBE, V15, P72, DOI 10.1016/j.chom.2013.12.006; Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480; Chu HH, 2016, IMMUNITY, V45, P159, DOI 10.1016/j.immuni.2016.06.013; Cibrian D, 2017, EUR J IMMUNOL, V47, P946, DOI 10.1002/eji.201646837; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dauphinee SM, 2014, GENES IMMUN, V15, P282, DOI 10.1038/gene.2014.17; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dileepan T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002252; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Eisele NA, 2013, CELL HOST MICROBE, V14, P171, DOI 10.1016/j.chom.2013.07.010; Eisenstein TK, 2001, MICROBES INFECT, V3, P1223, DOI 10.1016/S1286-4579(01)01482-4; Ernst JD, 2018, J INFECT DIS, V218, P1653, DOI 10.1093/infdis/jiy142; Ester M., 1996, P 2 INT C KNOWL DISC, P226; Eva MM, 2014, J IMMUNOL, V192, P259, DOI 10.4049/jimmunol.1301370; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Hardison SE, 2012, J IMMUNOL, V189, P4060, DOI 10.4049/jimmunol.1103455; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Jackson NP, 2013, EUR J IMMUNOL, V43, P897, DOI 10.1002/eji.201242983; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Karunakaran KP, 2017, J PROTEOME RES, V16, P298, DOI 10.1021/acs.jproteome.6b00926; Kauffman KD, 2018, MUCOSAL IMMUNOL, V11, P462, DOI 10.1038/mi.2017.60; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Lee WI, 2011, J FORMOS MED ASSOC, V110, P750, DOI 10.1016/j.jfma.2011.11.004; Li NZ, 2003, J NEUROSCI, V23, P10302; Loomis WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111763; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; Pagan AJ, 2018, ANNU REV IMMUNOL, V36, P639, DOI 10.1146/annurev-immunol-032712-100022; Pagan AJ, 2015, CELL HOST MICROBE, V18, P15, DOI 10.1016/j.chom.2015.06.008; Park SY, 2014, MOL MICROBIOL, V91, P135, DOI 10.1111/mmi.12449; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Peters NC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004538; Powell DA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00206; Prando C, 2013, MEDICINE, V92, P109, DOI 10.1097/MD.0b013e31828a01f9; Ravindran R, 2005, J IMMUNOL, V175, P4603, DOI 10.4049/jimmunol.175.7.4603; Roy MF, 2007, J EXP MED, V204, P2949, DOI 10.1084/jem.20062606; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Sallin MA, 2017, CELL REP, V18, P3091, DOI 10.1016/j.celrep.2017.03.007; Sharma S, 2001, ASIAN PAC J ALLERGY, V19, P213; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sologuren I, 2011, HUM MOL GENET, V20, P1509, DOI 10.1093/hmg/ddr029; Tian T, 2015, NUCLEIC ACIDS RES, V43, P7137, DOI 10.1093/nar/gkv635; Tubo NJ, 2014, CLIN MICROBIOL REV, V27, P200, DOI 10.1128/CMR.00097-13; Uppaluri R, 2008, TRANSPLANTATION, V86, P137, DOI 10.1097/TP.0b013e31817b8e4b; Urdahl KB, 2014, SEMIN IMMUNOL, V26, P578, DOI 10.1016/j.smim.2014.10.003; Weintraub BC, 1997, INFECT IMMUN, V65, P2306, DOI 10.1128/IAI.65.6.2306-2312.1997; Yang JB, 2004, HUM IMMUNOL, V65, P692, DOI 10.1016/j.humimm.2004.04.001	71	35	36	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1090	+		10.1016/j.immuni.2018.10.009	http://dx.doi.org/10.1016/j.immuni.2018.10.009			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30552021	Bronze, Green Accepted			2022-12-18	WOS:000453556500014
J	Shan, MM; Carrillo, J; Yeste, A; Gutzeit, C; Segura-Garzon, D; Walland, AC; Pybus, M; Grasset, EK; Yeiser, JR; Matthews, DB; van de Veen, W; Comerma, L; He, B; Boonpiyathad, T; Lee, H; Blanco, J; Osborne, LC; Siracusa, MC; Akdis, M; Artis, D; Mehandru, S; Sampson, HA; Berin, MC; Chen, K; Cerutti, A				Shan, Meimei; Carrillo, Jorge; Yeste, Ada; Gutzeit, Cindy; Segura-Garzon, Daniel; Walland, A. Cooper; Pybus, Marc; Grasset, Emilie K.; Yeiser, John R.; Matthews, Dean B.; van de Veen, Willem; Comerma, Laura; He, Bing; Boonpiyathad, Tadech; Lee, Haekyung; Blanco, Julia; Osborne, Lisa C.; Siracusa, Mark C.; Akdis, Mubeccel; Artis, David; Mehandru, Saurabh; Sampson, Hugh A.; Berin, M. Cecilia; Chen, Kang; Cerutti, Andrea			Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44	IMMUNITY			English	Article							B-CELLS; MICE; IMMUNITY; INFLAMMATION; MECHANISMS; TOLERANCE; GLYCANS; INNATE; SWITCH	B cells thwart antigenic aggressions by releasing immunoglobulin M (IgM), IgG, IgA, and IgE, which deploy well-understood effector functions. In contrast, the role of secreted IgD remains mysterious. We found that some B cells generated IgD-secreting plasma cells following early exposure to external soluble antigens such as food proteins. Secreted IgD targeted basophils by interacting with the CD44-binding protein galectin-9. When engaged by antigen, basophil-bound IgD increased basophil secretion of interleukin-4 (IL-4), IL-5, and IL-13, which facilitated the generation of T follicular helper type 2 cells expressing IL-4. These germinal center T cells enhanced IgG1 and IgE but not IgG2a and IgG2b responses to the antigen initially recognized by basophil-bound IgD. In addition, IgD ligation by antigen attenuated allergic basophil degranulation induced by IgE co-ligation. Thus, IgD may link B cells with basophils to optimize humoral T helper type 2-mediated immunity against common environmental soluble antigens.	[Shan, Meimei; Carrillo, Jorge; Gutzeit, Cindy; Walland, A. Cooper; Grasset, Emilie K.; Yeiser, John R.; Matthews, Dean B.; He, Bing; Lee, Haekyung; Mehandru, Saurabh; Cerutti, Andrea] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY 10029 USA; [Shan, Meimei; Artis, David; Chen, Kang; Cerutti, Andrea] NIAID, MIST, NIH, Bethesda, MD 20982 USA; [Carrillo, Jorge; Blanco, Julia] UAB, IGTP, SIDA IrsiCaixa HIVACAT, Inst Recerca, Barcelona 08916, Spain; [Yeste, Ada; Segura-Garzon, Daniel; Pybus, Marc; Comerma, Laura; Cerutti, Andrea] Inst Hosp Mar Invest Med IMIM, Program Inflammatory & Cardiovasc Disorders, Barcelona 08003, Spain; [Grasset, Emilie K.] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Ctr Mol Med, S-17177 Stockholm, Sweden; [van de Veen, Willem; Boonpiyathad, Tadech; Akdis, Mubeccel] Univ Zurich, Swiss Inst Allergy & Asthma Res, Christine Kuhne Res Ctr Allergy & Educ, CH-7270 Davos, Switzerland; [Blanco, Julia] Univ Vic, UVIC UCC, Barcelona 08500, Spain; [Osborne, Lisa C.; Artis, David] Cornell Univ, Weill Med Coll, Jill Roberts Inst Res Inflammatory Bowel Dis, Dept Med, New York, NY 10021 USA; [Siracusa, Mark C.] Rutgers New Jersey Med Sch, Dept Med, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Mehandru, Saurabh] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Gastroenterol, New York, NY 10029 USA; [Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Inst Immunol, Div Pediat Allergy & Immunol, New York, NY 10029 USA; [Chen, Kang] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Cerutti, Andrea] Catalan Inst Res & Adv Studies ICREA, Barcelona 08003, Spain	Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Karolinska Institutet; Karolinska University Hospital; Swiss Institute of Allergy & Asthma Research; University of Zurich; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Cornell University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Wayne State University; ICREA	Cerutti, A (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY 10029 USA.; Cerutti, A (corresponding author), NIAID, MIST, NIH, Bethesda, MD 20982 USA.; Cerutti, A (corresponding author), Inst Hosp Mar Invest Med IMIM, Program Inflammatory & Cardiovasc Disorders, Barcelona 08003, Spain.; Cerutti, A (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona 08003, Spain.	acerutti@imim.es	Blesa, Laura Comerma/AAQ-9455-2020; Carrillo, Jorge/AAL-9481-2021; Blanco, Julià/A-5347-2008	Blesa, Laura Comerma/0000-0002-0249-4636; Carrillo, Jorge/0000-0003-0221-5948; Blanco, Julià/0000-0002-2225-0217; van de Veen, Willem/0000-0001-9951-6688; Boonpiyathad, Tadech/0000-0001-8690-7647; Pybus, Marc/0000-0002-6195-5738; berin, cecilia/0000-0002-9051-9249; Artis, David/0000-0002-1753-4100	European Advanced Grant [ERC-2011-ADG-20110310]; Ministerio de Ciencia e Innovacion [SAF2014-52483R]; Burroughs Wellcome Fund grant [1013738]; Swiss National Foundation [320030_159870]; European 7th frame work project MeDALL: Mechanisms of the Development of Allergy [261357]; US National Institutes of Health [U01 AI95613, R01 AI57653, P01 AI61093, U01 AI95776, R21 AI122256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776, R01AI057653, P01AI061093, U01AI095613, R21AI122256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112296] Funding Source: NIH RePORTER	European Advanced Grant; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Burroughs Wellcome Fund grant(Burroughs Wellcome Fund); Swiss National Foundation(Swiss National Science Foundation (SNSF)); European 7th frame work project MeDALL: Mechanisms of the Development of Allergy; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	For access to CoFAR3 specimens, we thank the Consortium of Food Allergy Research Investigators (Wesley Burks, Donald Leung, Stacie Jones, Scott Sicherer, Robert Wood), the EMMES statistical coordinating center (Robert Lindblad), NIAID (Marshall Plaut, Wendy Davidson), and the Mucosal Immunology Studies Team at NAID (Annette L. Rothermel). For provision of other specimens, we thank Anna Nowak-Wegrzyn. Supported by US National Institutes of Health grants U01 AI95613, R01 AI57653, and P01 AI61093 to A.C.; by European Advanced Grant ERC-2011-ADG-20110310 and by Ministerio de Ciencia e Innovacion grant SAF2014-52483R to A.C.; by US National Institutes of Health grants U01 AI95776 Young Investigator Award and R21 AI122256 and by Burroughs Wellcome Fund grant 1013738 to K.C.; and by the Swiss National Foundation grant 320030_159870 and by European 7th frame work project MeDALL: Mechanisms of the Development of Allergy (grant 261357) to M.A.	AMIN AR, 1993, INT IMMUNOL, V5, P607, DOI 10.1093/intimm/5.6.607; Ben Mkaddem S, 2014, CURR TOP MICROBIOL, V382, P221, DOI 10.1007/978-3-319-07911-0_10; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Choi JH, 2017, P NATL ACAD SCI USA, V114, pE1196, DOI 10.1073/pnas.1621258114; Chorny A, 2016, J EXP MED, V213, P2167, DOI 10.1084/jem.20150282; de Kivit S, 2012, ALLERGY, V67, P343, DOI 10.1111/j.1398-9995.2011.02771.x; Flajnik MF, 2018, NAT REV IMMUNOL, V18, P438, DOI 10.1038/s41577-018-0003-9; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gutzeit C, 2018, EUR J IMMUNOL, V48, P1101, DOI 10.1002/eji.201646547; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kim Y, 2008, MOL IMMUNOL, V45, P2537, DOI 10.1016/j.molimm.2008.01.008; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Panda SK, 2018, J CLIN INVEST, V128, P1873, DOI 10.1172/JCI97333; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, P881, DOI 10.1016/j.jaci.2013.06.008; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Rouaud P, 2014, J EXP MED, V211, P975, DOI 10.1084/jem.20131385; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swenson CD, 1998, EUR J IMMUNOL, V28, P2366, DOI 10.1002/(SICI)1521-4141(199808)28:08<2366::AID-IMMU2366>3.0.CO;2-D; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; XUE B, 1984, J EXP MED, V159, P103, DOI 10.1084/jem.159.1.103	32	35	36	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					709	+		10.1016/j.immuni.2018.08.013	http://dx.doi.org/10.1016/j.immuni.2018.08.013			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30291028	Bronze, Green Accepted			2022-12-18	WOS:000447386700016
J	Stadtmueller, BM; Bridges, MD; Dam, KM; Lerch, MT; Huey-Tubman, KE; Hubbell, WL; Bjorkman, PJ				Stadtmueller, Beth M.; Bridges, Michael D.; Dam, Kim-Marie; Lerch, Michael T.; Huey-Tubman, Kathryn E.; Hubbell, Wayne L.; Bjorkman, Pamela J.			DEER Spectroscopy Measurements Reveal Multiple Conformations of HIV-1 SOSIP Envelopes that Show Similarities with Envelopes on Native Virions	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; CRYO-EM STRUCTURE; DISTANCE MEASUREMENTS; DYNAMICS; TRIMERS; SITE; RECOGNITION; VIRUS	HIV-1 Envelope (Env) mediates viral-host membrane fusion after binding host-receptor CD4 and coreceptor. Soluble envelopes (SOSIPs), designed to mimic prefusion conformational states of virion-bound envelopes, are proposed immunogens for eliciting neutralizing antibodies, yet only static structures are available. To evaluate conformational landscapes of ligand-free, CD4-bound, inhibitor-bound, and antibody-bound SOSIPs, we measured inter-subunit distances throughout spin-labeled SOSIPs using double electron-electron resonance (DEER) spectroscopy and compared results to soluble and virion-bound Env structures, and single-molecule fluorescence resonance energy transfer (smFRET)-derived dynamics of virion-bound Envs. Unliganded SOSIP measurements were consistent with closed, neutralizing antibody-bound structures and shielding of non-neutralizing epitopes, demonstrating homogeneity at Env apex, increased flexibility near Env base, and no evidence for the intra-subunit flexibility near Env apex suggested by smFRET. CD4 binding increased inter-subunit distances and heterogeneity, consistent with rearrangements required for coreceptor binding. Results suggest similarities between SOSIPs and virion-bound Envs and demonstrate DEER's relevance for immunogen design.	[Stadtmueller, Beth M.; Dam, Kim-Marie; Huey-Tubman, Kathryn E.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Bridges, Michael D.; Lerch, Michael T.; Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bridges, Michael D.; Lerch, Michael T.; Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lerch, Michael T.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Medical College of Wisconsin	Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	bjorkman@caltech.edu		Dam, Kim-Marie/0000-0002-1416-4757; Stadtmueller, Beth/0000-0003-0637-3206	Caltech Baxter Senior Post-doctoral fellowship; NIH [HIVRAD P01 AI100148, R01 EY05216, T33 EY07026, 5P41EB001980]; Bill and Melinda Gates Foundation [CAVD] [OPP1124068]; Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE [T32EY007026, R01EY005216, P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	Caltech Baxter Senior Post-doctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation [CAVD]; Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank J. Vielmetter, H. Gao, and the Caltech Protein Expression Center for producing proteins, J. Keeffe and A. Voll for cloning assistance, M.E. Abernathy and H. Wang for making chemical structure and ET map figures, respectively, M. Murphy for assistance with other figures, C. Altenbach for advice on DEER acquisition and analysis, and members of the Bjorkman laboratory for critical reading of the manuscript. B.M.S. was supported by a Caltech Baxter Senior Post-doctoral fellowship. This research was supported by the NIH Grant HIVRAD P01 AI100148 (P.J.B.), the Bill and Melinda Gates Foundation [CAVD Grant OPP1124068 (P.J.B.)], the Jules Stein Professorship Endowment and NIH Grants R01 EY05216, T33 EY07026, and 5P41EB001980.	Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; El Mkami H, 2015, METHOD ENZYMOL, V564, P125, DOI 10.1016/bs.mie.2015.05.027; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Fleissner MR, 2009, P NATL ACAD SCI USA, V106, P21637, DOI 10.1073/pnas.0912009106; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; KHRAMTSOV VV, 1989, ANAL BIOCHEM, V182, P58, DOI 10.1016/0003-2697(89)90718-5; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li ZF, 2013, ANTIMICROB AGENTS CH, V57, P4172, DOI 10.1128/AAC.00513-13; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ma X., 2018, ELIFE, V7, P7; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; Munro JB, 2018, CURR HIV RES, V16, P5, DOI 10.2174/1570162X16666171222110025; Munro JB, 2015, J VIROL, V89, P5752, DOI 10.1128/JVI.03187-14; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2017, NAT CHEM BIOL, V13, P1115, DOI [10.1038/NCHEMBIO.2460, 10.1038/nchembio.2460]; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Schrodinger L., 2011, PYMOL MOL GRAPHICS S; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Wang HQ, 2016, P NATL ACAD SCI USA, V113, pE7151, DOI 10.1073/pnas.1615939113; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; Warshaviak DT, 2013, J MAGN RESON, V232, P53, DOI 10.1016/j.jmr.2013.04.013; Yokoyama M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00110	44	35	35	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					235	+		10.1016/j.immuni.2018.06.017	http://dx.doi.org/10.1016/j.immuni.2018.06.017			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30076100	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000442354500010
J	Luo, JL; Qian, AH; Oetjen, LK; Yu, WH; Yang, P; Feng, J; Xie, ZL; Liu, SB; Yin, SJ; Dryn, D; Cheng, JZ; Riehl, TE; Zholos, AV; Stenson, WF; Kim, BS; Hu, HZ				Luo, Jialie; Qian, Aihua; Oetjen, Landon K.; Yu, Weihua; Yang, Pu; Feng, Jing; Xie, Zili; Liu, Shenbin; Yin, Shijin; Dryn, Dari; Cheng, Jizhong; Riehl, Terrence E.; Zholos, Alexander, V; Stenson, William F.; Kim, Brian S.; Hu, Hongzhen			TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle Cells	IMMUNITY			English	Article							IRRITABLE-BOWEL-SYNDROME; ALTERNATIVELY ACTIVATED MACROPHAGES; RECEPTOR POTENTIAL CHANNELS; POSTOPERATIVE ILEUS; SMALL-INTESTINE; VISCERAL HYPERSENSITIVITY; MUSCULARIS MACROPHAGES; TISSUE MACROPHAGES; INTERSTITIAL-CELLS; NERVOUS-SYSTEM	Intestinal macrophages are critical for gastrointestinal (GI) homeostasis, but our understanding of their role in regulating intestinal motility is incomplete. Here, we report that CX3C chemokine receptor 1-expressing muscularis macrophages (MMs) were required to maintain normal GI motility. MMs expressed the transient receptor potential vanilloid 4 (TRPV4) channel, which senses thermal, mechanical, and chemical cues. Selective pharmacologic inhibition of TRPV4 or conditional deletion of TRPV4 from macrophages decreased intestinal motility and was sufficient to reverse the GI hypermotility that is associated with chemotherapy treatment. Mechanistically, stimulation of MMs via TRPV4 promoted the release of prostaglandin E2 and elicited colon contraction in a paracrine manner via prostaglandin E receptor signaling in intestinal smooth muscle cells without input from the enteric nervous system. Collectively, our data identify TRPV4-expressing MMs as an essential component required for maintaining normal GI motility and provide potential drug targets for GI motility disorders.	[Luo, Jialie; Yang, Pu; Feng, Jing; Xie, Zili; Liu, Shenbin; Kim, Brian S.; Hu, Hongzhen] Washington Univ, Sch Med, Dept Anesthesiol, Ctr Study Itch, St Louis, MO 63110 USA; [Qian, Aihua] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China; [Oetjen, Landon K.; Kim, Brian S.] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; [Yu, Weihua] Chongqing Med Univ, Dept Anat, Chongqing 400016, Peoples R China; [Yin, Shijin] South Cent Univ Nationalities, Coll Pharm, Wuhan 430073, Hubei, Peoples R China; [Dryn, Dari; Zholos, Alexander, V] Taras Shevchenko Natl Univ Kyiv, Inst Biol, Dept Biophys, UA-03022 Kiev, Ukraine; [Cheng, Jizhong] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Riehl, Terrence E.; Stenson, William F.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dryn, Dari] Natl Acad Sci Ukraine, AA Bogomoletz Inst Physiol, 4 Bogomoletz St, UA-01024 Kiev, Ukraine	Washington University (WUSTL); Shanghai Jiao Tong University; Washington University (WUSTL); Chongqing Medical University; South Central Minzu University; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Baylor College of Medicine; Washington University (WUSTL); Washington University (WUSTL); National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Kim, BS; Hu, HZ (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Ctr Study Itch, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	briankim@wustl.edu; hongzhen.hu@wustl.edu	Zholos, Alexander/A-7017-2011; Dryn, Dariia/AAD-8207-2019; Yu, Weihua/GLR-7246-2022; Kim, Brian/GZK-6649-2022	Zholos, Alexander/0000-0002-4320-149X; Dryn, Dariia/0000-0002-0708-5372; Kim, Brian/0000-0002-8100-7161; Hu, Hongzhen/0000-0002-8967-7522	National Institutes of Health [R01GM101218, R01DK103901]; Washington University DDRCC [NIDDK P30 DK052574]; Center for the Study of Itch of the Department of Anesthesiology of Washington University School of Medicine;  [K08AR065577];  [R01AR070116]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070116, K08AR065577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK103901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University DDRCC; Center for the Study of Itch of the Department of Anesthesiology of Washington University School of Medicine; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. M. Suzuki and A. Mizuno for providing TRPV4 KO mice and Drs. Zhou- Feng Chen and Gwen Randolph for sharing breeder pairs of mice. We would also like to thank Lenard Lichtenberger, Qingyun Liu, Richard Breyer, Richard Clark, Edgar Walters, and Carmen Dessauer for constructive discussions. This work was supported, in whole or in part, by grants from the National Institutes of Health (R01GM101218 and R01DK103901), Washington University DDRCC (NIDDK P30 DK052574), Center for the Study of Itch of the Department of Anesthesiology of Washington University School of Medicine to H.H., and K08AR065577 and R01AR070116 to B.S.K.	Ambudkar IS, 2009, GASTROENTEROLOGY, V137, P1211, DOI 10.1053/j.gastro.2009.08.025; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Boesmans W, 2015, GLIA, V63, P229, DOI 10.1002/glia.22746; BOTELLA A, 1993, EUR J PHARMACOL, V237, P131, DOI 10.1016/0014-2999(93)90102-N; Brown JM, 2017, CLIN CANCER RES, V23, P3241, DOI 10.1158/1078-0432.CCR-16-3122; Cash BD, 2005, GASTROENTEROL CLIN N, V34, P205, DOI 10.1016/j.gtc.2005.03.001; Cenac N, 2015, GASTROENTEROLOGY, V149, P433, DOI 10.1053/j.gastro.2015.04.011; Cenac N, 2010, GUT, V59, P481, DOI 10.1136/gut.2009.192567; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; De Schepper S, 2018, CELL IMMUNOL, V330, P142, DOI 10.1016/j.cellimm.2017.12.009; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Farro G, 2017, GUT, V66, P2098, DOI 10.1136/gutjnl-2016-313144; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gao N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044426; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grainger JR, 2017, PFLUG ARCH EUR J PHY, V469, P527, DOI [10.1007/s00424-017-1958, 10.1007/s00424-017-1958-2]; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Grasa L, 2006, PROSTAG OTH LIPID M, V79, P206, DOI 10.1016/j.prostaglandins.2006.01.001; Greenwood-Van Meerveld B, 2017, HANDB EXP PHARMACOL, V239, P1, DOI 10.1007/164_2016_118; Holzer P, 2007, CURR OPIN PHARMACOL, V7, P563, DOI 10.1016/j.coph.2007.09.004; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Houchen CW, 2000, AM J PHYSIOL-GASTR L, V279, pG858, DOI 10.1152/ajpgi.2000.279.5.G858; Hu HZ, 2003, BRIT J PHARMACOL, V138, P1221, DOI 10.1038/sj.bjp.0705180; Hu HZ, 2002, J COMP NEUROL, V442, P189, DOI 10.1002/cne.1424; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jacob F, 2013, PURINERG SIGNAL, V9, P285, DOI 10.1007/s11302-013-9357-4; Joeris T, 2017, MUCOSAL IMMUNOL, V10, P845, DOI 10.1038/mi.2017.22; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Luo JL, 2018, J ALLERGY CLIN IMMUN, V141, P608, DOI 10.1016/j.jaci.2017.05.051; Luo JL, 2015, CELL MOL LIFE SCI, V72, P3201, DOI 10.1007/s00018-015-1904-4; Manning BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1388, DOI 10.1152/ajpgi.00141.2002; Markel TA, 2007, J LEUKOCYTE BIOL, V81, P393, DOI 10.1189/jlb.0906579; McQuade RM, 2016, NEUROGASTROENT MOTIL, V28, P1861, DOI 10.1111/nmo.12890; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Mori D, 2014, J PHARMACOL SCI, V125, P394, DOI 10.1254/jphs.14060FP; Mowat AM, 2017, NAT MED, V23, P1258, DOI 10.1038/nm.4430; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Okada Y, 2000, BRIT J PHARMACOL, V131, P745, DOI 10.1038/sj.bjp.0703627; Ozaki H, 2004, NEUROGASTROENT MOTIL, V16, P39, DOI 10.1046/j.1365-2982.2003.00461.x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Sauvant C, 2002, J AM SOC NEPHROL, V13, P1981, DOI 10.1097/01.ASN.0000024437.62046.AF; Schwarz NT, 2001, GASTROENTEROLOGY, V121, P1354, DOI 10.1053/gast.2001.29605; Shah SK, 2010, NEUROGASTROENT MOTIL, V22, P1132, DOI 10.1111/j.1365-2982.2010.01546.x; Soncin I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02834-8; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Stenson WF, 2007, CURR OPIN GASTROEN, V23, P107, DOI 10.1097/MOG.0b013e3280143cb6; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2014, HANDB EXP PHARMACOL, V223, P729, DOI 10.1007/978-3-319-05161-1_1; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wouters MM, 2016, GASTROENTEROLOGY, V150, P875, DOI 10.1053/j.gastro.2015.12.034; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yin SJ, 2013, J CLIN INVEST, V123, P3941, DOI 10.1172/JCI66413; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077	80	35	40	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					107	+		10.1016/j.immuni.2018.04.021	http://dx.doi.org/10.1016/j.immuni.2018.04.021			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29958798	Bronze, Green Accepted			2022-12-18	WOS:000438949100015
J	Tomov, VT; Palko, O; Lau, CW; Pattekar, A; Sun, YH; Tacheva, R; Bengsch, B; Manne, S; Cosma, GL; Eisenlohr, LC; Nice, TJ; Virgin, HW; Wherry, EJ				Tomov, Vesselin T.; Palko, Olesya; Lau, Chi Wai; Pattekar, Ajinkya; Sun, Yuhang; Tacheva, Ralitza; Bengsch, Bertram; Manne, Sasikanth; Cosma, Gabriela L.; Eisenlohr, Laurence C.; Nice, Timothy J.; Virgin, Herbert W.; Wherry, E. John			Differentiation and Protective Capacity of Virus-Specific CD8(+) T Cells Suggest Murine Norovirus Persistence in an Immune-Privileged Enteric Niche	IMMUNITY			English	Article							MEMORY; INFECTION; RESIDENT; ABSENCE; REPLICATION; ACTIVATION; REVEALS; GENES	Noroviruses can establish chronic infections with active viral shedding in healthy humans but whether persistence is associated with adaptive immune dysfunction is unknown. We used genetically engineered strains of mouse norovirus (MNV) to investigate CD8(+) T cell differentiation during chronic infection. We found that chronic infection drove MNV-specific tissue-resident memory (Trm) CD8(+) T cells to a differentiation state resembling inflationary effector responses against latent cytomegalovirus with only limited evidence of exhaustion. These MNV-specific Trm cells remained highly functional yet appeared ignorant of ongoing viral replication. Pre-existing MNV-specific Trm cells provided partial protection against chronic infection but largely ceased to detect virus within 72 hours of challenge, demonstrating rapid sequestration of viral replication away from T cells. Our studies revealed a strategy of immune evasion by MNV via the induction of a CD8(+) T cell program normally reserved for latent pathogens and persistence in an immune-privileged enteric niche.	[Tomov, Vesselin T.; Palko, Olesya; Lau, Chi Wai; Pattekar, Ajinkya; Sun, Yuhang; Tacheva, Ralitza] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bengsch, Bertram; Manne, Sasikanth; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bengsch, Bertram; Manne, Sasikanth; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cosma, Gabriela L.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Eisenlohr, Laurence C.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Res Inst, Philadelphia, PA 19104 USA; [Eisenlohr, Laurence C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nice, Timothy J.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University; Washington University (WUSTL)	Tomov, VT (corresponding author), Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	tomovv@pennmedicine.upenn.edu; wherry@pennmedicine.upenn.edu	Nice, Timothy/X-9114-2019; Pattekar, Dr. Ajinkya/AHC-7868-2022; Pattekar, Ajinkya/AHC-7838-2022; Wherry, John/ABI-1280-2020; Bengsch, Bertram/ABF-2142-2020	Nice, Timothy/0000-0002-4471-7666; Pattekar, Dr. Ajinkya/0000-0002-1416-1230; Pattekar, Ajinkya/0000-0002-1416-1230; Bengsch, Bertram/0000-0003-2552-740X; Virgin, Herbert/0000-0001-8580-7628	NIH/NIDDK [T32-DK007066, P30DK050306, K08-DK097301]; NIH [U01-AI-095608, U19 AI AI082630, P01 AI AI112521, U19-AI109725]; German Research Foundation Fellowship [BE5496/1-1]; NCI Comprehensive Cancer Center Support Grant [P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095608, P01AI112521, U19AI109725, U19AI082630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, T32DK007066, R03DK110397, K08DK097301] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation Fellowship(German Research Foundation (DFG)); NCI Comprehensive Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Staupe and E. Stelekati for helpful discussions and critically reading the manuscript. We thank K. Pauken, J. Schenkel, R. Herati, J. Johnnidis, and M. and J. Kurachi for technical advice and/or help with flow cytometry and cell sorting. This work was supported by the following grants: NIH/NIDDK T32-DK007066 Training Program in Gastrointestinal Sciences; NIH/NIDDK P30DK050306 Center for Molecular Studies in Digestive and Liver Diseases; NIH U01-AI-095608, U19 AI AI082630, and P01 AI AI112521 to E. J. W.; NIH/NIDDK K08-DK097301 to V.T.T.; German Research Foundation Fellowship BE5496/1-1 to B.B.; and NIH U19-AI109725 to H.W.V. The authors also thank the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory. The ACC Flow Cytometry and Cell Sorting Shared Resource are partially supported by NCI Comprehensive Cancer Center Support Grant (P30 CA016520). E.J.W. is a member of the Parker Institute for Cancer Immunotherapy, which supports the UPenn Cancer Immunotherapy Program. Washington University and H.W.V. receive income based on licenses for MNV technology.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; Carbone FR, 2013, CURR OPIN IMMUNOL, V25, P329, DOI 10.1016/j.coi.2013.05.007; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Gasiorowski RE, 2013, IMMUNOL LETT, V149, P93, DOI 10.1016/j.imlet.2012.10.005; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Quinn M, 2015, J IMMUNOL, V194, P1726, DOI 10.4049/jimmunol.1402757; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Snyder CM, 2011, IMMUNOL RES, V51, P195, DOI 10.1007/s12026-011-8251-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomov VT, 2013, J VIROL, V87, P7015, DOI 10.1128/JVI.03389-12; van de Berg PJEJ, 2012, CLIN VACCINE IMMUNOL, V19, P772, DOI 10.1128/CVI.00011-12; Welten SPM, 2013, J VIROL, V87, P6851, DOI 10.1128/JVI.03305-12; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2000, METH MOL B, V156, P89; Woodham AW, 2016, PAPILLOMAVIRUS RES, V2, P21, DOI 10.1016/j.pvr.2016.01.002; Zhu S, 2016, MUCOSAL IMMUNOL, V9, P1559, DOI 10.1038/mi.2016.15; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	36	35	37	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					723	+		10.1016/j.immuni.2017.09.017	http://dx.doi.org/10.1016/j.immuni.2017.09.017			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29031786	Green Accepted, Bronze			2022-12-18	WOS:000413091600016
J	Bernink, JH; Mjosberg, J; Spits, H				Bernink, Jochem H.; Mjosberg, Jenny; Spits, Hergen			Human ILC1: To Be or Not to Be	IMMUNITY			English	Letter							INNATE LYMPHOID-CELLS; HETEROGENEITY		[Bernink, Jochem H.; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Mjosberg, Jenny] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Ctr Infect Med, S-14186 Stockholm, Sweden; [Mjosberg, Jenny] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden; [Bernink, Jochem H.] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands	University of Amsterdam; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338; Mjosberg, Jenny/0000-0002-1119-0976				Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Roan F, 2016, J IMMUNOL, V196, P2051, DOI 10.4049/jimmunol.1501491; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482	6	35	35	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					756	757		10.1016/j.immuni.2017.05.001	http://dx.doi.org/10.1016/j.immuni.2017.05.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514676	Green Published, hybrid			2022-12-18	WOS:000401316300005
J	Yang, S; Wang, BW; Humphries, F; Hogan, AE; O'Shea, D; Moynagh, PN				Yang, Shuo; Wang, Bingwei; Humphries, Fiachra; Hogan, Andrew E.; O'Shea, Donal; Moynagh, Paul N.			The E3 Ubiquitin Ligase Pellino3 Protects against Obesity-Induced Inflammation and Insulin Resistance	IMMUNITY			English	Article							HIGH-FAT DIET; ADIPOSE-TISSUE; METABOLIC INFLAMMATION; HIF-ALPHA; ACTIVATION; MACROPHAGES; PROTEINS; IRAK1; TOLL-LIKE-RECEPTOR-4; HIF-1-ALPHA	Diet-induced obesity can induce low-level inflammation and insulin resistance. Interleukin-1 beta (IL-1 beta) is one of the key proinflammatory cytokines that contributes to the generation of insulin resistance and diabetes, but the mechanisms that regulate obesity-driven inflammation are ill defined. Here we found reduced expression of the E3 ubiquitin ligase Pellino3 in human abdominal adipose tissue from obese subjects and in adipose tissue of mice fed a high-fat diet and showing signs of insulin resistance. Pellino3-deficient mice demonstrated exacerbated high-fat-diet-induced inflammation, IL-1 beta expression, and insulin resistance. Mechanistically, Pellino3 negatively regulated TNF receptor associated 6 (TRAF6)-mediated ubiquitination and stabilization of hypoxia-inducible factor 1 alpha (HIF1 alpha), resulting in reduced HIF1 alpha-induced expression of IL-1 beta. Our studies identify a regulatory mechanism controlling diet-induced insulin resistance by highlighting a critical role for Pellino3 in regulating IL-1 beta expression with implications for diseases like type 2 diabetes.	[Yang, Shuo; Wang, Bingwei; Humphries, Fiachra; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Dept Biol, Maynooth, Kildare, Ireland; [Hogan, Andrew E.; O'Shea, Donal] Univ Coll Dublin, St Vincents Univ Hosp, Educ & Res Ctr, Dublin 4, Ireland; [Moynagh, Paul N.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast BT9 7AE, Antrim, North Ireland	Maynooth University; University College Dublin; Saint Vincent's University Hospital; Queens University Belfast	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Inst Immunol, Dept Biol, Maynooth, Kildare, Ireland.	paul.moynagh@nuim.ie		Moynagh, Paul/0000-0002-4139-3061; Hogan, Andrew/0000-0001-5875-230X; O'Shea, Donal/0000-0002-1408-5274; Humphries, Fiachra/0000-0003-0216-5776; wang, Bingwei/0000-0002-9306-4323	SFI [12/IA/1736]	SFI(Science Foundation Ireland)	This work was funded by a SFI grant to P.N.M. (12/IA/1736).	Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Boni-Schnetzler M, 2013, BRIT J CLIN PHARMACO, V76, P263, DOI 10.1111/j.1365-2125.2012.04297.x; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hodson L, 2014, ADIPOCYTE, V3, P75, DOI 10.4161/adip.27114; Item F, 2012, OBES REV, V13, P30, DOI 10.1111/j.1467-789X.2012.01035.x; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kihira Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093856; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsuzawa Y., 1995, OBES RES S2, V3, p187S; Moynagh PN, 2014, NAT REV IMMUNOL, V14, P122, DOI 10.1038/nri3599; Moynagh PN, 2011, NAT IMMUNOL, V12, P927, DOI 10.1038/ni.2108; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Shin MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046562; Siednienko J, 2012, NAT IMMUNOL, V13, P1055, DOI 10.1038/ni.2429; Skeldon AM, 2014, IMMUNOL CELL BIOL, V92, P304, DOI 10.1038/icb.2014.5; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Strelow A, 2003, FEBS LETT, V547, P157, DOI 10.1016/S0014-5793(03)00697-5; Sun H, 2013, CANCER RES, V73, P4950, DOI 10.1158/0008-5472.CAN-13-0370; Tack CJ, 2012, IMMUNOL REV, V249, P239, DOI 10.1111/j.1600-065X.2012.01145.x; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3583; Yang S, 2013, NAT IMMUNOL, V14, P927, DOI 10.1038/ni.2669	48	35	36	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					973	987		10.1016/j.immuni.2014.11.013	http://dx.doi.org/10.1016/j.immuni.2014.11.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526310	Green Accepted, Bronze			2022-12-18	WOS:000346654100015
J	Chappert, P; Bouladoux, N; Naik, S; Schwartz, RH				Chappert, Pascal; Bouladoux, Nicolas; Naik, Shruti; Schwartz, Ronald H.			Specific Gut Commensal Flora Locally Alters T Cell Tuning to Endogenous Ligands	IMMUNITY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; ADAPTIVE TOLERANCE; IMMUNE-SYSTEM; INTESTINAL MICROBIOTA; ACTIVATION THRESHOLD; VIRAL-INFECTION; IN-VIVO; RESPONSES; INDUCTION; CD4(+)	Differences in gut commensal flora can dramatically influence autoimmune responses, but the mechanisms behind this are still unclear. We report, in a Th1-cell-driven murine model of autoimmune arthritis, that specific gut commensals, such as segmented filamentous bacteria, have the ability to modulate the activation threshold of self-reactive T cells. In the local microenvironment of gut-associated lymphoid tissues, inflammatory cytokines elicited by the commensal flora dynamically enhanced the antigen responsiveness of T cells that were otherwise tuned down to a systemic self-antigen. Together with subtle differences in early lineage differentiation, this ultimately led to an enhanced recruitment of pathogenic Th1 cells and the development of a more severe form of autoimmune arthritis. These findings define a key role for the gut commensal flora in sustaining ongoing autoimmune responses through the local fine tuning of T-cell-receptor-proximal activation events in autoreactive T cells.	[Chappert, Pascal; Schwartz, Ronald H.] NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Naik, Shruti] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chappert, P (corresponding author), Univ Paris 05, Sorbonne Paris Cite, INSERM U1013, F-75743 Paris 15, France.	pascal.chappert@inserm.fr		chappert, pascal/0000-0002-9799-4608; Bouladoux, Nicolas/0000-0003-1593-671X	Intramural Research Program of the NIAID at the National Institutes of Health, Bethesda, MD, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000485] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID at the National Institutes of Health, Bethesda, MD, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N.J. Singh for helpful discussions and comments on the design of the experiments; N.J. Singh, Y. Belkaid, J. Davoust, and D.A. Gross for helpful comments on the manuscript; N. Shulzhenko and A. Morgun for help on the design of the antibiotic-treatment experiments and the analysis of SFB colonization; E.J. Chuang for technical assistance; and D. Trageser-celser, C. Acevedo, and the National Institutes of Allergy and Infectious Diseases (NIAID) germ-free facility for maintaining the mice used in these experiments and technical assistance. This work was supported by the Intramural Research Program of the NIAID at the National Institutes of Health, Bethesda, MD, USA.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Allen A, 2004, J IMMUNOL, V172, P4797, DOI 10.4049/jimmunol.172.8.4797; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; Choi S, 2011, J IMMUNOL, V187, P805, DOI 10.4049/jimmunol.1003314; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nishikomori R, 2002, J IMMUNOL, V169, P4388, DOI 10.4049/jimmunol.169.8.4388; O'Sullivan A, 2004, J BIOL CHEM, V279, P7339, DOI 10.1074/jbc.M309979200; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Rehermann B, 1996, J VIROL, V70, P7092, DOI 10.1128/JVI.70.10.7092-7102.1996; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Singh NJ, 2006, PLOS BIOL, V4, P1957, DOI 10.1371/journal.pbio.0040340; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; YANAGIDA T, 1994, J IMMUNOL, V152, P4919; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	47	35	37	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1198	1210		10.1016/j.immuni.2013.06.005	http://dx.doi.org/10.1016/j.immuni.2013.06.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809163	Bronze, Green Accepted			2022-12-18	WOS:000330947500015
J	Marek, LR; Kagan, JC				Marek, Lorri R.; Kagan, Jonathan C.			Phosphoinositide Binding by the Toll Adaptor dMyD88 Controls Antibacterial Responses in Drosophila	IMMUNITY			English	Article							NF-KAPPA-B; IMMUNE-RESPONSE; EXPRESSION; PATHWAY; COMPLEX; EMBRYO; MYD88; TOLL-LIKE-RECEPTOR-4; SPECIFICITY; ENDOCYTOSIS	The cell biological principles that govern innate immune responses in Drosophila are unknown. Here, we report that Toll signaling in flies was dictated by the subcellular localization of the adaptor protein dMyD88. dMyD88 was located at the plasma membrane by a process dependent on a C-terminal phosphoinositide-binding domain. In vivo analysis revealed that lipid binding by dMyD88 was necessary for its antimicrobial and developmental functions as well as for the recruitment of the downstream cytosolic adaptor Tube to the cell surface. These data are reminiscent of the interactions between the mammalian Toll adaptors MyD88 and TIRAP with one major exception. In the mammalian system, MyD88 is the cytosolic adaptor that depends on the phosphoinositide-binding protein TIRAP for its recruitment to the cell surface. We therefore propose that dMyD88 is the functional homolog of TIRAP and that both proteins function as sorting adaptors to recruit downstream signaling adaptors to activated receptors.	[Marek, Lorri R.; Kagan, Jonathan C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Gasteroenterol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Div Gasteroenterol, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			Harvard Digestive Disease Center [P30 DK34854];  [5T32HD007466];  [R00A1072955]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Harvard Digestive Disease Center; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank R. Medzhitov, J.L. Imler, C. Kocks, S. Wassermann, M. Muskavitch, and P. Watnick for providing reagents used in this study. We would particularly like to thank P. Watnick for the generous use of the fly facility and fly equipment in her lab. We thank Z. Wang for helpful conversations and assistance with infection assays, as well as the members of the Kagan lab for insightful discussions. This work is supported by grants 5T32HD007466 (L.R.M), R00A1072955 (J.C.K.) and the Harvard Digestive Disease Center P30 DK34854 (J.C.K.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; BRAND AH, 1993, DEVELOPMENT, V118, P401; Charatsi I, 2003, MECH DEVELOP, V120, P219, DOI 10.1016/S0925-4773(02)00410-0; Chen LY, 2006, CURR BIOL, V16, P1183, DOI 10.1016/j.cub.2006.05.050; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Huang HR, 2010, P NATL ACAD SCI USA, V107, P8322, DOI 10.1073/pnas.1004031107; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kambris Z, 2003, EMBO REP, V4, P64, DOI 10.1038/sj.embor.embor714; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lund VK, 2010, P NATL ACAD SCI USA, V107, P18028, DOI 10.1073/pnas.1009157107; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Maxton-Kuchenmeister J, 1999, MECH DEVELOP, V83, P107, DOI 10.1016/S0925-4773(99)00041-6; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	37	35	36	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					612	622		10.1016/j.immuni.2012.01.019	http://dx.doi.org/10.1016/j.immuni.2012.01.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22464168	Green Accepted, Bronze			2022-12-18	WOS:000303223900013
J	Cannon, JP; Haire, RN; Magis, AT; Eason, DD; Winfrey, KN; Prada, JAH; Bailey, KM; Jakoncic, J; Litman, GW; Ostrov, DA				Cannon, John P.; Haire, Robert N.; Magis, Andrew T.; Eason, Donna D.; Winfrey, Kelley N.; Prada, Jose A. Hernandez; Bailey, Kate M.; Jakoncic, Jean; Litman, Gary W.; Ostrov, David A.			A bony fish immunological receptor of the NITR multigene family mediates allogeneic recognition	IMMUNITY			English	Article							IMMUNE-TYPE RECEPTOR; NK-LIKE CELLS; CHANNEL CATFISH; GENE-CLUSTER; MOLECULES; COMPLEX; IDENTIFICATION; ANTIGEN; VECTOR; HEALTH	Novel immune-type receptors (NITRs) comprise an exceptionally large, diversified family of activating and inhibitory receptors that has been identified in bony fish. Here, we characterized the structure of an activating NITR that is expressed by a cytotoxic natural killer (NK)-like cell line and that specifically binds an allogeneic B cell target. A single amino acid residue within the NITR immunoglobulin variable M-type domain accounts for specificity of the interaction. Structures solved by X-ray crystallography revealed that the V-type domains of NITRs form homodimers resembling rearranging antigenbinding receptor heterodimers. CDR1 elements of both subunits of NITR dimers form ligand-binding surfaces that determine specificity for the nonself target. In the evolution of immune function, it appears that a specific NK type of innate recognition may be mediated by a complex germline multigene family of V structures resembling those that are somatically diversified in adaptive immunological responses.	[Cannon, John P.; Haire, Robert N.; Eason, Donna D.; Litman, Gary W.] Univ S Florida, Coll Med, Dept Pediat, St Petersburg, FL 33701 USA; [Cannon, John P.; Eason, Donna D.; Litman, Gary W.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Magis, Andrew T.; Prada, Jose A. Hernandez; Bailey, Kate M.; Ostrov, David A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Winfrey, Kelley N.; Litman, Gary W.] Univ S Florida, All Childrens Hosp, Dept Mol Genet, St Petersburg, FL 33701 USA; [Jakoncic, Jean] Brookhaven Natl Lab Natl Synchrotron Light Source, Upton, NY 11973 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Litman, GW (corresponding author), Univ S Florida, Coll Med, Dept Pediat, St Petersburg, FL 33701 USA.	litmang@allkids.org		Jakoncic, Jean/0000-0002-6315-0933; Magis, Andrew/0000-0003-0576-677X	National Institutes of Health [R01 AI23338, R01 AI57559, R01 DE013883, R21 HL080222]; Cure Autism Now Foundation [2908051-12]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL080222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057559, R01AI023338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Autism Now Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Lanier for helpful discussion regarding the GFP assay, providing the pCP03 plasmid and suggesting the acid dissociation analyses. We thank T. Saito for provision of the 43-1 T cell hybridoma line. We thank N. Miller for providing catfish cell lines and culture media. We thank B. Pryor for editorial assistance and M. O'Driscoll for technical assistance. Flow cytometry was performed by M. Morrow at the Immunodiagnostics Laboratory at the University of South Florida/All Children's Hospital Children's Research Institute. This work was supported by the National Institutes of Health (R01 AI23338 and R01 AI57559 to G.W.L.; R01 DE013883 and R21 HL080222 to D.A.O.); D.A.O. is additionally supported by the Cure Autism Now Foundation 2908051-12.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cannon JP, 2006, IMMUNOGENETICS, V58, P362, DOI 10.1007/s00251-006-0112-7; Cantoni C, 2003, STRUCTURE, V11, P725, DOI 10.1016/S0969-2126(03)00095-9; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evenhuis J, 2007, IMMUNOGENETICS, V59, P661, DOI 10.1007/s00251-007-0230-x; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Hawke NA, 2001, P NATL ACAD SCI USA, V98, P13832, DOI 10.1073/pnas.231418598; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Khakoo SI, 2002, J EXP MED, V196, P911, DOI 10.1084/jem.20020304; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; McPherson A., 1999, CRYSTALLIZATION BIOL; MILLER NW, 1994, J IMMUNOL, V152, P2180; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panagos PG, 2006, IMMUNOGENETICS, V58, P31, DOI 10.1007/s00251-005-0064-3; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; PENCE D, 1999, J EXP MED, V190, P1505; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Polakova K, 2003, HUM IMMUNOL, V64, P256, DOI 10.1016/S0198-8859(02)00777-2; Prada JAH, 2006, NAT IMMUNOL, V7, P875, DOI 10.1038/ni1359; SHELDRICK GM, 1994, SIEMENS ANAL XRAY IN; Shen LL, 2004, DEV COMP IMMUNOL, V28, P139, DOI 10.1016/S0145-305X(03)00119-8; Shen LL, 2003, DEV COMP IMMUNOL, V27, P699, DOI 10.1016/S0145-305X(03)00042-9; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Stafford JL, 2006, IMMUNOGENETICS, V58, P758, DOI 10.1007/s00251-006-0134-1; Stafford JL, 2006, J IMMUNOL, V177, P2505, DOI 10.4049/jimmunol.177.4.2505; Strong SJ, 1999, P NATL ACAD SCI USA, V96, P15080, DOI 10.1073/pnas.96.26.15080; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Wang LM, 2007, NAT STRUCT MOL BIOL, V14, P169, DOI 10.1038/nsmb1193; Wei S, 2007, IMMUNOGENETICS, V59, P813, DOI 10.1007/s00251-007-0250-6; Yoder JA, 2004, P NATL ACAD SCI USA, V101, P15706, DOI 10.1073/pnas.0405242101; Yoder JA, 2001, P NATL ACAD SCI USA, V98, P6771, DOI 10.1073/pnas.121101598; Yoder JA, 2008, IMMUNOGENETICS, V60, P257, DOI 10.1007/s00251-008-0285-3; Zelensky AN, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-51; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	49	35	38	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					228	237		10.1016/j.immuni.2008.05.018	http://dx.doi.org/10.1016/j.immuni.2008.05.018			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18674935	Green Accepted, Bronze			2022-12-18	WOS:000258610800011
J	Zhu, MH; Koonpaew, S; Liu, Y; Shen, SD; Denning, T; Dzhagalov, I; Rhee, I; Zhang, WG				Zhu, Minghua; Koonpaew, Surapong; Liu, Yan; Shen, Shudan; Denning, Timothy; Dzhagalov, Ivan; Rhee, Inmoo; Zhang, Weiguo			Negative regulation of T cell activation and autoimmunity by the transmembrane adaptor protein LAB	IMMUNITY			English	Article							PHOSPHOLIPASE C-GAMMA-1; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; C-CBL; SLP-76; MUTATION; LINKER; PLC-GAMMA-1; IMMUNITY; BINDING	LAB (linker for activation of B cells), also known as NTAL (non-T cell activation linker), is a LAT (linker for activation of T cells)-like adaptor protein that is expressed in B, NK, and mast cells. Its role in lymphocytes has not been clearly demonstrated. Here, we showed that aged LAB-deficient (Lat2(-/-)) mice developed an autoimmune syndrome. Lat2(-/-) T cells were hyperactivated and produced more cytokines than Lat2(+/+) T cells. Even though LAB was absent in naive T cells, LAB could be detected in activated Lat2(+/+) T cells. LAT-mediated signaling events were enhanced in Lat2(-/-) T cells; however, they were suppressed in T cells that overexpressed LAB. Mice with the Lat2 gene conditionally deleted from T cells also developed the autoimmune syndrome like Lat2(-/-) mice. Together, these data demonstrated an important role of LAB in limiting autoimmune response and exposed a mechanism regulating T cell activation.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA	Duke University; La Jolla Institute for Immunology	Zhang, WG (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	zhang033@mc.duke.edu	Koonpaew, Surapong/C-8295-2011; Zhu, Minghua/ABH-2671-2020; Denning, Timothy/F-2271-2011	Dzhagalov, Ivan/0000-0001-9209-4582; Denning, Timothy/0000-0002-1072-7444	NIAID NIH HHS [AI056156, AI048674, R01 AI056156, R01 AI048674] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048674, R56AI056156, R01AI056156] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; HEISSMEYER V, 2004, SCI STKE, pPE29; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Janssen E, 2004, J IMMUNOL, V172, P6810, DOI 10.4049/jimmunol.172.11.6810; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Marie-Cardine A, 1999, J EXP MED, V189, P1181, DOI 10.1084/jem.189.8.1181; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Veillette A, 2004, J EXP MED, V199, P1175, DOI 10.1084/jem.20040588; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wang Y, 2005, MOL CELL BIOL, V25, P4455, DOI 10.1128/MCB.25.11.4455-4465.2005; Yablonski D, 2001, ADV IMMUNOL, V79, P93, DOI 10.1016/S0065-2776(01)79003-7; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223; Zhu MH, 2002, J BIOL CHEM, V277, P46151, DOI 10.1074/jbc.M208946200	34	35	37	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2006	25	5					757	768		10.1016/j.immuni.2006.08.025	http://dx.doi.org/10.1016/j.immuni.2006.08.025			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17081783	Bronze			2022-12-18	WOS:000242063100009
J	TAKAESU, NT; LOWER, JA; ROBERTSON, EJ; BIKOFF, EK				TAKAESU, NT; LOWER, JA; ROBERTSON, EJ; BIKOFF, EK			MAJOR HISTOCOMPATIBILITY CLASS-II PEPTIDE OCCUPANCY, ANTIGEN PRESENTATION, AND CD4(+) T-CELL FUNCTION IN MICE LACKING THE P41 ISOFORM OF INVARIANT CHAIN	IMMUNITY			English	Article							ALPHA-BETA-HETERODIMERS; HLA-DR MOLECULES; SURFACE EXPRESSION; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; COMPLEX-MOLECULES; IMMUNE INTERFERON; MHC MOLECULES; IA ANTIGENS; DIFFERENTIAL EXPRESSION	We used a ''hit and run'' gene targeting strategy to generate mice expressing only the p31 isoform of the conserved invariant (li) chain associated with major histocompatibility complex (MHC) class II molecules. Spleen cells from these mice appear indistinguishable from wild type with respect to class II subunit assembly, transport, peptide acquisition, surface expression, and the ability to present intact protein antigens. Moreover, these mutant mice have normal numbers of thymic and peripheral CD4(+) T cells, and intact CD4(+) T-dependent proliferative responses towards a soluble antigen. In short, MHC class II expression and function are surprisingly unaffected in mice lacking p41 invariant chain, implying that the p31 and p41 isoforms may be functionally redundant in the intact animal.			TAKAESU, NT (corresponding author), HARVARD UNIV,BIOL LABS,DEPT MOLEC & CELLULAR BIOL,CAMBRIDGE,MA 02138, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019047, R01AI019047] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-19047] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; ARUNACHALAM B, 1993, INT IMMUNOL, V6, P439; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAAKE O, 1990, CELL, V63, P707; BERTOLINO P, 1995, J IMMUNOL, V154, P5620; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BIKOFF E, 1986, J IMMUNOL, V137, P28; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BIKOFF EK, 1991, EUR J IMMUNOL, V21, P1997, DOI 10.1002/eji.1830210905; BIKOFF EK, 1992, J IMMUNOL, V149, P1; BIKOFF EK, 1995, IMMUNITY, V2, P2301; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; BOPNNEROT C, 1994, EMBO J, V13, P934; BUSCH R, 1995, EUR J IMMUNOL, V25, P48, DOI 10.1002/eji.1830250110; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DORNMAIR K, 1990, P NATL ACAD SCI USA, V87, P4134, DOI 10.1073/pnas.87.11.4134; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; FIERZ W, 1985, J IMMUNOL, V134, P3785; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, p9N703; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HAMMERLING GJ, 1979, IMMUNOGENETICS, V8, P433, DOI 10.1007/BF01561454; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; HEDLEY ML, 1994, P NATL ACAD SCI USA, V91, P10479, DOI 10.1073/pnas.91.22.10479; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; JANEWAY CA, 1983, NATURE, V306, P80, DOI 10.1038/306080a0; JANEWAY CA, 1984, J IMMUNOL, V132, P662; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; KAMPGEN E, 1991, P NATL ACAD SCI USA, V88, P3014, DOI 10.1073/pnas.88.8.3014; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; KOCH N, 1982, NATURE, V299, P644, DOI 10.1038/299644a0; KOCH N, 1984, J IMMUNOL, V132, P12; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAMB CA, 1992, J IMMUNOL, V148, P3478; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LOSS GE, 1993, J EXP MED, V178, P73, DOI 10.1084/jem.178.1.73; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; MEHRINGER JH, 1991, J IMMUNOL, V146, P920; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOMBURG F, 1988, CLIN EXP IMMUNOL, V72, P367; MOMBURG F, 1993, J EXP MED, V178, P1453, DOI 10.1084/jem.178.4.1453; MOMBURG F, 1986, J IMMUNOL, V136, P940; NADIMI F, 1991, EUR J IMMUNOL, V21, P1255, DOI 10.1002/eji.1830210524; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NIJENHUIS M, 1994, EUR J IMMUNOL, V24, P247, DOI 10.1002/eji.1830240139; NUCHTERN JG, 1990, NATURE, V343, P74, DOI 10.1038/343074a0; OSULLIVAN DM, 1987, J EXP MED, V166, P444, DOI 10.1084/jem.166.2.444; OZATO K, 1981, J IMMUNOL, V126, P317; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; PINET V, 1994, J IMMUNOL, V152, P4852; POBER JS, 1983, NATURE, V305, P726, DOI 10.1038/305726a0; POLLA BS, 1986, P NATL ACAD SCI USA, V83, P4878, DOI 10.1073/pnas.83.13.4878; PUJOLBORRELL R, 1987, NATURE, V326, P304, DOI 10.1038/326304a0; PUJOLBORRELL R, 1983, NATURE, V304, P71, DOI 10.1038/304071a0; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROCHE PA, 1992, EMBO J, V11, P2841, DOI 10.1002/j.1460-2075.1992.tb05351.x; ROEHM NW, 1982, J EXP MED, V156, P191, DOI 10.1084/jem.156.1.191; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SCHAIFF WT, 1992, J EXP MED, V176, P657, DOI 10.1084/jem.176.3.657; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; SUNG E, 1981, MOL IMMUNOL, V18, P899, DOI 10.1016/0161-5890(81)90013-4; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; VIDAL K, 1993, J IMMUNOL, V151, P4642; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; ZHU L, 1990, MOL CELL BIOL, V10, P3906, DOI 10.1128/MCB.10.8.3906	90	35	35	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					385	396		10.1016/1074-7613(95)90122-1	http://dx.doi.org/10.1016/1074-7613(95)90122-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7553002	Bronze			2022-12-18	WOS:A1995RX64500012
J	Meylan, M; Petitprez, F; Becht, E; Bougouin, A; Pupier, G; Calvez, A; Giglioli, I; Verkarre, V; Lacroix, G; Verneau, J; Sun, CM; Laurent-Puig, P; Vano, YA; Elaidi, R; Mejean, A; Sanchez-Salas, R; Barret, E; Cathelineau, X; Oudard, S; Reynaud, CA; de Reynies, A; Sautes-Fridman, C; Fridman, WH				Meylan, Maxime; Petitprez, Florent; Becht, Etienne; Bougouein, Antoine; Pupier, Guilhem; Calvez, Anne; Giglioli, Ilenia; Verkarre, Virginie; Lacroix, Guillaume; Verneau, Johanna; Sun, Chen-Ming; Laurent-Puig, Pierre; Vano, Yann-Alexandre; Elaidi, Reza; Mejean, Arnaud; Sanchez-Salas, Rafael; Barret, Eric; Cathelineau, Xavier; Oudard, Stephane; Reynaud, Claude-Agnes; de Reynies, Aurelien; Sautes-Fridman, Catherine; Fridman, Wolf Herman			Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer	IMMUNITY			English	Article							B-CELLS; PLASMA-CELLS; RNA-SEQ; IMMUNE; IMMUNOTHERAPY; CARCINOMA; BREAST; LYMPHOCYTES; PROGNOSIS; RESPONSES	The presence of intratumoral tertiary lymphoid structures (TLS) is associated with positive clinical outcomes and responses to immunotherapy in cancer. Here, we used spatial transcriptomics to examine the nature of B cell responses within TLS in renal cell carcinoma (RCC). B cells were enriched in TLS, and therein, we could identify all B cell maturation stages toward plasma cell (PC) formation. B cell repertoire analysis revealed clonal diversification, selection, expansion in TLS, and the presence of fully mature clonotypes at distance. In TLS+ tumors, IgG-and IgA-producing PCs disseminated into the tumor beds along fibroblastic tracks. TLS+ tumors exhibited high frequencies of IgG-producing PCs and IgG-stained and apoptotic malignant cells, suggestive of anti-tumor effector activity. Therapeutic responses and progression-free survival correlated with IgG-stained tumor cells in RCC patients treated with immune checkpoint inhibitors. Thus, intratumoral TLS sustains B cell maturation and antibody production that is associated with response to immunotherapy, potentially via direct anti-tumor effects.	[Meylan, Maxime; Bougouein, Antoine; Pupier, Guilhem; Calvez, Anne; Giglioli, Ilenia; Lacroix, Guillaume; Verneau, Johanna; Sun, Chen-Ming; Vano, Yann-Alexandre; Sautes-Fridman, Catherine; Fridman, Wolf Herman] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc,INSERM, F-75006 Paris, France; [Petitprez, Florent; Becht, Etienne; Vano, Yann-Alexandre; de Reynies, Aurelien] Ligue Natl Canc, Programme Cartes Identite Tumeurs CIT, F-75013 Paris, France; [Petitprez, Florent; Vano, Yann-Alexandre; de Reynies, Aurelien] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Verkarre, Virginie] Hop Europeen Georges Pompidou, AP HP, Paris Ctr, Dept Pathol, F-75015 Paris, France; [Laurent-Puig, Pierre; de Reynies, Aurelien] Univ Paris, Sorbonne Univ, EPIGENETEC, INSERM,Ctr Rech Cordeliers, F-75006 Paris, France; [Vano, Yann-Alexandre; Oudard, Stephane] Hop Europeen Georges Pompidou, AP HP, Paris Ctr, Dept Oncol Med, F-75015 Paris, France; [Elaidi, Reza] Assoc Rech Therapeut Innovantes Cancerol, F-75015 Paris, France; [Mejean, Arnaud] Univ Paris, Hop Europeen Georges Pompidou, Dept Urol, F-75015 Paris, France; [Sanchez-Salas, Rafael; Barret, Eric; Cathelineau, Xavier] Univ Paris, Inst Mutualiste Montsouris, Dept Urol, F-75014 Paris, France; [Reynaud, Claude-Agnes] Univ Paris, Inst Necker Enfants Malad INEM, INSERM U1151, CNRS UMRS8253, F-75015 Paris, France; [Verkarre, Virginie; Vano, Yann-Alexandre; Oudard, Stephane; de Reynies, Aurelien] Univ Paris, F-75006 Paris, France; [Verkarre, Virginie; Vano, Yann-Alexandre] INSERM, Equipe Labellisee Ligue Canc, PARCC, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fridman, WH (corresponding author), Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc,INSERM, F-75006 Paris, France.	herve.fridman@crc.jussieu.fr	laurent-puig, pierre/B-2226-2013; Sun, Cheng-Ming/G-6505-2018	laurent-puig, pierre/0000-0001-8475-5459; Becht, Etienne/0000-0003-1859-9202; Meylan, Maxime/0000-0002-6175-1954; Sun, Cheng-Ming/0000-0002-2392-7701; OUDARD, Stephane/0000-0003-0893-285X; Pupier, Guilhem/0000-0001-6828-0465	INSERM; Sorbonne Universite; Universite de Paris; CARPEM (Cancer Research for Personalized Medicine) program of the Sites Integres de Recherche sur le Cancer (SIRIC); Labex Immunooncology; INCa (HTE program); Canceropole Ile-de-France; Association pour la recherche en the rapeutiques innovantes en cancerologie (ARTIC, BIONIKK) [R17169DD]; Foncer Contre le Cancer; Ligue Contre le Cancer (Equipe labellisee)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Sorbonne Universite; Universite de Paris; CARPEM (Cancer Research for Personalized Medicine) program of the Sites Integres de Recherche sur le Cancer (SIRIC); Labex Immunooncology; INCa (HTE program); Canceropole Ile-de-France(Region Ile-de-France); Association pour la recherche en the rapeutiques innovantes en cancerologie (ARTIC, BIONIKK); Foncer Contre le Cancer; Ligue Contre le Cancer (Equipe labellisee)	We thank Simon Lefranc and Francois Xavier Huchet from the Centre de Ressources Biologiques (IMM, Institut Mutualiste Montsouris) for providing tumor samples and sections, Natalia Juiz and Mickael Ploquin (10X Genomics), and Christophe Klein from the Histology, cell imaging and flow cytometry platform (CHIC) from Centre de Recherche des Cordeliers for their help on this study. This work was supported by INSERM, Sorbonne Universite ', Universite de Paris, Ligue Contre le Cancer (Equipe labellisee), CARPEM (Cancer Research for Personalized Medicine) program of the Sites Integres de Recherche sur le Cancer (SIRIC), Labex Immunooncology, INCa (HTE program), Canceropole Ile-de-France, Association pour la recherche en the rapeutiques innovantes en cance ' rologie (ARTIC, BIONIKK contract [R17169DD], MM fellowship), and Foncer Contre le Cancer (fond de dotation).	Andreani V, 2018, P NATL ACAD SCI USA, V115, pE9630, DOI 10.1073/pnas.1809739115; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5; Becht E, 2016, CLIN CANCER RES, V22, P4057, DOI 10.1158/1078-0432.CCR-15-2879; Biswas S, 2021, NATURE, V591, P464, DOI 10.1038/s41586-020-03144-0; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bournazos S, 2020, NAT REV IMMUNOL, V20, P633, DOI 10.1038/s41577-020-00410-0; Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Cable DM, 2022, NAT BIOTECHNOL, V40, P517, DOI 10.1038/s41587-021-00830-w; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Calderaro J, 2019, J HEPATOL, V70, P58, DOI 10.1016/j.jhep.2018.09.003; Chang HD, 2018, IMMUNOL REV, V283, P86, DOI 10.1111/imr.12656; Cipponi A, 2012, CANCER RES, V72, P3997, DOI 10.1158/0008-5472.CAN-12-1377; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Coronella JA, 2002, J IMMUNOL, V169, P1829, DOI 10.4049/jimmunol.169.4.1829; Courcier J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197146; de Chaisemartin L, 2011, CANCER RES, V71, P6391, DOI 10.1158/0008-5472.CAN-11-0952; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; Fridman WH, 2021, J EXP MED, V218, DOI 10.1084/jem.20200851; Gao JJ, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1086-y; Garaud S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129641; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Iglesia MD, 2014, CLIN CANCER RES, V20, P3818, DOI 10.1158/1078-0432.CCR-13-3368; ITO T, 1986, BREAST CANCER RES TR, V7, P97, DOI 10.1007/BF01806794; Gunderson AJ, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1900635; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Katoh H, 2017, CELL REP, V20, P1073, DOI 10.1016/j.celrep.2017.07.016; King HW, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe6291; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lindquist RL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00788; Lutz ER, 2014, CANCER IMMUNOL RES, V2, P616, DOI 10.1158/2326-6066.CIR-14-0027; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Maldonado L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007323; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Meylan M, 2020, CLIN CANCER RES, V26, P4381, DOI 10.1158/1078-0432.CCR-19-2929; Montfort A, 2017, CLIN CANCER RES, V23, P250, DOI 10.1158/1078-0432.CCR-16-0081; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Nzula S, 2003, CANCER RES, V63, P3275; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Posch F, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1378844; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Roumenina LT, 2019, NAT REV CANCER, V19, P698, DOI 10.1038/s41568-019-0210-0; Russick J, 2020, SEMIN IMMUNOL, V48, DOI 10.1016/j.smim.2020.101407; Saul L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29736; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Silina K, 2018, CANCER RES, V78, P1308, DOI 10.1158/0008-5472.CAN-17-1987; Silva-Cayetano A, 2020, CURR OPIN IMMUNOL, V64, P26, DOI 10.1016/j.coi.2020.03.007; Tokunaga R, 2020, INT J CANCER, V147, P532, DOI 10.1002/ijc.32982; Vanhersecke L, 2021, NAT CANCER, V2, P794, DOI 10.1038/s43018-021-00232-6; Vano Y, 2020, ANN ONCOL, V31, pS1157, DOI 10.1016/j.annonc.2020.08.2254; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Weiner AB, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21245-w; Wieland A, 2021, NATURE, V597, P274, DOI 10.1038/s41586-020-2931-3	67	34	34	27	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					527	+		10.1016/j.immuni.2022.02.001	http://dx.doi.org/10.1016/j.immuni.2022.02.001			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ5WU	35231421				2022-12-18	WOS:000767175700003
J	Lercher, A; Baazim, H; Bergthaler, A				Lercher, Alexander; Baazim, Hatoon; Bergthaler, Andreas			Systemic Immunometabolism: Challenges and Opportunities	IMMUNITY			English	Review							PYRUVATE-KINASE M2; CELL EFFECTOR FUNCTION; T-CELLS; ADIPOSE-TISSUE; CANCER CACHEXIA; IMMUNE-SYSTEM; SUCCINATE-DEHYDROGENASE; GENE-EXPRESSION; LARGE-INTESTINE; KETOGENIC DIET	Over the past 10 years, the field of immunometabolism made great strides to unveil the crucial role of intracellular metabolism in regulating immune cell function. Emerging insights into how systemic inflammation and metabolism influence each other provide a critical additional dimension on the organismal level. Here, we discuss the concept of systemic immunometabolism and review the current understanding of the communication circuits that underlie the reciprocal impact of systemic inflammation and metabolism across organs in inflammatory and infectious diseases, as well as how these mechanisms apply to homeostasis. We present current challenges of systemic immunometabolic research, and in this context, highlight opportunities and put forward ideas to effectively explore organismal physiological complexity in both health and disease.	[Lercher, Alexander; Baazim, Hatoon; Bergthaler, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14 AKH BT25-3, A-1090 Vienna, Austria; [Baazim, Hatoon] Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Dept Mol Metab, Hotamisligil Lab, Boston, MA USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Bergthaler, A (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14 AKH BT25-3, A-1090 Vienna, Austria.	abergthaler@cemm.oeaw.ac.at	Bergthaler, Andreas/ABG-5047-2020	Bergthaler, Andreas/0000-0003-0597-1976; /0000-0003-4243-4950; Lercher, Alexander/0000-0003-3478-5304	DOC fellowship of the Austrian Academy of Sciences; European Research Council (ERC) under the European Union [677006]	DOC fellowship of the Austrian Academy of Sciences; European Research Council (ERC) under the European Union(European Research Council (ERC))	We thank Jakob-Wendelin Genger and Henrique Colaco for valuable feedback. A.L. was supported by a DOC fellowship of the Austrian Academy of Sciences. A.B. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement 677006; ``CMIL'' awarded to A.B.). The authors apologize for not being able to cite all related studies due to space constraints.	Abou-Alfa GK, 2018, ANN ONCOL, V29, P1402, DOI 10.1093/annonc/mdy101; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Alexandrov T, 2020, ANNU REV BIOMED DA S, V3, P61, DOI 10.1146/annurev-biodatasci-011420-031537; Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; [Anonymous], 2019, BIORXIV, DOI DOI 10.1101/613901; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Ayres JS, 2020, NAT METAB, V2, P572, DOI 10.1038/s42255-020-0237-2; Ayres JS, 2020, CELL, V181, P250, DOI 10.1016/j.cell.2020.03.036; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Baazim H, 2019, NAT IMMUNOL, V20, P701, DOI 10.1038/s41590-019-0397-y; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Baracos V.E., 2018, CANC ASS CACHEXIA; Becher B, 2018, IMMUNITY, V48, P835, DOI 10.1016/j.immuni.2018.05.002; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Ben-Moshe S, 2019, NAT REV GASTRO HEPAT, V16, P395, DOI 10.1038/s41575-019-0134-x; Benechet AP, 2019, NATURE, V574, P200, DOI 10.1038/s41586-019-1620-6; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Borner T, 2020, CELL METAB, V31, P351, DOI 10.1016/j.cmet.2019.12.004; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Brand MW, 2015, ILAR J, V56, P169, DOI 10.1093/ilar/ilv012; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brunner JS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14285-1; Buck M.D., 2017, METABOLIC INSTRUCTIO; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chapman N. M., 2019, NAT REV IMMUNOL, V20, P55, DOI DOI 10.1038/S41577-019-0203-Y; Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Choi SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06686-0; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chu C, 2020, IMMUNITY, V52, P464, DOI 10.1016/j.immuni.2020.02.017; Colosimo DA, 2019, CELL HOST MICROBE, V26, P273, DOI 10.1016/j.chom.2019.07.002; Constantinides MG, 2019, SCIENCE, V366, P445, DOI 10.1126/science.aax6624; Crispe IN, 2016, J IMMUNOL, V196, P17, DOI 10.4049/jimmunol.1501668; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; De Santo C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0612-6; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Do MH, 2020, J EXP MED, V217, DOI 10.1084/jem.20190848; Doherty M, 2004, TRENDS IMMUNOL, V25, P623, DOI 10.1016/j.it.2004.10.008; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Dyar KA, 2018, CELL, V174, P1571, DOI 10.1016/j.cell.2018.08.042; Dybing JK, 2000, J VIROL, V74, P1443, DOI 10.1128/JVI.74.3.1443-1450.2000; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Ensor CM, 2002, CANCER RES, V62, P5443; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; FERRARO R, 1992, J CLIN INVEST, V90, P780, DOI 10.1172/JCI115951; Ferus M, 2017, P NATL ACAD SCI USA, V114, P4306, DOI 10.1073/pnas.1700010114; Feun LG, 2012, BRIT J CANCER, V106, P1481, DOI 10.1038/bjc.2012.106; Fine EJ, 2012, NUTRITION, V28, P1028, DOI 10.1016/j.nut.2012.05.001; Fischer E., 1891, BER DTSCH CHEM GES, V24, P1836; Fritsch SD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00630; Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Ghazarian M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7616; Goldberg EL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav2026; Gross CC, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000183; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Han XP, 2020, NATURE, V581, P303, DOI 10.1038/s41586-020-2157-4; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hartmann FJ, 2020, NAT REV RHEUMATOL, V16, P87, DOI 10.1038/s41584-019-0338-z; HOFFMAN RM, 1976, P NATL ACAD SCI USA, V73, P1523, DOI 10.1073/pnas.73.5.1523; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hotamisligil G.S., 2017, INFLAMMATION METAFLA; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Ikeda K, 2017, CELL REP, V21, P1824, DOI 10.1016/j.celrep.2017.10.082; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Vaquero JJ, 2015, ANNU REV BIOMED ENG, V17, P385, DOI 10.1146/annurev-bioeng-071114-040723; JUNGERMANN K, 1978, TRENDS BIOCHEM SCI, V3, P198, DOI 10.1016/S0968-0004(78)91764-4; Kanarek N, 2020, NATURE, V579, P507, DOI 10.1038/s41586-020-2124-0; Karreman MA, 2016, TRENDS CELL BIOL, V26, P848, DOI 10.1016/j.tcb.2016.07.003; Kennedy EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01534; Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012; Komiya T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00423; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; Krebs H.A., 1932, UNTERSUCHUNGEN UEBER, V11, P757; Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415; Kurachi M, 2019, IMMUNITY, V51, P591, DOI 10.1016/j.immuni.2019.09.010; Lammertsma AA, 2017, J NUCL MED, V58, P1019, DOI 10.2967/jnumed.116.188029; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Lazzer S, 2010, OBESITY, V18, P71, DOI 10.1038/oby.2009.162; Legoux F, 2019, SCIENCE, V366, P494, DOI 10.1126/science.aaw2719; Lercher A, 2019, IMMUNITY, V51, P1074, DOI 10.1016/j.immuni.2019.10.014; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Miller A, 2017, CELL METAB, V26, P788, DOI 10.1016/j.cmet.2017.08.014; Miller DR, 2006, BRIT J HAEMATOL, V134, P20, DOI 10.1111/j.1365-2141.2006.06119.x; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Miura D, 2012, J PROTEOMICS, V75, P5052, DOI 10.1016/j.jprot.2012.02.011; Miyajima M, 2017, NAT IMMUNOL, V18, P1342, DOI 10.1038/ni.3867; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; Moor AE, 2017, CURR OPIN BIOTECH, V46, P126, DOI 10.1016/j.copbio.2017.02.004; Mrowietz U, 2017, BRIT J DERMATOL, V176, P615, DOI 10.1111/bjd.14947; Muehlenbein MP, 2010, AM J HUM BIOL, V22, P546, DOI 10.1002/ajhb.21045; Murray C, 2015, BRAIN BEHAV IMMUN, V48, P274, DOI 10.1016/j.bbi.2015.04.009; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Norata G.D.D., 2015, CELLULAR MOL BASIS T; O'Neill LAJ, 2019, NAT REV IMMUNOL, V19, P273, DOI 10.1038/s41577-019-0128-5; Okin D, 2016, CELL, V165, P343, DOI 10.1016/j.cell.2016.02.023; Olivares-Villagomez D, 2018, TRENDS IMMUNOL, V39, P264, DOI 10.1016/j.it.2017.11.003; Padmanabha D, 2014, TRENDS ENDOCRIN MET, V25, P518, DOI 10.1016/j.tem.2014.03.011; Palsson-McDermott EM, 2020, CELL RES, V30, P300, DOI 10.1038/s41422-020-0291-z; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Pareek V, 2020, SCIENCE, V368, P283, DOI 10.1126/science.aaz6465; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Patel HJ, 2017, LIFE SCI, V170, P56, DOI 10.1016/j.lfs.2016.11.033; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Prendergast GC, 2017, CANCER RES, V77, P6795, DOI 10.1158/0008-5472.CAN-17-2285; Priest C, 2019, NAT METAB, V1, P1177, DOI 10.1038/s42255-019-0145-5; Protzer U., 2012, LIVING LIVER HEPATIC; Pryor R, 2019, CELL, V178, P1299, DOI 10.1016/j.cell.2019.08.003; Qiu J, 2019, CELL REP, V27, P2063, DOI 10.1016/j.celrep.2019.04.022; Quinn RA, 2020, NATURE, V579, P123, DOI 10.1038/s41586-020-2047-9; Racanelli V., 2006, HEPATOLOGY S1, V43, pS54; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Rao S, 2017, CELL, V168, P503, DOI 10.1016/j.cell.2017.01.006; Rappez L, 2019, BIORXIV, DOI DOI 10.1101/510222; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Ronda C, 2019, NAT METHODS, V16, P167, DOI 10.1038/s41592-018-0301-y; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosshart S.P., 2019, SCIENCE, V365, P80; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Roy DG, 2020, CELL METAB, V31, P250, DOI 10.1016/j.cmet.2020.01.006; Russell DG, 2019, NAT REV IMMUNOL, V19, P291, DOI 10.1038/s41577-019-0124-9; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6; Schieber AMP, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw106; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sdelci S, 2019, NAT GENET, V51, P990, DOI 10.1038/s41588-019-0413-z; Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032; Shi H, 2019, IMMUNITY, V51, P1012, DOI 10.1016/j.immuni.2019.10.001; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Srivastava A, 2016, CURR OPIN VIROL, V21, P75, DOI 10.1016/j.coviro.2016.08.003; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stark R, 2019, NAT REV GENET, V20, P631, DOI 10.1038/s41576-019-0150-2; Stein EM, 2019, BLOOD, V133, P676, DOI 10.1182/blood-2018-08-869008; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Straub RH, 2010, J INTERN MED, V267, P543, DOI 10.1111/j.1365-2796.2010.02218.x; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Sun CL, 2019, P NATL ACAD SCI USA, V116, P52, DOI 10.1073/pnas.1808950116; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Tsai VWW, 2016, INT J OBESITY, V40, P193, DOI 10.1038/ijo.2015.242; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; Van De Velde LA, 2016, CELL REP, V17, P2247, DOI 10.1016/j.celrep.2016.10.079; Van den Eynde BJ, 2020, ANNU REV CANC BIOL, V4, P241, DOI 10.1146/annurev-cancerbio-030419-033635; van Konijnenburg DPH, 2017, CELL, V171, P783, DOI 10.1016/j.cell.2017.08.046; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Vickovic S, 2019, NAT METHODS, V16, P987, DOI 10.1038/s41592-019-0548-y; Visconti A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12476-z; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WARBURG O, 1958, Z NATURFORSCH PT B, V13, P515, DOI 10.1515/znb-1958-0806; Weber DD, 2018, AGING-US, V10, P164, DOI 10.18632/aging.101382; Weger BD, 2019, CELL METAB, V29, P362, DOI 10.1016/j.cmet.2018.09.023; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WICK AN, 1957, J BIOL CHEM, V224, P963; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhang DF, 2019, IMMUNITY, V51, P671, DOI 10.1016/j.immuni.2019.08.001; Zhao JJ, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0157-z; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97; Zhu AZ, 2011, SEMIN ONCOL, V38, P55, DOI 10.1053/j.seminoncol.2010.11.012; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3	240	34	34	5	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					496	509		10.1016/j.immuni.2020.08.012	http://dx.doi.org/10.1016/j.immuni.2020.08.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937151	Bronze, Green Published			2022-12-18	WOS:000569806100008
J	Alexander, M; Turnbaugh, PJ				Alexander, Margaret; Turnbaugh, Peter J.			Deconstructing Mechanisms of Diet-Microbiome-Immune Interactions	IMMUNITY			English	Review							SEGMENTED FILAMENTOUS BACTERIA; REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; GUT MICROBIOTA; INTESTINAL MICROBIOTA; MAINTAIN HOMEOSTASIS; COMMENSAL BACTERIA; METABOLIC SYNDROME; HOST METABOLISM; PPAR-GAMMA	Emerging evidence suggests that the effect of dietary intake on human health and disease is linked to both the immune system and the microbiota. Yet, we lack an integrated mechanistic model for how these three complex systems relate, limiting our ability to understand and treat chronic and infectious disease. Here, we review recent findings at the interface of microbiology, immunology, and nutrition, with an emphasis on experimentally tractable models and hypothesis-driven mechanistic work. We outline emerging mechanistic concepts and generalizable approaches to bridge the gap between microbial ecology and molecular mechanism. These set the stage for a new era of precision human nutrition informed by a deep and comprehensive knowledge of the diverse cell types in and on the human body.	[Alexander, Margaret; Turnbaugh, Peter J.] Univ Calif San Francisco, Dept Microbiol & Immunol, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Turnbaugh, Peter J.] Chan Zuckerberg Biohub, 499 Illinois St, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Turnbaugh, PJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 513 Parnassus Ave, San Francisco, CA 94143 USA.; Turnbaugh, PJ (corresponding author), Chan Zuckerberg Biohub, 499 Illinois St, San Francisco, CA 94158 USA.	peter.turnbaugh@ucsf.edu		Turnbaugh, Peter/0000-0002-0888-2875; Alexander, Margaret/0000-0003-2972-7521	National Institutes of Health [R01HL122593, R21CA227232, R01AR074500, 5T32AI060537, 1F32AI147456]; Damon Runyon Cancer Research Foundation [DRR42-16]; Searle Scholars Program [SSP-2016-1352]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Searle Scholars Program	We thank Kathy Lam, Djem Kissiov, and Qi Yan Ang for critical feedback on the manuscript. Figures were created using BioRender.com. This project was supported by the National Institutes of Health (R01HL122593, R21CA227232, R01AR074500, 5T32AI060537, and 1F32AI147456). P.J.T. is a Chan Zuckerberg Biohub investigator and was a Nadia's Gift Foundation Innovator supported, in part, by the Damon Runyon Cancer Research Foundation (DRR42-16) and the Searle Scholars Program (SSP-2016-1352).	Ang QY, 2020, CELL, V181, P1263, DOI 10.1016/j.cell.2020.04.027; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bisanz JE, 2020, CELL HOST MICROBE, V27, P1001, DOI 10.1016/j.chom.2020.04.006; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Bradley CP, 2017, CELL HOST MICROBE, V22, P697, DOI 10.1016/j.chom.2017.10.007; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cantorna MT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01772; Carmody RN, 2019, NAT MICROBIOL, V4, P2052, DOI 10.1038/s41564-019-0569-4; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Carmody RN, 2014, J CLIN INVEST, V124, P4173, DOI 10.1172/JCI72335; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chandra RK, 1996, P NATL ACAD SCI USA, V93, P14304, DOI 10.1073/pnas.93.25.14304; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036; Chun E, 2019, IMMUNITY, V51, P871, DOI 10.1016/j.immuni.2019.09.014; Cignarella F, 2018, CELL METAB, V27, P1222, DOI 10.1016/j.cmet.2018.05.006; Colosimo DA, 2019, CELL HOST MICROBE, V26, P273, DOI 10.1016/j.chom.2019.07.002; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippis F, 2019, CELL HOST MICROBE, V25, P444, DOI 10.1016/j.chom.2019.01.004; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; DREW L, 2020, NATURE, V577, pS24, DOI DOI 10.1038/D41586-020-00202-5; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Eidenschenk C, 2014, CURR TOP MICROBIOL, V380, P213, DOI 10.1007/978-3-662-43492-5_10; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fiorucci S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01853; Fulde M, 2018, NATURE, V560, P489, DOI 10.1038/s41586-018-0395-5; Gehrig JL, 2019, SCIENCE, V365, P139, DOI 10.1126/science.aau4732; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Grizotte-Lake M, 2018, IMMUNITY, V49, P1103, DOI 10.1016/j.immuni.2018.11.018; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hibberd MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4069; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jariwala PB, 2020, ACS CHEM BIOL, V15, P217, DOI 10.1021/acschembio.9b00788; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Johnson AJ, 2019, CELL HOST MICROBE, V25, P789, DOI 10.1016/j.chom.2019.05.005; Johnston BC, 2019, ANN INTERN MED, V171, P756, DOI 10.7326/M19-1621; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Khare A, 2015, J IMMUNOL, V195, P431, DOI 10.4049/jimmunol.1500474; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8; Kuang Z, 2019, SCIENCE, V365, P1428, DOI 10.1126/science.aaw3134; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Lam KN, 2019, CELL HOST MICROBE, V26, P22, DOI 10.1016/j.chom.2019.06.011; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Levan SR, 2019, NAT MICROBIOL, V4, P1851, DOI 10.1038/s41564-019-0498-2; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Nagai M, 2019, CELL, V178, P1072, DOI 10.1016/j.cell.2019.07.047; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Petersen C, 2019, SCIENCE, V365, P340, DOI 10.1126/science.aat9351; Poole AC, 2019, CELL HOST MICROBE, V25, P553, DOI 10.1016/j.chom.2019.03.001; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Raman AS, 2019, SCIENCE, V365, P140, DOI 10.1126/science.aau4735; Rangan P, 2019, CELL REP, V26, P2704, DOI 10.1016/j.celrep.2019.02.019; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schroeder BO, 2018, CELL HOST MICROBE, V23, P27, DOI 10.1016/j.chom.2017.11.004; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Skelly AN, 2019, NAT REV IMMUNOL, V19, P305, DOI 10.1038/s41577-019-0144-5; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walter J, 2020, CELL, V180, P221, DOI 10.1016/j.cell.2019.12.025; Wegorzewska MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9079; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Wolf AR, 2019, CELL HOST MICROBE, V26, P463, DOI 10.1016/j.chom.2019.09.001; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yao LN, 2018, ELIFE, V7, DOI 10.7554/eLife.37182; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zegarra-Ruiz DF, 2019, CELL HOST MICROBE, V25, P113, DOI 10.1016/j.chom.2018.11.009; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zou J, 2018, CELL HOST MICROBE, V23, P41, DOI 10.1016/j.chom.2017.11.003	103	34	34	6	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					264	276		10.1016/j.immuni.2020.07.015	http://dx.doi.org/10.1016/j.immuni.2020.07.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814025	Green Accepted, Bronze			2022-12-18	WOS:000561190600008
J	Ohkura, N; Yasumizu, Y; Kitagawa, Y; Tanaka, A; Nakamura, Y; Motooka, D; Nakamura, S; Okada, Y; Sakaguchi, S				Ohkura, Naganari; Yasumizu, Yoshiaki; Kitagawa, Yohko; Tanaka, Atsushi; Nakamura, Yamami; Motooka, Daisuke; Nakamura, Shota; Okada, Yukinori; Sakaguchi, Shimon			Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases	IMMUNITY			English	Article							GENOME-WIDE ASSOCIATION; IMMUNE DYSREGULATION; FOXP3 EXPRESSION; SUPER-ENHANCERS; PARTITIONING HERITABILITY; EPIGENETIC CHANGES; ENTEROPATHY; LANDSCAPE; POLYENDOCRINOPATHY; POPULATION	The contribution of FOXP3-expressing naturally occurring regulatory T (Treg) cells to common polygenic autoimmune diseases remains ambiguous. Here, we characterized genome-wide epigenetic profiles (CpG methylation and histone modifications) of human Treg and conventional T (Tconv) cells in naive and activated states. We found that single-nucleotide polymorphisms (SNPs) associated with common autoimmune diseases were predominantly enriched in CpG demethylated regions (DRs) specifically present in naive Treg cells but much less enriched in activation-induced DRs common in Tconv and Treg cells. Naive Treg cell-specific DRs were largely included in Treg cell-specific super-enhancers and closely associated with transcription and other epigenetic changes in naive and effector Treg cells. Thus, naive Treg cell-specific CpG hypomethylation had a key role in controlling Treg cell-specific gene transcription and epigenetic modification. The results suggest possible contribution of altered function or development of natural Treg cells to the susceptibility to common autoimmune diseases.	[Ohkura, Naganari; Yasumizu, Yoshiaki; Kitagawa, Yohko; Tanaka, Atsushi; Nakamura, Yamami; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan; [Ohkura, Naganari; Tanaka, Atsushi] Osaka Univ, Ctr Med Innovat & Translat Res, Grad Sch Med, Dept Frontier Res Tumor Immunol, Suita, Osaka 5650871, Japan; [Yasumizu, Yoshiaki] Osaka Univ, Fac Med, Suita, Osaka 5650871, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Genome Informat Res Ctr, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Suita, Osaka 5650871, Japan; [Okada, Yukinori] Osaka Univ, Immunol Frontier Res Ctr, Lab Stat Immunol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Sakaguchi, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan.	shimon@ifrec.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Tanaka, Atsushi/U-6761-2019	Tanaka, Atsushi/0000-0003-1660-9892; Yasumizu, Yoshiaki/0000-0002-9872-4909	Japanese Society for the Promotion of Science (JSPS) [15H04744, 16H06295]; Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency [17 gm0410016h0006]; Leading Advanced Projects for medical innovation (LEAP) from Japan's Agency for Medical Research and Development (AMED) [18 gm0010005h0001]; Osaka University Medical Doctor Scientist Training Program	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Leading Advanced Projects for medical innovation (LEAP) from Japan's Agency for Medical Research and Development (AMED); Osaka University Medical Doctor Scientist Training Program	Bioinformatics analyses were conducted by using the computer system of the Genome Information Research Center of the Research Institute for Microbial Diseases at Osaka University. This work was supported by Grants-in-Aid by Japanese Society for the Promotion of Science (JSPS) for Scientific Research B 15H04744 to N.O. and for Specially Promoted Research 16H06295 to S.S., by the Core Research for Evolutional Science and Technology (CREST, no. 17 gm0410016h0006) program from the Japan Science and Technology Agency to S.S., and by Leading Advanced Projects for medical innovation (LEAP, no. 18 gm0010005h0001) from Japan's Agency for Medical Research and Development (AMED) to S.S. Y.Y. is supported by the Osaka University Medical Doctor Scientist Training Program. The authors thank Kelvin Chen for critical comments on the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arvey A, 2015, ELIFE, V4, DOI 10.7554/eLife.07571; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Cuadrado E, 2018, IMMUNITY, V48, P1046, DOI 10.1016/j.immuni.2018.04.008; Dominguez-Villar M, 2019, J AUTOIMMUN, V96, P40, DOI 10.1016/j.jaut.2018.08.002; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Howson JMM, 2009, GENES IMMUN, V10, pS74, DOI 10.1038/gene.2009.96; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Liu YM, 2013, HUM MOL GENET, V22, P5065, DOI 10.1093/hmg/ddt356; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Miyara M, 2015, P NATL ACAD SCI USA, V112, P7225, DOI 10.1073/pnas.1508224112; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vandenbon A, 2016, P NATL ACAD SCI USA, V113, pE2393, DOI 10.1073/pnas.1604351113; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wing JB, 2019, IMMUNITY, V50, P302, DOI 10.1016/j.immuni.2019.01.020; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	52	34	34	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1119	+		10.1016/j.immuni.2020.04.006	http://dx.doi.org/10.1016/j.immuni.2020.04.006			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32362325	Bronze			2022-12-18	WOS:000541890000022
J	Sangesland, M; Ronsard, L; Kazer, SW; Bals, J; Boyoglu-Barnum, S; Yousif, AS; Barnes, R; Feldman, J; Quirindongo-Crespo, M; McTamney, PM; Rohrer, D; Lonberg, N; Chackerian, B; Graham, BS; Kanekiyo, M; Shalek, AK; Lingwood, D				Sangesland, Maya; Ronsard, Larance; Kazer, Samuel W.; Bals, Julia; Boyoglu-Barnum, Seyhan; Yousif, Ashraf S.; Barnes, Ralston; Feldman, Jared; Quirindongo-Crespo, Maricel; McTamney, Patrick M.; Rohrer, Daniel; Lonberg, Nils; Chackerian, Bryce; Graham, Barney S.; Kanekiyo, Masaru; Shalek, Alex K.; Lingwood, Daniel			Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus	IMMUNITY			English	Article							MEMORY B-CELLS; HEMAGGLUTININ-STEM; HUMAN-ANTIBODIES; HIV; IMMUNIZATION; MICE; IMMUNITY; REPERTOIRE; PRECURSORS; EXPRESSION	Antibody paratopes are formed by hypervariable complementarity-determining regions (CDRH3s) and variable gene-encoded CDRs. The latter show biased usage in human broadly neutralizing antibodies (bnAbs) against both HIV and influenza virus, suggesting the existence of gene-endowed targeting solutions that may be amenable to pathway amplification. To test this, we generated transgenic mice with human CDRH3 diversity but simultaneously constrained to individual user-defined human immunoglobulin variable heavy-chain (V-H) genes, including IGHV1-69, which shows biased usage in human bnAbs targeting the hemagglutinin stalk of group 1 influenza A viruses. Sequential immunization with a stalk-only hemagglutinin nanoparticle elicited group 1 bnAbs, but only in IGHV1-69 mice. This V-H-endowed response required minimal affinity maturation, was elicited alongside pre-existing influenza immunity, and when IGHV1-69 B cells were diluted to match the frequency measured in humans. These results indicate that the human repertoire could, in principle, support germline-encoded bnAb elicitation using a single recombinant hemagglutinin immunogen.	[Sangesland, Maya; Ronsard, Larance; Kazer, Samuel W.; Bals, Julia; Yousif, Ashraf S.; Feldman, Jared; Shalek, Alex K.; Lingwood, Daniel] MIT, Massachusetts Gen Hosp, Ragon Inst, 400 Technol Sq, Cambridge, MA 02139 USA; [Sangesland, Maya; Ronsard, Larance; Kazer, Samuel W.; Bals, Julia; Yousif, Ashraf S.; Feldman, Jared; Shalek, Alex K.; Lingwood, Daniel] Harvard Univ, 400 Technol Sq, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] MIT, Dept Chem, IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] MIT, Broad Inst, 415 Main St, Cambridge, MA 02142 USA; [Kazer, Samuel W.; Shalek, Alex K.] Harvard Univ, 415 Main St, Cambridge, MA 02142 USA; [Boyoglu-Barnum, Seyhan; Graham, Barney S.; Kanekiyo, Masaru] NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA; [Barnes, Ralston; Quirindongo-Crespo, Maricel; Rohrer, Daniel; Lonberg, Nils] Bristol Myers Squibb, 700 Bay Rd, Redwood City, CA 94063 USA; [McTamney, Patrick M.] Medimmune LLC, One Medimmune Way, Gaithersburg, MD 20878 USA; [Chackerian, Bryce] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, 2425 Camino Salud, Albuquerque, NM 87106 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Bristol-Myers Squibb; AstraZeneca; Medimmune; University of New Mexico	Lingwood, D (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, 400 Technol Sq, Cambridge, MA 02139 USA.; Lingwood, D (corresponding author), Harvard Univ, 400 Technol Sq, Cambridge, MA 02139 USA.	dlingwood@mgh.harvard.edu	Yousif, Ashraf Siddig/U-2876-2019; Ronsard, Larance/H-2731-2019; Kanekiyo, Masaru/Y-9820-2018	Yousif, Ashraf Siddig/0000-0001-9215-3853; Ronsard, Larance/0000-0002-5307-1940; Kanekiyo, Masaru/0000-0001-5767-1532; Kazer, Samuel/0000-0002-7380-9594; Sangesland, Maya/0000-0001-8316-039X; Bals, Julia/0000-0002-9740-7637	NIH [R01AI137057-01, DP2DA042422, R01AI124378, 1DP2OD020839, 2U19AI089992, 1U54CA217377, P01AI039671, 5U24AI118672, 2RM1HG006193, 1R33CA202820, 2R01HL095791, 1R01AI138546, 1R01HL126554, 1R01DA046277]; Harvard University Milton Award; Gilead Research Scholars Program; Strategic Initiatives and Sundry funding from the Ragon Institute; NSF Graduate Research Fellowship Program; Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars; Sloan Fellowship in Chemistry; Bill and Melinda Gates Foundation [OPP1139972]; Ragon Institute NIH-funded Centers for AIDS Research (Harvard University Center for AIDS Research) [P30 AI060354]; BMGF [OPP1116944]; NIH; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; OAR; NATIONAL CANCER INSTITUTE [U54CA217377, R33CA202820] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095791] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, R01AI124378, R01AI138546, P30AI060354, R01AI137057, U24AI118672, U19AI089992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA042422, R01DA046277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Milton Award; Gilead Research Scholars Program; Strategic Initiatives and Sundry funding from the Ragon Institute; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars; Sloan Fellowship in Chemistry; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute NIH-funded Centers for AIDS Research (Harvard University Center for AIDS Research); BMGF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC; OAR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	D.L. was supported by NIH grants (R01AI137057-01, DP2DA042422, and R01AI124378), the Harvard University Milton Award, the Gilead Research Scholars Program, and Strategic Initiatives and Sundry funding from the Ragon Institute. M.S. and S.W.K. were supported by the NSF Graduate Research Fellowship Program. A.K.S. was supported by the Searle Scholars Program; the Beckman Young Investigator Program, the Pew-Stewart Scholars; a Sloan Fellowship in Chemistry; NIH grants 1DP2OD020839, 2U19AI089992, 1U54CA217377, P01AI039671, 5U24AI118672, 2RM1HG006193, 1R33CA202820, 2R01HL095791, 1R01AI138546, 1R01HL126554, 1R01DA046277, and 2R01HL095791; and Bill and Melinda Gates Foundation grants OPP1139972 and BMGF OPP1116944. Support was also provided by the Ragon Institute NIH-funded Centers for AIDS Research (P30 AI060354, Harvard University Center for AIDS Research), supported by NIH co-funding and participating institutes and centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, and OAR. We thank BMS for gifting transgenic mice to D.L. and Roy Jeffris for providing the G6 antibody. We also thank Facundo Batista for helpful discussion; Celina Keating, Thalia Bracamonte Moreno, Vintus Okonkwo, and Matthew Smoot for recombinant protein production; and the MGH Center for Comparative Medicine for their help with animal experiments.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Altman MO, 2015, ELIFE, V4, DOI 10.7554/eLife.07467; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; Avnir Y, 2017, CELL REP, V21, P3243, DOI 10.1016/j.celrep.2017.11.056; Avnir Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20842; Avnir Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004103; Bonsignori M, 2018, IMMUNITY, V49, P1162, DOI 10.1016/j.immuni.2018.10.015; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; CASALI P, 1989, ANNU REV IMMUNOL, V7, P513, DOI 10.1146/annurev.immunol.7.1.513; Cho A, 2016, CURR OPIN VIROL, V17, P110, DOI 10.1016/j.coviro.2016.03.002; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeWitt WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160853; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dosenovic P, 2019, J EXP MED, V216, P2316, DOI 10.1084/jem.20190446; Dosenovic P, 2018, P NATL ACAD SCI USA, V115, P4743, DOI 10.1073/pnas.1803457115; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Duan HY, 2018, IMMUNITY, V49, P301, DOI 10.1016/j.immuni.2018.07.005; Dunand CJH, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0238; Erbelding EJ, 2018, J INFECT DIS, V218, P347, DOI 10.1093/infdis/jiy103; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Fahnrich A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1575-2; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Guthmiller JJ, 2018, CURR OPIN IMMUNOL, V53, P187, DOI 10.1016/j.coi.2018.05.010; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; He WQ, 2016, P NATL ACAD SCI USA, V113, P11931, DOI 10.1073/pnas.1609316113; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; KIPPS TJ, 1990, J EXP MED, V171, P189, DOI 10.1084/jem.171.1.189; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Kosik I, 2019, J EXP MED, V216, P304, DOI 10.1084/jem.20181624; Krammer F, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028845; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Lu Y, 2014, P NATL ACAD SCI USA, V111, P125, DOI 10.1073/pnas.1308701110; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pape KA, 2018, IMMUNITY, V48, P1135, DOI 10.1016/j.immuni.2018.04.019; Pape KA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029116; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Pease S, 2011, ADV PROTOCOLS ANIMAL; Peterhoff D, 2017, CURR OPIN HIV AIDS, V12, P257, DOI 10.1097/COH.0000000000000356; Petrie JG, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6020017; Raymond DD, 2018, P NATL ACAD SCI USA, V115, P168, DOI 10.1073/pnas.1715471115; Rettig TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190982; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; Shlomchik MJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029405; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan HX, 2019, J CLIN INVEST, V129, P850, DOI 10.1172/JCI123366; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Umotoy J, 2019, IMMUNITY, V51, P141, DOI 10.1016/j.immuni.2019.06.004; Verkoczy L, 2017, IMMUNOL REV, V275, P89, DOI 10.1111/imr.12505; Villar RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep36298; Weaver GC, 2016, NAT PROTOC, V11, P193, DOI 10.1038/nprot.2016.009; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Wu NC, 2017, J MOL BIOL, V429, P2694, DOI 10.1016/j.jmb.2017.06.015; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	81	34	34	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					735	+		10.1016/j.immuni.2019.09.001	http://dx.doi.org/10.1016/j.immuni.2019.09.001			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31563464	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000490141700018
J	Moon, HG; Kim, SJ; Jeong, JJ; Han, SS; Jarjour, NN; Lee, H; Abboud-Werner, SL; Chung, S; Choi, HS; Natarajan, V; Ackerman, SJ; Christman, JW; Park, GY				Moon, Hyung-Geun; Kim, Seung-jae; Jeong, Jong Jin; Han, Seon-Sook; Jarjour, Nizar N.; Lee, Hyun; Abboud-Werner, Sherry L.; Chung, Sangwoon; Choi, Hak Soo; Natarajan, Viswanathan; Ackerman, Steven J.; Christman, John W.; Park, Gye Young			Airway Epithelial Cell-Derived Colony Stimulating Factor-1 Promotes Allergen Sensitization	IMMUNITY			English	Article							HOUSE-DUST MITE; FLOW-CYTOMETRIC ANALYSIS; INFLUENZA-A VIRUS; DENDRITIC CELLS; MONONUCLEAR PHAGOCYTES; LUNG INFLAMMATION; LYMPH-NODES; MACROPHAGES; IMMUNITY; ASTHMA	Airway epithelial cells (AECs) secrete innate immune cytokines that regulate adaptive immune effector cells. In allergen-sensitized humans and mice, the airway and alveolar microenvironment is enriched with colony stimulating factor-1 (CSF1) in response to allergen exposure. In this study we found that AEC-derived CSF1 had a critical role in the production of allergen reactive-IgE production. Furthermore, spatiotemporally secreted CSF1 regulated the recruitment of alveolar dendritic cells (DCs) and enhanced the migration of conventional DC2s (cDC2s) to the draining lymph node in an interferon regulatory factor 4 (IRF4)-dependent manner. CSF1 selectively upregulated the expression of the chemokine receptor CCR7 on the CSF1R(+) cDC2, but not the cDC1, population in response to allergen stimuli. Our data describe the functional specification of CSF1-dependent DC subsets that link the innate and adaptive immune responses in T helper 2 (Th2) cell-mediated allergic lung inflammation.	[Moon, Hyung-Geun; Kim, Seung-jae; Jeong, Jong Jin; Han, Seon-Sook; Natarajan, Viswanathan; Park, Gye Young] Univ Chicago, Dept Med, Div Pulm Crit Care Sleep & Allergy, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Jarjour, Nizar N.] Univ Wisconsin, Dept Med, Allergy Pulm & Crit Care Div, Madison, WI USA; [Lee, Hyun] Univ Illinois, Coll Pharm, Ctr Biomol Sci, Chicago, IL USA; [Lee, Hyun] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Abboud-Werner, Sherry L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Chung, Sangwoon; Christman, John W.] Ohio State Univ, Davis Heart & Lung Res Ctr, Sect Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA; [Choi, Hak Soo] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA; [Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Ackerman, Steven J.] Univ Illinois, Dept Biochem & Mol Genet & Med, Chicago, IL USA; [Jeong, Jong Jin] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Han, Seon-Sook] Kangwon Natl Univ, Sch Med, Dept Med, Chunchon, South Korea	University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Health San Antonio; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Kangwon National University	Park, GY (corresponding author), Univ Chicago, Dept Med, Div Pulm Crit Care Sleep & Allergy, 5841 S Maryland Ave, Chicago, IL 60637 USA.	parkgy@uic.edu	Choi, Hak Soo/C-9954-2011	Lee, Hyun/0000-0003-2570-8120	NIH [R01HL126852, R01 HL137224, R01 AG045040, P01 HL088594]; Respiratory Health Association Grant [RHA2016-01-Lung Cancer]; UIC CCTS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126852, R01HL137224, P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Respiratory Health Association Grant; UIC CCTS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all of the generous asthmatic subjects who volunteered for the SBP-AG protocol, and the entire staff of the Clinical Research Core, Research Resource Center (Histology Core and Flow Cytometry Core) at the University of Illinois Center for Clinical and Translational Sciences (CCTS). We also thank Eleanor Rivera, R.N., and Drs. H. Ari Jaffe and Sharmilee Nyenhuis for assistance with the SBP-AG protocol. This work was supported by NIH grant R01HL126852 and Respiratory Health Association Grant (RHA2016-01-Lung Cancer) (to G.Y.P.) and in part by NIH grants R01 HL137224 (to J.W.C.), R01 AG045040 (to S.L.A.-W.), and P01 HL088594 (to N.N.J.). Performance of the SGP-AG protocol was supported in part by a pilot grant from the UIC CCTS (to S.J.A.).	Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Brightbill HD, 2010, J CLIN INVEST, V120, P2218, DOI 10.1172/JCI40141; Choi HS, 2013, NAT BIOTECHNOL, V31, P148, DOI 10.1038/nbt.2468; Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC; Fixe P, 1998, CYTOKINE, V10, P32, DOI 10.1006/cyto.1997.0249; Fu PF, 2013, AM J RESP CELL MOL, V48, P477, DOI 10.1165/rcmb.2012-0242OC; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Kerrin A, 2017, THORAX, V72, P620, DOI 10.1136/thoraxjnl-2015-207358; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lee YG, 2015, AM J RESP CELL MOL, V52, P772, DOI 10.1165/rcmb.2014-0255OC; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Moon HG, 2010, ALLERGY, V65, P1093, DOI 10.1111/j.1398-9995.2010.02352.x; Moon HG, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.282; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pang IK, 2013, NAT IMMUNOL, V14, P246, DOI 10.1038/ni.2514; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Patel VI, 2017, J IMMUNOL, V198, P1183, DOI 10.4049/jimmunol.1600777; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rivera A, 2016, NAT IMMUNOL, V17, P356, DOI 10.1038/ni.3375; Roquilly A, 2017, IMMUNITY, V47, P135, DOI 10.1016/j.immuni.2017.06.021; Shin EK, 2010, HUM GENET, V128, P293, DOI 10.1007/s00439-010-0850-3; Stanley E. R., 2014, COLD SPRING HARB PER, V6, P6; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Wang YQ, 2015, KIDNEY INT, V88, P1274, DOI 10.1038/ki.2015.295; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116; Yu YRA, 2016, AM J RESP CELL MOL, V54, P13, DOI 10.1165/rcmb.2015-0146OC	44	34	35	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					275	+		10.1016/j.immuni.2018.06.009	http://dx.doi.org/10.1016/j.immuni.2018.06.009			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30054206	Green Accepted, Bronze			2022-12-18	WOS:000442354500013
J	Ouyang, WM; Oh, SA; Ma, Q; Bivona, MR; Zhu, JF; Li, MO				Ouyang, Weiming; Oh, Soyoung A.; Ma, Qian; Bivona, Michael R.; Zhu, Jinfang; Li, Ming O.			TGF-beta Cytokine Signaling Promotes CD8(+) T Cell Development and Low-Affinity CD4(+) T Cell Homeostasis by Regulation of Interleukin-7 Receptor alpha Expression	IMMUNITY			English	Article							ROR-GAMMA-T; NEGATIVE SELECTION; IN-VIVO; DIFFERENTIATION; NAIVE; TRANSCRIPTION; MECHANISMS; SURVIVAL; IL-7; PROLIFERATION	Interleukin-7 receptor alpha chain (IL-7R alpha) is induced upon T cell positive selection and controls thymic CD8-lineage specification and peripheral naive T cell homeostasis. How IL-7R alpha expression is regulated in developing thymocytes is unclear. Here, we show that transforming growth factor beta (TGF-beta) signaling promoted IL-7R alpha expression and CD8(+) T cell differentiation. In addition, TGF-beta signaling was required for high IL-7R alpha expression in CD4(+) T cells bearing low-affinity T cell receptors, and the abrogation of TGF-beta receptor expression led to failed maintenance of peripheral CD4(+) T cells. Compromised IL-7R alpha expression in TGF-beta-receptor-deficient T cells was associated with increased expression of the Il7ra transcriptional repressor, Gfi-1. IL-7R alpha transgenesis or T-cell-specific ablation of Gfi-1 restored IL-7R alpha expression and largely ameliorated the development and homeostasis defects of TGF-beta-receptor-deficient T cells. These findings reveal functions for TGF-beta signaling in controlling IL-7R alpha expression and in promoting T cell repertoire diversification.	[Ouyang, Weiming; Oh, Soyoung A.; Ma, Qian; Bivona, Michael R.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Zhu, Jinfang] NIAID, Immunol Lab, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745; li, ming/0000-0002-1383-0535	National Institute of Arthritis, Musculoskeletal, and Skin Diseases [RO1 AR060723]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA;  [T32-CA9149-35]; NATIONAL CANCER INSTITUTE [T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060723] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal, and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Bottomly for providing AND mice, and A. Singer for providing IL-7R transgenic mice. The projects described were supported by grants from the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (RO1 AR060723 to M.O.L.). J.Z. is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. S.A.O. is supported by T32-CA9149-35.	Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Catlett IM, 2005, NAT IMMUNOL, V6, P715, DOI 10.1038/ni1211; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Donkor MK, 2011, IMMUNITY, V35, P123, DOI 10.1016/j.immuni.2011.04.019; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Ichiyama K, 2009, INT IMMUNOL, V21, P881, DOI 10.1093/intimm/dxp054; Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Robinson RT, 2007, J IMMUNOL, V179, P71, DOI 10.4049/jimmunol.179.1.71; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666	38	34	36	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					335	346		10.1016/j.immuni.2013.07.016	http://dx.doi.org/10.1016/j.immuni.2013.07.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23932572	Green Accepted, Bronze			2022-12-18	WOS:000330948800015
J	Carpenter, AC; Grainger, JR; Xiong, YM; Kanno, Y; Chu, HH; Wang, L; Naik, S; dos Santos, L; Wei, L; Jenkins, MK; O'Shea, JJ; Belkaid, Y; Bosselut, R				Carpenter, Andrea C.; Grainger, John R.; Xiong, Yumei; Kanno, Yuka; Chu, H. Hamlet; Wang, Lie; Naik, Shruti; dos Santos, Liliane; Wei, Lai; Jenkins, Marc K.; O'Shea, John J.; Belkaid, Yasmine; Bosselut, Remy			The Transcription Factors Thpok and LRF Are Necessary and Partly Redundant for T Helper Cell Differentiation	IMMUNITY			English	Article							ZINC-FINGER PROTEIN; LEISHMANIA-MAJOR INFECTION; LINEAGE FATE; GENE-EXPRESSION; CD4 EXPRESSION; COMMITMENT; RECEPTOR; SUPPRESSION; LYMPHOCYTES; ACTIVATION	T helper (Th) cells are critical for defenses against infection and recognize peptides bound to class II major histocompatibility complex (MHC II) molecules. Although transcription factors have been identified that direct Th cells into specific effector fates, whether a "master" regulator controls the developmental program common to all Th cells remains unclear. Here, we showed that the two transcription factors Thpok and LRF share this function. Although disruption of both factors did not prevent the generation of MHC II-specific T cells, these cells failed to express Th cell genes or undergo Th cell differentiation in vivo. In contrast, T cells lacking Thpok, which only displayed LRF-dependent functions, contributed to multiple effector responses, both in vitro and in vivo, with the notable exception of Th2 cell responses that control extracellular parasites. These findings identify the Thpok-LRF pair as a core node of Th cell differentiation and function.	[Carpenter, Andrea C.; Xiong, Yumei; Wang, Lie; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Grainger, John R.; Naik, Shruti; dos Santos, Liliane; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Kanno, Yuka; Wei, Lai; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Chu, H. Hamlet; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Minnesota System; University of Minnesota Twin Cities	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov	Santos, Liliane Martins dos/AAR-9220-2020; Jenkins, Marc K/G-1063-2012; Kanno, Yuka/B-5802-2013; Wei, Lai/D-1088-2014	Santos, Liliane Martins dos/0000-0002-4466-8868; Jenkins, Marc K/0000-0001-8009-7655; Kanno, Yuka/0000-0001-5668-9319; Grainger, John/0000-0002-4052-5923; Bohrer, Andrea/0000-0003-4268-4853; Belkaid, Yasmine/0000-0001-9962-3571	Intramural Research Programs of the National Cancer Institute; Center for Cancer Research, of the National Institute of Allergy and Infectious Diseases; National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER	Intramural Research Programs of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research, of the National Institute of Allergy and Infectious Diseases; National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P.P. Pandolfi for Zbtb7a mutant mice, N. Bouladoux for assistance with L. major experiments, B. Taylor and S. Banerjee for cell sorting, L. Williams and Q. Xiao for help with experiments, K. Beacht, E. Castro, and L. Stepanian for expert mouse technical support, M. Mehaffey, B. Tran, and Y. Zhao for assistance with Chipseq analyses, and J. Ashwell, A. Gegonne, J. Konkel, P. Schwartzberg, and M. Vacchio for reading the manuscript. This work benefitted from data assembled by the ImmGen consortium. This work was supported by the Intramural Research Programs of the National Cancer Institute, Center for Cancer Research, of the National Institute of Allergy and Infectious Diseases, and of the National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health.	Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beaulieu AM, 2011, J IMMUNOL, V187, P2841, DOI 10.4049/jimmunol.1004006; Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 1998, EUR J IMMUNOL, V28, P1389, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1389::AID-IMMU1389&gt;3.0.CO;2-1; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Campbell KA, 1996, IMMUNITY, V4, P283, DOI 10.1016/S1074-7613(00)80436-7; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; Flamand L, 1998, P NATL ACAD SCI USA, V95, P3111, DOI 10.1073/pnas.95.6.3111; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Levanon D, 2007, NAT IMMUNOL, V8, P145; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park K, 2010, EMBO J, V29, P2329, DOI 10.1038/emboj.2010.113; Paul W.E., 2004, ANNU REV IMMUNOL, V22, P307; ROY M, 1993, J IMMUNOL, V151, P2497; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Sakurai N, 2011, J CLIN INVEST, V121, P2583, DOI 10.1172/JCI45682; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Xiong YM, 2012, CURR OPIN IMMUNOL, V24, P139, DOI 10.1016/j.coi.2012.02.002; Xiong YM, 2011, EUR J IMMUNOL, V41, P568, DOI 10.1002/eji.201041098; Yang LP, 1998, J EXP MED, V187, P1139, DOI 10.1084/jem.187.7.1139; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	60	34	34	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 19	2012	37	4					622	633		10.1016/j.immuni.2012.06.019	http://dx.doi.org/10.1016/j.immuni.2012.06.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23041065	Green Accepted, Bronze			2022-12-18	WOS:000310185400008
J	Chang, HC; Tan, KM; Ouyang, J; Parisini, E; Liu, JH; Le, Y; Wang, XS; Reinherz, EL; Wang, JH				Chang, HC; Tan, KM; Ouyang, J; Parisini, E; Liu, JH; Le, Y; Wang, XS; Reinherz, EL; Wang, JH			Structural and mutational analyses of a CD8 alpha beta heterodimer and comparison with the CD8 alpha alpha homodimer	IMMUNITY			English	Article							CLASS-I MOLECULE; T-CELL-RECEPTOR; CD8 BETA-CHAIN; IMMUNOGLOBULIN SUPERFAMILY DOMAINS; CRYSTAL-STRUCTURE; CORECEPTOR FUNCTION; DIFFERENTIAL EXPRESSION; ECTODOMAIN FRAGMENT; POSITIVE SELECTION; VARIABLE DOMAINS	The crystal structure of a recombinant mouse single chain CD8 alpha beta ectodomains at 2.4 A resolution reveals paired immunoglobulin variable region-like domains with a striking resemblance to CD8 alpha alpha in size, shape, and surface electrostatic potential of complementarity determining regions (CDR), despite < 20% sequence identity between the CD8 alpha and CD8 beta subunits. Unlike the CD8 alpha subunit(s) in the heterodimer or homodimer, the CDR1 loop of CD8 beta tilts away from its corresponding CDR2 and CDR3 loops. Consistent with this observation, independent mutational studies reveal that alanine substitutions of residues in the CDR1 loop of CD8 beta have no effect on CD8 alpha beta coreceptor function, whereas mutations in CD8 beta CDR2 and CDR3 loops abolish CD8 alpha beta coreceptor activity. The implications of these findings and additional CD8 alpha beta mutational studies for CD8 alpha beta- versus CD8 alpha-MHCI binding are discussed.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Lab Immunobiol,Dept Med Oncol,Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Chang, HC (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Lab Immunobiol,Dept Med Oncol,Dept Med, 44 Binney St, Boston, MA 02115 USA.	hsiu-ching_chang@dfci.harvard.edu		PARISINI, Emilio/0000-0002-5529-0039; Le, Yi/0000-0002-7734-3808	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019807, R01AI045789, R01AI019807, R56AI019807] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48675] Funding Source: Medline; NIAID NIH HHS [AI19807, AI45789] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Carrasco YR, 1999, BLOOD, V94, P3491, DOI 10.1182/blood.V94.10.3491.422k30_3491_3498; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CLASSON BJ, 1992, INT IMMUNOL, V4, P215, DOI 10.1093/intimm/4.2.215; CONNOLLY JM, 1990, P NATL ACAD SCI USA, V87, P2137, DOI 10.1073/pnas.87.6.2137; CROOKS MEC, 1994, IMMUNITY, V1, P277; DETOTERO D, 1992, BLOOD, V80, P1765; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Gangadharan D, 2004, CURR OPIN IMMUNOL, V16, P264, DOI 10.1016/j.coi.2004.03.015; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; IRIE HY, 1995, J EXP MED, V181, P1267, DOI 10.1084/jem.181.4.1267; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; KIRSZBAUM L, 1989, J IMMUNOL, V142, P3931; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Merry AH, 2003, J BIOL CHEM, V278, P27119, DOI 10.1074/jbc.M213056200; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANACCIO M, 1987, P NATL ACAD SCI USA, V84, P6874, DOI 10.1073/pnas.84.19.6874; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Renard V, 1996, EUR J IMMUNOL, V26, P2999, DOI 10.1002/eji.1830261227; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SHIUE L, 1988, J EXP MED, V168, P1993, DOI 10.1084/jem.168.6.1993; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUNZ Y, 2004, P NATL ACAD SCI USA, V101, P16867; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; TORRESNAGEL N, 1992, EUR J IMMUNOL, V22, P2841, DOI 10.1002/eji.1830221113; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wang JH, 2002, MOL IMMUNOL, V38, P1039, DOI 10.1016/S0161-5890(02)00033-0; Weber DA, 2002, J IMMUNOL, V169, P5708, DOI 10.4049/jimmunol.169.10.5708; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Witte T, 1999, CELL IMMUNOL, V191, P90, DOI 10.1006/cimm.1998.1412; Wong JS, 2003, J IMMUNOL, V171, P867, DOI 10.4049/jimmunol.171.2.867; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2	63	34	37	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2005	23	6					661	671		10.1016/j.immuni.2005.11.002	http://dx.doi.org/10.1016/j.immuni.2005.11.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356863	Bronze			2022-12-18	WOS:000234316900012
J	Bobbitt, KR; Addo, MM; Altfeld, M; Filzen, T; Onafuwa, AA; Walker, BD; Collins, KL				Bobbitt, KR; Addo, MM; Altfeld, M; Filzen, T; Onafuwa, AA; Walker, BD; Collins, KL			Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FULL-LENGTH CLONES; CD8(+) LYMPHOCYTES; RNA EXPRESSION; HIV-1; INFECTION; ESCAPE; NEF; PROGRESSION; GENES	The HIV Nef protein is thought to promote HIV immune evasion by downmodulating MHC-I and protecting infected cells from CTL killing. In addition, we demonstrated that Rev, an HIV regulatory protein needed for expression of the HIV late genes, can influence CTL killing. When Rev activity level was reduced by virtue of amino acid alterations in the Rev protein sequence, infected cells were more resistant to anti-Gag and anti-Env CTL killing. A screen of primary viral isolates revealed that viruses derived from asymptomatic, infected people had lower Rev activity, lower Gag levels, and greater resistance to anti-Gag CTL killing. Thus, rev alleles with low activity may have a selective advantage in infected people with effective immune responses.	Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Massachusetts Gen Hosp, Ctr AIDS Res, Charlestown, MA 02114 USA; Massachusetts Gen Hosp, Infect Dis Unit, Charlestown, MA 02114 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Collins, KL (corresponding author), Univ Michigan, Dept Internal Med, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	klcollin@umich.edu	Altfeld, Marcus/AAE-7306-2019; Addo, Marylyn M./GNP-2548-2022	Altfeld, Marcus/0000-0001-5972-2997; Addo, Marylyn/0000-0003-2836-9224	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001448, R01AI051192, T32AI007528] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051192, 5T32AI07528-03, K08 AI01448] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Carr JK, 2001, VIROLOGY, V286, P168, DOI 10.1006/viro.2001.0976; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; FURTADO MR, 1995, J VIROL, V69, P2092, DOI 10.1128/JVI.69.4.2092-2100.1995; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; HIGUCHI R, 1990, RECOMBINANT PCR; Hua J, 1996, VIROLOGY, V222, P423, DOI 10.1006/viro.1996.0439; IVERSEN AKN, 1995, J VIROL, V69, P5743, DOI 10.1128/JVI.69.9.5743-5753.1995; Kitchen SG, 1998, J VIROL, V72, P9054, DOI 10.1128/JVI.72.11.9054-9060.1998; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; MARTINS LP, 1991, J VIROL, V65, P4502, DOI 10.1128/JVI.65.8.4502-4507.1991; McBreen S, 2001, J VIROL, V75, P4091, DOI 10.1128/JVI.75.9.4091-4102.2001; MICHAEL NL, 1995, J VIROL, V69, P1868, DOI 10.1128/JVI.69.3.1868-1877.1995; Munch J, 2001, J VIROL, V75, P10532, DOI 10.1128/JVI.75.21.10532-10536.2001; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; Novitsky VA, 1999, J VIROL, V73, P4427, DOI 10.1128/JVI.73.5.4427-4432.1999; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; POTTS BJ, 1990, VIROLOGY, V175, P465, DOI 10.1016/0042-6822(90)90431-P; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; RIDDELL SR, 1992, SCIENCE, V257, P238; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; Walker BD, 2001, INFEC DIS S, P237; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 2002, J VIROL, V76, P1626, DOI 10.1128/JVI.76.4.1626-1631.2002; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	48	34	35	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2003	18	2					289	299		10.1016/S1074-7613(03)00031-1	http://dx.doi.org/10.1016/S1074-7613(03)00031-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594955	Bronze			2022-12-18	WOS:000181138100012
J	Bankovich, AJ; Garcia, KC				Bankovich, AJ; Garcia, KC			Not just any T cell receptor will do	IMMUNITY			English	Article							CRYSTAL-STRUCTURE; REPERTOIRE; COMPLEXES; PEPTIDES; FRAGMENT	Although our structural understanding of T cell recognition has rapidly evolved due to recent crystallographic results, the reality is that detailed answers to many of the most fundamental questions still remain elusive. In this issue, high-resolution insight into the phenomenon of TCR chain bias takes down another brick from the wall.	Stanford Univ, Sch Med, Dept Biol Struct, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 94305 USA.			Bankovich, Alexander/0000-0003-2368-4479	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Degermann S, 1999, J EXP MED, V189, P1679, DOI 10.1084/jem.189.10.1679; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERMAIN RN, 1990, NATURE, V344, P19, DOI 10.1038/344019a0; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Wallace ME, 2000, IMMUNITY, V12, P547, DOI 10.1016/S1074-7613(00)80206-X; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	22	34	35	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					7	11		10.1016/S1074-7613(02)00517-4	http://dx.doi.org/10.1016/S1074-7613(02)00517-4			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530971	Bronze			2022-12-18	WOS:000180860600002
J	Amrani, A; Serra, P; Yamanouchi, J; Han, BY; Thiessen, S; Verdaguer, J; Santamaria, P				Amrani, A; Serra, P; Yamanouchi, J; Han, BY; Thiessen, S; Verdaguer, J; Santamaria, P			CD154-dependent priming of diabetogenic CD4(+) T cells dissociated from activation of antigen-presenting cells	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; CD40-CD40 LIGAND INTERACTIONS; CD40 LIGAND; DENDRITIC CELLS; IN-VIVO; COSTIMULATORY SIGNAL; ALLOGRAFT-REJECTION; IMMUNE-RESPONSES; CROSS-LINKING; CUTTING EDGE	We followed the fate of K-d- or I-A(g7)-restricted beta cell-autoreactive T cells in monoclonal TCR-transgenic NOD mice expressing or lacking CD154. 8.3-NOD.RAG-2(/-)/ CD154(-/-) mice, which bear autoreactive CD8(+) T cells, developed diabetes with the same incidence and tempo as 8.3-NOD.RAG-2(-/-)CD154(+) mice. Recruitment of CD154(-/-) 8.3-CD8(+) CTL was accelerated by CD154(+) CD4(+) T cells, by expression of a B7.1 transgene in P cells or by treatment of the mice with CpG-DNA or an agonistic anti-CD40 antibody. In contrast, the autoreactive CD4(+) T cells maturing in 4.1-NOD.RAG2(-/-) mice lost their diabetogenic potential if they lacked CD154, even in the presence of CD154(+)CD4(+) T cells, B7.1 molecules on 11 cells, CpG-DNA treatment, or systemic CD40 ligation. These results demonstrate the existence of a novel, CD154-dependent pathway of CD4(+) T cell activation that is independent of CD40-mediated activation of APCs.	Univ Calgary, Dept Microbiol & Infect Dis, Fac Med, Calgary, AB T2N 4N1, Canada; Univ Calgary, Julia McFarlane Diabet Res Ctr, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Santamaria, P (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Autonell, Joan Verdaguer/A-2059-2010; Santamaria, Pere/ABF-6823-2021	Autonell, Joan Verdaguer/0000-0003-1768-9310; 				Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2000, J CLIN INVEST, V105, P459, DOI 10.1172/JCI8185; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Balasa B, 1997, J IMMUNOL, V159, P4620; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blair PJ, 2000, J EXP MED, V191, P651, DOI 10.1084/jem.191.4.651; Blotta MH, 1996, J IMMUNOL, V156, P3133; Borrow P, 1998, J VIROL, V72, P7440, DOI 10.1128/JVI.72.9.7440-7449.1998; Brenner B, 1997, FEBS LETT, V417, P301, DOI 10.1016/S0014-5793(97)01306-9; Buhlmann JE, 1999, J IMMUNOL, V162, P4373; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; den Haan JMM, 2000, P NATL ACAD SCI USA, V97, P12950, DOI 10.1073/pnas.97.24.12950; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; DING L, 1994, EUR J IMMUNOL, V24, P859, DOI 10.1002/eji.1830240413; Green EA, 2000, J EXP MED, V191, P225, DOI 10.1084/jem.191.2.225; Green EA, 1999, J EXP MED, V189, P1017; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P5138, DOI 10.1073/pnas.91.11.5138; Gurunathan S, 1998, J IMMUNOL, V161, P4563; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HERMANN P, 1995, EUR J IMMUNOL, V25, P2972, DOI 10.1002/eji.1830251039; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; Kishimoto K, 2000, J CLIN INVEST, V106, P63, DOI 10.1172/JCI9586; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Koppenhoefer U, 1997, FEBS LETT, V414, P444, DOI 10.1016/S0014-5793(97)01035-1; Lefrancois L, 1999, J EXP MED, V190, P1275, DOI 10.1084/jem.190.9.1275; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mandelbrot DA, 2001, J IMMUNOL, V167, P1174, DOI 10.4049/jimmunol.167.3.1174; Moodycliffe AM, 2000, J EXP MED, V191, P2011, DOI 10.1084/jem.191.11.2011; Moritani M, 1996, J CLIN INVEST, V98, P1851, DOI 10.1172/JCI118986; NAGATA M, 1994, J IMMUNOL, V152, P2042; Newell KA, 1999, J IMMUNOL, V163, P2358; Peng XH, 1996, EUR J IMMUNOL, V26, P1621, DOI 10.1002/eji.1830260732; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROY M, 1993, J IMMUNOL, V151, P2497; Ruedl C, 1999, J EXP MED, V189, P1875, DOI 10.1084/jem.189.12.1875; Sad S, 1997, EUR J IMMUNOL, V27, P914, DOI 10.1002/eji.1830270417; SANTAMARIA P, 1995, J IMMUNOL, V154, P2494; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Shinde S, 1996, J IMMUNOL, V157, P2764; Stephens LA, 1995, INT IMMUNOL, V7, P1885, DOI 10.1093/intimm/7.12.1885; Stout RD, 1996, IMMUNOL TODAY, V17, P487, DOI 10.1016/0167-5699(96)10060-I; THIVOLET C, 1991, J IMMUNOL, V146, P85; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Yang YP, 1996, SCIENCE, V273, P1862, DOI 10.1126/science.273.5283.1862	67	34	37	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2002	16	5					719	732		10.1016/S1074-7613(02)00315-1	http://dx.doi.org/10.1016/S1074-7613(02)00315-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049723	Bronze			2022-12-18	WOS:000175820400010
J	Yamagami, T; ten Boekel, E; Schaniel, C; Andersson, J; Rolink, A; Melchers, F				Yamagami, T; ten Boekel, E; Schaniel, C; Andersson, J; Rolink, A; Melchers, F			Four of five RAG-expressing JC kappa(-/-) small pre-Bll cells have no L chain gene rearrangements: Detection by high-efficiency single cell PCR	IMMUNITY			English	Article							B-CELLS; LIGHT-CHAIN; HEAVY-CHAIN; KAPPA LOCUS; IMMATURE; ANTIBODY; OCCUR; STAGE; MODEL	Single cell PCR assays have been further developed that detect over 80% of all V kappa J kappa V kappa RS, and V lambda J lambda rearrangements at efficiencies between 70% and 90%. These IgL chain gene rearrangement assays were used with small pre-BII cells that develop in comparably high numbers in the bone marrow of wild-type, C kappa-deficient, and JC kappa-deficient homozygous and heterozygous mice. In all of these mice, only 15%-25% of all small pre-BII cells carry V lambda J lambda rearrangements. These results confirm that lambda L chain gene rearrangements occur independently of kappa L chain gene rearrangement and expression. They also show that a large part of the small pre-BII cells that express the rearrangement machinery can develop without IgL chain gene rearrangements.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Melchers, F (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.		Schaniel, Chrisoph/C-9655-2012; Schaniel, Christoph/P-3836-2019	Schaniel, Christoph/0000-0002-1343-4858				ALT FW, 1980, CELL, V21, P1, DOI 10.1016/0092-8674(80)90109-9; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Berg J, 1990, Dev Immunol, V1, P53, DOI 10.1155/1990/56014; Ceredig R, 1998, INT IMMUNOL, V10, P49, DOI 10.1093/intimm/10.1.49; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHEN JZ, 1993, CURR OPIN IMMUNOL, V5, P194, DOI 10.1016/0952-7915(93)90004-C; COLECLOUGH C, 1990, IMMUNOL REV, V115, P173, DOI 10.1111/j.1600-065X.1990.tb00786.x; DOGLIO L, 1994, DEV IMMUNOL, V4, P13, DOI 10.1155/1994/87352; Gorman JR, 1998, ADV IMMUNOL, V69, P113, DOI 10.1016/S0065-2776(08)60607-0; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; Kirschbaum T, 1996, EUR J IMMUNOL, V26, P1613, DOI 10.1002/eji.1830260731; LANGMAN RE, 1992, 47 FOR IMM PAR I PAS, P803; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; Liu D, 1997, J IMMUNOL, V159, P6061; NADEL B, 1990, EMBO J, V9, P435, DOI 10.1002/j.1460-2075.1990.tb08128.x; PERSIANI DM, 1987, J EXP MED, V165, P1655, DOI 10.1084/jem.165.6.1655; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; ROLINK AG, 1996, IMMUNITY, V5, P433; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	26	34	34	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					309	316		10.1016/S1074-7613(00)80106-5	http://dx.doi.org/10.1016/S1074-7613(00)80106-5			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514009	Bronze			2022-12-18	WOS:000082918500006
J	Leibson, PJ				Leibson, PJ			Cytotoxic lymphocyte recognition of HLA-E: Utilizing a nonclassical window to peer into classical MHC	IMMUNITY			English	Review							NATURAL-KILLER-CELLS; CYTOLYTIC T-LYMPHOCYTES; CLASS-I MOLECULES; INHIBITORY RECEPTORS; FOREIGN ANTIGEN; CD94; EXPRESSION; GENE; IDENTIFICATION; TRANSDUCTION		Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Leibson, PJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA.							ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; ARAMBURU J, 1991, J IMMUNOL, V147, P714; Binstadt BA, 1997, IMMUNOL REV, V155, P197, DOI 10.1111/j.1600-065X.1997.tb00952.x; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Burshtyn DN, 1997, TRENDS CELL BIOL, V7, P473, DOI 10.1016/S0962-8924(97)01167-7; Colonna M, 1997, IMMUNOL REV, V155, P127, DOI 10.1111/j.1600-065X.1997.tb00945.x; DeCloux A, 1997, J IMMUNOL, V158, P2183; Dissen E, 1997, EUR J IMMUNOL, V27, P2080, DOI 10.1002/eji.1830270836; FERRINI S, 1994, EUR J IMMUNOL, V24, P2294, DOI 10.1002/eji.1830241005; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; Grimsley C, 1997, HUM IMMUNOL, V52, P33, DOI 10.1016/S0198-8859(96)00241-8; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; KOLLER BH, 1988, J IMMUNOL, V141, P897; KUREPA Z, 1998, IN PRESS J EXP MED; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lee N, 1998, J IMMUNOL, V160, P4951; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; LLANO M, 1998, IN PRESS EUR J IMMUN; LopezBotet M, 1997, IMMUNOL REV, V155, P165, DOI 10.1111/j.1600-065X.1997.tb00949.x; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; MINGARI MC, 1995, INT IMMUNOL, V7, P697, DOI 10.1093/intimm/7.4.697; Mingari MC, 1998, P NATL ACAD SCI USA, V95, P1172, DOI 10.1073/pnas.95.3.1172; Mingari MC, 1998, IMMUNOL TODAY, V19, P153, DOI 10.1016/S0167-5699(97)01236-X; Mingari MC, 1997, INT IMMUNOL, V9, P485, DOI 10.1093/intimm/9.4.485; Mingari MC, 1996, P NATL ACAD SCI USA, V93, P12433, DOI 10.1073/pnas.93.22.12433; Moretta A, 1997, CURR OPIN IMMUNOL, V9, P694, DOI 10.1016/S0952-7915(97)80051-9; MORETTA A, 1990, J EXP MED, V171, P695, DOI 10.1084/jem.171.3.695; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Renard V, 1997, IMMUNOL REV, V155, P205, DOI 10.1111/j.1600-065X.1997.tb00953.x; Sivori S, 1996, EUR J IMMUNOL, V26, P2487, DOI 10.1002/eji.1830261032; Smith KM, 1998, J IMMUNOL, V161, P7; SOLOSKI MJ, 1995, IMMUNOL REV, V147, P67, DOI 10.1111/j.1600-065X.1995.tb00088.x; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; VIDOVIC D, 1989, NATURE, V340, P646, DOI 10.1038/340646a0; WEI XH, 1990, HUM IMMUNOL, V29, P131, DOI 10.1016/0198-8859(90)90076-2; Westgaard IH, 1998, EUR J IMMUNOL, V28, P1839, DOI 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Yokoyama WM, 1997, J EXP MED, V186, P1803, DOI 10.1084/jem.186.11.1803	50	34	39	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1998	9	3					289	294		10.1016/S1074-7613(00)80611-1	http://dx.doi.org/10.1016/S1074-7613(00)80611-1			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768748	Bronze			2022-12-18	WOS:000076202300001
J	Garza, KM; Griggs, ND; Tung, KSK				Garza, KM; Griggs, ND; Tung, KSK			Neonatal injection of an ovarian peptide induces autoimmune ovarian disease in female mice: Requirement of endogenous neonatal ovaries	IMMUNITY			English	Article							MYELIN BASIC-PROTEIN; ZONA-PELLUCIDA; TOLERANCE; ENCEPHALOMYELITIS; ANTIBODIES; MECHANISM	Neonatal female mice injected with the self ZP3 peptide are not tolerant to the peptide; they develop autoimmune ovarian disease (AOD) and autoantibody response 5 weeks rater. ZP3 challenge leads to severe AOD and ZP3-specific T cell and antibody responses. In contrast, neonatal tolerance to foreign ZP3 peptide is established in male mice: ZP3 peptide-specific T cell proliferative response is reduced and AOD is absent in ovarian grafts. Tolerance is associated with a Th2-dominant T cell cytokine and antibody isotype profiles. As controls, neonatal tolerance to foreign peptides, with Th2 deviation, was induced in both male and female mice. Endogenous ZP3 is important for the gender difference. Ablation of ovaries in female mice on days 2 and 5, but not on day 7 or 14, switches the ZP3 autoimmune response to a tolerogenic response with a concomitant change in cytokine profile. Thus, neonatal self ZP3 peptide, supported by endogenous ovaries within a neonatal time window, evokes a pathogenic autoimmune response.	UNIV VIRGINIA, DEPT MICROBIOL, CHARLOTTESVILLE, VA 22908 USA	University of Virginia	Garza, KM (corresponding author), UNIV VIRGINIA, DEPT PATHOL, CHARLOTTESVILLE, VA 22908 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM017853] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-41236] Funding Source: Medline; NICHD NIH HHS [HD 28934] Funding Source: Medline; NIGMS NIH HHS [1 F31 GM17853-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACCINNI L, 1980, AM J PATHOL, V99, P589; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BYSKOV AG, 1978, VERTEBRATE OVARY COM, P54; CHEN JS, 1991, J IMMUNOL, V147, P3672; CHEN NX, 1995, TRANSPLANTATION, V59, P933, DOI 10.1097/00007890-199504150-00002; CLAYTON JP, 1989, J EXP MED, V169, P1681, DOI 10.1084/jem.169.5.1681; DEAN J, 1992, J CLIN INVEST, V89, P1055, DOI 10.1172/JCI115684; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; GAMMON G, 1986, NATURE, V319, P413, DOI 10.1038/319413a0; GARZA KM, 1995, J IMMUNOL, V155, P5444; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Holt PG, 1996, J EXP MED, V183, P1297, DOI 10.1084/jem.183.4.1297; JONES LA, 1990, J EXP MED, V172, P1277, DOI 10.1084/jem.172.5.1277; LABARBERA AR, 1988, AM J REPROD IMMUNOL, V16, P115; LOU YH, 1995, J IMMUNOL, V155, P2715; MATSUO S, 1985, J CLIN INVEST, V75, P1369, DOI 10.1172/JCI111838; MIGLIORINI P, 1991, J IMMUNOL METHODS, V139, P107, DOI 10.1016/0022-1759(91)90357-L; POWELL TJ, 1990, J IMMUNOL, V144, P854; QIN Y, 1989, EUR J IMMUNOL, V19, P373, DOI 10.1002/eji.1830190223; RHIM SH, 1992, J CLIN INVEST, V89, P28, DOI 10.1172/JCI115572; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; SCHNEIDER R, 1989, J EXP MED, V178, P419; Singh RR, 1996, J EXP MED, V183, P1613, DOI 10.1084/jem.183.4.1613; SMITH H, 1992, J IMMUNOL, V149, P2212; SMITH H, 1989, SCIENCE, V245, P749, DOI 10.1126/science.2788921; TUNG KSK, 1991, INT ACA PAT, V33, P308; YOUNG CR, 1983, J IMMUNOGENET, V10, P161	30	34	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1997	6	1					89	96		10.1016/S1074-7613(00)80245-9	http://dx.doi.org/10.1016/S1074-7613(00)80245-9			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052840	Bronze			2022-12-18	WOS:A1997XB16100009
J	Klawonn, AM; Fritz, M; Castany, S; Pignatelli, M; Canal, C; Simila, F; Tejeda, HA; Levinsson, J; Jaarola, M; Jakobsson, J; Hidalgo, J; Heilig, M; Bonci, A; Engblom, D				Klawonn, Anna M.; Fritz, Michael; Castany, Silvia; Pignatelli, Marco; Canal, Carla; Simila, Fredrik; Tejeda, Hugo A.; Levinsson, Julia; Jaarola, Maarit; Jakobsson, Johan; Hidalgo, Juan; Heilig, Markus; Bonci, Antonello; Engblom, David			Microglial activation elicits a negative affective state through prostaglandin-mediated modulation of striatal neurons	IMMUNITY			English	Article							DEPRESSIVE-LIKE BEHAVIOR; IMMUNE-SYSTEM; INTERFERON-GAMMA; DOUBLE-BLIND; BRAIN; INFLAMMATION; METAANALYSIS; REWARD; STRESS; SUSCEPTIBILITY	Microglia are activated in many neurological diseases and have been suggested to play an important role in the development of affective disorders including major depression. To investigate how microglial signaling regulates mood, we used bidirectional chemogenetic manipulations of microglial activity in mice. Activation of microglia in the dorsal striatum induced local cytokine expression and a negative affective state characterized by anhedonia and aversion, whereas inactivation of microglia blocked aversion induced by systemic inflammation. Interleukin-6 signaling and cyclooxygenase-1 mediated prostaglandin synthesis in the microglia were critical for the inflammation-induced aversion. Correspondingly, microglial activation led to a prostaglandin-dependent reduction of the excitability of striatal neurons. These findings demonstrate a mechanism by which microglial activation causes negative affect through prostaglandin-dependent modulation of striatal neurons and indicate that interference with this mechanism could milden the depressive symptoms in somatic and psychiatric diseases involving microglial activation.	[Klawonn, Anna M.; Fritz, Michael; Castany, Silvia; Simila, Fredrik; Levinsson, Julia; Jaarola, Maarit; Heilig, Markus; Engblom, David] Linkoping Univ, Dept Biomed & Clin Sci, S-58185 Linkoping, Sweden; [Klawonn, Anna M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Pignatelli, Marco; Tejeda, Hugo A.] NIDA, Synapt Plastic Sect, Cellular Neurobiol Res Branch, Baltimore, MD 21224 USA; [Pignatelli, Marco] Washington Univ, Dept Psychiat, Sch Med, St Louis, MO 63110 USA; [Pignatelli, Marco] Washington Univ, Taylor Family Inst Innovat Psychiat Res, Sch Med, St Louis, MO 63110 USA; [Canal, Carla; Hidalgo, Juan] Autonomous Univ Barcelona, Inst Neurosci, Barcelona 08028, Spain; [Canal, Carla; Hidalgo, Juan] Autonomous Univ Barcelona, Dept Cellular Biol Physiol & Immunol, Barcelona 08028, Spain; [Jakobsson, Johan] Lund Univ, Dept Expt Med Sci, Lab Mol Neurogenet, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden; [Jakobsson, Johan] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden; [Bonci, Antonello] Global Inst Addict, Miami, FL 33132 USA; [Fritz, Michael] Univ Ulm, Dept Forens Psychiat & Psychotherapy, Ulm, Germany	Linkoping University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Washington University (WUSTL); Washington University (WUSTL); Autonomous University of Barcelona; Autonomous University of Barcelona; Lund University; Lund University; Ulm University	Engblom, D (corresponding author), Linkoping Univ, Dept Biomed & Clin Sci, S-58185 Linkoping, Sweden.	david.engblom@liu.se	Jakobsson, Johan/E-7745-2014; Klawonn, Anna Mathia/AAA-6408-2022; Castany, Silvia/AEA-5806-2022; Quintana, Sílvia Castany/N-6261-2019; Fritz, Michael/AGE-9635-2022; Tejeda, Hugo/AAX-2529-2021; Hidalgo, Juan/C-9082-2011	Jakobsson, Johan/0000-0003-0669-7673; Quintana, Sílvia Castany/0000-0002-9530-2647; Hidalgo, Juan/0000-0003-0921-1122; Klawonn, Anna Mathia/0000-0002-0272-6951	Swedish Medical Research Council; Knut and Alice Wallenberg Foundation; Swedish Brain Foundation; Linkoping Parkinson Foundation; Lars Hierta Memorial Foundation; County Council of Ostergotland;  [SAF2014-56546-R];  [RTI2018-101105B-I00];  [B18P0023]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Brain Foundation; Linkoping Parkinson Foundation; Lars Hierta Memorial Foundation; County Council of Ostergotland; ; ; 	This work was supported by the Swedish Medical Research Council (including a postdoc fellowship to A.M.K.), the Knut and Alice Wallenberg Foundation, the Swedish Brain Foundation, the Linkoping Parkinson Foundation, the Lars Hierta Memorial Foundation, and the County Council of Ostergotland. J.H. acknowledges the support of SAF2014-56546-R and RTI2018-101105B-I00. C.C. was supported by a PhD fellowship; B18P0023. We thank Lindsay De Biase for generous support in the planning and implementation of the electrophysiology experiments. We also thank Joanna Zajdel and Anton Forsberg for contributing to the immunohistochemistry experiments. We thank Markus Schwaninger for providing the Slco1c1-creER line, Michel Vierboom for providing brain tissue from rhesus macaques, and Henrik Druid and Kanar Alkass for providing the human brain samples.	Aerblom M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2801; BARDO MT, 1995, NEUROSCI BIOBEHAV R, V19, P39, DOI 10.1016/0149-7634(94)00021-R; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Blomqvist A, 2018, NEUROSCIENTIST, V24, P381, DOI 10.1177/1073858418760481; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Capuron L, 2012, ARCH GEN PSYCHIAT, V69, P1044, DOI 10.1001/archgenpsychiatry.2011.2094; D'Mello C, 2014, BRAIN BEHAV IMMUN, V35, P9, DOI 10.1016/j.bbi.2013.10.009; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; Emadi-Kouchak H, 2016, INT CLIN PSYCHOPHARM, V31, P20, DOI 10.1097/YIC.0000000000000098; Engler H, 2017, MOL PSYCHIATR, V22, P1448, DOI 10.1038/mp.2016.264; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Francis TC, 2017, BIOL PSYCHIAT, V81, P645, DOI 10.1016/j.biopsych.2016.09.007; Fritz M, 2018, BRAIN BEHAV IMMUN, V67, P54, DOI 10.1016/j.bbi.2017.08.020; Fritz M, 2016, J CLIN INVEST, V126, P695, DOI 10.1172/JCI83844; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Goldsmith DR, 2016, MOL PSYCHIATR, V21, P1696, DOI 10.1038/mp.2016.3; Grace PM, 2018, EXP NEUROL, V304, P125, DOI 10.1016/j.expneurol.2018.03.005; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kessing LV, 2019, ACTA PSYCHIAT SCAND, V139, P68, DOI 10.1111/acps.12957; Klawonn AM, 2018, COLD SH Q B, V83, P119, DOI 10.1101/sqb.2018.83.037457; Klawonn AM, 2018, J CLIN INVEST, V128, P3160, DOI 10.1172/JCI97854; Kohler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Kohler-Forsherg O, 2019, ACTA PSYCHIAT SCAND, V139, P404, DOI 10.1111/acps.13016; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Labonte B, 2017, NAT MED, V23, P1102, DOI 10.1038/nm.4386; Lehmann ML, 2019, J NEUROSCI, V39, P5594, DOI 10.1523/JNEUROSCI.0184-19.2019; Lehmann ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28737-8; Lindqvist D, 2013, BRAIN BEHAV IMMUN, V33, P183, DOI 10.1016/j.bbi.2013.07.007; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Liu XY, 2019, IMMUNITY, V50, P317, DOI [10.1016/j.immuni.2019.02.012, 10.1016/j.immuni.2018.12.012]; Massaly N, 2019, NEURON, V102, P564, DOI 10.1016/j.neuron.2019.02.029; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Naviaux JC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.33; Nie X, 2018, NEURON, V99, P464, DOI 10.1016/j.neuron.2018.06.035; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pignatelli M, 2017, NEURON, V93, P425, DOI 10.1016/j.neuron.2016.12.030; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Sanchis P, 2020, GLIA, V68, P999, DOI 10.1002/glia.23758; Savitz JB, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0073-7; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Singh AK, 2017, J CLIN INVEST, V127, P1370, DOI 10.1172/JCI90678; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tanaka K, 2012, J NEUROSCI, V32, P4319, DOI 10.1523/JNEUROSCI.5952-11.2012; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Torres-Platas SG, 2014, BRAIN BEHAV IMMUN, V42, P50, DOI 10.1016/j.bbi.2014.05.007; Wang AK, 2018, SCHIZOPHRENIA BULL, V44, P75, DOI 10.1093/schbul/sbx035; Weber MD, 2019, BIOL PSYCHIAT, V85, P667, DOI 10.1016/j.biopsych.2018.10.009; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Zabala A, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708743; Zhao XF, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0114-19.2019	64	33	34	5	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					225	+		10.1016/j.immuni.2020.12.016	http://dx.doi.org/10.1016/j.immuni.2020.12.016		FEB 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33476547	Bronze			2022-12-18	WOS:000627407700008
J	Umotoy, J; Bagaya, BS; Joyce, C; Schiffner, T; Menis, S; Saye-Francisco, KL; Biddle, T; Mohan, S; Vollbrecht, T; Kalyuzhniy, O; Madzorera, S; Kitchin, D; Lambson, B; Nonyane, M; Kilembe, W; Poignard, P; Schief, WR; Burton, DR; Murrell, B; Moore, PL; Briney, B; Sok, D; Landais, E				Umotoy, Jeffrey; Bagaya, Bernard S.; Joyce, Collin; Schiffner, Torben; Menis, Sergey; Saye-Francisco, Karen L.; Biddle, Trevor; Mohan, Sanjay; Vollbrecht, Thomas; Kalyuzhniy, Oleksander; Madzorera, Sharon; Kitchin, Dale; Lambson, Bronwen; Nonyane, Molati; Kilembe, William; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Murrell, Ben; Moore, Penny L.; Briney, Bryan; Sok, Devin; Landais, Elise		IAVI Protocol C Investigators; IAVI African Hiv Res Network	Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan	IMMUNITY			English	Article							MONOCLONAL-ANTIBODIES; CD4 BINDING; B-CELLS; ENVELOPE; GERMLINE; POTENT; SEQUENCE; VACCINE; DIVERSIFICATION; RECOMBINANT	The VH1-2 restricted VRC01-class of antibodies targeting the HIV envelope CD4 binding site are a major focus of HIV vaccine strategies. However, a detailed analysis of VRC01-class antibody development has been limited by the rare nature of these responses during natural infection and the lack of longitudinal sampling of such responses. To inform vaccine strategies, we mapped the development of a VRC01-class antibody lineage (PCIN63) in the subtype C infected IAVI Protocol C neutralizer PC063. PCIN63 monoclonal antibodies had the hallmark VRC01-class features and demonstrated neutralization breadth similar to the prototype VRC01 antibody, but were 2- to 3-fold less mutated. Maturation occurred rapidly within similar to 24 months of emergence of the lineage and somatic hypermutations accumulated at key contact residues. This longitudinal study of broadly neutralizing VRC01-class antibody lineage reveals early binding to the N276-glycan during affinity maturation, which may have implications for vaccine design.	[Umotoy, Jeffrey; Menis, Sergey; Kalyuzhniy, Oleksander; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Sok, Devin; Landais, Elise] Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Umotoy, Jeffrey; Menis, Sergey; Kalyuzhniy, Oleksander; Sok, Devin; Landais, Elise] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Bagaya, Bernard S.] UVRI IAVI HIV Vaccine Program, Entebbe, Uganda; [Bagaya, Bernard S.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Immunol & Mol Biol, Kampala, Uganda; [Joyce, Collin; Schiffner, Torben; Saye-Francisco, Karen L.; Biddle, Trevor; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Briney, Bryan; Sok, Devin; Landais, Elise] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Schiffner, Torben; Schief, William R.; Burton, Dennis R.; Briney, Bryan; Sok, Devin] Scripps Res Inst, CHAVI ID, La Jolla, CA 92037 USA; [Mohan, Sanjay; Vollbrecht, Thomas; Murrell, Ben] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Madzorera, Sharon; Kitchin, Dale; Lambson, Bronwen; Nonyane, Molati; Moore, Penny L.] NHLS, Natl Inst Communicable Dis, Ctr HIV & STIs, ZA-2131 Johannesburg, South Africa; [Kilembe, William] Rwanda Zambia HIV Res Grp, Lusaka, Zambia; [Kilembe, William] Rwanda Zambia HIV Res Grp, Ndola, Zambia; [Poignard, Pascal] Univ Grenoble Alpes, Inst Biol Struct, CEA, CNRS, F-38044 Grenoble, France; [Poignard, Pascal] Ctr Hosp Univ Grenoble Alpes, F-38044 Grenoble, France; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02114 USA; [Murrell, Ben] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Moore, Penny L.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, ZA-2050 Johannesburg, South Africa; [Moore, Penny L.] Univ KwaZulu Natal, CAPRISA, ZA-4013 Durban, South Africa	International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; Makerere University; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Karolinska Institutet; University of Witwatersrand; University of Kwazulu Natal	Sok, D; Landais, E (corresponding author), Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.; Sok, D; Landais, E (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10004 USA.; Sok, D; Landais, E (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Sok, D (corresponding author), Scripps Res Inst, CHAVI ID, La Jolla, CA 92037 USA.	dsok@iavi.org; elandais@iavi.org	poignard, pascal/N-6678-2013; Vollbrecht, Thomas/S-4847-2018; poignard, pascal/AAB-4613-2020; Schief, William/ABF-3645-2020; Murrell, Ben/AAM-1188-2021	Vollbrecht, Thomas/0000-0003-1151-8844; Schief, William/0000-0002-1120-0150; Murrell, Ben/0000-0002-0393-4445; Biddle, Trevor/0000-0001-9245-0188; Umotoy, Jeffrey/0000-0003-0687-5820; Poignard, Pascal/0000-0002-0021-7192; Joyce, Collin/0000-0002-8739-3219; Kalyuzhniy, Oleksandr/0000-0002-5273-1951	Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; World Bank; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); USAID; National Institute of Health (NIH) Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant [UM1AI100663]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grants [OPP1084519, OPP1115782]; National Institute of Allergy and Infectious Diseases (NIAID) [R00AI120851, UM1AI068618]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa [98341]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068618, P30AI036214, R00AI120851, UM1AI100663] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; World Bank(The World Bank India); Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); USAID(United States Agency for International Development (USAID)); National Institute of Health (NIH) Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grants; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan in partnership with The World Bank, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org.This study was made possible by the generous support of the American people through USAID. The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government. This work was also supported by National Institute of Health (NIH) Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663 to BB, DS and DRB, as well as the International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grants OPP1084519 and OPP1115782. BM was supported by grants R00AI120851 and UM1AI068618 from the National Institute of Allergy and Infectious Diseases (NIAID). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. P.L.M. is supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No 98341). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institute of General Medical Sciences or the National Institutes of Health.	Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bonsignori M, 2018, IMMUNITY, V49, P1162, DOI 10.1016/j.immuni.2018.10.015; Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Borst AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37688; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Briney B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23901; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eren K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006498; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Fauci AS, 2017, JAMA-J AM MED ASSOC, V318, P1535, DOI 10.1001/jama.2017.13505; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2016, IMMUNITY, V44, P939, DOI 10.1016/j.immuni.2016.03.006; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Landais E, 2017, IMMUNITY, V47, P990, DOI 10.1016/j.immuni.2017.11.002; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rantalainen K, 2018, CELL REP, V23, P3249, DOI 10.1016/j.celrep.2018.05.046; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Rusert P, 2016, NAT MED, V22, P1260, DOI 10.1038/nm.4187; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Smith ML, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew018; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang P, 2018, CELL HOST MICROBE, V23, P832, DOI 10.1016/j.chom.2018.05.002; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	56	33	33	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					141	+		10.1016/j.immuni.2019.06.004	http://dx.doi.org/10.1016/j.immuni.2019.06.004			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315032	Green Published, hybrid			2022-12-18	WOS:000475561000017
J	Li, X; Deng, M; Petrucelli, AS; Zhu, C; Mo, JY; Zhang, L; Tam, JW; Ariel, P; Zhao, BY; Zhang, S; Ke, HM; Li, PW; Dokholyan, NV; Duncan, JA; Ting, JPY				Li, Xin; Deng, Meng; Petrucelli, Alex S.; Zhu, Cheng; Mo, Jinyao; Zhang, Lu; Tam, Jason W.; Ariel, Pablo; Zhao, Baoyu; Zhang, Song; Ke, Hengming; Li, Pingwei; Dokholyan, Nikolay, V; Duncan, Joseph A.; Ting, Jenny P-Y			Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor that Activates Type I Interferon	IMMUNITY			English	Article							INNATE IMMUNE SENSOR; GMP-AMP SYNTHASE; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; ATP BINDING; INFLAMMASOME; FAMILY; NOD1; PEPTIDOGLYCAN; RECOGNITION	Immune suppression is a crucial component of immunoregulation and a subgroup of nucleotide-binding domain (NBD), leucine-rich repeat (LRR)-containing proteins (NLRB) attenuate innate immunity. How this inhibitory function is controlled is unknown. A key question is whether microbial ligands can regulate this inhibition. NLRC3 is a negative regulator that attenuates type I interferon (IFN-I) response by sequestering and attenuating stimulator of interferon genes (STING) activation. Here, we report that NLRC3 binds viral DNA and other nucleic acids through its LRR domain. DNA binding to NLRC3 increases its ATPase activity, and ATP-binding by NLRC3 diminishes its interaction with STING, thus licensing an IFN-I response. This work uncovers a mechanism wherein viral nucleic acid binding releases an inhibitory innate receptor from its target.	[Li, Xin; Deng, Meng; Petrucelli, Alex S.; Zhang, Lu; Tam, Jason W.; Zhang, Song; Dokholyan, Nikolay, V; Ting, Jenny P-Y] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ting, Jenny P-Y] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Deng, Meng] Univ N Carolina, Oral & Craniofacial Biomed PhD Program, Sch Dent, Chapel Hill, NC 27599 USA; [Zhu, Cheng; Ke, Hengming; Dokholyan, Nikolay, V] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Mo, Jinyao; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Zhang, Lu] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Med Ctr, Durham, NC 27701 USA; [Zhang, Lu] Duke Univ, Duke Mol Physiol Inst, Med Ctr, Durham, NC 27701 USA; [Ariel, Pablo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Zhao, Baoyu; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Dokholyan, Nikolay, V] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Dokholyan, Nikolay, V] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Ting, JPY (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Zhu, Cheng/AAR-5827-2020; deng, meng/X-8242-2019; Dokholyan, Nikolay/B-2238-2009	Zhu, Cheng/0000-0003-0260-6287; deng, meng/0000-0002-9051-7534; Dokholyan, Nikolay/0000-0002-8225-4025; Zhang, Song/0000-0003-1492-8988	NIH [U19-AI109965, R01AI029564, U19-AI067798, R01GM114015, R01GM123247];  [T32CA009156]; NATIONAL CANCER INSTITUTE [P30CA016086, T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109965, U19AI067798, R01AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114015, R01GM123247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Ashutosh Tripathy, Director of the Center for Structural Biology University of North Carolina (UNC) Macromolecular Interactions Facility, for providing core and technical support. We also thank William G. Fusco at UNC for assistance with the EMSA. This work was supported by NIH U19-AI109965 to J.P.-Y.T. and J.A.D and NIH R01AI029564 and U19-AI067798 to J.P.-Y.T. N.V.D. acknowledges NIH support grants R01GM114015 and R01GM123247. A.S.P. and J.W.T. were supported by T32CA009156.	Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Eren E, 2017, J BIOL CHEM, V292, P12691, DOI 10.1074/jbc.M116.769695; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hara H, 2018, CELL, V175, P1651, DOI 10.1016/j.cell.2018.09.047; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu SF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007266; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Kalamvoki M, 2014, P NATL ACAD SCI USA, V111, pE611, DOI 10.1073/pnas.1323414111; Karki R, 2016, NATURE, V540, P583, DOI 10.1038/nature20597; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Lu PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145420; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Petrucelli A, 2012, J VIROL, V86, P8653, DOI 10.1128/JVI.00465-12; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tocker AM, 2017, J IMMUNOL, V199, P2896, DOI 10.4049/jimmunol.1601370; Uchimura T, 2018, IMMUNITY, V49, P1049, DOI 10.1016/j.immuni.2018.10.008; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z	45	33	40	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					591	+		10.1016/j.immuni.2019.02.009	http://dx.doi.org/10.1016/j.immuni.2019.02.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893587	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000461660500011
J	Roy, K; Mitchell, S; Liu, Y; Ohta, S; Lin, YS; Metzig, MO; Nutt, SL; Hoffmann, A				Roy, Koushik; Mitchell, Simon; Liu, Yi; Ohta, Sho; Lin, Yu-Sheng; Metzig, Marie Oliver; Nutt, Stephen L.; Hoffmann, Alexander			A Regulatory Circuit Controlling the Dynamics of NF kappa B cRel Transitions B Cells from Proliferation to Plasma Cell Differentiation	IMMUNITY			English	Article							TRANSCRIPTION FACTORS; TERMINAL DIFFERENTIATION; C-MYC; GENE-EXPRESSION; BLIMP-1; LYMPHOCYTES; ACTIVATION; REPRESSION; GENERATION; PU.1	Humoral immunity depends on efficient activation of B cells and their subsequent differentiation into antibody-secreting cells (ASCs). The transcription factor NFKB cRel is critical for B cell proliferation, but incorporating its known regulatory interactions into a mathematical model of the ASC differentiation circuit prevented ASC generation in simulations. Indeed, experimental ectopic cRel expression blocked ASC differentiation by inhibiting the transcription factor Blimp1 , and in wild-type (WT) cells cRel was dynamically repressed during ASC differentiation by Blimp1 binding the Rel locus. Including this bi-stable circuit of mutual cRel-Blimp1 antagonism into a multi-scale model revealed that dynamic repression of cRel controls the switch from B cell proliferation to ASC generation phases and hence the respective cell population dynamics. Our studies provide a mechanistic explanation of how dysregulation of this bi-stable circuit might result in pathologic B cell population phenotypes and thus offer new avenues for diagnostic stratification and treatment.	[Roy, Koushik; Mitchell, Simon; Liu, Yi; Ohta, Sho; Lin, Yu-Sheng; Metzig, Marie Oliver; Hoffmann, Alexander] Univ Calif Los Angeles, Signaling Syst Lab, Inst Quantitat & Computat Biosci, Los Angeles, CA 90095 USA; [Roy, Koushik; Mitchell, Simon; Liu, Yi; Ohta, Sho; Lin, Yu-Sheng; Metzig, Marie Oliver; Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia; [Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Walter & Eliza Hall Institute; University of Melbourne	Hoffmann, A (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	ahoffmann@ucla.edu	Nutt, Stephen L/C-9256-2013; Mitchell, Simon/N-4390-2013; Roy, Koushik/AAM-2109-2021	Nutt, Stephen L/0000-0002-0020-6637; Mitchell, Simon/0000-0003-1091-6349; Roy, Koushik/0000-0003-1818-9027; Hoffmann, Alexander/0000-0002-5607-3845	National Health and Medical Research Council of Australia [1054925, 1058238]; NIH National Institute of Allergy and Infectious Diseases [R01AI132731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132731] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Sherie Morrison (University of California, Los Angeles [UCLA]) for the generous gift of BCL1 cell line, Lynn Corcoran (Walter and Eliza Hall Institute [WEHI]) and Meinrad Busslinger (Research Institute of Molecular Pathology [IMP Vienna]) for depositing high-quality datasets, Dinesh Rao (UCLA) for helpful discussions, and the Johnson Comprehensive Cancer Center Flow Cytometry Core Facility (UCLA) for expert support. S.L.N. was supported by National Health and Medical Research Council of Australia grants (1054925 and 1058238). This work was supported by a grant from the NIH National Institute of Allergy and Infectious Diseases (R01AI132731) to A.H.	Almaden JV, 2014, CELL REP, V9, P2098, DOI 10.1016/j.celrep.2014.11.024; Alves BN, 2014, J IMMUNOL, V192, P3121, DOI 10.4049/jimmunol.1302351; Arjunaraja S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00913; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Cattoretti G, 2005, J PATHOL, V206, P76, DOI 10.1002/path.1752; Ceribelli M, 2014, P NATL ACAD SCI USA, V111, P11365, DOI 10.1073/pnas.1411701111; Couter CJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54114; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Heinzel S, 2017, NAT IMMUNOL, V18, P96, DOI 10.1038/ni.3598; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hunter JE, 2016, ONCOGENE, V35, P3476, DOI 10.1038/onc.2015.399; Kaileh M, 2012, IMMUNOL REV, V246, P254, DOI 10.1111/j.1600-065X.2012.01106.x; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kaplan D, 2012, UNDERSTANDING NONLIN; Kim Y, 2009, MOL IMMUNOL, V46, P3283, DOI 10.1016/j.molimm.2009.07.027; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Martinez MR, 2012, P NATL ACAD SCI USA, V109, P2672, DOI 10.1073/pnas.1113019109; Mendez A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004696; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Mitchell S, 2018, P NATL ACAD SCI USA, V115, pE2888, DOI 10.1073/pnas.1715639115; Moens L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00065; Morgan MAJ, 2009, MOL CELL BIOL, V29, P5813, DOI 10.1128/MCB.00670-09; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; O'Dea E, 2009, WIRES SYST BIOL MED, V1, P107, DOI 10.1002/wsbm.30; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shinohara H, 2014, SCIENCE, V344, P760, DOI 10.1126/science.1250020; Shokhirev MN, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145554; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Willis SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01605-1; Xia Y, 2017, LEUKEMIA, V31, P625, DOI 10.1038/leu.2016.243; Yoon H, 2010, J IMMUNOL, V184, P5018, DOI 10.4049/jimmunol.1000079; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	56	33	33	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					616	+		10.1016/j.immuni.2019.02.004	http://dx.doi.org/10.1016/j.immuni.2019.02.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30850343	Green Accepted, Bronze			2022-12-18	WOS:000461660500013
J	Gawden-Bone, CM; Frazer, GL; Richard, AC; Ma, CY; Strege, K; Griffiths, GM				Gawden-Bone, Christian M.; Frazer, Gordon L.; Richard, Arianne C.; Ma, Claire Y.; Strege, Katharina; Griffiths, Gillian M.			PIP5 Kinases Regulate Membrane Phosphoinositide and Actin Composition for Targeted Granule Secretion by Cytotoxic Lymphocytes	IMMUNITY			English	Article							CELL-MEDIATED CYTOTOXICITY; PLECKSTRIN-HOMOLOGY-DOMAIN; IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; T-CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PROTEIN TRAFFICKING; MULTIPLE POOLS; SURFACE-CHARGE; PRIMARY CILIA	How cytotoxic T lymphocytes (CTLs) sense T cell receptor (TCR) signaling in order to specialize an area of plasma membrane for granule secretion is not understood. Here, we demonstrate that immune synapse formation led to rapid localized changes in the phosphoinositide composition of the plasma membrane, both reducing phosphoinositide-4-phosphate (PI(4) P), PI(4,5)P2, and PI(3,4,5)P3 and increasing diacylglycerol (DAG) and PI(3,4)P2 within the first 2 min of synapse formation. These changes reduced negative charge across the synapse, triggering the release of electrostatically bound PIP5 kinases that are required to replenish PI(4,5)P2. As PI(4,5)P2 decreased, actin was depleted from the membrane, allowing secretion. Forced localization of PIP5K beta across the synapse prevented actin depletion, blocking both centrosome docking and secretion. Thus, PIP5Ks act as molecular sensors of TCR activation, controlling actin recruitment across the synapse, ensuring exquisite co-ordination between TCR signaling and CTL secretion	[Gawden-Bone, Christian M.; Frazer, Gordon L.; Richard, Arianne C.; Ma, Claire Y.; Strege, Katharina; Griffiths, Gillian M.] Cambridge Inst Med Res, Cambridge Biomed Campus, Cambridge CB2 0XY, England; [Richard, Arianne C.] Canc Res UK Cambridge, Cambridge Biomed Campus, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Griffiths, GM (corresponding author), Cambridge Inst Med Res, Cambridge Biomed Campus, Cambridge CB2 0XY, England.	gg305@cam.ac.uk		Griffiths, Gillian/0000-0003-0434-5842; Gawden-Bone, Christian/0000-0003-0413-3727; Ma, Claire/0000-0002-4244-7535; Richard, Arianne/0000-0002-8708-9997	Wellcome Trust [103930, 100140]; MRC Skills Development Fellowship [P014178]; Addenbrooke's Charitable Trust Clinical Research Fellowship [23/17]; MRC [MR/P014178/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Skills Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Addenbrooke's Charitable Trust Clinical Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research was funded by Wellcome Trust grants 103930 and 100140 to G.M.G., an MRC Skills Development Fellowship to A.C.R. (P014178), and an Addenbrooke's Charitable Trust Clinical Research Fellowship to C.Y.M. (23/17). We thank Yukako Asano for generating the EL4-FR cell line and Figure S5; Sergio Grinstein for helpful discussions; Reiner Schulte and Chiara Cossetti from the cell cytometry facility; and Jane Stinchcombe, Yukako Asano, and Alison Schuldt for critical reading of the manuscript.	Anderson KE, 2000, CURR BIOL, V10, P1403, DOI 10.1016/S0960-9822(00)00794-6; Basu R, 2016, CELL, V165, P100, DOI 10.1016/j.cell.2016.01.021; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Carisey AF, 2018, CURR BIOL, V28, P489, DOI 10.1016/j.cub.2017.12.044; Chauveau A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005287; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dyson JM, 2017, J CELL BIOL, V216, P247, DOI 10.1083/jcb.201511055; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hakim S, 2012, CURR TOP MICROBIOL, V362, P246, DOI 10.1007/978-94-007-5025-8_12; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hsu HT, 2016, J CELL BIOL, V215, P875, DOI 10.1083/jcb.201604136; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jenkins MR, 2014, ELIFE, V3, DOI 10.7554/eLife.01310; KALINA M, 1976, CELL IMMUNOL, V25, P41, DOI 10.1016/0008-8749(76)90095-2; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Kolay S, 2016, BIOCHEM J, V473, P1681, DOI 10.1042/BCJ20160069; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lai CL, 2013, J MOL BIOL, V425, P3073, DOI 10.1016/j.jmb.2013.05.026; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu AZ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600925; Ma YQ, 2017, NAT BIOTECHNOL, V35, P363, DOI 10.1038/nbt.3828; Nakatsu F, 2015, DEV CELL, V34, P379, DOI 10.1016/j.devcel.2015.08.008; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Phua SC, 2018, CURR OPIN CELL BIOL, V50, P72, DOI 10.1016/j.ceb.2018.01.008; Pirruccello M, 2012, TRENDS BIOCHEM SCI, V37, P134, DOI 10.1016/j.tibs.2012.01.002; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Ritter AT, 2017, P NATL ACAD SCI USA, V114, pE6585, DOI 10.1073/pnas.1710751114; Ritter AT, 2015, IMMUNITY, V42, P864, DOI 10.1016/j.immuni.2015.04.013; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; SANDERSON CJ, 1976, PROC R SOC SER B-BIO, V192, P221, DOI 10.1098/rspb.1976.0010; SANDERSON CJ, 1979, IMMUNOLOGY, V36, P119; SANDERSON CJ, 1977, PROC R SOC SER B-BIO, V198, P315, DOI 10.1098/rspb.1977.0100; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2015, CURR BIOL, V25, P3239, DOI 10.1016/j.cub.2015.10.028; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Trimble WS, 2015, J CELL BIOL, V208, P259, DOI 10.1083/jcb.201410071; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Varnai P, 2017, CELL CALCIUM, V64, P72, DOI 10.1016/j.ceca.2016.12.008; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13	59	33	33	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					427	+		10.1016/j.immuni.2018.08.017	http://dx.doi.org/10.1016/j.immuni.2018.08.017			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30217409	hybrid, Green Published			2022-12-18	WOS:000444909600011
J	Vance, RE				Vance, Russell E.			Cytosolic DNA Sensing: The Field Narrows	IMMUNITY			English	Editorial Material							INNATE IMMUNE-RESPONSE; IFI16; PROTEIN; SENSOR	The innate response to many pathogens involves type I interferon production that is initiated upon cytosolic detection of double-stranded DNA (dsDNA), but how dsDNA is detected is controversial. In this issue of Immunity, Gray et al. (2016) use genetics to bring some much-needed clarity to the field.	[Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA.	rvance@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Li T, 2013, CELL HOST MICROBE, V14, P591, DOI 10.1016/j.chom.2013.10.007; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932	10	33	34	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					227	228		10.1016/j.immuni.2016.08.006	http://dx.doi.org/10.1016/j.immuni.2016.08.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533006	Bronze			2022-12-18	WOS:000382267300002
J	Gu, AD; Zhang, S; Wang, YQ; Xiong, H; Curtis, TA; Wan, YSY				Gu, Ai-Di; Zhang, Song; Wang, Yunqi; Xiong, Hui; Curtis, Thomas A.; Wan, Yisong Y.			A Critical Role for Transcription Factor Smad4 in T Cell Function that Is Independent of Transforming Growth Factor beta Receptor Signaling	IMMUNITY			English	Article							TGF-BETA; C-MYC; REQUIREMENTS; INACTIVATION; AUTOIMMUNITY; LYMPHOCYTES; MECHANISMS; EXPRESSION; PLASTICITY; INDUCTION	Transforming growth factor-beta (TGF-beta) suppresses T cell function to maintain self-tolerance and to promote tumor immune evasion. Yet how Smad4, a transcription factor component of TGF-beta signaling, regulates T cell function remains unclear. Here we have demonstrated an essential role for Smad4 in promoting T cell function during autoimmunity and anti-tumor immunity. Smad4 deletion rescued the lethal autoimmunity resulting from transforming growth factor-beta receptor (TGF-beta R) deletion and compromised T-cell-mediated tumor rejection. Although Smad4 was dispensable for T cell generation, homeostasis, and effector function, it was essential for T cell proliferation after activation in vitro and in vivo. The transcription factor Myc was identified to mediate Smad4-controlled T cell proliferation. This study thus reveals a requirement of Smad4 for T-cell-mediated autoimmunity and tumor rejection, which is beyond the current paradigm. It highlights a TGF-beta R-independent role for Smad4 in promoting T cell function, autoimmunity, and anti-tumor immunity.	[Gu, Ai-Di; Zhang, Song; Wang, Yunqi; Xiong, Hui; Curtis, Thomas A.; Wan, Yisong Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gu, Ai-Di; Zhang, Song; Wang, Yunqi; Xiong, Hui; Curtis, Thomas A.; Wan, Yisong Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Wan, Yisong Y.] Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Inst Canc, Xuzhou 221002, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Xuzhou Medical University	Wan, YSY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	wany@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Zhang, Song/I-9531-2018; Wan, Yisong/ABE-1200-2021	Zhang, Song/0000-0003-1492-8988; Wan, Yisong/0000-0003-4346-9717	NIH [R01AI097392]; National Multiple Sclerosis Society [RG4654]; University Cancer Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); University Cancer Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Robertson and E. Bikoff (University of Oxford, UK) for Smad4<SUP>fl/fl</SUP> mice and H. Moses (Vanderbilt University) for Tgfbr2<SUP>fl/fl</SUP> mice, N. Fisher and J. Kalnitsky (University of North Carolina) for cell sorting, and M. Su (University of North Carolina) for discussions. This study is supported by the NIH (R01AI097392), National Multiple Sclerosis Society (RG4654), and the University Cancer Research Fund (Y.Y.W.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Gu AD, 2012, P NATL ACAD SCI USA, V109, P905, DOI 10.1073/pnas.1108352109; Hahn JN, 2011, J CLIN INVEST, V121, P4030, DOI 10.1172/JCI45114; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Ishigame H, 2013, P NATL ACAD SCI USA, V110, P6961, DOI 10.1073/pnas.1304498110; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lim SK, 2006, P NATL ACAD SCI USA, V103, P18580, DOI 10.1073/pnas.0604773103; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miyaki M, 2003, BIOCHEM BIOPH RES CO, V306, P799, DOI 10.1016/S0006-291X(03)01066-0; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Taylor IW, 2008, CELL, V133, DOI 10.1016/j.cell.2008.04.007; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yoshioka Y, 2012, EUR J IMMUNOL, V42, P749, DOI 10.1002/eji.201141702; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319	47	33	34	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					68	79		10.1016/j.immuni.2014.12.019	http://dx.doi.org/10.1016/j.immuni.2014.12.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25577439	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000348197500012
J	Singh, NJ; Bando, JK; Schwartz, RH				Singh, Nevil J.; Bando, Jennifer K.; Schwartz, Ronald H.			Subsets of Nonclonal Neighboring CD4(+) T Cells Specifically Regulate the Frequency of Individual Antigen-Reactive T Cells	IMMUNITY			English	Article							HOMEOSTATIC PROLIFERATION; ADAPTIVE TOLERANCE; CLONAL COMPETITION; GAMMA-CHAIN; SURVIVAL; NAIVE; MEMORY; LYMPHOCYTES; MOLECULES; SELECTION	After an immune response, the expanded population of antigen-specific CD4(+) T cells contract to steady state levels. We have found that the contraction is neither cell-autonomous nor mediated by competition for generic trophic factors, but regulated by relatively rare subsets of neighboring CD4(+) T cells not necessarily of a conventional regulatory T cell lineage. These regulators, referred to as deletors, specifically limit the frequency of particular antigen-specific T cells even though they are not reactive to the same agonist as their targets. Instead, an isolated deletor could outcompete the target for recognition of a shared, nonstimulatory endogenous peptide-MHC ligand. This mechanism was sufficient to prevent even agonist-driven autoimnnune disease in a lymphopenic environment. Such a targeted regulation of homeostasis within narrow colonies of T cells with related TCR specificities for subthreshold ligands might help to prevent the loss of unrelated TCRs during multiple responses, preserving the valuable diversity of the repertoire.	[Singh, Nevil J.; Schwartz, Ronald H.] NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA; [Bando, Jennifer K.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco	Singh, NJ (corresponding author), NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA.	ns117r@nih.gov		Singh, Nevil/0000-0002-8384-9290; Bando, Jennifer/0000-0002-1331-7424	NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000485] Funding Source: NIH RePORTER	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Chen and E. Chuang for assistance with experiments, C. Henry and C. Eigsti for FACS sorting, Q. Su and T. Myers for microarray hybridization, P. Chappert for hearty discussions, and R. Germain and Y. Belkaid for comments on improving the manuscript. This research was supported by the Intramural Research Program of the NIH, NIAID.	Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; DiSanto JP, 1996, J EXP MED, V183, P1111, DOI 10.1084/jem.183.3.1111; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Leitao C, 2009, J IMMUNOL, V182, P5232, DOI 10.4049/jimmunol.0804071; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Min B, 2004, P NATL ACAD SCI USA, V101, P3874, DOI 10.1073/pnas.0400606101; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; Oehen S, 1996, J EXP MED, V183, P2617, DOI 10.1084/jem.183.6.2617; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Quiel J, 2011, P NATL ACAD SCI USA, V108, P3312, DOI 10.1073/pnas.1018525108; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Singh NJ, 2006, PLOS BIOL, V4, P1957, DOI 10.1371/journal.pbio.0040340; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Smith A, 2000, IMMUNITY, V13, P783, DOI 10.1016/S1074-7613(00)00076-5; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Troy AE, 2003, J IMMUNOL, V170, P672, DOI 10.4049/jimmunol.170.2.672; Vanasek TL, 2006, J IMMUNOL, V176, P5880, DOI 10.4049/jimmunol.176.10.5880; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965	40	33	33	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 19	2012	37	4					735	746		10.1016/j.immuni.2012.08.008	http://dx.doi.org/10.1016/j.immuni.2012.08.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23021952	Green Accepted, Bronze			2022-12-18	WOS:000310185400017
J	Cole, C; Thomas, S; Filak, H; Henson, PM; Lenz, LL				Cole, Caroline; Thomas, Stacey; Filak, Holly; Henson, Peter M.; Lenz, Laurel L.			Nitric Oxide Increases Susceptibility of Toll-like Receptor-Activated Macrophages to Spreading Listeria monocytogenes	IMMUNITY			English	Article							INTRACELLULAR GROWTH; CELL SPREAD; PROTEIN; PHAGOSOME; INFECTION; INHIBITION; MATURATION; SUPPRESS; VACUOLES; SYNTHASE	Toll-like receptor (TLR) stimulation activates macrophages to resist intracellular pathogens. Yet, the intracellular bacterium Listeria monocytogenes (Lm) causes lethal infections in spite of innate immune cell activation. Lm uses direct cell-cell spread to disseminate within its; host. Here, we have shown that TLR-activated macrophages killed cell-free Lm but failed to prevent infection by spreading Lm. Instead, TLR signals increased the efficiency of Lm spread from "donor" to "recipient" macrophages. This enhancement required nitric oxide (NO) production by nitric oxide synthase-2 (NOS2). NO increased Lm escape from secondary vacuoles in recipient cells and delayed maturation of phagosomes containing membrane-like particles that mimic Lm-containing pseudopods. NO also promoted Lm spread during systemic in vivo infection, as shown by the fact that inhibition of NOS2 with 1400W reduced spread-dependent Lm burdens in mouse livers. These findings reveal a mechanism by which pathogens capable of cell-cell spread can avoid the consequences of innate immune cell activation by TLR stimuli.	[Filak, Holly; Lenz, Laurel L.] Natl Jewish Hlth, Dept Immunol, Denver, CO 80206 USA; [Cole, Caroline; Thomas, Stacey; Henson, Peter M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Lenz, LL (corresponding author), Natl Jewish Hlth, Dept Immunol, Denver, CO 80206 USA.	lenzl@njhealth.org		Lenz, Laurel/0000-0002-4933-8913; Thomas, Stacey/0000-0002-5666-4311	National Institutes of Health [HL68864, HL81151, GM61031, AI065638, AI055701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, R01HL068864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065638, R21AI055701, R01AI055701, R01AI065638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants HL68864, HL81151, and GM61031 to P.M.H. and AI065638 and AI055701 to L.L.L. from the National Institutes of Health.	Akaike T, 2010, NITRIC OXIDE-BIOL CH, V23, P166, DOI 10.1016/j.niox.2010.06.006; Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Bennion JR, 2008, CLIN INFECT DIS, V47, P867, DOI 10.1086/591131; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Burrack LS, 2009, CELL MICROBIOL, V11, P1382, DOI 10.1111/j.1462-5822.2009.01338.x; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Endres R, 1997, IMMUNITY, V7, P419, DOI 10.1016/S1074-7613(00)80363-5; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fernandez-Sabe N, 2009, CLIN INFECT DIS, V49, P1153, DOI 10.1086/605637; Forgac M, 1999, J BIOL CHEM, V274, P1301, DOI 10.1074/jbc.274.3.1301; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; GREGORY SH, 1993, J IMMUNOL, V150, P2901; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Pizarro-Cerda J, 2009, ANNU REV CELL DEV BI, V25, P649, DOI 10.1146/annurev.cellbio.042308.113331; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Poussin MA, 2005, INFECT IMMUN, V73, P4410, DOI 10.1128/IAI.73.7.4410-4413.2005; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sidhu G, 2005, J BIOL CHEM, V280, P11379, DOI 10.1074/jbc.M414533200; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; SWALLOW CJ, 1991, J EXP MED, V174, P1009, DOI 10.1084/jem.174.5.1009; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tancred L, 2011, J MED MICROBIOL, V60, P1570, DOI 10.1099/jmm.0.032870-0; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TOJO A, 1994, AM J PHYSIOL-RENAL, V267, pF509, DOI 10.1152/ajprenal.1994.267.4.F509; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Young SH, 2009, EXP LUNG RES, V35, P570, DOI 10.1080/01902140902763201	46	33	35	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					807	820		10.1016/j.immuni.2012.03.011	http://dx.doi.org/10.1016/j.immuni.2012.03.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22542147	Green Accepted, Bronze			2022-12-18	WOS:000304976000014
J	Chen, C; Huang, X; Atakilit, A; Zhu, QS; Corey, SJ; Sheppard, D				Chen, Chun; Huang, Xiaozhu; Atakilit, Amha; Zhu, Quan-Sheng; Corey, Seth J.; Sheppard, Dean			The integrin alpha 9 beta 1 contributes to granulopoiesis by enhancing granulocyte colony-stimulating factor receptor signaling	IMMUNITY			English	Article							PROGRAMMED CELL-DEATH; FACTOR G-CSF; INTEGRIN ALPHA(9)BETA(1); CYTOPLASMIC DOMAIN; ENDOTHELIAL-CELLS; EGF RECEPTOR; III REPEAT; ACTIVATION; ADHESION; MUTATIONS	The integrin alpha 9 beta 1 is widely expressed on neutrophils, smooth muscle, hepatocytes, endothelia, and some epithelia. We now show that mice lacking this integrin have a dramatic defect in neutrophil development, with decreased numbers of granulocyte precursors in bone marrow and impaired differentiation of bone marrow cells into granulocytes. In response to granulocyte colony-stimulating factor (G-CSF), alpha 9-deficient bone marrow cells or human bone marrow cells incubated with alpha 9 beta 1-locking antibody demonstrated decreased phosphorylation of signal transducer and activator of transcription 3 and extracellular signal-regulated protein kinase. These effects depended on the alpha 9 subunit cytoplasmic domain, which was required for formation of a physical complex between alpha 9 beta 1 and ligated G-CSF receptor. Integrin alpha 9 beta 1 was required for granulopoiesis and played a permissive role in the G-CSF-signaling pathway, suggesting that this integrin could play an important role in disorders of granulocyte development and other conditions characterized by defective G-CSF signaling.	Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94158 USA; Univ Texas, MD Anderson Canc Ctr, Div Pediat, Dept Leukemia, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center	Sheppard, D (corresponding author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94158 USA.	dean.sheppard@ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064353, R01HL053949, P01HL056385, U01HL066600, P50HL056385, R37HL053949] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66600, HL56385, HL53949, HL64353] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baron W, 2002, EMBO J, V21, P1957, DOI 10.1093/emboj/21.8.1957; Bridges LC, 2005, BIOCHEM J, V387, P101, DOI 10.1042/BJ20041444; Chen C, 2004, J CELL BIOL, V167, P161, DOI 10.1083/jcb.200312166; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COLOTTA F, 1992, BLOOD, V80, P2012; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Dong F, 1997, LEUKEMIA, V11, P120, DOI 10.1038/sj.leu.2400537; Dong F, 1998, J IMMUNOL, V161, P6503; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Fuste B, 2004, HAEMATOLOGICA, V89, P578; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Hynes RO, 1999, BRAZ J MED BIOL RES, V32, P501, DOI 10.1590/S0100-879X1999000500002; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 1997, THROMB HAEMOSTASIS, V78, P83; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154; REX JH, 1995, TRANSFUSION, V35, P605, DOI 10.1046/j.1537-2995.1995.35795357886.x; Ross EA, 2006, BLOOD, V107, P1178, DOI 10.1182/blood-2005-07-2692; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Seiffert M, 1998, MATRIX BIOL, V17, P47, DOI 10.1016/S0945-053X(98)90124-X; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; SIMMONS PJ, 1992, BLOOD, V80, P388; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Tomczuk M, 2003, EXP CELL RES, V290, P68, DOI 10.1016/S0014-4827(03)00307-0; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Yamate T, 1997, ENDOCRINOLOGY, V138, P3047, DOI 10.1210/en.138.7.3047; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214; Zhu QS, 2004, BLOOD, V103, P3305, DOI 10.1182/blood-2003-06-1861; Zhuang DZ, 2005, J LEUKOCYTE BIOL, V78, P1008, DOI 10.1189/jlb.0105032	50	33	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					895	906		10.1016/j.immuni.2006.10.013	http://dx.doi.org/10.1016/j.immuni.2006.10.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17137800	Bronze			2022-12-18	WOS:000243087500009
J	Li, ZQ; Zhao, CF; Iglesias-Ussel, MD; Polonskaya, Z; Zhuang, M; Yang, GZ; Luo, ZH; Edelmann, W; Scharff, MD				Li, ZQ; Zhao, CF; Iglesias-Ussel, MD; Polonskaya, Z; Zhuang, M; Yang, GZ; Luo, ZH; Edelmann, W; Scharff, MD			The mismatch repair protein Msh6 influences the in vivo AID targeting to the Ig locus	IMMUNITY			English	Article							DNA-POLYMERASE-ETA; CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SINGLE-STRANDED-DNA; IMMUNOGLOBULIN GENE HYPERMUTATION; SOMATIC HYPERMUTATION; CUTTING EDGE; MUTATIONS; MICE; TRANSCRIPTION	Somatic hypermutation (SHM) and class switch recombination (CSR) are initiated by activation-induced cytidine deaminase (AID), which preferentially deaminates deoxycytidines at WRC (W = A/T, R = A/G) motifs in vitro. The mechanisms responsible for targeting AID and for organizing the queue of enzymes involved in vivo have been elusive. Here, we examined point mutant knockin Msh6 mice (Msh6(TD/TD)), which lack the second phase of SHM but retain all the proteins involved, and found that AID was frequently targeted to non-WRC motifs. Unexpectedly, by comparing SHM and CSR in wild-type, Msh6(TD)/(TD), and age-matched Msh6(-/-) mice, we discovered that the presence of Msh6 protein influenced the AID targeting in phase one of SHM and mediated the proper targeting of recombination sites in CSR in vivo. Our data suggest that Msh6 plays a scaffolding role in the first phase of SHM, in addition to its enzymatic role in the second phase of SHM.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Li, ZQ (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	zli@aecom.yu.edu; scharff@aecom.yu.edu		Iglesias de Ussel, Maria/0000-0002-3679-9681	NATIONAL CANCER INSTITUTE [R01CA072649, R01CA076329, R01CA093484, R01CA102705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NCI NIH HHS [CA93484, CA76329, CA102705, CA 72649] Funding Source: Medline; NIAID NIH HHS [AI57158] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Bardwell PD, 2003, J IMMUNOL, V170, P1620, DOI 10.4049/jimmunol.170.4.1620; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Barreto VM, 2005, TRENDS IMMUNOL, V26, P90, DOI 10.1016/j.it.2004.12.004; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Larson ED, 2005, CURR BIOL, V15, P470, DOI 10.1016/j.cub.2004.12.077; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Li ZQ, 2004, P NATL ACAD SCI USA, V101, P15428, DOI 10.1073/pnas.0406827101; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Li ZQ, 2003, NAT IMMUNOL, V4, P945, DOI 10.1038/ni1003-945; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martic M, 2004, ASIAN J ANDROL, V6, P3; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Martomo SA, 2005, P NATL ACAD SCI USA, V102, P8656, DOI 10.1073/pnas.0501852102; Masuda K, 2005, P NATL ACAD SCI USA, V102, P13986, DOI 10.1073/pnas.0505636102; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Shapiro GS, 1999, J IMMUNOL, V163, P259; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zheng NY, 2005, J EXP MED, V201, P1467, DOI 10.1084/jem.20042483	57	33	33	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					393	403		10.1016/j.immuni.2006.02.011	http://dx.doi.org/10.1016/j.immuni.2006.02.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618598	Bronze			2022-12-18	WOS:000237153000009
J	Palese, P; Tumpey, TM; Garcia-Sastre, A				Palese, P; Tumpey, TM; Garcia-Sastre, A			What can we learn from reconstructing the extinct 1918 pandemic influenza virus?	IMMUNITY			English	Editorial Material							A VIRUS; GENES; HEMAGGLUTININ		CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Influenza Branch, Atlanta, GA 30333 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Centers for Disease Control & Prevention - USA	Palese, P (corresponding author), CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	peter.palese@mssm.edu		Garcia-Sastre, Adolfo/0000-0002-6551-1827; Palese, Peter/0000-0002-0337-5823	NIAID NIH HHS [P01 AI058113, P01 AI052106, U19 AI062623] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113, P01AI052106, U19AI062623] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gulati U, 2005, VACCINE, V23, P1414, DOI 10.1016/j.vaccine.2004.08.053; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; LINDER FE, 1947, VITAL STATISTICS RAT; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Nabel GJ, 2004, NAT MED, V10, P135, DOI 10.1038/nm990; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; Welsh RM, 1999, CURR OPIN MICROBIOL, V2, P382; ZAMARIN D, 2003, 8 INT KILM MEM C OS, P308	25	33	35	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					121	124		10.1016/j.immuni.2006.01.007	http://dx.doi.org/10.1016/j.immuni.2006.01.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473822	Bronze			2022-12-18	WOS:000235479000001
J	Simmons, A; Gangadharan, B; Hodges, A; Sharrocks, K; Prabhakar, S; Garcia, A; Dwek, R; Zitzmann, N; McMichael, A				Simmons, A; Gangadharan, B; Hodges, A; Sharrocks, K; Prabhakar, S; Garcia, A; Dwek, R; Zitzmann, N; McMichael, A			Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling	IMMUNITY			English	Article							KINASE-BINDING PROTEINS; GROWTH-FACTOR RECEPTOR; HIV-1 NEF; C-CBL; P21-ACTIVATED KINASE; ANTIGEN RECEPTOR; TYROSINE KINASE; NEGATIVE REGULATION; PLASMA-MEMBRANE; DOWN-REGULATION	Lentiviral Nef increases T cell signaling activity, but the molecular nature of the stimulus involved is incompletely described. We explored CD4 T cell lipid raft composition in the presence and absence of Nef. Here, the E2 ubiquitin-conjugating enzyme UbcH7, which acts in conjunction with c-Cbl, is absent from lipid rafts. This Nef-mediated exclusion is associated with failure of ubiquitination of activated Vav. In the presence of Nef, lipid raft Cdc42 is activated and forms a ternary complex between the c-Cbl-interacting protein p85Cool-1/beta Pix and c-Cbl, displacing UbcH7 from rafts. Suppression of p85Cool-1/beta Pix expression restores UbcH7 raft localization and Vav ubiquitination and diminishes Cdc42 activity. Moreover, p85Cool-1/ beta Pix knockdown attenuates HIV replication. Thresholds for activation of signaling involve the intricate balance of positive and negative regulators. Here we provide evidence for Nef disruption of a negative regulator of T cell signaling in promoting HIV replication.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England; Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Simmons, A (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England.	alison.simmons@molecular-medicine.oxford.ac.uk	Garcia, Angel/F-6736-2016	Garcia, Angel/0000-0003-1176-5917; Gangadharan, Bevin/0000-0002-7466-2977; Simmons, Alison/0000-0003-3454-0710				Alexander M, 2004, J VIROL, V78, P1685, DOI 10.1128/JVI.78.4.1685-1696.2004; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Cantrell D, 2003, EUR J IMMUNOL, V33, P1070, DOI 10.1002/eji.200323942; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fackler OT, 2001, CURR BIOL, V11, P1294, DOI 10.1016/S0960-9822(01)00373-6; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; Flanders JA, 2003, FEBS LETT, V550, P119, DOI 10.1016/S0014-5793(03)00853-6; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; JARADHAN A, 2004, PLOS BIOL, V2; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kramer-Hammerle S, 2001, AIDS RES HUM RETROV, V17, P597, DOI 10.1089/088922201300119699; Krautkramer E, 2004, J VIROL, V78, P4085, DOI 10.1128/JVI.78.8.4085-4097.2004; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Marengere LEM, 1997, J IMMUNOL, V159, P70; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Verma S, 2004, MOL CELL BIOL, V24, P8716, DOI 10.1128/MCB.24.19.8716-8726.2004; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; WOLLBERG P, 1992, MOL CELL BIOCHEM, V110, P161, DOI 10.1007/BF02454193; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Yang PL, 2005, VIROLOGY, V336, P219, DOI 10.1016/j.virol.2005.03.021; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	55	33	33	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2005	23	6					621	634		10.1016/j.immuni.2005.11.003	http://dx.doi.org/10.1016/j.immuni.2005.11.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356860	Bronze			2022-12-18	WOS:000234316900009
J	Perez, OD; Nolan, GP				Perez, OD; Nolan, GP			Resistance is futile: Assimilation of cellular machinery by HIV-1	IMMUNITY			English	Article							UBIQUITIN; TRAFFICKING; DOMAINS; RELEASE	HIV-1 budding appears to require Vps4 and Tsg101-two proteins that have links to endosomal sorting machinery. A picture emerges wherein divergent viruses recruit endosomal proteins like Tsg101 to gain access to ubiquitin processes that play a crucial role during viral budding.	Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.		Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043				Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gonzalez SA, 1996, J VIROL, V70, P6384; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; PUTTERMAN D, 1990, VIROLOGY, V176, P633, DOI 10.1016/0042-6822(90)90035-P; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Scheuring S, 1999, GENE, V234, P149, DOI 10.1016/S0378-1119(99)00163-8; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vogt VM, 2000, P NATL ACAD SCI USA, V97, P12945, DOI 10.1073/pnas.97.24.12945; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000	21	33	33	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					687	690		10.1016/S1074-7613(01)00238-2	http://dx.doi.org/10.1016/S1074-7613(01)00238-2			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728331	Bronze			2022-12-18	WOS:000172528200002
J	Davis, DP; Raffen, R; Dul, JL; Vogen, SM; Williamson, EK; Stevens, FJ; Argon, Y				Davis, DP; Raffen, R; Dul, JL; Vogen, SM; Williamson, EK; Stevens, FJ; Argon, Y			Inhibition of amyloid fiber assembly by both BiP and its target peptide	IMMUNITY			English	Article							AMINO-ACID SUBSTITUTION; IG LIGHT-CHAINS; ENDOPLASMIC-RETICULUM; FIBRIL FORMATION; MOLECULAR CHAPERONES; DOMAIN INTERACTIONS; DEPOSITION DISEASE; BINDING-PROTEIN; VARIABLE DOMAIN; ATPASE ACTIVITY	Immunoglobulin light chain (LC) normally is a soluble, secreted protein, but some LC assemble into ordered fibrils whose deposition in tissues results in amyloidosis and organ failure. Here we reconstitute fibril formation in vitro and show that preformed fibrils can nucleate polymerization of soluble LC. This prion-like behavior has important physiological implications, since somatic mutations generate multiple related LC sequences. Furthermore, we demonstrate that fibril formation in vitro and aggregation of whole LC within cells are inhibited by BiP and by a synthetic peptide that is identical to a major LC binding site for Sip. We propose that LC form fibrils via an interprotein loop swap and that the underlying conformational change should be amenable to drug therapy.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Argon, Y (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.							BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BRANCACCIO D, 1995, J AM SOC NEPHROL, V6, P1262; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; BURKHARDT JK, 1993, J EXP MED, V178, P1845, DOI 10.1084/jem.178.6.1845; BUXBAUM JN, 1990, ANN INTERN MED, V112, P455, DOI 10.7326/0003-4819-76-3-112-6-455; Davis DP, 1999, J IMMUNOL, V163, P3842; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DENOROY L, 1994, IMMUNOL LETT, V42, P63, DOI 10.1016/0165-2478(94)90036-1; DUL JL, 1990, P NATL ACAD SCI USA, V87, P8135, DOI 10.1073/pnas.87.20.8135; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Gething MJ, 1995, COLD SPRING HARB SYM, V60, P417, DOI 10.1101/SQB.1995.060.01.046; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; HUANG DB, 1994, BIOCHEMISTRY-US, V33, P14848, DOI 10.1021/bi00253a024; HUBER C, 1993, EUR J IMMUNOL, V23, P2868, DOI 10.1002/eji.1830231121; ISHIHARA T, 1991, LAB INVEST, V64, P265; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; MA J, 1990, MOL IMMUNOL, V27, P623, DOI 10.1016/0161-5890(90)90004-J; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Oza VB, 1999, BIOORG MED CHEM LETT, V9, P1, DOI 10.1016/S0960-894X(98)00696-9; Pokkuluri PR, 1998, STRUCT FOLD DES, V6, P1067, DOI 10.1016/S0969-2126(98)00107-5; Raffen R, 1998, PROTEIN ENG, V11, P303, DOI 10.1093/protein/11.4.303; Raffen R, 1999, PROTEIN SCI, V8, P509; SHAPIRO AL, 1966, NATURE, V211, P243, DOI 10.1038/211243a0; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Solomon A, 1998, P NATL ACAD SCI USA, V95, P9547, DOI 10.1073/pnas.95.16.9547; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Stevens FJ, 1999, IMMUNOL TODAY, V20, P451, DOI 10.1016/S0167-5699(99)01502-9; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; STEVENS FJ, 1999, ANTIBODIES, P175; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Takeda S, 1996, BIOCHEMISTRY-US, V35, P4636, DOI 10.1021/bi952903o; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tuite MF, 1996, TRENDS GENET, V12, P467, DOI 10.1016/0168-9525(96)10045-7; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133	49	33	35	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					433	442		10.1016/S1074-7613(00)00043-1	http://dx.doi.org/10.1016/S1074-7613(00)00043-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070162	Bronze			2022-12-18	WOS:000090079100003
J	WEBER, GF; ABROMSONLEEMAN, S; CANTOR, H				WEBER, GF; ABROMSONLEEMAN, S; CANTOR, H			A SIGNALING PATHWAY COUPLED TO T-CELL RECEPTOR LIGATION BY MMTV SUPERANTIGEN LEADING TO TRANSIENT ACTIVATION AND PROGRAMMED CELL-DEATH	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INCOMPATIBLE STRAIN C3H; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ARACHIDONIC-ACID; CONVENTIONAL ANTIGEN; APOPTOTIC THYMOCYTES; HUMAN-LYMPHOCYTES; GENE-EXPRESSION; MICE	Stimulation of T cells by retroviral and bacterial superantigens is followed by specific T cell elimination, in contrast with stimulation of T cells by peptide, which is usually associated with clonal expansion. We show here that this differential response phenotype is apparent at the level of individual T cell clones following TCR ligation with peptide or MTV antigen. We exploited selective coupling of apoptosis to TCR ligation by MTV7 to examine some of the intracellular biochemical events that underlie this response. MTV-dependent activation resulting in apoptosis was associated with activation of phospholipase Aa and the generation of reactive oxygen intermediates. Inhibition of these biochemical events prevented both MTV-dependent activation and apoptosis without affecting the peptide-dependent response of the same T cell clones. These results indicate that clonal expansion or programmed cell death following TCR ligation may be consequences of distinct TCR-coupled signaling pathways.	HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	WEBER, GF (corresponding author), DANA FARBER CANC INST, IMMUNOPATHOL LAB, BOSTON, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012184, R01AI013600, R01AI036105, R01AI012184] Funding Source: NIH RePORTER; NIAID NIH HHS [AI36105, AI13600, AI12184] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABROMSONLEEMAN S, 1995, J IMMUNOL, V154, P388; ACHAORBEA H, 1993, IMMUNOL REV, V131, P5, DOI 10.1111/j.1600-065X.1993.tb01527.x; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BARINAGA M, 1993, SCIENCE, V259, P309, DOI 10.1126/science.8093563; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; COFFEY RG, 1981, J BIOL CHEM, V256, P4418; Cohen J J, 1992, Semin Immunol, V4, P363; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DANNECKER G, 1991, J IMMUNOL, V146, P2083; DOMINO SE, 1991, METHOD ENZYMOL, V195, P345; FRIEDMAN S, 1987, IMMUNOGENETICS, V26, P193, DOI 10.1007/BF00346512; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; HACK N, 1991, BIOCHEM J, V275, P563, DOI 10.1042/bj2750563; HALIDAY EM, 1991, EMBO J, V10, P109, DOI 10.1002/j.1460-2075.1991.tb07926.x; HALLEPANNENKO O, 1986, J IMMUNOGENET, V13, P437; HENDRICKSON HS, 1991, METHOD ENZYMOL, V197, P90; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; IGNATOWICZ L, 1992, J EXP MED, V175, P917, DOI 10.1084/jem.175.4.917; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; IWATA M, 1992, J IMMUNOL, V149, P3302; JACOBSSON H, 1975, SCAND J IMMUNOL, V4, P181, DOI 10.1111/j.1365-3083.1975.tb02615.x; JANEWAY CA, 1983, NATURE, V306, P80, DOI 10.1038/306080a0; JANEWAY CA, 1993, IMMUNOL REV, V131, P189, DOI 10.1111/j.1600-065X.1993.tb01536.x; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; LEGRANDPOELS S, 1990, AIDS RES HUM RETROV, V12, P1396; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LILLIEHOOK B, 1975, SCAND J IMMUNOL, V4, P209, DOI 10.1111/j.1365-3083.1975.tb02619.x; LIU H, 1991, P NATL ACAD SCI USA, V88, P8705, DOI 10.1073/pnas.88.19.8705; MACDONALD HR, 1993, J EXP MED, V177, P1487, DOI 10.1084/jem.177.5.1487; ORMEROD MG, 1993, CYTOMETRY, V14, P595, DOI 10.1002/cyto.990140603; OROURKE AM, 1990, SCIENCE, V249, P171, DOI 10.1126/science.2164711; OYAIZU N, 1992, P NATL ACAD SCI USA, V89, P8035, DOI 10.1073/pnas.89.17.8035; PARKER CW, 1979, J EXP MED, V149, P1487, DOI 10.1084/jem.149.6.1487; PATARCA R, 1991, P NATL ACAD SCI USA, V88, P2736, DOI 10.1073/pnas.88.7.2736; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; RAMAKRISHNAN N, 1992, J IMMUNOL, V148, P1817; REID T, 1991, J BIOL CHEM, V266, P16580; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SANDSTROM PA, 1993, P NATL ACAD SCI USA, V90, P4708, DOI 10.1073/pnas.90.10.4708; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SIMPSON E, 1993, IMMUNOL REV, V131, P93, DOI 10.1111/j.1600-065X.1993.tb01532.x; SPINELLA DG, 1987, J IMMUNOL, V138, P3991; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; SUBRAMANYAM M, 1993, IMMUNOL REV, V131, P117, DOI 10.1111/j.1600-065X.1993.tb01533.x; SUN XM, 1992, ANAL BIOCHEM, V204, P351, DOI 10.1016/0003-2697(92)90251-2; UCKER DS, 1989, J IMMUNOL, V143, P3461; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WEBER GF, 1994, J IMMUNOL, V152, P4433; WEBER GF, 1990, J CLIN CHEM CLIN BIO, V28, P569; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; ZINKERNAGEL RM, 1993, IMMUNOL REV, V133, P199, DOI 10.1111/j.1600-065X.1993.tb01517.x	56	33	33	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1995	2	4					363	372		10.1016/1074-7613(95)90144-2	http://dx.doi.org/10.1016/1074-7613(95)90144-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719939	Bronze			2022-12-18	WOS:A1995QU61600006
J	Duong, E; Fessenden, TB; Lutz, E; Dinter, T; Yim, L; Blatt, S; Bhutkar, A; Wittrup, KD; Spranger, S				Duong, Ellen; Fessenden, Tim B.; Lutz, Emi; Dinter, Teresa; Yim, Leon; Blatt, Sarah; Bhutkar, Arjun; Wittrup, Karl Dane; Spranger, Stefani			Type I interferon activates MHC class I-dressed CD11b(+) conventional dendritic cells to promote protective anti-tumor CD8(+) T cell immunity	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; TRANSCRIPTION FACTORS; CROSS-PRESENTATION; TUMOR-CELLS; EXPRESSION; RECEPTOR; INNATE; DIFFERENTIATION; RESPONSES; MELANOMA	Tumor-infiltrating dendritic cells (DCs) assume varied functional states that impact anti-tumor immunity. To delineate the DC states associated with productive anti-tumor T cell immunity, we compared spontaneously regressing and progressing tumors. Tumor-reactive CD8+ T cell responses in Batf3(-/-) mice lacking type 1 DCs (DC1s) were lost in progressor tumors but preserved in regressor tumors. Transcriptional profiling of intra-tumoral DCs within regressor tumors revealed an activation state of CD11b(+) conventional DCs (DC2s) characterized by expression of interferon (IFN)-stimulated genes (ISGs) (ISG(+) DCs). ISG(+) DC-activated CD8(+) T cells ex vivo comparably to DC1. Unlike cross-presenting DC1, ISG(+) DCs acquired and presented intact tumor-derived peptide-major histocompatibility complex class I (MHC class I) complexes. Constitutive type I IFN production by regressor tumors drove the ISG+ DC state, and activation of MHC class I-dressed ISG(+) DCs by exogenous IFN-b rescued anti-tumor immunity against progressor tumors in Batf3(-/-) mice. The ISG(+) DC gene signature is detectable in human tumors. Engaging this functional DC state may present an approach for the treatment of human disease.	[Duong, Ellen; Fessenden, Tim B.; Lutz, Emi; Dinter, Teresa; Yim, Leon; Blatt, Sarah; Bhutkar, Arjun; Wittrup, Karl Dane; Spranger, Stefani] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Duong, Ellen; Dinter, Teresa; Spranger, Stefani] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lutz, Emi; Wittrup, Karl Dane] MIT, Dept Biol Engn, Cambridge, MA USA; [Spranger, Stefani] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Spranger, S (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Spranger, S (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Spranger, S (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	spranger@mit.edu		Spranger, Stefani/0000-0003-3257-4546; Duong, Ellen/0000-0002-4015-7112; /0000-0003-2398-5896; Dinter, Teresa/0000-0003-4764-501X; Blatt, Sarah/0000-0002-3284-9354; Lutz, Emi/0000-0002-7649-4241	NIH [P30 CA014051-49, T32GM007287]; David H. Koch Graduate Fellowship; Pew-Stewart Scholarship; Ho-ward S. and Linda B. Stern Career Development Professorship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David H. Koch Graduate Fellowship; Pew-Stewart Scholarship; Ho-ward S. and Linda B. Stern Career Development Professorship	We thank P. Sharp, T. Jacks, D. Irvine, and A. Amon for advice and review of the manuscript; J. Cyster (UCSF) and T. Mempel (Harvard/MGH) for providing zDC-DTR mice; R. Warner in the Mempel Lab for assistance with zDC-DTR BMC experiments; M. Duquette for mouse colony maintenance; and P. Thompson for administrative support. We thank the Koch Institute's Robert A. Swanson (1969) Biotechnology Center and the Whitehead Institute Genome Technology Core for providing core services. This work was supported by NIH cancer core grant P30 CA014051-49 and in part by the NIH pre-doctoral training grant T32GM007287, the David H. Koch Graduate Fellowship, the Ho-ward S. (1953) and Linda B. Stern Career Development Professorship, and the Pew-Stewart Scholarship.	Albacker LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176181; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bosteels C, 2020, IMMUNITY, V52, P1039, DOI 10.1016/j.immuni.2020.04.005; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Bullock TNJ, 2003, J IMMUNOL, V170, P1822, DOI 10.4049/jimmunol.170.4.1822; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng SJ, 2021, CELL, V184, P792, DOI 10.1016/j.cell.2021.01.010; Das Mohapatra A, 2020, CANCER IMMUNOL RES, V8, P1287, DOI 10.1158/2326-6066.CIR-20-0248; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Embgenbroich M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01643; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gerhard GM, 2021, J EXP MED, V218, DOI 10.1084/jem.20200264; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Heidegger I, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00490; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; INABA K, 1987, J EXP MED, V166, P182, DOI 10.1084/jem.166.1.182; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Iurescia S, 2020, CANCERS, V12, DOI 10.3390/cancers12113158; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Kalbasi A, 2020, NAT REV IMMUNOL, V20, P25, DOI 10.1038/s41577-019-0218-4; Katlinskaya YV, 2016, CELL REP, V15, P171, DOI 10.1016/j.celrep.2016.03.006; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laoui D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13720; Le Naour J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1777624; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Linsley PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109760; Liu HY, 2019, NAT MED, V25, P95, DOI 10.1038/s41591-018-0302-5; Liu XJ, 2018, CELL REP, V24, P2101, DOI 10.1016/j.celrep.2018.07.062; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Michea Paula, 2018, Nat Immunol, V19, P885, DOI 10.1038/s41590-018-0145-8; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Musella M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1314424; Nakayama M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051155; Nguyen KB, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201908224; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Raval A, 1998, EXP MOL MED, V30, P1, DOI 10.1038/emm.1998.1; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schadt L, 2019, CELL REP, V29, P1236, DOI 10.1016/j.celrep.2019.09.065; Schmid ET, 2016, ELIFE, V5, DOI 10.7554/eLife.12414; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sharma MD, 2018, IMMUNITY, V48, P91, DOI 10.1016/j.immuni.2017.12.014; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Spranger S, 2018, ANNU REV CANC BIOL, V2, P213, DOI 10.1146/annurev-cancerbio-030617-050606; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Squadrito ML, 2018, NAT METHODS, V15, P183, DOI [10.1038/NMETH.4579, 10.1038/nmeth.4579]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Sykulev Y, 2012, J IMMUNOL, V188; Takahashi M, 2021, NAT IMMUNOL, V22, P485, DOI 10.1038/s41590-021-00896-3; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trujillo JA, 2018, CANCER IMMUNOL RES, V6, P990, DOI 10.1158/2326-6066.CIR-18-0277; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Yang L, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0804-8; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	97	32	33	41	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					308	+		10.1016/j.immuni.2021.10.020	http://dx.doi.org/10.1016/j.immuni.2021.10.020			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX8WB	34800368				2022-12-18	WOS:000754375200001
J	Harb, H; Benamar, M; Lai, PS; Contini, P; Griffith, JW; Crestani, E; Schmitz-Abe, K; Chen, Q; Fong, J; Marri, L; Filaci, G; Del Zotto, G; Pishesha, N; Kolifrath, S; Broggi, A; Ghosh, S; Gelmez, MY; Oktelik, FB; Cetin, EA; Kiykim, A; Kose, M; Wang, ZW; Cui, Y; Yu, XG; Li, JZ; Berra, L; Stephen-Victor, E; Charbonnier, LM; Zanoni, I; Ploegh, H; Deniz, G; De Palma, R; Chatila, TA				Harb, Hani; Benamar, Mehdi; Lai, Peggy S.; Contini, Paola; Griffith, Jason W.; Crestani, Elena; Schmitz-Abe, Klaus; Chen, Qian; Fong, Jason; Marri, Luca; Filaci, Gilberto; Del Zotto, Genny; Pishesha, Novalia; Kolifrath, Stephen; Broggi, Achille; Ghosh, Sreya; Gelmez, Metin Yusuf; Oktelik, Fatma Betul; Cetin, Esin Aktas; Kiykim, Ayca; Kose, Murat; Wang, Ziwei; Cui, Ye; Yu, Xu G.; Li, Jonathan Z.; Berra, Lorenzo; Stephen-Victor, Emmanuel; Charbonnier, Louis-Marie; Zanoni, Ivan; Ploegh, Hidde; Deniz, Gunnur; De Palma, Raffaele; Chatila, Talal A.			Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections	IMMUNITY			English	Article							INFLUENZA-VIRUS; AMPHIREGULIN; IMMUNITY; IL-6; ACTIVATION; PROTECTION; SURVIVAL	A cardinal feature of COVID-19 is lung inflammation and respiratory failure. In a prospective multi-country cohort of COVID-19 patients, we found that increased Notch4 expression on circulating regulatory T (Treg) cells was associated with disease severity, predicted mortality, and declined upon recovery. Deletion of Notch4 in Treg cells or therapy with anti-Notch4 antibodies in conventional and humanized mice normalized the dysregulated innate immunity and rescued disease morbidity and mortality induced by a synthetic analog of viral RNA or by influenza H1N1 virus. Mechanistically, Notch4 suppressed the induction by interleukin-18 of amphiregulin, a cytokine necessary for tissue repair. Protection by Notch4 inhibition was recapitulated by therapy with Amphiregulin and, reciprocally, abrogated by its antagonism. Amphiregulin declined in COVID-19 subjects as a function of disease severity and Notch4 expression. Thus, Notch4 expression on Treg cells dynamically restrains amphiregulin-dependent tissue repair to promote severe lung inflammation, with therapeutic implications for COVID-19 and related infections.	[Harb, Hani; Benamar, Mehdi; Crestani, Elena; Schmitz-Abe, Klaus; Chen, Qian; Fong, Jason; Broggi, Achille; Ghosh, Sreya; Wang, Ziwei; Cui, Ye; Stephen-Victor, Emmanuel; Charbonnier, Louis-Marie; Zanoni, Ivan; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Harb, Hani; Benamar, Mehdi; Crestani, Elena; Schmitz-Abe, Klaus; Chen, Qian; Fong, Jason; Pishesha, Novalia; Kolifrath, Stephen; Broggi, Achille; Ghosh, Sreya; Wang, Ziwei; Cui, Ye; Stephen-Victor, Emmanuel; Charbonnier, Louis-Marie; Zanoni, Ivan; Ploegh, Hidde; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Lai, Peggy S.; Griffith, Jason W.] Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA; [Lai, Peggy S.; Griffith, Jason W.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Contini, Paola; De Palma, Raffaele] Univ Genoa, Dept Internal Med, Genoa, Italy; [Contini, Paola; Marri, Luca; De Palma, Raffaele] IRCCS Osped Policlin San Martino, Unit Clin Immunol & Translat Med, Genoa, Italy; [Filaci, Gilberto] IRCCS Osped Policlin San Martino, Biotherapy Unit, Genoa, Italy; [Del Zotto, Genny] IRCCS Ist Giannina Gaslini, Dept Res & Diagnost, Genoa, Italy; [Pishesha, Novalia; Kolifrath, Stephen; Ploegh, Hidde] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Gelmez, Metin Yusuf; Oktelik, Fatma Betul; Cetin, Esin Aktas; Deniz, Gunnur] Istanbul Univ, Aziz Sancar Inst Expt Med Aziz Sancar DETAE, Dept Immunol, Istanbul, Turkey; [Kiykim, Ayca] Istanbul Univ Cerrahpasa, Fac Med, Div Pediat Allergy & Immunol, Istanbul, Turkey; [Kose, Murat] Istanbul Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Yu, Xu G.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Yu, Xu G.] Harvard Med Sch, Boston, MA 02115 USA; [Li, Jonathan Z.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Berra, Lorenzo] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [De Palma, Raffaele] CNR Inst Biomol Chem IBC, Via Campi Flegrei 34, I-80078 Naples, Italy	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Harb, Hani/HGB-7333-2022; gelmez, metin yusuf/AAC-1885-2020; Stephen Victor, Emmanuel/HDN-0252-2022; ÖKTELİK, FATMA BETÜL/AAL-4978-2021; Deniz, Gunnur/AAC-2909-2020; Oktelik, Fatma Betul/AAE-2139-2020; Broggi, Achille/GWV-1694-2022; Del Zotto, Genny/J-9694-2019; KIYKIM, Ayca/J-6400-2017	Harb, Hani/0000-0001-8218-2538; Stephen Victor, Emmanuel/0000-0001-5049-7017; Oktelik, Fatma Betul/0000-0002-7994-5618; Broggi, Achille/0000-0002-7244-2401; Del Zotto, Genny/0000-0001-7272-7776; KIYKIM, Ayca/0000-0001-5821-3963; MARRI, LUCA/0000-0003-0614-2950; CHEN, Qian/0000-0002-7771-2802; Fong, Jason/0000-0001-6164-6110; Zanoni, Ivan/0000-0002-3423-7474; Schmitz-Abe, Klaus E./0000-0002-7242-8861; Crestani, Elena/0000-0001-7718-0431; Benamar, Mehdi/0000-0003-1532-8642	National Institutes of Health [R01 AI115699, R01 AI065617, R01 AI06561720S1, 1R01AI121066, 1R01DK115217, NIAID-DAIT-NIHAI201700100]; German Research Society [HA 8465/1-1]; Istanbul University BAP Project [TSG2020-36834]; Burroughs Wellcome Fund; Digitalis Ventures	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Society(German Research Foundation (DFG)); Istanbul University BAP Project(Istanbul University); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Digitalis Ventures	We thank Jacob Vieira, Hui-Yu Sui, and Naci Senkal for data collection and entry. This work was supported by National Institutes of Health grants R01 AI115699, R01 AI065617, and R01 AI06561720S1 (to T.A.C.) and 1R01AI121066, 1R01DK115217, and NIAID-DAIT-NIHAI201700100 (to I.Z.); German Research Society grant HA 8465/1-1 (to H.H.); and Istanbul University BAP Project TSG2020-36834 (to G.D.). I.Z. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. T.A.C. is the recipient of a grant from Digitalis Ventures.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bashir MF, 2020, AIR QUAL ATMOS HLTH, V13, P1403, DOI 10.1007/s11869-020-00894-8; Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Charbonnier LM, 2015, NAT IMMUNOL, V16, P1162, DOI 10.1038/ni.3288; Cho JL, 2012, J IMMUNOL, V189, P2879, DOI 10.4049/jimmunol.1102483; Copaescu A, 2020, J ALLERGY CLIN IMMUN, V146, P518, DOI 10.1016/j.jaci.2020.07.001; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Esty B, 2019, J ALLER CL IMM-PRACT, V7, P1639, DOI 10.1016/j.jaip.2019.02.043; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Glenn JD, 2017, J EXP MED, V214, P297, DOI 10.1084/jem.20160517; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2100433, 10.1056/NEJMoa2103417]; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Harb H, 2020, NAT IMMUNOL, V21, P1359, DOI 10.1038/s41590-020-0777-3; Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; JOHNSON GR, 1994, J BIOL CHEM, V269, P27149; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lowther DE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85935; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Messerschmidt D, 2016, DEVELOPMENT, V143, P1993, DOI 10.1242/dev.133439; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Perumalsamy LR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002859; Pyle CJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006640; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Tachdjian R, 2009, J EXP MED, V206, P2191, DOI 10.1084/jem.20091480; Thornton AM, 2019, EUR J IMMUNOL, V49, P398, DOI 10.1002/eji.201847935; Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Veiga VC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n84; Verma MK, 2017, J IMMUNOL METHODS, V446, P47, DOI 10.1016/j.jim.2017.03.021; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Woodham AW, 2020, NAT METHODS, V17, P1025, DOI 10.1038/s41592-020-0934-5; Xia MC, 2018, J ALLERGY CLIN IMMUN, V142, P1243, DOI 10.1016/j.jaci.2018.03.009; Xia MC, 2015, J ALLERGY CLIN IMMUN, V136, P441, DOI 10.1016/j.jaci.2015.02.014; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Yang ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep43829; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	64	32	32	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1186	+		10.1016/j.immuni.2021.04.002	http://dx.doi.org/10.1016/j.immuni.2021.04.002		JUN 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33915108	Green Published, Bronze			2022-12-18	WOS:000659882900011
J	Hirai, T; Yang, Y; Zenke, Y; Li, HY; Chaudhri, VK; Diaz, JSD; Zhou, PYF; Nguyen, BAT; Bartholin, L; Workman, CJ; Griggs, DW; Vignali, DAA; Singh, H; Masopust, D; Kaplan, DH				Hirai, Toshiro; Yang, Yi; Zenke, Yukari; Li, Haiyue; Chaudhri, Virendra K.; Diaz, Jacinto S. De La Cruz; Zhou, Paul Yifan; Nguyen, Breanna Anh-Thu; Bartholin, Laurent; Workman, Creg J.; Griggs, David W.; Vignali, Dario A. A.; Singh, Harinder; Masopust, David; Kaplan, Daniel H.			Competition for Active TGF beta Cytokine Allows for Selective Retention of Antigen-Specific Tissue-Resident Memory T Cells in the Epidermal Niche	IMMUNITY			English	Article							LOCAL ANTIGEN; RM CELLS; IMMUNITY; MICE; ACTIVATION; MIGRATION; PATHWAY; ABSENCE; IL-15	Following antigen-driven expansion in lymph node, transforming growth factor-beta (TGF beta) is required for differentiation of skin-recruited CD8(+) T cell effectors into epidermal resident memory T (Trm) cells and their epidermal persistence. We found that the source of TGF beta-supporting Trm cells was autocrine. In addition, antigen-specific Trm cells that encountered cognate antigen in the skin, and bystander Trm cells that did not, both displayed long-term persistence in the epidermis under steady-state conditions. However, when the active-TGF beta was limited or when new T cell clones were recruited into the epidermis, antigen-specific Trm cells were more efficiently retained than bystander Trm cells. Genetically enforced TGF beta signaling allowed bystander Trm cells to persist in the epidermis as efficiently as antigen-specific Trm cells in both contexts. Thus, competition between T cells for active TGF beta represents an unappreciated selective pressure that promotes the accumulation and persistence of antigen-specific Trm cells in the epidermal niche.	[Hirai, Toshiro; Yang, Yi; Zenke, Yukari; Li, Haiyue; Diaz, Jacinto S. De La Cruz; Zhou, Paul Yifan; Nguyen, Breanna Anh-Thu; Kaplan, Daniel H.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15261 USA; [Hirai, Toshiro; Yang, Yi; Zenke, Yukari; Li, Haiyue; Chaudhri, Virendra K.; Diaz, Jacinto S. De La Cruz; Zhou, Paul Yifan; Nguyen, Breanna Anh-Thu; Workman, Creg J.; Vignali, Dario A. A.; Singh, Harinder; Kaplan, Daniel H.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Yang, Yi] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China; [Yang, Yi] Cent South Univ, Xiangya Hosp 3, Changsha, Peoples R China; [Zenke, Yukari] St Lukes Int Hosp, Dept Dermatol, Tokyo, Japan; [Li, Haiyue] Tsinghua Univ, Sch Med, 1 Tsinghua Yuan, Beijing 100084, Peoples R China; [Chaudhri, Virendra K.; Singh, Harinder] Univ Pittsburgh, Ctr Syst Immunol, Pittsburgh, PA USA; [Bartholin, Laurent] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS 5286,TGF B & Pancreat Canc Lab, INSERM 1052,Ctr Leon Berard,Ctr Rech Cancerol Lyo, Lyon, France; [Workman, Creg J.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Griggs, David W.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA; [Masopust, David] Univ Minnesota, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA; [Hirai, Toshiro] Osaka Univ, Res Inst Microbial Dis, BIKEN Innovat Vaccine Res Alliance Labs, Osaka, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University; St. Luke's International Hospital; Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities; Osaka University	Hirai, T; Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15261 USA.; Hirai, T; Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.; Hirai, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, BIKEN Innovat Vaccine Res Alliance Labs, Osaka, Japan.	t-hirai@biken.osaka-u.ac.jp; dankaplan@pitt.edu	Yang, Ye/GZM-4812-2022; yang, yang/HGT-7999-2022	Zhou, Paul/0000-0002-1290-3982; Hirai, Toshiro/0000-0002-9212-1664	NIH [1S10OD011925-01, T32 AI089443, AR060744S1, R01AR060744, P01AI108545]; JSPS Overseas Research Fellowships	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Overseas Research Fellowships	We thank Kate M. Vignali and Andrea L. Workman for constructing E8IcreERT2 and ROSA26.LSL.hNGFR reporter mice. We thank the members of the Kaplan and Vignali laboratory and members throughout the departments of Dermatology and Immunology for helpful discussions. We also thank the Division of Laboratory Animal Resources of the University of Pittsburgh for excellent animal care. The graphical abstract was created with BioRender.com. This work benefitted from SPECIAL BDLSRFORTESSATM, funded by NIH 1S10OD011925-01. T.H. was supported by JSPS Overseas Research Fellowships; J.S.D. by NIH T32 AI089443 and AR060744S1; D.H.K. by NIH R01AR060744; and D.A.A.V. by NIH P01AI108545.	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Bartholin L, 2008, GENESIS, V46, P724, DOI 10.1002/dvg.20425; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chaudhri VK, 2020, NAT IMMUNOL, V21, P210, DOI 10.1038/s41590-019-0565-0; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gamradt P, 2019, J ALLERGY CLIN IMMUN, V143, P2147, DOI 10.1016/j.jaci.2018.11.048; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Hamze M., 2019, SCIENCE, V366, DOI [10.1126/science.aav5728, DOI 10.1126/SCIENCE.AAV5728]; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hirai T, 2020, J INVEST DERMATOL, V140, P748, DOI 10.1016/j.jid.2019.09.014; Hirai T, 2019, IMMUNITY, V50, P1249, DOI 10.1016/j.immuni.2019.03.002; Hobbs SJ, 2019, CELL REP, V29, P2990, DOI 10.1016/j.celrep.2019.10.126; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Liu C, 2020, NAT IMMUNOL, V21, P1010, DOI 10.1038/s41590-020-0733-2; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McMaster SR, 2018, MUCOSAL IMMUNOL, V11, P1071, DOI 10.1038/s41385-018-0003-x; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Muschaweckh A, 2016, J EXP MED, V213, P3075, DOI 10.1084/jem.20160888; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Reynoso GV, 2019, NAT IMMUNOL, V20, P602, DOI 10.1038/s41590-019-0342-0; Richmond JM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7710; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Vincent DF, 2010, GENESIS, V48, P559, DOI 10.1002/dvg.20653; Wakim LM, 2015, MUCOSAL IMMUNOL, V8, P1060, DOI 10.1038/mi.2014.133; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Yang Y, 2019, J DERMATOL SCI, V94, P290, DOI 10.1016/j.jdermsci.2019.04.008; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	50	32	32	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					84	+		10.1016/j.immuni.2020.10.022	http://dx.doi.org/10.1016/j.immuni.2020.10.022		JAN 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33212014	Green Accepted, Bronze			2022-12-18	WOS:000607814000012
J	van der Veeken, J; Zhong, Y; Sharma, R; Mazutis, L; Dao, P; Pe'er, D; Leslie, CS; Rudensky, AY				van der Veeken, Joris; Zhong, Yi; Sharma, Roshan; Mazutis, Linas; Phuong Dao; Pe'er, Dana; Leslie, Christina S.; Rudensky, Alexander Y.			Natural Genetic Variation Reveals Key Features of Epigenetic and Transcriptional Memory in Virus-Specific CD8 T Cells	IMMUNITY			English	Article							STATISTICAL FRAMEWORK; EXPRESSION; BET; ENHANCERS; EFFECTOR; DIFFERENTIATION; MECHANISMS; LANDSCAPES; DISCOVERY; BINDING	Stable changes in chromatin states and gene expression in cells of the immune system form the basis for memory of infections and other challenges. Here, we used naturally occurring cis-regulatory variation in wild-derived inbred mouse strains to explore the mechanisms underlying long-lasting versus transient gene regulation in CD8 T cells responding to acute viral infection. Stably responsive DNA elements were characterized by dramatic and congruent chromatin remodeling events affecting multiple neighboring sites and required distinct transcription factor (TF) binding motifs for their accessibility. Specifically, we found that cooperative recruitment of T-box and Runx family transcription factors to shared targets mediated stable chromatin remodeling upon T cell activation. Our observations provide insights into the molecular mechanisms driving virus-specific CD8 T cell responses and suggest a general mechanism for the formation of transcriptional and epigenetic memory applicable to other immune and non-immune cells.	[van der Veeken, Joris; Zhong, Yi; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [van der Veeken, Joris; Zhong, Yi; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [van der Veeken, Joris; Zhong, Yi; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA; [Zhong, Yi; Sharma, Roshan; Mazutis, Linas; Phuong Dao; Pe'er, Dana; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Sharma, Roshan] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.	rudenska@mskcc.org	Mazutis, Linas/A-5408-2012	Mazutis, Linas/0000-0002-5552-6427; Pe'er, Dana/0000-0002-9259-8817; van der Veeken, Joris/0000-0001-7299-2174	NIH [R37AI034206, U54 CA209975, U01 HG007893]; NIH/NCI Cancer Center [P30CA008748]; Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative; NATIONAL CANCER INSTITUTE [U54CA209975, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Rudensky lab for discussions and technical assistance. We thank Ichiro Taniuchi for the CBF-beta antibody and the NIH tetramer core for critical reagents. This study was supported by NIH grants R37AI034206, U54 CA209975, and U01 HG007893; NIH/NCI Cancer Center Support Grant P30CA008748; the Ludwig Center at Memorial Sloan Kettering Cancer Center; and the Hilton-Ludwig Cancer Prevention Initiative. A.Y. Rudensky is an investigator with the Howard Hughes Medical Institute.	Azizi E., 2017, SINGLE CELL IMMUNE M; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Berland R, 2010, J IMMUNOL, V185, P7537, DOI 10.4049/jimmunol.1002173; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chen JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11101; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Crowley JJ, 2015, NAT GENET, V47, P353, DOI 10.1038/ng.3222; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; de Santiago I, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1165-7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Gate RE, 2018, NAT GENET, V50, P1140, DOI 10.1038/s41588-018-0156-2; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Huang SP, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau057; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Levina E., 2001, EARTH MOVERS DISTANC; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; LI Q., 2011, ANN APPL STAT, V5, P815; Li Q, 2011, ANN APPL STAT, V5; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; Liu Z, 2018, J CELL BIOL, V217, P1181, DOI 10.1083/jcb.201710038; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Miller SA, 2010, IMMUNOL REV, V238, P233, DOI 10.1111/j.1600-065X.2010.00952.x; Moon K. R., 2019, BIORXIV, DOI [10.1101/120378, DOI 10.1101/120378]; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reinius B, 2018, NAT GENET, V50, P1199, DOI 10.1038/s41588-018-0189-6; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Signor SA, 2018, TRENDS GENET, V34, P532, DOI 10.1016/j.tig.2018.03.007; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; van der Veeken J, 2016, CELL, V166, P977, DOI 10.1016/j.cell.2016.07.006; van Dijk D., 2017, CELL, V174, P716; Vigneau S, 2018, NAT GENET, V50, P1198, DOI 10.1038/s41588-018-0188-7; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; 2009, PROTEOMICS, V9, P205, DOI DOI 10.1002/PMIC.200800275; 2010, J IMMUNOL, V185, P4988, DOI DOI 10.4049/JIMMUNOL.1002042; 2009, TRENDS GENET, V25, P234, DOI DOI 10.1016/J.TIG.2009.03.007; 2009, SCIENCE, V323, P505, DOI DOI 10.1126/SCIENCE.1166831; 2016, NAT IMMUNOL, V17, P851, DOI DOI 10.1038/NI.3441; 2015, NAT METHODS, V12, P1061, DOI DOI 10.1038/NMETH.3582; 2005, NAT IMMUNOL, V6, P1236, DOI DOI 10.1038/NI1268; 2007, IMMUNITY, V27, P281, DOI DOI 10.1016/J.IMMUNI.2007.07.010; 2014, NAT IMMUNOL, V15, P373, DOI DOI 10.1038/NI.2834; 2016, NAT IMMUNOL, V17, P422, DOI DOI 10.1038/NI.3410	81	32	32	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1202	+		10.1016/j.immuni.2019.03.031	http://dx.doi.org/10.1016/j.immuni.2019.03.031			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31027997	Green Accepted, Bronze			2022-12-18	WOS:000468429500012
J	Xu, D; Liao, CB; Zhang, B; Tolbert, WD; He, WX; Dai, ZJ; Zhang, W; Yuan, WR; Pazgier, M; Liu, JK; Yu, J; Sansonetti, PJ; Bevins, CL; Shao, YP; Lu, WY				Xu, Dan; Liao, Chongbing; Zhang, Bing; Tolbert, W. David; He, Wangxiao; Dai, Zhijun; Zhang, Wei; Yuan, Weirong; Pazgier, Marzena; Liu, Jiankang; Yu, Jun; Sansonetti, Philippe J.; Bevins, Charles L.; Shao, Yongping; Lu, Wuyuan			Human Enteric alpha-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion	IMMUNITY			English	Article							ANTIMICROBIAL PEPTIDES; EPITHELIAL-CELLS; PANETH CELLS; SECRETION; PATHOGENESIS; EXPRESSION; ENTRY; STEP; NEOVASCULARIZATION; INFLAMMATION	Shigella is a Gram-negative bacterium that causes bacillary dysentery worldwide. It invades the intestinal epithelium to elicit intense inflammation and tissue damage, yet the underlying mechanisms of its host selectivity and low infectious inoculum remain perplexing. Here, we report that Shigella coopts human alpha-defensin 5 (HD5), a host defense peptide important for intestinal homeostasis and innate immunity, to enhance its adhesion to and invasion of mucosal tissues. HD5 promoted Shigella infection in vitro in a structure-dependent manner. Shigella, commonly devoid of an effective host-adhesion apparatus, preferentially targeted HD5 to augment its ability to colonize the intestinal epithelium through interactions with multiple bacterial membrane proteins. HD5 exacerbated infectivity and Shigella-induced pathology in a culture of human colorectal tissues and three animal models. Our findings illuminate how Shigella exploits innate immunity by turning HD5 into a virulence factor for infection, unveiling a mechanism of action for this highly proficient human pathogen.	[Xu, Dan; Liao, Chongbing; Zhang, Bing; He, Wangxiao; Zhang, Wei; Liu, Jiankang; Shao, Yongping; Lu, Wuyuan] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian, Shaanxi, Peoples R China; [Xu, Dan; Liao, Chongbing; He, Wangxiao; Shao, Yongping; Lu, Wuyuan] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Ctr Translat Med, Xian, Shaanxi, Peoples R China; [Xu, Dan; Tolbert, W. David; He, Wangxiao; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Xu, Dan; Tolbert, W. David; He, Wangxiao; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Dai, Zhijun] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Xian, Shaanxi, Peoples R China; [Yu, Jun] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris, France; [Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Xi'an Jiaotong University; University of Strathclyde; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Davis	Shao, YP; Lu, WY (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian, Shaanxi, Peoples R China.; Shao, YP; Lu, WY (corresponding author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Ctr Translat Med, Xian, Shaanxi, Peoples R China.; Lu, WY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Lu, WY (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	yongping.shao@xjtu.edu.cn; wlu@ihv.umaryland.edu	Liu, Jiankang/A-1610-2011; He, Wangxiao/F-3296-2019; Lu, Wuyuan/J-8452-2017; Liao, Chongbing/GSJ-0326-2022; Bevins, Charles L/P-4438-2015; Dai, Zhi-Jun/O-6826-2014	He, Wangxiao/0000-0002-2054-6022; Lu, Wuyuan/0000-0003-1318-9968; Bevins, Charles L/0000-0003-2725-2622; Dai, Zhi-Jun/0000-0001-5209-8626; Liao, Chongbing/0000-0001-9400-6603	Program 985 of Xi'an Jiaotong University; Natural Science Foundation of China [31401211, 31770146]; National Institutes of Health [R01GM106710, R01CA219150, R37AI032738]; NATIONAL CANCER INSTITUTE [R01CA219150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106710] Funding Source: NIH RePORTER	Program 985 of Xi'an Jiaotong University; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Program 985 of Xi'an Jiaotong University (to W.L.) and grants from the Natural Science Foundation of China (31401211 and 31770146 to D.X.) and the National Institutes of Health (R01GM106710 and R01CA219150 to W.L. and R37AI032738 to C.L.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrosi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049625; Arena ET, 2015, P NATL ACAD SCI USA, V112, pE3282, DOI 10.1073/pnas.1509091112; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Brotcke Zumsteg Anna, 2014, Cell Host Microbe, V15, P435, DOI 10.1016/j.chom.2014.03.001; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Campbell-Valois FX, 2014, CELL HOST MICROBE, V15, P177, DOI 10.1016/j.chom.2014.01.005; Carayol N, 2013, CURR OPIN MICROBIOL, V16, P32, DOI 10.1016/j.mib.2012.11.010; Chart H, 2000, J APPL MICROBIOL, V89, P1048, DOI 10.1046/j.1365-2672.2000.01211.x; Chavakis T, 2004, FASEB J, V18, P1306, DOI 10.1096/fj.03-1009fje; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; Edwards RA, 1998, TRENDS MICROBIOL, V6, P282, DOI 10.1016/S0966-842X(98)01288-8; Eilers B, 2010, CELL MICROBIOL, V12, P1134, DOI 10.1111/j.1462-5822.2010.01459.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; Mahmoud RY, 2016, MOL MICROBIOL, V99, P658, DOI 10.1111/mmi.13255; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Pazgier M, 2013, BIOCHEMISTRY-US, V52, P1547, DOI 10.1021/bi301008r; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Philpott DJ, 2000, PHILOS T R SOC B, V355, P575, DOI 10.1098/rstb.2000.0599; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sawasvirojwong S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002293; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SERENY B, 1955, Acta Microbiol Acad Sci Hung, V2, P293; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Snellings NJ, 1997, INFECT IMMUN, V65, P2462, DOI 10.1128/IAI.65.6.2462-2467.1997; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tenge VR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004360; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Wilson SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006446; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100	67	32	33	6	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1233	+		10.1016/j.immuni.2018.04.014	http://dx.doi.org/10.1016/j.immuni.2018.04.014			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29858013	Bronze, Green Accepted			2022-12-18	WOS:000436456900021
J	Da Ros, F; Carnevale, R; Cifelli, G; Bizzotto, D; Casaburo, M; Perrotta, M; Carnevale, L; Vinciguerra, I; Fardella, S; Iacobucci, R; Bressan, GM; Braghetta, P; Lembo, G; Carnevale, D				Da Ros, Francesco; Carnevale, Raimondo; Cifelli, Giuseppe; Bizzotto, Dario; Casaburo, Manuel; Perrotta, Marialuisa; Carnevale, Lorenzo; Vinciguerra, Iolanda; Fardella, Stefania; Iacobucci, Roberta; Bressan, Giorgio M.; Braghetta, Paola; Lembo, Giuseppe; Carnevale, Daniela			Targeting Interleukin-1 beta Protects from Aortic Aneurysms Induced by Disrupted Transforming Growth Factor beta Signaling	IMMUNITY			English	Article							VASCULAR SMOOTH-MUSCLE; NF-KAPPA-B; JUVENILE POLYPOSIS SYNDROME; ARTERIAL STIFFNESS; MICE; SMAD4; PROGRESSION; DISSECTIONS; MUTATIONS; HYPERTENSION	Aortic aneurysms are life-threatening conditions with effective treatments mainly limited to emergency surgery or trans-arterial endovascular stent grafts, thus calling for the identification of specific molecular targets. Genetic studies have highlighted controversial roles of transforming growth factor beta (TGF-beta) signaling in aneurysm development. Here, we report on aneurysms developing in adult mice after smooth muscle cell (SMC)-specific inactivation of Smad4, an intracellular transducer of TGF-beta. The results revealed that Smad4 inhibition activated interleukin- 1 beta (IL-1 beta) in SMCs. This danger signal later recruited innate immunity in the adventitia through chemokine (C-C motif) ligand 2 (CCL2) and modified the mechanical properties of the aortic wall, thus favoring vessel dilation. SMC-specific Smad4 deletion in Il1r1- or Ccr2-null mice resulted in milder aortic pathology. A chronic treatment with anti-IL-1 beta antibody effectively hampered aneurysm development. These findings identify a mechanistic target for controlling the progression of aneurysms with compromised TGF-beta signaling, such as those driven by SMAD4 mutations.	[Da Ros, Francesco; Bizzotto, Dario; Bressan, Giorgio M.; Braghetta, Paola] Univ Padua, Dept Mol Med, I-35131 Padua, Italy; [Da Ros, Francesco; Lembo, Giuseppe; Carnevale, Daniela] Sapienza Univ Rome, Dept Mol Med, I-00161 Rome, Italy; [Carnevale, Raimondo; Cifelli, Giuseppe; Casaburo, Manuel; Perrotta, Marialuisa; Carnevale, Lorenzo; Vinciguerra, Iolanda; Fardella, Stefania; Iacobucci, Roberta; Lembo, Giuseppe; Carnevale, Daniela] IRCCS Neuromed, Dept Angiocardioneurol & Translat Med, I-86077 Pozzilli, Italy	University of Padua; Sapienza University Rome; IRCCS Neuromed	Braghetta, P (corresponding author), Univ Padua, Dept Mol Med, I-35131 Padua, Italy.; Lembo, G; Carnevale, D (corresponding author), Sapienza Univ Rome, Dept Mol Med, I-00161 Rome, Italy.; Lembo, G; Carnevale, D (corresponding author), IRCCS Neuromed, Dept Angiocardioneurol & Translat Med, I-86077 Pozzilli, Italy.	braghett@bio.unipd.it; lembo@neuromed.it; daniela.carnevale@neuromed.it	Carnevale, Daniela/AAE-6319-2020; Lembo, Giuseppe/AAE-8096-2020; Casaburo, Manuel/T-9276-2019; Carnevale, Raimondo/AAC-2628-2021; Da Ros, Francesco/AAC-2012-2022; Fardella, Stefania/AAB-3107-2021; Perrotta, Marialuisa/AAB-7653-2019; Carnevale, Lorenzo/L-6549-2018; Cifelli, Giuseppe/AAB-6938-2019	Carnevale, Daniela/0000-0002-5016-3161; Lembo, Giuseppe/0000-0002-3510-223X; Casaburo, Manuel/0000-0002-3395-2708; Carnevale, Raimondo/0000-0003-0249-8239; Da Ros, Francesco/0000-0002-9869-077X; Perrotta, Marialuisa/0000-0002-0421-0721; Carnevale, Lorenzo/0000-0002-6422-8253; Cifelli, Giuseppe/0000-0002-6417-7185; BIZZOTTO, Dario/0000-0002-9036-5016	Ricerca Corrente of the Italian Ministry of Health; University of Padova [60A06-8034/14]	Ricerca Corrente of the Italian Ministry of Health(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); University of Padova	The authors thank Dr. Stefan Offermanns for supplying the Myh11-CreERT2 mice and Novartis for providing the IL-1 beta-neutralizing antibody. This work was supported by Ricerca Corrente of the Italian Ministry of Health (to G.L.) and the University of Padova (grant 60A06-8034/14 to P.B.).	Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; Andrabi S, 2011, AM J MED GENET A, V155A, P1165, DOI 10.1002/ajmg.a.33968; Aoki T, 2007, CIRCULATION, V116, P2830, DOI 10.1161/CIRCULATIONAHA.107.728303; Aoki T, 2009, ARTERIOSCL THROM VAS, V29, P1080, DOI 10.1161/ATVBAHA.108.180760; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bertoli-Avella AM, 2015, J AM COLL CARDIOL, V65, P1324, DOI 10.1016/j.jacc.2015.01.040; Carnevale D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13035; Carnevale D, 2014, IMMUNITY, V41, P737, DOI 10.1016/j.immuni.2014.11.002; Carnevale D, 2011, CIRCULATION, V124, P1337, DOI 10.1161/CIRCULATIONAHA.111.050500; Daugherty A, 2014, ARTERIOSCL THROM VAS, V34, P691, DOI 10.1161/ATVBAHA.114.303353; Davis FM, 2014, HEART, V100, P1498, DOI 10.1136/heartjnl-2014-305648; Deguchi JO, 2009, LAB INVEST, V89, P315, DOI 10.1038/labinvest.2008.167; Denes A, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002006; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gillis E, 2013, CIRC RES, V113, P327, DOI 10.1161/CIRCRESAHA.113.300675; Guo DC, 2001, CIRCULATION, V103, P2461; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; HE CM, 1994, J VASC SURG, V20, P6, DOI 10.1016/0741-5214(94)90169-4; Heald B, 2015, AM J MED GENET A, V167, P1758, DOI 10.1002/ajmg.a.37093; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Jagadesham VP, 2008, TRENDS MOL MED, V14, P522, DOI 10.1016/j.molmed.2008.09.008; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Martin-Alonso M, 2015, CIRC RES, V117, pE13, DOI 10.1161/CIRCRESAHA.117.305108; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Moriwaki T, 2006, STROKE, V37, P900, DOI 10.1161/01.STR.0000204028.39783.d9; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Raaz U, 2015, CIRCULATION, V131, P1783, DOI 10.1161/CIRCULATIONAHA.114.012377; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sager HB, 2015, CIRCULATION, V132, P1880, DOI 10.1161/CIRCULATIONAHA.115.016160; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen MC, 2015, ARTERIOSCL THROM VAS, V35, P888, DOI 10.1161/ATVBAHA.114.305115; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Teekakirikul P, 2013, AM J MED GENET A, V161A, P185, DOI 10.1002/ajmg.a.35659; Trask AJ, 2012, VASC PHARMACOL, V57, P187, DOI 10.1016/j.vph.2012.07.007; Ucar A, 2015, CLIN ENDOCRINOL, V82, P719, DOI 10.1111/cen.12626; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35444; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zhang P, 2016, CIRC RES, V118, P388, DOI 10.1161/CIRCRESAHA.115.308040	49	32	32	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					959	+		10.1016/j.immuni.2017.10.016	http://dx.doi.org/10.1016/j.immuni.2017.10.016			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29150241	Green Published, Bronze			2022-12-18	WOS:000416483700018
J	Andrabi, R; Su, CY; Liang, CH; Shivatare, SS; Briney, B; Voss, JE; Nawazi, SK; Wu, CY; Wong, CH; Burton, DR				Andrabi, Raiees; Su, Ching-Yao; Liang, Chi-Hui; Shivatare, Sachin S.; Briney, Bryan; Voss, James E.; Nawazi, Salar Khan; Wu, Chung-Yi; Wong, Chi-Huey; Burton, Dennis R.			Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development	IMMUNITY			English	Article							RECOGNITION; MATURATION; LINEAGE; EPITOPE; REVEAL; IMMUNIZATION; COEVOLUTION; PRECURSORS; BINDING; DESIGN	Apex broadly neutralizing HIV antibodies (bnAbs) recognize glycans and protein surface close to the 3-fold axis of the envelope (Env) trimer and are among the most potent and broad Abs described. The evolution of apex bnAbs from one donor (CAP256) has been studied in detail and many Abs at different stages of maturation have been described. Using diverse engineering tools, we investigated the involvement of glycan recognition in the development of the CAP256. VRC26 Ab lineage. We found that sialic acid-bearing glycans were recognized by germline-encoded and somatically mutated residues on the Ab heavy chain. This recognition provided an "anchor'' for the Abs as the core protein epitope varies, prevented complete neutralization escape, and eventually led to broadening of the response. These findings illustrate how glycan-specific maturation enables a human Ab to cope with pathogen escape mechanisms and will aid in optimization of immunization strategies to induce V2 apex bnAb responses.	[Andrabi, Raiees; Su, Ching-Yao; Liang, Chi-Hui; Briney, Bryan; Voss, James E.; Nawazi, Salar Khan; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Andrabi, Raiees; Su, Ching-Yao; Liang, Chi-Hui; Briney, Bryan; Voss, James E.; Nawazi, Salar Khan; Burton, Dennis R.] Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA; [Andrabi, Raiees; Su, Ching-Yao; Liang, Chi-Hui; Briney, Bryan; Voss, James E.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Shivatare, Sachin S.; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02114 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Academia Sinica - Taiwan; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02114 USA.	burton@scripps.edu	Shivatare, Sachin S/G-7264-2017; Wu, Chung-Yi/K-8334-2018	Shivatare, Sachin S/0000-0002-7512-752X; 	International AIDS Vaccine Initiative (IAVI) through Neutralizing Antibody Consortium [SFP1849]; National Institute of Allergy and Infectious Diseases (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery) [UM1AI100663]; Ragon Institute of MGH, MIT, and Harvard; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); USAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI) through Neutralizing Antibody Consortium; National Institute of Allergy and Infectious Diseases (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery); Ragon Institute of MGH, MIT, and Harvard; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); USAID(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank John R. Mascola and Nicole A. Doria-Rose for providing CAP256.08 and CAP256.09 antibodies. We thank James C. Paulson for critical comments on the manuscript and Lars Hangartner, Lynn Morris, Penny Moore, and Jinal N. Bhiman for useful discussions. This work was supported by the International AIDS Vaccine Initiative (IAVI) through Neutralizing Antibody Consortium SFP1849 (D.R.B.); the National Institute of Allergy and Infectious Diseases (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663 to D.R.B.); and the Ragon Institute of MGH, MIT, and Harvard (D.R.B.). This study was made possible by the generous support of the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) and the American people through USAID. We thank Christina Corbaci and for her help in the preparation of figures.	Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Briney B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23901; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lin CW, 2015, P NATL ACAD SCI USA, V112, P10611, DOI 10.1073/pnas.1513456112; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori D.C., 2005, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1211S64; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Panico M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32956; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shivatare SS, 2016, NAT CHEM, V8, P338, DOI [10.1038/NCHEM.2463, 10.1038/nchem.2463]; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029	52	32	32	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					524	+		10.1016/j.immuni.2017.08.006	http://dx.doi.org/10.1016/j.immuni.2017.08.006			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28916265	Green Accepted, Bronze			2022-12-18	WOS:000411128200016
J	Procaccini, C; Carbone, F; Di Silvestre, D; Brambilla, F; De Rosa, V; Galgani, M; Faicchia, D; Marone, G; Tramontano, D; Corona, M; Alviggi, C; Porcellini, A; La Cava, A; Mauri, P; Matarese, G				Procaccini, Claudio; Carbone, Fortunata; Di Silvestre, Dario; Brambilla, Francesca; De Rosa, Veronica; Galgani, Mario; Faicchia, Deriggio; Marone, Gianni; Tramontano, Donatella; Corona, Marco; Alviggi, Carlo; Porcellini, Antonio; La Cava, Antonio; Mauri, Pierluigi; Matarese, Giuseppe			The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements (vol 44, pg 406, 2016)	IMMUNITY			English	Correction												giuseppe.matarese@unina.it	/AAG-9576-2020; Galgani, Mario/AAC-3298-2022; Porcellini, Antonio/E-1900-2011; Porcellini, Antonio/AAC-6097-2019; Alviggi, Carlo/B-9096-2011; Procaccini, Claudio/AAB-3696-2019; Mauri, Pietro Luigi/AAC-3095-2019; Tramontano, Donatella/AAS-1740-2020	/0000-0002-8839-0933; Porcellini, Antonio/0000-0001-6882-9518; Mauri, Pietro Luigi/0000-0003-4364-0393; Brambilla, Francesca/0000-0002-9532-175X; MARONE, Gianni/0000-0002-9849-4701; Tramontano, Donatella/0000-0002-9308-034X; Matarese, Giuseppe/0000-0001-9429-0616; Alviggi, Carlo/0000-0001-9116-020X	European Foundation for the Study of Diabetes [JDRF Lilly 2015_4] Funding Source: researchfish; NIAID NIH HHS [R21 AI109677] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109677] Funding Source: NIH RePORTER	European Foundation for the Study of Diabetes; NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028	1	32	32	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					712	712		10.1016/j.immuni.2016.02.022	http://dx.doi.org/10.1016/j.immuni.2016.02.022			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	28843073	hybrid, Green Published			2022-12-18	WOS:000372784200026
J	Chen, LF; Chen, ZG; Baker, K; Halvorsen, EM; da Cunha, AP; Flak, MB; Gerber, G; Huang, YH; Hosomi, S; Arthur, JC; Dery, KJ; Nagaishi, T; Beauchemin, N; Holmes, KV; Ho, JWK; Shively, JE; Jobin, C; Onderdonk, AB; Bry, L; Weiner, HL; Higgins, DE; Blumberg, RS				Chen, Lanfen; Chen, Zhangguo; Baker, Kristi; Halvorsen, Elizabeth M.; da Cunha, Andre Pires; Flak, Magdalena B.; Gerber, Georg; Huang, Yu-Hwa; Hosomi, Shuhei; Arthur, Janelle C.; Dery, Ken J.; Nagaishi, Takashi; Beauchemin, Nicole; Holmes, Kathryn V.; Ho, Joshua W. K.; Shively, John E.; Jobin, Christian; Onderdonk, Andrew B.; Bry, Lynn; Weiner, Howard L.; Higgins, Darren E.; Blumberg, Richard S.			The Short Isoform of the CEACAM1 Receptor in Intestinal T Cells Regulates Mucosal Immunity and Homeostasis via Tfh Cell Induction	IMMUNITY			English	Article							BILIARY GLYCOPROTEIN CD66A; ADHESION MOLECULE; LISTERIA-MONOCYTOGENES; CYTOPLASMIC DOMAIN; DENDRITIC CELLS; PEYERS-PATCHES; LAMINA PROPRIA; IGA RESPONSES; IN-VIVO; ACTIVATION	Carcinoembryonic antigen cell adhesion molecule like I (CEACAM1) is expressed on activated T cells and signals through either a long (L) cytoplasmic tail containing immune receptor tyrosine based inhibitory motifs, which provide inhibitory function, or a short (S) cytoplasmic tail with an unknown role. Previous studies on peripheral T cells show that CEACAM1-L isoforms predominate with little to no detectable CEACAM1-S isoforms in mouse and human. We show here that this was not the case in tissue resident T cells of intestines and gut associated lymphoid tissues, which demonstrated predominant expression of CEACAM1-S isoforms relative to CEACAM1-L isoforms in human and mouse. This tissue resident predominance of CEACAM1-S expression was determined by the intestinal environment where it served a stimulatory function leading to the regulation of T cell subsets associated with the generation of secretory IgA immunity, the regulation of mucosal commensalism, and defense of the barrier against enteropathogens.	[Chen, Lanfen; Chen, Zhangguo; Baker, Kristi; Flak, Magdalena B.; Huang, Yu-Hwa; Hosomi, Shuhei; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Gastroenterol Div, Boston, MA 02115 USA; [da Cunha, Andre Pires; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Gerber, Georg; Onderdonk, Andrew B.; Bry, Lynn] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ho, Joshua W. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Halvorsen, Elizabeth M.; Higgins, Darren E.] Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA; [Arthur, Janelle C.; Jobin, Christian] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA; [Dery, Ken J.; Shively, John E.] Beckman Res Inst City Hope, Dept Immunol, Duarte, CA 91010 USA; [Nagaishi, Takashi] Tokyo Med & Dent Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Tokyo 1138519, Japan; [Beauchemin, Nicole] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Holmes, Kathryn V.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; City of Hope; Beckman Research Institute of City of Hope; Tokyo Medical & Dental University (TMDU); McGill University; University of Colorado System; University of Colorado Anschutz Medical Campus	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Gastroenterol Div, Boston, MA 02115 USA.	rblumberg@partners.org	Chen, Lanfen/B-7975-2016; Flak, Magdalena/AAG-5272-2020; Ho, Joshua W. K./AAK-7759-2020; Chen, Zhangguo/AAW-2032-2021; Flak, Magdalena B/M-7106-2016; Young, Richard A/F-6495-2012	Chen, Lanfen/0000-0002-9413-1284; Flak, Magdalena/0000-0002-8238-9835; Ho, Joshua W. K./0000-0003-2331-7011; Flak, Magdalena B/0000-0002-8238-9835; Young, Richard A/0000-0001-8855-8647; Chen, Zhangguo/0000-0002-2741-0080; Baker, Kristi/0000-0002-2993-3889; Arthur, Janelle/0000-0002-4796-0207; Bry, Lynn/0000-0002-8792-8527	Crohn's & Colitis Foundation of America; National Institutes of Health (NIH) [DK051362, DK044319, DK053056, DK088199, T32 DK007737, AI059576, CA84202, DK73338, DK47700]; Harvard Digestive Diseases Center [NIH P30DK034854]; High Pointe Foundation; Stanley L. Robbins Memorial Research Award; Canadian Institutes of Health Research; BWH Gnotobiotics and Microbiome Core; Japanese Ministry of Education, Culture, Sports, Science and Technology; Nihon Univ. Medical Association; Abbott Japan Research Fund; Foundation for Advancement of International Science; Takeda Science Foundation;  [HD061916]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI059576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051362, T32DK007737, R01DK044319, R01DK053056, R01DK088199, R37DK044319, R56DK047700, P30DK034854, R01DK073338, R01DK047700] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22590696] Funding Source: KAKEN	Crohn's & Colitis Foundation of America; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; High Pointe Foundation; Stanley L. Robbins Memorial Research Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); BWH Gnotobiotics and Microbiome Core; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon Univ. Medical Association; Abbott Japan Research Fund; Foundation for Advancement of International Science(Foundation for Advancement of International Science (FAIS)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. Maas (Division of Genetics, Brigham and Women's Hospital) for microarray data analysis, C.G. Vinuesa (Australian National University), H. Cantor (Dana Farber Cancer Institute), and K. Smith (Addenbrooke's Hospital, University of Cambridge) for guidance on analysis of Tfh cells and J. Cusick for technical assistance. L.C. and T.N. were supported by Research Fellowship Awards from the Crohn's & Colitis Foundation of America. R.S.B. was supported by National Institutes of Health (NIH) DK051362, DK044319, DK053056, DK088199, Harvard Digestive Diseases Center (NIH P30DK034854), and the High Pointe Foundation. G.G. was supported by the Stanley L. Robbins Memorial Research Award. J.C.A. is supported by NIH T32 DK007737. K.H. was supported by NIH AI059576. K.B. and N.B. were supported by the Canadian Institutes of Health Research. J.E.S. was supported by NIH CA84202. C.J. was supported by NIH DK73338 and DK47700. L.B. was supported by the Harvard Digestive Diseases Center (NIH P30DK034854), HD061916, and the BWH Gnotobiotics and Microbiome Core. T.N. was supported by Japanese Ministry of Education, Culture, Sports, Science and Technology; Nihon Univ. Medical Association; Abbott Japan Research Fund; Foundation for Advancement of International Science; and Takeda Science Foundation.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Azuz-Lieberman N, 2005, INT IMMUNOL, V17, P837, DOI 10.1093/intimm/dxh270; Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BJORNEKLETT A, 1983, SCAND J GASTROENTERO, V18, P289, DOI 10.3109/00365528309181596; Boirivant M, 2008, GASTROENTEROLOGY, V135, P1612, DOI 10.1053/j.gastro.2008.07.028; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Chen ZG, 2008, J IMMUNOL, V180, P6085, DOI 10.4049/jimmunol.180.9.6085; Cong YZ, 2009, EUR J IMMUNOL, V39, P3134, DOI 10.1002/eji.200939052; COUTELIER JP, 1994, EUR J IMMUNOL, V24, P1383, DOI 10.1002/eji.1830240622; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; DVEKSLER GS, 1993, P NATL ACAD SCI USA, V90, P1716, DOI 10.1073/pnas.90.5.1716; Edlund M, 1996, J BIOL CHEM, V271, P1393, DOI 10.1074/jbc.271.3.1393; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Fantini MC, 2007, NAT PROTOC, V2, P1789, DOI 10.1038/nprot.2007.258; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hashizume T, 2008, INFECT IMMUN, V76, P927, DOI 10.1128/IAI.01145-07; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Hurst SD, 1999, J IMMUNOL, V163, P5937; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kirshner J, 2003, J BIOL CHEM, V278, P50338, DOI 10.1074/jbc.M309115200; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lobo EO, 2009, J LEUKOCYTE BIOL, V86, P205, DOI 10.1189/jlb.0109037; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2001, MICROBES INFECT, V3, P1021, DOI 10.1016/S1286-4579(01)01460-5; Manohar M, 2001, INFECT IMMUN, V69, P3542, DOI 10.1128/IAI.69.6.3542-3549.2001; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Morales VM, 1999, J IMMUNOL, V163, P1363; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nakajima A, 2002, J IMMUNOL, V168, P1028, DOI 10.4049/jimmunol.168.3.1028; NIEMIR ZI, 1995, KIDNEY INT, V48, P1530, DOI 10.1038/ki.1995.443; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shannon CE, 1997, M D COMPUT, V14, P306; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Taylor JM, 2007, INFECT IMMUN, V75, P3462, DOI 10.1128/IAI.01470-06; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049	62	32	33	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					930	946		10.1016/j.immuni.2012.07.016	http://dx.doi.org/10.1016/j.immuni.2012.07.016			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23123061	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000311460000018
J	Martinon, F				Martinon, Fabio			Dangerous Liaisons: Mitochondrial DNA Meets the NLRP3 Inflammasome	IMMUNITY			English	Editorial Material								Danger signals released by damaged organelles can promote inflammation. In this issue of Immunity, Shimada et al. (2012) report that oxidized DNA, released by mitochondria, directly binds and activates the NLRP3 inflammasome.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Martinon, F (corresponding author), Univ Lausanne, Dept Biochem, 155 Ch Des Boveresses, CH-1066 Epalinges, Switzerland.	fabio.martinon@unil.ch	Martinon, Fabio/A-5575-2009	Martinon, Fabio/0000-0002-6969-822X				Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	7	32	35	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 23	2012	36	3					313	315		10.1016/j.immuni.2012.03.005	http://dx.doi.org/10.1016/j.immuni.2012.03.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22444626	Bronze			2022-12-18	WOS:000302048400002
J	Frittoli, E; Matteoli, G; Palamidessi, A; Mazzini, E; Maddaluno, L; Disanza, A; Yang, CS; Svitkina, T; Rescigno, M; Scita, G				Frittoli, Emanuele; Matteoli, Gianluca; Palamidessi, Andrea; Mazzini, Elise; Maddaluno, Luigi; Disanza, Andrea; Yang, Changsong; Svitkina, Tatyana; Rescigno, Maria; Scita, Giorgio			The Signaling Adaptor Eps8 Is an Essential Actin Capping Protein for Dendritic Cell Migration	IMMUNITY			English	Article							ALDRICH-SYNDROME PROTEIN; CONTACT HYPERSENSITIVITY; FILAMENT NUCLEATION; LANGERHANS CELLS; IN-VIVO; RECEPTOR; EXPRESSION; MOTILITY; DYNAMICS; DISTINCT	Dendritic cells (DCs) flexibly adapt to different micro-environments by using diverse migration strategies that are ultimately dependent on the dynamics and structural organization of the actin cytoskeleton. Here, we have shown that DCs require the actin capping activity of the signaling adaptor Eps8 to polarize and to form elongated migratory protrusions. DCs from Eps8-deficient mice are impaired in directional and chemotactic migration in 3D in vitro and are delayed in reaching the draining lymph node (DLN) in vivo after inflammatory challenge. Hence, Eps8-deficient mice are unable to mount a contact hypersensitivity response. We have also shown that the DC migratory defect is cell autonomous and that Eps8 is required for the proper architectural organization of the actin meshwork and dynamics of cell protrusions. Yet, Eps8 is not necessary for antigen uptake, processing, and presentation. Thus, we have identified Eps8 as a unique actin capping protein specifically required for DC migration.	[Matteoli, Gianluca; Mazzini, Elise; Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, IEO, Via Ripamonti 435, I-20141 Milan, Italy; [Frittoli, Emanuele; Palamidessi, Andrea; Maddaluno, Luigi; Disanza, Andrea; Scita, Giorgio] FIRC Inst Mol Oncol Fdn, IFOM, I-20139 Milan, Italy; [Scita, Giorgio] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy; [Yang, Changsong; Svitkina, Tatyana] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Pennsylvania	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, IEO, Via Ripamonti 435, I-20141 Milan, Italy.	maria.rescigno@ifom-ieo-campus.it; giorgio.scita@ifom-ieo-campus.it	Rescigno, Maria/J-9704-2012; Scita, Giorgio/J-9670-2012; Palamidessi, Andrea/F-1203-2018	Rescigno, Maria/0000-0002-6464-509X; Matteoli, Gianluca/0000-0002-2902-4976; Scita, Giorgio/0000-0001-7984-1889; Disanza, Andrea/0000-0001-5101-2907; palamidessi, andrea/0000-0002-7134-7023	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Education-University-Research (MIUR-PRIN); Italian Ministry of Health; AICR (International Association For Cancer Research -AICR); CARIPLO Foundations; European Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070898] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education-University-Research (MIUR-PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); AICR (International Association For Cancer Research -AICR); CARIPLO Foundations(Fondazione Cariplo); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Sixt for sharing protocols and for discussion, A. Prescot for initial technical support on DC imaging, and R. Gunby for critically reading and editing the manuscript. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to G.S., A.D. and M.R; the Italian Ministries of Education-University-Research (MIUR-PRIN) and of Health to G.S.; the AICR (International Association For Cancer Research -AICR) to G.S. and M.R.; the CARIPLO Foundations to G.S. and M.R.; and the European Research Council to M.R. and G.S.	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Bouma G, 2007, BLOOD, V110, P4278, DOI 10.1182/blood-2007-06-096875; Bouma G, 2009, IMMUNOBIOLOGY, V214, P778, DOI 10.1016/j.imbio.2009.06.009; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Dearman RJ, 1996, FUND APPL TOXICOL, V33, P24, DOI 10.1006/faat.1996.0139; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Eddy RJ, 1997, J CELL BIOL, V139, P1243, DOI 10.1083/jcb.139.5.1243; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl Peter, 2004, Methods Mol Biol, V239, P77; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; HEIT B, 2003, SCI STKE, pPL5; Hertzog M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000387; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lambotin M, 2010, J VIROL, V84, P8964, DOI 10.1128/JVI.00517-10; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Maly IV, 2001, P NATL ACAD SCI USA, V98, P11324, DOI 10.1073/pnas.181338798; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Monypenny J, 2011, EUR J CELL BIOL, V90, P198, DOI 10.1016/j.ejcb.2010.05.009; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pulecio J, 2008, J IMMUNOL, V181, P1135, DOI 10.4049/jimmunol.181.2.1135; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; SULLIVAN S, 1986, J IMMUNOL, V137, P2460; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 1999, TRENDS BIOCHEM SCI, V24, P432, DOI 10.1016/S0968-0004(99)01461-9; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; Theodoridis AA, 2011, BLOOD, V118, P107, DOI 10.1182/blood-2010-07-294363; Tocchetti A, 2003, GENOMICS, V81, P234, DOI 10.1016/S0888-7543(03)00002-8; Tocchetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009468; Wang BH, 1997, J IMMUNOL, V159, P6148; Wang YF, 1997, INT IMMUNOL, V9, P211, DOI 10.1093/intimm/9.2.211; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153	54	32	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 23	2011	35	3					388	399		10.1016/j.immuni.2011.07.007	http://dx.doi.org/10.1016/j.immuni.2011.07.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21835647	Green Accepted, Bronze			2022-12-18	WOS:000295748100010
J	Zikherman, J; Weiss, A				Zikherman, Julie; Weiss, Arthur			Alternative Splicing of CD45: The Tip of the Iceberg	IMMUNITY			English	Editorial Material							PRE-MESSENGER-RNA; SYSTEM; CELLS	Mechanisms underlying the regulated splicing of CD45 RNA have been long-standing puzzles. In this issue of Immunity, Wu et al. (2008) identify hnRNPLL as a critical regulator of both signal-induced exon skipping in CD45 and global alternative-transcript expression in memory T cells.	[Zikherman, Julie; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Rosalind Russell Med Res Ctr Arthrit, Div Rheumatol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Rosalind Russell Med Res Ctr Arthrit, Div Rheumatol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu		Zikherman, Julie/0000-0002-0873-192X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; ROTHSTEIN DM, 1992, J BIOL CHEM, V267, P7139; ten Dam GB, 2000, J IMMUNOL, V164, P5287, DOI 10.4049/jimmunol.164.10.5287; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004	11	32	32	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					839	841		10.1016/j.immuni.2008.12.005	http://dx.doi.org/10.1016/j.immuni.2008.12.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100695	Bronze			2022-12-18	WOS:000262012400002
J	Muller, S				Muller, Stefanie			Dicing with viruses: MicroRNAs as antiviral factors	IMMUNITY			English	Editorial Material							DROSOPHILA; DEFENSE; IMMUNITY; CELLS	In plants and invertebrates, Dicer genes play a critical role against infections by RNA viruses. In this issue, Otsuka et al. (2007) report that Dicer mutant mice are hypersusceptible to infection by the RNA virus VSV.	Univ Strasbourg 1, Fac Sci Vie, F-67070 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Muller, S (corresponding author), Univ Strasbourg 1, Fac Sci Vie, F-67070 Strasbourg, France.	jl.imler@ibmc.u-strasbg.fr	Becker, Stefanie/AEM-2050-2022					Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Marcus PI, 1998, J VIROL, V72, P542, DOI 10.1128/JVI.72.1.542-549.1998; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694	10	32	37	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2007	27	1					1	3		10.1016/j.immuni.2007.07.003	http://dx.doi.org/10.1016/j.immuni.2007.07.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17663977	Bronze			2022-12-18	WOS:000248398100001
J	Pipkin, ME; Ljutic, B; Cruz-Guilloty, F; Nouzova, M; Rao, A; Zuniga-Pflucker, JC; Lichtenheld, MG				Pipkin, Matthew E.; Ljutic, Belma; Cruz-Guilloty, Fernando; Nouzova, Marcela; Rao, Anjana; Zuniga-Pflucker, Juan Carlos; Lichtenheld, Mathias G.			Chromosome transfer activates and delineates a locus control region for perforin	IMMUNITY			English	Article							BETA-GLOBIN LOCUS; EMBRYONIC STEM-CELLS; POSITION EFFECT VARIEGATION; NATURAL-KILLER-CELLS; T-CELLS; CHROMATIN-STRUCTURE; IN-VITRO; TRANSCRIPTION FACTORS; MICROCELL HYBRIDS; GENE-EXPRESSION	Perforin gene (PRF1) transcription regulates perforin expression in NK cells and CTL. Here we identified the locus-wide ensemble of cis-acting sequences that drives PRF1 transcription physiologically. By using chromosome transfer, we revealed that de novo, activation of a silent PRF1 locus was controlled by a 150 kb domain comprised of 16 DNase I hypersensitive sites (DHSs). These cis-acting sequences included a locus control region (LCR) and conferred developmentally appropriate and lineage-specific expression of human perforin from BAC transgenes. The LCR included four distal DHSs that were required for perforin expression from its natural locus, and their engineered deletion from the PRF1 BAC transgene abolished LCR function and led to rapid gene silencing. Thus, LCR function is central for regulating the developmental and activation-specific PRF1 promoter activity characteristic of NK cells and CTL.	Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada; Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	University of Miami; University of Miami; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lichtenheld, MG (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	mlichten@med.miami.edu	Zuniga-Pflucker, Juan C/H-1295-2012; Nouzova, Marcela/AAK-8609-2021	Nouzova, Marcela/0000-0002-4562-1383; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Pipkin, Matthew/0000-0002-9688-0190	NIAID NIH HHS [AI 44432] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Rosa SC, 2004, J IMMUNOL, V172, P1637, DOI 10.4049/jimmunol.172.3.1637; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; GARCIASANZ JA, 1993, EUR J IMMUNOL, V23, P1877, DOI 10.1002/eji.1830230822; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; LICHTENHELD MG, 1992, J IMMUNOL, V149, P2619; LICHTENHELD MG, 1995, J IMMUNOL, V154, P2153; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAKATA M, 1992, INT IMMUNOL, V4, P1049, DOI 10.1093/intimm/4.9.1049; Ohkawa T, 2001, IMMUNOLOGY, V103, P281, DOI 10.1046/j.1365-2567.2001.01248.x; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; PERSHOUSE MA, 1993, CANCER RES, V53, P5043; PING L, 1992, J IMMUNOL, V148, P3354; Pipkin ME, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl006; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rollini P, 2000, NUCLEIC ACIDS RES, V28, P3605, DOI 10.1093/nar/28.18.3605; Rollini P, 1999, GENOMICS, V56, P22, DOI 10.1006/geno.1998.5680; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; SALCEDO TW, 1993, J IMMUNOL, V151, P2511; SCHLESINGER BC, 1994, IMMUNOLOGY, V81, P291; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Schubeler D, 2000, GENE DEV, V14, P940; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang ZD, 2001, GENOME RES, V11, P137, DOI 10.1101/gr.159001; Youn BS, 1996, J IMMUNOL, V157, P3499; Zhang J, 1999, J EXP MED, V190, P1297, DOI 10.1084/jem.190.9.1297; Zhang YG, 1997, J IMMUNOL, V158, P1734	50	32	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					29	41		10.1016/j.immuni.2006.11.009	http://dx.doi.org/10.1016/j.immuni.2006.11.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17222571	Bronze			2022-12-18	WOS:000243959000007
J	Asmal, M; Colgan, J; Naef, F; Yu, B; Lee, Y; Magnasco, M; Luban, J				Asmal, M; Colgan, J; Naef, F; Yu, B; Lee, Y; Magnasco, M; Luban, J			Production of ribosome components in effector CD4(+) T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK	IMMUNITY			English	Article							PROTEIN MESSENGER-RNAS; NUCLEOLAR RNP PROTEIN; TRANSLATIONAL CONTROL; GENE-EXPRESSION; YEAST HOMOLOG; IN-VIVO; ACTIVATION; RAPAMYCIN; TRANSCRIPTION; SIGNALS	Effector CD4(+) T cells rapidly activate high-level cytokine expression following TCR stimulation. Consistent with accelerated protein production in these cells, global mRNA profiles revealed that, after cytokines, the most impressive cluster of activated genes encode rRNA-maturation factors. Activation of these genes was ERK-MAPK dependent, accompanied by increased rRNA transcription and faster maturation kinetics, and much greater in effector CD4(+) T cells than in naive cells. Ribosomal protein subunit (RPS) synthesis was also ERK-MAPK dependent and increased to match rRNA production, but without evident increase in RPS mRNA. Instead, stimulation promoted polysome loading of RPS mRNA via cis-acting, 5'-terminal oligopyrimidines. These results demonstrate how, in response to extracellular signals, effector CD4(+) T cells coordinately increase multiple ribosomal components to accommodate burgeoning cytokine production.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Columbia University; Columbia University; Rockefeller University	Luban, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	jl45@columbia.edu	Naef, Felix/C-9527-2011	Naef, Felix/0000-0001-9786-3037; Luban, Jeremy/0000-0001-5650-4054; Colgan, John/0000-0001-9273-2644	NIAID NIH HHS [AI 36199, R01 AI036199] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036199] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; ALONI R, 1992, MOL CELL BIOL, V12, P2203, DOI 10.1128/MCB.12.5.2203; Atherfold PA, 1999, MOL IMMUNOL, V36, P543, DOI 10.1016/S0161-5890(99)00076-0; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; Brennan P, 1999, MOL CELL BIOL, V19, P4729; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Charette M, 2000, IUBMB LIFE, V49, P341; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Colgan J, 2000, GENOMICS, V68, P167, DOI 10.1006/geno.2000.6295; DEPHILIP RM, 1980, BIOCHEMISTRY-US, V19, P1662, DOI 10.1021/bi00549a022; Frankel A, 1999, BIOCHEM BIOPH RES CO, V259, P391, DOI 10.1006/bbrc.1999.0779; FRANKLIN RA, 1994, J IMMUNOL, V153, P4890; Franklin RA, 2000, MOL IMMUNOL, V37, P675, DOI 10.1016/S0161-5890(00)00087-0; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Garcia-Sanz JA, 1998, FASEB J, V12, P299, DOI 10.1096/fasebj.12.3.299; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; Glimcher LH, 2000, GENE DEV, V14, P1693; HARIHARAN N, 1989, NUCLEIC ACIDS RES, V17, P5323, DOI 10.1093/nar/17.13.5323; HARIHARAN N, 1990, P NATL ACAD SCI USA, V87, P1526, DOI 10.1073/pnas.87.4.1526; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Huber MD, 2000, J BIOL CHEM, V275, P28764, DOI 10.1074/jbc.M000594200; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; MELLOR H, 1994, FEBS LETT, V350, P143, DOI 10.1016/0014-5793(94)00756-X; MEYUHAS O, 1987, MOL CELL BIOL, V7, P2691, DOI 10.1128/MCB.7.8.2691; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Mikulits W, 2000, FASEB J, V14, P1641, DOI 10.1096/fj.14.11.1641; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493, DOI 10.1128/MCB.14.4.2493; Nadano D, 2000, JPN J CANCER RES, V91, P802, DOI 10.1111/j.1349-7006.2000.tb01017.x; Naef F, 2002, GENOME BIOL, V3; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PIERANDREIAMALDI P, 1985, DEV BIOL, V107, P281, DOI 10.1016/0012-1606(85)90311-2; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Scotet E, 2001, BLOOD, V98, P2568, DOI 10.1182/blood.V98.8.2568; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Stoecklin G, 2001, RNA, V7, P1578; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Swain SL, 1999, CURR OPIN IMMUNOL, V11, P180, DOI 10.1016/S0952-7915(99)80030-2; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WODNARFILIPOWICZ A, 1990, P NATL ACAD SCI USA, V87, P777, DOI 10.1073/pnas.87.2.777; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	59	32	34	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					535	548		10.1016/S1074-7613(03)00268-1	http://dx.doi.org/10.1016/S1074-7613(03)00268-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563318	Bronze			2022-12-18	WOS:000186051900010
J	Bai, A; Broen, J; Forman, J				Bai, A; Broen, J; Forman, J			The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1(b)	IMMUNITY			English	Article							CLASS-I MOLECULES; MAJOR HISTOCOMPATIBILITY COMPLEX; SITE-DIRECTED MUTAGENESIS; ANTIGEN PRESENTATION; SIGNAL SEQUENCE; ENDOPLASMIC-RETICULUM; INHIBITOR LACTACYSTIN; RESTRICTED PEPTIDES; GLYCOSYLATION SITE; CELL RECOGNITION	Qa-1(b) and its human homolog, HLA-E, predominantly bind leader peptides derived from other class I molecules. Their presentation is TAP-dependent and proteasome-independent. We demonstrate that D-d targeted to the cytosol does not generate the Qa-1(b) peptide epitope even in the presence of lactacystin. Cells expressing herpes virus ICP-47 block the generation of this epitope, demonstrating that TAP functions in the transport of the peptide from cytosol to ER. This reveals a pathway for antigen presentation of leader peptides that involves translocation of a protein to the ER where its leader is cleaved followed by its release into the cytosol and transport back into the ER. Further, it ensures that Qa-1(b) expression mirrors the normal expression of class Ia molecules.	Dept Microbiol, Dallas, TX 75235 USA; Grad Program Immunol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Forman, J (corresponding author), Dept Microbiol, Dallas, TX 75235 USA.	iforma@mednet.swmed.edu			NIAID NIH HHS [R01-AI37942, R01-AI34930, P01-AI37818] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037818, R01AI034930, R01AI037942] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Bacik I, 1997, J EXP MED, V186, P479, DOI 10.1084/jem.186.4.479; Bai AL, 1997, J IMMUNOL, V159, P2139; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; Cotterill LA, 1997, EUR J IMMUNOL, V27, P2123, DOI 10.1002/eji.1830270902; DeCloux A, 1997, J IMMUNOL, V158, P2183; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; Ferris RL, 1996, J IMMUNOL, V156, P834; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; HAMMOND SA, 1995, J IMMUNOL, V154, P6140; HAMMOND SA, 1993, NATURE, V364, P158, DOI 10.1038/364158a0; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOMBACH J, 1995, J EXP MED, V182, P1615, DOI 10.1084/jem.182.5.1615; HOWARD JC, 1995, CURR OPIN IMMUNOL, V7, P69, DOI 10.1016/0952-7915(95)80031-X; INOUYE S, 1982, P NATL ACAD SCI-BIOL, V79, P3438, DOI 10.1073/pnas.79.11.3438; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Lanier LL, 1997, IMMUNITY, V6, P371, DOI 10.1016/S1074-7613(00)80280-0; Lee SP, 1996, EUR J IMMUNOL, V26, P1875, DOI 10.1002/eji.1830260831; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; LOWEN LC, 1993, J IMMUNOL, V151, P6155; Luckey CJ, 1998, J IMMUNOL, V161, P112; LYKO F, 1995, J BIOL CHEM, V270, P19873, DOI 10.1074/jbc.270.34.19873; MACKETT M, 1985, DNA CLONING PRACTICA, P191; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Mosse CA, 1998, J EXP MED, V187, P37, DOI 10.1084/jem.187.1.37; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Snyder HL, 1997, J EXP MED, V186, P1087, DOI 10.1084/jem.186.7.1087; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TAKEBE Y, 1988, MOL CELL BIOL, V8, P4466; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; Uger RA, 1997, J IMMUNOL, V158, P685; Vinitsky A, 1997, J IMMUNOL, V159, P554; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; YAMAMOTO Y, 1990, BIOCHEMISTRY-US, V29, P8998, DOI 10.1021/bi00490a017; YellenShaw AJ, 1997, J IMMUNOL, V158, P3227; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	55	32	32	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					413	421		10.1016/S1074-7613(00)80624-X	http://dx.doi.org/10.1016/S1074-7613(00)80624-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768761	Bronze			2022-12-18	WOS:000076202300014
J	DILLON, SR; MACKAY, VL; FINK, PJ				DILLON, SR; MACKAY, VL; FINK, PJ			A FUNCTIONALLY COMPROMISED INTERMEDIATE IN EXTRATHYMIC CD8(+) T-CELL DELETION	IMMUNITY			English	Article							RECEPTOR ALPHA-CHAIN; TRANSGENIC MICE; MONOCLONAL-ANTIBODY; CLONAL DELETION; DIFFERENTIAL EXPRESSION; PERIPHERAL SELECTION; FLOW-CYTOMETRY; IMMUNE-SYSTEM; GENE-PRODUCTS; LYMPHOCYTES-T	We have established a model system for analyzing the induction of self-tolerance among mature peripheral T cells in V beta 5 TCR Tg mice. Both CD4(+)V beta 5(+) and CD8(+)V beta 5(+) cells undergo a superantigen-driven chronic deletion in the periphery of I-E(-) mice. Prior to their disappearance, CD4(+) transgene-expressing cells are activated and then rendered anergic to further stimulation through their TCRs. This scenario differs strikingly in the CD8(+) cellular compartment, which is characterized by a distinct population of CD8(lo)V beta 5(lo) cells localized to the blood and spleen. CD8(lo) cells are small, express the surface phenotype of memory cells, and rapidly incorporate BrdU in vive. The kinetics of their appearance and disappearance in adult thymectomized mice, the rapid chasing of BrdU from labeled cells, and their in vivo cortisone sensitivity all suggest CD8(lo) cells are slated for deletion. Furthermore, their functional incompetence can be documented in vitro in the absence of internucleosomal DNA fragmentation. Thus, we have identified an intermediate population of T cells targeted for peripheral deletion that, although functionally compromised, has not yet undergone programmed cell death.	ZYMOGENET INC,SEATTLE,WA 98102	Zymogenet Inc.	DILLON, SR (corresponding author), UNIV WASHINGTON,SCH MED,DEPT IMMUNOL,BOX 357650,SEATTLE,WA 98195, USA.				NCI NIH HHS [CA90537] Funding Source: Medline; NIA NIH HHS [AG13078] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013078] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHAORBEA H, 1991, IMMUNOL TODAY, V12, P356, DOI 10.1016/0167-5699(91)90066-3; AKBAR AN, 1993, IMMUNOL TODAY, V14, P526, DOI 10.1016/0167-5699(93)90181-J; ANDERSON SJ, 1993, J IMMUNOL, V151, P5123; BEVAN MJ, 1975, J IMMUNOL, V114, P559; BHANDOOLA A, 1993, J IMMUNOL, V151, P2355; BILL J, 1990, J MOL CELL IMMUNOL, V4, P269; BLACKMAN MA, 1993, J IMMUNOL, V151, P556; BLACKMAN MA, 1990, NATURE, V345, P540, DOI 10.1038/345540a0; BOUR S, 1994, IMMUNOL REV, V140, P147, DOI 10.1111/j.1600-065X.1994.tb00869.x; BRANDTCARLSON C, 1993, VIROLOGY, V193, P171, DOI 10.1006/viro.1993.1113; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; CARBONE FR, 1992, INT IMMUNOL, V4, P861, DOI 10.1093/intimm/4.8.861; COHEN GM, 1993, J IMMUNOL, V151, P566; COHEN JC, 1982, J VIROL, V44, P882, DOI 10.1128/JVI.44.3.882-885.1982; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; Crispe I N, 1994, Semin Immunol, V6, P39, DOI 10.1006/smim.1994.1006; DILLON SR, 1994, J IMMUNOL, V152, P1790; FERRICK DA, 1992, INT IMMUNOL, V4, P805, DOI 10.1093/intimm/4.7.805; FINK PJ, 1994, J IMMUNOL, V152, P4270; FINK PJ, 1992, J EXP MED, V176, P1733, DOI 10.1084/jem.176.6.1733; FINK PJ, 1988, ANNU REV IMMUNOL, V6, P115; FOOPHILLIPS M, 1992, J IMMUNOL, V149, P3440; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GEIER SS, 1986, J IMMUNOL, V137, P1239; GOLLOB KJ, 1993, J IMMUNOL, V150, P3705; GOLLOB KJ, 1992, P NATL ACAD SCI USA, V89, P5138, DOI 10.1073/pnas.89.11.5138; HAMMERLING GJ, 1993, IMMUNOL REV, V133, P93, DOI 10.1111/j.1600-065X.1993.tb01511.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HELD W, 1994, IMMUNOL TODAY, V15, P184, DOI 10.1016/0167-5699(94)90317-4; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; HUANG L, 1993, J IMMUNOL, V151, P1844; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JENKINS MK, 1992, IMMUNOL TODAY, V13, P69, DOI 10.1016/0167-5699(92)90137-V; JOHNSON P, 1989, J EXP MED, V169, P1179, DOI 10.1084/jem.169.3.1179; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KANAGAWA O, 1991, J IMMUNOL, V147, P1307; KEMENY DM, 1994, IMMUNOL TODAY, V15, P107, DOI 10.1016/0167-5699(94)90152-X; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIAO NS, 1990, J IMMUNOL, V144, P844; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; LUSSOW AR, 1993, EUR J IMMUNOL, V23, P578, DOI 10.1002/eji.1830230244; MACKAY CR, 1991, IMMUNOL TODAY, V12, P189, DOI 10.1016/0167-5699(91)90051-T; MCNICHOLAS JM, 1982, J EXP MED, V155, P490, DOI 10.1084/jem.155.2.490; MILLER JFAP, 1993, IMMUNOL REV, V133, P131, DOI 10.1111/j.1600-065X.1993.tb01514.x; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NISHIMURA T, 1985, CELL IMMUNOL, V94, P122, DOI 10.1016/0008-8749(85)90090-5; NUNEZ G, 1994, IMMUNOL TODAY, V15, P582, DOI 10.1016/0167-5699(94)90221-6; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAZVI ES, 1995, J IMMUNOL, V154, P620; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; SCHONRICH G, 1992, INT IMMUNOL, V4, P581, DOI 10.1093/intimm/4.5.581; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SMITH HP, 1992, J IMMUNOL, V149, P887; SPRENT J, 1976, CELL IMMUNOL, V21, P278, DOI 10.1016/0008-8749(76)90057-5; TAKEI F, 1985, J IMMUNOL, V134, P1403; TASWELL C, 1981, J IMMUNOL, V126, P1614; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VACCHIO MS, 1993, J IMMUNOL, V151, P1322; VEIS DJ, 1993, J IMMUNOL, V151, P2546; WAANDERS GA, 1993, INT IMMUNOL, V5, P55, DOI 10.1093/intimm/5.1.55; WANG A, 1984, SCIENCE, V224, P1431, DOI 10.1126/science.6427925; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; Webb S R, 1992, Semin Immunol, V4, P329; WILSON A, 1982, J IMMUNOL METHODS, V52, P283, DOI 10.1016/0022-1759(82)90002-3; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; WOODLAND DL, 1991, NATURE, V349, P529, DOI 10.1038/349529a0; WOODLAND DL, 1991, J EXP MED, V174, P1255, DOI 10.1084/jem.174.5.1255	78	32	32	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					321	333		10.1016/1074-7613(95)90117-5	http://dx.doi.org/10.1016/1074-7613(95)90117-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552997	Bronze			2022-12-18	WOS:A1995RX64500007
J	VanBlargan, LA; Adams, LJ; Liu, ZM; Chen, RE; Gilchuk, P; Raju, S; Smith, BK; Zhao, H; Case, JB; Winkler, ES; Whitener, BM; Droit, L; Aziati, ID; Bricker, TL; Joshi, A; Shi, PY; Creanga, A; Pegu, A; Handley, SA; Wang, D; Boon, ACM; Crowe, JE; Whelan, SPJ; Fremont, DH; Diamond, MS				VanBlargan, Laura A.; Adams, Lucas J.; Liu, Zhuoming; Chen, Rita E.; Gilchuk, Pavlo; Raju, Saravanan; Smith, Brittany K.; Zhao, Haiyan; Case, James Brett; Winkler, Emma S.; Whitener, Bradley M.; Droit, Lindsay; Aziati, Ishmael D.; Bricker, Traci L.; Joshi, Astha; Shi, Pei-Yong; Creanga, Adrian; Pegu, Amarendra; Handley, Scott A.; Wang, David; Boon, Adrianus C. M.; Crowe, James E., Jr.; Whelan, Sean P. J.; Fremont, Daved H.; Diamond, Michael S.			A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope	IMMUNITY			English	Article							BEAM-INDUCED MOTION	With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increased transmissibility and potential resistance, antibodies and vaccines with broadly inhibitory activity are needed. Here, we developed a panel of neutralizing anti-SARS-CoV-2 monoclonal antibodies (mAbs) that bound the receptor binding domain of the spike protein at distinct epitopes and blocked virus attachment to its host receptor, human angiotensin converting enzyme-2 (hACE2). Although several potently neutralizing mAbs protected K18-hACE2 transgenic mice against infection caused by ancestral SARS-CoV-2 strains, others induced escape variants in vivo or lost neutralizing activity against emerging strains. One mAb, SARS2-38, potently neutralized all tested SARS-CoV-2 variants of concern and protected mice against challenge by multiple SARS-CoV-2 strains. Structural analysis showed that SARS2-38 engaged a conserved epitope proximal to the receptor binding motif. Thus, treatment with or induction of neutralizing antibodies that bind conserved spike epitopes may limit the loss of potency of therapies or vaccines against emerging SARS-CoV-2 variants.	[VanBlargan, Laura A.; Chen, Rita E.; Raju, Saravanan; Case, James Brett; Winkler, Emma S.; Whitener, Bradley M.; Aziati, Ishmael D.; Bricker, Traci L.; Joshi, Astha; Boon, Adrianus C. M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Adams, Lucas J.; Chen, Rita E.; Raju, Saravanan; Smith, Brittany K.; Zhao, Haiyan; Winkler, Emma S.; Handley, Scott A.; Boon, Adrianus C. M.; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Liu, Zhuoming; Droit, Lindsay; Wang, David; Boon, Adrianus C. M.; Whelan, Sean P. J.; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Gilchuk, Pavlo; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA; [Creanga, Adrian; Pegu, Amarendra] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Vanderbilt University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Fremont, DH; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Fremont, DH; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Fremont, DH; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	fremont@wustl.edu; diamond@wusm.wustl.edu	Crowe, James/B-5549-2009; Joshi, Astha/U-9014-2019	Crowe, James/0000-0002-0049-1079; Joshi, Astha/0000-0003-4914-8228; Fremont, Daved/0000-0002-8544-2689; Whitener, Bradley/0000-0001-6652-0701; Liu, Zhuoming/0000-0001-8198-0976; Adams, Lucas/0000-0002-1724-8120; VanBlargan, Laura/0000-0002-8922-8946	NIH [75N93019C00062, HHSN272201700060C, 75N93019C00074, U01 AI151810, R01 AI118938, R01 AI157155]; Defense Advanced Research Project Agency [HR001117S0019]; Helen Hay Whitney Foundation postdoctoral fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Helen Hay Whitney Foundation postdoctoral fellowship	This study was supported by contracts and grants from the NIH (75N93019C00062, HHSN272201700060C, 75N93019C00074, U01 AI151810, R01 AI118938, and R01 AI157155) and the Defense Advanced Research Project Agency (HR001117S0019). J.B.C. is supported by a Helen Hay Whitney Foundation postdoctoral fellowship. We acknowledge the originating and submitting laboratories who generated and shared genetic sequence data via the GISAID Initiative. We also thank Charles Chiu and Raul Andino for providing the B.1.429 isolate and Barney Graham for cell lines and experimental advice. The Graphical Abstract was created with BioRender.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alsoussi WB, 2020, J IMMUNOL, V205, P915, DOI 10.4049/jimmunol.2000583; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Case JB, 2020, VIROLOGY, V548, P39, DOI 10.1016/j.virol.2020.05.015; Cathcart A. L., 2021, DUAL FUNCTION MONOCL, DOI [10.1101/2021.03.09.434607v6, DOI 10.1101/2021.03.09.434607, 10.1101/2021.03.09.434607, 10.1101/2021.03.09.434607(2021]; Cerutti G, 2021, STRUCTURE, V29, P655, DOI 10.1016/j.str.2021.05.014; Chen AT, 2021, ELIFE, V10, DOI 10.7554/eLife.63409; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chen RE, 2021, NATURE, V596, P103, DOI 10.1038/s41586-021-03720-y; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Chu H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20457-w; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Dekkers G, 2017, MABS-AUSTIN, V9, P767, DOI 10.1080/19420862.2017.1323159; Dong Jinhui, 2021, bioRxiv, DOI 10.1101/2021.01.27.428529; Earnest JT, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108962; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Golden JW, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142032; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li D., FUNCTIONS SARS COV2; Li T., ULTRAPOTENT SARS COV; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu ZM, 2021, CELL HOST MICROBE, V29, P477, DOI 10.1016/j.chom.2021.01.014; Martinez David R, 2021, bioRxiv, DOI 10.1101/2021.04.27.441655; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; O'Brien MP, 2021, NEW ENGL J MED, V385, P1184, DOI 10.1056/NEJMoa2109682; Oladunni FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19891-7; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Sanchez-Garcia R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02399-1; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Scheid JF, 2021, CELL, V184, P3205, DOI 10.1016/j.cell.2021.04.032; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schmitz AJ, 2021, IMMUNITY, V54, P2159, DOI [10.1016/j.immuni.2021.08.013, 10.1101/2021.03.24.436864]; Shen XY, 2021, NEW ENGL J MED, V384, P2352, DOI 10.1056/NEJMc2103740; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Song G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23074-3; Starr T.N., NATURE; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Suryadevara N, 2021, CELL, V184, P2316, DOI 10.1016/j.cell.2021.03.029; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Tortorici M Alejandra, 2021, bioRxiv, DOI 10.1101/2021.04.07.438818; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	84	31	30	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2399	+		10.1016/j.immuni.2021.08.016	http://dx.doi.org/10.1016/j.immuni.2021.08.016		OCT 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34481543	Bronze, Green Published			2022-12-18	WOS:000706854100023
J	Schmitz, AJ; Turner, JS; Liu, ZM; Zhou, JQ; Aziati, ID; Chen, RE; Joshi, A; Bricker, TL; Darling, TL; Adelsberg, DC; Altomare, CG; Alsoussi, WB; Case, JB; VanBlargan, LA; Lei, TT; Thapa, M; Amanat, F; Jeevan, T; Fabrizio, T; O'Halloran, JA; Shi, PY; Presti, RM; Webby, RJ; Krammer, F; Whelan, SPJ; Bajic, G; Diamond, MS; Boon, ACM; Ellebedy, AH				Schmitz, Aaron J.; Turner, Jackson S.; Liu, Zhuoming; Zhou, Julian Q.; Aziati, Ishmael D.; Chen, Rita E.; Joshi, Astha; Bricker, Traci L.; Darling, Tamarand L.; Adelsberg, Daniel C.; Altomare, Clara G.; Alsoussi, Wafaa B.; Case, James Brett; VanBlargan, Laura A.; Lei, Tingting; Thapa, Mahima; Amanat, Fatima; Jeevan, Trushar; Fabrizio, Thomas; O'Halloran, Jane A.; Shi, Pei-Yong; Presti, Rachel M.; Webby, Richard J.; Krammer, Florian; Whelan, Sean P. J.; Bajic, Goran; Diamond, Michael S.; Boon, Adrianus C. M.; Ellebedy, Ali H.			A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants	IMMUNITY			English	Article							NEUTRALIZING ANTIBODIES; SEQUENCE ALIGNMENT; REPERTOIRE; CELL	The emergence of SARS-CoV-2 antigenic variants with increased transmissibility is a public health threat. Some variants show substantial resistance to neutralization by SARS-CoV-2 infection- or vaccination-induced antibodies. Here, we analyzed receptor binding domain-binding monoclonal antibodies derived from SARS-CoV-2 mRNA vaccine-elicited germinal center B cells for neutralizing activity against the WA1/2020 D614G SARS-CoV-2 strain and variants of concern. Of five monoclonal antibodies that potently neutralized the WA1/2020 D614G strain, all retained neutralizing capacity against the B.1.617.2 variant, four also neutralized the B.1.1.7 variant, and only one, 2C08, also neutralized the B.1.351 and B.1.1.28 variants. 2C08 reduced lung viral load and morbidity in hamsters challenged with the WA1/2020 D614G, B.1.351, or B.1.617.2 strains. Clonal analysis identified 2C08-like public clonotypes among B cells responding to SARS-CoV-2 infection or vaccination in 41 out of 181 individuals. Thus, 2C08-like antibodies can be induced by SARS-CoV-2 vaccines and mitigate resistance by circulating variants of concern.	[Schmitz, Aaron J.; Turner, Jackson S.; Zhou, Julian Q.; Chen, Rita E.; Alsoussi, Wafaa B.; Lei, Tingting; Thapa, Mahima; Diamond, Michael S.; Boon, Adrianus C. M.; Ellebedy, Ali H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Liu, Zhuoming; Alsoussi, Wafaa B.; Whelan, Sean P. J.; Diamond, Michael S.; Boon, Adrianus C. M.; Ellebedy, Ali H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Aziati, Ishmael D.; Chen, Rita E.; Joshi, Astha; Bricker, Traci L.; Darling, Tamarand L.; Case, James Brett; VanBlargan, Laura A.; O'Halloran, Jane A.; Presti, Rachel M.; Diamond, Michael S.; Boon, Adrianus C. M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Adelsberg, Daniel C.; Altomare, Clara G.; Amanat, Fatima; Krammer, Florian; Bajic, Goran] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Amanat, Fatima] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Jeevan, Trushar; Fabrizio, Thomas; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Presti, Rachel M.; Diamond, Michael S.; Ellebedy, Ali H.] Washington Univ, Ctr Vaccines & Immun Microbial Pathogens, Sch Med, St Louis, MO 63130 USA; [Diamond, Michael S.; Ellebedy, Ali H.] Washington Univ, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); Washington University (WUSTL)	Boon, ACM; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Boon, ACM; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Boon, ACM (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Ellebedy, AH (corresponding author), Washington Univ, Ctr Vaccines & Immun Microbial Pathogens, Sch Med, St Louis, MO 63130 USA.; Ellebedy, AH (corresponding author), Washington Univ, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Sch Med, St Louis, MO 63130 USA.	jboon@wustl.edu; ellebedy@wustl.edu	Joshi, Astha/U-9014-2019; Krammer, Florian/H-3237-2019	Joshi, Astha/0000-0003-4914-8228; Krammer, Florian/0000-0003-4121-776X; Schmitz, Aaron/0000-0002-8077-6751; Adelsberg, Daniel/0000-0003-0591-7136; Bajic, Goran/0000-0003-0480-4324; Al Soussi, Wafaa/0000-0002-5805-4461; Zhou, Julian/0000-0001-9602-2092; Darling, Tamarand/0000-0001-6640-9165; Liu, Zhuoming/0000-0001-8198-0976	NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program [U24 GM129539]; Simons Foundation [SF349247]; NIAID [5T32CA009547, U01AI141990, U01AI150747]; NIAID Centers of Excellence for Influenza Research and Surveillance contract [HHSN272201400006C, HHSN272201400008C, 75N93021C00016]; NY State Assembly Majority; NIAID Collaborative Influenza Vaccine Innovation Centers contract [75N93019C00051]; NIH [75N93019C00062, R01 AI157155, R01-AI118938, U01-AI151810, AI134907, UL1TR001439]; Children's Discovery Institute grant [PDII2018702]; Sealy & Smith Foundation; Kleberg Foundation; John S. Dunn Foundation; Amon G. Carter Foundation; Gilson Longenbaugh Foundation; Summerfield Roberts Foundation; NIH/National Center for Advancing Translational Sciences grant [UL1 TR002345]; Helen Hay Whitney postdoctoral fellowship	NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Centers of Excellence for Influenza Research and Surveillance contract; NY State Assembly Majority; NIAID Collaborative Influenza Vaccine Innovation Centers contract; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute grant; Sealy & Smith Foundation; Kleberg Foundation; John S. Dunn Foundation; Amon G. Carter Foundation; Gilson Longenbaugh Foundation; Summerfield Roberts Foundation; NIH/National Center for Advancing Translational Sciences grant; Helen Hay Whitney postdoctoral fellowship	The Vero-TMPRSS2 cells were kindly provided by S. Ding (Washington University School of Medicine, St. Louis, MO). The clinical sample for isolation of the B.1.617.2 variant was kindly provided by A. Patel (Poplar Healthcare, Memphis, TN). We thank W. Kim for helpful discussions. Some of this work was performed at the National Center for CryoEM Access and Training (NCCAT) and the Simons Electron Microscopy Center located at the New York Structural Biology Center, supported by the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program (U24 GM129539) and by grants from the Simons Foundation (SF349247) and NY State Assembly Majority. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIAID or NIH. The Ellebedy laboratory was supported by NIAID grants U01AI141990 and U01AI150747 and NIAID Centers of Excellence for Influenza Research and Surveillance contract HHSN272201400006C. The Ellebedy and Krammer laboratories were supported by NIAID Centers of Excellence for Influenza Research and Surveillance contract HHSN272201400008C and NIAID Collaborative Influenza Vaccine Innovation Centers contract 75N93019C00051. The Diamond laboratory was supported by NIH contract 75N93019C00062 and grant R01 AI157155. The Boon laboratory was supported by NIH grants R01-AI118938 and U01-AI151810 and the Children's Discovery Institute grant PDII2018702. The Webby laboratory was supported by the NIAID Centers of Excellence for Influenza Research and Response contract 75N93021C00016. The Shi laboratory was supported by NIH grants AI134907 and UL1TR001439 and awards from the Sealy & Smith Foundation, Kleberg Foundation, the John S. Dunn Foundation, the Amon G. Carter Foundation, the Gilson Longenbaugh Foundation, and the Summerfield Roberts Foundation. The SARS-CoV-2 vaccine study was in part supported by NIH/National Center for Advancing Translational Sciences grant UL1 TR002345. J.S.T. was supported by NIAID 5T32CA009547. J.B.C. was supported by a Helen Hay Whitney postdoctoral fellowship.	Alsoussi WB, 2020, J IMMUNOL, V205, P915, DOI 10.4049/jimmunol.2000583; Amanat F, 2021, CELL, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Andreano E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103154118; Andreano E, 2021, CELL, V184, P1821, DOI 10.1016/j.cell.2021.02.035; Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bajic G, 2021, ACS INFECT DIS, V7, P1, DOI 10.1021/acsinfecdis.0c00726; Bajic G, 2019, CELL HOST MICROBE, V25, P827, DOI 10.1016/j.chom.2019.04.003; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Case JB, 2020, CELL HOST MICROBE, V28, P475, DOI 10.1016/j.chom.2020.06.021; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chen RE, 2021, NATURE, V596, P103, DOI 10.1038/s41586-021-03720-y; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Corrie BD, 2018, IMMUNOL REV, V284, P24, DOI 10.1111/imr.12666; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Dong Jinhui, 2021, bioRxiv, DOI 10.1101/2021.01.27.428529; Edara VV, 2021, NEW ENGL J MED, V385, P664, DOI 10.1056/NEJMc2107799; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galson JD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.605170; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Lee K, 2009, GLOB INST, P1; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Liu ZM, 2021, CELL HOST MICROBE, V29, P477, DOI 10.1016/j.chom.2021.01.014; Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901; Nielsen SCA, 2020, CELL HOST MICROBE, V28, P516, DOI 10.1016/j.chom.2020.09.002; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Scheid JF, 2021, CELL, V184, P3205, DOI 10.1016/j.cell.2021.04.032; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Singer J.B., 2020, COV GLUE WEB APPL TR, DOI [DOI 10.1016/j.cell.2020.11.020, 10.20944/preprints202006.0225.v1, DOI 10.20944/PREPRINTS202006.0225.V1]; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; U.S. Food & Drug Administration, 2021, FDA REC INV COVID 19; Nonaka CKV, 2021, EMERG INFECT DIS, V27, P1522, DOI 10.3201/eid2705.210191; Wang Pengfei, 2021, bioRxiv, DOI 10.1101/2021.01.25.428137; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	68	31	32	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2159	+		10.1016/j.immuni.2021.08.013	http://dx.doi.org/10.1016/j.immuni.2021.08.013		SEP 2021	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34464596	Bronze, Green Published			2022-12-18	WOS:000695789800021
J	Dersh, D; Phelan, JD; Gumina, ME; Wang, BY; Arbuckle, JH; Holly, J; Kishton, RJ; Markowitz, TE; Seedhom, MO; Fridlyand, N; Wright, GW; Huang, DW; Ceribelli, M; Thomas, CJ; Lack, JB; Restifo, NP; Kristie, TM; Staudt, LM; Yewdell, JW				Dersh, Devin; Phelan, James D.; Gumina, Megan E.; Wang, Boya; Arbuckle, Jesse H.; Holly, Jaroslav; Kishton, Rigel J.; Markowitz, Tovah E.; Seedhom, Mina O.; Fridlyand, Nathan; Wright, George W.; Huang, Da Wei; Ceribelli, Michele; Thomas, Craig J.; Lack, Justin B.; Restifo, Nicholas P.; Kristie, Thomas M.; Staudt, Louis M.; Yewdell, Jonathan W.			Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas	IMMUNITY			English	Article							B-CELL LYMPHOMA; CYTOLYTIC T-LYMPHOCYTES; FOLLOW-UP; KAPPA-B; EXPRESSION; EZH2; PROMOTES; SURVIVAL; INACTIVATION; THYMIDYLATE	Tumors frequently subvert major histocompatibility complex class 1 (MHC-1) peptide presentation to evade CD8(+) T cell immunosurveillance, though how this is accomplished is not always well defined. To identify the global regulatory networks controlling antigen presentation, we employed genome-wide screening in human diffuse large B cell lymphomas (DLBCLs). This approach revealed dozens of genes that positively and negatively modulate MHC-I cell surface expression. Validated genes clustered in multiple pathways including cytokine signaling, mRNA processing, endosomal trafficking, and protein metabolism. Genes can exhibit lymphoma subtype- or tumor-specific MHC-I regulation, and a majority of primary DLBCL tumors displayed genetic alterations in multiple regulators. We established SUGT1 as a major positive regulator of both MHC-I and MHC-II cell surface expression. Further, pharmacological inhibition of two negative regulators of antigen presentation, EZH2 and thymidylate synthase, enhanced DLBCL MHC-I presentation. These and other genes represent potential targets for manipulating MHC-I immunosurveillance in cancers, infectious diseases, and autoimmunity.	[Dersh, Devin; Gumina, Megan E.; Arbuckle, Jesse H.; Holly, Jaroslav; Seedhom, Mina O.; Fridlyand, Nathan; Kristie, Thomas M.; Yewdell, Jonathan W.] NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Phelan, James D.; Wang, Boya; Seedhom, Mina O.; Huang, Da Wei; Staudt, Louis M.] NCI, Lymphoid Malignancies Branch, NIH, Bethesda, MD 20892 USA; [Kishton, Rigel J.; Restifo, Nicholas P.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Markowitz, Tovah E.; Lack, Justin B.] NIAID, NIAID Collaborat Bioinformat Resource, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Markowitz, Tovah E.; Lack, Justin B.] Frederick Natl Lab Canc Res, Adv Biomed Computat Sci, Frederick, MD 21702 USA; [Wright, George W.] NCI, Biometr Res Branch, Div Canc Diag & Treatment, NIH, Bethesda, MD 20892 USA; [Ceribelli, Michele; Thomas, Craig J.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Kishton, Rigel J.; Restifo, Nicholas P.] Lyell Immunopharma, San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Dersh, D; Yewdell, JW (corresponding author), NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	devin.dersh@nih.gov; jyewdell@niaid.nih.gov	Arbuckle, Jesse H/H-7513-2019	Arbuckle, Jesse H/0000-0003-3652-3543; Gumina, Megan/0000-0003-2590-9547; Thomas, Craig/0000-0001-9386-9001	NIHNIAID; NCI; NCATS; NCI FLEX award	NIHNIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI FLEX award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Special thanks to the NIAID Research Technologies Branch, including Tim Myers, the Genomic Technologies facility, Teresa Hawley, and the Flow Cytometry facility. Thanks to the NCI Center for Cancer Research sequencing facility, as well as support personnel in the laboratories of L.M.S. and J.W.Y. We also acknowledge the Centre for Clinical Immunology and Biomedical Studies at the Institute for Immunology & Infectious Diseases for HLA typing. This research was supported by the Intramural Research Program of the NIHNIAID, NCI, and NCATS-and specifically the NCI FLEX award to J.W.Y. and L.M.S.	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Ansell SM, 2019, J CLIN ONCOL, V37, P481, DOI 10.1200/JCO.18.00766; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Berg RW, 2001, J PHARMACOL EXP THER, V298, P477; Boyle LH, 2013, P NATL ACAD SCI USA, V110, P3465, DOI 10.1073/pnas.1222342110; Bruno A, 2014, ONCOTARGET, V5, P5065, DOI 10.18632/oncotarget.2080; Bujisic B, 2017, BLOOD, V129, P2420, DOI 10.1182/blood-2016-09-741348; Burr ML, 2019, CANCER CELL, V36, P385, DOI 10.1016/j.ccell.2019.08.008; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Cuevas M.V.R., 2020, MOST NONCANONICAL PR; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Dersh D, 2021, NAT REV IMMUNOL, V21, P116, DOI 10.1038/s41577-020-0390-6; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Dufva O, 2020, CANCER CELL, V38, P380, DOI 10.1016/j.ccell.2020.06.002; Ennishi D, 2019, CANCER DISCOV, V9, P546, DOI 10.1158/2159-8290.CD-18-1090; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; ESTEBAN F, 1990, BRIT J CANCER, V62, P1047, DOI 10.1038/bjc.1990.437; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Gandin V, 2013, MOL CELL BIOL, V33, P2510, DOI 10.1128/MCB.01362-12; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Harel M, 2019, CELL, V179, P236, DOI 10.1016/j.cell.2019.08.012; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; HELLSTROM KE, 1960, J NATL CANCER I, V25, P237; Hermann C, 2015, ELIFE, V4, DOI 10.7554/eLife.09617; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Italiano A, 2018, LANCET ONCOL, V19, P649, DOI 10.1016/S1470-2045(18)30145-1; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Jongsma M.L.M., 2020, IMMUNITY, V54; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kraan W, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.28; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Laumont CM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau5516; Lesokhin AM, 2016, J CLIN ONCOL, V34, P2698, DOI 10.1200/JCO.2015.65.9789; Liang Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005145; Liepe J, 2019, CANCER IMMUNOL RES, V7, P62, DOI 10.1158/2326-6066.CIR-18-0424; Lu L, 2018, P NATL ACAD SCI USA, V115, pE498, DOI 10.1073/pnas.1715118115; Ludigs K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005088; Lue J.K., 2018, CURR HEMATOL MALIG R, V13, pe1211; Lue JK, 2018, CURR HEMATOL MALIG R, V13, P369, DOI 10.1007/s11899-018-0466-6; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McGranahan N, 2017, CELL, V171, P1259, DOI 10.1016/j.cell.2017.10.001; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Nijland M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1295202; Nissen MD, 2020, CYTOM PART A, V97, P620, DOI 10.1002/cyto.a.23919; Novosylna O, 2015, BIOCHIMIE, V119, P137, DOI 10.1016/j.biochi.2015.10.026; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Phelan JD, 2018, NATURE, V560, P387, DOI 10.1038/s41586-018-0290-0; Ramsuran V, 2015, HUM MOL GENET, V24, P4268, DOI 10.1093/hmg/ddv158; Read JA, 2014, CL LYMPH MYELOM LEUK, V14, P460, DOI 10.1016/j.clml.2014.05.002; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rose Michal G, 2002, Clin Colorectal Cancer, V1, P220, DOI 10.3816/CCC.2002.n.003; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Schaer DA, 2019, CLIN CANCER RES, V25, P7175, DOI 10.1158/1078-0432.CCR-19-0433; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Shi YK, 2019, CHINESE J CANCER RES, V31, P152, DOI 10.21147/j.issn.1000-9604.2019.01.10; Sledzinska A, 2020, IMMUNITY, V52, P151, DOI 10.1016/j.immuni.2019.12.007; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; WAHBA AJ, 1962, J BIOL CHEM, V237, P3794; Wang SS, 2018, CANCER RES, V78, P4086, DOI 10.1158/0008-5472.CAN-17-2900; Webster DE, 2019, METHODS MOL BIOL, V1956, P337, DOI 10.1007/978-1-4939-9151-8_16; Wright GW, 2020, CANCER CELL, V37, P551, DOI 10.1016/j.ccell.2020.03.015; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001; Zhang MH, 2010, MOL CELL, V39, P269, DOI 10.1016/j.molcel.2010.05.010; Zhou LY, 2020, CLIN CANCER RES, V26, P290, DOI 10.1158/1078-0432.CCR-19-1351; Zingg D, 2017, CELL REP, V20, P854, DOI 10.1016/j.celrep.2017.07.007	89	31	33	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					116	+		10.1016/j.immuni.2020.11.002	http://dx.doi.org/10.1016/j.immuni.2020.11.002		JAN 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33271120	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000607814000014
J	Gruber, CN; Calis, JJA; Buta, S; Evrony, G; Martin, JC; Uhl, SA; Caron, R; Jarchin, L; Dunkin, D; Phelps, R; Webb, BD; Saland, JM; Merad, M; Orange, JS; Mace, EM; Rosenberg, BR; Gelb, BD; Bogunovic, D				Gruber, Conor N.; Calis, Jorg J. A.; Buta, Sofija; Evrony, Gilad; Martin, Jerome C.; Uhl, Skyler A.; Caron, Rachel; Jarchin, Lauren; Dunkin, David; Phelps, Robert; Webb, Bryn D.; Saland, Jeffrey M.; Merad, Miriam; Orange, Jordan S.; Mace, Emily M.; Rosenberg, Brad R.; Gelb, Bruce D.; Bogunovic, Dusan			Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function	IMMUNITY			English	Article							GENE-EXPRESSION; MONOALLELIC EXPRESSION; ALLELIC EXPRESSION; MUTATIONS; PHARMACOKINETICS; INTERFERON; DEFICIENCY; TOFACITINIB; REVEALS; DISEASE	Autoinflammatory disease can result from monogenic errors of immunity. We describe a patient with early-onset multi-organ immune dysregulation resulting from a mosaic, gain-of-function mutation (S7031) in JAK1, encoding a kinase essential for signaling downstream of >25 cytokines. By custom single-cell RNA sequencing, we examine mosaicism with single-cell resolution. We find that JAK1 transcription was predominantly restricted to a single allele across different cells, introducing the concept of a mutational "transcriptotype" that differs from the genotype. Functionally, the mutation increases JAK1 activity and transactivates partnering JAKs, independent of its catalytic domain. S7031 JAK1 is not only hypermorphic for cytokine signaling but also neomorphic, as it enables signaling cascades not canonically mediated by JAK1 Given these results, the patient was treated with tofacitinib, a JAK inhibitor, leading to the rapid resolution of clinical disease. These findings offer a platform for personalized medicine with the concurrent discovery of fundamental biological principles.	[Gruber, Conor N.; Buta, Sofija; Uhl, Skyler A.; Caron, Rachel; Rosenberg, Brad R.; Bogunovic, Dusan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Calis, Jorg J. A.] Rockefeller Univ, Program Immunogen, New York, NY 10065 USA; [Calis, Jorg J. A.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Calis, Jorg J. A.] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Dept Pediat Immunol & Rheumatol, Utrecht, Netherlands; [Evrony, Gilad] NYU, Ctr Genet & Genom, Grossman Sch Med, New York, NY USA; [Martin, Jerome C.; Merad, Miriam; Bogunovic, Dusan] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Martin, Jerome C.; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Martin, Jerome C.] Univ Nantes, ITUN, CHU Nantes, INSERM,UMR 1064,Ctr Rech Transplant & Immunol, F-44000 Nantes, France; [Martin, Jerome C.] CHU Nantes, Lab Immunol, Ctr Immuno Monitoring Nantes Atlantique CIMNA, F-44000 Nantes, France; [Jarchin, Lauren; Dunkin, David; Webb, Bryn D.; Saland, Jeffrey M.; Gelb, Bruce D.; Bogunovic, Dusan] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Jarchin, Lauren; Dunkin, David] Icahn Sch Med Mt Sinai, Dept Gastroenterol, New York, NY 10029 USA; [Phelps, Robert] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Phelps, Robert] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Webb, Bryn D.; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Dunkin, David; Webb, Bryn D.; Gelb, Bruce D.; Bogunovic, Dusan] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Orange, Jordan S.; Mace, Emily M.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pediat, Irving Med Ctr, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Rockefeller University; Rockefeller University; Utrecht University; Utrecht University Medical Center; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; NewYork-Presbyterian Hospital	Bogunovic, D (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Bogunovic, D (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Bogunovic, D (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.; Bogunovic, D (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.	dusan.bogunovic@mssm.edu	Martin, Jerome/GZG-4189-2022	Martin, Jerome/0000-0003-0068-8776; Evrony, Gilad/0000-0001-7621-2630; Walker, Laura/0000-0003-4944-1993; Rosenberg, Brad/0000-0002-5885-1276; Caron, Rachel/0000-0003-1421-4256; orange, jordan/0000-0001-7117-7725	National Institute of Allergy and Infectious Diseases [R01AI127372, R21 AI134366, R21AI129827]; March of Dimes; Genetic Disease Foundation; "Prix pour les jeunes chercheurs'' de la Fondation Bettencourt-Schueller; Philippe Foundation; T32 training grant [5T32HD075735-07]; Netherlands Organization for Scientific Research (NWO Rubicon);  [R01AI137275];  [R01AI120989];  [R03DK117218];  [DP5 OD012142]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); March of Dimes(March of Dimes); Genetic Disease Foundation; "Prix pour les jeunes chercheurs'' de la Fondation Bettencourt-Schueller; Philippe Foundation; T32 training grant; Netherlands Organization for Scientific Research (NWO Rubicon)(Netherlands Organization for Scientific Research (NWO)); ; ; ; 	We thank Adeeb Rahman, Brian Lee, Kevin Tuballes, and Laura Walker from the Human Immune Monitoring Center; Rachel Brody from the Biorepository and Pathology CoRE; and Fadi El Salem in the Department of Pathology at the Icahn School of Medicine for their technical assistance and guidance in experimental design. This research was supported by National Institute of Allergy and Infectious Diseases grants R01AI127372, R21 AI134366, and R21AI129827; the March of Dimes (to D.B.); and the Genetic Disease Foundation (to B.D.G.). This study was also funded by R01AI137275 to E.M.M., R01AI120989 to J.S.O., and R03DK117218 to D.D. Research in the Rosenberg laboratory was supported by DP5 OD012142. J.C.M. was supported by ``Prix pour les jeunes chercheurs'' de la Fondation Bettencourt-Schueller and by the Philippe Foundation. C.N.G. was supported by T32 training grant 5T32HD075735-07. J.J.A.C. was supported by the Netherlands Organization for Scientific Research (NWO Rubicon).	Babon JJ, 2014, BIOCHEM J, V462, P1, DOI 10.1042/BJ20140712; Borel C, 2015, AM J HUM GENET, V96, P70, DOI 10.1016/j.ajhg.2014.12.001; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen XJ, 2014, CLIN PHARM DRUG DEV, V3, P34, DOI 10.1002/cpdd.77; Del Bel KL, 2017, J ALLERGY CLIN IMMUN, V139, P2016, DOI 10.1016/j.jaci.2016.12.957; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Eletto D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13992; Etheridge SL, 2014, BLOOD, V123, P1059, DOI 10.1182/blood-2012-12-473777; Fabre A, 2019, J ALLER CL IMM-PRACT, V7, P1958, DOI 10.1016/j.jaip.2019.02.018; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Jeffries AR, 2012, STEM CELLS, V30, P1938, DOI 10.1002/stem.1155; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Krishnaswami S, 2014, J CLIN PHARMACOL, V54, P46, DOI 10.1002/jcph.178; Lamba M, 2016, J CLIN PHARMACOL, V56, P1362, DOI 10.1002/jcph.734; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Ma CA, 2017, BLOOD, V129, P650, DOI 10.1182/blood-2016-09-737817; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mead AJ, 2012, NEW ENGL J MED, V366, P967, DOI 10.1056/NEJMc1200349; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Moore K., 2015, WE ARE BORN ESSENTIA; O'Shea JJ, 2019, NAT REV RHEUMATOL, V15, P74, DOI 10.1038/s41584-018-0155-9; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Rosenberg BR, 2018, J INFECT DIS, V217, P650, DOI 10.1093/infdis/jix593; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Savova V, 2016, NUCLEIC ACIDS RES, V44, pD753, DOI 10.1093/nar/gkv1106; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/NMETH.4612, 10.1038/nmeth.4612]; Splinter K, 2018, NEW ENGL J MED, V379, P2131, DOI 10.1056/NEJMoa1714458; Tuttle KR, 2018, NEPHROL DIAL TRANSPL, V33, P1950, DOI 10.1093/ndt/gfx377; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Van Rompaey L, 2013, J IMMUNOL, V191, P3568, DOI 10.4049/jimmunol.1201348; Vargas-Hernandez A., 2017, J ALLERGY CLIN IMMUN, V141; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154	49	31	31	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					672	+		10.1016/j.immuni.2020.07.006	http://dx.doi.org/10.1016/j.immuni.2020.07.006			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32750333	Green Published, Bronze			2022-12-18	WOS:000569806100020
J	Kim, D; Nguyen, QT; Lee, J; Lee, SH; Janocha, A; Kim, S; Le, HT; Dvorina, N; Weiss, K; Cameron, MJ; Asosingh, K; Erzurum, SC; Baldwin, WM; Lee, JS; Min, B				Kim, Dongkyun; Quang Tam Nguyen; Lee, Juyeun; Lee, Sung Hwan; Janocha, Allison; Kim, Sohee; Le, Hongnga T.; Dvorina, Nina; Weiss, Kelly; Cameron, Mark J.; Asosingh, Kewal; Erzurum, Serpil C.; Baldwin, William M., III; Lee, Ju-Seog; Min, Booki			Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp(3)(+) Regulatory T Cells via a miR-342-Dependent Mechanism	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; RECEPTOR; APOPTOSIS; TARGETS; GENE; DIFFERENTIATION; INFLAMMATION; LYMPHOCYTES; METABOLISM; GLUCOSE	Glucocorticoids (GC) are the mainstay treatment option for inflammatory conditions. Despite the broad usage of GC, the mechanisms by which GC exerts its effects remain elusive. Here, utilizing murine autoimmune and allergic inflammation models, we report that Foxp3(+) regulatory T (Treg) cells are irreplaceable GC target cells in vivo. Dexamethasone (Dex) administered in the absence of Treg cells completely lost its ability to control inflammation, and the lack of glucocorticoid receptor in Treg cells alone resulted in the loss of therapeutic ability of Dex. Mechanistically, Dex induced miR-342-3p specifically in Treg cells and miR-342-3p directly targeted the mTORC2 component, Rictor. Altering miRNA-342-3p or Rictor expression in Treg cells dysregulated metabolic programming in Treg cells, controlling their regulatory functions in vivo. Our results uncover a previously unknown contribution of Treg cells during glucocorticoid-mediated treatment of inflammation and the underlying mechanisms operated via the Dex-miR-342-Rictor axis.	[Kim, Dongkyun; Quang Tam Nguyen; Lee, Juyeun; Janocha, Allison; Kim, Sohee; Le, Hongnga T.; Dvorina, Nina; Weiss, Kelly; Asosingh, Kewal; Erzurum, Serpil C.; Baldwin, William M., III; Min, Booki] Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Lee, Sung Hwan; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77230 USA; [Cameron, Mark J.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University	Min, B (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA.	booki.min@northwestern.edu	Lee, Sung Hwan/V-9069-2019; Lee, Ju-Seog/X-1786-2018	Lee, Sung Hwan/0000-0003-3365-0096; Lee, Ju-Seog/0000-0002-5666-9753; Lee, Juyeun/0000-0001-8276-5020	National Institutes of Health [HL103453, HL081064, HL60917, HL109250, R01-AI125247, R01-AI147498]; National Multiple Sclerosis Society Research Grants [RG1411-02051, RG1806-31374]; Cancer Prevention & Research Institute of Texas [RP170307]; Congressionally Directed Medical Research Program [CA160616]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Research Grants(National Multiple Sclerosis Society); Cancer Prevention & Research Institute of Texas; Congressionally Directed Medical Research Program(United States Department of Defense)	The authors thank Ms. Jennifer Powers for cell sorting and Brian Richardson for RNA-seq data preparation. This work was supported by the National Institutes of Health grants R01-AI125247 and R01-AI147498 (B.M.) and by the National Multiple Sclerosis Society Research Grants RG1411-02051 and RG1806-31374 (B.M.). This work was also supported in part by Cancer Prevention & Research Institute of Texas grant RP170307 (J-S.L.), by Congressionally Directed Medical Research Program grant CA160616 (J-S.L.), and by National Institutes of Health grants HL103453, HL081064, HL60917, and HL109250 (K.A. and S.C.E).	Alangari AA, 2014, ANN THORAC MED, V9, P187, DOI 10.4103/1817-1737.140120; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes D, 1997, LANCET, V349, P902, DOI 10.1016/S0140-6736(96)06453-7; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2018, SCIENCE, V362, P154, DOI 10.1126/science.aau2688; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cari L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051142; Chapman NM, 2014, IMMUNOTHERAPY-UK, V6, P1295, DOI 10.2217/imt.14.84; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dominguez-Villar M, 2018, NAT IMMUNOL, V19, P665, DOI 10.1038/s41590-018-0120-4; Du H., 2006, CHINA PART, V4, P25, DOI [DOI 10.1016/S1672-2515(07)60228-0, 10.1016/S1672-2515(07)60228-0]; Engler JB, 2017, P NATL ACAD SCI USA, V114, pE181, DOI 10.1073/pnas.1617115114; Estin ML, 2017, P NATL ACAD SCI USA, V114, pE2901, DOI 10.1073/pnas.1701886114; Franco LM, 2019, J EXP MED, V216, P384, DOI 10.1084/jem.20180595; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hamdi H, 2007, BLOOD, V110, P211, DOI 10.1182/blood-2006-10-052506; Howie D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89160; Jang E, 2017, J IMMUNOL, V199, P3943, DOI 10.4049/jimmunol.1700211; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kale SL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42341; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Kim D, 2019, J IMMUNOL, V202, P1680, DOI 10.4049/jimmunol.1800898; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; Klassen C, 2017, J IMMUNOL, V199, P48, DOI 10.4049/jimmunol.1601691; Li ZH, 2018, TRANSL RES, V192, P46, DOI 10.1016/j.trsl.2017.11.005; LILES WC, 1995, BLOOD, V86, P3181; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Meagher LC, 1996, J IMMUNOL, V156, P4422; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Nguyen QT, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123216; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Ohta K, 1999, J ALLERGY CLIN IMMUN, V104, P14, DOI 10.1016/S0091-6749(99)70107-7; Olsen PC, 2015, EUR J PHARMACOL, V747, P52, DOI 10.1016/j.ejphar.2014.11.034; Pan CW, 2017, EMBO J, V36, P995, DOI 10.15252/embj.201695534; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Rocamora-Reverte L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00472; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sbiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024345; SCHLEIMER RP, 1994, J ALLERGY CLIN IMMUN, V94, P1202, DOI 10.1016/0091-6749(94)90333-6; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Ugor E, 2018, IMMUNOBIOLOGY, V223, P422, DOI 10.1016/j.imbio.2017.10.010; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434; Xie YH, 2009, ACTA BIOCH BIOPH SIN, V41, P781, DOI 10.1093/abbs/gmp067; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	69	31	31	4	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					581	+		10.1016/j.immuni.2020.07.002	http://dx.doi.org/10.1016/j.immuni.2020.07.002			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32707034	Green Accepted, Bronze			2022-12-18	WOS:000569806100015
J	Lee, AH; Dixit, VD				Lee, Aileen H.; Dixit, Vishwa Deep			Dietary Regulation of Immunity	IMMUNITY			English	Review							ADIPOSE-TISSUE MACROPHAGES; DELTA T-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; SYMPATHETIC-NERVOUS-SYSTEM; INVARIANT NKT CELLS; CHAIN AMINO-ACIDS; INSULIN-RESISTANCE; HYDROGEN-SULFIDE; NLRP3 INFLAMMASOME; INDUCED OBESITY	Integrated immunometabolic responses link dietary intake, energy utilization, and storage to immune regulation of tissue function and is therefore essential for the maintenance and restoration of homeostasis. Adipose-resident leukocytes have non-traditional immunological functions that regulate organismal metabolism by controlling insulin action, lipolysis, and mitochondrial respiration to control the usage of substrates for production of heat versus ATP. Energetically expensive vital functions such as immunological responses might have thus evolved to respond accordingly to dietary surplus and deficit of macronutrient intake. Here, we review the interaction of dietary intake of macronutrients and their metabolism with the immune system. We discuss immunometabolic checkpoints that promote health span and highlight how dietary fate and regulation of glucose, fat, and protein metabolism might affect immunity.	[Lee, Aileen H.; Dixit, Vishwa Deep] Yale Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; [Lee, Aileen H.; Dixit, Vishwa Deep] Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Dixit, Vishwa Deep] Yale Sch Med, Yale Ctr Res Aging, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Dixit, VD (corresponding author), Yale Sch Med, Dept Comparat Med, New Haven, CT 06520 USA.; Dixit, VD (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Dixit, VD (corresponding author), Yale Sch Med, Yale Ctr Res Aging, New Haven, CT 06520 USA.	vishwa.dixit@yale.edu			Gruber Science Fellowship; NSF GRFP; NIH [P01AG051459, AR070811]; Cure Alzheimer's Fund	Gruber Science Fellowship; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund	A.L. is supported by the Gruber Science Fellowship and the NSF GRFP. The Dixit lab is supported in part by NIH grants P01AG051459 and AR070811, and the Cure Alzheimer's Fund. Figures were created by using biorender.com.	Altintas MM, 2011, J LIPID RES, V52, P480, DOI 10.1194/jlr.M011338; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Anderson RM, 2018, J GERONTOL A-BIOL, V73, P1, DOI 10.1093/gerona/glx212; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Basic A, 2017, CLIN EXP DENT RES, V3, P115, DOI 10.1002/cre2.69; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Camell C, 2015, SEMIN IMMUNOL, V27, P334, DOI 10.1016/j.smim.2015.10.004; Camell CD, 2019, CELL METAB, V30, P1024, DOI 10.1016/j.cmet.2019.10.006; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Castelblanco M, 2018, J BIOL CHEM, V293, P2546, DOI 10.1074/jbc.M117.806869; Chi JY, 2018, CELL METAB, V27, P226, DOI 10.1016/j.cmet.2017.12.011; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020; Chusyd DE, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00010; Codo A.C., 2020, CELL METAB, DOI [10.1016/j.cmet.2020.07.007, DOI 10.1016/J.CMET.2020.07.007.]; Collins N, 2019, CELL, V178, P1088, DOI 10.1016/j.cell.2019.07.049; Cruz-Migoni S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00612; Damouche A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005153; Davanzo G. G., 2020, CELL METAB, V32, DOI [10.1016/j.cmet.2020.07.007, DOI 10.1016/J.CMET.2020.07.007]; De Rosa V, 2015, SEMIN IMMUNOL, V27, P300, DOI 10.1016/j.smim.2015.10.001; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Drucker DJ, 2020, ENDOCR REV, V41, P457, DOI 10.1210/endrev/bnaa011; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Elshorbagy AK, 2013, J NUTR, V143, P1982, DOI 10.3945/jn.113.179192; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Glorieux G, 2020, TOXINS, V12, DOI 10.3390/toxins12040245; Goldberg EL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav2026; Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Haka AS, 2016, J LIPID RES, V57, P980, DOI 10.1194/jlr.M064089; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hales Craig M, 2020, NCHS Data Brief, P1; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Hasegawa Y, 2018, CELL METAB, V27, P180, DOI 10.1016/j.cmet.2017.12.005; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hilgendorf KI, 2019, CELL, V179, P1289, DOI 10.1016/j.cell.2019.11.005; Hill AA, 2015, MOL METAB, V4, P665, DOI 10.1016/j.molmet.2015.07.005; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Honce R, 2020, MBIO, V11, DOI 10.1128/mBio.03341-19; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; Huang Z, 2017, CELL METAB, V26, P493, DOI 10.1016/j.cmet.2017.08.003; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Kane H, 2019, TRENDS IMMUNOL, V40, P857, DOI 10.1016/j.it.2019.07.006; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kirkwood TBL, 2000, J ANAT, V197, P587, DOI 10.1046/j.1469-7580.2000.19740587.x; Kitada M, 2019, EBIOMEDICINE, V43, P632, DOI 10.1016/j.ebiom.2019.04.005; Kiyotake R, 2015, J BIOL CHEM, V290, P25322, DOI 10.1074/jbc.M115.645234; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kostarnoy AV, 2017, P NATL ACAD SCI USA, V114, pE2758, DOI 10.1073/pnas.1611665114; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee CC, 2016, DIABETES CARE, V39, P582, DOI 10.2337/dc15-2284; Lees EK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10381-3; Lin Z, 2018, BBA-MOL BASIS DIS, V1864, P2890, DOI 10.1016/j.bbadis.2018.05.023; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Liu JL, 2016, CELL, V167, P1052, DOI 10.1016/j.cell.2016.10.015; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Lynch L, 2016, CELL METAB, V24, P510, DOI 10.1016/j.cmet.2016.08.003; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Mauro C, 2017, CELL METAB, V25, P593, DOI 10.1016/j.cmet.2017.01.008; Mehta P, 2015, J LEUKOCYTE BIOL, V97, P121, DOI 10.1189/jlb.3A0414-211RR; Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Misumi I, 2019, CELL REP, V27, P1387, DOI 10.1016/j.celrep.2019.04.004; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moro K., 2010, J IMMUNOL, V463, P184; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nagai M, 2019, CELL, V178, P1072, DOI 10.1016/j.cell.2019.07.047; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nishimura S, 2013, CELL METAB, V18, P759, DOI 10.1016/j.cmet.2013.09.017; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Obata F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9332; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; ORENTREICH N, 1993, J NUTR, V123, P269; Pacifico L, 2006, EUR J ENDOCRINOL, V154, P691, DOI 10.1530/eje.1.02138; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186; Rebeles J, 2019, J INFECT DIS, V219, P1652, DOI 10.1093/infdis/jiy700; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Rodriguez JJV, 2006, METABOLISM, V55, P620, DOI 10.1016/j.metabol.2005.12.009; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Salvestrini V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00266; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; SEGALL PE, 1975, FED PROC, V34, P83; SEGALL PE, 1976, MECH AGEING DEV, V5, P109, DOI 10.1016/0047-6374(76)90012-9; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7; Silva HM, 2019, J EXP MED, V216, P786, DOI 10.1084/jem.20181049; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; SLAVIN BG, 1978, ANAT REC, V191, P377, DOI 10.1002/ar.1091910310; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Spadaro O, 2017, CELL REP, V19, P225, DOI 10.1016/j.celrep.2017.03.046; Spiller F, 2010, AM J RESP CRIT CARE, V182, P360, DOI 10.1164/rccm.200907-1145OC; Sun Q, 2017, MOL MED, V23, P188, DOI 10.2119/molmed.2017.00077; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tanaka M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5982; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vaya A, 2012, CLIN HEMORHEOL MICRO, V52, P49, DOI 10.3233/CH-2012-1544; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wang H., 2019, NAT COMMUN, V10, P1, DOI DOI 10.1038/s41467-018-07882-8; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Waqas SFH, 2017, J LEUKOCYTE BIOL, V102, P845, DOI 10.1189/jlb.1A0317-082RR; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Yang HW, 2009, J IMMUNOL, V183, P3040, DOI 10.4049/jimmunol.0900562; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Yoshida S, 2018, AGING CELL, V17, DOI 10.1111/acel.12796; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zapata RC, 2018, OBESITY, V26, P730, DOI 10.1002/oby.22136; Zhang X, 2019, BBA-MOL BASIS DIS, V1865, P1690, DOI 10.1016/j.bbadis.2019.04.006; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	171	31	31	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					510	523		10.1016/j.immuni.2020.08.013	http://dx.doi.org/10.1016/j.immuni.2020.08.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937152	Green Published, Bronze			2022-12-18	WOS:000569806100009
J	Dinh, HQ; Eggert, T; Meyer, MA; Zhu, YFPP; Olingy, CE; Llewellyn, R; Wu, RP; Hedrick, CC				Dinh, Huy Q.; Eggert, Tobias; Meyer, Melissa A.; Zhu, Yanfang Peipei; Olingy, Claire E.; Llewellyn, Ryan; Wu, Runpei; Hedrick, Catherine C.			Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow	IMMUNITY			English	Article							TRANSFERRIN RECEPTOR CD71; EXPRESSION; CELLS; DIFFERENTIATION; EXPANSION; MARKER; CYTOMETRY; KINETICS; BACTERIA; MOUSE	Neutrophils are the most abundant peripheral immune cells and thus, are continually replenished by bone marrow-derived progenitors. Still, how newly identified neutrophil subsets fit into the bonemarrow neutrophil lineage remains unclear. Here, we use mass cytometry to show that two recently defined human neutrophil progenitor populations contain a homogeneous progenitor subset we term "early neutrophil progenitors" (eNePs) (Lin(-) CD66b(+)CD117(+)CD71(+)). Surface marker- and RNA-expression analyses, together with in vitro colony formation and in vivo adoptive humanized mouse transfers, indicate that eNePs are the earliest human neutrophil progenitors. Furthermore, we identified CD71 as a marker associated with the earliest neutrophil developmental stages. Expression of CD71 marks proliferating neutrophils, which were expanded in the blood of melanoma patients and detectable in blood and tumors from lung cancer patients. In summary, we establish CD117(+)CD71(+) eNeP as the inceptive human neutrophil progenitor and propose a refined model of the neutrophil developmental lineage in bone marrow.	[Dinh, Huy Q.; Eggert, Tobias; Meyer, Melissa A.; Zhu, Yanfang Peipei; Olingy, Claire E.; Llewellyn, Ryan; Wu, Runpei; Hedrick, Catherine C.] La Jolla Inst Immunol, Ctr Canc Immunotherapy, La Jolla, CA 92037 USA; [Dinh, Huy Q.; Eggert, Tobias; Meyer, Melissa A.; Zhu, Yanfang Peipei; Olingy, Claire E.; Llewellyn, Ryan; Wu, Runpei; Hedrick, Catherine C.] La Jolla Inst Immunol, Ctr Autoimmun & Inflammat, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Hedrick, CC (corresponding author), La Jolla Inst Immunol, Ctr Canc Immunotherapy, La Jolla, CA 92037 USA.; Hedrick, CC (corresponding author), La Jolla Inst Immunol, Ctr Autoimmun & Inflammat, La Jolla, CA 92037 USA.	hedrick@lji.org	; Dinh, Huy/M-8646-2016	Meyer, Melissa/0000-0003-3050-4819; Dinh, Huy/0000-0002-3307-1126; Zhu, Yanfang Peipei/0000-0001-6908-0860	Tullie and Rickey Families' SPARK Awards program at La Jolla Institute; National Institutes of Health [2T32AR064194]; NIH [U01 CA224766, R01 CA202987, R01 HL134236, P01 HL136275, S10 RR027366, S10 OD018499]; CyTOF Mass Cytometer [S10 OD018499]	Tullie and Rickey Families' SPARK Awards program at La Jolla Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CyTOF Mass Cytometer	We thank Daniel Araujo for critical editing and helpful discussions. Sequencing data were generated from a grant supported by the Tullie and Rickey Families' SPARK Awards program at La Jolla Institute (LJI) for Immunology to H.Q.D. M.A.M acknowledges support from the National Institutes of Health (2T32AR064194). This work was supported by NIH grants U01 CA224766, R01 CA202987, R01 HL134236, and P01 HL136275 (all to C.C.H.). We would like to thank the LJI Flow Cytometry Core Facility for assistance with cell sorting. The FACSAria-3 cell sorter and the Fluidigm CyTOF Helios were acquired through the NIH Shared Instrumentation Grant (SIG) Program S10 (FACSAria II Cell Sorter S10 RR027366 and CyTOF Mass Cytometer S10 OD018499 to LJI).	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; BEGUIN Y, 1993, LEUKEMIA, V7, P2019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRANDT J, 1992, BLOOD, V79, P634; Chan KT, 2014, ONCOL REP, V31, P1296, DOI 10.3892/or.2014.2981; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen XJ, 2019, MOL CARCINOGEN, V58, P388, DOI 10.1002/mc.22936; Chen XW, 2017, CELL STEM CELL, V21, P747, DOI 10.1016/j.stem.2017.11.003; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Drissen R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7148; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Feng QQ, 2019, J ENG FIBER FABR, V14, DOI 10.1177/1558925019843615; FEREMANS W, 1991, AM J HEMATOL, V36, P215, DOI 10.1002/ajh.2830360313; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Gelfand MV, 2014, ELIFE, V3, DOI 10.7554/eLife.03720; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Grassi L, 2018, CELL REP, V24, P2784, DOI 10.1016/j.celrep.2018.08.018; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Hidalgo A, 2019, TRENDS IMMUNOL, V40, P584, DOI 10.1016/j.it.2019.04.013; Kwon HS, 2019, BLOOD, V133, P2104, DOI 10.1182/blood-2018-06-853879; Lahoz-Beneytez J, 2016, BLOOD, V127, P3431, DOI 10.1182/blood-2016-03-700336; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leung THY, 2019, MOL CANCER RES, V17, P1867, DOI 10.1158/1541-7786.MCR-19-0068; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Marsee DK, 2010, AM J CLIN PATHOL, V134, P429, DOI 10.1309/AJCPCRK3MOAOJ6AT; Mori Y, 2015, P NATL ACAD SCI USA, V112, P9638, DOI 10.1073/pnas.1512076112; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Motamedi M, 2016, J IMMUNOL METHODS, V437, P43, DOI 10.1016/j.jim.2016.08.002; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; OLWEUS J, 1995, BLOOD, V85, P2402, DOI 10.1182/blood.V85.9.2402.bloodjournal8592402; Pliyev BK, 2012, HUM IMMUNOL, V73, P1087, DOI 10.1016/j.humimm.2012.07.327; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SCHEINECKER C, 1995, BLOOD, V86, P4115, DOI 10.1182/blood.V86.11.4115.bloodjournal86114115; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wu JM, 2006, AM J CLIN PATHOL, V126, P39, DOI 10.1309/X8LBRRBBC43PL9HC; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Zhu YFPP, 2018, CELL REP, V24, P2329, DOI 10.1016/j.celrep.2018.07.097; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	51	31	31	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					319	+		10.1016/j.immuni.2020.07.017	http://dx.doi.org/10.1016/j.immuni.2020.07.017			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814027	Bronze, Green Accepted			2022-12-18	WOS:000561190600012
J	Xu, JJ; Zanvit, P; Hu, L; Tseng, PY; Liu, N; Wang, F; Liu, OS; Zhang, DF; Jin, WW; Guo, N; Han, YC; Yin, J; Cain, A; Hoon, MA; Wang, SL; Chen, WJ				Xu, Junji; Zanvit, Peter; Hu, Lei; Tseng, Pang-Yen; Liu, Na; Wang, Fu; Liu, Ousheng; Zhang, Dunfang; Jin, Wenwen; Guo, Nancy; Han, Yichen; Yin, Jessica; Cain, Alexander; Hoon, Mark A.; Wang, Songlin; Chen, WanJun			The Cytokine TGF-beta Induces Interleukin-31 Expression from Dermal Dendritic Cells to Activate Sensory Neurons and Stimulate Wound Itching	IMMUNITY			English	Article							T-CELLS; IL-31; RECEPTOR; MACROPHAGES; DERMATITIS; INDUCTION; RESPONSES; PRURITUS; GROWTH; DIFFERENTIATION	Cutaneous wound healing is associated with the unpleasant sensation of itching. Here we investigated the mechanisms underlying this type of itch, focusing on the contribution of soluble factors released during healing. We found high amounts of interleukin 31 (IL-31) in skin wound tissue during the peak of itch responses. Il31(-/-) mice lacked wound-induced itch responses. IL-31 was released by dermal conventional type 2 dendritic cells (cDC2s) recruited to wounds and increased itch sensory neuron sensitivity. Transfer of cDC2s isolated from late-stage wounds into healthy skin was sufficient to induce itching in a manner dependent on IL-31 expression. Addition of the cytokine TGF-beta 1, which promotes wound healing, to dermal DCs in vitro was sufficient to induce Il31 expression, and Tgfbr1(f/f) CD11c-Cre mice exhibited reduced scratching and decreased Il31 expression in wounds in vivo. Thus, cDC2s promote itching during skin would healing via a TGF-beta-IL-31 axis with implications for treatment of wound itching.	[Xu, Junji; Zanvit, Peter; Liu, Na; Wang, Fu; Liu, Ousheng; Zhang, Dunfang; Jin, Wenwen; Guo, Nancy; Han, Yichen; Yin, Jessica; Cain, Alexander; Chen, WanJun] NIDCR, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA; [Hu, Lei; Wang, Songlin] Capital Med Univ, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing 100050, Peoples R China; [Tseng, Pang-Yen; Hoon, Mark A.] NIDCR, Mol Genet Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA; [Wang, Fu] Dalian Med Univ, Sch Stomatol, Dalian 114044, Peoples R China; [Liu, Ousheng] Cent South Univ, Xiangya Stomatol Hosp, Sch Stomatol, Changsha 410000, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Capital Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Dalian Medical University; Central South University	Chen, WJ (corresponding author), NIDCR, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA.	wchen@mail.nih.gov	liu, ousheng/C-6772-2008; hu, lei/AAE-6706-2022; Wang, Fu/P-9950-2019; TSENG, PANG-YEN/B-3218-2013	Wang, Fu/0000-0001-9615-1038; Liu, Na/0000-0001-9903-1314; , liu ou sheng/0000-0003-3293-9824; Zhang, Dunfang/0000-0001-7545-9930	Intramural Research Program of the U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR)	Intramural Research Program of the U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR)	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR). We thank Dr. Susumu Nakae (The Institute of Medical Science, The University of Tokyo) for providing gene-mutated mice. We thank the NIDCR combined technical research core (ZIC DE000729-09) and imaging core for technical assistance.	Arai I, 2013, EXP DERMATOL, V22, P669, DOI 10.1111/exd.12222; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Bilsborough J, 2010, J IMMUNOL, V185, P6023, DOI 10.4049/jimmunol.0902769; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clausen BE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00534; Colwell AS, 2005, PLAST RECONSTR SURG, V116, P1387, DOI 10.1097/01.prs.0000182343.99694.28; Cukjati D, 2001, MED BIOL ENG COMPUT, V39, P263, DOI 10.1007/BF02344811; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Esebanmen GE, 2017, IMMUNOL RES, V65, P987, DOI 10.1007/s12026-017-8944-9; Feld M, 2016, J ALLERGY CLIN IMMUN, V138, P500, DOI 10.1016/j.jaci.2016.02.020; Felker P, 2010, J IMMUNOL, V185, P5326, DOI 10.4049/jimmunol.0903950; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hawro T, 2014, ALLERGY, V69, P113, DOI 10.1111/all.12316; Huang J, 2018, NAT NEUROSCI, V21, P707, DOI 10.1038/s41593-018-0119-z; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Kashem SW, 2017, ANNU REV IMMUNOL, V35, P469, DOI 10.1146/annurev-immunol-051116-052215; Kasutani K, 2014, BRIT J PHARMACOL, V171, P5049, DOI 10.1111/bph.12823; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kitajima M, 2013, J IMMUNOL, V191, P4903, DOI 10.4049/jimmunol.1302175; LYMAN IR, 1970, SURG GYNECOL OBSTETR, V130, P616; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Massague J, 1999, NAT CELL BIOL, V1, pE117, DOI 10.1038/12944; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Meckmongkol TT, 2007, BIOCHEM BIOPH RES CO, V360, P709, DOI 10.1016/j.bbrc.2007.06.121; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Nattkemper LA, 2018, J INVEST DERMATOL, V138, P1311, DOI 10.1016/j.jid.2017.12.029; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Parnell LKS, 2012, J BURN CARE RES, V33, P407, DOI 10.1097/BCR.0b013e318239d206; Prasad A, 2019, BURNS, V45, P348, DOI 10.1016/j.burns.2018.06.011; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; ROSS R, 1968, J CELL BIOL, V39, P152, DOI 10.1083/jcb.39.1.152; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Solinski HJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav5464; Solinski HJ, 2019, CELL REP, V26, P3561, DOI 10.1016/j.celrep.2019.02.089; Steinhoff M, 2018, IMMUNOL REV, V282, P248, DOI 10.1111/imr.12635; Steward-Tharp SM, 2014, BLOOD, V123, P2978, DOI 10.1182/blood-2013-09-523167; Takamori A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25094-4; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002; Trier AM, 2018, CURR OPIN IMMUNOL, V54, P7, DOI 10.1016/j.coi.2018.05.005; Tu E, 2018, IMMUNITY, V48, P745, DOI 10.1016/j.immuni.2018.03.025; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; van Duivenvoorde LM, 2006, IMMUNOBIOLOGY, V211, P627, DOI 10.1016/j.imbio.2006.05.014; Wang Z, 2007, J PLAST RECONSTR AES, V60, P1193, DOI 10.1016/j.bjps.2006.05.007; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang Q, 2008, CYTOKINE GROWTH F R, V19, P347, DOI 10.1016/j.cytogfr.2008.08.003	61	31	33	8	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					371	+		10.1016/j.immuni.2020.06.023	http://dx.doi.org/10.1016/j.immuni.2020.06.023			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32673566	Green Published, Bronze			2022-12-18	WOS:000561190600015
J	Fasolino, M; Goldman, N; Wang, WL; Cattau, B; Zhou, YQ; Petrovic, J; Link, VM; Cote, A; Chandra, A; Silverman, M; Joyce, EF; Little, SC; Kaestner, KH; Naji, A; Raj, A; Henao-Mejia, J; Faryabi, RB; Vahedi, G				Fasolino, Maria; Goldman, Naomi; Wang, Wenliang; Cattau, Benjamin; Zhou, Yeqiao; Petrovic, Jelena; Link, Verena M.; Cote, Allison; Chandra, Aditi; Silverman, Michael; Joyce, Eric F.; Little, Shawn C.; Kaestner, Klaus H.; Naji, Ali; Raj, Arjun; Henao-Mejia, Jorge; Faryabi, Robert B.; Vahedi, Golnaz		HPAP Consortium	Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression	IMMUNITY			English	Article							GENOME; MAP; MACROPHAGE; EVOLUTION; PROTEINS; IDENTITY; PANCREAS; CONTACTS; ALLELES; SYSTEM	Genetics is a major determinant of susceptibility to autoimmune disorders. Here, we examined whether genome organization provides resilience or susceptibility to sequence variations, and how this would contribute to the molecular etiology of an autoimmune disease. We generated high-resolution maps of linear and 3D genome organization in thymocytes of NOD mice, a model of type 1 diabetes (T1D), and the diabetes-resistant C57BL/6 mice. Multi enhancer interactions formed at genomic regions harboring genes with prominent roles in T cell development in both strains. However, diabetes risk-conferring loci coalesced enhancers and promoters in NOD, but not C57BL/6 thymocytes. 3D genome mapping of NODxC57BL/6 F1 thymocytes revealed that genomic misfolding in NOD mice is mediated in cis. Moreover, immune cells infiltrating the pancreas of humans with T1D exhibited increased expression of genes located on misfolded loci in mice. Thus, genetic variation leads to altered 3D chromatin architecture and associated changes in gene expression that may underlie autoimmune pathology.	[Fasolino, Maria; Goldman, Naomi; Wang, Wenliang; Cattau, Benjamin; Chandra, Aditi; Joyce, Eric F.; Kaestner, Klaus H.; Vahedi, Golnaz] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fasolino, Maria; Goldman, Naomi; Wang, Wenliang; Cattau, Benjamin; Chandra, Aditi; Naji, Ali; Henao-Mejia, Jorge; Vahedi, Golnaz] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fasolino, Maria; Goldman, Naomi; Wang, Wenliang; Cattau, Benjamin; Cote, Allison; Chandra, Aditi; Joyce, Eric F.; Kaestner, Klaus H.; Raj, Arjun; Vahedi, Golnaz] Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fasolino, Maria; Goldman, Naomi; Wang, Wenliang; Cattau, Benjamin; Chandra, Aditi; Kaestner, Klaus H.; Naji, Ali; Vahedi, Golnaz] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhou, Yeqiao; Petrovic, Jelena; Henao-Mejia, Jorge; Faryabi, Robert B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhou, Yeqiao; Petrovic, Jelena; Faryabi, Robert B.; Vahedi, Golnaz] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Link, Verena M.] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cote, Allison; Raj, Arjun] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Silverman, Michael] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Little, Shawn C.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kaestner, Klaus H.; Naji, Ali; Vahedi, Golnaz; HPAP Consortium] Univ Penn, Human Pancreas Anal Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Naji, Ali] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Vahedi, G (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Human Pancreas Anal Program, Perelman Sch Med, Philadelphia, PA 19104 USA.	vahedi@pennmedicine.upenn.edu	Faryabi, Robert/AAN-5512-2020	Faryabi, Robert/0000-0002-7931-2175; Cote, Allison/0000-0001-9567-3184	NIH [R01 HL-145754, T32 A1055428, R01-CA-230800, UC4 DK112217]; Penn Epigenetics pilot award; Sloan Foundation; LLS Fellow Award; Abramson Cancer Center Cooper award; Abramson Family Cancer Research Institute investigator award; Institution for Translational Medicine and Therapeutics TAPITMAT award; Concern Foundation Conquer Cancer Now award; Susan G. Komen [CCR185472448]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Epigenetics pilot award; Sloan Foundation(Alfred P. Sloan Foundation); LLS Fellow Award; Abramson Cancer Center Cooper award; Abramson Family Cancer Research Institute investigator award; Institution for Translational Medicine and Therapeutics TAPITMAT award; Concern Foundation Conquer Cancer Now award; Susan G. Komen(Susan G. Komen Breast Cancer Foundation)	The authors thank Dr. Andrea Stout and the Microscopy Core. We are grateful to Maxwell Mumbach for HiChIP protocol. We thank Dr. E. John Wherry for being generous with his lab's resources. We are grateful to Drs. Ken Zaret, Shelley Berger, and Mitch Lazar for discussions. This study is funded by the NIH R01 HL-145754, the Penn Epigenetics pilot award, and the Sloan Foundation grant to G.V.; NIH T32 A1055428 to N.G.; LLS Fellow Award to J.P; and NIH R01-CA-230800, an Abramson Cancer Center Cooper award, an Abramson Family Cancer Research Institute investigator award, an Institution for Translational Medicine and Therapeutics TAPITMAT award, a Concern Foundation Conquer Cancer Now award, and Susan G. Komen CCR185472448 to R.B.F. Funding for scRNA-seq data was provided by NIH UC4 DK112217 to A.N., K.H.K., and G.V.	Akdemir KC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0767-1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andrews S., 2017, FASTQC BABRAHAM BIOI; [Anonymous], 2008, GENOME BIOL; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beagrie RA, 2017, NATURE, V543, P519, DOI 10.1038/nature21411; Beliveau BJ, 2018, P NATL ACAD SCI USA, V115, pE2183, DOI 10.1073/pnas.1714530115; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Berry GJ, 2015, J IMMUNOL, V194, P2654, DOI 10.4049/jimmunol.1401288; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Boudaoud I, 2017, GENETICS, V207, P139, DOI 10.1534/genetics.117.202291; Bruno M, 2019, ANNU REV GENET, V53, P393, DOI 10.1146/annurev-genet-112618-043717; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Chen YG, 2008, DIABETES, V57, P3273, DOI 10.2337/db08-0767; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P5; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Dufort MJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125556; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fang RX, 2016, CELL RES, V26, P1345, DOI 10.1038/cr.2016.137; Feng N, 2011, J IMMUNOL, V186, P826, DOI 10.4049/jimmunol.1002630; Feng T, 2011, GASTROENTEROLOGY, V140, P2031, DOI 10.1053/j.gastro.2011.03.009; Finn EH, 2019, CELL, V176, P1502, DOI 10.1016/j.cell.2019.01.020; Hamilton-Williams EE, 2010, DIABETES, V59, P1478, DOI 10.2337/db09-1801; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001; Iwafuchi-Doi M, 2016, DEVELOPMENT, V143, P1833, DOI 10.1242/dev.133900; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Krueger F., 2017, TRIM GALORE BABRAHAM; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Lilue JT, 2018, NAT GENET, V50, P1574, DOI 10.1038/s41588-018-0223-8; Link VM, 2018, NUCLEIC ACIDS RES, V46, P7006, DOI 10.1093/nar/gky491; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Mudge J.M., 2015, MOUSE C57BL6 J GENOM, DOI [10.1007/s00335-015-9583-x, DOI 10.1007/S00335-015-9583-X]; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Petrovic J, 2019, MOL CELL, V73, P1174, DOI 10.1016/j.molcel.2019.01.006; Phanstiel DH, 2017, MOL CELL, V67, P1037, DOI 10.1016/j.molcel.2017.08.006; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pliner HA, 2019, NAT METHODS, V16, P983, DOI 10.1038/s41592-019-0535-3; Rahim MMA, 2015, IMMUNOL REV, V267, P137, DOI 10.1111/imr.12318; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenbloom K.R., 2015, ENCODE DATA UCSC GEN; Schwartz GW, 2020, NAT METHODS, V17, P405, DOI 10.1038/s41592-020-0748-5; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Steward CA, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat032; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stunnenberg HG, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.12.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Treger RS, 2019, IMMUNITY, V50, P334, DOI 10.1016/j.immuni.2018.12.022; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Wang YJ, 2019, CELL METAB, V29, P769, DOI 10.1016/j.cmet.2019.01.003; Wang YJ, 2016, DIABETES, V65, P3028, DOI 10.2337/db16-0405; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; Wolf G, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0050-8; Yamanouchi J, 2010, DIABETES, V59, P272, DOI 10.2337/db09-0648; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111; Yui MA, 2004, J IMMUNOL, V173, P5381, DOI 10.4049/jimmunol.173.9.5381; Yui MA, 2013, J IMMUNOL, V190, P3276, DOI 10.4049/jimmunol.1202970; ZHOU YY, 2019, NAT COMMUN, V10, DOI DOI 10.1038/S41467-019-09234-6	87	31	31	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					257	+		10.1016/j.immuni.2020.01.003	http://dx.doi.org/10.1016/j.immuni.2020.01.003			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32049053	Bronze, Green Accepted			2022-12-18	WOS:000515082000010
J	Bachus, H; Kaur, K; Papillion, AM; Marquez-Lago, TT; Yu, ZH; Ballesteros-Tato, A; Matalon, S; Leon, B				Bachus, Holly; Kaur, Kamaljeet; Papillion, Amber M.; Marquez-Lago, Tatiana T.; Yu, Zhihong; Ballesteros-Tato, Andre; Matalon, Sadis; Leon, Beatriz			Impaired Tumor-Necrosis-Factor-alpha-driven Dendritic Cell Activation Limits Lipopolysaccharide-Induced Protection from Allergic Inflammation in Infants	IMMUNITY			English	Article							T-BET; TRANSCRIPTION FACTOR; IMMUNE-RESPONSES; TYPE-2 IMMUNITY; DUST; SENSITIZATION; ENDOTOXIN; MACROPHAGES; INDUCTION; PROGRAM	Infants have a higher risk of developing allergic asthma than adults. However, the underlying mechanism remains unknown. We show here that sensitization of mice with house-dust mites (HDMs) in the presence of low-dose lipopolysaccharide (LPS) prevented T helper 2 (Th2) cell allergic responses in adult, but not infant, mice. Mechanistically, adult CD11b(+) migratory dendritic cells (mDCs) upregulated the transcription factor T-bet in response to tumor necrosis factor-alpha (TNF-alpha), which was rapidly induced after HDM + LPS sensitization. Consequently, adult CD11b(+) mDCs produced interleukin-12 (IL-12), which prevented Th2 cell development by promoting T-bet upregulation in responding T cells. Conversely, infants failed to induce TNF-alpha after HDM + LPS sensitization. Therefore, CD11b(+) mDCs failed to upregulate T-bet and did not secrete IL-12 and Th2 cell responses normally developed in infant mice. Thus, the availability of TNF-alpha dictates the ability of CD11b(+) mDCs to suppress allergic Th2-cell responses upon dose-dependent endotoxin sensitization and is a key mediator governing susceptibility to allergic airway inflammation in infant mice.	[Bachus, Holly; Papillion, Amber M.; Ballesteros-Tato, Andre] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Kaur, Kamaljeet; Leon, Beatriz] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Marquez-Lago, Tatiana T.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Yu, Zhihong; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Leon, B (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	bleon@uab.edu			University of Alabama at Birmingham; NIH [R01 AI116584, U01 ES026458, R01 AI110480]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110480, R01AI116584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR069516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES026458] Funding Source: NIH RePORTER	University of Alabama at Birmingham; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. J. Zhu (National Institute of Allergy and Infectious Diseases, NIH, Bethesda) for providing TBGR mice and Becca Burnham, Uma Mudunuru, and Thomas S. Simpler for animal husbandry. The work was supported by University of Alabama at Birmingham and NIH grant R01 AI116584 to B.L., grant U01 ES026458 to S.M., and grant R01 AI110480 to A.B.T.	Akbari M, 2014, J IMMUNOL, V192, P2271, DOI 10.4049/jimmunol.1301914; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Holt PG, 1996, J EXP MED, V183, P1297, DOI 10.1084/jem.183.4.1297; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Leon B, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0714-1; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Lipscomb MW, 2009, J IMMUNOL, V183, P7250, DOI 10.4049/jimmunol.0901477; Lodge CJ, 2011, J ALLERGY CLIN IMMUN, V128, P782, DOI 10.1016/j.jaci.2011.06.038; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Reynolds LA, 2017, NAT REV IMMUNOL, V17, P518, DOI 10.1038/nri.2017.39; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Song WF, 2011, AM J RESP CELL MOL, V45, P88, DOI 10.1165/rcmb.2010-0226OC; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu Z, 2010, CLIN EXP ALLERGY, V40, P536, DOI 10.1111/j.1365-2222.2010.03477.x	38	31	32	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					225	+		10.1016/j.immuni.2018.11.012	http://dx.doi.org/10.1016/j.immuni.2018.11.012			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30635238	Bronze, Green Accepted			2022-12-18	WOS:000455661600022
J	Schwartz, DM; Farley, TK; Richoz, N; Yao, C; Shih, HY; Petermann, F; Zhang, Y; Sun, HW; Hayes, E; Mikami, Y; Jiang, K; Davis, FP; Kanno, Y; Milner, JD; Siegel, R; Laurence, A; Meylan, F; O'Shea, JJ				Schwartz, Daniella M.; Farley, Taylor K.; Richoz, Nathan; Yao, Chen; Shih, Han-Yu; Petermann, Franziska; Zhang, Yuan; Sun, Hong-Wei; Hayes, Erika; Mikami, Yohei; Jiang, Kan; Davis, Fred P.; Kanno, Yuka; Milner, Joshua D.; Siegel, Richard; Laurence, Arian; Meylan, Francoise; O'Shea, John J.			Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology	IMMUNITY			English	Article							REGULATORY T-CELLS; TGF-BETA; LINEAGE COMMITMENT; TH17 CELLS; DIFFERENTIATION; EXPRESSION; INDUCTION; INFLAMMATION; RESPONSES; GENES	CD4(+) T helper (Th) differentiation is regulated by diverse inputs, including the vitamin A metabolite retinoic acid (RA). RA acts through its receptor RAR alpha to repress transcription of inflammatory cytokines, but is also essential for Th-mediated immunity, indicating complex effects of RA on Th specification and the outcome of the immune response. We examined the impact of RA on the genome-wide transcriptional response during Th differentiation to multiple subsets. RA effects were subset-selective and were most significant in Th9 cells. RA globally antagonized Th9-promoting transcription factors and inhibited Th9 differentiation. RA directly targeted the extended Il9 locus and broadly modified the Th9 epigenome through RAR alpha. RA-RAR alpha activity limited murine Th9-associated pulmonary inflammation, and human allergic inflammation was associated with reduced expression of RA target genes. Thus, repression of the Th9 program is a major function of RA-RAR alpha signaling in Th differentiation, arguing for a role for RA in interleukin 9 (IL-9) related diseases.	[Schwartz, Daniella M.; Yao, Chen; Shih, Han-Yu; Petermann, Franziska; Mikami, Yohei; Jiang, Kan; Davis, Fred P.; Kanno, Yuka; O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Farley, Taylor K.; Richoz, Nathan; Hayes, Erika; Siegel, Richard; Meylan, Francoise] NIAMS, Immunoregulat Sect, Autoimmun Branch, NIH, Rockville, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Off Sci & Technol, NIH, Rockville, MD 20892 USA; [Laurence, Arian] Univ Oxford, Translat Gastroenterol Unit, Expt Med Div, John Radcliffe Hosp, Oxford, England; [Schwartz, Daniella M.; Zhang, Yuan; Milner, Joshua D.] NIAID, Genenet & Pathogenesis Allergy Sect, Lab Allerg Dis, NIH, Rockville, MD 20892 USA; [Farley, Taylor K.] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, Rockville, MD 20892 USA; [Mikami, Yohei] Keio Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Keio University	Schwartz, DM (corresponding author), NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.; Schwartz, DM (corresponding author), NIAID, Genenet & Pathogenesis Allergy Sect, Lab Allerg Dis, NIH, Rockville, MD 20892 USA.	daniella.schwartz@nih.gov	Kanno, Yuka/B-5802-2013; Siegel, Richard/AAX-1779-2020; Zhang, Yuan/C-7777-2018; MIKAMI, YOHEI/GRJ-8133-2022; Laurence, Arian/A-8770-2009	Kanno, Yuka/0000-0001-5668-9319; Siegel, Richard/0000-0001-5953-9893; Zhang, Yuan/0000-0001-9932-917X; MIKAMI, YOHEI/0000-0001-5104-4415; Farley, Taylor/0000-0002-2375-3422; Yao, Chen/0000-0001-6852-5661; Laurence, Arian/0000-0003-0942-8292; Shih, Han-Yu/0000-0002-7525-5433; Schwartz, Daniella/0000-0002-1660-8438	NIAMS; NIAID; Office of Dietary Supplements (ODS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041159] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Simone, J. Lay, and K. Tinsley (NIAMS) for expert assistance in flow cytometry and the NIAMS LACU staff for technical support. We thank C. Liu and F. Zhang (NHLBI) for generating knockout mouse lines. We thank G. Gutierrez-Cruz and S. Dell'Orso (NIAMS) for deep-sequencing support. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster (NIH). This work was supported by the Intramural Research Programs of NIAMS and NIAID, and by the Office of Dietary Supplements (ODS).	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Arora P, 2002, PEDIATR ALLERGY IMMU, V13, P223, DOI 10.1034/j.1399-3038.2002.00010.x; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Brown CC, 2015, IMMUNITY, V42, P499, DOI 10.1016/j.immuni.2015.02.003; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Clark LB, 1999, J IMMUNOL, V162, P2546; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dong C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.49.pe1; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hu D., 2017, NAT COMMUN, V8; Humblin E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01070-w; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaplan MH, 2017, SEMIN IMMUNOPATHOL, V39, P11, DOI 10.1007/s00281-016-0600-2; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Koh B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07202-0; Kwok SK, 2012, J IMMUNOL, V189, P1062, DOI 10.4049/jimmunol.1102706; Larange A, 2016, ANNU REV IMMUNOL, V34, P369, DOI 10.1146/annurev-immunol-041015-055427; le Maire A, 2014, SUBCELL BIOCHEM, V70, P37, DOI 10.1007/978-94-017-9050-5_3; Lee W, 2015, IMMUNOL CELL BIOL, V93, P472, DOI 10.1038/icb.2014.104; Li H, 2013, AM J RESP CRIT CARE, V187, P812, DOI 10.1164/rccm.201211-2073OC; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Malik S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00995; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Maret M, 2007, J NUTR, V137, P2730, DOI 10.1093/jn/137.12.2730; Marquez Hector A, 2016, Mol Cell Pediatr, V3, P28, DOI 10.1186/s40348-016-0054-6; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mizutani N, 2015, EUR J PHARMACOL, V764, P149, DOI 10.1016/j.ejphar.2015.07.004; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nous S, 2010, AM J RESP CRIT CARE, V181, P1318, DOI 10.1164/rccm.200909-1396OC; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pedersen MB, 2007, J INVEST DERMATOL, V127, P2585, DOI 10.1038/sj.jid.5700902; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Rampal R, 2016, J LEUKOCYTE BIOL, V100, P111, DOI 10.1189/jlb.3VMA1015-476R; Raverdeau M, 2014, J IMMUNOL, V192, P2953, DOI 10.4049/jimmunol.1303245; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Richard AC, 2015, J IMMUNOL, V194, P3567, DOI 10.4049/jimmunol.1401220; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Sehra S, 2015, J ALLERGY CLIN IMMUN, V136, P433, DOI 10.1016/j.jaci.2015.01.021; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Su P, 2016, J IMMUNOL, V197, P1054, DOI 10.4049/jimmunol.1502457; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Troy NM, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0171-z; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xiao X, 2018, J EXP MED, V215, P559, DOI 10.1084/jem.20170928; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	68	31	33	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					106	+		10.1016/j.immuni.2018.12.014	http://dx.doi.org/10.1016/j.immuni.2018.12.014			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650370	Green Accepted, Bronze			2022-12-18	WOS:000455661600014
J	Becher, B; Waisman, A; Lu, LF				Becher, Burkhard; Waisman, Ari; Lu, Li-Fan			Conditional Gene-Targeting in Mice: Problems and Solutions	IMMUNITY			English	Letter									[Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Obere Zahlbacher Str 67, D-55131 Mainz, Germany; [Lu, Li-Fan] Univ Calif San Diego, Div Biol Sci, Ctr Microbiome Innovat, San Diego, CA 92093 USA; [Lu, Li-Fan] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92093 USA	University of Zurich; Johannes Gutenberg University of Mainz; University of California System; University of California San Diego; University of California System; University of California San Diego	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Lu, Li-Fan/0000-0002-9727-0036	NIAID NIH HHS [R01 AI108651, R21 AI140095, R56 AI127751] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108651, R21AI140095, R56AI127751] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479	10	31	34	4	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					835	836		10.1016/j.immuni.2018.05.002	http://dx.doi.org/10.1016/j.immuni.2018.05.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768166	Bronze, Green Accepted			2022-12-18	WOS:000432488600001
J	Glasner, A; Levi, A; Enk, J; Isaacson, B; Viukov, S; Orlanski, S; Scope, A; Neuman, T; Enk, CD; Hanna, JH; Sexl, V; Jonjic, S; Seliger, B; Zitvogel, L; Mandelboim, O				Glasner, Ariella; Levi, Assi; Enk, Jonatan; Isaacson, Batya; Viukov, Sergey; Orlanski, Shari; Scope, Alon; Neuman, Tzahi; Enk, Claes D.; Hanna, Jacob H.; Sexl, Veronika; Jonjic, Stipan; Seliger, Barbara; Zitvogel, Laurence; Mandelboim, Ofer			NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis (vol 48, pg 107, 2018)	IMMUNITY			English	Correction												oferm@ekmd.huji.ac.il	levi, assi/AAM-1613-2021; Jonjic, Stipan/C-5657-2016	Jonjic, Stipan/0000-0001-5003-3108; ZITVOGEL, laurence/0000-0003-1596-0998; Seliger, Barbara/0000-0002-5544-4958; Mandelboim, Ofer/0000-0002-9354-1855; Scope, Alon/0000-0001-9160-7411				Glasner A, 2018, IMMUNITY, V48, P107, DOI 10.1016/j.immuni.2017.12.007	1	31	33	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					396	398		10.1016/j.immuni.2018.01.010	http://dx.doi.org/10.1016/j.immuni.2018.01.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466761	Green Published, Bronze			2022-12-18	WOS:000425507800023
J	Riquelme, SA; Hopkins, BD; Wolfe, AL; DiMango, E; Kitur, K; Parsons, R; Prince, A				Riquelme, Sebastian A.; Hopkins, Benjamin D.; Wolfe, Andrew L.; DiMango, Emily; Kitur, Kipyegon; Parsons, Ramon; Prince, Alice			Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity	IMMUNITY			English	Article							PHE508DEL CFTR; INFLAMMATION; INFECTION; CANCER; PHOSPHORYLATION; PHOSPHATASE; RECEPTOR; 3-KINASE; CELLS; MACROPHAGES	The tumor suppressor PTEN controls cell proliferation by regulating phosphatidylinositol-3-kinase (PI3K) activity, but the participation of PTEN in host defense against bacterial infection is less well understood. Anti-inflammatory PI3K-Akt signaling is suppressed in patients with cystic fibrosis (CF), a disease characterized by hyper-inflammatory responses to airway infection. We found that Ptenl(-/-) mice, which lack the NH2-amino terminal splice variant of PTEN, were unable to eradicate Pseudomonas aeruginosa from the airways and could not generate sufficient anti-inflammatory PI3K activity, similar to what is observed in CF. PTEN and the CF transmembrane conductance regulator (CFTR) interacted directly and this interaction was necessary to position PTEN at the membrane. CF patients under corrector-potentiator therapy, which enhances CFTR transport to the membrane, have increased PTEN amounts. These findings suggest that improved CFTR trafficking could enhance P. aeruginosa clearance from the CF airway by activating PTEN-mediated anti-bacterial responses and might represent a therapeutic strategy.	[Riquelme, Sebastian A.; Kitur, Kipyegon; Prince, Alice] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Hopkins, Benjamin D.] Weill Cornell Med, Meyer Canc Ctr, New York, NY 10021 USA; [Wolfe, Andrew L.; Parsons, Ramon] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [DiMango, Emily] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Cornell University; Icahn School of Medicine at Mount Sinai; Columbia University	Prince, A (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10032 USA.	asp7@columbia.edu		Parsons, Ramon/0000-0002-6656-3514; Wolfe, Andrew/0000-0003-0418-716X	NIH [1R35HL135800, R01CA184016]; CFF [17F0/PG008837]; Damon Runyon Cancer Research Foundation [DRG-2214-15]; CFFT [CFFDIMANG14YO]; CFF Center [CFFCC021-16AD229]; NATIONAL CANCER INSTITUTE [R01CA184016] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001873] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135800] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF; Damon Runyon Cancer Research Foundation; CFFT; CFF Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A.P. is supported by NIH 1R35HL135800. S.A.R. is supported by a CFF Post-doctoral fellowship CFF RIQUEL 17F0/PG008837. R.P. is supported by NIH R01CA184016. A.L.W. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2214-15). E.D. is supported by a CFFT grant CFFDIMANG14YO and CFF Center grant CFFCC021-16AD229. Research reported in this publication was performed in the CCTI Flow Cytometry Core at CUMC, NIH (S10RR027050).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Bae Yoe-Sik, 2017, Advances in Biological Regulation, V63, P92, DOI 10.1016/j.jbior.2016.09.006; Bonfield TL, 2012, J LEUKOCYTE BIOL, V92, P1111, DOI 10.1189/jlb.0412188; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Doukas J, 2009, J PHARMACOL EXP THER, V328, P758, DOI 10.1124/jpet.108.144311; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Elborn JS, 2016, LANCET RESP MED, V4, P617, DOI 10.1016/S2213-2600(16)30121-7; Geborek A, 2011, J CYST FIBROS, V10, P187, DOI 10.1016/j.jcf.2011.01.005; Gosselin D, 1998, AM J RESP CRIT CARE, V157, P1253, DOI 10.1164/ajrccm.157.4.9702081; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Hector A, 2015, AM J RESP CRIT CARE, V191, P914, DOI 10.1164/rccm.201407-1381OC; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Huang GC, 2012, J BIOL CHEM, V287, P23196, DOI 10.1074/jbc.M112.351940; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kral JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23034; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liu F, 2017, CELL, V169, pe88 ; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Lording A, 2006, J CYST FIBROS, V5, P101, DOI 10.1016/j.jcf.2005.11.005; Maisonneuve P, 2013, JNCI-J NATL CANCER I, V105, P122, DOI 10.1093/jnci/djs481; Naguib A, 2015, MOL CELL, V58, P255, DOI 10.1016/j.molcel.2015.03.011; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Perez-Garcia V, 2014, MOL CELL BIOL, V34, P3359, DOI 10.1128/MCB.00167-14; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rehman A, 2015, NEW ENGL J MED, V373, P1783, DOI 10.1056/NEJMc1510466; Sapey E, 2011, AM J RESP CRIT CARE, V183, P1176, DOI 10.1164/rccm.201008-1285OC; Schabbauer G, 2010, J IMMUNOL, V185, P468, DOI 10.4049/jimmunol.0902221; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Than BLN, 2016, ONCOGENE, V35, P4191, DOI 10.1038/onc.2015.483; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Xie C, 2013, ONCOGENE, V32, P2282, DOI 10.1038/onc.2012.251; Zaidi AH, 2016, BIOCHEM J, V473, P859, DOI 10.1042/BJ20150624; Zhang PX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7221; Zhang PX, 2013, J IMMUNOL, V190, P5196, DOI 10.4049/jimmunol.1201607	52	31	31	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1169	+		10.1016/j.immuni.2017.11.010	http://dx.doi.org/10.1016/j.immuni.2017.11.010			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29246444	Green Accepted, Bronze			2022-12-18	WOS:000418486500019
J	Pimenova, AA; Marcora, E; Goate, AM				Pimenova, Anna A.; Marcora, Edoardo; Goate, Alison M.			A Tale of Two Genes: Microglial Apoe and Trem2	IMMUNITY			English	Editorial Material							ALZHEIMERS-DISEASE; DEFICIENCY; MODEL	Microglial cell function is implicated in the etiology of Alzheimer's disease by human genetics. In this issue of Immunity, Krasemann et al. (2017) describe a gene expression signature associated with an APOE- and TREM2-dependent response of microglia to brain tissue damage that accumulates in aging and disease, defining an axis that might be amenable to therapeutic targeting.	[Pimenova, Anna A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Marcora, Edoardo; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Pimenova, Anna A.; Marcora, Edoardo; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Pimenova, Anna A.; Marcora, Edoardo; Goate, Alison M.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA.	alison.goate@mssm.edu		Goate, Alison/0000-0002-0576-2472; Pimenova, Anna/0000-0003-3342-8778; Marcora, Edoardo/0000-0002-3829-4927	NIA NIH HHS [RF1 AG054011] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [RF1AG054011] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015	10	31	31	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					398	400		10.1016/j.immuni.2017.08.015	http://dx.doi.org/10.1016/j.immuni.2017.08.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930654	Bronze			2022-12-18	WOS:000411128200005
J	Purbey, PK; Scumpia, PO; Kim, PJ; Tong, AJ; Iwamoto, KS; McBride, WH; Smale, ST				Purbey, Prabhat K.; Scumpia, Philip O.; Kim, Peter J.; Tong, Ann-Jay; Iwamoto, Keisuke S.; McBride, William H.; Smale, Stephen T.			Defined Sensing Mechanisms and Signaling Pathways Contribute to the Global Inflammatory Gene Expression Output Elicited by Ionizing Radiation	IMMUNITY			English	Article							DNA-DAMAGE; TRANSCRIPTION FACTORS; ATM; PHOSPHORYLATION; KINASE; TARGET; P53; ACTIVATION; MACROPHAGE; RESPONSES	Environmental insults are often detected by multiple sensors that activate diverse signaling pathways and transcriptional regulators, leading to a tailored transcriptional output. To understand how a tailored response is coordinated, we examined the inflammatory response elicited in mouse macrophages by ionizing radiation (IR). RNA-sequencing studies revealed that most radiation-induced genes were strongly dependent on only one of a small number of sensors and signaling pathways, notably the DNA damage-induced kinase ATM, which regulated many IR-response genes, including interferon response genes, via an atypical IRF1-dependent, STING-independent mechanism. Moreover, small, defined sets of genes activated by p53 and NRF2 accounted for the selective response to radiation in comparison to a microbial inducer of inflammation. Our findings reveal that genes comprising an environmental response are activated by defined sensing mechanisms with a high degree of selectivity, and they identify distinct components of the radiation response that might be susceptible to therapeutic perturbation.	[Purbey, Prabhat K.; Tong, Ann-Jay; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Purbey, Prabhat K.; Tong, Ann-Jay; Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Scumpia, Philip O.; Kim, Peter J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Iwamoto, Keisuke S.; McBride, William H.] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu		Purbey, Prabhat/0000-0001-6373-6283	NIH [R01GM086372, P50AR063020, K08AR066545, K08AR062593, U19AI067769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR066545, K08AR062593, P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Garcia for maintaining mouse colonies, X. Liu for help with ChIP-seq optimization, L. Smale for designing the model figures, and the UCLA Broad Stem Cell Research Center Core for sequencing. This work was supported by NIH grants R01GM086372 (S.T.S.), P50AR063020 (S.T.S.), K08AR066545 (P.O.S.), K08AR062593 (P.J.K.), and U19AI067769 (W.H.M).	Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anuranjani, 2014, REDOX BIOL, V2, P832, DOI 10.1016/j.redox.2014.02.008; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bartoletti-Stella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.187; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Candeias SM, 2015, CANCER LETT, V368, P173, DOI 10.1016/j.canlet.2015.02.007; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Dempsey A, 2015, VIROLOGY, V479, P146, DOI 10.1016/j.virol.2015.03.013; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dong XR, 2015, INT J RADIAT BIOL, V91, P224, DOI 10.3109/09553002.2014.988895; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Gannon HS, 2012, CANCER CELL, V21, P668, DOI 10.1016/j.ccr.2012.04.011; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Groves AM, 2015, RADIAT RES, V184, P639, DOI 10.1667/RR14178.1; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heslet L, 2012, INT J GEN MED, V5, P105, DOI 10.2147/IJGM.S22177; Homer MJ, 2016, RADIAT PROT DOSIM, V171, P85, DOI 10.1093/rpd/ncw226; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kozlov SV, 2016, MOL CELL PROTEOMICS, V15, P1032, DOI 10.1074/mcp.M115.055723; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SJ, 1998, ONCOGENE, V17, P1821, DOI 10.1038/sj.onc.1202088; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lo PK, 2001, J BIOL CHEM, V276, P37186, DOI 10.1074/jbc.M104701200; Lorimore SA, 2001, ONCOGENE, V20, P7085, DOI 10.1038/sj.onc.1204903; Mboko WP, 2012, J VIROL, V86, P6899, DOI 10.1128/JVI.07119-11; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rashi-Elkeles S, 2011, MOL ONCOL, V5, P336, DOI 10.1016/j.molonc.2011.06.004; Rosen EM, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00381; RStudio Team, 2015, RSTUDIO INT DEV ENV; Ryoo IG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2428153; SALKOWSKI CA, 1995, J IMMUNOL, V155, P3168; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schaue D, 2010, RADIAT RES, V173, P406, DOI 10.1667/RR1931.1; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	59	31	33	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					421	+		10.1016/j.immuni.2017.08.017	http://dx.doi.org/10.1016/j.immuni.2017.08.017			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930658	Bronze, Green Accepted			2022-12-18	WOS:000411128200009
